Citrus Sinensis ID: 005226
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9N5 | 685 | Probable inactive leucine | no | no | 0.953 | 0.983 | 0.388 | 1e-140 | |
| Q94C77 | 757 | Receptor protein kinase-l | no | no | 0.940 | 0.878 | 0.358 | 1e-106 | |
| C0LGS3 | 768 | Probable LRR receptor-lik | no | no | 0.949 | 0.873 | 0.353 | 1e-105 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.845 | 0.762 | 0.328 | 5e-83 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.844 | 0.932 | 0.326 | 3e-78 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.824 | 0.870 | 0.337 | 1e-77 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.834 | 0.921 | 0.309 | 3e-77 | |
| Q9SCT4 | 836 | Probably inactive leucine | no | no | 0.797 | 0.674 | 0.349 | 3e-76 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.768 | 0.825 | 0.347 | 3e-75 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.827 | 0.894 | 0.318 | 2e-74 |
| >sp|Q9C9N5|Y1668_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 OS=Arabidopsis thaliana GN=At1g66830 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 500 bits (1288), Expect = e-140, Method: Compositional matrix adjust.
Identities = 278/716 (38%), Positives = 418/716 (58%), Gaps = 42/716 (5%)
Query: 1 MKNSFFFPFFL--YFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGI 58
M F F+ +F + +L+ GL LLS K +I SVF +WN +D PC W G+
Sbjct: 1 MSQLFLILCFILTHFFAIATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGV 60
Query: 59 SCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATS 118
+C D RVV + + K + G + +GSL+ LR +NL +N+ G LP +LF
Sbjct: 61 TCNY-----DMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKG 115
Query: 119 LHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
L S+ L GN+ SG +P + +L L LDLS NSF+GS+ L CK+L+ L+L++N FS
Sbjct: 116 LQSLVLSGNSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFS 175
Query: 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL 238
G +P G+ L +L L+LS N G IP D+G L++L TL+LS+N SG IP SLGNL
Sbjct: 176 GDLPTGLGSNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNL 235
Query: 239 PVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPS 298
P + DL NNLSG IP+ N GP AF NP LCG P++ SC ST + Q
Sbjct: 236 PELLYVDLSYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISC--STRNTQVV---- 289
Query: 299 PDSDKSKKKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDS------NGGCSCTVKS 352
P +++ L ++++A +I L +++Y+ +K S +C +
Sbjct: 290 PSQLYTRRANHHSRLCIILTATGGTVAGIIFLASLFIYYLRKASARANKDQNNRTCHINE 349
Query: 353 KFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASA 412
K F +C F+ +SE E ++ K + + +D F+LD+LL+ASA
Sbjct: 350 KLKKTTKPEF---LC---FKTGNSE---SETLDENKNQQVFMPMDPEIEFDLDQLLKASA 400
Query: 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
++LGKS +G+VYKVVL NG+ +AVRRL + G R +EF+ +V+A+AK+KHPN++ L+A
Sbjct: 401 FLLGKSRIGLVYKVVLENGLMLAVRRLEDKGWLRLKEFLADVEAMAKIKHPNVLNLKACC 460
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPST-SLSWSTRLRIAKGTARGLAYLHECSPRK 531
W+P+EKLLI D+I NG+L +A++GR G S L+W+ RL+I +G A+GL Y+HE SP++
Sbjct: 461 WSPEEKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKR 520
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+VHG I SNILL + +P +S FGL R+++ + + S M + P + + +
Sbjct: 521 YVHGHINTSNILLGPNLEPKVSGFGLGRIVDTSSDIRSDQISPMETSSPIL-----SRES 575
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651
Y+APEA +P QKWDVYSFG+V+LE++TGKSP S DLV WV+ E
Sbjct: 576 YYQAPEAASKMTKPSQKWDVYSFGLVILEMVTGKSPVSSEM--------DLVMWVESASE 627
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707
P ++D +L ++ + ++ V + LAC + +P+ RP M++V E+ E++ T
Sbjct: 628 RNKPAWYVLDPVLARDRDLEDSMVQVIKIGLACVQKNPDKRPHMRSVLESFEKLVT 683
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 278/776 (35%), Positives = 401/776 (51%), Gaps = 111/776 (14%)
Query: 9 FFLYFLHLCF------ALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMN 62
F L H F AL+ DG+ LL+ K +I SV +WN +D TPC W+G++C
Sbjct: 10 FSLVLFHFLFVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVTCTE 69
Query: 63 ITGFPDP----RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATS 118
+ G P+ RV + + K++ G I +L S+ YLR L+L +N GSLPD +FNAT
Sbjct: 70 L-GKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNATE 128
Query: 119 LHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
L SI L NNLSG LP SV ++ LQ L+LS N+F+G +P + K L + L++N FS
Sbjct: 129 LQSISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNTFS 188
Query: 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI-PKSLGN 237
G IP+G E LDLS N G +P DLG +SL LNLS+N + G+I P
Sbjct: 189 GDIPSG----FEAAQILDLSSNLLNGSLPKDLGG-KSLHY-LNLSHNKVLGEISPNFAEK 242
Query: 238 LPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCK-DSTESQ----Q 292
P + DL NNL+G IP + S NQ +F N LCG PL+ C ST S
Sbjct: 243 FPANATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLSNPPNIS 302
Query: 293 ETQNPS------------PDSDKSKKKG---LGPGLIVLISAADAAAVAVIGLVIVYVYW 337
ET +P+ P ++K + G L P I I+ AD +A IGL+++YVY
Sbjct: 303 ETTSPAIAVKPRSTAPINPLTEKPNQTGKSKLKPSTIAAITVADIVGLAFIGLLVLYVYQ 362
Query: 338 KKKDSNGGCS--------CTVKSKFGGN-------------ENGSFC-PCVCVNGFR--- 372
+K S C K++ + E + C C+ + G R
Sbjct: 363 VRKRRRYPESSKFSFFKFCLEKNEAKKSKPSTTEVTVPESPEAKTTCGSCIILTGGRYDE 422
Query: 373 --NEDSEVEDQEKVES----------GKGEGELVAIDKGFTFELDELLRASAYVLGKSGL 420
+S+VE+Q+ V++ + +LV +D +LD LL+ASAY+LG +G
Sbjct: 423 TSTSESDVENQQTVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAYILGTTGT 482
Query: 421 GIVYKVVLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK 478
GIVYK VL NG AVRR+ + +EF EV+AIAK++HPN+V++R + W DEK
Sbjct: 483 GIVYKAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFCWGDDEK 542
Query: 479 LLISDFISNGNL--------ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
LLISD++ NG+L A++ + L++ RL+IA+G ARGL+Y++E +
Sbjct: 543 LLISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYINE---K 599
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
K VHG+IKP+NILL+ + +P I+D GL RL+ P+ G +
Sbjct: 600 KQVHGNIKPNNILLNAENEPIITDLGLDRLM-----TPARESHTTGPT----------SS 644
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ Y+ PE +P KWDVYSFGV+LLELLT K S ++
Sbjct: 645 SPYQPPEWST-SLKPNPKWDVYSFGVILLELLTSK------VFSVDHDIDQFSNLSDSAA 697
Query: 651 EEENPLSDMVDAMLLQEVHAKKE-VIAVFHLALACTEADPEVRPRMKNVSENLERI 705
EE ++D + +V ++ +A F L + C + P+ RP MK + + LE+I
Sbjct: 698 EENGRFLRLIDGAIRSDVARHEDAAMACFRLGIECVSSLPQKRPSMKELVQVLEKI 753
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGS3|Y4372_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g37250 OS=Arabidopsis thaliana GN=At4g37250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (981), Expect = e-105, Method: Compositional matrix adjust.
Identities = 275/777 (35%), Positives = 386/777 (49%), Gaps = 106/777 (13%)
Query: 4 SFFFPFFLYFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNI 63
S F FF L AL+ DGL L+ KS++ S+ WN +PC W GISC N
Sbjct: 7 SVIFFFFCSVLS-SSALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISCNN- 64
Query: 64 TGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIF 123
D +V+ +++ + G IPS+LGSL+ L+ L+L NN+ G LP FNA L +
Sbjct: 65 ----DSKVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLD 120
Query: 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA 183
L N +SG +P ++ +L L L+LS+N+ +G LP L + + L + L N FSG+IP
Sbjct: 121 LSSNMISGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPG 180
Query: 184 GIWPELENLVQLDLSDNDFKGPIPNDLG--ELQSLSATLNLSYNHLSGKIPKSLG-NLPV 240
G W +E LDLS N G +P D G LQ LN+S+N +SG+IP +G N P
Sbjct: 181 G-WRVVE---FLDLSSNLINGSLPPDFGGYSLQ----YLNVSFNQISGEIPPEIGVNFPR 232
Query: 241 TVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSC------KDSTESQQET 294
V+ DL NNL+G IP + F NQ F NP LCG P + C +E+ T
Sbjct: 233 NVTVDLSFNNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVPT 292
Query: 295 QNP------------------SPDSDKSKKKGLGPGLIVLISAADAAAVAVIGLVIVYVY 336
P S +D + + GL PG+I+ I D A + ++ ++ +Y+Y
Sbjct: 293 STPAIAAIPNTIGSNPVTDPNSQQTDPNPRTGLRPGVIIGIVVGDIAGIGILAVIFLYIY 352
Query: 337 WKKK------DSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESG--- 387
KK ++N + + S FR +D E S
Sbjct: 353 RCKKNKIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRKDPETTPSEEED 412
Query: 388 ---------------KGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGI 432
G+ +LV +D E++ LL+ASAY+LG +G I+YK VL +G
Sbjct: 413 EDDEDEESGYNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGR 472
Query: 433 PVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
AVRRLGE G ++R ++F ++AI K+ HPN+V+L +YW DEKL+I DF+ NG+L
Sbjct: 473 VFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSL 532
Query: 491 ANALRGRNGQPSTS---LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND 547
N R R G S+S L W TRL+IAKG ARGLAYLHE +K VHG++KPSNILL +D
Sbjct: 533 VNP-RYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHD 588
Query: 548 FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK------------------ 589
+P I DFGL RL +TG G + + +
Sbjct: 589 MEPKIGDFGLERL--LTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGA 646
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649
+ Y APE+ +P KWDVY FGV+LLELLTGK + V ++V
Sbjct: 647 MSPYCAPES-FRSLKPSPKWDVYGFGVILLELLTGK----------IVSVEEIVLGNGLT 695
Query: 650 FEEENPLSDMVDAMLLQEVHAKKE-VIAVFHLALACTEADPEVRPRMKNVSENLERI 705
E+ + M D + E+ K+E ++ F L +C P+ RP MK LER
Sbjct: 696 VEDGHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERF 752
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 244/742 (32%), Positives = 363/742 (48%), Gaps = 144/742 (19%)
Query: 45 WNENDPTPCR--WSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHN 102
WN + + C W+GI C +V+ + + K++ G I ++G L LR+L+LH+
Sbjct: 81 WNGSGFSACSGGWAGIKC------AQGQVIVIQLPWKSLGGRISEKIGQLQALRKLSLHD 134
Query: 103 NNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLK 162
NNL GS+P L +L + L+ N L+GS+P S+ LQ LDLSNN S +P L
Sbjct: 135 NNLGGSIPMSLGLIPNLRGVQLFNNRLTGSIPASLGVSHFLQTLDLSNNLLSEIIPPNLA 194
Query: 163 NCKQLQRLILARNKFSGQIP---------------------------------------- 182
+ +L RL L+ N SGQIP
Sbjct: 195 DSSKLLRLNLSFNSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSLD 254
Query: 183 ----AGIWP-ELENLVQLD---LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKS 234
+G +P L NL QL S N +G +P++L +L L +++S N +SG IP++
Sbjct: 255 HNSLSGPFPFSLCNLTQLQDFSFSHNRIRGTLPSELSKLTKLRK-MDISGNSVSGHIPET 313
Query: 235 LGNLPVTVSFDLRGNNLSGEIP------QTGSFAN------QGP-----------TAFLS 271
LGN+ + DL N L+GEIP ++ +F N GP ++F+
Sbjct: 314 LGNISSLIHLDLSQNKLTGEIPISISDLESLNFFNVSYNNLSGPVPTLLSQKFNSSSFVG 373
Query: 272 NPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKK---KGLGPGLIVLISAADAAAVAVI 328
N LLCG+ + C PSP +K +K + L I+LI A+ A + ++
Sbjct: 374 NSLLCGYSVSTPCPTL---------PSPSPEKERKPSHRNLSTKDIILI-ASGALLIVML 423
Query: 329 GLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGK 388
LV V +K +N ++K G E G P ++ E + E+G
Sbjct: 424 ILVCVLCCLLRKKAN-------ETKAKGGEAG---PGAVA-------AKTEKGGEAEAG- 465
Query: 389 GE--GELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR 446
GE G+LV D F D+LL A+A ++GKS G VYK L +G VAV+RL E +
Sbjct: 466 GETGGKLVHFDGPMAFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKITKS 525
Query: 447 HREFVTEVQAIAKVKHPNIVKLRAYYWAPD-EKLLISDFISNGNLANALRGRNGQPSTSL 505
+EF E+ + +++HPN++ LRAYY P EKL++ D++S G+LA L R P +
Sbjct: 526 QKEFENEINVLGRIRHPNLLALRAYYLGPKGEKLVVFDYMSRGSLATFLHARG--PDVHI 583
Query: 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN-IT 564
+W TR+ + KG ARGL YLH + +HG++ SN+LLD + ISD+GLSRL+
Sbjct: 584 NWPTRMSLIKGMARGLFYLH--THANIIHGNLTSSNVLLDENITAKISDYGLSRLMTAAA 641
Query: 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
G++ ++ G +G YRAPE + K DVYS GV++LELLTG
Sbjct: 642 GSSVIATAGALG----------------YRAPELS-KLKKANTKTDVYSLGVIILELLTG 684
Query: 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAK-KEVIAVFHLALA 683
KSP S ++ DL +WV +EE +++ D LL +V+ E++ LAL
Sbjct: 685 KSP------SEALNGVDLPQWVATAVKEEWT-NEVFDLELLNDVNTMGDEILNTLKLALH 737
Query: 684 CTEADPEVRPRMKNVSENLERI 705
C +A P RP + V L I
Sbjct: 738 CVDATPSTRPEAQQVMTQLGEI 759
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 293 bits (751), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 232/710 (32%), Positives = 341/710 (48%), Gaps = 113/710 (15%)
Query: 4 SFFFPFFLYFLHLCFA-LSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMN 62
SFFF L A L+ D LL+ +++ +WN+N W GI+C
Sbjct: 12 SFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPK---LNWNKNLSLCSSWIGITCDE 68
Query: 63 ITGFPDPRVVGVAISGKNVRGYIP-SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHS 121
P RVV V + G + G IP + LG L L+ L+L +N+LFG
Sbjct: 69 SN--PTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFG-------------- 112
Query: 122 IFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLP-DGLKNC-KQLQRLILARNKFSG 179
+LP + +LP L+ L L +N+FSG L + L + KQL L L+ N SG
Sbjct: 113 ----------TLPSDILSLPSLEYLYLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSG 162
Query: 180 QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLP 239
IP+G+ L + L L +N F GPI D +L S+ +NLSYN+LSG IP+ L P
Sbjct: 163 NIPSGLR-NLSQITVLYLQNNSFDGPI--DSLDLPSVKV-VNLSYNNLSGPIPEHLKKSP 218
Query: 240 VTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSP 299
+F+ N LLCG PL + P
Sbjct: 219 --------------------------EYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLT 252
Query: 300 DSDKSKKKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNEN 359
++ ++ I+ I + AV +G+V + KK G V+++ GG
Sbjct: 253 ENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVRTQMGG--- 309
Query: 360 GSFCPCVCVNGFRNED--SEVEDQEKVESGKGEGELVAIDK-GFTFELDELLRASAYVLG 416
VN + +D S V+D EK +L ++ F+L++LL+ASA VLG
Sbjct: 310 --------VNSKKPQDFGSGVQDPEK-------NKLFFFERCNHNFDLEDLLKASAEVLG 354
Query: 417 KSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP 475
K G YK VL + V V+RL E + +EF +++ + K+ +H N V L AYY++
Sbjct: 355 KGSFGTAYKAVLEDTTAVVVKRLREVVASK-KEFEQQMEIVGKINQHSNFVPLLAYYYSK 413
Query: 476 DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHG 535
DEKLL+ +++ G+L + G G + W TR++IA GT++ ++YLH KFVHG
Sbjct: 414 DEKLLVYKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL---KFVHG 468
Query: 536 DIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRA 595
DIK SNILL D +P +SD L L N+ P T +T Y A
Sbjct: 469 DIKSSNILLTEDLEPCLSDTSLVTLFNL--------------------PTHTPRTIGYNA 508
Query: 596 PEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENP 655
PE + R Q+ DVYSFGVV+LE+LTGK+P P V DL RWV+ EE
Sbjct: 509 PEV-IETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWT 567
Query: 656 LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+++ D LL+ + ++E++ + LALAC +PE RP+M+ V+ +E +
Sbjct: 568 -AEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDV 616
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (745), Expect = 1e-77, Method: Compositional matrix adjust.
Identities = 238/706 (33%), Positives = 342/706 (48%), Gaps = 123/706 (17%)
Query: 23 DGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVR 82
D TLL+ K D T WN PC+W+G+SC RV + + N+
Sbjct: 31 DSETLLNFKLTADSTGK--LNSWNTTT-NPCQWTGVSCNR------NRVTRLVLEDINLT 81
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
G I S L SL LR L+L +NNL G +P+ L N T+L +FL N SG+ P S+ +L R
Sbjct: 82 GSI-SSLTSLTSLRVLSLKHNNLSGPIPN-LSNLTALKLLFLSNNQFSGNFPTSITSLTR 139
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L LDLS N+FSG +P L + L L L N+FSGQIP N+ DL D +
Sbjct: 140 LYRLDLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIP--------NINLSDLQDFNV 191
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA 262
G N+ +G+IP SL P +V
Sbjct: 192 SG--------------------NNFNGQIPNSLSQFPESV-------------------- 211
Query: 263 NQGPTAFLSNPLLCGFPLQKSCKDSTE---------------SQQETQNPSPDS----DK 303
F NP LCG PL K K S++ ++ ET SP S DK
Sbjct: 212 ------FTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDK 265
Query: 304 SKKKG-LGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSF 362
S + ++ I D ++ + L++ Y +W++ N K K G
Sbjct: 266 SNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVN-------KKKHSKILEGE- 317
Query: 363 CPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGI 422
+ + S + + + +G++V + FEL++LLRASA +LGK G G
Sbjct: 318 --KIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGT 375
Query: 423 VYKVVLGNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLI 481
YK VL +G VAV+RL + +EF +++ + +++H N+V L+AYY+A +EKLL+
Sbjct: 376 AYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLV 435
Query: 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH-ECSPRKFVHGDIKPS 540
D++ NG+L L G G T L W+TRL+IA G ARGLA++H C K HGDIK +
Sbjct: 436 YDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKST 495
Query: 541 NILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT-EKTNNYRAPEAR 599
N+LLD +SDFGLS P QT K+N YRAPE
Sbjct: 496 NVLLDRSGNARVSDFGLS----------------------IFAPSQTVAKSNGYRAPEL- 532
Query: 600 VPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDM 659
+ G + QK DVYSFGV+LLE+LTGK P + T + V DL RWV+ EE +++
Sbjct: 533 IDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAV-DLPRWVQSVVREE-WTAEV 590
Query: 660 VDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
D L++ ++E++ + +A+ACT + RP+M +V + +E I
Sbjct: 591 FDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDI 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 223/720 (30%), Positives = 336/720 (46%), Gaps = 130/720 (18%)
Query: 4 SFFFPFFLYFLHLCFA--LSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCM 61
+F F F+ C + + D LL S + + +WN P W+GI+C
Sbjct: 7 AFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRK---LNWNSTIPICASWTGITC- 62
Query: 62 NITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNAT-SLH 120
S N R + L L + L+G LP++ F +L
Sbjct: 63 ---------------SKNNAR------------VTALRLPGSGLYGPLPEKTFEKLDALR 95
Query: 121 SIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQ 180
I L N+L G++P + +LP +++L N+FSG++P L + +L L L+ N SG
Sbjct: 96 IISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPVLSH--RLVNLDLSANSLSGN 153
Query: 181 IPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPV 240
IP + L L L L +N GPIPN L+ LNLS+N+L+G +P S+ + P
Sbjct: 154 IPTSLQ-NLTQLTDLSLQNNSLSGPIPNLPPRLK----YLNLSFNNLNGSVPSSVKSFPA 208
Query: 241 TVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPD 300
+ +F N LLCG PL T + T PSP
Sbjct: 209 S--------------------------SFQGNSLLCGAPL-------TPCPENTTAPSPS 235
Query: 301 SDK-------------SKKKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCS 347
+ KK L G IV I+ + + +I +I KK+D +
Sbjct: 236 PTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDST 295
Query: 348 CTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDEL 407
K+K G ++N + S V++ EK + EG + F+L++L
Sbjct: 296 AVPKAKPGRSDNKA----------EEFGSGVQEAEKNKLVFFEG------SSYNFDLEDL 339
Query: 408 LRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIV 466
LRASA VLGK G YK +L G V V+RL E + REF +++A+ ++ H N+
Sbjct: 340 LRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGK-REFEQQMEAVGRISPHVNVA 398
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
LRAYY++ DEKLL+ D+ GN + L G N +L W TRLRI ARG++++H
Sbjct: 399 PLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHS 458
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
S K +HG+IK N+LL + +SDFG++ L++ PS S G
Sbjct: 459 ASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLG------------- 505
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
YRAPEA + + QK DVYSFGV+LLE+LTGK+ + T+ EV DL +WV
Sbjct: 506 ------YRAPEA-IETRKHTQKSDVYSFGVLLLEMLTGKA---AGKTTGHEEVVDLPKWV 555
Query: 647 KKGFEEENPLSDMVDAMLLQEVH-AKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ EE ++ D L+++ H ++E++ + +A+AC P+ RP M+ V +E I
Sbjct: 556 QSVVREEW-TGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEI 614
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 215/615 (34%), Positives = 305/615 (49%), Gaps = 51/615 (8%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154
L+ LNL +N G++P L + L + + N LSGS+P LP LQ+LD S NS +
Sbjct: 241 LKTLNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSIN 300
Query: 155 GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQ 214
G++PD N L L L N G IP I L NL +L+L N GPIP +G +
Sbjct: 301 GTIPDSFSNLSSLVSLNLESNHLKGPIPDAI-DRLHNLTELNLKRNKINGPIPETIGNIS 359
Query: 215 SLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274
+ L+LS N+ +G IP SL +L SF++ N LSG +P S ++FL N
Sbjct: 360 GIKK-LDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLS-KKFNSSSFLGNIQ 417
Query: 275 LCGFPLQKSCKDSTESQQETQNPSPDSD--KSKKKGLGPGLIVLISAADAAAVAVIGLVI 332
LCG+ C T +P+ + K + L ++LI+ A+ ++ I
Sbjct: 418 LCGYSSSNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIAIGALLAILLLLCCI 477
Query: 333 VYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGE 392
+ KK + +K K G ++ V G + E+ G+
Sbjct: 478 LLCCLIKKRA------ALKQKDGKDKTSEKTVSAGVAGTASAGGEMG-----------GK 520
Query: 393 LVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVT 452
LV D F F D+LL A+A ++GKS G YK L +G VAV+RL E + +EF
Sbjct: 521 LVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEG 580
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPD-EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
EV A+ K++H N++ LRAYY P EKLL+ D++S G+L+ L R P T + W TR+
Sbjct: 581 EVTALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHARG--PETLIPWETRM 638
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
+IAKG +RGLA+LH S +H ++ SNILLD +I+D+GLSRL+
Sbjct: 639 KIAKGISRGLAHLH--SNENMIHENLTASNILLDEQTNAHIADYGLSRLMT--------- 687
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631
A + T T YRAPE N K DVYS G+++LELLTGKSP P
Sbjct: 688 ------AAAATNVIATAGTLGYRAPEFSKIKNASA-KTDVYSLGIIILELLTGKSPG-EP 739
Query: 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHA-KKEVIAVFHLALACTEADPE 690
T DL +WV +EE +++ D L++E + E++ LAL C + P
Sbjct: 740 TNGM-----DLPQWVASIVKEE-WTNEVFDLELMRETQSVGDELLNTLKLALHCVDPSPA 793
Query: 691 VRPRMKNVSENLERI 705
RP V E LE I
Sbjct: 794 ARPEANQVVEQLEEI 808
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (725), Expect = 3e-75, Method: Compositional matrix adjust.
Identities = 210/604 (34%), Positives = 307/604 (50%), Gaps = 61/604 (10%)
Query: 115 NATSLHSIFLYGNNLSGSLPP-SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILA 173
N +S+HS+ L G L G +P S+ L L+ L L +N SG +P N L+ L L
Sbjct: 64 NQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQ 123
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPK 233
N+FSG+ P + +L NL++LD+S N+F G IP + L L+ L L N SG +P
Sbjct: 124 HNEFSGEFPTS-FTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTG-LFLGNNGFSGNLPS 181
Query: 234 -SLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQ 292
SLG V F++ NNL+G IP S + +F N LCG PL K CK S
Sbjct: 182 ISLG----LVDFNVSNNNLNGSIPS--SLSRFSAESFTGNVDLCGGPL-KPCKSFFVS-- 232
Query: 293 ETQNPSPDSDKSKKKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKS 352
PSP + P + + + A++ +++ ++
Sbjct: 233 ----PSPSPSL-----INPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRK 283
Query: 353 KFGGNENGSFCPCVCVNGFRNED------SEVEDQEKVESGKG----EGELVAIDKG-FT 401
+ G NE + P RN D S E+ SG G +LV + G ++
Sbjct: 284 RRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYS 343
Query: 402 FELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK 461
F+L++LLRASA VLGK +G YK VL G V V+RL + + +EF T+++ + K+K
Sbjct: 344 FDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASK-KEFETQMEVVGKIK 402
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
HPN++ LRAYY++ DEKLL+ DF+ G+L+ L G G T L W R+RIA ARGL
Sbjct: 403 HPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGL 462
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
A+LH + K VHG+IK SNILL + +SD+GL++L +N S G
Sbjct: 463 AHLHVSA--KLVHGNIKASNILLHPNQDTCVSDYGLNQLF----SNSSPPNRLAG----- 511
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641
Y APE + + K DVYSFGV+LLELLTGKSP + I++P
Sbjct: 512 -----------YHAPEV-LETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLP- 558
Query: 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701
RWV EE +++ D L++ + ++E++ + +A+AC P+ RP M+ V
Sbjct: 559 --RWVLSVVREE-WTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRM 615
Query: 702 LERI 705
+E +
Sbjct: 616 IEDV 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 229/718 (31%), Positives = 345/718 (48%), Gaps = 133/718 (18%)
Query: 4 SFFFPFFLYFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNI 63
SF F + + L+ D LL+ +++ +WN + W G++C +
Sbjct: 29 SFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRR---LNWNSTNHICKSWVGVTCTSD 85
Query: 64 -TGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSI 122
T R+ G+ + G P+ LG L LR L+L +N L
Sbjct: 86 GTSVHALRLPGIGLLGP----IPPNTLGKLESLRILSLRSNLL----------------- 124
Query: 123 FLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP 182
SG+LPP + +LP L + L +N+FSG +P + +QL L L+ N F+G+IP
Sbjct: 125 -------SGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVS--RQLNILDLSFNSFTGKIP 175
Query: 183 AGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLS-ATLNLSYNHLSGKIPKSLGNLPVT 241
A + L+ L L L +N GP+PN L ++S LNLS NHL+G IP +LG P
Sbjct: 176 A-TFQNLKQLTGLSLQNNKLSGPVPN----LDTVSLRRLNLSNNHLNGSIPSALGGFP-- 228
Query: 242 VSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQN----- 296
++F N LLCG PLQ C S+ T +
Sbjct: 229 ------------------------SSSFSGNTLLCGLPLQP-CATSSPPPSLTPHISTPP 263
Query: 297 --PSPDSDKSKKKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKF 354
P P + SK+K L I+ I+A AA + +I ++I+ KKKD VK+
Sbjct: 264 LPPFPHKEGSKRK-LHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKT-- 320
Query: 355 GGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGE-----LVAIDK-GFTFELDELL 408
+ ++ K E G G E LV + + F+L++LL
Sbjct: 321 -----------------------LTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLL 357
Query: 409 RASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVK 467
RASA VLGK G YK VL V V+RL E + REF +++ I++V HP++V
Sbjct: 358 RASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGK-REFEQQMEIISRVGNHPSVVP 416
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
LRAYY++ DEKL++ D+ GNL++ L G G T L W +R++I A+G+A+LH
Sbjct: 417 LRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAA 476
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
KF HG+IK SN+++ + ISDFGL+ L+ + P+
Sbjct: 477 GGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAV--------------------PIAP 516
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647
+ YRAPE + + K DVYSFGV++LE+LTGKSP SP+ +++P RWV+
Sbjct: 517 MRGAGYRAPEV-METRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLP---RWVQ 572
Query: 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
EE S++ D L++ + ++E++ + +A+AC PEVRP M +V +E I
Sbjct: 573 SVVREEW-TSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEI 629
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | ||||||
| 255547770 | 810 | protein with unknown function [Ricinus c | 0.958 | 0.837 | 0.822 | 0.0 | |
| 449435464 | 712 | PREDICTED: probable inactive leucine-ric | 0.971 | 0.964 | 0.774 | 0.0 | |
| 449495011 | 694 | PREDICTED: probable inactive leucine-ric | 0.971 | 0.989 | 0.774 | 0.0 | |
| 359473574 | 709 | PREDICTED: probable inactive leucine-ric | 0.950 | 0.947 | 0.776 | 0.0 | |
| 357506189 | 721 | Receptor protein kinase-like protein [Me | 0.971 | 0.952 | 0.742 | 0.0 | |
| 297738391 | 674 | unnamed protein product [Vitis vinifera] | 0.925 | 0.970 | 0.758 | 0.0 | |
| 297841443 | 718 | predicted protein [Arabidopsis lyrata su | 0.967 | 0.952 | 0.732 | 0.0 | |
| 356521068 | 706 | PREDICTED: probable inactive leucine-ric | 0.974 | 0.975 | 0.738 | 0.0 | |
| 356568150 | 706 | PREDICTED: probable inactive leucine-ric | 0.973 | 0.974 | 0.732 | 0.0 | |
| 15220455 | 719 | leucine-rich repeat-like protein [Arabid | 0.968 | 0.952 | 0.717 | 0.0 |
| >gi|255547770|ref|XP_002514942.1| protein with unknown function [Ricinus communis] gi|223545993|gb|EEF47496.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1154 bits (2984), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 564/686 (82%), Positives = 623/686 (90%), Gaps = 8/686 (1%)
Query: 16 LCFALSPDGLTLLSLKSAIDQTD-TSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGV 74
L +LSPDGL+LLSLKSA+DQ D + F+DWNE+DPTPC+W+GISCMN+TGFPDPRVVG+
Sbjct: 26 LIVSLSPDGLSLLSLKSAVDQPDGDNPFSDWNEDDPTPCKWTGISCMNVTGFPDPRVVGI 85
Query: 75 AISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP 134
AISGKN+RGYIPSELG+L+YLRRLNLH+NN +GS+P LFNATSLHS+FLYGNNLSGSLP
Sbjct: 86 AISGKNLRGYIPSELGTLLYLRRLNLHSNNFYGSIPADLFNATSLHSLFLYGNNLSGSLP 145
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
PS+CNLPRLQNLDLSNNS SGSLP+ L NCKQLQRLIL+RNKFSG+IPAGIWPEL+NLVQ
Sbjct: 146 PSICNLPRLQNLDLSNNSLSGSLPENLNNCKQLQRLILSRNKFSGEIPAGIWPELDNLVQ 205
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
LDLSDN+F G IPNDLGEL+SLS TLNLS+N LSG+IPKSLGNLPVTVSFDLR NNL+GE
Sbjct: 206 LDLSDNEFTGSIPNDLGELKSLSNTLNLSFNQLSGRIPKSLGNLPVTVSFDLRNNNLTGE 265
Query: 255 IPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSP---DSDKSKKKGLGP 311
IPQTGSFANQGPTAFL+NPLLCGFPLQKSCKDS++S +QN SP +S+ S KKGL
Sbjct: 266 IPQTGSFANQGPTAFLNNPLLCGFPLQKSCKDSSQSSPASQN-SPQESNSNNSLKKGLSS 324
Query: 312 GLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCP-CVCVNG 370
GLI+LIS DA VA IGLVIVY YWKKKD + GCSCT K+KFGGNE C C CVNG
Sbjct: 325 GLIILISVVDAFGVAFIGLVIVYFYWKKKDDSNGCSCTGKTKFGGNEKHRACALCSCVNG 384
Query: 371 FRNEDSEVEDQEK--VESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL 428
F NEDSE ED EK E GKG+GELVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVL
Sbjct: 385 FSNEDSEAEDIEKAATERGKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVL 444
Query: 429 GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488
GNGIPVAVRRLGEGGEQR++EFV EVQAI KVKHPN+VKLRAYYWAPDEKLLISDFISNG
Sbjct: 445 GNGIPVAVRRLGEGGEQRYKEFVAEVQAIGKVKHPNVVKLRAYYWAPDEKLLISDFISNG 504
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
NLA AL+GR+GQPS SLSW+TRLRIAKGTARGLAYLHECSPRKFVHGD+KPSNILLDN+F
Sbjct: 505 NLAYALKGRSGQPSPSLSWATRLRIAKGTARGLAYLHECSPRKFVHGDVKPSNILLDNEF 564
Query: 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
QP+ISDFGLSRLINITGNNPSSSGGF+GGALPY+K VQ+E+TNNYRAPEARVPGNRP QK
Sbjct: 565 QPHISDFGLSRLINITGNNPSSSGGFIGGALPYLKSVQSERTNNYRAPEARVPGNRPTQK 624
Query: 609 WDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEV 668
WDVYSFGVVLLELLTGKSPELSPTTS SIE+PD+VRWV+KGFEEEN LS+MVD LLQEV
Sbjct: 625 WDVYSFGVVLLELLTGKSPELSPTTSNSIEIPDIVRWVRKGFEEENTLSEMVDPALLQEV 684
Query: 669 HAKKEVIAVFHLALACTEADPEVRPR 694
HAKKEV+A+FH+ALACTEADPE R +
Sbjct: 685 HAKKEVLALFHVALACTEADPERRSK 710
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435464|ref|XP_004135515.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/692 (77%), Positives = 612/692 (88%), Gaps = 5/692 (0%)
Query: 18 FALSPDGLTLLSLKSAIDQT-DTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAI 76
ALSPDGL+LLSLKSA+DQ+ D+SVF+DWNEND TPC+WSGISCMN++G D RVVG+A+
Sbjct: 24 LALSPDGLSLLSLKSAVDQSPDSSVFSDWNENDSTPCQWSGISCMNVSG--DSRVVGIAL 81
Query: 77 SGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPS 136
SGKN+RGYIPSELGSL+YLRRLNLHNNNL+GS+P+QLFNATSLHS+FLY NNLSG PPS
Sbjct: 82 SGKNLRGYIPSELGSLVYLRRLNLHNNNLYGSIPEQLFNATSLHSLFLYSNNLSGPFPPS 141
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+CN+PRLQNLDLSNNS +G +PD L+NCKQLQRLILARN+F G+IP+G+W ++NLVQLD
Sbjct: 142 ICNIPRLQNLDLSNNSLAGPVPDELRNCKQLQRLILARNQFDGEIPSGVWSGMDNLVQLD 201
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
LS NDF G IP DLGEL++LS TLNLS+NHLSGKIPK+LG+LPVTVSFDLR NNLSG IP
Sbjct: 202 LSSNDFSGSIPEDLGELKTLSGTLNLSFNHLSGKIPKTLGDLPVTVSFDLRSNNLSGSIP 261
Query: 257 QTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVL 316
QTGSFANQGPTAFL+NP LCGFPLQKSC++S + P S + +KGL GLI+L
Sbjct: 262 QTGSFANQGPTAFLNNPELCGFPLQKSCENSERGSPGNPDSKP-SYITPRKGLSAGLIIL 320
Query: 317 ISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGF-RNED 375
ISAADAA VA IGLVIVYVYW++KDS+ GCSCT K KFGGN+ C C+NG +NE+
Sbjct: 321 ISAADAAGVAFIGLVIVYVYWRRKDSSNGCSCTSKRKFGGNQKDGLCNFPCMNGNDKNEE 380
Query: 376 SEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA 435
SE+E+ E + + EG LVA+DKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA
Sbjct: 381 SEMEEPENSDRSREEGGLVAVDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA 440
Query: 436 VRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR 495
VRRLGEGGEQR++EF EVQAI +VKHPNIVKLRAYYWAPDEKLLISDFISNGNLA+ALR
Sbjct: 441 VRRLGEGGEQRYKEFAAEVQAIGRVKHPNIVKLRAYYWAPDEKLLISDFISNGNLASALR 500
Query: 496 GRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555
G+NGQPS+SLSWSTRLRI KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF P+ISDF
Sbjct: 501 GKNGQPSSSLSWSTRLRITKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFHPHISDF 560
Query: 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFG 615
GL+RLI+ITGNNPSSSGG +GGA Y+K VQT++TNNY APEAR PG RP QKWDVYSFG
Sbjct: 561 GLNRLISITGNNPSSSGGLIGGAFSYLKSVQTDRTNNYCAPEARAPGGRPTQKWDVYSFG 620
Query: 616 VVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVI 675
V++LELLTGKSPELSP TSTS+E+PDLVRWV+KGFEE PLSD+VD LLQEVHAKKEV+
Sbjct: 621 VMVLELLTGKSPELSPNTSTSLEIPDLVRWVRKGFEEAKPLSDLVDPALLQEVHAKKEVL 680
Query: 676 AVFHLALACTEADPEVRPRMKNVSENLERIGT 707
AVFH+ALACTE+DPEVRPRMK VSE+ +RIG+
Sbjct: 681 AVFHVALACTESDPEVRPRMKTVSESFDRIGS 712
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495011|ref|XP_004159709.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1093 bits (2826), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/692 (77%), Positives = 612/692 (88%), Gaps = 5/692 (0%)
Query: 18 FALSPDGLTLLSLKSAIDQT-DTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAI 76
ALSPDGL+LLSLKSA+DQ+ D+SVF+DWNEND TPC+WSGISCMN++G D RVVG+A+
Sbjct: 6 LALSPDGLSLLSLKSAVDQSPDSSVFSDWNENDSTPCQWSGISCMNVSG--DSRVVGIAL 63
Query: 77 SGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPS 136
SGKN+RGYIPSELGSL+YLRRLNLHNNNL+GS+P+QLFNATSLHS+FLY NNLSG PPS
Sbjct: 64 SGKNLRGYIPSELGSLVYLRRLNLHNNNLYGSIPEQLFNATSLHSLFLYSNNLSGPFPPS 123
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+CN+PRLQNLDLSNNS +G +PD L+NCKQLQRLILARN+F G+IP+G+W ++NLVQLD
Sbjct: 124 ICNIPRLQNLDLSNNSLAGPVPDELRNCKQLQRLILARNQFDGEIPSGVWSGMDNLVQLD 183
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
LS NDF G IP DLGEL++LS TLNLS+NHLSGKIPK+LG+LPVTVSFDLR NNLSG IP
Sbjct: 184 LSSNDFSGSIPEDLGELKTLSGTLNLSFNHLSGKIPKTLGDLPVTVSFDLRSNNLSGSIP 243
Query: 257 QTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVL 316
QTGSFANQGPTAFL+NP LCGFPLQKSC++S + P S + +KGL GLI+L
Sbjct: 244 QTGSFANQGPTAFLNNPELCGFPLQKSCENSERGSPGNPDSKP-SYITPRKGLSAGLIIL 302
Query: 317 ISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGF-RNED 375
ISAADAA VA IGLVIVYVYW++KDS+ GCSCT K KFGGN+ C C+NG +NE+
Sbjct: 303 ISAADAAGVAFIGLVIVYVYWRRKDSSNGCSCTSKRKFGGNQKDGLCNFPCMNGNDKNEE 362
Query: 376 SEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA 435
SE+E+ E + + EG LVA+DKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA
Sbjct: 363 SEMEEPENSDRSREEGGLVAVDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVA 422
Query: 436 VRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR 495
VRRLGEGGEQR++EF EVQAI +VKHPNIVKLRAYYWAPDEKLLISDFISNGNLA+ALR
Sbjct: 423 VRRLGEGGEQRYKEFAAEVQAIGRVKHPNIVKLRAYYWAPDEKLLISDFISNGNLASALR 482
Query: 496 GRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555
G+NGQPS+SLSWSTRLRI KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF P+ISDF
Sbjct: 483 GKNGQPSSSLSWSTRLRITKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFHPHISDF 542
Query: 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFG 615
GL+RLI+ITGNNPSSSGG +GGA Y+K VQT++TNNY APEAR PG RP QKWDVYSFG
Sbjct: 543 GLNRLISITGNNPSSSGGLIGGAFSYLKSVQTDRTNNYCAPEARAPGGRPTQKWDVYSFG 602
Query: 616 VVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVI 675
V++LELLTGKSPELSP TSTS+E+PDLVRWV+KGFEE PLSD+VD LLQEVHAKKEV+
Sbjct: 603 VMVLELLTGKSPELSPNTSTSLEIPDLVRWVRKGFEEAKPLSDLVDPALLQEVHAKKEVL 662
Query: 676 AVFHLALACTEADPEVRPRMKNVSENLERIGT 707
AVFH+ALACTE+DPEVRPRMK VSE+ +RIG+
Sbjct: 663 AVFHVALACTESDPEVRPRMKTVSESFDRIGS 694
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359473574|ref|XP_002265151.2| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 526/677 (77%), Positives = 601/677 (88%), Gaps = 5/677 (0%)
Query: 33 AIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSL 92
A+D S F+DWNE+DP PCRW+GISCMN++GF DPRVVG+AISG+N+RGYIPSELG+L
Sbjct: 36 AVDDA-ASAFSDWNEDDPNPCRWTGISCMNVSGFSDPRVVGIAISGRNLRGYIPSELGNL 94
Query: 93 IYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNS 152
YLRRLNLH NN +GS+P QLFNA+SLHSIFLYGNNLSG+LPP++C LPRLQN+D SNNS
Sbjct: 95 FYLRRLNLHGNNFYGSIPVQLFNASSLHSIFLYGNNLSGTLPPAMCQLPRLQNVDFSNNS 154
Query: 153 FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212
SGS+P+GLK CKQLQRL++ RN+FSG+IP GIWPE+ENLVQLDLS N+F G IP+D+GE
Sbjct: 155 LSGSIPEGLKKCKQLQRLVVTRNQFSGEIPEGIWPEMENLVQLDLSSNEFNGSIPDDIGE 214
Query: 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272
L+SLS TLNLS+NH +GKIPKSLGNLP TVSFDLR NNLSGEIPQTG+FANQGPTAFL+N
Sbjct: 215 LKSLSGTLNLSHNHFTGKIPKSLGNLPETVSFDLRSNNLSGEIPQTGAFANQGPTAFLNN 274
Query: 273 PLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLISAADAAAVAVIGLVI 332
P LCGFPLQKSC++ + S E Q+ SP+S + +KGL PGLI+LIS ADAA VA IGL+I
Sbjct: 275 PDLCGFPLQKSCRNPSRSSPEGQSSSPESGTNARKGLSPGLIILISVADAAGVAFIGLII 334
Query: 333 VYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKG-EG 391
VY+YWK +DS GCSCT K K G + C C+ + F+N DSE+E +K GKG EG
Sbjct: 335 VYIYWKNRDSQ-GCSCTGKEKLGSTGRSALCSCLSAHSFQNNDSEME-SDKERGGKGAEG 392
Query: 392 ELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFV 451
+LVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVLGNG+PVAVRRLGEGGEQR++EFV
Sbjct: 393 DLVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAVRRLGEGGEQRYKEFV 452
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
EVQAI +VKHPN+VKLRAYYWAPDEKLLISDFISNGNLANALRGR+GQPS+SLSWSTRL
Sbjct: 453 AEVQAIGRVKHPNVVKLRAYYWAPDEKLLISDFISNGNLANALRGRSGQPSSSLSWSTRL 512
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
+IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN+FQPYISDFGL+RLI ITGNNP+SS
Sbjct: 513 KIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNEFQPYISDFGLNRLITITGNNPASS 572
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL-S 630
GGF+GGALPY+K VQ E+ NNY+APEARV +RP QKWDVYSFGVVLLELLTGKSPEL S
Sbjct: 573 GGFIGGALPYLKSVQPERPNNYKAPEARVANSRPTQKWDVYSFGVVLLELLTGKSPELSS 632
Query: 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPE 690
PTTSTS EVPDLV+WV+KGFEEENPLSDMVD +LLQEV AKKEV+AVFH+ALACTE DPE
Sbjct: 633 PTTSTSTEVPDLVKWVRKGFEEENPLSDMVDPLLLQEVQAKKEVLAVFHVALACTEGDPE 692
Query: 691 VRPRMKNVSENLERIGT 707
+RPRMK +SENLERIG+
Sbjct: 693 LRPRMKTLSENLERIGS 709
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506189|ref|XP_003623383.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355498398|gb|AES79601.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1052 bits (2720), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 527/710 (74%), Positives = 600/710 (84%), Gaps = 23/710 (3%)
Query: 15 HLCFALSPDGLTLLSLKSAIDQTDT-SVFADWNENDPTPCRWSGISCMNITGFPDPRVVG 73
H +LS DGL LL+LKSA+D DT + F+DWNEND TPC WSGISC NI+G PD RVVG
Sbjct: 16 HPVVSLSSDGLALLTLKSAVDGGDTATTFSDWNENDLTPCHWSGISCSNISGEPDSRVVG 75
Query: 74 VAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSL 133
+ ++GK +RGY+PSELG+LIYLRRL+LH N GS+P QLFNA+SLHSIFL+GNNLSG+L
Sbjct: 76 IGLAGKGLRGYLPSELGNLIYLRRLSLHTNLFHGSIPVQLFNASSLHSIFLHGNNLSGNL 135
Query: 134 PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLV 193
PS CNLPRLQNLDLS+NS +G++P + NC QLQRLILARN FSG IP W +L+NLV
Sbjct: 136 SPSACNLPRLQNLDLSDNSLAGNIPQSIGNCSQLQRLILARNNFSGYIPVTPWKKLKNLV 195
Query: 194 QLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
QLDLS N +G IP +GEL SL+ TLNLS+NHL+GK+PKSLG LPVTVSFDLR N+LSG
Sbjct: 196 QLDLSANVLEGSIPEQIGELNSLTGTLNLSFNHLTGKVPKSLGKLPVTVSFDLRSNDLSG 255
Query: 254 EIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSK----KKGL 309
EIPQTGSF+NQGPTAFL+NP LCGFPLQK C S S+ SP S + + KKGL
Sbjct: 256 EIPQTGSFSNQGPTAFLNNPKLCGFPLQKDCTGSASSE---PGASPGSTRQRMNRSKKGL 312
Query: 310 GPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGN----ENGSFCPC 365
PGLI++I+ ADAAAVA+IGLV+VYVYWKKKD N GCSCT+K KFGGN + S C C
Sbjct: 313 SPGLIIIITVADAAAVALIGLVVVYVYWKKKDKNNGCSCTLKRKFGGNGSNERSNSCCLC 372
Query: 366 V---CVNGFRNEDSEVEDQEK-------VESGKGEGELVAIDKGFTFELDELLRASAYVL 415
+ CV GF+++DSE+E+ EK G+GEGELVAIDKGF+FELDELLRASAYVL
Sbjct: 373 LALGCVKGFKSDDSEMEESEKGGREGNGRGEGEGEGELVAIDKGFSFELDELLRASAYVL 432
Query: 416 GKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP 475
GKSGLGIVYKVVLGNG+PVAVRRLGEGGEQR++EF TEVQAI KVKHPNIVKLRAYYWA
Sbjct: 433 GKSGLGIVYKVVLGNGVPVAVRRLGEGGEQRYKEFATEVQAIGKVKHPNIVKLRAYYWAH 492
Query: 476 DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHG 535
DEKLLISDF+SNGNLANALRGRNGQPS +LSWS RLRIAKGTARGLAYLHECSPRKFVHG
Sbjct: 493 DEKLLISDFVSNGNLANALRGRNGQPSPNLSWSIRLRIAKGTARGLAYLHECSPRKFVHG 552
Query: 536 DIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRA 595
D+KPSNILLD DFQP ISDFGL+RLI+ITGNNP S+GGFMGGALPYMK QTE+TNNY+A
Sbjct: 553 DLKPSNILLDTDFQPLISDFGLNRLISITGNNP-STGGFMGGALPYMKSSQTERTNNYKA 611
Query: 596 PEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENP 655
PEA+VPG RP QKWDVYSFGVVLLELLTGKSP+ SP STS+EVPDLVRWVKKGFE+E+P
Sbjct: 612 PEAKVPGCRPTQKWDVYSFGVVLLELLTGKSPDSSPGASTSVEVPDLVRWVKKGFEQESP 671
Query: 656 LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
LS+MVD LLQE+HAKKEV+AVFH+AL+CTE DPEVRPRMK VS+NLERI
Sbjct: 672 LSEMVDPSLLQEIHAKKEVLAVFHVALSCTEGDPEVRPRMKTVSDNLERI 721
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738391|emb|CBI27592.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2703), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/678 (75%), Positives = 586/678 (86%), Gaps = 24/678 (3%)
Query: 32 SAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGS 91
SA+D S F+DWNE+DP PCRW+GISCMN++GF DPRVVG+AISG+N+RGYIPSELG+
Sbjct: 19 SAVDDA-ASAFSDWNEDDPNPCRWTGISCMNVSGFSDPRVVGIAISGRNLRGYIPSELGN 77
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151
L YLRRLNLH NN +GS+P QLFNA+SLHSIFLYGNNLSG+LPP++C LPRLQN+D SNN
Sbjct: 78 LFYLRRLNLHGNNFYGSIPVQLFNASSLHSIFLYGNNLSGTLPPAMCQLPRLQNVDFSNN 137
Query: 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG 211
S SGS+P+GLK CKQLQRL++ RN+FSG+IP GIWPE+ENLVQLDLS N+F G IP+D+G
Sbjct: 138 SLSGSIPEGLKKCKQLQRLVVTRNQFSGEIPEGIWPEMENLVQLDLSSNEFNGSIPDDIG 197
Query: 212 ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS 271
EL+SLS TLNLS+NH +GKIPKSLGNLP TVSFDLR NNLSGEIPQTG+FANQGPTAFL+
Sbjct: 198 ELKSLSGTLNLSHNHFTGKIPKSLGNLPETVSFDLRSNNLSGEIPQTGAFANQGPTAFLN 257
Query: 272 NPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLISAADAAAVAVIGLV 331
NP LCGFPLQKSC++ + S E Q+ SP+S + +KGL PGLI+LIS ADAA VA IGL+
Sbjct: 258 NPDLCGFPLQKSCRNPSRSSPEGQSSSPESGTNARKGLSPGLIILISVADAAGVAFIGLI 317
Query: 332 IVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKG-E 390
IVY+YWK +DS GCSCT K K G + C C+ + F+N DSE+E +K GKG E
Sbjct: 318 IVYIYWKNRDSQ-GCSCTGKEKLGSTGRSALCSCLSAHSFQNNDSEME-SDKERGGKGAE 375
Query: 391 GELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREF 450
G+LVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVLGNG+PVAVRRLGEGGEQR++EF
Sbjct: 376 GDLVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAVRRLGEGGEQRYKEF 435
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
V EVQAI +VKHPN+VKLRAYYWAPDEKLLISDFISNGNLANALRGR+GQPS+SLSWSTR
Sbjct: 436 VAEVQAIGRVKHPNVVKLRAYYWAPDEKLLISDFISNGNLANALRGRSGQPSSSLSWSTR 495
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
L+IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN+FQPYISDFGL+RLI ITGNNP+S
Sbjct: 496 LKIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNEFQPYISDFGLNRLITITGNNPAS 555
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL- 629
SGGF+ APEARV +RP QKWDVYSFGVVLLELLTGKSPEL
Sbjct: 556 SGGFI-------------------APEARVANSRPTQKWDVYSFGVVLLELLTGKSPELS 596
Query: 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689
SPTTSTS EVPDLV+WV+KGFEEENPLSDMVD +LLQEV AKKEV+AVFH+ALACTE DP
Sbjct: 597 SPTTSTSTEVPDLVKWVRKGFEEENPLSDMVDPLLLQEVQAKKEVLAVFHVALACTEGDP 656
Query: 690 EVRPRMKNVSENLERIGT 707
E+RPRMK +SENLERIG+
Sbjct: 657 ELRPRMKTLSENLERIGS 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297841443|ref|XP_002888603.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297334444|gb|EFH64862.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1042 bits (2695), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/702 (73%), Positives = 600/702 (85%), Gaps = 18/702 (2%)
Query: 18 FALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAIS 77
+LSPDGL LLSLKSA+DQ+ +S F+DWN+ND PCRWSGISCMNI+ D RVVG++++
Sbjct: 21 LSLSPDGLALLSLKSAVDQSSSSPFSDWNDNDSDPCRWSGISCMNISESSDSRVVGISLA 80
Query: 78 GKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV 137
GK++RGYIPSELGSL+YLRRLNLHNN LFGS+P QLFNATSLHS+FLYGNNLSGSLPPS+
Sbjct: 81 GKHLRGYIPSELGSLVYLRRLNLHNNELFGSIPTQLFNATSLHSLFLYGNNLSGSLPPSI 140
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
C+LP+LQNLDLS NS SG+L L CKQLQRLILA N FSG+IP IWPEL+NL QLDL
Sbjct: 141 CHLPKLQNLDLSGNSLSGTLSPDLNQCKQLQRLILAANNFSGEIPGEIWPELKNLAQLDL 200
Query: 198 SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
S N+F G IP DLGEL+SLS TLNLS+NHLSG+IPKSLGNLPVTVS DLR N+ SGEIPQ
Sbjct: 201 SANEFTGEIPKDLGELKSLSGTLNLSFNHLSGEIPKSLGNLPVTVSLDLRNNDFSGEIPQ 260
Query: 258 TGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLI 317
+GSF+NQGPTAFL+NP LCGFPLQK+CKD+ E+ T+ SP+++ ++GL GLIVLI
Sbjct: 261 SGSFSNQGPTAFLNNPKLCGFPLQKACKDTDENSPGTRK-SPENNADSRRGLSTGLIVLI 319
Query: 318 SAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGF-RNEDS 376
S ADAA+VA+IGLV+VY+YWKKKDS GGCSCT K GG+E G PC C+ GF + +DS
Sbjct: 320 SVADAASVALIGLVLVYLYWKKKDSEGGCSCTGNEKLGGSEKGK--PCCCIAGFPKGDDS 377
Query: 377 EVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAV 436
E E+ E+ E GKG+GELVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVLGNG+PVAV
Sbjct: 378 EAEENERGE-GKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAV 436
Query: 437 RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRG 496
RRLGEGGEQR++EFVTEVQA+ KVKHPN+VKLRAYYWAPDEKLLISDF++NG+LA+ALRG
Sbjct: 437 RRLGEGGEQRYKEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFVNNGSLADALRG 496
Query: 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556
RNGQPS SL+WSTRL+IAKG ARGLAYLHECSPRK VHGD+KPSNILLD+ F PYISDFG
Sbjct: 497 RNGQPSPSLTWSTRLKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLDSSFTPYISDFG 556
Query: 557 LSRLINITG-----NNPSSS---GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
L+RLI IT N PSSS GGF+GGALPY ++++N Y+APEAR+PG RP QK
Sbjct: 557 LTRLITITAPSAFSNEPSSSSAAGGFLGGALPYTSIKPSDRSNGYKAPEARLPGGRPTQK 616
Query: 609 WDVYSFGVVLLELLTGK-----SPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAM 663
WDVYSFGVVL+ELLTGK S +++ +EVPDLV+WV+KGFEEE PLSDMVD M
Sbjct: 617 WDVYSFGVVLMELLTGKSPESSPLSSSSSSTVVVEVPDLVKWVRKGFEEETPLSDMVDPM 676
Query: 664 LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
LLQEVHAK++V++VFHLALACTE DPEVRPRMKNVSEN+++I
Sbjct: 677 LLQEVHAKQQVLSVFHLALACTEGDPEVRPRMKNVSENIDKI 718
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521068|ref|XP_003529180.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1035 bits (2677), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/695 (73%), Positives = 594/695 (85%), Gaps = 6/695 (0%)
Query: 15 HLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGV 74
H +LS DG+ LL+LKSA+D + F+DWN+ D TPCRWSG++C NI+G P+PRVVG+
Sbjct: 15 HPAVSLSSDGIALLTLKSAVDAPGAAAFSDWNDADATPCRWSGVTCANISGLPEPRVVGL 74
Query: 75 AISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP 134
A+SGK +RGY+PSELG+L+YLRRLNLH N L G++P QLFNAT+LHS+FL+GNNLSG+LP
Sbjct: 75 ALSGKGLRGYLPSELGTLLYLRRLNLHTNALRGAIPAQLFNATALHSVFLHGNNLSGNLP 134
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
PSVC LPRL+NLDLS+N+ SG++PD L+ C LQRLILARNKFSG+IPA WPEL++LVQ
Sbjct: 135 PSVCTLPRLENLDLSDNALSGAIPDTLRKCSNLQRLILARNKFSGEIPASPWPELKSLVQ 194
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
LDLS N +G IP+ LGEL++L+ TLNLS+NHLSGKIPKSLGNLPV VSFDLR N+LSGE
Sbjct: 195 LDLSSNLLEGSIPDKLGELKTLTGTLNLSFNHLSGKIPKSLGNLPVAVSFDLRNNDLSGE 254
Query: 255 IPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLI 314
IPQ GSF+NQGPTAFL+NP LCGFPLQK C S S+ S KGL PGLI
Sbjct: 255 IPQMGSFSNQGPTAFLNNPNLCGFPLQKPCTGSAPSEPGLSPGSRRPAHRSAKGLSPGLI 314
Query: 315 VLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGG-NENGSFCPCVCVNGFRN 373
+LIS ADAA VA+IGLV+VYVYWK+K + GCSC++K KFGG +E S C C C NG ++
Sbjct: 315 ILISVADAAGVALIGLVVVYVYWKRKGKSNGCSCSLKRKFGGESEKLSLC-CWC-NGVKS 372
Query: 374 EDS--EVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNG 431
+DS E ++E+ E G+GEG+LVAIDKGF FELDELLRASAYVLGKSGLGIVYKVVLGNG
Sbjct: 373 DDSEVEEGEKEEGEGGRGEGDLVAIDKGFNFELDELLRASAYVLGKSGLGIVYKVVLGNG 432
Query: 432 IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
+PVAVRRLGEGGEQR++EF EVQAI KVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA
Sbjct: 433 VPVAVRRLGEGGEQRYKEFAAEVQAIGKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 492
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
ALRGRNGQPS +LSWSTRL+I KG ARGLAYLHECSPRKFVHGDIKPSN+LLD DFQP+
Sbjct: 493 TALRGRNGQPSPNLSWSTRLKIIKGAARGLAYLHECSPRKFVHGDIKPSNLLLDTDFQPH 552
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
ISDFGL+RLI+ITGNNP SSGGFMGG+LPY+KP QTE+TNNY+APEARVPG RP QKWDV
Sbjct: 553 ISDFGLNRLISITGNNP-SSGGFMGGSLPYLKPSQTERTNNYKAPEARVPGCRPTQKWDV 611
Query: 612 YSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAK 671
YSFGVVLLELLTGKSP+ S STS+EVPDLVRWV+KGFE+E+PLS++VD +L EVHAK
Sbjct: 612 YSFGVVLLELLTGKSPDSSLAASTSMEVPDLVRWVRKGFEQESPLSEIVDPSMLHEVHAK 671
Query: 672 KEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706
KEV+A FH+AL CTE DPEVRPRMK VSENLERIG
Sbjct: 672 KEVLAAFHVALQCTEGDPEVRPRMKTVSENLERIG 706
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568150|ref|XP_003552276.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/695 (73%), Positives = 592/695 (85%), Gaps = 7/695 (1%)
Query: 15 HLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGV 74
H +LS DG+ LL+LKSA+D + S F+DWN+ D TPC+WSG++C +I+G P+PRVVGV
Sbjct: 16 HPAVSLSSDGIALLTLKSAVDASGASAFSDWNDADATPCQWSGVTCADISGLPEPRVVGV 75
Query: 75 AISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP 134
A+SGK +RGY+PSELG+L+YLRRLNLH N L G++P QLFNAT+LHS+FL+GNNLSG+LP
Sbjct: 76 ALSGKGLRGYLPSELGTLLYLRRLNLHTNALRGAIPAQLFNATALHSVFLHGNNLSGNLP 135
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
SVC LPRL+NLDLS+N+ SG++PD L+ C LQRLILARNKFSG+IPA WPELENLVQ
Sbjct: 136 TSVCTLPRLENLDLSDNALSGAIPDALRKCSNLQRLILARNKFSGEIPASPWPELENLVQ 195
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
LDLS N +G IP+ LGEL+ L+ TLNLS+NHLSGKIPKSLGNLPV VSFDLR N+LSGE
Sbjct: 196 LDLSSNLLEGSIPDKLGELKILTGTLNLSFNHLSGKIPKSLGNLPVVVSFDLRNNDLSGE 255
Query: 255 IPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLI 314
IPQTGSF+NQGPTAFL+NP LCGFPLQK C S S+ S + + K+ L P I
Sbjct: 256 IPQTGSFSNQGPTAFLNNPNLCGFPLQKPCAGSAPSEPGLSPGSRGAHRPTKR-LSPSSI 314
Query: 315 VLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGG-NENGSFCPCVCVNGFRN 373
+LIS ADAA VA+IGLV+VYVYWK+K + GCSCT+K KFGG +E S C C C NG ++
Sbjct: 315 ILISVADAAGVALIGLVVVYVYWKRKGKSNGCSCTLKRKFGGESEELSLC-CWC-NGVKS 372
Query: 374 EDS--EVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNG 431
+DS E ++ + ESG+GEG+LVAIDKGF FELDELLRASAYVLGKSGLGIVYKVVLGNG
Sbjct: 373 DDSEVEEGEKGEGESGRGEGDLVAIDKGFNFELDELLRASAYVLGKSGLGIVYKVVLGNG 432
Query: 432 IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
+PVAVRRLGEGGEQR++EF EVQAI KVKHPNIV+LRAYYWAPDEKLLISDFISNGNLA
Sbjct: 433 VPVAVRRLGEGGEQRYKEFAAEVQAIGKVKHPNIVRLRAYYWAPDEKLLISDFISNGNLA 492
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
ALRGRNGQPS +LSWSTRL+I K TARGLAYLHECSPRKFVHGD+KPSNILL DFQP+
Sbjct: 493 TALRGRNGQPSPNLSWSTRLKIIKRTARGLAYLHECSPRKFVHGDVKPSNILLSTDFQPH 552
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
ISDFGL+RLI+ITGNNP SSGG MGGALPY+KP QTE+TNNY+APEARV G P QKWDV
Sbjct: 553 ISDFGLNRLISITGNNP-SSGGLMGGALPYLKPSQTERTNNYKAPEARVLGCIPTQKWDV 611
Query: 612 YSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAK 671
YSFGVVLLELLTGK+P+ SP STS++VPDLVRWV+KGFE+E+PLS++VD +L EVHAK
Sbjct: 612 YSFGVVLLELLTGKAPDSSPAASTSMDVPDLVRWVRKGFEQESPLSEIVDPSMLHEVHAK 671
Query: 672 KEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706
KEV+AVFH+AL CTE DPEVRPRMK VSENLERIG
Sbjct: 672 KEVLAVFHVALQCTEGDPEVRPRMKTVSENLERIG 706
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15220455|ref|NP_176918.1| leucine-rich repeat-like protein [Arabidopsis thaliana] gi|12324677|gb|AAG52300.1|AC011020_7 putative receptor protein kinase [Arabidopsis thaliana] gi|3176660|gb|AAC18784.1| Similar to ERECTA receptor protein kinase gb|U47029 from A. thaliana [Arabidopsis thaliana] gi|224589465|gb|ACN59266.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332196536|gb|AEE34657.1| leucine-rich repeat-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/702 (71%), Positives = 594/702 (84%), Gaps = 17/702 (2%)
Query: 18 FALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAIS 77
+LSPDG+ LLSLKSA+D + +S F+DWN+ND PC WSGISCMNI+ RVVG++++
Sbjct: 21 LSLSPDGIALLSLKSAVDHSSSSAFSDWNDNDTDPCHWSGISCMNISDSSTSRVVGISLA 80
Query: 78 GKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV 137
GK++RGYIPSELGSLIYLRRLNLHNN L+GS+P QLFNATSLHSIFLYGNNLSG+LPPS+
Sbjct: 81 GKHLRGYIPSELGSLIYLRRLNLHNNELYGSIPTQLFNATSLHSIFLYGNNLSGTLPPSI 140
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
C LP+LQNLDLS NS SG+L L CKQLQRLIL+ N FSG+IP IWPEL NL QLDL
Sbjct: 141 CKLPKLQNLDLSMNSLSGTLSPDLNKCKQLQRLILSANNFSGEIPGDIWPELTNLAQLDL 200
Query: 198 SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
S N+F G IP D+GEL+SLS TLNLS+NHLSG+IP SLGNLPVTVS DLR N+ SGEIPQ
Sbjct: 201 SANEFSGEIPKDIGELKSLSGTLNLSFNHLSGQIPNSLGNLPVTVSLDLRNNDFSGEIPQ 260
Query: 258 TGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLI 317
+GSF+NQGPTAFL+NP LCGFPLQK+CKD+ E+ T+ SP+++ ++GL GLIVLI
Sbjct: 261 SGSFSNQGPTAFLNNPKLCGFPLQKTCKDTDENSPGTRK-SPENNADSRRGLSTGLIVLI 319
Query: 318 SAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGF-RNEDS 376
S ADAA+VA IGLV+VY+YWKKKDS GGCSCT +K GG C C+ GF + +DS
Sbjct: 320 SVADAASVAFIGLVLVYLYWKKKDSEGGCSCTGNAKLGGGSVKGKS-CCCITGFPKEDDS 378
Query: 377 EVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAV 436
E E E+ E GKG+GELVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVLGNG+PVAV
Sbjct: 379 EAEGNERGE-GKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAV 437
Query: 437 RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRG 496
RRLGEGGEQR++EFVTEVQA+ KVKHPN+VKLRAYYWAPDEKLLISDF++NG+LA+ALRG
Sbjct: 438 RRLGEGGEQRYKEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFVNNGSLADALRG 497
Query: 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556
RNGQPS SL+WSTR++IAKG ARGLAYLHECSPRK VHGD+KPSNILLD+ F PYISDFG
Sbjct: 498 RNGQPSPSLTWSTRIKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLDSSFTPYISDFG 557
Query: 557 LSRLINIT--------GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
L+RLI IT ++ S++GGF+GGALPY ++++N Y+APEAR+PG RP QK
Sbjct: 558 LTRLITITAASASSNEPSSSSAAGGFLGGALPYTSIKPSDRSNGYKAPEARLPGGRPTQK 617
Query: 609 WDVYSFGVVLLELLTGKSPELSPTTSTS-----IEVPDLVRWVKKGFEEENPLSDMVDAM 663
WDVYSFGVVL+ELLTGKSP+ SP +S+S +EVPDLV+WV+KGFEEE PLSDMVD M
Sbjct: 618 WDVYSFGVVLMELLTGKSPDSSPLSSSSTSTVVVEVPDLVKWVRKGFEEETPLSDMVDPM 677
Query: 664 LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
LLQEVHAK++V++VFHLALACTE DPEVRPRMKNVSEN+++I
Sbjct: 678 LLQEVHAKQQVLSVFHLALACTEGDPEVRPRMKNVSENIDKI 719
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 707 | ||||||
| TAIR|locus:2008793 | 719 | AT1G67510 [Arabidopsis thalian | 0.966 | 0.949 | 0.679 | 1.9e-257 | |
| TAIR|locus:2038706 | 716 | AT2G01210 [Arabidopsis thalian | 0.490 | 0.484 | 0.492 | 2.4e-142 | |
| TAIR|locus:2033000 | 702 | AT1G25320 [Arabidopsis thalian | 0.483 | 0.487 | 0.474 | 3.1e-138 | |
| TAIR|locus:2095773 | 662 | AT3G57830 [Arabidopsis thalian | 0.454 | 0.484 | 0.491 | 8.9e-113 | |
| TAIR|locus:2033379 | 685 | AT1G66830 [Arabidopsis thalian | 0.826 | 0.852 | 0.397 | 2.2e-112 | |
| TAIR|locus:2053751 | 646 | AT2G42290 [Arabidopsis thalian | 0.471 | 0.515 | 0.472 | 6.4e-108 | |
| TAIR|locus:2058598 | 773 | AT2G23300 [Arabidopsis thalian | 0.485 | 0.443 | 0.387 | 1.8e-99 | |
| TAIR|locus:2115120 | 768 | AT4G37250 [Arabidopsis thalian | 0.446 | 0.411 | 0.403 | 2.3e-97 | |
| TAIR|locus:2157182 | 751 | RLK "receptor-like kinase" [Ar | 0.438 | 0.412 | 0.418 | 7.8e-95 | |
| TAIR|locus:2124296 | 757 | AT4G34220 [Arabidopsis thalian | 0.434 | 0.405 | 0.376 | 1.9e-90 |
| TAIR|locus:2008793 AT1G67510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2478 (877.4 bits), Expect = 1.9e-257, P = 1.9e-257
Identities = 477/702 (67%), Positives = 555/702 (79%)
Query: 19 ALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISG 78
+LSPDG+ LLSLKSA+D + +S F+DWN+ND PC WSGISCMNI+ RVVG++++G
Sbjct: 22 SLSPDGIALLSLKSAVDHSSSSAFSDWNDNDTDPCHWSGISCMNISDSSTSRVVGISLAG 81
Query: 79 KNVRGYIPSELGSLIYXXXXXXXXXXXFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC 138
K++RGYIPSELGSLIY +GS+P QLFNATSLHSIFLYGNNLSG+LPPS+C
Sbjct: 82 KHLRGYIPSELGSLIYLRRLNLHNNELYGSIPTQLFNATSLHSIFLYGNNLSGTLPPSIC 141
Query: 139 NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198
LP+LQNLDLS NS SG+L L CKQLQRLIL+ N FSG+IP IWPEL NL QLDLS
Sbjct: 142 KLPKLQNLDLSMNSLSGTLSPDLNKCKQLQRLILSANNFSGEIPGDIWPELTNLAQLDLS 201
Query: 199 DNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
N+F G IP D+GEL+SLS TLNLS+NHLSG+IP SLGNLPVTVS DLR N+ SGEIPQ+
Sbjct: 202 ANEFSGEIPKDIGELKSLSGTLNLSFNHLSGQIPNSLGNLPVTVSLDLRNNDFSGEIPQS 261
Query: 259 GSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNXXXXXXXXXXXXXXXXXXXXXX 318
GSF+NQGPTAFL+NP LCGFPLQK+CKD+ E+ T+
Sbjct: 262 GSFSNQGPTAFLNNPKLCGFPLQKTCKDTDENSPGTRKSPENNADSRRGLSTGLIVLISV 321
Query: 319 XXXXXXXXXXXXXXXXXYWKKKDSNGGCSCTVKSKFGGNE-NGSFCPCVCVNGF-RNEDS 376
YWKKKDS GGCSCT +K GG G C C C+ GF + +DS
Sbjct: 322 ADAASVAFIGLVLVYL-YWKKKDSEGGCSCTGNAKLGGGSVKGKSC-C-CITGFPKEDDS 378
Query: 377 EVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAV 436
E E E+ E GKG+GELVAIDKGF+FELDELLRASAYVLGKSGLGIVYKVVLGNG+PVAV
Sbjct: 379 EAEGNERGE-GKGDGELVAIDKGFSFELDELLRASAYVLGKSGLGIVYKVVLGNGVPVAV 437
Query: 437 RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRG 496
RRLGEGGEQR++EFVTEVQA+ KVKHPN+VKLRAYYWAPDEKLLISDF++NG+LA+ALRG
Sbjct: 438 RRLGEGGEQRYKEFVTEVQAMGKVKHPNVVKLRAYYWAPDEKLLISDFVNNGSLADALRG 497
Query: 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556
RNGQPS SL+WSTR++IAKG ARGLAYLHECSPRK VHGD+KPSNILLD+ F PYISDFG
Sbjct: 498 RNGQPSPSLTWSTRIKIAKGAARGLAYLHECSPRKLVHGDVKPSNILLDSSFTPYISDFG 557
Query: 557 LSRLINITG-----NNPSSS---GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
L+RLI IT N PSSS GGF+GGALPY ++++N Y+APEAR+PG RP QK
Sbjct: 558 LTRLITITAASASSNEPSSSSAAGGFLGGALPYTSIKPSDRSNGYKAPEARLPGGRPTQK 617
Query: 609 WDVYSFGVVLLELLTGKSPELSPTTSTS-----IEVPDLVRWVKKGFEEENPLSDMVDAM 663
WDVYSFGVVL+ELLTGKSP+ SP +S+S +EVPDLV+WV+KGFEEE PLSDMVD M
Sbjct: 618 WDVYSFGVVLMELLTGKSPDSSPLSSSSTSTVVVEVPDLVKWVRKGFEEETPLSDMVDPM 677
Query: 664 LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
LLQEVHAK++V++VFHLALACTE DPEVRPRMKNVSEN+++I
Sbjct: 678 LLQEVHAKQQVLSVFHLALACTEGDPEVRPRMKNVSENIDKI 719
|
|
| TAIR|locus:2038706 AT2G01210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 2.4e-142, Sum P(2) = 2.4e-142
Identities = 186/378 (49%), Positives = 252/378 (66%)
Query: 346 CSCTVKSKFGGNENGS--FCPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFE 403
C+C +++FG + C+C FR ++SE E VE ++V +D F
Sbjct: 347 CACNRENQFGVEKESKKRASECLC---FRKDESETPS-ENVE----HCDIVPLDAQVAFN 398
Query: 404 LDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHP 463
L+ELL+ASA+VLGKSG+GIVYKVVL NG+ +AVRRLGEGG QR +EF TEV+AI K+KHP
Sbjct: 399 LEELLKASAFVLGKSGIGIVYKVVLENGLTLAVRRLGEGGSQRFKEFQTEVEAIGKLKHP 458
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS-LSWSTRLRIAKGTARGLA 522
NI LRAYYW+ DEKLLI D++SNGNLA AL G+ G + + L+WS RLRI KG A GL
Sbjct: 459 NIASLRAYYWSVDEKLLIYDYVSNGNLATALHGKPGMMTIAPLTWSERLRIMKGIATGLV 518
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG-NNPS--SSGGFMGGAL 579
YLHE SP+K+VHGD+KPSNIL+ D +P ISDFGL+RL NI G ++P+ S+
Sbjct: 519 YLHEFSPKKYVHGDLKPSNILIGQDMEPKISDFGLARLANIAGGSSPTIQSNRIIQTDQQ 578
Query: 580 P------YMKPVQTEKTNN------YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P + K V +E T + Y+APE + +P QKWDVYS+G++LLEL+ G+SP
Sbjct: 579 PQERQQHHHKSVSSEFTAHSSSGSYYQAPET-LKMVKPSQKWDVYSYGIILLELIAGRSP 637
Query: 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEA 687
+ TS E+ DLVRWV+ EE+ PL D++D L E + E++AV +A++C +
Sbjct: 638 AVEVGTS---EM-DLVRWVQVCIEEKKPLCDVLDPCLAPEAETEDEIVAVLKIAISCVNS 693
Query: 688 DPEVRPRMKNVSENLERI 705
PE RP M++VS+ L+R+
Sbjct: 694 SPEKRPTMRHVSDTLDRL 711
|
|
| TAIR|locus:2033000 AT1G25320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 3.1e-138, Sum P(2) = 3.1e-138
Identities = 170/358 (47%), Positives = 231/358 (64%)
Query: 350 VKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLR 409
V K G + GSFC FR + SE E +E + +LV +DK +LDELL+
Sbjct: 356 VLEKEGKEKKGSFC-------FRRDGSESPSSENLEP---QQDLVLLDKHIALDLDELLK 405
Query: 410 ASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
ASA+VLGK G GIVYKVVL +G+ VAVRRLGEGG QR +EF TEV+AI K++HPNIV L+
Sbjct: 406 ASAFVLGKGGNGIVYKVVLEDGLTVAVRRLGEGGSQRCKEFQTEVEAIGKLRHPNIVSLK 465
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS-LSWSTRLRIAKGTARGLAYLHECS 528
AYYW+ +EKLLI D+I NG+L NAL G G S LSW RL+I +G +RGL YLHE S
Sbjct: 466 AYYWSVEEKLLIYDYIPNGSLTNALHGNPGMVSFKPLSWGVRLKIMRGISRGLVYLHEFS 525
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
P+K+VHG +K SNILL D +P+ISDFGL L +I G S++
Sbjct: 526 PKKYVHGSLKLSNILLGQDMEPHISDFGLMHLSSIAGTLESTTVDRPSNKTASSIGSSAN 585
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
++ Y APEA +P QKWDVYSFGV+LLE++TG+ P + S E+ ++V+W++
Sbjct: 586 LSSFYLAPEATKATVKPSQKWDVYSFGVILLEMITGRLPIVFVGKS---EM-EIVKWIQM 641
Query: 649 GFEEENPLSDMVDAMLL-QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+E+ +SD++D L+ + ++EVIAV +A+AC PE RP MK++++ L +I
Sbjct: 642 CIDEKKEMSDILDPYLVPNDTEIEEEVIAVLKIAMACVSTSPEKRPPMKHIADALTQI 699
|
|
| TAIR|locus:2095773 AT3G57830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 8.9e-113, Sum P(2) = 8.9e-113
Identities = 172/350 (49%), Positives = 228/350 (65%)
Query: 375 DSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNG--- 431
D +++EK EG+ V +D+GF EL++LLRASAYV+GKS GIVY+VV G G
Sbjct: 320 DDAADEEEK------EGKFVVMDEGFELELEDLLRASAYVVGKSRSGIVYRVVAGMGSGT 373
Query: 432 --------IPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482
VAVRRL +G R ++F EV+AI++V+HPNIV+LRAYY+A DE+LLI+
Sbjct: 374 VAATFTSSTVVAVRRLSDGDATWRRKDFENEVEAISRVQHPNIVRLRAYYYAEDERLLIT 433
Query: 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNI 542
D+I NG+L +AL G SLSW RL IA+GTARGL Y+HE SPRK+VHG++K + I
Sbjct: 434 DYIRNGSLYSALHGGPSNTLPSLSWPERLLIAQGTARGLMYIHEYSPRKYVHGNLKSTKI 493
Query: 543 LLDNDFQPYISDFGLSRLIN----ITGNNPSSSGGFMGGALPYMKPVQ--TEKTNNYRAP 596
LLD++ P IS FGL+RL++ + G+ ++ L V T T Y AP
Sbjct: 494 LLDDELLPRISGFGLTRLVSGYSKLIGSLSATRQSLDQTYLTSATTVTRITAPTVAYLAP 553
Query: 597 EARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENP 655
EAR G + QK DVYSFGVVL+ELLTG+ P S + +LVR V+ +EE P
Sbjct: 554 EARASSGCKLSQKCDVYSFGVVLMELLTGRLPNASSKNNGE----ELVRVVRNWVKEEKP 609
Query: 656 LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
LS+++D +L + HA K+VIA H+AL CTE DPEVRPRM++VSE+L RI
Sbjct: 610 LSEILDPEILNKGHADKQVIAAIHVALNCTEMDPEVRPRMRSVSESLGRI 659
|
|
| TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
Identities = 245/616 (39%), Positives = 349/616 (56%)
Query: 19 ALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISG 78
+L+ GL LLS K +I SVF +WN +D PC W G++C N D RVV + +
Sbjct: 21 SLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTC-NY----DMRVVSIRLPN 75
Query: 79 KNVRGYIPSELGSLIYXXXXXXXXXXXFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC 138
K + G + +GSL+ G LP +LF L S+ L GN+ SG +P +
Sbjct: 76 KRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSGNSFSGFVPEEIG 135
Query: 139 NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198
+L L LDLS NSF+GS+ L CK+L+ L+L++N FSG +P G+ L +L L+LS
Sbjct: 136 SLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLGSNLVHLRTLNLS 195
Query: 199 DNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
N G IP D+G L++L TL+LS+N SG IP SLGNLP + DL NNLSG IP+
Sbjct: 196 FNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYVDLSYNNLSGPIPKF 255
Query: 259 GSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNXXXXXXXXXXXXXXXXXXXXXX 318
N GP AF NP LCG P++ SC S + TQ
Sbjct: 256 NVLLNAGPNAFQGNPFLCGLPIKISC-----STRNTQVVPSQLYTRRANHHSRLCIILTA 310
Query: 319 XXXXXXXXXXXXXXXXXYWKK------KDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFR 372
Y +K KD N +C + K F +C F+
Sbjct: 311 TGGTVAGIIFLASLFIYYLRKASARANKDQNNR-TCHINEKLKKTTKPEF---LC---FK 363
Query: 373 NEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGI 432
+SE E ++ K + + +D F+LD+LL+ASA++LGKS +G+VYKVVL NG+
Sbjct: 364 TGNSE---SETLDENKNQQVFMPMDPEIEFDLDQLLKASAFLLGKSRIGLVYKVVLENGL 420
Query: 433 PVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492
+AVRRL + G R +EF+ +V+A+AK+KHPN++ L+A W+P+EKLLI D+I NG+L +
Sbjct: 421 MLAVRRLEDKGWLRLKEFLADVEAMAKIKHPNVLNLKACCWSPEEKLLIYDYIPNGDLGS 480
Query: 493 ALRGRNGQPSTS-LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
A++GR G S L+W+ RL+I +G A+GL Y+HE SP+++VHG I SNILL + +P
Sbjct: 481 AIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRYVHGHINTSNILLGPNLEPK 540
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
+S FGL R+++ + + S M + P + + + Y+APEA +P QKWDV
Sbjct: 541 VSGFGLGRIVDTSSDIRSDQISPMETSSPILS-----RESYYQAPEAASKMTKPSQKWDV 595
Query: 612 YSFGVVLLELLTGKSP 627
YSFG+V+LE++TGKSP
Sbjct: 596 YSFGLVILEMVTGKSP 611
|
|
| TAIR|locus:2053751 AT2G42290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 6.4e-108, Sum P(2) = 6.4e-108
Identities = 163/345 (47%), Positives = 225/345 (65%)
Query: 369 NGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL 428
+G+ +E + + EG+ VA D+GF EL++LLRASAYV+GKS GIVY+VV
Sbjct: 305 DGYNSETKTTTVVSEFDEEGQEGKFVAFDEGFELELEDLLRASAYVIGKSRSGIVYRVVA 364
Query: 429 G--NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485
+ VAVRRL +G + R ++FV EV++I ++ HPNIV+LRAYY+A DEKLLI+DFI
Sbjct: 365 AESSSTVVAVRRLSDGNDTWRFKDFVNEVESIGRINHPNIVRLRAYYYAEDEKLLITDFI 424
Query: 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545
+NG+L +AL G +LSW+ RL IA+GTARGL Y+HE S RK+VHG++K S ILLD
Sbjct: 425 NNGSLYSALHGGPSNTRPTLSWAERLCIAQGTARGLMYIHEYSSRKYVHGNLKSSKILLD 484
Query: 546 NDFQPYISDFGLSRLIN----ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP 601
N+ P++S FGL+RL++ +T ++ SS + V Y APEAR
Sbjct: 485 NELHPHVSGFGLTRLVSGYPKVTDHSLSSMTQSIDQGFATRLSVSAPAAA-YLAPEARAS 543
Query: 602 GNRPMQ-KWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMV 660
+ + K DVYSFGV+LLELLTG+ P S E LV ++K +EE L++++
Sbjct: 544 SDCKLSHKCDVYSFGVILLELLTGRLPYGSSENEGEEE---LVNVLRKWHKEERSLAEIL 600
Query: 661 DAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
D LL++ A K+VIA H+AL CTE DP++RPRM++VSE L RI
Sbjct: 601 DPKLLKQDFANKQVIATIHVALNCTEMDPDMRPRMRSVSEILGRI 645
|
|
| TAIR|locus:2058598 AT2G23300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 589 (212.4 bits), Expect = 1.8e-99, Sum P(2) = 1.8e-99
Identities = 149/385 (38%), Positives = 205/385 (53%)
Query: 347 SCTVKSKFGGNENGSFCPCVCVNGFRNED-SEVEDQEKVESGK-GE---GELVAIDKGFT 401
S T S ++ F C+ + D +E ED+E SG+ GE G LV ID G
Sbjct: 387 SSTTTSSSSPEQSSRFAKWSCLRKNQETDETEEEDEENQRSGEIGENKKGTLVTIDGGEK 446
Query: 402 -FELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG---EQRHREFVTEVQAI 457
E++ LL+ASAY+LG +G I+YK VL +G +AVRRLGE G ++R ++F ++AI
Sbjct: 447 ELEVETLLKASAYILGATGSSIMYKTVLEDGTVLAVRRLGENGLSQQRRFKDFEAHIRAI 506
Query: 458 AKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGT 517
K+ HPN+V+LR +YW DEKL+I DF+ NG+L NA + G L W TRL+I KG
Sbjct: 507 GKLVHPNLVRLRGFYWGTDEKLVIYDFVPNGSLVNARYRKGGSSPCHLPWETRLKIVKGL 566
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI--NITGNNPSSSGGFM 575
ARGLAYLH+ +K VHG++KPSNILL D +P I DFGL RL+ + + N S S
Sbjct: 567 ARGLAYLHD---KKHVHGNLKPSNILLGQDMEPKIGDFGLERLLAGDTSYNRASGSSRIF 623
Query: 576 G--------------GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
G P P + Y APE+ + +P KWDV+ FGV+LLEL
Sbjct: 624 SSKRLTASSREFGTIGPTPSPSPSSVGPISPYCAPES-LRNLKPNPKWDVFGFGVILLEL 682
Query: 622 LTGKSPELSPT-TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKE-VIAVFH 679
LTGK + + V E+ N M D + E+ K++ ++ +F
Sbjct: 683 LTGKIVSIDEVGVGNGLTV-----------EDGNRALIMADVAIRSELEGKEDFLLGLFK 731
Query: 680 LALACTEADPEVRPRMKNVSENLER 704
L +C P+ RP MK ER
Sbjct: 732 LGYSCASQIPQKRPTMKEALVVFER 756
|
|
| TAIR|locus:2115120 AT4G37250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 548 (198.0 bits), Expect = 2.3e-97, Sum P(2) = 2.3e-97
Identities = 144/357 (40%), Positives = 197/357 (55%)
Query: 375 DSEVEDQEKVESG------KGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL 428
+ E ED E ESG G+ +LV +D E++ LL+ASAY+LG +G I+YK VL
Sbjct: 409 EEEDEDDEDEESGYNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVL 468
Query: 429 GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486
+G AVRRLGE G ++R ++F ++AI K+ HPN+V+L +YW DEKL+I DF+
Sbjct: 469 EDGRVFAVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVP 528
Query: 487 NGNLANALRGRNGQPSTS---LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNIL 543
NG+L N R R G S+S L W TRL+IAKG ARGLAYLHE +K VHG++KPSNIL
Sbjct: 529 NGSLVNP-RYRKGGGSSSPYHLPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNIL 584
Query: 544 LDNDFQPYISDFGLSRLIN-----ITGNNPS---SSGGFMGGALPYMK--PVQTEKTNNY 593
L +D +P I DFGL RL+ I S SS + + + P + ++
Sbjct: 585 LGHDMEPKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSV 644
Query: 594 RAPEAR-VPGN----RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
A P + +P KWDVY FGV+LLELLTGK + V ++V
Sbjct: 645 GAMSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGKI----------VSVEEIVLGNGL 694
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKE-VIAVFHLALACTEADPEVRPRMKNVSENLER 704
E+ + M D + E+ K+E ++ F L +C P+ RP MK LER
Sbjct: 695 TVEDGHRAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLER 751
|
|
| TAIR|locus:2157182 RLK "receptor-like kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 7.8e-95, Sum P(2) = 7.8e-95
Identities = 144/344 (41%), Positives = 202/344 (58%)
Query: 373 NEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGI 432
N S ++DQEK +G LV +D E++ LL+ASAY+LG +G I+YK VL +G
Sbjct: 422 NRRSGLDDQEK------KGTLVNLDSEKELEIETLLKASAYILGATGSSIMYKAVLQDGT 475
Query: 433 PVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492
VAVRR+ E G R R+F +V+A+AK+ HPN+V++R +YW DEKL+I DF+ NG+LAN
Sbjct: 476 AVAVRRIAECGLDRFRDFEAQVRAVAKLIHPNLVRIRGFYWGSDEKLVIYDFVPNGSLAN 535
Query: 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYI 552
A + G L W RL+IAKG ARGL Y+H+ +K+VHG++KPSNILL D +P +
Sbjct: 536 ARYRKVGSSPCHLPWDARLKIAKGIARGLTYVHD---KKYVHGNLKPSNILLGLDMEPKV 592
Query: 553 SDFGLSRLINITGNNPSSSGG---FMGG-----AL---PYMKPVQTEKTNNYRAPEARVP 601
+DFGL +L+ G+ +GG G +L P P + Y APE+ +
Sbjct: 593 ADFGLEKLL--IGDMSYRTGGSAPIFGSKRSTTSLEFGPSPSPSPSSVGLPYNAPES-LR 649
Query: 602 GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVD 661
+P KWDVYSFGV+LLELLTGK + +V LV + G E + M D
Sbjct: 650 SIKPNSKWDVYSFGVILLELLTGKIVVVDELG----QVNGLV--IDDG---ERAIR-MAD 699
Query: 662 AMLLQEVHAKKE-VIAVFHLALACTEADPEVRPRMKNVSENLER 704
+ + E+ K+E V+A + LAC P+ RP +K + LER
Sbjct: 700 SAIRAELEGKEEAVLACLKMGLACASPIPQRRPNIKEALQVLER 743
|
|
| TAIR|locus:2124296 AT4G34220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.9e-90, Sum P(2) = 1.9e-90
Identities = 132/351 (37%), Positives = 193/351 (54%)
Query: 375 DSEVEDQEKVES------GK----GEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVY 424
+S+VE+Q+ V++ G+ + +LV +D +LD LL+ASAY+LG +G GIVY
Sbjct: 427 ESDVENQQTVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAYILGTTGTGIVY 486
Query: 425 KVVLGNGIPVAVRRLG-EG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482
K VL NG AVRR+ E + +EF EV+AIAK++HPN+V++R + W DEKLLIS
Sbjct: 487 KAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGFCWGDDEKLLIS 546
Query: 483 DFISNGNLA---NALRGRNGQPSTS-----LSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
D++ NG+L A + + S+S L++ RL+IA+G ARGL+Y++E +K VH
Sbjct: 547 DYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSYINE---KKQVH 603
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
G+IKP+NILL+ + +P I+D GL RL+ P+ G P + Y+
Sbjct: 604 GNIKPNNILLNAENEPIITDLGLDRLMT-----PARESHTTG-------PTSSSP---YQ 648
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEEN 654
PE +P KWDVYSFGV+LLELLT K + + D F
Sbjct: 649 PPEWST-SLKPNPKWDVYSFGVILLELLTSKVFSVDHDIDQFSNLSDSAAEENGRFLR-- 705
Query: 655 PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
L D A+ + +A F L + C + P+ RP MK + + LE+I
Sbjct: 706 -LID--GAIRSDVARHEDAAMACFRLGIECVSSLPQKRPSMKELVQVLEKI 753
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00035047001 | SubName- Full=Chromosome chr1 scaffold_75, whole genome shotgun sequence; (709 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 707 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-39 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-35 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-22 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-06 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.003 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 0.004 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 0.004 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 26/210 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG+ G G VY G VA++ + E E + E++ + K+ HPNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ L+ ++ G+L + L+ G+ LS LRI GL YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSN---GI 113
Query: 533 VHGDIKPSNILLDND-FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KP NILLD+D + ++DFGLS+L+ + + G T
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG----------------TP 157
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
Y APE + +K D++S GV+L EL
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 71/218 (32%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LG G VYK G G VAV+ L E ++ + E++ + ++ HPNIV+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEK-SKKDQTARREIRILRRLSHPNIVRLI 64
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ D L+ ++ G+L + L LS +IA RGL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+H D+KP NILLD + I+DFGL++ + + ++ ++ G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVG---------------- 160
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE + GN K DV+S GV+L ELLTGK P
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 2e-38
Identities = 95/253 (37%), Positives = 139/253 (54%), Gaps = 12/253 (4%)
Query: 5 FFFPFFLYFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNIT 64
F F FL+ + + LLS KS+I ++WN + C W GI+C N +
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPLKYLSNWNSSA-DVCLWQGITCNNSS 69
Query: 65 GFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFN-ATSLHSIF 123
RVV + +SGKN+ G I S + L Y++ +NL NN L G +PD +F ++SL +
Sbjct: 70 -----RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124
Query: 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA 183
L NN +GS+P ++P L+ LDLSNN SG +P+ + + L+ L L N G+IP
Sbjct: 125 LSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182
Query: 184 GIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVS 243
+ L +L L L+ N G IP +LG+++SL + L YN+LSG+IP +G L
Sbjct: 183 SL-TNLTSLEFLTLASNQLVGQIPRELGQMKSLK-WIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 244 FDLRGNNLSGEIP 256
DL NNL+G IP
Sbjct: 241 LDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 83/296 (28%), Positives = 126/296 (42%), Gaps = 55/296 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG+ G VYK L + VAV+ L + EQ+ EF+ E + + K+ HPN+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L + ++ +++ G+L + LR + LS S L A ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLES- 120
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPV 585
+ F+H D+ N L+ + ISDFGLSR + GG LP M
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-----GGKLPIRWM--- 170
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644
APE+ G + K DV+SFGV+L E+ T G+ P + +++
Sbjct: 171 ---------APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEQPYP------GMSNEEVLE 214
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700
++K G+ P + + + L L C DPE RP + E
Sbjct: 215 YLKNGYRLPQP-PNCPPEL--------------YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 87/310 (28%), Positives = 134/310 (43%), Gaps = 69/310 (22%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G VYK L G VAV+ L E E+ ++F+ E + + K+ HPN+V+L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR----NGQPSTSLSWSTRLRIAKGTARGLAYL 524
+ L+ +++ G+L + LR ++LS L A A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YM 582
+KFVH D+ N L+ D ISDFGLSR + + GG LP +M
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT----GGKLPIRWM 174
Query: 583 KP------VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTT 633
P + T K+ DV+SFGV+L E+ T G +P LS
Sbjct: 175 APESLKDGIFTSKS-------------------DVWSFGVLLWEIFTLGATPYPGLSNE- 214
Query: 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
+++ +++KG+ P + E ++ L L+C + DPE RP
Sbjct: 215 -------EVLEYLRKGYRLPKPE------------YCPDE---LYELMLSCWQLDPEDRP 252
Query: 694 RMKNVSENLE 703
+ E LE
Sbjct: 253 TFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 87/300 (29%), Positives = 130/300 (43%), Gaps = 58/300 (19%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G VYK L G + VAV+ L E ++ EF+ E + + K+ HPNIVK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L + +++ +++ G+L + LR + LS S L A ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLES- 121
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPV 585
+ F+H D+ N L+ + ISDFGLSR + GG LP M
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-----GGKLPIRWM--- 171
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTSTSIEVPDL 642
APE+ G + K DV+SFGV+L E+ T G+ P +S ++
Sbjct: 172 ---------APESLKEG-KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA--------EV 213
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
+ ++KKG+ P + + + L L C DPE RP + E L
Sbjct: 214 LEYLKKGYRLPKP-PNCPPEL--------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKLRAY 471
LG+ G VY G VA++ + + ++ RE + E++ + K+KHPNIV+L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ D+ L+ ++ G+L + L+ R LS + L YLH +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHS---KG 117
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
VH D+KP NILLD D ++DFGL+R + + F+G T
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL----DPGEKLTTFVG-------------TP 160
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE + G + D++S GV+L ELLTGK P
Sbjct: 161 EYMAPE-VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 83/298 (27%), Positives = 131/298 (43%), Gaps = 54/298 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G VYK L G VAV+ L EG + R EF+ E + K+ HPNIV+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L + ++++++ G+L + LR L+ L++A A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES- 120
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ FVH D+ N L+ + ISDFGLSR I GG + P+
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--------PI-- 168
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTSTSIEVPDLVR 644
+ APE+ + + K DV+SFGV+L E+ T G+ P +S +++
Sbjct: 169 ----KWMAPES-LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--------EVLE 215
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
++ G+ L + + E ++ L L C DPE RP + E+L
Sbjct: 216 LLEDGY------------RLPRPENCPDE---LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-33
Identities = 85/213 (39%), Positives = 120/213 (56%), Gaps = 22/213 (10%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN 139
N+ G IP E+G L L L+L NNL G +P L N +L +FLY N LSG +PPS+ +
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 140 LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199
L +L +LDLS+NS SG +P+ + + L+ L L N F+G+IP + L L L L
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL-TSLPRLQVLQLWS 341
Query: 200 NDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSL---GNLPVTVSFDLRGNNLSGEIP 256
N F G IP +LG+ +L+ L+LS N+L+G+IP+ L GNL + F N+L GEIP
Sbjct: 342 NKFSGEIPKNLGKHNNLT-VLDLSTNNLTGEIPEGLCSSGNLFKLILFS---NSLEGEIP 397
Query: 257 --------------QTGSFANQGPTAFLSNPLL 275
Q SF+ + P+ F PL+
Sbjct: 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLV 430
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-32
Identities = 79/181 (43%), Positives = 104/181 (57%), Gaps = 3/181 (1%)
Query: 78 GKNV-RGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPS 136
G NV G IP+ L +L L L L +N L G +P +L SL I+L NNLSG +P
Sbjct: 172 GGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYE 231
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+ L L +LDL N+ +G +P L N K LQ L L +NK SG IP I+ L+ L+ LD
Sbjct: 232 IGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIF-SLQKLISLD 290
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
LSDN G IP + +LQ+L L+L N+ +GKIP +L +LP L N SGEIP
Sbjct: 291 LSDNSLSGEIPELVIQLQNLE-ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
Query: 257 Q 257
+
Sbjct: 350 K 350
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 70/222 (31%), Positives = 106/222 (47%), Gaps = 28/222 (12%)
Query: 414 VLGKSGLGIVYKV-VLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G G VYK G VA++ + +++ + + E+Q + K KHPNIVK Y
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
DE ++ +F S G+L + L+ N +L+ S + K +GL YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H DIK +NILL +D + + DFGLS ++ ++ M G +M
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNT---MVGTPYWM---------- 164
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPT 632
APE + G K D++S G+ +EL GK P EL P
Sbjct: 165 --APE-VINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-28
Identities = 77/187 (41%), Positives = 97/187 (51%), Gaps = 5/187 (2%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
+S N+ G IP L S L +L L +N+L G +P L SL + L N+ SG LP
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQL 195
LP + LD+SNN+ G + + LQ L LARNKF G +P + L L
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS--KRLENL 480
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
DLS N F G +P LG L L L LS N LSG+IP L + VS DL N LSG+I
Sbjct: 481 DLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQI 539
Query: 256 PQTGSFA 262
P SF+
Sbjct: 540 P--ASFS 544
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 5e-28
Identities = 77/209 (36%), Positives = 106/209 (50%), Gaps = 27/209 (12%)
Query: 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN 128
P V + IS N++G I S + L+ L+L N FG LPD F + L ++ L N
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD-SFGSKRLENLDLSRNQ 486
Query: 129 LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE 188
SG++P + +L L L LS N SG +PD L +CK+L L L+ N+ SGQIPA + E
Sbjct: 487 FSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS-FSE 545
Query: 189 LENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248
+ L QLDLS N G IP +LG ++SL +N+S+NHL
Sbjct: 546 MPVLSQLDLSQNQLSGEIPKNLGNVESL-VQVNISHNHL--------------------- 583
Query: 249 NNLSGEIPQTGSFANQGPTAFLSNPLLCG 277
G +P TG+F +A N LCG
Sbjct: 584 ---HGSLPSTGAFLAINASAVAGNIDLCG 609
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 63/222 (28%), Positives = 111/222 (50%), Gaps = 30/222 (13%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAY 471
VLG+ G+VYKV G A++++ G++ R + + E++ + + P +VK
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
++ E ++ +++ G+LA+ L+ P L+ IA+ +GL YLH + R
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH--TKRH 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H DIKPSN+L+++ + I+DFG+S+++ T + ++ F+G YM P E+
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT---FVGTV-TYMSP---ERIQ 173
Query: 592 N--YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631
Y D++S G+ LLE GK P L P
Sbjct: 174 GESYSYAA------------DIWSLGLTLLECALGKFPFLPP 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 58/222 (26%), Positives = 100/222 (45%), Gaps = 34/222 (15%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+LG+ G VY + G +AV+ L E+ E++ ++ ++HPNIV+
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 471 YYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTA---RGLAYLH 525
++ + +++S G+L+ +L + G+ + I K T GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLS-SLLKKFGKLPEPV-------IRKYTRQILEGLAYLH 118
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
VH DIK +NIL+D+D ++DFG ++ + G + G +M
Sbjct: 119 S---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG--DIETGEGTGSVRGTPYWM--- 170
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
APE + G + D++S G ++E+ TGK P
Sbjct: 171 ---------APEV-IRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 81/292 (27%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G V++ + N + VA++ L + ++F EVQA+ +++H +++ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ +I++ + G+L LR GQ L ++ + +A A G+AYL E + +H
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEE---QNSIH 127
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ NIL+ D ++DFGL+RLI S +PY +
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDK------KIPY----------KWT 171
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
APEA G K DV+SFG++L E+ T G+ P EV D + G+
Sbjct: 172 APEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ---ITAGYRMP 224
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P QE++ + L C A+PE RP K + E L+ I
Sbjct: 225 CPAK------CPQEIY---------KIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 74/311 (23%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 415 LGKSGLGIVYKVVL-----GNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G V G VAV+ L G EQ +F E++ + + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 469 RAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ P + LI +++ +G+L + L+ Q ++ L + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDYLGS 127
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI-----TGNNPSSSGGFMGGALPY 581
++++H D+ NIL++++ ISDFGL++++ P S
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES---------- 174
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641
P+ + APE + ++ DV+SFGV L EL T P SP
Sbjct: 175 --PIF------WYAPEC-LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE-----FL 220
Query: 642 LVRWVKKGFEEENPLSDMVDAMLLQE-------VHAKKEVIAVFHLALACTEADPEVRPR 694
+ + +G + ++ +++ LL+E E V+ L C EA+P+ RP
Sbjct: 221 RMIGIAQG---QMIVTRLLE--LLKEGERLPRPPSCPDE---VYDLMKLCWEAEPQDRPS 272
Query: 695 MKNVSENLERI 705
++ ++R+
Sbjct: 273 FADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 65/221 (29%), Positives = 94/221 (42%), Gaps = 24/221 (10%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHP-NIVKLR 469
LG+ G VY + VA++ L E + F+ E+Q +A + HP NIVKL
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
++ L+ +++ G+L + L+ LS S L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK--KIGRKGPLSESEALFILAQILSALEYLHS--- 119
Query: 530 RKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+ +H DIKP NILLD + + DFGL++L+ G V T
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL-------PDPGSTSSIPALPSTSVGTP 172
Query: 589 KTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE + D++S G+ L ELLTG P
Sbjct: 173 ---GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-23
Identities = 79/255 (30%), Positives = 118/255 (46%), Gaps = 40/255 (15%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
+E+ + K++HPNIVKL + LI ++I NL+ LR LSW R
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRR 783
Query: 512 RIAKGTARGLAYLH-ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
+IA G A+ L +LH CSP V G++ P I++D +P++ L L+ S
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVV-GNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
S Y APE R +K D+Y FG++L+ELLTGKSP
Sbjct: 842 SA--------------------YVAPETR-ETKDITEKSDIYGFGLILIELLTGKSP--- 877
Query: 631 PTTSTSIEVPD-LVRWVKKGFEEENPLSDMVDAMLLQEVHA-KKEVIAVFHLALACTEAD 688
V +V W + + + + L +D + +V + E++ V +LAL CT D
Sbjct: 878 --ADAEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD 934
Query: 689 PEVRPRMKNVSENLE 703
P RP +V + LE
Sbjct: 935 PTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 50/292 (17%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
+GK G V G VAV+ L + + F+ E + ++HPN+V+L
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ +++++++ G+L + LR R ++ + +L A G+ YL E + FVH
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEE---KNFVH 125
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ N+L+ D +SDFGL++ +S G G LP +
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPV----------KWT 166
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
APEA + + K DV+SFG++L E+ + G+ P I + D+V V+KG+ E
Sbjct: 167 APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP------YPRIPLKDVVPHVEKGYRME 219
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P + V+ + C E DP RP K + E L I
Sbjct: 220 AP---------------EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+GK G VY V +G ++ L E+ + + EV+ + K+ HPNI+K
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 471 YYWAPDEKLLISDFISNGNLANAL--RGRNGQP---STSLSWSTRLRIAKGTARGLAYLH 525
+ + ++ ++ G+L+ + + + G+P L W +L +A L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLH 120
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
RK +H DIKP NI L ++ + DFG+S++++ T + + G PY
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG-----TPY---- 168
Query: 586 QTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE P N K D++S G VL EL T K P
Sbjct: 169 -------YLSPELCQNKPYN---YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 59/302 (19%)
Query: 414 VLGKSGLGIVYK---VVLGNG--IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + G IPVA++ L E + ++E + E +A V HP++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 468 LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYL 524
L ++ LI+ + G L + +R L+W + IAKG ++YL
Sbjct: 74 L--LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ--IAKG----MSYL 125
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
E ++ VH D+ N+L+ I+DFGL++L+++ + GG + P
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--------P 174
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP-ELSPTTSTSIEVPDL 642
++ + A E+ + K DV+S+GV + EL+T G P E P +E+PDL
Sbjct: 175 IK------WMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDL 223
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
++KG P +D V+ + + C D E RP K +
Sbjct: 224 ---LEKGERLPQPPICTID---------------VYMVLVKCWMIDAESRPTFKELINEF 265
Query: 703 ER 704
+
Sbjct: 266 SK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 68/275 (24%), Positives = 126/275 (45%), Gaps = 45/275 (16%)
Query: 432 IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
I VA++ L G +++ +F+TE + + HPNI++L ++I++++ NG+L
Sbjct: 33 IDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL 92
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
LR +G+ + + + +G A G+ YL S +VH D+ NIL++++
Sbjct: 93 DKFLRENDGK----FTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVNSNLVC 145
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWD 610
+SDFGLSR + + ++ GG +P + APEA + + D
Sbjct: 146 KVSDFGLSRRL----EDSEATYTTKGGKIPIR----------WTAPEA-IAYRKFTSASD 190
Query: 611 VYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVH 669
V+SFG+V+ E+++ G+ P + D+++ V+ G+ P M L +
Sbjct: 191 VWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRLPPP---MDCPSALYQ-- 239
Query: 670 AKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704
L L C + D RP + L++
Sbjct: 240 ----------LMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-21
Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 26/200 (13%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
G IP + SL L L+L +N+L G +P+ + +L + L+ NN +G +P ++ +LPR
Sbjct: 274 GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 143 LQ------------------------NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
LQ LDLS N+ +G +P+GL + L +LIL N
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393
Query: 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL 238
G+IP + +L ++ L DN F G +P++ +L L L++S N+L G+I ++
Sbjct: 394 GEIPKSL-GACRSLRRVRLQDNSFSGELPSEFTKLP-LVYFLDISNNNLQGRINSRKWDM 451
Query: 239 PVTVSFDLRGNNLSGEIPQT 258
P L N G +P +
Sbjct: 452 PSLQMLSLARNKFFGGLPDS 471
|
Length = 968 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 77/307 (25%), Positives = 126/307 (41%), Gaps = 56/307 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIV 466
LG+ G V+ + P VAV+ L E ++F E + + +H NIV
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALR---------GRNGQPSTSLSWSTRLRIAKGT 517
K D +++ +++ +G+L LR P L+ S L+IA
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A G+ YL + + FVH D+ N L+ D I DFG+SR ++ + GG
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHT-- 184
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTS 636
M P++ + PE+ + + DV+SFGVVL E+ T GK P +
Sbjct: 185 ----MLPIR------WMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696
IE + +G + P + V+ + L C + DP+ R +K
Sbjct: 234 IEC------ITQGRLLQRP-----------RTCPSE----VYDIMLGCWKRDPQQRINIK 272
Query: 697 NVSENLE 703
++ E L+
Sbjct: 273 DIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
++G+ G+VYK + L G VA+++ L + E+ + + E+ + +KHPNIVK
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
D +I ++ NG+L ++ + G SL +GLAYLHE +
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK-KFGPFPESLV----AVYVYQVLQGLAYLHE---Q 118
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H DIK +NIL D ++DFG++ +N + +S G T
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG----------------T 162
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPT 632
+ APE + + D++S G ++ELLTG P +L+P
Sbjct: 163 PYWMAPEV-IEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM 205
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 44/277 (15%)
Query: 432 IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
I VA++ L G E++ R+F++E + + HPNI+ L ++I++F+ NG L
Sbjct: 33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL 92
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
+ LR +GQ T + LR G A G+ YL E + +VH D+ NIL++++
Sbjct: 93 DSFLRQNDGQ-FTVIQLVGMLR---GIAAGMKYLSEMN---YVHRDLAARNILVNSNLVC 145
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWD 610
+SDFGLSR + ++P+ + +GG +P + APEA + + D
Sbjct: 146 KVSDFGLSRFLEDDTSDPTYTSS-LGGKIPI----------RWTAPEA-IAYRKFTSASD 193
Query: 611 VYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVH 669
V+S+G+V+ E+++ G+ P + D++ +++ + P+
Sbjct: 194 VWSYGIVMWEVMSYGERPYWDMSNQ------DVINAIEQDYRLPPPM------------- 234
Query: 670 AKKEVIAVFH-LALACTEADPEVRPRMKNVSENLERI 705
+ H L L C + D RP+ + L+++
Sbjct: 235 ---DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G V+ VAV+ L G F+ E Q + K++H +V+L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ ++++++S G+L + L+ G+ L + +A A G+AYL R ++H
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLES---RNYIH 126
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ NIL+ + I+DFGL+RLI F P++ +
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF---------PIK------WT 171
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
APEA G R K DV+SFG++L E++T G+ P
Sbjct: 172 APEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G V++ + N PVAV+ L + G ++F+ E Q + K++HP +++L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ ++++ + G+L L+G G +L + +A A G+AYL + ++H
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEA---QNYIH 126
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ N+L+ + ++DFGL+R+I F P++ +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF---------PIK------WT 171
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
APEA NR K DV+SFG++L E++T G+ P
Sbjct: 172 APEA-ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 70/276 (25%), Positives = 134/276 (48%), Gaps = 44/276 (15%)
Query: 432 IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
IPVA++ L G E++ R+F++E + + HPNI+ L +++++++ NG+L
Sbjct: 33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL 92
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
LR +GQ T + LR G A G+ YL + +VH D+ NIL++++
Sbjct: 93 DAFLRKHDGQ-FTVIQLVGMLR---GIASGMKYLSDMG---YVHRDLAARNILVNSNLVC 145
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWD 610
+SDFGLSR++ ++P ++ GG +P + APEA + + D
Sbjct: 146 KVSDFGLSRVLE---DDPEAAYTTRGGKIPI----------RWTAPEA-IAYRKFTSASD 191
Query: 611 VYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVH 669
V+S+G+V+ E+++ G+ P + D+++ +++G+ P+
Sbjct: 192 VWSYGIVMWEVMSYGERPYWEMSNQ------DVIKAIEEGYRLPAPMDCPA--------- 236
Query: 670 AKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
A+ L L C + D RP+ + + L+++
Sbjct: 237 ------ALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 75/300 (25%), Positives = 142/300 (47%), Gaps = 52/300 (17%)
Query: 414 VLGKSGLGIVYKVVLG----NGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKL 468
V+G G V++ +L + VA++ L G ++ R +F++E + + H NI++L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
++I++++ NG L LR +G+ +S LR G A G+ YL + +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQLVGMLR---GIAAGMKYLSDMN 127
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+VH D+ NIL++++ + +SDFGLSR++ ++P + GG +P
Sbjct: 128 ---YVHRDLAARNILVNSNLECKVSDFGLSRVLE---DDPEGTYTTSGGKIPI------- 174
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTSTSIEVPDLVRW 645
+ APEA + + DV+SFG+V+ E+++ G+ P ++S ++++
Sbjct: 175 ---RWTAPEA-IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKA 222
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ GF P+ AV+ L L C + D RPR ++ L+++
Sbjct: 223 INDGFRLPAPMDCPS---------------AVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 78/293 (26%), Positives = 132/293 (45%), Gaps = 50/293 (17%)
Query: 415 LGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG G VY+ V + VAV+ L E + EF+ E + ++KHPN+V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+I++F++ GNL + LR N ++ L +A + + YL + + F+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFI 126
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG--FMGGALPYMKPVQTEKTN 591
H D+ N L+ + ++DFGLSRL +TG+ ++ G F P++
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKF---------PIK----- 170
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ APE+ + N+ K DV++FGV+L E+ T G SP I++ + ++KG+
Sbjct: 171 -WTAPES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKGY 222
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
E P V+ L AC + +P RP + + E
Sbjct: 223 RMERPEGCPPK---------------VYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 69/233 (29%), Positives = 111/233 (47%), Gaps = 32/233 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRR-LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LG G+V KV+ G +AV+ E E ++ + E+ + K P IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQ-PSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
++ + + +++ G+L L+ G+ P L +IA +GL YLHE
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE--KH 120
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
K +H D+KPSNIL+++ Q + DFG+S +L+N S + F+G
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN------SLAKTFVG------------- 161
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
T++Y APE R+ GN K D++S G+ L+EL TG+ P P + +L
Sbjct: 162 TSSYMAPE-RIQGNDYSVKSDIWSLGLSLIELATGRFP-YPPENDPPDGIFEL 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 6e-18
Identities = 56/187 (29%), Positives = 82/187 (43%), Gaps = 47/187 (25%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
TE ++++ HP IVKL Y + +EKL L+ ++ G L + L S
Sbjct: 42 TERNILSRINHPFIVKL-HYAFQTEEKLYLVLEYAPGGELFSHL-------------SKE 87
Query: 511 LRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
R ++ AR L YLH ++ D+KP NILLD D ++DFGL++
Sbjct: 88 GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAK-EL 143
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLE 620
+ S + F G T Y APE + + D +S GV+L E
Sbjct: 144 SSEG--SRTNTFCG-------------TPEYLAPEVLLGKGYGKAV---DWWSLGVLLYE 185
Query: 621 LLTGKSP 627
+LTGK P
Sbjct: 186 MLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 87/344 (25%), Positives = 143/344 (41%), Gaps = 85/344 (24%)
Query: 394 VAIDKGFTFELDELLRASAYVLGKS-GLGIVYKVVLGN--GIP-------VAVRRL-GEG 442
+ +D + D L LGK G G +VV G+ VAV+ L +
Sbjct: 1 LPLDPEWELPRDRL------TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA 54
Query: 443 GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQ- 500
E+ + V+E++ + + KH NI+ L ++ ++ ++GNL + LR R
Sbjct: 55 TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPG 114
Query: 501 ----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
P +L+ + A ARG+ +L + +K +H D+ N+L+ D
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVM 171
Query: 551 YISDFGLSRLINI------TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA---RVP 601
I+DFGL+R I+ T N G LP + APEA RV
Sbjct: 172 KIADFGLARDIHHIDYYRKTTN----------GRLPV----------KWMAPEALFDRVY 211
Query: 602 GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVD 661
++ DV+SFGV+L E+ T L + I V +L + +K+G+ E P + +
Sbjct: 212 THQS----DVWSFGVLLWEIFT-----LGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQE 262
Query: 662 AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++HL C P RP K + E+L+R+
Sbjct: 263 ---------------LYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G VYK VL VAV+ R + + R+F+ E + + + HPNIVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
++ + + G+L LR + + L+ L+++ A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+ N L+ + ISDFG+SR G + S G +K + + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDG--------LKQIPIKWT-- 162
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651
APEA G R + DV+S+G++L E + G +P + + E ++ G+
Sbjct: 163 --APEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER------IESGYR 213
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
P + ++ L L C DPE RP + L+
Sbjct: 214 MPAPQLCPEE---------------IYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 34/223 (15%)
Query: 415 LGKSGLGIVYK-----VVLGN-GIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G+VY+ VV G VA++ + E R R EF+ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGR-------NGQPSTSLSWSTRLRIAKGTARG 520
L L++ + ++ G+L + LR R G +L +++A A G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ--KFIQMAAEIADG 131
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+AYL +KFVH D+ N ++ D I DFG++R I T G +
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL----- 183
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
PV+ + APE+ G K DV+SFGVVL E+ T
Sbjct: 184 ---PVR------WMAPESLKDGVFTT-KSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 80/309 (25%), Positives = 124/309 (40%), Gaps = 59/309 (19%)
Query: 414 VLGKSGLGIVYKVVL--------GNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPN 464
VLG+ G KV L G G VAV+ L Q++ + E+ + + H N
Sbjct: 11 VLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 465 IVKLRAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
IVK + K LI +++ G+L + L P L+ + L A+ G+A
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMA 121
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
YLH + ++H D+ N+LLDND I DFGL++ + P G Y
Sbjct: 122 YLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV------PE-------GHEYYR 165
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
+ + A E + N+ DV+SFGV L ELLT + SP
Sbjct: 166 VREDGDSPVFWYAVEC-LKENKFSYASDVWSFGVTLYELLTHCDSKQSPP---------- 214
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIA--------VFHLALACTEADPEVRPR 694
KK E P + + L E+ + + V+ L C E + + RP
Sbjct: 215 ----KKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT 270
Query: 695 MKNVSENLE 703
+++ L+
Sbjct: 271 FRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 62/214 (28%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 421 GIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-- 475
G VY V L G +AV+ R+ + + +E E++ + +KHPN+VK YY
Sbjct: 14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---YYGVEVH 70
Query: 476 DEKLLI-SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
EK+ I ++ S G L L + GLAYLH VH
Sbjct: 71 REKVYIFMEYCSGGTLEELLEHGRILDEHVIR-----VYTLQLLEGLAYLHSH---GIVH 122
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQTEKTNNY 593
DIKP+NI LD++ + DFG + + + G YM P V T
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
A D++S G V+LE+ TGK P
Sbjct: 183 HGRAA-----------DIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 81/318 (25%), Positives = 131/318 (41%), Gaps = 70/318 (22%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVK 467
+G+ G V++ +P VAV+ L E +F E +A+ HPNIVK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRN-----------------GQPSTSLSWSTR 510
L L+ ++++ G+L LR R+ G LS + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
L IAK A G+AYL E RKFVH D+ N L+ + I+DFGLSR I +S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
+ P++ + PE+ + NR + DV+++GVVL E+ S +
Sbjct: 190 ENDAI--------PIR------WMPPES-IFYNRYTTESDVWAYGVVLWEIF---SYGMQ 231
Query: 631 PTTSTSIEVPDLVRWVKKG----FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTE 686
P + E +++ +V+ G + PL +++L C
Sbjct: 232 PYYGMAHE--EVIYYVRDGNVLSCPDNCPLE-------------------LYNLMRLCWS 270
Query: 687 ADPEVRPRMKNVSENLER 704
P RP +++ L+R
Sbjct: 271 KLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQR--HREFVTEVQAIAKVKHPNIVKLR 469
+GK G+V+KVV + A++++ R E + E + +AK+ I++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR-- 63
Query: 470 AYY--WAPDEKL-LISDFISNGNLANALRGRNGQP-STSLSWSTRLRIAKGTARGLAYLH 525
YY + KL ++ ++ NG+L L+ + G+P W R GLA+LH
Sbjct: 64 -YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLH 118
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+K +H DIK N+ LD I D G+++L++ N ++ G PY
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVG-----TPY---- 166
Query: 586 QTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
Y +PE + ++P +K DV++ GVVL E TGK P
Sbjct: 167 -------YLSPE--LCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 82/302 (27%), Positives = 144/302 (47%), Gaps = 49/302 (16%)
Query: 406 ELLRASAYVLGKSGLGIVYKVVLG--NG-IPVAVRRLGEGGEQRHREFVTEVQAIAKVKH 462
E+ R S ++ K G G +V +G NG VAV+ L + G F+ E Q + K++H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
+V+L A + + ++++++S G+L + L+ G+ +L + +A A G+A
Sbjct: 61 DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGR---ALKLPNLVDMAAQVAAGMA 116
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
Y+ + ++H D++ +NIL+ + I+DFGL+RLI F
Sbjct: 117 YIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-------- 165
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPD 641
P++ + APEA + G R K DV+SFG++L EL+T G+ P P + +
Sbjct: 166 -PIK------WTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP--YPGMNNR----E 211
Query: 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701
++ V++G+ P + I++ L L C + DPE RP + +
Sbjct: 212 VLEQVERGYRMPCP---------------QDCPISLHELMLQCWKKDPEERPTFEYLQSF 256
Query: 702 LE 703
LE
Sbjct: 257 LE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 403 ELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKV 460
EL+ + R +G G VYKV+ G A++ + G + R+ E++ + V
Sbjct: 75 ELERVNR-----IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV 129
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
HPN+VK + E ++ +F+ G+L + +A+ G
Sbjct: 130 NHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VARQILSG 180
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+AYLH R VH DIKPSN+L+++ I+DFG+SR++ T + +SS G +
Sbjct: 181 IAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIA 233
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
YM P + N+ A + D++S GV +LE G+ P
Sbjct: 234 YMSPERINTDLNHGAYDGYAG--------DIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 74/307 (24%), Positives = 129/307 (42%), Gaps = 54/307 (17%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G V+ N P VAV+ L + + ++F E + + ++H +IVK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR--------NGQPSTSLSWSTRLRIAKGTARG 520
D +++ +++ +G+L LR G L+ S L IA+ A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+ YL + + FVH D+ N L+ + I DFG+SR ++ + GG +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIR 187
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEV 639
+M P ++ YR + + DV+S GVVL E+ T GK P + + IE
Sbjct: 188 WMPP----ESIMYR---------KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234
Query: 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
+ +G + P + +E V+ L L C + +P +R +K +
Sbjct: 235 ------ITQGRVLQRPRT------CPKE---------VYDLMLGCWQREPHMRLNIKEIH 273
Query: 700 ENLERIG 706
L+ +
Sbjct: 274 SLLQNLA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 71/290 (24%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G V+ VA++ L +G F+ E + +++HP +V+L A
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ +I++++ NG+L + L+ G L+ + + +A A G+A++ + ++H
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D++ +NIL+ I+DFGL+RLI F P++ +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF---------PIK------WT 170
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
APEA G + K DV+SFG++L E++T G+ P T P++++ +++G+
Sbjct: 171 APEAINYGTFTI-KSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLERGYRMP 223
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
P D L + L C + PE RP + + LE
Sbjct: 224 RP--DNCPEEL-------------YELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 52/288 (18%)
Query: 423 VYKVVLGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLI 481
VY + G + VAV+ L + +EF+ E +A++ HP IV+L +L+
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PLMLV 73
Query: 482 SDFISNGNLANALRG-RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540
+ G L L+ R S + ++ A G+AYL FVH D+
Sbjct: 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESK---HFVHRDLAAR 124
Query: 541 NILLDNDFQPYISDFGLSRLINITGNN--PSSSGGFMGGALPYMKPVQTEKTNNYRAPEA 598
N+LL N Q ISDFG+SR + G++ +++ G P++ + APE
Sbjct: 125 NVLLVNRHQAKISDFGMSRALG-AGSDYYRATTAG--------RWPLK------WYAPEC 169
Query: 599 RVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLS 657
G + K DV+S+GV L E + G P ++ +++ ++ G P
Sbjct: 170 INYG-KFSSKSDVWSYGVTLWEAFSYGAKP------YGEMKGAEVIAMLESGERLPRP-- 220
Query: 658 DMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ ++ + L+C + PE RP + R
Sbjct: 221 -------------EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 77/291 (26%), Positives = 121/291 (41%), Gaps = 50/291 (17%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G+V+ I VA++ + EG +F+ E + + K+ HPN+V+L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+++++++NG L N LR R G+ T L + + YL F+H
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTE----WLLDMCSDVCEAMEYLESNG---FIH 123
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG--FMGGALPYMKPVQTEKTNN 592
D+ N L+ D +SDFGL+R + + +SS G F PV+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKF---------PVK------ 166
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651
+ PE +R K DV+SFGV++ E+ + GK P S S ++V V G+
Sbjct: 167 WAPPEV-FDYSRFSSKSDVWSFGVLMWEVFSEGKMP--YERFSNS----EVVESVSAGYR 219
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
P A EV + + C PE RP K + L
Sbjct: 220 LYRPKL------------APTEVYTIMYS---CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 67/269 (24%), Positives = 107/269 (39%), Gaps = 58/269 (21%)
Query: 415 LGKSGLGIVYK-VVLGNGIPVA-----VRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
+G+ GIV+K G VA +RRL G + + E++A+ +HP +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR----GLAYL 524
+ +L+ +++ + L+ LR + K R G+AY+
Sbjct: 65 LDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEA--------QVKSYMRMLLKGVAYM 115
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H +H D+KP+N+L+ D I+DFGL+RL + Y
Sbjct: 116 HA---NGIMHRDLKPANLLISADGVLKIADFGLARLFS------------EEEPRLYSHQ 160
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP---------EL------ 629
V T YRAPE + D+++ G + ELL G SP +L
Sbjct: 161 VATRW---YRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRT 216
Query: 630 --SPTTSTSIEVPDLVRWVKKGFEEENPL 656
+P T + L + K F E P+
Sbjct: 217 LGTPNEETWPGLTSLPDYNKITFPESKPI 245
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 63/217 (29%), Positives = 92/217 (42%), Gaps = 45/217 (20%)
Query: 421 GIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE 477
G+VYK G VA++ RL E + E+ + ++KHPNIVKL +
Sbjct: 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK 72
Query: 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI 537
L+ ++ +L L R G LS + I RGLAY H + +H D+
Sbjct: 73 LYLVFEYCDM-DLKKYLDKRPGP----LSPNLIKSIMYQLLRGLAYCHS---HRILHRDL 124
Query: 538 KPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE 597
KP NIL++ D ++DFGL+R I Y V T YRAPE
Sbjct: 125 KPQNILINRDGVLKLADFGLARAFGIPLR-------------TYTHEVVTLW---YRAPE 168
Query: 598 ----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
++ V D++S G + E++TGK
Sbjct: 169 ILLGSKHYSTAV---------DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 76/307 (24%), Positives = 126/307 (41%), Gaps = 56/307 (18%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G V+ N +P VAV+ L E E ++F E + + ++H +IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 469 RAYYWAPDEKLLISDFISNGNL----------ANALRGRNGQPSTSLSWSTRLRIAKGTA 518
L++ +++ +G+L A L G L+ L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G+ YL + FVH D+ N L+ I DFG+SR +I + GG
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLP 187
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637
+ +M P ++ YR + + D++SFGVVL E+ T GK P + + +I
Sbjct: 188 IRWMPP----ESILYR---------KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
E + +G E E P + EV A+ C + +P+ R +K+
Sbjct: 235 EC------ITQGRELERPRT------------CPPEVYAIMQ---GCWQREPQQRMVIKD 273
Query: 698 VSENLER 704
+ L+
Sbjct: 274 IHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 80/303 (26%), Positives = 139/303 (45%), Gaps = 57/303 (18%)
Query: 414 VLGKSGLGIVYK-VVLGNG----IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + + G IPVA++ L E G + + EF+ E +A + HP++V+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSL--SWSTRLRIAKGTARGLAYLH 525
L +P +L ++ + +G L + + + L +W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
E R+ VH D+ N+L+ + I+DFGL+RL+ ++ GG M P+
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--------PI 175
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT--GKSPELSPTTSTSIEVPDLV 643
+ + A E + + + DV+S+GV + EL+T GK + PT E+PDL
Sbjct: 176 K------WMALEC-IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR----EIPDL- 223
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
++KG P +D V+ + + C D + RP+ K ++
Sbjct: 224 --LEKGERLPQPPICTID---------------VYMVMVKCWMIDADSRPKFKELAAEFS 266
Query: 704 RIG 706
R+
Sbjct: 267 RMA 269
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 9e-16
Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 49/256 (19%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWST 509
F+ E + K+ H N+V+L + ++ + +S GNL N LR R G+ S+
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTR-GRALVSVI--Q 101
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
L+ + A G+ YL +K VH D+ NIL+ D +SDFGL+R+
Sbjct: 102 LLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV--------- 149
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPE 628
S G LP + APEA + + K DV+S+GV+L E+ + G++P
Sbjct: 150 GSMGVDNSKLPV----------KWTAPEA-LKHKKFSSKSDVWSYGVLLWEVFSYGRAP- 197
Query: 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEAD 688
P S + ++ V+KG+ E P D V+ L +C E +
Sbjct: 198 -YPKMS----LKEVKECVEKGYRMEPPEGCPAD---------------VYVLMTSCWETE 237
Query: 689 PEVRPRMKNVSENLER 704
P+ RP + E LE+
Sbjct: 238 PKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 71/229 (31%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 415 LGKSGLGIVY----KVVLGNG---IPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIV 466
LG G VY +LG G I VAV+ L +G +Q +EF+ E ++ HPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYL 524
KL + + +I + + G+L + LR + L+ L I A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 525 HECSPRKFVHGDIKPSNILL-----DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
+ F+H D+ N L+ D D I DFGL+R +I ++ G G L
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEG--EGLL 175
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
P + APE+ + G Q DV+SFGV++ E+LT G+ P
Sbjct: 176 PV----------RWMAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 37/222 (16%)
Query: 415 LGKSGLGIVYK-VVLGNGIPVAVRRL-----GEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG G VY+ + L +G AV+ + G+ G++ ++ E+ ++K++HPNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 469 RAYYWAP--DEKLLIS-DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
Y ++ L I + + G+LA L+ P + TR + GL YLH
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+ R VH DIK +NIL+D + ++DFG+++ + + + S G+ +M P
Sbjct: 120 D---RNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKS---FKGSPYWMAPE 171
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ Y D++S G +LE+ TGK P
Sbjct: 172 VIAQQGGYGLAA------------DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 34/220 (15%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LGK G VYKV L + A++ LG ++ + V E++ +A V HPNI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPS---TSLSWSTRLRIAKGTARGLAYLHECS 528
+ ++ ++ ++ G+L+ A+ R + W +++ RGL LHE
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALHE-- 121
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+K +H D+K +NILL + I D G+S++ + N M Q
Sbjct: 122 -QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKN---------------MAKTQI- 162
Query: 589 KTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
T +Y APE V RP K D++S G +L E+ T P
Sbjct: 163 GTPHYMAPE--VWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRH--RE----FVT-EVQAIAKVK-HPN 464
++G+ V A++ L ++R +E +V E + + ++ HP
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL----DKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 465 IVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
I+KL YY DE+ L + ++ NG L +R SL A L
Sbjct: 64 IIKL--YYTFQDEENLYFVLEYAPNGELLQYIR-----KYGSLDEKCTRFYAAEILLALE 116
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
YLH + +H D+KP NILLD D I+DFG +++++ + S+ G
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 583 KPVQTEK----TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
K + T Y +PE + + D+++ G ++ ++LTGK P
Sbjct: 174 KNRRRFASFVGTAEYVSPEL-LNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG+ G V+ VA++ L + G F+ E Q + K++H +V+L A +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ ++++++S G+L + L+G + L + +A A G+AY+ + +VH
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 125
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D++ +NIL+ + ++DFGL+RLI F P++ +
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---------PIK------WT 170
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
APEA + G R K DV+SFG++L EL T G+ P
Sbjct: 171 APEAALYG-RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 53/184 (28%), Positives = 84/184 (45%), Gaps = 27/184 (14%)
Query: 447 HREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTS 504
++ + E++ K P IVK + + ++ G+L +++ + +
Sbjct: 43 QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGR 101
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINI 563
+ +IA+ +GL+YLH RK +H DIKPSNILL Q + DFG+S L+N
Sbjct: 102 IGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157
Query: 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
S +G F G T+ Y APE R+ G DV+S G+ LLE+
Sbjct: 158 -----SLAGTFTG-------------TSFYMAPE-RIQGKPYSITSDVWSLGLTLLEVAQ 198
Query: 624 GKSP 627
+ P
Sbjct: 199 NRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 42/217 (19%)
Query: 421 GIVYKVV-LGNGIPVAVRRLGEGGEQRHREF-VT---EVQAIAKVKHPNIVKLRAYYWAP 475
G VYK G VA++++ E F +T E++ + K++HPNIV+L+ +
Sbjct: 13 GQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK 70
Query: 476 DEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+ ++ +++ + +L L P + S K GL YLH +
Sbjct: 71 GKGSIYMVFEYMDH-DLTGLLD----SPEVKFTESQIKCYMKQLLEGLQYLHS---NGIL 122
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN- 592
H DIK SNIL++ND ++DFGL+R +S + TN
Sbjct: 123 HRDIKGSNILINNDGVLKLADFGLARPY-----TKRNSADY---------------TNRV 162
Query: 593 ----YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
YR PE + R + D++S G +L EL GK
Sbjct: 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 84/338 (24%), Positives = 135/338 (39%), Gaps = 81/338 (23%)
Query: 389 GEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ-RH 447
GEGE + K F L G++G VAV+ L E
Sbjct: 9 GEGEFGKVVKATAFRLK----------GRAGY-----------TTVAVKMLKENASSSEL 47
Query: 448 REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR-GRNGQPSTSLS 506
R+ ++E + +V HP+++KL LLI ++ G+L + LR R PS S
Sbjct: 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGS 107
Query: 507 WSTR------------------LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
R + A +RG+ YL E K VH D+ N+L+
Sbjct: 108 DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGR 164
Query: 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
+ ISDFGLSR + + Y+K + + A E+ + + +
Sbjct: 165 KMKISDFGLSRDVYEEDS--------------YVKRSKGRIPVKWMAIES-LFDHIYTTQ 209
Query: 609 WDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQE 667
DV+SFGV+L E++T G +P I L +K G+ E P + + M
Sbjct: 210 SDVWSFGVLLWEIVTLGGNP------YPGIAPERLFNLLKTGYRMERP-ENCSEEM---- 258
Query: 668 VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++L L C + +P+ RP ++S+ LE++
Sbjct: 259 ----------YNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 76/290 (26%), Positives = 124/290 (42%), Gaps = 48/290 (16%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G+V+ I VA++ + EG +F+ E + + K+ HP +V+L
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
++++F+ NG L N LR R G+ LS L + + G+ YL S F+H
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ N L+ + +SDFG++R + + SSSG PV+ +
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKF--------PVK------WS 168
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
PE ++ K DV+SFGV++ E+ T GK P ++ EV V + +GF
Sbjct: 169 PPEV-FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK---KSNYEV---VEMISRGFRLY 221
Query: 654 NP-LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
P L+ M V+ + +C PE RP + +
Sbjct: 222 RPKLASMT----------------VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
+G G+V+ VA++ + EG +F+ E Q + K+ HP +V+L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
L+ +F+ +G L++ LR + G S T L + G+AYL + +H
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D+ N L+ + +SDFG++R + + SS+G PV+ +
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKF--------PVK------WS 168
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
+PE K DV+SFGV++ E+ + GK+P + + S +E
Sbjct: 169 SPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 40/229 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV------RRLGEGGEQRHREFV----TEVQAIAKVKH 462
++GK G VY + + G +AV + + R ++ V +E++ + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARG 520
NIV+ + + + +++ G++ + LR GR + + G
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-------FTEQVLEG 120
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI-NITGNNPSSSGGFMGGAL 579
LAYLH + +H D+K N+L+D D ISDFG+S+ +I N+ + S M G++
Sbjct: 121 LAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS---MQGSV 174
Query: 580 PYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+M P V + Y A K D++S G V+LE+ G+ P
Sbjct: 175 FWMAPEVIHSYSQGYSA------------KVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQR--HREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK G VA++++ E + + E++ + ++ HPNI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ + L+ +F+ +L ++ R L S +GLA+ H
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HG 118
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KP N+L++ + ++DFGL+R S Y+ T
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-------GSPVRPY---THYV------VTR 162
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
YRAPE + D++S G + ELL+ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 401 TFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK 459
F++ E LG+ G VYK + G VA++ + + + E + E+ + +
Sbjct: 4 VFDILE-------KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ--EIIKEISILKQ 54
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
P IVK Y+ + ++ ++ G++++ ++ N +L+ I T +
Sbjct: 55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN----KTLTEEEIAAILYQTLK 110
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL YLH K +H DIK NILL+ + Q ++DFG+S + T + +G
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM---AKRNTVIGTPF 164
Query: 580 PYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+M P V E N +A D++S G+ +E+ GK P
Sbjct: 165 -WMAPEVIQEIGYNNKA--------------DIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 79/312 (25%), Positives = 135/312 (43%), Gaps = 61/312 (19%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G V+ N P VAV+ L + ++F E + + ++H +IVK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR--------NGQPSTS---LSWSTRLRIAKGT 517
D +++ +++ +G+L LR +GQP + L S L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A G+ YL + + FVH D+ N L+ + I DFG+SR ++ + GG
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTML 187
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTS 634
+ +M P ++ YR + + DV+SFGV+L E+ T GK P +LS T
Sbjct: 188 PIRWMPP----ESIMYR---------KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-- 232
Query: 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+++ + +G E P V K+ V+ + L C + +P+ R
Sbjct: 233 ------EVIECITQGRVLERP-----------RVCPKE----VYDIMLGCWQREPQQRLN 271
Query: 695 MKNVSENLERIG 706
+K + + L +G
Sbjct: 272 IKEIYKILHALG 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREF---VTEVQAIAKVKHPNIVKLR 469
V+G +VY + L N VA++R+ E+ EVQA+++ HPN+VK
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDL--EKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ DE L+ ++S G+L + ++ P L + + K +GL YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSY--PRGGLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+H DIK NILL D I+DFG+S + G+ G +M P E+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ Y K D++SFG+ +EL TG +P
Sbjct: 181 VHGYD------------FKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 39/103 (37%), Positives = 60/103 (58%)
Query: 98 LNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSL 157
L L N L G +P+ + L SI L GN++ G++PPS+ ++ L+ LDLS NSF+GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 158 PDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
P+ L L+ L L N SG++PA + L + + +DN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 42/108 (38%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL 238
G IP +L +L ++LS N +G IP LG + SL L+LSYN +G IP+SLG L
Sbjct: 432 GFIPND-ISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGSIPESLGQL 489
Query: 239 PVTVSFDLRGNNLSGEIPQT--GSFANQGPTAFLSNPLLCGFPLQKSC 284
+L GN+LSG +P G ++ F N LCG P ++C
Sbjct: 490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 55/302 (18%)
Query: 414 VLGKSGLGIVYK-VVLGNG----IPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + + +G IPVA++ L E + ++E + E +A V P + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS--LSWSTRLRIAKGTARGLAYLH 525
L +L ++ + G L + +R + + L+W ++ A+G++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
E + VH D+ N+L+ + I+DFGL+RL++I + GG + P+
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--------PI 175
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644
+ + A E+ + R + DV+S+GV + EL+T G P E+PDL
Sbjct: 176 K------WMALES-ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL-- 223
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704
++KG P +D V+ + + C D E RPR + + + R
Sbjct: 224 -LEKGERLPQPPICTID---------------VYMIMVKCWMIDSECRPRFRELVDEFSR 267
Query: 705 IG 706
+
Sbjct: 268 MA 269
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 51/226 (22%)
Query: 415 LGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREF--------VTEVQAIAKVK-HPN 464
LG G VY G VA++++ ++F + EV+++ K+ HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 465 IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
IVKL+ + DE + +++ GNL ++ R G+P S S I +GLA++
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP---FSESVIRSIIYQILQGLAHI 115
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H+ F H D+KP N+L+ I+DFGL+R I + P PY
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR---SRP-----------PY--- 155
Query: 585 VQTE--KTNNYRAPEA--RVPG-NRPMQKWDVYSFGVVLLELLTGK 625
T+ T YRAPE R + P+ D+++ G ++ EL T +
Sbjct: 156 --TDYVSTRWYRAPEILLRSTSYSSPV---DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 63/311 (20%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGE-GGEQRHREFVTEVQAIAKV-KHPNIVKL 468
V+G+ G V + ++ G + A++ L E E HR+F E++ + K+ HPNI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 469 ------RAYYW-----APDEKLLISDFISNGNLAN---ALRGRNGQPSTSLSWSTRLRIA 514
R Y + AP LL DF+ + A +G ST L+ L+ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLL--DFLRKSRVLETDPAFAKEHGTAST-LTSQQLLQFA 125
Query: 515 KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
A G+ YL E ++F+H D+ N+L+ + I+DFGLSR
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR--------------- 167
Query: 575 MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634
G Y+K + A E+ + + K DV+SFGV+L E+++ L T
Sbjct: 168 --GEEVYVKKTMGRLPVRWMAIES-LNYSVYTTKSDVWSFGVLLWEIVS-----LGGTPY 219
Query: 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+ +L + +G+ E P + V+ L C P RP
Sbjct: 220 CGMTCAELYEKLPQGYRMEKP---------------RNCDDEVYELMRQCWRDRPYERPP 264
Query: 695 MKNVSENLERI 705
+S L R+
Sbjct: 265 FAQISVQLSRM 275
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 28/176 (15%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
E + + ++ HP +V L Y + +E + L+ D + G+L L + + S +
Sbjct: 50 ERRILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEE---QVKF 104
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
I + L YLH + +H DIKP NILLD +I+DF ++ + S+S
Sbjct: 105 WICE-IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G YM P + Y D +S GV E L GK P
Sbjct: 161 -----GTPGYMAP-EVLCRQGYSVAV------------DWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 79/303 (26%), Positives = 129/303 (42%), Gaps = 56/303 (18%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKL 468
V+GK G VY L G I AV+ L + + +F+ E + HPN++ L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 469 RAYYWAPDE--KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
P E L++ ++ +G+L N +R P+ L++AKG + YL
Sbjct: 62 LGICL-PSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG----MEYLAS 116
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY----M 582
+KFVH D+ N +LD F ++DFGL+R +I S G LP +
Sbjct: 117 ---KKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
+ +QT+K K DV+SFGV+L EL+T +P ++ D+
Sbjct: 172 ESLQTQKFTT---------------KSDVWSFGVLLWELMTRGAPPYP-----DVDSFDI 211
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
++ +G LLQ + ++ + L+C PE+RP + +
Sbjct: 212 TVYLLQG------------RRLLQPEYCPD---PLYEVMLSCWHPKPEMRPTFSELVSRI 256
Query: 703 ERI 705
E+I
Sbjct: 257 EQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+G+ G VYK G VA++++ +Q + E+ + KHPNIV Y
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
DE ++ +++ G+L + + Q ++ + + +GL YLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIIT----QNFVRMNEPQIAYVCREVLQGLEYLHS---QNV 137
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKPVQTEKTN 591
+H DIK NILL D ++DFG + + + +S + G PY M
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS----VVGT-PYWM--------- 183
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
APE + K D++S G++ +E+ G+ P
Sbjct: 184 ---APEV-IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 80/306 (26%), Positives = 129/306 (42%), Gaps = 53/306 (17%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRH--REFVTEVQAIAKVKHPNIVK 467
+LG+ G V + L G+ + VAV+ + EF++E + HPN++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 468 LRAYYWAPDEK------LLISDFISNGNL-ANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
L + ++I F+ +G+L + L R G L T L+ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+ YL S R F+H D+ N +L D ++DFGLS+ I S + G +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-------YSGDYYRQGRIA 175
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEV 639
M PV+ + A E+ + K DV++FGV + E+ T G++P P E+
Sbjct: 176 KM-PVK------WIAIES-LADRVYTSKSDVWAFGVTMWEIATRGQTP--YPGVENH-EI 224
Query: 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
D +R + + E+ L ++ D M +C ADP+ RP +
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLM------------------YSCWRADPKDRPTFTKLR 266
Query: 700 ENLERI 705
E LE I
Sbjct: 267 EVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 63/225 (28%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 415 LGKSGLGIVYK---VVLGNGIP---VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G VYK + VA++ L E E + + EF E + ++ ++HPNIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLRIAKG 516
L ++ +++++G+L L + +SL S L IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
A G+ YL S FVH D+ N L+ ISDFGLSR I S +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI--------YSADY-- 179
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
Y ++ + PEA + G + + D++SFGVVL E+
Sbjct: 180 ----YRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 432 IPVAVRRLGEGGEQRH-REFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGN 489
+ VAV+ L + + + V+E++ + + KH NI+ L ++ ++ S GN
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 490 LANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIK 538
L LR R P L++ + A ARG+ YL + +K +H D+
Sbjct: 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLA 161
Query: 539 PSNILLDNDFQPYISDFGLSRLI-NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE 597
N+L+ D I+DFGL+R + NI +++G PV+ + APE
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL---------PVK------WMAPE 206
Query: 598 ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLS 657
A Q DV+SFGV+L E+ T L + I V +L + +K+G + P +
Sbjct: 207 ALFDRVYTHQS-DVWSFGVLLWEIFT-----LGGSPYPGIPVEELFKLLKEGHRMDKPAN 260
Query: 658 DMVDA-MLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707
+ M+++E C A P RP K + E+L+R+ T
Sbjct: 261 CTHELYMIMRE----------------CWHAVPSQRPTFKQLVEDLDRVLT 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 43/119 (36%), Positives = 63/119 (52%), Gaps = 20/119 (16%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+ L Y+H +H D+KPSNILL++D + ++DFGL+R ++ NP +
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN-------- 166
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635
PV T+ T YRAPE + R + D++S G +L E+L GK L P TST
Sbjct: 167 -----PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP--LFPGTST 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 90/316 (28%), Positives = 133/316 (42%), Gaps = 61/316 (19%)
Query: 406 ELLRASAYVLGKSGLGIVYK-VVLGNG-----IPVAVRRLGE-GGEQRHREFVTEVQAIA 458
LLRA LG G VY+ + G + VAV+ L E EQ +F+ E ++
Sbjct: 9 TLLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS 64
Query: 459 KVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL---RGRNGQPSTSLSWSTRLRIAK 515
K H NIV+L + + ++ + ++ G+L + L R R +PS SL+ L A+
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS-SLTMKDLLFCAR 123
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSG 572
A+G YL E F+H DI N LL I+DFG++R +I + G
Sbjct: 124 DVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYRASYYRKG 178
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSP 631
G M P++ + PEA + G K DV+SFGV+L E+ + G P
Sbjct: 179 G------RAMLPIK------WMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPY--- 222
Query: 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV 691
T+ EV + V G + P K V+ + C + PE
Sbjct: 223 PGRTNQEVMEF---VTGGGRLDPP---------------KGCPGPVYRIMTDCWQHTPED 264
Query: 692 RPRMKNVSENLERIGT 707
RP + LERI
Sbjct: 265 RPNFATI---LERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAYY 472
+LGK G V+K L + PVAV+ E Q + +F++E + + + HPNIVKL
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
++ + + G+ + LR + + L ++ A A G+AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+ N L+ + ISDFG+SR + SSSG +K + + T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSG---------LKQIPIKWT-- 161
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651
APEA G R + DV+S+G++L E + G P T + E V+KG+
Sbjct: 162 --APEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE------QVEKGYR 212
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
P + V+ + C + PE RP+ + + L
Sbjct: 213 MSCPQ------------KCPDD---VYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 434 VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANA 493
VA++ + EG EF+ E + + K+ H +V+L ++++++SNG L N
Sbjct: 31 VAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 494 LRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553
LR + S L + K G+AYL ++F+H D+ N L+D+ +S
Sbjct: 90 LREHGKRFQPS----QLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVS 142
Query: 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYS 613
DFGLSR + + +SS +G P + PE + ++ K DV++
Sbjct: 143 DFGLSRYV--LDDEYTSS---VGSKFPV----------RWSPPEVLLY-SKFSSKSDVWA 186
Query: 614 FGVVLLELLT-GKSP 627
FGV++ E+ + GK P
Sbjct: 187 FGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 75/291 (25%), Positives = 124/291 (42%), Gaps = 50/291 (17%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G+VY+ + + VA++ + E R R EF+ E + + ++V+
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRG----RNGQPSTSL-SWSTRLRIAKGTARGLA 522
L L+I + ++ G+L + LR P + S +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
YL + KFVH D+ N ++ DF I DFG++R +I + GG G LP
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGG--KGLLPV- 185
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
+ +PE+ G DV+SFGVVL E+ T L+ + +
Sbjct: 186 ---------RWMSPESLKDGVFTTYS-DVWSFGVVLWEIAT-----LAEQPYQGMSNEQV 230
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
+R+V +G + P D ML F L C + +P++RP
Sbjct: 231 LRFVMEGGLLDKP--DNCPDML-------------FELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 57/213 (26%)
Query: 434 VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492
VAV+ L R +F+ EV+ ++++ PNI +L +I +++ NG+L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 493 ALRGRNGQPST------SLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN 546
L+ + S SLS+ST L +A A G+ YL FVH D+ N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 547 DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM 606
++ I+DFG+SR N Y + RV G P+
Sbjct: 166 NYTIKIADFGMSR-------------------------------NLYSSDYYRVQGRAPL 194
Query: 607 ----------------QKWDVYSFGVVLLELLT 623
K DV++FGV L E+LT
Sbjct: 195 PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 56/296 (18%)
Query: 414 VLGKSGLGIVYKVVLGN--GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+GK G V+LG+ G VAV+ + + + F+ E + +++H N+V+L
Sbjct: 13 TIGKGEFG---DVMLGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 472 YWAPDEKLLI-SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
L I +++++ G+L + LR R + L L+ + + YL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN-- 122
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
FVH D+ N+L+ D +SDFGL++ + T + G LP
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---------GKLPV--------- 163
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649
+ APEA + + K DV+SFG++L E+ + G+ P I + D+V V+KG
Sbjct: 164 -KWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP------YPRIPLKDVVPRVEKG 215
Query: 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ + P D V+ + C D RP + E LE I
Sbjct: 216 YKMDAP--DGCPP-------------VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 25/214 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG+ G V+ VA++ L + G F+ E Q + K++H +V L A +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ ++++F+ G+L + L+ +G+ L + +A A G+AY+ + ++H
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMN---YIH 125
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D++ +NIL+ ++ I+DFGL+RLI F P++ +
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF---------PIK------WT 170
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
APEA + G R K DV+SFG++L EL+T G+ P
Sbjct: 171 APEAALYG-RFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 85/318 (26%), Positives = 134/318 (42%), Gaps = 65/318 (20%)
Query: 414 VLGKS-GLGIVYKVVLGNGI-----------PVAVRRL-GEGGEQRHREFVTEVQAIAKV 460
VLGK G G +VV+ I VAV+ L + E+ + ++E++ + +
Sbjct: 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80
Query: 461 -KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWS 508
KH NI+ L +I ++ S GNL LR R P LS+
Sbjct: 81 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 509 TRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568
+ A ARG+ YL + +K +H D+ N+L+ D I+DFGL+R I+
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
++ G + PV+ + APEA Q DV+SFGV+L E+ T G SP
Sbjct: 198 KTTNGRL--------PVK------WMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSP 242
Query: 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEA 687
+ V +L + +K+G + P + + ++ C A
Sbjct: 243 ------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---------------DCWHA 281
Query: 688 DPEVRPRMKNVSENLERI 705
P RP K + E+L+RI
Sbjct: 282 VPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 415 LGKSGLGIV----YKVVLGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVKLR 469
LG G+V + G IPVAV+ L +F+ E + + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL- 61
Query: 470 AYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
Y L ++++ G+L + LR ++ +S T A A G+ YL
Sbjct: 62 -YGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLIS--TLCDYAVQIANGMRYLES-- 115
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
++F+H D+ NILL +D + I DFGL R + ++ +P+
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME---EHLKVPFA------ 165
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
+ APE+ + DV+ FGV L E+ T G+ P
Sbjct: 166 ----WCAPES-LRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 78/314 (24%), Positives = 130/314 (41%), Gaps = 69/314 (21%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKV-KHPNIVKL 468
V+G+ G V K + G + A++R+ E + HR+F E++ + K+ HPNI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 469 ------RAYYWAPDEKLLISDFISNGNLANALRGRN-----------GQPSTSLSWSTRL 511
R Y + L ++ +GNL + LR +++LS L
Sbjct: 74 LGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
A ARG+ YL S ++F+H D+ NIL+ ++ I+DFGLSR
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 172
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631
G Y+K + A E+ + + DV+S+GV+L E+++ L
Sbjct: 173 -----GQEVYVKKTMGRLPVRWMAIES-LNYSVYTTNSDVWSYGVLLWEIVS-----LGG 221
Query: 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV 691
T + +L + +G+ E PL+ E V+ L C P
Sbjct: 222 TPYCGMTCAELYEKLPQGYRLEKPLN------------CDDE---VYDLMRQCWREKPYE 266
Query: 692 RPRMKNVSENLERI 705
RP + +L R+
Sbjct: 267 RPSFAQILVSLNRM 280
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 43/126 (34%), Positives = 70/126 (55%), Gaps = 16/126 (12%)
Query: 45 WNENDPTPC-----RWSGISCM--NITG--FPDPRVVGVAISGKNVRGYIPSELGSLIYL 95
WN + PC WSG C + G F D G+ + + +RG+IP+++ L +L
Sbjct: 392 WNGD---PCVPQQHPWSGADCQFDSTKGKWFID----GLGLDNQGLRGFIPNDISKLRHL 444
Query: 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG 155
+ +NL N++ G++P L + TSL + L N+ +GS+P S+ L L+ L+L+ NS SG
Sbjct: 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 156 SLPDGL 161
+P L
Sbjct: 505 RVPAAL 510
|
Length = 623 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 64/253 (25%), Positives = 118/253 (46%), Gaps = 33/253 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474
LG G V+ N VAV+ L + G + F+ E + ++H +V+L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
+ +I+++++ G+L + L+ G + + + A G+AY+ + ++H
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYR 594
D++ +N+L+ I+DFGL+R+I F P++ +
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF---------PIK------WT 171
Query: 595 APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF--- 650
APEA G+ + K DV+SFG++L E++T GK P P S S D++ +++G+
Sbjct: 172 APEAINFGSFTI-KSDVWSFGILLYEIVTYGKIP--YPGMSNS----DVMSALQRGYRMP 224
Query: 651 EEENPLSDMVDAM 663
EN ++ D M
Sbjct: 225 RMENCPDELYDIM 237
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHRE---F-VT---EVQAIAKVKHPNIV 466
LG+ G VYK + G VA++++ H E F +T E++ + K+KHPN+V
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI-----LMHNEKDGFPITALREIKILKKLKHPNVV 70
Query: 467 KL--RAYYWAPDE-KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523
L A + S ++ + + L G PS L+ S G+ Y
Sbjct: 71 PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY 130
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
LHE +H DIK +NIL+DN I+DFGL+R G P+ GG GG Y
Sbjct: 131 LHE---NHILHRDIKAANILIDNQGILKIADFGLAR--PYDGPPPNPKGGGGGGTRKYTN 185
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
V T YR PE + R D++ G V E+ T +
Sbjct: 186 LVVTRW---YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 53/290 (18%)
Query: 432 IPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGN 489
+ VAV+ L + E+ + V+E++ + + KH NI+ L +I ++ S GN
Sbjct: 48 VTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 490 LANALRGR-----------NGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIK 538
L LR R P +++ + ARG+ YL + +K +H D+
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLA 164
Query: 539 PSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA 598
N+L+ + I+DFGL+R +N ++ G + PV+ + APEA
Sbjct: 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL--------PVK------WMAPEA 210
Query: 599 RVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLS 657
Q DV+SFGV++ E+ T G SP I V +L + +K+G + P
Sbjct: 211 LFDRVYTHQS-DVWSFGVLMWEIFTLGGSP------YPGIPVEELFKLLKEGHRMDKP-- 261
Query: 658 DMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707
A E ++ + C A P RP K + E+L+RI T
Sbjct: 262 ----ANCTNE---------LYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 53/172 (30%), Positives = 80/172 (46%), Gaps = 41/172 (23%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSS 570
+IA GL YL+ + +H DIKPSNIL+++ Q + DFG+S LIN S
Sbjct: 107 KIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN------SI 158
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK----- 625
+ F+G T+ Y +PE R+ G + K DV+S G+ ++EL GK
Sbjct: 159 ADTFVG-------------TSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204
Query: 626 SPELSPTTSTSIEVPDLVRWVKKGFEEENP----------LSDMVDAMLLQE 667
S + + DL++ + +E P L D VDA LL++
Sbjct: 205 SNIDDDGQDDPMGILDLLQQI---VQEPPPRLPSSDFPEDLRDFVDACLLKD 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 28/232 (12%)
Query: 400 FTFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIA 458
+ +E DE VLGK GIVY L + +A++ + E + + E+ +
Sbjct: 3 YEYEYDE--NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 459 KVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTA 518
+KH NIV+ + + + G+L+ LR + G + T + K
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIIFYTKQIL 118
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY--ISDFGLSRLINITGNNPSSSGGFMG 576
GL YLH+ + VH DIK N+L+ N + ISDFG S+ + G NP +
Sbjct: 119 EGLKYLHD---NQIVHRDIKGDNVLV-NTYSGVVKISDFGTSK--RLAGINPCTET--FT 170
Query: 577 GALPYMKPVQTEK-TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G L YM P +K Y AP D++S G ++E+ TGK P
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPA------------DIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 67/264 (25%), Positives = 114/264 (43%), Gaps = 54/264 (20%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGE-GGEQRHREFVTEVQAIAKV-KHPNIVKL 468
V+G+ G V K + G + A++R+ E + HR+F E++ + K+ HPNI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 469 ------RAYYWAPDEKLLISDFISNGNLANALR-----------GRNGQPSTSLSWSTRL 511
R Y + E + +GNL + LR +++LS L
Sbjct: 62 LGACEHRGYLYLAIE------YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
A ARG+ YL + ++F+H D+ NIL+ ++ I+DFGLSR
Sbjct: 116 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631
G Y+K + A E+ + + DV+S+GV+L E+++ L
Sbjct: 161 -----GQEVYVKKTMGRLPVRWMAIES-LNYSVYTTNSDVWSYGVLLWEIVS-----LGG 209
Query: 632 TTSTSIEVPDLVRWVKKGFEEENP 655
T + +L + +G+ E P
Sbjct: 210 TPYCGMTCAELYEKLPQGYRLEKP 233
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 73/304 (24%), Positives = 137/304 (45%), Gaps = 53/304 (17%)
Query: 406 ELLRASAYV---LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH 462
E+ R S + LG G V+ VAV+ + + G F+ E + ++H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNG--QPSTSLSWSTRLRIAKGTARG 520
+VKL A + +I++F++ G+L + L+ G QP L + + A G
Sbjct: 61 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEG 114
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+A++ + R ++H D++ +NIL+ I+DFGL+R+I F
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF------ 165
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEV 639
P++ + APEA G+ + K DV+SFG++L+E++T G+ P P S
Sbjct: 166 ---PIK------WTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIP--YPGMSN---- 209
Query: 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
P+++R +++G+ + E ++++ + C + PE RP + +
Sbjct: 210 PEVIRALERGYR-------------MPRPENCPE--ELYNIMMRCWKNRPEERPTFEYIQ 254
Query: 700 ENLE 703
L+
Sbjct: 255 SVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 415 LGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL-RAYY 472
LG G VYK G+ A + + E+ +F+ E+ +++ KHPNIV L AY+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR-IAKGTARGLAYLHECSPRK 531
+ +LI +F G L +++ + T ++R + + L +LH K
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELERGLT----EPQIRYVCRQMLEALNFLHS---HK 123
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP----VQ 586
+H D+K NILL D ++DFG+S T + F+G PY M P +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGT--PYWMAPEVVACE 178
Query: 587 TEKTN--NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPT 632
T K N +Y+A D++S G+ L+EL + P EL+P
Sbjct: 179 TFKDNPYDYKA--------------DIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 31/177 (17%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL---ANALRGRNGQPSTSLSWST 509
EV ++ +KHPNIV+ + + ++ D+ G+L NA RG L W
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
++ +A L ++H+ RK +H DIK NI L D + DFG++R++N T
Sbjct: 109 QICLA------LKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGK 625
+ G PY Y +PE + NRP K D+++ G VL E+ T K
Sbjct: 160 TCIG-----TPY-----------YLSPE--ICENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 60/231 (25%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 415 LGKSGLGIV----YKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LGK G V Y + N G VAV++L + R+F E++ + ++H NIVK +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 470 AYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
++ + L+ +++ G+L + L+ + L L A +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER----LDHRKLLLYASQICKGMEYL--- 124
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI-----NITGNNPSSSGGFMGGALPYM 582
+++VH D+ NIL++++ + I DFGL++++ P S F
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-------- 176
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633
+ APE+ + ++ DV+SFGVVL EL T SP
Sbjct: 177 ----------WYAPES-LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 78/307 (25%), Positives = 131/307 (42%), Gaps = 55/307 (17%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVK 467
+LGK G V + L G+ VAV+ L EF+ E + + HPN++K
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 468 L-------RAYYWAPDEKLLISDFISNGNL-ANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
L RA P ++I F+ +G+L L R G+ +L T +R A
Sbjct: 66 LIGVSLRSRAKGRLP-IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
G+ YL S + F+H D+ N +L+ + ++DFGLS+ I SG +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI--------YSGDYYRQGC 173
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
PV+ + A E+ + N DV++FGV + E++T G++P +E
Sbjct: 174 ASKLPVK------WLALES-LADNVYTTHSDVWAFGVTMWEIMTRGQTP------YAGVE 220
Query: 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
++ ++ KG + P + D V+ L C +P+ RP +++
Sbjct: 221 NSEIYNYLIKGNRLKQPPDCLED---------------VYELMCQCWSPEPKCRPSFQHL 265
Query: 699 SENLERI 705
+ LE I
Sbjct: 266 RDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 46/212 (21%)
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
P + KL + + D L+ ++++ G+ A+ ++ G P W+ + IA+ G+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWA-KQYIAE-VVLGVE 111
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
LH+ R +H DIKP N+L+D ++DFGLSR N G
Sbjct: 112 DLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVG---------- 155
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
T +Y APE + G + D +S G V+ E L G P E PD
Sbjct: 156 -------TPDYLAPET-ILGVGDDKMSDWWSLGCVIFEFLFGYPP-------FHAETPDA 200
Query: 643 V---------RWVKKGFEEENPLS-DMVDAML 664
V W ++ E +P + D+++ +L
Sbjct: 201 VFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)
Query: 415 LGKSGLGIVYK-VVLGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G G VYK + G VA++ +L G + E+ + + +HPNIV AY
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDD--FEIIQQEISMLKECRHPNIV---AY 65
Query: 472 Y--WAPDEKLLIS-DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ + +KL I ++ G+L + + G LS + + T +GLAYLHE
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHE-- 119
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP--V 585
+H DIK +NILL D ++DFG+S + T S F+G PY M P
Sbjct: 120 -TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIG--TPYWMAPEVA 173
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
E+ Y K D+++ G+ +EL + P
Sbjct: 174 AVERKGGYD------------GKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 49/234 (20%)
Query: 414 VLGKSGLGIVYKVVLG----NGIPVAVRRL-----GEGGEQRHREFVT----EVQAIAKV 460
++G G VY LG +G +AV+++ + R R + E+ + ++
Sbjct: 7 LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
+H NIV+ D + +++ G++A L T + + +G
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-----NFVRQILKG 118
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI--NIT-----GNNPSSSGG 573
L YLH R +H DIK +NIL+DN ISDFG+S+ + N G PS
Sbjct: 119 LNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS---- 171
Query: 574 FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ G++ +M P ++T+ R K D++S G +++E+LTGK P
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTR-------------KADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 33/226 (14%)
Query: 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+GK G V KV +G + + + G E+ ++ V+EV + ++KHPNIV+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY- 64
Query: 470 AYYWAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
Y D ++ ++ G+LA ++ + + + RI L H
Sbjct: 65 -YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ-KCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 526 ECSP--RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
S +H D+KP+NI LD + + DFGL++++ + + ++G PY
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT---YVG--TPY-- 175
Query: 584 PVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE + + K D++S G ++ EL P
Sbjct: 176 ---------YMSPEQLNHMSYDE---KSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 414 VLGKSGLGIVYK-VVLGNG----IPVAVRRLGE-GGEQRHREFVTEVQAIAKVKHPNIVK 467
+LG G V+K + + G IPVA++ + + G Q +E + A+ + H IV+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 468 LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYL 524
L P L L++ G+L + +R P L+W ++ A+G+ YL
Sbjct: 74 LLGI--CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
E + VH ++ NILL +D I+DFG++ L+ P F +K
Sbjct: 126 EE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL-----YPDDKKYFYSEHKTPIK- 176
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643
+ A E+ + G Q DV+S+GV + E+++ G P EVPDL
Sbjct: 177 --------WMALESILFGRYTHQS-DVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDL- 223
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
++KG P +D V+ + + C D VRP K ++
Sbjct: 224 --LEKGERLAQPQICTID---------------VYMVMVKCWMIDENVRPTFKELANEFT 266
Query: 704 RI 705
R+
Sbjct: 267 RM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 31/187 (16%)
Query: 450 FVT--EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSW 507
F T E++ + ++KH NI+ L Y D L+ D I +L + + L+
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK-----IRLTE 118
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
S I GL LH+ F+H D+ P+NI +++ I+DFGL+R G
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARR---YGYP 172
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNN---------YRAPEARVPGNRPMQKWDVYSFGVVL 618
P S K ++ YRAPE + + D++S G +
Sbjct: 173 PYSD--------TLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224
Query: 619 LELLTGK 625
ELLTGK
Sbjct: 225 AELLTGK 231
|
Length = 335 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 77/305 (25%), Positives = 127/305 (41%), Gaps = 68/305 (22%)
Query: 415 LGKSGLGIVYKVVLGNG-------IPVAVRRLGEGGEQRHRE-----FVTEVQAIAK-VK 461
LG G VYKV N + V G ++R R+ V+EV I + ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLA---NALRGRNGQPSTSLSWSTRLRIAKGTA 518
HPNIV+ + D ++ D I L N+L+ + + + W+ +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV---- 123
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
L YLH+ ++ VH D+ P+NI+L D + I+DFGL++ P S
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPES-------- 168
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSPELSP---TTS 634
+ V T Y PE + N P +K DV++FG +L ++ T + P S + +
Sbjct: 169 --KLTSVV--GTILYSCPE--IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222
Query: 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
T I V+ +E PL + + + + +V C D E RP
Sbjct: 223 TKI--------VEAVYE---PLPEGMYSEDVTDVITS------------CLTPDAEARPD 259
Query: 695 MKNVS 699
+ VS
Sbjct: 260 IIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 49/186 (26%), Positives = 86/186 (46%), Gaps = 28/186 (15%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
+ E++ + + P IV +++ E + + + G+L L+ P L
Sbjct: 47 IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG---- 102
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPS 569
+I+ RGL YL E K +H D+KPSNIL+++ + + DFG+S +LI+ N+
Sbjct: 103 -KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-- 157
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629
F+G T +Y +PE R+ G + D++S G+ L+E+ G+ P
Sbjct: 158 ----FVG-------------TRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199
Query: 630 SPTTST 635
P
Sbjct: 200 PPDAKE 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 48/193 (24%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSS 570
+IA + L YLH +H D+KPSN+L++ + Q + DFG+S L++ S
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD------SV 158
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ----KWDVYSFGVVLLELLTGK- 625
+ G PYM APE R+ + K DV+S G+ ++EL TG+
Sbjct: 159 AKTIDAGCKPYM------------APE-RINPELNQKGYDVKSDVWSLGITMIELATGRF 205
Query: 626 -------------------SPELSPTTSTSIEVPDLV-RWVKKGFEEENPLSDMVDAMLL 665
SP+L P S E D V + +KK ++E +++
Sbjct: 206 PYDSWKTPFQQLKQVVEEPSPQL-PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
Query: 666 QEVHAKKEVIAVF 678
+ +K +A F
Sbjct: 265 ELHLSKNTDVASF 277
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-12
Identities = 67/179 (37%), Positives = 88/179 (49%), Gaps = 8/179 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
SEL L L L+L NNN+ +P + S +N SLP + NLP L+N
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKN 167
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
LDLS N S LP L N L L L+ NK S +P I L L +LDLS+N
Sbjct: 168 LDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-E 223
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQ 264
+ + L L++LS L LS N+ +P+S+GNL + DL N +S I GS N
Sbjct: 224 LLSSLSNLKNLS-GLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNL 279
|
Length = 394 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 72/265 (27%), Positives = 105/265 (39%), Gaps = 72/265 (27%)
Query: 397 DKGFTFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQ 455
D FEL E V+G+ G VYK G VA++ + + E E
Sbjct: 3 DPTGIFELVE-------VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYN 54
Query: 456 AIAKV-KHPNIVKLRAYYWA---------PDEKLLISDFISNG---NLANALRGRNGQPS 502
+ K HPNI +Y A D+ L+ + G +L LR +
Sbjct: 55 ILRKYSNHPNIAT---FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK--- 108
Query: 503 TSLSWSTRLR------IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556
RL+ I + T RGLAYLHE K +H DIK NILL + + + DFG
Sbjct: 109 -------RLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158
Query: 557 LSRLINITGNNPSSSGGFMGGALPY-MKP------VQTEKTNNYRAPEARVPGNRPMQKW 609
+S ++ T ++ G PY M P Q + + + R+
Sbjct: 159 VSAQLDSTLGRRNTFIG-----TPYWMAPEVIACDEQPDASYDARS-------------- 199
Query: 610 DVYSFGVVLLELLTGKSP--ELSPT 632
DV+S G+ +EL GK P ++ P
Sbjct: 200 DVWSLGITAIELADGKPPLCDMHPM 224
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 36/223 (16%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRH-----REFVTEVQAIAKVKHPNIVKL 468
LG+ G VY + G +AV+++ + E+Q + ++H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ- 68
Query: 469 RAYYWAPDEKLLISDFI---SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
YY + +S F+ G++ + L+ +L+ + + + G+ YLH
Sbjct: 69 --YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLH 121
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKP 584
VH DIK +NIL D+ + DFG S RL I SSG MK
Sbjct: 122 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-----CSSGTG-------MKS 166
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
V T + +PE + G +K DV+S G ++E+LT K P
Sbjct: 167 VT--GTPYWMSPEV-ISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 15/136 (11%)
Query: 434 VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492
VAV+ L + R +F+ E++ ++++K+PNI++L + D +I++++ NG+L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 493 ALRGR---------NGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNIL 543
L R N P S+S + L +A A G+ YL + FVH D+ N L
Sbjct: 107 FLSQREIESTFTHANNIP--SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 544 LDNDFQPYISDFGLSR 559
+ N + I+DFG+SR
Sbjct: 162 VGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 42/133 (31%), Positives = 72/133 (54%), Gaps = 10/133 (7%)
Query: 434 VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492
VAV+ L E + R +F+ E++ ++++K PNI++L A D +I++++ NG+L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 493 ALRGRNGQ------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN 546
L Q ++S+ST + +A A G+ YL S FVH D+ N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 547 DFQPYISDFGLSR 559
++ I+DFG+SR
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 61/290 (21%)
Query: 434 VAVRRLGEGGEQRH-REFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
VAV+ L + + + ++E++ + + KH NI+ L +I ++ + GNL
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 492 NALRGRN-----------GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540
LR R P LS+ + A ARG+ YL R+ +H D+
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 541 NILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA-- 598
N+L+ D I+DFGL+R ++ +S G + PV+ + APEA
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL--------PVK------WMAPEALF 209
Query: 599 -RVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPL 656
RV ++ DV+SFG+++ E+ T G SP I V +L + +++G + P
Sbjct: 210 DRVYTHQS----DVWSFGILMWEIFTLGGSP------YPGIPVEELFKLLREGHRMDKPS 259
Query: 657 SDMVDA-MLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ + ML++E C A P RP K + E L+++
Sbjct: 260 NCTHELYMLMRE----------------CWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 55/295 (18%)
Query: 414 VLGKSGLGIVYK---VVLGNG--IPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + G IPVA++ L E + ++E + E +A V +P++ +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS--LSWSTRLRIAKGTARGLAYLH 525
L +L I+ + G L + +R + L+W ++ A+G+ YL
Sbjct: 74 LLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE 126
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
E R+ VH D+ N+L+ I+DFGL++L+ + GG + P+
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--------PI 175
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644
+ + A E+ + Q DV+S+GV + EL+T G P I ++
Sbjct: 176 K------WMALESILHRIYTHQS-DVWSYGVTVWELMTFGSKP------YDGIPASEISS 222
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
++KG P +D V+ + + C D + RP+ + +
Sbjct: 223 ILEKGERLPQPPICTID---------------VYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 55/180 (30%), Positives = 82/180 (45%), Gaps = 32/180 (17%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNG---QPSTSLSWST 509
EV +AK+KHPNIV A + ++ ++ G+L + + G LSW
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNP 568
++ + GL ++H+ RK +H DIK NI L N + DFG++R +N +
Sbjct: 109 QI------SLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159
Query: 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ G PY Y +PE + NRP K D++S G VL EL T K P
Sbjct: 160 YTCVG-----TPY-----------YLSPE--ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 54/303 (17%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
LG+ G+VY+ + I VAV+ + E R R EF+ E + ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALR-------GRNGQPSTSLSWSTRLRIAKGTARG 520
L L++ + +++G+L + LR G+P +L +++A A G
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 131
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+AYL + +KFVH D+ N ++ +DF I DFG++R +I + GG G LP
Sbjct: 132 MAYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGG--KGLLP 184
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640
+ APE+ G D++SFGVVL E+ ++ E P
Sbjct: 185 V----------RWMAPESLKDGVFTTSS-DMWSFGVVLWEI------------TSLAEQP 221
Query: 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700
+G E L ++D L + E V L C + +P++RP +
Sbjct: 222 ------YQGLSNEQVLKFVMDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVN 273
Query: 701 NLE 703
L+
Sbjct: 274 LLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVK-LRAYY 472
LG G VYK G+ A + + E+ +++ E+ +A HPNIVK L A+Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ + +LI +F + G + + + L+ + K T L YLHE K
Sbjct: 73 YENNLWILI-EFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHE---NKI 124
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+K NIL D ++DFG+S T S F+G PY
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS---FIG--TPY----------- 168
Query: 593 YRAPEA---RVPGNRPMQ-KWDVYSFGVVLLELLTGKSP--ELSP 631
+ APE +RP K DV+S G+ L+E+ + P EL+P
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 49/196 (25%), Positives = 94/196 (47%), Gaps = 28/196 (14%)
Query: 436 VRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKL---LISDFISNGNLAN 492
VR E+ E++ +A++ HP+I+++ A E L ++++ G++++
Sbjct: 36 VRNTSSEQEEVVEALRKEIRLMARLNHPHIIRM---LGATCEDSHFNLFVEWMAGGSVSH 92
Query: 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY- 551
L + G ++ + ++ RGL+YLHE + +H D+K +N+L+D+ Q
Sbjct: 93 LLS-KYGAFKEAVIINYTEQLL----RGLSYLHE---NQIIHRDVKGANLLIDSTGQRLR 144
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
I+DFG + + G G + G + +M APE + G + + DV
Sbjct: 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFM------------APEV-LRGEQYGRSCDV 191
Query: 612 YSFGVVLLELLTGKSP 627
+S G V++E+ T K P
Sbjct: 192 WSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 30/168 (17%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
+PN +KL +LI D+I +G+L + L+ + G+ S + + I +
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAE---VKK-IIRQLVEA 121
Query: 521 LAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
L LH+ +H DIK N+L D + Y+ D+GL ++I PS G L
Sbjct: 122 LNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII----GTPSC----YDGTL 170
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y P EK + W V GV+ ELLTGK P
Sbjct: 171 DYFSP---EKIK-------GHNYDVSFDWWAV---GVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G+V KV + R+L E + + E+Q + + P IV +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
++ E + + + G+L L+ P L +++ RGLAYL E +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQI 125
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KPSNIL+++ + + DFG+S +LI+ N+ F+G T
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVG-------------TR 166
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
+Y +PE R+ G + D++S G+ L+EL G+ P + P + +E
Sbjct: 167 SYMSPE-RLQGTHYSVQSDIWSMGLSLVELAIGRYP-IPPPDAKELE 211
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 66/303 (21%)
Query: 410 ASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKV-KHPNIVK 467
A+AY L KS + VAV+ L RE ++E++ ++ + H NIV
Sbjct: 54 ATAYGLSKSDAVM----------KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVN 103
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L L+I+++ G+L N LR R + + L+ L + A+G+A+L
Sbjct: 104 LLGACTIGGPILVITEYCCYGDLLNFLR-RKRE--SFLTLEDLLSFSYQVAKGMAFL--- 157
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ + +H D+ N+LL + I DFGL+R I N + PV+
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--------PVK- 208
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV--- 643
+ APE+ + DV+S+G++L E+ + G +P P +
Sbjct: 209 -----WMAPESIFNCVYTFES-DVWSYGILLWEIFSLGSNP-----------YPGMPVDS 251
Query: 644 ---RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700
+ +K+G+ + Q HA E ++ + C +ADP RP K + +
Sbjct: 252 KFYKLIKEGYR------------MAQPEHAPAE---IYDIMKTCWDADPLKRPTFKQIVQ 296
Query: 701 NLE 703
+
Sbjct: 297 LIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 42/223 (18%)
Query: 415 LGKSGLGIVYK-VVLGNGIPVAVR--RLGEGGEQR---HREFVTEVQAIAKVKHPNIVKL 468
LG+ +VYK G VA++ +LGE E + + + E++ + ++KHPNI+ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ L+ +F+ +L ++ + S L+ + T RGL YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+H D+KP+N+L+ +D ++DFGL+R G S M T
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLAR---SFG----SPNRKM-----------TH 161
Query: 589 K--TNNYRAPE----ARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ T YRAPE AR G D++S G + ELL
Sbjct: 162 QVVTRWYRAPELLFGARHYGV----GVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 36/227 (15%)
Query: 415 LGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRH-REFVTEVQAIAKVKHPNIVKL 468
LG+ G +YK L + VA++ L + + EF E +A++ HPNIV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR------------NGQPSTSLSWSTRLRIAKG 516
++ ++++ G+L L R +G +SL L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
A G+ YL S FVH D+ NIL+ ISD GLSR I S +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREI--------YSADYYR 181
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
+ P++ + PEA + G D++SFGVVL E+ +
Sbjct: 182 VQPKSLLPIR------WMPPEAIMYGKFSSDS-DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 1e-10
Identities = 39/109 (35%), Positives = 56/109 (51%), Gaps = 20/109 (18%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL YLH +H D+KPSNIL++++ I DFGL+R ++ + GF+
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK----GFL--- 163
Query: 579 LPYMKPVQTEK--TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
TE T YRAPE + +R + D++S G + ELLT K
Sbjct: 164 --------TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 33/184 (17%)
Query: 452 TEVQAIAKVKHPNIVKLRAYY-WAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWST 509
TE +++ + P +VKL YY + + L L+ +++ G+LA+ L
Sbjct: 42 TERDILSQAQSPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV----A 95
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-----RLINIT 564
R+ IA+ L YLH +H D+KP NIL+D++ ++DFGLS R
Sbjct: 96 RIYIAE-IVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151
Query: 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW-DVYSFGVVLLELLT 623
++ +G T +Y APE V + K D +S G +L E L
Sbjct: 152 NDDEKEDKRIVG-------------TPDYIAPE--VILGQGHSKTVDWWSLGCILYEFLV 196
Query: 624 GKSP 627
G P
Sbjct: 197 GIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+GK G VYK + VA++ + E E + E+Q +++ + P I K Y
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---Y 64
Query: 472 Y--WAPDEKL-LISDFISNGNLANALR-GRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y + KL +I ++ G+ + L+ G+ + + I + GL YLHE
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLHE- 116
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-V 585
K +H DIK +NILL + ++DFG+S + T + ++ F+G P+ M P V
Sbjct: 117 -EGK-IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVG--TPFWMAPEV 169
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
+ + +A D++S G+ +EL G+ P +L P
Sbjct: 170 IKQSGYDEKA--------------DIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 60/221 (27%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 415 LGKSGLGIVYKV-VLGNGIPVAVRRLGE------GGEQRHREFVTEVQAIAKVKHPNIVK 467
LGK G G V V G A ++L + GEQ + E + + KV IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA---LNEKKILEKVSSRFIVS 57
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRI-AKGTARGLAYLHE 526
L + D+ L+ ++ G+L + G+P + R A GL +LH+
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEA---RAIFYAAQIICGLEHLHQ 113
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R+ V+ D+KP N+LLD+ ISD GL+ + + G K
Sbjct: 114 ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGK---------------KIKG 153
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE + G D ++ G L E++ G+SP
Sbjct: 154 RAGTPGYMAPEV-LQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 50/278 (17%)
Query: 432 IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
+PVA+ L G +++ R F+ E + + H NIV+L + +++++++SNG L
Sbjct: 34 LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL 93
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
+ LR GQ L + + G A G+ YL E +VH + +L+++D
Sbjct: 94 DSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146
Query: 551 YISDFGLSRLINITGNNPSSSGGF--MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
IS F S + M G P + + APEA + +
Sbjct: 147 KISGFR-------RLQEDKSEAIYTTMSGKSPVL----------WAAPEA-IQYHHFSSA 188
Query: 609 WDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQE 667
DV+SFG+V+ E+++ G+ P + D+++ V+ GF P
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAVEDGFRLPAP------RNCPNL 236
Query: 668 VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+H L L C + + RPR + L ++
Sbjct: 237 LH---------QLMLDCWQKERGERPRFSQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 35/217 (16%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+LG G VYK L +AV+ + + + ++ ++E++ + K P I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
++ + + ++F+ G+L + P L RIA +GL YL K
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRK----IPEHVLG-----RIAVAVVKGLTYLWSL---K 115
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSR-LINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+KPSN+L++ Q + DFG+S L+N S + ++G T
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------SIAKTYVG-------------T 156
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
N Y APE R+ G + DV+S G+ +EL G+ P
Sbjct: 157 NAYMAPE-RISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 35/225 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLG------EGGEQRHREFVTEVQAIAKVKHPNIVK 467
VLGK G VY + G +AV+++ E+ + + EV + +KH NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV- 65
Query: 468 LRAYYWAPDEKLLIS---DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
Y + IS +F+ G++++ L P + K G+AYL
Sbjct: 66 --QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-----KYTKQILDGVAYL 118
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF--MGGALPYM 582
H VH DIK +N++L + + DFG +R + G + + S M G +M
Sbjct: 119 HN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P ++ R K D++S G + E+ TGK P
Sbjct: 176 APEVINESGYGR-------------KSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 50/288 (17%)
Query: 431 GIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK--LLISDFISN 487
G VAV+ L E G + E++ + + H NIVK + LI +F+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 488 GNLANAL-RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN 546
G+L L R +N ++ +L+ A +G+ YL R++VH D+ N+L+++
Sbjct: 93 GSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVES 144
Query: 547 DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM 606
+ Q I DFGL++ I T + + + + P ++ Y A
Sbjct: 145 EHQVKIGDFGLTKAIE-TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS---------- 193
Query: 607 QKWDVYSFGVVLLELLTGKSPELSPT---------TSTSIEVPDLVRWVKKGFEEENPLS 657
DV+SFGV L ELLT E SP T + V LVR +++G P
Sbjct: 194 ---DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRP-- 248
Query: 658 DMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ +E V+ L C E P R +N+ E E I
Sbjct: 249 ----------PNCPEE---VYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 48/226 (21%)
Query: 415 LGKSGLGIVYKV-VLGNGIPVAVRRLG-----EGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG G G V V V A++ + E G+Q H +E + + + HP IVKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEH--IFSEKEILEECNHPFIVKL 58
Query: 469 RAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLS-WSTRLRIAKGTARGLAYLH 525
+ D+K + + ++ G L LR R ++ R IA YLH
Sbjct: 59 YRTF--KDKKYIYMLMEYCLGGELWTILRDRG-----LFDEYTARFYIA-CVVLAFEYLH 110
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG----FMGGALPY 581
R ++ D+KP N+LLD++ + DFG ++ + SG F G
Sbjct: 111 N---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--------KSGQKTWTFCG----- 154
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE + D +S G++L ELLTG+ P
Sbjct: 155 --------TPEYVAPEI-ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 44/203 (21%)
Query: 434 VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANA 493
VAV+++ +QR EV + +HPNIV++ + Y DE ++ +F+ G L
Sbjct: 47 VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL--- 103
Query: 494 LRGRNGQPSTSLSWSTRLR------IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND 547
T + TR+ + + L++LH + +H DIK +ILL +D
Sbjct: 104 ---------TDIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSD 151
Query: 548 FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVP-GNR 604
+ +SDFG ++ S G PY + APE +R+P G
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRRKSLVG-----TPY-----------WMAPEVISRLPYGTE 195
Query: 605 PMQKWDVYSFGVVLLELLTGKSP 627
D++S G++++E++ G+ P
Sbjct: 196 V----DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 63/233 (27%), Positives = 95/233 (40%), Gaps = 28/233 (12%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLG-EGGEQR---HREFVTEVQAIAKVKHPNIVKL 468
+LGK +G V+ V L G G A++ L + +R R TE + +A + HP + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATLDHPFLPTL 66
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWST-RLRIAKGTARGLAYLHEC 527
A + L+ D+ G L L R QP LS R A+ L YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGKCLSEEVARFYAAEVLL-ALEYLHLL 122
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLS-------RLINITGNNPSSSGGFMGGALP 580
V+ D+KP NILL +SDF LS ++ S
Sbjct: 123 G---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 581 YMKPVQTEKTNN------YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ ++N+ Y APE + G+ D ++ G++L E+L G +P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEV-ISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 70/263 (26%)
Query: 444 EQRHREFVTEVQAIAKVKHPNIVKLRAYY--WAPDEKLLIS-DFISNGNLANALRGRNGQ 500
E+ R+ + E+ ++ ++HPNI+ AYY + D LLI ++ + G L + + + GQ
Sbjct: 40 EKERRDALNEIVILSLLQHPNII---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ 96
Query: 501 --PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558
+ W ++Y+H+ +H DIK NI L + DFG+S
Sbjct: 97 LFEEEMVLW-----YLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS 148
Query: 559 RLINITGNNPSSSGGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGV 616
+++ + S + G YM P Q K N K D+++ G
Sbjct: 149 KIL----GSEYSMAETVVGTPYYMSPELCQGVKYNF---------------KSDIWALGC 189
Query: 617 VLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHA------ 670
VL ELLT +K+ F+ NPL+ +V + Q +
Sbjct: 190 VLYELLT----------------------LKRTFDATNPLNLVVKIV--QGNYTPVVSVY 225
Query: 671 KKEVIAVFHLALACTEADPEVRP 693
E+I++ H + + DPE RP
Sbjct: 226 SSELISLVH---SLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 31/226 (13%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIV 466
LG+ G V+ G V V+ L + ++ EF E+ K+ H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALR----GRNGQPSTSLSWSTRLRIAKGTARGLA 522
+L + +I ++ G+L LR LS ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
+L S +FVH D+ N L+ + + +S LS+ + +S Y
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------DVYNS--------EYY 173
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
K + APEA V + K DV+SFGV++ E+ T G+ P
Sbjct: 174 KLRNALIPLRWLAPEA-VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 406 ELLRASAYVLGKSGLGIVY--KVVLGNGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKV 460
E L + +G G VY + V + + VA++++ G+Q + ++ + EV+ + K+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
+HPN ++ R Y L+ ++ A+ L + +P + + + G +G
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAA---VTHGALQG 127
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
LAYLH +H D+K NILL + DFG + ++ P++ F+G P
Sbjct: 128 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANX--FVG--TP 175
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQ--KWDVYSFGVVLLELLTGKSP 627
Y + APE + + K DV+S G+ +EL K P
Sbjct: 176 Y-----------WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 73/300 (24%), Positives = 115/300 (38%), Gaps = 55/300 (18%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKL 468
+G+ G VY+ V I VAV+ RE F+ E + + HP+IVKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ ++ + G L + L+ SL ++ + + + LAYL
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQ----VNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMKPVQ 586
++FVH DI N+L+ + + DFGLSR + +S G LP +M P
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-----GKLPIKWMAP-- 177
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645
++ N+R R DV+ FGV + E+L G P + D++
Sbjct: 178 --ESINFR---------RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGR 220
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ G E P+ L + L C DP RPR + L I
Sbjct: 221 IENG--ERLPMPPNCPPTL-------------YSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 33/180 (18%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL---RGRNGQPSTSLSWST 509
E +AK+KHPNIV + + A ++ ++ G+L + RG+ T L W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
++ + G+ ++HE ++ +H DIK NI L + + + DFG +RL+ +P
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL----TSPG 154
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ G PY P PE +P N K D++S G +L EL T K P
Sbjct: 155 AYACTYVGT-PYYVP-----------PEIWENMPYN---NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 34/218 (15%)
Query: 414 VLGKSGLGIVYKV-VLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
V+G+ G+V K G VA+++ E E + + EV+ + +++H NIV L+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPST---SLSWSTRLRIAKGTARGLAYLHEC 527
+ L+ +++ L G P S W + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS- 118
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+H DIKP NIL+ + DFG +R + A P V T
Sbjct: 119 --HNIIHRDIKPENILVSESGVLKLCDFGFARALR------------ARPASPLTDYVAT 164
Query: 588 EKTNNYRAPEARVPGNRPMQK-WDVYSFGVVLLELLTG 624
YRAPE V G+ K DV++ G ++ ELL G
Sbjct: 165 RW---YRAPELLV-GDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 18/146 (12%)
Query: 429 GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487
G + VAV+ L + R +F+ EV+ ++++K PNI++L D +I++++ N
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 488 GNLANALRGR-------NGQPST-------SLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
G+L L NG + ++S+S+ L +A A G+ YL S FV
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSR 559
H D+ N L+ + I+DFG+SR
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 59/242 (24%), Positives = 109/242 (45%), Gaps = 32/242 (13%)
Query: 430 NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489
+G VAV+ + +QR EV + +H N+V++ Y +E ++ +F+ G
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549
L + + T L+ + + + L YLH + +H DIK +ILL D +
Sbjct: 105 LTDIVS------QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGR 155
Query: 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQ 607
+SDFG I+ + P +G PY + APE +R P +
Sbjct: 156 VKLSDFGFC--AQISKDVPKRK-SLVG--TPY-----------WMAPEVISRTPYGTEV- 198
Query: 608 KWDVYSFGVVLLELLTGKSPELSPTTSTSIE-VPDLVRWVKKGFEEENP-LSDMVDAMLL 665
D++S G++++E++ G+ P S + +++ + D K + +P L D ++ ML
Sbjct: 199 --DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 666 QE 667
+E
Sbjct: 257 RE 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ G VY + + G VA+R++ + + + E+ + + K+PNIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ ++++ G+L + + T + + + + L +LH + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H DIK NILL D ++DFG I + S+ G PY +
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-----TPY-----------W 182
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
APE V K D++S G++ +E++ G+ P L+
Sbjct: 183 MAPEV-VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 71/291 (24%), Positives = 116/291 (39%), Gaps = 46/291 (15%)
Query: 415 LGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+G+ G V+ L + PVAV+ E +F+ E + + + HPNIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
++ + + G+ LR + L +++ + A G+ YL +
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYLES---KHC 115
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+ N L+ ISDFG+SR +S+GG MK + + T
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGG--------MKQIPVKWT-- 163
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651
APEA G R + DV+SFG++L E + G P + + + E +++G
Sbjct: 164 --APEALNYG-RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA------IEQGVR 214
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
P + AV+ L C E DP RP V + L
Sbjct: 215 LPCP---------------ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G+V+KV + R+L E + + E+Q + + P IV +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
++ E + + + G+L L+ P L +++ +GL YL E K
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE--KHKI 125
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KPSNIL+++ + + DFG+S +LI+ N+ F+G T
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS------FVG-------------TR 166
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
+Y +PE R+ G + D++S G+ L+E+ G+ P + P + +E
Sbjct: 167 SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYP-IPPPDAKELE 211
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ G VY + + G VA++++ + + + E+ + + KHPNIV Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ ++++ G+L + + T + + + + L +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS---NQVI 137
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H DIK NILL D ++DFG I + S+ G PY +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-----TPY-----------W 181
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
APE V K D++S G++ +E++ G+ P L+
Sbjct: 182 MAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-09
Identities = 13/41 (31%), Positives = 24/41 (58%)
Query: 20 LSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISC 60
L+ D LL+ KS+++ + + WN + PC W+G++C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 58/198 (29%), Positives = 89/198 (44%), Gaps = 24/198 (12%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWS 508
E +A P IVKL Y + +E L L+ +++ G+L N L ++ P +
Sbjct: 48 VRAERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET---- 102
Query: 509 TRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN-- 566
R IA+ L +H+ F+H DIKP NIL+D D ++DFGL + +N +
Sbjct: 103 ARFYIAELVL-ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 567 ---NPSSSGGFMGGALPYMKPVQTEK--------TNNYRAPEARVPGNRPMQKWDVYSFG 615
N S + F L + + + T +Y APE + G + D +S G
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEV-LRGTPYGLECDWWSLG 217
Query: 616 VVLLELLTGKSPELSPTT 633
V+L E+L G P S T
Sbjct: 218 VILYEMLYGFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 33/199 (16%)
Query: 434 VAVRRLGEGGEQRH---REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
VAV+++ G+Q + ++ + EV+ + ++KHPN ++ + Y L+ ++
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS-- 106
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
A+ L + +P + + I G +GLAYLH +H DIK NILL Q
Sbjct: 107 ASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQV 160
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ--K 608
++DFG + + S + F+G PY + APE + + K
Sbjct: 161 KLADFG-------SASKSSPANSFVG--TPY-----------WMAPEVILAMDEGQYDGK 200
Query: 609 WDVYSFGVVLLELLTGKSP 627
DV+S G+ +EL K P
Sbjct: 201 VDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 39/109 (35%), Positives = 54/109 (49%), Gaps = 19/109 (17%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
GL Y+H + +H D+KP N+L++ D + I DFGL+R + NP + GFM
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSE---NPGENAGFM--- 166
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
TE T YRAPE + + DV+S G +L ELL K
Sbjct: 167 --------TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 40/121 (33%), Positives = 56/121 (46%), Gaps = 26/121 (21%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSS 570
++ + L YL E +H D+KPSNILLD + DFG+S RL++ S+
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW----DVYSFGVVLLELLTGKS 626
G YM APE R+ P K+ DV+S G+ L+EL TG+
Sbjct: 176 ------GCAAYM------------APE-RIDPPDPNPKYDIRADVWSLGISLVELATGQF 216
Query: 627 P 627
P
Sbjct: 217 P 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 20/109 (18%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H + +H D+KPSN+LL+ + I DFGL+R+ + ++ GF+
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH----TGFL--- 166
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
TE T YRAPE + + D++S G +L E+L+ +
Sbjct: 167 --------TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 35/107 (32%), Positives = 49/107 (45%), Gaps = 18/107 (16%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL YLH +H DIKP N+L++++ I DFGL+R+ P S
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV-----EEPDES------- 158
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+M Q T YRAPE + D++S G + ELL +
Sbjct: 159 -KHM--TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 33/199 (16%)
Query: 434 VAVRRLGEGGEQ---RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
VA++++ G+Q + ++ + EV+ + ++KHPN ++ + Y L+ ++
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS-- 110
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
A+ L + +P + + I G +GLAYLH +H DIK NILL Q
Sbjct: 111 ASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQV 164
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ--K 608
++DFG + + +P++S F+G PY + APE + + K
Sbjct: 165 KLADFGSASIA-----SPANS--FVG--TPY-----------WMAPEVILAMDEGQYDGK 204
Query: 609 WDVYSFGVVLLELLTGKSP 627
DV+S G+ +EL K P
Sbjct: 205 VDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+V+K G VA+++ E + + + E++ + ++KHPN+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ + L+ ++ + L + G P + +I T + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCHK---HN 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KP NIL+ Q + DFG +R++ G Y V T
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILT-------------GPGDDYTDYVATRW-- 165
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
YRAPE V + DV++ G V ELLTG
Sbjct: 166 -YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 28/173 (16%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
E++ + ++H NI+ L + +P E + + +L L R + + ++
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI- 117
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
RGL Y+H VH D+KPSNIL++ + I DFGL+R+ +P +G
Sbjct: 118 -----LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTG 164
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
Y+ T YRAPE + + + D++S G + E+L GK
Sbjct: 165 --------YV------STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 50/196 (25%), Positives = 78/196 (39%), Gaps = 26/196 (13%)
Query: 436 VRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL-ISDFISNGNLANAL 494
+R E + F E A++ HPNIV L AP L + +++ L L
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL 70
Query: 495 RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPY-- 551
+L R+ LA H + VH D+KP NI++ +P+
Sbjct: 71 -----AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKW 609
+ DFG+ L+ + A TE T Y APE ++ G
Sbjct: 123 VLDFGIGTLLPGVRD-----------ADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNS 170
Query: 610 DVYSFGVVLLELLTGK 625
D+Y++G++ LE LTG+
Sbjct: 171 DLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 43/134 (32%), Positives = 66/134 (49%), Gaps = 25/134 (18%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL +LH+ + ++ D+K N+LLD D I+DFG+ + N+ G +S+ F G
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKAST--FCG--- 158
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-----ELSPTTS 634
T +Y APE + G + + D +SFGV+L E+L G+SP E S
Sbjct: 159 ----------TPDYIAPEI-LKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS 207
Query: 635 TSIEVPDLVRWVKK 648
+ P RW+ K
Sbjct: 208 ILNDRPHFPRWISK 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ G VY + + G VA++++ + + + E+ + + K+PNIV Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ ++++ G+L + + T + + + + L +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHS---NQVI 137
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H DIK NILL D ++DFG I + S+ G PY +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-----TPY-----------W 181
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
APE V K D++S G++ +E++ G+ P L+
Sbjct: 182 MAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 61/268 (22%), Positives = 117/268 (43%), Gaps = 53/268 (19%)
Query: 449 EFVTEVQAIAKVKHPNIVKL---------RAYYWAPDEKLLISDFISNGNLAN-ALRGRN 498
+F++E + + HPN+++L Y +P ++I F+ +G+L + L R
Sbjct: 46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP---VVILPFMKHGDLHSFLLYSRL 102
Query: 499 GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558
G L ++ A G+ YL S + F+H D+ N +L+ + ++DFGLS
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVL 618
+ I + + G + M PV+ + A E+ + K DV+SFGV +
Sbjct: 160 KKI-------YNGDYYRQGRIAKM-PVK------WIAIES-LADRVYTTKSDVWSFGVTM 204
Query: 619 LELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAV 677
E+ T G++P +E ++ ++++G + P D +D +
Sbjct: 205 WEIATRGQTP------YPGVENSEIYDYLRQGNRLKQP-PDCLDGL-------------- 243
Query: 678 FHLALACTEADPEVRPRMKNVSENLERI 705
+ L +C +P+ RP + + LE+
Sbjct: 244 YSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 57/180 (31%), Positives = 83/180 (46%), Gaps = 35/180 (19%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWS---T 509
E +A+V HP IVKL + + LI DF+ G+L L S + ++
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-------SKEVMFTEEDV 100
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
+ +A+ A L +LH ++ D+KP NILLD + ++DFGLS+ +I +
Sbjct: 101 KFYLAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKA 155
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRP--MQKWDVYSFGVVLLELLTGKSP 627
S F G T Y APE NR Q D +SFGV++ E+LTG P
Sbjct: 156 YS--FCG-------------TVEYMAPEVV---NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 415 LGKSGLGIV-YKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ GIV V +G VAV+++ +QR EV + +H N+V++ Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ +F+ G L + + T ++ + + L+ LH + +
Sbjct: 88 VGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLKALSVLHA---QGVI 138
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK---- 589
H DIK +ILL +D + +SDFG ++ K V K
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVS--------------------KEVPRRKSLVG 178
Query: 590 TNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T + APE +R+P + D++S G++++E++ G+ P
Sbjct: 179 TPYWMAPELISRLPYGPEV---DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 430 NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489
G VAV+++ +QR EV + H N+V + Y DE ++ +F+ G
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549
L + + T ++ + R L+YLH + +H DIK +ILL +D +
Sbjct: 106 LTDIV------THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGR 156
Query: 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQ 607
+SDFG ++ S G PY + APE +R+P +
Sbjct: 157 IKLSDFGFCAQVSKEVPKRKSLVG-----TPY-----------WMAPEVISRLPYGTEV- 199
Query: 608 KWDVYSFGVVLLELLTGKSPELS-PTTSTSIEVPD-LVRWVKKGFEEENPLSDMVDAMLL 665
D++S G++++E++ G+ P + P + D L VK + + L +D ML+
Sbjct: 200 --DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV 257
Query: 666 QE 667
+E
Sbjct: 258 RE 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 415 LGKSGLGIVYKVVL---GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKLRA 470
LG G V K V I VA++ L E+ R E + E + + ++ +P IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
A + +L+ + S G L L G+ + + S + + + G+ YL +
Sbjct: 63 VCEA-EALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEG---K 114
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
FVH D+ N+LL N ISDFGLS+ + G + S G P
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKAL---GADDSYYKARSAGKWPL--------- 162
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
+ APE + + + DV+S+G+ + E + G+ P
Sbjct: 163 -KWYAPEC-INFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 57/236 (24%), Positives = 92/236 (38%), Gaps = 38/236 (16%)
Query: 415 LGKSGLGIVYKVVLGN----GIPVAVRRLGE---GGEQRHREFVTEVQAIAKVKHPNIVK 467
+GK G+G VY L VA++++ E + F+ E + A + HP IV
Sbjct: 10 IGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 468 LRA--------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTS------LSWSTRLRI 513
+ + YY P +I L + L+ + S S S L I
Sbjct: 67 VYSICSDGDPVYYTMP--------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573
+ Y+H + +H D+KP NILL + I D+G + + +
Sbjct: 119 FHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 574 FMGGAL--PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P + T +Y APE R+ G + D+Y+ GV+L ++LT P
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPE-RLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 41/106 (38%), Positives = 52/106 (49%), Gaps = 18/106 (16%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL Y H+ + F+H DIK SNILL+N Q ++DFGL+RL N +
Sbjct: 128 GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYN------------SEESR 172
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
PY V T YR PE + R DV+S G +L EL T K
Sbjct: 173 PYTNKVITLW---YRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/231 (29%), Positives = 97/231 (41%), Gaps = 44/231 (19%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL-RAYY 472
LG G VYK G A + + E+ +++ E++ +A HP IVKL A+Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 473 WAPDEKLLISDFISNGNLANAL-----RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
W D KL I G +A+ RG +P + I + L YLH
Sbjct: 80 W--DGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQV-------ICRQMLEALQYLHS- 128
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-- 584
K +H D+K N+LL D ++DFG+S T S F+G PY M P
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS---FIG--TPYWMAPEV 181
Query: 585 --VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
+T K Y K D++S G+ L+E+ + P EL+P
Sbjct: 182 VMCETMKDTPYD------------YKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 40/118 (33%), Positives = 56/118 (47%), Gaps = 23/118 (19%)
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLINITGNNPSSS 571
IA T + L YL E K +H D+KPSNILLD + + DFG+S +L++ S +
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIA 163
Query: 572 GGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G PYM P + + Y + DV+S G+ L E+ TGK P
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDV------------RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 75/302 (24%)
Query: 414 VLGKSGLGIVY--------KVVLGNGIPVAVRRLGEGGEQRHREFV-TEVQAIAKVKHPN 464
V+G+ GIV+ K+V+ IPV E + R E Q + + HPN
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPV------EQMTKDERLAAQNECQVLKLLSHPN 60
Query: 465 IVKLRAYY--WAPDEKLLIS-DFISNGNLANALRGRNGQ---PSTSLSWSTRLRIAKGTA 518
I++ YY + D+ L+I ++ G LA ++ R T L + ++ +A
Sbjct: 61 IIE---YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---- 113
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
LH + +H D+K NILLD + I DFG+S+++ ++ S + +G
Sbjct: 114 -----LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL----SSKSKAYTVVG- 163
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSPELSPTTSTS 636
T Y +PE + +P QK D+++ G VL EL + K +
Sbjct: 164 ------------TPCYISPE--LCEGKPYNQKSDIWALGCVLYELASLKR------AFEA 203
Query: 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696
+P LV + G P+SD L Q L L+ DP RP++
Sbjct: 204 ANLPALVLKIMSG--TFAPISDRYSPDLRQ-------------LILSMLNLDPSKRPQLS 248
Query: 697 NV 698
+
Sbjct: 249 QI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 40/116 (34%), Positives = 53/116 (45%), Gaps = 40/116 (34%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN--ITGNNPSSSGGFMG 576
RGL Y+H +H D+KPSNI ++ D + I DFGL+R + +TG
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG----------- 174
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW-------DVYSFGVVLLELLTGK 625
Y V T YRAPE M W D++S G ++ ELLTGK
Sbjct: 175 ----Y---VATRW---YRAPEI-------MLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 452 TEVQAIAKVKH-PNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWST 509
TE Q + V+ P +V L Y + D KL LI D+++ G L L R + +
Sbjct: 53 TERQVLEAVRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV---- 107
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
R+ IA+ L +LH+ ++ DIK NILLD++ ++DFGLS+
Sbjct: 108 RVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKE--FLAEEEE 161
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW-DVYSFGVVLLELLTGKSP 627
+ F G T Y APE G+ K D +S GV+ ELLTG SP
Sbjct: 162 RAYSFCG-------------TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 19/106 (17%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H +H D+KPSN+L++ D + I DFG++R ++ ++P+ FM
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS---SSPTEHKYFM--- 168
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELL 622
TE T YRAPE + D++S G + E+L
Sbjct: 169 --------TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 54/224 (24%), Positives = 99/224 (44%), Gaps = 40/224 (17%)
Query: 414 VLGKSGLGIVYK---VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH---PNIVK 467
++G+ G VY+ V G + + + L + + + EV +++++ PNI K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINL-DTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 468 LRAYY--WAPDEKL-LISDFISNGNLANALR-GRNGQPSTSLSWSTRLRIAKGTARGLAY 523
YY + +L +I ++ G++ ++ G + S+ I + L Y
Sbjct: 67 ---YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKY 116
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
+H+ +H DIK +NIL+ N + DFG++ L+N + S+ F+G PY
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVG--TPY-- 166
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ APE G K D++S G+ + E+ TG P
Sbjct: 167 ---------WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 60/194 (30%), Positives = 88/194 (45%), Gaps = 32/194 (16%)
Query: 444 EQRHREFVTEVQAIAK-VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS 502
E++H ++E + K VKHP +V L + D+ + D+I+ G L L+ +
Sbjct: 38 EEKH--IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ----RER 91
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
L R A+ A L YLH + V+ D+KP NILLD+ ++DFGL + N
Sbjct: 92 CFLEPRARFYAAE-IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE-N 146
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLE 620
I N +S+ F G T Y APE + P +R + W G VL E
Sbjct: 147 IEHNGTTST--FCG-------------TPEYLAPEVLHKQPYDRTVDWW---CLGAVLYE 188
Query: 621 LLTGKSPELSPTTS 634
+L G P S T+
Sbjct: 189 MLYGLPPFYSRNTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 52/180 (28%), Positives = 75/180 (41%), Gaps = 29/180 (16%)
Query: 457 IAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKG 516
+ VKHP +V L + D+ + D+++ G L L Q S A
Sbjct: 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL-----QRERSFPEPRARFYAAE 104
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
A L YLH ++ D+KP NILLD+ ++DFGL + I + +S+ F G
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTST--FCG 158
Query: 577 GALPYMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634
T Y APE + P +R + W G VL E+L G P S T+
Sbjct: 159 -------------TPEYLAPEVLRKQPYDRTVDWW---CLGAVLYEMLYGLPPFYSRDTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/217 (22%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ G V+ + + G VA++++ + + + E+ + ++K+PNIV +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ ++++ G+L + + T + + + + + L +LH + +
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLH---ANQVI 137
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H DIK N+LL D ++DFG I + S+ G PY +
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG-----TPY-----------W 181
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
APE V K D++S G++ +E++ G+ P L+
Sbjct: 182 MAPEV-VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 39/109 (35%), Positives = 51/109 (46%), Gaps = 23/109 (21%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H + +H D+KPSN+LL+ + I DFGL+R S G FM
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-------TTSEKGDFM--- 165
Query: 579 LPYMKPVQTEK--TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
TE T YRAPE + + DV+S G + ELL K
Sbjct: 166 --------TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 50/171 (29%), Positives = 79/171 (46%), Gaps = 24/171 (14%)
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
P IV L+ + + L++D++S G L L+ + G+ S + IA+ L
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSED---RAKFYIAE-LVLALE 110
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
+LH+ V+ D+KP NILLD + DFGLS+ N+T N +++ F G
Sbjct: 111 HLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT--FCG------ 158
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633
T Y APE + + D +S GV++ E+ G SP + T
Sbjct: 159 -------TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 52/221 (23%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLG--EGGEQRHRE-FVTEVQAIAKVKHPNIVKLRA 470
+GK +VYK + L +G VA++++ E + + R+ + E+ + ++ HPN++K A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQ----PSTSLSWSTRLRIAKGTARGLAYLHE 526
+ +E ++ + G+L+ ++ Q P ++ W +++ L ++H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLC----SALEHMHS 124
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
++ +H DIKP+N+ + + D GL R + S G PY
Sbjct: 125 ---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG-----TPY----- 171
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE R+ N K D++S G +L E+ +SP
Sbjct: 172 ------YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 43/202 (21%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL +LH + ++ D+K N++LD D I+DFG+ + N+ G+N +S+ F G
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFGDNRAST--FCG--- 158
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-----ELSPTTS 634
T +Y APE + G + D +SFGV+L E+L G+SP E S
Sbjct: 159 ----------TPDYIAPEI-LQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207
Query: 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHL----------ALAC 684
++ P RW+ K + D+++ + ++ + V+ AL
Sbjct: 208 IRVDTPHYPRWITKESK------DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEK 261
Query: 685 TEADPEVRPRMKNVSE--NLER 704
E DP +P++K+ S+ N +R
Sbjct: 262 RELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 43/147 (29%), Positives = 63/147 (42%), Gaps = 10/147 (6%)
Query: 419 GLGIVYKVVLG---NGIPVA---VRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAY 471
G G KV+LG G+ A V+ L F+ EVQ ++ HPN+++
Sbjct: 4 GNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQ 63
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
LL+ +F G+L N LR G + R+A A GL +LH+
Sbjct: 64 CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--- 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLS 558
F+H D+ N L D I D+GL+
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 28/229 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LGK G VYKV+ G+ +A++ RL E E + + + E+ + K P IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 472 YWAPDEKLLISDFISNGNLANALRG---RNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
++ + +++ G+L G G P L RI +GL +L E
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-----RITYAVVKGLKFLKE-- 120
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+H D+KP+N+L++ + Q + DFG+S GN +S G YM P + +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIK 174
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637
+ P V DV+S G+ +LE+ G+ P P T +I
Sbjct: 175 SGGPNQNPTYTVQS-------DVWSLGLSILEMALGRYP-YPPETYANI 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/188 (28%), Positives = 77/188 (40%), Gaps = 34/188 (18%)
Query: 444 EQRHREFVTEVQAIAK-VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS 502
EQ+H + E + K VKHP +V L + ++ + DF++ G L L+ P
Sbjct: 38 EQKH--IMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE 95
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL-I 561
R A+ A L YLH V+ D+KP NILLD+ ++DFGL + I
Sbjct: 96 PR----ARFYAAE-IASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI 147
Query: 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLL 619
+ + G T Y APE + P + + W G VL
Sbjct: 148 AQSDTTTTFCG-----------------TPEYLAPEVIRKQPYDNTVDWW---CLGAVLY 187
Query: 620 ELLTGKSP 627
E+L G P
Sbjct: 188 EMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 54/282 (19%)
Query: 430 NGIPVAVRRLGE---GGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKL----LIS 482
N V +R + G + E++ + ++ NI+K+ + + L LI
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNI 542
++ + G L L LS+ T+L +A +GL L++ + + + ++ +
Sbjct: 102 EYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSF 154
Query: 543 LLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQTEKTNNYRAPEARVP 601
L+ + Y L I + P + FM Y + + + Y
Sbjct: 155 LVTEN---YKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEY-------- 199
Query: 602 GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVD 661
K D+YS GVVL E+ TGK P + TT E+ DL+ + K + PL
Sbjct: 200 ----TIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLI--INKNNSLKLPLD---C 247
Query: 662 AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
+ ++ + V ACT D RP +K + NL
Sbjct: 248 PLEIKCI-----VE-------ACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 61/287 (21%)
Query: 421 GIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVK-LRAYYWAPDE 477
GI+ G V V+ + + Q + E + + H NI+ L +
Sbjct: 25 GILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPILHVCIEDGEP 83
Query: 478 KLLISDFISNGNLANALR-GRNGQPSTSLSWSTRLRIAKGT--ARGLAYLHECSPRKFVH 534
++ +++ GNL L+ R G+ + + ST+ + A G++YLH+ R +H
Sbjct: 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIH 140
Query: 535 GDIKPSNILLDNDFQPYISDFGLSRLI-----NITGNNPSSSGGFMGGALPYMKPVQTEK 589
DI N ++D + Q I+D LSR + + G+N + +PV+
Sbjct: 141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-------------RPVK--- 184
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTSTSIEVPDLVRWV 646
+ A E+ V DV+SFGV+L EL+T G++P E+ P ++ ++
Sbjct: 185 ---WMALESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPF--------EMAAYL 232
Query: 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
K G+ L Q ++ E+ AV C DPE RP
Sbjct: 233 KDGYR------------LAQPINCPDELFAVM---ACCWALDPEERP 264
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 42/149 (28%), Positives = 62/149 (41%), Gaps = 10/149 (6%)
Query: 419 GLGIVYKVVLG------NGIPVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
G G KV+LG V V+ L Q +F+ E Q ++H N+++
Sbjct: 4 GNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQ 63
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
LL+ +F G+L LR + +T R+A A GL +LH+
Sbjct: 64 CTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NN 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRL 560
F+H D+ N LL D I D+GLS
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 57/222 (25%), Positives = 103/222 (46%), Gaps = 40/222 (18%)
Query: 415 LGKSGLGIVY--KVVLGNGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVKHPNIVKLR 469
+G G VY + V N + VA++++ G+Q + ++ + EV+ + +++HPN ++ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 470 AYYWAPDEKLLISDFI--SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y L+ ++ S ++ + +P + + I G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHK----KPLQEVEIAA---ICHGALQGLAYLHS- 133
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ +H DIK NILL ++DFG + L+ +P++S F+G PY
Sbjct: 134 --HERIHRDIKAGNILLTEPGTVKLADFGSASLV-----SPANS--FVG--TPY------ 176
Query: 588 EKTNNYRAPEARVPGNRPMQ--KWDVYSFGVVLLELLTGKSP 627
+ APE + + K DV+S G+ +EL K P
Sbjct: 177 -----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 29/179 (16%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLS--WS 508
+ E +A+V P IV L+ + +P++ L+ FI+ G L + L+ R G+ S + ++
Sbjct: 41 LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYT 99
Query: 509 TRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568
L A L LH+ + ++ D+KP NILLD + DFGL +L N+ ++
Sbjct: 100 AELLCA------LENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDK 149
Query: 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+++ F G T Y APE + G+ + D ++ GV+L E+LTG P
Sbjct: 150 TNT--FCG-------------TPEYLAPEL-LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 65/196 (33%), Positives = 90/196 (45%), Gaps = 16/196 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+PS L +L L+ L+L N+L LP L N ++L+++ L GN +S LPP + L L+
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALE 212
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
LDLSNNS L L N K L L L+ NK +P I L NL LDLS+N +
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI-GNLSNLETLDLSNN--QI 267
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQ 264
+ LG L +L L+LS N LS +P L + L + T
Sbjct: 268 SSISSLGSLTNL-RELDLSGNSLSNALPLIALLLLL--------LELLLNLLLTLKALEL 318
Query: 265 GPTAFLSNPLLCGFPL 280
+ L N +
Sbjct: 319 KLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 37/190 (19%)
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
P IV + + PD+ I D ++ G+L L + + A GL
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLE 111
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
++H R V+ D+KP+NILLD ISD GL+ + + P +S G
Sbjct: 112 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVG--------- 157
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP----------ELSPT 632
T+ Y APE G D +S G +L +LL G SP E+
Sbjct: 158 -------THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210
Query: 633 TST-SIEVPD 641
T T ++E+PD
Sbjct: 211 TLTVNVELPD 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 44/179 (24%), Positives = 86/179 (48%), Gaps = 30/179 (16%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL--RGRNG--QPSTSLS 506
+ E+ + ++KH NIV+L ++ +L+ +++ +L + G G P+T S
Sbjct: 46 IREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKS 104
Query: 507 WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566
++ +L +G+A+ HE + +H D+KP N+L++ + ++DFGL+R I N
Sbjct: 105 FTYQL------LKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155
Query: 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
S+ T YRAP+ + D++S G ++ E++TG+
Sbjct: 156 TFSNE----------------VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 59/220 (26%), Positives = 92/220 (41%), Gaps = 37/220 (16%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK G VA++ RL E + E+ + +++HPNIV L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 472 YWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
LI +F+S +L L + L S +I +G + C
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG-------ILFCHS 119
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
R+ +H D+KP N+L+DN ++DFGL+R I PV+
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--------------------PVRVYT 159
Query: 590 ----TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T YRAPE + R D++S G + E+ T K
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 32/90 (35%), Positives = 52/90 (57%), Gaps = 2/90 (2%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
+SG ++RG IP LGS+ L L+L N+ GS+P+ L TSL + L GN+LSG +P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
Query: 136 SVCNLP-RLQNLDLSNNSFSGSLPDGLKNC 164
++ + + ++N+ +P GL+ C
Sbjct: 509 ALGGRLLHRASFNFTDNAGLCGIP-GLRAC 537
|
Length = 623 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 38/180 (21%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E + + +V HP I++L D++ L + +++ G L + LR S ST
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEH--DQRFLYMLMEYVPGGELFSYLRNSG-----RFSNSTG 103
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR-LINITGNNPS 569
L A L YLH ++ V+ D+KP NILLD + ++DFG ++ L + T
Sbjct: 104 LFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT--- 157
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ G T Y APE N+ + W + G+++ E+L G P
Sbjct: 158 -----LCG------------TPEYLAPEVIQSKGHNKAVDWW---ALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 50/196 (25%), Positives = 86/196 (43%), Gaps = 39/196 (19%)
Query: 435 AVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANA 493
A RR + EQ E Q ++++KHPNIV R + D L ++ F G+L +
Sbjct: 38 ASRRERKAAEQ-------EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHK 90
Query: 494 LRGRNGQ---PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
L+ + G+ + + W ++ +A L YLHE + +H D+K N+ L
Sbjct: 91 LKEQKGKLLPENQVVEWFVQIAMA------LQYLHE---KHILHRDLKTQNVFLTRTNII 141
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKW 609
+ D G++R++ N + G YM P + + K NY++
Sbjct: 142 KVGDLGIARVL----ENQCDMASTLIGTPYYMSPELFSNKPYNYKS-------------- 183
Query: 610 DVYSFGVVLLELLTGK 625
DV++ G + E+ T K
Sbjct: 184 DVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 17/140 (12%)
Query: 423 VYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIV-KLRAYYWAPDEKLL 480
VY + + ++ + RE EV + + + V K+ A + L
Sbjct: 14 VYLLGTKDE-DYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540
+ ++I G+ +S + IA+ A LA LH+ HGD+ P
Sbjct: 71 LMEWIE------------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG 118
Query: 541 NILLDNDFQPYISDFGLSRL 560
NIL+D+ I D+ +
Sbjct: 119 NILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 46/169 (27%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
KHP + +L + + D + ++++ G+L + Q S A G
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIVLG 108
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +LHE R ++ D+K N+LLD++ I+DFG+ + I G +S+ F G
Sbjct: 109 LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTST--FCG---- 158
Query: 581 YMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE + P + W + GV+L E+L G+SP
Sbjct: 159 ---------TPDYIAPEILSYQPYGPAVDWW---ALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 44/170 (25%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRR----LGEGGEQRHREFVTEVQAIAKVK------HP 463
+G+ G VYK L G VA+++ L E G ++ ++ IA +K HP
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-----LSTLREIALLKQLESFEHP 61
Query: 464 NIVKLR--AYYWAPDEKLLI-----------SDFISNGNLANALRGRNGQPSTSLSWSTR 510
NIV+L + D +L + + ++S P L T
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK------------CPKPGLPPETI 109
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
+ + RG+ +LH S R VH D+KP NIL+ +D Q I+DFGL+R+
Sbjct: 110 KDLMRQLLRGVDFLH--SHR-IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 49/221 (22%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ VY+ L +G+PVA++++ + + + E+ + ++ HPN++K A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQ----PSTSLSWSTRLRIAKGTARGLAYLHE 526
+ +E ++ + G+L+ ++ Q P ++ W +++ L ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-WKYFVQLCSA----LEHMHS 124
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R+ +H DIKP+N+ + + D GL R + + +++ +G PY
Sbjct: 125 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG--TPY----- 171
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE R+ N K D++S G +L E+ +SP
Sbjct: 172 ------YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 39/128 (30%), Positives = 61/128 (47%), Gaps = 24/128 (18%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H +H D+KPSN+ ++ D + I DFGL+R + G++
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVA-- 179
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
T YRAPE + Q D++S G ++ ELLTG++ L P T +
Sbjct: 180 -----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT--LFPGTDHIDQ 226
Query: 639 VPDLVRWV 646
+ ++R V
Sbjct: 227 LKLILRLV 234
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 39/179 (21%)
Query: 453 EVQAIAKVK-HPNIVKL-RAYYWAPDEKL-LISDFISNGNLANALRGRNGQP---STSLS 506
E+QA+ ++ HPNI++L + +L L+ + + + NL ++GR +P S
Sbjct: 47 EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRK-RPLPEKRVKS 104
Query: 507 WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566
+ +L + L ++H H DIKP NIL+ +D ++DFG R I
Sbjct: 105 YMYQL------LKSLDHMHRNG---IFHRDIKPENILIKDDILK-LADFGSCRGI----- 149
Query: 567 NPSSSGGFMGGALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
Y KP TE T YRAPE + K D+++ G V E+L+
Sbjct: 150 --------------YSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 26/177 (14%)
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
P IV + + PD+ I D ++ G+L L ++G S + A GL
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHG----VFSEAEMRFYAAEIILGLE 111
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
++H R V+ D+KP+NILLD ISD GL+ + + P +S G
Sbjct: 112 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASVG--------- 157
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEV 639
T+ Y APE G D +S G +L +LL G SP T E+
Sbjct: 158 -------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/181 (30%), Positives = 85/181 (46%), Gaps = 31/181 (17%)
Query: 452 TEVQAIAKVKH-PNIVKLRAYYWAPDEKL-LISDFISNGNLANAL--RGRNGQPSTSLSW 507
TE Q + ++ P +V L Y + D KL LI D+I+ G L L R R + + +
Sbjct: 53 TERQVLEHIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQI-Y 110
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
S + +A L +LH+ ++ DIK NILLD++ ++DFGLS+ +
Sbjct: 111 SGEIVLA------LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE 161
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW-DVYSFGVVLLELLTGKS 626
+ S G + YM AP+ G+ K D +S GV++ ELLTG S
Sbjct: 162 RAYS---FCGTIEYM------------APDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206
Query: 627 P 627
P
Sbjct: 207 P 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 65/318 (20%), Positives = 115/318 (36%), Gaps = 65/318 (20%)
Query: 410 ASAYVLGK--SGLGIVYKVVLG----NGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVK 461
++GK L IV+ L VAV++ L ++ + E+ +++
Sbjct: 1 ELLTLIGKCFEDLMIVH---LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ 57
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGR--NGQPSTSLSWSTRLRIAKGTAR 519
HPNI+ + E ++S ++ G+ + L+ G P ++++ I K
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF-----ILKDVLN 112
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
L Y+H + F+H +K S+ILL D + +S GL +++ G +
Sbjct: 113 ALDYIHS---KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMI------KHGKR-QRV 160
Query: 580 PYMKPVQTEKTNNYRAPEA---RVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPT-- 632
+ P + K + +PE + G K D+YS G+ EL G P ++ T
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNE--KSDIYSVGITACELANGHVPFKDMPATQM 218
Query: 633 --------------TSTSIEVPDLVRWVKKGFEEEN---PLSDMVDAMLLQEVHAKKEVI 675
ST D + + E N + + H
Sbjct: 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFH------ 272
Query: 676 AVFHLALACTEADPEVRP 693
C + DPE RP
Sbjct: 273 ---QFVELCLQRDPESRP 287
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 63/277 (22%), Positives = 115/277 (41%), Gaps = 47/277 (16%)
Query: 434 VAVRRLGEGGEQRH--REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
VA+++ E + + + + E++ + +++H N+V L + L+ +F+ + L
Sbjct: 29 VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD 88
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
+ + NG L S + RG+ + H +H DIKP NIL+
Sbjct: 89 DLEKYPNG-----LDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVK 140
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
+ DFG +R + G Y V T YRAPE V + + D+
Sbjct: 141 LCDFGFARTLAAPGEV-------------YTDYVATRW---YRAPELLVGDTKYGRAVDI 184
Query: 612 YSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK---------KGFEEENP------L 656
++ G ++ E+LTG+ L P S ++ L +K + ++NP L
Sbjct: 185 WAVGCLVTEMLTGEP--LFPGDS---DIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 657 SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
++ + L++ K + + LA C DP+ RP
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 35/107 (32%), Positives = 49/107 (45%), Gaps = 19/107 (17%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G+A+LH+ +H D+K SN+LL+N I DFGL+R +
Sbjct: 117 SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLARE-------------YGSPL 160
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
PY + V T YRAPE + D++S G + ELLT K
Sbjct: 161 KPYTQLVVTLW---YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 51/175 (29%), Positives = 74/175 (42%), Gaps = 26/175 (14%)
Query: 453 EVQAIAKVKHPNIVKLR--AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+ + ++HPNIV+L+ D L+ ++ +LA+ L T S S
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM----PTPFSESQV 110
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
+ RGL YLHE +H D+K SN+LL + I+DFGL+R G
Sbjct: 111 KCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART---YGLPAKP 164
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
M P T YRAPE + D+++ G +L ELL K
Sbjct: 165 -----------MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 67/253 (26%), Positives = 109/253 (43%), Gaps = 43/253 (16%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQA----IAKVKHPNIVKL 468
V+G+ G V V G A+++L + E +E V V+A +A+ +P +VKL
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 469 RAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
YY DE LI +++ G++ L ++ T TR IA+ T + +H+
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAE-TILAIDSIHK 119
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI----------NITGNNPSSSGGFMG 576
++H DIKP N+LLD +SDFGL + ++ PS+ F+
Sbjct: 120 L---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 577 GALPYMKPVQTEKTN------------NYRAPEARVP-GNRPMQKWDVYSFGVVLLELLT 623
+ + +T K N +Y APE + G W +S GV++ E+L
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW--WSLGVIMYEMLV 234
Query: 624 GKSPELSPTTSTS 636
G P S +
Sbjct: 235 GYPPFCSDNPQET 247
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 76/306 (24%), Positives = 122/306 (39%), Gaps = 56/306 (18%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVK 467
LG+ G VYK L P VA++ L + E RE F E ++++HPNIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQP-----------STSLSWSTRLRIAKG 516
L +I + S+ +L L R+ ++L + + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
A G+ +L S VH D+ N+L+ + ISD GL R + + MG
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV-----YAADYYKLMG 184
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636
+ + P++ + +PEA + G + D++S+GVVL E+ S L P S
Sbjct: 185 NS---LLPIR------WMSPEAIMYGKFSIDS-DIWSYGVVLWEVF---SYGLQPYCGYS 231
Query: 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696
+ D++ ++ + P D A V+ L L C P RPR K
Sbjct: 232 NQ--DVIEMIRN--RQVLPCPDDCPAW-------------VYTLMLECWNEFPSRRPRFK 274
Query: 697 NVSENL 702
++ L
Sbjct: 275 DIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 63/227 (27%), Positives = 95/227 (41%), Gaps = 56/227 (24%)
Query: 415 LGKSGLGIVYKV------------VLGNGIPVAVRRLGEGGEQRHREFV---TEVQAIAK 459
LGK G VY V VL IPV GE E V E Q ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKE-IPV--------GELNPNETVQANQEAQLLSK 58
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR-----GRNGQPSTSLSWSTRLRIA 514
+ HP IVK A + D +I+++ +L L G+ + W +L +
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117
Query: 515 KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
G+ Y+H+ R+ +H D+K NI L N+ I DFG+SRL+ + + ++ G
Sbjct: 118 -----GVHYMHQ---RRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTG- 167
Query: 575 MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
PY Y +PEA + K D++S G +L E+
Sbjct: 168 ----TPY-----------YMSPEA-LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 52/222 (23%)
Query: 448 REFVTEVQA----IAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQP 501
R V+A +A+ + +VKL YY D+ L + D+I G++ + L R G
Sbjct: 42 RNQAAHVKAERDILAEADNEWVVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIF 98
Query: 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561
L+ R IA+ T + +H+ F+H DIKP NIL+D D ++DFGL
Sbjct: 99 EEDLA---RFYIAELTC-AIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
Query: 562 NITGNN---------------PSSSGGFMGGALPYMKPVQTEK--------------TNN 592
T ++ PS + +KP++ + T N
Sbjct: 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC--RLKPLERRRKRQHQRCLAHSLVGTPN 209
Query: 593 YRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
Y APE R Q D +S GV+L E+L G+ P L+ T
Sbjct: 210 YIAPEVLLRTGYT---QLCDWWSVGVILYEMLVGQPPFLADT 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 43/134 (32%), Positives = 65/134 (48%), Gaps = 25/134 (18%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL +LH + V+ D+K NILLD D I+DFG+ + N+ G+ + + F G
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKTCT--FCG--- 158
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-----ELSPTTS 634
T +Y APE + G + D +SFGV+L E+L G+SP E S
Sbjct: 159 ----------TPDYIAPEILL-GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207
Query: 635 TSIEVPDLVRWVKK 648
++ P RW+ +
Sbjct: 208 IRMDNPCYPRWLTR 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 63/225 (28%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+GL Y+H +H D+KP N+ ++ D + I DFGL+R S G++
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR------QTDSEMTGYV--- 176
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS-----------P 627
T YRAPE + Q D++S G ++ E+LTGK
Sbjct: 177 ----------VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM 226
Query: 628 ELSPTTSTSIE--------------VPDLVRWVKKGF----EEENPLS-DMVDAMLLQEV 668
E+ T T + V L R+ KK F NPL+ ++++ ML+ +
Sbjct: 227 EIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLV--L 284
Query: 669 HAKKEVIAVFHLALAC------TEADPEVRP---RMKNVSENLER 704
A+ + A LA E + E P V ++LE
Sbjct: 285 DAESRITAAEALAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLEE 329
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 32/173 (18%)
Query: 453 EVQAIAKVKHPNIVKLR-AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
E + V HP++++++ +++ + + +L L R S L L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY--SSDLYTYLTKR----SRPLPIDQAL 160
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
I K GL YLH ++ +H D+K NI +++ Q I D G ++ P +
Sbjct: 161 IIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF-------PVVA 210
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELL 622
F+G A T +TN APE AR N K D++S G+VL E+L
Sbjct: 211 PAFLGLA-------GTVETN---APEVLARDKYN---SKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 415 LGKSGLGIVYKV---VLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK + G + + RL E + E+ + ++ HPNIVKL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
++ L+ +F+ + +L + + P + + +GLA+ C +
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQLLQGLAF---CHSHR 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK-- 589
+H D+KP N+L++ + ++DFGL+R + PV+T
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGV--------------------PVRTYTHE 160
Query: 590 --TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626
T YRAPE + D++S G + E++T ++
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 7e-07
Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 30/169 (17%)
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
++HP +V L + L+ +++ G L + LR ++G+ + R A+
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV---ARFYAAQVVL- 112
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
L YLH V+ D+KP N+LLD+D I+DFG ++ + G + G
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYTLCG------- 160
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQK-WDVYSFGVVLLELLTGKSP 627
T Y APE + ++ K D ++ G+++ E+L G P
Sbjct: 161 ----------TPEYLAPE--IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 22/108 (20%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H +H D+KPSN+ ++ D + I DFGL+R + G++
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD------DEMTGYVA-- 177
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626
T YRAPE + Q D++S G ++ ELL GK+
Sbjct: 178 -----------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 30/180 (16%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+Q + ++H IV+ P+EK L +++ G++ + L+ +L+ +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-----ALTENVT 108
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN---ITGNN 567
R + +G++YLH VH DIK +NIL D+ + DFG S+ I ++G
Sbjct: 109 RRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
S G PY + +PE + G +K DV+S ++E+LT K P
Sbjct: 166 IKSVTG-----TPY-----------WMSPEV-ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+PS L L+ L L+ + + L N L S+ L N L ++ + L L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLD-GSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLT 119
Query: 145 NLDLSNNSFS-----------------------GSLPDGLKNCKQLQRLILARNKFSGQI 181
+LDL NN+ + SLP L+N L+ L L+ N S +
Sbjct: 120 SLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DL 178
Query: 182 PAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT 241
P + L NL LDLS N +P ++ L +L L+LS N + ++ SL NL
Sbjct: 179 PKLL-SNLSNLNNLDLSGNKIS-DLPPEIELLSALE-ELDLSNNSII-ELLSSLSNLKNL 234
Query: 242 VSFDLRGNNL 251
+L N L
Sbjct: 235 SGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 32/187 (17%)
Query: 444 EQRHREFVTEVQAIAK-VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS 502
EQ H + E + K +KHP +V L + ++ + D+++ G L L+ +
Sbjct: 38 EQNH--IMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ----RER 91
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
L R A+ A + YLH + ++ D+KP NILLD+ ++DFGL +
Sbjct: 92 CFLEPRARFYAAE-VASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCK--- 144
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLE 620
G P + G T Y APE + P +R + W G VL E
Sbjct: 145 -EGVEPEETTSTFCG------------TPEYLAPEVLRKEPYDRTVDWW---CLGAVLYE 188
Query: 621 LLTGKSP 627
+L G P
Sbjct: 189 MLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 32/108 (29%), Positives = 55/108 (50%), Gaps = 17/108 (15%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
RGL Y+H + +H D+KP+N+ ++ D I DFGL+R+++ + S G
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD---PHYSHKG----- 173
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
Y+ + T YR+P + N + D+++ G + E+LTGK
Sbjct: 174 ---YLS--EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 44/222 (19%)
Query: 415 LGKSGLGIV---YKVVLGNGIPVAVRRLGEGGE-QRH-REFVTEVQAIAKVKHPNIVKLR 469
+G GIV + VLG I VAV++L + Q H + E+ + V H NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLG--INVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 470 AYYWAPDEKL-------LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
+ P + L L+ + + + NL + S L G+
Sbjct: 87 NVF-TPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-------GIK 137
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
+LH +H D+KPSNI++ +D I DFGL+R ++ FM PY+
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---------TACTNFM--MTPYV 183
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
T YRAPE + G + D++S G ++ EL+ G
Sbjct: 184 ------VTRYYRAPEV-ILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 39/207 (18%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
E+ + KH NIV Y D+ + +F G+L + + LS S
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIY-----HVTGPLSESQIAY 110
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+++ T +GL YLH + +H DIK +NILL ++ ++DFG+S I T S
Sbjct: 111 VSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-- 165
Query: 573 GFMGGALPY-MKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-- 627
F+G PY M P E+ Y Q D+++ G+ +EL + P
Sbjct: 166 -FIG--TPYWMAPEVAAVERKGGYN------------QLCDIWAVGITAIELAELQPPMF 210
Query: 628 ELSP------TTSTSIEVP---DLVRW 645
+L P T ++ + P D ++W
Sbjct: 211 DLHPMRALFLMTKSNFQPPKLKDKMKW 237
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 64/229 (27%), Positives = 97/229 (42%), Gaps = 45/229 (19%)
Query: 447 HREFVTEVQA----IAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS 502
+R V V+A +A+ + +VKL + D + D+I G++ + L P
Sbjct: 41 NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE 100
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
R IA+ T + +H+ F+H DIKP NIL+D D ++DFGL
Sbjct: 101 VL----ARFYIAELTL-AIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152
Query: 563 ITGNN---------------PSS-----SGGFMGGALPYMKPVQTEK-----------TN 591
T N+ PS S G L ++ T++ T
Sbjct: 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP 212
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT-TSTSIEV 639
NY APE + Q D +S GV+L E+L G+ P L+PT T T ++V
Sbjct: 213 NYIAPEVLLRKGY-TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV 260
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 33/110 (30%), Positives = 50/110 (45%), Gaps = 22/110 (20%)
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
GL Y+H +H D+KP N+ ++ D + I DFGL+R + M
Sbjct: 126 MLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----------HADAEMT 172
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626
G + T YRAPE + Q D++S G ++ E+LTGK+
Sbjct: 173 GYV---------VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 41/225 (18%)
Query: 468 LRAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
++ +Y D++ LI +F+ G++ L ++ T +T+ IA+ T + +H
Sbjct: 64 VKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD----TLSEEATQFYIAE-TVLAIDAIH 118
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI----------NITGNNPSSSGGFM 575
+ F+H DIKP N+LLD +SDFGL + N+T N PS F
Sbjct: 119 QLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD---FS 172
Query: 576 GGALPYMKPVQTEKTN------------NYRAPEARV-PGNRPMQKWDVYSFGVVLLELL 622
+ + +T K N +Y APE + G + W +S GV++ E+L
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW--WSLGVIMYEML 230
Query: 623 TGKSPELSPTTSTSIEVPDLVRWVKK-GFEEENPLSDMVDAMLLQ 666
G P S T + ++ W + F E P+S+ ++L+
Sbjct: 231 IGYPPFCSETPQETYR--KVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 48/180 (26%), Positives = 80/180 (44%), Gaps = 30/180 (16%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+Q + ++H IV+ EK L +++ G++ + L+ +L+ S
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-----ALTESVT 108
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR---LINITGNN 567
+ + G++YLH VH DIK +NIL D+ + DFG S+ I ++G
Sbjct: 109 RKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
S G PY + +PE + G +K DV+S G ++E+LT K P
Sbjct: 166 IRSVTG-----TPY-----------WMSPEV-ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 52/179 (29%), Positives = 76/179 (42%), Gaps = 28/179 (15%)
Query: 452 TEVQAIAKVKH-PNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWST 509
TE + V+ P +V L Y + + KL LI D++S G + L R+ +
Sbjct: 53 TERNVLEHVRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV---- 107
Query: 510 RLRIAKG-TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568
R G L +LH+ V+ DIK NILLD++ ++DFGLS+
Sbjct: 108 --RFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK--EFLSEEK 160
Query: 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ F G T Y APE + D +S G+++ ELLTG SP
Sbjct: 161 ERTYSFCG-------------TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 61/245 (24%), Positives = 101/245 (41%), Gaps = 46/245 (18%)
Query: 397 DKGFTFELDELLRASAYVLGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREFVTEVQ 455
D FEL EL+ G G VYK + G A++ + G++ E E+
Sbjct: 3 DPAGIFELVELV-------GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEIN 54
Query: 456 AIAKVKHPNIVKLRAYYWA---------PDEKLLISDFISNGNLANALRGRNGQPSTSLS 506
+ K H + YY A D+ L+ +F G++ + ++ G +L
Sbjct: 55 MLKKYSHHR--NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLK 109
Query: 507 WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566
I + RGL++LH+ K +H DIK N+LL + + + DFG+S ++ T
Sbjct: 110 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166
Query: 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ----KWDVYSFGVVLLELL 622
++ F+G PY + APE P K D++S G+ +E+
Sbjct: 167 RRNT---FIG--TPY-----------WMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 210
Query: 623 TGKSP 627
G P
Sbjct: 211 EGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 37/211 (17%)
Query: 432 IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
+ V ++ LG F ++++ H ++VKL DE +++ +++ G L
Sbjct: 31 VSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLD 88
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL-----DN 546
L R SL W +L +AK A L YL + +K VHG++ NIL+ +
Sbjct: 89 VFLH-REKNN-VSLHW--KLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNE 141
Query: 547 DFQPYI--SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA-RVPGN 603
+ P+I SD G+ L + V+ + APE R
Sbjct: 142 GYVPFIKLSDPGIPI-----------------TVLSREERVERIP---WIAPECIRNGQA 181
Query: 604 RPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634
D +SFG LLE+ + LS +S
Sbjct: 182 SLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 49/221 (22%), Positives = 102/221 (46%), Gaps = 33/221 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLG--EGGEQRHRE-FVTEVQAIAKVKHPNIVKLRA 470
+G+ VY+ L + PVA++++ E + + R+ V E+ + ++ HPN++K
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQ----PSTSLSWSTRLRIAKGTARGLAYLHE 526
+ +E ++ + G+L+ ++ Q P ++ W +++ + ++H
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSA----VEHMHS 124
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R+ +H DIKP+N+ + + D GL R + + +++ +G PY
Sbjct: 125 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG--TPY----- 171
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE R+ N K D++S G +L E+ +SP
Sbjct: 172 ------YMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 30/180 (16%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+Q + + H IV+ P E+ L + + G++ + L+ +L+ +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-----ALTENVT 108
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR---LINITGNN 567
+ + G++YLH VH DIK +NIL D+ + DFG S+ I ++G
Sbjct: 109 RKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
S G PY + +PE + G +K D++S G ++E+LT K P
Sbjct: 166 MKSVTG-----TPY-----------WMSPEV-ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 17/114 (14%)
Query: 446 RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSL 505
R R E + +AK + + Y PD L++ ++I L +AL
Sbjct: 43 RERT-RREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------- 90
Query: 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559
R + + R + LH+ VHGD+ SNI+L + Y DFGL
Sbjct: 91 -EEARPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGG-RIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 78/335 (23%), Positives = 123/335 (36%), Gaps = 105/335 (31%)
Query: 434 VAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLL-ISDFISNGNL 490
VAV+ L EG ++ +TE++ + + H N+V L P L+ I ++ GNL
Sbjct: 40 VAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99
Query: 491 ANALRG-RNG------------------------------QPSTSLSWST--RLRIAKG- 516
+N LR R Q S S + L +
Sbjct: 100 SNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159
Query: 517 ----------------------TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554
ARG+ +L + RK +H D+ NILL + I D
Sbjct: 160 EEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICD 216
Query: 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA---RVPGNRPMQKWDV 611
FGL+R I +P Y++ + APE+ +V + DV
Sbjct: 217 FGLARDIY---KDPD-----------YVRKGDARLPLKWMAPESIFDKVYTT----QSDV 258
Query: 612 YSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAK 671
+SFGV+L E+ + + SP I+ + R +K+G P +A
Sbjct: 259 WSFGVLLWEIFSLGA---SPYPGVQID-EEFCRRLKEGTRMRAP------------EYAT 302
Query: 672 KEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706
E ++ + L C +PE RP SE +E +G
Sbjct: 303 PE---IYSIMLDCWHNNPEDRP---TFSELVEILG 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPV-AVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G V+K + V A++ + E E + E+ +++ P + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ +I +++ G+ + LR P +T L K +GL YLH K
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATML---KEILKGLDYLHS---EKK 122
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H DIK +N+LL ++DFG++ + T ++ F+G T
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVG-------------TPF 166
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ APE + + K D++S G+ +EL G+ P
Sbjct: 167 WMAPEV-IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLS-WSTRLRIAKGTARG 520
HP +V L + + + ++++ G+L ++ + P +S + +A
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------ 108
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L YLHE R ++ D+K N+LLD++ ++D+G+ + G P + G
Sbjct: 109 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTSTFCG--- 158
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY APE + G D ++ GV++ E++ G+SP
Sbjct: 159 ---------TPNYIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 67/246 (27%), Positives = 98/246 (39%), Gaps = 36/246 (14%)
Query: 414 VLGKSGLGIVYKV-VLGNGIPVAVRRLGEGGEQRHRE----FVTEVQAIAKVKHPNIVKL 468
VLGK G G V V G A ++L E + R+ + E Q + KV +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKL-EKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 469 RAYYWAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
Y D L+ ++ G+L + G G + A GL LH+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-----YAAEICCGLEDLHQ 120
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
+ V+ D+KP NILLD+ ISD GL+ + G G +G
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKGRVGTVG---------- 166
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
Y APE V R D ++ G +L E++ G+SP I+ ++ R V
Sbjct: 167 ------YMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQSP--FQQRKKKIKREEVERLV 217
Query: 647 KKGFEE 652
K+ EE
Sbjct: 218 KEVQEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 415 LGKSGLGIVYKVVLGN-GIPVAVRRLGE------GGEQRHREFVTEVQAIAKVKHPNIVK 467
LGK G G V V + N G A ++L + GE+ + E + + KV P IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA---LLEKEILEKVNSPFIVN 57
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR---GLAYL 524
L + + L+ ++ G+L + G+ + R+ +A+ G+ +L
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEME-----RVIHYSAQITCGILHL 111
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H V+ D+KP N+LLD+ +SD GL+ + + +
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTIT-------------- 152
Query: 585 VQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Q TN Y APE P + P+ D ++ G + E++ G++P
Sbjct: 153 -QRAGTNGYMAPEILKEEPYSYPV---DWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 63/247 (25%), Positives = 99/247 (40%), Gaps = 50/247 (20%)
Query: 397 DKGFTFELDELLRASAYVLGKSGLGIVYK---VVLGNGIPVAVRRLGEGGEQRHREFVTE 453
D FEL E V+G G VYK V G + V + E E+ E E
Sbjct: 13 DPAGIFELVE-------VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLE 62
Query: 454 VQAIAKVKHPNIVKLRAYYWA---------PDEKLLISDFISNGNLANALRGRNGQPSTS 504
+ + K H + YY A D+ L+ +F G++ + ++ G +
Sbjct: 63 INMLKKYSHHR--NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---A 117
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564
L I + RGLA+LH K +H DIK N+LL + + + DFG+S ++ T
Sbjct: 118 LKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174
Query: 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW----DVYSFGVVLLE 620
++ F+G PY + APE P + D++S G+ +E
Sbjct: 175 VGRRNT---FIG--TPY-----------WMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
Query: 621 LLTGKSP 627
+ G P
Sbjct: 219 MAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 80/334 (23%), Positives = 119/334 (35%), Gaps = 107/334 (32%)
Query: 434 VAVRRLGEGGE-QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLL-ISDFISNGNL 490
VAV+ L EG H+ ++E++ + + H N+V L P+ L+ I +F GNL
Sbjct: 40 VAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99
Query: 491 ANALRGRNG-----------------------------------------QPSTSLS--- 506
+N LR + QPSTS S
Sbjct: 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159
Query: 507 -------WSTRLRIAK------GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553
W + L + ARG+ +L + RK +H D+ NILL + I
Sbjct: 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKIC 216
Query: 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN-----NYRAPEARVPGNRPMQK 608
DFGL+R I Y P K + + APE+ Q
Sbjct: 217 DFGLARDI-------------------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQS 257
Query: 609 WDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEV 668
DV+SFGV+L E+ S SP I + + +K G P
Sbjct: 258 -DVWSFGVLLWEIF---SLGASPYPGVQIN-EEFCQRLKDGTRMRAP------------- 299
Query: 669 HAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
+ ++ + LAC + DP+ RP + E L
Sbjct: 300 --ENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 36/109 (33%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +H + +H DIK +NILL ++ + DFG S++ S G P
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTP 209
Query: 581 YMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y Y APE R P ++ K D++S GV+L ELLT K P
Sbjct: 210 Y-----------YVAPEIWRRKPYSK---KADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 33/143 (23%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL+Y H+ RK +H D+KP N+L++ + ++DFGL+R
Sbjct: 114 RGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR------------------- 151
Query: 579 LPYMKPVQTEKTNN------YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
K V T+ +N YR P+ + D++ G +L E+ TG+ + P
Sbjct: 152 ---AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP--MFPG 206
Query: 633 TSTSIEVPDLVRWVKKGFEEENP 655
++ E+ + R + EE P
Sbjct: 207 STVKEELHLIFRLLGTPTEETWP 229
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 21/106 (19%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
G+ +LH +H D+KPSNI++ +D I DFGL+R ++ FM
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM---- 173
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
M P T YRAPE + G + D++S G ++ E++ G
Sbjct: 174 --MTPYVV--TRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 480 LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKP 539
LI +F+ G++ L ++ T T+ IA+ T + +H+ F+H DIKP
Sbjct: 78 LIMEFLPGGDMMTLLMKKD----TLTEEETQFYIAE-TVLAIDSIHQLG---FIHRDIKP 129
Query: 540 SNILLDNDFQPYISDFGLSRLI----------NITGNNPSSSGGFMGGALPYMKPVQTEK 589
N+LLD+ +SDFGL + N+ + PS F + + +T K
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD---FTFQNMNSKRKAETWK 186
Query: 590 TN------------NYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636
N +Y APE + G + W +S GV++ E+L G P S T +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW--WSLGVIMYEMLIGYPPFCSETPQET 244
Query: 637 IEVPDLVRWVKK-GFEEENPLSDMVDAMLLQ 666
+ ++ W + F E P+S+ ++L+
Sbjct: 245 YK--KVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 65/219 (29%), Positives = 88/219 (40%), Gaps = 30/219 (13%)
Query: 414 VLGKSGLGIVYKV-VLGNGIPVAVRRLGEGGEQRHRE----FVTEVQAIAKVKHPNIVKL 468
VLGK G G V V G A +RL E + R+ + E Q + KV +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRL-EKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
Y D L+ ++ G+L + G P L A GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNM-GNPG--FEEERALFYAAEILCGLEDLHR-- 120
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
V+ D+KP NILLD+ ISD GL+ I G + G +G YM P E
Sbjct: 121 -ENTVYRDLKPENILLDDYGHIRISDLGLAVKIP-EGESIRGRVGTVG----YMAP---E 171
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
NN R P D + G ++ E++ G+SP
Sbjct: 172 VLNNQRY------TLSP----DYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 25/177 (14%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
+TE + + +HP + L+ + D + ++ + G L L R S R
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSED---RAR 98
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
A+ L YLH C V+ D+K N++LD D I+DFGL + I+
Sbjct: 99 FYGAE-IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMK 153
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ F G T Y APE + N + D + GVV+ E++ G+ P
Sbjct: 154 T--FCG-------------TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 22/85 (25%), Positives = 39/85 (45%), Gaps = 16/85 (18%)
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
PD K ++ ++I L + + N + + R + LH+ VH
Sbjct: 69 PDNKTIVMEYIEGKPLKDVIEEGN------------DELLREIGRLVGKLHKA---GIVH 113
Query: 535 GDIKPSNILLDNDFQPYISDFGLSR 559
GD+ SNI++ +D + Y+ DFGL +
Sbjct: 114 GDLTTSNIIVRDD-KLYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 20/108 (18%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
GL +LH+ R+ ++ D+KP N+LLDND ISD GL+ + + S + G+ G
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELK---DGQSKTKGYAG--- 159
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T + APE + G D ++ GV L E++ + P
Sbjct: 160 ----------TPGFMAPEL-LQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 47/178 (26%), Positives = 76/178 (42%), Gaps = 27/178 (15%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWST 509
VTE + + +HP + L+ + D + ++ + G L L R R + +
Sbjct: 43 VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 102
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
+ A L YLH R V+ DIK N++LD D I+DFGL + I+ + +
Sbjct: 103 EIVSA------LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GIS--DGA 150
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ F G T Y APE + N + D + GVV+ E++ G+ P
Sbjct: 151 TMKTFCG-------------TPEYLAPEV-LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 53/186 (28%), Positives = 79/186 (42%), Gaps = 29/186 (15%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
+E+ +A H IVK + + D+ LLI ++ S G+L ++ R L
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR---------LKEHL 164
Query: 512 RIAKGTARGLAY-----LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566
+ L Y L E RK +H D+K +NI L + DFG S+ + + +
Sbjct: 165 PFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224
Query: 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626
+S F G PY Y APE R +K D++S GV+L ELLT
Sbjct: 225 LDVASS-FCG--TPY-----------YLAPELW-ERKRYSKKADMWSLGVILYELLTLHR 269
Query: 627 PELSPT 632
P P+
Sbjct: 270 PFKGPS 275
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 43/227 (18%)
Query: 414 VLGKSGLGIVYKV--VLG--NGIPVAVRRLGEGGEQRHREFVTEVQA----IAKVKHPNI 465
VLGK G G V++V V G G A++ L + R+++ +A + VKHP I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 466 VKLRAYYWAPDEKL-LISDFISNGNLANALRGRNG--QPSTSLSWSTRLRIAKGTARGLA 522
V L Y + KL LI +++S G L L R G T+ + + + +A L
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLA------LE 114
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
+LH+ + ++ D+KP NILLD ++DFGL + G + + F G
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG---TVTHTFCG------ 162
Query: 583 KPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE R + + W S G ++ ++LTG P
Sbjct: 163 -------TIEYMAPEILMRSGHGKAVDWW---SLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 71/301 (23%), Positives = 113/301 (37%), Gaps = 51/301 (16%)
Query: 429 GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488
G + V + L E+ + EV +HPNI+ + +IS F++ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
+ + L+ P +S + I G RGL YLH+ ++H +IK S+IL+ D
Sbjct: 85 SANSLLK--TYFPE-GMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGD- 137
Query: 549 QPYISDFGLSRLINITGNNPSSSG-----GFMGGALPYMKP-VQTEKTNNYRAPEARVPG 602
+S GLS L ++ N + F LP++ P + + Y
Sbjct: 138 -GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV------- 189
Query: 603 NRPMQKWDVYSFGVVLLELLTG-----------------KSPELSPTTSTSI-----EVP 640
K D+YS G+ EL TG K P SP T+ +
Sbjct: 190 -----KSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMK 244
Query: 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVH---AKKEVIAVFHLALACTEADPEVRPRMKN 697
+ V G E + M M + + +K A +L C + DPE RP +
Sbjct: 245 NSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS 304
Query: 698 V 698
+
Sbjct: 305 L 305
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 42/178 (23%), Positives = 73/178 (41%), Gaps = 27/178 (15%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWST 509
+TE + + +HP + L+ + D + ++++ G L L R R + +
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA 102
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
+ L YLH K V+ D+K N++LD D I+DFGL + G +
Sbjct: 103 EI------VSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK----EGITDA 149
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
++ G Y+ P E + RA D + GVV+ E++ G+ P
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAV-------------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 33/171 (19%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTA 518
K P + +L + + D + ++++ G+L ++ G+ +P A A
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-------YAAEIA 111
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
GL +LH + ++ D+K N++LD + I+DFG+ + NI G ++ F G
Sbjct: 112 IGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFG--GKTTRTFCG-- 163
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE A P + + W +FGV+L E+L G+ P
Sbjct: 164 -----------TPDYIAPEIIAYQPYGKSVDWW---AFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 30/174 (17%)
Query: 456 AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWSTRLRIA 514
+HP +V L A + D + ++ + G+L + +P A
Sbjct: 55 TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-------YA 107
Query: 515 KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
GL YLHE K V+ D+K N+LLD + I+DFGL + G
Sbjct: 108 ACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTST 160
Query: 575 MGGALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G ++ P V TE + RA D + GV++ E+L G+SP
Sbjct: 161 FCGTPEFLAPEVLTETSYT-RAV-------------DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 33/143 (23%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGLAY H RK +H D+KP N+L++ + ++DFGL+R
Sbjct: 115 RGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLAR------------------- 152
Query: 579 LPYMKPVQTEKTNN------YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
K V T+ +N YR P+ + + + D++ G + E+ +G+ L P
Sbjct: 153 ---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP--LFPG 207
Query: 633 TSTSIEVPDLVRWVKKGFEEENP 655
++ E+ + R + EE P
Sbjct: 208 STVEDELHLIFRLLGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 30/228 (13%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAI-AKVKHPNIVKLRAYY 472
+GK G V+KV+ NG AV+ L + E E + A HPN+VK Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 473 WAPDEK-----LLISDFISNGNLANALRG--RNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ D K L+ + + G++ + ++G + G+ + L A GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA---LMGLQHLH 141
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
K +H D+K +NILL + + DFG+S + T ++S G P +
Sbjct: 142 V---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
+ + + Y A + DV+S G+ +EL G P +L P
Sbjct: 199 EQQLDSTYDA------------RCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G V+K + V ++ E E + E+ +++ P + K Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ +I +++ G+ + L +P L + I + +GL YLH K
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPG-PLDETQIATILREILKGLDYLHS---EKK 122
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H DIK +N+LL + ++DFG++ + T F+G P+ + K +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKRNTFVG--TPFWMAPEVIKQSA 177
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
Y + K D++S G+ +EL G+ P EL P
Sbjct: 178 YDS------------KADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 47/225 (20%)
Query: 415 LGKSGLGIVYKV---VLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK V I + RL + E + E+ + +++H NIV+L+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKG----TARGLAYLHEC 527
+ L+ +++ + +L +S ++ R+ K RG+AY C
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKK-------HMDSSPDFAKNPRLIKTYLYQILRGIAY---C 118
Query: 528 SPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
+ +H D+KP N+L+D N + ++DFGL+R I P
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALK--LADFGLARAFGI--------------------P 156
Query: 585 VQTEK----TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
V+T T YRAPE + D++S G + E++ K
Sbjct: 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 62/260 (23%), Positives = 112/260 (43%), Gaps = 48/260 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
++G G+VY+ + + VA++++ + + ++RE + + + H NI+ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDYY 128
Query: 473 WA----PDEKLL----ISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARGLA 522
+ +EK + + +FI + ++ RN +L + R LA
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNH---ALPLFLVKLYSYQLCRALA 184
Query: 523 YLHECSPRKFV-HGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
Y+H KF+ H D+KP N+L+D N + DFG S+ + G
Sbjct: 185 YIHS----KFICHRDLKPQNLLIDPNTHTLKLCDFG-------------SAKNLLAG--- 224
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640
+ V + YRAPE + D++S G ++ E++ G P S V
Sbjct: 225 -QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-----YPIFSGQSSVD 278
Query: 641 DLVRWVKK-GFEEENPLSDM 659
LVR ++ G E+ L +M
Sbjct: 279 QLVRIIQVLGTPTEDQLKEM 298
|
Length = 440 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 4e-05
Identities = 23/62 (37%), Positives = 32/62 (51%), Gaps = 3/62 (4%)
Query: 142 RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
L++LDLSNN + +PDG K L+ L L+ N + P L +L LDLS N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFS-GLPSLRSLDLSGN 58
Query: 201 DF 202
+
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 61/234 (26%), Positives = 98/234 (41%), Gaps = 48/234 (20%)
Query: 448 REFVTEVQA----IAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPST 503
R V V+A +A+ + +V+L + D + D+I G++ + L R G
Sbjct: 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPE 100
Query: 504 SLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563
L+ R IA+ T + +H+ F+H DIKP NIL+D D ++DFGL
Sbjct: 101 DLA---RFYIAELTC-AVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153
Query: 564 TGNNPSSSGG------FMGGALPY-----------MKPVQTEK--------------TNN 592
T ++ G M + + +KP++ T N
Sbjct: 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT-TSTSIEVPDLVRW 645
Y APE + Q D +S GV+L E+L G+ P L+ T T ++V + W
Sbjct: 214 YIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV---INW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 42/222 (18%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK G VA++ RL E + E+ + ++ HPNIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 472 YWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGT---ARGLAYLHEC 527
+ + KL L+ +F+ + +L + + P T L I +G+AY C
Sbjct: 67 VHS-ENKLYLVFEFL-DLDLKKYM---DSSPLTGL---DPPLIKSYLYQLLQGIAY---C 115
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ +H D+KP N+L+D + ++DFGL+R + PV+T
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV--------------------PVRT 155
Query: 588 EK----TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T YRAPE + + D++S G + E++ +
Sbjct: 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G VYK + V ++ E E + E+ +++ P I + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ +I +++ G+ + L+ P +T LR +GL YLH S RK
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILR---EILKGLDYLH--SERK- 122
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQTEKTN 591
+H DIK +N+LL ++DFG++ + T ++ F+G +M P V +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVGTPF-WMAPEVIKQSAY 178
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+++A D++S G+ +EL G+ P
Sbjct: 179 DFKA--------------DIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 21/106 (19%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
G+ +LH +H D+KPSNI++ +D I DFGL+R ++ FM
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM---- 181
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
M P T YRAPE + G + D++S G ++ E++ G
Sbjct: 182 --MTPYVV--TRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 39/152 (25%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 415 LGKSGLGIVYKVVLGN-GIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G V+K VA++R L + E + E+ + ++KH NIV+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ D+KL + + +L NG + S ++ +GLA+ H
Sbjct: 68 LHS-DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL----KGLAFCHS---HN 119
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563
+H D+KP N+L++ + + ++DFGL+R I
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 62/218 (28%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 414 VLGKSGLGIVYKV-VLGNGIPVAVRRLGEGG-EQRHREFVT--EVQAIAKVKHPNIVKLR 469
VLGK G G V V G A ++L + ++R E + E Q + KV +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
Y D L+ ++ G+L + G P + A GL LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNM-GNPG--FDEERAVFYAAEITCGLEDLHR--- 120
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+ V+ D+KP NILLD+ ISD GL+ + I G +G
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIR--GRVG------------- 163
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE V R D + G ++ E++ GKSP
Sbjct: 164 TVGYMAPEV-VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 21/120 (17%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGLAY+H + +H D+KP N+L+ + ++DFGL+R +I PS +
Sbjct: 114 RGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI----PSQT------- 159
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
Y V T YR P+ + D++ G + +E+L G P P S E
Sbjct: 160 --YSSEVVTLW---YRPPDVLLGATDYSSALDIWGAGCIFIEMLQG-QP-AFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 23/111 (20%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL-INITGNNPSSSGGFMGG 577
R L Y+H + H D+KP NIL + D + I DFGL+R+ N T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT-----------PT 159
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGN---RPMQKWDVYSFGVVLLELLTGK 625
A+ + V T YRAPE + G+ + D++S G + E+LTGK
Sbjct: 160 AIFWTDYVATRW---YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 45/182 (24%), Positives = 74/182 (40%), Gaps = 29/182 (15%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSW 507
F E +A IV+L +Y D+K L + +++ G+L N + W
Sbjct: 90 FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW 143
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
R A+ L +H F+H D+KP N+LLD ++DFG ++ G
Sbjct: 144 -ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 568 PSSSGGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ G Y+ P ++++ + Y E D +S GV L E+L G
Sbjct: 199 RCDTA---VGTPDYISPEVLKSQGGDGYYGREC-----------DWWSVGVFLYEMLVGD 244
Query: 626 SP 627
+P
Sbjct: 245 TP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 42/177 (23%), Positives = 71/177 (40%), Gaps = 32/177 (18%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS-TSLSWSTRL 511
E + ++ HP IV + + + + +F+ G L LR P+ + + L
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
+A YLH ++ D+KP N+LLDN ++DFG ++ + P +
Sbjct: 128 VLA------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV------PDRT 172
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEA-RVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G T Y APE + G+ W ++ GV+L E + G P
Sbjct: 173 FTLCG-------------TPEYLAPEVIQSKGHGKAVDW--WTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 21/137 (15%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y H RK +H D+KP N+L++ + ++DFGL+R +I P+ +
Sbjct: 115 RGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI----PTKT------- 160
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
Y V T YR P+ + + D++ G + E+ TG+ L P ++ +
Sbjct: 161 --YSNEVVTLW---YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP--LFPGSTVEEQ 213
Query: 639 VPDLVRWVKKGFEEENP 655
+ + R + EE P
Sbjct: 214 LHFIFRILGTPTEETWP 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 41/171 (23%), Positives = 78/171 (45%), Gaps = 33/171 (19%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTA 518
K P + +L + + D + ++++ G+L ++ G+ +P A +
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF-------YAAEIS 111
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
GL +LH R ++ D+K N++LD++ I+DFG+ + + G ++ F G
Sbjct: 112 VGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCG-- 163
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE A P + + W ++GV+L E+L G+ P
Sbjct: 164 -----------TPDYIAPEIIAYQPYGKSVDWW---AYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561
S L+ L ARG+ +L + + VH D+ N+LL I DFGL+R I
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
Query: 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
N S F+ PV+ + APE+ + N DV+S+G++L E+
Sbjct: 288 MHDSNYVSKGSTFL--------PVK------WMAPES-IFDNLYTTLSDVWSYGILLWEI 332
Query: 622 LT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHL 680
+ G +P ++ +K G+ P HA +E V+ +
Sbjct: 333 FSLGGTPYPGMIVDST-----FYNKIKSGYRMAKP------------DHATQE---VYDI 372
Query: 681 ALACTEADPEVRPRMKNVSENLERI 705
+ C ++PE RP ++S+ +E +
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 26/194 (13%)
Query: 434 VAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
VA+++ E E+ + E++ + +K NIV+L+ + + L+ +++ L
Sbjct: 29 VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE 88
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
NG P + S ++ K +H C VH DIKP N+L+ ++
Sbjct: 89 LLEEMPNGVPPEKVR-SYIYQLIKA-------IHWCHKNDIVHRDIKPENLLISHNDVLK 140
Query: 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDV 611
+ DFG +R ++ G+N + Y + V T YR+PE + G + D+
Sbjct: 141 LCDFGFARNLS-EGSNAN-----------YTEYVATRW---YRSPELLL-GAPYGKAVDM 184
Query: 612 YSFGVVLLELLTGK 625
+S G +L EL G+
Sbjct: 185 WSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 44/184 (23%), Positives = 85/184 (46%), Gaps = 29/184 (15%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWA-PDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+ + ++KHPN++ L+ + + D K+ L+ D+ + +L + ++ +
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK----KP 102
Query: 511 LRIAKGTARGLAY-----LHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRLI 561
+++ +G + L Y +H +H D+KP+NIL+ + + I+D G +RL
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
N +P L + PV T YRAPE + + D+++ G + EL
Sbjct: 163 N----SPLKP-------LADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209
Query: 622 LTGK 625
LT +
Sbjct: 210 LTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 9e-05
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 16/122 (13%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEK--------LLISDFISNGNLANALRGRNGQPSTS 504
E++ + +KH N+V L L+ +F + +LA L +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS----NKNVK 115
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564
+ S ++ K GL Y+H K +H D+K +NIL+ D ++DFGL+R +++
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 565 GN 566
N
Sbjct: 173 KN 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 30/184 (16%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
E+ + + KH NIV Y + ++ + ++ G+L + +++
Sbjct: 56 EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY----- 110
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+ + T +GLAYLH + +H DIK +NILL ++ ++DFG++ I T S
Sbjct: 111 VCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-- 165
Query: 573 GFMGGALPY-MKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-- 627
F+G PY M P EK Y Q D+++ G+ +EL + P
Sbjct: 166 -FIG--TPYWMAPEVAAVEKNGGYN------------QLCDIWAVGITAIELAELQPPMF 210
Query: 628 ELSP 631
+L P
Sbjct: 211 DLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 118 SLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNK 176
+L S+ L N L+ +P LP L+ LDLS N+ + P+ L+ L L+ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 177 F 177
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 36/179 (20%)
Query: 480 LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKP 539
++ +++ G+ A L+ P R+ A+ T L YLH VH D+KP
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDM----ARMYFAE-TVLALEYLHNYG---IVHRDLKP 129
Query: 540 SNILLDNDFQPYISDFGLSR--LINIT-----GNNPSSSGGFMGGALPYMKPVQTEKTNN 592
N+L+ + ++DFGLS+ L+++T G+ + F+ Q T
Sbjct: 130 DNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK--------QVCGTPE 181
Query: 593 YRAPEA--RVPGNRPMQKWDVYSFGVVLLELLT------GKSPE--LSPTTSTSIEVPD 641
Y APE R +P+ W + G++L E L G +PE S IE P+
Sbjct: 182 YIAPEVILRQGYGKPVDWW---AMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 42/171 (24%), Positives = 82/171 (47%), Gaps = 33/171 (19%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTA 518
K P + +L + + D + ++++ G+L ++ GR +P ++ ++ + I
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH-AVFYAAEIAI----- 112
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
GL +LH + ++ D+K N++LD++ I+DFG+ + G ++ F G
Sbjct: 113 -GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCG-- 163
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE A P + + W +FGV+L E+L G++P
Sbjct: 164 -----------TPDYIAPEIIAYQPYGKSVDWW---AFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 26/221 (11%)
Query: 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYW 473
+GK G VYKV +A ++ + E E + + HPN+VK ++
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 474 APDEKL-----LISDFISNGNLANALRG--RNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
D+ + L+ + + G++ ++G GQ L + I G GL +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ---RLDEAMISYILYGALLGLQHLHN 146
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
+ +H D+K +NILL + + DFG+S + T ++S G P + +
Sbjct: 147 ---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ +Y A + DV+S G+ +EL G P
Sbjct: 204 QQYDYSYDA------------RCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/167 (23%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLS-WSTRLRIAKGTARG 520
+P +V L + + L+ ++++ G+L ++ + P ++ + IA
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------ 108
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +LHE R ++ D+K N+LLD D ++D+G+ + G P + G
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTSTFCG--- 158
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY APE + G D ++ GV++ E++ G+SP
Sbjct: 159 ---------TPNYIAPEI-LRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 37/114 (32%), Positives = 50/114 (43%), Gaps = 32/114 (28%)
Query: 520 GLAYLHECSPRKFV-HGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGF 574
G+ YLH +V H D+KP+NIL+ + I D GL+RL N P
Sbjct: 120 GVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF----NAPL----- 166
Query: 575 MGGALPYMKPVQTEK----TNNYRAPEARVPGNRPMQKW-DVYSFGVVLLELLT 623
KP+ T YRAPE + G R K D+++ G + ELLT
Sbjct: 167 --------KPLADLDPVVVTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 26/178 (14%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWST 509
+TE + + +HP + L+ + D + ++ + G L L R R + +
Sbjct: 43 LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
+ A L YLH S + V+ D+K N++LD D I+DFGL + G
Sbjct: 103 EIVSA------LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDG 150
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
++ G Y+ P E + RA D + GVV+ E++ G+ P
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAV-------------DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-04
Identities = 22/85 (25%), Positives = 40/85 (47%), Gaps = 17/85 (20%)
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH 534
P+EK ++ ++I +L + L G + + +A LH+ VH
Sbjct: 408 PEEKTIVMEYIGGKDLKDVLEGN-------------PELVRKVGEIVAKLHK---AGIVH 451
Query: 535 GDIKPSNILLDNDFQPYISDFGLSR 559
GD+ SN ++ +D + Y+ DFGL +
Sbjct: 452 GDLTTSNFIVRDD-RLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 44/188 (23%), Positives = 70/188 (37%), Gaps = 30/188 (15%)
Query: 452 TEVQAIAKVKHPNIVKL-RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+ + + H I+ L AY W +++ + +L + S L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDR-----SGPLPLEQA 187
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
+ I + LAYLH R +H D+K NI LD + DFG + ++ + P
Sbjct: 188 ITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244
Query: 571 SGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628
G T +TN +PE A P K D++S G+VL E+
Sbjct: 245 YGW-----------SGTLETN---SPELLALDP---YCAKTDIWSAGLVLFEMSVKNVTL 287
Query: 629 LSPTTSTS 636
+S
Sbjct: 288 FGKQVKSS 295
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 19/108 (17%)
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
+H +VH DIKP N+LLD + ++DFG +N G SS +G
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG------- 165
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKW----DVYSFGVVLLELLTGKSP 627
T +Y +PE M K+ D +S GV + E+L G++P
Sbjct: 166 ------TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWSTRLRIAKGTARG 520
HP +V L + + + +F+S G+L + R R + +S + +A
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------ 108
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +LHE R ++ D+K N+LLD + ++D+G+ + G+ S+ F G
Sbjct: 109 LNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST---FCG---- 158
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY APE + G D ++ GV++ E++ G+SP
Sbjct: 159 ---------TPNYIAPEI-LRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 25/128 (19%), Positives = 50/128 (39%), Gaps = 32/128 (25%)
Query: 446 RHREF---------VTEVQAIAK-----VKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
RH E E + +++ V P + Y+ P+ +++ ++I L
Sbjct: 33 RHPELDERIRRERTRREARIMSRARKAGVNVPAV-----YFVDPENFIIVMEYIEGEPLK 87
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
+ + L +++ R + LH +HGD+ SN++L + Y
Sbjct: 88 DLINSNG---------MEELELSREIGRLVGKLHS---AGIIHGDLTTSNMILSGG-KIY 134
Query: 552 ISDFGLSR 559
+ DFGL+
Sbjct: 135 LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 40/212 (18%)
Query: 430 NGIPVAVRRLGEGGEQRHREFVTEVQA---IAKV-KHPNIVKLRAYYWAPDEKLLISDFI 485
G V VRR+ E E VT +Q ++K+ HPNIV RA + A +E +++ F+
Sbjct: 24 TGEYVTVRRINL--EACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81
Query: 486 SNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNIL 543
+ G+ + + +G ++++ I +G + L Y+H +VH +K S+IL
Sbjct: 82 AYGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHHMG---YVHRSVKASHIL 133
Query: 544 LDNDFQPYISDF-GLSRLIN------ITGNNPSSSGGFMGGALPYMKP-VQTEKTNNYRA 595
+ D + Y+S +IN + + P S LP++ P V + Y A
Sbjct: 134 ISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS----VKVLPWLSPEVLQQNLQGYDA 189
Query: 596 PEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
K D+YS G+ EL G P
Sbjct: 190 ------------KSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 21/106 (19%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
G+ +LH +H D+KPSNI++ +D I DFGL+R ++ FM
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFM--MT 176
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
PY+ T YRAPE + G + D++S G ++ E++ K
Sbjct: 177 PYV------VTRYYRAPEV-ILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 34/133 (25%), Positives = 58/133 (43%), Gaps = 14/133 (10%)
Query: 432 IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
I V ++ L F + +V H +IV L E +++ +F+ G L
Sbjct: 33 IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL-----DN 546
+ + S L+ + ++AK A L+YL + + VHG++ NILL D
Sbjct: 93 LFMH----RKSDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDG 145
Query: 547 DFQPYI--SDFGL 557
+ P+I SD G+
Sbjct: 146 ECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 415 LGKSGLGIVYK---VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LG+ VYK V G + + V RL E E + E + +KH NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ L+ +++ + + + P + +L + + RGL+Y+H+ R
Sbjct: 72 IHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQ-LLRGLSYIHQ---RY 123
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KP N+L+ + + ++DFGL+R ++ PS + Y V T
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSV----PSHT---------YSNEVVTLW-- 168
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
YR P+ + D++ G + +E++ G
Sbjct: 169 -YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 50/212 (23%)
Query: 444 EQRHREFVTEVQAIAKVKHPNIVK-LRAYYWAPDEKLLI-SDFISNGNLANALRGRNGQP 501
E+ + V EV + ++KH NIV+ + + ++KL I +F G+L+ RN Q
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLS-----RNIQK 107
Query: 502 STSLSWSTR----LRIAKGTARGLAYLHEC----SPRKFVHGDIKPSNILLDNDFQ---- 549
+ + I + LAY H + + +H D+KP NI L +
Sbjct: 108 CYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167
Query: 550 -------------PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAP 596
I DFGLS+ I I S G PY Y +P
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVG------TPY-----------YWSP 210
Query: 597 EARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
E + + K D+++ G ++ EL +GK+P
Sbjct: 211 ELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 20/107 (18%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY-ISDFGLSRLINITGNNPSSSGGFMGG 577
+G+A+ H+ +H D+KP N+L+D I+D GL R +I
Sbjct: 121 KGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-------------- 163
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
P T YRAPE + D++S G + E+
Sbjct: 164 --PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 39/187 (20%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
E+ A+ ++ H NI+K+ + +I+ + L TR
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-A 271
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
I K + Y+H+ +K +H DIK NI L+ D + + DFG
Sbjct: 272 IMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGT--------------- 313
Query: 573 GFMGGALPYMKP--------VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
A+P+ K V T TN +PE + G+ + D++S G++LL++L
Sbjct: 314 -----AMPFEKEREAFDYGWVGTVATN---SPEI-LAGDGYCEITDIWSCGLILLDML-- 362
Query: 625 KSPELSP 631
S + P
Sbjct: 363 -SHDFCP 368
|
Length = 501 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 27/183 (14%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWA-PDEKL-LISDFISNGNLANALR----GRNGQPSTSLS 506
E+ + ++KHPN++ L+ + + D K+ L+ D+ + +L + ++ + + L
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLP 106
Query: 507 WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRLIN 562
S + G+ YLH +H D+KP+NIL+ + + I+D G +RL N
Sbjct: 107 RSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELL 622
+P L + PV T YRAPE + + D+++ G + ELL
Sbjct: 164 ----SPLKP-------LADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 623 TGK 625
T +
Sbjct: 211 TSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559
RGLAY H+ R+ +H D+KP N+L+ + ++DFGL+R
Sbjct: 114 RGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 40/189 (21%)
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A+G+ +L + RK +H D+ NILL + I DFGL+R I +P
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY---KDPD-------- 234
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637
Y++ + APE +Q DV+SFGV+L E+ S SP I
Sbjct: 235 ---YVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLWEIF---SLGASPYPGVKI 287
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
+ + R +K+G P D + Q + L C +P RP
Sbjct: 288 D-EEFCRRLKEGTRMRAP--DYTTPEMYQTM-------------LDCWHGEPSQRP---T 328
Query: 698 VSENLERIG 706
SE +E +G
Sbjct: 329 FSELVEHLG 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 16/27 (59%), Positives = 19/27 (70%)
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLS 558
F+H DIKP NIL+D +SDFGLS
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 39/207 (18%)
Query: 499 GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558
+ S L LR + A+G+ +L + + +H D+ N+LL + I DFGL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVL 618
R I N + PV+ + APE+ +Q DV+S+G++L
Sbjct: 260 RDIMNDSNYVVKGNARL--------PVK------WMAPESIFDCVYTVQS-DVWSYGILL 304
Query: 619 LELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAV 677
E+ + GKSP ++ + VK+G++ P A E+ ++
Sbjct: 305 WEIFSLGKSPYPGILVNSK-----FYKMVKRGYQMSRP------------DFAPPEIYSI 347
Query: 678 FHLALACTEADPEVRPRMKNVSENLER 704
C +P RP +S+ ++R
Sbjct: 348 MK---MCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 41/189 (21%)
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A+G+++L + + +H D+ NILL + I DFGL+R I N +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELS-PTTST 635
PV+ + APE+ + DV+S+G++L E+ + G SP P S
Sbjct: 279 ------PVK------WMAPESIFNCVYTFES-DVWSYGILLWEIFSLGSSPYPGMPVDSK 325
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695
+ +K+G+ +P A E+ + +C +ADP RP
Sbjct: 326 ------FYKMIKEGYRMLSP------------ECAPSEMYDIMK---SCWDADPLKRPTF 364
Query: 696 KNVSENLER 704
K + + +E+
Sbjct: 365 KQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 18/109 (16%)
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
G+ YL E FVH D+ N+LL ISDFGLS+ + N + G
Sbjct: 107 GMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT---HGKW 160
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
P +K E N Y+ K DV+SFGV++ E + G+ P
Sbjct: 161 P-VKWYAPECMNYYKFS----------SKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 38/142 (26%), Positives = 59/142 (41%), Gaps = 7/142 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ S L +L L L L NN L LP+ + N ++L ++ L N +S S+ +L L+
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS--ISSLGSLTNLR 280
Query: 145 NLDLSNNSFSGSLPD--GLKNCKQLQRLILARNKFSGQIPAGIW--PELENLVQLDLSDN 200
LDLS NS S +LP L +L +L K I + + + +
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEA 340
Query: 201 DFKGPIPNDLGELQSLSATLNL 222
N+L L + NL
Sbjct: 341 LSILESLNNLWTLDNALDESNL 362
|
Length = 394 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 31/178 (17%)
Query: 451 VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR 510
TE + + HP+I++L+ + LI +L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDI----- 184
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL-INITGNNPS 569
L I + R + YLHE + +H DIK NI +++ + DFG + ++I N
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-- 239
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGK 625
Y T TN APE AR P + D++S G+VL E+ T
Sbjct: 240 -----------YYGWAGTIATN---APELLARDPYGPAV---DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 54/211 (25%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
HP + +L + PD + +F++ G+L + Q S + A
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI-----QKSRRFDEARARFYAAEITSA 108
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +LH+ + ++ D+K N+LLD++ ++DFG+ + G S+ F G
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST---FCG---- 158
Query: 581 YMKPVQTEKTNNYRAPE---ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637
T +Y APE + G P W ++ GV+L E+L G +P
Sbjct: 159 ---------TPDYIAPEILQEMLYG--PSVDW--WAMGVLLYEMLCGHAP---------- 195
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEV 668
FE EN D+ +A+L EV
Sbjct: 196 ------------FEAENE-DDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 21/53 (39%), Positives = 29/53 (54%), Gaps = 3/53 (5%)
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565
I K L Y+HE HGDIKP NI++D + + YI D+G++ I G
Sbjct: 131 IMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180
|
Length = 294 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 24/62 (38%), Positives = 33/62 (53%), Gaps = 2/62 (3%)
Query: 166 QLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYN 225
L+ L L+ N+ + IP G + L NL LDLS N+ P L SL +L+LS N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLR-SLDLSGN 58
Query: 226 HL 227
+L
Sbjct: 59 NL 60
|
Length = 60 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 19/42 (45%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
RGL +LH + VH D+KP NIL+ + Q ++DFGL+R+
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.9 bits (84), Expect = 0.003
Identities = 16/38 (42%), Positives = 21/38 (55%), Gaps = 2/38 (5%)
Query: 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
L+ LDLSNN + LP L N L+ L L+ NK +
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 39/174 (22%), Positives = 74/174 (42%), Gaps = 39/174 (22%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL-RGRNGQPSTSLSWSTRLRIAKGTAR 519
KHP + L + D + ++++ G+L + R R S ++ + +A
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA----- 108
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
L +LH ++ D+K NILLD + ++DFG+ + I +++ F G
Sbjct: 109 -LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTT--FCG--- 158
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKW------DVYSFGVVLLELLTGKSP 627
T +Y APE +Q+ D ++ GV++ E++ G+ P
Sbjct: 159 ----------TPDYIAPEI-------LQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
RGL +LH VH D+KP NIL+ + Q ++DFGL+R+
Sbjct: 119 RGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 27/124 (21%), Positives = 56/124 (45%), Gaps = 23/124 (18%)
Query: 437 RRLGEGGEQRHREFVTEV----------------QAIAKVKHPNIVKLRAYYWAPDEKLL 480
R +G+ GE E + +V ++++ H ++V DE ++
Sbjct: 17 REVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76
Query: 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540
+ +++ G+L L+ +N ++SW +L +AK A L +L + + HG++
Sbjct: 77 VQEYVKFGSLDTYLK-KNKN-LINISW--KLEVAKQLAWALHFLED---KGLTHGNVCAK 129
Query: 541 NILL 544
N+LL
Sbjct: 130 NVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 36/187 (19%)
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLS-WSTRLRIAKGTARGL 521
PN+V L Y + D L+ G L + + P + W+ + +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
LH V D+ P+NILLD+ ++ F + + + +
Sbjct: 99 DALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE---------- 145
Query: 582 MKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKS-PELSPT---TSTS 636
N Y APE V G + + D +S G +L ELLTGK+ E P+ T T+
Sbjct: 146 ---------NMYCAPE--VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTT 194
Query: 637 IEVPDLV 643
+ +P+ V
Sbjct: 195 LNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.85 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.81 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.81 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.67 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.63 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.59 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.54 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.52 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.51 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.24 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.98 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.91 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.83 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.72 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.66 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.38 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.35 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-68 Score=646.18 Aligned_cols=542 Identities=32% Similarity=0.528 Sum_probs=391.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|
T Consensus 404 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~l 482 (968)
T PLN00113 404 RSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482 (968)
T ss_pred CCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEEC
Confidence 356666666666666666666666666666666666666666666667777777777777766666655 3477888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++.+|..+.++++|+.|+|++|++++.+|..+ ..+++|++|+|++|.+++.+|..+.++++| +.|+|++|+++
T Consensus 483 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~ 560 (968)
T PLN00113 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL-SSCKKLVSLDLSHNQLSGQIPASFSEMPVL-SQLDLSQNQLS 560 (968)
T ss_pred cCCccCCccChhhhhhhccCEEECcCCcceeeCChHH-cCccCCCEEECCCCcccccCChhHhCcccC-CEEECCCCccc
Confidence 8888888888889999999999999999998888765 789999999999999999999999999999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCCCCC---CCCCCCCcCcCCCCCCCCCccccc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQ---KSCKDSTESQQETQNPSPDSDKSK 305 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~~~~---~~c~~~~~~~~~~~~p~~~~~~~~ 305 (707)
|.+|..+..++.|+.|++++|+++|.+|..+.+..+....+.||+.+|+.+.. +.|.. .
T Consensus 561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~------------------~ 622 (968)
T PLN00113 561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR------------------V 622 (968)
T ss_pred ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc------------------c
Confidence 99999999999999999999999999999888888888999999999985421 11210 0
Q ss_pred cCCCCCCceEeeeecchhHHHHHHhheeeEEEEeecCCCCccccccccCCCCCCCCccCccccCCCCCCCchhhhhhhhh
Q 005226 306 KKGLGPGLIVLISAADAAAVAVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVE 385 (707)
Q Consensus 306 ~~~~~~~~i~~i~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (707)
.+ .....+.++++.++++++++++++++++|++++... .. .. ...+. +..
T Consensus 623 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~-----~~~~~-------~~~-------------- 672 (968)
T PLN00113 623 RK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLEL-KR-VE-----NEDGT-------WEL-------------- 672 (968)
T ss_pred cc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccc-cc-cc-----ccccc-------ccc--------------
Confidence 00 111111111111111121222222222222221110 00 00 00000 000
Q ss_pred cCCCCcceEeecCCcccchHHHHHhc--cceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC
Q 005226 386 SGKGEGELVAIDKGFTFELDELLRAS--AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH 462 (707)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H 462 (707)
..........+.++++..+. .++||+|+||.||+|.. .++..||||++....... ..|++++++++|
T Consensus 673 ------~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~H 742 (968)
T PLN00113 673 ------QFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQH 742 (968)
T ss_pred ------cccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCC
Confidence 00000001112333333322 45899999999999996 578999999987543322 346889999999
Q ss_pred CceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCe
Q 005226 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNI 542 (707)
Q Consensus 463 ~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NI 542 (707)
||||+++|+|.+++..++||||+++|+|.++++ .++|.++.+|+.|||+||+|||+.+.++|+||||||+||
T Consensus 743 pnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Ni 814 (968)
T PLN00113 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKI 814 (968)
T ss_pred CCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhE
Confidence 999999999999999999999999999999996 289999999999999999999965558999999999999
Q ss_pred EEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHH
Q 005226 543 LLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELL 622 (707)
Q Consensus 543 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ell 622 (707)
+++.++.+++. ||.+...... ....++..|+|||++.. ..++.++|||||||++|||+
T Consensus 815 l~~~~~~~~~~-~~~~~~~~~~--------------------~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~ 872 (968)
T PLN00113 815 IIDGKDEPHLR-LSLPGLLCTD--------------------TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELL 872 (968)
T ss_pred EECCCCceEEE-eccccccccC--------------------CCccccccccCcccccC-CCCCcccchhhHHHHHHHHH
Confidence 99999988876 6654332110 12245889999999764 67899999999999999999
Q ss_pred hCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhh-hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 623 TGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQE-VHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 623 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
||+.||+.... ....+.+|++..+.... ....+|+.+... ....+++.++.+++.+||+.||++||+|+||+++
T Consensus 873 tg~~p~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 873 TGKSPADAEFG----VHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred hCCCCCCcccC----CCCcHHHHHHHhcCccc-hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 99999864322 23457777766554332 245556555322 1234566788999999999999999999999999
Q ss_pred HHhhc
Q 005226 702 LERIG 706 (707)
Q Consensus 702 L~~i~ 706 (707)
|+++.
T Consensus 948 L~~~~ 952 (968)
T PLN00113 948 LESAS 952 (968)
T ss_pred HHHhh
Confidence 99873
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=456.43 Aligned_cols=284 Identities=43% Similarity=0.687 Sum_probs=241.9
Q ss_pred CcccchHHHHHhc-----cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEE
Q 005226 399 GFTFELDELLRAS-----AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473 (707)
Q Consensus 399 ~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 473 (707)
...|.++++..|+ .++||+|+||.||+|.+.+|..||||++........++|.+|++++.+++|||+|+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 4468888888887 36899999999999999999999999988765431366999999999999999999999999
Q ss_pred cCC-cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEE
Q 005226 474 APD-EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYI 552 (707)
Q Consensus 474 ~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl 552 (707)
+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.++++||||||||+|||+|+++++||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999 499999999999999999986532 7899999999999999999999998889999999999999999999999
Q ss_pred ecccccccccccCCCCCCCCCCcCCCCCCCCcccc-ccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 553 SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT-EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 553 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
+|||+|+......... ... .||.+|+|||+... +..++|+|||||||+|+||+||+.|.+..
T Consensus 219 sDFGLa~~~~~~~~~~----------------~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSV----------------STTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCccCcccCCccccce----------------eeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 9999996554211000 112 67999999999776 78899999999999999999999888754
Q ss_pred CCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhh-HHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHA-KKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.+. ....+++|+...+... .+.+++|+.+...... .+++.++..++.+|++.+|++||+|.+|+++|+.+.
T Consensus 282 ~~~---~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 282 RPR---GELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CCc---ccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 422 2334899998777766 4699999998743333 378899999999999999999999999999997764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=395.80 Aligned_cols=251 Identities=32% Similarity=0.449 Sum_probs=205.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchh--hHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-cceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ--RHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-EKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~gs 489 (707)
..+|+|+||+||+|.+.....||||++...... ..++|.+|+.+|.+++|||||+++|+|.++. ..++|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 359999999999999966555999999875432 2469999999999999999999999999887 7899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCCeEEcCCC-CeEEecccccccccccCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK-FVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 567 (707)
|.++++.. ....+++..+++|+.|||+||+|||+ .+ ||||||||+|||++.++ ++||+|||+++.......
T Consensus 127 L~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~- 199 (362)
T KOG0192|consen 127 LSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT- 199 (362)
T ss_pred HHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc-
Confidence 99999874 13479999999999999999999999 56 99999999999999998 999999999987664321
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
......||..|||||++.. ...++.|+|||||||++|||+||+.||..... ......+
T Consensus 200 ---------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v 258 (362)
T KOG0192|consen 200 ---------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAV 258 (362)
T ss_pred ---------------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence 0122567999999999774 36899999999999999999999999976433 1222222
Q ss_pred H-hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 647 K-KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 647 ~-~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. ...+...+ ......+..++.+||+.||..||++.+++..|+.+.
T Consensus 259 ~~~~~Rp~~p---------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 259 VVGGLRPPIP---------------KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred HhcCCCCCCC---------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1 11121111 224456788899999999999999999999998763
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=395.65 Aligned_cols=252 Identities=31% Similarity=0.473 Sum_probs=216.3
Q ss_pred ccceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 411 SAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..+.||+|-||.||.|.+.....||+|.++...... ++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~-~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP-EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccCh-hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 345799999999999999888899999998875554 7899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++|+... ...+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+...+......
T Consensus 289 l~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~- 361 (468)
T KOG0197|consen 289 LDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS- 361 (468)
T ss_pred HHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec-
Confidence 99999743 2468999999999999999999999 8999999999999999999999999999995443322221
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....-+..|.|||.+.. .+++.|||||||||+||||+| |+.|+... ...+.++.+.++
T Consensus 362 --------------~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~m------sn~ev~~~le~G 420 (468)
T KOG0197|consen 362 --------------EGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGM------SNEEVLELLERG 420 (468)
T ss_pred --------------CCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCC------CHHHHHHHHhcc
Confidence 22333778999999776 788999999999999999999 67776543 445788888888
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
++...+ ..+...+.+++..||+.+|++|||++.+...|+.+.
T Consensus 421 yRlp~P---------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 421 YRLPRP---------------EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CcCCCC---------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 887765 345567789999999999999999999999998874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.90 Aligned_cols=256 Identities=27% Similarity=0.400 Sum_probs=207.2
Q ss_pred cchHHHHHhccceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-cc
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-EK 478 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~ 478 (707)
+.+.++.+ ...||+|..|+|||+.++ +++.+|+|++... .....+++.+|++++++.+||+||.+||.|..++ +.
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 34444432 347999999999999976 6888999999544 4445689999999999999999999999999999 59
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
.++||||.+|+|++++...+ .+++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccccc
Confidence 99999999999999998653 699999999999999999999964 79999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
+.+..+. . ....||..|||||.+.+ ..|+.++||||||++++|+.+|+.||..... ....
T Consensus 227 ~~lvnS~-----a-------------~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~ 286 (364)
T KOG0581|consen 227 GILVNSI-----A-------------NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLD 286 (364)
T ss_pred HHhhhhh-----c-------------ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCC
Confidence 8876431 1 23567999999999765 7899999999999999999999999976521 1122
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..++..++-..-....+ ......++.+++..|++.||.+||+++|+++
T Consensus 287 ~~~Ll~~Iv~~ppP~lP--------------~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 IFELLCAIVDEPPPRLP--------------EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHHHHHHhcCCCCCCC--------------cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33344433322222211 0124456889999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=397.32 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=213.7
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +...||||.+++.... ...+|++|+++++.++|||||+|+|.|.+++..+||+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 347999999999999842 4578999999988655 678999999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 485 ISNGNLANALRGRNGQP---------STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
|..|||.+||+.+.... ..+++..+.+.||.|||.||+||-+ +.+|||||..+|+||.++..|||+||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsDf 647 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISDF 647 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEeccc
Confidence 99999999998765432 2348999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+++.....+..... ....-..+|||||.++. +++|++||||||||+|||+++ |+.||.+....
T Consensus 648 GLsRdiYssDYYk~~--------------~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 648 GLSRDIYSSDYYKVR--------------GNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred ccchhhhhhhhhccc--------------CCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 999988765543321 11222778999999876 889999999999999999999 88898765443
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+.++.++.+..-. -.+..+.++.+|+..||+.+|.+||+++||-..|+..
T Consensus 713 ------EVIe~i~~g~lL~---------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 713 ------EVIECIRAGQLLS---------------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ------HHHHHHHcCCccc---------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 3444444332211 1245667889999999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=375.55 Aligned_cols=242 Identities=24% Similarity=0.392 Sum_probs=201.4
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+++||+|||+.||+++. ..|..||+|++.+. .....+...+||++.++|+|||||+++++|++.++.|+|.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 44899999999999997 88999999998764 233446788999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.++++.++ .+++.++..+.+||+.||.|||+ .+|||||||..|+|+++++++||+|||+|......+..
T Consensus 103 ~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 103 GSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred ccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 99999998543 79999999999999999999999 89999999999999999999999999999987743221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. .+..||++|+|||++.. ...+..+||||+||++|.|+.|++||...... +....++
T Consensus 175 k----------------~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------ety~~Ik 231 (592)
T KOG0575|consen 175 K----------------KTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------ETYNKIK 231 (592)
T ss_pred c----------------ceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHH------HHHHHHH
Confidence 1 34567999999999875 77789999999999999999999999653211 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ....+.....+..+||.++++.||.+|||+.+|+.
T Consensus 232 ~~----------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LN----------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hc----------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 10 00111233456789999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=360.39 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=198.1
Q ss_pred cceecccCeeEEEEEE-eCCCceEEEEEcCCCchh-------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQ-------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.|-+|. ..+|+.||||.+++.... ......+|+++|++|+|||||++++++..++..|||||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 4589999999999998 458999999998765211 12334689999999999999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEeccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRL 560 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~ 560 (707)
||+||+|.+.+..++ .+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 257 ~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 257 YVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 999999999998765 68888889999999999999999 899999999999999766 7899999999997
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN--RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
.....-. .+..||+.|.|||++...+ .+..+.|+||+||+||-+++|.+||......
T Consensus 329 ~g~~sfm-----------------~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---- 387 (475)
T KOG0615|consen 329 SGEGSFM-----------------KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---- 387 (475)
T ss_pred cccceeh-----------------hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----
Confidence 6522111 3456899999999976522 2334889999999999999999999864432
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.+.+..+--.-. . ....+..++..+++.+++..||++|||+.|+++
T Consensus 388 -~sl~eQI~~G~y~f~---p---------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 388 -PSLKEQILKGRYAFG---P---------LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -ccHHHHHhcCccccc---C---------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 224444333211110 0 122345567889999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=354.19 Aligned_cols=194 Identities=29% Similarity=0.452 Sum_probs=172.8
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.||+|+||+||+|+++ ++..||||.+.+. .....+.+..|+.+|+.++|||||+++++++.++..|+|||||.+|+|
T Consensus 17 ~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 17 EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 4999999999999965 6799999998776 455567788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC------CCeEEeccccccccccc
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND------FQPYISDFGLSRLINIT 564 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~------~~~kl~DfGla~~~~~~ 564 (707)
.++++.++ .+++......+.|+|.||++||+ ++||||||||.|||++.. -.+||+|||+|+.+...
T Consensus 97 s~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 97 SDYIRRRG-----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 99999875 69999999999999999999999 999999999999999865 45899999999987632
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
.-. ++..|++-|||||++.. .+|+.|+|+||.|+++|++++|+.||+..+.
T Consensus 169 ~~a-----------------~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 169 SMA-----------------ETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hHH-----------------HHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 211 45678999999999765 7899999999999999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.56 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=202.1
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEE-EEEcCCc-ceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRA-YYWAPDE-KLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV~e~~~~g 488 (707)
.||+|.||+|||+. +.+|..+|.|.+.-. +.....+...|+.+|++|+|||||++++ .+.++.+ .++||||+..|
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 79999999999998 569999999998744 4455678899999999999999999998 4555555 78999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
+|..+++..+ +..+.+++..+++++.|++.||.++|+..++ -|+||||||.||+++.+|.||++|||+++.+......
T Consensus 106 DLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf 184 (375)
T KOG0591|consen 106 DLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF 184 (375)
T ss_pred CHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH
Confidence 9999997654 3356799999999999999999999995543 2899999999999999999999999999987643221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ...+||+.||+||.+.. ..|+.||||||+||++|||+.-++||.+. ....+.+.+.
T Consensus 185 A----------------~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~ 241 (375)
T KOG0591|consen 185 A----------------HSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIE 241 (375)
T ss_pred H----------------HhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHH
Confidence 1 23578999999999776 88999999999999999999999999763 2334444443
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
++-- ..+ ...-...++..|+..|+.+||+.||+...+++.+
T Consensus 242 qgd~-----~~~---------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 242 QGDY-----PPL---------PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred cCCC-----CCC---------cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 3311 111 1133456788999999999999999865555544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=374.97 Aligned_cols=255 Identities=27% Similarity=0.536 Sum_probs=216.0
Q ss_pred HhccceecccCeeEEEEEEeC----CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEE
Q 005226 409 RASAYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 409 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 483 (707)
....++||.|.||.||+|+++ ....||||.++.. .++...+|..|+.||.++.||||++|-|+.......++|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 334679999999999999975 3468999999987 44556899999999999999999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
||++|+|+.||+.+.| .+.+-+..-++++||.||+||-+ .++|||||.++|||++.+..+||+|||++|.+.+
T Consensus 711 yMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999998864 49999999999999999999999 7999999999999999999999999999997764
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 642 (707)
... ......||.+ ..+|.|||.+. .+++|.++|||||||+|||.++ |..||...... +.
T Consensus 784 d~~---~~ytt~GGKI----------PiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------dV 843 (996)
T KOG0196|consen 784 DPE---AAYTTLGGKI----------PIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DV 843 (996)
T ss_pred CCC---ccccccCCcc----------ceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchH------HH
Confidence 431 1111222332 67899999965 4899999999999999999887 88998765443 55
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+-+..+++-..+ .++...+.+|++-||+.|-.+||.+.+|+..|.++
T Consensus 844 IkaIe~gyRLPpP---------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 844 IKAIEQGYRLPPP---------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHHhccCCCCC---------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 5555566655443 56778899999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=341.70 Aligned_cols=235 Identities=27% Similarity=0.351 Sum_probs=193.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
++||+|+||.||.++.. +++.+|+|++++.. ..+.+...+|..+|.+++||.||+++-.|++.+..|+|+||+.||
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 48999999999999965 68899999998763 235577889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
.|..+|...+ .+++..+.-++..|+.||.|||+ ++||||||||+|||+|.+|+++|+|||+++.....+...
T Consensus 111 eLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 111 ELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred cHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 9999998654 69999999999999999999999 899999999999999999999999999998654332211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|||||++.. ..++..+|.||+|+++|||++|.+||.... ..++...
T Consensus 183 ----------------~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~---------~~~~~~~ 236 (357)
T KOG0598|consen 183 ----------------RTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAED---------VKKMYDK 236 (357)
T ss_pred ----------------ccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCcc---------HHHHHHH
Confidence 23467999999999876 688999999999999999999999997543 2233333
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 693 (707)
....+.. ....-...+..+++.+.+..||++|-
T Consensus 237 I~~~k~~------------~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 237 ILKGKLP------------LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HhcCcCC------------CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2222200 00111334567889999999999996
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=344.79 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=196.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--cceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--EKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 488 (707)
.+.||+|+||+||++... +|...|||..........+.+.+|+.+|.+++|||||+++|.....+ ..+++|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 348999999999999975 48999999987654333577899999999999999999999866655 588999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++...++ .+++..+.++++||++||+|||+ ++||||||||+|||++. ++.+||+|||+++........
T Consensus 102 sL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 102 SLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999997653 49999999999999999999999 89999999999999999 799999999999876531110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
+.......||+.|||||++..+.....++|||||||++.||+||++||... .....++.
T Consensus 175 -------------~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--------~~~~~~~~ 233 (313)
T KOG0198|consen 175 -------------SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--------FEEAEALL 233 (313)
T ss_pred -------------ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--------cchHHHHH
Confidence 111234678999999999875333446999999999999999999999753 01111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
........ .. .......+..+++.+|+..||++||||.++++.
T Consensus 234 ~ig~~~~~-P~----------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 234 LIGREDSL-PE----------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred HHhccCCC-CC----------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 11111100 00 112233456799999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.56 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=202.1
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~g 488 (707)
.||+|.||.||+|+ ..+|+.||+|++.... .....-..+||.+|++|+||||++|.+...+. ...|||+|||+.
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh- 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH- 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence 69999999999999 5689999999987654 34456678999999999999999999999887 688999999987
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.-++... ...|+..++..++.|++.||+|+|+ ++|+|||||.+|||+|.+|.+||+|||+|+++......+
T Consensus 203 DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 203 DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 888888753 3469999999999999999999999 899999999999999999999999999999876443222
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc-------chh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE-------VPD 641 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~-------~~~ 641 (707)
- +..+-|.+|+|||.+++...|+.+.|+||.||||.||++|++.|.+.++-...+ ...
T Consensus 276 ~---------------T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 276 Y---------------TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred c---------------ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 1 345569999999999998999999999999999999999999988754321110 000
Q ss_pred HHHHHHhhcc------ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFE------EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
-..|....+. ...++...+... ........++|+..++..||.+|.|+.++++
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~------~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRET------FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHH------hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0112211111 111111111111 1233456788999999999999999998874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=353.66 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=202.1
Q ss_pred ccceecccCeeEEEEEEeCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 411 SAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+..||+|+||+||+|.+.. .||||+++... ....+.|+.|+.++++-||.||+-++|||..++. .+|+.+++|-
T Consensus 396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs 472 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS 472 (678)
T ss_pred ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence 35689999999999999833 48999987663 3456899999999999999999999999998887 9999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|+.+||..+ ..|+..+.+.||.|||+||.|||. ++|||||||+.||++.+++.|||+|||++..-..-
T Consensus 473 SLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w---- 541 (678)
T KOG0193|consen 473 SLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW---- 541 (678)
T ss_pred hhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeee----
Confidence 9999999764 469999999999999999999999 99999999999999999999999999998643311
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.+...+ ....|...|||||++.. ...+++.+||||||+|+|||+||..||.....+ .+.-.+
T Consensus 542 -------~g~~q~---~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d------qIifmV 605 (678)
T KOG0193|consen 542 -------SGEQQL---EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD------QIIFMV 605 (678)
T ss_pred -------cccccc---CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh------heEEEe
Confidence 111111 33456888999999764 367889999999999999999999999732211 011011
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+++...+ ... .......++.+|+..||..++++||.+.+|+..|+++
T Consensus 606 GrG~l~pd-------~s~----~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 606 GRGYLMPD-------LSK----IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cccccCcc-------chh----hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 12211111 111 1133455788899999999999999999999988876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=342.62 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=203.5
Q ss_pred ccchHHHHHhccceecccCeeEEEEEEeCCCceEEEEEcCCCchhh---HHHHHHHHHHHHhcCCCceeeeEEEEEc---
Q 005226 401 TFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR---HREFVTEVQAIAKVKHPNIVKLRAYYWA--- 474 (707)
Q Consensus 401 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~--- 474 (707)
.++.+++.......||+|++|.||+|.+ +|..||||+++...... .+.|.+|++++++++||||++++|++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 3455555555556899999999999998 78899999997653322 4678899999999999999999999977
Q ss_pred -CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 005226 475 -PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553 (707)
Q Consensus 475 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~ 553 (707)
....++||||+++|+|.+++.... .++|....+++.+++.||+|||+. .+++||||||+||++++++.+||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEc
Confidence 346789999999999999998643 589999999999999999999973 378899999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 554 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
|||+++...... ....++..|+|||++.. ...++.++|||||||++|||++|+.||....
T Consensus 166 dfg~~~~~~~~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 166 CHGLEKILSSPP-------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ccchHhhhcccc-------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 999987653211 12345788999999653 2578899999999999999999999997532
Q ss_pred CCCCccchhHHHHHHh-hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 633 TSTSIEVPDLVRWVKK-GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 633 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. .++...+.. ..+.. ........+.+++.+||+.||++||||+++++.|+.+.
T Consensus 227 ~------~~~~~~i~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 227 T------KEIYDLIINKNNSLK---------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred H------HHHHHHHHhcCCCCC---------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1 122222111 11100 00122346789999999999999999999999998864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=378.31 Aligned_cols=255 Identities=31% Similarity=0.458 Sum_probs=208.8
Q ss_pred ccceecccCeeEEEEEEeCC--C----ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEE
Q 005226 411 SAYVLGKSGLGIVYKVVLGN--G----IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 483 (707)
..+.||+|.||.||+|...+ | ..||||.+++. +.++..+|.+|..+|++++|||||+++|+|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 35689999999999999642 3 35999999876 45667899999999999999999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 484 FISNGNLANALRGRNGQP--STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
||++|+|..+|+..+... ...+.....+.++.|||+|+.||++ ++.|||||.++|+|++....|||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 999999999998764322 3568999999999999999999999 89999999999999999999999999999966
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVP 640 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 640 (707)
......... ....-...|||||.+.. ..++.|+|||||||++||++| |..||..... .
T Consensus 853 y~~~yyr~~--------------~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~ 911 (1025)
T KOG1095|consen 853 YDKDYYRKH--------------GEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------F 911 (1025)
T ss_pred hhchheecc--------------CccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcch------H
Confidence 544332211 01122578999999886 788999999999999999999 6677754332 2
Q ss_pred hHHH-HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 641 DLVR-WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 641 ~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
++.. |...+ +... ...+...+.+++..||+.+|++||++..+++++..|
T Consensus 912 ~v~~~~~~gg-RL~~---------------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 912 EVLLDVLEGG-RLDP---------------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred HHHHHHHhCC-ccCC---------------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 3333 33333 3222 245566788999999999999999999999988776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=351.38 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=196.9
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCC-cceEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPD-EKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 482 (707)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++.++ +||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 45899999999999974 235689999987543 33446789999999999 8999999999987654 578999
Q ss_pred EeecCCChHHHHhCCCCC---------------------------------------------------------CCCCC
Q 005226 483 DFISNGNLANALRGRNGQ---------------------------------------------------------PSTSL 505 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~l 505 (707)
||+++|+|.+++...... ....+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999999753210 02358
Q ss_pred CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCcc
Q 005226 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585 (707)
Q Consensus 506 ~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (707)
++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......... ...
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--------------~~~ 234 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------------RKG 234 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchh--------------ccc
Confidence 899999999999999999999 899999999999999999999999999998653221100 011
Q ss_pred ccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHH
Q 005226 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAML 664 (707)
Q Consensus 586 ~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 664 (707)
...++..|+|||++.. ..++.++|||||||++|||++ |+.||...... ..+...........
T Consensus 235 ~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~~~~~~~~~----------- 297 (338)
T cd05102 235 SARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----EEFCQRLKDGTRMR----------- 297 (338)
T ss_pred CCCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHhcCCCCC-----------
Confidence 2234678999998765 678899999999999999997 99998653221 11222111111000
Q ss_pred HhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 665 LQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 665 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........+.+++.+||+.||++||++.+|++.|+++-
T Consensus 298 ----~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 298 ----APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01122345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=355.30 Aligned_cols=260 Identities=29% Similarity=0.422 Sum_probs=209.3
Q ss_pred cchHHHHHhccceecccCeeEEEEEEeCC--C--ce-EEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEE
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVLGN--G--IP-VAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 473 (707)
+++..-.......||+|+||.||+|.+.. + .. ||||..+.. ......+|.+|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44333333344799999999999999643 2 23 899998852 3455689999999999999999999999999
Q ss_pred cCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 005226 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553 (707)
Q Consensus 474 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~ 553 (707)
.....++|||+|.||+|.++|+...+ .++..++++++.+.|+||+|||+ +++|||||.++|+|++.++.+||+
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeC
Confidence 99999999999999999999997652 59999999999999999999999 899999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 005226 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPT 632 (707)
Q Consensus 554 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~ 632 (707)
|||+++.-.... +.+....-+..|+|||.+.. ..+++++|||||||++||+++ |..||.+..
T Consensus 305 DFGLs~~~~~~~----------------~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 305 DFGLSRAGSQYV----------------MKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred ccccccCCccee----------------eccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 999987532100 01112233678999999877 588999999999999999999 788886543
Q ss_pred CCCCccchhHHHHH-HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 633 TSTSIEVPDLVRWV-KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 633 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..+...++ ...++...+ ......+..++.+||..||+.||+|.++.+.|+.+.
T Consensus 368 ------~~~v~~kI~~~~~r~~~~---------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 368 ------NYEVKAKIVKNGYRMPIP---------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred ------HHHHHHHHHhcCccCCCC---------------CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 33566666 445554433 123345667778999999999999999999998863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=343.71 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=200.7
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchhh-HHHHHHHHHHHHhcC-CCceeeeEEEEEcCC-cceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVK-HPNIVKLRAYYWAPD-EKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV~e~~~~g 488 (707)
+.||.|.||.||+|+ ...|..||||+++..-... .-.=.||+..|++|+ |||||++.+++.+.+ ..++|||||. .
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~ 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-C 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-h
Confidence 369999999999999 4578999999998653322 123368999999998 999999999999988 8999999995 5
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|+++++.++ ..+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||.+......
T Consensus 95 NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY- 166 (538)
T KOG0661|consen 95 NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY- 166 (538)
T ss_pred hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCCCc-
Confidence 9999998763 579999999999999999999999 89999999999999999999999999999987643211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
+..+.|.+|+|||++.....|+.+.||||+||+++|+.+-++-|-+..+- ++...+.+.+..
T Consensus 167 ----------------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~--Dqi~KIc~VLGt 228 (538)
T KOG0661|consen 167 ----------------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI--DQIYKICEVLGT 228 (538)
T ss_pred ----------------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH--HHHHHHHHHhCC
Confidence 33456999999999998899999999999999999999999888664332 111111211111
Q ss_pred hccccCCCchhchHHHHhhh--------------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEV--------------HAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~--------------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
--...++.. ..+.... -......+.++++..|++.||.+|||++++++.
T Consensus 229 P~~~~~~eg----~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEG----YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhH----HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111100 1111100 011245678999999999999999999998763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.70 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=201.1
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+++||.|+|++||+|+. ..+..+|||++.+. .+...+...+|-++|.+| .||.|++|+-.|+++...|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 45899999999999994 47899999998765 223345677899999999 89999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++|++.+ .|++.....++.+|+.||+|||+ .|||||||||+|||+|.||++||+|||-|+.+.....
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999765 69999999999999999999999 8999999999999999999999999999998864332
Q ss_pred CCCCCCCCcCCCCCCCCc--cccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 567 NPSSSGGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... .....+... ...+||..|.+||++.. ...++.+|+|+|||++|.|+.|++||.+..+. ...+
T Consensus 230 ~~~~-----~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liFq 297 (604)
T KOG0592|consen 230 SQEN-----PVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIFQ 297 (604)
T ss_pred cccC-----ccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHHH
Confidence 2110 001111111 34679999999999765 78889999999999999999999999865433 1111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.. -. ..+.+.-.+.+.+|+.+.+..||.+|++.++|.+
T Consensus 298 kI~~-------------l~---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 KIQA-------------LD---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHH-------------hc---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111 00 0111222355778999999999999999988754
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=333.35 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=203.3
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
++||.|..++||+|+ .+.+..||||++.-.... +.+.+.+|+..|+.++||||++++..|..+.+.|+||.||.+|++
T Consensus 32 e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ 111 (516)
T KOG0582|consen 32 EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSL 111 (516)
T ss_pred EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcH
Confidence 389999999999999 457799999998765433 358899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++++..- ...+++..+..|.+++++||.|||+ +|-||||||+.|||++.+|.|||+|||.+-.+...+...
T Consensus 112 ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~-- 183 (516)
T KOG0582|consen 112 LDIIKTYY---PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ-- 183 (516)
T ss_pred HHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCcee--
Confidence 99998654 3459999999999999999999999 899999999999999999999999999987776543111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCC-CCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEA-RVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~-~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
...-....||+.|||||+ ......|+.|+||||||++..||.+|..||....+. - -....
T Consensus 184 ----------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------k-vLl~t 244 (516)
T KOG0582|consen 184 ----------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------K-VLLLT 244 (516)
T ss_pred ----------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------H-HHHHH
Confidence 111134578999999999 445578899999999999999999999999754332 1 11111
Q ss_pred ccccCC--CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP--LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~--~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+ .....|.. ........+.+++..|+..||.+|||++++++
T Consensus 245 Lqn~pp~~~t~~~~~d-----~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 245 LQNDPPTLLTSGLDKD-----EDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hcCCCCCcccccCChH-----HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111 01111111 11223347889999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=321.93 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=195.4
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+|+|++|+|||++.+ +|+.||||++..... ...+-..+|+++|++++|+|+|.++.+|......+||+||++. ++
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-Tv 87 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TV 87 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HH
Confidence 6899999999999965 689999999977643 3345678999999999999999999999999999999999977 55
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+-|... ...++.....+++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||+|+.....+..-
T Consensus 88 L~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y-- 158 (396)
T KOG0593|consen 88 LHELERY----PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY-- 158 (396)
T ss_pred HHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh--
Confidence 5555443 2358899999999999999999999 899999999999999999999999999999876322211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH-H---
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW-V--- 646 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~-~--- 646 (707)
+..+.|.+|+|||.+.+...|...+||||+||++.||++|.+.|.+..+- +.-..... +
T Consensus 159 --------------TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi---DQLy~I~ktLG~L 221 (396)
T KOG0593|consen 159 --------------TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI---DQLYLIRKTLGNL 221 (396)
T ss_pred --------------hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH---HHHHHHHHHHccc
Confidence 23445999999999998889999999999999999999999988654321 11111111 0
Q ss_pred ----HhhccccCCCc-----hhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 ----KKGFEEENPLS-----DMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ----~~~~~~~~~~~-----~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+.....+. +.-++.-.... ......-+++++..|++.||.+|++.++++.
T Consensus 222 ~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k-~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 222 IPRHQSIFSSNPFFHGVRLPEPEHPEPLERK-YPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CHHHHHHhccCCceeeeecCCCCCccchhhh-cccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00111000000 00000000000 0122345789999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=311.38 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=201.6
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchh--hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQ--RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+++|+|.||+||+|. ..+|+.||||+++..... ......+||+.|+.++|+||+.+++.|-..+..-+|+|||+. +
T Consensus 8 ~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-d 86 (318)
T KOG0659|consen 8 EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-D 86 (318)
T ss_pred hhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-c
Confidence 479999999999999 468999999998766432 235678999999999999999999999999999999999976 9
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|...++... ..++..++..++.++.+|++|||+ +.|+||||||.|+|++.+|.+||+|||+|+.+.......
T Consensus 87 Le~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 87 LEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred HHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 999998754 478999999999999999999999 899999999999999999999999999999876433211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
+..+.|.+|+|||.+.+.+.|+...||||.||++.||+-|.+-|.+..+ ...+..-.+..
T Consensus 159 ---------------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-----idQL~~If~~L 218 (318)
T KOG0659|consen 159 ---------------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-----IDQLSKIFRAL 218 (318)
T ss_pred ---------------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-----HHHHHHHHHHc
Confidence 2235599999999999989999999999999999999998876654322 11222211111
Q ss_pred ---ccccCC-CchhchHHHHh-------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 ---FEEENP-LSDMVDAMLLQ-------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ---~~~~~~-~~~~~d~~l~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..+.|+ ...+-|-.-.+ ..-......++++++..++..||.+|++++|++++
T Consensus 219 GTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 219 GTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011111 00111111000 00112334566899999999999999999999864
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.20 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=196.0
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHh--cCCCceeeeEEEEEcCC----cceEEEEeecC
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK--VKHPNIVKLRAYYWAPD----EKLLISDFISN 487 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e~~~~ 487 (707)
+||+|+||.||||.+ +++.||||++... +...|..|-++++- ++|+||++++++-.... +.+||+||.+.
T Consensus 217 li~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 799999999999999 5589999999654 33668888777665 58999999999876655 78999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC------CCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP------RKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~------~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|+|.++|+.+ .++|....+|+..+++||+|||+..+ ++|+|||||++||||.+|+++.|+|||+|..+
T Consensus 293 GsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 293 GSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred CcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999999976 59999999999999999999998653 57999999999999999999999999999887
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCC-----CCchhhHHHHHHHHHHHHhCCCCCCC-CCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNR-----PMQKWDVYSFGVVLLELLTGKSPELS-PTTST 635 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DV~S~Gv~l~elltg~~P~~~-~~~~~ 635 (707)
........ ....+||.+|||||++.+.-. .-.+.||||+|.|||||+++...++. ..+..
T Consensus 367 ~p~~~~~d--------------~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 367 EPGKPQGD--------------THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred cCCCCCcc--------------hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 63221111 123578999999998764222 22478999999999999998766542 11111
Q ss_pred Cccc------hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 636 SIEV------PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 636 ~~~~------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.... -.-.+.++..+-.+.. .+.+.........+..+.+.+..||..||+.|-|+.-|-+++.++.
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 1000 0011111111111110 0111111222355677889999999999999999999999888763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=344.61 Aligned_cols=242 Identities=24% Similarity=0.382 Sum_probs=202.1
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|+.|.||.|. ..+++.||||++........+-...|+.+|+..+|+|||.++..|...++.+.|||||++|+|.+
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 69999999999998 45789999999988776666778899999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
.+... .+++.++..|++++++||+|||. ++|||||||.+|||++.+|.+||+|||++..+.......
T Consensus 360 vVt~~------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR---- 426 (550)
T KOG0578|consen 360 VVTKT------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR---- 426 (550)
T ss_pred hhhcc------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc----
Confidence 99865 49999999999999999999999 899999999999999999999999999988765433222
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
...+||+.|||||+... ..|.+|.||||||++++||+-|.+||....+. ..-|.-. ..
T Consensus 427 ------------~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl-------rAlyLIa--~n 484 (550)
T KOG0578|consen 427 ------------STMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIA--TN 484 (550)
T ss_pred ------------ccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChH-------HHHHHHh--hc
Confidence 34678999999999665 88999999999999999999999999753322 1111111 00
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+ . -...+.....+.+++.+|+..||++||+++|+++
T Consensus 485 g~P-------~---lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 GTP-------K---LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCC-------C---cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 100 0 0122344466889999999999999999999986
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.85 Aligned_cols=260 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|-||.|.++....+..||||+++..... ..++|.+|+++|.+++|||||+++|+|..++..++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 5689999999999999988899999999987544 458999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.++... ...-...++|+.|||.||+||.+ -.+|||||.++|+|+|.++++||+|||+++-+...+.....
T Consensus 623 nqFl~aheap---t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 623 NQFLSAHELP---TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HHHHHhccCc---ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 9999887522 24556678899999999999999 79999999999999999999999999999976644432211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT--GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
-..+-..+|||||.+.. ++++.++|||+||+++||+++ ...||...+.. +.++-...
T Consensus 697 --------------gr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e------~vven~~~ 755 (807)
T KOG1094|consen 697 --------------GRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE------QVVENAGE 755 (807)
T ss_pred --------------cceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH------HHHHhhhh
Confidence 11233689999999876 788999999999999999876 56787654332 33333333
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.++.+.. +.+- .....+...+.+++.+||..|-++||+++++...|++..
T Consensus 756 ~~~~~~~--~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 756 FFRDQGR--QVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hcCCCCc--ceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 3332221 0000 012334567889999999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.52 Aligned_cols=262 Identities=23% Similarity=0.320 Sum_probs=201.1
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc--CCCceeeeEEEEEcCC----cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV--KHPNIVKLRAYYWAPD----EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~lV~e~~~ 486 (707)
+.||+|.||.||+|.+ .|+.||||++...++ +.+.+|.++++.+ ||+||+.+++.-..+. +.+||++|.+
T Consensus 217 e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 217 EIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 4899999999999999 688999999987654 5678888888875 9999999998876554 5689999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS-----PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
.|||++||... .++-...++++..+|.||+|||..- .+.|.|||||+.|||+..++.+.|+|+|+|...
T Consensus 293 ~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999864 5999999999999999999999632 367999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCC-----CCchhhHHHHHHHHHHHHhC----------CC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNR-----PMQKWDVYSFGVVLLELLTG----------KS 626 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DV~S~Gv~l~elltg----------~~ 626 (707)
....+.. ..++...+||.+|||||++...-. .-..+||||||.|+||+.-+ +.
T Consensus 367 ~~~t~~i------------di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 367 DSDTDTI------------DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred cccCCcc------------cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 6443222 224567899999999999764211 12478999999999999863 24
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
||+...+. ..-.+.++..+-.++. ...++ ......+.+..+.+++..||..+|..|-|+-.|.+.|.++.
T Consensus 435 Pyyd~Vp~-----DPs~eeMrkVVCv~~~-RP~ip----nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 435 PYYDVVPS-----DPSFEEMRKVVCVQKL-RPNIP----NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CcccCCCC-----CCCHHHHhcceeeccc-CCCCC----cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 55543332 1112222322221111 11111 12234577888999999999999999999999999988763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=329.33 Aligned_cols=250 Identities=24% Similarity=0.426 Sum_probs=197.6
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.++||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||+++++++..++..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 458999999999999853 46789999988653 2334679999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..++|..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||.+........
T Consensus 90 ~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 90 NGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 999999997643 258999999999999999999999 8999999999999999999999999998764321110
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. .....++..|+|||++.. ..++.++|||||||++||+++ |+.||..... ..+.+.
T Consensus 163 ~~---------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~ 220 (266)
T cd05064 163 YT---------------TMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKA 220 (266)
T ss_pred hc---------------ccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHH
Confidence 00 011233678999998654 678899999999999999775 9999865322 223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ .......+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 221 ~~~~~~~~~---------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGFRLPA---------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCCCCCC---------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 322211110 112334678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=346.11 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=199.1
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|++++..+ +||||++++++|...+..++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 45899999999999973 245689999987543 33446788999999999 89999999999999999999999
Q ss_pred eecCCChHHHHhCCCCC---------------------------------------------------------------
Q 005226 484 FISNGNLANALRGRNGQ--------------------------------------------------------------- 500 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 500 (707)
|+++|+|.++++.....
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 99999999999753210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCC
Q 005226 501 -------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573 (707)
Q Consensus 501 -------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 573 (707)
....++|..+.+++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..........
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~---- 272 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV---- 272 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc----
Confidence 11258999999999999999999999 8999999999999999999999999999986543221100
Q ss_pred CcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 574 FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..+.+++......
T Consensus 273 ----------~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~~ 336 (375)
T cd05104 273 ----------KGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----SKFYKMIKEGYRM 336 (375)
T ss_pred ----------cCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----HHHHHHHHhCccC
Confidence 011223567999999765 678899999999999999998 88888643221 2233333322211
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+ .....++.+++.+||+.||++||+|.+|++.|++.
T Consensus 337 ~~~---------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSP---------------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCC---------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 110 11124578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=339.18 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=195.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC----ch-hhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG----GE-QRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||.|.. .++..||+|.+... .. ...+...+|+.++++++ ||||++++.++......++||||+
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 4799999999999985 47899999976653 11 22355668999999998 999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEeccccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINIT 564 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~ 564 (707)
.+|+|++++...+ .+.+..+.+++.|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||++......
T Consensus 103 ~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 103 SGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred CCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 9999999998743 58889999999999999999999 899999999999999999 99999999999877411
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN-RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ......|++.|+|||++.... +...++||||+||+||.|++|+.||+.... ..+.
T Consensus 175 ~~----------------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~ 232 (370)
T KOG0583|consen 175 DG----------------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLY 232 (370)
T ss_pred CC----------------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHH
Confidence 11 113456799999999988755 446899999999999999999999986221 1222
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
..+. ...-.+...++ ..++..++.+|+..||.+|+++.+|+
T Consensus 233 ~ki~---~~~~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RKIR---KGEFKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHh---cCCccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 2211 11111111111 45678999999999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.88 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=196.0
Q ss_pred ceecccCeeEEEEEEeCC-----------------CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc
Q 005226 413 YVLGKSGLGIVYKVVLGN-----------------GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 474 (707)
+.||+|+||.||++...+ +..||+|.+.... .....+|.+|++++.+++||||+++++++.+
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 479999999999997532 3469999987653 3334679999999999999999999999999
Q ss_pred CCcceEEEEeecCCChHHHHhCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 005226 475 PDEKLLISDFISNGNLANALRGRNG--------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540 (707)
Q Consensus 475 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~ 540 (707)
.+..++||||+++|+|.+++..... .....++|..+.+++.||+.||+|||+ .+|+||||||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp~ 167 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATR 167 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcchh
Confidence 9999999999999999999965321 111357899999999999999999999 89999999999
Q ss_pred CeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHH
Q 005226 541 NILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLE 620 (707)
Q Consensus 541 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~e 620 (707)
|||++.++.+||+|||+++.......... .....++..|+|||++.. ..++.++||||||+++||
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDYYRI--------------QGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWE 232 (304)
T ss_pred heEEcCCccEEECCCccceecccCceeEe--------------cCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHH
Confidence 99999999999999999976532211000 012234678999998665 668899999999999999
Q ss_pred HHh--CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHH
Q 005226 621 LLT--GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698 (707)
Q Consensus 621 llt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 698 (707)
|++ +..||..... ......+...+..... ... ..........+.+++.+||+.||++||||.+|
T Consensus 233 l~~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 233 ILMLCKEQPYGELTD------EQVIENAGEFFRDQGR--QVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred HHHccCCCCCCcCCH------HHHHHHHHHHhhhccc--ccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 997 4566654322 1222222222211100 000 00011233568899999999999999999999
Q ss_pred HHHHHh
Q 005226 699 SENLER 704 (707)
Q Consensus 699 ~~~L~~ 704 (707)
.+.|++
T Consensus 299 ~~~l~~ 304 (304)
T cd05096 299 HAFLTE 304 (304)
T ss_pred HHHHhC
Confidence 998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.90 Aligned_cols=246 Identities=26% Similarity=0.452 Sum_probs=197.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+.||+|+||.||++.+.++..+|+|.+...... ..+|.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccCCcc-HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 479999999999999988889999998754333 3678999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
+++... ..++|..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.++.........
T Consensus 89 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~---- 157 (256)
T cd05114 89 YLRQRQ----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS---- 157 (256)
T ss_pred HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec----
Confidence 997543 258999999999999999999999 899999999999999999999999999987653211100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||.... ......++.....
T Consensus 158 -----------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~------~~~~~~~i~~~~~ 219 (256)
T cd05114 158 -----------SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS------NYEVVEMISRGFR 219 (256)
T ss_pred -----------cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCCCC
Confidence 011223567999999654 677899999999999999999 899986432 1233333333221
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...+ ......+.+++.+||+.+|.+||+|.++++.|.
T Consensus 220 ~~~~---------------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRP---------------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCC---------------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 112245789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=338.90 Aligned_cols=238 Identities=29% Similarity=0.418 Sum_probs=194.2
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHHH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANA 493 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 493 (707)
-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+||||+.+.|+|.....+|+|||||+.|-|+++
T Consensus 131 WlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 599999999999999 56679999986532 2468889999999999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCC
Q 005226 494 LRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573 (707)
Q Consensus 494 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 573 (707)
|+..+ .+.....+.|..+||.||.|||. +.|||||||+-||||+.+..|||+|||-++........
T Consensus 203 Lka~~-----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk------ 268 (904)
T KOG4721|consen 203 LKAGR-----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK------ 268 (904)
T ss_pred HhccC-----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh------
Confidence 98764 68888999999999999999999 89999999999999999999999999999876532111
Q ss_pred CcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcccc
Q 005226 574 FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653 (707)
Q Consensus 574 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (707)
....||+.|||||++.. ..+++|+||||||||||||+||..||...+.. .+-|- +. .
T Consensus 269 -----------MSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwG---VG-s 325 (904)
T KOG4721|consen 269 -----------MSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWG---VG-S 325 (904)
T ss_pred -----------hhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchh-------eeEEe---cc-C
Confidence 22467999999999765 78899999999999999999999998753321 00110 00 0
Q ss_pred CCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 654 ~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+. | .-.-...+...+.-|+.+||..-|+.||++++++..|.-.
T Consensus 326 Ns--------L-~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 326 NS--------L-HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred Cc--------c-cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00 0 0011234556677889999999999999999999988643
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.82 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=197.9
Q ss_pred ccceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
..+.||+|+||.||+|.. .++..||||+++... ......+.+|+++++.+ +|+|||+++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 356899999999999874 234579999997653 33346788999999999 8999999999999999999999
Q ss_pred EeecCCChHHHHhCCCC---------------------------------------------------------------
Q 005226 483 DFISNGNLANALRGRNG--------------------------------------------------------------- 499 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~--------------------------------------------------------------- 499 (707)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999999864321
Q ss_pred --CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCC
Q 005226 500 --QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577 (707)
Q Consensus 500 --~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 577 (707)
.....+++.++.+|+.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~-------- 270 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV-------- 270 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee--------
Confidence 012358999999999999999999999 8999999999999999999999999999876542211000
Q ss_pred CCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCC
Q 005226 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPL 656 (707)
Q Consensus 578 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (707)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.||...... ..+............+
T Consensus 271 ------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----~~~~~~~~~~~~~~~~- 337 (374)
T cd05106 271 ------KGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----SKFYKMVKRGYQMSRP- 337 (374)
T ss_pred ------ccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----HHHHHHHHcccCccCC-
Confidence 011223567999999764 678899999999999999997 99998653221 1111111111111100
Q ss_pred chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 657 SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.....++.+++.+||+.||++||++.+|+++|+++
T Consensus 338 --------------~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 --------------DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred --------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 01134678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.95 Aligned_cols=261 Identities=28% Similarity=0.447 Sum_probs=215.6
Q ss_pred ccchHHHHHhccceecccCeeEEEEEEeCC-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcce
Q 005226 401 TFELDELLRASAYVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKL 479 (707)
Q Consensus 401 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 479 (707)
.++++.-.......||-|.||.||.|.|+. .-.||||.++..... .++|.+|+.+|+.++|||+|+|+|+|......|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 344444444456689999999999999864 578999999886554 489999999999999999999999999999999
Q ss_pred EEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 480 LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+|+|||.+|+|.++|+.... ..++--..+.++.||+.||+||.. +.+|||||.++|+|+.++..|||+|||+++
T Consensus 340 IiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999998752 346667789999999999999999 899999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
+|........ .-..-..-|.|||-+-- ..++.|+|||+|||+|||+.| |-.||. +.+
T Consensus 414 lMtgDTYTAH---------------AGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYP------Gid 471 (1157)
T KOG4278|consen 414 LMTGDTYTAH---------------AGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYP------GID 471 (1157)
T ss_pred hhcCCceecc---------------cCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCC------Ccc
Confidence 9874332221 22233678999998543 678899999999999999998 555553 344
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.....+.+..+++.+.+ +.+...+.+|+..||+.+|.+||++.|+-+.++.+
T Consensus 472 lSqVY~LLEkgyRM~~P---------------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 472 LSQVYGLLEKGYRMDGP---------------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHHHHhccccccCC---------------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 45556666666666554 45567788999999999999999999999999875
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=324.33 Aligned_cols=250 Identities=23% Similarity=0.413 Sum_probs=200.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.++++++|+||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchh-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 3479999999999999888889999998764433 478899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--- 160 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA--- 160 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCceec---
Confidence 9997543 2358999999999999999999999 899999999999999999999999999998654221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||+... ..++.++|||||||++|||+| |+.||.... ......++....
T Consensus 161 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~~ 221 (261)
T cd05072 161 ------------REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMS------NSDVMSALQRGY 221 (261)
T ss_pred ------------cCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCC------HHHHHHHHHcCC
Confidence 011234678999998654 667889999999999999998 999986432 122333333222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... ......++.+++.+|+..+|++||++.++.+.|+++
T Consensus 222 ~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPR---------------MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCC---------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1110 011234578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=330.62 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=198.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+||+|+||.||+|+.+ +|..+|+|++++... ...+....|-++|...++|.||+|+-.|++.+..||||||.|||
T Consensus 147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGG 226 (550)
T KOG0605|consen 147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGG 226 (550)
T ss_pred eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCc
Confidence 48999999999999954 789999999988744 34466788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++..+|...+ .|++..+..++.+++-|++-+|+ .|+|||||||+|+|||..|++||+|||++.-........
T Consensus 227 D~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 227 DMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred cHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999998765 69999999999999999999999 899999999999999999999999999996443211100
Q ss_pred C---------CCCCCcCCCCC-------CCC---------------ccccccCccccCCCCCCCCCCCCchhhHHHHHHH
Q 005226 569 S---------SSGGFMGGALP-------YMK---------------PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV 617 (707)
Q Consensus 569 ~---------~~~~~~~~~~~-------~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~ 617 (707)
. ..........+ .+. -...+||+.|+|||++.+ ..|+..+|.||+|||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHHHHHH
Confidence 0 00000000111 000 012478999999999886 668999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC
Q 005226 618 LLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694 (707)
Q Consensus 618 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 694 (707)
+|||+.|.+||.+.++.. ....+..|-........ .....+..+||.+|+. ||++|--
T Consensus 378 myEmLvGyPPF~s~tp~~--T~rkI~nwr~~l~fP~~----------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQE--TYRKIVNWRETLKFPEE----------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHhCCCCCCCCCHHH--HHHHHHHHhhhccCCCc----------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999876542 23445555544332221 1222567899999998 9999975
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=329.71 Aligned_cols=248 Identities=34% Similarity=0.545 Sum_probs=190.5
Q ss_pred ceecccCeeEEEEEEeC-----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||.|.||.||+|.+. .+..|+||.++... ....++|.+|++.+++++||||++++|+|...+..++|+||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 47999999999999976 36789999996643 3346889999999999999999999999998888999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++|+... ...+++.++.+|+.|||.||+|||+ .+++|+||+++||+++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 85 GGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999998762 2369999999999999999999999 8999999999999999999999999999987621111
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. ..........|+|||.+.. ..++.++||||||+++|||++ |+.||... ...++...
T Consensus 159 ~~--------------~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~ 217 (259)
T PF07714_consen 159 YK--------------NDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEK 217 (259)
T ss_dssp EE--------------ESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHH
T ss_pred cc--------------ccccccccccccccccccc-cccccccccccccccccccccccccccccc------cccccccc
Confidence 00 0012334778999998654 557899999999999999999 67887543 12233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
+....+... .......+.+++..||+.||++||+|+++++.|
T Consensus 218 ~~~~~~~~~---------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 LKQGQRLPI---------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHTTEETTS---------------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccccee---------------ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 333222111 112234577999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=326.22 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=200.1
Q ss_pred ceecccCeeEEEEEEeCC------CceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLGN------GIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|.... ...|++|.+..... ....+|.+|++++++++||||+++++++...+..+++|||+
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence 479999999999998642 25799999875533 33467899999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 486 SNGNLANALRGRNGQPS-----------TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
++|+|.+++........ ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEECC
Confidence 99999999976432111 468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTT 633 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~ 633 (707)
||+++......... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.....
T Consensus 168 fg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 168 FGLSRDIYSADYYR--------------VQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred Ccceeecccccccc--------------ccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99997654221100 0112234778999998665 668899999999999999998 9999865322
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.++..++....... .......++.+++.+||+.||++||++++|++.|+.+
T Consensus 233 ------~~~~~~i~~~~~~~---------------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 ------QEVIEMIRSRQLLP---------------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------HHHHHHHHcCCcCC---------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 23333332211110 0123346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=306.99 Aligned_cols=202 Identities=24% Similarity=0.341 Sum_probs=176.8
Q ss_pred cchHHHHHhccceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE 477 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 477 (707)
+.+++.. .-..||.|+||.|.+++.+ +|..+|+|++++... ...+....|..+|+.+.||+++++++.|.+.+.
T Consensus 41 ~~l~dfe--~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFE--RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhh--heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 4444432 2347999999999999964 789999999987643 334567789999999999999999999999999
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
.+|||||++||.|..+|++.+ ++++..+.-+|.+|+.||+|||+ .+|++|||||+|||+|.+|.+||+|||+
T Consensus 119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccc
Confidence 999999999999999999765 69999999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
|+...... .+..||+.|+|||++.. ..+..++|.|||||++|||+.|.+||....+
T Consensus 191 AK~v~~rT-------------------~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 191 AKRVSGRT-------------------WTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred eEEecCcE-------------------EEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 99875221 34568999999999776 7888999999999999999999999986543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.09 Aligned_cols=250 Identities=27% Similarity=0.482 Sum_probs=200.1
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|++|.||+|...++..||+|.++..... .++|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCccc-HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 3589999999999999888888999998765433 367899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+.+++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++..........
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-- 161 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-- 161 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc--
Confidence 9997643 2368999999999999999999999 8999999999999999999999999999987652211000
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....+..|+|||+... ..++.++||||||+++|||+| |+.||..... ......+....
T Consensus 162 -------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~ 221 (261)
T cd05068 162 -------------EGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------AEVLQQVDQGY 221 (261)
T ss_pred -------------CCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC
Confidence 11112457999998654 678899999999999999999 9999864321 12222222111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ........+.+++.+|++.+|++||++.++.+.|+++
T Consensus 222 ~~~---------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 RMP---------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCC---------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 100 0112235688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=321.95 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=198.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... ++..|++|.+..... ...++.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 457999999999999965 588899999876433 346789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-- 161 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-- 161 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec--
Confidence 99997543 2358999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....++..|+|||+... ..++.++|||||||++|||++ |..||..... ....+.....
T Consensus 162 -------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~ 221 (263)
T cd05052 162 -------------HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKG 221 (263)
T ss_pred -------------cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCC
Confidence 011223567999998654 677899999999999999998 8888854221 1222222221
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... .......+.+++.+||..||++||++.++.++|+++
T Consensus 222 ~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMER---------------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCC---------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11110 112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.39 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=198.6
Q ss_pred ccceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 482 (707)
..++||+|+||.||+|... .+..||||++.... ......|.+|++++++++ ||||++++++|.+.+..++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 3458999999999999852 23469999997543 333467999999999995 999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCC--------------------------------------------------------------
Q 005226 483 DFISNGNLANALRGRNGQ-------------------------------------------------------------- 500 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~-------------------------------------------------------------- 500 (707)
||+++|+|.++++.....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999998753210
Q ss_pred -----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 501 -----------------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 501 -----------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
....+++..+.+++.||+.||+|||+ .+|+||||||+||++++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEE
Confidence 01348899999999999999999999 8999999999999999999999
Q ss_pred EecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005226 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELS 630 (707)
Q Consensus 552 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~ 630 (707)
|+|||+++......... ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||..
T Consensus 278 L~DfGla~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 278 ICDFGLARDIMHDSNYV--------------SKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EEeCCcceecccccccc--------------ccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 99999998654221110 0112234678999998765 667899999999999999997 8999864
Q ss_pred CCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... ..+...+........ .......+.+++.+||+.||++||++.+|.+.|+++
T Consensus 343 ~~~~-----~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 343 MIVD-----STFYNKIKSGYRMAK---------------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred cchh-----HHHHHHHhcCCCCCC---------------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 3221 112222222111110 112235678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=320.71 Aligned_cols=250 Identities=28% Similarity=0.463 Sum_probs=204.0
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||.|+||.||+|...++..+++|.+.........++.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (261)
T cd05148 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLL 90 (261)
T ss_pred hhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHH
Confidence 34799999999999998889999999998776655678999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.+..........
T Consensus 91 ~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--- 161 (261)
T cd05148 91 AFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--- 161 (261)
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccccc---
Confidence 9998653 2358999999999999999999999 899999999999999999999999999997654221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||.... ..++.++||||||+++|+|++ |+.||..... ....+......
T Consensus 162 -------------~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~ 221 (261)
T cd05148 162 -------------SDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQITAGY 221 (261)
T ss_pred -------------cCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHHhCC
Confidence 12234678999998654 677899999999999999998 8999864321 22333332221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... .......+.+++.+||..||.+|||++++++.|+.+
T Consensus 222 ~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPC---------------PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCC---------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111 122335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.37 Aligned_cols=241 Identities=24% Similarity=0.320 Sum_probs=203.3
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+.|.|..|++ .+|+.+|||.+.+.. ........+|+-+|+-+.||||+++++++.+..+.|+|.||+++|.
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 799999999999995 589999999987662 2234567889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|++++..++ .+.+.++.+++.||+.|+.|+|. .+|+||||||+|+|+|..+++||+|||+|..-....-.
T Consensus 99 LFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL-- 168 (786)
T KOG0588|consen 99 LFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL-- 168 (786)
T ss_pred hHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCccc--
Confidence 999998765 68899999999999999999999 79999999999999999999999999999865433322
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
++..|.+.|.|||++++..+...++||||.||+||.|+||+.||++. +...+...++++
T Consensus 169 ---------------eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~LLlKV~~G 227 (786)
T KOG0588|consen 169 ---------------ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRVLLLKVQRG 227 (786)
T ss_pred ---------------cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHHHHHHHHcC
Confidence 33456999999999888677789999999999999999999999742 334455555554
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.-+.. .....++.+|+.+|+..||+.|.|++||.+.
T Consensus 228 ~f~MP----------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 228 VFEMP----------------SNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cccCC----------------CcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 33221 1223457899999999999999999999863
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=325.36 Aligned_cols=246 Identities=24% Similarity=0.277 Sum_probs=192.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++.. .+++.||+|.+..... .....+.+|++++++++|+||+++++++.+++..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 4799999999999985 5789999998865422 22346788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++.........
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05631 86 DLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV- 158 (285)
T ss_pred cHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee-
Confidence 9998886432 2358999999999999999999999 89999999999999999999999999998765321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ....+...+.
T Consensus 159 ----------------~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~- 218 (285)
T cd05631 159 ----------------RGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRVK- 218 (285)
T ss_pred ----------------cCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHhh-
Confidence 12356899999999765 678899999999999999999999997543221 0001111110
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
..... ........+.+|+.+||+.||++||+ ++++++
T Consensus 219 --~~~~~-------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 219 --EDQEE-------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccccc-------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000 01122346789999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.51 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=201.1
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..++||||+
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 89 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence 34799999999999984 234668999987765555578999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 486 SNGNLANALRGRNG--------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 486 ~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCCc
Confidence 99999999975431 122358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTS 636 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~ 636 (707)
++......... ......++..|+|||++.. ..++.++|||||||++|||+| |+.||.....
T Consensus 167 ~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--- 228 (288)
T cd05093 167 SRDVYSTDYYR--------------VGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--- 228 (288)
T ss_pred cccccCCceee--------------cCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 87654221100 0012234678999998654 678899999999999999999 8988864322
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+.+........ ......++.+++.+||+.||.+||++.+|.+.|+.+.
T Consensus 229 ---~~~~~~i~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 229 ---NEVIECITQGRVLQR---------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ---HHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 122222222111000 0112345789999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.70 Aligned_cols=255 Identities=26% Similarity=0.426 Sum_probs=201.8
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 47999999999999742 356689999877666555789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 487 NGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 487 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
+++|.+++..... .....++|..+++++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECCC
Confidence 9999999975431 112358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+++......... ......++..|+|||++.. ..++.++||||||+++|||+| |+.||.....
T Consensus 168 g~a~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~- 231 (291)
T cd05094 168 GMSRDVYSTDYYR--------------VGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSN- 231 (291)
T ss_pred CcccccCCCceee--------------cCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 9987654221100 0012334678999998665 678899999999999999999 9999865322
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+.......... .......+.+++.+||+.||++||++++|+++|+++.
T Consensus 232 -----~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 232 -----TEVIECITQGRVLER---------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -----HHHHHHHhCCCCCCC---------------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 122222222111110 0112346789999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=333.02 Aligned_cols=240 Identities=24% Similarity=0.296 Sum_probs=192.0
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 699999999999986 478899999987542 2334567889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 151 (323)
T cd05571 82 LFFHLSRER-----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--
Confidence 999997543 58999999999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+...+..
T Consensus 152 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~- 209 (323)
T cd05571 152 --------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM- 209 (323)
T ss_pred --------------ccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHc-
Confidence 123457999999999764 6788999999999999999999999964321 112221111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
....+ ......++.+++.+|++.||++|| ++.++++
T Consensus 210 --~~~~~-------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 210 --EEIRF-------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCCCC-------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 11110 112234577899999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=331.45 Aligned_cols=237 Identities=24% Similarity=0.305 Sum_probs=188.1
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||.||+|... ++..||+|++... .......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 5788999998653 223346788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--- 149 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--- 149 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc---
Confidence 99997543 58999999999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .+......
T Consensus 150 -------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~---------~~~~~~~~ 206 (312)
T cd05585 150 -------------TNTFCGTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---------NEMYRKIL 206 (312)
T ss_pred -------------cccccCCcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCH---------HHHHHHHH
Confidence 022457899999999765 6788999999999999999999999964221 11112212
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 698 (707)
.....+. ......+.+++.+||+.||++||++..+
T Consensus 207 ~~~~~~~-------------~~~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 207 QEPLRFP-------------DGFDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred cCCCCCC-------------CcCCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 1111111 1122456789999999999999865433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.10 Aligned_cols=240 Identities=24% Similarity=0.353 Sum_probs=198.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||||+.+ +.+.||+|.+.+.. .++.+...+|++++++++|||||.++++|++..+.++|+||+.+ +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 46999999999999954 67899999987663 34567899999999999999999999999999999999999976 9
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..+|...+ .++++++..|+.++..||.|||+ .+|+|||+||.|||++..+.+|+||||+|+-+......
T Consensus 87 L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v-- 156 (808)
T KOG0597|consen 87 LFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV-- 156 (808)
T ss_pred HHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCcee--
Confidence 999998654 69999999999999999999999 89999999999999999999999999999987642211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
-+...||+.|||||... +..|+..+|+||+||++||+.+|++||... .+.+.++..
T Consensus 157 --------------ltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~---------si~~Lv~~I 212 (808)
T KOG0597|consen 157 --------------LTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYAR---------SITQLVKSI 212 (808)
T ss_pred --------------eeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHH---------HHHHHHHHH
Confidence 13467899999999966 488899999999999999999999999742 223333333
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.-. ........+..++...+..||..|.+-.+++.
T Consensus 213 ~~d~v~-------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 213 LKDPVK-------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred hcCCCC-------------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 322211 11233455778889999999999998877653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.14 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=196.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||++...++..+|+|.+...... ...|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 9 ~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 9 LKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhccCCCceEEEeEecCCccEEEEEeccCCCC-HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 3479999999999999877788999998654333 257889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..++|..+..|+.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.........
T Consensus 88 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~--- 157 (256)
T cd05059 88 NYLRERK----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS--- 157 (256)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc---
Confidence 9997643 258999999999999999999999 899999999999999999999999999987654211100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||..... ......+....
T Consensus 158 ------------~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~ 218 (256)
T cd05059 158 ------------SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN------SEVVESVSAGY 218 (256)
T ss_pred ------------cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCH------HHHHHHHHcCC
Confidence 011123567999998665 678899999999999999999 7889864322 12222222221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.... ......++.+++.+||..+|++||+|.++++.|.
T Consensus 219 ~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 RLYR---------------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cCCC---------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1111 1123456889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.84 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=200.2
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... ++..||||.++..... ..+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 90 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM 90 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence 47999999999999863 3478999998766443 3478999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 486 SNGNLANALRGRNG---------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 486 ~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
++|+|.+++...+. .....+++.++..++.|++.|++|||+ ++++||||||+||+++.++.+||+|||
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~g 167 (280)
T cd05049 91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFG 167 (280)
T ss_pred CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCcc
Confidence 99999999976531 223458999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTST 635 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~ 635 (707)
+++......... ......++..|+|||++.. ..++.++|||||||++|||++ |+.||.....
T Consensus 168 ~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-- 230 (280)
T cd05049 168 MSRDVYTTDYYR--------------VGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-- 230 (280)
T ss_pred cceecccCccee--------------cCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 987543221100 0012234678999998765 678899999999999999999 9999864322
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
....+.+........ .......+.+++.+||..||++||++.||++.|++
T Consensus 231 ----~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 ----EEVIECITQGRLLQR---------------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----HHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 233333332111110 01223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=318.45 Aligned_cols=258 Identities=24% Similarity=0.320 Sum_probs=193.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc-----ceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE-----KLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV~e~~ 485 (707)
.+++|+|+||.||+|... +++.||||+.-..... -.+|+++|++++|||||++.-+|....+ ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 358999999999999964 6799999987654332 2469999999999999999988865432 35899999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEeccccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINIT 564 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~ 564 (707)
|. +|.++++... .....++.-.+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||-|+.....
T Consensus 105 P~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 88 9999998431 112357777888899999999999999 899999999999999977 99999999999988755
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
....+ ...+..|+|||.+.+...|+.+.||||.|||+.||+-|++-|.+.... ..+++
T Consensus 180 epniS-----------------YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-----dQL~e 237 (364)
T KOG0658|consen 180 EPNIS-----------------YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-----DQLVE 237 (364)
T ss_pred CCcee-----------------EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-----HHHHH
Confidence 43332 233889999999999899999999999999999999999998764322 12222
Q ss_pred HHHhhcccc-C-------CCchhchHHHHhh----hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEE-N-------PLSDMVDAMLLQE----VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~-~-------~~~~~~d~~l~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.++..-... + .+.+.-.+.+... ........+..+++.+++..+|.+|.++.|+++
T Consensus 238 Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 238 IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 222111000 0 0001111111111 122344567899999999999999999999875
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=317.68 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=196.7
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
..||+|+||+||+|...++..+|+|.+...... ..+|.+|+.++++++||||+++++++...+..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCccc-HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 479999999999999877778999998755433 3679999999999999999999999999889999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++.++++++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||.++.........
T Consensus 89 ~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~---- 157 (256)
T cd05113 89 YLREHG----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS---- 157 (256)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee----
Confidence 997643 258999999999999999999999 899999999999999999999999999987653221100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||.... ..++.++||||||+++|||++ |+.||..... ......+....+
T Consensus 158 -----------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~ 219 (256)
T cd05113 158 -----------SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLR 219 (256)
T ss_pred -----------cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCCC
Confidence 011234678999998754 567889999999999999999 9999864321 122333322211
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...+ ......+.+++.+||+.||.+||++.++++.|+
T Consensus 220 ~~~~---------------~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRP---------------HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC---------------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1100 112356789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=315.84 Aligned_cols=248 Identities=28% Similarity=0.471 Sum_probs=197.0
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..+|+|.+...... .+.|.+|+.++++++|+|++++++++. .+..++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (260)
T cd05070 11 IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (260)
T ss_pred hheeccccCceEEEEEecCCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHH
Confidence 3579999999999999888888999998765443 367899999999999999999999874 56689999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++.++..++.+++.||+|||+ .+|+||||||+||++++++.++|+|||++...........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~-- 160 (260)
T cd05070 89 DFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-- 160 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc--
Confidence 9997643 2358999999999999999999999 8999999999999999999999999999976542211100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||+... ..++.++||||||+++|||++ |+.||.... ..+..++.....
T Consensus 161 -------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~~~ 220 (260)
T cd05070 161 -------------QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVLEQVERGY 220 (260)
T ss_pred -------------cCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCC
Confidence 11223567999998654 678899999999999999999 888886422 122333332221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.... .......+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 221 ~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPC---------------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCC---------------CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1110 11223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.38 Aligned_cols=193 Identities=25% Similarity=0.375 Sum_probs=165.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 47999999999999965 67889999887542 23346799999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 91 ~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 159 (331)
T cd06649 91 DQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---- 159 (331)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccccc----
Confidence 99997643 589999999999999999999982 3699999999999999999999999999875532110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
....|+..|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 160 --------------~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 160 --------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred --------------ccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 12346889999999764 67889999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=316.70 Aligned_cols=251 Identities=27% Similarity=0.493 Sum_probs=199.7
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|.+. +...||||.++... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 458999999999999874 24679999987653 3344678999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 89 NGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 999999997643 258999999999999999999999 8999999999999999999999999999987641111
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....++..|+|||.... ..++.++||||||+++|||++ |..||.... ...+.+.
T Consensus 162 ~~~--------------~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~------~~~~~~~ 220 (266)
T cd05033 162 TYT--------------TKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMS------NQDVIKA 220 (266)
T ss_pred cee--------------ccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Confidence 000 011223678999998654 678899999999999999998 999985422 1223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 221 ~~~~~~~~~---------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 VEDGYRLPP---------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHcCCCCCC---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 322211111 112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.53 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=196.4
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+||+|+||.||+|...++..+|+|.+..... .....|.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999988899999999876533 233578899999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~---- 150 (250)
T cd05085 82 FLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS---- 150 (250)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc----
Confidence 997543 248999999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||++.. ..++.++||||||+++||+++ |..||..... ......+.....
T Consensus 151 -----------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~~~~~~ 212 (250)
T cd05085 151 -----------SGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQVEKGYR 212 (250)
T ss_pred -----------CCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHHcCCC
Confidence 011233567999998754 678899999999999999998 9999864321 122222222111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
... .......+.+++.+|+..+|++||++.++++.|.
T Consensus 213 ~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 MSC---------------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCC---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 110 0122356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.52 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=194.0
Q ss_pred ceecccCeeEEEEEEeC-CCc----eEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGI----PVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|.+. ++. .||+|.++... ....++|.+|+.+++.++||||++++|+|... ..++|+||++
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~ 91 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 91 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence 47999999999999853 333 48999987543 33457889999999999999999999999764 5789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+++++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 92 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 999999998653 358899999999999999999999 8999999999999999999999999999987653221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ....++..|+|||++.. ..++.++|||||||++|||++ |+.||.... ...+...
T Consensus 165 ~~~~--------------~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~~~~~~ 223 (316)
T cd05108 165 EYHA--------------EGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEISSI 223 (316)
T ss_pred ceec--------------cCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Confidence 1100 11123567999998765 677899999999999999998 999986422 1122222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
......... .......+.+++.+||..||.+||++.+++..+..+
T Consensus 224 ~~~~~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 224 LEKGERLPQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HhCCCCCCC---------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 221111100 011234578899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.85 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=190.6
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+||+|+||.||++.. .+|..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 699999999999986 47899999998754 22334667889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 151 (323)
T cd05595 82 LFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--
Confidence 999987543 58999999999999999999999 89999999999999999999999999998743211100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...+.+
T Consensus 152 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~--- 207 (323)
T cd05595 152 --------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELI--- 207 (323)
T ss_pred --------------cccccCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH---
Confidence 012357899999999765 67789999999999999999999999643211 111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
......+. ......+.+++.+|++.||++|| ++.++++
T Consensus 208 ~~~~~~~p-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 208 LMEEIRFP-------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred hcCCCCCC-------------CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11111100 11234567899999999999998 7777764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=320.69 Aligned_cols=248 Identities=27% Similarity=0.322 Sum_probs=190.2
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCch--------------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--C
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--------------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--D 476 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 476 (707)
.||+|.||.|-+|+. .+++.||||++.+... ...+...+||.+|++++|||||+|+.+..+. +
T Consensus 104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 699999999999995 4789999999865321 1124778999999999999999999998775 5
Q ss_pred cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 477 EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
..|||+|||..|.+...=.. ...++..+++++++++..||+|||. ++||||||||+|+|++++|+|||+|||
T Consensus 184 ~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred ceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeeccc
Confidence 67999999998876443221 1239999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
.+............ ..-....||+.|+|||.+..+ ...+.+.||||+||+||.|+.|+.||.+...
T Consensus 256 Vs~~~~~~~~~~~d-----------~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSD-----------DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred eeeecccCCccccH-----------HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 99766433111100 000235789999999998763 3446789999999999999999999975322
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. .+. ..++..-+ ......+..+++.+|+.+++..||+.|.+..+|..
T Consensus 325 ~------~l~-------------~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 325 L------ELF-------------DKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred H------HHH-------------HHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 1 111 11111111 11122345678899999999999999999998864
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.23 Aligned_cols=269 Identities=21% Similarity=0.265 Sum_probs=207.7
Q ss_pred cchHHHHHhccceecccCeeEEEEEEeCCC-ceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEE-EEEcC---
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVLGNG-IPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRA-YYWAP--- 475 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~~--- 475 (707)
+++........++|.+|||+.||.|....+ ..||+|++-..++...+...+||++|++|+ |||||.+++ .....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 333333334456899999999999997666 999999998777777889999999999995 999999999 33221
Q ss_pred ---CcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEE
Q 005226 476 ---DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYI 552 (707)
Q Consensus 476 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl 552 (707)
-+.+|.||||.+|.|.+++..+. ...|++.++++|+.|+++|+++||... .+|||||||-+|||++.+++.||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence 25689999999999999998654 235999999999999999999999865 58999999999999999999999
Q ss_pred ecccccccccccCCCCCCCCCCcCCCCCCCCc-cccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 553 SDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 553 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
||||-|...-..... ...+.+... .....|+-|+|||++. .+..+++|+|||||||+||-|+....||.
T Consensus 188 CDFGSatt~~~~~~~--------~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 188 CDFGSATTKILSPTS--------AQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred CcccccccccCCCcc--------HHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 999988643211100 000011111 1234599999999853 56788999999999999999999999997
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..... .+++....- .........+.+||..||++||.+||++-+|++.+.+|.
T Consensus 260 ~sg~l-----------------------aIlng~Y~~-P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 260 ESGKL-----------------------AILNGNYSF-PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred cCcce-----------------------eEEeccccC-CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 53211 111111110 111456678899999999999999999999999998874
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=313.68 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=193.9
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.||+|+||.||+|... +++.+|+|...... ......|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6899999999999964 78899999876543 333467999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .. .
T Consensus 82 ~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~-~ 152 (252)
T cd05084 82 TFLRTEG----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-AS-T 152 (252)
T ss_pred HHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccc-cc-c
Confidence 9997543 258999999999999999999999 8999999999999999999999999999875432110 00 0
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
. .....+..|+|||.+.. ..++.++||||||+++|||++ |..||...... .....+....
T Consensus 153 ~------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~~~~~~~~~~ 213 (252)
T cd05084 153 G------------GMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------QTREAIEQGV 213 (252)
T ss_pred C------------CCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------HHHHHHHcCC
Confidence 0 11123457999998765 567899999999999999998 88888543211 1111111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
... ........+.+++.+|+..+|++||++.+|.++|++
T Consensus 214 ~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RLP---------------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCC---------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 100 011223467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=314.33 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=196.1
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
..||+|++|.||+|....+..+|+|.+...... .+.|.+|++++++++|||++++++++. .+..++||||+++|+|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcccCCcc-HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence 479999999999999877778999988754433 367889999999999999999998874 566899999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
+++... ...++|..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++..........
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~--- 160 (260)
T cd05069 90 FLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR--- 160 (260)
T ss_pred HHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc---
Confidence 997643 2358999999999999999999999 8999999999999999999999999999976542211100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||+... ..++.++||||||+++|||+| |+.||..... ....++......
T Consensus 161 ------------~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~ 221 (260)
T cd05069 161 ------------QGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------REVLEQVERGYR 221 (260)
T ss_pred ------------CCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC
Confidence 11234678999998654 678899999999999999999 8989864321 123333322211
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... .......+.+++.+||+.||++||++++|++.|++.
T Consensus 222 ~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 222 MPC---------------PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCC---------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 110 112235678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.21 Aligned_cols=249 Identities=23% Similarity=0.264 Sum_probs=195.0
Q ss_pred cceecccCeeEEEEEEeC-C-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-N-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||+|... + +..||+|.+..........+.+|++++++++|||||++++++..++..++||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 347999999999999854 3 57788887765555555678889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 152 L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~- 226 (478)
T PTZ00267 152 LNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD- 226 (478)
T ss_pred HHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc-
Confidence 999886432 123468999999999999999999999 899999999999999999999999999998654221100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 227 -------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~ 286 (478)
T PTZ00267 227 -------------VASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG 286 (478)
T ss_pred -------------cccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC
Confidence 0123457999999998665 6788999999999999999999999864221 1122211111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. .+. .......+.+++.+||+.||++||++.+++.
T Consensus 287 ~~--~~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 287 KY--DPF-------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CC--CCC-------------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00 000 0112345789999999999999999999874
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.89 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=198.6
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... ....+++|.+.... .....++.+|+.++++++||||+++++.+..++..++|+||+
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence 47999999999999853 23568888887553 334467899999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC
Q 005226 486 SNGNLANALRGRNG-------------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN 546 (707)
Q Consensus 486 ~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~ 546 (707)
++|+|.+++..... .....+++..++.++.|++.||+|||+ .+|+||||||+||++++
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~~ 162 (290)
T cd05045 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAE 162 (290)
T ss_pred CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEcC
Confidence 99999999865321 112458999999999999999999999 89999999999999999
Q ss_pred CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CC
Q 005226 547 DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GK 625 (707)
Q Consensus 547 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~ 625 (707)
++.+||+|||+++......... ......++..|+|||+... ..++.++||||||+++|||+| |+
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSYV--------------KRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred CCcEEeccccccccccCccchh--------------cccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCC
Confidence 9999999999987653222110 0011233668999998654 678899999999999999999 99
Q ss_pred CCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 626 SPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 626 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.||.... ...+.++.........+ ......+.+++.+|++.+|++||+++++++.|+++
T Consensus 228 ~p~~~~~------~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 228 NPYPGIA------PERLFNLLKTGYRMERP---------------ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred CCCCCCC------HHHHHHHHhCCCCCCCC---------------CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 9985432 22333333322211110 11234678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.65 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=191.3
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+||+|+||.||++... ++..||+|++... .......+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999864 7899999998754 22344678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 151 (328)
T cd05593 82 LFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-- 151 (328)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--
Confidence 999997543 58999999999999999999999 89999999999999999999999999998753211100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+ ..
T Consensus 152 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~---~~ 207 (328)
T cd05593 152 --------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFE---LI 207 (328)
T ss_pred --------------cccccCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHH---Hh
Confidence 012357899999999764 6778999999999999999999999964321 11111 11
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
......+. .....++.+++.+|+..||++|| ++.++++
T Consensus 208 ~~~~~~~p-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 208 LMEDIKFP-------------RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ccCCccCC-------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 11111100 11224567899999999999997 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.35 Aligned_cols=238 Identities=20% Similarity=0.274 Sum_probs=190.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 458999999999999975 68899999986542 22346788999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 103 GELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred ChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 99999997643 58899999999999999999999 899999999999999999999999999997653211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus 173 -----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~ 228 (329)
T PTZ00263 173 -----------------FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKIL 228 (329)
T ss_pred -----------------ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHh
Confidence 12346889999999765 6678999999999999999999999964321 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVS 699 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~ 699 (707)
. ....+... ....+.+++.+||+.||.+||+ +++++
T Consensus 229 ~---~~~~~p~~-------------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 229 A---GRLKFPNW-------------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred c---CCcCCCCC-------------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 1 11111111 1234678999999999999997 56665
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=318.60 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=196.0
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... .+..||+|++.... .....+|.+|+.++++++||||+++++++..+...++||||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~ 90 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 90 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence 457999999999999753 34679999986543 23446789999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 485 ISNGNLANALRGRNGQ-----PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+++|+|.++++..... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~ 167 (277)
T cd05062 91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCcc
Confidence 9999999999754311 12357899999999999999999999 899999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
......... ......++..|+|||++.. ..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----- 227 (277)
T cd05062 168 DIYETDYYR--------------KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----- 227 (277)
T ss_pred ccCCcceee--------------cCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 554221100 0112234678999999664 668899999999999999999 6888864321
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
....+.+....... ........+.+++.+|++.||++||++.++++.|++
T Consensus 228 -~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 -EQVLRFVMEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 12222221110000 001223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=314.13 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=193.8
Q ss_pred eecccCeeEEEEEEeC---CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|.+. ++..||+|++..... ...+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999763 456799999876533 33467999999999999999999999885 457899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+.+++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++..........
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 999997543 358999999999999999999999 8999999999999999999999999999875542221110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......++..|+|||.+.. ..++.++|||||||++||+++ |+.||..... .+....+..
T Consensus 154 -------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~ 213 (257)
T cd05115 154 -------------ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSFIEQ 213 (257)
T ss_pred -------------ccCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHC
Confidence 0011223568999998654 567889999999999999996 9999865322 122222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+... ......++.+++.+||..||++||++.+|.+.|+.+
T Consensus 214 ~~~~~~---------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDC---------------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 211110 112245677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.97 Aligned_cols=239 Identities=22% Similarity=0.326 Sum_probs=188.4
Q ss_pred eecccCeeEEEEEEeCC-------------CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceE
Q 005226 414 VLGKSGLGIVYKVVLGN-------------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 480 (707)
.||+|+||.||+|.... ...|++|.+..........|..|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 23588998876655555678899999999999999999999999999999
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC-------eEEe
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ-------PYIS 553 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~-------~kl~ 553 (707)
||||+++|+|..+++... ..+++..+++++.||+.||+|||+ ++|+||||||+|||++.++. +|++
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999987543 258999999999999999999999 89999999999999987664 8999
Q ss_pred cccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCC
Q 005226 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELL-TGKSPELSPT 632 (707)
Q Consensus 554 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ell-tg~~P~~~~~ 632 (707)
|||++...... ....++..|+|||.+..+..++.++|||||||++|||+ +|+.|+....
T Consensus 155 d~g~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 155 DPGIPITVLSR--------------------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCCCccccCc--------------------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99988654311 12235778999998765577889999999999999998 5888875422
Q ss_pred CCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
.. ... ... ..... . .......+.+++.+||+.||++||++.+|++.+
T Consensus 215 ~~------~~~-~~~---~~~~~---~----------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 215 LA------EKE-RFY---EGQCM---L----------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hh------HHH-HHH---hcCcc---C----------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11 111 110 00000 0 011234578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=303.70 Aligned_cols=262 Identities=23% Similarity=0.245 Sum_probs=196.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh--hHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ--RHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.|++|+||.||+|+.. +++.||+|+++..... -.-.-.+||.+|.+.+|||||.+-.+.... +..|+|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 47999999999999954 7889999999876432 123457899999999999999998887654 578999999977
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
+|...+..-. +++...++.-+..|+++|++|||. ..|+|||||++|+|+...|.+||+|||+|+.+.....
T Consensus 162 -DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 162 -DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred -hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 9999998653 479999999999999999999999 8999999999999999999999999999998764321
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
+-+..+-|.+|+|||.+.+...|++..|+||+||++.||+++++-|.+..+... ...+.....
T Consensus 233 ---------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~llG 295 (419)
T KOG0663|consen 233 ---------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFKLLG 295 (419)
T ss_pred ---------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHHHhC
Confidence 113455699999999999989999999999999999999999998876443211 001111100
Q ss_pred hhccccCC---Cchhc---------hHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENP---LSDMV---------DAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~---~~~~~---------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.--+..|+ ....+ -..+..........+.-.+|+...+..||++|-|+++.++
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000110 00000 0111111111112355678999999999999999999874
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=320.42 Aligned_cols=258 Identities=21% Similarity=0.257 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++||||+++++++..++..++||||++ |+|
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDL 89 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCH
Confidence 47999999999999865 688999999865422 223567899999999999999999999999999999999997 599
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~-- 160 (288)
T cd07871 90 KQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-- 160 (288)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc--
Confidence 99987543 257899999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.+...++.++||||+||++|||+||+.||...... +....+....
T Consensus 161 --------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~ 220 (288)
T cd07871 161 --------------SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK------EELHLIFRLL 220 (288)
T ss_pred --------------cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHh
Confidence 12346889999998776567889999999999999999999999654321 1111111111
Q ss_pred cc----cCC-------CchhchHHHHhh---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EE----ENP-------LSDMVDAMLLQE---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~----~~~-------~~~~~d~~l~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. .++ +.....+..... ........++.+++.+|+..||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 000 000000000000 000112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=314.32 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=194.0
Q ss_pred eecccCeeEEEEEEe---CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|.+ .++..+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 367889999986543 233468899999999999999999999885 45779999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999997543 58999999999999999999999 899999999999999999999999999998664322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||..... ..+.+.+.
T Consensus 153 ~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~i~ 212 (257)
T cd05116 153 K-------------AKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQMIE 212 (257)
T ss_pred e-------------ecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 0 0011223578999998654 667889999999999999998 9999865322 22333332
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....... .......+.+++.+||+.||++||++.+|++.|++.
T Consensus 213 ~~~~~~~---------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGERMEC---------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCC---------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2111110 012234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=313.93 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=204.4
Q ss_pred ccchHHHHHhccceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC
Q 005226 401 TFELDELLRASAYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD 476 (707)
Q Consensus 401 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 476 (707)
+|++.+ .||+|.||.|-+|.. ..|+.||||.+++.. .++.-.+.+||++|..|+||||++++.+|.+.+
T Consensus 54 RyE~~e-------tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 54 RYEITE-------TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred HHHHHH-------HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 455555 799999999999984 689999999998763 334456789999999999999999999999999
Q ss_pred cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 477 EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
...+||||..+|.|++++..++ .+++.++.++++||..|+.|+|. ++++|||||.+|||+|.++++||+|||
T Consensus 127 KIvivMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccc
Confidence 9999999999999999998765 69999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
++-++....-. .+..|.+-|.+||++.+..+-.+..|-||+||+||.|+.|.-||++.+
T Consensus 199 LSNly~~~kfL-----------------qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---- 257 (668)
T KOG0611|consen 199 LSNLYADKKFL-----------------QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---- 257 (668)
T ss_pred hhhhhccccHH-----------------HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----
Confidence 99877643322 234568889999997775666789999999999999999999997642
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+++.+..+. ..+.+......-||..|+..+|++|-|+.+|..
T Consensus 258 --hk~lvrQIs~Ga-----------------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 258 --HKRLVRQISRGA-----------------YREPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred --HHHHHHHhhccc-----------------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 224444443322 122333445667889999999999999999865
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.75 Aligned_cols=240 Identities=23% Similarity=0.345 Sum_probs=187.7
Q ss_pred eecccCeeEEEEEEeCC-------------------------CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeee
Q 005226 414 VLGKSGLGIVYKVVLGN-------------------------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 468 (707)
.||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 24588998876544445678899999999999999999
Q ss_pred EEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 469 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
+++|.++...++||||+++|+|..++.... ..+++..+.+++.||++||+|||+ ++|+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccC
Confidence 999999999999999999999999997543 258899999999999999999999 8999999999999997643
Q ss_pred -------CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHH
Q 005226 549 -------QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621 (707)
Q Consensus 549 -------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~el 621 (707)
.+|++|||++...... ....++..|+|||.+.....++.++||||||+++|||
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~--------------------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR--------------------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cccCccceeeecCCccccccccc--------------------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 3899999987543211 1123467899999876556778999999999999999
Q ss_pred H-hCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 622 L-TGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 622 l-tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+ +|+.||...... ....+... ..... ......+.+++.+||+.+|++||+|.+|++
T Consensus 215 ~~~g~~p~~~~~~~------~~~~~~~~----~~~~~-------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~ 271 (274)
T cd05076 215 CFDGEVPLKERTPS------EKERFYEK----KHRLP-------------EPSCKELATLISQCLTYEPTQRPSFRTILR 271 (274)
T ss_pred HhCCCCCccccChH------HHHHHHHh----ccCCC-------------CCCChHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5 789988653221 11111111 10000 111235789999999999999999999999
Q ss_pred HHH
Q 005226 701 NLE 703 (707)
Q Consensus 701 ~L~ 703 (707)
.|+
T Consensus 272 ~L~ 274 (274)
T cd05076 272 DLT 274 (274)
T ss_pred hhC
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.77 Aligned_cols=258 Identities=23% Similarity=0.348 Sum_probs=198.6
Q ss_pred ccceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 482 (707)
..+.||+|+||.||+|.+. .+..||+|+++... ......+.+|++++.++. ||||++++++|...+..++|+
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 3568999999999999853 34679999997653 233457889999999996 999999999999999999999
Q ss_pred EeecCCChHHHHhCCCC---------------------------------------------------------------
Q 005226 483 DFISNGNLANALRGRNG--------------------------------------------------------------- 499 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~--------------------------------------------------------------- 499 (707)
||+++|+|.++++..+.
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC
Q 005226 500 ------------------------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549 (707)
Q Consensus 500 ------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~ 549 (707)
.....++|..+++++.|++.||+|||+ ++|+||||||+||++++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCE
Confidence 011357889999999999999999999 89999999999999999999
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPE 628 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~ 628 (707)
+||+|||+++.......... .....++..|+|||.+.. ..++.++|||||||++|||++ |+.||
T Consensus 278 ~kL~DfGla~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 278 VKICDFGLARDIMRDSNYIS--------------KGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred EEEEecCcceeccccccccc--------------CCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999999986532211100 011234778999998765 567899999999999999998 88898
Q ss_pred CCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
...... ..+...+....+... ......++.+++.+||..+|++||++++|++.|+.+-
T Consensus 343 ~~~~~~-----~~~~~~~~~~~~~~~---------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 343 PELPMN-----EQFYNAIKRGYRMAK---------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCch-----HHHHHHHHcCCCCCC---------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 643211 111111111111100 0112356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.52 Aligned_cols=258 Identities=28% Similarity=0.434 Sum_probs=199.6
Q ss_pred hccceecccCeeEEEEEEe--------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcce
Q 005226 410 ASAYVLGKSGLGIVYKVVL--------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKL 479 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 479 (707)
.....||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (304)
T cd05101 18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 97 (304)
T ss_pred eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence 3456899999999999974 134579999987542 33457789999999999 8999999999999999999
Q ss_pred EEEEeecCCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 480 LISDFISNGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
+||||+++|+|.+++...... +...++|.++..++.||+.||+|||+ ++|+||||||+||++++++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENN 174 (304)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCC
Confidence 999999999999999764321 12458999999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P 627 (707)
.+||+|||+++.......... .....++..|+|||++.. ..++.++||||||+++|||++ |..|
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKK--------------TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred cEEECCCccceeccccccccc--------------ccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999986643221110 011234668999998765 668899999999999999998 7778
Q ss_pred CCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
|.... ...+.+.+........ .......+.+++.+||+.+|.+||+|.+|++.|+++.
T Consensus 240 ~~~~~------~~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 240 YPGIP------VEELFKLLKEGHRMDK---------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred cccCC------HHHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 75321 1122222221111000 1123356788999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.38 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=190.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 47999999999999965 68899999986432 223456889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 87 ELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 9999997643 58999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|++.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+..
T Consensus 156 ----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~ 212 (291)
T cd05612 156 ----------------WTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILA 212 (291)
T ss_pred ----------------ccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 12346889999998664 6678999999999999999999999965321 112221111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
....+. ......+.+++.+|++.||.+||+ ++++++
T Consensus 213 ---~~~~~~-------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 213 ---GKLEFP-------------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---CCcCCC-------------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 111100 111235679999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=326.28 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=196.1
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC-CcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP-DEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV~ 482 (707)
.++||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.++ +|+||++++++|... ...++|+
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ 91 (337)
T cd05054 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (337)
T ss_pred hcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEE
Confidence 358999999999999642 34789999987543 33346788899999999 899999999988765 4578999
Q ss_pred EeecCCChHHHHhCCCCC--------------------------------------------------------CCCCCC
Q 005226 483 DFISNGNLANALRGRNGQ--------------------------------------------------------PSTSLS 506 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~l~ 506 (707)
||+++|+|.+++...... ....++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 999999999999653210 013689
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccc
Q 005226 507 WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586 (707)
Q Consensus 507 ~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (707)
|..+.+++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+....... ....
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~--------------~~~~ 234 (337)
T cd05054 172 LEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------------RKGD 234 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh--------------hccC
Confidence 99999999999999999999 899999999999999999999999999998654221110 0012
Q ss_pred cccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHH
Q 005226 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLL 665 (707)
Q Consensus 587 ~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 665 (707)
..++..|+|||++.. ..++.++|||||||++|||++ |+.||...... ..+...........
T Consensus 235 ~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~------------ 296 (337)
T cd05054 235 ARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----EEFCRRLKEGTRMR------------ 296 (337)
T ss_pred CCCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----HHHHHHHhccCCCC------------
Confidence 334678999998765 678899999999999999998 99998653221 11222221111100
Q ss_pred hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 666 QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 666 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.......++.+++.+||+.+|++||++.+|++.|+++
T Consensus 297 ---~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 297 ---APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred ---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112235678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=318.13 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred cceecccCeeEEEEEEeCC-----CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLGN-----GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~ 484 (707)
.++||+|+||.||+|...+ +..|++|++... .......+.+|+.++++++||||+++++++.. +...++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 4589999999999999765 788999998755 33445778999999999999999999999876 4678999999
Q ss_pred ecCCChHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 485 ISNGNLANALRGRNGQ---PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999999754311 12468999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVP 640 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 640 (707)
........ .....++..|+|||++.. ..++.++||||||+++||+++ |+.||..... .
T Consensus 168 ~~~~~~~~--------------~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~ 226 (280)
T cd05043 168 FPMDYHCL--------------GDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------F 226 (280)
T ss_pred cCCceEEe--------------CCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------H
Confidence 42211100 011234677999998754 668899999999999999999 9999865322 2
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
++..++......... ......+.+++.+||..||++||++.+|++.|+.+.
T Consensus 227 ~~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 227 EMAAYLKDGYRLAQP---------------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred HHHHHHHcCCCCCCC---------------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 344444332221111 112245789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.23 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=194.5
Q ss_pred eecccCeeEEEEEEeCC-Cc--eEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLGN-GI--PVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|...+ +. .+++|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999753 33 57888887543 33446789999999999 8999999999999999999999999999
Q ss_pred ChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 489 NLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 489 sL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
+|.++++.... .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 99999975431 112358999999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTS 636 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~ 636 (707)
++...... .......+..|+|||+... ..++.++|||||||++|||++ |..||.....
T Consensus 159 ~~~~~~~~-----------------~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--- 217 (270)
T cd05047 159 SRGQEVYV-----------------KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 217 (270)
T ss_pred ccccchhh-----------------hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCH---
Confidence 85322100 0011122567999998654 678899999999999999997 9999864321
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.+..+.+........ .......+.+++.+||+.||.+||++.++++.|+++-
T Consensus 218 ---~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 218 ---AELYEKLPQGYRLEK---------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---HHHHHHHhCCCCCCC---------------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 122222221111110 0112245789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=317.10 Aligned_cols=250 Identities=25% Similarity=0.392 Sum_probs=193.0
Q ss_pred ceecccCeeEEEEEEeC-CCc----eEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGI----PVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||+||+|.+. ++. .+++|.+.... .....++..|+.++++++||||+++++++. ....++++||++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~ 91 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSP 91 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCC
Confidence 57999999999999863 343 47788876442 233467888999999999999999999875 456789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++... ..++|..+..|+.||+.||+|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 92 ~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 92 LGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 999999997643 258999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....++..|+|||++.. ..++.++||||||+++||+++ |+.||..... ....+.
T Consensus 165 ~~~--------------~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~ 223 (279)
T cd05111 165 KYF--------------YSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------HEVPDL 223 (279)
T ss_pred ccc--------------cCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 100 012335678999998765 668899999999999999998 9999865322 122233
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........+ ......+.+++.+||..||++||++.|+++.|+.+.
T Consensus 224 ~~~~~~~~~~---------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 224 LEKGERLAQP---------------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHCCCcCCCC---------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2221111100 012235678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=330.72 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=187.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||+++++++..++..++||||+++|+|
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 47999999999999964 68999999986543 23346789999999999999999999999999999999999999998
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+.. ...+..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 160 ~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~-- 225 (353)
T PLN00034 160 EGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC-- 225 (353)
T ss_pred cccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc--
Confidence 6432 35677888999999999999999 899999999999999999999999999998654221100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....||..|+|||++.. +...+.++|||||||++|||++|+.||...... ++....
T Consensus 226 --------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~ 285 (353)
T PLN00034 226 --------------NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLM 285 (353)
T ss_pred --------------cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHH
Confidence 22357899999998642 234456899999999999999999999732211 111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
......... ........++.+++.+||+.||++||++.|+++.
T Consensus 286 ~~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 286 CAICMSQPP------------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHhccCCC------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111000000 0011223457899999999999999999999863
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=313.15 Aligned_cols=249 Identities=27% Similarity=0.456 Sum_probs=195.3
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
...||+|+||.||+|...++..||+|++...... .+.|.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCccC-HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 3479999999999999877778999998764333 367899999999999999999999874 45689999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++.........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~--- 159 (262)
T cd05071 89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--- 159 (262)
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc---
Confidence 9997543 2357999999999999999999999 899999999999999999999999999997664322110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||+... ..++.++||||||+++|||+| |+.||...... ..........
T Consensus 160 ------------~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~ 220 (262)
T cd05071 160 ------------RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY 220 (262)
T ss_pred ------------ccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC
Confidence 012234678999998654 668899999999999999999 78787543211 1111111110
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
. .+ ...+....+.+++.+|++.||++||++.++.+.|++.
T Consensus 221 ~--~~-------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 R--MP-------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C--CC-------------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 00 0123345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.29 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=191.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+++..++||||++ ++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL 89 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence 47999999999999975 788999999875432 223467889999999999999999999999999999999995 688
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 160 (303)
T cd07869 90 CQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-- 160 (303)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC--
Confidence 88887543 358899999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||...... ....+.+....
T Consensus 161 --------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~ 221 (303)
T cd07869 161 --------------SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-----QDQLERIFLVL 221 (303)
T ss_pred --------------CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHHh
Confidence 12345889999998766566789999999999999999999999753211 11111111100
Q ss_pred ccc----CC------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEE----NP------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~----~~------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ++ +.......+............+.+++.+|++.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 222 GTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000 00 000000000000000011245779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=315.68 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=190.9
Q ss_pred eecccCeeEEEEEEeCC---CceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGN---GIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|...+ +..+++|.++.... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 45789998876532 334578899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++..........++..+.+++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 9999976543223457888899999999999999999 8999999999999999999999999999865432111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG------NRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 642 (707)
+.......++..|+|||++... ..++.++||||||+++|||++ |+.||...... ..
T Consensus 156 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~------~~ 218 (269)
T cd05087 156 -----------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE------QV 218 (269)
T ss_pred -----------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH------HH
Confidence 0011223457789999986431 235789999999999999996 99999653221 11
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
......... ....++.+. ......+.+++..|| .+|++|||+.+|++.|+
T Consensus 219 ~~~~~~~~~-----~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYTVREQQ-----LKLPKPRLK-----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHhhccc-----CCCCCCccC-----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111000 011111110 112234677889999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.00 Aligned_cols=261 Identities=18% Similarity=0.216 Sum_probs=191.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 47999999999999975 67889999987542 2234678899999999999999999999999999999999999877
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 157 (287)
T cd07848 87 LELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN- 157 (287)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc-
Confidence 76554432 258999999999999999999999 899999999999999999999999999998654221110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH------
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV------ 643 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~------ 643 (707)
.....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 158 --------------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 220 (287)
T cd07848 158 --------------YTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPL 220 (287)
T ss_pred --------------ccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCC
Confidence 012356889999999765 567899999999999999999999997533210 000000
Q ss_pred --HHHHhhccccCCCchhchHHHHh-----hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 --RWVKKGFEEENPLSDMVDAMLLQ-----EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 --~~~~~~~~~~~~~~~~~d~~l~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+........ .......+.... ..........+.+++.+|++.||++|||++++++
T Consensus 221 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 221 PAEQMKLFYSNP-RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHhhhccc-hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 000000000000 0000112356899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=314.99 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=194.1
Q ss_pred cceecccCeeEEEEEEeCCC---ceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceE
Q 005226 412 AYVLGKSGLGIVYKVVLGNG---IPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 480 (707)
.+.||+|+||.||+|...+. ..+|+|.++.. .....+.|.+|++++++++||||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 45799999999999997543 25899988654 234457889999999999999999999988542 24689
Q ss_pred EEEeecCCChHHHHhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 481 ISDFISNGNLANALRGRN-GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
|+||+++|+|.+++.... +.....+++.....++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCccc
Confidence 999999999999885332 1223458999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
.+....... ......++..|+|||+... ..++.++||||||+++|||++ |+.||.....
T Consensus 161 ~~~~~~~~~--------------~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 220 (272)
T cd05075 161 KIYNGDYYR--------------QGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----- 220 (272)
T ss_pred ccCccccee--------------cCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 664321100 0012234667999998654 678899999999999999999 7888864221
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+.+.+....... ........+.+++.+||+.||++||++.++++.|+++
T Consensus 221 -~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 221 -SEIYDYLRQGNRLK---------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -HHHHHHHHcCCCCC---------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12222222111000 0012234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=313.70 Aligned_cols=248 Identities=26% Similarity=0.467 Sum_probs=197.5
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||+|.+...... ..+|.+|+.++++++||||+++++++ ..+..++||||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCc-HHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHH
Confidence 3589999999999999889999999998765443 36789999999999999999999987 456789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++...........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~-- 160 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-- 160 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc--
Confidence 9997543 2368999999999999999999999 8999999999999999999999999999876542111000
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.. ..++.++||||||+++|||++ |+.||.... ............
T Consensus 161 -------------~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~ 220 (260)
T cd05067 161 -------------EGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPEVIQNLERGY 220 (260)
T ss_pred -------------cCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHHHcCC
Confidence 11234678999998654 667889999999999999999 999986432 122333322221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.... ......++.+++.+|+..+|++||+++++.+.|+.
T Consensus 221 ~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPR---------------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCC---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1110 01123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=317.44 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=196.3
Q ss_pred ceecccCeeEEEEEEe-----CCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|.. .++..|++|.+..... .....|.+|++++++++||||+++++++..++..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 4799999999999984 3567899999875433 334678999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 487 NGNLANALRGRNG------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 487 ~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
+|+|.+++..... .....+++.+.+.++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEecc
Confidence 9999999964321 112358999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTT 633 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~ 633 (707)
||+++......... ......++..|+|||++.. ..++.++||||||+++|||++ |..||.....
T Consensus 168 fg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 168 LGLSREIYSADYYR--------------VQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred ccccccccCCccee--------------cccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99997654221100 0012234677999998754 567899999999999999999 8889864321
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
....+.+....... .......++.+++.+||+.||++||++.+|.+.|..
T Consensus 233 ------~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ------QEVIEMVRKRQLLP---------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 12222222211100 001123457889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.52 Aligned_cols=265 Identities=25% Similarity=0.411 Sum_probs=196.4
Q ss_pred ceecccCeeEEEEEEe-----CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~ 485 (707)
+.||+|+||+||++.. .++..||+|++........+.|.+|++++++++||||+++++++... ...++|+||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 4799999999999974 35789999999877666567899999999999999999999987543 4578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..++|..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 90 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 162 (284)
T cd05081 90 PYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162 (284)
T ss_pred CCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence 9999999997543 258999999999999999999999 899999999999999999999999999998664321
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ......++..|+|||+... ..++.++|||||||++|||++|..|+...... +.+.
T Consensus 163 ~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~ 221 (284)
T cd05081 163 EYYK-------------VREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-------FMRM 221 (284)
T ss_pred ccee-------------ecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-------hhhh
Confidence 1100 0011223456999998754 66789999999999999999998776432211 0000
Q ss_pred HHhhccccCCCchhchHHHHhh---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQE---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+............+.+ .+... .........+.+++.+||+.+|++||||.+|++.|+.++
T Consensus 222 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 222 MGNDKQGQMIVYHLIE-LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cccccccccchHHHHH-HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 0000000000000000 00000 001122356889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.74 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=195.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-----CCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-----PDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~e~ 484 (707)
+.||+|++|.|..|.. .+|..||||++... ..-..++..+|+++|+.++|+||+.+.+.+.. -...|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 3699999999999985 47899999998743 44455788899999999999999999999866 2467999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
| +-+|.+.++... .++......+++|+++||.|+|+ .+|+||||||+|++++.+..+||+|||+|+.....
T Consensus 108 M-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred H-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeecccc
Confidence 9 559999998653 58999999999999999999999 89999999999999999999999999999987543
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ++ +....|.+|+|||++.....|+.+.||||.||++.||++|++-|.+.+..... +
T Consensus 179 -~~~~----~m---------TeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql------~ 238 (359)
T KOG0660|consen 179 -FEDG----FM---------TEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL------Q 238 (359)
T ss_pred -Cccc----ch---------hcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH------H
Confidence 1111 01 22345999999999988899999999999999999999999988764321100 0
Q ss_pred HHHhhccccC--CCchhc----hHHHHhhh---------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEEN--PLSDMV----DAMLLQEV---------HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~--~~~~~~----d~~l~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+........ .+..+- .+-+.... -........++|+.+|+..||.+|+|++|.++
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0001000000 000000 00000000 00122346789999999999999999999875
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.41 Aligned_cols=241 Identities=25% Similarity=0.301 Sum_probs=189.5
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 3699999999999985 357889999987532 12235678899999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... .+.+..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999997543 57888999999999999999999 89999999999999999999999999998754321
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..
T Consensus 154 ~~~~----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~-- 208 (323)
T cd05584 154 GTVT----------------HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KT-- 208 (323)
T ss_pred CCcc----------------cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HH--
Confidence 1100 12357899999999765 56788999999999999999999999643211 11
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
..........+. ......+.+++.+|++.||++|| ++.++++
T Consensus 209 -~~~~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 -IDKILKGKLNLP-------------PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -HHHHHcCCCCCC-------------CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111111111 11224567999999999999999 6777654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.80 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=197.2
Q ss_pred eecccCeeEEEEEEeC--C--CceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG--N--GIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... + +..+|+|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 6999999999999753 2 26899999876543 34478999999999999999999999875 45679999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 81 PLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred cHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999998643 58999999999999999999999 899999999999999999999999999998664322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.......++..|+|||.... ..++.++||||||+++|||++ |+.||.... ...+..++.
T Consensus 153 -------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~------~~~~~~~~~ 212 (257)
T cd05060 153 -------------RATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK------GAEVIAMLE 212 (257)
T ss_pred -------------ccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHH
Confidence 01112223567999998754 678899999999999999998 999986432 223444443
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....... .......+.+++.+||..+|++||++.++++.|+.+.
T Consensus 213 ~~~~~~~---------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLPR---------------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCCC---------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 3221111 0122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=314.50 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=197.8
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------ce
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------KL 479 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~ 479 (707)
.+.||+|+||.||+|.... +..||+|+++.. .......+.+|++.+++++||||+++++++...+. .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 3579999999999998642 367999998754 23344689999999999999999999999876554 68
Q ss_pred EEEEeecCCChHHHHhCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 480 LISDFISNGNLANALRGRNG-QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
+|+||+++|+|..++..... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccce
Confidence 99999999999999865421 223468999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~ 637 (707)
+.+....... ......++..|+|||++.. ..++.++||||||+++|||++ |..||.....
T Consensus 161 ~~~~~~~~~~--------------~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---- 221 (273)
T cd05035 161 KKIYSGDYYR--------------QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---- 221 (273)
T ss_pred eecccccccc--------------ccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----
Confidence 8664322110 0011223667999998654 677899999999999999999 8888854321
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....++........ ........+.+++.+||+.||.+||++.+|++.|+++
T Consensus 222 --~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 222 --HEIYDYLRHGNRLK---------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHHHHHHHcCCCCC---------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 22333332221111 0112345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.65 Aligned_cols=194 Identities=24% Similarity=0.384 Sum_probs=165.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++||||++++++|.+++..++||||+++|+
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCc
Confidence 347999999999999975 6788899987654 22334678999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... .+++.....++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||++........
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--- 159 (333)
T cd06650 90 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 159 (333)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc---
Confidence 999997543 588999999999999999999972 3799999999999999999999999999875532110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
....|+..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 160 ---------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 160 ---------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---------------ccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 12346889999999754 67889999999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=319.35 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=199.0
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +||||+++++++..++..++|||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 458999999999999863 2367999998754 233446788999999999 89999999999999999999999
Q ss_pred eecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEE
Q 005226 484 FISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYI 552 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl 552 (707)
|+++|+|.++++.... .....+++..+++++.|++.||+|||+ ++|+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEe
Confidence 9999999999975321 123468999999999999999999999 89999999999999999999999
Q ss_pred ecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 005226 553 SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSP 631 (707)
Q Consensus 553 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~ 631 (707)
+|||+++.+......... ....++..|+|||+... ..++.++|||||||++|||++ |..||...
T Consensus 174 ~Dfg~~~~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 174 ADFGLARDIHHIDYYRKT--------------TNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred Cccccccccccccceecc--------------CCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999866432211100 11223567999998654 677899999999999999998 88887542
Q ss_pred CCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.. ..+.+.......... .......+.+++.+||..||++|||++++++.|+.+-
T Consensus 239 ~~------~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 239 PV------EELFKLLKEGYRMEK---------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CH------HHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 21 122222221111000 1122346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.85 Aligned_cols=252 Identities=27% Similarity=0.511 Sum_probs=198.1
Q ss_pred cceecccCeeEEEEEEeC-CC---ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NG---IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... ++ ..+++|.+... .......+.+|++++++++||||+++.+++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 458999999999999964 23 36999998755 23345678999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+++|.+++.... ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 90 NGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999997543 258999999999999999999999 8999999999999999999999999999876543221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ......+..|+|||++.. ..++.++|||||||++|||++ |+.||..... ......
T Consensus 163 ~~~~-------------~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~ 222 (268)
T cd05063 163 GTYT-------------TSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKA 222 (268)
T ss_pred ccee-------------ccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHH
Confidence 1100 001122457999998765 667899999999999999998 9999864321 122222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 i~~~~~~~~---------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 INDGFRLPA---------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HhcCCCCCC---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 222111110 112235678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=292.51 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=201.6
Q ss_pred cchHHHHHhccceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE 477 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 477 (707)
+.+++. ..++.||+|-||.||.|+. +++..||+|++.+... +...++.+|+++-+.|+||||+++++|+.+...
T Consensus 19 ~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 19 WTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 444443 2356899999999999995 4788999999977632 334789999999999999999999999999999
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
.||++||.+.|+++..|.... ...+++.....++.|+|.||.|+|. ++||||||||+|+|++.++..||+|||-
T Consensus 97 iyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCc
Confidence 999999999999999999654 3468888899999999999999999 8999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
+...... . . ....||..|.+||...+ ...+..+|+|++|++.||++.|.+||......
T Consensus 171 sV~~p~~-k-R----------------~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--- 228 (281)
T KOG0580|consen 171 SVHAPSN-K-R----------------KTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--- 228 (281)
T ss_pred eeecCCC-C-c----------------eeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhH---
Confidence 8654311 1 1 33457999999999665 77889999999999999999999999764321
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+..+.++. .+..++ ......+.+++.+|+..+|.+|.+..||+.
T Consensus 229 ---etYkrI~k--------~~~~~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 229 ---ETYKRIRK--------VDLKFP--------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---HHHHHHHH--------ccccCC--------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 22222221 111111 223345789999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.22 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=200.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||||.+... .......|.+|++++++++||||+++++++...+..++|+||+++|
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 47999999999999954 7899999987542 2333467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 88 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 163 (267)
T cd08228 88 DLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred cHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence 99999864321 12358899999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ...+...+..
T Consensus 164 ----------------~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~ 222 (267)
T cd08228 164 ----------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQ 222 (267)
T ss_pred ----------------hcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhc
Confidence 12345788999998765 56788999999999999999999998643211 1122222211
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.. .+ .. ........+.+++.+||..+|++||++.+|++.++.++
T Consensus 223 ~~---~~--~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 223 CD---YP--PL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC---CC--CC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11 00 00 01223356789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.63 Aligned_cols=201 Identities=23% Similarity=0.342 Sum_probs=161.2
Q ss_pred cceecccCeeEEEEEEeC---CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~ 486 (707)
+..||+|+||+||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++... ...++|+||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999864 467899999875432 24577899999999999999999998653 45689999985
Q ss_pred CCChHHHHhCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE----cCCCCeEEeccccc
Q 005226 487 NGNLANALRGRNG----QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL----DNDFQPYISDFGLS 558 (707)
Q Consensus 487 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla 558 (707)
++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 589888764321 112358999999999999999999999 899999999999999 45678999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
+......... .......+|+.|+|||++.....++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPL-------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccc-------------cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 8654221100 01123456899999999776567889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=321.10 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=200.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|.||.||||.. ..++.||+|++.-. ...+..+..+|+.++..++++||.++||.+..+...+++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 3799999999999995 46889999999765 334567889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+.|+... .+++..+.-|++++..||.|||. .+.+|||||+.|||+..+|.+|++|||++-.+.......
T Consensus 99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-- 168 (467)
T KOG0201|consen 99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-- 168 (467)
T ss_pred hhhhccCC-----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--
Confidence 99998654 35777888899999999999999 899999999999999999999999999998776443222
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....||+.|||||++. +..|+.|+||||||++.+||.+|.+|+....+.... -.+
T Consensus 169 --------------~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------flI 223 (467)
T KOG0201|consen 169 --------------KTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------FLI 223 (467)
T ss_pred --------------ccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------Eec
Confidence 3456799999999987 578999999999999999999999999875542110 001
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... .+.+. ......+.+++..|+..||+.||+++++++.
T Consensus 224 pk~~------PP~L~-----~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 224 PKSA------PPRLD-----GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cCCC------CCccc-----cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1111 11121 1233457899999999999999999999863
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=325.29 Aligned_cols=244 Identities=20% Similarity=0.270 Sum_probs=188.3
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999964 6789999998754 223345678899998887 8999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~- 152 (329)
T cd05618 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT- 152 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-
Confidence 9999987543 58999999999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||........ .......++..
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~ 215 (329)
T cd05618 153 ---------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN-PDQNTEDYLFQ 215 (329)
T ss_pred ---------------cccccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCC-cccccHHHHHH
Confidence 122457899999999765 6778999999999999999999999964322111 01111222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
....... . ........+.+++.+|++.||++||++
T Consensus 216 ~i~~~~~--~----------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 216 VILEKQI--R----------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHhcCCC--C----------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1111110 0 011223457799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=315.21 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=189.2
Q ss_pred eecccCeeEEEEEEeCC---CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGN---GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|...+ ...+++|.+.... ......|.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568888776543 2334678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++...........++.....++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 9999987654333456788899999999999999999 899999999999999999999999999986543211100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVP------GNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~ 642 (707)
......++..|+|||+... ...++.++|||||||++|||++ |..||..... .+.
T Consensus 158 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~ 218 (269)
T cd05042 158 -------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD------EQV 218 (269)
T ss_pred -------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH------HHH
Confidence 0112234677999998532 2456789999999999999999 7778754321 111
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.......... ...++.+ .......+.+++..|| .||++||++++|++.|.
T Consensus 219 ~~~~~~~~~~-----~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVREQDI-----KLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhhccCc-----cCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111110 1111111 1122344567788898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.75 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=194.2
Q ss_pred cceecccCeeEEEEEEeCC-C--ceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN-G--IPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
..+||+|+||.||+|...+ + ..+++|.++.. .....+.|.+|+++++++ +||||+++++++...+..++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 3489999999999998753 3 34788888753 233446789999999999 79999999999999999999999999
Q ss_pred CCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 487 NGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 487 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
+|+|.++++..... ....+++..+..|+.|++.||+|||+ ++|+||||||+||++++++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCc
Confidence 99999999754311 12358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|++........ ......+..|+|||+... ..++.++|||||||++|||++ |+.||.....
T Consensus 164 g~~~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~- 224 (297)
T cd05089 164 GLSRGEEVYVK-----------------KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC- 224 (297)
T ss_pred CCCccccceec-----------------cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence 99864321100 011112457999998654 667899999999999999998 9999865322
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.++............ .......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 225 -----~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 225 -----AELYEKLPQGYRMEK---------------PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred -----HHHHHHHhcCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 122222211111100 011234578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=311.40 Aligned_cols=251 Identities=26% Similarity=0.416 Sum_probs=191.2
Q ss_pred eecccCeeEEEEEEeC----CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEeecC
Q 005226 414 VLGKSGLGIVYKVVLG----NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDFISN 487 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~ 487 (707)
.||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ++..++|+||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 6899999999999853 2457999998654 33445788999999999999999999998764 4567899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 82 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 82 GDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999997543 246788889999999999999999 89999999999999999999999999998765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS-PELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~-P~~~~~~~~~~~~~~~~~~~ 646 (707)
... ......++..|+|||+... ..++.++||||||+++|||++|+. ||... +...+...+
T Consensus 155 ~~~------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~ 215 (262)
T cd05058 155 SVH------------NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYL 215 (262)
T ss_pred eec------------ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHH
Confidence 000 0012234668999998654 678899999999999999999654 44321 122233332
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
........ .......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 216 ~~~~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 216 LQGRRLLQ---------------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred hcCCCCCC---------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22111000 011224578999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.26 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=197.7
Q ss_pred hccceecccCeeEEEEEEeC--------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcce
Q 005226 410 ASAYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKL 479 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 479 (707)
...+.||+|+||.||++... +...+|+|.+.... .....++.+|+++++++ +||||+++++++..++..+
T Consensus 21 ~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 100 (307)
T cd05098 21 VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY 100 (307)
T ss_pred EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 34558999999999999752 23569999987642 33446788999999999 8999999999999999999
Q ss_pred EEEEeecCCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 480 LISDFISNGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
+||||+++|+|.+++...... ....++|.++++++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCC
Confidence 999999999999999765321 12458999999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P 627 (707)
.+||+|||.++........... ....++..|+|||++.. ..++.++|||||||++|||++ |+.|
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKKT--------------TNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred cEEECCCcccccccccchhhcc--------------ccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999998765421111000 11123467999998665 667899999999999999998 8888
Q ss_pred CCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
|.... ...+.+.+....... .......++.+++.+|++.+|++||+|.+|++.|+++
T Consensus 243 ~~~~~------~~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 243 YPGVP------VEELFKLLKEGHRMD---------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CCcCC------HHHHHHHHHcCCCCC---------------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 75321 112222221111100 0112235678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=315.63 Aligned_cols=254 Identities=24% Similarity=0.389 Sum_probs=198.6
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 458999999999999864 23689999987553 23346788999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 485 ISNGNLANALRGRNGQ-----PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+++|+|.+++...... ....++|..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccch
Confidence 9999999999754321 12347899999999999999999999 899999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
.......... .....++..|+|||.+.. ..++.++|||||||++||++| |+.||.....
T Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 227 (277)
T cd05032 168 DIYETDYYRK--------------GGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----- 227 (277)
T ss_pred hhccCccccc--------------CCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCH-----
Confidence 6543221100 012234678999998654 568899999999999999998 8888854221
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
....++......... .......+.+++.+||..+|++|||+.++++.|++
T Consensus 228 -~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 -EEVLKFVIDGGHLDL---------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -HHHHHHHhcCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 233333321111000 01124567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=316.41 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=190.9
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||+||++... +++.||+|.+..... ...+.+..|++++++++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999864 788999999865422 2235678899999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
..++.... .....+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 153 (280)
T cd05608 81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--- 153 (280)
T ss_pred HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc---
Confidence 99886432 123468999999999999999999999 89999999999999999999999999998765422111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..........
T Consensus 154 -------------~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~ 214 (280)
T cd05608 154 -------------TKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-----ENKELKQRIL 214 (280)
T ss_pred -------------ccccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-----hHHHHHHhhc
Confidence 012356889999999765 677899999999999999999999997532210 0111111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
..... ........+.+++.+|++.||++|| +++++++
T Consensus 215 ~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 215 NDSVT-------------YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCC-------------CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11000 0112345678999999999999999 5666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=327.58 Aligned_cols=258 Identities=19% Similarity=0.233 Sum_probs=189.5
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++..+...++|+|++. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 34799999999999996 4678999997532 456789999999999999999999999999999999985 799
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+|+.........
T Consensus 170 ~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~-- 239 (391)
T PHA03212 170 YCYLAAKR-----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-- 239 (391)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc--
Confidence 99987543 58999999999999999999999 899999999999999999999999999997533211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc-cchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI-EVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.|+......... ........+...
T Consensus 240 -------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 240 -------------YYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred -------------cccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 012457999999999765 67889999999999999999999887643221100 001111111110
Q ss_pred ccc---cCCC--chhchHHH---Hhh-----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEE---ENPL--SDMVDAML---LQE-----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~---~~~~--~~~~d~~l---~~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ..+. ...++... ... ........++.+++.+|++.||++|||++|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000 00011100 000 000123457889999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=328.62 Aligned_cols=246 Identities=22% Similarity=0.253 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++..++..++||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 58899999987542 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~---- 154 (333)
T cd05600 87 DFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY---- 154 (333)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccccc----
Confidence 9999997543 58999999999999999999999 89999999999999999999999999998755321
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +....+..
T Consensus 155 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~ 212 (333)
T cd05600 155 ---------------ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN------ETWENLKY 212 (333)
T ss_pred ---------------cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHH------HHHHHHHh
Confidence 022356899999999765 57889999999999999999999999753221 11111111
Q ss_pred hcc-ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFE-EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
... ...+ ...++ ......++.+++.+|+..+|.+||+++++++.
T Consensus 213 ~~~~~~~~--~~~~~-------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 WKETLQRP--VYDDP-------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCC--CCCcc-------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 0000 00000 01223567889999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=324.42 Aligned_cols=244 Identities=20% Similarity=0.258 Sum_probs=188.8
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||++... ++..||+|+++... ....+.+.+|..++.++ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999964 68899999987542 22345688899999998 7999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~- 152 (329)
T cd05588 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT- 152 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc-
Confidence 9999987543 58999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||........ ......++...
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~~~~~~~~~ 215 (329)
T cd05588 153 ---------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN-PDQNTEDYLFQ 215 (329)
T ss_pred ---------------cccccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCccccccccc-ccccchHHHHH
Confidence 123457899999999765 6778999999999999999999999964322110 01111222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
....... . ........+.+++.+|++.||.+||++
T Consensus 216 ~~~~~~~--~----------~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 216 VILEKQI--R----------IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHcCCC--C----------CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 2211110 0 001123457899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=313.88 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=195.4
Q ss_pred ceecccCeeEEEEEEe-CCCc----eEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGI----PVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||+||+|.+ .++. .||+|.+... .....+++.+|+.+++.++||||+++++++.. ...++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCC
Confidence 4799999999999985 3444 4899998754 33344778999999999999999999999975 45789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++... ..+++..++.++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 92 ~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 92 YGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999997643 358999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ....++..|+|||.... ..++.++|||||||++|||++ |..||.... ...+..+
T Consensus 165 ~~~~--------------~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~ 223 (279)
T cd05109 165 EYHA--------------DGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP------AREIPDL 223 (279)
T ss_pred eeec--------------CCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHH
Confidence 1000 11223678999998754 668899999999999999998 888886432 1223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........ .......+.+++.+||..||++||++.++++.|++++
T Consensus 224 ~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 224 LEKGERLPQ---------------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred HHCCCcCCC---------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 332211110 0112345779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.52 Aligned_cols=250 Identities=29% Similarity=0.470 Sum_probs=199.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..|+||.+...... .+++.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccC-HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 3479999999999999888889999998765443 367899999999999999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+..++.+++.|++|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~---- 159 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT---- 159 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh----
Confidence 9998653 2358999999999999999999999 89999999999999999999999999998765421100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
......++..|+|||.+.. ..++.++||||||+++||++| |+.||.... .....+......
T Consensus 160 -----------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------~~~~~~~~~~~~ 221 (261)
T cd05034 160 -----------AREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMT------NREVLEQVERGY 221 (261)
T ss_pred -----------hhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC
Confidence 0011223567999998764 668899999999999999999 999985422 112223222222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....+ ......+.+++.+|+..+|++||+++++.+.|+.+
T Consensus 222 ~~~~~---------------~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 222 RMPRP---------------PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCC---------------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11111 11134678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=295.99 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=205.0
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~ 486 (707)
+.+|+|||+-||.+. ..++..+|+|++......+.+..++|++..++++|||++++++++..+. +.|+++.|..
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 379999999999998 6688999999998877666788999999999999999999999886543 4799999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
.|+|.+.+..... ....+++.+.++|+.+|++||++||+.. ++++||||||.|||+++++.+++.|||.+......-.
T Consensus 107 ~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~ 184 (302)
T KOG2345|consen 107 RGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE 184 (302)
T ss_pred cccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence 9999999976542 2346999999999999999999999944 3599999999999999999999999999876543211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
... .+....+......|..|+|||.+. .+...++++|||||||++|+|+.|..||...... +....
T Consensus 185 ~~~-------~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSla---- 252 (302)
T KOG2345|consen 185 GSR-------QALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSLA---- 252 (302)
T ss_pred chH-------HHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeEE----
Confidence 110 001111112234588999999864 3466789999999999999999999999754331 10000
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+....+.- .......+.+.+++..|+++||.+||++.+++..+..+
T Consensus 253 ------------LAv~n~q~s~-P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ------------LAVQNAQISI-PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------------Eeeecccccc-CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111110 11122567889999999999999999999999998765
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=324.97 Aligned_cols=247 Identities=25% Similarity=0.288 Sum_probs=190.9
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
+.||+|+||.||+++. .++..||+|++.... ....+.+.+|++++.++ +||||+++++++..++..++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 4799999999999875 367899999986532 22335678899999999 59999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 86 YVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999997543 58999999999999999999999 8999999999999999999999999999876432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
...... ....||..|+|||++.....++.++|||||||++|||+||+.||....... ....+.
T Consensus 158 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~ 220 (332)
T cd05614 158 EEKERT---------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVS 220 (332)
T ss_pred cCCCcc---------------ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHH
Confidence 211100 123579999999997654557889999999999999999999996533221 111111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
. ........+. ......+.+++.+|++.||++|| +++++++
T Consensus 221 ~---~~~~~~~~~~-------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 R---RILKCDPPFP-------------SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred H---HHhcCCCCCC-------------CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 1111111111 11224567899999999999999 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=316.15 Aligned_cols=240 Identities=20% Similarity=0.339 Sum_probs=188.2
Q ss_pred eecccCeeEEEEEEeCC--------CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGN--------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.||+|+||.||+|.... ...|++|.+........+.|..|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998632 2348888876655555578899999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC--------eEEecccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ--------PYISDFGL 557 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~DfGl 557 (707)
++|+|.++++... ..+++..+++++.||+.||+|||+ ++|+||||||+||+++.++. ++++|||+
T Consensus 82 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 82 KFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998653 258999999999999999999999 89999999999999988765 58999998
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK-SPELSPTTSTS 636 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~-~P~~~~~~~~~ 636 (707)
+...... ....++..|+|||++.....++.++||||||+++|||++|. .|+......
T Consensus 155 ~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-- 212 (258)
T cd05078 155 SITVLPK--------------------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-- 212 (258)
T ss_pred ccccCCc--------------------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH--
Confidence 7643211 22345778999999776556789999999999999999995 454322111
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...... .....+ ......++.+++.+||+.||++|||++++++.|+
T Consensus 213 ----~~~~~~----~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 ----KKLQFY----EDRHQL-------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----HHHHHH----HccccC-------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111100 101000 0112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.06 Aligned_cols=239 Identities=22% Similarity=0.268 Sum_probs=190.2
Q ss_pred cceecccCeeEEEEEEeCC--CceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN--GIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
...||+|+||.||+|...+ +..||+|++.... ......+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 3579999999999998543 3689999886432 2334678899999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 115 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~- 185 (340)
T PTZ00426 115 GGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT- 185 (340)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc-
Confidence 999999997643 58999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .....+
T Consensus 186 ------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i 240 (340)
T PTZ00426 186 ------------------YTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKI 240 (340)
T ss_pred ------------------ceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHH
Confidence 12356899999999764 66789999999999999999999999753211 111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.. ....+. ......+.+++.+|++.||++|+ +++++++
T Consensus 241 ~~---~~~~~p-------------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 241 LE---GIIYFP-------------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hc---CCCCCC-------------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11 111001 11123467899999999999995 7888764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.36 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=198.4
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
...||+|+||.||++.. .++..+++|.+..........|.+|++++++++|+||+++++++...+..++|+||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 34799999999999963 246689999988776666678999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 486 SNGNLANALRGRNG----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 486 ~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
++|+|.++++.... .....+++..++.++.|++.|++|||+ .+++||||||+||++++++.+||+||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECCC
Confidence 99999999976431 112358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+++......... ......++..|+|||.+.. ..++.++|||||||++|||++ |++||.....
T Consensus 167 g~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 230 (280)
T cd05092 167 GMSRDIYSTDYYR--------------VGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN- 230 (280)
T ss_pred CceeEcCCCceee--------------cCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-
Confidence 9987654211100 0011223678999998664 678899999999999999998 8999864322
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+............. .......+.+++.+||+.||++||++.+|.+.|++
T Consensus 231 -----~~~~~~~~~~~~~~~---------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 231 -----TEAIECITQGRELER---------------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----HHHHHHHHcCccCCC---------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 122222111111000 01123457899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=309.07 Aligned_cols=245 Identities=29% Similarity=0.498 Sum_probs=198.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 458999999999999874 78899999977654 4478999999999999999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----- 157 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----- 157 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-----
Confidence 9997653 2358999999999999999999999 8999999999999999999999999999986532111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....+..|+|||++.. ..++.++||||||+++||+++ |+.||..... .++...+....
T Consensus 158 --------------~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~ 216 (256)
T cd05039 158 --------------SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPHVEKGY 216 (256)
T ss_pred --------------cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHhcCC
Confidence 1122567999998764 667889999999999999997 9999864321 12222222211
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... .......+.+++.+|+..+|++||++.+++++|+.+
T Consensus 217 ~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 RMEA---------------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCC---------------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1100 012235678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.19 Aligned_cols=252 Identities=29% Similarity=0.466 Sum_probs=194.6
Q ss_pred cceecccCeeEEEEEEeC-CCc--eEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGI--PVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... ++. .+++|.+... .......|.+|++++.++ +||||+++++++..++..++|+||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 358999999999999864 443 4678877654 233446789999999999 89999999999999999999999999
Q ss_pred CCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 487 NGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 487 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
+|+|.++++.... .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCcc
Confidence 9999999975431 112358999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+++...... .......+..|+|||+... ..++.++|||||||++|||+| |..||.....
T Consensus 169 g~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~- 229 (303)
T cd05088 169 GLSRGQEVYV-----------------KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC- 229 (303)
T ss_pred ccCcccchhh-----------------hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCCh-
Confidence 9986322100 0011123567999998654 567899999999999999998 9999864322
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+..+.+........+ ......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 230 -----~~~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 230 -----AELYEKLPQGYRLEKP---------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -----HHHHHHHhcCCcCCCC---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1222222211111000 11224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.73 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=198.5
Q ss_pred ccceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
..+.||+|+||.||++.. ..+..||||+++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 39 ~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred EcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEE
Confidence 356899999999999974 234579999987653 33346789999999999 8999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+++|+|.++++.... ..+++.++..++.|++.||+|||+ ++|+|+||||+||+++.++.+|++|||+++...
T Consensus 119 e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 119 EYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 99999999999975431 248999999999999999999999 899999999999999999999999999987654
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchh
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~ 641 (707)
...... ......++..|+|||.+.. ..++.++|||||||++|||++ |+.||...... ..
T Consensus 193 ~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----~~ 252 (302)
T cd05055 193 NDSNYV--------------VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----SK 252 (302)
T ss_pred CCCcee--------------ecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----HH
Confidence 221100 0011234678999998665 567899999999999999998 99998653321 12
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+.+.......... .......+.+++.+|+..+|++||++.+|++.|+++
T Consensus 253 ~~~~~~~~~~~~~---------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 253 FYKLIKEGYRMAQ---------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2222222111110 011234678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.23 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=195.7
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... ++..||+|+++..... ..+.|.+|+.++++++||||+++++++...+..++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 36999999999999853 3578999999765432 3467889999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 486 SNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 486 ~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
++++|.+++..... .....+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEecc
Confidence 99999999964321 112358999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTT 633 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~ 633 (707)
||+++.......... . ....+++.|+|||.+.. ..++.++||||||+++|||++ |..||.....
T Consensus 168 fg~~~~~~~~~~~~~-~-------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 168 LGLFREVYAADYYKL-M-------------GNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred cccccccccchheee-c-------------cCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999886542211000 0 11224678999998764 567899999999999999998 7778754221
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+..+.+....... ........+.+++..||+.+|++||++++|++.|+.
T Consensus 233 ------~~~~~~i~~~~~~~---------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ------QDVIEMIRNRQVLP---------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHHHHHHcCCcCC---------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 12222222211100 011233457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.01 Aligned_cols=254 Identities=27% Similarity=0.512 Sum_probs=199.2
Q ss_pred cceecccCeeEEEEEEeCC-C---ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN-G---IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|.... + ..||||.+... ......+|..|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 4589999999999999643 3 36999998765 33445789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 89 NGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred CCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999997643 258999999999999999999999 8999999999999999999999999999876543221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... +..+.....+..|+|||++.. ..++.++|||||||++||+++ |..||.... ..+...+
T Consensus 162 ~~~-----------~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~------~~~~~~~ 223 (269)
T cd05065 162 DPT-----------YTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMS------NQDVINA 223 (269)
T ss_pred ccc-----------cccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCC------HHHHHHH
Confidence 111 000011112457999999654 677899999999999999887 999986432 1233444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ ..+....+.+++.+||..+|.+||++.+|++.|+.+
T Consensus 224 i~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 224 IEQDYRLPP---------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHcCCcCCC---------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 432211111 012234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.02 Aligned_cols=266 Identities=26% Similarity=0.356 Sum_probs=196.4
Q ss_pred ceecccCeeEEEEEEe-----CCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--cceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--EKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~ 484 (707)
+.||+|+||+||++.. .++..||+|.+..... .....|.+|++++++++||||+++++++...+ ..++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 4799999999988653 3678899999876432 33467889999999999999999999987643 57899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 90 VPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred CCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 9999999999753 48999999999999999999999 89999999999999999999999999998865432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......++..|+|||.... ..++.++||||||+++|||+||+.|+....... .++..
T Consensus 161 ~~~~~-------------~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~----~~~~~ 222 (283)
T cd05080 161 HEYYR-------------VREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF----EEMIG 222 (283)
T ss_pred chhhc-------------cCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh----hhhhc
Confidence 11000 0011234667999998654 667899999999999999999999986533210 01110
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
+...... ...+.+.++..... .........+.+++.+||+.||++||++++|++.|+++.+
T Consensus 223 ~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 223 PKQGQMT-VVRLIELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred ccccccc-hhhhhhhhhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 0000000 00001111110000 0011234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.72 Aligned_cols=246 Identities=22% Similarity=0.292 Sum_probs=190.7
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||.||++... +|+.+|+|++..... .....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999864 689999999864321 1234566799999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---- 150 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---- 150 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----
Confidence 99986543 2358999999999999999999999 8999999999999999999999999999876542111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+......
T Consensus 151 -------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-----~~~~~~~~~~ 211 (277)
T cd05607 151 -------------ITQRAGTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-----AKEELKRRTL 211 (277)
T ss_pred -------------eeccCCCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-----hHHHHHHHhh
Confidence 012346889999999765 558899999999999999999999986532210 1111111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..... . .......++.+++.+|++.||++||+++|+++.
T Consensus 212 ~~~~~---~---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 212 EDEVK---F---------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccccc---c---------ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 11100 0 001123457899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.83 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=212.3
Q ss_pred ecCCcccchHHHHHhccceecccCeeEEEEEEeC---C--CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeE
Q 005226 396 IDKGFTFELDELLRASAYVLGKSGLGIVYKVVLG---N--GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLR 469 (707)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 469 (707)
...+..|++..-.....++||.|.||.||+|.+- . ...||||..+.. .....+.|.+|..+|++++|||||+++
T Consensus 378 ~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 378 TPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 3344556666655566779999999999999853 2 356889988774 444568899999999999999999999
Q ss_pred EEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC
Q 005226 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549 (707)
Q Consensus 470 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~ 549 (707)
|+|.+ ...++|||.++-|.|.++|+.++ ..++......++.||..||+|||+ ++.|||||.++|||+...-.
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~C 529 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQC 529 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcce
Confidence 99965 46799999999999999998765 368999999999999999999999 89999999999999999999
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPE 628 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~ 628 (707)
||++|||+++.+........ ....-+.-|||||.+.- ++++.++|||.|||++||++. |..||
T Consensus 530 VKLaDFGLSR~~ed~~yYka---------------S~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPf 593 (974)
T KOG4257|consen 530 VKLADFGLSRYLEDDAYYKA---------------SRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPF 593 (974)
T ss_pred eeecccchhhhccccchhhc---------------cccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcc
Confidence 99999999999875543322 22233678999998654 889999999999999999987 89999
Q ss_pred CCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....... ....+..+-+. .-.+.+...+..|+.+||+.||.+||.+.++...|+++.
T Consensus 594 qgvkNsD------VI~~iEnGeRl---------------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 594 QGVKNSD------VIGHIENGERL---------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ccccccc------eEEEecCCCCC---------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 8754431 11111111111 112345667789999999999999999999999998763
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=327.69 Aligned_cols=235 Identities=23% Similarity=0.336 Sum_probs=194.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
-.+||+|.||.|+++..+ +++.+|||++++.. ..+.+..+.|.+++.-. +||.+++++..|++.++.|.||||+.
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 358999999999999965 67899999998873 34557788898888877 69999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
||++..+.+.. .+++..+.-++..|+.||+|||+ ++||+||||.+|||+|.+|++||+|||+++.--..++
T Consensus 453 Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 453 GGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99966555533 59999999999999999999999 8999999999999999999999999999986432222
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. .+..||+.|+|||++.. ..|+..+|.|||||+||||+.|..||.+.++
T Consensus 524 ~T----------------sTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE------------- 573 (694)
T KOG0694|consen 524 RT----------------STFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDE------------- 573 (694)
T ss_pred cc----------------ccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------
Confidence 21 34567999999999775 8899999999999999999999999976433
Q ss_pred HhhccccCCCchhchHHHHhhh-hhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEV-HAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
.+++|..+..+. .......+.++++.+.+..+|++|--+
T Consensus 574 ----------ee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 ----------EEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----------HHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 233333332221 223445667899999999999999866
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.72 Aligned_cols=244 Identities=26% Similarity=0.445 Sum_probs=193.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||++.. .|..|++|.++.... .+.|.+|+.++++++|+|++++++++.. ++..++|+||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEE-cCCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 45899999999999987 477899998865432 3678999999999999999999998654 4568999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++++... ...+++..+++++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99998653 2358999999999999999999999 899999999999999999999999999987543211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||+... ..++.++||||||+++|||++ |+.||.... ...+..++...
T Consensus 157 --------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~ 215 (256)
T cd05082 157 --------------DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKG 215 (256)
T ss_pred --------------CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcC
Confidence 11123567999998654 678899999999999999998 999885321 12233333222
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 216 ~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 YKMDA---------------PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCC---------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11110 012234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.51 Aligned_cols=252 Identities=26% Similarity=0.491 Sum_probs=198.4
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++++++||||+++++++..++..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 458999999999999863 23479999987543 2334688999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++.++..|+.|++.||+|||+ ++++||||||+||+++.++.++++|||+++.+.....
T Consensus 89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 999999997643 258999999999999999999999 8999999999999999999999999999986643211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ......++..|+|||++.. ..++.++||||||+++||+++ |+.||..... .+...+
T Consensus 162 ~~~-------------~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~------~~~~~~ 221 (267)
T cd05066 162 AAY-------------TTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSN------QDVIKA 221 (267)
T ss_pred eee-------------ecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCH------HHHHHH
Confidence 100 0011122567999999764 668899999999999999887 9999864322 123333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....+... .......+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 222 ~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 IEEGYRLPA---------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HhCCCcCCC---------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 332221110 011234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.58 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=187.2
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||+||+|... ++..||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999965 67899999987532 23346678899998877 7999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~- 152 (320)
T cd05590 82 DLMFHIQKSR-----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT- 152 (320)
T ss_pred hHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-
Confidence 9999997543 58999999999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+..
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~ 210 (320)
T cd05590 153 ---------------TSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN 210 (320)
T ss_pred ---------------ccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc
Confidence 123457999999998764 6778999999999999999999999965321 122222211
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
....+. .....++.+++.+|++.||++||++
T Consensus 211 ---~~~~~~-------------~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 211 ---DEVVYP-------------TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---CCCCCC-------------CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111101 1122456789999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=309.80 Aligned_cols=248 Identities=24% Similarity=0.462 Sum_probs=197.8
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||++...++..+++|.+..... ..+.|.+|++++++++|+||+++++++.. ...++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChh-HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 347999999999999987888899998875433 34678999999999999999999999887 7789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+.........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 158 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT---- 158 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc----
Confidence 9997643 2358999999999999999999999 89999999999999999999999999998765321110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
......++..|+|||++.. ..++.++|||||||++||++| |+.||.... ...+..+.....
T Consensus 159 -----------~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~~ 220 (260)
T cd05073 159 -----------AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALERGY 220 (260)
T ss_pred -----------cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCC
Confidence 0112234677999999764 667889999999999999999 898986432 223333333222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.... ......++.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~~~~---------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPR---------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCC---------------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1110 01223467899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=320.61 Aligned_cols=237 Identities=22% Similarity=0.299 Sum_probs=185.5
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|... +++.||+|.++... ....+.+..|..++... +||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999964 67889999987542 22334566777777765 8999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~- 152 (316)
T cd05592 82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK- 152 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc-
Confidence 9999997543 58999999999999999999999 89999999999999999999999999998754321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+...+.
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i~- 209 (316)
T cd05592 153 ---------------ASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSIL- 209 (316)
T ss_pred ---------------cccccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-
Confidence 123457899999999764 6688999999999999999999999965321 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
.....+. ......+.+++.+||+.||.+||++.+
T Consensus 210 --~~~~~~~-------------~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 210 --NDRPHFP-------------RWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred --cCCCCCC-------------CCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 1111111 112234678999999999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=312.55 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEeCC------CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLGN------GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|...+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 479999999999999753 5789999887543 333467999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEeccccccc
Q 005226 486 SNGNLANALRGRNG--QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~ 560 (707)
++|+|.+++..... .....++|..+++++.||+.||+|||+ ++++||||||+||+++.++ .+||+|||+++.
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~ 168 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccccc
Confidence 99999999976532 122358999999999999999999999 8999999999999998764 599999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEV 639 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~ 639 (707)
.......... .....+..|+|||++.. ..++.++|||||||++|||++ |+.||......
T Consensus 169 ~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----- 228 (277)
T cd05036 169 IYRASYYRKG--------------GRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----- 228 (277)
T ss_pred cCCccceecC--------------CCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence 6322110000 01122467999999765 668999999999999999997 99998653221
Q ss_pred hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+.+.+........ .......+.+++.+|++.+|++||++.+|++.|++
T Consensus 229 -~~~~~~~~~~~~~~---------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 229 -EVMEFVTGGGRLDP---------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -HHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 12221111100000 11223467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.04 Aligned_cols=260 Identities=21% Similarity=0.328 Sum_probs=189.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~ 484 (707)
+.||+|+||.||+|... ++..||||++... .......+.+|++++++++||||+++++++.... ..++||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 47999999999999954 7899999998643 2233457889999999999999999999886542 46999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 86 ME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred CC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 95 69999987543 58999999999999999999999 89999999999999999999999999999754322
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
..... ......||..|+|||++.. ...++.++|||||||++|||+||+.||...... ...
T Consensus 157 ~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~------~~~ 217 (338)
T cd07859 157 TPTAI-------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV------HQL 217 (338)
T ss_pred cCccc-------------cccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH------HHH
Confidence 11100 0022457899999998653 256788999999999999999999999653221 111
Q ss_pred HHHHhhccccCC----------CchhchHHHHhhh-----hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENP----------LSDMVDAMLLQEV-----HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~----------~~~~~d~~l~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+......... ..+.++....... ........+.+++.+||+.||++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 218 DLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111111110000 0000000000000 00012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=325.11 Aligned_cols=241 Identities=24% Similarity=0.289 Sum_probs=190.3
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||++.. .++..||+|.+.... ......+..|++++++++||||+++++++..++..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 699999999999985 478999999987532 2234567889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..++.... .+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~- 153 (325)
T cd05594 82 LFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM- 153 (325)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc-
Confidence 999987543 589999999999999999999962 589999999999999999999999999987532111100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||..|+|||++.. ..++.++|||||||++|||+||+.||..... ....+.+.
T Consensus 154 ---------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i~-- 209 (325)
T cd05594 154 ---------------KTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL-- 209 (325)
T ss_pred ---------------ccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHHh--
Confidence 12347899999999754 6778999999999999999999999964321 11111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.....+. .....++.+++.+|++.||++|+ +++++++
T Consensus 210 -~~~~~~p-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 210 -MEEIRFP-------------RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -cCCCCCC-------------CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1111101 11224567899999999999996 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.43 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=189.1
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|... +++.||+|++.... ......+..|.+++..+ +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6999999999999965 57899999987542 23345677899999876 8999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 152 (321)
T cd05591 82 DLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT- 152 (321)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-
Confidence 9999997543 58999999999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~- 209 (321)
T cd05591 153 ---------------TTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESIL- 209 (321)
T ss_pred ---------------ccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHH-
Confidence 122357899999998654 6778999999999999999999999965321 12222211
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-------ChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-------RMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~~v~~ 700 (707)
........ ....++.+++.+|++.||++|| +++++++
T Consensus 210 --~~~~~~p~-------------~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 210 --HDDVLYPV-------------WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --cCCCCCCC-------------CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 11111001 1124567899999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.32 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=198.9
Q ss_pred hccceecccCeeEEEEEEeC--------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcce
Q 005226 410 ASAYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKL 479 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 479 (707)
.....||+|+||.||+|... .+..||+|.++... ....+++.+|+++++++ +||||++++++|..++..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 34568999999999999742 12468999887543 33457899999999999 8999999999999999999
Q ss_pred EEEEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 480 LISDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
+|+||+++|+|.+++..... .....++|.+++.++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCC
Confidence 99999999999999975431 123468999999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P 627 (707)
.+||+|||+++.......... .....++..|+|||++.. ..++.++||||||+++|||++ |..|
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKK--------------TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred cEEECCcccceeccccccccc--------------ccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999976542211100 011223567999998765 677889999999999999999 8888
Q ss_pred CCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
|.... ..++...+........ .......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 237 ~~~~~------~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 237 YPGIP------VEELFKLLKEGHRMDK---------------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCCCC------HHHHHHHHHcCCCCCC---------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 75422 1122222211111000 0122346789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=307.63 Aligned_cols=246 Identities=25% Similarity=0.430 Sum_probs=195.8
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+.||+|+||.||++...++..+|+|.+....... .+|.+|++++++++|||++++++++......++|+||+++|+|.+
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCCCH-HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 4799999999999998778899999987654333 678999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++..+..++.+++.|++|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~---- 157 (256)
T cd05112 89 YLRAQR----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS---- 157 (256)
T ss_pred HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc----
Confidence 997643 248899999999999999999999 899999999999999999999999999987553211000
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++.+|+|||++.. ..++.++||||||+++|||++ |+.||..... ..+.+.......
T Consensus 158 -----------~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~ 219 (256)
T cd05112 158 -----------STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGFR 219 (256)
T ss_pred -----------cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCCC
Confidence 011223568999998764 678899999999999999998 8999864221 122322222111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
... + ......+.+++.+||+.+|++||++.+|+++|.
T Consensus 220 ~~~-------~--------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYK-------P--------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC-------C--------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 100 0 112356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=325.81 Aligned_cols=238 Identities=26% Similarity=0.285 Sum_probs=188.4
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||++.. .+|..||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 3699999999999874 3678999999875422 233567789999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999997542 58999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ....|+..|+|||++.. ..++.++|||||||++|||++|+.||..... ......+
T Consensus 154 ~~----------------~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i 210 (318)
T cd05582 154 KA----------------YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMI 210 (318)
T ss_pred ce----------------ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHH
Confidence 00 12346889999999664 6678899999999999999999999964321 1122211
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
. .....+. ......+.+++.+||+.||++||++.+
T Consensus 211 ~---~~~~~~p-------------~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 L---KAKLGMP-------------QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred H---cCCCCCC-------------CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 1111101 112245678999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.08 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=188.6
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999964 67889999987642 23345688999999998 7999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 152 (327)
T cd05617 82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT- 152 (327)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-
Confidence 9999987543 58999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..++...
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~---~~~~~~~ 213 (327)
T cd05617 153 ---------------TSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN---TEDYLFQ 213 (327)
T ss_pred ---------------eecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc---cHHHHHH
Confidence 022357899999999764 677899999999999999999999997543321111 1112111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
....... . ........+.+++.+|+..||++||++.
T Consensus 214 ~~~~~~~--~----------~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 214 VILEKPI--R----------IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHhCCC--C----------CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1111100 0 0011224567899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.74 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=200.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++.. .++..++||.+... ......+|.+|++++++++||||+++++++..++..++||||++++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 4799999999999995 58899999987653 2233467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++..... ....+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 88 ~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd08229 88 DLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCccc
Confidence 99999874321 23468999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||+... ..++.++||||||+++|||++|..||...... ...+.+.+..
T Consensus 164 ----------------~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~ 222 (267)
T cd08229 164 ----------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ 222 (267)
T ss_pred ----------------ccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhc
Confidence 12345788999998654 66788999999999999999999998643211 1111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. ..+ . .........+.+++.+||+.||.+||||.+|++.++++.
T Consensus 223 ~---~~~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 C---DYP--P---------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---CCC--C---------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 000 0 001123356789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=316.55 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=197.8
Q ss_pred ccceecccCeeEEEEEEeC--------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceE
Q 005226 411 SAYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 480 (707)
..+.||+|+||.||++... ....+|+|.++... .....++.+|+++++++ +||||+++++++...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999742 34578999987543 23446788999999999 69999999999999999999
Q ss_pred EEEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC
Q 005226 481 ISDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~ 549 (707)
||||+++|+|.+++..... .....++|.++.+++.|++.||+|||+ ++|+||||||+||+++.++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCc
Confidence 9999999999999976431 112458999999999999999999999 89999999999999999999
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPE 628 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~ 628 (707)
+||+|||+++........... ....++..|+|||++.. ..++.++||||||+++|||++ |+.||
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKT--------------SNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred EEEcccccccccccccccccc--------------ccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 999999999865422111100 11123457999998765 678899999999999999999 88888
Q ss_pred CCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..... ..+.+......... . ......++.+++.+||..||++||++.++++.|+++.
T Consensus 238 ~~~~~------~~~~~~~~~~~~~~-----~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 238 PGIPV------EELFKLLREGHRMD-----K----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCH------HHHHHHHHcCCCCC-----C----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 54321 12222222111000 0 0112345778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.83 Aligned_cols=260 Identities=26% Similarity=0.384 Sum_probs=197.8
Q ss_pred ceecccCeeEEEEEEeCC-----------------CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc
Q 005226 413 YVLGKSGLGIVYKVVLGN-----------------GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 474 (707)
+.||+|+||.||+|...+ +..||+|.+.... ....+.|.+|++++++++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV 90 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 479999999999988542 2458999987653 3345788999999999999999999999999
Q ss_pred CCcceEEEEeecCCChHHHHhCCCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 475 PDEKLLISDFISNGNLANALRGRNGQP------STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 475 ~~~~~lV~e~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
++..++|+||+++++|.+++....... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCCC
Confidence 999999999999999999997654221 2368999999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh--CCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT--GKS 626 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt--g~~ 626 (707)
.++|+|||+++.......... .....++..|+|||++.. ..++.++|||||||++|||++ |..
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYYRV--------------QGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred ceEEccccceeecccCcceee--------------cCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCC
Confidence 999999999876542211100 012234678999998665 568899999999999999998 667
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
||.... .....+.....+..... ....+ .......++.+++.+|++.||.+||++.+|++.|++
T Consensus 233 p~~~~~------~~~~~~~~~~~~~~~~~-~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 233 PYEHLT------DQQVIENAGHFFRDDGR-QIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCcC------hHHHHHHHHhccccccc-cccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 775432 12233333222211111 00000 011123568999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=312.06 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=195.5
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 90 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL 90 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence 358999999999999753 245799998875532 3335688999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 485 ISNGNLANALRGRNGQ-----PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+++|+|.++++..... ....+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~ 167 (288)
T cd05061 91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167 (288)
T ss_pred CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCccc
Confidence 9999999999753311 12346788899999999999999999 899999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
.......... .....++..|+|||.+.. ..++.++|||||||++|||++ |..||.....
T Consensus 168 ~~~~~~~~~~--------------~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----- 227 (288)
T cd05061 168 DIYETDYYRK--------------GGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----- 227 (288)
T ss_pred cccccccccc--------------cCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 6542211100 011233667999998664 667899999999999999999 7888864321
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+..+.+..... .. ........+.+++.+|++.||++||++.++++.|++.
T Consensus 228 -~~~~~~~~~~~~--~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 228 -EQVLKFVMDGGY--LD-------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -HHHHHHHHcCCC--CC-------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 122222211100 00 0012235688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=308.99 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=195.9
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|...+ ...|++|...... ....+.|.+|+.++++++||||+++++++.. +..++||||++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 4589999999999998643 3568999887654 3445789999999999999999999998865 56789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..++.+++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 90 LGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence 999999997543 258999999999999999999999 8999999999999999999999999999876542211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....++..|+|||.+.. ..++.++||||||+++||+++ |+.||...... ....+
T Consensus 163 ~~~---------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~ 220 (270)
T cd05056 163 YKA---------------SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGR 220 (270)
T ss_pred eec---------------CCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHH
Confidence 000 11223567999998654 677899999999999999996 99998654321 22223
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
......... .......+.+++.+|+..+|.+||++.++++.|+++.
T Consensus 221 ~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 221 IENGERLPM---------------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred HHcCCcCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222111100 1122346788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=316.04 Aligned_cols=201 Identities=23% Similarity=0.343 Sum_probs=161.0
Q ss_pred cceecccCeeEEEEEEeC---CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 486 (707)
+..||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 347999999999999964 457899998875432 2457889999999999999999999854 456789999986
Q ss_pred CCChHHHHhCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE----cCCCCeEEeccccc
Q 005226 487 NGNLANALRGRNG----QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL----DNDFQPYISDFGLS 558 (707)
Q Consensus 487 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla 558 (707)
++|.+++..... .....+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 588888754321 122358999999999999999999999 899999999999999 56678999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
+......... .......+|..|+|||++.....++.++|||||||++|||+||++||...
T Consensus 160 ~~~~~~~~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPL-------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccc-------------cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 8654321110 01123456889999999776566889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=306.28 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=201.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +|..||+|.++.. .....+.+.+|++++++++|+|++++++++..++..++||||+++|
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 47999999999999976 7899999987642 2233568899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .....+++.++..++.+++.||+|||+ .+|+||||||+||+++.++.++|+|||+++.........
T Consensus 88 ~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 163 (267)
T cd08224 88 DLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence 9999996532 123458999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+....
T Consensus 164 ----------------~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~ 222 (267)
T cd08224 164 ----------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK 222 (267)
T ss_pred ----------------ceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc
Confidence 12345788999998764 6678899999999999999999999864321 11112221111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..... .........+.+++.+||..+|++||++.+|+++|+++.
T Consensus 223 ~~~~~--------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPP--------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCC--------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11000 001123356789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.43 Aligned_cols=249 Identities=23% Similarity=0.273 Sum_probs=193.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--------cceEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--------EKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~lV 481 (707)
+.||+|+||+||+|.. .+++.||||++... .......+.+|+..+..++|+||+++++.+...+ ..++|
T Consensus 38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 4799999999999985 47899999998654 3344567889999999999999999988775433 25799
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+++|+|.++++... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~ 193 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMY 193 (496)
T ss_pred EeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence 99999999999997543 223468999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
........ .....||+.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 194 ~~~~~~~~--------------~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------- 249 (496)
T PTZ00283 194 AATVSDDV--------------GRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGEN--------- 249 (496)
T ss_pred cccccccc--------------cccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---------
Confidence 42211110 023457899999999765 678899999999999999999999996421
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..+.+......... . .......++.+++.+||+.||.+||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~---~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 250 MEEVMHKTLAGRYD---P---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHHhcCCCC---C---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11111111111100 0 011223457899999999999999999998763
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.01 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=200.6
Q ss_pred eecccCeeEEEEEEeCC----CceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLGN----GIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|.... +..|++|.+...... ..+.+.+|++.++.++|+||+++++++......++||||+++|
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 68999999999999753 788999998876443 3578999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 489 NLANALRGRNGQ----PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 489 sL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+|.+++...... ....+++..+.+++.|++.||+|||+ ++++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999865210 12468999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 643 (707)
... .......++..|+|||.+.. ..++.++||||+|+++|||++ |+.||.... ...+.
T Consensus 159 ~~~--------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~ 217 (262)
T cd00192 159 DYY--------------RKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVL 217 (262)
T ss_pred ccc--------------ccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHH
Confidence 210 01123345788999998765 578899999999999999999 589986542 12233
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
+.+........ ......++.+++.+|+..+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 EYLRKGYRLPK---------------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHcCCCCCC---------------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 33322111110 1122456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.57 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=196.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|++|.||+|... ++..|++|.+... ......++.+|++++++++||||+++++++..++..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 47999999999999964 6889999987643 33455789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++... ...+++..+.+++.+++.||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 86 L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~- 158 (256)
T cd08529 86 LHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA- 158 (256)
T ss_pred HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh-
Confidence 999998642 2368999999999999999999999 899999999999999999999999999987654321110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||+... ..++.++||||||+++|||++|+.||..... ..........
T Consensus 159 ---------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~ 216 (256)
T cd08529 159 ---------------NTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRG 216 (256)
T ss_pred ---------------hccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC
Confidence 12345788999999765 5678999999999999999999999864321 1222222111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... ........+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPP---------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCC---------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1100 011233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=314.71 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=194.0
Q ss_pred ceecccCeeEEEEEEeCC---------------CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC
Q 005226 413 YVLGKSGLGIVYKVVLGN---------------GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD 476 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 476 (707)
+.||+|+||.||++...+ ...||+|.++.. .......|.+|++++++++|||++++++++..++
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 90 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD 90 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 479999999999987532 235899998764 2333467999999999999999999999999999
Q ss_pred cceEEEEeecCCChHHHHhCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC
Q 005226 477 EKLLISDFISNGNLANALRGRNGQ-------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~ 549 (707)
..++||||+++++|.+++...... ....++|..+++++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYT 167 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCCc
Confidence 999999999999999999654210 11247899999999999999999999 89999999999999999999
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh--CCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT--GKSP 627 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt--g~~P 627 (707)
+||+|||+++.......... .....++..|+|||+... ..++.++|||||||++|||++ |..|
T Consensus 168 ~kl~dfg~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 168 IKIADFGMSRNLYSGDYYRI--------------QGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred EEecccccccccccCcceec--------------cCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 99999999876532211000 011234678999998665 668899999999999999998 5567
Q ss_pred CCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
|..... .................... .........+.+++.+||+.||++||+|.+|++.|++
T Consensus 233 ~~~~~~------~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 233 YSLLSD------EQVIENTGEFFRNQGRQIYL--------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CcccCh------HHHHHHHHHhhhhccccccC--------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 654322 12222211111110000000 0001123568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.10 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=197.0
Q ss_pred eecccCeeEEEEEEeCC--C--ceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLGN--G--IPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|++|.||+|.+.+ + ..||+|.+..... ...+.|.+|++++++++||||+++++++.. ...++|+||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999998643 2 3689999987655 556789999999999999999999999988 8889999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++..... ..++|..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 153 (257)
T cd05040 81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH- 153 (257)
T ss_pred cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc-
Confidence 99999986531 468999999999999999999999 89999999999999999999999999999876432211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
+.......++..|+|||++.. ..++.++||||||+++|||++ |+.||..... .+......
T Consensus 154 ------------~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~ 214 (257)
T cd05040 154 ------------YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKID 214 (257)
T ss_pred ------------eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 001112345778999998654 667899999999999999999 9999864321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.. ..... ........+.+++.+|++.+|++||++.++++.|.
T Consensus 215 ~~-~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 KE-GERLE-------------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred hc-CCcCC-------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 10 00000 00122356789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.15 Aligned_cols=239 Identities=22% Similarity=0.333 Sum_probs=188.0
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... ++..||||+++... ......+..|..++... +||||+++++++.+++..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999965 57889999987542 22335567788888865 9999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 152 (316)
T cd05619 82 DLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK- 152 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-
Confidence 9999997542 58999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+..
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~~ 210 (316)
T cd05619 153 ---------------TCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIRM 210 (316)
T ss_pred ---------------eeeecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 123457899999999764 6788999999999999999999999965321 122222211
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH-HHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK-NVS 699 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~v~ 699 (707)
. ...+. ......+.+++.+|++.||++||++. ++.
T Consensus 211 ~---~~~~~-------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 211 D---NPCYP-------------RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C---CCCCC-------------ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 00000 11223567899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.21 Aligned_cols=257 Identities=23% Similarity=0.277 Sum_probs=186.6
Q ss_pred ceecccCeeEEEEEEeC--CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhc---CCCceeeeEEEEEc-----CCcceE
Q 005226 413 YVLGKSGLGIVYKVVLG--NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKV---KHPNIVKLRAYYWA-----PDEKLL 480 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~~l 480 (707)
+.||+|+||.||+|... ++..||+|+++... ......+.+|+.+++++ +||||++++++|.. ....++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 47999999999999863 46789999886542 22234566788877766 69999999999853 345789
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
||||++ ++|.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred EEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 999996 69999997543 2358999999999999999999999 8999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
...... .....|+..|+|||.+.. ..++.++|||||||++|||++|++||......
T Consensus 160 ~~~~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~------ 215 (290)
T cd07862 160 YSFQMA-----------------LTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------ 215 (290)
T ss_pred ccCCcc-----------------cccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHH------
Confidence 542210 022346889999998754 67788999999999999999999999754321
Q ss_pred hHHHHHHhhcc----ccCCCc-hhchHHHHhh------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFE----EENPLS-DMVDAMLLQE------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~----~~~~~~-~~~d~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+..... ..++.. ......+... .........+.+++.+|++.||++|||+.++++
T Consensus 216 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 216 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11122211110 000000 0000000000 000122345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=320.11 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=194.9
Q ss_pred ccceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC-CcceEE
Q 005226 411 SAYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP-DEKLLI 481 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV 481 (707)
..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 345899999999999973 356889999997643 23346788999999999 789999999988765 456899
Q ss_pred EEeecCCChHHHHhCCCCC-------------------------------------------------------------
Q 005226 482 SDFISNGNLANALRGRNGQ------------------------------------------------------------- 500 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~------------------------------------------------------------- 500 (707)
|||+++|+|.++++...+.
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999999753210
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCC
Q 005226 501 -PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579 (707)
Q Consensus 501 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~ 579 (707)
....++|.++.+++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----------- 236 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----------- 236 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-----------
Confidence 01247899999999999999999999 899999999999999999999999999987653221100
Q ss_pred CCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCCch
Q 005226 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSD 658 (707)
Q Consensus 580 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 658 (707)
......++..|+|||.+.. ..++.++||||||+++|||++ |..||...... ..+...+........ ..
T Consensus 237 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~--~~ 305 (343)
T cd05103 237 ---RKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTRMRA--PD 305 (343)
T ss_pred ---hcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----HHHHHHHhccCCCCC--CC
Confidence 0112234667999998664 677899999999999999997 88888643211 111111111111100 00
Q ss_pred hchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 659 MVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 659 ~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....++.+++..||+.||++||++.+|++.|+.+-
T Consensus 306 -------------~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 306 -------------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred -------------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11235789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.77 Aligned_cols=240 Identities=24% Similarity=0.319 Sum_probs=190.3
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999865 57899999987542 23345677899999888 7999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 152 (318)
T cd05570 82 DLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT- 152 (318)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-
Confidence 9999987543 58999999999999999999999 89999999999999999999999999998643211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....|+..|+|||++.. ..++.++|||||||++|||++|+.||..... ..+...+..
T Consensus 153 ---------------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~ 210 (318)
T cd05570 153 ---------------TSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILE 210 (318)
T ss_pred ---------------ccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHc
Confidence 012346889999999765 6788999999999999999999999964321 122221111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh-----HHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM-----KNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~~v~~ 700 (707)
....+ .......+.+++.+||+.||.+||++ .++++
T Consensus 211 ---~~~~~-------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 211 ---DEVRY-------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---CCCCC-------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11000 01123457899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=310.19 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=195.5
Q ss_pred eecccCeeEEEEEEeCC-------CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGN-------GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.||+|+||.||+|...+ +..+++|.+.... .....+|.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998642 2578999876543 234578899999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-----CeEEeccccc
Q 005226 486 SNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-----QPYISDFGLS 558 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~DfGla 558 (707)
++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999754321 23458999999999999999999999 8999999999999999887 8999999998
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~ 637 (707)
+.......... .....++..|+|||++.. ..++.++|||||||++|||+| |+.||.....
T Consensus 159 ~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---- 219 (269)
T cd05044 159 RDIYKSDYYRK--------------EGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---- 219 (269)
T ss_pred ccccccccccc--------------CcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCH----
Confidence 76542211100 011234678999998765 667899999999999999998 9999864321
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+....+....... ........+.+++.+||..+|.+||++.+|++.|++
T Consensus 220 --~~~~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 220 --QEVLQHVTAGGRLQ---------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --HHHHHHHhcCCccC---------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 12222222111000 011223567899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.78 Aligned_cols=261 Identities=24% Similarity=0.280 Sum_probs=189.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|.. .++..||+|++.... ......+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 4799999999999985 467899999986542 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 87 DMMSLLIRME-----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 9999997643 58899999999999999999999 899999999999999999999999999986432111000
Q ss_pred CCCCCC--------------------cCC--------CC---CCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHH
Q 005226 569 SSSGGF--------------------MGG--------AL---PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV 617 (707)
Q Consensus 569 ~~~~~~--------------------~~~--------~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~ 617 (707)
....+. .+. .. .........||+.|+|||++.. ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhH
Confidence 000000 000 00 0000012468999999999765 667899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHh--ccCCCCCCCCCh
Q 005226 618 LLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALA--CTEADPEVRPRM 695 (707)
Q Consensus 618 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~ 695 (707)
+|||+||+.||...... .....+... ....... .......++.+++.+ |+..+|..||++
T Consensus 238 l~elltG~~Pf~~~~~~------~~~~~i~~~-~~~~~~~-----------~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 238 LFEMLVGQPPFLAPTPT------ETQLKVINW-ENTLHIP-----------PQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred HHHHHhCCCCCcCCCHH------HHHHHHHcc-ccccCCC-----------CCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 99999999999753321 111111000 0000000 000112345566665 667778889999
Q ss_pred HHHHH
Q 005226 696 KNVSE 700 (707)
Q Consensus 696 ~~v~~ 700 (707)
.++++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=305.63 Aligned_cols=238 Identities=25% Similarity=0.379 Sum_probs=188.1
Q ss_pred eecccCeeEEEEEEeCCCc-----------eEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 414 VLGKSGLGIVYKVVLGNGI-----------PVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999975432 4777877654433 4788999999999999999999999988 7889999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-------CeEEecc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-------QPYISDF 555 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-------~~kl~Df 555 (707)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998643 158999999999999999999999 8999999999999999888 7999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLT-GKSPELSPTT 633 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~ 633 (707)
|++...... ....++..|+|||++... ..++.++||||||+++|||++ |..||.....
T Consensus 153 g~a~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 153 GIPITVLSR--------------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred Ccccccccc--------------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 998765421 122346679999997653 377899999999999999999 5777754321
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
. ....+... ... . .......+.+++.+||..+|.+||++.+|++.|+
T Consensus 213 ~------~~~~~~~~----~~~-~------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 213 S------EKERFYQD----QHR-L------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred h------hHHHHHhc----CCC-C------------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 11111110 000 0 0011156789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=317.84 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=187.5
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|... +|..||+|.++... ......+..|..++... +||||+++++++.+++..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 6999999999999965 68899999987542 22335667788888765 8999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 82 DLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 9999997543 58899999999999999999999 8999999999999999999999999999864321111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......||..|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+..
T Consensus 152 --------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~~~ 210 (316)
T cd05620 152 --------------RASTFCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESIRV 210 (316)
T ss_pred --------------ceeccCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 0123457999999999765 6788999999999999999999999964321 122222111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH-HHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK-NVS 699 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~v~ 699 (707)
....+.. ....++.+++.+|++.||++||++. ++.
T Consensus 211 ---~~~~~~~-------------~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 211 ---DTPHYPR-------------WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCCCCCC-------------CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111011 1224567899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.49 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e 483 (707)
.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+++++.++||||+++++++...+ ..++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 34799999999999996 47899999998654 2233467889999999999999999999998776 7899999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 85 LMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred ccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 996 58888886532 58999999999999999999999 8999999999999999999999999999976532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
..... .....++..|+|||++.+...++.++|||||||++|||++|+.||...... ...
T Consensus 156 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~ 214 (372)
T cd07853 156 DESKH---------------MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI------QQL 214 (372)
T ss_pred Ccccc---------------CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH------HHH
Confidence 21100 012345889999999776566789999999999999999999999754321 111
Q ss_pred HHHHhhccccCCCchhc------hHHHHhh-----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMV------DAMLLQE-----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~------d~~l~~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+....... +..++. ...+... .........+.+++.+|++.||++|||+.++++
T Consensus 215 ~~i~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 215 DLITDLLGTP-SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHHcCCC-CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 1111110000 000000 0000000 000112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.57 Aligned_cols=246 Identities=25% Similarity=0.271 Sum_probs=192.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
++||+|+||+||++... ++..||+|++..... .....+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 47999999999999964 688999999865422 22345788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++........
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05605 86 DLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI- 158 (285)
T ss_pred cHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc-
Confidence 9999886532 2358999999999999999999999 89999999999999999999999999998765321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ...+.+..
T Consensus 159 ----------------~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~------~~~~~~~~ 215 (285)
T cd05605 159 ----------------RGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK------VKREEVER 215 (285)
T ss_pred ----------------ccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchh------hHHHHHHH
Confidence 12346889999999765 66789999999999999999999999753221 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
....... .........+.+++.+||..||.+|| ++.++++
T Consensus 216 ~~~~~~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 216 RVKEDQE------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred Hhhhccc------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1111000 00112334578999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.87 Aligned_cols=236 Identities=26% Similarity=0.331 Sum_probs=184.4
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHH-HHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQ-AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||+||+|... +|+.||+|++.... .....++..|.. +++.++||||+++++++..++..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999965 78999999986532 122344555655 467789999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 152 (323)
T cd05575 82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT- 152 (323)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc-
Confidence 9999997543 58999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+ .
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~---~ 207 (323)
T cd05575 153 ---------------TSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYD---N 207 (323)
T ss_pred ---------------cccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHH---H
Confidence 022357899999999765 6788999999999999999999999964321 11111 1
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
.......+ .......+.+++.+|++.||.+||+++
T Consensus 208 i~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 208 ILNKPLRL-------------KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHcCCCCC-------------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11111000 011234578899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.28 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=202.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc-ceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE-KLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~e~~~~g 488 (707)
+.+|+|+||.++..+++ ++..+++|.+.-. .....+...+|+.++++++|||||.+.+.+..++. .++||+|++||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 47999999999998854 6778999987654 33444678899999999999999999999999998 89999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++.+.+...++ ..++++++..++.|++.|+.|||+ +.|+|||||+.||+++.+..|||+|||+|+.+.......
T Consensus 90 ~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 90 DLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred CHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 99999987653 469999999999999999999998 899999999999999999999999999999887443222
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+.||++.+ ..|..|+|||||||++|||++-+++|...+ ...++..+-.
T Consensus 164 ----------------~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~ 220 (426)
T KOG0589|consen 164 ----------------STVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINR 220 (426)
T ss_pred ----------------heecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhh
Confidence 34678999999999765 889999999999999999999999997532 2233322222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..- .+ -......++..++..|++.+|+.||++.+++.+
T Consensus 221 ~~~--~P-------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 GLY--SP-------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccC--CC-------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 110 11 123445667889999999999999999999875
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=310.03 Aligned_cols=261 Identities=27% Similarity=0.374 Sum_probs=196.2
Q ss_pred cceecccCeeEEEEEEe-----CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 483 (707)
-+.||+|+||.||++.. .++..||+|.++... ......+.+|++++++++||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05079 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 88 (284)
T ss_pred ceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEE
Confidence 34799999999999974 357889999987553 33346799999999999999999999999875 56789999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++++|.+++.... ..++|..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 89 FLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999997542 258999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC------c
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS------I 637 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~------~ 637 (707)
..... .......++..|+|||+... ..++.++||||||+++|||+|++.|+........ .
T Consensus 162 ~~~~~-------------~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05079 162 DKEYY-------------TVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH 227 (284)
T ss_pred Cccce-------------eecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccc
Confidence 22110 00112335677999998664 6688999999999999999998877543211000 0
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.......++... ..... ..........+.+++.+|++.||++||++.++++.|+++
T Consensus 228 ~~~~~~~~~~~~-~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 228 GQMTVTRLVRVL-EEGKR-----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccHHHHHHHH-HcCcc-----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000011111100 00000 000112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.11 Aligned_cols=249 Identities=23% Similarity=0.292 Sum_probs=194.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|+||.||+|.. .++..||+|++..........+.+|+.++++++||||+++++++..++..++|+||+++|+|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 4799999999999996 578899999987654444467889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 95 ~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~---- 162 (267)
T cd06646 95 DIYHVTG-----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---- 162 (267)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc----
Confidence 9997543 58999999999999999999999 89999999999999999999999999999865421110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....++..|+|||.+. ....++.++|||||||++|||++|+.||....... ....+....
T Consensus 163 ------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----~~~~~~~~~ 225 (267)
T cd06646 163 ------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMSKSN 225 (267)
T ss_pred ------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----hheeeecCC
Confidence 01234678899999864 23456789999999999999999999986432210 000000000
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
... +... ........+.+++.+||..||++||+++++++.+
T Consensus 226 ~~~---------~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQP---------PKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCC---------CCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0000 0112235678999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.16 Aligned_cols=235 Identities=24% Similarity=0.319 Sum_probs=182.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHH---HhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAI---AKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
..||+|+||.||+|... +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 47999999999999864 68999999987542 22335566676655 5678999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|..+++.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 85 AGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred CCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999988643 58999999999999999999999 899999999999999999999999999986432111
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. .....|++.|+|||++.. ..++.++|||||||++|||++|+.||..... ......
T Consensus 156 ~~----------------~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~ 212 (324)
T cd05589 156 DR----------------TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDS 212 (324)
T ss_pred Cc----------------ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 10 022457899999999764 6778999999999999999999999964321 111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
+. .....+ .......+.+++.+|++.||.+||++
T Consensus 213 i~---~~~~~~-------------p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 213 IV---NDEVRY-------------PRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred HH---hCCCCC-------------CCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 11 111100 01123456789999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=322.83 Aligned_cols=246 Identities=27% Similarity=0.371 Sum_probs=199.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
-+||+|.+|+||-|+.. +...+|||-+.........-+..||.+-++++|+|||+++|.|.+++..-+.||.+|||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999954 56789999998776666677888999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-CCCCeEEecccccccccccCCCC
Q 005226 492 NALRGRNGQPSTSL--SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 492 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+.|+..-| ++ .+.+.-.+.+||++||.|||+ ..|||||||-+|||++ ..|.+||+|||-+++...-. +
T Consensus 661 sLLrskWG----PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P 731 (1226)
T KOG4279|consen 661 SLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--P 731 (1226)
T ss_pred HHHHhccC----CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCC--c
Confidence 99987754 34 677788899999999999999 8999999999999995 67999999999998765211 1
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. .++..||..|||||++..+ +.|..++|||||||++.||.||++||....... ..-+--
T Consensus 732 ~--------------TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkV 791 (1226)
T KOG4279|consen 732 C--------------TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKV 791 (1226)
T ss_pred c--------------ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhhh
Confidence 1 1455689999999998654 678899999999999999999999997643321 111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+..+.+ -..+...+...++.+|..+||..||+++++++
T Consensus 792 GmyKvHP~-------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GMYKVHPP-------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cceecCCC-------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11111111 12445567889999999999999999999875
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=303.13 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=196.2
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|+||.||++...+++.|++|.+...... ....|.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 68999999999999877999999998765433 44689999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++..+..++.+++.||+|||+ ++++||||||+||+++.++.+||+|||+++..........
T Consensus 82 ~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--- 151 (251)
T cd05041 82 FLRKKK----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS--- 151 (251)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec---
Confidence 997543 257899999999999999999999 8999999999999999999999999999875432111000
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
......+..|+|||.+.. ..++.++||||||+++|||+| |..||..... ......+.....
T Consensus 152 -----------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~~~~~~~~~ 213 (251)
T cd05041 152 -----------DGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTRERIESGYR 213 (251)
T ss_pred -----------cccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHHHHHhcCCC
Confidence 011223567999998654 678899999999999999999 7888754322 122222221111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.. ........+.+++.+|+..+|.+||++.||++.|+
T Consensus 214 ~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 214 MP---------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CC---------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 00 01122346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=300.40 Aligned_cols=265 Identities=23% Similarity=0.294 Sum_probs=196.1
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCc-eeeeEEEEEcCC------cceEEEE
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPN-IVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~~~lV~e 483 (707)
.||+|+||+||+|+. .+|+.||+|+++-... +......+|+.++++++|+| ||++++++.... ..++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 599999999999994 5789999999875533 33456789999999999999 999999998877 6789999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+.. +|..++....... ..++...+..+++||++||+|||+ ++|+||||||.|||++++|.+||+|||+|+....
T Consensus 98 ~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred eecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 9965 9999998764211 457778999999999999999999 8999999999999999999999999999985442
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
... .-+...+|.+|+|||++.+...|+...||||+||++.||+++++-|.+..+.. +...+.
T Consensus 173 p~~----------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If 234 (323)
T KOG0594|consen 173 PMR----------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIF 234 (323)
T ss_pred Ccc----------------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHH
Confidence 111 11345679999999999987789999999999999999999998887643210 000000
Q ss_pred HHHHhhccccCCCc-hhchHHH--Hhhh-------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 644 RWVKKGFEEENPLS-DMVDAML--LQEV-------HAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 644 ~~~~~~~~~~~~~~-~~~d~~l--~~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
+-+..--...|+-. .+.|-.. .... ..........+++.+|++.+|..|.|++.+++.
T Consensus 235 ~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 235 RLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 00000001111100 0000000 0000 001111467899999999999999999998874
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=311.28 Aligned_cols=253 Identities=29% Similarity=0.434 Sum_probs=195.6
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
..||+|+||.||+|... ++..||+|.+.... ....++|.+|+.++++++||||+++++++..++..++|+||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM 90 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence 47999999999999853 46789999987653 233467999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 486 SNGNLANALRGRNG-----------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 486 ~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
++|+|.+++..... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 167 (288)
T ss_pred CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCC
Confidence 99999999975321 112357899999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P 627 (707)
.+||+|||+++......... .......+..|+|||.... ..++.++|||||||++|||++ |..|
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p 232 (288)
T cd05050 168 VVKIADFGLSRNIYSADYYK--------------ASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQP 232 (288)
T ss_pred ceEECccccceecccCcccc--------------ccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999987553221100 0111223567999998654 678899999999999999998 8888
Q ss_pred CCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
|..... .+....+.. ... .. .......++.+++.+|++.||.+||++.|+++.|++
T Consensus 233 ~~~~~~------~~~~~~~~~----~~~-~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 233 YYGMAH------EEVIYYVRD----GNV-LS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCH------HHHHHHHhc----CCC-CC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 754221 122222211 100 00 001223567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.01 Aligned_cols=252 Identities=29% Similarity=0.469 Sum_probs=202.2
Q ss_pred ccceecccCeeEEEEEEe-CC----CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 411 SAYVLGKSGLGIVYKVVL-GN----GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
-..+||.|+||+||||.+ +. ..+||+|++... ..+...++..|+.+|++++|||+++|+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 356899999999999985 33 357899988665 3444588999999999999999999999998766 8899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
|+.|+|.++++.+++ .+.-...+.|..|||+||.|||. +++|||||.++||||..-..+||.|||+|+.....
T Consensus 779 mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999998763 47788899999999999999999 89999999999999999999999999999988755
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 643 (707)
+......++ .-.+-|||-|.+.. +.++.++|||||||++||++| |..|++..... +..++
T Consensus 852 ~~ey~~~~g--------------K~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~---eI~dl- 912 (1177)
T KOG1025|consen 852 EKEYSAPGG--------------KVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE---EIPDL- 912 (1177)
T ss_pred ccccccccc--------------ccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH---HhhHH-
Confidence 443332211 12567999998665 889999999999999999999 88887654332 22222
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
++.+-+-. ..+-...++..++.+||..|+..||+++++.....++.
T Consensus 913 --le~geRLs---------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 913 --LEKGERLS---------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --HhccccCC---------------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 22211111 11334567788899999999999999999999988764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=311.42 Aligned_cols=243 Identities=23% Similarity=0.369 Sum_probs=193.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|+||.||+|.. .++..|++|.+..........+.+|+.++++++||||+++++++..++..++||||+++|+|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 3799999999999985 478899999987665555577899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 106 ~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--- 173 (296)
T cd06654 106 DVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 173 (296)
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc---
Confidence 999643 47899999999999999999999 899999999999999999999999999987643221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+..+...
T Consensus 174 -------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~~~~~--- 231 (296)
T cd06654 174 -------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATN--- 231 (296)
T ss_pred -------------CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHHHhcC---
Confidence 12346889999998664 66789999999999999999999999653321 111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... . ........+.+++.+||..||++||++.++++
T Consensus 232 ~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 232 GTPEL-Q----------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCC-C----------CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11000 0 01122345778999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=291.14 Aligned_cols=245 Identities=25% Similarity=0.349 Sum_probs=195.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch--------hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
+++|+|..++|.+... ++|...|+|++..... .-.++-.+|+.+|+++ .||+|+++.++|.++...++|+
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF 102 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF 102 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence 4799999999988875 4788899998754321 1134567899999998 8999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
|.|+.|.|+++|...- .+++....+|++|+..|++|||. +.||||||||+|||+|++.++||+|||+|+.+.
T Consensus 103 dl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999998653 69999999999999999999999 899999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV-----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
.+... ....||++|.|||.+. ....|+...|+||.||++|.|+.|.+||....
T Consensus 175 ~GekL-----------------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk----- 232 (411)
T KOG0599|consen 175 PGEKL-----------------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK----- 232 (411)
T ss_pred CchhH-----------------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----
Confidence 54432 2345799999999854 34678899999999999999999999996421
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..-+..-+..+ +. +.- .....+......+|+.+|++.||.+|.|++|+++
T Consensus 233 -QmlMLR~ImeG---ky---qF~------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 233 -QMLMLRMIMEG---KY---QFR------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHHHHHHhc---cc---ccC------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 00111111110 00 000 1112344566789999999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=314.91 Aligned_cols=258 Identities=20% Similarity=0.277 Sum_probs=192.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|... ++..||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+++ +|
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 90 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DL 90 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CH
Confidence 47999999999999865 678899999875432 2235678899999999999999999999999999999999975 89
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-- 161 (309)
T cd07872 91 KQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-- 161 (309)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc--
Confidence 88887543 358899999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.....++.++|||||||++|||+||+.||...... +....+....
T Consensus 162 --------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~------~~~~~~~~~~ 221 (309)
T cd07872 162 --------------SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE------DELHLIFRLL 221 (309)
T ss_pred --------------ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHh
Confidence 12345889999998766567889999999999999999999999654321 1111111111
Q ss_pred cccC----C----CchhchHHHHhh------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEEN----P----LSDMVDAMLLQE------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~----~----~~~~~d~~l~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... + ..+..+...... ........++.+++.+|++.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 0 000000000000 000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.33 Aligned_cols=261 Identities=18% Similarity=0.190 Sum_probs=190.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
...||+|+||.||++... .++.||||.... ..+.+|++++++++|+|||++++++..++..++||||+. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 357999999999999975 578899996432 346789999999999999999999999999999999994 799
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..++|.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 318 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF- 318 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc-
Confidence 99987543 259999999999999999999999 8999999999999999999999999999986542211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC--ccchhHHHHHHh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS--IEVPDLVRWVKK 648 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~--~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|..|+........ .....+.+.+..
T Consensus 319 -------------~~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~ 384 (461)
T PHA03211 319 -------------HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQ 384 (461)
T ss_pred -------------ccccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHh
Confidence 122457999999999765 6788999999999999999999877654321110 011122222222
Q ss_pred hccccCCCchhchHHHHhhhh---------------h---HHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVH---------------A---KKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~---------------~---~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.......+.......+..... . ......+.+|+.+|++.||++|||+.|+++.
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 385 AQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111000001100111100000 0 0112357889999999999999999999863
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.61 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=186.5
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHH-HHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQA-IAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... +|+.||+|++.... ......+..|..+ ++.++||||+++++++..++..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 6999999999999864 78999999986532 2233456666654 67789999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 152 (325)
T cd05604 82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT- 152 (325)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC-
Confidence 9999987543 58999999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~-- 208 (325)
T cd05604 153 ---------------TTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNI-- 208 (325)
T ss_pred ---------------cccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHH--
Confidence 123457899999999765 6778999999999999999999999964321 1111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
...... + .......+.+++.+|++.||.+||++++.++.
T Consensus 209 -~~~~~~----~---------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 209 -LHKPLV----L---------RPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -HcCCcc----C---------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 111100 0 01123456789999999999999998744433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.09 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=191.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||++... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 458999999999999965 68899999986432 22335578899999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 9999999753 37888899999999999999999 89999999999999999999999999998765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
. .....||+.|+|||++... ..++.++|||||||++|||++|+.||..... .....
T Consensus 199 ~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~ 257 (370)
T cd05596 199 R---------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYS 257 (370)
T ss_pred c---------------CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHH
Confidence 0 1234579999999986542 3478899999999999999999999975321 11111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC--CCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV--RPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~v~~ 700 (707)
.+. ..... ... .........+.+++.+|+..+|.+ ||++.++++
T Consensus 258 ~i~---~~~~~-~~~--------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 258 KIM---DHKNS-LTF--------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HHH---cCCCc-CCC--------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 111 11100 000 000112356778999999999987 999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=329.39 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=185.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--------CcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--------DEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV~ 482 (707)
.+.||+|+||.||+|... ++..||||++.... ....+|+.++++++|||||++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 348999999999999964 68899999885432 2335799999999999999999987532 1356899
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLI 561 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~ 561 (707)
||+++ +|.+++.... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 147 E~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred ecCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 99975 7877775321 123468999999999999999999999 8999999999999999664 7999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... ....||+.|+|||++.+...++.++|||||||++|||++|++||...... ..
T Consensus 222 ~~~~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-----~~ 279 (440)
T PTZ00036 222 LAGQRS-----------------VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-----DQ 279 (440)
T ss_pred cCCCCc-----------------ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HH
Confidence 422111 12345889999998776567899999999999999999999999754321 11
Q ss_pred HHHHHHhhccccC--------------CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEEN--------------PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+...+. ...... .+.......+.. ........++.+++.+||..||.+|||+.|+++
T Consensus 280 ~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 280 LVRIIQ-VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHH-HhCCCCHHHHHHhchhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111111 000000 000000111110 011122356889999999999999999999874
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.85 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=198.9
Q ss_pred ceecccCeeEEEEEEeC-----CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-----NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~ 484 (707)
+.||+|+||.||+|.+. ++..+|||.+...... ..+.|.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 47999999999999853 3688999999866443 45789999999999999999999999987 4578999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.+......
T Consensus 90 ~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 90 LPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred CCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 99999999998653 258999999999999999999999 89999999999999999999999999999876522
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc-------
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI------- 637 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~------- 637 (707)
...... .....++..|+|||.... ..++.++||||||+++|||+||+.|+.........
T Consensus 163 ~~~~~~-------------~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 228 (284)
T cd05038 163 KDYYYV-------------KEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG 228 (284)
T ss_pred Ccceec-------------cCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence 111000 011233567999998665 57788999999999999999999998653221100
Q ss_pred --cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 638 --EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 638 --~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+.++....... ........++.+++.+||+.+|++||+|.+|+++|+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 229 QMIVTRLLELLKEGERL---------------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred cccHHHHHHHHHcCCcC---------------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 000111111110000 001122356889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.51 Aligned_cols=246 Identities=25% Similarity=0.328 Sum_probs=192.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|+||.||+|... ++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999954 67889999987766555678999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCCC
Q 005226 492 NALRGRNGQPSTSL--SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 492 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+++.... ..+ ++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||.+.........
T Consensus 94 ~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~- 165 (268)
T cd06624 94 ALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC- 165 (268)
T ss_pred HHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-
Confidence 9998542 124 888899999999999999999 89999999999999986 679999999998755321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....++..|+|||++... ..++.++||||||+++|||++|+.||...... ....+..
T Consensus 166 ---------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~------~~~~~~~ 224 (268)
T cd06624 166 ---------------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKV 224 (268)
T ss_pred ---------------cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh------hhhHhhh
Confidence 0123468899999986543 34778999999999999999999998643211 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........+ ......++.+++.+||+.+|.+||++.++++
T Consensus 225 ~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 GMFKIHPEI-------------PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhccCCCC-------------CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111111110 1122345778999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.94 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=194.7
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEc--CCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc--ceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRL--GEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE--KLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~--~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~e~~~ 486 (707)
+||+|+|-+||||... +|..||---+ .+. .......|..|+.+|+.|+|||||+++.++.+... .-+|+|.|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 8999999999999964 6777764322 221 23345789999999999999999999999988766 568999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITG 565 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~ 565 (707)
.|+|..|+++.+ .++....++|++||++||.|||+.. ++|||||||-+||+|+.+ |.|||+|+|+|..+....
T Consensus 127 SGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 127 SGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred CCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999998775 6888899999999999999999977 599999999999999765 899999999999876432
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
. ....||+.|||||+.. ..|.+.+||||||++++||+|+.+||..-. ..+.+.+.
T Consensus 201 a------------------ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKK 255 (632)
T KOG0584|consen 201 A------------------KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKK 255 (632)
T ss_pred c------------------ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHH
Confidence 2 2356899999999854 688999999999999999999999986432 23455555
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+..+..... +..+- ..++.++|.+|+.. ..+|||+.|+++
T Consensus 256 V~SGiKP~s-l~kV~-------------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 256 VTSGIKPAA-LSKVK-------------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHcCCCHHH-hhccC-------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 555443321 12222 24567899999999 999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.56 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=194.8
Q ss_pred ceecccCeeEEEEEEeC-----------------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc
Q 005226 413 YVLGKSGLGIVYKVVLG-----------------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 474 (707)
+.||+|+||.||++... ++..+|+|++.... .....+|.+|++++++++|+||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT 90 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 47999999999998532 24568999987543 3344689999999999999999999999999
Q ss_pred CCcceEEEEeecCCChHHHHhCCCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 475 PDEKLLISDFISNGNLANALRGRNGQ------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 475 ~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
++..++||||+++|+|.+++...... ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcCCC
Confidence 99999999999999999999764321 12358899999999999999999999 8999999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh--CCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT--GKS 626 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt--g~~ 626 (707)
.++|+|||+++.+........ .....++..|+|||.... ..++.++|||||||++|||++ |..
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~--------------~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 168 TIKIADFGMSRNLYSGDYYRI--------------QGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred CEEeccCcccccccCCcceec--------------cCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCC
Confidence 999999999876542211000 011223567999998654 568899999999999999998 678
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
||...... .........+..... .... .........+.+++.+||+.||++||++.+|++.|++
T Consensus 233 p~~~~~~~------~~~~~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 233 PYSQLSDE------QVIENTGEFFRDQGR-QVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CccccChH------HHHHHHHHHHhhccc-cccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 87643221 111111111111000 0000 0001223567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.64 Aligned_cols=236 Identities=23% Similarity=0.306 Sum_probs=183.4
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHH-HHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQ-AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+||+|+||.||+|... ++..||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999975 67899999986532 122345556655 578889999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 152 (321)
T cd05603 82 ELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET- 152 (321)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc-
Confidence 9999887532 58889999999999999999999 89999999999999999999999999998743211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+.
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~- 209 (321)
T cd05603 153 ---------------TSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNIL- 209 (321)
T ss_pred ---------------cccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHh-
Confidence 022356899999999764 6788999999999999999999999965321 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
..... ........+.+++.+|++.||++||++.
T Consensus 210 --~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 --HKPLQ-------------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --cCCCC-------------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11100 0012234578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.35 Aligned_cols=245 Identities=24% Similarity=0.340 Sum_probs=189.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
++||+|+||.||+|.. .++..||+|.+... ......+|.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 4799999999999985 57889999988654 233346789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---- 150 (279)
T cd06619 87 DVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---- 150 (279)
T ss_pred HHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----
Confidence 7552 36788899999999999999999 8999999999999999999999999999875532110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.. ..++.++||||||+++|||++|+.||......... .....+.....
T Consensus 151 --------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 213 (279)
T cd06619 151 --------------KTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS--LMPLQLLQCIV 213 (279)
T ss_pred --------------cCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc--cchHHHHHHHh
Confidence 12346889999999765 56789999999999999999999999753322100 00011111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..... . + .......++.+++.+|++.||++||+++++++.
T Consensus 214 ~~~~~--~-----~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 214 DEDPP--V-----L----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ccCCC--C-----C----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11100 0 0 011123457899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=305.82 Aligned_cols=246 Identities=24% Similarity=0.349 Sum_probs=193.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++..++..++|+||+++|+|.
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 46999999999999965 57788999987665555678999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
.++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~---- 159 (282)
T cd06643 91 AVMLELE----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR---- 159 (282)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccc----
Confidence 9887532 358999999999999999999999 89999999999999999999999999998754321110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....++..|+|||++. .+..++.++|||||||++|||++|+.||...... ........
T Consensus 160 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~ 222 (282)
T cd06643 160 ------------RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAK 222 (282)
T ss_pred ------------cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----HHHHHHhh
Confidence 01234688999999864 2345678999999999999999999998643211 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+ .... .......+.+++.+||+.||.+||++.++++
T Consensus 223 ----~~~~--~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 223 ----SEPP--TLAQ--------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----cCCC--CCCC--------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100 0000 0112346789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.04 Aligned_cols=236 Identities=21% Similarity=0.284 Sum_probs=185.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+++++.++| ++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 57889999987532 2334678889999999966 5688899999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 86 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 86 GDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999997543 58999999999999999999999 89999999999999999999999999998643211100
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||..|+|||++.. ..++.++|||||||++|||+||+.||..... ......+.
T Consensus 158 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i~ 214 (324)
T cd05587 158 ----------------TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE------DELFQSIM 214 (324)
T ss_pred ----------------eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 123457899999999765 6678999999999999999999999964321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
. ....+. ......+.+++.+|++.||.+||+.
T Consensus 215 ~---~~~~~~-------------~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 215 E---HNVSYP-------------KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred c---CCCCCC-------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 111111 1122456789999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.51 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=193.6
Q ss_pred ceecccCeeEEEEEEeC-CCc----eEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGI----PVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++. .||+|.+..... ....++.+|+.++++++||||++++++|... ..++|+||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 47999999999999853 443 478888875532 3335788999999999999999999998754 5679999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 92 ~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 92 HGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 999999997643 258999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....++..|+|||++.. ..++.++||||||+++|||++ |+.||.... .....++
T Consensus 165 ~~~--------------~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~------~~~~~~~ 223 (303)
T cd05110 165 EYN--------------ADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP------TREIPDL 223 (303)
T ss_pred ccc--------------cCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 100 011234678999998654 678899999999999999998 889986432 1223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........ .......+.+++..||..+|++||+++++++.|+++.
T Consensus 224 ~~~~~~~~~---------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 224 LEKGERLPQ---------------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred HHCCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 322111100 0112346788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.51 Aligned_cols=260 Identities=24% Similarity=0.284 Sum_probs=195.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... +++.||+|+++... ......+.+|++++..++||||+++++++.+++..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 47999999999999975 68999999987542 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 87 DLMNLLIRKD-----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999998652 58999999999999999999999 899999999999999999999999999998665332000
Q ss_pred CCCCC-------------CcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005226 569 SSSGG-------------FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635 (707)
Q Consensus 569 ~~~~~-------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~ 635 (707)
..... ...............||+.|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 00000 0000000011123468999999999765 57889999999999999999999999753311
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-hHHHHH
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-MKNVSE 700 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~v~~ 700 (707)
.....+... .....+. ........+.+++.+|+. ||.+||+ ++++++
T Consensus 237 -----~~~~~i~~~-~~~~~~p-----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 237 -----ETYNKIINW-KESLRFP-----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred -----HHHHHHhcc-CCcccCC-----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 111111110 0000000 001123557789999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.72 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=200.4
Q ss_pred ceecccCeeEEEEEEeC----CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|.||+|++|.|. +...||||.++..... ...+|.+|+.+|.+|+|||+++|||+..+ ....||+|.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 37999999999999974 2356999999887554 66899999999999999999999999987 678899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+.|++.. ...|-....-.++.|||.||.||.+ +++|||||.++|+|+-....|||+|||+.+-+......
T Consensus 195 GSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 195 GSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred chHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 99999999722 3468888889999999999999999 89999999999999999999999999999977644332
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .|.+ ...-...|.|||.+.. .+++.++|||+|||++|||+| |..||-+... ..+.+-+
T Consensus 269 Y------------vm~p-~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL~~i 328 (1039)
T KOG0199|consen 269 Y------------VMAP-QRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQILKNI 328 (1039)
T ss_pred e------------EecC-CCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHHHhc
Confidence 1 1222 2334778999999665 888999999999999999999 6778865332 2222221
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
...-+ | ...+.+.+++.+++..||..+|++||+|..+.+.+
T Consensus 329 D~~er------------L---pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGER------------L---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccc------------C---CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 11111 1 12356778899999999999999999999997544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.64 Aligned_cols=255 Identities=19% Similarity=0.262 Sum_probs=185.6
Q ss_pred eecccCeeEEEEEEeCCC---ceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGNG---IPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 345667665443 3345789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++..... ....++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~ 156 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-IE 156 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchh-hh
Confidence 99999864321 2356778888999999999999999 8999999999999999999999999998764321110 00
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCC------CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCCccchhH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVP------GNRPMQKWDVYSFGVVLLELLTG-KSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DV~S~Gv~l~elltg-~~P~~~~~~~~~~~~~~~ 642 (707)
......++..|+|||+... ...++.++|||||||++|||+++ ..||..... ...
T Consensus 157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~ 217 (268)
T cd05086 157 -------------TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REV 217 (268)
T ss_pred -------------cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence 0012345788999998642 12456899999999999999975 667643221 111
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...+ ..... ....++.+. ......+.+++..|| .+|++||++++|++.|.
T Consensus 218 ~~~~---~~~~~--~~~~~~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHV---IKDQQ--VKLFKPQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHH---Hhhcc--cccCCCccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111 11110 111122111 112245677888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.37 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=195.9
Q ss_pred cceecccCeeEEEEEEeC-CC----ceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NG----IPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||.||+|... +| ..+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++|+||+
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 90 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM 90 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence 358999999999999864 23 2589998876543 334678999999999999999999999987 7889999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 91 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 91 PLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999998653 248999999999999999999999 899999999999999999999999999998765221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... .....++..|+|||.... ..++.++||||||+++||+++ |+.||..... .++..
T Consensus 164 ~~~~--------------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~ 222 (279)
T cd05057 164 KEYH--------------AEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPD 222 (279)
T ss_pred ccee--------------cCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHH
Confidence 1100 011123567999998654 677899999999999999999 9999865321 22333
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+........ .......+.+++.+||..||.+||++.++++.|+++
T Consensus 223 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 223 LLEKGERLPQ---------------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHhCCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 3322111100 011224577899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.30 Aligned_cols=241 Identities=25% Similarity=0.298 Sum_probs=185.6
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHH-HHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQ-AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||+||+|... ++..||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999965 66789999986532 122234445544 467789999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+.+.....++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~- 152 (325)
T cd05602 82 ELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT- 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC-
Confidence 9999997543 57888889999999999999999 89999999999999999999999999998753211110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+..
T Consensus 153 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~ 210 (325)
T cd05602 153 ---------------TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN 210 (325)
T ss_pred ---------------cccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHh
Confidence 123457899999998765 6788999999999999999999999964321 122222211
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
....+ .......+.+++.+|++.||.+||++.+.+..
T Consensus 211 ---~~~~~-------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 211 ---KPLQL-------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred ---CCcCC-------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 11000 01223456789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=290.80 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=193.9
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+||+|.|+.||+... .+|+.+|+|.++-. .....+++.+|+++.+.|+|||||+|...+.+...+|+|+|+|.||+|
T Consensus 18 ~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl 97 (355)
T KOG0033|consen 18 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 97 (355)
T ss_pred HHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHH
Confidence 799999999999885 47888888876533 333557889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc---CCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~~ 567 (707)
..-+..+. .+++..+-..+.||+++|.|+|. ++|||||+||.|+++- ..--+|++|||+|..+.. +.
T Consensus 98 ~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-g~- 167 (355)
T KOG0033|consen 98 FEDIVARE-----FYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-GE- 167 (355)
T ss_pred HHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC-cc-
Confidence 98886542 57888999999999999999999 8999999999999994 334589999999987762 11
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.. --..||++|||||++.. ..++..+|||+-||+||-|+.|++||.+.+. ..+.+.+.
T Consensus 168 --~~-------------~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~------~rlye~I~ 225 (355)
T KOG0033|consen 168 --AW-------------HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYEQIK 225 (355)
T ss_pred --cc-------------ccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccH------HHHHHHHh
Confidence 11 12467999999999765 7889999999999999999999999986432 23444433
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.-.-+. + ......+...+|+.+|+..||.+|.|+.|.++
T Consensus 226 ~g~yd~~~------~------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 AGAYDYPS------P------EWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccccCCCC------c------ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 32111100 0 11223356789999999999999999988764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=315.79 Aligned_cols=190 Identities=26% Similarity=0.345 Sum_probs=158.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 106 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEe
Confidence 47999999999999864 6889999998654 2233467889999999999999999999986543 4689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+.+ +|.+.++. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 107 ~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 107 LMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred CCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 9965 67777653 37889999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
... .....+|..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 176 ~~~-----------------~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 176 NFM-----------------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred Ccc-----------------CCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 110 022356889999999765 67889999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=337.95 Aligned_cols=270 Identities=21% Similarity=0.256 Sum_probs=198.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|++.... ....++|.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 47999999999999965 68899999987542 223467999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 489 NLANALRGRNG------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 489 sL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
+|.+++..... .....+++..+++++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~ 164 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceecc
Confidence 99999964211 112346788899999999999999999 899999999999999999999999999998763
Q ss_pred ccCCCCCCCCCC-cCC-CCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 563 ITGNNPSSSGGF-MGG-ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 563 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
............ .+. ......+....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 165 ~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~------ 237 (932)
T PRK13184 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGR------ 237 (932)
T ss_pred cccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh------
Confidence 221111000000 000 001112234568999999998664 67789999999999999999999999653221
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-ChHHHHHHHHhh
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-RMKNVSENLERI 705 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~v~~~L~~i 705 (707)
..... ..... + ..+ .........+.+++.+|++.||++|| +++++.+.|+..
T Consensus 238 ki~~~--~~i~~--P-~~~--------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 238 KISYR--DVILS--P-IEV--------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hhhhh--hhccC--h-hhc--------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000 00000 0 000 00112334577899999999999996 667777777654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=321.59 Aligned_cols=210 Identities=24% Similarity=0.297 Sum_probs=168.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||++... +++.||+|++.... ......+.+|+.++.+++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 47999999999999864 68899999987542 223356788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 87 DMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999997643 58999999999999999999999 899999999999999999999999999997654221100
Q ss_pred CCCCC--C---------cC-----C---CCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 569 SSSGG--F---------MG-----G---ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 569 ~~~~~--~---------~~-----~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
..... . .. . ...........||+.|+|||++.. ..++.++|||||||++|||++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00000 0 00 0 000000123468999999999765 678899999999999999999999997
Q ss_pred CC
Q 005226 630 SP 631 (707)
Q Consensus 630 ~~ 631 (707)
..
T Consensus 238 ~~ 239 (363)
T cd05628 238 SE 239 (363)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.16 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=192.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 47999999999999864 788999999875422 23467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 87 DLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999998652 258999999999999999999999 899999999999999999999999999997654221110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------- 215 (330)
T cd05601 160 ---------------SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------- 215 (330)
T ss_pred ---------------eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH---------
Confidence 122357899999998652 356778999999999999999999999643221
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+........... ... .........+.+++..|+. +|.+||++.++++
T Consensus 216 ~~~~~i~~~~~~-~~~--------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 216 KTYNNIMNFQRF-LKF--------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHcCCCc-cCC--------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111111111100 000 0001123456788899997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.41 Aligned_cols=237 Identities=23% Similarity=0.278 Sum_probs=182.9
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc---CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV---KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
||+|+||+||+|... ++..||||++.... ......+..|..++.+. +||||+++++++.+++..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 68999999986532 12234456677777665 699999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 99999997543 58999999999999999999999 89999999999999999999999999998753221110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||..|+|||++.....++.++|||||||++|||++|+.||..... ..+...+.
T Consensus 153 ----------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~ 210 (330)
T cd05586 153 ----------------TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIA 210 (330)
T ss_pred ----------------ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHH
Confidence 02235789999999976655678999999999999999999999965321 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
. ....+. .......+.+++.+|+..||.+||++.
T Consensus 211 ~---~~~~~~------------~~~~~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 211 F---GKVRFP------------KNVLSDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred c---CCCCCC------------CccCCHHHHHHHHHHcCCCHHHCCCCC
Confidence 1 110000 011224567899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.95 Aligned_cols=203 Identities=25% Similarity=0.314 Sum_probs=164.1
Q ss_pred ceeccc--CeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKS--GLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
++||+| +|++||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 379999 7899999986 578999999987542 22335677899999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||.+.........
T Consensus 84 ~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 84 GSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999997543 1248999999999999999999999 89999999999999999999999999875443211110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
.... .+ .+....++..|+|||++... ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~----~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVV----HD-----FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccc----cc-----ccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0000 00 01223457789999997643 4578999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.31 Aligned_cols=248 Identities=19% Similarity=0.239 Sum_probs=188.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence 457999999999999975 5788999998643 222335678899999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 9999999753 37889999999999999999999 89999999999999999999999999999865422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
. .....||+.|+|||++... ..++.++|||||||++|||++|+.||...... ....
T Consensus 199 ~---------------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~ 257 (370)
T cd05621 199 R---------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYS 257 (370)
T ss_pred e---------------cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 0 1234579999999987542 23678999999999999999999999653211 1111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC--CCChHHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV--RPRMKNVSEN 701 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~v~~~ 701 (707)
.+ ...... ... .........+.+++..|+..+|.+ ||++.++++.
T Consensus 258 ~i---~~~~~~-~~~--------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 258 KI---MDHKNS-LNF--------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HH---HhCCcc-cCC--------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11 111000 000 000112344667888888755543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.79 Aligned_cols=236 Identities=21% Similarity=0.288 Sum_probs=186.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
..||+|+||.||+|... ++..||+|.+.... ......+..|..++..+ +|++|+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999865 57899999987542 22335567788888887 689999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 86 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 86 GDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999997543 58999999999999999999999 89999999999999999999999999998753311110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ..+...+.
T Consensus 158 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~------~~~~~~i~ 214 (323)
T cd05616 158 ----------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM 214 (323)
T ss_pred ----------------cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 123457899999999765 6788999999999999999999999964321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
. ....+ ......++.+++.+|++.||.+|++.
T Consensus 215 ~---~~~~~-------------p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 215 E---HNVAY-------------PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred h---CCCCC-------------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 11000 01123456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.72 Aligned_cols=242 Identities=29% Similarity=0.482 Sum_probs=191.2
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||++.. ++..||+|....... ...+.+|+.++++++|||++++++++..+ ..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 45899999999999975 677899999865432 36788999999999999999999998654 579999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~----- 155 (254)
T cd05083 87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD----- 155 (254)
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC-----
Confidence 9997643 2358999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....+..|+|||++.. ..++.++||||||+++|||++ |+.||..... ...........
T Consensus 156 --------------~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~ 214 (254)
T cd05083 156 --------------NSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKGY 214 (254)
T ss_pred --------------CCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhCCC
Confidence 1112467999998654 677899999999999999998 8999864322 12222222211
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.... .......+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~~---------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEP---------------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCC---------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1110 01223567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.31 Aligned_cols=260 Identities=23% Similarity=0.260 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 4799999999999985 478899999986532 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 87 DLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999997543 58899999999999999999999 899999999999999999999999999997432211000
Q ss_pred CC--------CCCC-------cCCCC----------------CCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHH
Q 005226 569 SS--------SGGF-------MGGAL----------------PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV 617 (707)
Q Consensus 569 ~~--------~~~~-------~~~~~----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~ 617 (707)
.. .... ..... .........||+.|+|||++.. ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 00 0000 00000 0000012458999999999764 678899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCC---CC
Q 005226 618 LLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR---PR 694 (707)
Q Consensus 618 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps 694 (707)
+|||+||+.||...... +....+... .....+.+ .......+.+++.+|+. +|.+| |+
T Consensus 238 l~elltG~~Pf~~~~~~------~~~~~i~~~-~~~~~~p~-----------~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 238 MFECLIGWPPFCSENSH------ETYRKIINW-RETLYFPD-----------DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred hhhhhcCCCCCCCCCHH------HHHHHHHcc-CCccCCCC-----------CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 99999999999653221 111111100 00000000 00122456788889997 66665 58
Q ss_pred hHHHHH
Q 005226 695 MKNVSE 700 (707)
Q Consensus 695 ~~~v~~ 700 (707)
+.++++
T Consensus 299 ~~~~l~ 304 (377)
T cd05629 299 AHEIKS 304 (377)
T ss_pred HHHHhc
Confidence 888775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=301.24 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=193.1
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|++|.||++.. .++..+++|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 34899999999999986 468999999876432 123457889999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++++|.+++.... .+++..+.+++.|++.||.|||+ .+|+||||||+||++++++.++|+|||+++......
T Consensus 87 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 87 PGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred CCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 9999999997543 58899999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ......++..|+|||++.. ..++.++||||||+++|||++|+.||..... .....+
T Consensus 159 ~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~ 218 (263)
T cd06625 159 SSGT-------------GMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFK 218 (263)
T ss_pred cccc-------------cccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHH
Confidence 1000 0012345788999999765 5688999999999999999999999864321 111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... .....+ .......+.+++.+||..+|.+||++.++++.
T Consensus 219 ~~~~-~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 219 IATQ-PTNPQL-------------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred Hhcc-CCCCCC-------------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1110 000000 11223457789999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.07 Aligned_cols=260 Identities=21% Similarity=0.260 Sum_probs=191.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 47999999999999964 68899999987542 223356788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 87 DMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred HHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999997643 58999999999999999999999 899999999999999999999999999987653221100
Q ss_pred CCCCCC---c--------------CCCCCCC-----CccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 005226 569 SSSGGF---M--------------GGALPYM-----KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626 (707)
Q Consensus 569 ~~~~~~---~--------------~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~ 626 (707)
...... . .....|. ......||+.|+|||++.. ..++.++|||||||++|||++|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCC
Confidence 000000 0 0000000 0012358999999999765 677899999999999999999999
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC---hHHHHH
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR---MKNVSE 700 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~~v~~ 700 (707)
||...... .....+... ...+ ... ........+.+++.+|+. +|.+|++ +.++++
T Consensus 238 Pf~~~~~~------~~~~~i~~~---~~~~-~~~--------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNPQ------ETYRKIINW---KETL-QFP--------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCHH------HHHHHHHcC---CCcc-CCC--------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99753221 111111110 0000 000 000112356688888886 9999998 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.63 Aligned_cols=243 Identities=21% Similarity=0.370 Sum_probs=193.3
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence 3799999999999985 578999999987655545577889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++.++..++.+++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 105 ~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--- 172 (296)
T cd06655 105 DVVTET------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--- 172 (296)
T ss_pred HHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC---
Confidence 999743 48999999999999999999999 899999999999999999999999999987654221110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..... ....
T Consensus 173 -------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~-----~~~~~-~~~~-- 230 (296)
T cd06655 173 -------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-----RALYL-IATN-- 230 (296)
T ss_pred -------------CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH-HHhc--
Confidence 12245788999998664 66789999999999999999999999653221 11111 1110
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... . .........+.+++.+||..||++||++.++++
T Consensus 231 ~~~~---~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 231 GTPE---L--------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcc---c--------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000 0 001112345678999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.16 Aligned_cols=246 Identities=25% Similarity=0.259 Sum_probs=190.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... +++.+|+|.+..... .....+.+|++++++++|+||+++++++..++..++||||+++|
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 47999999999999864 688999999865422 22345788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||++.........
T Consensus 86 ~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 158 (285)
T cd05632 86 DLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI- 158 (285)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc-
Confidence 9999987543 2359999999999999999999999 89999999999999999999999999998754321100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|+..|+|||++.. ..++.++||||||+++|||++|+.||...... .........
T Consensus 159 ----------------~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~ 216 (285)
T cd05632 159 ----------------RGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRR 216 (285)
T ss_pred ----------------cCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHh
Confidence 12346899999999765 67889999999999999999999999653221 011111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
....... ........+.+++..|++.||++||+ +.+++.
T Consensus 217 ~~~~~~~-------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 217 VLETEEV-------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hhccccc-------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1111100 01122345678999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.73 Aligned_cols=246 Identities=25% Similarity=0.280 Sum_probs=191.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
++||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++|++|+++++.+.+++..++||||+++|
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 47999999999999864 688999998865422 22355778999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 86 ~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 158 (285)
T cd05630 86 DLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI- 158 (285)
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc-
Confidence 9999996543 2358999999999999999999999 89999999999999999999999999998754321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|+..|+|||++.. ..++.++|||||||++|||++|+.||........ .... ..
T Consensus 159 ----------------~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~----~~ 215 (285)
T cd05630 159 ----------------KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEV----ER 215 (285)
T ss_pred ----------------cCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHH----Hh
Confidence 12346889999999765 6688999999999999999999999975322100 0000 00
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
..... ... ........+.+++.+||+.||++||+ ++++++
T Consensus 216 ~~~~~-------~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 216 LVKEV-------QEE-----YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhh-------hhh-----cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00000 000 01112345779999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=303.38 Aligned_cols=259 Identities=24% Similarity=0.278 Sum_probs=192.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|++|.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||++ ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 47999999999999964 68999999986542 2234678899999999999999999999999999999999997 68
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++..... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 85 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 157 (285)
T cd07861 85 LKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-- 157 (285)
T ss_pred HHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--
Confidence 9999865431 2468999999999999999999999 89999999999999999999999999998754321100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....++..|+|||++.....++.++||||||+++|||+||+.||...... ..........
T Consensus 158 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-----~~~~~~~~~~ 218 (285)
T cd07861 158 --------------YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-----DQLFRIFRIL 218 (285)
T ss_pred --------------ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHHHh
Confidence 012245788999998766566788999999999999999999999753221 1111111100
Q ss_pred cc---ccCC-----------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FE---EENP-----------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~---~~~~-----------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ..+. ........+.. .......++.+++.+|+..||++|||+.+|++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 219 GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRS--AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCChhhhhcchhhHHHHhhccccCcchhHH--hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 0000 00000000000 00112356679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.57 Aligned_cols=210 Identities=24% Similarity=0.298 Sum_probs=167.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++||||+++++.+.+++..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 4799999999999986 468899999987542 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 87 DMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999997543 58889999999999999999999 899999999999999999999999999986432111000
Q ss_pred CCCCCCcC-----------C--------------------CCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHH
Q 005226 569 SSSGGFMG-----------G--------------------ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV 617 (707)
Q Consensus 569 ~~~~~~~~-----------~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~ 617 (707)
....+... + ...........||+.|+|||++.. ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 00000000 0 000000112468999999999765 678899999999999
Q ss_pred HHHHHhCCCCCCCC
Q 005226 618 LLELLTGKSPELSP 631 (707)
Q Consensus 618 l~elltg~~P~~~~ 631 (707)
+|||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.87 Aligned_cols=246 Identities=23% Similarity=0.314 Sum_probs=194.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||++... ++..+|+|.++.. .....+.+.+|+.++++++||||+++++++..++..++||||+++|+
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 357999999999999864 6889999987643 23345678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ...+++.....++.|++.||+|||+ ++|+|+||||+||++++++.++++|||.++.........
T Consensus 85 l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 157 (255)
T cd08219 85 LMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA- 157 (255)
T ss_pred HHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccccc-
Confidence 999987543 2357899999999999999999999 899999999999999999999999999987654221110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.. ..++.++||||||+++|+|++|+.||..... ......+...
T Consensus 158 ---------------~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~~ 215 (255)
T cd08219 158 ---------------CTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQG 215 (255)
T ss_pred ---------------ccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhcC
Confidence 12346888999998654 6688999999999999999999999964321 1111111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
... + +. ......+.+++.+||+.||++||++.+++..
T Consensus 216 ~~~--~----~~---------~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYK--P----LP---------SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCC--C----CC---------cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 100 0 00 1122356799999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.45 Aligned_cols=247 Identities=25% Similarity=0.319 Sum_probs=193.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|.. .++..||+|.++.........+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence 3699999999999985 468899999987655444567889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++...+ .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 95 ~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~----- 161 (267)
T cd06645 95 DIYHVTG-----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA----- 161 (267)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-----
Confidence 9997543 58999999999999999999999 8999999999999999999999999999876532111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
......|+..|+|||++. ....++.++|||||||++|||++|+.||...... ..........
T Consensus 162 -----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~ 225 (267)
T cd06645 162 -----------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALFLMTKSN 225 (267)
T ss_pred -----------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhHHhhhccC
Confidence 012235688999999864 2345788999999999999999999998643221 0111111110
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ...+ .......+.+++.+|++.+|++||++++|++
T Consensus 226 ~~~~-~~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 226 FQPP-KLKD-----------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred CCCC-cccc-----------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 0000 0011235678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.04 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=192.2
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|+||+++++|.
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHH
Confidence 6999999999999864 67889999887543 334467899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++..+..++.|++.|+.|||+ ++++|+||+|+||++++++.++++|||++.........
T Consensus 91 ~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 91 DLLKPG------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred HHhhcC------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 998643 48999999999999999999999 89999999999999999999999999998765422110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||++.. ..++.++|||||||++|||++|+.|+...... ....+.....
T Consensus 158 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~~~~~- 217 (277)
T cd06642 158 ------------RNTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPM------RVLFLIPKNS- 217 (277)
T ss_pred ------------hhcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchh------hHHhhhhcCC-
Confidence 012345788999999765 56788999999999999999999998643221 1111111100
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+ . ........+.+++.+||+.+|++||+|.+|++
T Consensus 218 --~~-------~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 --PP-------T-----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred --CC-------C-----CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 0 01123356789999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=307.26 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=193.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 347999999999999864 6788999988654 22334678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++... .+++..+..++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++........
T Consensus 86 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 86 LDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 999997643 589999999999999999999972 4899999999999999999999999999865432110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ....+....
T Consensus 156 ---------------~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~ 213 (308)
T cd06615 156 ---------------NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK------ELEAMFGRP 213 (308)
T ss_pred ---------------ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchh------hHHHhhcCc
Confidence 12345889999998654 66789999999999999999999998643211 111111110
Q ss_pred ccccC-------------------CCchhchHHHHhhh---hhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEEN-------------------PLSDMVDAMLLQEV---HAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~-------------------~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..... ...+..+....... .......++.+++.+|+..||++||++++|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000000000000 001123468899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=304.95 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=196.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++|+|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 47999999999999964 68889999876542 23347889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++...+ .+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++........
T Consensus 91 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~---- 159 (284)
T cd06620 91 DRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---- 159 (284)
T ss_pred HHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc----
Confidence 99987643 589999999999999999999973 4799999999999999999999999999865421110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC--ccchhHHHHHHh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS--IEVPDLVRWVKK 648 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~--~~~~~~~~~~~~ 648 (707)
....|+..|+|||++.. ..++.++|||||||++||++||+.||........ .....+.++...
T Consensus 160 --------------~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 160 --------------DTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred --------------CccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 12346889999998765 5778899999999999999999999976433211 011122222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
......+ . .........+.+++.+|+..||++||++.||++..
T Consensus 225 ~~~~~~~--~---------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 225 IVQEPPP--R---------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred HhhccCC--C---------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 2211110 0 00111335678999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=303.38 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=192.8
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++||||+++++++..++..++||||+++++|..
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 6999999999999965 588999999887666666789999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~----- 166 (292)
T cd06644 99 IMLELD----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR----- 166 (292)
T ss_pred HHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-----
Confidence 886543 258999999999999999999999 89999999999999999999999999988653321110
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||++.. ...++.++|||||||++|||++|+.||...... ......
T Consensus 167 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~--- 227 (292)
T cd06644 167 -----------RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKI--- 227 (292)
T ss_pred -----------cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHHH---
Confidence 022345788999998642 244678999999999999999999998643211 011111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+ ... .......++.+++.+||..||++||++.++++
T Consensus 228 -~~~~~~--~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 228 -AKSEPP--TLS--------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -hcCCCc--cCC--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111110 000 01122345788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.62 Aligned_cols=257 Identities=19% Similarity=0.234 Sum_probs=189.4
Q ss_pred ceecccCeeEEEEEEeC---CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|+||.||++... .+..|++|.+... +.+.+|++++++++||||+++++++......++||||+. ++
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 171 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD 171 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence 47999999999999753 4578999988653 345679999999999999999999999999999999985 68
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 172 l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 172 LFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 99998533 368999999999999999999999 8999999999999999999999999999976543221110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||..|+|||++.. ..++.++|||||||++|||++|+.||....... ....+..-.+ .
T Consensus 244 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~l~~i~~-~ 305 (392)
T PHA03207 244 --------------CYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS--SSSQLRSIIR-C 305 (392)
T ss_pred --------------ccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC--cHHHHHHHHH-H
Confidence 013457999999999764 678899999999999999999999997644321 1111111111 1
Q ss_pred ccccC-CCch----hchHHHHhh-------------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEEN-PLSD----MVDAMLLQE-------------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~-~~~~----~~d~~l~~~-------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..... .+.. -+.+.+... ........++.+++.+|+..||++||++.|++..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10000 0000 000000000 0000123467789999999999999999999863
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.68 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=191.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 37999999999999865 67899999886442 2223567889999999999999999999999999999999997 599
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 161 (301)
T cd07873 91 KQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-- 161 (301)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc--
Confidence 99987543 258899999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.....++.++|||||||++|||+||+.||...... +....+....
T Consensus 162 --------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~------~~~~~~~~~~ 221 (301)
T cd07873 162 --------------SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE------EQLHFIFRIL 221 (301)
T ss_pred --------------cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHc
Confidence 12245788999998766566788999999999999999999999754321 1111111111
Q ss_pred ccc--CCCchhc--------------hHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEE--NPLSDMV--------------DAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~--~~~~~~~--------------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... .....+. ...+.. ........+.+++.+|++.||++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHN--HAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CCCChhhchhhhccccccccccCccccccHHh--hcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0000000 000000 00112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.31 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=195.7
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
..||+|+||.||+|... +...|++|.+...... ....|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT 90 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence 36999999999999864 3467999988765443 3478999999999999999999999999989999999999
Q ss_pred cCCChHHHHhCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 486 SNGNLANALRGRNGQP----STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
++|+|.++++...... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||+++..
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~ 167 (275)
T cd05046 91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167 (275)
T ss_pred CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccccccccc
Confidence 9999999997654211 2258999999999999999999999 89999999999999999999999999998644
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVP 640 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 640 (707)
..... .......++..|+|||.+.. ...+.++||||||+++|||++ |..||..... .
T Consensus 168 ~~~~~---------------~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~ 225 (275)
T cd05046 168 YNSEY---------------YKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------E 225 (275)
T ss_pred Ccccc---------------cccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccch------H
Confidence 31111 01122344677999998664 567889999999999999999 7788854321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+......... .++. .......+.+++.+|++.||.+||++.++++.|++
T Consensus 226 ~~~~~~~~~~~-~~~~-------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 226 EVLNRLQAGKL-ELPV-------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HHHHHHHcCCc-CCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 22222221110 0110 01223467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.12 Aligned_cols=243 Identities=21% Similarity=0.365 Sum_probs=193.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 4799999999999995 578999999987655555577889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~--- 172 (297)
T cd06656 105 DVVTET------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 172 (297)
T ss_pred HHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc---
Confidence 999643 48899999999999999999999 899999999999999999999999999987654221110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||.... ..++.++|||||||++|+|++|+.||........ .......
T Consensus 173 -------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-----~~~~~~~--- 230 (297)
T cd06656 173 -------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATN--- 230 (297)
T ss_pred -------------CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-----eeeeccC---
Confidence 12245788999998664 6678999999999999999999999965432110 0000000
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .. ........+.+++.+||+.||++||++++|++
T Consensus 231 ~~~~---~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 231 GTPE---LQ--------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCC---CC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 01122344678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=299.41 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=192.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh---------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ---------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
..||+|+||.||+|... ++..+|+|.+...... ..+.+.+|++++++++||||+++++++...+..++|+
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 47999999999999864 6789999987644221 1256889999999999999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 86 EYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999997543 58899999999999999999999 899999999999999999999999999998664
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ..
T Consensus 158 ~~~~~~~~----------~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~ 220 (267)
T cd06628 158 ANSLSTKT----------NGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QA 220 (267)
T ss_pred cccccCCc----------cccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HH
Confidence 21110000 000112346889999998664 56788999999999999999999999653211 11
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........... ........+.+++.+||+.||.+||++.+|++
T Consensus 221 ~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 IFKIGENASPE---------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHhccCCCc---------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111110000 01122356788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.82 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=193.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCc------hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG------EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||.||+|...++..+|+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 35799999999999998889999999876432 122356889999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 85 PGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999997543 57899999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
...... .......++..|+|||++.. ..++.++||||||+++|||++|+.||...... .....
T Consensus 157 ~~~~~~----------~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~- 219 (265)
T cd06631 157 LHGTHS----------NMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMFY- 219 (265)
T ss_pred cccccc----------ccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHHH-
Confidence 110000 00122346889999999664 66789999999999999999999999643211 11110
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......... + .......+.+++.+||+.+|.+||++.++++
T Consensus 220 ~~~~~~~~~~----~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGLMPR----L---------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCCCCC----C---------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 0 1122345789999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.89 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=193.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|+||.||++... ++..||||.+........+.+.+|+.++++++||||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 36999999999999864 68899999987655555577899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||++.........
T Consensus 108 ~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~---- 174 (292)
T cd06658 108 DIVTHT------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---- 174 (292)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc----
Confidence 998642 48899999999999999999999 89999999999999999999999999998754321110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||+... ..++.++||||||+++|||++|+.||...... ....-+.....
T Consensus 175 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~ 235 (292)
T cd06658 175 ------------RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRRIRDNLP 235 (292)
T ss_pred ------------CceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcCC
Confidence 012346889999998654 66788999999999999999999998643211 11111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... ........+.+++.+|+..||.+|||++++++.
T Consensus 236 ~~~~-------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 236 PRVK-------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred Cccc-------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1000 001223457788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.57 Aligned_cols=245 Identities=22% Similarity=0.305 Sum_probs=189.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC------CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP------DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~~~~lV~e~ 484 (707)
+.||+|+||.||+|... +++.||+|.+...... ...+.+|+.++.++ +||||+++++++... ...++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 36999999999999864 6788999998654433 36788999999999 799999999998753 357899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ...++|..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999998643 2358999999999999999999999 89999999999999999999999999998765321
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
... .....|+..|+|||++.. +..++.++|||||||++|||++|+.||......
T Consensus 165 ~~~----------------~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------ 222 (272)
T cd06637 165 VGR----------------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------ 222 (272)
T ss_pred ccc----------------CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------
Confidence 110 022346888999998752 245778999999999999999999998643211
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+... ..... ....+ ......+.+++.+||..||.+||++.++++
T Consensus 223 --~~~~~~-~~~~~--~~~~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 --RALFLI-PRNPA--PRLKS---------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --HHHHHH-hcCCC--CCCCC---------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111100 00000 00111 112245789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=323.22 Aligned_cols=210 Identities=24% Similarity=0.288 Sum_probs=166.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++.+.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999964 688999999865321 22356889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|..........
T Consensus 87 ~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 87 DMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999997643 58889999999999999999999 899999999999999999999999999985432110000
Q ss_pred CC-------------CCCCcCCC--------------CCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHH
Q 005226 569 SS-------------SGGFMGGA--------------LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621 (707)
Q Consensus 569 ~~-------------~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~el 621 (707)
.. ........ ..........||+.|+|||++.. ..++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeeh
Confidence 00 00000000 00000112468999999999764 6778999999999999999
Q ss_pred HhCCCCCCCC
Q 005226 622 LTGKSPELSP 631 (707)
Q Consensus 622 ltg~~P~~~~ 631 (707)
++|+.||...
T Consensus 238 l~G~~Pf~~~ 247 (376)
T cd05598 238 LVGQPPFLAD 247 (376)
T ss_pred hhCCCCCCCC
Confidence 9999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.52 Aligned_cols=186 Identities=24% Similarity=0.343 Sum_probs=156.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++...+..++|+||+ .|+|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcH
Confidence 458999999999999975 5678999975432 2356999999999999999999999999999999999 4699
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 144 ~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--- 213 (357)
T PHA03209 144 YTYLTKRS----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--- 213 (357)
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCccc---
Confidence 99987543 358999999999999999999999 89999999999999999999999999998753311110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
....||..|+|||++.. ..++.++|||||||++|||+++..|+.
T Consensus 214 --------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 214 --------------LGLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred --------------ccccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12346899999999765 678899999999999999999766654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.82 Aligned_cols=237 Identities=20% Similarity=0.286 Sum_probs=186.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
...||+|+||.||+|... ++..||+|++.... ....+.+..|.++++.+. |++|+++++++.+.+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 358999999999999864 68899999987542 223456788999998885 5778889999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999997543 58999999999999999999999 8999999999999999999999999999875321111
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....||..|+|||++.. ..++.++|||||||++|||++|+.||..... ....+.+
T Consensus 157 ~----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~------~~~~~~i 213 (323)
T cd05615 157 T----------------TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE------DELFQSI 213 (323)
T ss_pred c----------------ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 0 122347899999998764 6678999999999999999999999965321 1222222
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
.. ....+ .......+.+++.+|++.||.+|++.
T Consensus 214 ~~---~~~~~-------------p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 214 ME---HNVSY-------------PKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred Hh---CCCCC-------------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11 11110 01122456789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=298.18 Aligned_cols=247 Identities=32% Similarity=0.520 Sum_probs=196.9
Q ss_pred ceecccCeeEEEEEEeCC-----CceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLGN-----GIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||++...+ +..||+|.+...... ..+.+.+|++++.+++|+||+++++++.+.+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 479999999999999753 488999999766443 45789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.......
T Consensus 85 ~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 85 GGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred CCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999986431 128999999999999999999999 8999999999999999999999999999876653311
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. .....++..|+|||... +..++.++||||+|++++||++ |+.||... ....+.+.
T Consensus 159 ~~---------------~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~~ 216 (258)
T smart00219 159 YK---------------KKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLEY 216 (258)
T ss_pred cc---------------cccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHH
Confidence 11 01122578899999864 4778899999999999999999 78887542 12233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
+........+ .....++.+++.+|+..||++|||+.++++.|
T Consensus 217 ~~~~~~~~~~---------------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGYRLPKP---------------ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCCCCCCC---------------CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 3222111100 11335678899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=302.90 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=194.1
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||.|+||.||++... ++..+|+|..........+.|.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence 6999999999999964 688999999876665566789999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++...+ ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++.........
T Consensus 92 ~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~----- 159 (280)
T cd06611 92 IMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK----- 159 (280)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-----
Confidence 997543 358999999999999999999999 89999999999999999999999999988654321110
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||.+. ....++.++||||||+++|||++|+.||...... ..+..+ ..
T Consensus 160 -----------~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~ 222 (280)
T cd06611 160 -----------RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----RVLLKI-LK 222 (280)
T ss_pred -----------cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----HHHHHH-hc
Confidence 12234688899999864 2245678999999999999999999998643211 111111 11
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
...+ .. + ........+.+++.+||+.+|++||++.+|++.
T Consensus 223 ---~~~~--~~-~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 ---SEPP--TL-D-------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCCC--Cc-C-------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1100 00 0 001122457789999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=300.63 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=193.3
Q ss_pred ceecccCeeEEEEEEeC----CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceE
Q 005226 413 YVLGKSGLGIVYKVVLG----NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLL 480 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 480 (707)
++||+|+||.||+|... ++..||||++... .....+++.+|++++++++||||+++++++.... ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 47999999999999853 4688999988654 2334567899999999999999999999886542 2368
Q ss_pred EEEeecCCChHHHHhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 481 ISDFISNGNLANALRGRN-GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
++||+++|+|.+++.... +.....+++....+++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccccc
Confidence 899999999999885432 1122358999999999999999999999 899999999999999999999999999988
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
......... ......++..|++||.... ..++.++||||||+++|||++ |+.||.....
T Consensus 162 ~~~~~~~~~--------------~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----- 221 (273)
T cd05074 162 KIYSGDYYR--------------QGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----- 221 (273)
T ss_pred cccCCccee--------------cCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----
Confidence 654221100 0011223567999998654 567889999999999999999 8888764321
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+..+......... .......+.+++.+|++.+|++||++.++.+.|+++
T Consensus 222 -~~~~~~~~~~~~~~~---------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 222 -SEIYNYLIKGNRLKQ---------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -HHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 223333222111000 011234688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.84 Aligned_cols=248 Identities=20% Similarity=0.230 Sum_probs=187.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.+++..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 458999999999999975 67889999986432 22335678899999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++... .++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 9999999753 37888899999999999999999 89999999999999999999999999999865422111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
. .....||+.|+|||++... ..++.++|||||||++|||++|+.||...... ....
T Consensus 199 ~---------------~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~ 257 (371)
T cd05622 199 R---------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS 257 (371)
T ss_pred c---------------ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 0 1234579999999987542 23788999999999999999999999753211 1111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC--CCChHHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV--RPRMKNVSEN 701 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~v~~~ 701 (707)
.+. ..... .... ........+.+++..|+..++.+ ||++.++++.
T Consensus 258 ~i~---~~~~~-~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 258 KIM---NHKNS-LTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHH---cCCCc-ccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111 11100 0000 00122345678889999844433 7788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.53 Aligned_cols=242 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..||.|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+++|+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 36999999999999964 68899999887543 34457889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... .+++.+...++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++..........
T Consensus 90 ~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-- 158 (277)
T cd06640 90 LDLLRAG------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR-- 158 (277)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc--
Confidence 9999743 48899999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.. ..++.++|||||||++|||+||+.||...... ....-.
T Consensus 159 --------------~~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------~~~~~~---- 213 (277)
T cd06640 159 --------------NTFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPM------RVLFLI---- 213 (277)
T ss_pred --------------ccccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------hHhhhh----
Confidence 12345778999998764 56789999999999999999999998653221 111100
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..... . .........+.+++.+||+.+|++||++.++++.
T Consensus 214 ~~~~~--~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 PKNNP--P---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hcCCC--C---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000 0 0112334567899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.81 Aligned_cols=258 Identities=21% Similarity=0.255 Sum_probs=187.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 47999999999999864 6889999998754 2233467888999999999999999999986543 4689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 103 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred hhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 9965 77777753 37899999999999999999999 8999999999999999999999999999975432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.... ....+|..|+|||++.. ..++.++|||||||++|||++|+.||....... ......
T Consensus 172 ~~~~-----------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~ 231 (355)
T cd07874 172 SFMM-----------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVI 231 (355)
T ss_pred cccc-----------------CCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence 1110 12356889999999754 678899999999999999999999997532110 000000
Q ss_pred H---------------HHHhhccccCCCchhchHHH-Hhh------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 644 R---------------WVKKGFEEENPLSDMVDAML-LQE------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 644 ~---------------~~~~~~~~~~~~~~~~d~~l-~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
+ .+...............+.. ... .........+.+++.+|++.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0 00000000000000000000 000 0001123567899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=297.34 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=193.7
Q ss_pred ceecccCeeEEEEEEeCC-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|...+ +..+++|.+..... ..++.+|++++++++||||+++++++..+...++++||+++++|.
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 86 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS 86 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence 379999999999999764 78999999875533 578999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 87 ~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~---- 155 (256)
T cd06612 87 DIMKITN----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---- 155 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc----
Confidence 9997543 358999999999999999999999 89999999999999999999999999998865432110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .... ...
T Consensus 156 ------------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-----~~~~-~~~--- 213 (256)
T cd06612 156 ------------RNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-----AIFM-IPN--- 213 (256)
T ss_pred ------------cccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-----hhhh-hcc---
Confidence 022345788999998654 678899999999999999999999987532210 0000 000
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ... .........+.+++.+||+.||++||++++|++
T Consensus 214 ~~~--~~~--------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 214 KPP--PTL--------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC--CCC--------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 000 001112345788999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=311.94 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=186.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 483 (707)
..||+|+||.||+|.. .++..||||++..... ...+.+.+|++++++++||||+++++++... ...++++|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 4799999999999985 4678999999875422 2335678899999999999999999987543 34689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
++ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 101 LM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 87 78999888643 48999999999999999999999 8999999999999999999999999999876432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....||..|+|||++.....++.++|||||||++|||++|+.||...... +..
T Consensus 171 ~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~ 225 (343)
T cd07878 171 EM-------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI------DQL 225 (343)
T ss_pred Cc-------------------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHH
Confidence 10 12346889999999766567889999999999999999999999643211 111
Q ss_pred HHHHhhccccCCCchhchHH--------HHh---hh------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAM--------LLQ---EV------HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~--------l~~---~~------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+....... ..+..... +.. .. ........+.+++.+|+..||++|||++++++
T Consensus 226 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 226 KRIMEVVGTP--SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHHhCCC--CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111100000 00000000 000 00 00011234679999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=299.44 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=193.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..||.|++|.||+|... ++..|++|.+.... ......+.+|++++++++|+||+++++++.++...++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 36999999999999965 68899999986543 33446788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++.........
T Consensus 87 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-- 155 (274)
T cd06609 87 LDLLKPG------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR-- 155 (274)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccccc--
Confidence 9999753 58999999999999999999999 899999999999999999999999999998765321111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.. ..++.++||||||+++|||+||+.||...... .....+....
T Consensus 156 --------------~~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~~ 214 (274)
T cd06609 156 --------------NTFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIPKNN 214 (274)
T ss_pred --------------ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhhhcC
Confidence 22345788999999765 55899999999999999999999998643211 1111111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ...+ ......+.+++.+||..||++||+++++++
T Consensus 215 ~~-----~~~~---------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PP-----SLEG---------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CC-----CCcc---------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00 0000 012345778999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=292.80 Aligned_cols=259 Identities=23% Similarity=0.265 Sum_probs=198.1
Q ss_pred eecccCeeEEEEEEeCC-CceEEEEEcCCCchh---hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|.-|+||++.+.+ +..+|+|++.+.... ...+...|-+||+.++||.++.||+.+..+...|+|||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 69999999999999764 588999999876432 34566779999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|...++... ...+++..+.-++..|+-||+|||. .|||.|||||+||||.++|++.|+||.++...........
T Consensus 164 L~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~ 237 (459)
T KOG0610|consen 164 LHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVK 237 (459)
T ss_pred HHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeec
Confidence 999998764 4579999999999999999999999 8999999999999999999999999999865422110000
Q ss_pred ------------C----CCCCc-----CCCC-------------CC-CCc-----cccccCccccCCCCCCCCCCCCchh
Q 005226 570 ------------S----SGGFM-----GGAL-------------PY-MKP-----VQTEKTNNYRAPEARVPGNRPMQKW 609 (707)
Q Consensus 570 ------------~----~~~~~-----~~~~-------------~~-~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~ 609 (707)
. ...+. ..+. .. ..| ..-+||-.|.|||++.+ ...+.++
T Consensus 238 s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsAV 316 (459)
T KOG0610|consen 238 SSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSAV 316 (459)
T ss_pred cCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCchh
Confidence 0 00000 0010 01 112 23468999999999775 6678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCC
Q 005226 610 DVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689 (707)
Q Consensus 610 DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP 689 (707)
|.|+|||++|||+.|+.||.+..... .+...+.+ .+ ...........+.+||.+.+..||
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~-----Tl~NIv~~--------------~l-~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKE-----TLRNIVGQ--------------PL-KFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchh-----hHHHHhcC--------------CC-cCCCCCcchhHHHHHHHHHhccCh
Confidence 99999999999999999998755431 11111111 11 011112445678899999999999
Q ss_pred CCCCC----hHHHH
Q 005226 690 EVRPR----MKNVS 699 (707)
Q Consensus 690 ~~RPs----~~~v~ 699 (707)
.+|-- +.||.
T Consensus 377 ~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhccccchHHhh
Confidence 99987 55553
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=306.52 Aligned_cols=242 Identities=22% Similarity=0.337 Sum_probs=192.5
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 6999999999999864 688999999866544445678899999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 108 ~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~---- 174 (297)
T cd06659 108 IVSQT------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---- 174 (297)
T ss_pred HHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc----
Confidence 88642 48999999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
....++..|+|||++.. ..++.++|||||||++|||++|+.||...... .....+......
T Consensus 175 ------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~ 235 (297)
T cd06659 175 ------------KSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDSPPP 235 (297)
T ss_pred ------------cceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCC
Confidence 12346889999999765 56789999999999999999999998643211 111111111000
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ........+.+++.+|++.+|++||+++++++
T Consensus 236 ~~~-------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 236 KLK-------------NAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred Ccc-------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000 00112245778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=295.02 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=195.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 47999999999999964 57889999987665545678999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+..........
T Consensus 89 ~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~--- 158 (262)
T cd06613 89 DIYQVTR----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--- 158 (262)
T ss_pred HHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc---
Confidence 9997642 258999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPG--NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||..... ..++.++||||||+++|||+||+.||...... ..........
T Consensus 159 -------------~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----~~~~~~~~~~ 220 (262)
T cd06613 159 -------------KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----RALFLISKSN 220 (262)
T ss_pred -------------ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcc
Confidence 123457789999986542 26788999999999999999999998753321 0111111110
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+... .. .........+.+++.+||..+|.+||++++|+.
T Consensus 221 ~~~~----~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 221 FPPP----KL--------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCc----cc--------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00 011233456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=314.28 Aligned_cols=190 Identities=23% Similarity=0.320 Sum_probs=158.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 47999999999999864 6788999998754 2233467889999999999999999999886543 4689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++ +|.+.+.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 110 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9964 78877753 37889999999999999999999 8999999999999999999999999999976532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
.... ....+|..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~-----------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 179 SFMM-----------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CCcc-----------------cCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 1110 12346889999999765 67889999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.67 Aligned_cols=249 Identities=30% Similarity=0.448 Sum_probs=194.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhH--HHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRH--REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||+||++... +++.+|+|.+........ ....+|+.++++++||||+++++++......++||||++++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 357999999999999975 566899999987754332 23456999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS--
T ss_pred ccccccccc-----cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc--
Confidence 999999832 258999999999999999999999 8999999999999999999999999999875411100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......++..|+|||++..+...+.++||||+|+++|+|++|+.||..... .+.......
T Consensus 154 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~------~~~~~~~~~ 213 (260)
T PF00069_consen 154 --------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS------DDQLEIIEK 213 (260)
T ss_dssp --------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH------HHHHHHHHH
T ss_pred --------------ccccccccccccccccccccccccccccccccccccccccccccccccccc------hhhhhhhhh
Confidence 012345688999999976457889999999999999999999999875310 011111111
Q ss_pred hccccCCCchhchHHHHhhh-hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEV-HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ..+.... ........+.+++.+|++.||++||++.++++
T Consensus 214 ~~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 214 ILK----------RPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHH----------THHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccc----------ccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 00111367899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.31 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=190.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
..||+|++|.||+|... ++..||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||++ ++|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCH
Confidence 47999999999999965 688999999865422 223457789999999999999999999999999999999997 499
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 160 (291)
T cd07844 90 KQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-- 160 (291)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc--
Confidence 99987543 258999999999999999999999 899999999999999999999999999986543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.+...++.++||||||+++|||++|+.||...... .+.........
T Consensus 161 --------------~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~ 221 (291)
T cd07844 161 --------------SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-----EDQLHKIFRVL 221 (291)
T ss_pred --------------cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-----HHHHHHHHHhc
Confidence 11234778999998765566789999999999999999999999643311 01111000000
Q ss_pred cccC----------------CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEEN----------------PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~----------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .........+............+.+++.+|++.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 0000000111000001111256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.55 Aligned_cols=245 Identities=22% Similarity=0.289 Sum_probs=195.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
++||+|+||.||.+.. .++..+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 5799999999999885 46888999987643 33445778999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 86 L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~-- 157 (256)
T cd08221 86 LYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-- 157 (256)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccccc--
Confidence 999997643 2358999999999999999999999 79999999999999999999999999998765432210
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....++..|+|||+..+ ..++.++||||||+++|||++|+.||..... .......
T Consensus 158 --------------~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~--- 213 (256)
T cd08221 158 --------------AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKI--- 213 (256)
T ss_pred --------------ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH---
Confidence 022346889999998664 5678899999999999999999999864321 1111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
...... .. .......+.+++.+||..+|++||+++++++.
T Consensus 214 ~~~~~~--~~----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 214 VQGNYT--PV----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HcCCCC--CC----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 111110 00 01223457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.22 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=192.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++++..++..++||||+++++|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL 86 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence 47999999999999975 7899999988654 333446789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ....+++..+..++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~---- 158 (286)
T cd06622 87 DKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---- 158 (286)
T ss_pred HHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----
Confidence 99987532 123689999999999999999999962 4899999999999999999999999999875532110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-----NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
....++..|+|||.+... ..++.++|||||||++|||++|+.||...... .....
T Consensus 159 --------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~ 218 (286)
T cd06622 159 --------------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA------NIFAQ 218 (286)
T ss_pred --------------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh------hHHHH
Confidence 122357789999986432 23578999999999999999999999643221 11111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.........+ . .......++.+++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~--~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 219 LSAIVDGDPP--T----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHhhcCCC--C----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111111100 0 01123456779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=304.79 Aligned_cols=259 Identities=20% Similarity=0.225 Sum_probs=190.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|... +|..+|+|++.... ......+.+|++++++++||||+++++++.+.+..++|+||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 47999999999999964 68899999886432 2223567889999999999999999999999999999999996 58
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 85 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~- 156 (284)
T cd07839 85 LKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY- 156 (284)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc-
Confidence 888886543 258999999999999999999999 899999999999999999999999999987553211100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.+...++.++|||||||++|||+||+.|+...... ....+.....
T Consensus 157 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~ 216 (284)
T cd07839 157 ---------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-----DDQLKRIFRL 216 (284)
T ss_pred ---------------CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-----HHHHHHHHHH
Confidence 12345788999998766556789999999999999999999997542211 1111111111
Q ss_pred ccccC-------------CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEEN-------------PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~-------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... ...........-.........++.+++.+|++.||.+|||++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 217 LGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 10000 0000000000000000122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=329.91 Aligned_cols=266 Identities=28% Similarity=0.414 Sum_probs=212.8
Q ss_pred cchHHHHHhccceecccCeeEEEEEEeC--------CCceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEE
Q 005226 402 FELDELLRASAYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAY 471 (707)
Q Consensus 402 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 471 (707)
+++..-.....+.+|.|.||.|++|... ....||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3333333345559999999999999842 1567999999866 335668899999999999 79999999999
Q ss_pred EEcCCcceEEEEeecCCChHHHHhCCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 005226 472 YWAPDEKLLISDFISNGNLANALRGRN---------GQPST--SLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540 (707)
Q Consensus 472 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~ 540 (707)
|...+..++|+||+..|+|.++|+.++ ..... .+.....+.++.|||.||+||++ .++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhh
Confidence 999999999999999999999998776 11122 38999999999999999999999 89999999999
Q ss_pred CeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHH
Q 005226 541 NILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLE 620 (707)
Q Consensus 541 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~e 620 (707)
|||+..+..+||+|||+|+............. ...-...|||||.+.. ..++.|+|||||||+|||
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~-------------~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~E 513 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSS-------------AGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWE 513 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCC-------------CCccceeecCHHHhcc-CcccccchhhHHHHHHHH
Confidence 99999999999999999997654332211000 0001456999999776 889999999999999999
Q ss_pred HHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 621 LLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 621 llt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
|+| |..||.... ...++.++++.+.+...+ ..+..++.+++..||+.+|++||++.+++
T Consensus 514 ifsLG~~PYp~~~-----~~~~l~~~l~~G~r~~~P---------------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 514 IFTLGGTPYPGIP-----PTEELLEFLKEGNRMEQP---------------EHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HhhCCCCCCCCCC-----cHHHHHHHHhcCCCCCCC---------------CCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 999 677775411 134567788888776655 22345567999999999999999999999
Q ss_pred HHHHh
Q 005226 700 ENLER 704 (707)
Q Consensus 700 ~~L~~ 704 (707)
+.++.
T Consensus 574 ~~~~~ 578 (609)
T KOG0200|consen 574 EFFEK 578 (609)
T ss_pred HHHHH
Confidence 99876
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=333.70 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=188.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
..||+|+||+||+|... .+..+|+|.+... .......|..|+.++++++|||||++++++... +..++||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 47999999999999965 5678899987654 233457789999999999999999999988654 457899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCceecCCCCCCeEEcCC----------------
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP----RKFVHGDIKPSNILLDND---------------- 547 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~iiHrDlk~~NIll~~~---------------- 547 (707)
|+|.++|..... ....+++..++.|+.||+.||+|||+... ++||||||||+|||++.+
T Consensus 99 GSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng 177 (1021)
T PTZ00266 99 GDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177 (1021)
T ss_pred CcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence 999999975321 12369999999999999999999998421 359999999999999642
Q ss_pred -CCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCC
Q 005226 548 -FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 548 -~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~ 625 (707)
..+||+|||+++.+...... ....||+.|+|||++.. ...++.++|||||||++|||+||+
T Consensus 178 ~~iVKLsDFGlAr~l~~~s~~-----------------~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 178 RPIAKIGDFGLSKNIGIESMA-----------------HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred CCceEEccCCccccccccccc-----------------cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 35899999999765321110 12356999999998753 245789999999999999999999
Q ss_pred CCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 626 SPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 626 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.||..... ...+...+.. ...+ ........+.+|+..||..+|.+||++.+++.
T Consensus 241 ~PF~~~~~-----~~qli~~lk~----~p~l------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANN-----FSQLISELKR----GPDL------------PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCc-----HHHHHHHHhc----CCCC------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99964221 1111111111 1000 00112345789999999999999999999983
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=310.22 Aligned_cols=196 Identities=23% Similarity=0.311 Sum_probs=165.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... +++.||+|++... .....+.|.+|+.++..++|+||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 47999999999999965 6889999998653 2223456889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..........
T Consensus 87 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 87 DLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 9999997532 258999999999999999999999 899999999999999999999999999987654221111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 160 ---------------SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---------------ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 022357999999998752 24567899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.44 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=185.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 483 (707)
.+.||+|+||.||+|... ++..|++|++.... ......+.+|+.++++++||||+++++++... +..++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 358999999999999864 68899999875431 22345788999999999999999999998764 45689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++++|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 999999999997543 48899999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
...... ......++..|+|||++.. ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------- 215 (266)
T cd06651 159 ICMSGT-------------GIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------- 215 (266)
T ss_pred ccccCC-------------ccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchH---------
Confidence 111000 0122346889999998764 67789999999999999999999998643211
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.+........ ...+ .......+.+++ +||..+|++||+|+||++
T Consensus 216 ~~~~~~~~~~~--~~~~---------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 216 AAIFKIATQPT--NPQL---------PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHHHHHhcCCC--CCCC---------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111111000 0000 011123344555 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.41 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=193.0
Q ss_pred ceecccCeeEEEEEEeCC--CceEEEEEcCCC----------chhhHHHHHHHHHHHHh-cCCCceeeeEEEEEcCCcce
Q 005226 413 YVLGKSGLGIVYKVVLGN--GIPVAVRRLGEG----------GEQRHREFVTEVQAIAK-VKHPNIVKLRAYYWAPDEKL 479 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~ 479 (707)
+.||+|+||.||+|.... +..+|+|.+... ......++.+|+.++.+ ++||||+++++++..++..+
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 85 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence 379999999999999764 688999987532 12234567889998876 69999999999999999999
Q ss_pred EEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 480 LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+||||+++++|.+++.... .....+++..+++++.|++.||.|||+. .+++||||||+||+++.++.+||+|||.+.
T Consensus 86 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 162 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLK-EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162 (269)
T ss_pred EEEecCCCCcHHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccccee
Confidence 9999999999999885422 1123589999999999999999999952 579999999999999999999999999997
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEV 639 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~ 639 (707)
........ ....++..|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~~-----------------~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------ 218 (269)
T cd08528 163 QKQPESKL-----------------TSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNM------ 218 (269)
T ss_pred eccccccc-----------------ccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCH------
Confidence 65432110 12346888999999765 6678999999999999999999999864221
Q ss_pred hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
......+...... + . ........+.+++.+||+.||++||++.||.++++
T Consensus 219 ~~~~~~~~~~~~~--~---~---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 219 LSLATKIVEAVYE--P---L---------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHHhhccCC--c---C---------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111111000 0 0 00112346789999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=294.28 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=191.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-cceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-EKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~ 487 (707)
.+.||+|++|.||++... +++.+++|++... .....+.+.+|++++++++|+|++++++.+...+ ..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG 84 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence 347999999999999964 5788999998643 2234467889999999999999999999876544 57899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++.... ...+++.++..++.+++.|++|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 85 GDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99999997643 2358999999999999999999999 89999999999999999999999999998766422111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ....++..|+|||+... ..++.++||||||++++||++|+.||..... ..+..
T Consensus 159 ~----------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---------~~~~~ 212 (257)
T cd08223 159 A----------------STLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------NSLVY 212 (257)
T ss_pred c----------------ccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---------HHHHH
Confidence 0 22346888999998665 6778899999999999999999999864211 11111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+ . ........+.+++.+|++.||++||++.++++
T Consensus 213 ~~~~~~~~--~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 213 RIIEGKLP--P----------MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHhcCCC--C----------CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111000 0 01122346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.11 Aligned_cols=242 Identities=26% Similarity=0.298 Sum_probs=184.6
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHh---cCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAK---VKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+||+|+||.||++... ++..+|+|.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 688999998865421 122334455444333 479999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 999999997543 59999999999999999999999 8999999999999999999999999999865432110
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....|+..|+|||....+..++.++|||||||++|||++|+.||...... ....+..
T Consensus 153 ------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~~-- 209 (279)
T cd05633 153 ------------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDR-- 209 (279)
T ss_pred ------------------cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc---CHHHHHH--
Confidence 12346889999998765566789999999999999999999999754321 1111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
........+ ......++.+++.+|+..||.+|| +++++++
T Consensus 210 -~~~~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 210 -MTLTVNVEL-------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred -HhhcCCcCC-------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 111111000 112234678999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=302.92 Aligned_cols=262 Identities=22% Similarity=0.335 Sum_probs=193.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++|+||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 47999999999999975 588999998765422 234678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++..... .++|.++..++.||+.||+|||+ .+++||||+|+||++++++.++|+|||++..........
T Consensus 87 l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~- 157 (286)
T cd07846 87 LDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY- 157 (286)
T ss_pred HHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc-
Confidence 988876432 48999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.....++.++||||||+++|||++|++||...... .....+..+....
T Consensus 158 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~~~~~~~~~~~ 220 (286)
T cd07846 158 ---------------TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQLYHIIKCLGNL 220 (286)
T ss_pred ---------------CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHHHHHHHHhCCC
Confidence 11235788999999765556788999999999999999999988643211 0001111111100
Q ss_pred ccccCC---CchhchH----HHHh----hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP---LSDMVDA----MLLQ----EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~---~~~~~d~----~l~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ...+++. .... ..........+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 0000000 0000 0001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.66 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=192.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++||||++++.
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 47999999999999975 68999999886442 2223568899999999999999999999999999999999999998
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 87 l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~- 157 (286)
T cd07847 87 LNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY- 157 (286)
T ss_pred HHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcccc-
Confidence 888876432 58999999999999999999999 899999999999999999999999999998664322100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.....++.++||||||+++|||++|+.||....... ............
T Consensus 158 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~ 220 (286)
T cd07847 158 ---------------TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDL 220 (286)
T ss_pred ---------------cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence 112347789999987655667889999999999999999999997533210 000000000000
Q ss_pred cc-------ccCCCchhchHHHHh----hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FE-------EENPLSDMVDAMLLQ----EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~-------~~~~~~~~~d~~l~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ..........+.... ..........+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000000000 0000112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.02 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... ++..|++|++.... ......+.+|+.++++++||||+++++++..+...++|+||+ ++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~ 83 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS 83 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence 347999999999999964 78999999987553 233467899999999999999999999999999999999999 99
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ..+++.++..++.||+.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9999997543 358999999999999999999999 899999999999999999999999999987654322100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||++.....++.++||||+|++++||+||++||...... ....++..
T Consensus 157 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~------~~~~~~~~ 215 (286)
T cd07832 157 ---------------YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI------EQLAIVFR 215 (286)
T ss_pred ---------------cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH------HHHHHHHH
Confidence 012346889999999766566789999999999999999998777543211 11111111
Q ss_pred hccccCC-----Cchhch-----------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENP-----LSDMVD-----------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~-----~~~~~d-----------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+..... +.++.+ ..+.. ........+.+++.+|+..||++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 216 TLGTPNEETWPGLTSLPDYNKITFPESKPIPLEE--IFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HcCCCChHHHhhccCcchhhcccCCCCCcchHHH--hCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1110000 000000 00000 00122367889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=294.85 Aligned_cols=243 Identities=25% Similarity=0.374 Sum_probs=192.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 47999999999999976 78999999875532 2234678999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+++|.+++.... .+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 86 GGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999997542 58899999999999999999999 8999999999999999999999999999876542210
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. ....++..|+|||.+.....++.++||||||+++|+|++|+.||..... ......+.
T Consensus 158 ~-----------------~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~ 215 (258)
T cd06632 158 A-----------------KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIG 215 (258)
T ss_pred c-----------------cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHH
Confidence 0 1234578899999876533478999999999999999999999864321 11111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ....... ......+.+++.+||+.+|.+||++.++++
T Consensus 216 ~~--~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 RS--KELPPIP-------------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred hc--ccCCCcC-------------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 10 0000000 112345678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.40 Aligned_cols=261 Identities=22% Similarity=0.260 Sum_probs=185.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhc---CCCceeeeEEEEEcC-----CcceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKV---KHPNIVKLRAYYWAP-----DEKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~~~~lV 481 (707)
+.||+|+||+||+|... +++.||+|.++.... .....+.+|+++++++ +||||+++++++... ...++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 47999999999999865 688999998865321 1224566787777665 799999999998653 346899
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||++ ++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 86 FEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred Ecccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 99997 58999987543 2358999999999999999999999 89999999999999999999999999998765
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
..... .....++..|+|||++.. ..++.++|||||||++|||++|++||....... ....
T Consensus 159 ~~~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~ 218 (288)
T cd07863 159 SCQMA-----------------LTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK 218 (288)
T ss_pred cCccc-----------------CCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHH
Confidence 42211 012345888999999765 678899999999999999999999986432210 0011
Q ss_pred HHHHHHhhccccCCC-----chhchHHHHh--hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPL-----SDMVDAMLLQ--EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~-----~~~~d~~l~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+..+........++. ...+.+.... ..........+.+++.+|++.||++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111110000000000 0000000000 0000123356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.56 Aligned_cols=249 Identities=24% Similarity=0.321 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc-----CCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA-----PDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV~e~~ 485 (707)
+.||+|+||.||++... ++..+|+|.+...... ..++.+|+.+++++ +||||+++++++.. ++..++||||+
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeeccccch-HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 37999999999999864 6788999987654322 36688899999999 79999999998853 34679999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.++++... .....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFL-KRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhh-ccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 9999999886432 122468999999999999999999999 899999999999999999999999999987654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
.. .....|+..|+|||++.. +..++.++|||||||++|||++|+.||...... ..
T Consensus 179 ~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~ 237 (286)
T cd06638 179 LR----------------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RA 237 (286)
T ss_pred Cc----------------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HH
Confidence 10 122346889999998642 244688999999999999999999998653221 01
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
+... ..... ....++ ......+.+++.+||+.||++||++.||++.
T Consensus 238 ~~~~----~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKI----PRNPP--PTLHQP--------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhhc----cccCC--CcccCC--------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1110 00000 000000 1112357899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.01 Aligned_cols=258 Identities=21% Similarity=0.279 Sum_probs=191.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|... ++..||||++.... ......+.+|++++++++||||+++++++.+++..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 47999999999999864 68899999886542 2223578899999999999999999999999999999999995 68
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||+++.........
T Consensus 85 l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~- 157 (284)
T cd07860 85 LKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 157 (284)
T ss_pred HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc-
Confidence 999987543 2358999999999999999999999 899999999999999999999999999987553221100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.+...++.++||||||+++|||+||+.||..... ...+.+.....
T Consensus 158 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~ 217 (284)
T cd07860 158 ---------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-----IDQLFRIFRTL 217 (284)
T ss_pred ---------------ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHHh
Confidence 1123477899999876545568899999999999999999999864321 11111111110
Q ss_pred ccccCC--------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP--------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~--------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
-..... +.......+... .......+.+++.+|++.||.+||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 218 GTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCCChhhhhhhhHHHHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000 000000000000 0112245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.66 Aligned_cols=196 Identities=23% Similarity=0.297 Sum_probs=165.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... +++.+|+|.+.+.. ......|..|+.++..++|+||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 47999999999999965 56789999986532 223355888999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.++++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 87 DLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999997642 258999999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
.....||+.|+|||++.. ...++.++|||||||++|||++|+.||..
T Consensus 160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 160 ---------------SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred ---------------ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 022457999999998652 34678899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=295.33 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=194.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||++... +++.|++|.+... .....+++.+|++++++++||||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 347999999999999854 6889999988643 2334568899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++.++.+++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 85 DLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 9999997543 2357899999999999999999999 89999999999999999999999999998765422110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||+... ..++.++|||||||+++||++|+.||.... ..+... .
T Consensus 158 ---------------~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~---~ 212 (256)
T cd08218 158 ---------------ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVL---K 212 (256)
T ss_pred ---------------hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHH---H
Confidence 012346788999999765 667889999999999999999999986421 111111 1
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+ . ........+.+++.+||+.+|.+||+|.+|++
T Consensus 213 ~~~~~~~--~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 213 IIRGSYP--P----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HhcCCCC--C----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111100 0 01122356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.65 Aligned_cols=262 Identities=20% Similarity=0.244 Sum_probs=193.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..++..++||||+++|
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 47999999999999965 57889999887553 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 87 DCATLLKNIG-----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999997543 58999999999999999999999 899999999999999999999999999987432111100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
..... ..............++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ..+......
T Consensus 159 ~~~~~-~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~~~~ 230 (305)
T cd05609 159 LYEGH-IEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQVIS 230 (305)
T ss_pred ccccc-cccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 00000 000000001112346888999999665 6678999999999999999999999864321 111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
... ..+ .........+.+++.+||+.||++||++.++.+.|+
T Consensus 231 ~~~-~~~------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 231 DDI-EWP------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccc-CCC------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 000 000 000112345789999999999999999766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=300.73 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=194.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... +++.|++|+++.. .....+.+.+|++++++++|+||+++++++..++..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 347999999999999975 6789999988654 2233467899999999999999999999999999999999999987
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
.+..+.... ..+++.++..++.||+.||+|||+ .+++||||||+||++++++.+||+|||++..........
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 776665432 248999999999999999999999 899999999999999999999999999987765322100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
. ....++..|+|||++.....++.++||||||+++|||++|+.||...... +.......
T Consensus 158 ~---------------~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~ 216 (288)
T cd07833 158 L---------------TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI------DQLYLIQK 216 (288)
T ss_pred c---------------cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHH
Confidence 0 12345788999999876447889999999999999999999998643211 11111111
Q ss_pred hcc-----------ccC-----CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFE-----------EEN-----PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~-----------~~~-----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ... .+.+..+..............++.+++.+||..+|++||+++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 217 CLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000 0001111111111111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.14 Aligned_cols=271 Identities=22% Similarity=0.239 Sum_probs=194.8
Q ss_pred ceecccCeeEEEEEEeC---CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 484 (707)
..||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++... +..++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 47999999999999965 47899999987643 23336678899999999999999999999988 778999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC----CCCeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN----DFQPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~----~~~~kl~DfGla~~ 560 (707)
+++ +|.+++..........+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 975 78777754432223468999999999999999999999 89999999999999999 89999999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc--
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE-- 638 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~-- 638 (707)
........ .......++..|+|||++.....++.++|||||||+++||++|++||..........
T Consensus 162 ~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 228 (316)
T cd07842 162 FNAPLKPL-------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228 (316)
T ss_pred cCCCcccc-------------cccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence 54322110 111234568889999987665667899999999999999999999997644321000
Q ss_pred --chhHHHHHHhhccc----------cCCCchh--------ch-HHHHhhhh-hHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 639 --VPDLVRWVKKGFEE----------ENPLSDM--------VD-AMLLQEVH-AKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 639 --~~~~~~~~~~~~~~----------~~~~~~~--------~d-~~l~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
...+.+.+...-.. ...+... .. ..+..... ......++.+++.+|++.||++|||+.
T Consensus 229 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ 308 (316)
T cd07842 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAE 308 (316)
T ss_pred hHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 00111111100000 0000000 00 00000000 002345688999999999999999999
Q ss_pred HHHH
Q 005226 697 NVSE 700 (707)
Q Consensus 697 ~v~~ 700 (707)
++++
T Consensus 309 eil~ 312 (316)
T cd07842 309 EALE 312 (316)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.74 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=191.6
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch----------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE----------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 480 (707)
.+.||.|+||.||+|.. .+++.||+|.++.... ...+.+.+|+.++++++|||++++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 34799999999999985 4688999998753211 112467889999999999999999999999999999
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
||||+++|+|.++++... .+++..+..++.||+.||.|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 86 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 86 FLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999997652 58999999999999999999999 8999999999999999999999999999875
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN-RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEV 639 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~ 639 (707)
........ ......++..|+|||.+.... .++.++||||||+++||+++|+.||......
T Consensus 158 ~~~~~~~~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----- 218 (272)
T cd06629 158 SDDIYDND--------------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----- 218 (272)
T ss_pred cccccccc--------------ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----
Confidence 43211100 002234688999999866533 4788999999999999999999998532111
Q ss_pred hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.+..... ... .++... .......+.+++.+||..||.+||++.+|++
T Consensus 219 ~~~~~~~~~~--~~~----~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 219 AAMFKLGNKR--SAP----PIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHHHhhccc--cCC----cCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0111110000 000 011100 1122456789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.64 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=193.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh-----hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ-----RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 47999999999999964 6899999998765322 2355778999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 85 ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999999997542 258999999999999999999999 8999999999999999999999999999976643211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ....++..|+|||.+.....++.++|||||||++|||++|.+||...... +..+..
T Consensus 158 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~------~~~~~~ 215 (298)
T cd07841 158 KM----------------THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI------DQLGKI 215 (298)
T ss_pred cc----------------cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH------HHHHHH
Confidence 00 12234778999998765567789999999999999999998777543221 111111
Q ss_pred HhhccccCC--------Cchhc------hHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 647 KKGFEEENP--------LSDMV------DAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 647 ~~~~~~~~~--------~~~~~------d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
...+..... ..... .... ..........+.+++.+||+.||++||+++||++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 216 FEALGTPTEENWPGVTSLPDYVEFKPFPPTPL--KQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHcCCCchhhhhhcccccccccccccCCcch--hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 110000000 00000 0000 00011224567899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=298.13 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=189.6
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC-----CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP-----DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~~~lV~e~~ 485 (707)
..||+|+||.||++.. .+++.+|+|.+...... ...+.+|+.+++++ +|||++++++++... +..++|+||+
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccccH-HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 3799999999999996 46889999998654332 36678899999999 899999999998754 3579999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.++++... .....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 107 ~~~sL~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 107 NGGSVTELVKGLL-ICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred CCCcHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 9999999986432 112358999999999999999999999 899999999999999999999999999987654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN----RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
... ....++..|+|||.+.... .++.++|||||||++|||++|+.||...... ..
T Consensus 183 ~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----~~ 241 (291)
T cd06639 183 LRR----------------NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----KT 241 (291)
T ss_pred ccc----------------cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----HH
Confidence 110 1234678899999865422 3578999999999999999999998643221 11
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.++.+. .. ..+.+ .......+.+++.+|++.+|++||++.++++
T Consensus 242 ~~~~~~~----~~--~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKIPRN----PP--PTLLH--------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhcC----CC--CCCCc--------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 00 01101 1122345889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=296.80 Aligned_cols=255 Identities=25% Similarity=0.313 Sum_probs=194.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~g 488 (707)
+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++||||++++++|... +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 47999999999999974 678899998875432 3447789999999999999999999998654 3678999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-- 160 (287)
T cd06621 87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-- 160 (287)
T ss_pred CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc--
Confidence 99998764321 23458999999999999999999999 8999999999999999999999999999865432110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||.... ..++.++||||||+++|||++|+.||...... .....++..+...
T Consensus 161 ----------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~ 222 (287)
T cd06621 161 ----------------GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSYIVN 222 (287)
T ss_pred ----------------ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHHHhc
Confidence 11234778999998654 67789999999999999999999999764321 1122233344332
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... .+..+ ........+.+++.+||+.+|.+|||+.||++
T Consensus 223 ~~~~~~--~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 223 MPNPEL--KDEPG-------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCchhh--ccCCC-------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111000 00000 00122456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=296.73 Aligned_cols=243 Identities=22% Similarity=0.357 Sum_probs=193.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcC---CCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVK---HPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|.. .++..|++|.+... ......++.+|++++++++ |||++++++++..+...++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 4799999999999996 57899999998654 2334467889999999997 99999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++... .+++.....++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++.........
T Consensus 87 ~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 87 GSVRTLMKAG------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred CcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence 9999998643 58999999999999999999999 89999999999999999999999999998766432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....|+..|+|||++..+..++.++|||||||++|+|++|+.||...... ....+..
T Consensus 158 ----------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~~ 215 (277)
T cd06917 158 ----------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLIP 215 (277)
T ss_pred ----------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhccc
Confidence 022346888999998766566789999999999999999999999653221 1111110
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. .. + .. + .......++.+++.+||+.||++||++.++++
T Consensus 216 ~---~~-~-~~-----~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 216 K---SK-P-PR-----L----EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred c---CC-C-CC-----C----CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0 00 0 00 0 00113356789999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.46 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=193.1
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc------hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG------EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|++|.||++.. .++..||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 35799999999999985 578999999886432 12346789999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINI 563 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~ 563 (707)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||.+.....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999997543 58899999999999999999999 8999999999999998776 599999999877653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
....... ......++..|+|||.+.. ..++.++||||+|+++++|++|+.||...... ...
T Consensus 157 ~~~~~~~------------~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~ 217 (268)
T cd06630 157 KGTGAGE------------FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS------NHL 217 (268)
T ss_pred ccccCCc------------cccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc------chH
Confidence 2111000 0112346889999999654 67789999999999999999999998643221 111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
............ . .........+.+++.+|+..+|.+||++.++++
T Consensus 218 ~~~~~~~~~~~~--~---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 ALIFKIASATTA--P---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HHHHHHhccCCC--C---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 111110000000 0 011123356778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.38 Aligned_cols=210 Identities=24% Similarity=0.297 Sum_probs=168.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... ++..||+|++.... ......+.+|+.++.+++||||+++++.+.+++..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 47999999999999865 68899999986532 223467888999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 87 DMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999997543 58999999999999999999999 899999999999999999999999999987553211100
Q ss_pred CCC---C-CCcCCCCC---------------CCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 569 SSS---G-GFMGGALP---------------YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 569 ~~~---~-~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
... . .....+.. ........||+.|+|||++.. ..++.++|||||||++|||+||+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCC
Confidence 000 0 00000000 000113468999999999765 678899999999999999999999997
Q ss_pred CC
Q 005226 630 SP 631 (707)
Q Consensus 630 ~~ 631 (707)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.93 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=182.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCC------ceeeeEEEEEcC-CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHP------NIVKLRAYYWAP-DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~~-~~~~lV~e 483 (707)
.+.||+|+||+||+|... .++.||||+++..... .+++..|++++++++|. +++++++++..+ +..++|||
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~ 212 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP 212 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence 347999999999999864 6788999998654322 24566788888777654 588999998765 46788888
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---------------
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF--------------- 548 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~--------------- 548 (707)
++ +++|.+++...+ .+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 213 ~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 213 KY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred cc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 87 779999987543 589999999999999999999972 3899999999999998765
Q ss_pred -CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005226 549 -QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627 (707)
Q Consensus 549 -~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P 627 (707)
.+||+|||.+...... .....||..|+|||++.. ..++.++|||||||++|||++|+.|
T Consensus 285 ~~vkl~DfG~~~~~~~~-------------------~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 285 CRVRICDLGGCCDERHS-------------------RTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred ceEEECCCCccccCccc-------------------cccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 4999999987532211 123457999999999765 6788999999999999999999999
Q ss_pred CCCCCCCCCccchhHHH---------HHHh--------hccccCCCchhchHHHH-h---h--hhhHHHHHHHHHHHHhc
Q 005226 628 ELSPTTSTSIEVPDLVR---------WVKK--------GFEEENPLSDMVDAMLL-Q---E--VHAKKEVIAVFHLALAC 684 (707)
Q Consensus 628 ~~~~~~~~~~~~~~~~~---------~~~~--------~~~~~~~~~~~~d~~l~-~---~--~~~~~~~~~l~~l~~~C 684 (707)
|...... +...... |... .+.....+....++... . . .........+.+|+.+|
T Consensus 345 f~~~~~~---~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 421 (467)
T PTZ00284 345 YDTHDNL---EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421 (467)
T ss_pred CCCCChH---HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence 9754321 1001110 1100 00000000000111000 0 0 00011234577999999
Q ss_pred cCCCCCCCCChHHHHH
Q 005226 685 TEADPEVRPRMKNVSE 700 (707)
Q Consensus 685 l~~dP~~RPs~~~v~~ 700 (707)
+..||++|||++|+++
T Consensus 422 L~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 422 LHYDRQKRLNARQMTT 437 (467)
T ss_pred CCcChhhCCCHHHHhc
Confidence 9999999999999986
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=298.12 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=199.2
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCchh--hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQ--RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.||+|-|++|-+|++ =+|..||||++.+.... ....+.+|++-|+-++|||||+||.+...+...|||+|.-.+|+|
T Consensus 25 TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl 104 (864)
T KOG4717|consen 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDL 104 (864)
T ss_pred hhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchH
Confidence 799999999999984 38999999999877443 336788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
++|+-++. ..+.+....+++.||..|+.|+|+ ..+|||||||+||.+-+ -|-||+.|||++-.+......
T Consensus 105 ~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL-- 175 (864)
T KOG4717|consen 105 FDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL-- 175 (864)
T ss_pred HHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh--
Confidence 99997664 469999999999999999999999 79999999999998864 588999999999776543322
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
+...|...|.|||++.+..+..++.||||+||+||-|++|++||......+.
T Consensus 176 ---------------~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------------- 227 (864)
T KOG4717|consen 176 ---------------TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------------- 227 (864)
T ss_pred ---------------hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------
Confidence 2345688999999999877777999999999999999999999986544311
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.-++|-... -......++.+||.+|+..||.+|-+.++|+.
T Consensus 228 ------LTmImDCKYt---vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 ------LTMIMDCKYT---VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ------hhhhhccccc---CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1112221111 12334456789999999999999999999874
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=296.15 Aligned_cols=259 Identities=20% Similarity=0.217 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .++..|++|++..... .....+.+|++++++++|+||+++++++..++..++|+||+. ++|
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 3799999999999985 4688999999865432 223467889999999999999999999999999999999995 788
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+.+..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-- 160 (291)
T cd07870 90 AQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY-- 160 (291)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC--
Confidence 88776432 247888999999999999999999 899999999999999999999999999987543211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||...... ...........
T Consensus 161 --------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~ 221 (291)
T cd07870 161 --------------SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVL 221 (291)
T ss_pred --------------CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHc
Confidence 12235788999998765456788999999999999999999999753321 01100000000
Q ss_pred cc------------cCCCchh----chHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EE------------ENPLSDM----VDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~------------~~~~~~~----~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ....... ....+............+.+++.+|+..||.+|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 0000000 00000000000112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.77 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=194.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||.|+||.||++.. .++..+++|.+... .....+.+..|++++++++||||+++++++... ...+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 4799999999999985 46788999988643 333446788999999999999999999988653 456899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS--PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|.+++.... .....+++..++.++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 164 (265)
T cd08217 86 GDLAQLIQKCK-KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164 (265)
T ss_pred CCHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence 99999997542 12346899999999999999999999221 1799999999999999999999999999988664322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....++..|+|||++.. ..++.++||||||+++++|++|+.||.... ...+.+.
T Consensus 165 ~~~----------------~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~ 221 (265)
T cd08217 165 SFA----------------KTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLASK 221 (265)
T ss_pred ccc----------------cccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHHHH
Confidence 100 12345888999999765 567899999999999999999999987532 1223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
+....... ........+.+++.+|++.+|++||++++|++.
T Consensus 222 ~~~~~~~~---------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 222 IKEGKFRR---------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HhcCCCCC---------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 22211100 011233567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.22 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=198.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh---hHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|.||.||++..+ +|..+|+|.+.+.... ......+|+.+|+++. |||||.+++.+.+....++|||++.|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 47999999999999976 5999999999776432 3368899999999997 99999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC----CCeEEecccccccccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND----FQPYISDFGLSRLINI 563 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~~~~ 563 (707)
|.|.+.+... .+++..+..++.||+.+++|||+ .+|+||||||+|+|+... +.+|++|||+|.....
T Consensus 121 GeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 121 GELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred chHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 9999999865 28999999999999999999999 899999999999999643 4799999999988764
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
... . ....||+.|+|||++.. ..++..+||||+||++|.|++|.+||....... ...
T Consensus 192 ~~~-~----------------~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-----~~~ 248 (382)
T KOG0032|consen 192 GER-L----------------HTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-----IFL 248 (382)
T ss_pred Cce-E----------------eeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-----HHH
Confidence 111 1 34578999999999664 788999999999999999999999998755321 111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.-....+.-. ..........+.+++..|+..||..|+|+.++++
T Consensus 249 ~i~~~~~~f~-------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 249 AILRGDFDFT-------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHHcCCCCCC-------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111000 0112333566789999999999999999999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=294.22 Aligned_cols=242 Identities=22% Similarity=0.353 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .++..||+|...... ......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 89 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence 4799999999999986 468899999876543 23346788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... .+++..+..++.+++.|++|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 90 ~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~-- 158 (277)
T cd06641 90 LDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-- 158 (277)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh--
Confidence 9999743 48999999999999999999999 899999999999999999999999999987654211100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||.+.. ...+.++|||||||++|||++|..||...... .....+..
T Consensus 159 --------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-- 215 (277)
T cd06641 159 --------------NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK-- 215 (277)
T ss_pred --------------ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc--
Confidence 12345778999998764 56788999999999999999999998643211 11111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
...+ .+ .......+.+++.+||+.+|.+||++.++++.
T Consensus 216 -~~~~---~~---------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 -NNPP---TL---------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCC---CC---------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1100 00 11223457789999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.56 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=193.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
..||+|++|.||++.. .++..+++|++........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 4899999999999985 478899999886554444567889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||.+.........
T Consensus 105 ~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---- 171 (285)
T cd06648 105 DIVTHT------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---- 171 (285)
T ss_pred HHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc----
Confidence 999752 48999999999999999999999 89999999999999999999999999987654321100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....|+..|+|||.... ..++.++|||||||++|||++|+.||...... ...+.....
T Consensus 172 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-- 230 (285)
T cd06648 172 ------------RKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-- 230 (285)
T ss_pred ------------cccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc--
Confidence 012346889999999655 56789999999999999999999998643211 111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+ ... ........+.+++.+||+.+|++||++.++++
T Consensus 231 -~~~--~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 -LPP--KLK--------NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -CCC--CCc--------ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 100 000 00112356889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=291.92 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=192.9
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||++.. .++..+|+|.+... .......+.+|++++++++||||+++++.+..++..++|+||++++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence 34799999999999986 47788999988654 2334578899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++.... ...+++..+.+++.+++.||+|||+ ++++||||||+||+++++ +.+||+|||.+........
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 85 TLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 9999997643 2358999999999999999999999 899999999999999865 4689999999876542211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... .....+..
T Consensus 158 ----------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~ 214 (256)
T cd08220 158 ----------------AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIM 214 (256)
T ss_pred ----------------ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHH
Confidence 012345788999999765 5678899999999999999999999864321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .+ . .......+.+++.+||+.+|++||++.++++
T Consensus 215 ~~~~--~~---~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 215 SGTF--AP---I----------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred hcCC--CC---C----------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1110 00 0 0112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=296.26 Aligned_cols=254 Identities=21% Similarity=0.245 Sum_probs=190.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... ++..||+|+++... ........+|+.++.++. |+|++++++++.++ +..++|+||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 47999999999999854 68899999987542 222234567999999995 99999999999987 88999999996
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ..++|.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++........
T Consensus 84 ~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 84 MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 58888887543 358999999999999999999999 89999999999999999 99999999999765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||..... .+...+..
T Consensus 156 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~------~~~~~~~~ 212 (282)
T cd07831 156 -----------------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE------LDQIAKIH 212 (282)
T ss_pred -----------------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH------HHHHHHHH
Confidence 1123578899999866556678899999999999999999999965322 12222222
Q ss_pred hhccccCC---------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENP---------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~---------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ +.......+.. ........+.+++.+|++.+|++||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK--LLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHcCCCCHHHHHhhcccccccccCcccccccHHH--HcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 21111000 00000000000 01123577899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=298.78 Aligned_cols=241 Identities=23% Similarity=0.389 Sum_probs=189.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|.+.... ....+++.+|++++++++||||++++++|..++..++|+||++ |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 47999999999999864 68899999886432 2334678899999999999999999999999999999999996 6
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||++......
T Consensus 100 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 100 SASDILEVHK----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred CHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 8888776432 258999999999999999999999 89999999999999999999999999998654311
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....++..|+|||++.. ...++.++||||||+++|||+||+.||..... .......
T Consensus 169 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~ 226 (307)
T cd06607 169 ----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI 226 (307)
T ss_pred ----------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHH
Confidence 11235778999998642 35678899999999999999999999864321 1111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
. ....+ .. ........+.+++.+||..||++||++.+|+..
T Consensus 227 ~---~~~~~--~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 227 A---QNDSP--TL---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred h---cCCCC--CC---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 11100 00 011233568899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=292.77 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=198.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 347999999999999954 67889999987543 2245789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++.... ...+++.....++.|++.||+|||+ .+++||||||+||++++++.++|+|||++...........
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999976431 2358999999999999999999999 8999999999999999999999999999877653321110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.......++..|+|||++.....++.++|||||||++|||++|+.||...... ..+.+....
T Consensus 161 ------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-----~~~~~~~~~- 222 (267)
T cd06610 161 ------------KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQN- 222 (267)
T ss_pred ------------cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-----hhHHHHhcC-
Confidence 01123356889999999776447889999999999999999999999754321 111121111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+.. ..........+.+++.+|+..||++||+++++++
T Consensus 223 --~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 223 --DPPSLET--------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --CCCCcCC--------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0001123356789999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=291.73 Aligned_cols=251 Identities=26% Similarity=0.356 Sum_probs=194.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... ++..|++|.+..... ...+.+..|++++++++|+||+++++++...+..++|+||++++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG 84 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence 357999999999999864 788999999876543 35578999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..|+.+++.||+|||+ .+|+|+||+|+||++++++.+||+|||++..........
T Consensus 85 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 85 TLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999997542 47899999999999999999999 899999999999999999999999999988765332211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN--RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
... .....++..|+|||++.... ..+.++||||||+++||+++|+.||...... .......
T Consensus 157 ~~~------------~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~ 219 (264)
T cd06626 157 GEE------------VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHV 219 (264)
T ss_pred ccc------------ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHH
Confidence 100 01234578899999976532 3788999999999999999999999643211 1111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. .....+.. .......+.+++.+||+.+|++||++.+++.
T Consensus 220 ~~--~~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 220 GA--GHKPPIPD-----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred hc--CCCCCCCc-----------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 10100000 0112345678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=308.49 Aligned_cols=196 Identities=23% Similarity=0.290 Sum_probs=165.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.++..++|+||+++++++.+++..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 67889999986532 223356888999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 87 DLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 9999997642 258999999999999999999999 899999999999999999999999999997654221110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC----CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG----NRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
.....||+.|+|||++... ..++.++|||||||++|||++|+.||..
T Consensus 160 ---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 160 ---------------SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ---------------eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 0224579999999986531 3567899999999999999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=292.19 Aligned_cols=246 Identities=20% Similarity=0.269 Sum_probs=187.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 483 (707)
.+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 358999999999999864 68899999875321 22346788999999999999999999988764 35679999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++|+|.+++.... .+++....+++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||+++....
T Consensus 87 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 87 HMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 999999999997543 47889999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
...... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...... .
T Consensus 159 ~~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~ 216 (265)
T cd06652 159 ICLSGT-------------GMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--------A 216 (265)
T ss_pred cccccc-------------ccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchH--------H
Confidence 111000 0122346889999998765 66789999999999999999999998642111 1
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ......... ... ........+.+++.+|+. +|++||++++|++
T Consensus 217 ~-~~~~~~~~~--~~~---------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 217 A-IFKIATQPT--NPV---------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred H-HHHHhcCCC--CCC---------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 111111000 000 112233456788888984 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=310.00 Aligned_cols=192 Identities=28% Similarity=0.375 Sum_probs=163.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CC-----ceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HP-----NIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~e~~ 485 (707)
++||+|+||.|-||.. ++++.||||+++...... .+-..|+.+|..|+ |. |+|++++||...++.|||+|.+
T Consensus 192 e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 192 EVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEecccccceeEEEEecCCCcEEEEEeeccChHHH-HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 3899999999999995 579999999998764433 56677999999997 53 8999999999999999999988
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC--CeEEecccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF--QPYISDFGLSRLINI 563 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~--~~kl~DfGla~~~~~ 563 (707)
. -+|+++|+.+. ...++...+..|+.||+.||.+||+ .+|||+||||+|||+.+-. .+||+|||.|.....
T Consensus 271 ~-~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 271 S-TNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred h-hhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 5 49999999875 4569999999999999999999999 8999999999999997543 699999999987653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
.-. ...-+..|+|||++.+ ..|+.+.||||||||+.||++|.+.|.+..
T Consensus 344 ~vy-------------------tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 344 RVY-------------------TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cce-------------------eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 221 1122778999999886 888999999999999999999987776543
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.65 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=192.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||.|++|.||+|... +|..|++|++.... ......+.+|++++++++|||++++++++.+++..++||||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 47999999999999864 78999999886543 2223568899999999999999999999999999999999995 69
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++..... ..+++..+.+++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||+++.........
T Consensus 84 l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~- 156 (283)
T cd07835 84 LKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY- 156 (283)
T ss_pred HHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc-
Confidence 9999976431 358999999999999999999999 899999999999999999999999999987553221100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.....++.++||||||+++|||++|+.||...... ..+.+.....
T Consensus 157 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 216 (283)
T cd07835 157 ---------------THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI-----DQLFRIFRTL 216 (283)
T ss_pred ---------------CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHh
Confidence 11234778999998765456788999999999999999999998653211 1111111110
Q ss_pred cccc---C-------C----CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEE---N-------P----LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~---~-------~----~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... + . +.......... ........+.+++.+|++.||++||+++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSK--VVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhh--hcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0 0 00000000000 00112256789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.32 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc------CCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA------PDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~e~ 484 (707)
..||+|+||.||+|.. .+++.+|+|.+..... ...++..|+.+++++ +||||+++++++.. .+..++||||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 3799999999999996 4678999998865433 336788899999999 79999999999853 3567899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999997643 2357889999999999999999999 89999999999999999999999999998755321
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
... +....++..|+|||.+.. ...++.++|||||||++|||++|+.||.......
T Consensus 175 ~~~----------------~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~----- 233 (282)
T cd06636 175 VGR----------------RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR----- 233 (282)
T ss_pred ccC----------------CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----
Confidence 110 122346889999998652 2457789999999999999999999996432210
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... . ..... ... ........+.+++.+||+.||.+||++.|+++
T Consensus 234 ~~~~-~---~~~~~--~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 ALFL-I---PRNPP--PKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhh-H---hhCCC--CCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 0 00000 000 01123356889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=297.77 Aligned_cols=244 Identities=23% Similarity=0.363 Sum_probs=193.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||++.. .++..|++|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++|+|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 4799999999999985 467889999987554444577899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 105 ~~~~~~------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~--- 172 (293)
T cd06647 105 DVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 172 (293)
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc---
Confidence 999753 47899999999999999999999 899999999999999999999999999887554221110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||.+.. ..++.++||||||+++||+++|+.||....... .+..... .
T Consensus 173 -------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-----~~~~~~~---~ 230 (293)
T cd06647 173 -------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIAT---N 230 (293)
T ss_pred -------------ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-----heeehhc---C
Confidence 12245788999998765 567889999999999999999999997543211 0000000 0
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... ..........+.+++.+||..+|++||++.+++..
T Consensus 231 ~~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPE-----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCC-----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00011223457789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=294.84 Aligned_cols=258 Identities=24% Similarity=0.297 Sum_probs=194.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||.|+||.||+|... ++..+|+|++.... ......+.+|++++++++|||++++++++... +..++|+||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 47999999999999975 58899999987653 33346788999999999999999999999988 789999999974
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++.... ..+++..+..++.||+.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 85 -~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 85 -DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred -cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 8999987542 368999999999999999999999 89999999999999999999999999999866533210
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.. ....++..|+|||.+.+...++.++||||||+++|||+||+.||...... .....+.
T Consensus 157 ~~---------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~------~~~~~~~ 215 (287)
T cd07840 157 DY---------------TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL------EQLEKIF 215 (287)
T ss_pred cc---------------cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHH
Confidence 00 12234778999998665456789999999999999999999998654321 1111111
Q ss_pred hhccc----cCC------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEE----ENP------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~----~~~------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... .++ ........+. ..........+.+++.+|+..+|++||+++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 216 ELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHhCCCchhhccccccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11000 000 0001111111 1111112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.14 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=198.7
Q ss_pred EeecCCcc--cchHHHHHhccceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeee
Q 005226 394 VAIDKGFT--FELDELLRASAYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKL 468 (707)
Q Consensus 394 ~~~~~~~~--~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l 468 (707)
+.++.+.+ .++.|+.. -..||.|+.|+|++++.. .|..+|||.+... ...+.+++...++++.+- +.|+||+.
T Consensus 79 lti~~g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c 156 (391)
T KOG0983|consen 79 LTIGGGQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQC 156 (391)
T ss_pred EEecCCcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeee
Confidence 34443333 35555533 346999999999999965 6899999999876 344567788888888777 48999999
Q ss_pred EEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 469 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
+|||..+...++.||.|.. -++.+++.-. .++++...-++...+..||.||.+. ++|||||+||+|||+|+.|
T Consensus 157 ~GyFi~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~G 229 (391)
T KOG0983|consen 157 FGYFITNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 229 (391)
T ss_pred eeEEeeCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCC
Confidence 9999999999999999853 4555555432 3588888899999999999999886 6899999999999999999
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKS 626 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~ 626 (707)
++|+||||++.++.++..+ +...|.+.|||||.+.. ...|+.++||||||++++||.||+.
T Consensus 230 niKlCDFGIsGrlvdSkAh-----------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y 292 (391)
T KOG0983|consen 230 NIKLCDFGISGRLVDSKAH-----------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY 292 (391)
T ss_pred CEEeecccccceeeccccc-----------------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence 9999999999887644332 34457889999998764 3677889999999999999999999
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
||..-..+ .+....+.. +..+ .++.. ..-...+.++...|+..|+++||...++++
T Consensus 293 Py~~c~td-----Fe~ltkvln---~ePP---~L~~~-------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 293 PYKGCKTD-----FEVLTKVLN---EEPP---LLPGH-------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCcc-----HHHHHHHHh---cCCC---CCCcc-------cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99753221 122222222 1111 11111 113356788999999999999999988875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.63 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=194.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|++|.||+|... +|..||||.+..... .....+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l 84 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DL 84 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cH
Confidence 47999999999999975 688999999875432 2346678899999999999999999999999999999999984 89
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++..... ...+++..+.+++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++.........
T Consensus 85 ~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-- 157 (284)
T cd07836 85 KKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF-- 157 (284)
T ss_pred HHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc--
Confidence 998875431 2358999999999999999999999 899999999999999999999999999987553221100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH-----
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW----- 645 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~----- 645 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||....... ......+.
T Consensus 158 --------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 221 (284)
T cd07836 158 --------------SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED--QLLKIFRIMGTPT 221 (284)
T ss_pred --------------ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCC
Confidence 122357889999987665667899999999999999999999987543210 00000000
Q ss_pred ------HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 ------VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+...-.-...+....+.... .........+.+++.+|++.||.+||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 222 ESTWPGISQLPEYKPTFPRYPPQDLQ--QLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhhHHHHhcCchhcccccCCChHHHH--HHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000011110 001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=281.60 Aligned_cols=203 Identities=26% Similarity=0.355 Sum_probs=171.8
Q ss_pred ceecccCeeEEEEEEeCC-----CceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLGN-----GIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~ 484 (707)
..||+|.+|.||+|.-.+ ...+|+|+++.... +......+|+.+++.++||||+.|..++.+ +...++++||
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 469999999999996432 34799999976532 223456899999999999999999999887 6778999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC----CCeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND----FQPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~ 560 (707)
.+. +|.+.++.++......++......|+.||+.|+.|||+ +-|+||||||.|||+..+ |.|||+|||+|+.
T Consensus 110 AEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~ 185 (438)
T KOG0666|consen 110 AEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLARL 185 (438)
T ss_pred hhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHHHH
Confidence 977 99999988776666789999999999999999999999 789999999999999888 8999999999998
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
+...-. +.++...++-|.+|+|||.+.+...||.+.||||.||++.||+|-++-|....
T Consensus 186 ~~~plk-------------pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 186 FNNPLK-------------PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred hhcccc-------------ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 764321 11122345669999999999998999999999999999999999998887643
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.21 Aligned_cols=242 Identities=21% Similarity=0.325 Sum_probs=192.5
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|+||.||++.. .++..||+|++..........+.+|+.++++++|+||+++++++..++..++||||+++++|.+
T Consensus 27 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (292)
T cd06657 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106 (292)
T ss_pred HcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence 699999999999986 4789999999866555555779999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++... .+++.....++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 107 ~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~----- 172 (292)
T cd06657 107 IVTHT------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR----- 172 (292)
T ss_pred HHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-----
Confidence 88643 48999999999999999999999 89999999999999999999999999988654321100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
.....++..|+|||.... ..++.++||||||+++|||++|+.||..... .............
T Consensus 173 -----------~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~~~~~~~~~ 234 (292)
T cd06657 173 -----------RKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNLPP 234 (292)
T ss_pred -----------ccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhhCCc
Confidence 012345788999998654 6678899999999999999999999864321 1111222211111
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ........+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~-------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 235 KLK-------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccC-------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 100 00112234678899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=294.57 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=186.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHH-HHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQA-IAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||++... +|..||+|+++... .....++..|+.. ++.++||||+++++++..++..++||||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 47999999999999965 68999999987642 2233556667776 555699999999999999999999999996 68
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
|.+++..... ....+++..+..++.||+.||+|||+ + +++||||||+||+++.++.+||+|||+++.......
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (283)
T cd06617 86 LDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA-- 159 (283)
T ss_pred HHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--
Confidence 9888865321 22468999999999999999999998 5 899999999999999999999999999876532110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.....++..|+|||.+... ..++.++||||||+++|||++|+.||...... ...+...
T Consensus 160 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~ 220 (283)
T cd06617 160 ---------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQQLKQV 220 (283)
T ss_pred ---------------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HHHHHHH
Confidence 0123457889999986531 34678999999999999999999998642211 1111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. . ...+ ... .......+.+++.+|+..+|.+||++.++++
T Consensus 221 ~-~---~~~~--~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 V-E---EPSP--QLP---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred H-h---cCCC--CCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 1 1000 000 0112345789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.17 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=189.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++|||++++++++.+++..++||||++ |
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-G 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-C
Confidence 47999999999999964 68899999986432 2234578899999999999999999999999999999999996 5
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+.+.... ..++|.++..++.+++.||.|||+ .+|+||||+|+||+++.++.+||+|||++......
T Consensus 110 ~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 110 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 8888876433 258999999999999999999999 89999999999999999999999999987643311
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....++..|+|||++. ....++.++|||||||++|||++|+.||...... .....+.
T Consensus 179 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~ 237 (317)
T cd06635 179 ----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIA 237 (317)
T ss_pred ----------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHH
Confidence 1234578899999864 2356788999999999999999999998643211 1111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
...... .........+.+++.+||+.+|.+||++.+|++.+
T Consensus 238 ~~~~~~---------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 238 QNESPT---------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred hccCCC---------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 111000 00112234578999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.50 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=191.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... +++.+++|.++.... .....+.+|++++++++||||+++++++..+ +..++|+||++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE- 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence 47999999999999975 688999999865432 2224577899999999999999999999877 78999999997
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++.... ..+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 90 HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 59999987643 258999999999999999999999 89999999999999999999999999998865432110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH---
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR--- 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~--- 644 (707)
. ....++..|+|||.+......+.++||||||+++|||++|+.||....... ....+..
T Consensus 163 ~----------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~ 224 (293)
T cd07843 163 Y----------------TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLG 224 (293)
T ss_pred c----------------ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhC
Confidence 0 122357889999987655556889999999999999999999997543210 0000000
Q ss_pred ------HHHh-hcc--ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 ------WVKK-GFE--EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ------~~~~-~~~--~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
|... .+. ............+............+.+++.+|++.||++||++.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000 0000000001111111000002456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=302.43 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=193.7
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCchh---hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||.|+||.||-|+. .+...||||++.-.... ...++.+|+..|++++|||+|.+-|+|..+...+||||||- |+
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GS 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-cc
Confidence 499999999999995 57889999999766433 34678999999999999999999999999999999999995 57
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
-.+++.-.+ +++.+..+..|..+.+.||+|||+ .+.||||||+.|||+++.|.||++|||.|..+...
T Consensus 112 AsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 112 ASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred HHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 777775443 368899999999999999999999 89999999999999999999999999998766522
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
...+||+.|||||++. ..+.|+-|+||||+|++..||.-+++|...... ....-.+.
T Consensus 180 ---------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIA 238 (948)
T KOG0577|consen 180 ---------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA 238 (948)
T ss_pred ---------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHH
Confidence 2356799999999975 357889999999999999999999999764321 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. +... + ...+....+.+++..|++.-|.+|||..++++
T Consensus 239 QN--esPt--------L----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 239 QN--ESPT--------L----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hc--CCCC--------C----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 1111 1 12345567889999999999999999998875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.66 Aligned_cols=262 Identities=20% Similarity=0.206 Sum_probs=191.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCc-----ceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDE-----KLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-----~~lV~ 482 (707)
.+.||+|+||.||+|... ++..||+|...... ......+.+|+.+++++ +||||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 347999999999999965 68999999876542 22336788899999999 56999999999987665 79999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLI 561 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~ 561 (707)
||+++ +|.+++..........+++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++..
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 89999875443223468999999999999999999999 89999999999999998 889999999998755
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... .....+++.|+|||++.....++.++||||||+++|||++|+.||...... ..
T Consensus 162 ~~~~~~----------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~ 220 (295)
T cd07837 162 SIPVKS----------------YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-----QQ 220 (295)
T ss_pred CCCccc----------------cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH-----HH
Confidence 321110 012234778999998765566789999999999999999999998653211 11
Q ss_pred HHHHHHhhcccc-CCCchh------------chHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEE-NPLSDM------------VDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~-~~~~~~------------~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.+.....-... ...... ....+.. ........+.+++.+|+..||.+||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 221 LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSR--AVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHH--hccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111000000000 000000 0000000 01123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=292.51 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=191.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCC------cceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPD------EKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------~~~lV~e~ 484 (707)
+.||+|+||.||+|... +++.+++|.+...... .++|.+|+++++++ +|+||+++++++.... ..++||||
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 47999999999999975 6788999998765443 36789999999999 7999999999997654 37999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++++|.+++.... .....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 99999999987532 112468999999999999999999999 89999999999999999999999999998765422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
... .....++..|+|||++.. ...++.++||||||+++|||++|+.||...... .
T Consensus 167 ~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~ 225 (275)
T cd06608 167 LGR----------------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----R 225 (275)
T ss_pred hhh----------------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----H
Confidence 111 012346888999998643 245678999999999999999999999643211 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.+.. .... ..+. ........+.+++.+|+..||++|||+.++++
T Consensus 226 ~~~~~~----~~~~--~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 226 ALFKIP----RNPP--PTLK--------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHHHhh----ccCC--CCCC--------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 0000 0110 01123456789999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=298.63 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=189.9
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.||+||.+.||++...+.+.+|+|++... +.....-|..|+..|.+| .|.+||+|++|-..++..||||||- ..+|
T Consensus 368 ~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL 446 (677)
T KOG0596|consen 368 QIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDL 446 (677)
T ss_pred hhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccH
Confidence 79999999999999888888888876543 444567899999999999 6999999999999999999999986 5699
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++|+.+... ..+| .+..+..||+.|+.++|+ .+|||.||||.|+|+-. |.+||+|||+|.-+........
T Consensus 447 ~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~- 517 (677)
T KOG0596|consen 447 NKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIV- 517 (677)
T ss_pred HHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcccccee-
Confidence 9999876532 3445 677889999999999999 89999999999999954 6899999999987763321111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPG----------NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
.....||+.||+||.+... -+++.++||||+||+||+|+.|+.||... .
T Consensus 518 -------------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--------~ 576 (677)
T KOG0596|consen 518 -------------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--------I 576 (677)
T ss_pred -------------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--------H
Confidence 1345789999999986531 13568999999999999999999998631 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. .|.+- ..+.|+...-+........++.+++..|++.||.+||+.-++++
T Consensus 577 n--~~aKl--------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 577 N--QIAKL--------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred H--HHHHH--------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1 12111 22222211111111122233889999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=287.51 Aligned_cols=255 Identities=21% Similarity=0.291 Sum_probs=207.5
Q ss_pred ceecccCeeEEEEEEeC------CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~ 484 (707)
.++-+|.||.||+|.+. +.+.|.||.++.... -....|.+|...+..+.|||+.++.+++.++ +..+.+|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 46789999999999653 456788888876533 3457889999999999999999999999776 456888999
Q ss_pred ecCCChHHHHhCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 485 ISNGNLANALRGRNG---QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
+.-|+|..+|...++ ...+.++..+.+.++.|++.|++|||+ ++|||.||.++|+++|+..++||+|=.++|..
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhcccc
Confidence 999999999984443 224568888999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccch
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVP 640 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~ 640 (707)
-..+.+.- | .....+..||+||.+.. ..++.++|||||||+||||+| |+.|+...+ ..
T Consensus 447 FP~DYhcL------G--------DnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeID------Pf 505 (563)
T KOG1024|consen 447 FPGDYHCL------G--------DNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEID------PF 505 (563)
T ss_pred Cccccccc------C--------CCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccC------HH
Confidence 54332211 1 22344778999999765 889999999999999999999 888886543 34
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
++..+++.+++-..+ ..++.++..++..||+.+|++||++++++..|.++.
T Consensus 506 Em~~ylkdGyRlaQP---------------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 506 EMEHYLKDGYRLAQP---------------FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred HHHHHHhccceecCC---------------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 667777777776655 233456788999999999999999999999999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.21 Aligned_cols=247 Identities=26% Similarity=0.422 Sum_probs=198.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|++|.||+|... ++..|++|++..... .....+.+|++.+.+++|+||+++++++..++..++|+||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 58999999999999976 589999999876643 3457899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... ..+++..+..++.|+++||+|||+. .+++||||+|+||+++.++.++|+|||.+..........
T Consensus 87 ~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-- 157 (264)
T cd06623 87 ADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-- 157 (264)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--
Confidence 9999754 2589999999999999999999983 489999999999999999999999999987664322110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||.... ..++.++||||||+++|||+||+.||...... ....+.+++....
T Consensus 158 --------------~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~ 219 (264)
T cd06623 158 --------------NTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAICDGP 219 (264)
T ss_pred --------------cceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHhcCC
Confidence 12345788999999665 57788999999999999999999998754321 1222333332111
Q ss_pred cccCCCchhchHHHHhhhhhHH-HHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKK-EVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.... ... ....+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~---------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSL---------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCC---------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1000 011 34568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=297.21 Aligned_cols=261 Identities=23% Similarity=0.273 Sum_probs=194.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..+|+|.+..... ...+.+..|++++++++||||+++++.+...+..++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 47999999999999975 589999999876532 24467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 87 ~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 87 ELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 9999997542 2468999999999999999999999 899999999999999999999999999987654221111
Q ss_pred CCCCCCc-------------CCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005226 569 SSSGGFM-------------GGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635 (707)
Q Consensus 569 ~~~~~~~-------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~ 635 (707)
....... .....-.......|+..|+|||++.. ..++.++||||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~- 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD- 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence 0000000 00000001122357889999999765 66789999999999999999999998643221
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC----hHHHHH
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR----MKNVSE 700 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~~v~~ 700 (707)
..+.. .......+ .........+.+++.+|+..||++||+ +.++++
T Consensus 239 ----~~~~~----~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ----ETFSN----ILKKEVTF-----------PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----HHHHH----HhcCCccC-----------CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11111 01111000 001113466889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.35 Aligned_cols=242 Identities=23% Similarity=0.288 Sum_probs=191.0
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||.|++|.||++... +++.+++|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999975 48899999986542 23346789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~--- 149 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT--- 149 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc---
Confidence 99997643 48999999999999999999999 89999999999999999999999999998766432100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||.+.. ..++.++||||||+++|||++|+.||...... . .+......
T Consensus 150 --------------~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~---~~~~~~~~ 207 (262)
T cd05572 150 --------------WTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDED----P---MEIYNDIL 207 (262)
T ss_pred --------------ccccCCcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----H---HHHHHHHh
Confidence 12245788999998654 66789999999999999999999999754321 1 11111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
..... ..........+.+++.+||+.+|++||+ ++|+++
T Consensus 208 ~~~~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 208 KGNGK-----------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCCC-----------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 10000 0001111356789999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=284.93 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=197.8
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.||+|+||+|+|-.++ .|+..|||+++... ..+++++..|.++..+- +.||||+++|.+..++..++.||.|. -+|
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence 5999999999999864 78999999998764 36678899999986665 89999999999999999999999994 466
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
+.+-+.-.......+++...-+|...+..||.||.+. ..|||||+||+|||+|..|.+|+||||++..+..+-
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si----- 222 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI----- 222 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH-----
Confidence 6554322112234688888889999999999999886 689999999999999999999999999987654321
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNR-PMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
+.+...|...|||||.+..... ++.++||||+|++|+|+.||+.|+.. ..+..+.+.+.
T Consensus 223 ------------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~--------w~svfeql~~V 282 (361)
T KOG1006|consen 223 ------------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK--------WDSVFEQLCQV 282 (361)
T ss_pred ------------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch--------HHHHHHHHHHH
Confidence 1244567889999999775444 88999999999999999999999863 23455556555
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+.+ .+............+..++..|+..|-..||...++.+
T Consensus 283 v~gdpp-------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 283 VIGDPP-------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HcCCCC-------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 554443 11111122234456889999999999999999988765
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.74 Aligned_cols=265 Identities=20% Similarity=0.245 Sum_probs=190.4
Q ss_pred ecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+|.|+++.||++.. ++..||||++... .....+.+.+|++++++++||||+++++++..++..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44555555555555 7899999998654 33445789999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+.............
T Consensus 89 ~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~- 161 (314)
T cd08216 89 LLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV- 161 (314)
T ss_pred HHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccc-
Confidence 998643 2258899999999999999999999 899999999999999999999999999887654222110000
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
...+....++..|+|||++... ..++.++|||||||++|||++|+.||...... ..+.+.......
T Consensus 162 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~-----~~~~~~~~~~~~ 228 (314)
T cd08216 162 --------HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT-----QMLLEKVRGTVP 228 (314)
T ss_pred --------ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhccCc
Confidence 0011234567889999987543 35788999999999999999999999753321 111111111000
Q ss_pred c----c------CCCch----hchHHHH---hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 E----E------NPLSD----MVDAMLL---QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~----~------~~~~~----~~d~~l~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. . ..... ..+.... ..........++.+++.+||..||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 0 00000 0000000 00111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.65 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=188.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.++. ||||+++++++..++..+++|||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 47999999999999864 68999999987543 234467889999999995 99999999999999999999999864 5
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+.++...........+++..+.+++.+++.||+|||+. .+++||||||+||+++.++.+||+|||+++........
T Consensus 89 l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-- 164 (288)
T cd06616 89 LDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-- 164 (288)
T ss_pred HHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc--
Confidence 55443211001124689999999999999999999973 48999999999999999999999999998765422110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG--NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....++..|+|||++... ..++.++|||||||++|||++|+.||.... ...+.+.
T Consensus 165 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~ 221 (288)
T cd06616 165 ---------------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--------SVFDQLT 221 (288)
T ss_pred ---------------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--------hHHHHHh
Confidence 123457889999997654 368899999999999999999999986422 1111122
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+ .+.. .........+.+++.+||+.||++||++.+|++
T Consensus 222 ~~~~~~~~-------~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 222 QVVKGDPP-------ILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred hhcCCCCC-------cCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21111111 0000 001123456889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=293.59 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=193.1
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||.||++... +|+.+++|.+..... .....+.+|++++++++||||+++++.+..+...++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875533 3446788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.||+.||+|||+ .+++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~- 151 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL- 151 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-
Confidence 99997643 58999999999999999999999 8999999999999999999999999999875432211000
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
...........++..|+|||.... ...+.++||||||+++||+++|+.||..... ...........
T Consensus 152 -------~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~ 217 (265)
T cd05579 152 -------NDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILNGK 217 (265)
T ss_pred -------ccccccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCC
Confidence 000001122345778999998765 5578899999999999999999999864321 11222211100
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...+ . .......+.+++.+|++.+|.+||++++|.+.|+
T Consensus 218 -~~~~--~-----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 -IEWP--E-----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -cCCC--c-----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 0 0001456789999999999999999966665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=291.08 Aligned_cols=248 Identities=27% Similarity=0.372 Sum_probs=195.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++++..++..++|+||+++++|
T Consensus 7 ~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (265)
T cd06605 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSL 86 (265)
T ss_pred HHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcH
Confidence 37999999999999975 68899999887653 33447789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+.+++.|++.||+|||+. .+++||||||+||++++++.++|+|||.+........
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 156 (265)
T cd06605 87 DKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---- 156 (265)
T ss_pred HHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence 99997642 3689999999999999999999983 5899999999999999999999999999875532111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||++.. ..++.++||||||+++|+|++|+.||...... .....+.+....
T Consensus 157 --------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~ 217 (265)
T cd06605 157 --------------KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDP----PDGIFELLQYIV 217 (265)
T ss_pred --------------hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccc----cccHHHHHHHHh
Confidence 01345778999999765 67889999999999999999999998654321 111222222221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+ .. ........+.+++.+||..||++||++.+++.
T Consensus 218 ~~~~~--~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 218 NEPPP--RL---------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cCCCC--CC---------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11111 00 00113445789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.66 Aligned_cols=242 Identities=26% Similarity=0.288 Sum_probs=184.5
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHH---HHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQA---IAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+||+|+||.||+|.. .+++.||+|.+..... .....+..|..+ ++..+||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999986 4688999998865421 111234444443 444579999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 999999987542 59999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....|+..|+|||++..+..++.++||||+||++|||++|+.||....... .... ...
T Consensus 153 ------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---~~~~-~~~ 210 (278)
T cd05606 153 ------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEI-DRM 210 (278)
T ss_pred ------------------cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---hHHH-HHH
Confidence 123468899999997655568899999999999999999999997643221 0010 100
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.. .....+ .......+.+++.+|+..+|.+|| ++.++++
T Consensus 211 ~~--~~~~~~-------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 TL--TMAVEL-------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred hh--ccCCCC-------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 00 000000 011235678999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=296.63 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=188.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc--------ceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE--------KLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--------~~lV 481 (707)
..||+|+||.||+|... ++..||||.+.... ......+.+|++++++++||||++++++|...+. .++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 47999999999999964 68999999876432 2222456789999999999999999999876544 3999
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+. ++|.+.+.... ..+++.++..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 98 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 98 FEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 99996 58888886542 258999999999999999999999 89999999999999999999999999999866
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
.......... .....++..|+|||.+.....++.++||||||+++|||+||+.||...... ....
T Consensus 170 ~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~ 234 (310)
T cd07865 170 SLSKNSKPNR------------YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLT 234 (310)
T ss_pred cCCcccCCCC------------ccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH
Confidence 4322111000 012345788999998765455788999999999999999999998653321 1111
Q ss_pred HHHHHHhhccccC-C---Cchhch---------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEEN-P---LSDMVD---------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~-~---~~~~~d---------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+........ + ..+..+ ...............+.+++.+||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1111111000000 0 000000 000000000011245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.01 Aligned_cols=260 Identities=19% Similarity=0.302 Sum_probs=190.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~ 485 (707)
+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++.... ..++|+||+
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 90 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence 4799999999999985 478999999986532 223466888999999999999999999876543 468999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
+ ++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 91 ~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 91 E-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred c-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 6 4888888643 48999999999999999999999 899999999999999999999999999987654322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ......++..|+|||.+.....++.++|||||||++|||++|+.||..... .....+
T Consensus 161 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~------~~~~~~ 221 (336)
T cd07849 161 DHTG-------------FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY------LHQLNL 221 (336)
T ss_pred cccC-------------CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 1111 012235688999999866556788999999999999999999999964321 111111
Q ss_pred HHhhccccCC--CchhchHHHHhh-------------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 646 VKKGFEEENP--LSDMVDAMLLQE-------------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 646 ~~~~~~~~~~--~~~~~d~~l~~~-------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
+...+..... ...+.+...... .........+.+++.+||+.||++||++.++++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 222 ILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111100 000000000000 0001123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=277.50 Aligned_cols=269 Identities=20% Similarity=0.300 Sum_probs=205.0
Q ss_pred chHHHHHhccceecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceE
Q 005226 403 ELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 403 ~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 480 (707)
.++++..-++++||+|+++.|-.++ ..+|..+|||++.+..-.......+|++++.+. .|+||++|+++|.++...||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 3556666677899999999999887 678999999999887555567888999999998 79999999999999999999
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEecccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGL 557 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGl 557 (707)
|||-|.||+|..+++.+. .+++.++.++..+||.||.|||. ++|.||||||+|||-..... +|||||.+
T Consensus 154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999998765 69999999999999999999999 99999999999999976543 89999998
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
..-+.....-. ...+... ....|+..|||||+.. ....|+.++|.||+||++|-|++|.+||.+...
T Consensus 226 gSg~k~~~~~s------pastP~L---~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 226 GSGIKLNNDCS------PASTPEL---LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred ccccccCCCCC------CCCCccc---cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 86554322111 1111111 2457888999999843 235778999999999999999999999987543
Q ss_pred CC-Cccc--------hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 634 ST-SIEV--------PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 634 ~~-~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. +.+- ..+.+-+..+. .+.-|+.. .....+..+++...+..|+.+|-++.+++.
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQEGk------YeFPdkdW------ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQEGK------YEFPDKDW------AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhccC------CcCChhhh------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 20 0110 01111111110 11112211 223355678888888999999999888765
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.16 Aligned_cols=241 Identities=25% Similarity=0.308 Sum_probs=186.2
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||+||++... +|..+|+|.+.... ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886532 22235677899999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 150 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---- 150 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----
Confidence 999976532 358999999999999999999999 8999999999999999999999999999876542111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||++.. ..++.++||||||+++|+|++|+.||....... ....+.. ...
T Consensus 151 -------------~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~---~~~ 211 (277)
T cd05577 151 -------------IKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKR---RTL 211 (277)
T ss_pred -------------cccccCCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHh---ccc
Confidence 012345778999999765 558899999999999999999999996543210 0011110 000
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
..... ........+.+++.+||+.||.+||++++
T Consensus 212 ~~~~~-------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 212 EMAVE-------------YPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccccc-------------CCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 00000 01112345789999999999999994443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=292.45 Aligned_cols=237 Identities=22% Similarity=0.297 Sum_probs=190.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 47999999999999965 68999999986542 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||+|+||+++.++.+||+|||+++......
T Consensus 87 ~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~--- 155 (290)
T cd05580 87 ELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--- 155 (290)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC---
Confidence 9999997653 58999999999999999999999 899999999999999999999999999987654220
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....+++.|+|||.+.. ...+.++||||||+++|+|++|+.||..... ....+.+.
T Consensus 156 ----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~- 211 (290)
T cd05580 156 ----------------YTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL- 211 (290)
T ss_pred ----------------CCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-
Confidence 12345888999998765 5678899999999999999999999864321 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVS 699 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~ 699 (707)
.....+. ......+.+++.+||..||.+|| ++++++
T Consensus 212 --~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 212 --EGKVRFP-------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --cCCccCC-------------ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1111111 11134567899999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=317.30 Aligned_cols=262 Identities=17% Similarity=0.187 Sum_probs=180.1
Q ss_pred cceecccCeeEEEEEEeCC--CceEEEE------------------EcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGN--GIPVAVR------------------RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 471 (707)
.+.||+|+||.||++.... +..+++| .+.. .......+.+|++++++++||||++++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcEeEE
Confidence 3579999999999987532 2222222 1111 11223568899999999999999999999
Q ss_pred EEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 472 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
+...+..++|+|++. ++|.+++..................|+.||+.||+|||+ ++||||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 999999999999984 688888765432222234456778899999999999999 8999999999999999999999
Q ss_pred EecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 552 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
|+|||+++.+....... .....||..|+|||++.. ..++.++|||||||++|||++|+.++...
T Consensus 308 L~DFGla~~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 308 LGDFGTAMPFEKEREAF---------------DYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEeCCCceecCcccccc---------------cccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 99999998664221110 012457999999999765 67889999999999999999998654322
Q ss_pred CCCCCccchhHHHHHHhhccccCCCc----h---------------hchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCC
Q 005226 632 TTSTSIEVPDLVRWVKKGFEEENPLS----D---------------MVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692 (707)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~---------------~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 692 (707)
.... ....+.+.+...-.....+. + .+...+.. ......+.+++.+|++.||.+|
T Consensus 372 ~~~~--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 372 GGGK--PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN----LGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred CCCC--HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh----cCCChHHHHHHHHHhccCcccC
Confidence 1110 11112111111000000000 0 00111100 0112356778999999999999
Q ss_pred CChHHHHH
Q 005226 693 PRMKNVSE 700 (707)
Q Consensus 693 Ps~~~v~~ 700 (707)
|++.|+++
T Consensus 446 psa~elL~ 453 (501)
T PHA03210 446 PGAAELLA 453 (501)
T ss_pred cCHHHHhh
Confidence 99999986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.87 Aligned_cols=266 Identities=24% Similarity=0.277 Sum_probs=193.0
Q ss_pred eeccc--CeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKS--GLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+| +||+||++.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999996 478999999986542 334477889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++||+.+..........
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 85 SANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999998643 2358999999999999999999999 899999999999999999999999998664433211111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
...+..+....++..|+|||++..+ ..++.++|||||||++|||++|+.||...... ..+.....
T Consensus 159 ---------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~-----~~~~~~~~ 224 (328)
T cd08226 159 ---------KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT-----QMLLQKLK 224 (328)
T ss_pred ---------cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH-----HHHHHHhc
Confidence 0111122233456779999997653 34688999999999999999999999653211 01111100
Q ss_pred hhccccC------------------C-------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 648 KGFEEEN------------------P-------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 648 ~~~~~~~------------------~-------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
....... . ...+.+..+ ...........+.+++.+||..||++|||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~ 303 (328)
T cd08226 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303 (328)
T ss_pred CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHH
Confidence 0000000 0 000000011 0011223456789999999999999999999
Q ss_pred HHHH
Q 005226 697 NVSE 700 (707)
Q Consensus 697 ~v~~ 700 (707)
++++
T Consensus 304 e~l~ 307 (328)
T cd08226 304 SLLS 307 (328)
T ss_pred HHhh
Confidence 9974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.82 Aligned_cols=245 Identities=23% Similarity=0.299 Sum_probs=192.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||++... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++++..++..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 347999999999999965 67889999886542 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+.........
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999997643 2358999999999999999999999 8999999999999999885 4699999998765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ....|+..|+|||+... ..++.++||||||+++|||++|+.||.... ..+++.
T Consensus 159 ~----------------~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---------~~~~~~ 212 (257)
T cd08225 159 A----------------YTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNN---------LHQLVL 212 (257)
T ss_pred c----------------cccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHH
Confidence 0 12346888999998654 567899999999999999999999986422 112222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ .. .......+.+++.+|+..+|++||++.++++
T Consensus 213 ~~~~~~~~--~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 213 KICQGYFA--PI----------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHhcccCC--CC----------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 21111100 00 0112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=302.99 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=195.9
Q ss_pred eecccCeeEEEEEEeCC-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||.|+||.||+|..++ +...|.|++.-.+..+..+|.-||++|+..+||+||+|++.|...+..+++.|||.||-.+.
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 48999999999999654 45566788776677778999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++-.-+ ..+.+.++.-++++++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+-.........
T Consensus 119 imlEL~----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR---- 187 (1187)
T KOG0579|consen 119 IMLELG----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR---- 187 (1187)
T ss_pred HHHHhc----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHhhh----
Confidence 887653 479999999999999999999999 899999999999999999999999999986543221111
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|||||+.+ ....|+.++||||||++|.||..+.+|-....+. .. +..
T Consensus 188 ------------DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RV---llK 246 (1187)
T KOG0579|consen 188 ------------DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RV---LLK 246 (1187)
T ss_pred ------------ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HH---HHH
Confidence 2345799999999865 3467889999999999999999999996543221 11 111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+ .|. ........+.+++.+|+..||+.||++.++++
T Consensus 247 iaKSePP-------TLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 247 IAKSEPP-------TLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HhhcCCC-------ccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111111 111 12334556789999999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.99 Aligned_cols=258 Identities=19% Similarity=0.238 Sum_probs=176.6
Q ss_pred ceecccCeeEEEEEEeCC----CceEEEEEcCCCchh---h--------HHHHHHHHHHHHhcCCCceeeeEEEEEcCC-
Q 005226 413 YVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGGEQ---R--------HREFVTEVQAIAKVKHPNIVKLRAYYWAPD- 476 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~--------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 476 (707)
++||+|+||+||+|...+ +..+++|........ + ......+...+..++|+|++++++++....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 479999999999999654 345666653322111 0 011233445566779999999999776543
Q ss_pred ---cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 005226 477 ---EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553 (707)
Q Consensus 477 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~ 553 (707)
..++++|+.. .++.+.+.... ..++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.++|+
T Consensus 98 ~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 98 RMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred CceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEE
Confidence 2367777664 36666665432 35788899999999999999999 899999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 554 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
|||+|+............ ........||+.|+|||+... ..++.++|||||||++|||++|+.||.....
T Consensus 169 DFGla~~~~~~~~~~~~~---------~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYS---------KEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCceeeccCCcccccc---------cccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999998764322111100 001122457999999998654 7789999999999999999999999976422
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.. .+...... +.+.+..............+.+++..|+..+|++||++.++++.++
T Consensus 239 ~~-----~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NG-----NLIHAAKC---------DFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred ch-----HHHHHhHH---------HHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11 11111110 0000000000011122456889999999999999999999998763
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.49 Aligned_cols=260 Identities=24% Similarity=0.336 Sum_probs=192.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|... ++..|++|++..... .......+|+..+++++ ||||+++++++..++..++||||+ +|+
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 47999999999999975 578899999865422 22234567999999998 999999999999999999999999 889
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ...+++..+..++.|++.+|+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 84 l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 155 (283)
T cd07830 84 LYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-- 155 (283)
T ss_pred HHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--
Confidence 999997653 2358999999999999999999999 89999999999999999999999999998765422111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH------
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV------ 643 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~------ 643 (707)
....++..|+|||++.....++.++||||||++++||++|++||....... ......
T Consensus 156 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~--~~~~~~~~~~~~ 218 (283)
T cd07830 156 ---------------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID--QLYKICSVLGTP 218 (283)
T ss_pred ---------------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH--HHHHHHHhcCCC
Confidence 122357889999987665677899999999999999999999986543210 000000
Q ss_pred ---HHHHhhcc---ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 ---RWVKKGFE---EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ---~~~~~~~~---~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.|...... ....+.......+. .. .......+.+++.+||+.||++||+++|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 219 TKQDWPEGYKLASKLGFRFPQFAPTSLH-QL-IPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ChhhhhhHhhhhccccccccccccccHH-HH-cccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 01100000 00000000000010 00 0112356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.84 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=189.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|++|.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 47999999999999965 788999998865422 233678899999999999999999999999999999999996 58
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~ 568 (707)
|.+++.... ...+++.....++.||+.||+|||+ ++++||||||+||+++. ++.+||+|||++..........
T Consensus 87 l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 87 LKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred HHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 888886543 2246888899999999999999999 89999999999999985 5679999999997553211100
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||++.....++.++|||||||++|+|+||+.||....... .......+...
T Consensus 161 ----------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~ 222 (294)
T PLN00009 161 ----------------THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGT 222 (294)
T ss_pred ----------------ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 122357889999987665567899999999999999999999996532210 00000000000
Q ss_pred hccccCC-Cchhch----------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENP-LSDMVD----------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~-~~~~~d----------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+. .....+ ..+. .........+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 223 PNEETWPGVTSLPDYKSAFPKWPPKDLA--TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CChhhccccccchhhhhhcccCCCCCHH--HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000000 0000 001122355789999999999999999999985
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=290.05 Aligned_cols=243 Identities=24% Similarity=0.399 Sum_probs=193.4
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|++|.||+|... ++..+++|++..... ....+.+|++++++++|+|++++++++...+..++|+||+++++|.+
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence 6999999999999976 688999999876544 34678899999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..+++..+..++.+++.||+|||+ .+|+|+||||+||+++.++.++|+|||++..........
T Consensus 105 ~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~---- 173 (286)
T cd06614 105 IITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR---- 173 (286)
T ss_pred HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh----
Confidence 998653 369999999999999999999999 899999999999999999999999999886543221100
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
....++..|+|||++.. ..++.++|||||||++|+|++|+.||...... .....+.....
T Consensus 174 ------------~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----~~~~~~~~~~~-- 233 (286)
T cd06614 174 ------------NSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----RALFLITTKGI-- 233 (286)
T ss_pred ------------ccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC--
Confidence 12235778999998654 56789999999999999999999998642211 11111111000
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+ .......+.+++.+|++.+|.+||++.+|++
T Consensus 234 ----~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 234 ----PPLKN--------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ----CCCcc--------hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000 0112346789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=296.31 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=190.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCC--cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPD--EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~--~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++..+|+|++... .......+.+|+.+++++ +||||+++++++...+ ..++||||++
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME 92 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence 37999999999999965 6789999988543 223335677899999999 9999999999986543 5799999997
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
++|.+++... .++|..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 93 -~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 93 -TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred -cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 5999998753 48899999999999999999999 8999999999999999999999999999986643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
... ........++..|+|||++.....++.++||||||+++|||+||+.||...... ......
T Consensus 163 ~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~------~~~~~~ 225 (337)
T cd07852 163 NPE-----------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL------NQLEKI 225 (337)
T ss_pred ccc-----------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH
Confidence 100 001122356889999998766567788999999999999999999998643221 111111
Q ss_pred HhhccccCC----------CchhchHHHHhh-----hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 647 KKGFEEENP----------LSDMVDAMLLQE-----VHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 647 ~~~~~~~~~----------~~~~~d~~l~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
......... ..++++...... .........+.+++.+||+.||++||++.++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 226 IEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 111000000 000000000000 0001124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=297.10 Aligned_cols=269 Identities=23% Similarity=0.221 Sum_probs=193.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhh--------------HHHHHHHHHHHHhcCCCceeeeEEEEEcCCc
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQR--------------HREFVTEVQAIAKVKHPNIVKLRAYYWAPDE 477 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 477 (707)
+.||+|+||+||+|... +++.||||.+....... ...+.+|++++++++||||+++++++..++.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 47999999999999964 68999999886542211 1257789999999999999999999999999
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
.++||||+. |+|.+++.... .+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 999999996 69999997532 58999999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
++................. ..........++..|+|||++.+...++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--- 240 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI--- 240 (335)
T ss_pred eeecccccccccccccccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---
Confidence 9866422111100000000 00000112345788999999776556789999999999999999999999754321
Q ss_pred cchhHHHHHHhhcccc----CC----------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEE----NP----------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~----~~----------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+....... ++ +.....+..... .......+.+++.+|++.+|++||++.+++.
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI--FPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHh--CcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111100 00 000011111000 0122356789999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=281.87 Aligned_cols=244 Identities=29% Similarity=0.423 Sum_probs=196.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|++|.||++... ++..+++|++..........+.+|++++++++|||++++++++..++..++++||+++++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 47999999999999975 68899999998765545578999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.+++.||+|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 86 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 153 (253)
T cd05122 86 DLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA----- 153 (253)
T ss_pred HHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-----
Confidence 9997652 358999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....++..|+|||++.. ..++.++||||||+++++|++|+.||...... ........
T Consensus 154 ------------~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--- 211 (253)
T cd05122 154 ------------RNTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT--- 211 (253)
T ss_pred ------------ccceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh---
Confidence 022345788999999765 55789999999999999999999998653211 11111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ....+ .......+.+++.+|++.||.+||++.++++
T Consensus 212 ~~~--~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 212 NGP--PGLRN--------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCC--CCcCc--------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000 0111356789999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.15 Aligned_cols=259 Identities=20% Similarity=0.314 Sum_probs=191.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC----CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP----DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++... ...++|+||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 47999999999999964 68999999987542 22346678899999999999999999987643 4578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
. |+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 91 ~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 91 E-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred h-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 5 69999987543 48999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
..... ......++..|+|||++.....++.++|||||||++|||++|+.||...... .....
T Consensus 162 ~~~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~------~~~~~ 223 (334)
T cd07855 162 TEHKY------------FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV------HQLKL 223 (334)
T ss_pred cCCCc------------ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH------HHHHH
Confidence 11100 0012356888999998765456789999999999999999999999653221 11111
Q ss_pred HHhhccccCCCchhch----HHHHh---------hh----hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVD----AMLLQ---------EV----HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d----~~l~~---------~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....... ..+..+ ..+.. .. ........+.+++.+|++.||++||++.+++.
T Consensus 224 ~~~~~g~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 224 ILSVLGSP--SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHhCCC--hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11110000 000000 00000 00 00123467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=284.52 Aligned_cols=242 Identities=22% Similarity=0.253 Sum_probs=184.5
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHH-hcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIA-KVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||.||+|... +++.||+|.+..... .....+..|..++. ..+|+|++++++++..++..++|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 5899999999999864 688999999875432 22234555655544 458999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+.+++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||+++.....
T Consensus 83 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 83 DCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 9999997543 58899999999999999999999 89999999999999999999999999988753321
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||.+.. ..++.++||||||+++|||++|..||...... ........
T Consensus 151 ----------------~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~ 207 (260)
T cd05611 151 ----------------KKFVGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILS 207 (260)
T ss_pred ----------------ccCCCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh
Confidence 12345788999999765 45789999999999999999999999643211 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
... ..+ .. ........+.+++.+||+.||++||++.++.+.|
T Consensus 208 ~~~-~~~--~~---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 208 RRI-NWP--EE---------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccc-CCC--Cc---------ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 000 000 00 0012235678999999999999999886655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.61 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=198.3
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.||+|++|.||+|.++ .|..+|+|.+... .+..++.+|+.+|++.+.|++|++||.|......++|||||..|+..+
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 6999999999999864 7999999998653 334788999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
.++.++ +.+.+.++..|++..++||+|||. ..-||||||+.|||++-+|.+|++|||.|..+...-..
T Consensus 118 I~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK----- 185 (502)
T KOG0574|consen 118 IMRARR----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK----- 185 (502)
T ss_pred HHHHhc----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-----
Confidence 998764 579999999999999999999999 57799999999999999999999999999766533211
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
.....||+.|||||++.. -.|..++||||+|++..||..|++||....+.... -.+..
T Consensus 186 -----------RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI----------FMIPT 243 (502)
T KOG0574|consen 186 -----------RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI----------FMIPT 243 (502)
T ss_pred -----------hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccccee----------EeccC
Confidence 134678999999999765 66788999999999999999999999865443110 00011
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+ .- + ...+....++.+++.+|+-..|++|-|+.++++
T Consensus 244 ~PP-PT-----F---~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 244 KPP-PT-----F---KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCC-CC-----C---CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111 00 0 112344567889999999999999999988765
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=288.25 Aligned_cols=247 Identities=24% Similarity=0.291 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCch----hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGE----QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
..||+|+||.||++.. .+|..||+|++..... ...+.+.+|++++.++ +|+||+++++.+..+...++|+|
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 4799999999999985 3788999999875422 2336788899999999 69999999999999889999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 86 YINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999997643 58899999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
..... .....|+..|+|||.+... ..++.++||||||+++|+|++|+.||...... ...
T Consensus 158 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~ 217 (290)
T cd05613 158 DEVER---------------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-----NSQ 217 (290)
T ss_pred ccccc---------------cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-----ccH
Confidence 21100 0123467889999987642 34678999999999999999999998642211 111
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.+..........++. ......+.+++.+|++.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~~~~~~-------------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 218 AEISRRILKSEPPYP-------------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHHHHHhhccCCCCC-------------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 122222111111111 11234567999999999999997 5566543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.49 Aligned_cols=242 Identities=24% Similarity=0.294 Sum_probs=193.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||.|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 357999999999999975 68899999987542 23457899999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156 (258)
T ss_pred CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence 9999999754 258999999999999999999999 89999999999999999999999999998765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ...+..
T Consensus 157 -----------------~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~ 211 (258)
T cd05578 157 -----------------TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-------IRDQIR 211 (258)
T ss_pred -----------------cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-------HHHHHH
Confidence 12345788999999765 55789999999999999999999998754321 111111
Q ss_pred hhcc-ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh--HHHH
Q 005226 648 KGFE-EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM--KNVS 699 (707)
Q Consensus 648 ~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~~v~ 699 (707)
.... .... ........+.+++.+||+.||.+||++ +|++
T Consensus 212 ~~~~~~~~~-------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 AKQETADVL-------------YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHhcccccc-------------CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111 1110 111223567899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=290.51 Aligned_cols=239 Identities=28% Similarity=0.300 Sum_probs=192.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh---hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
++||+||||.||-+... +|+.+|.|++.+.... .......|-.+|.+++.+.||.+--.|.+.+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 58999999999998854 7899999988654221 1245678999999999999999998899999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.-+|...+ ...+++..++-++.+|+.||++||+ .+||.||+||+|||+|+.|+++|+|.|+|..+......
T Consensus 271 DLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 271 DLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred ceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 9999998765 2579999999999999999999999 89999999999999999999999999999887644322
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
..++||.+|||||++.. ..|+...|.||+||++|||+.|+.||...-+. ++
T Consensus 344 ----------------~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------vk---- 394 (591)
T KOG0986|consen 344 ----------------RGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------VK---- 394 (591)
T ss_pred ----------------ccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhh--------hh----
Confidence 23478999999999776 56999999999999999999999999753322 11
Q ss_pred hccccCCCchhchHHHHhhh--hhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 649 GFEEENPLSDMVDAMLLQEV--HAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
.+-+|++..... ..+.-.+++.++....++.||.+|--.
T Consensus 395 --------~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 395 --------REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --------HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 112233322211 123334567788888899999998643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.13 Aligned_cols=258 Identities=26% Similarity=0.307 Sum_probs=190.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC----------cc
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD----------EK 478 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------~~ 478 (707)
.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+.. ..
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 91 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence 347999999999999975 58899999986542 222356788999999999999999999987655 68
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
++|+||+++ ++...+.... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 92 ~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 92 YLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred EEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 999999975 7878776542 358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
........... ....++..|+|||.+......+.++|||||||++|||++|++||......
T Consensus 164 ~~~~~~~~~~~---------------~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---- 224 (302)
T cd07864 164 RLYNSEESRPY---------------TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---- 224 (302)
T ss_pred ccccCCccccc---------------ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH----
Confidence 86643221110 11234678999998765456788999999999999999999998643211
Q ss_pred chhHHHHHHhhccccCC--Cchh--------ch------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENP--LSDM--------VD------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~--~~~~--------~d------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+.+........+ +.++ .+ ...... .......+.+++.+||+.||.+||++.++++
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 --AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred --HHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh--cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111110000 0000 00 000000 0112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=283.32 Aligned_cols=234 Identities=23% Similarity=0.294 Sum_probs=180.9
Q ss_pred ecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 415 LGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 415 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+|+|+||.||++.. .++..+|+|......... .|+.....+ +||||+++++++..++..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 69999999999995 467889999876542221 122222223 79999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++.... .++|.++..++.||++||+|||+ .+++||||||+||+++.++ .++|+|||+++.....
T Consensus 99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------- 163 (267)
T PHA03390 99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------- 163 (267)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-------
Confidence 997643 68999999999999999999999 8999999999999999998 9999999998755321
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....++..|+|||++.. ..++.++||||||+++|||++|+.||...... ......+.... .
T Consensus 164 -------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~ 224 (267)
T PHA03390 164 -------------SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE----ELDLESLLKRQ-Q 224 (267)
T ss_pred -------------ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc----hhhHHHHHHhh-c
Confidence 11245888999999765 56789999999999999999999999743221 11222232222 1
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-hHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-MKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~v~~ 700 (707)
..... .......+.+++.+|++.||.+||+ ++++++
T Consensus 225 ~~~~~-------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPF-------------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCc-------------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11010 1123356789999999999999996 688874
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.07 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=187.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||+|... ++..||+|.+... .......+.+|+.++++++||||+++++++.... ..++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 47999999999999964 7899999998643 2333466788999999999999999999986543 4689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 102 LMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred ccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 995 588888863 27889999999999999999999 8999999999999999999999999999976542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc------
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI------ 637 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~------ 637 (707)
... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.........
T Consensus 171 ~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 232 (353)
T cd07850 171 SFM-----------------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQ 232 (353)
T ss_pred CCC-----------------CCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 111 012345788999999765 67889999999999999999999999653211000
Q ss_pred ---cchhHHHH----HHhhcccc-----CCCchhchHHHHhhh---hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 ---EVPDLVRW----VKKGFEEE-----NPLSDMVDAMLLQEV---HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ---~~~~~~~~----~~~~~~~~-----~~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...++... ........ .++.+.+...+.... ........+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 00000000 000011111000000 01123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=291.37 Aligned_cols=241 Identities=23% Similarity=0.385 Sum_probs=187.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..+++|.+... ......++.+|++++++++|+|++++++++......++|+||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 36999999999999964 6788999987642 22334678899999999999999999999999999999999996 6
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 100 ~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 100 SASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred CHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 8888876432 248999999999999999999999 89999999999999999999999999998754311
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....++..|+|||.+. ....++.++|||||||++|||++|+.||...... .....+.
T Consensus 169 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~ 227 (308)
T cd06634 169 ----------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIA 227 (308)
T ss_pred ----------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHHHh
Confidence 1223578899999864 2345788999999999999999999998542111 0111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.. ..+ .. ........+.+++.+||..+|++||++.++++.
T Consensus 228 ~~----~~~--~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 228 QN----ESP--AL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred hc----CCC--Cc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11 000 00 011233457899999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.04 Aligned_cols=251 Identities=25% Similarity=0.290 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
+.||+|++|.||++.. .++..||||.+.... ....+.+.+|++++.++ +||||+++++.+..+...++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 4799999999999874 357889999986532 22346788999999999 69999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++|+|.+++.... .+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||+++....
T Consensus 86 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 86 YVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred cCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999997542 58899999999999999999999 8999999999999999999999999999876542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN-RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
..... .....++..|+|||...... ..+.++||||||+++|||++|+.||...... ...
T Consensus 158 ~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~ 217 (288)
T cd05583 158 EEEER---------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-----NSQ 217 (288)
T ss_pred ccccc---------------cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-----chH
Confidence 21100 01234678899999865422 3678999999999999999999998643211 011
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.+..........+.. ......+.+++.+||+.||++|||+++|.+.|+.
T Consensus 218 ~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 218 SEISRRILKSKPPFP-------------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHHHHHHHccCCCCC-------------cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111111111111111 1122456789999999999999999988776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=291.56 Aligned_cols=256 Identities=26% Similarity=0.304 Sum_probs=188.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... +|..||+|+++.... .....+.+|+.++++++|+||+++++++... +..++||||+.
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 91 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE- 91 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-
Confidence 47999999999999964 689999998864322 2224567899999999999999999998765 45799999996
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++.... ..+++.++..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 92 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 92 QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 58998887543 358999999999999999999999 89999999999999999999999999999866432110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ....++..|+|||.+.+...++.++|||||||++|||++|+.||...... .....+.
T Consensus 165 ~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~------~~~~~~~ 222 (309)
T cd07845 165 M----------------TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI------EQLDLII 222 (309)
T ss_pred C----------------CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 0 11234678999998766566789999999999999999999999653321 1111111
Q ss_pred hhcccc----CC------Cchhch------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEE----NP------LSDMVD------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~----~~------~~~~~d------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ++ ....+. ..+... .......+.+++.+|++.||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK--FPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCCCCchHHh--ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 110000 00 000000 000000 0112455779999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=278.92 Aligned_cols=243 Identities=26% Similarity=0.418 Sum_probs=194.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
...||+|++|.||++... ++..|++|.+..... .....+.+|++++++++|||++++++++.+++..++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 357999999999999865 678899999877643 44578999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||.+.........
T Consensus 85 ~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 85 SLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999997642 58999999999999999999999 89999999999999999999999999999876532211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||.... ..++.++||||+|+++|+|++|+.||...... ..... .
T Consensus 156 ---------------~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~-~-- 211 (254)
T cd06627 156 ---------------DASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFR-I-- 211 (254)
T ss_pred ---------------ccccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHH-H--
Confidence 022345888999998665 45789999999999999999999998643211 11111 1
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+. ......+.+++.+|+..+|++||++.+++.
T Consensus 212 ~~~~~~~~~-------------~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQDDHPPLP-------------EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hccCCCCCC-------------CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111111111 112345679999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=280.50 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=195.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
+.||+|++|.||+|... ++..|++|++..... ...+.+.+|++++++++||||+++++.+... +..++|+||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 47999999999999976 788999999876542 3457899999999999999999999999988 888999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++.... .+++..+..++.+++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 86 GSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999998643 68999999999999999999999 89999999999999999999999999998876533210
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ......++..|+|||.... ...+.++||||||+++++|++|+.||..... ......
T Consensus 158 ~--------------~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~ 214 (260)
T cd06606 158 E--------------GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--------PMAALY 214 (260)
T ss_pred c--------------cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHH
Confidence 0 0022345788999998665 5578999999999999999999999875431 011111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ .. ........+.+++.+|++.||++||++.++++
T Consensus 215 ~~~~~~~~-~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 215 KIGSSGEP-PE----------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hccccCCC-cC----------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11100000 00 01122356789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=284.00 Aligned_cols=245 Identities=25% Similarity=0.359 Sum_probs=195.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||++... ++..+++|.+... ......++.+|++++++++|+||+++++++......++|+||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 347999999999999854 7789999998754 2334467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .....+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+|++|||+++.......
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 158 (256)
T cd08530 85 DLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA-- 158 (256)
T ss_pred CHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCCc--
Confidence 9999997632 123468999999999999999999999 8999999999999999999999999999976643210
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....++..|+|||.... ..++.++|+||||+++|||++|+.||..... ..+...+..
T Consensus 159 ----------------~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~ 215 (256)
T cd08530 159 ----------------KTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRYKVQR 215 (256)
T ss_pred ----------------ccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc
Confidence 11235778999999754 6778899999999999999999999864321 122221111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... ... ......++.+++.+|++.+|++||++.++++
T Consensus 216 ~~~-----~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 216 GKY-----PPI----------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCC-----CCC----------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 110 000 1123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=326.08 Aligned_cols=249 Identities=27% Similarity=0.357 Sum_probs=193.4
Q ss_pred cceecccCeeEEEEEE-eCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+..||.|.||.||-|. ..+|...|+|-++-. .....+...+|+.++..++|||+|+++|+-.+.+..++.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 5689999999999998 568899999976533 3334467788999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+.+...+ ..++.....+..|++.|+.|||+ .+||||||||.||+++.+|.+|.+|||.|..+.... .
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~--~ 1389 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA--Q 1389 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCch--h
Confidence 9999997654 35666777788999999999999 899999999999999999999999999998775321 0
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG--NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. +.|+. ....||+.|||||++.+. ....-++||||+|||+.||+||+.||...+.. ..+--.|
T Consensus 1390 ~-----~~~el-----~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V 1454 (1509)
T KOG4645|consen 1390 T-----MPGEL-----QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHV 1454 (1509)
T ss_pred c-----CCHHH-----HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHH
Confidence 0 11111 235689999999997652 33456899999999999999999999764432 0111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+...+- +.....+-.+++..|+..||+.|+++.|+++
T Consensus 1455 ~~gh~Pq~---------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1455 AAGHKPQI---------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hccCCCCC---------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11111111 1123344578999999999999999987765
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=288.65 Aligned_cols=240 Identities=24% Similarity=0.389 Sum_probs=187.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... ++..|++|++.... ......+.+|++++++++|||++++++++.+++..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 46999999999999864 68899999886432 2233568889999999999999999999999999999999995 6
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++.+++.... ..+++.++..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 106 ~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 106 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 8888886533 358999999999999999999999 89999999999999999999999999987532210
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....++..|+|||++.. ...++.++|||||||++|||++|+.||...... ....+.
T Consensus 175 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~ 232 (313)
T cd06633 175 ----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHI 232 (313)
T ss_pred ----------------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH
Confidence 12345788999998642 356788999999999999999999998653221 111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ...+ ... .......+.+++.+||+.+|.+||++.+++.
T Consensus 233 ~~---~~~~--~~~---------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 233 AQ---NDSP--TLQ---------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred Hh---cCCC--CCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 1110 000 0112235778999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=313.68 Aligned_cols=264 Identities=26% Similarity=0.363 Sum_probs=185.8
Q ss_pred chHHHHHhccceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----
Q 005226 403 ELDELLRASAYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP----- 475 (707)
Q Consensus 403 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~----- 475 (707)
+++|+. +||+||||.|||++.+ ||+.||||++.-.. ........+|+..+++|+|||||+++..+.+.
T Consensus 480 DFEEL~-----lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 480 DFEELE-----LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHHHH-----HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 555553 7999999999999965 99999999987653 33446788999999999999999986522100
Q ss_pred --------------------------------------------------------------------------------
Q 005226 476 -------------------------------------------------------------------------------- 475 (707)
Q Consensus 476 -------------------------------------------------------------------------------- 475 (707)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CcceEEEEeecCCChHHHHhCCCCCCCCCC-CHHHHHHHHHHHHHH
Q 005226 476 ----------------------------------DEKLLISDFISNGNLANALRGRNGQPSTSL-SWSTRLRIAKGTARG 520 (707)
Q Consensus 476 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~~ia~~ 520 (707)
-..|+=||||+.-.|.++++.+. .. .....++++++|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHH
Confidence 00256689998888888877553 11 467788999999999
Q ss_pred HHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc---cCCCCCCCCCCcCCCCCCCCccccccCccccCCC
Q 005226 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI---TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE 597 (707)
Q Consensus 521 L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 597 (707)
|.|+|+ .+||||||||.||++|++..|||+|||+|..... .............| ......+...||.-|+|||
T Consensus 710 LaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g-~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 710 LAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAG-SNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccC-CCCcccccccceeeeecHH
Confidence 999999 8999999999999999999999999999987321 00000000000000 0111224568999999999
Q ss_pred CCCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHH
Q 005226 598 ARVPGN--RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVI 675 (707)
Q Consensus 598 ~~~~~~--~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 675 (707)
++.... .|+.|+|+||+|||++||+. ||... ++-.....-.+.+--... .+.. .+.+.
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-----MERa~iL~~LR~g~iP~~--~~f~----------~~~~~ 845 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS-----MERASILTNLRKGSIPEP--ADFF----------DPEHP 845 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCch-----HHHHHHHHhcccCCCCCC--cccc----------cccch
Confidence 987655 69999999999999999987 55421 122222222221111110 1112 23334
Q ss_pred HHHHHHHhccCCCCCCCCChHHHHH
Q 005226 676 AVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 676 ~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.-.+++..+++.||.+|||+.|++.
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhh
Confidence 4468999999999999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=289.08 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=187.8
Q ss_pred ccceecccCeeEEEEEEeCC-CceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 411 SAYVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
..+.||+|+||.||+|...+ +..||||.++... .....++.+|+.++.+. .||||+++++++..+...++||||++
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 97 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS- 97 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence 34589999999999999864 8999999987543 22345677788877777 49999999999999999999999985
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
+++.+++.... ..+++..+.+++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 98 ~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 98 TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 57777776532 2689999999999999999999972 48999999999999999999999999998765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
....++..|+|||.+... ..++.++||||||+++|||++|+.||..... ..+...
T Consensus 172 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~ 229 (296)
T cd06618 172 -----------------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLT 229 (296)
T ss_pred -----------------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHH
Confidence 122357789999987542 2467899999999999999999999864211 011111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
++. ..... ..- .......++.+++.+||+.||++||++.++++.
T Consensus 230 ~~~---~~~~~--~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 230 KIL---QEEPP--SLP--------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHh---cCCCC--CCC--------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111 11100 000 000123467899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.17 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=188.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhc---CCCceeeeEEEEEcCCc-----ceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKV---KHPNIVKLRAYYWAPDE-----KLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----~~lV 481 (707)
+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++++ +|||++++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 47999999999999976 489999999874322 2234567788877666 59999999999988776 8999
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+. ++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||.+...
T Consensus 85 ~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 85 FEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred ehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 99997 58999887543 2358999999999999999999999 89999999999999999999999999998765
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... ....++..|+|||++.. ..++.++||||||+++|||++|++||...... ..
T Consensus 158 ~~~~~~-----------------~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-----~~ 214 (287)
T cd07838 158 SFEMAL-----------------TSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-----DQ 214 (287)
T ss_pred cCCccc-----------------ccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChH-----HH
Confidence 422110 11235788999999765 66789999999999999999999998753321 11
Q ss_pred HHHHHHhhcc---ccCC---------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFE---EENP---------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~---~~~~---------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.++...... ..++ +........ ..........+.+++.+||+.||.+||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 215 LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHcCCCChHhcCCCcccchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1111111000 0000 000000000 0001123466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.98 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=189.6
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~ 484 (707)
..||+|+||+||+|.. .++..||||.+... .......+.+|+.++++++||||+++++++.... ..++|+||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 4799999999999985 46899999998653 2223356788999999999999999999886542 46999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+. ++|.+++.... .+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 91 MD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred CC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 95 78999987543 58999999999999999999999 89999999999999999999999999999765422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ....
T Consensus 162 ~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~ 219 (337)
T cd07858 162 GDFM----------------TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV------HQLK 219 (337)
T ss_pred cccc----------------cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH------HHHH
Confidence 1100 12345788999998765456889999999999999999999999653211 1011
Q ss_pred HHHhhcccc--CCCchhchHHHHh-------------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 645 WVKKGFEEE--NPLSDMVDAMLLQ-------------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 645 ~~~~~~~~~--~~~~~~~d~~l~~-------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
......... .....+.+..... .........++.+++.+|++.||++||+++++++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 220 LITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 010000000 0000000000000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.26 Aligned_cols=241 Identities=22% Similarity=0.264 Sum_probs=196.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|.|+.|..|+.. .+..||+|.+.+..- .....+.+|+++|..++|||||+++.+.......|+||||+.+|.
T Consensus 62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge 141 (596)
T KOG0586|consen 62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE 141 (596)
T ss_pred eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence 37999999999999964 789999999987632 333458899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+++++..++ ++....+..++.|+.+|++|||+ +.|||||||++|||++.++++||+|||++..+.......
T Consensus 142 ~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq- 212 (596)
T KOG0586|consen 142 LFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ- 212 (596)
T ss_pred hHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccccc-
Confidence 999998775 46668888999999999999999 899999999999999999999999999998877433222
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
...|++.|.|||++.+....++++|+||+|+++|.|+.|..||++..... +.. +.
T Consensus 213 ----------------t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~------Lr~---rv 267 (596)
T KOG0586|consen 213 ----------------TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE------LRP---RV 267 (596)
T ss_pred ----------------ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc------ccc---hh
Confidence 23468899999998887777899999999999999999999998643321 111 11
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
++.... - ......++-+++++.+-.+|.+|+++.++.+
T Consensus 268 l~gk~r----------I---p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYR----------I---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeec----------c---cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111100 0 0112245668889999999999999998864
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=281.29 Aligned_cols=246 Identities=21% Similarity=0.298 Sum_probs=187.8
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC-----chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-----GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 483 (707)
.+.||+|+||.||+|.. .++..|++|.+... .......+.+|++++++++||||+++++++.+. +..++|+|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 45899999999999985 46899999987432 123346788999999999999999999998765 34689999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++++|.+++.... .+++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++....
T Consensus 87 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 87 YMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred eCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 999999999997543 47899999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
...... ......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....
T Consensus 159 ~~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~ 219 (264)
T cd06653 159 ICMSGT-------------GIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-----AAIF 219 (264)
T ss_pred ccccCc-------------cccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHH-----HHHH
Confidence 110000 0012346889999998765 56789999999999999999999998643211 1111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+. ..... ...+ .......+.+++.+|+. +|..||++.+++.
T Consensus 220 ~~----~~~~~--~~~~---------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 220 KI----ATQPT--KPML---------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HH----HcCCC--CCCC---------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 11000 0011 12233557899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=286.05 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=194.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..++..++|+||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 47999999999999864 788999999875532 2346788999999999999999999999999999999999975 9
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+..........
T Consensus 84 l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~- 155 (283)
T cd05118 84 LYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY- 155 (283)
T ss_pred HHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc-
Confidence 999887643 358999999999999999999999 899999999999999999999999999987664322000
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||.+.....++.++||||||+++|+|+||+.||...... +........
T Consensus 156 ---------------~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~------~~~~~~~~~ 214 (283)
T cd05118 156 ---------------THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI------DQLFKIFRT 214 (283)
T ss_pred ---------------cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHH
Confidence 11235778999999776447889999999999999999999998643211 111111110
Q ss_pred cccc--CCCchhch---HHH---H------hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEE--NPLSDMVD---AML---L------QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~--~~~~~~~d---~~l---~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .......+ ... . ..........++.+++.+||+.||.+||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 00000000 000 0 00001233567889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=289.30 Aligned_cols=271 Identities=24% Similarity=0.264 Sum_probs=189.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--------cceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--------EKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~lV 481 (707)
+.||+|+||.||+|... +++.+++|++..... .....+.+|++++++++||||+++++++.... ..++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 37999999999999965 688999998754322 12246778999999999999999999876543 35899
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
+||+.+ +|...+.... ..+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 94 ~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 94 TPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 999864 7888776532 359999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
.......... ............++..|+|||.+.....++.++|||||||++|||++|++||....... ....
T Consensus 166 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~--~~~~ 238 (311)
T cd07866 166 DGPPPNPKGG-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID--QLHL 238 (311)
T ss_pred cCCCcccccC-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence 4322211100 00001111334568889999987655667899999999999999999999986533210 0000
Q ss_pred HHHHHHhhccccC------------CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEEN------------PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+...........+ .........+... .......+.+++.+|+..||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER--FGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH--cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000000 0000000111000 0112256889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.63 Aligned_cols=197 Identities=29% Similarity=0.381 Sum_probs=169.3
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEEee
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~~ 485 (707)
.||+|+||.||+|+ ...|..||||.++... ....+...+|+++|++++|||||++.++-.+.. ...+|||||
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 79999999999999 5689999999998753 334577899999999999999999998765544 568999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc--CCC--CeEEecccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDF--QPYISDFGLSRLI 561 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~--~~~--~~kl~DfGla~~~ 561 (707)
.+|||+..|..-+ ....+++.+.+.++.+++.||.|||+ ++||||||||.||++- .+| .-||+|||.|+..
T Consensus 100 ~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 100 SGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred CCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999998653 34679999999999999999999999 8999999999999993 334 3699999999987
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
.+.... ....||..|.+||....++.++..+|.|||||++||.+||..||-...
T Consensus 175 ~d~s~~-----------------~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 175 DDNSLF-----------------TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred CCCCee-----------------eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 744321 345689999999997756888999999999999999999999997643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=270.41 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=191.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC----CcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP----DEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~~~lV~e~~ 485 (707)
..+||-|-.|.|-.+..+ +++.+|+|++.+. ...++|++.--+. .|||||+++++|.+. ...++|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 458999999999988864 7889999998765 3346788875555 799999999998653 3557999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEeccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLIN 562 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~ 562 (707)
+||.|++.+..++ ...+++.++-.|..||+.|+.|||+ ..|.||||||+|+|... +-.+||+|||+|+...
T Consensus 142 eGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 142 EGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred cchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 9999999998876 3469999999999999999999999 89999999999999964 4568999999998765
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
...... ...-|+.|.|||++-. .+|+..+|+||+||++|-|+.|.+||++...... ...+
T Consensus 216 ~~~~L~-----------------TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgM 275 (400)
T KOG0604|consen 216 EPGDLM-----------------TPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM 275 (400)
T ss_pred CCcccc-----------------CCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhH
Confidence 433222 2234999999999654 7799999999999999999999999987544211 1122
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
-..++.+.- ++-++ +.....++..+++...+..+|.+|-|+.++..
T Consensus 276 k~rI~~gqy------~FP~p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 276 KRRIRTGQY------EFPEP------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred HhHhhccCc------cCCCh------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222222211 11111 12344567789999999999999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=278.53 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=195.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||++... ++..+++|++..... .....+.+|++++++++|||++++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 47999999999999965 688999999876533 445778999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++..... ....+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 86 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-- 159 (258)
T cd08215 86 LSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-- 159 (258)
T ss_pred HHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcce--
Confidence 9999976431 12469999999999999999999999 89999999999999999999999999998765422100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....++..|+|||.... ..++.++||||+|+++++|++|+.||..... ..+.......
T Consensus 160 --------------~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~ 218 (258)
T cd08215 160 --------------AKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKILKG 218 (258)
T ss_pred --------------ecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHhcC
Confidence 012346788999998654 5678899999999999999999999864321 1222211111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ...+ .......+.+++.+||..+|++||++.++++
T Consensus 219 ~--~~~~-------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 219 Q--YPPI-------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred C--CCCC-------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000 0122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=291.31 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=186.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||++.. .++..||||++.... ......+.+|++++++++||||+++++++..+. ..++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 4799999999999985 478999999986432 223356889999999999999999999987654 3489999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 101 ~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 101 FM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 98 77999888642 48999999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....++..|+|||.+.....++.++||||||+++|++++|+.||...... ..+.
T Consensus 171 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-----~~~~ 226 (343)
T cd07880 171 EM-------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-----DQLM 226 (343)
T ss_pred Cc-------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence 11 11234788999998765456789999999999999999999999753211 0111
Q ss_pred HHHHhhccccCCCchhchHHHH--------hh----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLL--------QE----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~--------~~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+........ ...+...+. .. .........+.+++.+|++.||++|||+.++++
T Consensus 227 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 227 EIMKVTGTP----SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhcCCC----CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100000000 000000000 00 000122345789999999999999999999883
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.53 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=186.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--------------Cc
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--------------DE 477 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------------~~ 477 (707)
+.||.|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 4799999999999986 46889999998765555557788999999999999999999776544 34
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEeccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFG 556 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfG 556 (707)
.++|+||++ ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+|++|||
T Consensus 91 ~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred EEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 689999997 5999888643 48899999999999999999999 89999999999999974 5678999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
+++.......... ......++..|+|||.+.....++.++|||||||++|||++|+.||......
T Consensus 161 ~~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-- 225 (342)
T cd07854 161 LARIVDPHYSHKG-------------YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL-- 225 (342)
T ss_pred cceecCCcccccc-------------ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9876532211110 0012245788999998665567788999999999999999999999653221
Q ss_pred ccchhHHHHHHhhccccC-----CCchhchHHHHhhh---------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEEN-----PLSDMVDAMLLQEV---------HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~-----~~~~~~d~~l~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... ..... .........+.... .......++.+++.+|+..||++||++.++++
T Consensus 226 ---~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 226 ---EQMQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ---HHHHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000 00000 00000000000000 00112356789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=291.30 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=184.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
..||+|+||.||+|.. .+|..||+|++.... ......+.+|++++++++||||+++++++.... ..++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 4799999999999995 478999999986532 222356889999999999999999999987553 3589999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+.. +|..++. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 101 YMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred cccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 9964 7776653 148899999999999999999999 8999999999999999999999999999875431
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ...
T Consensus 170 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~------~~~ 224 (342)
T cd07879 170 EM-------------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQL 224 (342)
T ss_pred CC-------------------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 10 11234778999998765556789999999999999999999999753211 111
Q ss_pred HHHHhhccccCCCchhch-------------------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVD-------------------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d-------------------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+........ .+..+ ..+.. ........+.+++.+|++.||++||++++++.
T Consensus 225 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 225 TQILKVTGVPG--PEFVQKLEDKAAKSYIKSLPKYPRKDFST--LFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHhcCCCC--HHHHHHhcccchHHHHhhcCCcccchHHH--HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111000000 00000 00000 00112345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=287.76 Aligned_cols=261 Identities=22% Similarity=0.251 Sum_probs=186.8
Q ss_pred ceecccCeeEEEEEEeC-C--CceEEEEEcCCC--chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcC----CcceEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-N--GIPVAVRRLGEG--GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAP----DEKLLIS 482 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~~~lV~ 482 (707)
+.||+|+||.||++... . +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 47999999999999964 3 778999988643 222246788899999999 599999999876433 3457888
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+. ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 86 ELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred eccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 8885 69999997543 58999999999999999999999 899999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
........ ......|+..|+|||+......++.++|||||||++|+|++|+.||..... ...
T Consensus 157 ~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~------~~~ 218 (332)
T cd07857 157 ENPGENAG------------FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY------VDQ 218 (332)
T ss_pred cccccccc------------cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH------HHH
Confidence 22111000 011235688999999876556778999999999999999999999865321 111
Q ss_pred HHHHHhhccccC--CCchhchHHHH-------hh------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEEN--PLSDMVDAMLL-------QE------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~--~~~~~~d~~l~-------~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+........ .+..+.++... .. .........+.+++.+|++.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111110000 00000000000 00 000012356889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=290.66 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=195.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----cceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-----EKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e 483 (707)
...||+|+||.||+|... ++..|++|++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 347999999999999965 58999999987653 334477899999999999999999999998775 7799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|++ ++|.+++.... .+++..+..++.+++.||+|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 85 LME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred chh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 997 58999987543 69999999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
...... ......++..|+|||++.....++.++||||||+++|+|++|+.||...... +..
T Consensus 156 ~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~------~~~ 216 (330)
T cd07834 156 DEDEKG-------------FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI------DQL 216 (330)
T ss_pred cccccc-------------cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH------HHH
Confidence 321000 0012345788999999776447889999999999999999999999754321 111
Q ss_pred HHHHhhccccCC--C----chhchHHHHh---------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 644 RWVKKGFEEENP--L----SDMVDAMLLQ---------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 644 ~~~~~~~~~~~~--~----~~~~d~~l~~---------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..+......... . .......+.. ..........+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 217 NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111111000000 0 0000000000 00001134567899999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=282.88 Aligned_cols=258 Identities=25% Similarity=0.297 Sum_probs=193.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
..||+|++|.||+|... +++.+++|.+.... ....+.+.+|++++++++|+|++++++++.+.+..++|+||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 46999999999999975 58999999987653 2334678889999999999999999999999999999999997 59
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+.+++.+++.||+|||+ .+|+||||+|+||++++++.+||+|||.++.........
T Consensus 84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~- 155 (282)
T cd07829 84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY- 155 (282)
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc-
Confidence 999998652 358999999999999999999999 899999999999999999999999999987654221100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||.+.....++.++||||||+++|||++|+.||...... .....+...
T Consensus 156 ---------------~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~~ 214 (282)
T cd07829 156 ---------------THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI------DQLFKIFQI 214 (282)
T ss_pred ---------------CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHHH
Confidence 11223677999999776557889999999999999999999998653321 111111111
Q ss_pred ccccCC-----------CchhchHHHHhh--hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP-----------LSDMVDAMLLQE--VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~-----------~~~~~d~~l~~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ....+....... .........+.+++.+||..||++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 100000 000000000000 000112456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=286.08 Aligned_cols=256 Identities=22% Similarity=0.310 Sum_probs=187.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....++|+||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 47999999999999854 7899999987543 22234678899999999999999999999876 45678999998 56
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.++++.. .+++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.+.......
T Consensus 95 ~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~--- 162 (328)
T cd07856 95 DLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM--- 162 (328)
T ss_pred CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc---
Confidence 999988743 47888899999999999999999 899999999999999999999999999987543110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH----
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR---- 644 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~---- 644 (707)
....++..|+|||.+..+..++.++||||||+++|||+||+.||....... ....+.+
T Consensus 163 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~--~~~~~~~~~~~ 224 (328)
T cd07856 163 ----------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN--QFSIITDLLGT 224 (328)
T ss_pred ----------------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence 112347789999987655678899999999999999999999986432110 0000111
Q ss_pred ----HHHhhccccCCCchhchHHHHhhh-h----hHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 645 ----WVKKGFEEENPLSDMVDAMLLQEV-H----AKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 645 ----~~~~~~~~~~~~~~~~d~~l~~~~-~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
|........ . .+.+...-.... . .......+.+++.+|++.+|++||++.+++..
T Consensus 225 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSEN-T-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchh-h-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111000000 0 000000000000 0 01123578899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=289.99 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=184.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 483 (707)
..||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 4799999999999985 578999999987542 22336688899999999999999999988643 23577888
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
++ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 103 ~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 103 LM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred hc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 76 78999888643 48999999999999999999999 8999999999999999999999999999875431
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ...
T Consensus 173 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~------~~~ 227 (345)
T cd07877 173 EM-------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI------DQL 227 (345)
T ss_pred cc-------------------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 10 12245788999998665456788999999999999999999998543211 111
Q ss_pred HHHHhhcccc--CCCchhchH---HHHhh-------hh---hHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEE--NPLSDMVDA---MLLQE-------VH---AKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~--~~~~~~~d~---~l~~~-------~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+....... .....+.+. ..... .. .......+.+++.+|++.||.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 1110000000 000000000 00000 00 0012345789999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=274.39 Aligned_cols=236 Identities=26% Similarity=0.344 Sum_probs=189.0
Q ss_pred ecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 415 LGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
||+|+||.||++... +++.+++|.+..... .....+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 588999999876532 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-- 150 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-- 150 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcc--
Confidence 99997643 58999999999999999999999 899999999999999999999999999987654321100
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....++..|+|||.... ...+.++|+||||+++||+++|+.||..... ......+..
T Consensus 151 --------------~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-- 207 (250)
T cd05123 151 --------------NTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK-- 207 (250)
T ss_pred --------------cCCcCCccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc--
Confidence 22345788999998665 5678899999999999999999999864321 122222221
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
....+... ....+.+++.+||..||++||++++
T Consensus 208 -~~~~~~~~-------------~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 208 -DPLRFPEF-------------LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCC-------------CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111111 1345678999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=278.79 Aligned_cols=245 Identities=24% Similarity=0.314 Sum_probs=185.5
Q ss_pred ceecccCeeEEEEEEeCC-CceEEEEEcCCC-----chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLGN-GIPVAVRRLGEG-----GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++.+.+..++|+||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 479999999999998643 444555555432 22233467789999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+++|.+++.... .....+++..++.++.|++.||+|||+ .+++|+||||+||++++ +.+||+|||+++.......
T Consensus 86 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~ 160 (260)
T cd08222 86 GRDLDCKLEELK-HTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD 160 (260)
T ss_pred CCCHHHHHHHHh-hcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCcc
Confidence 999999987532 123469999999999999999999999 89999999999999975 5699999999876542211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....++..|+|||.... ..++.++||||||+++|+|++|+.||.... ..+..
T Consensus 161 ~----------------~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---------~~~~~ 214 (260)
T cd08222 161 L----------------ATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQN---------FLSVV 214 (260)
T ss_pred c----------------ccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHH
Confidence 1 012345788999998654 667889999999999999999999985321 11111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........+ .+ ......++.+++.+||..+|++||++.++++
T Consensus 215 ~~~~~~~~~---~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 215 LRIVEGPTP---SL---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHcCCCC---CC---------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111110 00 1122346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=290.46 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=187.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------ceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------KLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e 483 (707)
..||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++...+. .++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 47999999999999975 6789999998653 22233667889999999999999999998876654 799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 101 ~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 101 LM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 98 67999998752 58999999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....++..|+|||.+.....++.++|||||||++|||++|+.||...... ...
T Consensus 171 ~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~------~~~ 225 (343)
T cd07851 171 EM-------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI------DQL 225 (343)
T ss_pred cc-------------------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHH
Confidence 10 11234778999998765456789999999999999999999999643211 111
Q ss_pred HHHHhhccccCCCchhchH--------HHHh------h---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDA--------MLLQ------E---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~--------~l~~------~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+........ ..+.+. .+.. . ........++.+++.+|+..||++|||+.+|++
T Consensus 226 ~~i~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 226 KRIMNLVGTPD--EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhcCCCC--HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11111110000 000000 0000 0 000112467889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=280.25 Aligned_cols=257 Identities=21% Similarity=0.298 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... ++..|++|++... .....+.+.+|++++++++ ||||+++++++..++..++||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 47999999999999965 7899999998753 2233467889999999998 99999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
++|.+++.... .+++..+..|+.|++.||+|||+ .+++|+||||+||+++.++.++++|||++.........
T Consensus 87 ~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 87 GELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999998653 59999999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCCCCC----cCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 568 PSSSGGF----MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 568 ~~~~~~~----~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
....... ..............++..|+|||.... ..++.++||||||++++++++|+.||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~ 231 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTF 231 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHH
Confidence 1000000 000000111233456889999998665 56788999999999999999999998754311 111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh----HHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM----KNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~~v~~ 700 (707)
.... .....+. ......+.+++.+|++.+|.+||++ +++++
T Consensus 232 ~~~~---~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKIL---KLEYSFP-------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHH---hcCCCCC-------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 1111111 1123457899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=305.72 Aligned_cols=140 Identities=24% Similarity=0.368 Sum_probs=126.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||||++.... ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 47999999999999975 68899999987542 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
+|.+++.... .+++..++.|+.||+.||+|||+ .+||||||||+|||++.++.+||+|||+++.
T Consensus 90 ~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 90 DVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999997543 58899999999999999999999 8999999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=286.78 Aligned_cols=231 Identities=23% Similarity=0.311 Sum_probs=184.4
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+|.|+|+.|.++.. .+++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.++.+.|+|||++.+|-+.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 599999999999985 467889999998762 2234578777766 8999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE-cCCCCeEEecccccccccccCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL-DNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll-~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
+.+.... .+. ..+..|+.+|+.|+.|||+ ++||||||||+|||+ ++.++++|+|||.++.....-.
T Consensus 405 ~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~---- 471 (612)
T KOG0603|consen 405 RRIRSKP-----EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD---- 471 (612)
T ss_pred HHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc----
Confidence 8887653 233 6778899999999999999 899999999999999 5889999999999987764311
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
...-|..|.|||+.. ...++++||+||||++||+|++|+.||.....+ .++ ...+
T Consensus 472 ---------------tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei----~~~i 526 (612)
T KOG0603|consen 472 ---------------TPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEI----HTRI 526 (612)
T ss_pred ---------------ccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHH----HHhh
Confidence 112288899999976 588999999999999999999999999764332 111 1111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... .+.........+|+..|++.||.+||+|.++..
T Consensus 527 ~~~--------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 527 QMP--------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCC--------------ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 111233356789999999999999999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=268.09 Aligned_cols=220 Identities=21% Similarity=0.208 Sum_probs=172.7
Q ss_pred cCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhC
Q 005226 418 SGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRG 496 (707)
Q Consensus 418 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 496 (707)
|.+|.||++.. .+++.+|+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999996 478899999987643 234456666667899999999999999999999999999999999975
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcC
Q 005226 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576 (707)
Q Consensus 497 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 576 (707)
.. .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++++|||.+.......
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----------- 139 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----------- 139 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----------
Confidence 43 48999999999999999999999 899999999999999999999999999876544211
Q ss_pred CCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCC
Q 005226 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPL 656 (707)
Q Consensus 577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (707)
....++..|+|||.... ..++.++||||+|+++|||++|+.|+........ . .....+
T Consensus 140 --------~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~--~~~~~~ 197 (237)
T cd05576 140 --------DGEAVENMYCAPEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------T--HTTLNI 197 (237)
T ss_pred --------ccCCcCccccCCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------c--ccccCC
Confidence 11123567999998654 5678899999999999999999988653211000 0 000000
Q ss_pred chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 657 SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
. ......+.+++.+|++.||++||++.
T Consensus 198 ~-------------~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 198 P-------------EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred c-------------ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 0 11224567899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=264.86 Aligned_cols=233 Identities=24% Similarity=0.323 Sum_probs=187.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+||+|.||.|-+++- ..++.+|+|++++. ...+...-..|-++|+..+||.+..+--.|+..+..|+||||..||
T Consensus 174 KvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGG 253 (516)
T KOG0690|consen 174 KVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGG 253 (516)
T ss_pred HHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCc
Confidence 4899999999999984 47899999999876 2344456678999999999999999988899999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
.|+-+|...+ .++++...-+...|..||.|||+ ++||.||||.+|.|+|.||++||+|||+.+.--..+...
T Consensus 254 eLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 254 ELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred eEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccccee
Confidence 9999998654 68999999999999999999999 899999999999999999999999999987532222111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|.|||++.. ..|..+.|.|.+||++|||++|+.||+..+.. .+.+.+
T Consensus 326 ----------------kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------kLFeLI-- 380 (516)
T KOG0690|consen 326 ----------------KTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------KLFELI-- 380 (516)
T ss_pred ----------------ccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchh------HHHHHH--
Confidence 23567999999999765 78899999999999999999999999864432 111111
Q ss_pred hccccCCCchhchHHHHhh-hhhHHHHHHHHHHHHhccCCCCCCCC
Q 005226 649 GFEEENPLSDMVDAMLLQE-VHAKKEVIAVFHLALACTEADPEVRP 693 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RP 693 (707)
+..+ .+......+...|+...+..||.+|.
T Consensus 381 ---------------l~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 ---------------LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ---------------HhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1110 11222334456777888899999995
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=322.80 Aligned_cols=251 Identities=38% Similarity=0.631 Sum_probs=162.8
Q ss_pred HHHhhcCCcccHHHHHHHHhcCcCCCCCCCCCCCCCCCCCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCC
Q 005226 13 FLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSL 92 (707)
Q Consensus 13 ~~~~~~~~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l 92 (707)
++..+...+.|..||++||+.+. +|.+.+.+|+..+ +||.|.||+|.+. .+|+.|+|++|+++|.++..|..+
T Consensus 20 ~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~~~-~~c~w~gv~c~~~-----~~v~~L~L~~~~i~~~~~~~~~~l 92 (968)
T PLN00113 20 FLNFSMLHAEELELLLSFKSSIN-DPLKYLSNWNSSA-DVCLWQGITCNNS-----SRVVSIDLSGKNISGKISSAIFRL 92 (968)
T ss_pred HHHccCCCHHHHHHHHHHHHhCC-CCcccCCCCCCCC-CCCcCcceecCCC-----CcEEEEEecCCCccccCChHHhCC
Confidence 33455567889999999999996 7888899997544 7899999999752 589999999999999999999999
Q ss_pred CCCCEEEcccCCcCCCCCcccc-CCCCCceEEecCccCCCCCC----------------------cccCCCCCccEEecc
Q 005226 93 IYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLP----------------------PSVCNLPRLQNLDLS 149 (707)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p----------------------~~~~~l~~L~~L~Ls 149 (707)
++|+.|+|++|++++.+|..+. ++++|++|+|++|++++.+| ..++++++|+.|+|+
T Consensus 93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~ 172 (968)
T PLN00113 93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLG 172 (968)
T ss_pred CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECc
Confidence 9999999999999888887765 67777777777777665544 444445555555555
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|.+.+.+|..+.++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++.+|..++++++| ++|+|++|++++
T Consensus 173 ~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-~~L~L~~n~l~~ 250 (968)
T PLN00113 173 GNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPREL-GQMKSLKWIYLGYNNLSGEIPYEIGGLTSL-NHLDLVYNNLTG 250 (968)
T ss_pred cCcccccCChhhhhCcCCCeeeccCCCCcCcCChHH-cCcCCccEEECcCCccCCcCChhHhcCCCC-CEEECcCceecc
Confidence 555554555555555555555555555554444433 445555555555555555555555555555 455555555555
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCC
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSN 272 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N 272 (707)
.+|..+.++++|+.|++++|++++.+|. ...+.++..+.+.+|
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 294 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence 5555555555555555555555554442 122333444444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=263.36 Aligned_cols=238 Identities=30% Similarity=0.403 Sum_probs=191.2
Q ss_pred CeeEEEEEEeC-CCceEEEEEcCCCchhh-HHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhC
Q 005226 419 GLGIVYKVVLG-NGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRG 496 (707)
Q Consensus 419 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 496 (707)
+||.||+|... ++..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999987764433 58899999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcC
Q 005226 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576 (707)
Q Consensus 497 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~ 576 (707)
.. .+++..+..++.+++.++.|||+ .+++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--------- 143 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL--------- 143 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccccc---------
Confidence 43 28999999999999999999999 89999999999999999999999999999876533211
Q ss_pred CCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCC
Q 005226 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPL 656 (707)
Q Consensus 577 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 656 (707)
....++..|+|||.... ...+.++||||||++++++++|..||.... +.....++..........
T Consensus 144 --------~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~- 208 (244)
T smart00220 144 --------TTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKIGKPKPPFPP- 208 (244)
T ss_pred --------ccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHHhccCCCCcc-
Confidence 12345778999998664 667889999999999999999999986421 112233332221111100
Q ss_pred chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 657 SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 657 ~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......++.+++.+|+..+|++||++.++++
T Consensus 209 ------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 ------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00003356789999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=242.50 Aligned_cols=200 Identities=24% Similarity=0.340 Sum_probs=164.9
Q ss_pred ccceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 411 SAYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
....||+|++|.|-+-++ .+|+..|||++... ..++.++...|+++..+- .+|.+|.++|.+...+..++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 345699999999988885 48999999998765 445567888899986665 899999999999999999999999954
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
||+.+-+..- .....+++...-+||..|..||.|||+. ..|||||+||+|||++.+|++|+||||++..+..+-.
T Consensus 130 -Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 130 -SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred -hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 7777654321 1234689999999999999999999996 6899999999999999999999999999987653321
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP---GNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
.+...|...|||||.+.. +..|+-|+||||+|++++||.++++||..-
T Consensus 205 ----------------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 205 ----------------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ----------------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 133456778999998653 357889999999999999999999998753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=276.57 Aligned_cols=243 Identities=23% Similarity=0.282 Sum_probs=188.2
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.++||.|.||+||-|.+ ++|+.||||++.+... ....++..|+.+|++++||.||.+--.|++.+..+.|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 56899999999999996 4899999999876532 22377899999999999999999999999999999999999654
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~ 565 (707)
-|.-.|.... .++++....-++.||+.||.|||. ++|+|.||||+|||+... -++||||||+|+.+.+..
T Consensus 649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 4444454433 368888889999999999999999 899999999999999644 379999999999887432
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
-. ...+||+.|.|||++.. ..|...-|+||.||++|.-++|..||.. +.++.+.
T Consensus 722 FR-----------------rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNE--------dEdIndQ 775 (888)
T KOG4236|consen 722 FR-----------------RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNE--------DEDINDQ 775 (888)
T ss_pred hh-----------------hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCC--------ccchhHH
Confidence 21 34678999999999775 7788899999999999999999999963 2233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
+....-.-.+ ....+.....+++|...++..-++|-+..+.+
T Consensus 776 IQNAaFMyPp------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 776 IQNAAFMYPP------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred hhccccccCC------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 3322111000 01233344566777788888777887765543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=266.90 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=193.1
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-C-C----ceeeeEEEEEcCCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-H-P----NIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+|+|.||.|-.+... .+..||||+++...... +...-|+++++++. + | -+|++.+++...++.|+|+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 6999999999999853 57899999998765443 55677999999993 3 2 3788999999999999999988
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC--------------------
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-------------------- 546 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-------------------- 546 (707)
|-|++++|..+. ..+++...+..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 174 G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 174 GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 569999998765 4579999999999999999999999 89999999999999943
Q ss_pred CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCC
Q 005226 547 DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS 626 (707)
Q Consensus 547 ~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~ 626 (707)
+..+||+|||-|+...... ...+.|..|+|||++++ -.+++.+||||+||+|+|+.||..
T Consensus 248 s~~I~vIDFGsAtf~~e~h-------------------s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 248 STAIKVIDFGSATFDHEHH-------------------STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred CcceEEEecCCcceeccCc-------------------ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccce
Confidence 2358999999987654322 23456999999999886 889999999999999999999999
Q ss_pred CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHH--------------------------------HHhhhhhHHHH
Q 005226 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAM--------------------------------LLQEVHAKKEV 674 (707)
Q Consensus 627 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--------------------------------l~~~~~~~~~~ 674 (707)
.|+.....+. + .-+...+. ..+ ..|+.+. -........+.
T Consensus 308 LFqtHen~EH-----L-aMMerIlG-p~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 308 LFQTHENLEH-----L-AMMERILG-PIP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred ecccCCcHHH-----H-HHHHHhhC-CCc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 9986543211 1 11111111 000 1111111 00111234567
Q ss_pred HHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 675 IAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 675 ~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.++.+|+.+++..||.+|+|+.|++.
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhc
Confidence 88999999999999999999999875
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=299.78 Aligned_cols=195 Identities=25% Similarity=0.310 Sum_probs=172.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+||+|+||.|..++++ .++.||+|+++++. ..+..-|..|-++|..-+.+-|++++-.|+++.+.|+|||||+||
T Consensus 81 KvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGG 160 (1317)
T KOG0612|consen 81 KVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGG 160 (1317)
T ss_pred HHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCc
Confidence 48999999999999975 67899999998853 234467888999999989999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++..+.-++..|.-||.-||+ .|+|||||||+|||+|.+|++||+|||-+-.+...+...
T Consensus 161 DlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~ 232 (1317)
T KOG0612|consen 161 DLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR 232 (1317)
T ss_pred hHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE
Confidence 9999998754 58999999999999999999999 799999999999999999999999999887777554433
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC---C-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP---G-NRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~-~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
+ ...+|||.|++||++.. + +.|++.+|.||+||++|||+.|..||+.
T Consensus 233 s---------------~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 233 S---------------SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred e---------------ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 3 46789999999999653 3 6788999999999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=255.47 Aligned_cols=262 Identities=24% Similarity=0.323 Sum_probs=192.0
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--------CcceEEE
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--------DEKLLIS 482 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV~ 482 (707)
.||+|.||.||+|+.+ .|+.||+|+.-.. ..+-.....+|+++|..++|+|++.++..|... ...|+||
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 6999999999999965 5677888764332 222334568899999999999999999988653 2368999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
++++. +|.-.|.... ..++..++.++..++..||.|+|+ ..|+|||+||.|+|++.++.+||+|||+|+.+.
T Consensus 104 ~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 99976 8998887542 468999999999999999999999 899999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
...+.... +| +.++.|.+|++||.+.+.+.++++.|||+-||++.||+||.+-+.+.++... -.+
T Consensus 176 ~~~n~~kp---------ry---tnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq---l~~ 240 (376)
T KOG0669|consen 176 TSKNVVKP---------RY---TNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ---LHL 240 (376)
T ss_pred cccccCCC---------Cc---ccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH---HHH
Confidence 44332110 01 3455699999999999999999999999999999999999988876543311 111
Q ss_pred HHHHHhhc-cccCCCchhchHHHHhhh-----------hhHHH------HHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGF-EEENPLSDMVDAMLLQEV-----------HAKKE------VIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~-~~~~~~~~~~d~~l~~~~-----------~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ .+-|+ ++..-.+-... ..+.. ....++|+..++..||.+|+++.+++.
T Consensus 241 Is~LcGs~tkevWP--~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 241 ISQLCGSITKEVWP--NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHhccCCcccCC--CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 22111111 11111 00000000000 00111 125778999999999999999988864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=268.46 Aligned_cols=255 Identities=26% Similarity=0.305 Sum_probs=187.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC---c----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---G----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e 483 (707)
.+||+|||+.||+|.. ...+.||||+-.-. . ....+...+|.++-+.|+||.||++|+|+.- .+..|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 4799999999999984 46678888874322 1 1123567889999999999999999999965 467789999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEeccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRL 560 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~ 560 (707)
|++|.+|+-+|+.++ .+++.++..|+.||+.||.||.+.. .+|||-||||.|||+.+ .|.+||+|||+++.
T Consensus 549 YceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999998765 6899999999999999999999865 59999999999999954 47899999999999
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
|+........ + ..-.....||.+|.+||.+.-+ .+.+.|+||||.||++|..+.|+.||.....
T Consensus 623 MdddSy~~vd-G--------meLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---- 689 (775)
T KOG1151|consen 623 MDDDSYNSVD-G--------MELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---- 689 (775)
T ss_pred ccCCccCccc-c--------eeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh----
Confidence 9754332111 0 1112356789999999997643 5678899999999999999999999975322
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 698 (707)
..++.++..-.-... ...........+..++|.+|++.--++|-...++
T Consensus 690 -QQdILqeNTIlkAtE-----------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 690 -QQDILQENTILKATE-----------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred -HHHHHhhhchhccee-----------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 122222211100000 0011112223455677788887777777665554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=281.81 Aligned_cols=259 Identities=23% Similarity=0.277 Sum_probs=175.8
Q ss_pred cceecccCeeEEEEEEe-----------------CCCceEEEEEcCCCchhhHHH--------------HHHHHHHHHhc
Q 005226 412 AYVLGKSGLGIVYKVVL-----------------GNGIPVAVRRLGEGGEQRHRE--------------FVTEVQAIAKV 460 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~l 460 (707)
.++||+|+||+||+|.. .+++.||||++........++ +..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 45899999999999964 245679999987543332233 34577788888
Q ss_pred CCCce-----eeeEEEEEc--------CCcceEEEEeecCCChHHHHhCCCCC-------------------CCCCCCHH
Q 005226 461 KHPNI-----VKLRAYYWA--------PDEKLLISDFISNGNLANALRGRNGQ-------------------PSTSLSWS 508 (707)
Q Consensus 461 ~H~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~ 508 (707)
+|.++ +++++||.. .+..++||||+++|+|.++++...+. ....++|.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 76654 677888753 35679999999999999999754211 12346788
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccc
Q 005226 509 TRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588 (707)
Q Consensus 509 ~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (707)
.+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.+....... +....
T Consensus 310 ~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~---------------~~~g~ 371 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN---------------PLYGM 371 (507)
T ss_pred HHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC---------------ccccC
Confidence 999999999999999999 899999999999999999999999999997554221110 11123
Q ss_pred cCccccCCCCCCCCCC---------------------CCchhhHHHHHHHHHHHHhCCC-CCCCCCCCCC---ccchhHH
Q 005226 589 KTNNYRAPEARVPGNR---------------------PMQKWDVYSFGVVLLELLTGKS-PELSPTTSTS---IEVPDLV 643 (707)
Q Consensus 589 gt~~y~aPE~~~~~~~---------------------~~~~~DV~S~Gv~l~elltg~~-P~~~~~~~~~---~~~~~~~ 643 (707)
+++.|+|||.+..... ...+.||||+||+++||++|.. |+........ ....++.
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~ 451 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN 451 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH
Confidence 3778999998653111 1135799999999999999986 6543211100 0011122
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCC---CCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP---EVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~~v~~ 700 (707)
.|... ...... ... .........+++.+++..+| ++|+|++|+++
T Consensus 452 ~~r~~-~~~~~~-~~~----------~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 452 RWRMY-KGQKYD-FSL----------LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHhh-cccCCC-ccc----------ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 22211 000000 000 11223456788889998765 78999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=263.01 Aligned_cols=196 Identities=24% Similarity=0.326 Sum_probs=165.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+||+|+||.|.+|..+ ..+.+|||++++... .+.+--+.|-++|+-- +-|.+++++..+++-+..|.||||+.|
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 48999999999999854 568899999987622 2223345677788776 678999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|--+++..+ .+.+..+.-+|..||-||-+||+ ++||.||||.+||++|.+|++||+|||+.+.--..+..
T Consensus 435 GDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 435 GDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred chhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence 99999998654 58888999999999999999999 99999999999999999999999999998753221111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
. .+..||+.|+|||++.- ..|+..+|.|||||+||||+.|++||++.++
T Consensus 507 T----------------kTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 507 T----------------KTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred e----------------eeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 1 24567999999999665 7888999999999999999999999987544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=277.78 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=198.6
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc-----CCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA-----PDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV~e~~ 485 (707)
++||+|.+|.||+++ ..+++.+|+|++......+ ++...|.++++.. +|||++.++|++.. +++.+||||||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 389999999999998 4578899999987765544 6778899999988 89999999999964 57889999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
.+|+..++++... ...+.|..+..|++.++.|+.+||. ..++|||||-.|||++.++.||++|||++...+.+.
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~ 177 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTV 177 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeeccc
Confidence 9999999998765 4579999999999999999999999 899999999999999999999999999998776433
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
... .+..||+.|||||++.. ...|+.++|+||+|++..||-.|.+|+.+..+.
T Consensus 178 grR----------------nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------- 234 (953)
T KOG0587|consen 178 GRR----------------NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------- 234 (953)
T ss_pred ccc----------------cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence 221 23457999999999653 245567999999999999999999998765543
Q ss_pred HHHHHHhhcc-ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFE-EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+..+. ..++ .+.+. .......++.++|..|+..|-++||++.++++
T Consensus 235 -----raLF~IpRNP-----PPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 -----RALFLIPRNP-----PPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----hhhccCCCCC-----Ccccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 1111 11111 12455677899999999999999999998864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=231.13 Aligned_cols=191 Identities=25% Similarity=0.371 Sum_probs=163.6
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.||+|.+|+||+|+. ..++.||+|+++-. .++......+|+.+++.++|+|||++++...++...-+|+||+.. +|
T Consensus 9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dl 87 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HH
Confidence 699999999999994 56789999987543 344456778999999999999999999999999999999999954 88
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++.....| .++.+.....+.|+++||.|+|+ +.+.|||+||.|.+++.+|+.|++|||+|+-+...- .
T Consensus 88 kkyfdslng----~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv----r 156 (292)
T KOG0662|consen 88 KKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----R 156 (292)
T ss_pred HHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce----E
Confidence 888876553 58999999999999999999999 899999999999999999999999999998665221 0
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~ 628 (707)
+| .....|.+|++|.++.+..-|++..|+||-||++.|+.....|.
T Consensus 157 ---------cy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl 202 (292)
T KOG0662|consen 157 ---------CY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_pred ---------ee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence 11 22345899999999998888999999999999999999866554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=285.71 Aligned_cols=260 Identities=20% Similarity=0.186 Sum_probs=161.4
Q ss_pred cceecccCeeEEEEEEeC-C----CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEE------EEcCCcceE
Q 005226 412 AYVLGKSGLGIVYKVVLG-N----GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY------YWAPDEKLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~~~~~~~l 480 (707)
.+.||+|+||.||+|... + +..||||++......+ .+..| .+....+.++..++.. +..+++.++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 458999999999999975 4 6899999986543221 11111 1122222222222111 245567899
Q ss_pred EEEeecCCChHHHHhCCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 481 ISDFISNGNLANALRGRNGQ---------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
|+||+++++|.++++..... ......+..+..|+.||+.||+|||+ ++|+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEe
Confidence 99999999999999754210 00112234566899999999999999 8999999999999998
Q ss_pred C-CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---------------------C
Q 005226 546 N-DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---------------------N 603 (707)
Q Consensus 546 ~-~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------~ 603 (707)
. ++.+||+|||+|+.+....... +....+++.|+|||.+... .
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~---------------~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~ 354 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYI---------------PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL 354 (566)
T ss_pred CCCCcEEEEeCCCccccccccccC---------------CcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence 6 5799999999998654222111 1233457788888853211 1
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC----CccchhHHHHHHhhccccCCCchhchHHHHhhh-hhHHHHHHHH
Q 005226 604 RPMQKWDVYSFGVVLLELLTGKSPELSPTTST----SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEV-HAKKEVIAVF 678 (707)
Q Consensus 604 ~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~l~ 678 (707)
.++.++|||||||++|||+++..|+....... .....++..|....... ..+.+.... ..........
T Consensus 355 ~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~ 427 (566)
T PLN03225 355 NLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGW 427 (566)
T ss_pred cCCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHH
Confidence 23456799999999999999776643210000 00011122232111110 000000000 0001122345
Q ss_pred HHHHhccCCCCCCCCChHHHHH
Q 005226 679 HLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 679 ~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+|+.+|++.||++|||++++++
T Consensus 428 dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 428 ELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHHHHccCCcccCCCHHHHhC
Confidence 8999999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-31 Score=268.84 Aligned_cols=235 Identities=22% Similarity=0.297 Sum_probs=190.1
Q ss_pred eecccCeeEEEEEEeCCCc-eEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGNGI-PVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||-||||.|-++...... .+|+|.+++. .....+....|-.+|...+.|.||++|--|.+....|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 5999999999998875433 4888887765 33344667889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|...|+.++ .++..+..-++..+.+|++|||+ ++||.|||||+|.++|.+|-+||.|||+|+.+......
T Consensus 507 lWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT-- 576 (732)
T KOG0614|consen 507 LWTILRDRG-----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT-- 576 (732)
T ss_pred hhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCce--
Confidence 999999765 68889999999999999999999 99999999999999999999999999999988754332
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.+..||+.|.|||++.. ...+.++|.||+|+++|||+||++||.+.++.. ....+..+
T Consensus 577 ---------------wTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkG 634 (732)
T KOG0614|consen 577 ---------------WTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKG 634 (732)
T ss_pred ---------------eeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhh
Confidence 34567999999999876 667899999999999999999999998755431 11111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 694 (707)
+.. -..++.......+++.+.+..+|.+|--
T Consensus 635 id~--------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 635 IDK--------------IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhh--------------hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 110 0112333345678888888999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=261.26 Aligned_cols=213 Identities=24% Similarity=0.292 Sum_probs=169.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
..||-|+||.|.++... +...+|.|.+++.+. ........|-+||+.-+.+-||+|+-.|++++..|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 35899999999999854 456789998876532 22345678999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
++-.+|-..+ .|.+..+.-++..++.|+++.|. .|+|||||||+|||||.||++||+|||+..-+.-..+..
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999997654 68889999999999999999999 799999999999999999999999999975432111110
Q ss_pred CCCCCCcC------CCCCCCCc--------------------cccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHH
Q 005226 569 SSSGGFMG------GALPYMKP--------------------VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELL 622 (707)
Q Consensus 569 ~~~~~~~~------~~~~~~~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ell 622 (707)
-+..+... ....|.+. -..+||..|+|||++.. ..++..||.||.||+||||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHHHh
Confidence 00000000 00011110 11368999999999776 78899999999999999999
Q ss_pred hCCCCCCCCCCC
Q 005226 623 TGKSPELSPTTS 634 (707)
Q Consensus 623 tg~~P~~~~~~~ 634 (707)
.|+.||...++.
T Consensus 866 ~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 866 VGQPPFLADTPG 877 (1034)
T ss_pred hCCCCccCCCCC
Confidence 999999876654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=247.70 Aligned_cols=198 Identities=24% Similarity=0.373 Sum_probs=165.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e 483 (707)
.+-||-|+||.||.++.. +|+.|+.|++...-. ..-+.+.+|++++..++|.|++..+++..-. .+.|.|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 347999999999999864 799999999865422 2347788999999999999999998887654 35688999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
.|. .+|.+.+..- ..++-+.+.-.++||++||+|||+ .+|.||||||.|.|++.+...||||||+|+..+.
T Consensus 138 LmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 885 4888888643 468888889999999999999999 8999999999999999999999999999987653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
.....- +...-|..|+|||++++.+.|+.+.||||.||++.|++.++-.|....+
T Consensus 209 d~~~hM---------------TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 209 RDRLNM---------------THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhhhhh---------------HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 322110 3345588999999999989999999999999999999999988876543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=277.43 Aligned_cols=245 Identities=27% Similarity=0.338 Sum_probs=180.6
Q ss_pred cceecccCee-EEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLG-IVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+++|.|+-| .||+|.. +|+.||||++-.... +-..+|+..|+.- +|||||++++.-.++...|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 3479999886 6899999 677999999855322 3456899999988 79999999988888889999999994 59
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---C--CCeEEeccccccccccc
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---D--FQPYISDFGLSRLINIT 564 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~--~~~kl~DfGla~~~~~~ 564 (707)
|.+++... +.......--..+.+..|++.||++||+ -+||||||||.||||+. + ..++|+|||+++.+...
T Consensus 589 L~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 589 LQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred HHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 99999874 1111111113456788999999999999 79999999999999976 3 47999999999988643
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG-KSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg-~~P~~~~~~~~~~~~~~~~ 643 (707)
...-. ......||-+|+|||.+.. ..-+.++||||+||++|+.++| .+||...-..
T Consensus 665 ~sS~~-------------r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--------- 721 (903)
T KOG1027|consen 665 KSSFS-------------RLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--------- 721 (903)
T ss_pred cchhh-------------cccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHh---------
Confidence 32211 1134568999999999776 4556799999999999999997 8898642211
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
-...+.....+..+. ...++ +..+||.+|+++||..||++.+|+.
T Consensus 722 --~~NIl~~~~~L~~L~--------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 722 --QANILTGNYTLVHLE--------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --hhhhhcCccceeeec--------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011111111111100 00111 6789999999999999999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=244.10 Aligned_cols=127 Identities=22% Similarity=0.309 Sum_probs=107.8
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-----C---CceeeeEEEEEcC----Ccc
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-----H---PNIVKLRAYYWAP----DEK 478 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~~----~~~ 478 (707)
.+.||-|-|++||++.. .+.+.||+|+.+...... +....||++|++++ | .+||+|+++|... .+.
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYt-EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HV 161 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYT-EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHV 161 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhHHH-HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEE
Confidence 45799999999999995 467889999987754433 56788999999984 3 3699999999764 467
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
|||+|+. |.+|..+|.... .+.++...+.+|++||+.||.|||..| +|||-||||+|||+-
T Consensus 162 CMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 162 CMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 9999998 679999998764 457999999999999999999999986 899999999999994
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=238.90 Aligned_cols=242 Identities=19% Similarity=0.251 Sum_probs=183.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+||+|+++.|..+++. +.+.+|+|++++.-. .+.+=...|-.+..+- +||.+|.++.+|++....++|.||+++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 48999999999999964 678899998876422 1222334566666665 899999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|--+++..+ .++++.+.-+...|.-||.|||+ ++||.||||.+|||+|..|++|++|||+.+.--..+..
T Consensus 336 gdlmfhmqrqr-----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 336 GDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred cceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99988887654 58899999999999999999999 99999999999999999999999999998764433332
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. .+..||++|+|||++.+ ..|....|.|++||+++||+.|+.||+...-... .....++.-
T Consensus 408 t----------------stfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~--d~ntedylf 468 (593)
T KOG0695|consen 408 T----------------STFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP--DMNTEDYLF 468 (593)
T ss_pred c----------------ccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCc--ccchhHHHH
Confidence 2 23457999999999665 8889999999999999999999999985332111 111222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 693 (707)
+.+-++. ++ -.+........++..-+..||.+|.
T Consensus 469 qvilekq---------ir---iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 469 QVILEKQ---------IR---IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHhhhc---------cc---ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2221111 10 0122234556777788899999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=230.97 Aligned_cols=211 Identities=33% Similarity=0.502 Sum_probs=180.3
Q ss_pred ecccCeeEEEEEEeCC-CceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 415 LGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
||+|++|.||++...+ +..+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998876443 34678999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----- 148 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----- 148 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----
Confidence 997642 258999999999999999999999 89999999999999999 89999999999876543211
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
......+...|++||........+.++|+|++|+++++|
T Consensus 149 -----------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------ 187 (215)
T cd00180 149 -----------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------ 187 (215)
T ss_pred -----------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------
Confidence 001233577899999866533778899999999999998
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
..+.+++..|+..||.+||++.++++.
T Consensus 188 -----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 346788899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=253.39 Aligned_cols=191 Identities=21% Similarity=0.269 Sum_probs=163.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh--------hHHHHHHHHHHHHhcC---CCceeeeEEEEEcCCcceE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ--------RHREFVTEVQAIAKVK---HPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 480 (707)
..+|.|+||.|+.|.++ +...|+||.+.+...- .....-.||++|++++ |+||++++++|++++..|+
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 46999999999999975 5677889988664321 1123456999999997 9999999999999999999
Q ss_pred EEEee-cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 481 ISDFI-SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 481 V~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+||-. ++-+|++++..+. .+++..+.-|++||+.|+++||+ .+|||||||-+||.++.+|-+||+|||-|.
T Consensus 647 ~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred EecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchh
Confidence 99964 5679999998654 69999999999999999999999 899999999999999999999999999987
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
......- ...+||.+|.|||++.+..+....-|||++|++||.++....||+
T Consensus 719 ~~ksgpf------------------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 719 YTKSGPF------------------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhcCCCc------------------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6542211 345789999999998776666788899999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=223.88 Aligned_cols=252 Identities=17% Similarity=0.268 Sum_probs=187.8
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCc--ceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDE--KLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~--~~lV~e~~~~gs 489 (707)
.+|+|.++.||.|. ..+.+.++||.++.... +...+|+.+|+.|+ ||||+++++...++.. ..||+||+.+-+
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 69999999999998 45788999999987644 66789999999996 9999999999988754 579999998877
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~~ 568 (707)
....-. .++-..+..++.+++.||.|+|+ .||+|||+||.|+++|.. -..+|+|+|+|.+.......
T Consensus 122 fk~ly~--------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY- 189 (338)
T KOG0668|consen 122 FKQLYP--------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY- 189 (338)
T ss_pred HHHHhh--------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCcee-
Confidence 655543 36667788899999999999999 899999999999999965 56999999999876532211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH----
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR---- 644 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~---- 644 (707)
..+..+..|.-||.+..-..++..-|+|||||++..|+..+.||...... ...+++
T Consensus 190 ----------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN----~DQLVkIakV 249 (338)
T KOG0668|consen 190 ----------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVKIAKV 249 (338)
T ss_pred ----------------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC----HHHHHHHHHH
Confidence 23445777889999888788899999999999999999999998754332 222332
Q ss_pred --------HHHhhc-cccCCCchhchHHHHh----hhh---hHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 --------WVKKGF-EEENPLSDMVDAMLLQ----EVH---AKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 --------~~~~~~-~~~~~~~~~~d~~l~~----~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
++.... .-...+.+++...-+. ... ..-...++++++.+.+..|..+|||++|...
T Consensus 250 LGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 250 LGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 222211 0011111111111100 000 0111256789999999999999999999753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=228.53 Aligned_cols=197 Identities=34% Similarity=0.481 Sum_probs=168.0
Q ss_pred cceecccCeeEEEEEEeCC-CceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||.|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 3479999999999999865 889999999876544 55789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++..... .+++.....++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~- 155 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL- 155 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc-
Confidence 9999986531 18899999999999999999999 799999999999999999999999999988765332000
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
.....++..|++||.......++.++|||+||++++||++|+.||..
T Consensus 156 --------------~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 --------------LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --------------ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 01233467899999863446677899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=227.32 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=179.5
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEEe
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISDF 484 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~ 484 (707)
.+|.|.- .|--|.. -.+++||+|++... .....+...+|...+..++|+||++++.++.-.. +.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4666666 4444442 26788999987654 1223366788999999999999999999986443 56999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
| .++|...++. .++-.+...|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+.....
T Consensus 103 m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 103 M-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred h-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 9 4599999983 37888999999999999999999 89999999999999999999999999999865422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
-. -+....|..|.|||++.+. .+.+.+||||.||++.||++|+.-|.+.+ .+-+
T Consensus 172 ~~-----------------mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf~g~d--------~idQ 225 (369)
T KOG0665|consen 172 FM-----------------MTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLFPGKD--------HIDQ 225 (369)
T ss_pred cc-----------------cCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEecCch--------HHHH
Confidence 10 1234558899999998874 48899999999999999999998876422 1222
Q ss_pred HHHhhccccCCCchhchHHH----------------------------Hhhh-hhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 645 WVKKGFEEENPLSDMVDAML----------------------------LQEV-HAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l----------------------------~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
|.+..-..+.+ ..-+-..+ .... ..+-....+.+++.+|+..||++|-++
T Consensus 226 ~~ki~~~lgtp-d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv 304 (369)
T KOG0665|consen 226 WNKIIEQLGTP-DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV 304 (369)
T ss_pred HHHHHHHhcCC-CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH
Confidence 32221111111 00000000 0000 011123456789999999999999999
Q ss_pred HHHHH
Q 005226 696 KNVSE 700 (707)
Q Consensus 696 ~~v~~ 700 (707)
+++++
T Consensus 305 ~daL~ 309 (369)
T KOG0665|consen 305 DDALR 309 (369)
T ss_pred HHHhc
Confidence 99875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=223.09 Aligned_cols=248 Identities=18% Similarity=0.262 Sum_probs=181.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEE-EEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAY-YWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~e~~~~g 488 (707)
...+|+|.||.+-+++++ ..+.+++|-+..... ..++|.+|...--.| .|.||+.-|+. |++.+..++++||+|.|
T Consensus 29 ~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 29 NKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred HHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 347999999999999976 457788888766543 348899998876566 68999987754 45667778999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-C-CCCeEEecccccccccccCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-N-DFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~-~~~~kl~DfGla~~~~~~~~ 566 (707)
+|.+-+... .+.+....+++.|++.|++|||+ +.+||||||.+|||+- . ..++|+||||.++..+..-
T Consensus 108 dL~snv~~~------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 108 DLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred hhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 999988764 48888999999999999999999 8999999999999993 3 3479999999987544211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
....-+..|-|||.... .-...+.+|||.||+++|.++||+.||+.... ....+
T Consensus 178 ------------------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~----~d~~Y 235 (378)
T KOG1345|consen 178 ------------------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI----MDKPY 235 (378)
T ss_pred ------------------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc----cCchH
Confidence 11233667899997542 12345789999999999999999999985332 23345
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
.+|.....+....+.+.+ ..-.+.+..+..+-+.++|++|-...++.++.
T Consensus 236 ~~~~~w~~rk~~~~P~~F----------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 236 WEWEQWLKRKNPALPKKF----------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred HHHHHHhcccCccCchhh----------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 555544333221111111 22234566777788899999996666665554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=270.56 Aligned_cols=210 Identities=16% Similarity=0.143 Sum_probs=136.6
Q ss_pred hcCC-CceeeeEEEE-------EcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 005226 459 KVKH-PNIVKLRAYY-------WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530 (707)
Q Consensus 459 ~l~H-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 530 (707)
.++| +||++++++| ...+..+.++||+ +++|.++|... ...+++.+++.++.||++||+|||+ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS---Q 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---C
Confidence 4455 6888888887 2334567888987 66999999743 2359999999999999999999999 8
Q ss_pred CceecCCCCCCeEEcCCCCeEEe-------------------cccccccccccCCCCCCCCCCcCCCCCCCCccccccCc
Q 005226 531 KFVHGDIKPSNILLDNDFQPYIS-------------------DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591 (707)
Q Consensus 531 ~iiHrDlk~~NIll~~~~~~kl~-------------------DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 591 (707)
+|+||||||+|||++..+.+|++ |||+++.................+...-.......||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 99999999999999765555555 55544432110000000000000000000111245788
Q ss_pred cccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhH
Q 005226 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAK 671 (707)
Q Consensus 592 ~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 671 (707)
.|+|||++.. ..++.++|||||||+||||++|.+|+.... ..+....... ..+.. .
T Consensus 180 ~Y~APE~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~~----------~~~~~------~ 235 (793)
T PLN00181 180 WYTSPEEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHRV----------LPPQI------L 235 (793)
T ss_pred ceEChhhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHhh----------cChhh------h
Confidence 9999999765 667999999999999999999888754210 0111111110 00100 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 672 KEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 672 ~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+++.+||+.||.+||+|.||++
T Consensus 236 ~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 236 LNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred hcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 11233457888999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=231.04 Aligned_cols=208 Identities=24% Similarity=0.354 Sum_probs=166.2
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||.|.|++||++.+. ....||+|.+...+.. .....|+++|..+ .+.||+++.+++..++..++|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 357999999999999854 4678999998776443 4578899999999 69999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITG 565 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~ 565 (707)
...-.++... ++...+..+++.+..||+|+|. +|||||||||+|+|.+.. +.-.|.|||+|...+...
T Consensus 119 H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 119 HDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9998888873 6778899999999999999999 899999999999999854 678999999997322110
Q ss_pred ------C-----CCC-----C------CCCCcCCCC---CCCCcc---ccccCccccCCCCCCCCCCCCchhhHHHHHHH
Q 005226 566 ------N-----NPS-----S------SGGFMGGAL---PYMKPV---QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV 617 (707)
Q Consensus 566 ------~-----~~~-----~------~~~~~~~~~---~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~ 617 (707)
. ... . ......|.. ..+.+. .+.||+||+|||++.....-++++||||-||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 000 0 000001111 133333 35799999999999887788899999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 005226 618 LLELLTGKSPELSPT 632 (707)
Q Consensus 618 l~elltg~~P~~~~~ 632 (707)
++-++++++||....
T Consensus 268 ~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAK 282 (418)
T ss_pred eehhhccccccccCc
Confidence 999999999997644
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=236.39 Aligned_cols=269 Identities=21% Similarity=0.226 Sum_probs=198.2
Q ss_pred cccchHHHHHhcc---ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC------CceeeeE
Q 005226 400 FTFELDELLRASA---YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH------PNIVKLR 469 (707)
Q Consensus 400 ~~~~~~~~~~~~~---~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~ 469 (707)
+.+.+.|+...-. ...|+|-|++|.+|.. ..|..||||++....... +.=.+|+++|++|+. -|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 4456666654433 3468999999999985 357899999998764433 455789999999952 3789999
Q ss_pred EEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-C
Q 005226 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-F 548 (707)
Q Consensus 470 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~ 548 (707)
..|...++.|||+|-+ .-+|.++|+..+. ...|....+..++.|+.-||..|.. -+|+|.||||+|||+++. .
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKN 574 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcc
Confidence 9999999999999976 4599999987753 3468888999999999999999999 599999999999999876 4
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~ 628 (707)
.+||||||-|.........+ ......|.|||++++ -.|+...|+||.||+||||.||+..|
T Consensus 575 iLKLCDfGSA~~~~eneitP------------------YLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENEITP------------------YLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred eeeeccCccccccccccccH------------------HHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec
Confidence 67999999997765432211 122567999999876 78899999999999999999999988
Q ss_pred CCCCCCCCccchhHHHHHHh---h-----ccccCCCchhchH--------------------------------HHHhh-
Q 005226 629 LSPTTSTSIEVPDLVRWVKK---G-----FEEENPLSDMVDA--------------------------------MLLQE- 667 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~d~--------------------------------~l~~~- 667 (707)
.+.+.. ++...... - ++......+-+|. .+...
T Consensus 636 pG~TNN------~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q 709 (752)
T KOG0670|consen 636 PGRTNN------QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQ 709 (752)
T ss_pred CCCCcH------HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccC
Confidence 775533 12211100 0 0000000111111 11111
Q ss_pred ---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 668 ---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 668 ---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+..+.+|+..|+..||++|.|..+.++
T Consensus 710 ~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 710 RLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred CCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 122345678889999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=244.49 Aligned_cols=246 Identities=24% Similarity=0.316 Sum_probs=194.8
Q ss_pred eecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.+|.|.+|.|||++. ..++..|||+++-.......-..+|+-+++..+|||||.++|.+...+..++.|||+.+|+|.+
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 799999999999995 4789999999887655555677889999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
.-+..+ .+++.++..+.+...+||+|||+ .+=+|||||-.||++++.+.+|++|||.+-.+...-..
T Consensus 102 iy~~Tg-----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K----- 168 (829)
T KOG0576|consen 102 IYHVTG-----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK----- 168 (829)
T ss_pred eeeecc-----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-----
Confidence 988765 69999999999999999999999 78899999999999999999999999998765422211
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|||||+.- ....|.+++|||+.|++..|+---++|.....+.. .+.--.+..+
T Consensus 169 -----------rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-----~l~LmTkS~~ 232 (829)
T KOG0576|consen 169 -----------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-----ALFLMTKSGF 232 (829)
T ss_pred -----------hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----HHHHhhccCC
Confidence 12345799999999843 34677899999999999999988888865433220 0000001111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... .+ + ........+.+++..|+..+|++||+++.+++
T Consensus 233 qpp---------~l-k--Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPP---------TL-K--DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCC---------cc-c--CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 110 01 1 11234567889999999999999999987654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=205.07 Aligned_cols=167 Identities=21% Similarity=0.236 Sum_probs=123.4
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.++++..+ ..++|.++..|+.||+.||+|||+ .+ ||+||+++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--- 62 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE--- 62 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc---
Confidence 78999998643 259999999999999999999999 44 999999999999999 9998765421
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
...|++.|+|||++.. ..++.++|||||||++|||+||+.||...... ......+.
T Consensus 63 ------------------~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~ 118 (176)
T smart00750 63 ------------------QSRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILL 118 (176)
T ss_pred ------------------cCCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHH
Confidence 1135889999999765 67889999999999999999999998643221 11112111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHH--HHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEV--IAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~--~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.......+ ... ....... ..+.+++.+||..||++||++.++++.+..+
T Consensus 119 ~~~~~~~~-~~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 119 NGMPADDP-RDR--------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHhccCCc-ccc--------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11111111 000 0001111 3588999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-24 Score=201.88 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=182.8
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.|.+...|..|+|++. |..+++|+++.. .....++|..|.-.|+-+.||||+.++|.|..+.+..++..||+.|+|+
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 4677888999999994 555666776543 3334478999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCcee-cCCCCCCeEEcCCCCeEEe--cccccccccccCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVH-GDIKPSNILLDNDFQPYIS--DFGLSRLINITGNNP 568 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH-rDlk~~NIll~~~~~~kl~--DfGla~~~~~~~~~~ 568 (707)
..|+... ....+-.++++.+.+||+|++|||+. .+++- --|.+..|++|++.+++|+ |--++. ..
T Consensus 276 nvlhe~t---~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsf--qe----- 343 (448)
T KOG0195|consen 276 NVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE----- 343 (448)
T ss_pred HHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeee--ec-----
Confidence 9999764 34678899999999999999999996 34554 4688999999999998875 322211 00
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRP--MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....-.+.|++||.+...... -.++|+|||++++||+.|+..||....+.+- +. +..
T Consensus 344 ----------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--gm---kia 402 (448)
T KOG0195|consen 344 ----------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--GM---KIA 402 (448)
T ss_pred ----------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--hh---hhh
Confidence 001126789999987653222 2589999999999999999999987554310 00 011
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..+++.. + .......+.+++.-|...||.+||.+..|+-.|+++.
T Consensus 403 leglrv~------i---------ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVH------I---------PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hcccccc------C---------CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1111111 1 1223345678889999999999999999999998864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=211.49 Aligned_cols=161 Identities=23% Similarity=0.240 Sum_probs=120.6
Q ss_pred ceecccCeeEEEEEEeC--CCceEEEEEcCCC-----chhhHHHHHHHHHHHHhcCCCceee-eEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG--NGIPVAVRRLGEG-----GEQRHREFVTEVQAIAKVKHPNIVK-LRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||+||+|... +++.||||++... .......|.+|++++++++|+|+++ +++ .+..++||||
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~ 99 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGW 99 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEc
Confidence 48999999999999864 5777899986533 1223466899999999999999985 443 2568999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeEEcCCCCeEEecccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI-KPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
+++++|.. +... . ...++.++++||+|||+ ++|+|||| ||+|||++.++.+||+|||+|+....
T Consensus 100 ~~G~~L~~-~~~~--------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 100 TEGVPLHL-ARPH--------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred cCCCCHHH-hCcc--------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 99999963 2111 0 14678899999999999 89999999 99999999999999999999997753
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV 600 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 600 (707)
....... ..+..-....+++.|+|||++.
T Consensus 165 ~~~~~~~--------~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRI--------AAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred Ccchhhh--------hhhhhhhhhhccCccCCcccCC
Confidence 3211100 0001113456788899999865
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-24 Score=190.38 Aligned_cols=159 Identities=30% Similarity=0.508 Sum_probs=92.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.++++|.||+|.++ .+|+.+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|+|. .+|..|+.+|.|+.|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 45666666666666 44556666666666666666666 55666666666666666666666 56666666666666666
Q ss_pred cCCcccc-cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcC
Q 005226 149 SNNSFSG-SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227 (707)
Q Consensus 149 s~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l 227 (707)
++|+++. .+|..|..++.|+.|+|+.|.+. -+|.++ +.+++|+.|.+.+|.+- .+|.+++.+++| ++|++.+|++
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dv-g~lt~lqil~lrdndll-~lpkeig~lt~l-relhiqgnrl 185 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDV-GKLTNLQILSLRDNDLL-SLPKEIGDLTRL-RELHIQGNRL 185 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhh-hhhcceeEEeeccCchh-hCcHHHHHHHHH-HHHhccccee
Confidence 6666552 34555666666666666666665 555554 45555555555555554 455555555555 4555555555
Q ss_pred cCCCCCcC
Q 005226 228 SGKIPKSL 235 (707)
Q Consensus 228 ~~~~p~~~ 235 (707)
+ .+|.++
T Consensus 186 ~-vlppel 192 (264)
T KOG0617|consen 186 T-VLPPEL 192 (264)
T ss_pred e-ecChhh
Confidence 5 344433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-20 Score=196.37 Aligned_cols=261 Identities=21% Similarity=0.244 Sum_probs=184.4
Q ss_pred ceecccCeeEEEEEEeCCC--ceEEEEEcCCCchhhHHHHHHHHHHHHhcCC----CceeeeEEEE-EcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLGNG--IPVAVRRLGEGGEQRHREFVTEVQAIAKVKH----PNIVKLRAYY-WAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~lV~e~~ 485 (707)
..||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++||+..
T Consensus 24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~ 103 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL 103 (322)
T ss_pred eeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc
Confidence 4799999999999996543 4788887665433322367889999999863 5888998888 4777889999977
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-----CCeEEeccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-----FQPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-----~~~kl~DfGla~~ 560 (707)
|.+|.++..... ...++..+..+|+.|++.+|++||+ .+++||||||+|+++... ..+.|.|||+++.
T Consensus 104 -G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 104 -GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred -CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 779999886543 3579999999999999999999999 899999999999999865 4699999999984
Q ss_pred ccccCCCCCCCCCCcCCCCCCCC-ccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccc
Q 005226 561 INITGNNPSSSGGFMGGALPYMK-PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEV 639 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~ 639 (707)
.......... ..+.-. +....||..|.++..... ...+.+.|+||++.++.|+..|..||....... ..
T Consensus 177 ~~~~~~~~~~-------~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~--~~ 246 (322)
T KOG1164|consen 177 FKYVGDSGGN-------LRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTD--LK 246 (322)
T ss_pred ccccCCCCcc-------cccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccc--hH
Confidence 3311111000 000111 123458999999998654 677899999999999999999999996543221 11
Q ss_pred hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+.+........ . ........+.++...+-..+..++|....+...++..
T Consensus 247 ~~~~~~~~~~~~~---------~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRKLLTD---------R------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhhhccc---------c------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111100000 0 0111223455555566668999999999888887654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-23 Score=214.86 Aligned_cols=208 Identities=23% Similarity=0.271 Sum_probs=175.8
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
+++.|.|..|+|...-.+.|..|.++++|+|+.|+++..-...+.+|+.|+.||||+|.|..+-++.+.-.++|++|+||
T Consensus 246 Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs 325 (873)
T KOG4194|consen 246 SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLS 325 (873)
T ss_pred hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecc
Confidence 44445555566665666777788888888888888887778888999999999999999998888888889999999999
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCc---chhhhhccccEEEeccCc
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN---DLGELQSLSATLNLSYNH 226 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~~L~l~~N~ 226 (707)
+|+|+...+..|..|..|+.|+|++|+|+ .|-++.|..+++|++|||++|.|+..+-+ .|.+++.| +.|+|.+|+
T Consensus 326 ~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~L-rkL~l~gNq 403 (873)
T KOG4194|consen 326 SNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSL-RKLRLTGNQ 403 (873)
T ss_pred ccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhh-hheeecCce
Confidence 99999888889999999999999999998 89999999999999999999999876553 67889999 799999999
Q ss_pred CcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCCC
Q 005226 227 LSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 227 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~~ 279 (707)
|....-.+|..++.|+.|||.+|.|...-|....-..++.+.+..-.++|+|.
T Consensus 404 lk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCq 456 (873)
T KOG4194|consen 404 LKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQ 456 (873)
T ss_pred eeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEecc
Confidence 99666678999999999999999999877755444477888888888899864
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-23 Score=182.96 Aligned_cols=168 Identities=30% Similarity=0.514 Sum_probs=156.4
Q ss_pred CcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchh
Q 005226 88 ELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQL 167 (707)
Q Consensus 88 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 167 (707)
.+.++.+++.|-||+|+++ .+|..+..+.+|++|++++|+|+ .+|..++.+++|+.|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4567888999999999999 78888999999999999999999 99999999999999999999999 999999999999
Q ss_pred hhhhhcCCcccc-cCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEc
Q 005226 168 QRLILARNKFSG-QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL 246 (707)
Q Consensus 168 ~~L~l~~N~l~~-~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 246 (707)
+.|||.+|+++. .+|.++| .+..|+.|+|++|.+. .+|..++++++| +.|.+..|.+- .+|.+++.+..|++|++
T Consensus 105 evldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~l-qil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNL-QILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhcce-eEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 999999999973 5788776 7899999999999998 999999999999 89999999999 89999999999999999
Q ss_pred cCCcCcccCCCCCCCC
Q 005226 247 RGNNLSGEIPQTGSFA 262 (707)
Q Consensus 247 ~~N~l~~~~p~~~~~~ 262 (707)
++|.++-.+|+...+.
T Consensus 181 qgnrl~vlppel~~l~ 196 (264)
T KOG0617|consen 181 QGNRLTVLPPELANLD 196 (264)
T ss_pred ccceeeecChhhhhhh
Confidence 9999998888765543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-19 Score=191.05 Aligned_cols=262 Identities=28% Similarity=0.366 Sum_probs=191.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchh---hHHHHHHHHHHHHhcCCC-ceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ---RHREFVTEVQAIAKVKHP-NIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
..||.|+||.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......+++++|+.++
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 36899999999999986 77899988765332 357899999999999888 7999999997777789999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 567 (707)
++.+++...... ..+.......++.+++.+++|+|+ .+++|||+||+||+++... .++++|||.++........
T Consensus 84 ~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 84 SLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999777654211 358889999999999999999999 7899999999999999988 7999999999855432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG--NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... .......|+..|+|||..... ...+...|+||+|++++++++|..||...... .......+.
T Consensus 159 ~~~~----------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~ 226 (384)
T COG0515 159 SSIP----------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKI 226 (384)
T ss_pred cccc----------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHH
Confidence 1000 012345679999999997653 57788999999999999999999996543321 001122222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....... ......... .......+.+++..|+..+|..|.++.+...
T Consensus 227 ~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 227 ILELPTPS--LASPLSPSN-----PELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred HHhcCCcc--cccccCccc-----cchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 22221110 000000000 0112245778888999999999999887665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=183.83 Aligned_cols=138 Identities=18% Similarity=0.174 Sum_probs=107.9
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchh--h-------HHH-----------------HHHHHHHHHhcCCCcee
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ--R-------HRE-----------------FVTEVQAIAKVKHPNIV 466 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~niv 466 (707)
..||+|+||.||+|...+|+.||||+++..... . ... ..+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999889999999998654211 0 012 23499999999888764
Q ss_pred eeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceecCCCCCCeEEc
Q 005226 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL-HECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 467 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHrDlk~~NIll~ 545 (707)
....+.. ...++||||++++++....... ..+++....+++.|++.+|+|+ |+ .+|+||||||+||+++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 4433322 3348999999988776553222 2588999999999999999999 67 7999999999999998
Q ss_pred CCCCeEEecccccccc
Q 005226 546 NDFQPYISDFGLSRLI 561 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~ 561 (707)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.9e-23 Score=213.30 Aligned_cols=198 Identities=28% Similarity=0.382 Sum_probs=168.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
..++.||||+|+++ ..|..+..-.++.+|+||+|+|..+.-.-|.+|+.|-.||||+|+|. .+|+.+..|.+|++|+|
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~L 180 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKL 180 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhc
Confidence 57889999999998 56889999999999999999999444445678999999999999999 88888999999999999
Q ss_pred cCCccc-------------------------ccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 149 SNNSFS-------------------------GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 149 s~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
|+|.|. ..+|.++..|.+|..+|||.|.+. .+|+.++ .+++|+.|+||+|+|+
T Consensus 181 s~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly-~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 181 SNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY-KLRNLRRLNLSGNKIT 258 (1255)
T ss_pred CCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh-hhhhhheeccCcCcee
Confidence 999765 246778888899999999999998 8898886 8999999999999998
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc--ccCCCCCCCCCCCCcccCCCC
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS--GEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~--~~~p~~~~~~~~~~~~~~~N~ 273 (707)
.+.-..+...+| ++|+||.|+++ .+|+.++.|+.|+.|.+.+|+|+ |.+...+.+.++..+....|.
T Consensus 259 -eL~~~~~~W~~l-EtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~ 327 (1255)
T KOG0444|consen 259 -ELNMTEGEWENL-ETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNK 327 (1255)
T ss_pred -eeeccHHHHhhh-hhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccc
Confidence 677788888888 79999999999 89999999999999999999986 555555666666666666665
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=219.87 Aligned_cols=256 Identities=18% Similarity=0.217 Sum_probs=181.7
Q ss_pred hccceecccCeeEEEEEEeC-CCceEEEEEcC----CC-chhh-HHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 410 ASAYVLGKSGLGIVYKVVLG-NGIPVAVRRLG----EG-GEQR-HREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
....++|.|++|.|+.+... .....+.|.+. .. .... ...+..|+.+-..++|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34568999999977776632 33333444332 11 1111 122667888888999999998887777777777779
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+++ +|..++.... .+....+-.++.|+..|++|+|+ .+|.|||+|++|++++.++.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 9999998652 47788888999999999999999 899999999999999999999999999987654
Q ss_pred ccCCCC-CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 563 ITGNNP-SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 563 ~~~~~~-~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... ... ....|...|+|||++..........||||.|+++..|++|+.||.........-
T Consensus 472 ~~~e~~~~~~-------------~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--- 535 (601)
T KOG0590|consen 472 YPWEKNIHES-------------SGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--- 535 (601)
T ss_pred cCcchhhhhh-------------cCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---
Confidence 332211 111 234568889999998764555567899999999999999999998765432110
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ..+..+. ..... ...-..........++.++++.||.+|-|+++|++
T Consensus 536 --~~--~~~~~~~---~~~~~---~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 536 --KT--NNYSDQR---NIFEG---PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --hh--hcccccc---ccccC---hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00 0000000 00000 00011234456678899999999999999999986
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-22 Score=200.73 Aligned_cols=221 Identities=26% Similarity=0.369 Sum_probs=175.3
Q ss_pred eEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecC-ccCCC
Q 005226 58 ISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYG-NNLSG 131 (707)
Q Consensus 58 v~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ 131 (707)
|.|.. +|...++..+.++|..|+|+.+.|..|+.+.+|+.||||+|+|+.+-|++|.++.+|..|-|.+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 88874 5556678999999999999999999999999999999999999999999999999998887776 89984
Q ss_pred CCCcccCC------------------------CCCccEEeccCCcccccCCC-CCcccchhhhhhhcCCccc--------
Q 005226 132 SLPPSVCN------------------------LPRLQNLDLSNNSFSGSLPD-GLKNCKQLQRLILARNKFS-------- 178 (707)
Q Consensus 132 ~~p~~~~~------------------------l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~-------- 178 (707)
..-..|.+ |++|..|.|.+|.+. .++. .|..+.+++.+.+..|.+.
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wl 209 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWL 209 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchh
Confidence 33344444 455555555555555 3443 5666666666666666511
Q ss_pred -----------------------------------------------------ccCCCcccccCCCccEEeccCCCCCCC
Q 005226 179 -----------------------------------------------------GQIPAGIWPELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 179 -----------------------------------------------------~~lp~~~~~~l~~L~~L~ls~N~l~~~ 205 (707)
+.-|...|..|++|++|+|++|+|+++
T Consensus 210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i 289 (498)
T KOG4237|consen 210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRI 289 (498)
T ss_pred hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchh
Confidence 011223367789999999999999999
Q ss_pred CCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccCCCC
Q 005226 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCGFPL 280 (707)
Q Consensus 206 ~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~~~~ 280 (707)
-+.+|.++..+ ++|+|..|+|...-...|.++..|+.|+|.+|+|+..-|-. ..+..+..+.+.+|||.|.+.+
T Consensus 290 ~~~aFe~~a~l-~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 290 EDGAFEGAAEL-QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred hhhhhcchhhh-hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 99999999999 89999999999777888999999999999999999888732 2344567788999999997643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=174.41 Aligned_cols=202 Identities=23% Similarity=0.352 Sum_probs=164.3
Q ss_pred ceecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||.|+||.+|.|. ..+|..||||.-+.... ..++..|.++.+.|+| ..|..+..|..+...-.+|||.. |-+|
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 379999999999998 56899999998655432 2457789999999965 67888888888888999999987 7799
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~~~ 567 (707)
.+.+.... ..++..+.+-.+-|++.-++|+|. ++.|||||||+|+|..-+ ..+.++|||+|+.+.+....
T Consensus 98 EdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 98 EDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99987664 468999999999999999999999 899999999999999744 46899999999987643322
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~ 634 (707)
. .++|-......||.+|.+--...+ ..-+.+-|+-|+|.+|...--|..||++....
T Consensus 171 ~---------HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 171 Q---------HIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred c---------cCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 2 234555566788999988665443 44467889999999999999999999876543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=198.72 Aligned_cols=217 Identities=27% Similarity=0.384 Sum_probs=164.8
Q ss_pred HHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCc-eec
Q 005226 457 IAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF-VHG 535 (707)
Q Consensus 457 l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-iHr 535 (707)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...++|.....+.++|+.||+|+|. .+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 35689999999999999999999999999999999999874 3469999999999999999999999 444 999
Q ss_pred CCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC---CC---CCchh
Q 005226 536 DIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG---NR---PMQKW 609 (707)
Q Consensus 536 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~---~~~~~ 609 (707)
.++++|+++|..+.+|++|||+......... +++........-|.|||.+... .. .+++.
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~--------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~g 139 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAE--------------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKG 139 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccccc--------------ccccchhHHHHhccCHHHhcccccccccccccccC
Confidence 9999999999999999999999876643100 0111112235569999986542 11 46789
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCC
Q 005226 610 DVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689 (707)
Q Consensus 610 DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP 689 (707)
||||||++++|+++.+.||+...... +..+++.+++.. . ...+.+.+.... +...++..++..||..+|
T Consensus 140 diYs~~ii~~ei~~r~~~~~~~~~~~--~~~eii~~~~~~--~----~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 140 DIYSFGIIMYEILFRSGPFDLRNLVE--DPDEIILRVKKG--G----SNPFRPSIELLN---ELPPELLLLVARCWEEIP 208 (484)
T ss_pred CeehHHHHHHHHHhccCccccccccC--ChHHHHHHHHhc--C----CCCcCcchhhhh---hcchHHHHHHHHhcccCh
Confidence 99999999999999999998754432 123455554441 1 112222221111 223368899999999999
Q ss_pred CCCCChHHHHHHHHhh
Q 005226 690 EVRPRMKNVSENLERI 705 (707)
Q Consensus 690 ~~RPs~~~v~~~L~~i 705 (707)
++||++++|-..++.+
T Consensus 209 ~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 209 EKRPSIEQIRSKLLTI 224 (484)
T ss_pred hhCccHHHHHhhhhhh
Confidence 9999999998888765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-19 Score=175.10 Aligned_cols=202 Identities=20% Similarity=0.280 Sum_probs=168.3
Q ss_pred cceecccCeeEEEEEE-eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+..||+|.||..+.|+ +-++++||||.-...+ +.-++..|.+..+.| ..++|...+-|-..+-+-.||+|.. |-+
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 4589999999999998 5689999999754332 235677888888888 5689999887777777889999987 779
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-----CeEEeccccccccccc
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-----QPYISDFGLSRLINIT 564 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~DfGla~~~~~~ 564 (707)
|.++..-++ ..++..++.-||.|++.-++|+|+ +.+|.|||||+|+||...+ .+.|+|||+|+.+.+.
T Consensus 110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 998887654 369999999999999999999999 8999999999999997543 5899999999988755
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
.... .++|.+.....||.+||+-...++ +.-+.+-|+-|+|=+++..+-|..||.+.-.
T Consensus 183 ~Tkq---------HIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 183 KTKQ---------HIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cccc---------cCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 4433 356777777889999999887665 6667899999999999999999999987644
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-21 Score=202.27 Aligned_cols=205 Identities=22% Similarity=0.227 Sum_probs=139.6
Q ss_pred CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC------------
Q 005226 67 PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP------------ 134 (707)
Q Consensus 67 ~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------ 134 (707)
..++++.|+|.+|.|+.+-.+++..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+..-.
T Consensus 123 ~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl 202 (873)
T KOG4194|consen 123 ESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL 202 (873)
T ss_pred cccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence 34678888888888877766666666666666666666654333344444445555555555543333
Q ss_pred ------------cccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCC
Q 005226 135 ------------PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202 (707)
Q Consensus 135 ------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l 202 (707)
..|.+|++|+.|+|..|+|.-.---.|.+|++|+.|.|..|.|+ .+..+.|-.|.++++|+|+.|++
T Consensus 203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L~~N~l 281 (873)
T KOG4194|consen 203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNLETNRL 281 (873)
T ss_pred ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeecccchh
Confidence 44555555555555555555222345556666666666666666 67778888888999999999999
Q ss_pred CCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCC
Q 005226 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNP 273 (707)
Q Consensus 203 ~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~ 273 (707)
+..--.++.+|+.| +.|+||+|.|....++.+.-.++|+.|+|++|+|+...++. ..+..+..+.+..|.
T Consensus 282 ~~vn~g~lfgLt~L-~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Ns 352 (873)
T KOG4194|consen 282 QAVNEGWLFGLTSL-EQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNS 352 (873)
T ss_pred hhhhcccccccchh-hhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccc
Confidence 87777889999999 79999999999999999999999999999999999766632 122334445555553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=171.49 Aligned_cols=191 Identities=17% Similarity=0.130 Sum_probs=139.2
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhh----HHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR----HREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
..|++|+||+||.+.. .+.+++.+.+....... ...|.+|+++|++|. |+++++++++ +..+++|||+.|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4799999999997766 67788878776654311 135889999999994 5889999886 457999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCC-CCCCeEEcCCCCeEEecccccccccccCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI-KPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDl-k~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
.+|.+.+.. ....++.+++.+|+|+|+ .+|+|||| ||+|||++.++.++|+|||+|........
T Consensus 83 ~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 83 AAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 998754321 113577899999999999 89999999 79999999999999999999975432110
Q ss_pred CCCCCCCCcCCCCCCCC--------ccccccCccccCCCCCCCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005226 567 NPSSSGGFMGGALPYMK--------PVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSPELSPTTS 634 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~-~~~DV~S~Gv~l~elltg~~P~~~~~~~ 634 (707)
. ..++. .--...++.|++|+...--...+ ...+.++-|.-+|.++||+.|.....+.
T Consensus 148 ~-----------~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 148 W-----------MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred H-----------HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 0 00000 00122466777777522112223 5679999999999999999997665443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=181.67 Aligned_cols=165 Identities=13% Similarity=0.152 Sum_probs=125.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHH---------HHHHHHHHHHhcCCCceeeeEEEEEcC-------
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHR---------EFVTEVQAIAKVKHPNIVKLRAYYWAP------- 475 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~~~~~~~------- 475 (707)
.+++|.|+||.||.+.. ++..+|+|.+........+ .|.+|++.+.+++|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 45899999999999766 5778999999754322211 268999999999999999999886643
Q ss_pred -CcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 476 -DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 476 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
+..++||||++|.+|.++.. ++. ....+++.++..+|+ .+++|||+||+||+++.++ ++++|
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988732 222 245689999999999 8999999999999999988 99999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt 623 (707)
||..+........ ..+.. ...+..++|+||||+++.-...
T Consensus 178 fg~~~~~~e~~a~----------------------------d~~vl-er~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 178 LSGKRCTAQRKAK----------------------------DRIDL-ERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCCcccccchhhH----------------------------HHHHH-HhHhcccccccceeEeehHHHH
Confidence 9987644211100 00112 2445578999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=174.54 Aligned_cols=139 Identities=18% Similarity=0.243 Sum_probs=110.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchh--------------------------hHHHHHHHHHHHHhcCCCcee
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ--------------------------RHREFVTEVQAIAKVKHPNIV 466 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~niv 466 (707)
..||+|+||.||+|...+|+.||||+++..... ....+.+|.+.+.+++|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 479999999999999878999999998754210 012235789999999999875
Q ss_pred eeEEEEEcCCcceEEEEeecCCChHHH-HhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 467 KLRAYYWAPDEKLLISDFISNGNLANA-LRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 467 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
....+... ..++||||++++++... +.. ..++.....+++.+++.++.|+|+. .+|+||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE
Confidence 55444333 35899999998865443 432 2477888999999999999999984 5999999999999999
Q ss_pred CCCCeEEeccccccccc
Q 005226 546 NDFQPYISDFGLSRLIN 562 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~ 562 (707)
++.++|+|||+++...
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=205.04 Aligned_cols=132 Identities=32% Similarity=0.510 Sum_probs=82.3
Q ss_pred CCcccHHHHHHHHhcCcCCCCCCCCCCCCCCCC---CceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCC
Q 005226 19 ALSPDGLTLLSLKSAIDQTDTSVFADWNENDPT---PCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYL 95 (707)
Q Consensus 19 ~~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~---~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L 95 (707)
..+.|..||+.+|..+. ++.. .+|+. ++| .|.|.||.|..........|+.|+|++|++.|.+|..++.|++|
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPLR--FGWNG-DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cCchHHHHHHHHHHhcC-Cccc--CCCCC-CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 45679999999999995 3322 48974 332 13799999963221111247777777777777766666666666
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCccc
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 154 (707)
+.|+|++|+|+|.+|..+.++++|+.|||++|+|+|.+|+.++++++|+.|+|++|+|+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~ 503 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCccc
Confidence 66666666666666665666666666666555555555555555555555554444444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-22 Score=199.59 Aligned_cols=195 Identities=30% Similarity=0.466 Sum_probs=156.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.++..|+.++|.+. .+|+.++.+-.|..|+..+|+++ .+|+.++++.+|..|++.+|++. .+|+..-+++.|+.||.
T Consensus 114 ~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~ 190 (565)
T KOG0472|consen 114 ISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDC 190 (565)
T ss_pred hhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhccc
Confidence 34555566666665 44556666666666666666666 56666666777777777777777 44444444778888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchh-hhhccccEEEeccCcC
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG-ELQSLSATLNLSYNHL 227 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~l~~L~~~L~l~~N~l 227 (707)
.+|-+. .+|..++.+.+|+.|+|.+|+|. .+|+ |++++.|.+|+++.|+|+ .+|.+.. ++.++ ..|||..|++
T Consensus 191 ~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPe--f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l-~vLDLRdNkl 264 (565)
T KOG0472|consen 191 NSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPE--FPGCSLLKELHVGENQIE-MLPAEHLKHLNSL-LVLDLRDNKL 264 (565)
T ss_pred chhhhh-cCChhhcchhhhHHHHhhhcccc-cCCC--CCccHHHHHHHhcccHHH-hhHHHHhcccccc-eeeecccccc
Confidence 888887 88999999999999999999998 8884 689999999999999998 7887776 89999 6999999999
Q ss_pred cCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 228 SGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 228 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+ ..|+.++-+.+|..||+++|.+++.+++.+.+ .+..+.+.|||.
T Consensus 265 k-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 265 K-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred c-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCch
Confidence 9 89999999999999999999999999998888 888899999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-21 Score=203.25 Aligned_cols=178 Identities=30% Similarity=0.415 Sum_probs=138.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC------------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS------------------ 130 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------ 130 (707)
.+...|+||+|+|..+..+-|.+|+.|-.||||+|++. .+|..+..|..|++|+|++|.|.
T Consensus 126 Kn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 126 KNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred cCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 46788999999999666666789999999999999998 78888888999999999988775
Q ss_pred -------CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 131 -------GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 131 -------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
..+|.++..|.+|..+|||.|.|. .+|+.+.++.+|+.|+||+|+|+ ++.... ..+.+|++|+||.|+++
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~-~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTE-GEWENLETLNLSRNQLT 281 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccH-HHHhhhhhhccccchhc
Confidence 235777778888888889999888 88888888888888888888888 666655 56778888888888887
Q ss_pred CCCCcchhhhhccccEEEeccCcCc-CCCCCcCCCCCCccEEEccCCcCc
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLS-GKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
.+|+.+..+++| +.|++.+|+++ .-+|+.++.|.+|+++..++|+|.
T Consensus 282 -~LP~avcKL~kL-~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE 329 (1255)
T KOG0444|consen 282 -VLPDAVCKLTKL-TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE 329 (1255)
T ss_pred -cchHHHhhhHHH-HHHHhccCcccccCCccchhhhhhhHHHHhhccccc
Confidence 677777777777 56777766654 125555555555555555555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.6e-19 Score=170.91 Aligned_cols=134 Identities=17% Similarity=0.187 Sum_probs=105.1
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-----CCCceeeeEEEEEcCC---cce-EEE
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-----KHPNIVKLRAYYWAPD---EKL-LIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lV~ 482 (707)
...||+|+||.||. ...++.. +||++........+.+.+|+++++.+ +||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 45899999999996 3234444 68887665444457899999999999 5799999999998874 323 789
Q ss_pred Ee--ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCceecCCCCCCeEEcC----CCCeEEecc
Q 005226 483 DF--ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL-AYLHECSPRKFVHGDIKPSNILLDN----DFQPYISDF 555 (707)
Q Consensus 483 e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~iiHrDlk~~NIll~~----~~~~kl~Df 555 (707)
|| +++|+|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. ++.++|+||
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 99 5679999999653 25555 35678888777 99999 89999999999999974 347999995
Q ss_pred ccc
Q 005226 556 GLS 558 (707)
Q Consensus 556 Gla 558 (707)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.4e-20 Score=202.98 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=180.4
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCc-hhhHHHHHHHHHHH--HhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG-EQRHREFVTEVQAI--AKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l--~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.+|.+.|=.|.+|...+|. |+||++-+.. .-..+.|.++++-+ .-++|||.+++.-.-..+...|||-+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 347999999999999998887 8899986553 33345555544443 445999999987776777778899999865
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|++.|..+. .+..-+.+-|+.|++.||..+|. .+|+|||||.+|||++.=.=+.|+||.--+......+.+
T Consensus 106 nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 106 NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999998653 56777788899999999999999 899999999999999987779999998765544444433
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCC----------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG----------NRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~ 637 (707)
.. +.|.-.+... -..|+|||.+... ...+++.||||.||++.||++ |++||.
T Consensus 178 ad--------f~fFFDTSrR-RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------- 240 (1431)
T KOG1240|consen 178 AD--------FTFFFDTSRR-RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------- 240 (1431)
T ss_pred cc--------ceEEEecCCc-eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc--------
Confidence 32 2222222222 3469999986642 124678999999999999998 566663
Q ss_pred cchhHHHHHHhhccccCCCchhchHH-HHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAM-LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
...+.++-... ..|+. +.+ .-+...+.+++..|++.||..|-++.+.++.-.
T Consensus 241 -LSQL~aYr~~~---------~~~~e~~Le----~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 241 -LSQLLAYRSGN---------ADDPEQLLE----KIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred -HHHHHhHhccC---------ccCHHHHHH----hCcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 33444432221 11111 111 112235778999999999999999999998744
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-19 Score=193.41 Aligned_cols=186 Identities=29% Similarity=0.297 Sum_probs=154.7
Q ss_pred eecccCeeEEEEEEe----CCCceEEEEEcCCCchh--hHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQ--RHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
++|+|+||.|+.+.. ..|..+|.|.+++.... .......|..++..++ ||.+|++.-.++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999997652 35677888887665321 1124566888999996 9999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|...+.... .++..........+|-+++++|+ .+|+|||+|++||+++.+|++++.|||+++......
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK- 151 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh-
Confidence 999999997653 46677777788889999999999 899999999999999999999999999998765322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
...||.-|||||+.. .....+|.||||++++||+||..||..
T Consensus 152 -------------------~~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 -------------------IACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------------------hcccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 125689999999965 356789999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=174.78 Aligned_cols=230 Identities=24% Similarity=0.333 Sum_probs=145.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcC----------CCceeeeEEEEEcC---
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVK----------HPNIVKLRAYYWAP--- 475 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~~~--- 475 (707)
..||.|+++.||.++.. +++.+|||.+... .....+++.+|.-....+. |-.++-.++...-.
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 48999999999999975 5899999987433 2334577777776655532 22233222222211
Q ss_pred ------C--------cceEEEEeecCCChHHHHhC---CCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCC
Q 005226 476 ------D--------EKLLISDFISNGNLANALRG---RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIK 538 (707)
Q Consensus 476 ------~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk 538 (707)
. ..+++|+-+ .++|.+++.. .. .....+....++.+..|+++.+++||+ .+++|+|||
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-QTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-TTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred cceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-cccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 1 235677766 5688887642 21 112235566678888999999999999 899999999
Q ss_pred CCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-------CCCCCchhhH
Q 005226 539 PSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-------GNRPMQKWDV 611 (707)
Q Consensus 539 ~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DV 611 (707)
|+|++++.+|.++|+||+.......... . ...+..|.+||.... ...++.+.|.
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~------------------~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da 233 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYR------------------C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDA 233 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEE------------------G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceee------------------c-cCCCcccCChhhhhhhcccCcccceeeeccCH
Confidence 9999999999999999997765442111 0 123567888886432 1246789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC
Q 005226 612 YSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV 691 (707)
Q Consensus 612 ~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 691 (707)
|++|+++|.|.+|+.||.........+ | ....+.+..+.+..|+...++.||++
T Consensus 234 W~LG~~ly~lWC~~lPf~~~~~~~~~~------~--------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 234 WQLGITLYSLWCGRLPFGLSSPEADPE------W--------------------DFSRCRDMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHHHHHHHSS-STCCCGGGSTSG------G--------------------GGTTSS---HHHHHHHHHHT-SSGGG
T ss_pred HHHHHHHHHHHHccCCCCCCCcccccc------c--------------------cchhcCCcCHHHHHHHHHHccCCccc
Confidence 999999999999999997643321100 0 01122355567889999999999998
Q ss_pred C
Q 005226 692 R 692 (707)
Q Consensus 692 R 692 (707)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 8
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.6e-20 Score=184.30 Aligned_cols=191 Identities=29% Similarity=0.433 Sum_probs=169.5
Q ss_pred ceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCC
Q 005226 53 CRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGS 132 (707)
Q Consensus 53 C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 132 (707)
|+.+...|-....+.-..+..|+..+|+++ .+|+.++++.+|..|++.+|+++.. |...-+++.|+.||..+|-+. +
T Consensus 121 ~s~n~~~el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 121 CSSNELKELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccceeecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhh-c
Confidence 555554443322222246778889999999 6799999999999999999999954 445555999999999999999 9
Q ss_pred CCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhh
Q 005226 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212 (707)
Q Consensus 133 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 212 (707)
+|+.++.+.+|+-|+|.+|+|. .+| +|.+|..|++|+++.|+|. .+|++....+++|.+|||.+|+++ ..|+++.-
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 9999999999999999999999 788 9999999999999999999 999999999999999999999999 89999999
Q ss_pred hhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 213 l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
+.+| +.||+|+|.|+ .+|.+++++ .|+.|-+.+|++..
T Consensus 274 LrsL-~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 274 LRSL-ERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT 311 (565)
T ss_pred hhhh-hhhcccCCccc-cCCcccccc-eeeehhhcCCchHH
Confidence 9999 79999999999 689999999 99999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=161.89 Aligned_cols=134 Identities=18% Similarity=0.366 Sum_probs=114.2
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch--------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
..||+|++|.||+|.. +|..+++|+...... .....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3689999999999988 677888997654321 1124678899999999999998888888788889999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
+++++|.+++.... + .+..++.+++.+|.++|+ .+++|||++|.||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 788999999999999999 8999999999999999 78999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=189.87 Aligned_cols=190 Identities=22% Similarity=0.296 Sum_probs=150.5
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC---CCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK---HPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
...||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.+|+ -+-|..+...+...+..++|+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 45799999999999999899999999987765432 222234455555 234555555566778899999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-------CCCeEEecccccccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-------DFQPYISDFGLSRLI 561 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-------~~~~kl~DfGla~~~ 561 (707)
+|.+++... +.++|...+.++.|+++.+++||. .+|||+||||+|+||.. ...++|+|||.+-.|
T Consensus 780 tlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 780 TLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 999999843 479999999999999999999999 79999999999999942 345899999999877
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P 627 (707)
........ . ....+|-.+-.+|+.. ++.++..+|.|.++.+++.|+.|++-
T Consensus 852 ~lfp~~~~-F-------------~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 852 KLFPDGTK-F-------------KAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEcCCCcE-E-------------eeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 64432211 0 2234477788899854 58999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.5e-17 Score=163.66 Aligned_cols=138 Identities=19% Similarity=0.214 Sum_probs=107.5
Q ss_pred cceecccCeeEEEEEE--eCCCceEEEEEcCCCchh------------------------hHHHHHHHHHHHHhcCCC--
Q 005226 412 AYVLGKSGLGIVYKVV--LGNGIPVAVRRLGEGGEQ------------------------RHREFVTEVQAIAKVKHP-- 463 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~-- 463 (707)
...||+|+||.||+|. ..+|+.||+|.++..... ....+.+|++.+.++.+.
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i 112 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGV 112 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3589999999999998 568999999988643210 012356899999999753
Q ss_pred ceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceecCCCCCCe
Q 005226 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK-FVHGDIKPSNI 542 (707)
Q Consensus 464 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-iiHrDlk~~NI 542 (707)
.+.+++++ ...++||||+++++|........ .+...+...++.||+.+++|||+ .+ |+||||||+||
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 34444443 24589999999988876653221 35566678999999999999999 78 99999999999
Q ss_pred EEcCCCCeEEeccccccccc
Q 005226 543 LLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 543 ll~~~~~~kl~DfGla~~~~ 562 (707)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.3e-17 Score=159.76 Aligned_cols=130 Identities=22% Similarity=0.401 Sum_probs=108.2
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCch--------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+||+|+||.||+|.+ ++..+++|....... .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 677899998543211 12356788999999999988766666666777889999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
++++|.+++.... . .++.+++.+|.+||+ .+++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999886432 0 789999999999999 8999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.2e-17 Score=180.97 Aligned_cols=133 Identities=23% Similarity=0.364 Sum_probs=109.1
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCC-ch------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEG-GE------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||+||+|.+.+...++.++..+. .. ...+.+.+|++++++++|++++....++...+..++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 4589999999999998755443333222221 11 1235688999999999999999888888888888999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
+++++|.+++. ....++.+++.+|.|||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999885 346789999999999999 899999999999999 6789999999998753
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-19 Score=193.11 Aligned_cols=201 Identities=32% Similarity=0.403 Sum_probs=157.1
Q ss_pred CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEE
Q 005226 67 PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146 (707)
Q Consensus 67 ~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 146 (707)
.+..++++++++|++++. |..++.+.+|+.|+..+|+|+ .+|..+...++|+.|++.+|.+. .+|+....++.|++|
T Consensus 239 ~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTL 315 (1081)
T ss_pred ccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeee
Confidence 346888999999999965 588899999999999999986 66666666666666666666665 555555556666666
Q ss_pred eccCCccc-------------------------------------------------ccCCCCCcccchhhhhhhcCCcc
Q 005226 147 DLSNNSFS-------------------------------------------------GSLPDGLKNCKQLQRLILARNKF 177 (707)
Q Consensus 147 ~Ls~N~l~-------------------------------------------------~~~p~~~~~l~~L~~L~l~~N~l 177 (707)
+|..|+|. ...-..+.+.++|+.|+|++|+|
T Consensus 316 dL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 316 DLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred eehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 66666555 32223344566888999999999
Q ss_pred cccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc-cCC
Q 005226 178 SGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG-EIP 256 (707)
Q Consensus 178 ~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~-~~p 256 (707)
. .+|+..+.++..|+.|+||+|+|+ .+|..+.++..| ++|...+|+|. ..| .+..+++|+.+|++.|+|+- .+|
T Consensus 396 ~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L-~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~ 470 (1081)
T KOG0618|consen 396 N-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL-HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLP 470 (1081)
T ss_pred c-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh-HHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhh
Confidence 8 899988889999999999999998 788999999999 79999999998 788 88999999999999999984 445
Q ss_pred CCCCCCCCCCcccCCCCcc
Q 005226 257 QTGSFANQGPTAFLSNPLL 275 (707)
Q Consensus 257 ~~~~~~~~~~~~~~~N~~l 275 (707)
......++..+++.||.++
T Consensus 471 ~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 471 EALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hhCCCcccceeeccCCccc
Confidence 4444478889999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=154.81 Aligned_cols=133 Identities=18% Similarity=0.196 Sum_probs=105.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchh----------------------hHHHHHHHHHHHHhcCCCc--eee
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ----------------------RHREFVTEVQAIAKVKHPN--IVK 467 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n--iv~ 467 (707)
.+.||+|+||.||++...+|+.||||++...... ....+.+|+.++.++.|++ +..
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 4689999999999999888999999986543200 0123677899999998874 444
Q ss_pred eEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC
Q 005226 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND 547 (707)
Q Consensus 468 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~ 547 (707)
.++ ....++||||+++++|.+.... ....+++.+++.++.++|+ .+|+||||||+||+++++
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDD 161 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCC
Confidence 443 2456899999999998765431 2345788999999999999 899999999999999999
Q ss_pred CCeEEeccccccccc
Q 005226 548 FQPYISDFGLSRLIN 562 (707)
Q Consensus 548 ~~~kl~DfGla~~~~ 562 (707)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-16 Score=156.44 Aligned_cols=200 Identities=24% Similarity=0.294 Sum_probs=134.5
Q ss_pred CCCceeeeEEEEEcC---------------------------CcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHH
Q 005226 461 KHPNIVKLRAYYWAP---------------------------DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRI 513 (707)
Q Consensus 461 ~H~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 513 (707)
+|||||++.++|.+. ...|+||.-.+. +|.+++..+. .+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 699999998877541 134889987754 9999997653 555566778
Q ss_pred HHHHHHHHHHHhhcCCCCceecCCCCCCeEE--cCCC--CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccc-cc
Q 005226 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILL--DNDF--QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ-TE 588 (707)
Q Consensus 514 ~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll--~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 588 (707)
+.|+++|+.|||. ++|.|||+|++|||+ |+|. ...|+|||++---+. .|-..+|.+.+. .-
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~-----------hGlqlpy~S~~Vd~G 412 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN-----------HGLQLPYESDEVDLG 412 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccc-----------cccccccccccccCC
Confidence 8999999999999 899999999999999 4444 368899998642111 122234444433 34
Q ss_pred cCccccCCCCCCCCCCC-----CchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHH
Q 005226 589 KTNNYRAPEARVPGNRP-----MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAM 663 (707)
Q Consensus 589 gt~~y~aPE~~~~~~~~-----~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 663 (707)
|....||||+....... ..|+|.|+.|.+.||+++...||+...+.. -+...+....+ .++.+
T Consensus 413 GNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----L~~r~Yqe~qL---Palp~----- 480 (598)
T KOG4158|consen 413 GNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----LDTRTYQESQL---PALPS----- 480 (598)
T ss_pred CcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----echhhhhhhhC---CCCcc-----
Confidence 56678999986532111 268999999999999999999998632211 01111111100 01111
Q ss_pred HHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 664 LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 664 l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
.....+.+++...++.||.+||+..-....
T Consensus 481 --------~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 481 --------RVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred --------cCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 222345678888899999999987544433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=179.48 Aligned_cols=115 Identities=26% Similarity=0.317 Sum_probs=71.6
Q ss_pred CccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEE
Q 005226 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLN 221 (707)
Q Consensus 142 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~ 221 (707)
+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|... ++| +.|+
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt-~LP~l~---s~L-~~Ld 408 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLT-SLPVLP---SEL-KELM 408 (788)
T ss_pred ccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc----ccccceEEecCCccc-CCCCcc---cCC-CEEE
Confidence 4555555555555 344322 24445555555555 45532 246888888888888 466443 456 6888
Q ss_pred eccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 222 LSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 222 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+++|+|+ .+|.. ..+|+.|++++|+|+..+.....+..+..+.+.+|++
T Consensus 409 LS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 409 VSGNRLT-SLPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred ccCCcCC-CCCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCC
Confidence 8888888 46754 3467788888888884433344556666777777764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-16 Score=167.75 Aligned_cols=179 Identities=26% Similarity=0.306 Sum_probs=130.4
Q ss_pred cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 477 EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
..|+.|+++...+|.+||..+. .....+|...+.++.|++.|++| ++.+|||+||.||+...+..+||+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 4689999999999999997554 33467889999999999999999 388999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTST 635 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~ 635 (707)
+...+.... .+...+...+...||..||+||.+.+ ..|+.|+||||+|++++|+++ -..++..
T Consensus 402 l~ts~~~~~----------~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~er----- 465 (516)
T KOG1033|consen 402 LVTSQDKDE----------TVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFER----- 465 (516)
T ss_pred heeecccCC----------cccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHHH-----
Confidence 987665433 11223334466789999999999775 889999999999999999998 2222110
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHH
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v 698 (707)
......+ + ...+++....+. ..-..+..+++.+.|.+||++.++
T Consensus 466 ----~~t~~d~----r-----~g~ip~~~~~d~------p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 ----IATLTDI----R-----DGIIPPEFLQDY------PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----HHhhhhh----h-----cCCCChHHhhcC------cHHHHHHHHhcCCCcccCchHHHH
Confidence 0000000 0 222333332222 112467789999999999955444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-16 Score=177.47 Aligned_cols=216 Identities=22% Similarity=0.276 Sum_probs=138.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.|..|++|.||..+++ ..+.+|. ++++.. .+.+- ++.....|.+| |+-.
T Consensus 89 klisngAygavylvrh~~trqrfa~-kiNkq~-----lilRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAM-KINKQN-----LILRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhh-cccccc-----hhhhc--cccccCCccee---------------------chhh
Confidence 47899999999999875 4667777 333321 11111 22223334333 5666
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
..++.-+ .++- +++.+++|||+ .+|+|||+||+|.+++.-|++|++|||+++.......... .
T Consensus 140 tllk~~g-----~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl-~ 202 (1205)
T KOG0606|consen 140 TLLKNIG-----PLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL-K 202 (1205)
T ss_pred hhcccCC-----CCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh-h
Confidence 6665432 2222 22778999999 8999999999999999999999999999875432211111 1
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.+++.....-..+....||+.|+|||++.. ..|...+|.|++|+++||.+.|+.||...++. ++...+....-
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpe------elfg~visd~i 275 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISDDI 275 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHH------HHHhhhhhhhc
Confidence 111111112222355688999999999876 67889999999999999999999999876543 22222211110
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 694 (707)
.|+ + ..+....++.+++.+.++.+|..|--
T Consensus 276 -~wp-E-----------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 -EWP-E-----------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -ccc-c-----------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 000 0 01222345678888888999988853
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.3e-16 Score=178.01 Aligned_cols=166 Identities=22% Similarity=0.416 Sum_probs=86.2
Q ss_pred CCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCC--------
Q 005226 68 DPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN-------- 139 (707)
Q Consensus 68 ~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-------- 139 (707)
+..++.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+|. .+|..+..
T Consensus 198 p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls 270 (754)
T PRK15370 198 PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLF 270 (754)
T ss_pred ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECc
Confidence 4567777777777774 444433 46666666666666 3444332 23444444444444 33333321
Q ss_pred -----------CCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCc
Q 005226 140 -----------LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208 (707)
Q Consensus 140 -----------l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~ 208 (707)
.++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..++ ++|+.|++++|.|+ .+|.
T Consensus 271 ~N~L~~LP~~l~~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~Lt-~LP~ 342 (754)
T PRK15370 271 HNKISCLPENLPEELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP---PGLKTLEAGENALT-SLPA 342 (754)
T ss_pred CCccCccccccCCCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc---ccceeccccCCccc-cCCh
Confidence 124455555555544 2333322 24555555555555 4444332 45666666666665 3454
Q ss_pred chhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 209 ~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
.+. ++| +.|+|++|+|+ .+|..+ .++|+.|++++|+|+..
T Consensus 343 ~l~--~sL-~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~L 382 (754)
T PRK15370 343 SLP--PEL-QVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTNL 382 (754)
T ss_pred hhc--Ccc-cEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCCC
Confidence 442 355 56666666665 455444 24566666666666643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=7e-16 Score=176.29 Aligned_cols=182 Identities=25% Similarity=0.393 Sum_probs=134.6
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
.++.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|+
T Consensus 242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls 312 (754)
T PRK15370 242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ 312 (754)
T ss_pred cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence 4555555555555 3344443 46888888888888 5676554 58999999999998 5676553 579999999
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|+|+ .+|..+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++| +.|+|++|+|+
T Consensus 313 ~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~---~sL~~L~Ls~N~L~-~LP~~lp--~~L-~~LdLs~N~Lt- 380 (754)
T PRK15370 313 SNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP---PELQVLDVSKNQIT-VLPETLP--PTI-TTLDVSRNALT- 380 (754)
T ss_pred CCccc-cCCcccc--ccceeccccCCccc-cCChhhc---CcccEEECCCCCCC-cCChhhc--CCc-CEEECCCCcCC-
Confidence 99999 5676553 68999999999999 7887653 79999999999998 6787664 578 79999999999
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCCCCCC----CCCCCCcccCCCCc
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS----FANQGPTAFLSNPL 274 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~~~~~~~~N~~ 274 (707)
.+|..+. ..|+.|++++|+|++.+..... ...+..+.+.+||+
T Consensus 381 ~LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npl 427 (754)
T PRK15370 381 NLPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPF 427 (754)
T ss_pred CCCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCc
Confidence 5777654 4799999999999843221111 13334456666664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-15 Score=148.52 Aligned_cols=137 Identities=23% Similarity=0.295 Sum_probs=107.0
Q ss_pred hccceec-ccCeeEEEEEEeCCCceEEEEEcCCCc-------------hhhHHHHHHHHHHHHhcCCCce--eeeEEEEE
Q 005226 410 ASAYVLG-KSGLGIVYKVVLGNGIPVAVRRLGEGG-------------EQRHREFVTEVQAIAKVKHPNI--VKLRAYYW 473 (707)
Q Consensus 410 ~~~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~ 473 (707)
..+.+|| .||.|+||++... +..++||.+.... ......+.+|++++.+++|++| +..+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 3456898 8999999999885 6678888875321 1123567889999999998875 67777754
Q ss_pred cCCc----ceEEEEeecC-CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 474 APDE----KLLISDFISN-GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 474 ~~~~----~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
.... .++|+||+++ .+|.+++... .++.. .+.+|+.+|.+||+ .+|+||||||.|||++.++
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDG 179 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCC
Confidence 4322 2599999997 6999988642 24433 35689999999999 8999999999999999999
Q ss_pred CeEEeccccccc
Q 005226 549 QPYISDFGLSRL 560 (707)
Q Consensus 549 ~~kl~DfGla~~ 560 (707)
.++|+|||.++.
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.1e-15 Score=137.66 Aligned_cols=133 Identities=21% Similarity=0.172 Sum_probs=113.2
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC--CceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH--PNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++++++++....+..++++||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 368999999999999855 7899999866543 3678899999999976 5899999988888899999999988766
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4567778899999999999986545799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-17 Score=174.43 Aligned_cols=176 Identities=27% Similarity=0.440 Sum_probs=163.3
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
..+..||+.|++. .+|.++..+-.|+.|.|..|.|. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 4567899999998 77999999999999999999999 89999999999999999999999 9999999988 9999999
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|+++ .+|..++.+..|..||.+.|.|. .+|+.+ +.+.+|+.|.+..|++. .+|.++..|+-. .||+|.|+++
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql-~~l~slr~l~vrRn~l~-~lp~El~~LpLi--~lDfScNkis- 224 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQL-GYLTSLRDLNVRRNHLE-DLPEELCSLPLI--RLDFSCNKIS- 224 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHh-hhHHHHHHHHHhhhhhh-hCCHHHhCCcee--eeecccCcee-
Confidence 99999 99999999999999999999999 999987 69999999999999999 788899877644 8999999999
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
.+|-.|.+|+.|++|-|.+|+|+..+.
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCCChH
Confidence 899999999999999999999996544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.1e-15 Score=141.70 Aligned_cols=136 Identities=23% Similarity=0.319 Sum_probs=99.0
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchh--hHHH----------------------HHHHHHHHHhcCCCc--ee
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQ--RHRE----------------------FVTEVQAIAKVKHPN--IV 466 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--iv 466 (707)
+.||+|+||+||+|...+++.||||++...... .... ...|.+.+.++++.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 479999999999999888999999987653211 1111 135666677765443 44
Q ss_pred eeEEEEEcCCcceEEEEeecCCChHH-HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 467 KLRAYYWAPDEKLLISDFISNGNLAN-ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 467 ~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
+.+++ ...++||||++++++.. .+.... .. .....++.+++.++.++|.. .+|+||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE
Confidence 44443 34689999999965432 121110 11 56788999999999999984 5899999999999999
Q ss_pred CCCCeEEeccccccccc
Q 005226 546 NDFQPYISDFGLSRLIN 562 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~ 562 (707)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8999999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-15 Score=168.70 Aligned_cols=177 Identities=26% Similarity=0.364 Sum_probs=106.0
Q ss_pred CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceE--------------------EecC
Q 005226 67 PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSI--------------------FLYG 126 (707)
Q Consensus 67 ~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L--------------------~L~~ 126 (707)
.+.+++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|..+ ++|+.| +|++
T Consensus 220 l~~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~lp---~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~ 291 (788)
T PRK15387 220 LPAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVLP---PGLLELSIFSNPLTHLPALPSGLCKLWIFG 291 (788)
T ss_pred hhcCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCcc---cccceeeccCCchhhhhhchhhcCEEECcC
Confidence 34689999999999995 454 3588999999999999 455432 344444 4444
Q ss_pred ccCCCCCCcccCCCCCccEEeccCCcccccCCCCCccc-----------------chhhhhhhcCCcccccCCCcccccC
Q 005226 127 NNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNC-----------------KQLQRLILARNKFSGQIPAGIWPEL 189 (707)
Q Consensus 127 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----------------~~L~~L~l~~N~l~~~lp~~~~~~l 189 (707)
|+|+ .+|. .+++|+.|+|++|+|++ +|.....+ .+|+.|+|++|+|+ .+|.. .
T Consensus 292 N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~l----p 361 (788)
T PRK15387 292 NQLT-SLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTL----P 361 (788)
T ss_pred Cccc-cccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CCCCC----C
Confidence 4444 3333 13567888888888774 44322111 13444444444444 33321 1
Q ss_pred CCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCccc
Q 005226 190 ENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAF 269 (707)
Q Consensus 190 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~ 269 (707)
++|+.|++++|+|+ .+|... .+| +.|+|++|+|+ .+|.. .++|+.|++++|+|++ +|. ...++..+.+
T Consensus 362 ~~L~~L~Ls~N~L~-~LP~l~---~~L-~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~--l~~~L~~L~L 429 (788)
T PRK15387 362 SELYKLWAYNNRLT-SLPALP---SGL-KELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPM--LPSGLLSLSV 429 (788)
T ss_pred cccceehhhccccc-cCcccc---ccc-ceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCc--chhhhhhhhh
Confidence 33444444444444 233322 356 68888999888 46654 3578899999999986 553 2344555666
Q ss_pred CCCC
Q 005226 270 LSNP 273 (707)
Q Consensus 270 ~~N~ 273 (707)
.+|.
T Consensus 430 s~Nq 433 (788)
T PRK15387 430 YRNQ 433 (788)
T ss_pred ccCc
Confidence 6654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.2e-14 Score=172.66 Aligned_cols=199 Identities=25% Similarity=0.279 Sum_probs=131.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++. .++..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+.++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 56667777777766 4566667777777777776654445553 666777777777776555567777777777777777
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch------------------
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL------------------ 210 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~------------------ 210 (707)
++|..-+.+|..+ ++++|+.|+|++|...+.+|. ...+|++|+|++|.+. .+|..+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l 762 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKL 762 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccc----ccCCcCeeecCCCccc-cccccccccccccccccccchhhc
Confidence 7754444666655 566666666666654434443 2356667777777665 444322
Q ss_pred ------------hhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCccc
Q 005226 211 ------------GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLC 276 (707)
Q Consensus 211 ------------~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~ 276 (707)
...++| +.|+|++|...+.+|..++++++|+.|++++|+..+.+|....+.++..+.+.++..+.
T Consensus 763 ~~~~~~l~~~~~~~~~sL-~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~ 839 (1153)
T PLN03210 763 WERVQPLTPLMTMLSPSL-TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLR 839 (1153)
T ss_pred cccccccchhhhhccccc-hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCccc
Confidence 112356 67888888777788888888888888888887666667766566777777777765443
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.7e-14 Score=170.85 Aligned_cols=180 Identities=23% Similarity=0.283 Sum_probs=127.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++++..+.+| .+..+++|+.|+|++|.....+|..+.++++|+.|+|++|..-..+|..+ ++++|+.|+|
T Consensus 634 ~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~L 711 (1153)
T PLN03210 634 TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNL 711 (1153)
T ss_pred CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeC
Confidence 578899999876655666 48888999999999887666888889999999999999875444777765 6788888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcc-----------------------------cccCCCccEEeccC
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI-----------------------------WPELENLVQLDLSD 199 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~-----------------------------~~~l~~L~~L~ls~ 199 (707)
++|...+.+|.. ..+|+.|+|++|.+. .+|..+ +...++|+.|+|++
T Consensus 712 sgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~ 787 (1153)
T PLN03210 712 SGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSD 787 (1153)
T ss_pred CCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCC
Confidence 887655555543 345666677777765 555431 11234677778887
Q ss_pred CCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 200 NDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 200 N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
|...+.+|..++++++| +.|+|++|...+.+|..+ .+++|+.|++++|.....+|
T Consensus 788 n~~l~~lP~si~~L~~L-~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 788 IPSLVELPSSIQNLHKL-EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred CCCccccChhhhCCCCC-CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 77777788888888888 688888775444677655 56666666666654444444
|
syringae 6; Provisional |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-16 Score=157.27 Aligned_cols=182 Identities=25% Similarity=0.319 Sum_probs=151.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEccc-CCcCCCCCccccC------------------------CCCCceEE
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHN-NNLFGSLPDQLFN------------------------ATSLHSIF 123 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~------------------------l~~L~~L~ 123 (707)
.++++|||++|+|+.+-|.+|..|.+|..|-|-+ |+|+......|.+ +++|..|.
T Consensus 91 ~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLs 170 (498)
T KOG4237|consen 91 HRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLS 170 (498)
T ss_pred hhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhc
Confidence 6899999999999999999999999988876655 9998554444444 45555666
Q ss_pred ecCccCCCCCCc-ccCCCCCccEEeccCCccc------------c-----------------------------------
Q 005226 124 LYGNNLSGSLPP-SVCNLPRLQNLDLSNNSFS------------G----------------------------------- 155 (707)
Q Consensus 124 L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~------------~----------------------------------- 155 (707)
|.+|.+. .++. .|..+..++.+.+..|.+. -
T Consensus 171 lyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~e 249 (498)
T KOG4237|consen 171 LYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLE 249 (498)
T ss_pred ccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHH
Confidence 6666666 4444 7888889999988888722 0
Q ss_pred cC---------C------CCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEE
Q 005226 156 SL---------P------DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATL 220 (707)
Q Consensus 156 ~~---------p------~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L 220 (707)
.+ | ..|..|++|+.|+|++|+|+ .|..+.|.++..|+.|+|..|+|...-...|.++..| +.|
T Consensus 250 sl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~-~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L-~tL 327 (498)
T KOG4237|consen 250 SLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT-RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGL-KTL 327 (498)
T ss_pred hHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc-hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccc-eee
Confidence 00 1 12567889999999999999 8999999999999999999999997777889999999 799
Q ss_pred EeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 221 NLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 221 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
+|.+|+|+...|.+|..+..|.+|+|-.|++..
T Consensus 328 ~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 328 SLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred eecCCeeEEEecccccccceeeeeehccCcccC
Confidence 999999999999999999999999999999874
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-15 Score=167.25 Aligned_cols=173 Identities=34% Similarity=0.502 Sum_probs=137.9
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccc--------------------------cCCCCCceEE
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQL--------------------------FNATSLHSIF 123 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~--------------------------~~l~~L~~L~ 123 (707)
.++.|+...|.+. .+|+.+..+++|++|+|..|+|. .+|+.+ .....|+.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 4555566666666 55666666667777777777666 333322 1245688899
Q ss_pred ecCccCCCCCCcccCCCCCccEEeccCCcccccCC-CCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCC
Q 005226 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLP-DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202 (707)
Q Consensus 124 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l 202 (707)
|.+|.|+...-+.+.+.++|+.|+|++|+|. .+| ..+.++..|++|+||+|+|+ .||..+ ..++.|++|...+|+|
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tv-a~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTV-ANLGRLHTLRAHSNQL 442 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHH-HhhhhhHHHhhcCCce
Confidence 9999999877778899999999999999999 555 56889999999999999999 999776 6999999999999999
Q ss_pred CCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCc
Q 005226 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250 (707)
Q Consensus 203 ~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 250 (707)
. ..| ++..++.| +.+|+|.|+|+...-..-...++|++||+++|.
T Consensus 443 ~-~fP-e~~~l~qL-~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 443 L-SFP-ELAQLPQL-KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred e-ech-hhhhcCcc-eEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 8 788 99999999 899999999985433333334899999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-15 Score=168.23 Aligned_cols=247 Identities=25% Similarity=0.286 Sum_probs=180.1
Q ss_pred eecccCeeEEEEEEeC--CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVLG--NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
-||+|+|+.|-..... ....+|+|.+.... .........|..+=..+. |+|++.+++...+.+..+++.+|..+|
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 4899999999887753 34556666665443 222234445777777775 999999999999999999999999999
Q ss_pred ChHHHH-hCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccc-c
Q 005226 489 NLANAL-RGRNGQPSTSLSWSTRLRIAKGTARGLAYLH-ECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINI-T 564 (707)
Q Consensus 489 sL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~-~ 564 (707)
++.+-+ +... ...+......++.|+..++.|+| . .++.|||+||+|.+++..+ ..+++|||+|..... .
T Consensus 107 ~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 107 SLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred ccccccccCCc----cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 999988 4321 13555667789999999999999 6 7999999999999999999 999999999987654 2
Q ss_pred CCCCCCCCCCcCCCCCCCCcccccc-CccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEK-TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
+.... -....| ++.|+|||...+.....+..|+||.|+++.-+++|..||....... ....
T Consensus 180 g~~~~--------------~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~----~~~~ 241 (601)
T KOG0590|consen 180 GAERS--------------LKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD----GRYS 241 (601)
T ss_pred Cccee--------------eecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc----ccce
Confidence 21111 023455 8899999997654455788999999999999999999998755432 2233
Q ss_pred HHHHhhcc-ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 644 RWVKKGFE-EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 644 ~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
.|...... ...+ .........++..+++..+|..|.+.+++.
T Consensus 242 ~~~~~~~~~~~~~--------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 242 SWKSNKGRFTQLP--------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred eecccccccccCc--------------cccCChhhhhcccccccCCchhcccccccc
Confidence 33332211 0111 112223456777888889999999987764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-13 Score=148.14 Aligned_cols=139 Identities=24% Similarity=0.318 Sum_probs=101.4
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhH----------------------------------------HHHHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRH----------------------------------------REFVT 452 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~ 452 (707)
+.||.|++|.||+|++.+|+.||||+.+....... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 47999999999999999999999999865421100 13556
Q ss_pred HHHHHHhcC-----CCceeeeEEEE-EcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 005226 453 EVQAIAKVK-----HPNIVKLRAYY-WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR-GLAYLH 525 (707)
Q Consensus 453 E~~~l~~l~-----H~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH 525 (707)
|++.+.+++ ++++ .+-.++ ......++||||++|++|.++...... .. .+.+++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHH
Confidence 666666652 3443 322233 234567999999999999988753211 12 24457776666 467888
Q ss_pred hcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 526 ~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
. .+++|+|+||.||+++.++.++++|||++..+.
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 899999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.3e-15 Score=161.03 Aligned_cols=185 Identities=28% Similarity=0.356 Sum_probs=132.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCC---CCEEEcccCCcCC----CCCccccCC-CCCceEEecCccCCCC----CCcc
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIY---LRRLNLHNNNLFG----SLPDQLFNA-TSLHSIFLYGNNLSGS----LPPS 136 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~ 136 (707)
++++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 58899999999888766666666555 9999999998873 233445666 8889999999988843 3345
Q ss_pred cCCCCCccEEeccCCccccc----CCCCCcccchhhhhhhcCCcccccCCC---cccccCCCccEEeccCCCCCCCCCcc
Q 005226 137 VCNLPRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSGQIPA---GIWPELENLVQLDLSDNDFKGPIPND 209 (707)
Q Consensus 137 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~lp~---~~~~~l~~L~~L~ls~N~l~~~~p~~ 209 (707)
+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.-.. ..+..+++|++|++++|.+++.....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~ 240 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA 240 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence 66778899999999988742 334455566899999999988632111 12356788999999999888644444
Q ss_pred hhhh-----hccccEEEeccCcCc----CCCCCcCCCCCCccEEEccCCcCccc
Q 005226 210 LGEL-----QSLSATLNLSYNHLS----GKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 210 ~~~l-----~~L~~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
+... +.| +.|++++|.++ ..+...+..+++|+.+++++|+++..
T Consensus 241 l~~~~~~~~~~L-~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 241 LASALLSPNISL-LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHhccCCCc-eEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 4332 577 78999999886 23445566678889999999988844
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-15 Score=159.33 Aligned_cols=192 Identities=32% Similarity=0.506 Sum_probs=166.8
Q ss_pred EEEcCCCCccccCCCCc-CCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSEL-GSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.|.|++-.+....-+.. ..|+.-...||+.|++. .+|.++..+..|+.|.|++|.+. .+|..+++|..|++|||+.|
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 46677777765432222 45666778999999999 89999999999999999999999 99999999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
+++ .+|..++.|+ |+.|.+++|+++ .+|.++ +.+..|..||.+.|+|. .+|..++++.+| +.|++..|++. .+
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~i-g~~~tl~~ld~s~nei~-slpsql~~l~sl-r~l~vrRn~l~-~l 204 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEI-GLLPTLAHLDVSKNEIQ-SLPSQLGYLTSL-RDLNVRRNHLE-DL 204 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCccc-ccchhHHHhhhhhhhhh-hchHHhhhHHHH-HHHHHhhhhhh-hC
Confidence 999 8999999887 999999999999 999998 58999999999999999 899999999999 79999999999 78
Q ss_pred CCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
|.+++.| .|..||++.|+++..+-....+..+..+.+..||.
T Consensus 205 p~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPL 246 (722)
T KOG0532|consen 205 PEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPL 246 (722)
T ss_pred CHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCC
Confidence 8888865 58899999999996665555666666777777774
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-13 Score=150.73 Aligned_cols=176 Identities=37% Similarity=0.584 Sum_probs=78.9
Q ss_pred EEEEEcCCCCccccCCCCcCCCC-CCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 71 VVGVAISGKNVRGYIPSELGSLI-YLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 71 v~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
++.|++.+|+++ .+++....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus 118 l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls 194 (394)
T COG4886 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194 (394)
T ss_pred eeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence 444444444444 2233333442 4444455554444 33334444444555555555444 444443344444445555
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|+++ .+|.....+..|+.|++++|++. .++..+ ..+.++..|.+++|++. .++..++.++++ ++|++++|+++
T Consensus 195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~-~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l-~~L~~s~n~i~- 268 (394)
T COG4886 195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-SNLKNLSGLELSNNKLE-DLPESIGNLSNL-ETLDLSNNQIS- 268 (394)
T ss_pred CCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhh-hhcccccccccCCceee-eccchhcccccc-ceecccccccc-
Confidence 54444 44444334444444444444322 222222 34444444444444444 224444444444 44555555544
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
.++. ++.+.+++.|++++|.++..+|
T Consensus 269 ~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 269 SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred cccc-ccccCccCEEeccCccccccch
Confidence 2332 4444445555555554444433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.6e-15 Score=157.58 Aligned_cols=183 Identities=25% Similarity=0.283 Sum_probs=117.3
Q ss_pred CcEEEEEcCCCCccc------cCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCC---CceEEecCccCCC----CCCc
Q 005226 69 PRVVGVAISGKNVRG------YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATS---LHSIFLYGNNLSG----SLPP 135 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~------~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~ 135 (707)
+.++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457777777777662 23445667778888888888887666666655555 8888888888763 2233
Q ss_pred ccCCC-CCccEEeccCCccccc----CCCCCcccchhhhhhhcCCcccccCCCcc---cccCCCccEEeccCCCCCCCC-
Q 005226 136 SVCNL-PRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSGQIPAGI---WPELENLVQLDLSDNDFKGPI- 206 (707)
Q Consensus 136 ~~~~l-~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~lp~~~---~~~l~~L~~L~ls~N~l~~~~- 206 (707)
.+..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.+++.-...+ +..+++|+.|+|++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 45556 7788888888887732 33445566678888888888763211111 234457888888888876433
Q ss_pred ---CcchhhhhccccEEEeccCcCcCCCCCcCC-----CCCCccEEEccCCcCc
Q 005226 207 ---PNDLGELQSLSATLNLSYNHLSGKIPKSLG-----NLPVTVSFDLRGNNLS 252 (707)
Q Consensus 207 ---p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~-----~l~~L~~l~l~~N~l~ 252 (707)
+..+..+++| +.|++++|.+++.....+. ..+.|+.|++++|.++
T Consensus 211 ~~l~~~~~~~~~L-~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSL-EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCC-CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 2334455667 6888888877742222221 2367888888888776
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.4e-13 Score=146.83 Aligned_cols=194 Identities=36% Similarity=0.487 Sum_probs=165.9
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCC-CCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNAT-SLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 578888887533 345666789999999999999 7777788885 9999999999999 88888999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
+++ .+|.....+++|+.|++++|+++ .+|..+ ..+..|++|++++|++. ..+..+.++.++ ..|.+.+|++. .+
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~-~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l-~~l~l~~n~~~-~~ 247 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI-ELLSALEELDLSNNSII-ELLSSLSNLKNL-SGLELSNNKLE-DL 247 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhh-hhhhhhhhhhhcCCcce-ecchhhhhcccc-cccccCCceee-ec
Confidence 999 78887779999999999999999 999864 34566999999999755 578889999999 68999999998 56
Q ss_pred CCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCccc
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLC 276 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~ 276 (707)
+..++.+++++.|++++|.++...+ ...+.++..+.+.+|...-
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~ 291 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSN 291 (394)
T ss_pred cchhccccccceecccccccccccc-ccccCccCEEeccCccccc
Confidence 8889999999999999999995544 6777788888888886543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.1e-12 Score=129.44 Aligned_cols=207 Identities=20% Similarity=0.330 Sum_probs=137.0
Q ss_pred HHHHhcCCCceeeeEEEEEcCC-----cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 005226 455 QAIAKVKHPNIVKLRAYYWAPD-----EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529 (707)
Q Consensus 455 ~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 529 (707)
.-+-++-|.|||+++.|+.+.. +..++.|||..|++..+|+..+ +....+......+|+.||..||.|||++.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~-~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTK-KNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHH-HhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3455567999999999986543 4578999999999999997654 23456788888999999999999999966
Q ss_pred CCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchh
Q 005226 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW 609 (707)
Q Consensus 530 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 609 (707)
++|+|+++..+-|++..++-+|++----.... ++ .....-.......+-++|.|||+-.. ...+..+
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h------~s------~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~ 263 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH------PS------VNSTREAEKSVNTSLPGFSAPESGTT-TNTTGAS 263 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccc------hh------hhhhhHhhhhccccCCccccCCcCcc-cccccch
Confidence 69999999999999999988887531111000 00 00011111123345788999998332 4556789
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCC
Q 005226 610 DVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689 (707)
Q Consensus 610 DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP 689 (707)
|||+||...+||..+..-....... . ....-..-+....... .=.+++..|++..|
T Consensus 264 dIy~fgmcAlemailEiq~tnseS~-~-~~ee~ia~~i~~len~----------------------lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 264 DIYKFGMCALEMAILEIQSTNSESK-V-EVEENIANVIIGLENG----------------------LQRGSITKCLEGEP 319 (458)
T ss_pred hhhhhhHHHHHHHHheeccCCCcce-e-ehhhhhhhheeeccCc----------------------cccCcCcccccCCC
Confidence 9999999999999876532111100 0 0000000000000000 01256779999999
Q ss_pred CCCCChHHHHH
Q 005226 690 EVRPRMKNVSE 700 (707)
Q Consensus 690 ~~RPs~~~v~~ 700 (707)
..||+|++++.
T Consensus 320 ~~rp~ar~llf 330 (458)
T KOG1266|consen 320 NGRPDARLLLF 330 (458)
T ss_pred CCCcchhhhhc
Confidence 99999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.3e-11 Score=117.40 Aligned_cols=128 Identities=24% Similarity=0.301 Sum_probs=95.1
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCcee-eeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIV-KLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.++.|.++.||++... +..|++|........ ...+.+|+++++.+.+.+++ +++.+ .....++||||+++.++.+
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 5788999999999874 778999987654322 24567899999998665544 44443 3345689999999987754
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS--PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
. . . ....++.+++++|+.||+.. +..++|+|++|.||+++ ++.++++|||.+.
T Consensus 81 ~----~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 81 E----D------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred c----c------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 3 0 0 11245678999999999942 12369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.24 E-value=3e-11 Score=133.21 Aligned_cols=138 Identities=18% Similarity=0.309 Sum_probs=92.6
Q ss_pred ceecccCeeEEEEEEeCC-CceEEEEEcCCCchh---------------------------------h-H------HHHH
Q 005226 413 YVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQ---------------------------------R-H------REFV 451 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------~-~------~~~~ 451 (707)
..||.|++|+||+|++.+ |+.||||+.++.-.. + . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999987 999999998754110 0 0 1245
Q ss_pred HHHHHHHhcC----CCceeeeEEEEEc-CCcceEEEEeecCCChHHH--HhCCCCCCCCCCCHHHHHHHHHHHHHH-HHH
Q 005226 452 TEVQAIAKVK----HPNIVKLRAYYWA-PDEKLLISDFISNGNLANA--LRGRNGQPSTSLSWSTRLRIAKGTARG-LAY 523 (707)
Q Consensus 452 ~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~y 523 (707)
+|+..+.+++ +.+.+.+-.++++ ....++||||+.|+.+.++ +...+ .+.. .++...+.. +..
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g------~d~~---~la~~~v~~~~~Q 275 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG------TDMK---LLAERGVEVFFTQ 275 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC------CCHH---HHHHHHHHHHHHH
Confidence 5655555553 4444444444443 4578999999999999875 32221 2211 222222221 222
Q ss_pred HhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccccc
Q 005226 524 LHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRLIN 562 (707)
Q Consensus 524 LH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~~~ 562 (707)
++. .+++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 276 if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 334 6999999999999999988 99999999987664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=3e-12 Score=120.16 Aligned_cols=84 Identities=40% Similarity=0.559 Sum_probs=15.8
Q ss_pred CCCCCCCEEEcccCCcCCCCCcccc-CCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCC-cccchh
Q 005226 90 GSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGL-KNCKQL 167 (707)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L 167 (707)
.+..++++|+|++|+|+. +. .+. .+.+|+.|||++|.|+ .++ .+..+++|+.|+|++|+|+ .++..+ ..+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred cccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 344455556666665552 22 233 3455555555555555 222 3444555555555555555 222222 234444
Q ss_pred hhhhhcCCccc
Q 005226 168 QRLILARNKFS 178 (707)
Q Consensus 168 ~~L~l~~N~l~ 178 (707)
+.|+|++|+|.
T Consensus 91 ~~L~L~~N~I~ 101 (175)
T PF14580_consen 91 QELYLSNNKIS 101 (175)
T ss_dssp -EEE-TTS---
T ss_pred CEEECcCCcCC
Confidence 44444444443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=3e-12 Score=120.14 Aligned_cols=110 Identities=34% Similarity=0.454 Sum_probs=31.8
Q ss_pred ccCCCCCceEEecCccCCCCCCcccC-CCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCC
Q 005226 113 LFNATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 113 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
+.+..++++|+|.+|+|+ .+. .++ .+.+|+.|||++|.|+ .++ .+..+++|+.|++++|+|+ .++..+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 555667888888888888 443 455 5778888888888887 333 4666777777777777776 565444345677
Q ss_pred ccEEeccCCCCCCCCC-cchhhhhccccEEEeccCcCc
Q 005226 192 LVQLDLSDNDFKGPIP-NDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~ 228 (707)
|+.|+|++|+|...-- ..+..+++| +.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L-~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKL-RVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT---EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCc-ceeeccCCccc
Confidence 7777777777753111 233444444 45555555544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-11 Score=132.07 Aligned_cols=247 Identities=18% Similarity=0.175 Sum_probs=171.9
Q ss_pred cceecc--cCeeEEEEEEe---CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGK--SGLGIVYKVVL---GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
...+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+...+++ .|+|.++.+..+...+..++=+|
T Consensus 119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE 198 (524)
T KOG0601|consen 119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTE 198 (524)
T ss_pred ccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeec
Confidence 446888 99999999986 3678899988433211 2222335677777778 59999998888888888888888
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEeccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR----GLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLS 558 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla 558 (707)
++ +.+|.++.+... ..++....+.+..+... ||.++|+ ..++|-|+||.||+...+ ...+++|||+.
T Consensus 199 ~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 199 LC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCccee
Confidence 87 578888887654 23566666677777777 9999999 899999999999999999 88999999998
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
..+....-.... .......+...|++||... ..++...|+||+|.+..|..++..+....-
T Consensus 271 ~~i~~~~~~~~~-----------~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------ 331 (524)
T KOG0601|consen 271 SKISDGNFSSVF-----------KVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGK------ 331 (524)
T ss_pred EEccCCccccce-----------eeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCC------
Confidence 877644321110 0012235677899999754 577889999999999999999876643210
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...|... +.. -+-+. +...-..++...+.++++.+|..|++.+.+..
T Consensus 332 ---~~~W~~~--r~~----~ip~e------~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 332 ---NSSWSQL--RQG----YIPLE------FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---CCCcccc--ccc----cCchh------hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111110 000 00011 11111223344778899999999999877653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-10 Score=109.80 Aligned_cols=136 Identities=14% Similarity=0.160 Sum_probs=98.5
Q ss_pred ceecccCeeEEEEEEeCC-------CceEEEEEcCCCc----------------------hhhHHHHH----HHHHHHHh
Q 005226 413 YVLGKSGLGIVYKVVLGN-------GIPVAVRRLGEGG----------------------EQRHREFV----TEVQAIAK 459 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 459 (707)
..||.|--+.||.|...+ +..+|||..+-.. ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998543 4789999753210 01112333 79999999
Q ss_pred cCC--CceeeeEEEEEcCCcceEEEEeecCCChHH-HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCceec
Q 005226 460 VKH--PNIVKLRAYYWAPDEKLLISDFISNGNLAN-ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL-HECSPRKFVHG 535 (707)
Q Consensus 460 l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~iiHr 535 (707)
+.. -++..++++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|.+| |. .+|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 843 456666654 56899999997654422 2221 1245556778889999999999 77 799999
Q ss_pred CCCCCCeEEcCCCCeEEeccccccccc
Q 005226 536 DIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 536 Dlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||++.||+++ ++.+.|+|||.|....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.9e-10 Score=113.17 Aligned_cols=140 Identities=21% Similarity=0.284 Sum_probs=110.3
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCC--CceeeeEEEEEcCC---cceEEEEeecC
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKH--PNIVKLRAYYWAPD---EKLLISDFISN 487 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~e~~~~ 487 (707)
.|+.|.++.||++...+|..+++|....... .....+.+|+++++.+++ .++.+++.+..... ..++||||+++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 5899999999999987778999998765432 133678899999999965 34577777766543 56899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS--------------------------------------- 528 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------- 528 (707)
+++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 85 ~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 85 RVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 888776532 14677888889999999999998631
Q ss_pred --------------CCCceecCCCCCCeEEcC--CCCeEEecccccc
Q 005226 529 --------------PRKFVHGDIKPSNILLDN--DFQPYISDFGLSR 559 (707)
Q Consensus 529 --------------~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~ 559 (707)
+..++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 245799999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-11 Score=139.58 Aligned_cols=93 Identities=39% Similarity=0.676 Sum_probs=54.4
Q ss_pred CCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcC
Q 005226 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILAR 174 (707)
Q Consensus 95 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (707)
++.|+|++|.++|.+|..+.++++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~ls-------------------- 479 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN-------------------- 479 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCC--------------------
Confidence 445555555555555555555555555555555555555555555555555555555555
Q ss_pred CcccccCCCcccccCCCccEEeccCCCCCCCCCcchhh
Q 005226 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212 (707)
Q Consensus 175 N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 212 (707)
|.+|..+ ..+++|+.|+|++|+|+|.+|..+..
T Consensus 480 ----g~iP~~l-~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 480 ----GSIPESL-GQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred ----CCCchHH-hcCCCCCEEECcCCcccccCChHHhh
Confidence 4555443 56677777777777777777776653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.6e-10 Score=120.06 Aligned_cols=167 Identities=16% Similarity=0.196 Sum_probs=123.9
Q ss_pred eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCH
Q 005226 428 LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSW 507 (707)
Q Consensus 428 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~ 507 (707)
..++.+|.|...+...........+-++.|+.+|||||++++..+...+..|+|+|-+. .|..++... ..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence 44778888887766544333456677888999999999999999999999999999874 677777643 23
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCcccc
Q 005226 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587 (707)
Q Consensus 508 ~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 587 (707)
....-.+.||+.||.|||+. .+++|++|.-+-|+++..|+.||++|-++......... . ...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~---------------~-~~~ 165 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP---------------A-KSL 165 (690)
T ss_pred HHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc---------------c-ccc
Confidence 44555788999999999975 58999999999999999999999999987654322110 0 000
Q ss_pred ccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC
Q 005226 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 588 ~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~ 625 (707)
.--..|..|+.... -.-..|.|-||++++|++.|.
T Consensus 166 ~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 166 YLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhhhcccChhhcCc---cccchhhhhHHHHHHHHhCcc
Confidence 11234667775332 113579999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.3e-12 Score=124.23 Aligned_cols=132 Identities=31% Similarity=0.399 Sum_probs=106.7
Q ss_pred CCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEe
Q 005226 117 TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196 (707)
Q Consensus 117 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ 196 (707)
+.|++||||+|.|+ .+.++..-+|.++.|++|+|.|. .+- .+..|++|+.||||+|.++ ++...- ..+.|.+.|.
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh-~KLGNIKtL~ 358 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWH-LKLGNIKTLK 358 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhH-hhhcCEeeee
Confidence 56889999999999 78888888899999999999998 333 3888999999999999998 665433 5788999999
Q ss_pred ccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC-CCcCCCCCCccEEEccCCcCcccCC
Q 005226 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI-PKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 197 ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
|++|.|.. -..+..+-+| ..||+++|+|...- -..+++||.|+.+.|.+|+|.+.+.
T Consensus 359 La~N~iE~--LSGL~KLYSL-vnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIET--LSGLRKLYSL-VNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhh--hhhhHhhhhh-eeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999872 2467777788 68999999987321 3567889999999999999986553
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-11 Score=120.37 Aligned_cols=182 Identities=25% Similarity=0.329 Sum_probs=133.6
Q ss_pred cCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC-----------------------CCCCcccCCC
Q 005226 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS-----------------------GSLPPSVCNL 140 (707)
Q Consensus 84 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----------------------~~~p~~~~~l 140 (707)
.+|-.+.-+.+|+.+.+|.+.-.. +-+--..-+.|++|...+..++ |..-..+-.+
T Consensus 205 ~l~f~l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTW 283 (490)
T KOG1259|consen 205 RLSFNLNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTW 283 (490)
T ss_pred ccccchHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchH
Confidence 345556666777777777664331 2222223355666666555443 1112223456
Q ss_pred CCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEE
Q 005226 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATL 220 (707)
Q Consensus 141 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L 220 (707)
..|++||||+|.|+ .+.++..-++.++.|++|+|.|. .+.. +..+++|+.||||+|.++ .+..+-..+-++ ++|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n--La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI-KtL 357 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN--LAELPQLQLLDLSGNLLA-ECVGWHLKLGNI-KTL 357 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh--hhhcccceEeecccchhH-hhhhhHhhhcCE-eee
Confidence 78999999999999 78888888999999999999998 6655 468999999999999998 677777788888 899
Q ss_pred EeccCcCcCCCCCcCCCCCCccEEEccCCcCcc--cCCCCCCCCCCCCcccCCCCc
Q 005226 221 NLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG--EIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 221 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~p~~~~~~~~~~~~~~~N~~ 274 (707)
.|+.|.|.. -..+..|-+|..||+++|++.. .+...+.+..+..+.+.+||.
T Consensus 358 ~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 358 KLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred ehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 999999873 2446788899999999999974 344456667777788888874
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-09 Score=99.74 Aligned_cols=130 Identities=25% Similarity=0.419 Sum_probs=100.3
Q ss_pred eecccCeeEEEEEEeCCCceEEEEE-cCCC-chh------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRR-LGEG-GEQ------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~-~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+++|+-+.+|.+.+.+. ++++|. ..+. ... ......+|++++.+++--.|.-.+=|..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999977443 455553 3322 111 1245678999999997767666666777888999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
++-.|.+.+... +..++..|-.-+.-||. .+|||+||.++||++..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998888888753 23566677777888999 8999999999999998775 99999999864
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.9e-11 Score=122.93 Aligned_cols=181 Identities=23% Similarity=0.218 Sum_probs=129.3
Q ss_pred CcEEEEEcCCCCccccCC-CCcCCCCCCCEEEcccCCcCCCC--CccccCCCCCceEEecCccCCCCCCcc-cCCCCCcc
Q 005226 69 PRVVGVAISGKNVRGYIP-SELGSLIYLRRLNLHNNNLFGSL--PDQLFNATSLHSIFLYGNNLSGSLPPS-VCNLPRLQ 144 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~ 144 (707)
.+++.+.|.+..+.-... .....|++++.||||.|-|..-. -.-...|++|+.|+|+.|++..-.... -..++.|+
T Consensus 121 kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 121 KKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred HhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 467777777776653211 35678999999999999887432 233467999999999999997322221 23578899
Q ss_pred EEeccCCcccccC-CCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC--cchhhhhccccEEE
Q 005226 145 NLDLSNNSFSGSL-PDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP--NDLGELQSLSATLN 221 (707)
Q Consensus 145 ~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p--~~~~~l~~L~~~L~ 221 (707)
.|.|+.+.|+-.. -..+..+++|+.|+|..|... .+-..-..-+..|+.|||++|++. ..+ ...+.++.| +.|+
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L-~~Ln 277 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGL-NQLN 277 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCccc-ccccccccccccch-hhhh
Confidence 9999999987321 123456889999999999532 222222345678999999999987 444 567888888 7899
Q ss_pred eccCcCcCC-CCCc-----CCCCCCccEEEccCCcCc
Q 005226 222 LSYNHLSGK-IPKS-----LGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 222 l~~N~l~~~-~p~~-----~~~l~~L~~l~l~~N~l~ 252 (707)
++.+.+... .|+. ...+++|++|+++.|++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 999988742 2333 356789999999999996
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.4e-09 Score=95.99 Aligned_cols=141 Identities=20% Similarity=0.299 Sum_probs=103.8
Q ss_pred ceecccCeeEEEEEEeCCCceEEEE-EcCCC-c------hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVR-RLGEG-G------EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.++-+|+-+.|+++.+ .|+...|| ++.+. . .-..+...+|++.+.+++--.|.-..=++.+.....++|||
T Consensus 13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 3688999999999998 56665555 34332 1 11235678899999998766666555567788888999999
Q ss_pred ecC-CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEeccccccc
Q 005226 485 ISN-GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~ 560 (707)
+++ -++.+++...... ..........+.+|-+.+.-||. .+|||+||..+||++..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 4788888654311 12222236788888899999999 8999999999999997665 468999999753
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.98 E-value=7.3e-11 Score=120.93 Aligned_cols=182 Identities=23% Similarity=0.234 Sum_probs=118.2
Q ss_pred CCCCCCCEEEcccCCcCCCCC--ccccCCCCCceEEecCccCCCCCC--cccCCCCCccEEeccCCcccccCCCC-Cccc
Q 005226 90 GSLIYLRRLNLHNNNLFGSLP--DQLFNATSLHSIFLYGNNLSGSLP--PSVCNLPRLQNLDLSNNSFSGSLPDG-LKNC 164 (707)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l 164 (707)
.++.+|+...|.+.... ..+ .....|++++.||||+|-+....| .-...||+|+.|+|+.|++.-..... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46777888888887776 333 245568888888888888774322 23456788888888888886322221 2356
Q ss_pred chhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCC--CcCCCCCCcc
Q 005226 165 KQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIP--KSLGNLPVTV 242 (707)
Q Consensus 165 ~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p--~~~~~l~~L~ 242 (707)
++|+.|.|+.+.|+-.=-..+...+|+|+.|+|..|...+.-......++.| ++|||++|++- ..+ ...+.++.|.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L-~~LdLs~N~li-~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTL-QELDLSNNNLI-DFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHH-hhccccCCccc-ccccccccccccchh
Confidence 7788888888887621111223467888888888885433444455566677 78888888877 344 4566788888
Q ss_pred EEEccCCcCccc-CCCC------CCCCCCCCcccCCCCc
Q 005226 243 SFDLRGNNLSGE-IPQT------GSFANQGPTAFLSNPL 274 (707)
Q Consensus 243 ~l~l~~N~l~~~-~p~~------~~~~~~~~~~~~~N~~ 274 (707)
.|+++.+.++.. .|.. ..+.++..+....|+.
T Consensus 275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hhhccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 888888877642 2322 4455666666666664
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-10 Score=122.03 Aligned_cols=239 Identities=21% Similarity=0.223 Sum_probs=165.8
Q ss_pred eecccCeeEEEEEEe--CCCceEEEEEcCCCchhhH--HHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVL--GNGIPVAVRRLGEGGEQRH--REFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||.|.|+.|++... .++..+++|.+........ ..-..|+.+...+ -|.+++++...+...++.|+=-||++++
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGG 351 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCc
Confidence 589999999998774 3678889988766532211 2224567776666 6899999888887788888999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~~~ 567 (707)
++...+... ..++...++++..|++.++.++|+ +.++|+|+||+||++..+ +..+++|||++..+.....
T Consensus 352 s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~- 422 (524)
T KOG0601|consen 352 SSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG- 422 (524)
T ss_pred chhhhhHHH-----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence 888777332 247888899999999999999999 899999999999999886 8889999999865321110
Q ss_pred CCCCCCCcCCCCCCCCccccccCcccc-CCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYR-APEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....+-++. .+|++.....+-.+.|+||||..+.|.++|..--.. ...|.
T Consensus 423 ------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----------~~~~~ 473 (524)
T KOG0601|consen 423 ------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----------GVQSL 473 (524)
T ss_pred ------------------cccccccccccchhhccccccccccccccccccccccccCcccCcc-----------cccce
Confidence 011122334 355556556667899999999999999998753211 11111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
.. ..... . ........+..++..+...++..||.+.+.....+.
T Consensus 474 ~i--~~~~~-p-----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TI--RSGDT-P-----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ee--ecccc-c-----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 00000 0 000111344566677889999999998887665443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.7e-08 Score=102.46 Aligned_cols=140 Identities=14% Similarity=0.071 Sum_probs=100.5
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhh-H----------HHHHHHHHHHHhcCCCc--eeeeEEEEEc-----
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR-H----------REFVTEVQAIAKVKHPN--IVKLRAYYWA----- 474 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~n--iv~l~~~~~~----- 474 (707)
+++-.-....|++..+ +|+.+.||+........ . ..+.+|...+.++...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444444667766 67789999775443211 1 14788999998885433 3445556543
Q ss_pred CCcceEEEEeecCC-ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-------
Q 005226 475 PDEKLLISDFISNG-NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN------- 546 (707)
Q Consensus 475 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~------- 546 (707)
....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||. .+|+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23468999999886 8999985321 1235567778999999999999999 89999999999999985
Q ss_pred CCCeEEecccccc
Q 005226 547 DFQPYISDFGLSR 559 (707)
Q Consensus 547 ~~~~kl~DfGla~ 559 (707)
+..+.++||+.++
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4689999999875
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.7e-10 Score=85.81 Aligned_cols=60 Identities=42% Similarity=0.572 Sum_probs=31.3
Q ss_pred CCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcc
Q 005226 94 YLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153 (707)
Q Consensus 94 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 153 (707)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555544444555555555555555543
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.2e-08 Score=102.70 Aligned_cols=170 Identities=19% Similarity=0.230 Sum_probs=129.1
Q ss_pred eEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----CCcceEEEEeecC-CChHHHH
Q 005226 421 GIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA----PDEKLLISDFISN-GNLANAL 494 (707)
Q Consensus 421 g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~l 494 (707)
.+.||+.. .||..|++|+++.........-..-+++++++.|+|+|++..++.. +...++||+|.|+ ++|.+.-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 68899985 4899999999955433322233456889999999999999998863 3467899999886 6777765
Q ss_pred hCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 495 RGRNG----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 495 ~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
..... ......++...+.++.|++.||.++|+ .|+.-+-|.+++|+++.+.+++|+..|........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 43321 112346888999999999999999999 79999999999999999999999999987655422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P 627 (707)
.. |-+.. -++-|.=.||.+++.|.||..-
T Consensus 447 ~~------------------------------~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT------------------------------EPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC------------------------------cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 10 11111 2467999999999999999653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.1e-10 Score=127.99 Aligned_cols=255 Identities=19% Similarity=0.213 Sum_probs=152.9
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
-+-+|.++.++.+.-. .|...+.|+.... .....+...++-.+.-..+||-+++..--+.-....+||++|..+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 4566778877766532 2322223322211 11111222333333333455666654433334566789999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|...|+... ..+.+........+..+++|||. ..+.|||++|.|.+...++..+++|||.............
T Consensus 891 ~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 891 LPSKLHNSG-----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred chhhhhcCC-----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999765 23434444556667889999999 5699999999999999999999999995544322111110
Q ss_pred CCCCCcCCCC------------CC---CCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005226 570 SSGGFMGGAL------------PY---MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634 (707)
Q Consensus 570 ~~~~~~~~~~------------~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~ 634 (707)
..+....++. .. .......+|+.|.|||...+ ......+|.|++|++++|.++|.+||......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0000000000 00 01123467999999999775 66678999999999999999999999876554
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 696 (707)
..++ .......+ -.....+......+++...+..+|.+|-.|.
T Consensus 1042 ~~f~---------ni~~~~~~----------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFE---------NILNRDIP----------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhh---------ccccCCCC----------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 2211 11111100 0011122334456666777788888886654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.9e-10 Score=123.23 Aligned_cols=172 Identities=30% Similarity=0.315 Sum_probs=105.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
..+..|+|.+|+|.++. ..+..+++|++|+|++|.|+.+.+ +..++.|+.|++++|.|+ .+ ..+..+++|+.|++
T Consensus 95 ~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DI-SGLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhcc-cchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hc-cCCccchhhhcccC
Confidence 46677777777777542 226667777777777777764433 455666777777777776 22 33445677777777
Q ss_pred cCCcccccCCCC-CcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhc--cccEEEeccC
Q 005226 149 SNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQS--LSATLNLSYN 225 (707)
Q Consensus 149 s~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~--L~~~L~l~~N 225 (707)
++|++...-+ . ...+.+|+.+++.+|.+. .+.. +..+..+..+++..|.++..-+ +..+.. | +.+++++|
T Consensus 170 ~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~-~i~~--~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L-~~l~l~~n 242 (414)
T KOG0531|consen 170 SYNRIVDIEN-DELSELISLEELDLGGNSIR-EIEG--LDLLKKLVLLSLLDNKISKLEG--LNELVMLHL-RELYLSGN 242 (414)
T ss_pred Ccchhhhhhh-hhhhhccchHHHhccCCchh-cccc--hHHHHHHHHhhcccccceeccC--cccchhHHH-HHHhcccC
Confidence 7777763322 2 466677777777777776 3332 2344555556777777762221 111222 4 57777777
Q ss_pred cCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 226 HLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
.+. .++..+..+..+..|++.+|++..
T Consensus 243 ~i~-~~~~~~~~~~~l~~l~~~~n~~~~ 269 (414)
T KOG0531|consen 243 RIS-RSPEGLENLKNLPVLDLSSNRISN 269 (414)
T ss_pred ccc-cccccccccccccccchhhccccc
Confidence 777 454666677777777777777763
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.1e-09 Score=77.53 Aligned_cols=41 Identities=32% Similarity=0.870 Sum_probs=31.5
Q ss_pred cccHHHHHHHHhcCcCCCCCCCCCCCCCC-CCCceeceeEeC
Q 005226 21 SPDGLTLLSLKSAIDQTDTSVFADWNEND-PTPCRWSGISCM 61 (707)
Q Consensus 21 ~~d~~~l~~~k~~~~~~~~~~~~~W~~~~-~~~C~w~gv~c~ 61 (707)
+.|+.||++||+++..+|...+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57899999999999877889999999874 789999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-08 Score=95.88 Aligned_cols=124 Identities=23% Similarity=0.328 Sum_probs=82.7
Q ss_pred EEEEEeCCCceEEEEEcCCCc----------------------h----hhHHHHHHHHHHHHhcCCC--ceeeeEEEEEc
Q 005226 423 VYKVVLGNGIPVAVRRLGEGG----------------------E----QRHREFVTEVQAIAKVKHP--NIVKLRAYYWA 474 (707)
Q Consensus 423 Vy~~~~~~~~~vavK~~~~~~----------------------~----~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~ 474 (707)
||.|...+|..+|||..+... . .......+|++.|.++..- ++.+++++
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence 899999899999999753210 0 0113456899999999765 45666644
Q ss_pred CCcceEEEEeec--CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 475 PDEKLLISDFIS--NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY-LHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 475 ~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
...++||||++ +..+..+.... ++......++.+++..+.. +|. .+|+|+||.+.||+++++ .+.
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred -eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 25689999998 54554433321 2234456778888886666 467 799999999999999988 999
Q ss_pred Eecccccccc
Q 005226 552 ISDFGLSRLI 561 (707)
Q Consensus 552 l~DfGla~~~ 561 (707)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.5e-10 Score=122.72 Aligned_cols=173 Identities=26% Similarity=0.287 Sum_probs=111.3
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
.+..+++..|.|.. +-..+..+++|+.|+|.+|+|.+ +...+..+++|++|+|++|+|+... .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheec
Confidence 44555566666663 33456777788888888888873 3333667778888888888887432 35566668888888
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|.|+. ...+..+++|+.+++++|++. .++......+.+|+.+++.+|.+. ....+..+..+ ..+++..|.++.
T Consensus 149 ~N~i~~--~~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l-~~~~l~~n~i~~ 222 (414)
T KOG0531|consen 149 GNLISD--ISGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR--EIEGLDLLKKL-VLLSLLDNKISK 222 (414)
T ss_pred cCcchh--ccCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh--cccchHHHHHH-HHhhccccccee
Confidence 888762 234555778888888888887 555510246777888888888776 23344445555 356777777773
Q ss_pred CCCCcCCCCCC--ccEEEccCCcCccc
Q 005226 230 KIPKSLGNLPV--TVSFDLRGNNLSGE 254 (707)
Q Consensus 230 ~~p~~~~~l~~--L~~l~l~~N~l~~~ 254 (707)
.-+. ..+.. |+.+++++|++.-.
T Consensus 223 ~~~l--~~~~~~~L~~l~l~~n~i~~~ 247 (414)
T KOG0531|consen 223 LEGL--NELVMLHLRELYLSGNRISRS 247 (414)
T ss_pred ccCc--ccchhHHHHHHhcccCccccc
Confidence 2221 12222 77888888888743
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.7e-09 Score=82.44 Aligned_cols=61 Identities=31% Similarity=0.435 Sum_probs=57.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
++++.|+|++|+|+.+.+..|..+++|++|+|++|+|+...|..|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999988889999999999999999999988888999999999999999986
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.8e-10 Score=121.24 Aligned_cols=160 Identities=28% Similarity=0.320 Sum_probs=99.5
Q ss_pred CCCcCCCCCCCEEEcccCCcCCC---CC--c-----------------------cccC---CCCCceEEecCccCCCCCC
Q 005226 86 PSELGSLIYLRRLNLHNNNLFGS---LP--D-----------------------QLFN---ATSLHSIFLYGNNLSGSLP 134 (707)
Q Consensus 86 ~~~l~~l~~L~~L~L~~N~l~~~---~p--~-----------------------~~~~---l~~L~~L~L~~N~l~~~~p 134 (707)
|-.+..+..|++|.|.++.|... .+ . .+.+ -..|.+.+.+.|+|. .+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~mD 180 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-LMD 180 (1096)
T ss_pred CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-hHH
Confidence 66678888999999999888631 11 0 0010 024556667777776 666
Q ss_pred cccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhh
Q 005226 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQ 214 (707)
Q Consensus 135 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 214 (707)
.++.-++.|+.|||++|+++... .+..|++|++|||++|+|+ .+|.---.++. |..|.|++|.++.. ..+.+|.
T Consensus 181 ~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~Lk 254 (1096)
T KOG1859|consen 181 ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLK 254 (1096)
T ss_pred HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHHhh--hhHHhhh
Confidence 66666777777777777776332 6667777777777777776 66643322333 77777777777622 2566666
Q ss_pred ccccEEEeccCcCcCCCC-CcCCCCCCccEEEccCCcCcc
Q 005226 215 SLSATLNLSYNHLSGKIP-KSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 215 ~L~~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~ 253 (707)
+| +.|||++|-|.+.-. ..+..|..|+.|+|.+|++..
T Consensus 255 sL-~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 255 SL-YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred hh-hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 77 577777776664211 123345566667777777653
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.9e-10 Score=113.72 Aligned_cols=65 Identities=26% Similarity=0.343 Sum_probs=27.9
Q ss_pred ccCCCccEEeccCCCCCCC----CCcchhhhhccccEEEeccCcCcCCCCCcC-----CCCCCccEEEccCCcCc
Q 005226 187 PELENLVQLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSGKIPKSL-----GNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 187 ~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~-----~~l~~L~~l~l~~N~l~ 252 (707)
..+++|++|||.+|-|+.. +...+..++.| ++|+++++.++..-..+| ...++|++|.+.+|.++
T Consensus 210 ~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L-~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 210 EHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHL-RELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred HhCCcceeeecccchhhhHHHHHHHHHhcccchh-eeecccccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 3445555555555544421 11233334444 455555554442211111 12445555555555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.4e-10 Score=97.51 Aligned_cols=132 Identities=17% Similarity=0.265 Sum_probs=91.0
Q ss_pred cEEEEEcCCCCccccCCCC---cCCCCCCCEEEcccCCcCCCCCccccC-CCCCceEEecCccCCCCCCcccCCCCCccE
Q 005226 70 RVVGVAISGKNVRGYIPSE---LGSLIYLRRLNLHNNNLFGSLPDQLFN-ATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~---l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 145 (707)
..-.++|+++.|- .+++. +....+|+..+|++|.+. .+|..|.. .+.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456777777765 33333 445566777788888888 56666654 458888888888888 78888888888888
Q ss_pred EeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC
Q 005226 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207 (707)
Q Consensus 146 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p 207 (707)
|+++.|.|. ..|.-+..|.+|..|+..+|.+. .||.++| .-..+-..++.++.+.+.-+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLF-YSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHh-ccccHHHHHhcCCcccccCc
Confidence 888888888 77777777888888888888887 7777654 11222233345555554433
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.7e-10 Score=121.30 Aligned_cols=100 Identities=30% Similarity=0.428 Sum_probs=43.0
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCC-CCcccchhhhhhhcC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPD-GLKNCKQLQRLILAR 174 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~ 174 (707)
...+.++|+|. ....++.-++.|+.|||++|+++.. . .+..++.|++|||++|.|. .+|. .-.++. |..|.|++
T Consensus 167 ~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 167 ATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred hhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhc-cccccchhhhh-heeeeecc
Confidence 33444444444 3333444444455555555554421 1 4444445555555555544 2332 112222 44455555
Q ss_pred CcccccCCCcccccCCCccEEeccCCCCC
Q 005226 175 NKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 175 N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
|.++ .+-. ..+|.+|+.|||++|-|.
T Consensus 242 N~l~-tL~g--ie~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 242 NALT-TLRG--IENLKSLYGLDLSYNLLS 267 (1096)
T ss_pred cHHH-hhhh--HHhhhhhhccchhHhhhh
Confidence 5444 2221 134444445555555444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=8.1e-10 Score=95.89 Aligned_cols=104 Identities=29% Similarity=0.381 Sum_probs=47.3
Q ss_pred CCEEEcccCCcCCCCCccc---cCCCCCceEEecCccCCCCCCcccCC-CCCccEEeccCCcccccCCCCCcccchhhhh
Q 005226 95 LRRLNLHNNNLFGSLPDQL---FNATSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRL 170 (707)
Q Consensus 95 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 170 (707)
+..|+|++++|- .+++.. .....|+..+|++|.+. .+|+.|.. .+.++.|+|++|.|+ .+|.++..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445556665554 333332 23334444455555555 44444332 234555555555555 444444444444444
Q ss_pred hhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 171 ILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 171 ~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
+++.|.|. ..|.-++. |.+|..|+..+|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~-L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAP-LIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHH-HHhHHHhcCCCCccc
Confidence 44444444 33333322 444444444444443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.6e-07 Score=92.66 Aligned_cols=264 Identities=17% Similarity=0.167 Sum_probs=149.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEE----EcC--Cc-ceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYY----WAP--DE-KLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~----~~~--~~-~~lV~e 483 (707)
+.-||+|+-+.+|-.--- +.. +.|+..........+ -+..|... .||-+-.=+.+= +.. +. .-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 457999999999964321 222 346655443322111 23344444 565433211111 111 11 345666
Q ss_pred eecCC-ChHHHHhCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 484 FISNG-NLANALRGR-NGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 484 ~~~~g-sL~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
.+++. ....++... +.+......|...++.++.+|.+.+-||+ .|-+-+|+.++|+|+++++.+.+.|=.--...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 65553 222222211 11234568999999999999999999999 78888999999999999999999873321111
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTG-KSPELSPTTSTS 636 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg-~~P~~~~~~~~~ 636 (707)
... .. ..-.+|...|.+||... .+..-+...|-|.+||++++++.| ++||.+......
T Consensus 168 ~ng---~~--------------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 168 ANG---TL--------------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred cCC---ce--------------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 100 00 01235677899999743 123445789999999999999987 999976432111
Q ss_pred ccchhHHHHHHhhccccCCCchhchHH--HH---hhhhhHHHHHHHHHHHHhccCCC--CCCCCChHHHHHHHHhhc
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAM--LL---QEVHAKKEVIAVFHLALACTEAD--PEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~--l~---~~~~~~~~~~~l~~l~~~Cl~~d--P~~RPs~~~v~~~L~~i~ 706 (707)
....+..-+..+.- ...-|.. ++ ...........+..+..+|.... +.-||+++-.+..|.+++
T Consensus 231 -ap~p~E~~Ia~g~f-----~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 231 -APNPLETDIAHGRF-----AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred -CCCcchhhhhccee-----eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 11111101111000 0000000 00 00111222345667778887663 678999999999887763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.5e-09 Score=104.66 Aligned_cols=182 Identities=21% Similarity=0.274 Sum_probs=136.0
Q ss_pred CcEEEEEcCCCCcccc----CCCCcCCCCCCCEEEcccCCcCC----CCCc-------cccCCCCCceEEecCccCCCCC
Q 005226 69 PRVVGVAISGKNVRGY----IPSELGSLIYLRRLNLHNNNLFG----SLPD-------QLFNATSLHSIFLYGNNLSGSL 133 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~----~~p~-------~~~~l~~L~~L~L~~N~l~~~~ 133 (707)
..++.|+|++|.+... +...+.+.++|+..++|+= ++| .+|. .+...+.|++||||+|.|...-
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g 108 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKG 108 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccc
Confidence 6799999999988653 4556778889999998863 333 3443 3456779999999999998555
Q ss_pred Ccc----cCCCCCccEEeccCCcccccC-------------CCCCcccchhhhhhhcCCcccccCCC----cccccCCCc
Q 005226 134 PPS----VCNLPRLQNLDLSNNSFSGSL-------------PDGLKNCKQLQRLILARNKFSGQIPA----GIWPELENL 192 (707)
Q Consensus 134 p~~----~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~l~~N~l~~~lp~----~~~~~l~~L 192 (707)
++. +.++..|++|+|.+|.+.-.- ..-...-+.|+.+..++|++. .-+. ..|...+.|
T Consensus 109 ~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrle-n~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 109 IRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLE-NGGATALAEAFQSHPTL 187 (382)
T ss_pred hHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccc-cccHHHHHHHHHhcccc
Confidence 544 456889999999999887211 112344568999999999997 4443 346677899
Q ss_pred cEEeccCCCCCCC----CCcchhhhhccccEEEeccCcCcC----CCCCcCCCCCCccEEEccCCcCcc
Q 005226 193 VQLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSG----KIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 193 ~~L~ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
+.+.++.|.|... +...|..++.| +.|||..|-|+. .+...+..+++|+.|+++++.+..
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~L-evLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHL-EVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcc-eeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence 9999999998632 22467788999 899999999883 234567789999999999998873
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=1.4e-06 Score=83.76 Aligned_cols=138 Identities=18% Similarity=0.150 Sum_probs=101.9
Q ss_pred ecccCeeEEEEEEeCCCceEEEEEcCCCc------hhhHHHHHHHHHHHHhcCC--CceeeeEEEEE-cC----CcceEE
Q 005226 415 LGKSGLGIVYKVVLGNGIPVAVRRLGEGG------EQRHREFVTEVQAIAKVKH--PNIVKLRAYYW-AP----DEKLLI 481 (707)
Q Consensus 415 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~-~~----~~~~lV 481 (707)
-|+||-+-|++..+. |..+-+|+-...- ......|.+|+..+.++.. -.+.+.. ++. .. -..+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367888899998874 4468888764210 1223679999999999853 2344554 332 11 134799
Q ss_pred EEeecC-CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC--eEEeccccc
Q 005226 482 SDFISN-GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ--PYISDFGLS 558 (707)
Q Consensus 482 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla 558 (707)
+|-+.+ -+|.+++.... ....+...+..+..+|+..+.-||+ .++.|+|+-+.||+++.++. ++++||.-+
T Consensus 104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 997764 58999886532 1246777888999999999999999 89999999999999986666 999999976
Q ss_pred cc
Q 005226 559 RL 560 (707)
Q Consensus 559 ~~ 560 (707)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.3e-07 Score=87.51 Aligned_cols=105 Identities=27% Similarity=0.375 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcCCC--ceeeeEEEEEcCC----cceEEEEeecCC-ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHH
Q 005226 448 REFVTEVQAIAKVKHP--NIVKLRAYYWAPD----EKLLISDFISNG-NLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520 (707)
Q Consensus 448 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 520 (707)
..+.+|...+.++..- .+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++..
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALARL 130 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHHH
Confidence 4577888888887433 3556667665532 348999999884 8999997632 25566788999999999
Q ss_pred HHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEeccccccc
Q 005226 521 LAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDFGLSRL 560 (707)
Q Consensus 521 L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~ 560 (707)
+.-||+ .+|+|+|+++.|||++.+. .+.++||+-++.
T Consensus 131 i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 8999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=6.5e-07 Score=87.97 Aligned_cols=135 Identities=20% Similarity=0.173 Sum_probs=96.0
Q ss_pred HHhccceecccCeeEEEEEEeCCCceEEEEEcCCCc----------------------hhhHHHHHHHHHHHHhcCCC--
Q 005226 408 LRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG----------------------EQRHREFVTEVQAIAKVKHP-- 463 (707)
Q Consensus 408 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~H~-- 463 (707)
..+.++.||-|--+.||.|..+.|.++|||-=+... .-......+|.++|.+|.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345578999999999999999999999999521110 00123457899999999654
Q ss_pred ceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeE
Q 005226 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNIL 543 (707)
Q Consensus 464 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIl 543 (707)
.+.+.++ .+.+.+||||+++-.|...- ++....-.|+..|++-+.-.-. .||||+|+.+-||+
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNIL 234 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEE
Confidence 6666654 35678999999886554432 1122233444444444444334 69999999999999
Q ss_pred EcCCCCeEEecccccc
Q 005226 544 LDNDFQPYISDFGLSR 559 (707)
Q Consensus 544 l~~~~~~kl~DfGla~ 559 (707)
+++||.+.++||-.+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999998764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=3.6e-07 Score=100.39 Aligned_cols=149 Identities=22% Similarity=0.397 Sum_probs=100.0
Q ss_pred chHHHHHhcc-ceecccCeeEEEEEEeCCCceEEEEEcCCCchhh------------------------------HH---
Q 005226 403 ELDELLRASA-YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR------------------------------HR--- 448 (707)
Q Consensus 403 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~--- 448 (707)
.++++...+. +-|+.++-|.||+|++.+|+.||||+.+..-... .+
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 4455555554 6799999999999999999999999975431100 01
Q ss_pred -------HHHHHHHHHHhcC-----CCceeeeEEEEE-cCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHH
Q 005226 449 -------EFVTEVQAIAKVK-----HPNIVKLRAYYW-APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAK 515 (707)
Q Consensus 449 -------~~~~E~~~l~~l~-----H~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~ 515 (707)
+|.+|..-+.+++ .|++ .+=.+|+ ......|+|||++|-.+.+...... ..++ +..|+.
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~ 271 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAE 271 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHH
Confidence 2345555555542 3333 2333344 3578899999999998888843221 1244 334444
Q ss_pred HHHHH-HHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 516 GTARG-LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 516 ~ia~~-L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
.++++ +..+-. .++.|.|..|.||+++.++++.+.|||+.....
T Consensus 272 ~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 272 LLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 44443 222222 489999999999999999999999999987654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.6e-08 Score=94.35 Aligned_cols=62 Identities=23% Similarity=0.293 Sum_probs=27.1
Q ss_pred CCccEEeccCCCCCCCCC-cchhhhhccccEEEeccCcCcCCC-CCcCCCCCCccEEEccCCcCc
Q 005226 190 ENLVQLDLSDNDFKGPIP-NDLGELQSLSATLNLSYNHLSGKI-PKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 190 ~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~ 252 (707)
+++..+-+..|.|...-. ..+..++.+ .-|+|+.|+|...- -+++..+++|..|.+++|+|.
T Consensus 199 pnv~sv~v~e~PlK~~s~ek~se~~p~~-~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 199 PNVNSVFVCEGPLKTESSEKGSEPFPSL-SCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred ccchheeeecCcccchhhcccCCCCCcc-hhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 445555555554442111 122233333 24555555554211 133445555555555555554
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.1e-07 Score=111.38 Aligned_cols=129 Identities=29% Similarity=0.325 Sum_probs=87.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCC--cCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEE
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN--LFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~--l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 146 (707)
..+.++.+-+|.+... +.... .++|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~~~-~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIEHI-AGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchhhc-cCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 3566677777766532 33322 2367777777775 443333345668888888888776555788888888888888
Q ss_pred eccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCC
Q 005226 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201 (707)
Q Consensus 147 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~ 201 (707)
+|++..++ .+|..+.+|.+|.+|++..+.-...+ .++...|++|++|.+..-.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccc
Confidence 88888877 77888888888888888777765233 4555567888887775544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 707 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-41 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-40 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-25 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-17 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-16 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-17 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 8e-89
Identities = 115/336 (34%), Positives = 173/336 (51%), Gaps = 38/336 (11%)
Query: 375 DSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRA-----SAYVLGKSGLGIVYKVVLG 429
D E+ +V G+ K F+ EL A + +LG+ G G VYK L
Sbjct: 3 DVPAEEDPEVHLGQL--------KRFSLR--ELQVASDNFSNKNILGRGGFGKVYKGRLA 52
Query: 430 NGIPVAVRRLGEGGEQRH-REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488
+G VAV+RL E Q +F TEV+ I+ H N+++LR + P E+LL+ +++NG
Sbjct: 53 DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 112
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE-CSPRKFVHGDIKPSNILLDND 547
++A+ LR R L W R RIA G+ARGLAYLH+ C P K +H D+K +NILLD +
Sbjct: 113 SVASCLRERPESQPP-LDWPKRQRIALGSARGLAYLHDHCDP-KIIHRDVKAANILLDEE 170
Query: 548 FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ 607
F+ + DFGL++L++ + + G T + APE G + +
Sbjct: 171 FEAVVGDFGLAKLMD--YKDTHVTTAVRG-------------TIGHIAPEYLSTG-KSSE 214
Query: 608 KWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQE 667
K DV+ +GV+LLEL+TG+ + + L+ WVK +E+ L +VD L
Sbjct: 215 KTDVFGYGVMLLELITGQRA-FDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGN 272
Query: 668 VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
+EV + +AL CT++ P RP+M V LE
Sbjct: 273 YK-DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 1e-84
Identities = 95/323 (29%), Positives = 149/323 (46%), Gaps = 46/323 (14%)
Query: 392 ELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEG----GEQRH 447
EL + F + + +G+ G G+VYK + N VAV++L E+
Sbjct: 19 ELKNVTNNFD---ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 448 REFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSW 507
++F E++ +AK +H N+V+L + D+ L+ ++ NG+L + L +G P LSW
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP--PLSW 132
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
R +IA+G A G+ +LHE +H DIK +NILLD F ISDFGL+R +
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARA-SEKFAQ 188
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM-----QKWDVYSFGVVLLELL 622
+ +G T Y APEA + K D+YSFGVVLLE++
Sbjct: 189 TVMTSRIVG-------------TTAYMAPEA-------LRGEITPKSDIYSFGVVLLEII 228
Query: 623 TGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLAL 682
TG E L+ ++ +EE + D +D + V A++ +A
Sbjct: 229 TGLPA-----VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVAS 281
Query: 683 ACTEADPEVRPRMKNVSENLERI 705
C RP +K V + L+ +
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEM 304
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 3e-82
Identities = 99/324 (30%), Positives = 147/324 (45%), Gaps = 31/324 (9%)
Query: 386 SGKGEGELVAIDKGFTFELDELLRA-----SAYVLGKSGLGIVYKVVLGNGIPVAVRRLG 440
+ + + + L +L A +++G G VYK VL +G VA++R
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72
Query: 441 EGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQ 500
Q EF TE++ ++ +HP++V L + +E +LI ++ NGNL L G +
Sbjct: 73 PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL- 131
Query: 501 PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
P+ S+SW RL I G ARGL YLH R +H D+K NILLD +F P I+DFG+S+
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE-ARVPGNRPMQKWDVYSFGVVLL 619
S+ G T Y PE R +K DVYSFGVVL
Sbjct: 189 GTELDQTHLST-VVKG-------------TLGYIDPEYFI--KGRLTEKSDVYSFGVVLF 232
Query: 620 ELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFH 679
E+L +S + + E+ +L W + L +VD L ++ + +
Sbjct: 233 EVLCARSA-IVQSLPR--EMVNLAEWAVESHNNGQ-LEQIVDPNLADKIR-PESLRKFGD 287
Query: 680 LALACTEADPEVRPRMKNVSENLE 703
A+ C E RP M +V LE
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLE 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 6e-71
Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 62/315 (19%)
Query: 23 DGLTLLSLKSAIDQTDTSVFADWNEN-DPTPCRWSGISCMNITGFPDPRVVGVAISGKNV 81
D LL +K + + + + W D W G+ C T RV + +SG N+
Sbjct: 7 DKQALLQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQ--TYRVNNLDLSGLNL 62
Query: 82 RGY---------------------------IPSELGSLIYLRRLNLHNNNLFGSLPDQLF 114
IP + L L L + + N+ G++PD L
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 115 NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQR-LILA 173
+L ++ N LSG+LPPS+ +LP L + N SG++PD + +L + ++
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPK 233
RN+ +G+IP NL +DLS N +G G ++ ++L+ N L+ +
Sbjct: 183 RNRLTGKIPPTFA--NLNLAFVDLSRNMLEGDASVLFGSDKNTQ-KIHLAKNSLAFDLG- 238
Query: 234 SLGNLPVTVSFDLRGNNLSG------------------------EIPQTGSFANQGPTAF 269
+G DLR N + G EIPQ G+ +A+
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY 298
Query: 270 LSNPLLCGFPLQKSC 284
+N LCG PL +C
Sbjct: 299 ANNKCLCGSPL-PAC 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 5e-56
Identities = 65/255 (25%), Positives = 111/255 (43%), Gaps = 22/255 (8%)
Query: 12 YFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRV 71
+ +L + L+S K + D ++ DW+ ++ PC + G++C + +V
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLP--DKNLLPDWS-SNKNPCTFDGVTCRD------DKV 52
Query: 72 VGVAISGKN---VRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN 128
+ +S K + S L SL L L L N+++ GS+ + SL S+ L N+
Sbjct: 53 TSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNS 111
Query: 129 LSGSLPP--SVCNLPRLQNLDLSNNSFSGSLPD-GLKNCKQLQRLILARNKFSGQIPAGI 185
LSG + S+ + L+ L++S+N+ G L+ L L+ N SG G
Sbjct: 112 LSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGW 171
Query: 186 WP--ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVS 243
L L +S N G + + +L L++S N+ S IP LG+
Sbjct: 172 VLSDGCGELKHLAISGNKISGDVD--VSRCVNLE-FLDVSSNNFSTGIP-FLGDCSALQH 227
Query: 244 FDLRGNNLSGEIPQT 258
D+ GN LSG+ +
Sbjct: 228 LDISGNKLSGDFSRA 242
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 5e-55
Identities = 66/176 (37%), Positives = 92/176 (52%), Gaps = 4/176 (2%)
Query: 83 GYIPSELG--SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNL 140
G I L L+ L L NN G +P L N + L S+ L N LSG++P S+ +L
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+L++L L N G +P L K L+ LIL N +G+IP+G+ NL + LS+N
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS-NCTNLNWISLSNN 500
Query: 201 DFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
G IP +G L++L+ L LS N SG IP LG+ + DL N +G IP
Sbjct: 501 RLTGEIPKWIGRLENLA-ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-54
Identities = 62/193 (32%), Positives = 95/193 (49%), Gaps = 6/193 (3%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
G IP L + L L+L N L G++P L + + L + L+ N L G +P + +
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L+ L L N +G +P GL NC L + L+ N+ +G+IP I LENL L LS+N F
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG-RLENLAILKLSNNSF 526
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA 262
G IP +LG+ +SL L+L+ N +G IP ++ S + N ++G+
Sbjct: 527 SGNIPAELGDCRSLI-WLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKND 581
Query: 263 NQGPTAFLSNPLL 275
+ LL
Sbjct: 582 GMKKECHGAGNLL 594
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 3e-51
Identities = 57/177 (32%), Positives = 85/177 (48%), Gaps = 5/177 (2%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLP 141
G + + L+ LN+ +N G +P SL + L N +G +P +
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACD 294
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L LDLS N F G++P +C L+ L L+ N FSG++P ++ L LDLS N+
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT--VSFDLRGNNLSGEIP 256
F G +P L L + TL+LS N+ SG I +L P L+ N +G+IP
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-50
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 75 AISGKNVRGYIPSELGSLIYLRRLNLHNN--NLFGSLPDQLFNATSLHSIFLYGNNLSGS 132
I+ + G + + + + N G +QL ++ + + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL 192
P+ N + LD+S N SG +P + + L
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF------------------------ 659
Query: 193 VQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L+L ND G IP+++G+L+ L+ L+LS N L G+IP+++ L + DL NNLS
Sbjct: 660 -ILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717
Query: 253 GEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQ 295
G IP+ G F P FL+NP LCG+PL + + + Q
Sbjct: 718 GPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-48
Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 11/186 (5%)
Query: 76 ISGKNVRGYIPSEL---GSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGS 132
+S ++ G L+ L + N + G + + +L + + NN S
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215
Query: 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL 192
+P + + LQ+LD+S N SG + C +L+ L ++ N+F G IP L++L
Sbjct: 216 IP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP---LKSL 271
Query: 193 VQLDLSDNDFKGPIPNDL-GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNL 251
L L++N F G IP+ L G +L+ L+LS NH G +P G+ + S L NN
Sbjct: 272 QYLSLAENKFTGEIPDFLSGACDTLT-GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
Query: 252 SGEIPQ 257
SGE+P
Sbjct: 331 SGELPM 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-48
Identities = 51/177 (28%), Positives = 72/177 (40%), Gaps = 6/177 (3%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
G IP EL + L L L N+L G +P L N T+L+ I L N L+G +P + L
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L L LSNNSFSG++P L +C+ L L L N F+G IP + ++ N
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP----AAMFKQ-SGKIAANFI 570
Query: 203 KGPIPNDLGELQSLSA-TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
G + + G + L L ++ G T
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 76/332 (22%), Positives = 122/332 (36%), Gaps = 51/332 (15%)
Query: 399 GFTFELDELLRAS-----AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTE 453
G + L S V + G V+K L VAV+ +Q + E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYE 68
Query: 454 VQAIAKVKHPNIVKLRAY----YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWST 509
V ++ +KH NI++ + LI+ F G+L++ L+ +SW+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122
Query: 510 RLRIAKGTARGLAYLHECSPR-------KFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
IA+ ARGLAYLHE P H DIK N+LL N+ I+DFGL+
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE----ARVPGNRPMQKWDVYSFGVVL 618
G + + G +G T Y APE A + D+Y+ G+VL
Sbjct: 183 -AGKSAGDTHGQVG-------------TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVL 228
Query: 619 LELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLL-----QEVHAKKE 673
EL + + P + + + E+ + ++V
Sbjct: 229 WELASRCTAADGPVDEYMLPFEEEI-GQHPSLED---MQEVVVHKKKRPVLRDYWQKHAG 284
Query: 674 VIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ + C + D E R V E + ++
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQM 316
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-51
Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 38/297 (12%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
VLGK G KV G + ++ L E+ R F+ EV+ + ++HPN++K
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ I+++I G L ++ + Q WS R+ AK A G+AYLH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+ N L+ + ++DFGL+RL+ P V N
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV----VGN 185
Query: 593 YR--APEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEVPDLVRWVKK 648
APE + G +K DV+SFG+VL E++ + + P T V+
Sbjct: 186 PYWMAPEM-INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------VRG 238
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ P + F + + C + DPE RP + LE +
Sbjct: 239 FLDRYCP----------PNCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 72/302 (23%), Positives = 122/302 (40%), Gaps = 65/302 (21%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
V+G+ G+V K VA++++ E + F+ E++ +++V HPNIVKL
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
P L+ ++ G+L N L G P + + + ++G+AYLH P+ +
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 534 HGDIKPSNILLDNDFQPY-ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
H D+KP N+LL I DFG + I N G+ +M
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN-------NKGSAAWM---------- 170
Query: 593 YRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEV------PDLV 643
APE V +K DV+S+G++L E++T + P E+ + P L+
Sbjct: 171 --APE--VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
+ + K E L+ C DP RP M+ + + +
Sbjct: 227 KNLPKPIES-----------LMTR----------------CWSKDPSQRPSMEEIVKIMT 259
Query: 704 RI 705
+
Sbjct: 260 HL 261
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 62/303 (20%), Positives = 113/303 (37%), Gaps = 62/303 (20%)
Query: 414 VLGKSGLGIVYKVVLG--NGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
L ++ G ++K G G + V+ L + ++ R+F E + HPN++ +
Sbjct: 17 KLNENHSGELWK---GRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 470 AYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
+P I+ ++ G+L N L + S ++ A ARG+A+LH
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV---VDQSQAVKFALDMARGMAFLHTL 130
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
P + ++++D D IS + G A ++
Sbjct: 131 EP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWV----- 175
Query: 588 EKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEVPDLV 643
APEA + P + + D++SF V+L EL+T + P +LS +E+ V
Sbjct: 176 -------APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKV 223
Query: 644 RWVKKGFEEENP-LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
E P + + + + L C DP RP+ + L
Sbjct: 224 -----ALEGLRPTIPPGISPHVSK-------------LMKICMNEDPAKRPKFDMIVPIL 265
Query: 703 ERI 705
E++
Sbjct: 266 EKM 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 51/298 (17%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G G V++ +G VAV+ L E +R EF+ EV + +++HPNIV
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
P ++++++S G+L L L RL +A A+G+ YLH +P
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
VH ++K N+L+D + + DFGLSRL T + S+ G +M
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGT----PEWM--------- 206
Query: 592 NYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEVPDLVRWVKK 648
APE V + P +K DVYSFGV+L EL T + P L+P +V V
Sbjct: 207 ---APE--VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQVVAAV----- 251
Query: 649 GFEEENP-LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
GF+ + + ++ + + C +P RP + + L +
Sbjct: 252 GFKCKRLEIPRNLNPQVAA-------------IIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 75/306 (24%), Positives = 111/306 (36%), Gaps = 62/306 (20%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRH----REFVTEVQAIAKVKHPNIVKLR 469
++G G G VY+ G VAV+ ++ E + A +KHPNI+ LR
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
L+ +F G L L G+ + + A ARG+ YLH+ +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 530 RKFVHGDIKPSNILLDNDFQPY--------ISDFGLSRLINITGNNPSSSGGFMGGALPY 581
+H D+K SNIL+ + I+DFGL+R + T M A Y
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--------MSAAGAY 178
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEV 639
+ APE + + + DV+S+GV+L ELLTG+ P + + V
Sbjct: 179 ----------AWMAPEV-IRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----LAV 222
Query: 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
V P L C DP RP N+
Sbjct: 223 AYGV--AMNKLALPIP----------STCPE-----PFAKLMEDCWNPDPHSRPSFTNIL 265
Query: 700 ENLERI 705
+ L I
Sbjct: 266 DQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 71/322 (22%), Positives = 118/322 (36%), Gaps = 55/322 (17%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTE--VQAIAKVKHPNIVKL--- 468
++G+ G VYK L + PVAV+ Q F+ E + + ++H NI +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVG 75
Query: 469 --RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
R E LL+ ++ NG+L L + W + R+A RGLAYLH
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHT 129
Query: 527 CSPR------KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP--SSSGGFMG-- 576
PR H D+ N+L+ ND ISDFGLS + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636
G + YM P E N R E+ +++ D+Y+ G++ E+ + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXES------ALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKK-------------EVIAVFHLALA 683
++ F+ E + M + K+ V ++
Sbjct: 244 YQMA---------FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 684 CTEADPEVRPRMKNVSENLERI 705
C + D E R + E + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAEL 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-45
Identities = 71/308 (23%), Positives = 124/308 (40%), Gaps = 62/308 (20%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQ-------RHREFVTEVQAIAKVKHPNI 465
+GK G G+V+K + + VA++ L G + + +EF EV ++ + HPNI
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
VKL P ++ +F+ G+L + L + + WS +LR+ A G+ Y+
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEYMQ 139
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPY-----ISDFGLSRLINITGNNPSSSGGFMGGALP 580
+P VH D++ NI L + + ++DFGLS+ + S G +G
Sbjct: 140 NQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------SVHSVSGLLG---- 188
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSP--ELSPTTSTSI 637
+ APE +K D YSF ++L +LTG+ P E S
Sbjct: 189 ---------NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY-----G 234
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
++ + ++G + + L + C DP+ RP
Sbjct: 235 KIKFINMIREEG--LRPTIPEDCPPRLRN-------------VIELCWSGDPKKRPHFSY 279
Query: 698 VSENLERI 705
+ + L +
Sbjct: 280 IVKELSEL 287
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-42
Identities = 46/205 (22%), Positives = 69/205 (33%), Gaps = 5/205 (2%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-C 138
+ +G L+ L+L N + + L + +NL SV
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 139 NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198
+L L LD+S+ + L+ L +A N F I+ EL NL LDLS
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 199 DNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ P L SL LN+S+N+ L D N++ Q
Sbjct: 479 QCQLEQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
Query: 259 -GSFANQGPTAFLS-NPLLCGFPLQ 281
F + L+ N C Q
Sbjct: 538 LQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-37
Identities = 43/204 (21%), Positives = 74/204 (36%), Gaps = 7/204 (3%)
Query: 61 MNITGFPD---PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNAT 117
+N PD + +S +R S L+ L+L + + +
Sbjct: 17 LNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS 76
Query: 118 SLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKF 177
L ++ L GN + + L LQ L + + + + K L+ L +A N
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 178 SGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSA---TLNLSYNHLSGKIPKS 234
+ L NL LDLS N + DL L + +L+LS N ++ P +
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196
Query: 235 LGNLPVTVSFDLRGNNLSGEIPQT 258
+ + LR N S + +T
Sbjct: 197 FKEIRLH-KLTLRNNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-34
Identities = 39/183 (21%), Positives = 69/183 (37%), Gaps = 7/183 (3%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNL--FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV 137
+ +G L L L+L N L G F TSL + L N + + +
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 138 CNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
L +L++LD +++ + + L L ++ GI+ L +L L
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLK 451
Query: 197 LSDNDFKGPIPND-LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
++ N F+ D EL++L+ L+LS L P + +L ++ NN
Sbjct: 452 MAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLD 510
Query: 256 PQT 258
Sbjct: 511 TFP 513
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-30
Identities = 35/173 (20%), Positives = 61/173 (35%), Gaps = 3/173 (1%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLP 134
IS + R L L L + N+ + +F +L + L L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
+ +L LQ L++S+N+F K LQ L + N + +L
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 195 LDLSDNDFKGPIPN-DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL 246
L+L+ NDF + + L + + P +PV +S ++
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPV-LSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 35/194 (18%), Positives = 55/194 (28%), Gaps = 27/194 (13%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS-------------- 130
I L + +L + + + L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 131 -----GSLPPSVCNLPRLQNLDLSNN--SFSGSLPDGLKNCKQLQRLILARNKFSGQIPA 183
G S +LP L+ LDLS N SF G L+ L L+ N + +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390
Query: 184 GIWPELENLVQLDLSDNDFKGPIPND-LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTV 242
LE L LD ++ K L++L L++S+ H L
Sbjct: 391 NFL-GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI-YLDISHTHTRVAFNGIFNGLSSLE 448
Query: 243 SFDLRGNNLSGEIP 256
+ GN+
Sbjct: 449 VLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 40/185 (21%), Positives = 63/185 (34%), Gaps = 14/185 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNL-FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+G L L+ LN+ +N + LP+ N T+L + L N + + L ++
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Query: 144 QN----LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199
LDLS N + P K + L +L L N S + L L L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 200 NDFKG------PIPNDLGELQSLS-ATLNLSYNHLS-GKIPKSLGNLPVTVSFDLRGNNL 251
+F+ + L L +L+ L+Y I L SF L +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 252 SGEIP 256
Sbjct: 295 ERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 32/209 (15%), Positives = 47/209 (22%), Gaps = 33/209 (15%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGS---LPPSVCNL 140
I I L +L L NN ++ L L L
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 141 PRLQNLDLSNNSFS------GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
L NL + + + D + L +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD---FSYNFGWQH 308
Query: 195 LDLSDNDFKGPIPNDLGELQSLS------------------ATLNLSYNHLS--GKIPKS 234
L+L + F L L+ L+ L+LS N LS G +S
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 235 LGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
DL N +
Sbjct: 369 DFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 60/301 (19%), Positives = 113/301 (37%), Gaps = 49/301 (16%)
Query: 414 VLGKSGLGIVYKVVLG--NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLR 469
++GK G VY G +G VA+R + E + + F EV A + +H N+V
Sbjct: 40 LIGKGRFGQVYH---GRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+P +I+ L + +R L + +IA+ +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA--- 148
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG-GFMGGALPYMKPVQTE 588
+ +H D+K N+ DN + I+DFGL + + G L ++ P E
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP---E 204
Query: 589 --KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
+ + E ++P ++ DV++ G + EL + P
Sbjct: 205 IIRQLSPDTEEDKLPFSK---HSDVFALGTIWYELHAREWP------------------- 242
Query: 647 KKGFEEENPLS--DMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704
F+ + + + + + + + L C + E RP + + LE+
Sbjct: 243 ---FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
Query: 705 I 705
+
Sbjct: 300 L 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 69/303 (22%), Positives = 116/303 (38%), Gaps = 60/303 (19%)
Query: 415 LGKSGLGIVYKVVLG--NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G G VYK G +G VAV+ L Q+ + F EV + K +H NI+
Sbjct: 32 IGSGSFGTVYK---GKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
Y AP + +++ + +L + L + + IA+ TARG+ YLH +
Sbjct: 88 YSTAP-QLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHA---K 139
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+K +NI L D I DFGL+ + + G++ +M
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL--SGSILWM-------- 189
Query: 591 NNYRAPEA--RVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
APE N + DVY+FG+VL EL+TG+ P
Sbjct: 190 ----APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP--------------------- 224
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVI------AVFHLALACTEADPEVRPRMKNVSENL 702
+ N +++ + + + + L C + + RP + +
Sbjct: 225 -YSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283
Query: 703 ERI 705
E +
Sbjct: 284 EEL 286
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 69/319 (21%), Positives = 113/319 (35%), Gaps = 60/319 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVKLRAY- 471
+GK G V++ G VAV+ E+ RE TE+ ++H NI+ A
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASD 71
Query: 472 ---YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ + LI+ + G+L + L+ T+L + LRI A GLA+LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 529 PR-----KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
H D+K NIL+ + Q I+D GL+ + + + N G YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM- 184
Query: 584 PVQTEKTNNYRAPE-----ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
APE +V ++ D+++FG+VL E+ +
Sbjct: 185 -----------APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN---GIVEDYK 230
Query: 639 VPDLVRWVKKGFEEENP----LSDMVDAMLLQ-------EVHAKKEVIAVF-HLALACTE 686
P F + P DM + + + L C
Sbjct: 231 PP---------FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY 281
Query: 687 ADPEVRPRMKNVSENLERI 705
+P R + + L +I
Sbjct: 282 QNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 72/355 (20%), Positives = 128/355 (36%), Gaps = 57/355 (16%)
Query: 373 NEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGI 432
+ +E + SG G LV ++ + +GK G V+ G
Sbjct: 10 SLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVK-------QIGKGRYGEVWMGKW-RGE 61
Query: 433 PVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAY----YWAPDEKLLISDFISN 487
VAV+ E RE TE+ ++H NI+ A + + LI+D+ N
Sbjct: 62 KVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHEN 119
Query: 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-----KFVHGDIKPSNI 542
G+L + L+ ST+L + L++A + GL +LH H D+K NI
Sbjct: 120 GSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI 173
Query: 543 LLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG 602
L+ + I+D GL+ N G YM P +++ N ++
Sbjct: 174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS---- 229
Query: 603 NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENP----LSD 658
D+YSFG++L E+ +V + + + P D
Sbjct: 230 ---YIMADMYSFGLILWEVARRCVSG------------GIVEEYQLPYHDLVPSDPSYED 274
Query: 659 MVDAMLLQ--------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
M + + ++ + + + + L C +P R V + L ++
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 63/314 (20%), Positives = 115/314 (36%), Gaps = 50/314 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVKHPNIVKLRAYY 472
+GK G V++ G VAV+ E+ RE E+ ++H NI+ A
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 473 WAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ L+SD+ +G+L + L +++ +++A TA GLA+LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 529 PR-----KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
H D+K NIL+ + I+D GL+ + + + G YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643
P + + N + E+ ++ D+Y+ G+V E+ S ++P
Sbjct: 220 PEVLDDSINMKHFES-------FKRADIYAMGLVFWEIARRCSI---GGIHEDYQLP--- 266
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKK-----------EVIAVF-HLALACTEADPEV 691
+ + P V+ M K E + V + C A+
Sbjct: 267 ------YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 692 RPRMKNVSENLERI 705
R + + L ++
Sbjct: 321 RLTALRIKKTLSQL 334
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-37
Identities = 40/202 (19%), Positives = 72/202 (35%), Gaps = 20/202 (9%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNL--------FGSLPDQLFNATSLHSIFLYGN 127
+ +P+ L +L ++ +N+ N + I++ N
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315
Query: 128 NL-SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIW 186
NL + + S+ + +L L+ N G + +L L LA N+ + IPA
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFC 373
Query: 187 PELENLVQLDLSDNDFKG-PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTV--- 242
E + L + N K P D + +S ++ SYN + K+ L T
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMS-AIDFSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 243 ----SFDLRGNNLSGEIPQTGS 260
S +L N +S + S
Sbjct: 433 INVSSINLSNNQISKFPKELFS 454
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-37
Identities = 35/185 (18%), Positives = 67/185 (36%), Gaps = 17/185 (9%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ + L LR+ + N+ + + + + NL L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLT 252
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKF--------SGQIPAGIWPELENLVQLD 196
++++ N LP LK ++Q + +A N+ Q A P E + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA-PVGEKIQIIY 311
Query: 197 LSDNDFK-GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
+ N+ K P+ L +++ L L YN L GK+P + G+ S +L N ++
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLG-MLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369
Query: 256 PQTGS 260
Sbjct: 370 ANFCG 374
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 35/196 (17%), Positives = 65/196 (33%), Gaps = 25/196 (12%)
Query: 85 IPS--ELGSLIYLRRLNLHNNNL-------FGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
IP+ + S+ + ++ N + F L F ++ SI L N +S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 136 SVCNLPRLQNLDLSNNSFSG-------SLPDGLKNCKQLQRLILARNKFSGQIPAGIWP- 187
L +++L N + + KN L + L NK + +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRAT 510
Query: 188 ELENLVQLDLSDNDFKGPIPNDLGELQSL-----SATLNLSYNHLSGKIPKSLGNLPVTV 242
L LV +DLS N F P +L + N + P+ + P
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569
Query: 243 SFDLRGNNLSGEIPQT 258
+ N++ ++ +
Sbjct: 570 QLQIGSNDIR-KVNEK 584
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 8e-35
Identities = 41/199 (20%), Positives = 68/199 (34%), Gaps = 30/199 (15%)
Query: 85 IPSEL-GSLIYLRRLNLHNNNLFGSLPDQLF--NATSLHSIFLYGNNLSG-------SLP 134
IP+ G + L+ +N L +P+ + + + +I N + L
Sbjct: 368 IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE------ 188
P+ + +++LSNN S + L + L N + IP +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFK 485
Query: 189 -LENLVQLDLSDNDFKGPIPNDL--GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFD 245
L +DL N + +D L L ++LSYN S P N F
Sbjct: 486 NTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV-GIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 246 LR------GNNLSGEIPQT 258
+R GN E P+
Sbjct: 543 IRNQRDAQGNRTLREWPEG 561
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 39/185 (21%), Positives = 60/185 (32%), Gaps = 22/185 (11%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNL-------FGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
+ + L +NL N L + N L SI L N L+ L
Sbjct: 447 KFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSD 505
Query: 136 S--VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRL------ILARNKFSGQIPAGIWP 187
LP L +DLS NSFS P N L+ N+ + P GI
Sbjct: 506 DFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGIT- 563
Query: 188 ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247
+L QL + ND + + + ++S L++ N + + L
Sbjct: 564 LCPSLTQLQIGSNDIRK-VNEKI--TPNIS-VLDIKDNPNISIDLSYVCPYIEAGMYMLF 619
Query: 248 GNNLS 252
+
Sbjct: 620 YDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 35/294 (11%), Positives = 78/294 (26%), Gaps = 54/294 (18%)
Query: 19 ALSPDGLTLLSLKSAIDQTD-------TSVFADWNENDPTPCRWS---GISCMNITGFPD 68
D L L + A++ + T A+WN N W G+S +
Sbjct: 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKE-LDMWGAQPGVSLNSNG---- 81
Query: 69 PRVVGVAISGKNVRGYIPSELG----------------------------SLIYLRRLNL 100
RV G+++ G G +P +G + + +
Sbjct: 82 -RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQK 140
Query: 101 HNNNLFGSLPDQLFNA--TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLP 158
+ + D + L + + S+ S + + +N+ + +
Sbjct: 141 MRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVS 199
Query: 159 DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSA 218
+ +L++ + + F + E + L+ L+
Sbjct: 200 KAVMRLTKLRQFYMGNSPFVAENI------CEAWENENSEYAQQYKTEDLKWDNLKDLT- 252
Query: 219 TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272
+ + K+P L LP ++ N +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-30
Identities = 27/256 (10%), Positives = 63/256 (24%), Gaps = 34/256 (13%)
Query: 27 LLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIP 86
LS + + ++ W+ + G + + + + + V
Sbjct: 21 KLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGV----- 75
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG----SLPPSVCNLPR 142
L S + L+L G +PD + T L + L + P +
Sbjct: 76 -SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMS 134
Query: 143 LQNLDLSNNSFSGSLPDGLK--NCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+ + + D + L + + + I L Q+ N
Sbjct: 135 DEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL-KDTQIGQLSN 193
Query: 201 DFKGPIPNDLGELQSLSATLNLSYNHLSGK-------------------IPKSLGNLPVT 241
+ + + L L + + + NL
Sbjct: 194 NITF-VSKAVMRLTKLR-QFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDL 251
Query: 242 VSFDLRGNNLSGEIPQ 257
++ ++P
Sbjct: 252 TDVEVYNCPNLTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-28
Identities = 34/175 (19%), Positives = 50/175 (28%), Gaps = 26/175 (14%)
Query: 62 NITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF--NATSL 119
+T P KN + L ++L N L L D L
Sbjct: 468 MLTEIP-----------KNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYL 515
Query: 120 HSIFLYGNNLSGSLPPSVCNLPRLQ------NLDLSNNSFSGSLPDGLKNCKQLQRLILA 173
I L N+ S P N L+ D N P+G+ C L +L +
Sbjct: 516 VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIG 574
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228
N + I N+ LD+ DN + + L Y+
Sbjct: 575 SNDIRK-VNEKI---TPNISVLDIKDNPNISIDLSYVCPYIEAG-MYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 18/101 (17%), Positives = 29/101 (28%), Gaps = 8/101 (7%)
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG----KIPKSLGNLPVTVSFDL 246
+ L L G +P+ +G+L L L L + PK +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELE-VLALGSHGEKVNERLFGPKGISANMSDEQKQK 140
Query: 247 RGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDS 287
+ + + L + P QKS K S
Sbjct: 141 MRMHYQKTFVDYDPRED---FSDLIKDCINSDPQQKSIKKS 178
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 11/93 (11%), Positives = 28/93 (30%), Gaps = 8/93 (8%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
G P + L +L + +N++ + +++ ++ + + N
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDLS 605
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQ 168
VC L + ++ C L
Sbjct: 606 YVCPYIEAGMYMLFYDK-----TQDIRGCDALD 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-34
Identities = 45/202 (22%), Positives = 69/202 (34%), Gaps = 12/202 (5%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG--SLPPSVCNLPRL 143
E L + + L N + SL + L L S P L L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS----GQIPAGIWPELENLVQL---D 196
LDLSNN+ + D L+ ++L+ L L N + P G L+ L L +
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
L N F +L L ++L N+L+ N S +L+ N ++
Sbjct: 543 LESNGFDEIPVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 257 QT-GSFANQGPTAFLS-NPLLC 276
+ G + NP C
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 44/222 (19%), Positives = 70/222 (31%), Gaps = 9/222 (4%)
Query: 53 CRWSG----ISCMNITGFPD---PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNL 105
C S S + +T PD + + ++ +R + L L++ N +
Sbjct: 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 106 FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCK 165
P+ L + L N LS + L L L +NS + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 166 QLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLS-ATLNLSY 224
L L L+ N S LENL +L LS+N + +L + S L LS
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQ-LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 225 NHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGP 266
N + P + L L + +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANT 222
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-33
Identities = 42/183 (22%), Positives = 63/183 (34%), Gaps = 7/183 (3%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
P L L+ LNL +N L T+L + L N++ L
Sbjct: 65 EPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLI 124
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWP-ELENLVQLDLSDNDFK 203
LDLS+N S + + LQ L+L+ NK + +L +L+LS N K
Sbjct: 125 TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSF---DLRGNNLSGEIPQTGS 260
P + L L L+ L + + L S L + LS +
Sbjct: 185 EFSPGCFHAIGRLF-GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN--TT 241
Query: 261 FAN 263
F
Sbjct: 242 FLG 244
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 40/189 (21%), Positives = 64/189 (33%), Gaps = 7/189 (3%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
IS ++ L L LN+ +N++ G + +L + L + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 136 SV----CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191
+ L L+L+ N S D L+ L L N+ ++ W LEN
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG--KIPKSLGNLPVTVSFDLRGN 249
+ ++ LS N + N + SL L L L P L DL N
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQ-RLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 250 NLSGEIPQT 258
N++
Sbjct: 491 NIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 55/223 (24%), Positives = 72/223 (32%), Gaps = 35/223 (15%)
Query: 83 GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
PS L L L+L NNN+ D L L + L NNL+
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA------------ 517
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L ++ G LK L L L N F IP ++ +L L +DL N+
Sbjct: 518 ----RLWKHANPGGPIYFLKGLSHLHILNLESNGFDE-IPVEVFKDLFELKIIDLGLNNL 572
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT-VSFDLRGNNLSGEIPQTGSF 261
+ SL +LNL N ++ K G D+R N F
Sbjct: 573 NTLPASVFNNQVSLK-SLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631
Query: 262 AN-----QGPTAFLSNPLLCGFPLQ-----------KSCKDST 288
N LS+ LC P SCKDS
Sbjct: 632 VNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSA 674
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 42/205 (20%), Positives = 78/205 (38%), Gaps = 20/205 (9%)
Query: 76 ISGKNVRGYIPSELG---SLIYLRRLNLHNNNLFGSLPDQLFN--ATSLHSIFLYGNNLS 130
++ + + +L + +R L+L N+ L + T+L + L NNL+
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG--------QIP 182
S LP+L+ L N+ L ++ L L R+ +I
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 183 AGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGK--IPKSLGNLPV 240
+ L+ L L++ DND G N L +L L+LS + S + ++ +L
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK-YLSLSNSFTSLRTLTNETFVSLAH 380
Query: 241 T--VSFDLRGNNLSGEIPQTGSFAN 263
+ +L N +S +F+
Sbjct: 381 SPLHILNLTKNKISKIES--DAFSW 403
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 40/184 (21%), Positives = 61/184 (33%), Gaps = 14/184 (7%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNL--------FGSLPDQLFNATSLHSIFLYGN 127
+S N+ L L L L+L +NNL G L + LH + L N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 128 NLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWP 187
+L L+ +DL N+ + N L+ L L +N + P
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 188 ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI----PKSLGNLPVTVS 243
NL +LD+ N F + + + + + LS P PV
Sbjct: 607 AFRNLTELDMRFNPFDCTCES-IAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPV-RL 664
Query: 244 FDLR 247
FD
Sbjct: 665 FDTS 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 37/213 (17%), Positives = 63/213 (29%), Gaps = 34/213 (15%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNL-------------------FGSLPDQLFNATSLH 120
N +I + L L+ + N+ + + N L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLT 494
Query: 121 SIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG---------SLPDGLKNCKQLQRLI 171
+ LY LP + +LP LQ+L+++ N L D ++Q
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 172 LARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231
+ N + ++ L LD N + G L+ L L YN + I
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLT-DLKLDYNQIEE-I 610
Query: 232 PKSLG-NLPVTVSFDLRGNNLSGEIPQTGSFAN 263
P+ N L IP + +
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 6e-33
Identities = 41/217 (18%), Positives = 63/217 (29%), Gaps = 20/217 (9%)
Query: 62 NITGFPDP-RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLH 120
T +L L + L+N LPD L++ L
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518
Query: 121 SIFLYGNNLSG---------SLPPSVCNLPRLQNLDLSNNSFSGSLPD--GLKNCKQLQR 169
S+ + N L P++Q + N+ P L+ +L
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577
Query: 170 LILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229
L NK + A + L L L N + IP D L S+N L
Sbjct: 578 LDCVHNKVR-HLEA--FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY 633
Query: 230 KIPK--SLGNLPVTVSFDLRGNNLSGEIPQTGSFANQ 264
IP + ++ V S D N + E +
Sbjct: 634 -IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-31
Identities = 30/193 (15%), Positives = 59/193 (30%), Gaps = 25/193 (12%)
Query: 85 IPS--ELGSLIYLRRLNLHNNNLFGSLPDQLF------NATSLHSIFLYGNNLSGSLPPS 136
IP+ S+ + ++ N + GS + + ++ L N +
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 137 VCNLPRLQNLDLSNNSFS-------GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE- 188
+ + LSNN + KN L + L NK + +
Sbjct: 693 FATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATT 751
Query: 189 LENLVQLDLSDNDFKGPIPNDLGELQSL-----SATLNLSYNHLSGKIPKSLGNLPVTVS 243
L L +D+S N F P L + N + + P + P +
Sbjct: 752 LPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQ 810
Query: 244 FDLRGNNLSGEIP 256
+ N++ ++
Sbjct: 811 LQIGSNDIR-KVD 822
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-31
Identities = 37/198 (18%), Positives = 64/198 (32%), Gaps = 22/198 (11%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNL---------FGSLPDQLFNATSLHSIFLYG 126
+ +P L L L+ LN+ N + L D + ++
Sbjct: 498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY 557
Query: 127 NNLSGSLPPSV--CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAG 184
NNL P S + +L LD +N L +L L L N+ +IP
Sbjct: 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPED 613
Query: 185 IWPELENLVQLDLSDNDFKG-PIPNDLGELQSLSATLNLSYNHLSG---KIPKSLGNLPV 240
+ + L S N K P + + + +++ SYN + I S+ +
Sbjct: 614 FCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG-SVDFSYNKIGSEGRNISCSMDDYKG 672
Query: 241 T--VSFDLRGNNLSGEIP 256
+ L N +
Sbjct: 673 INASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-28
Identities = 36/225 (16%), Positives = 64/225 (28%), Gaps = 25/225 (11%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS----- 130
I + + I + L N + + + + +I L N ++
Sbjct: 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPEN 715
Query: 131 --GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLK--NCKQLQRLILARNKFSGQIPAGIW 186
+ N L +DL N + SL D + L + ++ N FS P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPL 773
Query: 187 PELENLVQLDL------SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPV 240
L + N P + SL L + N + K+ + L P
Sbjct: 774 -NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI-QLQIGSNDIR-KVDEKL--TPQ 828
Query: 241 TVSFDLRGNNL-SGEIPQTGSFANQGPTAFL--SNPLLCGFPLQK 282
D+ N S ++ + G L + G
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALG 873
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 36/195 (18%), Positives = 62/195 (31%), Gaps = 28/195 (14%)
Query: 85 IPSELGS-LIYLRRLNLHNNNLFGSLPDQLF--NATSLHSIFLYGNNLSG-----SLPPS 136
IP + + + L +N L +P+ + + S+ N + S
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE-------L 189
+ LS N + + +IL+ N + IP
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727
Query: 190 ENLVQLDLSDNDFKGPIPNDL--GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247
L +DL N + +D L LS +++SYN S P N +F +R
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLS-NMDVSYNCFSS-FPTQPLNSSQLKAFGIR 784
Query: 248 ------GNNLSGEIP 256
GN + + P
Sbjct: 785 HQRDAEGNRILRQWP 799
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 31/262 (11%), Positives = 69/262 (26%), Gaps = 45/262 (17%)
Query: 22 PDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNV 81
D L ++ A+D + ++ N W+ +++ G
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWG---------------- 312
Query: 82 RGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLP 141
+L + + L+L G +PD + T L + ++ + S
Sbjct: 313 -DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEEL 371
Query: 142 RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFS-----GQIPAGIWPELENLVQL 195
+ + L ++L L ++ + I L++ Q+
Sbjct: 372 TPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT-QI 430
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG-------------------KIPKSLG 236
N I + L L + + + + S
Sbjct: 431 GNLTNRITF-ISKAIQRLTKLQ-IIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
Query: 237 NLPVTVSFDLRGNNLSGEIPQT 258
NL +L ++P
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 20/169 (11%), Positives = 46/169 (27%), Gaps = 9/169 (5%)
Query: 98 LNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSL 157
N + L N + + L G G +P ++ L L+ L +S + S
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 158 PDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLS 217
+++ + L DL + ++ ++ S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR--NPEMKPIKKDS 421
Query: 218 AT------LNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS 260
+ N ++ I K++ L + + +
Sbjct: 422 RISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-33
Identities = 38/188 (20%), Positives = 58/188 (30%), Gaps = 4/188 (2%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLS 149
LR L+L N + L + + L S +L +L LD+S
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209
+ L L +A N F + ++ NL LDLS +
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 210 LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAF 269
L L LN+S+N+L L + D N + F
Sbjct: 493 FDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 270 LS-NPLLC 276
L+ N + C
Sbjct: 552 LTNNSVAC 559
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-30
Identities = 40/177 (22%), Positives = 62/177 (35%), Gaps = 4/177 (2%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ L+ L+L + L ++ L GN + P S L L+
Sbjct: 48 KSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE 107
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
NL + + L++L +A N + L NLV +DLS N +
Sbjct: 108 NLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
Query: 205 PIPNDLGELQSLSA---TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
NDL L+ +L++S N + I LRGN S I +T
Sbjct: 168 ITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-27
Identities = 36/184 (19%), Positives = 67/184 (36%), Gaps = 11/184 (5%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P ++ S + ++L N L N + L + L + + L L
Sbjct: 26 VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
NL L+ N P L+ L+ K + + + +L L +L+++ N
Sbjct: 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHS 142
Query: 205 -PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL----PVTVSFDLRGNNLSGEIPQTG 259
+P L +L ++LSYN++ L L V +S D+ N +
Sbjct: 143 CKLPAYFSNLTNLV-HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQD--Q 199
Query: 260 SFAN 263
+F
Sbjct: 200 AFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 3/144 (2%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQ 144
S SL L L++ N TSL+++ + GN+ + +V N L
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
LDLS +LQ L ++ N + + + +L +L LD S N +
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIET 535
Query: 205 PIPNDLGELQSLSATLNLSYNHLS 228
+SL+ NL+ N ++
Sbjct: 536 SKGILQHFPKSLA-FFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 38/248 (15%), Positives = 66/248 (26%), Gaps = 48/248 (19%)
Query: 56 SGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFN 115
+ G D + ++ N + L + ++L ++ + +
Sbjct: 248 EIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPK 305
Query: 116 ATSLHSIFLYGNNLS-------------------GSLPPSVCNLPRLQNLDLSNNSFSG- 155
S+ + L GS+ LP L LDLS N+ S
Sbjct: 306 HFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFS 365
Query: 156 ------------------------SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191
+ ++LQ L + + LE
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKS-LGNLPVTVSFDLRGNN 250
L+ LD+S + K L SL+ TL ++ N + N DL
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQ 484
Query: 251 LSGEIPQT 258
L
Sbjct: 485 LEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 41/207 (19%), Positives = 68/207 (32%), Gaps = 15/207 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFG-SLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+G LI L++LN+ +N + LP N T+L + L N + + L
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 144 QN----LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199
LD+S N + D +L L L N S I L L L
Sbjct: 180 PQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238
Query: 200 NDFKG------PIPNDLGELQSLSA-TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+FK P+ + L ++ L+Y + L + L G ++
Sbjct: 239 GEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298
Query: 253 GEIPQTGSFANQGPTAFLSNPLLCGFP 279
+ + + + L FP
Sbjct: 299 Y--LEDVPKHFKWQSLSIIRCQLKQFP 323
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 35/187 (18%), Positives = 63/187 (33%), Gaps = 13/187 (6%)
Query: 80 NVRGYIPSELGSLIYLRRLNLH--NNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV 137
N+ + PS + L + N F + ++ ++ L G ++ V
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDV 303
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
+ Q+L + L L+ L L NK S L +L LDL
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGSISFKKV---ALPSLSYLDL 357
Query: 198 SDNDFKGPIPNDLGELQSLS-ATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
S N +L + S L+LS+N + + L D + + L +
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VT 415
Query: 257 QTGSFAN 263
+ +F +
Sbjct: 416 EFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 34/153 (22%), Positives = 50/153 (32%), Gaps = 23/153 (15%)
Query: 131 GSLPPSVCNLPR--------------------LQNLDLSNNSFSGSLPDGLKNCKQLQRL 170
GSL P + +P +N+DLS N N +LQ L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61
Query: 171 ILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGK 230
L+R + I W L +L L L+ N + P L SL L L+
Sbjct: 62 DLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLE-NLVAVETKLASL 119
Query: 231 IPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+G L ++ N + F+N
Sbjct: 120 ESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-14
Identities = 23/105 (21%), Positives = 32/105 (30%), Gaps = 3/105 (2%)
Query: 76 ISGKNVRGYIPSE-LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP 134
++G + + S + L L+L L L + + NNL L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL-FLD 513
Query: 135 PSV-CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
S L L LD S N S K L L N +
Sbjct: 514 SSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 40/182 (21%), Positives = 68/182 (37%), Gaps = 16/182 (8%)
Query: 85 IPSELGSLIY--LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
L L L + L PDQ F + L + + L LP ++
Sbjct: 71 TADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI--------WPELENLVQ 194
L+ L L+ N +LP + + +L+ L + ++P + L NL
Sbjct: 129 LETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
L L + +P + LQ+L +L + + LS + ++ +LP DLRG
Sbjct: 188 LRLEWTGIRS-LPASIANLQNLK-SLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRN 244
Query: 255 IP 256
P
Sbjct: 245 YP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 40/181 (22%), Positives = 66/181 (36%), Gaps = 15/181 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
P + L +L+ + + L LPD + L ++ L N L +LP S+ +L RL+
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153
Query: 145 NLDLSNNSFSGSLPDGLKNC---------KQLQRLILARNKFSGQIPAGIWPELENLVQL 195
L + LP+ L + LQ L L +PA I L+NL L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSL 211
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
+ ++ + + L L L+L P G L+ + +
Sbjct: 212 KIRNSPLSA-LGPAIHHLPKLE-ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTL 269
Query: 256 P 256
P
Sbjct: 270 P 270
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 42/182 (23%), Positives = 64/182 (35%), Gaps = 16/182 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN----- 139
+P + L L L N L +LP + + L + + LP + +
Sbjct: 119 LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 140 ----LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQL 195
L LQ+L L SLP + N + L+ L + + S + I L L +L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH-HLPKLEEL 234
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLS-YNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
DL P G L L L ++L +P + L DLRG
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLK-RLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 255 IP 256
+P
Sbjct: 293 LP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 45/198 (22%), Positives = 77/198 (38%), Gaps = 20/198 (10%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA---------TSLHSIFLYGNNLSGSLPP 135
+P+ + SL LR L++ LP+ L + +L S+ L + SLP
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQL 195
S+ NL L++L + N+ S +L + + +L+ L L P L +L
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFG-GRAPLKRL 258
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
L D +P D+ L L L+L ++P + LP + +L ++
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQL 316
Query: 256 PQTGSFANQGPTAFLSNP 273
Q P A + P
Sbjct: 317 DQ------HRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 31/181 (17%), Positives = 56/181 (30%), Gaps = 13/181 (7%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154
L + D L ++ + + N Q + +
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK 69
Query: 155 GSLPDGLKNCKQ--LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212
+ D L++ Q L L Q P + L +L + + +P+ + +
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLP-QFPDQAF-RLSHLQHMTIDAAGLME-LPDTMQQ 125
Query: 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLS 271
L TL L+ N L +P S+ +L +R E+P+ S G L
Sbjct: 126 FAGLE-TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLV 183
Query: 272 N 272
N
Sbjct: 184 N 184
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 1/86 (1%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
+ G P G L+RL L + + +LP + T L + L G LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGL 161
+ LP + + + L
Sbjct: 296 LIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-32
Identities = 48/196 (24%), Positives = 74/196 (37%), Gaps = 6/196 (3%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
+L +L +L+ LNL N + L + L L S NL L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG--QIPAGIWPELENLVQLDLSDND 201
+ L+LS++ S LQ L L N F L L L LS D
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
+ L+ ++ ++LS+N L+ ++L +L +L N++S +P
Sbjct: 488 LSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPI 545
Query: 262 ANQGPTAFLS-NPLLC 276
+Q T L NPL C
Sbjct: 546 LSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 45/182 (24%), Positives = 68/182 (37%), Gaps = 7/182 (3%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLP 134
+S L L+L L F N L + L + L S
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 135 PSVCNLPRLQNLDLSNNSFSG---SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191
LP LQ+L+L N F + L+ +L+ L+L+ S I + L+
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKM 501
Query: 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNL 251
+ +DLS N L L+ + LNL+ NH+S +P L L + +LR N L
Sbjct: 502 MNHVDLSHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLPILSQQRTINLRQNPL 559
Query: 252 SG 253
Sbjct: 560 DC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-30
Identities = 44/189 (23%), Positives = 72/189 (38%), Gaps = 7/189 (3%)
Query: 76 ISGKNVRGYIPSE-LGSLIYLRRLNLHNNNL--FGSLPDQLFNATSLHSIFLYGNNLSGS 132
I G R + + L +L LR L+L ++++ QL N + L S+ L N
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELEN 191
+ P+L+ LDL+ +N L+ L L+ + ++ L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPA 450
Query: 192 LVQLDLSDNDFKGPIPNDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
L L+L N F LQ+L L LS+ LS + +L + DL N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 250 NLSGEIPQT 258
L+ +
Sbjct: 511 RLTSSSIEA 519
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 50/185 (27%), Positives = 71/185 (38%), Gaps = 7/185 (3%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
+PS L L L++L L N N SL + + GN L NL
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 143 LQNLDLSNN--SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
L+ LDLS++ S L+N LQ L L+ N+ + + E L LDL+
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFT 410
Query: 201 DFKG-PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-T 258
K + L L LNLS++ L + LP +L+GN+ Q T
Sbjct: 411 RLKVKDAQSPFQNLHLLK-VLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469
Query: 259 GSFAN 263
S
Sbjct: 470 NSLQT 474
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 46/175 (26%), Positives = 69/175 (39%), Gaps = 5/175 (2%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSN 150
+ + +NL + F + + L + L +LS LP + L L+ L LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 151 NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210
N F N L L + N ++ G LENL +LDLS +D +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET-SDCCN 369
Query: 211 GELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+L++LS +LNLSYN ++ P DL L + Q F N
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ-SPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 42/190 (22%), Positives = 64/190 (33%), Gaps = 9/190 (4%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNL--SGSLPPS 136
+ L L++ N L N +L + L +++ S
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+ NL LQ+L+LS N + K C QL+ L LA + + + L L L+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI---PKSLGNLPVTVSFDLRGNNLSG 253
LS + L +L LNL NH SL L L +LS
Sbjct: 432 LSHSLLDISSEQLFDGLPALQ-HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 254 EIPQTGSFAN 263
+F +
Sbjct: 491 IDQ--HAFTS 498
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 41/191 (21%), Positives = 67/191 (35%), Gaps = 7/191 (3%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
+ + L+ L+L +L LP L ++L + L N
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSG-QIPAGIWPELENLV 193
S N P L +L + N+ L G L+N + L+ L L+ + L +L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 194 QLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKS-LGNLPVTVSFDLRGNNLS 252
L+LS N+ E L L+L++ L K +S NL + +L + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLE-LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 253 GEIPQTGSFAN 263
F
Sbjct: 439 ISSE--QLFDG 447
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-29
Identities = 40/180 (22%), Positives = 63/180 (35%), Gaps = 3/180 (1%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ LI L L+L ++ D + L ++ L N L ++ L+
Sbjct: 49 QNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALK 108
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+L S L N K L+ L L N S I E L LD +N
Sbjct: 109 HLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 205 PIPNDLGELQSLSA-TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
D+ LQ + +LNL+ N ++G I + V S + G I + +
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 34/181 (18%), Positives = 55/181 (30%), Gaps = 6/181 (3%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
IP L + L N L +L + L + + + RL
Sbjct: 27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L L+ N L K L+ L + S I + L L L N
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISS 143
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLP--VTVSFDLRGNNLSGEIPQTGSFA 262
+ L L+ N + + + +L +S +L GN+++G P A
Sbjct: 144 IKLPKGFPTEKLK-VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSA 202
Query: 263 N 263
Sbjct: 203 V 203
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 36/184 (19%), Positives = 61/184 (33%), Gaps = 8/184 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNAT--SLHSIFLYGNNLSGSLPPSVCNLPR 142
I + LN + L N+T SL + P L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 143 --LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+++++L + F + LQ L L S ++P+G+ L L +L LS N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG-LSTLKKLVLSAN 311
Query: 201 DFKGPIPNDLGELQSLSATLNLSYNHLSGKI-PKSLGNLPVTVSFDLRGNNLSGEIPQTG 259
F+ SL+ L++ N ++ L NL DL +++
Sbjct: 312 KFENLCQISASNFPSLT-HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370
Query: 260 SFAN 263
N
Sbjct: 371 QLRN 374
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 33/178 (18%), Positives = 52/178 (29%), Gaps = 7/178 (3%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L L L N L L +L +F +S + N L+
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL--VQLDLSDNDF 202
+L L +N S ++L+ L N + L+ + L+L+ ND
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDI 191
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT--VSFDLRGNNLSGEIPQT 258
G I + +LN I K L N + + P
Sbjct: 192 AG-IEPGAFDSAVFQ-SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAV 247
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 34/180 (18%), Positives = 59/180 (32%), Gaps = 17/180 (9%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNL---FGSLPDQLFNATSLHSIFLYGNNLSGS 132
+S + L L+ LNL N+ + L L + L +LS
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL 192
+ +L + ++DLS+N + S + L + K + L LA N S I + P L
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISI-ILPSLLPILSQQ 549
Query: 193 VQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG------KIPKSLGNLPVTVSFDL 246
++L N + L + P L + ++ L
Sbjct: 550 RTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLS-DVTL 603
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 56/310 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LGK G V G VAV++L G + R+F E+Q + + IVK
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 469 RAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
R + P + L+ +++ +G L + L+ + L S L + +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLGS 145
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMKP 584
R+ VH D+ NIL++++ I+DFGL++L+ + + G P +
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE---PGQSPIFWY-- 197
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--------ELSPTTST 635
APE+ + N ++ DV+SFGVVL EL T +
Sbjct: 198 ----------APES-LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695
+ L+ +++G P EVH L C P+ RP
Sbjct: 247 VPALSRLLELLEEGQRLPAP------PACPAEVH---------ELMKLCWAPSPQDRPSF 291
Query: 696 KNVSENLERI 705
+ L+ +
Sbjct: 292 SALGPQLDML 301
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-31
Identities = 66/311 (21%), Positives = 123/311 (39%), Gaps = 57/311 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LGK G V G VAV++L E+ R+F E++ + ++H NIVK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 469 RAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ ++ + LI +++ G+L + L+ + + L+ +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLGT 132
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMKP 584
++++H D+ NIL++N+ + I DFGL++++ G P +
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPIFWY-- 184
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS-------- 636
APE+ + ++ DV+SFGVVL EL T SP
Sbjct: 185 ----------APES-LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 233
Query: 637 --IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+ V L+ +K P E ++ + C + RP
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP------------DGCPDE---IYMIMTECWNNNVNQRPS 278
Query: 695 MKNVSENLERI 705
++++ +++I
Sbjct: 279 FRDLALRVDQI 289
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 66/311 (21%), Positives = 123/311 (39%), Gaps = 57/311 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LGK G V G VAV++L E+ R+F E++ + ++H NIVK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 469 RAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ ++ + LI +++ G+L + L+ + + L+ +G+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLGT 163
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMKP 584
++++H D+ NIL++N+ + I DFGL++++ G P +
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESPIFWY-- 215
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS-------- 636
APE+ + ++ DV+SFGVVL EL T SP
Sbjct: 216 ----------APES-LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 264
Query: 637 --IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+ V L+ +K P E ++ + C + RP
Sbjct: 265 GQMIVFHLIELLKNNGRLPRP------------DGCPDE---IYMIMTECWNNNVNQRPS 309
Query: 695 MKNVSENLERI 705
++++ +++I
Sbjct: 310 FRDLALRVDQI 320
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 70/306 (22%), Positives = 111/306 (36%), Gaps = 51/306 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG+ G V V L +G A++R+ +Q E E HPNI++L AY
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 473 WAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
L+ F G L N + L+ L + G RGL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLK-DKGNFLTEDQILWLLLGICRGLEAIHA-- 152
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+ + H D+KP+NILL ++ QP + D G I AL
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ-------ALTLQDWAAQR 204
Query: 589 KTNNYRAPE-ARVPGNRPM-QKWDVYSFGVVLLELLTGKSP-ELSPTTSTSIEVPDLVRW 645
T +YRAPE V + + ++ DV+S G VL ++ G+ P + + +
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALA 259
Query: 646 VKKGFEEENP------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699
V+ L ++++M+ DP RP + +
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMM---------------------TVDPHQRPHIPLLL 298
Query: 700 ENLERI 705
LE +
Sbjct: 299 SQLEAL 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 76/327 (23%), Positives = 125/327 (38%), Gaps = 60/327 (18%)
Query: 392 ELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRH 447
ELV + L+ V+G+ G VY L G I AV+ L +
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 448 R-EFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL-ISDFISNGNLANALRGRNGQPSTSL 505
+F+TE + HPN++ L + L + ++ +G+L N +R P+
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK- 128
Query: 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565
+ A+G+ YL +KFVH D+ N +LD F ++DFGL+R +
Sbjct: 129 ---DLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--D 180
Query: 566 NNPSSSGGFMGGALP--YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
S G LP +M A E+ + + K DV+SFGV+L EL+T
Sbjct: 181 KEYYSVHNKTGAKLPVKWM------------ALES-LQTQKFTTKSDVWSFGVLLWELMT 227
Query: 624 -GKSP--ELSPTTSTSIEVPDLVRWVKKGFEEENPL--SDMVDAMLLQEVHAKKEVIAVF 678
G P +++ D+ ++ +G P D ++
Sbjct: 228 RGAPPYPDVNTF--------DITVYLLQGRRLLQPEYCPD-----------------PLY 262
Query: 679 HLALACTEADPEVRPRMKNVSENLERI 705
+ L C E+RP + + I
Sbjct: 263 EVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 50/297 (16%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G V+ L + VAV+ E +F+ E + + + HPNIV+L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
++ + + G+ LR + L T L++ A G+ YL +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEK 589
+H D+ N L+ ISDFG+SR ++SGG +P
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGG--LRQVPVKWT------- 282
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648
APEA + R + DV+SFG++L E + G SP ++ +V+K
Sbjct: 283 -----APEA-LNYGRYSSESDVWSFGILLWETFSLGASP------YPNLSNQQTREFVEK 330
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
G P D AVF L C +P RP + + L+ I
Sbjct: 331 GGRLPCP-ELCPD--------------AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 72/311 (23%), Positives = 115/311 (36%), Gaps = 57/311 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
LG+ G V G VAV+ L G + E++ + + H NIVK
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 468 LRA--YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ + LI +F+ +G+L L + ++ +L+ A +G+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYLG 143
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMK 583
R++VH D+ N+L++++ Q I DFGL++ I + P +
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPVFWY- 196
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVP-- 640
APE + ++ DV+SFGV L ELLT S + P
Sbjct: 197 -----------APEC-LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 641 ------DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
LV +K+G P EV+ L C E P R
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCP------PNCPDEVY---------QLMRKCWEFQPSNRTS 289
Query: 695 MKNVSENLERI 705
+N+ E E +
Sbjct: 290 FQNLIEGFEAL 300
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 50/295 (16%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG+ G V+ VA++ L G F+ E Q + K++H +V+L Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YA 246
Query: 474 APDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
E+ ++++++S G+L + L+G G+ L + +A A G+AY+
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER---MN 300
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+VH D++ +NIL+ + ++DFGL+RLI F P++
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---------PIK----- 346
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ APEA R K DV+SFG++L EL T G+ P + +++ V++G+
Sbjct: 347 -WTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP------YPGMVNREVLDQVERGY 398
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P E ++ L C +PE RP + + LE
Sbjct: 399 RMPCP-------PECPE--------SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-29
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 46/294 (15%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G VY+ V + VAV+ L E + EF+ E + ++KHPN+V+L
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+I++F++ GNL + LR N Q +S L +A + + YL + + F
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H ++ N L+ + ++DFGLSRL+ + G P
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-----GAKFPIKWT-------- 386
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFE 651
APE+ + N+ K DV++FGV+L E+ T G SP I++ + ++K +
Sbjct: 387 --APES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKDYR 437
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
E P + V+ L AC + +P RP + + E +
Sbjct: 438 MERP-EGCPE--------------KVYELMRACWQWNPSDRPSFAEIHQAFETM 476
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 78/308 (25%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVK 467
+LGK G V + L G+ + VAV+ L EF+ E + + HP++ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 468 L------RAYYWAPDEKLLISDFISNGNLANALRG-RNGQPSTSLSWSTRLRIAKGTARG 520
L ++I F+ +G+L L R G+ +L T +R A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+ YL S R F+H D+ N +L D ++DFGLSR I + G LP
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY--SGDYYRQGC--ASKLP 202
Query: 581 --YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637
++ A E+ + N DV++FGV + E++T G++P I
Sbjct: 203 VKWL------------ALES-LADNLYTVHSDVWAFGVTMWEIMTRGQTP------YAGI 243
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
E ++ ++ G + P +E V+ L C ADP+ RP
Sbjct: 244 ENAEIYNYLIGGNRLKQP------------PECMEE---VYDLMYQCWSADPKQRPSFTC 288
Query: 698 VSENLERI 705
+ LE I
Sbjct: 289 LRMELENI 296
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 74/327 (22%), Positives = 125/327 (38%), Gaps = 60/327 (18%)
Query: 392 ELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL----GNGIPVAVRRLGEG-GEQR 446
ELV + L+ V+G+ G VY L G I AV+ L
Sbjct: 74 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 133
Query: 447 HREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLL-ISDFISNGNLANALRGRNGQPSTSL 505
+F+TE + HPN++ L + L + ++ +G+L N +R P+
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK- 192
Query: 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565
+ A+G+ +L +KFVH D+ N +LD F ++DFGL+R +
Sbjct: 193 ---DLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 566 NNPSSSGGFMGGALP--YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
+ + G LP +M A E+ + + K DV+SFGV+L EL+T
Sbjct: 247 FDSVHNKT--GAKLPVKWM------------ALES-LQTQKFTTKSDVWSFGVLLWELMT 291
Query: 624 -GKSP--ELSPTTSTSIEVPDLVRWVKKGFEEENPL--SDMVDAMLLQEVHAKKEVIAVF 678
G P +++ D+ ++ +G P D ++
Sbjct: 292 RGAPPYPDVNTF--------DITVYLLQGRRLLQPEYCPD-----------------PLY 326
Query: 679 HLALACTEADPEVRPRMKNVSENLERI 705
+ L C E+RP + + I
Sbjct: 327 EVMLKCWHPKAEMRPSFSELVSRISAI 353
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 59/311 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
LG+ G V G G VAV+ L G Q + E+ + + H +I+K
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 468 LRAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ L+ +++ G+L + L S+ + L A+ G+AYLH
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH 151
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMK 583
+ ++H D+ N+LLDND I DFGL++ + G P +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE---DGDSPVFWY- 204
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTS------ 636
APE + + DV+SFGV L ELLT S + PT
Sbjct: 205 -----------APEC-LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 637 --IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+ V L +++G P + V+HL C E + RP
Sbjct: 253 GQMTVLRLTELLERGERLPRPDKCPAE---------------VYHLMKNCWETEASFRPT 297
Query: 695 MKNVSENLERI 705
+N+ L+ +
Sbjct: 298 FENLIPILKTV 308
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 66/302 (21%), Positives = 120/302 (39%), Gaps = 57/302 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + IPVA++ L E + ++E + E +A V +P++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 468 LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L + LI+ + G L + +R + L A+G+ YL +
Sbjct: 82 LLGI--CLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLED 135
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R+ VH D+ N+L+ I+DFGL++L+ + GG + P++
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--------PIK 184
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645
+ A E+ + + DV+S+GV + EL+T G P I ++
Sbjct: 185 ------WMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP------YDGIPASEISSI 231
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEV--IAVFHLALACTEADPEVRPRMKNVSENLE 703
++KG P + I V+ + C D + RP+ + +
Sbjct: 232 LEKGERLPQP-----------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274
Query: 704 RI 705
++
Sbjct: 275 KM 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-28
Identities = 72/297 (24%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG+ G V+ VA++ L G F+ E Q + K++H +V+L Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL---YA 329
Query: 474 APDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
E+ ++++++S G+L + L+G G+ L + +A A G+AY+
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVER---MN 383
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+VH D++ +NIL+ + ++DFGL+RLI F P++
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF---------PIK----- 429
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ APEA R K DV+SFG++L EL T G+ P + +++ V++G+
Sbjct: 430 -WTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVP------YPGMVNREVLDQVERGY 481
Query: 651 EEENPL--SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P + ++ L C +PE RP + + LE
Sbjct: 482 RMPCPPECPE-----------------SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-28
Identities = 66/299 (22%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA--- 470
LG G V+ VAV+ + G F+ E + ++H +VKL A
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 471 ---YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y +I++F++ G+L + L+ G + + A G+A++ +
Sbjct: 254 KEPIY-------IITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQ- 302
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
R ++H D++ +NIL+ I+DFGL+R+I G P
Sbjct: 303 --RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-----GAKFPI------ 349
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWV 646
+ APEA + K DV+SFG++L+E++T G+ P + P+++R +
Sbjct: 350 ----KWTAPEA-INFGSFTIKSDVWSFGILLMEIVTYGRIP------YPGMSNPEVIRAL 398
Query: 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++G+ P + +E ++++ + C + PE RP + + L+
Sbjct: 399 ERGYRMPRP------------ENCPEE---LYNIMMRCWKNRPEERPTFEYIQSVLDDF 442
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 66/309 (21%), Positives = 120/309 (38%), Gaps = 60/309 (19%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVK 467
+LG+ G V + L G + VAV+ + ++ EF++E + HPN+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 468 L-----RAYYWAPDEKLLISDFISNGNLANALRG-RNGQPSTSLSWSTRLRIAKGTARGL 521
L + ++I F+ G+L L R + T L+ A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP- 580
YL S R F+H D+ N +L +D ++DFGLS+ I + G +P
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY--SGDYYRQGR--IAKMPV 213
Query: 581 -YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
++ A E+ + K DV++FGV + E+ T G +P ++
Sbjct: 214 KWI------------AIES-LADRVYTSKSDVWAFGVTMWEIATRGMTP------YPGVQ 254
Query: 639 VPDLVRWVKKGFEEENPL--SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK 696
++ ++ G + P D ++ + +C DP RP
Sbjct: 255 NHEMYDYLLHGHRLKQPEDCLD-----------------ELYEIMYSCWRTDPLDRPTFS 297
Query: 697 NVSENLERI 705
+ LE++
Sbjct: 298 VLRLQLEKL 306
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 66/303 (21%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA--- 470
LG G V+ VAV+ L +G F+ E + +++H +V+L A
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 471 ---YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y +I++++ NG+L + L+ +G L+ + L +A A G+A++ E
Sbjct: 79 QEPIY-------IITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEE- 127
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPV 585
R ++H D++ +NIL+ + I+DFGL+RLI G P
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-----GAKFPIKWT--- 177
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644
APEA + K DV+SFG++L E++T G+ P + P++++
Sbjct: 178 ---------APEA-INYGTFTIKSDVWSFGILLTEIVTHGRIP------YPGMTNPEVIQ 221
Query: 645 WVKKGFEEENPL--SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
+++G+ P + ++ L C + PE RP + L
Sbjct: 222 NLERGYRMVRPDNCPE-----------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
Query: 703 ERI 705
E
Sbjct: 265 EDF 267
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 70/295 (23%), Positives = 113/295 (38%), Gaps = 50/295 (16%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG G+V VAV+ + EG EF E Q + K+ HP +VK
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+++++ISNG L N LR L S L + G+A+L +F+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLES---HQFI 126
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKTN 591
H D+ N L+D D +SDFG++R + S G P
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV-----GTKFPVKWS--------- 172
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
APE + K DV++FG+++ E+ + GK P ++V V +G
Sbjct: 173 ---APEV-FHYFKYSSKSDVWAFGILMWEVFSLGKMP------YDLYTNSEVVLKVSQGH 222
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P L + ++ + +C PE RP + + ++E +
Sbjct: 223 RLYRP-------HLASD--------TIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 50/296 (16%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G VY+ V + VAV+ L E + EF+ E + ++KHPN+V+L
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+I++F++ GNL + LR N Q +S L +A + + YL + F
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKT 590
+H D+ N L+ + ++DFGLSRL+ + G P
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-----GAKFPIKWT-------- 179
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649
APE+ + N+ K DV++FGV+L E+ T G SP I++ + ++K
Sbjct: 180 ----APES-LAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKD 228
Query: 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+ E P ++ V+ L AC + +P RP + + E +
Sbjct: 229 YRMERP------------EGCPEK---VYELMRACWQWNPSDRPSFAEIHQAFETM 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 50/295 (16%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G G+V+ N VA++ + EG +F+ E + + K+ HP +V+L
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
L+++F+ +G L++ LR + G + T L + G+AYL E +
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEE---ACVI 126
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKTN 591
H D+ N L+ + +SDFG++R + S+ G P
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-----GTKFPVKWA--------- 172
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
+PE +R K DV+SFGV++ E+ + GK P + ++V + GF
Sbjct: 173 ---SPEV-FSFSRYSSKSDVWSFGVLMWEVFSEGKIP------YENRSNSEVVEDISTGF 222
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P L V+ + C PE RP + L I
Sbjct: 223 RLYKP-------RLAST--------HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 60/295 (20%), Positives = 110/295 (37%), Gaps = 50/295 (16%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG G+V VA++ + EG EF+ E + + + H +V+L
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+I+++++NG L N LR + L + K + YL ++F+
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLES---KQFL 142
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKTN 591
H D+ N L+++ +SDFGLSR + S G P
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-----GSKFPVRWS--------- 188
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650
PE + ++ K D+++FGV++ E+ + GK P + + +G
Sbjct: 189 ---PPEV-LMYSKFSSKSDIWAFGVLMWEIYSLGKMP------YERFTNSETAEHIAQGL 238
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P A ++ V+ + +C + RP K + N+ +
Sbjct: 239 RLYRP------------HLASEK---VYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 67/302 (22%), Positives = 121/302 (40%), Gaps = 57/302 (18%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
VLG G V+K V IPV ++ + + G Q + + AI + H +IV+
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 468 LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L P L L++ ++ G+L + +R G L L A+G+ YL E
Sbjct: 80 LLGL--CPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYYLEE 133
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
VH ++ N+LL + Q ++DFG++ L+ S P++
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT--------PIK 182
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645
+ A E+ + + + DV+S+GV + EL+T G P + + ++
Sbjct: 183 ------WMALES-IHFGKYTHQSDVWSYGVTVWELMTFGAEP------YAGLRLAEVPDL 229
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEV--IAVFHLALACTEADPEVRPRMKNVSENLE 703
++KG P ++ I V+ + + C D +RP K ++
Sbjct: 230 LEKGERLAQP-----------------QICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272
Query: 704 RI 705
R+
Sbjct: 273 RM 274
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 56/303 (18%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKL 468
V+GK G+VY N I A++ L E + F+ E + + HPN++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 469 RAYYWAPDE-KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
P+ ++ ++ +G+L +R P+ + ARG+ YL
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK----DLISFGLQVARGMEYL--- 140
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP--YMKPV 585
+ +KFVH D+ N +LD F ++DFGL+R I LP +
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR--HARLPVKWT--- 195
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644
A E+ + R K DV+SFGV+L ELLT G P I+ DL
Sbjct: 196 ---------ALES-LQTYRFTTKSDVWSFGVLLWELLTRGAPP------YRHIDPFDLTH 239
Query: 645 WVKKGFEEENPL--SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
++ +G P D +++ + C EADP VRP + + +
Sbjct: 240 FLAQGRRLPQPEYCPD-----------------SLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 703 ERI 705
E+I
Sbjct: 283 EQI 285
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 56/296 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+GK G V G VAV+ + + F+ E + +++H N+V+L
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 474 APDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
L +++++++ G+L + LR R L L+ + + YL F
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKT 590
VH D+ N+L+ D +SDFGL++ + T + G LP
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---------TGKLPVKWT-------- 353
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649
APEA + + K DV+SFG++L E+ + G+ P I + D+V V+KG
Sbjct: 354 ----APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP------YPRIPLKDVVPRVEKG 402
Query: 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ + P V+ + C D RP + E LE I
Sbjct: 403 YKMDAP------------DGCPPA---VYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 48/228 (21%), Positives = 92/228 (40%), Gaps = 30/228 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
VLG+ G V K + A++++ E++ ++EV +A + H +V+ A +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 473 ------------WAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
L + ++ NG L + + N W R+ +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQILE 127
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
L+Y+H + +H D+KP NI +D I DFGL++ ++ + + + G+
Sbjct: 128 ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 580 PYMKPVQTEK-TNNYRAPEARVPGNRPM--QKWDVYSFGVVLLELLTG 624
+ + T Y A E V +K D+YS G++ E++
Sbjct: 185 DNLT---SAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 56/296 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+GK G V G VAV+ + + F+ E + +++H N+V+L
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 474 APDEKLLI-SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
L I +++++ G+L + LR R L L+ + + YL F
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQTEKT 590
VH D+ N+L+ D +SDFGL++ + T G LP
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWT-------- 181
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649
APEA + + K DV+SFG++L E+ + G+ P I + D+V V+KG
Sbjct: 182 ----APEA-LREKKFSTKSDVWSFGILLWEIYSFGRVP------YPRIPLKDVVPRVEKG 230
Query: 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ + P V+ + C D +RP + E LE I
Sbjct: 231 YKMDAP------------DGCPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 74/316 (23%), Positives = 121/316 (38%), Gaps = 64/316 (20%)
Query: 414 VLGKSGLGIVYK------VVLGNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKV-KHPNI 465
LG G V + + + VAV+ L R ++E++ ++ + H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGR-------------NGQPSTSLSWSTRLR 512
V L L+I+++ G+L N LR + +L L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+ A+G+A+L + + +H D+ NILL + I DFGL+R I N
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG- 205
Query: 573 GFMGGALPY--MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629
LP M APE+ + DV+S+G+ L EL + G SP
Sbjct: 206 ---NARLPVKWM------------APESIFNCVYTFES-DVWSYGIFLWELFSLGSSP-- 247
Query: 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689
P + + +K+GF +P HA E ++ + C +ADP
Sbjct: 248 YPGMPVDSKF---YKMIKEGFRMLSP------------EHAPAE---MYDIMKTCWDADP 289
Query: 690 EVRPRMKNVSENLERI 705
RP K + + +E+
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 65/300 (21%), Positives = 121/300 (40%), Gaps = 53/300 (17%)
Query: 414 VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVK 467
VLG G VYK + IPVA++ L E + ++E + E +A V +P++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 468 LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L + LI+ + G L + +R + L A+G+ YL +
Sbjct: 82 LLGI--CLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNYLED 135
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R+ VH D+ N+L+ I+DFGL++L+ + GG + P++
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--------PIK 184
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645
+ A E+ + + DV+S+GV + EL+T G P I ++
Sbjct: 185 ------WMALES-ILHRIYTHQSDVWSYGVTVWELMTFGSKP------YDGIPASEISSI 231
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++KG P + +V+ + + C D + RP+ + + ++
Sbjct: 232 LEKGERLPQP------PICTIDVY---------MIMVKCWMIDADSRPKFRELIIEFSKM 276
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 52/224 (23%), Positives = 82/224 (36%), Gaps = 45/224 (20%)
Query: 414 VLGKSGLGIVYK---VVLGNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKLR 469
+ GLG +Y + NG PV ++ L G+ + + E Q +A+V HP+IV++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 470 AYYWAPDEKLLISDFI-----SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
+ D +I +L + + L + + L+YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H V+ D+KP NI+L + Q + D G IN S G G
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-------SFGYLYG-------- 239
Query: 585 VQTEKTNNYRAPE-ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T ++APE R P D+Y+ G L L
Sbjct: 240 -----TPGFQAPEIVR---TGPTVATDIYTVGRTLAALTLDLPT 275
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 51/317 (16%), Positives = 102/317 (32%), Gaps = 83/317 (26%)
Query: 414 VLGKSGLGIVYK--------VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNI 465
LG+ ++K + V ++ L + F ++K+ H ++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
V DE +L+ +F+ G+L L+ ++ +L +AK A + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHFLE 130
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPY--------ISDFGLSRLINITGNNPSSSGGFMGG 577
E +HG++ NILL + +SD G+S +
Sbjct: 131 E---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---------------- 171
Query: 578 ALPYMKPVQTEKTNNYR------APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--E 628
+ + PE D +SFG L E+ + G P
Sbjct: 172 ----------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
Query: 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEAD 688
L S +++ + + P + + +L C + +
Sbjct: 222 LD-----SQRK---LQFYEDRHQLPAPKAA-----------------ELANLINNCMDYE 256
Query: 689 PEVRPRMKNVSENLERI 705
P+ RP + + +L +
Sbjct: 257 PDHRPSFRAIIRDLNSL 273
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAY 471
VL + G VY+ +G+G A++RL E+++R + EV + K+ HPNIV+ +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 472 YWAPDEK-------LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
E+ L+ + G L L+ + LS T L+I T R + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHM 152
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H P +H D+K N+LL N + DFG + I+ + S+
Sbjct: 153 HRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR--------RAL 203
Query: 585 VQTEKTNN----YRAPE-ARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
V+ E T N YR PE + N P+ +K D+++ G +L L + P
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 65/303 (21%), Positives = 112/303 (36%), Gaps = 78/303 (25%)
Query: 415 LGKSGLGIVYK---VVLGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG G+ V+ + VAV L R F E Q A + HP IV
Sbjct: 20 LGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 468 LRAYYWAPDEKLLIS----DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523
+ A + +++ L + + G ++ + + + L +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGP----MTPKRAIEVIADACQALNF 131
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
H+ +H D+KP+NI++ + DFG++R I +GN+ + + +G
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG------- 181
Query: 584 PVQTEKTNNYRAPE-ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
T Y +PE AR G+ + DVYS G VL E+LTG+ P
Sbjct: 182 ------TAQYLSPEQAR--GDSVDARSDVYSLGCVLYEVLTGEPP--------------- 218
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVI-----------AVFHLALACTEADPEV 691
F ++P+S + Q H +++ I + + L +PE
Sbjct: 219 -------FTGDSPVS-----VAYQ--HVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 264
Query: 692 RPR 694
R +
Sbjct: 265 RYQ 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 66/300 (22%), Positives = 116/300 (38%), Gaps = 77/300 (25%)
Query: 415 LGKSGLGIVYK---VVLGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG G+ VY +L VA+ E E R F EV +++ H NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVS 75
Query: 468 LRAYYWAPDEKL--LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ ++ L+ ++I L+ + +G LS T + G+ + H
Sbjct: 76 M--IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGP----LSVDTAINFTNQILDGIKHAH 128
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+ + VH DIKP NIL+D++ I DFG+++ ++ T + + +G
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--TQTNHVLG--------- 174
Query: 586 QTEKTNNYRAPE-ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644
T Y +PE A+ G + D+YS G+VL E+L G+ P
Sbjct: 175 ----TVQYFSPEQAK--GEATDECTDIYSIGIVLYEMLVGEPP----------------- 211
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVI----------AVFHLALACTEADPEVRPR 694
F E + ++ ++ + + ++ ++ L TE D R +
Sbjct: 212 -----FNGETAV-----SIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 73/300 (24%), Positives = 132/300 (44%), Gaps = 52/300 (17%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKL 468
++G G V L +PVA++ L G +R R +F++E + + HPNI++L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+++++++ NG+L LR +GQ + + + +G G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSD-- 169
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQ 586
+VH D+ N+L+D++ +SDFGLSR++ ++P ++ GG +P
Sbjct: 170 -LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWT---- 221
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645
APEA + DV+SFGVV+ E+L G+ P ++ D++
Sbjct: 222 --------APEA-IAFRTFSSASDVWSFGVVMWEVLAYGERP------YWNMTNRDVISS 266
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
V++G+ P + + L L C D RPR + L+ +
Sbjct: 267 VEEGYRLPAP------------MGCPHA---LHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 64/312 (20%), Positives = 111/312 (35%), Gaps = 74/312 (23%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIV 466
LG G+V + G + VAV+ L + +F+ EV A+ + H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 467 KLRA------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
+L ++++ G+L + LR G T R A A G
Sbjct: 85 RLYGVVLTPPMK-------MVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEG 133
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+ YL ++F+H D+ N+LL I DFGL R + ++ +P
Sbjct: 134 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE---HRKVP 187
Query: 581 Y--MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTST 635
+ APE+ + D + FGV L E+ T G+ P L+ +
Sbjct: 188 FAWC------------APES-LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--- 231
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEV--IAVFHLALACTEADPEVRP 693
++ + K+G P E ++++ + C PE RP
Sbjct: 232 --QILHKI--DKEGERLPRP-----------------EDCPQDIYNVMVQCWAHKPEDRP 270
Query: 694 RMKNVSENLERI 705
+ + L
Sbjct: 271 TFVALRDFLLEA 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 59/232 (25%), Positives = 93/232 (40%), Gaps = 47/232 (20%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
++G G G V+K +G ++R+ E+ RE V+A+AK+ H NIV +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 473 WAPDEKLLISD-----------FI-----SNGNLANALRGRNGQPSTSLSWSTRLRIAKG 516
D S FI G L + R G+ L L + +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVLALELFEQ 130
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
+G+ Y+H +K ++ D+KPSNI L + Q I DFGL + G S G
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG---- 183
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
T Y +PE ++ ++ D+Y+ G++L ELL
Sbjct: 184 -------------TLRYMSPE--QISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-26
Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 65/315 (20%)
Query: 415 LGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG+ G V+ N P VAV+ L + ++F E + + ++H +IVK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLRIAKGT 517
D +++ +++ +G+L LR Q L S L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A G+ YL + + FVH D+ N L+ + I DFG+SR ++ + GG
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGG--HT 195
Query: 578 ALP--YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPT 632
LP +M PE+ + + + DV+SFGV+L E+ T GK P +LS
Sbjct: 196 MLPIRWM------------PPES-IMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-- 240
Query: 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692
+++ + +G E P KE V+ + L C + +P+ R
Sbjct: 241 ------NTEVIECITQGRVLERP------------RVCPKE---VYDVMLGCWQREPQQR 279
Query: 693 PRMKNVSENLERIGT 707
+K + + L +G
Sbjct: 280 LNIKEIYKILHALGK 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 76/313 (24%), Positives = 123/313 (39%), Gaps = 64/313 (20%)
Query: 414 VLGKSGLGIVYKVVLGNGIP------VAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG+ G V+ N +P VAV+ L E E ++F E + + ++H +IV+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGR----------NGQPSTSLSWSTRLRIAKGT 517
L++ +++ +G+L LR L L +A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A G+ YL FVH D+ N L+ I DFG+SR +I + GG
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGG--RT 220
Query: 578 ALP--YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPT 632
LP +M PE+ + + + DV+SFGVVL E+ T GK P +LS
Sbjct: 221 MLPIRWM------------PPES-ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-- 265
Query: 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692
+ + + +G E E P E V+ + C + +P+ R
Sbjct: 266 ------NTEAIDCITQGRELERP------------RACPPE---VYAIMRGCWQREPQQR 304
Query: 693 PRMKNVSENLERI 705
+K+V L+ +
Sbjct: 305 HSIKDVHARLQAL 317
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 65/316 (20%)
Query: 414 VLGKSGLGIVYK--------VVLGNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHP 463
LG+ G V + VAV+ L + E+ + V+E++ + + KH
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLR 512
NI+ L +I ++ S GNL LR R N P +++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
ARG+ YL +K +H D+ N+L+ + I+DFGL+R IN ++
Sbjct: 208 CTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 573 GFMGGALPYMKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629
G + PV + APEA + + DV+SFGV++ E+ T G SP
Sbjct: 265 GRL--------PV--------KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSP-- 305
Query: 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689
I V +L + +K+G + P + E ++ + C A P
Sbjct: 306 ----YPGIPVEELFKLLKEGHRMDKP------------ANCTNE---LYMMMRDCWHAVP 346
Query: 690 EVRPRMKNVSENLERI 705
RP K + E+L+RI
Sbjct: 347 SQRPTFKQLVEDLDRI 362
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/223 (24%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 414 VLGKSGLGIVYK---VVLGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIV 466
++G+ G+G VY+ V VA+ L R R E + +++ P++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVV 97
Query: 467 KLRAYYWAPDEKLL-IS-DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
+ + + + L + I+ +LA LR R G L+ + I + L
Sbjct: 98 PI--HDFGEIDGQLYVDMRLINGVDLAAMLR-RQG----PLAPPRAVAIVRQIGSALDAA 150
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H H D+KP NIL+ D Y+ DFG++ + G +G
Sbjct: 151 HA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--TQLGNTVG-------- 197
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE R + + D+Y+ VL E LTG P
Sbjct: 198 -----TLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 79/316 (25%), Positives = 130/316 (41%), Gaps = 65/316 (20%)
Query: 414 VLGKSGLGIVYKVVL--------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHP 463
LG+ G V + VAV+ L + E+ + V+E++ + + KH
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLR 512
NI+ L +I ++ S GNL LR R N P +++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
ARG+ YL + +K +H D+ N+L+ + I+DFGL+R IN ++
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 573 GFMGGALPYMKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629
G + PV + APEA + + DV+SFGV++ E+ T G SP
Sbjct: 219 GRL--------PV--------KWMAPEA-LFDRVYTHQSDVWSFGVLMWEIFTLGGSP-- 259
Query: 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689
I V +L + +K+G + P + E ++ + C A P
Sbjct: 260 ----YPGIPVEELFKLLKEGHRMDKP------------ANCTNE---LYMMMRDCWHAVP 300
Query: 690 EVRPRMKNVSENLERI 705
RP K + E+L+RI
Sbjct: 301 SQRPTFKQLVEDLDRI 316
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 68/326 (20%), Positives = 118/326 (36%), Gaps = 88/326 (26%)
Query: 414 VLGKSGLGIVYK------VVLGNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNI 465
LG G V + + VAV+ L ++E++ ++ + +H NI
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGR---------NGQPSTSLSWSTRLRIAKG 516
V L L+I+++ G+L N LR + +++ S L +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
A+G+A+L + +H D+ N+LL N I DFGL+R I
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM-------------- 215
Query: 577 GALPYMKPVQTEKTNNYRAPE-ARVPGNRPMQKW---------------DVYSFGVVLLE 620
+NY AR+P KW DV+S+G++L E
Sbjct: 216 ------------NDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 621 LLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFH 679
+ + G +P P + + + VK G++ P A K ++
Sbjct: 259 IFSLGLNP--YPGILVNSKF---YKLVKDGYQMAQP------------AFAPKN---IYS 298
Query: 680 LALACTEADPEVRPRMKNVSENLERI 705
+ AC +P RP + + L+
Sbjct: 299 IMQACWALEPTHRPTFQQICSFLQEQ 324
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKL 468
V+G G V L I VA++ L G E++ R+F+ E + + HPNI++L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+++++++ NG+L + LR + Q + + + +G A G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSD-- 165
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPVQ 586
+VH D+ NIL++++ +SDFGL R++ ++P ++ GG +P
Sbjct: 166 -MGYVHRDLAARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPIRWT---- 217
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
+PEA + + DV+S+G+VL E+++ G+ P
Sbjct: 218 --------SPEA-IAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 37/289 (12%), Positives = 67/289 (23%), Gaps = 58/289 (20%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV---RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
L +V+ V + A+ E A A++ + + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 470 AY---------------------------YWAPDEKLLISDFISNGNLANALRGRNGQPS 502
Y + LL+ + L +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+ R A L + VHG P N+ + D + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLEL 621
G +S Y E + + G+ + +
Sbjct: 243 KVGTRGPASSV----------------PVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 622 LTGKSP--ELSPTTSTSIEVPDLV--RWVKKGFEEENPLSDMVDAMLLQ 666
P ++P S + P L F PL D V ++ +
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 40/179 (22%), Positives = 59/179 (32%), Gaps = 3/179 (1%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQ 144
L+ L+L N + ++ L + +NL SV +L L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
LD+S+ + L+ L +A N F I+ EL NL LDLS +
Sbjct: 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
P L SL LN++ N L L L N P+ +
Sbjct: 485 LSPTAFNSLSSLQ-VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 41/178 (23%), Positives = 67/178 (37%), Gaps = 8/178 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
S L+ L+L + ++ D + + + L ++ L GN + SL L L
Sbjct: 45 SYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
Q L + + + + K L+ L +A N + L NL LDLS N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 204 GPIPNDLGELQSLSA---TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
DL L + +L+LS N ++ I LR N S + +T
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 38/185 (20%), Positives = 66/185 (35%), Gaps = 13/185 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRL 143
IP L + L+L N L F+ L + L + ++ +L L
Sbjct: 22 IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
L L+ N LQ+L+ + + L+ L +L+++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
Query: 204 -GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLP----VTVSFDLRGNNLSGEIPQT 258
+P L +L L+LS N + L L + +S DL N ++ I
Sbjct: 138 SFKLPEYFSNLTNLE-HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ-P 194
Query: 259 GSFAN 263
G+F
Sbjct: 195 GAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 38/176 (21%), Positives = 61/176 (34%), Gaps = 9/176 (5%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPRLQNLDL 148
L L+RL +N + + + SL + L N LS G S L+ LDL
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
S N ++ +QL+ L + ++ L NL+ LD+S +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 209 DLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L SL L ++ N L DL L ++ +F +
Sbjct: 440 IFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP-TAFNS 492
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 5e-22
Identities = 28/147 (19%), Positives = 54/147 (36%), Gaps = 6/147 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPR 142
+ S L L L+ ++NL +F + +L + + + + L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 446
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ L ++ NSF + + L L L++ + Q+ + L +L L+++ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQ 505
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLS 228
K L SL + L N
Sbjct: 506 LKSVPDGIFDRLTSLQ-KIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 44/207 (21%), Positives = 70/207 (33%), Gaps = 16/207 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNL-FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+G L L+ LN+ +N + LP+ N T+L + L N + + L ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 145 N----LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
LDLS N + + G +L +L L N S + L L L
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 201 DFKG------PIPNDLGELQSLSAT-LNLSYNHLSG-KIPKSLGNLPVTVSFDLRGNNLS 252
+F+ + L L +L+ L+Y I L SF L +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 253 GEIPQTGSFANQGPTAFLSNPLLCGFP 279
+ S+ L N FP
Sbjct: 296 -RVKD-FSYNFGWQHLELVNCKFGQFP 320
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 32/194 (16%), Positives = 51/194 (26%), Gaps = 19/194 (9%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNN---------L 129
N +I I L +L L NN ++ L L
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPEL 189
S +CNL + + + + D + L ++
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF--SYN 303
Query: 190 ENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
L+L + F L L+ L + N S +LP DL N
Sbjct: 304 FGWQHLELVNCKFGQFPTLKLKSLKR----LTFTSNKGGNAF--SEVDLPSLEFLDLSRN 357
Query: 250 NLSGEIPQTGSFAN 263
LS + + S
Sbjct: 358 GLSFKGCCSQSDFG 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 43/206 (20%), Positives = 72/206 (34%), Gaps = 19/206 (9%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S L I + L+ +N++ + + L + L NNL+ + N P L +
Sbjct: 199 STLAIPIAVEELDASHNSI-NVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEV 253
Query: 147 DLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
DLS N + ++L+RL ++ N+ + P + L LDLS N
Sbjct: 254 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLLH- 309
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQG 265
+ + + L L L +N + + L + L N+ F N
Sbjct: 310 VERNQPQFDRLE-NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVA 364
Query: 266 PTAFLSNPLLCGFPLQ----KSCKDS 287
A C Q CK+S
Sbjct: 365 RPAVDDADQHCKIDYQLEHGLCCKES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 44/203 (21%), Positives = 74/203 (36%), Gaps = 11/203 (5%)
Query: 53 CRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQ 112
R C++ D V I + Y E +L + + N+ + LP
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAA 63
Query: 113 LF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQR 169
L + + + L + + +Q L + N+ LP +N L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 121
Query: 170 LILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229
L+L RN S +P GI+ L L +S+N+ + + SL L LS N L+
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ-NLQLSSNRLT- 178
Query: 230 KIPKSLGNLPVTVSFDLRGNNLS 252
+ L +P ++ N LS
Sbjct: 179 HVD--LSLIPSLFHANVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 49/199 (24%), Positives = 78/199 (39%), Gaps = 32/199 (16%)
Query: 85 IPSE-LGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLP 141
I + +++L + N + LP +F N L + L N+LS SLP + N P
Sbjct: 84 IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141
Query: 142 RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELE---------- 190
+L L +SNN+ + D + LQ L L+ N+ + + + P L
Sbjct: 142 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLS 199
Query: 191 ------NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSF 244
+ +LD S N + + L+ L L +N+L+ L N P V
Sbjct: 200 TLAIPIAVEELDASHNSINV-VRGPV--NVELT-ILKLQHNNLT-DTA-WLLNYPGLVEV 253
Query: 245 DLRGNNLSGEIPQTGSFAN 263
DL N L +I F
Sbjct: 254 DLSYNELE-KIMY-HPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 8/118 (6%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ L + L ++L N L + F L +++ N L +L +P L+
Sbjct: 241 TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
LDLS+N + +L+ L L N + L L LS ND+
Sbjct: 299 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST---HHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 27/165 (16%), Positives = 56/165 (33%), Gaps = 8/165 (4%)
Query: 101 HNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDG 160
+ + L + + + L + + N++ LP
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 161 -LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSAT 219
L + +Q++ L L + +I + + +L + N + P+ + L+
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT-V 121
Query: 220 LNLSYNHLSGKIPKSL-GNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L L N LS +P+ + N P + + NNL I +F
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQA 163
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 16/70 (22%), Positives = 32/70 (45%), Gaps = 4/70 (5%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ + L+ L+L +N+L + L +++L N++ +L S L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLK 342
Query: 145 NLDLSNNSFS 154
NL LS+N +
Sbjct: 343 NLTLSHNDWD 352
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 59/261 (22%), Positives = 99/261 (37%), Gaps = 40/261 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ G V +G ++ + + E EV +A +KHPNIV+ R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ ++ D+ G+L + + G L L ++H+ R
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKHVHD---R 144
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
K +H DIK NI L D + DFG++R++N T + G T
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG----------------T 188
Query: 591 NNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649
Y +PE + N+P K D+++ G VL EL T K + + + +LV + G
Sbjct: 189 PYYLSPE--ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISG 240
Query: 650 FEEENP------LSDMVDAML 664
L +V +
Sbjct: 241 SFPPVSLHYSYDLRSLVSQLF 261
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 73/362 (20%), Positives = 134/362 (37%), Gaps = 53/362 (14%)
Query: 351 KSKFGGNENGSFCPCVCVNGFRNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRA 410
+ + + + P ++ + V + F + L
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPE-ELKDKKLFLKRDNLLI 339
Query: 411 SAYVLGKSGLGIVYKVVL---GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIV 466
+ LG G V + V I VA++ L +G E+ E + E Q + ++ +P IV
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+L A + +L+ + G L L G+ + + S + + G+ YL E
Sbjct: 400 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE 454
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKP 584
+ FVH ++ N+LL N ISDFGLS+ + + ++ G P
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---AGKWPLKWY-- 506
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643
APE + + + DV+S+GV + E L+ G+ P ++ P+++
Sbjct: 507 ----------APEC-INFRKFSSRSDVWSYGVTMWEALSYGQKP------YKKMKGPEVM 549
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703
++++G E P E++A L C E RP V + +
Sbjct: 550 AFIEQGKRMECP------PECPPELYA---------LMSDCWIYKWEDRPDFLTVEQRMR 594
Query: 704 RI 705
Sbjct: 595 AC 596
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 75/307 (24%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIV 466
LG G VY+ + + + VAV+ L E EQ +F+ E I+K H NIV
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS--TSLSWSTRLRIAKGTARGLAYL 524
+ + ++ + ++ G+L + LR +PS +SL+ L +A+ A G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGALPY 581
F+H DI N LL I DFG++R I +
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML------ 207
Query: 582 MKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
PV + PEA + G K D +SFGV+L E+ + G P S
Sbjct: 208 --PV--------KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------YPSKS 250
Query: 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+++ +V G + P + V+ + C + PE RP +
Sbjct: 251 NQEVLEFVTSGGRMDPP------------KNCPGP---VYRIMTQCWQHQPEDRPNFAII 295
Query: 699 SENLERI 705
E +E
Sbjct: 296 LERIEYC 302
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 44/192 (22%), Positives = 69/192 (35%), Gaps = 13/192 (6%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSN 150
L+ L+L N + ++ L + +NL SV +L L LD+S+
Sbjct: 77 TTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 151 NSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209
+G L+ L +A N F I+ EL NL LDLS + P
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194
Query: 210 LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTA- 268
L SL LN+S+N+ L D N++ + + P++
Sbjct: 195 FNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK-QELQH-FPSSL 250
Query: 269 ---FLS-NPLLC 276
L+ N C
Sbjct: 251 AFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 35/172 (20%), Positives = 68/172 (39%), Gaps = 7/172 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPR 142
+ S L L L+ ++NL +F + +L + + + + L
Sbjct: 93 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 151
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ L ++ NSF + + L L L++ + Q+ + L +L L++S N+
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNN 210
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT-VSFDLRGNNLS 252
F L SL L+ S NH+ + L + P + +L N+ +
Sbjct: 211 FFSLDTFPYKCLNSLQ-VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 9/182 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNL-FGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
L L +L+L +N L F Q TSL + L N + ++ + L +L
Sbjct: 45 HGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL 103
Query: 144 QNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
++LD +++ + + + L L ++ GI+ L +L L ++ N F
Sbjct: 104 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSF 162
Query: 203 KGPIPND-LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
+ D EL++L+ L+LS L P + +L ++ NN + T +
Sbjct: 163 QENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLD-TFPY 219
Query: 262 AN 263
Sbjct: 220 KC 221
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 42/183 (22%), Positives = 66/183 (36%), Gaps = 11/183 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLS-GSLPPSV-CNLP 141
+P+ + RL L +N L SLP +F T L + L N LS
Sbjct: 22 VPTGI--PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ LDLS N ++ +QL+ L + ++ L NL+ LD+S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 202 FKGPIPNDLGELQSLSATLNLSYN-HLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS 260
+ L SL L ++ N +P L DL L ++ +
Sbjct: 138 TRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP-TA 194
Query: 261 FAN 263
F +
Sbjct: 195 FNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 30/124 (24%), Positives = 47/124 (37%), Gaps = 8/124 (6%)
Query: 84 YIPSE-LGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNL 140
+ L L L + N+ + +F +L + L L L P+ +L
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSL 198
Query: 141 PRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPEL-ENLVQLDLS 198
LQ L++S+N+F SL K LQ L + N +L L+L+
Sbjct: 199 SSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
Query: 199 DNDF 202
NDF
Sbjct: 257 QNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 29/148 (19%), Positives = 52/148 (35%), Gaps = 9/148 (6%)
Query: 118 SLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKF 177
S I L+ S+P + L+L +N QL +L L+ N
Sbjct: 8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 178 SGQ-IPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSL- 235
S + + +L LDLS N + ++ L+ L L+ +++L S+
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL-EHLDFQHSNLKQMSEFSVF 122
Query: 236 GNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+L + D+ + G F
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFN-GIFNG 148
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 50/263 (19%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREF-VTEVQAIAKVKHPNIVKLR 469
+G+ VY+ L +G+PVA++ ++ + + + R + E+ + ++ HPN++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
A + +E ++ + G+L+ ++ + + T + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMHS--- 154
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
R+ +H DIKP+N+ + + D GL R + S G
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG---------------- 198
Query: 590 TNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
T Y +PE K D++S G +L E+ +SP + + L + +++
Sbjct: 199 TPYYMSPE--RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ 252
Query: 649 GFEEENP-------LSDMVDAML 664
P L +V+ +
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCI 275
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 75/315 (23%), Positives = 118/315 (37%), Gaps = 63/315 (20%)
Query: 414 VLGKSGLGIVYK------VVLGNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNI 465
LG+ G V + VAV+ L EG HR ++E++ + + H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 466 VKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQ-----------PSTSLSWSTRLRI 513
V L P L +I +F GNL+ LR + + L+ +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573
+ A+G+ +L + RK +H D+ NILL I DFGL+R I +
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 574 FMGGALPYMKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELS 630
+ P+ + APE +Q DV+SFGV+L E+ + G SP
Sbjct: 211 RL--------PL--------KWMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASP--Y 251
Query: 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPE 690
P E R +K+G P + E ++ L C +P
Sbjct: 252 PGVKIDEEF---CRRLKEGTRMRAP------------DYTTPE---MYQTMLDCWHGEPS 293
Query: 691 VRPRMKNVSENLERI 705
RP + E+L +
Sbjct: 294 QRPTFSELVEHLGNL 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 78/303 (25%), Positives = 139/303 (45%), Gaps = 57/303 (18%)
Query: 414 VLGKSGLGIVYKVVLGNG-----IPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVK 467
V+G G VYK +L +PVA++ L G E++ +F+ E + + H NI++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++I++++ NG L LR ++G+ S + + +G A G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN- 165
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--MKPV 585
+VH D+ NIL++++ +SDFGLSR++ ++P ++ GG +P
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWT--- 217
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP--ELSPTTSTSIEVPDL 642
APEA + + DV+SFG+V+ E++T G+ P ELS + EV
Sbjct: 218 ---------APEA-ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKA 262
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702
+ GF P M A++ L + C + + RP+ ++ L
Sbjct: 263 IN---DGFRLPTP-------MDCPS--------AIYQLMMQCWQQERARRPKFADIVSIL 304
Query: 703 ERI 705
+++
Sbjct: 305 DKL 307
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 43/226 (19%)
Query: 415 LGKSGLGIVYKVVL---GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRA 470
LG G V + V I VA++ L +G + E + E Q + ++ +P IV+L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 471 ------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
L+ + G L L G+ + + S + + G+ YL
Sbjct: 78 VCQAEALM-------LVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL 126
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY--M 582
E + FVH D+ N+LL N ISDFGLS+ + + ++ G P
Sbjct: 127 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS---AGKWPLKWY 180
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
APE + + + DV+S+GV + E L+ G+ P
Sbjct: 181 ------------APEC-INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 50/197 (25%), Positives = 71/197 (36%), Gaps = 12/197 (6%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
+ + L L LH+N L + F L + L N S+ P+ L RL
Sbjct: 49 AASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRL 107
Query: 144 QNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L L L G + LQ L L N +P + +L NL L L N
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRI 165
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA 262
L SL L L N ++ P + +L ++ L NNLS +P + A
Sbjct: 166 SSVPERAFRGLHSLD-RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT-EALA 222
Query: 263 NQGPTAFL---SNPLLC 276
+L NP +C
Sbjct: 223 PLRALQYLRLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 41/184 (22%), Positives = 75/184 (40%), Gaps = 15/184 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
+P + +R+ LH N + +P F +L ++L+ N L+ + + L
Sbjct: 26 VPVGI--PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ LDLS+N+ S+ +L L L R ++ G++ L L L L DN
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 202 FKGPIPNDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTG 259
+ +P+D + L L L N +S ++ L L N ++ +
Sbjct: 141 LQA-LPDDT--FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH-PH 195
Query: 260 SFAN 263
+F +
Sbjct: 196 AFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 37/168 (22%), Positives = 60/168 (35%), Gaps = 17/168 (10%)
Query: 102 NNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDG 160
++P + + IFL+GN +S +P + L L L +N +
Sbjct: 19 PQQGLQAVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 161 LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND-LGELQSLSAT 219
L++L L+ N + + L L L L + + L +L
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQ-Y 133
Query: 220 LNLSYNHLSGKIP----KSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L L N L +P + LGNL L GN +S +P +F
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTH---LFLHGNRIS-SVP-ERAFRG 175
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 93/319 (29%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKL 468
+G+ G V++ + + VA++ + +F+ E + + HP+IVKL
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 469 RA------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
+ +I + + G L + L+ R L ++ + A + LA
Sbjct: 82 IGVITENPVW-------IIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALA 130
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
YL ++FVH DI N+L+ ++ + DFGLSR +
Sbjct: 131 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--------------------- 166
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKW---------------DVYSFGVVLLELLT-GKS 626
E + Y+A + ++P KW DV+ FGV + E+L G
Sbjct: 167 -----EDSTYYKASKGKLP-----IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
Query: 627 PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTE 686
P ++ D++ ++ G P + ++ L C
Sbjct: 217 P------FQGVKNNDVIGRIENGERLPMP------------PNCPPT---LYSLMTKCWA 255
Query: 687 ADPEVRPRMKNVSENLERI 705
DP RPR + L I
Sbjct: 256 YDPSRRPRFTELKAQLSTI 274
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 75/307 (24%), Positives = 117/307 (38%), Gaps = 56/307 (18%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIV 466
LG G VY+ + + + VAV+ L E EQ +F+ E I+K H NIV
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR--LRIAKGTARGLAYL 524
+ + ++ + ++ G+L + LR +PS S + L +A+ A G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGALPY 581
F+H DI N LL I DFG++R I G +
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML------ 248
Query: 582 MKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
PV + PEA + G K D +SFGV+L E+ + G P S
Sbjct: 249 --PV--------KWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------YPSKS 291
Query: 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+++ +V G + P + V+ + C + PE RP +
Sbjct: 292 NQEVLEFVTSGGRMDPP------------KNCPGP---VYRIMTQCWQHQPEDRPNFAII 336
Query: 699 SENLERI 705
E +E
Sbjct: 337 LERIEYC 343
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 56/307 (18%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIV 466
LG+ G+VY+ V VA++ + E R R EF+ E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGR-----NGQPSTSLSWSTRLRIAKGTARGL 521
+L L+I + ++ G+L + LR N S S +++A A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
AYL+ KFVH D+ N ++ DF I DFG++R I T G +
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------ 202
Query: 582 MKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638
PV R +PE+ + DV+SFGVVL E+ T + P +
Sbjct: 203 --PV--------RWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQP------YQGLS 245
Query: 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
++R+V +G + P + +F L C + +P++RP +
Sbjct: 246 NEQVLRFVMEGGLLDKP------------DNCPDM---LFELMRMCWQYNPKMRPSFLEI 290
Query: 699 SENLERI 705
+++
Sbjct: 291 ISSIKEE 297
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 71/321 (22%), Positives = 119/321 (37%), Gaps = 69/321 (21%)
Query: 414 VLGKSGLGIVYK------VVLGNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNI 465
VLG G V G I VAV+ L E ++E++ + ++ H NI
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGR------------------NGQPSTSLSW 507
V L LI ++ G+L N LR + + L++
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
L A A+G+ +L + VH D+ N+L+ + I DFGL+R I N
Sbjct: 172 EDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-G 624
+ PV + APE+ G ++ DV+S+G++L E+ + G
Sbjct: 229 VVRGNARL--------PV--------KWMAPESLFEGIYTIKS-DVWSYGILLWEIFSLG 271
Query: 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALAC 684
+P P L ++ GF+ + P +A +E ++ + +C
Sbjct: 272 VNP--YPGIPVDANFYKL---IQNGFKMDQP------------FYATEE---IYIIMQSC 311
Query: 685 TEADPEVRPRMKNVSENLERI 705
D RP N++ L
Sbjct: 312 WAFDSRKRPSFPNLTSFLGCQ 332
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 79/316 (25%), Positives = 128/316 (40%), Gaps = 65/316 (20%)
Query: 414 VLGKSGLGIVYKVVL--------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHP 463
LG+ G V VAV+ L E+ + ++E++ + + KH
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLR 512
NI+ L +I ++ S GNL L+ R + P LS +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
A ARG+ YL + +K +H D+ N+L+ D I+DFGL+R I+ ++
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 252
Query: 573 GFMGGALPYMKPVQTEKTNNYR--APEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629
G + PV + APEA + + DV+SFGV+L E+ T G SP
Sbjct: 253 GRL--------PV--------KWMAPEA-LFDRIYTHQSDVWSFGVLLWEIFTLGGSP-- 293
Query: 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689
+ V +L + +K+G + P + E ++ + C A P
Sbjct: 294 ----YPGVPVEELFKLLKEGHRMDKP------------SNCTNE---LYMMMRDCWHAVP 334
Query: 690 EVRPRMKNVSENLERI 705
RP K + E+L+RI
Sbjct: 335 SQRPTFKQLVEDLDRI 350
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/272 (23%), Positives = 104/272 (38%), Gaps = 40/272 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKLRAY 471
LG+ G G+V++ + A++R+ + RE + EV+A+AK++HP IV+
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 472 Y-------WAPDEKLLISDFI-----SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
+ + +I NL + + GR S L I A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAE 129
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL 579
+ +LH + +H D+KPSNI D + DFGL ++ + A
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638
+ T Y +PE K D++S G++L ELL ST +E
Sbjct: 187 HTGQ----VGTKLYMSPE--QIHGNSYSHKVDIFSLGLILFELLY--------PFSTQME 232
Query: 639 VPDLVRWVKKG-----FEEENP-LSDMVDAML 664
+ V+ F ++ P MV ML
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDML 264
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 40/284 (14%), Positives = 76/284 (26%), Gaps = 53/284 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV------------------------RRLGE----GGE 444
VLG+ + G V R L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 445 QRHREFVTEVQAIAKVKHPNIVKLRAY---YWAPDEKLLISDFISNGNLANALRGRNGQP 501
+ H F+ + + ++++R W L SN + +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561
SL RL++ R LA LH VH ++P +I+LD +++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
G + S G P + +D ++ G+ + +
Sbjct: 262 ---GASAVSPIGRGFAPPETTAER--------MLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
Query: 622 LTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE-NPLSDMVDAML 664
P W+ + + P+ +++ L
Sbjct: 311 WCADLPNTDDA------ALGGSEWIFRSCKNIPQPVRALLEGFL 348
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 76/335 (22%), Positives = 124/335 (37%), Gaps = 98/335 (29%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIV 466
LG+ G V K VAV+ L E R+ ++E + +V HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGR-------------------NGQPSTSLSW 507
KL LLI ++ G+L LR + +L+
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
+ A ++G+ YL + K VH D+ NIL+ + ISDFGLSR +
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY----- 201
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPE-ARVPGNRPMQKW---------------DV 611
+ ++Y R+P KW DV
Sbjct: 202 ---------------------EEDSYVKRSQGRIP-----VKWMAIESLFDHIYTTQSDV 235
Query: 612 YSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHA 670
+SFGV+L E++T G +P I L +K G E P +
Sbjct: 236 WSFGVLLWEIVTLGGNP------YPGIPPERLFNLLKTGHRMERP------------DNC 277
Query: 671 KKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+E ++ L L C + +P+ RP ++S++LE++
Sbjct: 278 SEE---MYRLMLQCWKQEPDKRPVFADISKDLEKM 309
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 57/265 (21%), Positives = 102/265 (38%), Gaps = 39/265 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G G K+ +G + + G E + V+EV + ++KHPNIV+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 471 YYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
L + ++ G+LA+ + + + L LR+ L H S
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 529 PRKF--VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
+H D+KP+N+ LD + DFGL+R++N + + G
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG------------- 178
Query: 587 TEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645
T Y +PE +K D++S G +L EL P + + +L
Sbjct: 179 ---TPYYMSPE--QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGK 227
Query: 646 VKKGFEEENP------LSDMVDAML 664
+++G P L++++ ML
Sbjct: 228 IREGKFRRIPYRYSDELNEIITRML 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 50/223 (22%), Positives = 94/223 (42%), Gaps = 19/223 (8%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKV-KHPNIVKLR 469
+G G V+K V +G A++R G + + EV A A + +H ++V+
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR-- 75
Query: 470 AYY--WAPDEKLLI-SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
Y+ WA D+ +LI +++ + G+LA+A+ N + + + + RGL Y+H
Sbjct: 76 -YFSAWAEDDHMLIQNEYCNGGSLADAIS-ENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
VH DIKPSNI + P + + G G + + Q
Sbjct: 134 ---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL--GHVTRISSPQ 188
Query: 587 TEK-TNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
E+ + + A E + N + K D+++ + ++ +
Sbjct: 189 VEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 63/311 (20%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKL 468
V+G+ G V K + G + A++R+ E + HR+F E++ + K+ HPNI+ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLRIAKGT 517
L ++ +GNL + LR +++LS L A
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
ARG+ YL S ++F+H D+ NIL+ ++ I+DFGLSR + G
Sbjct: 152 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKT--MG 201
Query: 578 ALP--YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634
LP +M A E+ + + DV+S+GV+L E+++ G +P
Sbjct: 202 RLPVRWM------------AIES-LNYSVYTTNSDVWSYGVLLWEIVSLGGTP------Y 242
Query: 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694
+ +L + +G+ E PL + E V+ L C P RP
Sbjct: 243 CGMTCAELYEKLPQGYRLEKPL------------NCDDE---VYDLMRQCWREKPYERPS 287
Query: 695 MKNVSENLERI 705
+ +L R+
Sbjct: 288 FAQILVSLNRM 298
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 57/229 (24%), Positives = 90/229 (39%), Gaps = 48/229 (20%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKL 468
+LG+ G VY+ V G I VAV+ + ++ +F++E + + HP+IVKL
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 469 RA-------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
+ +I + G L + L T + + + +
Sbjct: 79 IGIIEEEPTW--------IIMELYPYGELGHYLERNKNSLKVL----TLVLYSLQICKAM 126
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP- 580
AYL VH DI NIL+ + + DFGLSR I +S LP
Sbjct: 127 AYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS-----VTRLPI 178
Query: 581 -YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSP 627
+M +PE+ + R DV+ F V + E+L+ GK P
Sbjct: 179 KWM------------SPES-INFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 66/304 (21%), Positives = 117/304 (38%), Gaps = 63/304 (20%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVKL 468
+G+ G V++ + + VA++ R +F+ E + + HP+IVKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 469 RA------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
+ +I + + G L + L+ R L ++ + A + LA
Sbjct: 457 IGVITENPVW-------IIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALA 505
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
YL ++FVH DI N+L+ ++ + DFGLSR + + +S G
Sbjct: 506 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-------- 554
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPD 641
P++ + APE+ + R DV+ FGV + E+L G P ++ D
Sbjct: 555 -PIK------WMAPES-INFRRFTSASDVWMFGVCMWEILMHGVKP------FQGVKNND 600
Query: 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701
++ ++ G P + + + L C DP RPR +
Sbjct: 601 VIGRIENGERLPMP-PNCPPTL--------------YSLMTKCWAYDPSRRPRFTELKAQ 645
Query: 702 LERI 705
L I
Sbjct: 646 LSTI 649
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 53/219 (24%), Positives = 78/219 (35%), Gaps = 33/219 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLR 469
LG G V+KV +G AV+ G + + EV + KV +HP V+L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 470 AYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
W L L ++ +L G L + + T LA+LH
Sbjct: 124 -QAWEEGGILYLQTEL-CGPSLQQHCE-AWGAS---LPEAQVWGYLRDTLLALAHLHS-- 175
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+ VH D+KP+NI L + + DFGL + G G
Sbjct: 176 -QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG---------------- 218
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE + DV+S G+ +LE+
Sbjct: 219 -DPRYMAPE--LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 12/166 (7%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S L SL L + N + P + N T L+S+ + N ++ + NL +L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPLANLSQLTWL 248
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
++ N S + +K+ +L+ L + N+ S L L L L++N
Sbjct: 249 EIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVLN---NLSQLNSLFLNNNQLGNED 303
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+G L +L+ TL LS NH++ P L +L S D +
Sbjct: 304 MEVIGGLTNLT-TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 37/174 (21%), Positives = 60/174 (34%), Gaps = 14/174 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L ++ L L + + + + N T L+S+ L N + + +L L
Sbjct: 147 DLSPLSNMTGLNYLTVTESKV--KDVTPIANLTDLYSLSLNYNQIEDI--SPLASLTSLH 202
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
N + + N +L L + NK + P L L L++ N
Sbjct: 203 YFTAYVNQITDI--TPVANMTRLNSLKIGNNKITDLSPLA---NLSQLTWLEIGTNQISD 257
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ +L L LN+ N +S L NL S L N L E +
Sbjct: 258 INA--VKDLTKLK-MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEV 306
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 39/169 (23%), Positives = 65/169 (38%), Gaps = 13/169 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L +L LR L L+ +N+ P L N T ++S+ L N+ S + N+ L
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLN 158
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L ++ + P + N L L L N+ P L +L N
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA---SLTSLHYFTAYVNQITD 213
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
P + + L+ +L + N ++ P L NL ++ N +S
Sbjct: 214 ITP--VANMTRLN-SLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 36/170 (21%), Positives = 64/170 (37%), Gaps = 13/170 (7%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L R L ++ + S+ + + G ++ S+ + L L+ L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+L+ N + P L N +L L + NK + I A L NL +L L++++
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISA--LQNLTNLRELYLNEDNISDIS 126
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
P L L + +LNL NH L N+ + + + P
Sbjct: 127 P--LANLTKMY-SLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP 172
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 3e-21
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 13/171 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
L + +L + + S+ + T+L + L GN ++ + NL +L N
Sbjct: 37 VVTQEELESITKLVVAGEKV-ASIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTN 92
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
L + N + L+N L+ L L + S P L + L+L N
Sbjct: 93 LYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLA---NLTKMYSLNLGANHNLSD 147
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+ L + L+ L ++ + + P + NL S L N + P
Sbjct: 148 LSP-LSNMTGLN-YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP 194
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 13/170 (7%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L L LNL+ N + P L N L ++++ N ++ ++ NL L+ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLREL 115
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L+ ++ S L N ++ L L N + + + L L ++++ K
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPL-SNMTGLNYLTVTESKVKDVT 171
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
P + L L +L+L+YN + P L +L F N ++ P
Sbjct: 172 P--IANLTDLY-SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 27/140 (19%), Positives = 50/140 (35%), Gaps = 15/140 (10%)
Query: 117 TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNK 176
+L ++ N + +L L S + + + + + +L++A K
Sbjct: 3 ATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEK 55
Query: 177 FSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLG 236
+ L NL L+L+ N P L L L+ L + N ++ +L
Sbjct: 56 VASIQGIE---YLTNLEYLNLNGNQITDISP--LSNLVKLT-NLYIGTNKIT--DISALQ 107
Query: 237 NLPVTVSFDLRGNNLSGEIP 256
NL L +N+S P
Sbjct: 108 NLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 4/93 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
+ + L L+ LN+ +N + S L N + L+S+FL N L + L L
Sbjct: 258 INAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
L LS N + P L + ++ A
Sbjct: 316 LFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 14/114 (12%), Positives = 31/114 (27%), Gaps = 32/114 (28%)
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L + PD +L ++ L
Sbjct: 2 AATLATLPAPINQIFPD---------------------------ADLAEGIRAVLQKASV 34
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+ EL+S++ L ++ ++ + + L +L GN ++ P
Sbjct: 35 TDVVT--QEELESIT-KLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITDISP 83
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 51/236 (21%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+LG+ V++ G A+ + + RE + + K+ H NIVK
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKLNHKNIVK 71
Query: 468 LRAYYWAPDEKL--LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
L A + LI +F G+L L + L S L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMG---GA 578
E VH +IKP NI+ ++DFG +R + G
Sbjct: 130 E---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--------DDEQFVSLYGT 178
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKW-----DVYSFGVVLLELLTGKSP 627
Y+ P+ R + QK D++S GV TG P
Sbjct: 179 EEYL------------HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-23
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 25/171 (14%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P SL L+ +N L +LP+ + L + N L+ LP L +
Sbjct: 95 LPELPASL---EYLDACDNRL-STLPELPASLKHLD---VDNNQLT-MLPELPALL---E 143
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
++ NN + LP+ + L+ L + N+ + +P E+L LD+S N +
Sbjct: 144 YINADNNQLT-MLPELPTS---LEVLSVRNNQLT-FLP----ELPESLEALDVSTNLLES 194
Query: 205 PIPNDLGELQSLSAT---LNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+P T N ++ IP+++ +L T + L N LS
Sbjct: 195 -LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 2e-20
Identities = 37/172 (21%), Positives = 66/172 (38%), Gaps = 24/172 (13%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S + N L + L + L NLS SLP ++ P++
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLS-SLPDNLP--PQIT 83
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L+++ N+ SLP+ + L+ L N+ S +P +L LD+ +N
Sbjct: 84 VLEITQNALI-SLPELPAS---LEYLDACDNRLS-TLP----ELPASLKHLDVDNNQLTM 134
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+P L+ +N N L+ +P+ +L +R N L+ +P
Sbjct: 135 -LPELPALLE----YINADNNQLT-MLPELPTSL---EVLSVRNNQLT-FLP 176
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 9e-17
Identities = 34/163 (20%), Positives = 55/163 (33%), Gaps = 25/163 (15%)
Query: 98 LNLHNNNLFGSLPDQLFNA----TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153
N N + F+A N L C + + L L+ +
Sbjct: 15 QNSFYNTI-SGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNL 71
Query: 154 SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGEL 213
S SLPD L Q+ L + +N +P +L LD DN +P L
Sbjct: 72 S-SLPDNL--PPQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPELPASL 122
Query: 214 QSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+ L++ N L+ +P+ L + N L+ +P
Sbjct: 123 KH----LDVDNNQLT-MLPELPALL---EYINADNNQLT-MLP 156
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 25/126 (19%), Positives = 50/126 (39%), Gaps = 19/126 (15%)
Query: 140 LPRLQNLDLSNNSFSGSL---PDGLKNC-KQLQRLILA---RNKFSGQIPAGIWPELENL 192
LP N LS NSF ++ + + ++ L RN+ + + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL---INQF 61
Query: 193 VQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+L L+ + +P++L ++ L ++ N L +P+ +L D N LS
Sbjct: 62 SELQLNRLNLSS-LPDNLP--PQIT-VLEITQNALI-SLPELPASL---EYLDACDNRLS 113
Query: 253 GEIPQT 258
+P+
Sbjct: 114 -TLPEL 118
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 23/152 (15%), Positives = 42/152 (27%), Gaps = 14/152 (9%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHS----IFLYGNNLSGSLPPSVCNL 140
+P SL L++ N L SLP N ++ +P ++ +L
Sbjct: 175 LPELPESL---EALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229
Query: 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN----LVQLD 196
+ L +N S + + L R FS
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228
+ I + + + T + + LS
Sbjct: 290 ENKQSDVSQIWHAFEHEEH-ANTFSAFLDRLS 320
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-23
Identities = 43/175 (24%), Positives = 61/175 (34%), Gaps = 14/175 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
L SL L L+L NN + P L T L + L N +S + L L N
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTN 291
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
L+L+ N + N K L L L N S P L L +L +N
Sbjct: 292 LELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQRLFFYNNKVSDV 346
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS 260
L L +++ L+ +N +S P L NL L + +
Sbjct: 347 SS--LANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 45/170 (26%), Positives = 60/170 (35%), Gaps = 14/170 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ LG L L L+L+ N L L + T+L + L N +S + L +L L
Sbjct: 215 TPLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNL--APLSGLTKLTEL 270
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L N S L L L L N+ P L+NL L L N+
Sbjct: 271 KLGANQISNI--SPLAGLTALTNLELNENQLEDISPIS---NLKNLTYLTLYFNNISDIS 325
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
P + L L L N +S SL NL N +S P
Sbjct: 326 P--VSSLTKLQ-RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 14/168 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
S L L L L NN + P L T+L + L GN L ++ +L L +
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
LDL+NN S P L +L L L N+ S P L L L+L++N +
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA---GLTALTNLELNENQLEDI 302
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
P + L++L+ L L +N++S P + +L N +S
Sbjct: 303 SP--ISNLKNLT-YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-21
Identities = 52/170 (30%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L +L L RL L +N + S L TSL + GN ++ P + NL L+ L
Sbjct: 128 DPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
D+S+N S L L+ LI N+ S P G L NL +L L+ N K
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG---ILTNLDELSLNGNQLKDIG 237
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
L L +L+ L+L+ N +S P L L L N +S P
Sbjct: 238 T--LASLTNLT-DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 36/170 (21%), Positives = 62/170 (36%), Gaps = 15/170 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+L + L N+ ++ + + ++ + V L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+ SNN + P LKN +L +++ N+ + P L NL L L +N
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDID 128
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
P L L +L+ L LS N +S +L L GN ++ P
Sbjct: 129 P--LKNLTNLN-RLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 42/166 (25%), Positives = 64/166 (38%), Gaps = 12/166 (7%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S L L L L L+ N L P + N +L + LY NN+S P V +L +LQ L
Sbjct: 281 SPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
NN S L N + L N+ S P L + QL L+D +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQAWTNAP 391
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
N + + N++ ++ P ++ + D+ N S
Sbjct: 392 VNYKANVSIPNTVKNVTGALIA---PATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-19
Identities = 39/168 (23%), Positives = 59/168 (35%), Gaps = 15/168 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
L + L + D + +L I N L+ + P + NL +L +
Sbjct: 39 TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVD 94
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
+ ++NN + L N L L L N+ + P L NL +L+LS N
Sbjct: 95 ILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTISDI 149
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
L L SL L+ K L NL D+ N +S
Sbjct: 150 SA--LSGLTSLQ-QLSFGNQVTD---LKPLANLTTLERLDISSNKVSD 191
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-19
Identities = 49/171 (28%), Positives = 64/171 (37%), Gaps = 15/171 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
+ L L ++N NN L P L N T L I + N ++ + NL L
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTG 116
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
L L NN + D LKN L RL L+ N S L +L QL N
Sbjct: 117 LTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALS---GLTSLQQLSFG-NQVTDL 170
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
P L L +L L++S N +S L L S N +S P
Sbjct: 171 KP--LANLTTLE-RLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP 216
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 18/122 (14%), Positives = 36/122 (29%), Gaps = 6/122 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
S L +L + L+ +N + P L N T + + L + + P + + N
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT-NAPVNYKANVSIPN 402
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
+ P + + + N S + V + F G
Sbjct: 403 TVKNVTGAL-IAPATISDGGSYTEPDITWNLPS-YTNEVSY-TFSQPVTIGKGTTTFSGT 459
Query: 206 IP 207
+
Sbjct: 460 VT 461
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 56/290 (19%), Positives = 107/290 (36%), Gaps = 57/290 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ VYK + + VA + + + + F E + + ++HPNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 471 YYWAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ + + +L+++ +++G L L+ R + + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK-RFK----VMKIKVLRSWCRQILKGLQFLHT 147
Query: 527 CSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+P +H D+K NI + I D GL+ L + + G +M
Sbjct: 148 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA------VIGTPEFM--- 197
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPTTSTSIEVPDLV 643
APE + + + DVY+FG+ +LE+ T + P E +
Sbjct: 198 ---------APE--MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIY 239
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
R V G + + + KE+I C + + R
Sbjct: 240 RRVTSG-VKPASFDKVAIPEV-------KEII------EGCIRQNKDERY 275
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-23
Identities = 43/215 (20%), Positives = 74/215 (34%), Gaps = 19/215 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S L I + L+ +N++ + + L + L NNL+ + N P L +
Sbjct: 205 STLAIPIAVEELDASHNSI-NVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEV 259
Query: 147 DLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
DLS N + ++L+RL ++ N+ + P + L LDLS N
Sbjct: 260 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLLH- 315
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQG 265
+ + + L L L +N + + L + L N+ F N
Sbjct: 316 VERNQPQFDRLE-NLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVA 370
Query: 266 PTAFLSNPLLCGFPLQKS----CKDSTESQQETQN 296
A C Q CK+S + +
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-21
Identities = 44/203 (21%), Positives = 74/203 (36%), Gaps = 11/203 (5%)
Query: 53 CRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQ 112
R C++ D V I + Y E +L + + N+ + LP
Sbjct: 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAA 69
Query: 113 LF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQR 169
L + + + L + + +Q L + N+ LP +N L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127
Query: 170 LILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229
L+L RN S +P GI+ L L +S+N+ + + SL L LS N L+
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ-NLQLSSNRLT- 184
Query: 230 KIPKSLGNLPVTVSFDLRGNNLS 252
+ L +P ++ N LS
Sbjct: 185 HVD--LSLIPSLFHANVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 7e-20
Identities = 42/183 (22%), Positives = 74/183 (40%), Gaps = 24/183 (13%)
Query: 85 IPSE-LGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLP 141
I + +++L + N + LP +F N L + L N+LS SLP + N P
Sbjct: 90 IDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 147
Query: 142 RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+L L +SNN+ + D + LQ L L+ N+ + + + + +L ++S N
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL---IPSLFHANVSYN 202
Query: 201 DFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS 260
L ++ L+ S+N ++ L L+ NNL+ T
Sbjct: 203 LLS-----TLAIPIAVE-ELDASHNSINVVRGPVNVELT---ILKLQHNNLT----DTAW 249
Query: 261 FAN 263
N
Sbjct: 250 LLN 252
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 4e-17
Identities = 34/153 (22%), Positives = 53/153 (34%), Gaps = 11/153 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ L + L ++L N L + F L +++ N L +L +P L+
Sbjct: 247 TAWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 304
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
LDLS+N + +L+ L L N + L L LS ND+
Sbjct: 305 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST---HHTLKNLTLSHNDWD- 358
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGN 237
N L L A + KI L +
Sbjct: 359 --CNSLRALFRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 7e-16
Identities = 26/166 (15%), Positives = 52/166 (31%), Gaps = 8/166 (4%)
Query: 100 LHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPD 159
+ + L + + + L + + N++ LP
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 68
Query: 160 G-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND-LGELQSLS 217
L + +Q++ L L + +I + + +L + N + +P + L+
Sbjct: 69 ALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLT 126
Query: 218 ATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L L N LS N P + + NNL I +F
Sbjct: 127 -VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 29/130 (22%), Positives = 47/130 (36%), Gaps = 9/130 (6%)
Query: 84 YIPSE-LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142
I + L RL + NN L +L +L + L N+L + + R
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDR 325
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L+NL L +NS +L L+ L L+ N + + N+ + + D D
Sbjct: 326 LENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRAL---FRNVARPAVDDADQ 379
Query: 203 KGPIPNDLGE 212
I L
Sbjct: 380 HCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 25/179 (13%), Positives = 51/179 (28%), Gaps = 18/179 (10%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG-SLPPSVCNLPR 142
++ L L L +N++ +L +L ++ L N+ SL N+ R
Sbjct: 315 HVERNQPQFDRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWDCNSLRALFRNVAR 371
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
D + + CK+ + L R L+ + + +
Sbjct: 372 PAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL-------------LQYIALTSVVEKVQ 418
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTV-SFDLRGNNLSGEIPQTGS 260
+ + + +L+ G + L V L+ E Q
Sbjct: 419 RAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQ 477
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 37/184 (20%), Positives = 75/184 (40%), Gaps = 13/184 (7%)
Query: 85 IPSE-LGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLP 141
IP L L +L++ N + L D +F + +L S+ + N+L + L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLN 152
Query: 142 RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
L+ L L + + S+P L + L L L + I + L L L++S
Sbjct: 153 SLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHW 210
Query: 201 DFKGPIPNDLGELQSLSATLNLSYNHLSGKIP-KSLGNLPVTVSFDLRGNNLSGEIPQTG 259
+ + + +L+ +L++++ +L+ +P ++ +L +L N +S I
Sbjct: 211 PYLDTMTPNCLYGLNLT-SLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIE-GS 266
Query: 260 SFAN 263
Sbjct: 267 MLHE 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 39/180 (21%), Positives = 67/180 (37%), Gaps = 8/180 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
L L+ L + +N+L + + F+ SL + L NL+ S+P +L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGL 178
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
L L + + + K +L+ L ++ + + L NL L ++ +
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL-NLTSLSITHCNLT 237
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+ L L LNLSYN +S L L L G L+ + +F
Sbjct: 238 AVPYLAVRHLVYLR-FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEP-YAFRG 294
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-22
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 7/171 (4%)
Query: 85 IPSE-LGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCNLPR 142
IP+E L L L L L + N+ ++ D F L + + ++ P+
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN 225
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L +L +++ + + ++P +++ L+ L L+ N S I + EL L ++ L
Sbjct: 226 LTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQ 283
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
P L L LN+S N L+ ++ + L N L+
Sbjct: 284 LAVVEPYAFRGLNYLR-VLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 12/182 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
+P + R L+L N + D+ + L + L N +S ++ P NL L
Sbjct: 26 VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82
Query: 144 QNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+ L L +N +P G L +L ++ NK + ++ +L NL L++ DND
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
L SL L L +L+ IP +L +L + LR N++ I SF
Sbjct: 141 VYISHRAFSGLNSLE-QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIR-DYSF 196
Query: 262 AN 263
Sbjct: 197 KR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 11/170 (6%)
Query: 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFS 154
R + H ++P+ + T + L N + +L + P L+ L+L+ N S
Sbjct: 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS 69
Query: 155 GSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGEL 213
++ G N L+ L L N+ IP G++ L NL +LD+S+N + +L
Sbjct: 70 -AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDL 127
Query: 214 QSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+L +L + N L ++ L L NL+ IP T + ++
Sbjct: 128 YNL-KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIP-TEALSH 174
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 25/130 (19%), Positives = 51/130 (39%), Gaps = 7/130 (5%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLP 134
IS + + L L++ + NL ++P + L + L N +S ++
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-TIE 264
Query: 135 PSV-CNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENL 192
S+ L RLQ + L + + + L+ L ++ N+ + + ++ + NL
Sbjct: 265 GSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNL 322
Query: 193 VQLDLSDNDF 202
L L N
Sbjct: 323 ETLILDSNPL 332
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 67/321 (20%), Positives = 106/321 (33%), Gaps = 67/321 (20%)
Query: 400 FTFELD-ELLRASAYVLGKSGLGIVYKVVLGNG---IPVAVRRLGEG--GEQRHREFVTE 453
LD +LL LG G V K VAV+ L E + E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 454 VQAIAKVKHPNIVKLRA------YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSW 507
+ ++ +P IV++ + L+ + G L L+ ++
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAESWM-------LVMEMAELGPLNKYLQQNRHVKDKNI-- 119
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
+ + + G+ YL E FVH D+ N+LL ISDFGLS+ + N
Sbjct: 120 ---IELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173
Query: 568 PSSSGGFMGGALPY--MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-G 624
+ G P APE + + K DV+SFGV++ E + G
Sbjct: 174 YKAQT---HGKWPVKWY------------APEC-INYYKFSSKSDVWSFGVLMWEAFSYG 217
Query: 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALAC 684
+ P ++ ++ ++KG P ++ L C
Sbjct: 218 QKP------YRGMKGSEVTAMLEKGERMGCPAGCP---------------REMYDLMNLC 256
Query: 685 TEADPEVRPRMKNVSENLERI 705
D E RP V L
Sbjct: 257 WTYDVENRPGFAAVELRLRNY 277
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 39/269 (14%), Positives = 82/269 (30%), Gaps = 42/269 (15%)
Query: 414 VLGKSGLGIVYKVV------LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+LG+ VY+ N ++ ++ + +K
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
+ + + +L+ + S G L NA+ P + + A + +H+C
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 528 SPRKFVHGDIKPSNILLDNDFQPY-----------ISDFGLSRLINITGNNPSSSGGFMG 576
+ +HGDIKP N +L N F + D G S + + F
Sbjct: 192 ---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG----TIFTA 244
Query: 577 GALPYMKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPTTST 635
+T+ ++ E + N+P + D + + +L G ++
Sbjct: 245 KC----------ETSGFQCVE--MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAML 664
+ + ++ ML
Sbjct: 293 CKPEGLF-----RRLPHLDMWNEFFHVML 316
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 38/248 (15%), Positives = 68/248 (27%), Gaps = 49/248 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGE---------------------------- 444
VLG+ + G V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 445 QRHREFVTEVQAIAKVKHPNIVKLRAY---YWAPDEKLLISDFISNGNLANALRGRNGQP 501
+ H F+ + + ++++R W L SN + +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561
SL RL++ R LA LH VH ++P +I+LD +++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 255
Query: 562 NITGNNPSSSGGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLL 619
G SS + P T +Y + +D ++ G+V+
Sbjct: 256 --DGARVVSSVS-----RGFEPPELEARRATISYHRDRRTLMT----FSFDAWALGLVIY 304
Query: 620 ELLTGKSP 627
+ P
Sbjct: 305 WIWCADLP 312
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 53/219 (24%), Positives = 77/219 (35%), Gaps = 34/219 (15%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
L +L L L N++ + F SL+++ L+ N L+ +P L +L
Sbjct: 92 ADTFRHLHHLEVLQLGRNSI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKL 149
Query: 144 QNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+ L L NN S+P L RL L K I G + L NL L+L +
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208
Query: 203 KGPIPN--DLGELQSLS--------------------ATLNLSYNHLSGKIPKSLGNLPV 240
K +PN L L+ L L + + +S + L
Sbjct: 209 KD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLAS 267
Query: 241 TVSFDLRGNNLSGEIPQTGSFANQGPTAFL---SNPLLC 276
V +L NNLS +P F L NP C
Sbjct: 268 LVELNLAHNNLS-SLPH-DLFTPLRYLVELHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 42/196 (21%), Positives = 68/196 (34%), Gaps = 38/196 (19%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSF 153
++ L +P + ++ + L NN+ + +L L+ L L NS
Sbjct: 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSI 111
Query: 154 SGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP----N 208
+ G L L L N + IP+G + L L +L L +N + IP N
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFN 168
Query: 209 DLGELQSLS---------------------ATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247
+ L L LNL ++ +P +L L ++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 248 GNNLSGEIPQTGSFAN 263
GN+ EI GSF
Sbjct: 227 GNHFP-EIRP-GSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 32/119 (26%), Positives = 48/119 (40%), Gaps = 6/119 (5%)
Query: 84 YIPSE-LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLP 141
YI L L+ LNL N+ +P+ L L + + GN+ + P L
Sbjct: 186 YISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLS 242
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
L+ L + N+ S + L L LA N S +P ++ L LV+L L N
Sbjct: 243 SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 70/332 (21%), Positives = 110/332 (33%), Gaps = 98/332 (29%)
Query: 414 VLGKSGLGIVYKVVLGNG------IPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIV 466
LG+ G VYK L VA++ L + E R EF E A+++HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGR-----------NGQPSTSLSWSTRLRIAK 515
L +I + S+G+L L R + ++L + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFM 575
A G+ YL S VH D+ N+L+ + ISD GL R +
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-------------- 178
Query: 576 GGALPYMKPVQTEKTNNYRAPE-ARVPGNRPMQKW---------------DVYSFGVVLL 619
+ Y+ + +P +W D++S+GVVL
Sbjct: 179 ------------YAADYYKLLGNSLLP-----IRWMAPEAIMYGKFSIDSDIWSYGVVLW 221
Query: 620 ELLT-GKSP--ELSPTTSTSIEVPDLVRWVKKGFEEENPL--SDMVDAMLLQEVHAKKEV 674
E+ + G P S D+V ++ P
Sbjct: 222 EVFSYGLQPYCGYS--------NQDVVEMIRNRQVLPCPDDCPA---------------- 257
Query: 675 IAVFHLALACTEADPEVRPRMKNVSENLERIG 706
V+ L + C P RPR K++ L G
Sbjct: 258 -WVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 43/326 (13%)
Query: 374 EDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL-GNGI 432
E+ E+++Q++ E L K + D+ + S LG G+V+KV +G+
Sbjct: 5 EELELDEQQRKRL---EAFLTQKQKVGELKDDDFEKIS--ELGAGNGGVVFKVSHKPSGL 59
Query: 433 PVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLIS-DFISNG 488
+A + + E + + E+Q + + P IV +Y A D ++ I + + G
Sbjct: 60 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---FYGAFYSDGEISICMEHMDGG 116
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
+L L+ P L +++ +GL YL K +H D+KPSNIL+++
Sbjct: 117 SLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169
Query: 549 QPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ 607
+ + DFG+S +LI+ S + F+G T +Y +PE R+ G
Sbjct: 170 EIKLCDFGVSGQLID------SMANSFVG-------------TRSYMSPE-RLQGTHYSV 209
Query: 608 KWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQE 667
+ D++S G+ L+E+ G+ P P + P +
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
Query: 668 VHAKKEVIAVFHLALACTEADPEVRP 693
I F L P P
Sbjct: 270 DSRPPMAI--FELLDYIVNEPPPKLP 293
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 34/198 (17%), Positives = 67/198 (33%), Gaps = 23/198 (11%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
++ +++ + S S ++ L+L N L L T L + L N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQL 195
+ +L L+ LDL+NN L G ++ L A N S ++ + +
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS-RVSCSR---GQGKKNI 125
Query: 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG-KIPKSLGNLPVTVSFDLRGNNLSGE 254
L++N D G + L+L N + + + +L+ N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 255 IPQTGSFANQGPTAFLSN 272
+ +
Sbjct: 184 VK---------GQVVFAK 192
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 6e-22
Identities = 29/179 (16%), Positives = 64/179 (35%), Gaps = 13/179 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
I + + + +++L +L +A ++ + L GN LS + +L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L+LS+N D L++ L+ L L N ++ L ++N+
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQE------LLVGPSIETLHAANNNISR 113
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+ ++ + L+ N ++ G DL+ N + + A+
Sbjct: 114 VSCSRGQGKKN----IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 1e-21
Identities = 40/190 (21%), Positives = 66/190 (34%), Gaps = 25/190 (13%)
Query: 86 PSELGSLIYLRRLNLHNNNL-----FGSLPD------------QLFNATSLHSIFLYGNN 128
++L L LNL +N L SL +L S+ ++ NN
Sbjct: 51 AADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNN 110
Query: 129 LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE 188
+S + S +N+ L+NN + ++Q L L N+ A +
Sbjct: 111 IS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 189 LENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248
+ L L+L N + + L TL+LS N L+ + + LR
Sbjct: 168 SDTLEHLNLQYNFIYD-VKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWISLRN 223
Query: 249 NNLSGEIPQT 258
N L I +
Sbjct: 224 NKLV-LIEKA 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 2e-19
Identities = 23/174 (13%), Positives = 50/174 (28%), Gaps = 7/174 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L LNL N ++ + Q+ L ++ L N L+ + P + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+ L NN + L+ + L+ L N F + + + + +
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK-- 274
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ E ++ + L + + G +
Sbjct: 275 -LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER 327
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 8e-18
Identities = 28/156 (17%), Positives = 55/156 (35%), Gaps = 14/156 (8%)
Query: 108 SLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQL 167
++ + N + ++L +L + ++ LDLS N S L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 QRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227
+ L L+ N + L L LDL++N + +L S+ TL+ + N++
Sbjct: 61 ELLNLSSNVLY-ETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIE-TLHAANNNI 111
Query: 228 SGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
S + L N ++ +
Sbjct: 112 SRVSCSRGQGK---KNIYLANNKIT-MLRD-LDEGC 142
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 27/230 (11%), Positives = 64/230 (27%), Gaps = 16/230 (6%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS-GSLPPSVCNLPR 142
++ E S + ++L NN L + L + +L L GN G+L R
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+Q + + + C +PA P + L+ L ++
Sbjct: 264 VQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPA---PFADRLIALKRKEHAL 317
Query: 203 KGPIPNDLGELQSLSAT------LNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
++ L+ ++ I + ++ + + L +
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ-- 375
Query: 257 QTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKK 306
+ + LQ + ++ + Q + +
Sbjct: 376 VSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVE 425
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 15/173 (8%), Positives = 40/173 (23%), Gaps = 6/173 (3%)
Query: 89 LGSLIYLRRLNLH----NNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
LI L+R + L + N I +
Sbjct: 304 ADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L+ + + +G + +L + E L L ++
Sbjct: 364 TLEQKKKALDEQVSNGRRAHAELDGTLQQAV--GQIELQHATEEQSPLQLLRAIVKRYEE 421
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
+ ++ + + ++ + DL + + + +
Sbjct: 422 MYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQE 474
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 47/248 (18%), Positives = 87/248 (35%), Gaps = 20/248 (8%)
Query: 53 CRWSGISC----MNITGFPD--PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLF 106
C + G N+T P + +S +R S L L+ L L +
Sbjct: 2 CSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 107 GSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSL--PDGLK 162
++ + F N +L + L + + L P L L L L S ++ +
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFR 120
Query: 163 NCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLS-ATLN 221
N K L RL L++N+ + +L +L +D S N ++L LQ + + +
Sbjct: 121 NLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFS 180
Query: 222 LSYNHLSGKIPKSLGNLPVTV------SFDLRGNNLSGEIPQT--GSFANQGPTAFLSNP 273
L+ N L ++ G D+ GN + +I + + + +
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 274 LLCGFPLQ 281
+ G
Sbjct: 241 HIMGAGFG 248
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 2e-20
Identities = 40/187 (21%), Positives = 60/187 (32%), Gaps = 17/187 (9%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151
+R L+L + +F L + L N ++ + L LQ L+LS N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI----- 206
++ + L +N + I + LE L LDL DN
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
Query: 207 ------PNDLGELQSLSATLN---LSYNHLSG-KIPKSLGNLPVTVSFDLRGNNLSGEIP 256
N L L ++ T N LS N L I L +P L N S
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCS 442
Query: 257 QTGSFAN 263
+ +
Sbjct: 443 GDQTPSE 449
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 51/255 (20%), Positives = 86/255 (33%), Gaps = 42/255 (16%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC-----NLPR 142
L + +L+ L L+ N DQ + SL +FL N L + +C L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
LQ L L++N + +P G++ L L L L+ N
Sbjct: 482 LQVLYLNHNYLN-------------------------SLPPGVFSHLTALRGLSLNSNRL 516
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA 262
NDL +L L++S N L P +L D+ N E + +F
Sbjct: 517 TVLSHNDL--PANLE-ILDISRNQLLAPNPDVFVSLS---VLDITHNKFICEC-ELSTFI 569
Query: 263 NQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLISAADA 322
N +N + G P C +S S ++ ++ + L +
Sbjct: 570 N---WLNHTNVTIAGPPADIYC-VYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 323 AAVAVIGLVIVYVYW 337
+ + + I+ V
Sbjct: 626 VTLTLFLMTILTVTK 640
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 29/126 (23%), Positives = 49/126 (38%), Gaps = 7/126 (5%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLP 134
+ L +L+ L L++N L SLP +F + T+L + L N L+ L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
+ L+ LD+S N PD + L L + NKF + + N
Sbjct: 521 HND-LPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELSTFINWLNHTN 576
Query: 195 LDLSDN 200
+ ++
Sbjct: 577 VTIAGP 582
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 37/208 (17%), Positives = 72/208 (34%), Gaps = 41/208 (19%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV------ 137
+I S +L+ H++NL +P + N S + + + PP
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 138 -------CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE 190
C + L+L+N S SLP+ + L+ L+ + N + ++P L+
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELP-QSLK 114
Query: 191 NLVQLDLSDNDFKGPIPN---------------DLGELQSLSATLNLSYNHLSGKIPKSL 235
+L+ + + P +L L +++ N L K+P
Sbjct: 115 SLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLK-IIDVDNNSLK-KLPDLP 172
Query: 236 GNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+L N L E+P+ +
Sbjct: 173 PSL---EFIAAGNNQLE-ELPELQNLPF 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 39/189 (20%), Positives = 63/189 (33%), Gaps = 32/189 (16%)
Query: 85 IPSELGSLIYLRRLNLHNN----------------NLFGSLPDQLFNATSLHSIFLYGNN 128
+P SL L N + N LP+ L N++ L I + N+
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNS 164
Query: 129 LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE 188
L LP P L+ + NN LP+ L+N L + N ++P
Sbjct: 165 LK-KLPDL---PPSLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLK-KLP----DL 213
Query: 189 LENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248
+L + +N + +L L L+ T+ N L +P +L D
Sbjct: 214 PLSLESIVAGNNILE--ELPELQNLPFLT-TIYADNNLLK-TLPDLPPSLEALNVRDNYL 269
Query: 249 NNLSGEIPQ 257
+L
Sbjct: 270 TDLPELPQS 278
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 47/187 (25%), Positives = 73/187 (39%), Gaps = 39/187 (20%)
Query: 88 ELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147
EL +L +L + NN+L LPD + L SI N L P + NLP L +
Sbjct: 190 ELQNLPFLTAIYADNNSL-KKLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIY 243
Query: 148 LSNNSFSGSLPDGLKNCK-----------------QLQRLILARNKFSGQIPAGIWPELE 190
NN +LPD + + L L ++ N FS +
Sbjct: 244 ADNNLLK-TLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS-GLSE----LPP 297
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250
NL L+ S N+ + + + L+ LN+S N L ++P L N+
Sbjct: 298 NLYYLNASSNEIRS-LCDLPPSLE----ELNVSNNKLI-ELPALPPRL---ERLIASFNH 348
Query: 251 LSGEIPQ 257
L+ E+P+
Sbjct: 349 LA-EVPE 354
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 19/170 (11%)
Query: 88 ELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147
EL + +L+ +++ NN+L LPD + + N L P + NLP L +
Sbjct: 148 ELQNSSFLKIIDVDNNSL-KKLPDLPPSLEFIA---AGNNQLEE--LPELQNLPFLTAIY 201
Query: 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207
NNS LPD + L+ ++ N ++P L L + +N K +P
Sbjct: 202 ADNNSLK-KLPDLPLS---LESIVAGNNILE-ELPE--LQNLPFLTTIYADNNLLKT-LP 253
Query: 208 NDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
+ L++L N+ N+L+ +P+ +L + + LS P
Sbjct: 254 DLPPSLEAL----NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 30/183 (16%), Positives = 57/183 (31%), Gaps = 36/183 (19%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ +L LN +N + SL D SL + + N L LP L +
Sbjct: 292 LSELPPNL---YYLNASSNEI-RSLCDLP---PSLEELNVSNNKLI-ELPALPPRL---E 340
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIW---------------PEL 189
L S N + +P+ +N L++L + N + P
Sbjct: 341 RLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395
Query: 190 ENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
+NL QL + N + P+ ++ L ++ + + +
Sbjct: 396 QNLKQLHVETNPLRE-FPDIPESVEDL----RMNSERVVDPYEFAHETTDKLEDDVFEHH 450
Query: 250 NLS 252
+
Sbjct: 451 HHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 13/95 (13%), Positives = 30/95 (31%), Gaps = 12/95 (12%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
P S+ +L N+ +P+ N LH + N L P +
Sbjct: 371 EFPDIPESVE-----DLRMNSHLAEVPELPQNLKQLH---VETNPLR-EFPDI---PESV 418
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178
++L +++ + +L+ + +
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 48/184 (26%), Positives = 75/184 (40%), Gaps = 38/184 (20%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P L + L++ +N L SLP L Y N L+ SLP LQ
Sbjct: 136 LPVLPPGL---QELSVSDNQL-ASLPALPSELCKLW---AYNNQLT-SLPML---PSGLQ 184
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L +S+N + SLP L +L N+ + +PA L +L +S N
Sbjct: 185 ELSVSDNQLA-SLPTLPSE---LYKLWAYNNRLT-SLPA----LPSGLKELIVSGNRLTS 235
Query: 205 PIPNDLGELQSLSA----------------TLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248
+P EL+ L +L++ N L+ ++P+SL +L + +L G
Sbjct: 236 -LPVLPSELKELMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 249 NNLS 252
N LS
Sbjct: 294 NPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 8e-22
Identities = 37/162 (22%), Positives = 59/162 (36%), Gaps = 26/162 (16%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154
LN+ + L +LPD L + ++ + NNL+ SLP P L+ L++S N +
Sbjct: 42 NAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT 94
Query: 155 GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQ 214
SLP +L L +L + N +P LQ
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP--------ALPSGLCKLWIFGNQLTS-LPVLPPGLQ 144
Query: 215 SLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
L++S N L+ +P L N L+ +P
Sbjct: 145 E----LSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLP 177
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-21
Identities = 41/172 (23%), Positives = 63/172 (36%), Gaps = 29/172 (16%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P L + + L + +NNL SLP +L + GN L+ SLP L L
Sbjct: 55 LPDCLPAH--ITTLVIPDNNL-TSLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELS 107
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+LP G L +L + N+ + +P L +L +SDN
Sbjct: 108 IFSNPLTHLP-ALPSG------LCKLWIFGNQLT-SLP----VLPPGLQELSVSDNQLAS 155
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+P EL L N L+ +P L + N L+ +P
Sbjct: 156 -LPALPSELCK----LWAYNNQLT-SLPMLPSGL---QELSVSDNQLA-SLP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 19/176 (10%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P+ L +L +NN L SLP + L + + GN L+ SLP L +
Sbjct: 196 LPTLPSEL---YKLWAYNNRL-TSLPALP---SGLKELIVSGNRLT-SLPVLPSEL---K 244
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L +S N + SLP L L + RN+ + ++P + L + ++L N
Sbjct: 245 ELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLI-HLSSETTVNLEGNPLSE 298
Query: 205 PIPNDLGELQSLSATLN--LSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
L E+ S + ++ P+ L + + L P
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 26/119 (21%), Positives = 44/119 (36%), Gaps = 18/119 (15%)
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
C L++ + + +LPD L + L++ N + +P L L++
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLP----ALPPELRTLEV 88
Query: 198 SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
S N +P L LS + HL +P L L + GN L+ +P
Sbjct: 89 SGNQLTS-LPVLPPGLLELS-IFSNPLTHLP-ALPSGLCKL------WIFGNQLT-SLP 137
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 21/115 (18%), Positives = 37/115 (32%), Gaps = 7/115 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P L L+++ N L LP+ L + +S ++ L GN LS ++ +
Sbjct: 256 LPMLPSGL---LSLSVYRNQL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAP 311
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLI---LARNKFSGQIPAGIWPELENLVQLD 196
F + + + L L + PA W D
Sbjct: 312 GYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD 366
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 10/94 (10%)
Query: 164 CKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLS 223
L + + + +P + ++ L + DN+ +P EL++L +S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNLTS-LPALPPELRTL----EVS 89
Query: 224 YNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
N L+ +P L F +L
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSG 122
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 48/191 (25%), Positives = 73/191 (38%), Gaps = 14/191 (7%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLS 149
L L L L +N L ++P+ F + L ++L N + S+P +P L+ LDL
Sbjct: 111 LANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG 168
Query: 150 NNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
+ +G + L+ L LA +IP L L +LDLS N P
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPG 225
Query: 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTA 268
L L L + + + + NL V +L NNL+ +P F
Sbjct: 226 SFQGLMHLQ-KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPH-DLFTPLHHLE 282
Query: 269 FL---SNPLLC 276
+ NP C
Sbjct: 283 RIHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-22
Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 11/181 (6%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
+ L +L L L N++ ++ F +L+++ L+ N L+ ++P L +L
Sbjct: 81 VNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKL 138
Query: 144 QNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+ L L NN S+P L+RL L K I G + L NL L+L+ +
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA 262
+ IP +L L L L+LS NHLS P S L + + + I +F
Sbjct: 198 RE-IP-NLTPLIKLD-ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE-RNAFD 252
Query: 263 N 263
N
Sbjct: 253 N 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 49/196 (25%), Positives = 76/196 (38%), Gaps = 38/196 (19%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSF 153
++ NL +PD + T+ + L+ N + + + +L L+ L LS N
Sbjct: 45 FSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI 100
Query: 154 SGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP----N 208
++ G L L L N+ + IP G + L L +L L +N + IP N
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFN 157
Query: 209 DLGELQSLS---------------------ATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247
+ L+ L LNL+ +L +IP +L L DL
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 248 GNNLSGEIPQTGSFAN 263
GN+LS I GSF
Sbjct: 216 GNHLS-AIRP-GSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 5/113 (4%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLD 147
L LR LNL NL +P+ L L + L GN+LS ++ P L LQ L
Sbjct: 181 FEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLW 237
Query: 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+ + + N + L + LA N + +P ++ L +L ++ L N
Sbjct: 238 MIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 29/207 (14%), Positives = 65/207 (31%), Gaps = 35/207 (16%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
I + + + +++L +L +A ++ + L GN LS + +L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS------------------GQIPAGIW 186
L+LS+N D L++ L+ L L N ++
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR- 118
Query: 187 PELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG-KIPKSLGNLPVTVSFD 245
+ + L++N D G + L+L N + + + +
Sbjct: 119 --GQGKKNIYLANNKITMLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 246 LRGNNLSGEIPQTGSFANQGPTAFLSN 272
L+ N + ++ +
Sbjct: 176 LQYNFIY-DVK---------GQVVFAK 192
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 15/174 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
+L SL LR L+L+NN + +L S+ ++ NN+S + S +N
Sbjct: 73 TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKN 124
Query: 146 LDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+ L+NN + L D ++Q L L N+ A + + L L+L N
Sbjct: 125 IYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ + L TL+LS N L+ + + LR N L I +
Sbjct: 184 -VKGQVV-FAKLK-TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 30/174 (17%), Positives = 64/174 (36%), Gaps = 13/174 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF--NATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+ G ++ L+L N + ++ ++ +L + L N + + V +L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEI-DTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKL 193
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+ LDLS+N + + ++ + + L NK I + +NL DL N F
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALR-FSQNLEHFDLRGNGFH 250
Query: 204 -GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
G + + + Q + T+ + +P + G ++P
Sbjct: 251 CGTLRDFFSKNQRVQ-TVAKQTVKKLTGQNEEECTVP---TLGHYGAYCCEDLP 300
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 22/141 (15%), Positives = 47/141 (33%), Gaps = 7/141 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L LNL N ++ + Q+ L ++ L N L+ + P + +
Sbjct: 161 FAELAASSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+ L NN + L+ + L+ L N F + + + + ++ K
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKK 274
Query: 205 PIPNDLGELQSLSATLNLSYN 225
+ E ++ +
Sbjct: 275 -LTGQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 30/157 (19%), Positives = 59/157 (37%), Gaps = 16/157 (10%)
Query: 108 SLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQL 167
++ + N + ++L +L + ++ LDLS N S L +L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 168 QRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227
+ L L+ N + L L LDL++N + +L S+ TL+ + N++
Sbjct: 61 ELLNLSSNVLY-ETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIE-TLHAANNNI 111
Query: 228 SGKIPKSLG-NLPVTVSFDLRGNNLSGEIPQTGSFAN 263
S ++ S G + L N ++ +
Sbjct: 112 S-RVSCSRGQGK---KNIYLANNKIT-MLRD-LDEGC 142
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 24/145 (16%), Positives = 51/145 (35%), Gaps = 13/145 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ ++ L+ L+L +N L + + +A + I L N L + ++ L+
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 145 NLDLSNNSFS-GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+ DL N F G+L D +++Q + K ++ E +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCE 297
Query: 204 GPIPNDLGELQSLSATLNLSYNHLS 228
P + + L ++H
Sbjct: 298 DL-PAPFADR-----LIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 22/120 (18%), Positives = 39/120 (32%), Gaps = 10/120 (8%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS-GSLPPSVCNLPR 142
++ E S + ++L NN L + L + +L L GN G+L R
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+Q + L + + L +PA P + L + L +
Sbjct: 264 VQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPA---PFADRL--IALGHHHH 315
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 48/255 (18%)
Query: 385 ESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE 444
+ G E +V + K +F + VLG G + + + VAV+R+
Sbjct: 10 DDGDEETSVVIVGK-ISFCPKD-------VLGHGAEGTIVYRGMFDNRDVAVKRI----- 56
Query: 445 QRHREFVT----EVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNG 499
E + EVQ + + +HPN+++ + + + + L +
Sbjct: 57 --LPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVE---- 109
Query: 500 QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-----DFQPYISD 554
Q + + + + T GLA+LH VH D+KP NIL+ + ISD
Sbjct: 110 QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISD 166
Query: 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVY 612
FGL + + + ++ S G G T + APE + P D++
Sbjct: 167 FGLCKKLAVGRHSFSRRSGVPG-------------TEGWIAPEMLSEDCKENPTYTVDIF 213
Query: 613 SFGVVLLELLTGKSP 627
S G V +++ S
Sbjct: 214 SAGCVFYYVISEGSH 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 52/236 (22%), Positives = 81/236 (34%), Gaps = 51/236 (21%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+LG+ V++ G A+ + + RE + + K+ H NIVK
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKLNHKNIVK 71
Query: 468 LRAYYWAPDEKL--LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
L A + LI +F G+L L + L S L + + G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 526 ECSPRKFVHGDIKPSNILL----DNDFQPYISDFGLSRLINITGNNPSSSGGFMG---GA 578
E VH +IKP NI+ D ++DFG +R + G
Sbjct: 130 E---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--------DDEQFVSLYGT 178
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKW-----DVYSFGVVLLELLTGKSP 627
Y+ P+ R + QK D++S GV TG P
Sbjct: 179 EEYL------------HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 53/229 (23%), Positives = 85/229 (37%), Gaps = 33/229 (14%)
Query: 416 GKSGLGIVYKVV-LGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
G L V G V VRR L + E+ HPNIV Y
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP---YR 92
Query: 473 --WAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ D +L +++ F++ G+ + + L+ + I +G + L Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY---ILQGVLKALDYIHH--- 146
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG---GALPYMKP-V 585
+VH +K S+IL+ D + Y+S + + G F LP++ P V
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEV 206
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSPT 632
+ Y A K D+YS G+ EL G P ++ T
Sbjct: 207 LQQNLQGYDA------------KSDIYSVGITACELANGHVPFKDMPAT 243
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 46/236 (19%), Positives = 96/236 (40%), Gaps = 29/236 (12%)
Query: 398 KGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRR--LGEGGEQRHREFVTEVQ 455
KG + + + + G G V++V+ A++ L E Q + E+
Sbjct: 7 KGRIYSILKQI-------GSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 456 AIAKVKHPN--IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRI 513
+ K++ + I++L Y ++ + N +L + L+ + S+ R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSY 113
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI-NITGNNPSSSG 572
K + +H+ VH D+KP+N L+ + + DFG++ + T + S
Sbjct: 114 WKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS- 168
Query: 573 GFMGGALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G + YM P + +++ +++ + DV+S G +L + GK+P
Sbjct: 169 --QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS---DVWSLGCILYYMTYGKTP 219
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 42/230 (18%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPN--IVKLR 469
+G G V++V+ A++ L E Q + E+ + K++ + I++L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
Y ++ + N +L + L+ + S+ R K + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ--- 145
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLI--NITGNNPSSSGGFMGGALPYMKPVQT 587
VH D+KP+N L+ + + DFG++ + + T S G
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG-------------- 190
Query: 588 EKTNNYRAPEA------RVPGNRPMQKW----DVYSFGVVLLELLTGKSP 627
T NY PEA + K DV+S G +L + GK+P
Sbjct: 191 --TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-22
Identities = 74/335 (22%), Positives = 122/335 (36%), Gaps = 98/335 (29%)
Query: 414 VLGKSGLGIVYKVVLGNGIP------VAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIV 466
+G+ G V++ +P VAV+ L E +F E +A+ +PNIV
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGR-------------------NGQPSTSLSW 507
KL L+ ++++ G+L LR + LS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
+ +L IA+ A G+AYL E RKFVH D+ N L+ + I+DFGLSR I
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNI------ 224
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRA-PEARVPGNRPMQKW---------------DV 611
+ Y+A +P +W DV
Sbjct: 225 --------------------YSADYYKADGNDAIP-----IRWMPPESIFYNRYTTESDV 259
Query: 612 YSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHA 670
+++GVVL E+ + G P + +++ +V+ G P +
Sbjct: 260 WAYGVVLWEIFSYGLQP------YYGMAHEEVIYYVRDGNILACP------------ENC 301
Query: 671 KKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
E +++L C P RP ++ L+R+
Sbjct: 302 PLE---LYNLMRLCWSKLPADRPSFCSIHRILQRM 333
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 7e-22
Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 22/220 (10%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRR--LGEGGEQRHREFVTEVQAIAKVKHPN--IVKLR 469
+G G V++V+ A++ L E Q + E+ + K++ + I++L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
Y ++ + N +L + L+ + S+ R K + +H+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ--- 173
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLI-NITGNNPSSSGGFMGGALPYMKP-VQT 587
VH D+KP+N L+ + + DFG++ + T + S GA+ YM P
Sbjct: 174 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS---QVGAVNYMPPEAIK 229
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ +++ +++ + DV+S G +L + GK+P
Sbjct: 230 DMSSSRENGKSKSKISPKS---DVWSLGCILYYMTYGKTP 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 9e-22
Identities = 48/183 (26%), Positives = 68/183 (37%), Gaps = 15/183 (8%)
Query: 80 NVRGYIPSELGSLI--YLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG--SLPP 135
R +EL + L+ L++ + +Q+ +L ++ L N G L
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 136 SVC--NLPRLQNLDLSNN---SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE 190
++C P LQ L L N + SG QLQ L L+ N A
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250
L L+LS K +P L LS L+LSYN L P LP + L+GN
Sbjct: 254 QLNSLNLSFTGLKQ-VPKGL--PAKLS-VLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNP 307
Query: 251 LSG 253
Sbjct: 308 FLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 38/176 (21%), Positives = 60/176 (34%), Gaps = 15/176 (8%)
Query: 62 NITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP----DQLFNAT 117
+ + P + ++I+ + + ++ L L+L +N G
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 118 SLHSIFLYGNN---LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILA 173
+L + L SG +LQ LDLS+NS + QL L L+
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229
Q+P G+ L LDLS N P EL + L+L N
Sbjct: 262 FTGLK-QVPKGLPA---KLSVLDLSYNRLDR-NP-SPDELPQVG-NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 44/196 (22%), Positives = 59/196 (30%), Gaps = 22/196 (11%)
Query: 83 GYIPSELGSLIY--LRRLNLHNNNL--FGSLPDQLFN--ATSLHSIFLYGNNLSGSLPPS 136
G P L L LNL N + + +L L + + +
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 137 VCNLPRLQNLDLSNNSFSGSLPDGLKNC----KQLQRLILARNKFS--GQIPAGIWPELE 190
V P L LDLS+N G C LQ L L + + +
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS---GKIPKSLGNLPVTVSFDLR 247
L LDLS N + + S +LNLS+ L +P L L DL
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL------DLS 282
Query: 248 GNNLSGEIPQTGSFAN 263
N L P
Sbjct: 283 YNRLD-RNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 37/190 (19%), Positives = 63/190 (33%), Gaps = 18/190 (9%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQ---LFNATSLHSIFLYGNNLSGSLPPSV--CNL 140
+++ + L+RL + + + + + L + L ++G+ PP +
Sbjct: 61 FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 141 PRLQNLDLSNNSFSG--SLPDGLKNCKQ--LQRLILARNKFSGQIPAGIWPELENLVQLD 196
P L L+L N S++ + L+ + L+ L +A+ L LD
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLD 179
Query: 197 LSDNDFKGPI-------PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
LSDN G P LQ L+ N SG DL N
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLAL-RNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 250 NLSGEIPQTG 259
+L
Sbjct: 239 SLRDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 36/188 (19%), Positives = 60/188 (31%), Gaps = 17/188 (9%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPS------VCNL 140
+ + L+ L L N + G+ P L AT L N+S + +
Sbjct: 89 LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLK 148
Query: 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP---AGIWPELENLVQLDL 197
P L+ L ++ + ++ L L L+ N G+ A + L L L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 198 SDNDFK---GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT-VSFDLRGNNLS- 252
+ + G L L+LS+N L + P S +L L
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQ-GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ 267
Query: 253 --GEIPQT 258
+P
Sbjct: 268 VPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 29/122 (23%), Positives = 44/122 (36%), Gaps = 7/122 (5%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLP-RL 143
P + +L L N G L + L N+L + C+ P +L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+L+LS +P GL +L L L+ N+ P+ EL + L L N F
Sbjct: 256 NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPD--ELPQVGNLSLKGNPFL 309
Query: 204 GP 205
Sbjct: 310 DS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 26/160 (16%), Positives = 48/160 (30%), Gaps = 10/160 (6%)
Query: 118 SLHSIFLYGNNLSGSLPPS-VCNLPRLQNLDLSNNSFSGSLPDGLK---NCKQLQRLILA 173
SL + + + + + L+ L + + G LQ L L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLE 103
Query: 174 RNKFSGQIPAGIWPE-LENLVQLDLSDNDFKGPIPNDLGELQSLSAT----LNLSYNHLS 228
+ +G P + +L L+L + + L ELQ L+++ H
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTA 268
+ + P + DL N GE +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 1e-21
Identities = 57/234 (24%), Positives = 89/234 (38%), Gaps = 40/234 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVT-EVQAIAKVKHPNIVKLRAY 471
LG G G V + + G VA+++ + ++RE E+Q + K+ HPN+V R
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 472 Y------WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
D LL ++ G+L L + L + + L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMG---GAL 579
E + +H D+KP NI+L Q I D G ++ ++ G G L
Sbjct: 139 E---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--------QGELCTEFVGTL 187
Query: 580 PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633
Y+ APE + + D +SFG + E +TG P L
Sbjct: 188 QYL------------APEL-LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 13/174 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQ 144
P L+ L RL L N L LP+++ +L + ++ N ++ + SV L ++
Sbjct: 93 PGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMI 148
Query: 145 NLDLSNNSF-SGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
++L N S + +G + K+L + +A + IP G+ +L +L L N
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKI 204
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
L L +L+ L LS+N +S SL N P L N L ++P
Sbjct: 205 TKVDAASLKGLNNLA-KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 256
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 14/191 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNL-SGSLPPSV-CNLP 141
+P ++ L+ L +H N + + +F + + L N L S + +
Sbjct: 115 LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 171
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
+L + +++ + + ++P GL L L L NK + ++ A L NL +L LS N
Sbjct: 172 KLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
L L L+L+ N L K+P L + L NN+S I F
Sbjct: 228 ISAVDNGSLANTPHLR-ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS-NDF 283
Query: 262 ANQGPTAFLSN 272
G ++
Sbjct: 284 CPPGYNTKKAS 294
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 16/182 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ +L L L L NN + + F L ++L N L LP + LQ
Sbjct: 69 DGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQ 124
Query: 145 NLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKF-SGQIPAGIWPELENLVQLDLSDNDF 202
L + N + + Q+ + L N S I G + ++ L + ++D +
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
IP L SL+ L+L N ++ K+ SL L L N++S + GS
Sbjct: 184 TT-IPQGL--PPSLT-ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDN-GSL 236
Query: 262 AN 263
AN
Sbjct: 237 AN 238
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 18/168 (10%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSN 150
+ L + + + N+ ++P L SL + L GN ++ + + L L L LS
Sbjct: 170 MKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSF 225
Query: 151 NSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG----- 204
NS S ++ +G L N L+ L L NK ++P G+ + + + + L +N+
Sbjct: 226 NSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGL-ADHKYIQVVYLHNNNISAIGSND 282
Query: 205 -PIPNDLGELQSLSATLNLSYNHLSGKI--PKSLGNLPVTVSFDLRGN 249
P + S S ++L N + P + + V + L
Sbjct: 283 FCPPGYNTKKASYS-GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 16/174 (9%)
Query: 94 YLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNS 152
+LR + + L +P L + L N ++ + NL L L L NN
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK 87
Query: 153 FSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG 211
S + G +L+RL L++N+ ++P + + L +L + +N+ +
Sbjct: 88 IS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFN 142
Query: 212 ELQSLSATLNLSYNHL-SGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L + + L N L S I + + + N++ IPQ G +
Sbjct: 143 GLNQMI-VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-GLPPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 11/95 (11%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-------CNLPRL 143
+ +LR L+L+NN L +P L + + ++L+ NN+S ++ +
Sbjct: 238 NTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 144 QNLDLSNNSFS-GSLPDGLKNC-KQLQRLILARNK 176
+ L +N + C + L K
Sbjct: 296 SGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 10/76 (13%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-------NATSLHSIFLYGNNLS-GSLPPS 136
+P L Y++ + LHNNN+ ++ F S + L+ N + + PS
Sbjct: 255 VPGGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 137 V-CNLPRLQNLDLSNN 151
+ + L N
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 23/211 (10%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
S L+ L+L + ++ D + + + L ++ L GN + SL L L
Sbjct: 45 SYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 144 QNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
Q L + + SL + + K L+ L +A N + L NL LDLS N
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 203 KGPIPND----LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ I L ++ L+ +L+LS N ++ P + + + L N L +P
Sbjct: 162 QS-IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLK-ELALDTNQLK-SVPD- 217
Query: 259 GSFANQGPTAFL---SNPLLCGFPLQKSCKD 286
G F + +NP C SC
Sbjct: 218 GIFDRLTSLQKIWLHTNPWDC------SCPR 242
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 40/178 (22%), Positives = 69/178 (38%), Gaps = 17/178 (9%)
Query: 95 LRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNS 152
+ L+L N L L F + L + L + ++ +L L L L+ N
Sbjct: 30 TKNLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 153 FSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF-KGPIPNDL 210
SL G LQ+L+ + + L+ L +L+++ N +P
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 211 GELQSLSATLNLSYNHLSGKIP----KSLGNLPV-TVSFDLRGNNLSGEIPQTGSFAN 263
L +L L+LS N + I + L +P+ +S DL N ++ I G+F
Sbjct: 146 SNLTNLE-HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQ-PGAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 32/130 (24%), Positives = 50/130 (38%), Gaps = 12/130 (9%)
Query: 139 NLP-RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
NLP +NLDLS N L + +LQ L L+R + I G + L +L L
Sbjct: 25 NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLI 82
Query: 197 LSDNDFK---GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
L+ N + + L LQ L +L+ +G+L ++ N +
Sbjct: 83 LTGNPIQSLALGAFSGLSSLQ----KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ- 137
Query: 254 EIPQTGSFAN 263
F+N
Sbjct: 138 SFKLPEYFSN 147
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 9e-21
Identities = 48/236 (20%), Positives = 89/236 (37%), Gaps = 41/236 (17%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYY 472
+LG G V G PVAV+R+ + E++ + + HPN+++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 473 WAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ + N NL + + + + + + + + A G+A+LH
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 531 KFVHGDIKPSNILLDNDFQPY-------------ISDFGLSRLINITGNNPSSSGGFMGG 577
K +H D+KP NIL+ + ISDFGL + ++ ++ ++ G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 578 ALPYMKPVQTEKTNNYRAPE------ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T+ +RAPE R + D++S G V +L+
Sbjct: 195 ------------TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 42/199 (21%), Positives = 73/199 (36%), Gaps = 8/199 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRL 143
IPS L ++ L+L N + L +L + L + ++ ++ +L L
Sbjct: 20 IPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSL 76
Query: 144 QNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD-ND 201
++LDLS+N S SL L+ L L N + ++P L NL L + +
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
F D L SL+ L + L +SL ++ L + + +
Sbjct: 136 FSEIRRIDFAGLTSLN-ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 262 ANQGPTAFLSNPLLCGFPL 280
+ L + L F
Sbjct: 195 LSSVRYLELRDTNLARFQF 213
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 32/168 (19%), Positives = 58/168 (34%), Gaps = 14/168 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNL--FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+ G+ L+ L L N+L + L +L S+ + N +P S ++
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+ L+LS+ + + + L+ L ++ N L L +L +S N K
Sbjct: 413 RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLF----LPRLQELYISRNKLK 464
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNL 251
+P+ L + +S N L L L N
Sbjct: 465 T-LPDASL-FPVLL-VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 44/194 (22%), Positives = 72/194 (37%), Gaps = 18/194 (9%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLS-GSL 133
I + + + L ++R+ + N+ +F +P + SL + L N + L
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYL 351
Query: 134 PPSVC--NLPRLQNLDLSNNSFS--GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPEL 189
S C P LQ L LS N + L K L L ++RN F +P
Sbjct: 352 KNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ-WP 409
Query: 190 ENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
E + L+LS + + + Q+L L++S N+L L L + N
Sbjct: 410 EKMRFLNLSSTGIRV-VKTCI--PQTLE-VLDVSNNNLD-SFSLFLPRL---QELYISRN 461
Query: 250 NLSGEIPQTGSFAN 263
L +P F
Sbjct: 462 KLK-TLPDASLFPV 474
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 27/167 (16%), Positives = 58/167 (34%), Gaps = 10/167 (5%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSN 150
+L L N +++ L ++ + + L L L +++ + + N
Sbjct: 262 TLNGLGDFNPSESDVVSELG--KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319
Query: 151 NSFSGSLPDG-LKNCKQLQRLILARNKFSGQI--PAGIWPELENLVQLDLSDNDFKGPIP 207
+ +P ++ K L+ L L+ N + + +L L LS N + +
Sbjct: 320 SKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQ 377
Query: 208 NDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L +L +L++S N +P S +L +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 35/126 (27%), Positives = 48/126 (38%), Gaps = 6/126 (4%)
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
+ D + SF+ S+P GL ++ L L+ NK + I G NL L L
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLIL 57
Query: 198 SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257
+ + L SL L+LS NHLS G L +L GN +
Sbjct: 58 KSSRINTIEGDAFYSLGSLE-HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGV 115
Query: 258 TGSFAN 263
T F N
Sbjct: 116 TSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 22/113 (19%), Positives = 39/113 (34%), Gaps = 23/113 (20%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLF------------------NATSLHSIFLY 125
+P +R LNL + + + + L +++
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGI-RVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYIS 459
Query: 126 GNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKF 177
N L +LP + P L + +S N S+PDG LQ++ L N +
Sbjct: 460 RNKLK-TLPDAS-LFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 25/206 (12%), Positives = 69/206 (33%), Gaps = 21/206 (10%)
Query: 76 ISGKNVRGYIPSE-LGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSL 133
I I L L L + +L + Q + +H + L+ + + L
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSL-RNYQSQSLKSIRDIHHLTLHLSESAFLL 188
Query: 134 PPSVCNLPRLQNLDLSNNS---FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI---WP 187
L ++ L+L + + F S + +++L + + + +
Sbjct: 189 EIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLR 248
Query: 188 ELENLVQLDLSDNDFKG---------PIPNDLGELQSLS-ATLNLSYNHLSGKIPKSLGN 237
+ L +++ D G + ++LG++++++ L++ +L +
Sbjct: 249 YILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 238 LPVTVSFDLRGNNLSGEIPQTGSFAN 263
L + + + +P +
Sbjct: 309 LEKVKRITVENSKVF-LVPC-SFSQH 332
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 11/180 (6%)
Query: 95 LRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNL-SGSLPPSVCNLPRLQNLDLSNNS 152
L L +H+N + +P +F +++ I + GN L + P + +L L +S
Sbjct: 125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183
Query: 153 FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212
+ +P L + L L L NK I L +L L N + L
Sbjct: 184 LT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239
Query: 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272
L +L L+L N LS ++P L +L + L NN++ ++ F G +
Sbjct: 240 LPTLR-ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV-NDFCPVGFGVKRAY 295
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 40/168 (23%), Positives = 67/168 (39%), Gaps = 12/168 (7%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLS 149
L L++L + N+L +P L +SL + ++ N + +P V L + +++
Sbjct: 100 PLRKLQKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMG 155
Query: 150 NNSF-SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
N + G + +L L ++ K + IP + E L +L L N +
Sbjct: 156 GNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL---PETLNELHLDHNKIQAIELE 211
Query: 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
DL L L L +N + SL LP L N LS +P
Sbjct: 212 DLLRYSKLY-RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 39/182 (21%), Positives = 71/182 (39%), Gaps = 17/182 (9%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+ L +L L L NN + + ++ F L +++ N+L +PP++ L
Sbjct: 71 KDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV 126
Query: 145 NLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKF-SGQIPAGIWPELENLVQLDLSDNDF 202
L + +N +P G + + + + N + G + L L L +S+
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL 184
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
G IP DL ++L+ L+L +N + I L L N + I GS
Sbjct: 185 TG-IPKDL--PETLN-ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIEN-GSL 237
Query: 262 AN 263
+
Sbjct: 238 SF 239
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 9/137 (6%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSF 153
L L + L +P L +L+ + L N + ++ +L L L +N
Sbjct: 174 LNYLRISEAKL-TGIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 154 SGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212
+ +G L L+ L L NK S ++PAG+ P+L+ L + L N+ ND
Sbjct: 230 R-MIENGSLSFLPTLRELHLDNNKLS-RVPAGL-PDLKLLQVVYLHTNNITKVGVNDFCP 286
Query: 213 LQSLSATLNLSYNHLSG 229
+ + L
Sbjct: 287 VGFGVKRAYYNGISLFN 303
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 34/173 (19%), Positives = 67/173 (38%), Gaps = 15/173 (8%)
Query: 94 YLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNS 152
+LR + + L ++P ++ + L N++S L L L L L NN
Sbjct: 34 HLRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK 89
Query: 153 FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212
S ++LQ+L +++N +IP + +LV+L + DN +
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSG 145
Query: 213 LQSLSATLNLSYNHLSGKI--PKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L++++ + + N L P + L + + L+ IP+
Sbjct: 146 LRNMN-CIEMGGNPLENSGFEPGAFDGLKLNY-LRISEAKLT-GIPK-DLPET 194
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 21/126 (16%), Positives = 43/126 (34%), Gaps = 13/126 (10%)
Query: 85 IPSE-LGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPR 142
I E L L RL L +N + + + +L + L N LS +P + +L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 143 LQNLDLSNNSFSGSLPDG-------LKNCKQLQRLILARNKFS-GQIPAGIWPELENLVQ 194
LQ + L N+ + + + L N ++ + + + +
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 195 LDLSDN 200
+ +
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 14/77 (18%), Positives = 27/77 (35%), Gaps = 10/77 (12%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-------NATSLHSIFLYGNNLS-GSLPP 135
+P+ L L L+ + LH NN+ + F + I L+ N + + P
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 136 SV-CNLPRLQNLDLSNN 151
+ + + N
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 30/220 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
VLGK GIVY L N + +A++ + E + + E+ +KH NIV+ Y
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---YL 85
Query: 473 --WAPDEKLLIS-DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
++ + + I + + G+L+ LR + G + T K GL YLH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD--- 140
Query: 530 RKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP-VQT 587
+ VH DIK N+L++ ISDFG S+ + + G L YM P +
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET----FTGTLQYMAPEIID 196
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ Y D++S G ++E+ TGK P
Sbjct: 197 KGPRGYGK------------AADIWSLGCTIIEMATGKPP 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 49/229 (21%), Positives = 79/229 (34%), Gaps = 28/229 (12%)
Query: 444 EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS-DFISNGNLANALRGRNGQPS 502
+++ + N V + +P L I NL + + R
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVG-QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-- 158
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
L I A + +LH + +H D+KPSNI D + DFGL ++
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLEL 621
+ M + V T+ Y +PE K D++S G++L EL
Sbjct: 216 QDEEEQTVLTP-MPAYATHTGQVGTK---LYMSPE--QIHGNNYSHKVDIFSLGLILFEL 269
Query: 622 LTGKSPELSPTTSTSIEVPDLVRWVKKG-----FEEENP-LSDMVDAML 664
L ST +E ++ V+ F ++ P MV ML
Sbjct: 270 LYSF--------STQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDML 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 35/220 (15%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LGK G +++ A + L QR + E+ + H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 470 AYYWAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
++ D ++ + +L R +P + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-------YYLRQIVLGCQYLHR- 133
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ +H D+K N+ L+ D + I DFGL+ + G G
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG-------------- 177
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY APE + + DV+S G ++ LL GK P
Sbjct: 178 --TPNYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 38/212 (17%), Positives = 70/212 (33%), Gaps = 27/212 (12%)
Query: 422 IVYKVVLGNGIPVAVRRLGEGGEQRHREFV-TEVQAIAKVKHPNIVKLRAYYWAPDEKLL 480
K +L + + + E+Q I +K+ + DE +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 481 ISDFISNGNLANALRGR---NGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI 537
I +++ N ++ + + + I K +Y+H + + H D+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDV 178
Query: 538 KPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE 597
KPSNIL+D + + +SDFG S + G T + PE
Sbjct: 179 KPSNILMDKNGRVKLSDFGES---EYMVDKKIKG--SRG-------------TYEFMPPE 220
Query: 598 ARVPGNRPM--QKWDVYSFGVVLLELLTGKSP 627
K D++S G+ L + P
Sbjct: 221 F-FSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 45/231 (19%)
Query: 406 ELLRASAYVLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAK 459
E+ R LGK G VY + +A+ +L + G + EV+ +
Sbjct: 12 EIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSH 65
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGT 517
++HPNI++L Y+ LI ++ G + L+ + + T+
Sbjct: 66 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A L+Y H ++ +H DIKP N+LL + + I+DFG S PSS + G
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA------PSSRRTDLCG 169
Query: 578 ALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
L Y+ P + + ++ + D++S GV+ E L GK P
Sbjct: 170 TLDYLPPEMIEGRMHDEKV--------------DLWSLGVLCYEFLVGKPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 62/265 (23%), Positives = 105/265 (39%), Gaps = 63/265 (23%)
Query: 385 ESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRL-GEG 442
SGK G L + + E+++L +G G V+K+ G +AV+++ G
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 443 GEQRHREFVTEVQAIAK-VKHPNIVKLRAYYWAPDEKLLISDFISNGNL----------- 490
++ ++ + ++ + K P IV+ + FI+N ++
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQ---CFGT---------FITNTDVFIAMELMGTCA 110
Query: 491 -ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549
R + P L ++ + L YL +H D+KPSNILLD Q
Sbjct: 111 EKLKKRMQGPIPERILG-----KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQ 163
Query: 550 PYISDFGLS-RLIN-ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ 607
+ DFG+S RL++ + G Y APE R+ P +
Sbjct: 164 IKLCDFGISGRLVDDKAKDR------SAG-------------CAAYMAPE-RIDPPDPTK 203
Query: 608 -----KWDVYSFGVVLLELLTGKSP 627
+ DV+S G+ L+EL TG+ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
V+G +V VA++R+ E + E + E+QA+++ HPNIV Y
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS---Y 78
Query: 472 Y--WAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIA---KGTARGLAYLH 525
Y + ++L L+ +S G++ + ++ + IA + GL YLH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS--GGFMGGALPY-M 582
+ +H D+K NILL D I+DFG+S + G+ + F+G P M
Sbjct: 139 K---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG--TPCWM 193
Query: 583 KP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P ++ + +++A D++SFG+ +EL TG +P
Sbjct: 194 APEVMEQVRGYDFKA--------------DIWSFGITAIELATGAAP 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 54/250 (21%)
Query: 397 DKGFTFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRL-GEGGEQRHREFVTEV 454
++ + F ++L +G+ G V K+V +G +AV+R+ E+ ++ + ++
Sbjct: 14 EQHWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 455 QAIAK-VKHPNIVKLRAYYWAPDEKLLISDFISNGN-----------LANALRGRNGQPS 502
+ + P IV+ +Y A G+ +
Sbjct: 72 DVVMRSSDCPYIVQ---FYGA---------LFREGDCWICMELMSTSFDKFYKYVYSVLD 119
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RLI 561
+ +I T + L +L K +H DIKPSNILLD + DFG+S +L+
Sbjct: 120 DVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177
Query: 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ----KWDVYSFGVV 617
+ S + G PYM APE R+ + Q + DV+S G+
Sbjct: 178 D------SIAKTRDAGCRPYM------------APE-RIDPSASRQGYDVRSDVWSLGIT 218
Query: 618 LLELLTGKSP 627
L EL TG+ P
Sbjct: 219 LYELATGRFP 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 35/220 (15%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LGK G +++ A + L QR + E+ + H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 470 AYYWAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
++ D ++ + +L R +P + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-------YYLRQIVLGCQYLHR- 159
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ +H D+K N+ L+ D + I DFGL+ + G G
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG-------------- 203
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY APE + + DV+S G ++ LL GK P
Sbjct: 204 --TPNYIAPEV-LSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 38/172 (22%), Positives = 71/172 (41%), Gaps = 8/172 (4%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
S+L + L+ L L +N + ++ + F++ SL + L N LS +L S L L
Sbjct: 69 NSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSL 126
Query: 144 QNLDLSNNSFSGSLPDG--LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+L N + +L + + +LQ L + +I + L L +L++ +D
Sbjct: 127 TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
+ P L +Q++S L L + + +LR +L
Sbjct: 186 LQSYEPKSLKSIQNVS-HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 36/162 (22%), Positives = 62/162 (38%), Gaps = 8/162 (4%)
Query: 95 LRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNS 152
++ L+L NN + + + +L ++ L N ++ ++ +L L++LDLS N
Sbjct: 54 VKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 153 FSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP-NDL 210
S +L K L L L N + ++ L L L + + D I D
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 211 GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L L L + + L PKSL ++ L
Sbjct: 171 AGLTFLE-ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 28/171 (16%), Positives = 54/171 (31%), Gaps = 16/171 (9%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLS 149
L L+ L + N + F + + F T L + + ++L S P ++ + +L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILH 206
Query: 150 NNSFSGSLPDGL-KNCKQLQRLILARNKFSG----QIPAGIW---PELENLVQLDLSDND 201
L + ++ L L ++ G + + ++D
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKS-LGNLPVTVSFDLRGNNL 251
+ L ++ L L S N L +P L L N
Sbjct: 266 LF-QVMKLLNQISGLL-ELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/153 (24%), Positives = 57/153 (37%), Gaps = 19/153 (12%)
Query: 118 SLHSIFLYGNNLSGSLPPSVCNLP-RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARN 175
+L+ S+P L +++LDLSNN + + + L+ C LQ L+L N
Sbjct: 32 RNGICKGSSGSLN-SIPS---GLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSN 86
Query: 176 KFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND----LGELQSLSATLNLSYNHLSGKI 231
+ I + L +L LDLS N + + L L LNL N
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTF----LNLLGNPYKTLG 140
Query: 232 PKSL-GNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
SL +L + + +I FA
Sbjct: 141 ETSLFSHLTKLQILRVGNMDTFTKIQ-RKDFAG 172
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 36/221 (16%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGG--EQRHREFVTEVQAIAKVKHPNIV 466
LGK VY+ + G+ VA+ + + + G ++ E V+ ++KHP+I+
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE----VKIHCQLKHPSIL 74
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+L Y+ + L+ + NG + L+ R S + G+ YLH
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP----FSENEARHFMHQIITGMLYLHS 130
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
+H D+ SN+LL + I+DFGL+ + + + G
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG------------- 174
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T NY +PE + + DV+S G + LL G+ P
Sbjct: 175 ---TPNYISPEI-ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 32/300 (10%), Positives = 73/300 (24%), Gaps = 88/300 (29%)
Query: 402 FELDELLRASAYVLGKSGLGIVYK---VVLGNGIPVAVRRL---GEGGEQRHREFVTEVQ 455
+ L G ++ L VA+ + G + +E ++
Sbjct: 33 YRLLIFH-------GGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTL 83
Query: 456 AIAKVKHPNIVKLRAYYWAPDEKL--LISDFISNGNLANALRGRNGQPSTSLSWSTRLRI 513
++++ P + R +++++I G+L S +R
Sbjct: 84 RLSRIDKPGVA--RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRA 134
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573
+ A H PS + + D ++
Sbjct: 135 MQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------- 174
Query: 574 FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633
M P+ D+ G L LL + P
Sbjct: 175 -------TMPDA---------NPQD-----------DIRGIGASLYALLVNRWPLPEAGV 207
Query: 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
+ + ++ + +D + ++ A +A + D +R
Sbjct: 208 RSGLAP------AERDTAGQPIEPADIDRDIPFQISA---------VAARSVQGDGGIRS 252
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 54/237 (22%), Positives = 91/237 (38%), Gaps = 57/237 (24%)
Query: 406 ELLRASAYVLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAK 459
++ R LGK G VY N +A+ +L + G + E++ +
Sbjct: 17 DIGR----PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSH 70
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGT 517
++HPNI+++ Y+ L+ +F G L L+ GR + ++ +
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-------TFMEEL 123
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
A L Y HE RK +H DIKP N+L+ + I+DFG S
Sbjct: 124 ADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVH----------------- 163
Query: 578 ALPYMKPVQTEKTN------NYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ + +Y PE + + +K D++ GV+ E L G P
Sbjct: 164 -------APSLRRRTMCGTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 53/260 (20%), Positives = 83/260 (31%), Gaps = 63/260 (24%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+G+ G+V + A+ ++ + + TEV+ + K+ HPNI +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL---------------- 511
L Y L+ + G+L + L + +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 512 ---------------RIAKGTAR----GLAYLHECSPRKFVHGDIKPSNILL--DNDFQP 550
++ R L YLH + H DIKP N L + F+
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 551 YISDFGLSRLINITGNNPSSSGGFMGGAL--PYMKPVQTEKTNNYRAPEARVPGNRPM-Q 607
+ DFGLS+ + M PY + APE N
Sbjct: 210 KLVDFGLSKEFY---KLNNGEYYGMTTKAGTPY-----------FVAPEVLNTTNESYGP 255
Query: 608 KWDVYSFGVVLLELLTGKSP 627
K D +S GV+L LL G P
Sbjct: 256 KCDAWSAGVLLHLLLMGAVP 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 33/218 (15%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G V+++ G AV+ RL + E+ A A + P IV L
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ + + G+L ++ + G L L GL YLH R+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIK-QMG----CLPEDRALYYLGQALEGLEYLHT---RR 170
Query: 532 FVHGDIKPSNILLDND-FQPYISDFGLS-RLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+HGD+K N+LL +D + + DFG + L +G ++ G +M
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM------- 223
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
APE V G K D++S ++L +L G P
Sbjct: 224 -----APEV-VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 15/174 (8%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
+P L S Y L+L +NNL + T+LHS+ L N+L+ + +P
Sbjct: 33 VPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPN 89
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ LDLS+N +L + + + L+ L+L N + + ++ L +L LS N
Sbjct: 90 LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQ 147
Query: 202 FKGPIPND----LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLR-GNN 250
P + +L L L+LS N L L LP V L NN
Sbjct: 148 ISR-FPVELIKDGNKLPKLM-LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 41/143 (28%), Positives = 65/143 (45%), Gaps = 11/143 (7%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLS 149
L L L L +N+L + + F +L + L N+L +L + +L L+ L L
Sbjct: 63 LTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLY 120
Query: 150 NNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGI---WPELENLVQLDLSDNDFKGP 205
NN + ++ QLQ+L L++N+ S + P + +L L+ LDLS N K
Sbjct: 121 NNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 206 IPNDLGELQSLS-ATLNLSYNHL 227
DL +L + L L N L
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 31/127 (24%), Positives = 49/127 (38%), Gaps = 6/127 (4%)
Query: 139 NLPR-LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+LP LDLS+N+ S + L L+L+ N + I + + + NL LD
Sbjct: 36 SLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 197 LSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
LS N +LQ+L L L NH+ + ++ L N +S P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALE-VLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
Query: 257 QTGSFAN 263
+
Sbjct: 153 V-ELIKD 158
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 4e-18
Identities = 41/197 (20%), Positives = 65/197 (32%), Gaps = 13/197 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
IPS+L L L + F L I + N++ + V NLP+
Sbjct: 24 IPSDL--PRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 143 LQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L + + + + +N LQ L+++ +P V LD+ DN
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 202 FKGPIPND-LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS 260
I + L S L L+ N + +I S N +L NN E+P
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP-NDV 197
Query: 261 FANQGPTAFL---SNPL 274
F L +
Sbjct: 198 FHGASGPVILDISRTRI 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 40/183 (21%), Positives = 62/183 (33%), Gaps = 10/183 (5%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPRL 143
L ++ + N++ + +F N LH I + N + P NLP L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNL 106
Query: 144 QNLDLSNNSFSGSLPDGLK-NCKQLQRLILARNKFSGQIPAGIWPEL-ENLVQLDLSDND 201
Q L +SN LPD K + Q L + N I + L V L L+ N
Sbjct: 107 QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGS 260
+ I N L N+L ++P V D+ + +P +
Sbjct: 166 IQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLP-SYG 221
Query: 261 FAN 263
N
Sbjct: 222 LEN 224
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 39/280 (13%), Positives = 82/280 (29%), Gaps = 21/280 (7%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
+L L + + N + + F N +L + + + LP + + LD+
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 149 SNNSFSGSLPDGL--KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+N ++ + L L +N +I + + +N+ + +
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE-L 193
Query: 207 PND-LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQG 265
PND L++S + L NL + NL ++P
Sbjct: 194 PNDVFHGASGPV-ILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEKLVAL- 248
Query: 266 PTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSPDSDKSKKKGLGPGLIVLISAADAAAV 325
A L+ P C + S ++ + G + + +
Sbjct: 249 MEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSR 308
Query: 326 AVIGLVIVYVYWKKKDSNGGCSCTVKSKFGGNENGSFCPC 365
+ Y + +C+ K +F PC
Sbjct: 309 GFDMTYTEFDYDLCNE-VVDVTCSPKP-------DAFNPC 340
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 25/149 (16%), Positives = 50/149 (33%), Gaps = 10/149 (6%)
Query: 118 SLHSIFLYGNNLSGSLPPSVCNLPR-LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNK 176
S + ++ +P +LPR L L+++ +++N
Sbjct: 10 SNRVFLCQESKVT-EIPS---DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65
Query: 177 FSGQIPAGIWPELENLVQLDLSD-NDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPK-S 234
I A ++ L L ++ + N+ P L +L L +S + +P
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ-YLLISNTGIK-HLPDVH 123
Query: 235 LGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
+ V D++ N I + SF
Sbjct: 124 KIHSLQKVLLDIQDNINIHTIER-NSFVG 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 23/90 (25%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPR 142
I + + L LNL +NN LP+ +F A+ + + + SLP NL +
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKK 227
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLIL 172
L+ N LP L+ L L
Sbjct: 228 LRARSTYNLK---KLPT-LEKLVALMEASL 253
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 69/240 (28%), Positives = 96/240 (40%), Gaps = 52/240 (21%)
Query: 405 DELLRASAYVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVTEV 454
DE Y L K+ G G KV L G VA+ +L Q+ EV
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REV 65
Query: 455 QAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLR 512
+ + + HPNIVKL LI ++ S G + + L GR +
Sbjct: 66 RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-------MKEKEARS 118
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+ + Y H+ ++ VH D+K N+LLD D I+DFG S N + G
Sbjct: 119 KFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS--------NEFTVG 167
Query: 573 GFMG---GALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G + GA PY P Q +K Y PE DV+S GV+L L++G P
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKK---YDGPEV-----------DVWSLGVILYTLVSGSLP 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-18
Identities = 57/225 (25%), Positives = 83/225 (36%), Gaps = 43/225 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG G V + A+ + + EV + + HPNI+K
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL---EEVAVLKLLDHPNIMK 100
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++ L+ + G L + + R + I K G+ YLH+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHK- 154
Query: 528 SPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
VH D+KP N+LL++ D I DFGLS + + M L Y
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--------ENQKKMKERLGTAY- 203
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE V + +K DV+S GV+L LL G P
Sbjct: 204 ----------YIAPE--VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 52/251 (20%), Positives = 92/251 (36%), Gaps = 63/251 (25%)
Query: 400 FTFELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRL-GEGGEQRHREFVTEVQAI 457
+ D+L LG+ G+V K+ + +G +AV+R+ Q + + ++
Sbjct: 2 MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 458 AK-VKHPNIVKLRAYYWAPDEKLLISDFISNGNL---------------ANALRGRNGQP 501
+ V P V +Y A G++ + P
Sbjct: 60 MRTVDCPFTVT---FYGA---------LFREGDVWICMELMDTSLDKFYKQVIDKGQTIP 107
Query: 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS-RL 560
L +IA + L +LH S +H D+KPSN+L++ Q + DFG+S L
Sbjct: 108 EDILG-----KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ----KWDVYSFGV 616
++ + G Y APE R+ + K D++S G+
Sbjct: 161 VDDVAKDI-----DAG-------------CKPYMAPE-RINPELNQKGYSVKSDIWSLGI 201
Query: 617 VLLELLTGKSP 627
++EL + P
Sbjct: 202 TMIELAILRFP 212
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 60/228 (26%), Positives = 88/228 (38%), Gaps = 43/228 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFV-TEVQAIAKVKHPNIV 466
LG IV K G+ A R+ RE + EV + +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L Y + +LI + +S G L + L + SLS K G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT 133
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGAL--P 580
+K H D+KP NI+L + P + DFGL+ I G P
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFKNIFGTP 182
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ APE + P+ + D++S GV+ LL+G SP
Sbjct: 183 E-----------FVAPE--IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 47/212 (22%), Positives = 64/212 (30%), Gaps = 15/212 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRL 143
+ L L+ L + + + F +SL + L N L L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 144 QNLDLSNNSF-SGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
+ L L+ + L K L+ L+L N PA + + LDL+ N
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 202 FKGPIPNDLGELQSLSAT-LNLSYNHLSGKIPKSLGNLPVTVSF--------DLRGNNLS 252
K DL Q T L LS L LG F DL GN
Sbjct: 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225
Query: 253 GEIPQTGSFANQGPTAFLSNPLLCGFPLQKSC 284
E F T S L + + S
Sbjct: 226 -ESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 10/135 (7%)
Query: 95 LRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNS 152
++ +L + +F +L +F + T L + L N ++ + + L L L+LS N
Sbjct: 277 VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNF 334
Query: 153 FSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND-L 210
S+ + +N +L+ L L+ N + + L NL +L L N K +P+
Sbjct: 335 LG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS-VPDGIF 391
Query: 211 GELQSLSATLNLSYN 225
L SL + L N
Sbjct: 392 DRLTSLQ-KIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 46/215 (21%), Positives = 75/215 (34%), Gaps = 32/215 (14%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSI-------------FLYGNNLSGSLPPSVC 138
+ L+L N S+ + F+A + I N
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK-DPDNFTF 269
Query: 139 N---LPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
++ DLS + +L + + L++L LA+N+ + +I + L +L++
Sbjct: 270 KGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK 327
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
L+LS N L L L+LSYNH+ +S LP L N L
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLE-VLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-S 385
Query: 255 IPQTGSFANQGPTAFL---SNPLLCGFPLQKSCKD 286
+P G F + +NP C SC
Sbjct: 386 VPD-GIFDRLTSLQKIWLHTNPWDC------SCPR 413
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 8/141 (5%)
Query: 117 TSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILAR 174
++ + L N+++ L + L LQ L + + + + + L L L
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKG-PIPNDL-GELQSLSATLNLSYNHLSGKIP 232
N+F Q+ G + L NL L L+ + G + + L SL L L N++ P
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE-MLVLRDNNIKKIQP 146
Query: 233 KSL-GNLPVTVSFDLRGNNLS 252
S N+ DL N +
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 31/132 (23%), Positives = 47/132 (35%), Gaps = 7/132 (5%)
Query: 136 SVCNLPR-LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
V LP + +DLS NS + + LQ L + + I + L +L+
Sbjct: 24 QVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 195 LDLSDNDFKGPIPND-LGELQSLSATLNLSYNHL-SGKIPK-SLGNLPVTVSFDLRGNNL 251
L L N F + L +L L L+ +L + L LR NN+
Sbjct: 84 LKLDYNQFLQ-LETGAFNGLANLE-VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141
Query: 252 SGEIPQTGSFAN 263
+I F N
Sbjct: 142 K-KIQPASFFLN 152
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/226 (19%), Positives = 68/226 (30%), Gaps = 68/226 (30%)
Query: 95 LRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV---------------- 137
L L L +NN+ P F N H + L N + S+
Sbjct: 131 LEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSS 189
Query: 138 -------------------CNLPRLQNLDLSNNSFSGSLP---DGLKNCKQLQRLILARN 175
+ LDLS N F S+ ++Q LIL+ +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 176 KFSGQ---------IPAGIWPELE--NLVQLDLSDNDFK---GPIPNDLGELQSLSATLN 221
G + LE + DLS + + + +L+ L
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE----QLT 305
Query: 222 LSYNHLSGKIPK----SLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L+ N ++ KI L +L + +L N L I + F N
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHL---LKLNLSQNFLG-SID-SRMFEN 345
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 20/65 (30%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
+L L L+L N++ +L DQ F +L + L N L S+P + L LQ + L
Sbjct: 345 NLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402
Query: 149 SNNSF 153
N +
Sbjct: 403 HTNPW 407
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 61/233 (26%), Positives = 83/233 (35%), Gaps = 48/233 (20%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-------------RRLGEGGEQRHREFVTEVQAIAK 459
LG G V A+ + E+ H E E+ +
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
+ HPNI+KL + L+++F G L + R+ I K
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILS 157
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMG 576
G+ YLH+ VH DIKP NILL+N I DFGLS S +
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--------SKDYKLR 206
Query: 577 GAL--PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
L Y Y APE V + +K DV+S GV++ LL G P
Sbjct: 207 DRLGTAY-----------YIAPE--VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 62/228 (27%), Positives = 89/228 (39%), Gaps = 43/228 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFV-TEVQAIAKVKHPNIV 466
LG IV K G+ A R+ RE + EV + +V HPNI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L Y + +LI + +S G L + L + SLS K G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT 133
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGAL--P 580
+K H D+KP NI+L + P + DFGL+ I G P
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFKNIFGTP 182
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ APE + P+ + D++S GV+ LL+G SP
Sbjct: 183 E-----------FVAPE--IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 63/225 (28%), Positives = 92/225 (40%), Gaps = 42/225 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
VLGK G V G AV R++ + + EVQ + ++ HPNI+K
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVK--QKTDKESLLREVQLLKQLDHPNIMK 90
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++ L+ + + G L + + R S RI + G+ Y+H+
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHK- 144
Query: 528 SPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
K VH D+KP N+LL++ D I DFGLS + M + Y
Sbjct: 145 --NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIGTAY- 193
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE V +K DV+S GV+L LL+G P
Sbjct: 194 ----------YIAPE--VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 44/230 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHRE---FVTEVQAIAKVKHPN 464
LG G V VA+ R+ G + TE++ + K+ HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 465 IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
I+K++ ++ A D ++ + + G L + + G L +T + YL
Sbjct: 202 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYL 255
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGAL-- 579
HE +H D+KP N+LL + + I+DFG S+++ M
Sbjct: 256 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--------ETSLMRTLCGT 304
Query: 580 PYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P Y APE V + D +S GV+L L+G P
Sbjct: 305 PT-----------YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 41/232 (17%), Positives = 79/232 (34%), Gaps = 25/232 (10%)
Query: 49 DPTPCRWSG-----ISCMNITGFPD--PRVVGVAISGKNVRGYIPSE-LGSLIYLRRLNL 100
PC ++C +I P P + + ++R IPS +L + R+ +
Sbjct: 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYV 62
Query: 101 HNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNSFSGSLP 158
+ L F + + I + + P LP L+ L + N P
Sbjct: 63 SIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP 121
Query: 159 DG--LKNCKQLQRLILARNKFSGQIPAGIWPELEN-LVQLDLSDNDFKGPIPNDLGELQS 215
D + + L + N + IP + L N + L L +N F +
Sbjct: 122 DLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK 180
Query: 216 LSATLNLSYNHLSGKIPKS----LGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L + L+ N I K + + P + D+ +++ +P + +
Sbjct: 181 LD-AVYLNKNKYLTVIDKDAFGGVYSGPSLL--DVSQTSVT-ALP-SKGLEH 227
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 19/115 (16%), Positives = 43/115 (37%), Gaps = 10/115 (8%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFN--ATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ S L + +N S+P F ++ LY N + S+ N +L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 147 DLSNNSFSGSLP----DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
L+ N + + G+ + L +++ + +P+ L+ L+ +
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYS--GPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 47/189 (24%), Positives = 76/189 (40%), Gaps = 49/189 (25%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+ + K+ HPN+VKL P+E L + + ++ G + + T
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--------------MEVPTL 131
Query: 511 LRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+++ AR G+ YLH +K +H DIKPSN+L+ D I+DFG+S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS---- 184
Query: 563 ITGNNPSSSGGFMG---GALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVL 618
N S + G +M P +E + DV++ GV L
Sbjct: 185 ---NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKAL-----------DVWAMGVTL 230
Query: 619 LELLTGKSP 627
+ G+ P
Sbjct: 231 YCFVFGQCP 239
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 42/169 (24%), Positives = 62/169 (36%), Gaps = 16/169 (9%)
Query: 90 GSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC---NLPRLQN 145
+ L+ NN L + T L ++ L N L L + LQ
Sbjct: 321 SKISPFLHLDFSNNLL-TDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQ 378
Query: 146 LDLSNNSFSGSLPDGLKNC-KQLQRLILARNKFSGQIPAGIWPEL-ENLVQLDLSDNDFK 203
LD+S NS S G + K L L ++ N + I+ L + LDL N K
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSN----ILTDTIFRCLPPRIKVLDLHSNKIK 434
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNL 251
IP + +L++L LN++ N L +P L L N
Sbjct: 435 S-IPKQVVKLEALQ-ELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 36/212 (16%), Positives = 63/212 (29%), Gaps = 14/212 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVC-NLPR 142
+P +L LN+ N + L + + L + + N + L SV
Sbjct: 15 VPKDLSQ--KTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQE 70
Query: 143 LQNLDLSNNSFSGSLP-DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L+ LDLS+N + N L+ L L+ N F + + L L LS
Sbjct: 71 LEYLDLSHNKLV-KISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTH 126
Query: 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
+ + L L L + + P+ L + L + +
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE---SLHIVFPTNKEFHFILD 183
Query: 262 ANQGPTAFLSNPLLCGFPLQKSCKDSTESQQE 293
+ A L + C +
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 35/144 (24%), Positives = 56/144 (38%), Gaps = 10/144 (6%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLF---NATSLHSIFLYGNNLSGSLPPSVC-NLP 141
G L L L L N L L SL + + N++S C
Sbjct: 341 FENCGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L +L++S+N + ++ L +++ L L NK IP + +LE L +L+++ N
Sbjct: 400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVV-KLEALQELNVASNQ 455
Query: 202 FKGPIPNDLGELQSLSATLNLSYN 225
K L SL + L N
Sbjct: 456 LKSVPDGIFDRLTSLQ-KIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 36/166 (21%), Positives = 71/166 (42%), Gaps = 9/166 (5%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149
SL L + ++ +FG ++ ++++ + + +LD S
Sbjct: 274 SLKALSIHQVVSD-VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP--AGIWPELENLVQLDLSDNDFK-GPI 206
NN + ++ + + +L+ LIL N+ ++ A + ++++L QLD+S N
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
D +SL +LN+S N L+ I + L P DL N +
Sbjct: 392 KGDCSWTKSLL-SLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 24/185 (12%), Positives = 59/185 (31%), Gaps = 15/185 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S + ++ + + + L + + +L++I N+ L + +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYF 252
Query: 147 DLSNNSFSG-----SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
+SN G + K L + + F + I+ N+ + + +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF-PQSYIYEIFSNMNIKNFTVSG 311
Query: 202 FKG---PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ P+ + L+ S N L+ + ++ G+L + L+ N L
Sbjct: 312 TRMVHMLCPSKISPFL----HLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA 367
Query: 259 GSFAN 263
Sbjct: 368 EMTTQ 372
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 35/206 (16%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDLSNNS 152
++L+L +N L SLP + F+ T L ++L N L +LP + L L+ L +++N
Sbjct: 39 TKKLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 153 FSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND-- 209
+LP G+ L L L RN+ +P ++ L L L L N+ + +P
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVF 153
Query: 210 --LGELQSLSATLNLSYNHLSGKIPK----SLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L L+ L L N L ++P+ L L + L N L +P+ G+F +
Sbjct: 154 DKLTSLK----ELRLYNNQLK-RVPEGAFDKLTEL---KTLKLDNNQLK-RVPE-GAFDS 203
Query: 264 QGPTAFL---SNPLLCGFPLQKSCKD 286
L NP C +C
Sbjct: 204 LEKLKMLQLQENPWDC------TCNG 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 16/166 (9%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
L LR L L++N L +LP +F +L ++++ N L +LP V L L L L
Sbjct: 59 RLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 149 SNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207
N SLP + + +L L L N+ +P G++ +L +L +L L +N K +P
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VP 173
Query: 208 N----DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
L EL+ TL L N L + +L L+ N
Sbjct: 174 EGAFDKLTELK----TLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 46/167 (27%), Positives = 61/167 (36%), Gaps = 42/167 (25%)
Query: 127 NNLSGSLPPSVC---------------------NLP-RLQNLDLSNNSFSGSLPDG-LKN 163
N VC N+P + LDL +N S SLP
Sbjct: 1 NEALCKKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHR 59
Query: 164 CKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG-P--IPNDLGELQSLSATL 220
+L+ L L NK +PAGI+ EL+NL L ++DN + P + + L L L
Sbjct: 60 LTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLA----EL 114
Query: 221 NLSYNHLSGKIPK----SLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
L N L +P SL L L N L +P G F
Sbjct: 115 RLDRNQLK-SLPPRVFDSLTKL---TYLSLGYNELQ-SLP-KGVFDK 155
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 61/225 (27%), Positives = 83/225 (36%), Gaps = 43/225 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+LGK G V K AV EV+ + K+ HPNI+K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++ + + G L + + R S RI K G+ Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK- 139
Query: 528 SPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
VH D+KP NILL++ D I DFGLS M + Y
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--------QNTKMKDRIGTAY- 188
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE V +K DV+S GV+L LL+G P
Sbjct: 189 ----------YIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFV-TEVQAIAKVKHPNIV 466
LG IV K G G A RRL RE + EV + +++HPNI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L + + +LI + +S G L + L + SL+ + K G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS 126
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGAL--P 580
++ H D+KP NI+L + P + DFG++ I +G P
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------AGNEFKNIFGTP 175
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ APE + P+ + D++S GV+ LL+G SP
Sbjct: 176 E-----------FVAPE--IVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 38/227 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
V+GK +V + + G AV + + E +KHP+IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L Y + ++ +F+ +L + R S + + L Y H+
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 528 SPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
+H D+KP +LL +N + FG++ + SG GG + P+
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-------ESGLVAGGRVGTPH- 198
Query: 583 KPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ APE R P +P+ DV+ GV+L LL+G P
Sbjct: 199 ----------FMAPEVVKREPYGKPV---DVWGCGVILFILLSGCLP 232
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 22/146 (15%), Positives = 60/146 (41%), Gaps = 13/146 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ + ++ L ++N + + + + ++L + + G +++ P++ L L L
Sbjct: 60 TGIEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN---DFK 203
D+S+++ S+ + ++ + L+ N I L L L++ + D++
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYR 175
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSG 229
G + + L+ L + G
Sbjct: 176 G-----IEDFPKLN-QLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 27/130 (20%), Positives = 53/130 (40%), Gaps = 8/130 (6%)
Query: 126 GNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI 185
G + + ++ + + L + L+N + + L G++ ++ L + + P
Sbjct: 31 GQSSTANITEA--QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNPIS- 85
Query: 186 WPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFD 245
L NL +L + D +L L SL+ L++S++ I + LP S D
Sbjct: 86 --GLSNLERLRIMGKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSID 142
Query: 246 LRGNNLSGEI 255
L N +I
Sbjct: 143 LSYNGAITDI 152
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 22/104 (21%), Positives = 44/104 (42%), Gaps = 3/104 (2%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP 135
I GK+V L L L L++ ++ S+ ++ ++SI L N + P
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG 179
+ LP L++L++ + G+++ +L +L G
Sbjct: 155 -LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 53/221 (23%), Positives = 96/221 (43%), Gaps = 38/221 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLG-EGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+GK G V+K + VA++ + E E + E+ +++ P + K Y
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK---Y 85
Query: 472 Y--WAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
Y + D KL +I +++ G+ + L L + I + +GL YLH
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS-- 137
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-VQ 586
K +H DIK +N+LL + ++DFG++ + T ++ F+G P+ M P V
Sbjct: 138 -EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVG--TPFWMAPEVI 191
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ + +A D++S G+ +EL G+ P
Sbjct: 192 KQSAYDSKA--------------DIWSLGITAIELARGEPP 218
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 52/171 (30%), Positives = 69/171 (40%), Gaps = 20/171 (11%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLP--DQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+ L L +LNL L L L L ++ L N L SLP LP L
Sbjct: 48 LATLMPYTRLTQLNLDRAEL-TKLQVDGTL---PVLGTLDLSHNQLQ-SLPLLGQTLPAL 102
Query: 144 QNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
LD+S N + SLP G + +LQ L L N+ +P G+ L +L L++N+
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNL 160
Query: 203 KGPIP----NDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
+P N L L TL L N L IPK + L GN
Sbjct: 161 TE-LPAGLLNGLENLD----TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 37/119 (31%), Positives = 53/119 (44%), Gaps = 8/119 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC-NLPR 142
+P +L L L++ N L SLP L ++L GN L +LPP + P+
Sbjct: 92 LPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK 149
Query: 143 LQNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
L+ L L+NN+ + LP GL + L L+L N IP G + L L N
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFF-GSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 51/211 (24%), Positives = 79/211 (37%), Gaps = 42/211 (19%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNS- 152
+N NL +LP L + L N L + + RL L+L
Sbjct: 12 HLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL 67
Query: 153 -----FSG---------------SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL 192
SLP + L L ++ N+ + +P G L L
Sbjct: 68 TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGEL 126
Query: 193 VQLDLSDNDFKGPIPND----LGELQSLSATLNLSYNHLSGKIPKSL-GNLPVTVSFDLR 247
+L L N+ K +P +L+ L+L+ N+L+ ++P L L + L+
Sbjct: 127 QELYLKGNELKT-LPPGLLTPTPKLE----KLSLANNNLT-ELPAGLLNGLENLDTLLLQ 180
Query: 248 GNNLSGEIPQTGSFANQG-PTAFL-SNPLLC 276
N+L IP+ G F + P AFL NP LC
Sbjct: 181 ENSLYT-IPK-GFFGSHLLPFAFLHGNPWLC 209
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ G VY + + G VA+R++ + + + E+ + + K+PNIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
DE ++ ++++ G+L + + T + + + + L +LH + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS---NQVI 138
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-VQTEKTN 591
H DIK NILL D ++DFG I + S+ +G PY M P V T K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST---MVG--TPYWMAPEVVTRKAY 193
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
+ D++S G++ +E++ G+ P +P
Sbjct: 194 GPKV--------------DIWSLGIMAIEMIEGEPPYLNENP 221
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 61/225 (27%), Positives = 82/225 (36%), Gaps = 43/225 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
+LGK G V K AV EV+ + K+ HPNI+K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++ + + G L + + R S RI K G+ Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK- 139
Query: 528 SPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
VH D+KP NILL + D I DFGLS M + Y
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--------QQNTKMKDRIGTAY- 188
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE V +K DV+S GV+L LL+G P
Sbjct: 189 ----------YIAPE--VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 59/269 (21%), Positives = 96/269 (35%), Gaps = 52/269 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG G V+ V +G+ + + + ++ E++ + + HPNI+K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ---IEAEIEVLKSLDHPNIIKI 85
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ ++ + G L + + +LS + K LAY H
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHS-- 142
Query: 529 PRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMK 583
+ VH D+KP NIL + I DFGL+ L S A
Sbjct: 143 -QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--------KSDEHSTNAAGTAL-- 191
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643
Y APE V K D++S GVV+ LLTG P + ++
Sbjct: 192 ---------YMAPE--VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQ 234
Query: 644 RWVKKG---FEEE-NPLS----DMVDAML 664
+ + E PL+ D++ ML
Sbjct: 235 QKATYKEPNYAVECRPLTPQAVDLLKQML 263
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 4e-16
Identities = 53/218 (24%), Positives = 92/218 (42%), Gaps = 30/218 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G+V++V G A + + E E+Q ++ ++HP +V L +
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+E ++I +F+S G L + + +S + + +GL ++HE +
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 533 VHGDIKPSNILLDNDFQPYI--SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
VH D+KP NI+ + DFGL+ + +P S G
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL-----DPKQSVKVTTGT-AE--------- 321
Query: 591 NNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ APE V +P+ D++S GV+ LL+G SP
Sbjct: 322 --FAAPE--VAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 58/228 (25%), Positives = 90/228 (39%), Gaps = 43/228 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFV-TEVQAIAKVKHPNIV 466
LG +V K G+ A RR RE + EV + +++HPN++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L Y + +LI + ++ G L + L + SL+ K G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS 132
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGAL--P 580
+ H D+KP NI+L + P I DFGL+ I+ G P
Sbjct: 133 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFKNIFGTP 181
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
+ APE + P+ + D++S GV+ LL+G SP
Sbjct: 182 E-----------FVAPE--IVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G+ GIV +G VAV+ + +QR EV + +H N+V++ Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+E ++ +F+ G L + + L+ + + + LAYLH + +
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-VQTEKTN 591
H DIK +ILL D + +SDFG I+ S +G PY M P V +
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS---LVG--TPYWMAPEVISRSLY 218
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
D++S G++++E++ G+ P SP
Sbjct: 219 ATEV--------------DIWSLGIMVIEMVDGEPPYFSDSP 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 45/232 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV---------RRLGEGGEQRHREFVTEVQAIAKVK-H 462
+LG+ +V + + AV E ++ + EV + KV H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
PNI++L+ Y L+ D + G L + L + +LS +I + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVIC 138
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--P 580
LH+ VH D+KP NILLD+D ++DFG S ++ G + P
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--------PGEKLREVCGTP 187
Query: 581 YMKPVQTEKTNNYRAPE----ARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
Y APE + + ++ D++S GV++ LL G P
Sbjct: 188 S-----------YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 54/230 (23%), Positives = 87/230 (37%), Gaps = 44/230 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV----RRLGEGGEQRHREFV----TEVQAIAKVKHPN 464
LG G V VA+ +R G R + TE++ + K+ HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 465 IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
I+K++ ++ A D ++ + + G L + + G L +T + YL
Sbjct: 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYL 130
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGAL-- 579
HE +H D+KP N+LL + + I+DFG S+++ M
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--------GETSLMRTLCGT 179
Query: 580 PYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P Y APE V + D +S GV+L L+G P
Sbjct: 180 PT-----------YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 32/226 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G VYK G A + + E+ +++ E++ +A HP IVKL Y
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ + ++ +F G + + + L+ + + L +LH ++
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP----VQT 587
+H D+K N+L+ + ++DFG+S T S F+G PY M P +T
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIG--TPYWMAPEVVMCET 193
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
K Y K D++S G+ L+E+ + P EL+P
Sbjct: 194 MKDTPYD------------YKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 57/260 (21%), Positives = 101/260 (38%), Gaps = 38/260 (14%)
Query: 372 RNEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVV-LGN 430
+ D ED K K + V + +G ++ ++L LG G+V++ V
Sbjct: 24 NDYDKFYEDIWK----KYVPQPVEVKQGSVYDYYDILE----ELGSGAFGVVHRCVEKAT 75
Query: 431 GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490
G + + E+ + ++ HP ++ L + E +LI +F+S G L
Sbjct: 76 GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135
Query: 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550
+ + + +S + + + GL ++HE VH DIKP NI+ +
Sbjct: 136 FDRIAAEDY----KMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKAS 188
Query: 551 Y--ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM-Q 607
I DFGL+ + NP + APE + P+
Sbjct: 189 SVKIIDFGLATKL-----NPDEIVKVTTAT-AE-----------FAAPE--IVDREPVGF 229
Query: 608 KWDVYSFGVVLLELLTGKSP 627
D+++ GV+ LL+G SP
Sbjct: 230 YTDMWAIGVLGYVLLSGLSP 249
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 36/166 (21%), Positives = 67/166 (40%), Gaps = 19/166 (11%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ + L L +L +NN+ +L L T+L + N L+ +L V L +L L
Sbjct: 58 TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+ N + L + L L ARN + +I L +LD N +
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKL 164
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
D+ L+ TL+ S+N ++ ++ + + + NN++
Sbjct: 165 --DVTPQTQLT-TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 29/183 (15%), Positives = 62/183 (33%), Gaps = 30/183 (16%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
++ L L+ N + L + L+ + NN++ L + +L
Sbjct: 163 KLDVTPQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE-------NLVQLDLS 198
LD S+N + + + QL + N + ++ +L +L+++DL+
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 199 DN---------DFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
N + D+ L L+ ++ ++ L P V L
Sbjct: 273 HNTQLIYFQAEGCRKIKELDVTHNTQLY-LLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328
Query: 250 NLS 252
L+
Sbjct: 329 ELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 30/176 (17%), Positives = 51/176 (28%), Gaps = 20/176 (11%)
Query: 88 ELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147
+L I L L+ +N L + + T L N L+ L S L +L L
Sbjct: 207 DLNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLH 260
Query: 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207
+ L + QL + +I L LD
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCR---KIKELDVTHNTQLYLLDCQAAGIT---E 311
Query: 208 NDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263
DL + L L L+ L+ ++ + + S ++ + G
Sbjct: 312 LDLSQNPKLV-YLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSSVGKIPA 362
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 35/164 (21%), Positives = 55/164 (33%), Gaps = 19/164 (11%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148
+ L LN N L + + + T L + + N L V +L LD
Sbjct: 123 VSQNPLLTYLNCARNTL-TEID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
S N + L + K L RL N + ++ + L LD S N
Sbjct: 178 SFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKLTE---I 227
Query: 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
D+ L L+ + S N L+ +L L + +L
Sbjct: 228 DVTPLTQLT-YFDCSVNPLTELDVSTLSKLT---TLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 27/183 (14%), Positives = 60/183 (32%), Gaps = 21/183 (11%)
Query: 74 VAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSL 133
A ++ + P + + + +L S+ + ++++ +
Sbjct: 4 KAGQTQSFNDWFPDD-----NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DM 57
Query: 134 PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLV 193
+ L L L ++N+ + +L L L L NK + + L L
Sbjct: 58 TG-IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLDVT---PLTKLT 109
Query: 194 QLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
L+ N D+ + L+ LN + N L+ +I + + D N
Sbjct: 110 YLNCDTNKLT---KLDVSQNPLLT-YLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT 162
Query: 254 EIP 256
++
Sbjct: 163 KLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 28/169 (16%), Positives = 58/169 (34%), Gaps = 20/169 (11%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148
+ +L L L+ +L + L + T L G L V + +L LD
Sbjct: 250 VSTLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDC 304
Query: 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
+ L L +L L L + + ++ L L + + +
Sbjct: 305 QAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS---HNTKLKSLSCVNAHIQD-FSS 356
Query: 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVS-----FDLRGNNLS 252
+G++ +L+ + ++L N +T++ D GN ++
Sbjct: 357 -VGKIPALN-NNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 53/247 (21%), Positives = 87/247 (35%), Gaps = 73/247 (29%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV--------RRLGEGGEQRHREFVTEVQAIAK 459
Y++G G G KV AV RR+ G +E +Q + +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRR 62
Query: 460 VKHPNIVKLR-AYYWAPDEKL-LISDFISNGN---LANALRGRNGQPSTSLSWSTRLRIA 514
++H N+++L Y +K+ ++ ++ G L + R
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR---------------FP 107
Query: 515 KGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566
A GL YLH + VH DIKP N+LL IS G++ +
Sbjct: 108 VCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL----- 159
Query: 567 NPSSSGGFMGGALPYMKPVQTEKTN----NYRAPEARVPGNRPMQ--KWDVYSFGVVLLE 620
+P ++ +T+ ++ PE G K D++S GV L
Sbjct: 160 HPFAADDTC-------------RTSQGSPAFQPPEI-ANGLDTFSGFKVDIWSAGVTLYN 205
Query: 621 LLTGKSP 627
+ TG P
Sbjct: 206 ITTGLYP 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 46/227 (20%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LGK +V + V G+ A ++L Q+ E + K++HPNIV+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L L+ D ++ G L + R S + + +AY H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHS- 123
Query: 528 SPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
VH ++KP N+LL ++DFGL+ + + G P
Sbjct: 124 --NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--------NDSEAWHGFAGTPG- 172
Query: 583 KPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE + P ++P+ D+++ GV+L LL G P
Sbjct: 173 ----------YLSPEVLKKDPYSKPV---DIWACGVILYILLVGYPP 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 49/206 (23%), Positives = 78/206 (37%), Gaps = 39/206 (18%)
Query: 501 PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
L+ + + A+G+ +L + RK +H D+ NILL I DFGL+R
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLE 620
I + + P++ + APE +Q DV+SFGV+L E
Sbjct: 243 IYKDPDYVRKGDARL--------PLK------WMAPETIFDRVYTIQS-DVWSFGVLLWE 287
Query: 621 LLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFH 679
+ + G SP P E R +K+G P + E ++
Sbjct: 288 IFSLGASP--YPGVKIDEEF---CRRLKEGTRMRAP------------DYTTPE---MYQ 327
Query: 680 LALACTEADPEVRPRMKNVSENLERI 705
L C +P RP + E+L +
Sbjct: 328 TMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 33/167 (19%), Positives = 60/167 (35%), Gaps = 14/167 (8%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
L + L+ + ++ + +L + L N ++ L P + NL ++
Sbjct: 34 TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITE 89
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
L+LS N + + ++ L L + + P L NL L L N
Sbjct: 90 LELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTPLA---GLSNLQVLYLDLNQITN- 143
Query: 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
I L L +L L++ +S + L NL + N +S
Sbjct: 144 ISP-LAGLTNLQ-YLSIGNAQVS-DLT-PLANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 41/166 (24%), Positives = 66/166 (39%), Gaps = 14/166 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L L L L +N + + L N T + + L GN L ++ + L ++ L
Sbjct: 57 EGVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTL 112
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
DL++ + L LQ L L N+ + P L NL L + + +
Sbjct: 113 DLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPLA---GLTNLQYLSIGNAQVSD-L 166
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L L L+ TL N +S I L +LP + L+ N +S
Sbjct: 167 TP-LANLSKLT-TLKADDNKIS-DIS-PLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 32/166 (19%), Positives = 64/166 (38%), Gaps = 14/166 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+L ++ +N+ ++ + + ++ +G ++ ++ V L L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+L +N + L LKN ++ L L+ N + A L+++ LDL+
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDVT 123
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
P L L +L L L N ++ I L L + +S
Sbjct: 124 P--LAGLSNLQ-VLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 17/173 (9%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
S L L L+ L++ N + L L N + L ++ N +S + P + +LP L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEV 200
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L NN S + L N L + L + Q NLV ++ PI
Sbjct: 201 HLKNNQIS-DVS-PLANTSNLFIVTLTNQTITNQPVF----YNNNLVVPNVVKGPSGAPI 254
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTG 259
++S + +L+ + + N V+ +F+ + +P +G
Sbjct: 255 APA-----TISDNGTYASPNLTWNLTSFINN--VSYTFNQSVTFKNTTVPFSG 300
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 33/224 (14%)
Query: 413 YVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LG+ G VYK + G VA++++ E +E + E+ + + P++VK
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
Y+ + ++ ++ G++++ +R RN L+ I + T +GL YLH +
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLHF---MR 145
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP-VQTEK 589
+H DIK NILL+ + ++DFG++ + T ++ +G P+ M P V E
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIG--TPFWMAPEVIQEI 200
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP--ELSP 631
N A D++S G+ +E+ GK P ++ P
Sbjct: 201 GYNCVA--------------DIWSLGITAIEMAEGKPPYADIHP 230
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 57/222 (25%), Positives = 88/222 (39%), Gaps = 39/222 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
VLG V+ V G A++ + + R E+ + K+KH NIV L Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ L+ +S G L + + R + + + + YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGI 127
Query: 533 VHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMKPVQT 587
VH D+KP N+L + + + I+DFGLS++ G M A P
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---------NGIMSTACGTPG------ 172
Query: 588 EKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE A+ P ++ + D +S GV+ LL G P
Sbjct: 173 -----YVAPEVLAQKPYSKAV---DCWSIGVITYILLCGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 57/231 (24%), Positives = 86/231 (37%), Gaps = 44/231 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV--------RRLGEGGEQRHREFVTEVQAIAKVK-HP 463
V+G+ +V + V G AV R E E+ E + +V HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523
+I+ L Y + L+ D + G L + L + +LS I + +++
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSF 215
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PY 581
LH VH D+KP NILLD++ Q +SDFG S + G + P
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--------PGEKLRELCGTPG 264
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKW-----DVYSFGVVLLELLTGKSP 627
Y APE D+++ GV+L LL G P
Sbjct: 265 -----------YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 35/113 (30%), Positives = 51/113 (45%), Gaps = 7/113 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFN-ATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
LRR++L NN + L F SL+S+ LYGN ++ LP S+ L LQ L L
Sbjct: 54 PYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 149 SNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+ N + L ++ L L L NK I G + L + + L+ N
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 11/138 (7%)
Query: 144 QNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+ L N+ +P G K+L+R+ L+ N+ S ++ + L +L L L N
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 203 KGPIPNDLGELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
+ L SL L L+ N ++ + + +L L N L I + G+F
Sbjct: 93 TELPKSLFEGLFSLQ-LLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK-GTF 148
Query: 262 ANQGPTAFL---SNPLLC 276
+ + NP +C
Sbjct: 149 SPLRAIQTMHLAQNPFIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 17/65 (26%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
L L+ L L+ N + L F +L+ + LY N L ++ L +Q + L
Sbjct: 102 GLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHL 159
Query: 149 SNNSF 153
+ N F
Sbjct: 160 AQNPF 164
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 52/237 (21%), Positives = 91/237 (38%), Gaps = 47/237 (19%)
Query: 413 YVLGKSGLG-----IVYKVV-LGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVK- 461
Y L + LG V + L AV ++ G + RE V+ + + +
Sbjct: 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE----VEMLYQCQG 69
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTR--LRIAKGTAR 519
H N+++L ++ D L+ + + G++ + + R ++ + + A
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-------HFNELEASVVVQDVAS 122
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMG 576
L +LH + H D+KP NIL ++ Q I DF L I + G+ S +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 577 GAL--PYMKPVQTEKTNNYRAPE---ARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
Y APE A ++ D++S GV+L LL+G P
Sbjct: 180 TPCGSAE-----------YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 19/190 (10%)
Query: 66 FPDPR---VVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSI 122
FPD + + K+V + L + ++ +N+++ S+ + ++ +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKL 70
Query: 123 FLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP 182
FL GN L+ + P + NL L L L N L LK+ K+L+ L L N S I
Sbjct: 71 FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DIN 125
Query: 183 AGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTV 242
G+ L L L L +N L L L TL+L N +S I L L
Sbjct: 126 -GL-VHLPQLESLYLGNNKITDITV--LSRLTKLD-TLSLEDNQIS-DIV-PLAGLTKLQ 178
Query: 243 SFDLRGNNLS 252
+ L N++S
Sbjct: 179 NLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 8e-14
Identities = 45/172 (26%), Positives = 70/172 (40%), Gaps = 18/172 (10%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L + +L L+ N L P L N +L +FL N + L + +L +L++L
Sbjct: 59 QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSL 114
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L +N S + +GL + QL+ L L NK + L L L L DN
Sbjct: 115 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLS---RLTKLDTLSLEDNQIS--- 166
Query: 207 PNDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
D+ L L+ L LS NH+S ++L L +L +
Sbjct: 167 --DIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPI 214
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 5e-13
Identities = 45/192 (23%), Positives = 63/192 (32%), Gaps = 16/192 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L +L L L L N + L + L S+ L N +S + + +LP+L++L
Sbjct: 81 KPLTNLKNLGWLFLDENKI--KDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 136
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L NN + L +L L L N+ S I L L L LS N
Sbjct: 137 YLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHIS--- 188
Query: 207 PNDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQ 264
DL L L L L K NL V + +L + +
Sbjct: 189 --DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYE 246
Query: 265 GPTAFLSNPLLC 276
P P
Sbjct: 247 KPNVKWHLPEFT 258
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 34/161 (21%), Positives = 62/161 (38%), Gaps = 20/161 (12%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154
+ + + PD F L +++ + L + + +N+
Sbjct: 1 MGETITVSTPIKQIFPDDAF--AETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK 56
Query: 155 GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN---DFKGPIPNDLG 211
S+ G++ + +L L NK + I L+NL L L +N D L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT-DIKP--LTNLKNLGWLFLDENKIKDLSS-----LK 106
Query: 212 ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+L+ L +L+L +N +S I L +LP S L N ++
Sbjct: 107 DLKKLK-SLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 25/169 (14%), Positives = 47/169 (27%), Gaps = 10/169 (5%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L L L L+L +N + + L T L +++L N++S L + L L L
Sbjct: 147 TVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVL 202
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
+L + + N + + E
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVS 262
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255
+ A TVS+D+ G + ++
Sbjct: 263 FIFYQPVTIGKAKARFHGRVTQPLKEVY------TVSYDVDGTVIKTKV 305
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 66/241 (27%), Positives = 99/241 (41%), Gaps = 69/241 (28%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGG--EQRHREFVTEVQAIAKV 460
YVLG + G+G KV +G G VAV +++ + RE +Q +
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLF 68
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR- 519
+HP+I+KL P + ++ +++S G L + + R+ + AR
Sbjct: 69 RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-------------CKHGRVEEMEARR 115
Query: 520 -------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+ Y H VH D+KP N+LLD I+DFGLS N S G
Sbjct: 116 LFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLS--------NMMSDG 164
Query: 573 GFMGGALPYMKPVQTEKTN----NYRAPEARVPGNRPMQ--KWDVYSFGVVLLELLTGKS 626
F+ +T+ NY APE V R + D++S GV+L LL G
Sbjct: 165 EFL-------------RTSCGSPNYAAPE--VISGRLYAGPEVDIWSCGVILYALLCGTL 209
Query: 627 P 627
P
Sbjct: 210 P 210
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 58/239 (24%), Positives = 99/239 (41%), Gaps = 44/239 (18%)
Query: 402 FELDELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV 460
FEL E ++G G VYK + G A++ + + E E+ + K
Sbjct: 26 FELVE-------LVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKY 77
Query: 461 -KHPNIVK-----LRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRI 513
H NI ++ D++L L+ +F G++ + ++ G + I
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---I 134
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573
+ RGL++LH+ K +H DIK N+LL + + + DFG+S ++ T ++
Sbjct: 135 CREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--- 188
Query: 574 FMGGALPY-MKPVQTEKTNNYRAPEARVPGNRPM----QKWDVYSFGVVLLELLTGKSP 627
F+G PY M APE P K D++S G+ +E+ G P
Sbjct: 189 FIG--TPYWM------------APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 51/226 (22%), Positives = 85/226 (37%), Gaps = 44/226 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LGK +V + V G+ A + + ++ E + K++HPNIV+L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRL 93
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
L+ D ++ G L + R S + + +AY H
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS-- 146
Query: 529 PRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMK 583
VH ++KP N+LL ++DFGL+ +N G P
Sbjct: 147 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--------DSEAWHGFAGTPG-- 195
Query: 584 PVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE + P ++P+ D+++ GV+L LL G P
Sbjct: 196 ---------YLSPEVLKKDPYSKPV---DIWACGVILYILLVGYPP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 58/260 (22%), Positives = 97/260 (37%), Gaps = 64/260 (24%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKH 462
+ L ++ G G +V L VAV +R + E +E + + H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNH 64
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR--- 519
N+VK + + + L ++ S G L + + + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFF 111
Query: 520 -----GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
G+ YLH H DIKP N+LLD ISDFGL+ + ++
Sbjct: 112 HQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERL 163
Query: 575 MG---GALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
+ G LPY+ P + + + A DV+S G+VL +L G+ P
Sbjct: 164 LNKMCGTLPYVAPELLKRR--EFHAEPV-----------DVWSCGIVLTAMLAGELPWDQ 210
Query: 631 PTTSTSIEVPDLVRWVKKGF 650
P+ S + W +K
Sbjct: 211 PSDS----CQEYSDWKEKKT 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 50/220 (22%), Positives = 82/220 (37%), Gaps = 35/220 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+G+ G V V G I A +++ + + F E++ + + HPNI++L +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ L+ + + G L + + S RI K +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHK---LNV 127
Query: 533 VHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMKPVQT 587
H D+KP N L D + DFGL+ G M + PY
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF--------KPGKMMRTKVGTPY------ 173
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +P+ V + D +S GV++ LL G P
Sbjct: 174 -----YVSPQ--VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 46/218 (21%), Positives = 84/218 (38%), Gaps = 31/218 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG+ GIV++ V + + + G + E+ + +H NI+ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ +E ++I +FIS ++ + L+ + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 533 VHGDIKPSNILLDNDFQPY--ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
H DI+P NI+ I +FG +R + P + + A P
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-----PGDNFRLLFTA-PE--------- 168
Query: 591 NNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSP 627
Y APE V + + D++S G ++ LL+G +P
Sbjct: 169 --YYAPE--VHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 51/264 (19%), Positives = 83/264 (31%), Gaps = 63/264 (23%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVT---EVQAIAK 459
Y G G V V V ++ E + E+ +++
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGN-LAN--ALRGRNGQPSTSLSWSTRLRIAKG 516
V+H NI+K+ + L+ + +G L R L I +
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYIFRQ 138
Query: 517 TARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMG 576
+ YL + +H DIK NI++ DF + DFG + G
Sbjct: 139 LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA--------AYLERGKLFY 187
Query: 577 ---GALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP---- 627
G + Y P + YR PE +++S GV L L+ ++P
Sbjct: 188 TFCGTIEYCAPEVLMGNP---YRGPEL-----------EMWSLGVTLYTLVFEENPFCEL 233
Query: 628 ------ELSPTTSTSIEVPDLVRW 645
+ P S E+ LV
Sbjct: 234 EETVEAAIHPPYLVSKELMSLVSG 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 49/223 (21%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+ G+ G V G+ VA++++ + R+RE + +Q +A + HPNIV+L++Y+
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYF 88
Query: 473 WAPDEK-------LLISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARGLAY 523
+ E+ ++ +++ + L R R + ++ + + R +
Sbjct: 89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL--IKVFLFQ-LIRSIGC 144
Query: 524 LHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
LH S H DIKP N+L++ D + DFG ++ ++ + P+ + Y+
Sbjct: 145 LHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--PSEPNVA---------YI 192
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ YRAPE D++S G + E++ G+
Sbjct: 193 ------CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 59/237 (24%), Positives = 82/237 (34%), Gaps = 63/237 (26%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKH 462
Y K G G L VAV + QR E+ ++H
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR------EIINHRSLRH 75
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR--- 519
PNIV+ + P +I ++ S G L + G R ++ AR
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERIC-NAG------------RFSEDEARFFF 122
Query: 520 -----GLAYLHECSPRKFVHGDIKPSNILLDNDFQPY--ISDFGLSRLINITGNNPSSSG 572
G++Y H + H D+K N LLD P I DFG S+ + P S+
Sbjct: 123 QQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTV 178
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM--QKWDVYSFGVVLLELLTGKSP 627
G T Y APE V + + DV+S GV L +L G P
Sbjct: 179 G----------------TPAYIAPE--VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 50/232 (21%), Positives = 81/232 (34%), Gaps = 53/232 (22%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKH-PNIV 466
LG+ +V + + G A RR G+ E+ + K P ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH---EIAVLELAKSCPRVI 92
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR----GLA 522
L Y E +LI ++ + G + + + + + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE-------NDVIRLIKQILEGVY 145
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGAL 579
YLH+ VH D+KP NILL + + I DFG+SR I + +
Sbjct: 146 YLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIM 194
Query: 580 --PYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
P Y APE P D+++ G++ LLT SP
Sbjct: 195 GTPE-----------YLAPEILNYDPITTAT---DMWNIGIIAYMLLTHTSP 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 58/260 (22%), Positives = 97/260 (37%), Gaps = 64/260 (24%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKH 462
+ L ++ G G +V L VAV +R + E +E + + H
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNH 64
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR--- 519
N+VK + + + L ++ S G L + + + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFF 111
Query: 520 -----GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
G+ YLH H DIKP N+LLD ISDFGL+ + ++
Sbjct: 112 HQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERL 163
Query: 575 MG---GALPYMKP-VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630
+ G LPY+ P + + + A DV+S G+VL +L G+ P
Sbjct: 164 LNKMCGTLPYVAPELLKRR--EFHAEPV-----------DVWSCGIVLTAMLAGELPWDQ 210
Query: 631 PTTSTSIEVPDLVRWVKKGF 650
P+ S + W +K
Sbjct: 211 PSDS----CQEYSDWKEKKT 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 51/227 (22%), Positives = 83/227 (36%), Gaps = 45/227 (19%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LGK +V + V + G A ++L Q+ E + +KHPNIV+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVR 74
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L LI D ++ G L + R S + + + + H+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ- 128
Query: 528 SPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYM 582
VH ++KP N+LL ++DFGL+ + G P
Sbjct: 129 --MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-------GEQQAWFGFAGTPG- 178
Query: 583 KPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y +PE + P +P+ D+++ GV+L LL G P
Sbjct: 179 ----------YLSPEVLRKDPYGKPV---DLWACGVILYILLVGYPP 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 14/166 (8%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L + ++ +N+++ S+ + ++ +FL GN L+ + P + NL L L
Sbjct: 40 VTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL 95
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L N L LK+ K+L+ L L N S I G+ L L L L +N
Sbjct: 96 FLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DIN-GL-VHLPQLESLYLGNNKITDIT 150
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L L L TL+L N +S I L L + L N++S
Sbjct: 151 V--LSRLTKLD-TLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 18/168 (10%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L + +L L+ N L + L N +L +FL N + L + +L +L++L
Sbjct: 62 QGIQYLPNVTKLFLNGNKL-TDIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSL 117
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L +N S + +GL + QL+ L L NK + I L L L L DN
Sbjct: 118 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITV--LSRLTKLDTLSLEDNQIS--- 169
Query: 207 PNDLGELQSLSA--TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
D+ L L+ L LS NH+S + ++L L +L
Sbjct: 170 --DIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 20/169 (11%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ + NL ++ + S+ I +++ S+ + LP + L
Sbjct: 18 FSDDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNK---FSGQIPAGIWPELENLVQLDLSDNDFK 203
L+ N + + L N K L L L NK S +L+ L L L N
Sbjct: 74 FLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSL------KDLKKLKSLSLEHNGIS 125
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
I L L L +L L N ++ I L L + L N +S
Sbjct: 126 D-ING-LVHLPQLE-SLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 19/91 (20%), Positives = 33/91 (36%), Gaps = 4/91 (4%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
+ L L L L+L +N + S L T L +++L N++S L + L L L
Sbjct: 150 TVLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVL 205
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKF 177
+L + + N +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 48/221 (21%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK-VKHPNIVKLRAY 471
+G + + + + AV+ + ++ R+ E++ + + +HPNI+ L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
Y ++++ + G L + + + S + + + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHA---QG 136
Query: 532 FVHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
VH D+KPSNIL ++ I DFG ++ + + G + M P T
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-------AENGLL------MTPCYT 183
Query: 588 EKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
N+ APE V + D++S GV+L +LTG +P
Sbjct: 184 A---NFVAPE--VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 49/221 (22%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+LG G V+K G+ +A + + G + E E+ + ++ H N+++L +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ ++ +L+ +++ G L + + + +L+ + K G+ ++H+
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESY----NLTELDTILFMKQICEGIRHMHQ---MYI 208
Query: 533 VHGDIKPSNILLDN--DFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMKPVQTE 588
+H D+KP NIL N Q I DFGL+R + P
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPE------- 253
Query: 589 KTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ APE + P D++S GV+ LL+G SP
Sbjct: 254 ----FLAPEVVNYDFVSFPT---DMWSVGVIAYMLLSGLSP 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E+Q + ++HP +V L Y + +E + ++ D + G+L L+ +N + +
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEE---TVK 118
Query: 511 LRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570
L I + L YL ++ +H D+KP NILLD +I+DF ++ + +
Sbjct: 119 LFICE-LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQIT 172
Query: 571 SGGFMGGALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ M G PYM P + K Y + + D +S GV ELL G+ P
Sbjct: 173 T---MAGTKPYMAPEMFSSRKGAGY---------SFAV---DWWSLGVTAYELLRGRRP 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 69/241 (28%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGG--EQRHREFVTEVQAIAKV 460
Y+LG + G+G KV +G G VAV +++ + RE +Q +
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLF 73
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR- 519
+HP+I+KL P + ++ +++S G L + + R+ + +R
Sbjct: 74 RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI-------------CKNGRLDEKESRR 120
Query: 520 -------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
G+ Y H VH D+KP N+LLD I+DFGLS ++ S G
Sbjct: 121 LFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--------SDG 169
Query: 573 GFMGGALPYMKPVQTEKTN----NYRAPEARVPGNRPMQ--KWDVYSFGVVLLELLTGKS 626
F+ +T+ NY APE V R + D++S GV+L LL G
Sbjct: 170 EFL-------------RTSCGSPNYAAPE--VISGRLYAGPEVDIWSSGVILYALLCGTL 214
Query: 627 P 627
P
Sbjct: 215 P 215
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 37/166 (22%), Positives = 65/166 (39%), Gaps = 15/166 (9%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L + NL ++ + + + + +N+ SL + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
LS+N S L LK+ +L+ L + RN+ + L +L L +N+ +
Sbjct: 69 HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI---PSACLSRLFLDNNELRDTD 122
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L L++L L++ N L I LG L DL GN ++
Sbjct: 123 S--LIHLKNLE-ILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 6e-13
Identities = 40/166 (24%), Positives = 65/166 (39%), Gaps = 15/166 (9%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L ++ N N+N+ + T+L + L N +S L P + +L +L+ L
Sbjct: 35 VSQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEEL 90
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
++ N +G+ + L RL L N+ + L+NL L + +N K I
Sbjct: 91 SVNRNRLKN--LNGIPSAC-LSRLFLDNNELR-DTDS--LIHLKNLEILSIRNNKLKS-I 143
Query: 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
LG L L L+L N ++ L L DL G
Sbjct: 144 VM-LGFLSKLE-VLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 15/84 (17%), Positives = 29/84 (34%), Gaps = 4/84 (4%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
L L L L++ NN L L + L + L+GN ++ + + L ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT-NTGG-LTRLKKVNWI 177
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRL 170
DL+ +
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTV 201
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 56/260 (21%), Positives = 94/260 (36%), Gaps = 61/260 (23%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVT-EVQAIAKVKH--PN 464
+LG G G VY + + + +PVA+ R+ + GE + V EV + KV
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 465 IVKLRAYYWAPDEKLLISDFISN-GNLAN--ALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
+++L ++ PD +LI + +L + RG L +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-------LQEELARSFFWQVLEAV 162
Query: 522 AYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMG---G 577
+ H +H DIK NIL+D N + + DFG L+ G
Sbjct: 163 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---------KDTVYTDFDG 210
Query: 578 ALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-------- 627
Y P ++ + Y A V+S G++L +++ G P
Sbjct: 211 TRVYSPPEWIRYHR---YHGRSA-----------AVWSLGILLYDMVCGDIPFEHDEEII 256
Query: 628 --ELSPTTSTSIEVPDLVRW 645
++ S E L+RW
Sbjct: 257 RGQVFFRQRVSSECQHLIRW 276
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 42/224 (18%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
V+G G+VY+ + +G VA++++ + ++RE +Q + K+ H NIV+LR ++
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFF 116
Query: 473 WAPDEKL------LISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
++ EK L+ D++ + R R Q + +L + + R LAY+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIY--VKLYMYQ-LFRSLAYI 172
Query: 525 HECSPRKFVHGDIKPSNILLDNDFQPY-ISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
H H DIKP N+LLD D + DFG ++ + G
Sbjct: 173 HS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPN-------- 213
Query: 584 PVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ YRAPE DV+S G VL ELL G+
Sbjct: 214 ---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 11/145 (7%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
IP + Y L L+NN +F L I N ++ +
Sbjct: 26 IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASG 82
Query: 143 LQNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
+ + L++N ++ + K + L+ L+L N+ + + + L ++ L L DN
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 202 FKGPIPND-LGELQSLSATLNLSYN 225
+ L SLS TLNL N
Sbjct: 141 IT-TVAPGAFDTLHSLS-TLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 17/65 (26%), Positives = 30/65 (46%), Gaps = 4/65 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148
L L+ L L +N + + + F +S+ + LY N ++ ++ P L L L+L
Sbjct: 103 GLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNL 160
Query: 149 SNNSF 153
N F
Sbjct: 161 LANPF 165
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 44/187 (23%), Positives = 75/187 (40%), Gaps = 45/187 (24%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E ++++ HP VKL + + DEKL + NG L +R + G
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIG----------- 125
Query: 511 LRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+ R L YLH + +H D+KP NILL+ D I+DFG ++ +
Sbjct: 126 -SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK-VL 180
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLE 620
+ + + F+G T Y +PE + D+++ G ++ +
Sbjct: 181 SPESKQARANSFVG-------------TAQYVSPELLTEKSACKSS---DLWALGCIIYQ 224
Query: 621 LLTGKSP 627
L+ G P
Sbjct: 225 LVAGLPP 231
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.3 bits (174), Expect = 5e-13
Identities = 31/145 (21%), Positives = 54/145 (37%), Gaps = 10/145 (6%)
Query: 87 SELGSLIYLRRLNLHN--NNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
S L ++ +R L + + + + L +L+ + + L +
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVT 466
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+LDLS+N +LP L + L+ L + N + G+ L L +L L +N +
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV-ANLPRLQELLLCNNRLQQ 522
Query: 205 -PIPNDLGELQSLSATLNLSYNHLS 228
L L LNL N L
Sbjct: 523 SAAIQPLVSCPRLV-LLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 6e-13
Identities = 31/143 (21%), Positives = 58/143 (40%), Gaps = 21/143 (14%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
+R L+L + +L ++ L + + L N L +LPP++ L L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE------NLVQLDL 197
+ L S+N+ ++ G+ N +LQ L+L N+ ++ LV L+L
Sbjct: 489 EVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQ------SAAIQPLVSCPRLVLLNL 540
Query: 198 SDNDFKGPIPNDLGELQSLSATL 220
N + + G + L+ L
Sbjct: 541 QGN----SLCQEEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 1e-05
Identities = 32/169 (18%), Positives = 55/169 (32%), Gaps = 13/169 (7%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
+ + L R L L +L + L + ++ + L L
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 146 LDLSNNSFSGSLPDGLKNC--KQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+ FS LK + L R+KF + + V L L+ D
Sbjct: 401 EKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV-LHLAHKDLT 454
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+ + L +L ++ L+LS+N L +P +L L N L
Sbjct: 455 V-LCH-LEQLLLVT-HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 61/226 (26%), Positives = 91/226 (40%), Gaps = 32/226 (14%)
Query: 406 ELLRASAYVLGKSGLGIVYKV-VLGNGIPVAVRRLGEGG-EQRHREFVT--EVQAIAKVK 461
R VLGK G G V V G A ++L + ++R E + E Q + KV
Sbjct: 187 RQYR----VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 462 HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
+V L Y D L+ ++ G+L + GQ + + A+ GL
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARA-VFYAAE-ICCGL 299
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
LH + V+ D+KP NILLD+ ISD GL+ ++ +G
Sbjct: 300 EDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKG--RVG----- 347
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE V R D ++ G +L E++ G+SP
Sbjct: 348 --------TVGYMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+G G VY + N VA++++ G+ ++ ++ + EV+ + K++HPN ++ R
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
Y L+ ++ G+ ++ L L + G +GLAYLH
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS--- 172
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY-MKP--VQ 586
+H D+K NILL + DFG + ++ + + F+G PY M P +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-------APANSFVG--TPYWMAPEVIL 223
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y K DV+S G+ +EL K P
Sbjct: 224 AMDEGQYD------------GKVDVWSLGITCIELAERKPP 252
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 45/190 (23%), Positives = 76/190 (40%), Gaps = 46/190 (24%)
Query: 453 EVQAIAKVKHPNIVKLR-------AYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTS 504
E++ + +KH N+V L + Y + L+ DF + +LA L
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVK 120
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564
+ S R+ + GL Y+H K +H D+K +N+L+ D ++DFGL+R ++
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 565 GNNPSSSGGFMGGALPYMKPVQTEKTNN-----YRAPE----ARVPGNRPMQKWDVYSFG 615
N+ + Y TN YR PE R G D++ G
Sbjct: 178 KNSQPN---------RY--------TNRVVTLWYRPPELLLGERDYGP----PIDLWGAG 216
Query: 616 VVLLELLTGK 625
++ E+ T
Sbjct: 217 CIMAEMWTRS 226
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 56/222 (25%), Positives = 88/222 (39%), Gaps = 40/222 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG+ IVY+ G P A++ L + + TE+ + ++ HPNI+KL+ +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
P E L+ + ++ G L + + + S K +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGI 169
Query: 533 VHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGAL--PYMKPVQT 587
VH D+KP N+L D I+DFGLS+++ M P
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--------HQVLMKTVCGTPG------ 215
Query: 588 EKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE + D++S G++ LL G P
Sbjct: 216 -----YCAPEILRGCAYGPEV---DMWSVGIITYILLCGFEP 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 51/230 (22%), Positives = 80/230 (34%), Gaps = 45/230 (19%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK-----------VKH 462
+ G V V GIPVA++R+ + + K H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 463 PNIVKLRAYYWAPDEKL-----LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGT 517
PNI+ LR + +E L+++ + +LA + + +S
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR----IVISPQHIQYFMYHI 143
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
GL LHE VH D+ P NILL ++ I DF L+R ++
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--------EDTADANK-- 190
Query: 578 ALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T YRAPE + + D++S G V+ E+ K
Sbjct: 191 ---------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 54/233 (23%)
Query: 413 YVLGKS-GLGIVYKVVLG----NGIPVAV-----RRLGEGGEQRHREFVTEVQAIAKVKH 462
Y++ ++ G G KV L VA+ + L + E E+ + ++H
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRH 68
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANAL--RGRNGQPSTSLSWSTRLRIAKGTARG 520
P+I+KL P + +++ ++ G L + + + R ++ R +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR-------MTEDEGRRFFQQIICA 120
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
+ Y H K VH D+KP N+LLD++ I+DFGLS ++ + G F+
Sbjct: 121 IEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--------TDGNFL----- 164
Query: 581 YMKPVQTEKTN----NYRAPEARVPGNRPMQ--KWDVYSFGVVLLELLTGKSP 627
KT+ NY APE V + + DV+S G+VL +L G+ P
Sbjct: 165 --------KTSCGSPNYAAPE--VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 61/241 (25%)
Query: 406 ELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR----------------HRE 449
ELL+ VLG+ G KV L V+++ ++
Sbjct: 27 ELLK----VLGQGSFG---KVFL-------VKKISGSDARQLYAMKVLKKATLKVRDRVR 72
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWS 508
E + +V HP IVKL Y + + KL LI DF+ G+L L + +
Sbjct: 73 TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEED--- 127
Query: 509 TRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568
+ +A+ A L +LH ++ D+KP NILLD + ++DFGLS+ +I
Sbjct: 128 VKFYLAE-LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKK 182
Query: 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKS 626
+ S F G T Y APE R + D +SFGV++ E+LTG
Sbjct: 183 AYS--FCG-------------TVEYMAPEVVNRRGHTQSA---DWWSFGVLMFEMLTGTL 224
Query: 627 P 627
P
Sbjct: 225 P 225
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 41/253 (16%), Positives = 78/253 (30%), Gaps = 68/253 (26%)
Query: 414 VLGKSGLGIVYK-VVLGNGIPVAVRRLGEGGEQRHREFVT-EVQAIAKVKHPNIVKLRAY 471
LG GIV + + +G A++++ + + E+ + + H NI+KL Y
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL-----------------RIA 514
++ ++ + + + ++
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 515 KGTA-------------------RGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISD 554
K R + ++H H DIKP N+L++ D + D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVY 612
FG ++ + + YRAPE + D++
Sbjct: 186 FGSAKKLI--------PSEPS-----------VAYICSRFYRAPELMLGATEYTPSIDLW 226
Query: 613 SFGVVLLELLTGK 625
S G V EL+ GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 37/221 (16%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
V+G G+V++ L VA++++ + ++RE +Q + VKHPN+V L+A+++
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFFY 102
Query: 474 APDEKL------LISDFISNGNLANALR--GRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ +K L+ +++ + A R + Q L +L + + R LAY+H
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLL--IKLYMYQ-LLRSLAYIH 158
Query: 526 ECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H DIKP N+LLD + DFG ++++ P+ S Y
Sbjct: 159 S---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI--AGEPNVS---------Y--- 201
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ + YRAPE D++S G V+ EL+ G+
Sbjct: 202 ICSRY---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 47/274 (17%)
Query: 408 LRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFV-TEVQAIAKVK-HPN 464
L LG+ I K V + AV+ + +R E+ A+ + HPN
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEGHPN 67
Query: 465 IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
IVKL + L+ + ++ G L ++ + S + I + ++++
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-----HFSETEASYIMRKLVSAVSHM 122
Query: 525 HECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
H+ VH D+KP N+L +++ + I DFG +RL P
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-------------PL 166
Query: 582 MKPVQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSPELSPT-TSTSIEV 639
P T +Y APE + + D++S GV+L +L+G+ P S + T
Sbjct: 167 KTPCFTL---HYAAPE--LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA 221
Query: 640 PDLVRWVKKG---FEEE--NPLS----DMVDAML 664
++++ +KKG FE E +S D++ +L
Sbjct: 222 VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLL 255
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 51/238 (21%), Positives = 88/238 (36%), Gaps = 53/238 (22%)
Query: 406 ELLRASAYVLGKSGLGIVYKV-VLGNGIPVAV-----RRLGEGGEQRHREFVTEVQAIAK 459
R VLG+ G G V+ + G A +RL + + + E + +AK
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA--MVEKKILAK 241
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
V IV L + + L+ ++ G++ + + + A
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNP---------GFQEPRAI 292
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
GL +LH+ R ++ D+KP N+LLD+D ISD GL+ G +
Sbjct: 293 FYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTK- 347
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G+ G T + APE + + + + GV L E++ + P
Sbjct: 348 -GYAG-------------TPGFMAPELLLGEEYDFSVDYF---ALGVTLYEMIAARGP 388
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 47/222 (21%), Positives = 84/222 (37%), Gaps = 55/222 (24%)
Query: 421 GIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVT--EVQAIAKVKHPNIVKLRAYYWAPDE 477
G+V+K G VA+++ E + + + E++ + ++KHPN+V L +
Sbjct: 17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76
Query: 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI 537
L+ ++ + + + L L S I T + + + H+ +H D+
Sbjct: 77 LHLVFEYCDH-TVLHELDRYQRGVPEHLVKS----ITWQTLQAVNFCHK---HNCIHRDV 128
Query: 538 KPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN----- 592
KP NIL+ + DFG +RL+ + Y +
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPSD-------------YY--------DDEVATRW 167
Query: 593 YRAPE----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
YR+PE V DV++ G V ELL+G
Sbjct: 168 YRSPELLVGDTQYGPPV---------DVWAIGCVFAELLSGV 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 53/261 (20%), Positives = 88/261 (33%), Gaps = 61/261 (23%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAV-----RRLGEGGEQRHREFVT-EVQAIAKV----KH 462
+LGK G G V+ L + + VA+ R+ EV + KV H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGN-LAN--ALRGRNGQPSTSLSWSTRLRIAKGTAR 519
P +++L ++ + +L+ + L + +G L
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-------LGEGPSRCFFGQVVA 150
Query: 520 GLAYLHECSPRKFVHGDIKPSNILLDNDFQPY-ISDFGLSRLINITGNNPSSSGGFMG-- 576
+ + H R VH DIK NIL+D + DFG L++ +
Sbjct: 151 AIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--------DEPYTDFD 199
Query: 577 GALPYMKP--VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP------- 627
G Y P + + Y A A V+S G++L +++ G P
Sbjct: 200 GTRVYSPPEWISRHQ---YHALPA-----------TVWSLGILLYDMVCGDIPFERDQEI 245
Query: 628 ---ELSPTTSTSIEVPDLVRW 645
EL S + L+R
Sbjct: 246 LEAELHFPAHVSPDCCALIRR 266
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 62/233 (26%)
Query: 421 GIVYKVV---LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLR-AYYWAPD 476
G VYK + A++++ G E+ + ++KHPN++ L+ + D
Sbjct: 35 GHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHAD 92
Query: 477 EKL-LISDFISN---GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
K+ L+ D+ + + + + L + G+ YLH
Sbjct: 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWV 149
Query: 533 VHGDIKPSNILLDNDFQPY----ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ-- 586
+H D+KP+NIL+ + I+D G +RL N P++
Sbjct: 150 LHRDLKPANILVMGEGPERGRVKIADMGFARLFNS--------------------PLKPL 189
Query: 587 TEKTNN-----YRAPE----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
+ YRAPE AR + D+++ G + ELLT +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAI---------DIWAIGCIFAELLTSE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 66/276 (23%), Positives = 103/276 (37%), Gaps = 52/276 (18%)
Query: 369 NGFRNEDSEVEDQE----KVESGKGEGELVAIDKGFTFELD--ELLRASAYVLGKSGLGI 422
+G + + + D SG E E+ ++ E L+ +LGK G
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK----LLGKGTFG- 162
Query: 423 VYKVVL----GNGIPVAVRRLG-----EGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
KV+L G A++ L E H +TE + + +HP + L+ +
Sbjct: 163 --KVILVKEKATGRYYAMKILKKEVIVAKDEVAH--TLTENRVLQNSRHPFLTALKYSFQ 218
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
D + ++ + G L L R S R A+ L YLH S + V
Sbjct: 219 THDRLCFVMEYANGGELFFHLS-RERVFSEDR---ARFYGAE-IVSALDYLH--SEKNVV 271
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
+ D+K N++LD D I+DFGL + I + F G T Y
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKT--FCG-------------TPEY 315
Query: 594 RAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
APE R + W GVV+ E++ G+ P
Sbjct: 316 LAPEVLEDNDYGRAVDWW---GLGVVMYEMMCGRLP 348
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 61/276 (22%), Positives = 98/276 (35%), Gaps = 57/276 (20%)
Query: 413 YVLGKSGLG-----IVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNI 465
Y L K LG V + G A++ L + EV + P+I
Sbjct: 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHI 84
Query: 466 VKLRAYY----WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
V + Y L+I + + G L + ++ R Q T + I + +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA---EIMRDIGTAI 141
Query: 522 AYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+LH H D+KP N+L + D ++DFG ++ A
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-------------QNA 185
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPM-QKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637
L P T Y APE V G + D++S GV++ LL G P S T
Sbjct: 186 L--QTPCYTP---YYVAPE--VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI- 237
Query: 638 EVPDLVRWVKKG---FEEE--NPLS----DMVDAML 664
P + R ++ G F + +S ++ +L
Sbjct: 238 -SPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLL 272
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 40/194 (20%), Positives = 71/194 (36%), Gaps = 14/194 (7%)
Query: 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNN 128
+ + I+ + R +L L ++ N + L++ ++ L ++
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFL-FSKEALYSVFAEMNIKMLSISD 340
Query: 129 LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKF-SGQIPAGIWP 187
+ L+ + N F+ S+ G K+LQ LIL RN + A +
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTK 400
Query: 188 ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG----KIPKSLGNLPVTVS 243
+ +L LD+S N + LNLS N L+G +P + L
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVL----- 455
Query: 244 FDLRGNNLSGEIPQ 257
DL N + IP+
Sbjct: 456 -DLHNNRIM-SIPK 467
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 36/145 (24%), Positives = 54/145 (37%), Gaps = 8/145 (5%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
++ L LR L L +N + SL +F L + + N L ++ + L+
Sbjct: 69 MPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLR 124
Query: 145 NLDLSNNSFSGSLPDG--LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+LDLS N F LP N +L L L+ KF + + + LDL
Sbjct: 125 HLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHI 183
Query: 203 KGPIPNDLGELQSLSATLNLSYNHL 227
KG L + L N L
Sbjct: 184 KGGETESLQIPNTTVLHLVFHPNSL 208
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 14/146 (9%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSV----CNLP 141
+L L+ L L N L + ++ S+ +L+ SL C
Sbjct: 370 FQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLN-SLNSHAYDRTCAWA 427
Query: 142 R-LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+ L+LS+N +GS+ L +++ L L N+ IP + L+ L +L+++ N
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDV-THLQALQELNVASN 483
Query: 201 DFKGPIPND-LGELQSLSATLNLSYN 225
K +P+ L SL + L N
Sbjct: 484 QLKS-VPDGVFDRLTSLQ-YIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 26/84 (30%), Positives = 42/84 (50%), Gaps = 5/84 (5%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154
+ LNL +N L GS+ L + + L+ N + S+P V +L LQ L++++N
Sbjct: 430 ILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
Query: 155 GSLPDG-LKNCKQLQRLILARNKF 177
S+PDG LQ + L N +
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 33/115 (28%), Positives = 58/115 (50%), Gaps = 5/115 (4%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFN-ATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147
++ L L++ N+L D+ A S+ + L N L+GS+ C P+++ LD
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--CLPPKVKVLD 456
Query: 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
L NN S+P + + + LQ L +A N+ +P G++ L +L + L DN +
Sbjct: 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 34/138 (24%), Positives = 55/138 (39%), Gaps = 13/138 (9%)
Query: 118 SLHSIFLYGNNLSGSLPPSVCNLP-RLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARN 175
+ NL+ +P +LP R + L LS NS S L + +L+ L L+ N
Sbjct: 32 LESMVDYSNRNLT-HVPK---DLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHN 86
Query: 176 KFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL-SGKIPKS 234
+ + ++ ++L LD+S N + I + SL L+LS+N + K
Sbjct: 87 RIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLR-HLDLSFNDFDVLPVCKE 141
Query: 235 LGNLPVTVSFDLRGNNLS 252
GNL L
Sbjct: 142 FGNLTKLTFLGLSAAKFR 159
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 9e-09
Identities = 29/165 (17%), Positives = 51/165 (30%), Gaps = 10/165 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC--NLPRLQNLDL 148
L L++ +N L ++ SL + L N+ LP NL +L L L
Sbjct: 98 FNQDLEYLDVSHNRL-QNISCCPM--ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGL 153
Query: 149 SNNSFSGSLPDGLKNCKQLQRLI-LARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207
S F + + L+ L G + ++ L N
Sbjct: 154 SAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQV 213
Query: 208 NDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
N + L LS L+ + + L ++ N++
Sbjct: 214 NM---SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 26/170 (15%), Positives = 54/170 (31%), Gaps = 12/170 (7%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG----SLPPSV-CNLPRLQNL 146
+ LN++N + + + F + L ++ ++ +
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 147 DLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK-- 203
LS + + + + L +N F+ L+ L L L N K
Sbjct: 335 MLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSF-DLRGNNLS 252
+ + SL TL++S N L+ ++ +L N L+
Sbjct: 393 FKVALMTKNMSSLE-TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 45/192 (23%), Positives = 74/192 (38%), Gaps = 49/192 (25%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWS 508
F E +A P +V+L Y + D L ++ +++ G+L N +
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS------------- 161
Query: 509 TRLRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
+ + AR L +H F+H D+KP N+LLD ++DFG
Sbjct: 162 -NYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQK---WDVYSFG 615
+N G + +G T +Y +PE G+ + W +S G
Sbjct: 218 MNKEGMVRCDT--AVG-------------TPDYISPEVLKSQGGDGYYGRECDW--WSVG 260
Query: 616 VVLLELLTGKSP 627
V L E+L G +P
Sbjct: 261 VFLYEMLVGDTP 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 7e-12
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 20/109 (18%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H + +H D+KPSN+LL+ I DFGL+R+ + GF+
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA----DPDHDHTGFL--- 188
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
TE T YRAPE + + D++S G +L E+L+ +
Sbjct: 189 --------TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 46/193 (23%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWS 508
F E + I +L + + + L L+ ++ G+L L + G+
Sbjct: 108 FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGE-------- 157
Query: 509 TRLRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
RI AR + +H +VH DIKP NILLD ++DFG
Sbjct: 158 ---RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEA-RVPGNRPMQKW-----DVYSF 614
+ G S +G T +Y +PE + G P D ++
Sbjct: 212 LRADGTVRSLV--AVG-------------TPDYLSPEILQAVGGGPGTGSYGPECDWWAL 256
Query: 615 GVVLLELLTGKSP 627
GV E+ G++P
Sbjct: 257 GVFAYEMFYGQTP 269
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 26/173 (15%)
Query: 455 QAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIA 514
++ P IV + + PD+ I D ++ G+L L ++G S + R A
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAD---MRFYAA 299
Query: 515 KGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGF 574
+ GL ++H R V+ D+KP+NILLD ISD GL+ +
Sbjct: 300 E-IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD-----FSKKKPHAS 350
Query: 575 MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+G T+ Y APE G D +S G +L +LL G SP
Sbjct: 351 VG-------------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 47/193 (24%), Positives = 71/193 (36%), Gaps = 48/193 (24%)
Query: 450 FVTEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWS 508
F E + I L Y + D L L+ D+ G+L L
Sbjct: 121 FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFED--------- 170
Query: 509 TRLRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560
R+ + AR + +H+ +VH DIKP NIL+D + ++DFG
Sbjct: 171 ---RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE---ARVPGNRPMQK---WDVYSF 614
+ G SS +G T +Y +PE A G W +S
Sbjct: 225 LMEDGTVQSSV--AVG-------------TPDYISPEILQAMEGGKGRYGPECDW--WSL 267
Query: 615 GVVLLELLTGKSP 627
GV + E+L G++P
Sbjct: 268 GVCMYEMLYGETP 280
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 8/112 (7%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+ + YLH +H D+KPSNILL+ + ++DFGLSR ++ +
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 579 LPYMKPVQTEKTNN-----YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
Q T+ YRAPE + + + D++S G +L E+L GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 45/217 (20%), Positives = 81/217 (37%), Gaps = 45/217 (20%)
Query: 421 GIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVT--EVQAIAKVKHPNIVKLRAYYWAPDE 477
G+V K G VA+++ E + + + + E++ + +++H N+V L
Sbjct: 39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98
Query: 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI 537
L+ +F+ + + + L L + + G+ + H +H DI
Sbjct: 99 WYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDI 150
Query: 538 KPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE 597
KP NIL+ + DFG +R + G Y V T YRAPE
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGE-------------VYDDEVATRW---YRAPE 194
Query: 598 ----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
V DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAV---------DVWAIGCLVTEMFMGE 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 58/223 (26%)
Query: 421 GIVYKVVLGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK 478
G+VYK G VA++ RL E + E+ + ++ HPNIV L +
Sbjct: 35 GVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94
Query: 479 LLISDFISNGNLANALRGRNGQPSTSL--SWSTRLRIAKGTARGLAYLHECSPRKFVHGD 536
L+ +F+ +L L S + +L RG+A+ H+ + +H D
Sbjct: 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ---HRILHRD 144
Query: 537 IKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN---- 592
+KP N+L+++D ++DFGL+R I PV++ T+
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGI--------------------PVRS-YTHEVVTL 183
Query: 593 -YRAPE----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
YRAP+ ++ V D++S G + E++TGK
Sbjct: 184 WYRAPDVLMGSKKYSTSV---------DIWSIGCIFAEMITGK 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 32/112 (28%), Positives = 53/112 (47%), Gaps = 19/112 (16%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN---ITGNNPSSSGGFM 575
R + LH + +H D+KPSN+L++++ + DFGL+R+I+ + P+ M
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 576 GGALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
E T YRAPE + + + DV+S G +L EL +
Sbjct: 180 -----------VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 51/227 (22%), Positives = 91/227 (40%), Gaps = 62/227 (27%)
Query: 421 GIVYKVV-LGNGIPVAVRRLGEGGEQRHREFV--T---EVQAIAKVKHPNIVKLRAYYWA 474
VYK VA++++ G ++ + T E++ + ++ HPNI+ L +
Sbjct: 24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83
Query: 475 PDEKLLISDFISNGNLANALRGRNGQPSTSL--SWSTRLRIAKGTARGLAYLHECSPRKF 532
L+ DF+ +L ++ + + S ++ +GL YLH+
Sbjct: 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLHQ---HWI 133
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+KP+N+LLD + ++DFGL++ P + T+
Sbjct: 134 LHRDLKPNNLLLDENGVLKLADFGLAKSFGS--------------------PNRA-YTHQ 172
Query: 593 -----YRAPE----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
YRAPE AR V D+++ G +L ELL
Sbjct: 173 VVTRWYRAPELLFGARMYGVGV---------DMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 53/238 (22%), Positives = 91/238 (38%), Gaps = 88/238 (36%)
Query: 421 GIVYK-------------VVLGN---GIPV-AVRRLGEGGEQRHREFVTEVQAIAKVKHP 463
G+VYK + L GIP +R E+ + ++KH
Sbjct: 16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------------EISILKELKHS 60
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSL--SWSTRLRIAKGTARGL 521
NIVKL +L+ + + +L L G + S+ +L G+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL------LNGI 113
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
AY H+ R+ +H D+KP N+L++ + + I+DFGL+R I
Sbjct: 114 AYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI------------------ 152
Query: 582 MKPVQTEKTNN-----YRAPE----AR-----VPGNRPMQKWDVYSFGVVLLELLTGK 625
PV+ T+ YRAP+ ++ + D++S G + E++ G
Sbjct: 153 --PVRK-YTHEIVTLWYRAPDVLMGSKKYSTTI---------DIWSVGCIFAEMVNGT 198
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 9/121 (7%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G ++HE +H D+KP+N LL+ D + DFGL+R IN + +
Sbjct: 140 LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 579 LPYMKPVQTEK------TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
++ T YRAPE + + D++S G + ELL ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 633 T 633
T
Sbjct: 257 T 257
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 49/188 (26%), Positives = 81/188 (43%), Gaps = 49/188 (26%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRN-GQPSTSLSWSTRL 511
E+ + ++KH NIV+L ++ L+ +F+ N +L + R G L +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
+GLA+ HE K +H D+KP N+L++ Q + DFGL+R I
Sbjct: 112 YFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-------- 160
Query: 572 GGFMGGALPYMKPVQTEKTNN-----YRAPE----AR-----VPGNRPMQKWDVYSFGVV 617
PV T ++ YRAP+ +R + D++S G +
Sbjct: 161 ------------PVNT-FSSEVVTLWYRAPDVLMGSRTYSTSI---------DIWSCGCI 198
Query: 618 LLELLTGK 625
L E++TGK
Sbjct: 199 LAEMITGK 206
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 46/178 (25%), Positives = 70/178 (39%), Gaps = 29/178 (16%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRL 511
TE + + +HP + L+ + D + ++ + G L L R + R
Sbjct: 54 TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEER---ARF 109
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
A+ L YLH R V+ DIK N++LD D I+DFGL + I+ +
Sbjct: 110 YGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKT 164
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T Y APE R + W GVV+ E++ G+ P
Sbjct: 165 --FCG-------------TPEYLAPEVLEDNDYGRAVDWW---GLGVVMYEMMCGRLP 204
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 47/215 (21%), Positives = 82/215 (38%), Gaps = 37/215 (17%)
Query: 421 GIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE 477
G V+K VA++ RL + E + E+ + ++KH NIV+L + +
Sbjct: 16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75
Query: 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDI 537
L+ +F +L NG + S +GL + H R +H D+
Sbjct: 76 LTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKS----FLFQLLKGLGFCHS---RNVLHRDL 127
Query: 538 KPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN----- 592
KP N+L++ + + +++FGL+R I PV+ +
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGI--------------------PVRC-YSAEVVTLW 166
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
YR P+ D++S G + EL P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 50/187 (26%), Positives = 77/187 (41%), Gaps = 47/187 (25%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E + +VKHP IV L Y + KL LI +++S G L L
Sbjct: 70 AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-------------ERE 115
Query: 511 LRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+ TA L +LH+ + ++ D+KP NI+L++ ++DFGL + +
Sbjct: 116 GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-S 171
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLE 620
I + + F G T Y APE R NR + W S G ++ +
Sbjct: 172 IHDGTVTHT--FCG-------------TIEYMAPEILMRSGHNRAVDWW---SLGALMYD 213
Query: 621 LLTGKSP 627
+LTG P
Sbjct: 214 MLTGAPP 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 21/107 (19%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G+ +LH +H D+KPSNI++ +D I DFGL+R + + M
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMTP- 185
Query: 579 LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
Y+ T YRAPE + G + D++S G ++ E++ G
Sbjct: 186 --YV------VTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 22/95 (23%), Positives = 33/95 (34%), Gaps = 4/95 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV-CNLPR 142
L L L + N L + L ++ + + L + P PR
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKF 177
L L+LS N+ SL LQ L+L+ N
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.7 bits (136), Expect = 9e-09
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 3/102 (2%)
Query: 102 NNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP-SVCNLPRLQNLDLSNNSFSGSLPDG 160
+ L A +L +++ L + L L+NL + + PD
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 161 LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
+L RL L+ N + L +L +L LS N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 28/167 (16%), Positives = 48/167 (28%), Gaps = 5/167 (2%)
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
P C L + + L + L L + + + L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN--NLS 252
L + + + P+ LS LNLS+N L K++ L + L GN + S
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLS-RLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLHCS 118
Query: 253 GEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKDSTESQQETQNPSP 299
+ + +G L C + + T
Sbjct: 119 CALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNASCGVPTLKVQV 165
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 21/110 (19%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
RGL Y+H + +H D+KP+N+ ++ D I DFGL+R++ + S G +
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM----DPHYSHKGHL-- 181
Query: 578 ALPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+E T YR+P + N + D+++ G + E+LTGK
Sbjct: 182 ---------SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 26/109 (23%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+GL Y+H VH D+KP N+ ++ D + I DFGL+R +
Sbjct: 137 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD---------------- 177
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
M T T YRAPE + Q D++S G ++ E+LTGK
Sbjct: 178 -AEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 41/182 (22%), Positives = 70/182 (38%), Gaps = 42/182 (23%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
EV + +KH NIV L L+ +++ +L L ++
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIINMHNVKL 104
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
RGLAY H +K +H D+KP N+L++ + ++DFGL+R +I
Sbjct: 105 FLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI--------- 152
Query: 573 GFMGGALPYMKPVQTEKTNN-----YRAPE----ARVPGNRPMQKWDVYSFGVVLLELLT 623
P +T N YR P+ + + D++ G + E+ T
Sbjct: 153 -----------PTKT-YDNEVVTLWYRPPDILLGSTDYST----QIDMWGVGCIFYEMAT 196
Query: 624 GK 625
G+
Sbjct: 197 GR 198
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 33/109 (30%), Positives = 50/109 (45%), Gaps = 26/109 (23%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
+GL Y+H +H D+KP N+ ++ D + I DFGL+R +
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQAD---------------- 179
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
M T T YRAPE + R Q D++S G ++ E++TGK
Sbjct: 180 -SEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 39/178 (21%), Positives = 75/178 (42%), Gaps = 45/178 (25%)
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
HP +V L + + + ++++ G+L ++ R ++ + AR
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQR------------KLPEEHAR 113
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
L YLHE R ++ D+K N+LLD++ ++D+G+ + + + +S+
Sbjct: 114 FYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTST 169
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T NY APE + W + GV++ E++ G+SP
Sbjct: 170 --FCG-------------TPNYIAPEILRGEDYGFSVDWW---ALGVLMFEMMAGRSP 209
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 54/225 (24%), Positives = 88/225 (39%), Gaps = 51/225 (22%)
Query: 421 GIVYKVV-LGNGIPVAVR--RLGEGGEQRH-------REFVTEVQAIAKVKHPNIVKLR- 469
G VYK +G VA++ R+ GG RE V ++ + +HPN+V+L
Sbjct: 23 GTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE-VALLRRLEAFEHPNVVRLMD 81
Query: 470 ---AYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+ K+ L+ + + +L L P L T + + RGL +LH
Sbjct: 82 VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLH 137
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
VH D+KP NIL+ + ++DFGL+R+ + +
Sbjct: 138 A---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--------------MAL---- 176
Query: 586 QTEKTNN-----YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T YRAPE + + D++S G + E+ K
Sbjct: 177 ----TPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 14/127 (11%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G+ Y+H +H D+KP+N L++ D + DFGL+R ++ N S
Sbjct: 167 VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 579 LPYMKPVQTEKTNN-----------YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ K YRAPE + + DV+S G + ELL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 628 ELSPTTS 634
++
Sbjct: 284 NVAYHAD 290
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 39/178 (21%), Positives = 75/178 (42%), Gaps = 45/178 (25%)
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
HP +V L + + + ++++ G+L ++ R ++ + AR
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQR------------KLPEEHAR 156
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
L YLHE R ++ D+K N+LLD++ ++D+G+ + + + +S+
Sbjct: 157 FYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTST 212
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T NY APE + W + GV++ E++ G+SP
Sbjct: 213 --FCG-------------TPNYIAPEILRGEDYGFSVDWW---ALGVLMFEMMAGRSP 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 40/175 (22%)
Query: 461 KHPNIVKLR----AYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAK 515
+HPN+V+L + KL L+ + + +L L P + T +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMF 127
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFM 575
RGL +LH + VH D+KP NIL+ + Q ++DFGL+R+ +
Sbjct: 128 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ----------- 173
Query: 576 GGALPYMKPVQTEKTNN-----YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
+ T+ YRAPE + + D++S G + E+ K
Sbjct: 174 ---MAL--------TSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 40/177 (22%), Positives = 74/177 (41%), Gaps = 45/177 (25%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR- 519
K P + +L + + D + ++++ G+L + R + A
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-----------MYHIQQVGRFKEPH--AVF 446
Query: 520 -------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
GL +L + ++ D+K N++LD++ I+DFG+ + NI + +
Sbjct: 447 YAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKT- 501
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T +Y APE A P + + W +FGV+L E+L G++P
Sbjct: 502 -FCG-------------TPDYIAPEIIAYQPYGKSVDWW---AFGVLLYEMLAGQAP 541
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 26/109 (23%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
RGL Y+H +H D+KPSN+ ++ D + I DFGL+R + M
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----------HTADEM--- 186
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T T YRAPE + Q D++S G ++ ELLTG+
Sbjct: 187 --------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 40/196 (20%), Positives = 66/196 (33%), Gaps = 25/196 (12%)
Query: 84 YIPSELGSLIYLRRLNLHNNNL----FGSLPDQL-FNATSLHSIFLYGNNLS----GSLP 134
I S L L LNL +N L + L + + + L L+ G L
Sbjct: 47 DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106
Query: 135 PSVCNLPRLQNLDLSNNSFSGS----LPDGLK-NCKQLQRLILARNKFSGQIPAGIWPEL 189
++ LP LQ L LS+N + L +GL +L++L L S + L
Sbjct: 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVL 166
Query: 190 E---NLVQLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSGK----IPKSLGNL 238
+ +L +S+ND + L + L L ++ + + +
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226
Query: 239 PVTVSFDLRGNNLSGE 254
L N L
Sbjct: 227 ASLRELALGSNKLGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 45/202 (22%), Positives = 71/202 (35%), Gaps = 37/202 (18%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA-----TSLHSIFLYGNNLS----GSLP 134
+ S L +L L+ L+L +N L + L L + L +LS L
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 135 PSVCNLPRLQNLDLSNNSFSGS----LPDGLKNCK-QLQRLILARNKFSG---QIPAGIW 186
+ P + L +SNN + + L GLK+ QL+ L L + + GI
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 187 PELENLVQLDLSDNDFKGPIPNDLGELQSLSA----------TLNLSYNHLSGK----IP 232
+L +L L N D+G + L TL + ++ K +
Sbjct: 224 ASKASLRELALGSNKLG-----DVG-MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 233 KSLGNLPVTVSFDLRGNNLSGE 254
+ L L GN L E
Sbjct: 278 RVLRAKESLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 33/192 (17%), Positives = 59/192 (30%), Gaps = 27/192 (14%)
Query: 89 LGSLIYLRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNL---- 140
L L + + L + L + L +L + L N L V
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 141 -PRLQNLDLSNNSFS----GSLPDGLKNCKQLQRLILARNKFSGQ----IPAGIWPELEN 191
++Q L L N + G L L+ LQ L L+ N + G+
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCR 143
Query: 192 LVQLDLSDNDFKGPIPNDLGEL----QSLSATLNLSYNHLSGK----IPKSLGNLPVTV- 242
L +L L L + L +S N ++ + + L + P +
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFK-ELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 243 SFDLRGNNLSGE 254
+ L ++ +
Sbjct: 203 ALKLESCGVTSD 214
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 34/184 (18%), Positives = 61/184 (33%), Gaps = 27/184 (14%)
Query: 95 LRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLS----GSLPPSVCNLPRLQNL 146
++ L++ L + L L + L L+ + ++ P L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLL---QQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 147 DLSNNSFSGS----LPDGLKNCK-QLQRLILARNKFSGQIPAGIWPEL---ENLVQLDLS 198
+L +N + GL+ ++Q+L L +G + L L +L LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 199 DNDFKGP----IPNDLGELQSLSATLNLSYNHLSGK----IPKSLGNLPVTVSFDLRGNN 250
DN + L + Q L L Y LS + L P + N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 251 LSGE 254
++
Sbjct: 182 INEA 185
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 38/185 (20%), Positives = 64/185 (34%), Gaps = 25/185 (13%)
Query: 95 LRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNL-----PRLQN 145
LR L + + G L L SL + L GN L +C +L++
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 146 LDLSNNSFSG----SLPDGLKNCKQLQRLILARNKFSG----QIPAGIWPELENLVQLDL 197
L + + SF+ L + L L ++ N+ ++ G+ L L L
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWL 377
Query: 198 SDNDFKGPIPNDLGE-LQSLSA--TLNLSYNHLSGK----IPKSLGNLPVTV-SFDLRGN 249
+D D + L L + + L+LS N L + +S+ + L
Sbjct: 378 ADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDI 437
Query: 250 NLSGE 254
S E
Sbjct: 438 YWSEE 442
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 25/109 (22%)
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
G+ +LH +H D+KPSNI++ +D I DFGL+R + + M
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMM--- 220
Query: 579 LPYMKPVQTE--KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
T T YRAPE + G + D++S G ++ E++ K
Sbjct: 221 --------TPYVVTRYYRAPEVIL-GMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 50/161 (31%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 96 RRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDLSNNSF 153
+L+L + L +L D F T L + L N L +L V + L L L L+NN
Sbjct: 38 EKLDLQSTGL-ATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL 95
Query: 154 SGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN---- 208
+ SLP G+ + QL +L L N+ +P+G++ L L +L L+ N + IP
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFD 152
Query: 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249
L LQ TL+LS N L + L + L GN
Sbjct: 153 KLTNLQ----TLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 40/112 (35%), Positives = 53/112 (47%), Gaps = 7/112 (6%)
Query: 92 LIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLS 149
L L L L NN L SLP +F+ T L ++L GN L SLP V L +L+ L L+
Sbjct: 82 LTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLN 139
Query: 150 NNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
N S+P G LQ L L+ N+ +P G + L L + L N
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 47/176 (26%), Positives = 70/176 (39%), Gaps = 33/176 (18%)
Query: 124 LYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQI 181
L L+ +L + L +L L+L N +L G+ + +L L LA N+ + +
Sbjct: 42 LQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-SL 98
Query: 182 PAGIWPELENLVQLDLSDNDFKGPIPND----LGELQSLSATLNLSYNHLSGKIPK---- 233
P G++ L L +L L N K +P+ L +L+ L L+ N L IP
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLK----ELRLNTNQLQ-SIPAGAFD 152
Query: 234 SLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGP--TAFL-SNPLLCGFPLQKSCKD 286
L NL L N L +P G+F G T L N C S +
Sbjct: 153 KLTNLQT---LSLSTNQLQS-VPH-GAFDRLGKLQTITLFGNQFDC------SRCE 197
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 31/88 (35%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDL 148
L L +L L N L SLP +F T L + L N L S+P + L LQ L L
Sbjct: 105 HLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 149 SNNSFSGSLPDG-LKNCKQLQRLILARN 175
S N S+P G +LQ + L N
Sbjct: 163 STNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 54/171 (31%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 459 KVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTA 518
VKHP +V L + D+ + D+I+ G L L+ R R A+ A
Sbjct: 95 NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPR---ARFYAAE-IA 149
Query: 519 RGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGA 578
L YLH V+ D+KP NILLD+ ++DFGL + NI N+ +S+ F G
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTST--FCG-- 201
Query: 579 LPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T Y APE + P +R + D + G VL E+L G P
Sbjct: 202 -----------TPEYLAPEVLHKQPYDRTV---DWWCLGAVLYEMLYGLPP 238
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 40/224 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAY 471
VLG G V ++ A++ L Q + EV+ + + P+IV++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 472 Y----WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y L++ + + G L + ++ R Q T S I K + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLHS- 179
Query: 528 SPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H D+KP N+L + ++DFG ++ + N P
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHN-------------SLTTP 223
Query: 585 VQTEKTNNYRAPEARVPGNRP-MQKWDVYSFGVVLLELLTGKSP 627
T Y APE V G + D++S GV++ LL G P
Sbjct: 224 CYTP---YYVAPE--VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-10
Identities = 70/285 (24%), Positives = 107/285 (37%), Gaps = 85/285 (29%)
Query: 374 EDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIP 433
+ V+ + + + G E V I+ FEL L+ VLG G KV L
Sbjct: 31 QLLTVKHELRTANLTGHAEKVGIEN---FEL---LK----VLGTGAYG---KVFL----- 72
Query: 434 VAVRRLGEGGEQR--------------HREFV----TEVQAIAKVKH-PNIVKLRAYYWA 474
VR++ + + TE Q + ++ P +V L Y +
Sbjct: 73 --VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQ 129
Query: 475 PDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR--------GLAYLH 525
+ KL LI D+I+ G L L + R + + L +LH
Sbjct: 130 TETKLHLILDYINGGELFTHLS-QRE------------RFTEHEVQIYVGEIVLALEHLH 176
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+ ++ DIK NILLD++ ++DFGLS+ + F G
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCG--------- 222
Query: 586 QTEKTNNYRAPEARVPGNRPMQK---WDVYSFGVVLLELLTGKSP 627
T Y AP+ G+ K W +S GV++ ELLTG SP
Sbjct: 223 ----TIEYMAPDIVRGGDSGHDKAVDW--WSLGVLMYELLTGASP 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 40/178 (22%), Positives = 74/178 (41%), Gaps = 45/178 (25%)
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
K P + +L + + D + ++++ G+L + R + A
Sbjct: 78 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL-----------MYHIQQVGRFKEP--HAV 124
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
GL +L + ++ D+K N++LD++ I+DFG+ + NI + +
Sbjct: 125 FYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKT 180
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T +Y APE A P + + W +FGV+L E+L G++P
Sbjct: 181 --FCG-------------TPDYIAPEIIAYQPYGKSVDWW---AFGVLLYEMLAGQAP 220
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-10
Identities = 30/109 (27%), Positives = 43/109 (39%), Gaps = 7/109 (6%)
Query: 95 LRRLNLHNN-NLFGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPRLQNLDLSNN 151
+R L L N + G + +L + L L +LP LP+L+ L+LS N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSEN 81
Query: 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
G L + L L L+ NK +LE L LDL +
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 27/99 (27%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 79 KNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC 138
K+ G I + L L+L N L S+ L L + L N + G L
Sbjct: 35 KSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELSENRIFGGLDMLAE 92
Query: 139 NLPRLQNLDLSNNSFSGSLPD--GLKNCKQLQRLILARN 175
LP L +L+LS N + LK + L+ L L
Sbjct: 93 KLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 8/88 (9%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPRLQNL 146
L L L++L L N +FG L +L + L GN L +L P + L L++L
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSL 125
Query: 147 DLSNNSFSGSLPD----GLKNCKQLQRL 170
DL N + +L D K QL L
Sbjct: 126 DLFNCEVT-NLNDYRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 3/91 (3%)
Query: 162 KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLN 221
+ ++ L+L K + G+ E NL L L + + N L +L L L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLK-KLE 77
Query: 222 LSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
LS N + G + LP +L GN L
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-09
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 45/178 (25%)
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
+HP + + + + + ++++ G+L + + + A
Sbjct: 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-------------QSCHKFDLSRAT 121
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
GL +LH + V+ D+K NILLD D I+DFG+ + N+ G+ +++
Sbjct: 122 FYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNT 177
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
F G T +Y APE N + W SFGV+L E+L G+SP
Sbjct: 178 --FCG-------------TPDYIAPEILLGQKYNHSVDWW---SFGVLLYEMLIGQSP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 39/187 (20%), Positives = 68/187 (36%), Gaps = 48/187 (25%)
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
EV + +++H NI++L++ LI ++ N +L + + +S
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYM-----DKNPDVSMRVIKS 136
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY-----ISDFGLSRLINITGNN 567
G+ + H R+ +H D+KP N+LL I DFGL+R I
Sbjct: 137 FLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI---- 189
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNN-----YRAPE----ARVPGNRPMQKWDVYSFGVVL 618
P++ T+ YR PE +R D++S +
Sbjct: 190 ----------------PIRQ-FTHEIITLWYRPPEILLGSRHYST----SVDIWSIACIW 228
Query: 619 LELLTGK 625
E+L
Sbjct: 229 AEMLMKT 235
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 38/169 (22%), Positives = 76/169 (44%), Gaps = 29/169 (17%)
Query: 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARG 520
HP + +L + PD + +F++ G+L ++ ++ + + R A+
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEAR---ARFYAAE-IISA 136
Query: 521 LAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
L +LH+ + ++ D+K N+LLD++ ++DFG+ + I +++ F G
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTAT--FCG---- 186
Query: 581 YMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE + + W + GV+L E+L G +P
Sbjct: 187 ---------TPDYIAPEILQEMLYGPAVDWW---AMGVLLYEMLCGHAP 223
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-09
Identities = 33/111 (29%), Positives = 49/111 (44%), Gaps = 11/111 (9%)
Query: 95 LRRLNLHNN-NLFGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPRLQNLDLSNN 151
++ L L N+ + G L L + L+ +LP L +L+ L+LS+N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDN 74
Query: 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWP--ELENLVQLDLSDN 200
SG L + C L L L+ NK + I P +LENL LDL +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 8e-06
Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 7/95 (7%)
Query: 160 GLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSA- 218
+ ++ L+L ++ + G+ E E L L + + L L+
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKL 66
Query: 219 -TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
L LS N +SG + P +L GN +
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 8/88 (9%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPRLQNL 146
L L L++L L +N + G L +L + L GN + ++ P + L L++L
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSL 118
Query: 147 DLSNNSFSGSLPD----GLKNCKQLQRL 170
DL N + +L D K QL L
Sbjct: 119 DLFNCEVT-NLNDYRENVFKLLPQLTYL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-09
Identities = 24/120 (20%), Positives = 41/120 (34%), Gaps = 15/120 (12%)
Query: 87 SELGSLIYLRRLNLHNNNL--FGSLPDQLFNATSLHSIFLYGNNLS--GSLPPSVCNLPR 142
++ + + R L+L + +L L +I N + P L R
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDNEIRKLDGFP----LLRR 65
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWP--ELENLVQLDLSDN 200
L+ L ++NN + L LIL N + P L++L L + N
Sbjct: 66 LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE--LGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 22/109 (20%), Positives = 38/109 (34%), Gaps = 11/109 (10%)
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA--GIWPELENLVQLDLSDNDFK 203
+ L+ + N + + L L K IP + L+ +D SDN+ +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK----IPVIENLGATLDQFDAIDFSDNEIR 55
Query: 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252
+ L+ L TL ++ N + LP L N+L
Sbjct: 56 -KLDG-FPLLRRLK-TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 6/94 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCN-LPR 142
+P EL + +L ++L NN + +L +Q F N T L ++ L N L +PP + L
Sbjct: 46 VPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKS 103
Query: 143 LQNLDLSNNSFSGSLPDGL-KNCKQLQRLILARN 175
L+ L L N S +P+G + L L + N
Sbjct: 104 LRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 12/107 (11%)
Query: 115 NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILA 173
+ T L+ L GN + +P + N L +DLSNN S +L + N QL LIL+
Sbjct: 32 DVTELY---LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILS 86
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP----NDLGELQSL 216
N+ IP + L++L L L ND +P NDL L L
Sbjct: 87 YNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 34/110 (30%), Positives = 46/110 (41%), Gaps = 12/110 (10%)
Query: 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNSFS 154
L L N +P +L N L I L N +S +L N+ +L L LS N
Sbjct: 34 TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 155 GSLP----DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
+P DGL K L+ L L N S +P G + +L L L + N
Sbjct: 92 -CIPPRTFDGL---KSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 41/210 (19%), Positives = 69/210 (32%), Gaps = 44/210 (20%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFG-----SLPDQLFNATSLHSIFLYGNNLS-------- 130
+ L L + L +N FG L D L T L ++L+ N L
Sbjct: 85 LLLQALLKCPKLHTVRLSDNA-FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 131 -----GSLPPSVCNLPRLQNLDLSNNSFSG----SLPDGLKNCKQLQRLILARNKFSGQI 181
++ N P L+++ N ++ + L + + +N
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR--- 200
Query: 182 PAGIWPEL-------ENLVQLDLSDNDF--KG--PIPNDLGELQSLSATLNLSYNHLSGK 230
P GI L + L LDL DN F G + L +L L L+ LS +
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR-ELGLNDCLLSAR 259
Query: 231 ----IPKSLGNLPVT--VSFDLRGNNLSGE 254
+ + L + L+ N + +
Sbjct: 260 GAAAVVDAFSKLENIGLQTLRLQYNEIELD 289
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 43/196 (21%), Positives = 69/196 (35%), Gaps = 41/196 (20%)
Query: 95 LRRLNLHNNNL-------------FGSLPDQLFNATSLHSIFLYGNNLSG----SLPPSV 137
L L LHNN L ++ + NA L SI N L +
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183
Query: 138 CNLPRLQNLDLSNNSF-----SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIW------ 186
+ L + + N L +GL C++L+ L L N F+ G
Sbjct: 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIAL 240
Query: 187 PELENLVQLDLSDNDFKGP----IPNDLGELQSLS-ATLNLSYNHLSGKIPKSLG----- 236
NL +L L+D + + +L+++ TL L YN + ++L
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300
Query: 237 NLPVTVSFDLRGNNLS 252
+P + +L GN S
Sbjct: 301 KMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 29/198 (14%), Positives = 57/198 (28%), Gaps = 39/198 (19%)
Query: 95 LRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLSG----SLPPSVCNLPRLQNL 146
+ +L + + S+ L S+ I L GN + L ++ + L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 147 DLSNNSFS----------GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE---NLV 193
+ S+ L L C +L + L+ N F + L L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 194 QLDLSDNDF-------------KGPIPNDLGELQSLSATLNLSYNHLSGK----IPKSLG 236
L L +N + + L ++ N L K+
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLR-SIICGRNRLENGSMKEWAKTFQ 184
Query: 237 NLPVTVSFDLRGNNLSGE 254
+ + + + N + E
Sbjct: 185 SHRLLHTVKMVQNGIRPE 202
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 30/210 (14%), Positives = 57/210 (27%), Gaps = 42/210 (20%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFG-----SLPDQLFNATSLHSIFLYGNNLS--------- 130
+ + L ++ + L N + G L + + + L
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 82
Query: 131 -GSLPPSVCNLPRLQNLDLSNNSFSG----SLPDGLKNCKQLQRLILARNKFSGQ----- 180
L ++ P+L + LS+N+F L D L L+ L L N Q
Sbjct: 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142
Query: 181 -------IPAGIWPELENLVQLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSG 229
L + N + + L T+ + N +
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH-TVKMVQNGIRP 201
Query: 230 K-----IPKSLGNLPVTVSFDLRGNNLSGE 254
+ + + L DL+ N +
Sbjct: 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 47/237 (19%), Positives = 88/237 (37%), Gaps = 58/237 (24%)
Query: 406 ELLRASAYVLGKSGLGIVYKVVL-GNGIPVAVRRLG-----EGGEQRHREFVTEVQAIAK 459
+ ++ LG G V V +G A++ L + + H + E + +
Sbjct: 44 DRIK----TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH--TLNEKRILQA 97
Query: 460 VKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR 519
V P +VKL + ++ ++++ G + + LR R G R ++ AR
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIG------------RFSEPHAR 144
Query: 520 --------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571
YLH ++ D+KP N+L+D ++DFG ++ +
Sbjct: 145 FYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 197
Query: 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK-WDVYSFGVVLLELLTGKSP 627
G T APE + ++ K D ++ GV++ E+ G P
Sbjct: 198 --LCG-------------TPEALAPE--IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 39/139 (28%), Positives = 55/139 (39%), Gaps = 28/139 (20%)
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
NL ++ Q S + A + L LH+ + +H D+KP NILL
Sbjct: 184 NLYELIKKNKFQG---FSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQG 237
Query: 549 QPYIS--DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPM 606
+ I DFG S + Y +Q+ YRAPE + G R
Sbjct: 238 RSGIKVIDFGSSCYEH---QRVY----------TY---IQSR---FYRAPEV-ILGARYG 277
Query: 607 QKWDVYSFGVVLLELLTGK 625
D++S G +L ELLTG
Sbjct: 278 MPIDMWSLGCILAELLTGY 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 34/157 (21%), Positives = 59/157 (37%), Gaps = 28/157 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAY 471
VLG G V ++ A++ L Q + EV+ + + P+IV++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 472 Y----WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTAR----GLAY 523
Y L++ + + G L + ++ R Q T R A + + Y
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-------REASEIMKSIGEAIQY 132
Query: 524 LHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGL 557
LH H D+KP N+L + ++DFG
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 40/227 (17%), Positives = 81/227 (35%), Gaps = 54/227 (23%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQR-HREFVTEVQAIAKVK-------HPNI 465
LG+ V++ + + N V V+ L +++ RE +K PNI
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----------IKILENLRGGPNI 93
Query: 466 VKLRAYYWAPDEK--LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523
+ L P + L+ + ++N + + +L+ + L Y
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDY 145
Query: 524 LHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
H +H D+KP N+++D++ + + D+GL+ G
Sbjct: 146 CHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--------HPGQEY------- 187
Query: 583 KPVQTEK--TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ + ++ PE V D++S G +L ++ K P
Sbjct: 188 ----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 31/121 (25%), Positives = 52/121 (42%), Gaps = 30/121 (24%)
Query: 512 RIAKGTARGLAYLH-ECSPRKFVHGDIKPSNILLDNDFQPY------ISDFGLSRLINIT 564
+I+K GL Y+H C +H DIKP N+L++ P I+D G + +
Sbjct: 135 QISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-- 189
Query: 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624
+ ++ +Q T YR+PE + G D++S ++ EL+TG
Sbjct: 190 -EHYTN-------------SIQ---TREYRSPEV-LLGAPWGCGADIWSTACLIFELITG 231
Query: 625 K 625
Sbjct: 232 D 232
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 30/138 (21%), Positives = 53/138 (38%), Gaps = 19/138 (13%)
Query: 85 IPSELGSLIYLRRLNLHNNNL-----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN 139
+ + L +L + L L NN+ + +L + L N + +
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLSGM-------ENLRILSLGRNLIK-KIENLDAV 91
Query: 140 LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199
L+ L +S N + SL G++ L+ L ++ NK + L+ L L L+
Sbjct: 92 ADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149
Query: 200 NDFKGPIPNDLGELQSLS 217
N P+ ND E + S
Sbjct: 150 N----PLYNDYKENNATS 163
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 30/119 (25%), Positives = 50/119 (42%), Gaps = 15/119 (12%)
Query: 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148
L + LR L+L N + + + A +L +++ N ++ SL + L L+ L +
Sbjct: 66 LSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYM 122
Query: 149 SNNSFS--GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPE---------LENLVQLD 196
SNN + G + D L +L+ L+LA N L NL +LD
Sbjct: 123 SNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 25/140 (17%), Positives = 49/140 (35%), Gaps = 34/140 (24%)
Query: 115 NATSLHSIFLYG--NNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLIL 172
AT + L+G + + ++ L ++L LS N+ + L + L+ L L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSL 77
Query: 173 ARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIP 232
RN ++ENL + L+ L +SYN ++ +
Sbjct: 78 GRNLIK---------KIENLDAV--------------ADTLE----ELWISYNQIA-SL- 108
Query: 233 KSLGNLPVTVSFDLRGNNLS 252
+ L + N ++
Sbjct: 109 SGIEKLVNLRVLYMSNNKIT 128
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 49/185 (26%), Positives = 76/185 (41%), Gaps = 32/185 (17%)
Query: 91 SLIYLRRLNLHNNNLFGSLP--DQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLD 147
L + ++ +N+++ S+ L N L L GN L + L L L
Sbjct: 39 ELNSIDQIIANNSDI-KSVQGIQYLPNVRYLA---LGGNKLH-DIS--ALKELTNLTYLI 91
Query: 148 LSNNSFSGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206
L+ N SLP+G+ L+ L+L N+ +P G++ +L NL L+L+ N + +
Sbjct: 92 LTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-L 148
Query: 207 PN----DLGELQSLSATLNLSYNHLSGKIPK----SLGNLPVTVSFDLRGNNLSGEIPQT 258
P L L L+LSYN L +P+ L L L N L +P
Sbjct: 149 PKGVFDKLTNLT----ELDLSYNQLQ-SLPEGVFDKLTQL---KDLRLYQNQLKS-VPD- 198
Query: 259 GSFAN 263
G F
Sbjct: 199 GVFDR 203
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 96 RRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDLSNNSF 153
+ L LH+N + L +F++ +L ++L N L +LP V + L +L LDL N
Sbjct: 43 QILYLHDNQI-TKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100
Query: 154 SGSLPDGL-KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
+ LP + L+ L + NK + +P GI L +L L L N K
Sbjct: 101 T-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGI-ERLTHLTHLALDQNQLK 148
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 7/113 (6%)
Query: 117 TSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILAR 174
T+ ++L+ N ++ L P V +L L+ L L +N +LP G+ + QL L L
Sbjct: 40 TNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGT 97
Query: 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227
N+ + +P+ ++ L +L +L + N +P + L L+ L L N L
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLT-HLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 27/87 (31%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149
SL L L+L N L LP +F+ L +F+ N L+ LP + L L +L L
Sbjct: 86 SLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALD 143
Query: 150 NNSFSGSLPDG-LKNCKQLQRLILARN 175
N S+P G L L N
Sbjct: 144 QNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 38/156 (24%), Positives = 57/156 (36%), Gaps = 34/156 (21%)
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
Q L L +N + P + L+ L L N+ +P G++ L L LDL N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN--- 98
Query: 204 GPIPNDLGELQSLSA----------TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
+L L + L + N L+ ++P+ + L L N L
Sbjct: 99 --------QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS 149
Query: 254 EIPQTGSFANQGP--TAFL-SNPLLCGFPLQKSCKD 286
IP G+F A+L NP C C+D
Sbjct: 150 -IPH-GAFDRLSSLTHAYLFGNPWDC------ECRD 177
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 46/187 (24%), Positives = 79/187 (42%), Gaps = 50/187 (26%)
Query: 452 TEVQAIAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTR 510
E ++ V HP I+++ + +++ +I D+I G L + LR ++
Sbjct: 55 DERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQ----------- 101
Query: 511 LRIAKGTAR--------GLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
R A+ L YLH ++ D+KP NILLD + I+DFG ++ +
Sbjct: 102 -RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157
Query: 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLE 620
G T +Y APE + P N+ + D +SFG+++ E
Sbjct: 158 DVTYT------LCG-------------TPDYIAPEVVSTKPYNKSI---DWWSFGILIYE 195
Query: 621 LLTGKSP 627
+L G +P
Sbjct: 196 MLAGYTP 202
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 28/115 (24%), Positives = 44/115 (38%), Gaps = 13/115 (11%)
Query: 117 TSLHSIFLYGNNLSGSLPPSVC--NLPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILA 173
+ L N L + LP L L+L N + + + +Q L L
Sbjct: 29 LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN---DLGELQSLSATLNLSYN 225
NK +I ++ L L L+L DN + + L SL+ +LNL+ N
Sbjct: 87 ENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFE--HLNSLT-SLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 22/88 (25%), Positives = 38/88 (43%), Gaps = 6/88 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDL 148
L +L +L L N L + F A+ + + L N + + + L +L+ L+L
Sbjct: 52 RLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNL 109
Query: 149 SNNSFSGSLPDG-LKNCKQLQRLILARN 175
+N S + G ++ L L LA N
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 25/117 (21%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS--DFGLSRLINITGNNPS 569
+ A+ L +L +H D+KP NILL N + I DFG
Sbjct: 161 KFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG------------- 206
Query: 570 SSGGFMGGAL-PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625
S +G + Y +Q+ YR+PE + G D++S G +L+E+ TG+
Sbjct: 207 -SSCQLGQRIYQY---IQSR---FYRSPEV-LLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/191 (25%), Positives = 73/191 (38%), Gaps = 34/191 (17%)
Query: 95 LRRLNLHNNNL----FGSLPDQL-FNATSLHSIFLYGNN--------LSGSLPPSVCNLP 141
+ L+L NNL L S+ S+ L GN+ L L N
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN-- 81
Query: 142 RLQNLDLSNNSFSG----SLPDGLKNCK-QLQRLILARNKFSGQ----IPAGIWPELENL 192
+ +L+LS N S L L + L L N FS + ++
Sbjct: 82 -VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 193 VQLDLSDNDFKGPIPNDLGE-LQSLSAT---LNLSYNHLSGK----IPKSLGNLPVTV-S 243
L+L ND ++L + L ++ A LNL N+L+ K + K L ++P +V S
Sbjct: 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200
Query: 244 FDLRGNNLSGE 254
DL N L +
Sbjct: 201 LDLSANLLGLK 211
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 44/192 (22%), Positives = 68/192 (35%), Gaps = 34/192 (17%)
Query: 94 YLRRLNLHNNNLFGSLPDQLFNA-----TSLHSIFLYGNN--------LSGSLPPSVCNL 140
+ LNL N+L D+L ++ S+ L GN L +L
Sbjct: 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPF-- 109
Query: 141 PRLQNLDLSNNSFSGS----LPDGLKNC-KQLQRLILARNKFSGQ----IPAGIWPELEN 191
+ LDL N FS N + L L N + + + N
Sbjct: 110 -TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168
Query: 192 LVQLDLSDNDFKGPIPNDLGE-LQSLSAT---LNLSYNHLSGK----IPKSLGNLPVTV- 242
+ L+L N+ +L + L S+ A+ L+LS N L K + ++P V
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228
Query: 243 SFDLRGNNLSGE 254
S +L N L G
Sbjct: 229 SLNLCLNCLHGP 240
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 35/209 (16%), Positives = 64/209 (30%), Gaps = 37/209 (17%)
Query: 95 LRRLNLHNNN--------LFGSLPDQLFNATSLHSIFLYGNN--------LSGSLPPSVC 138
+ LNL N+ L L +++S+ L GNN L+ L
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAA---IPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 139 NLPRLQNLDLSNNSFSGS----LPDGLKNCK-QLQRLILARNKFSGQIPAGI---WPELE 190
++ +LDLS N L + + L L N G + L+
Sbjct: 197 SV---TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSAT------LNLSYNHLSGKIPKSLGNLPVTVSF 244
+L + L + K L + ++ + + + NL +S
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG 313
Query: 245 DLRGNNLSGEIPQTGSFANQGPTAFLSNP 273
+L + + +Q L+ P
Sbjct: 314 KADVPSLLNQC-LIFAQKHQTNIEDLNIP 341
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 41/161 (25%), Positives = 63/161 (39%), Gaps = 23/161 (14%)
Query: 117 TSLHSIFLYGNNLSGSLPPSVC-----NLPRLQNLDLSNNSFS----GSLPDGLK-NCKQ 166
+ S+ L NNL + + +L+LS NS L L
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 167 LQRLILARNKFSGQIPAGIWPELEN----LVQLDLSDNDFKGPIPNDLGE-LQSLSAT-- 219
+ L L+ N S + + L + LDL NDF ++ + +L A+
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 220 -LNLSYNHLSGK----IPKSLGNLPVTV-SFDLRGNNLSGE 254
LNL N L K + + L +P V S +LRGNNL+ +
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK 182
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 36/184 (19%), Positives = 59/184 (32%), Gaps = 27/184 (14%)
Query: 95 LRRLNLHNNNL----FGSLPDQL-FNATSLHSIFLYGNNLSGS----LPPSVCNLPR-LQ 144
+ LNL N L L L ++ + L N+ S + NLP +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 145 NLDLSNNSFSG----SLPDGLKNC-KQLQRLILARNKFS----GQIPAGIWPELENLVQL 195
+L+L N L L + L L N + ++ + ++ L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSL 201
Query: 196 DLSDNDFKGPIPNDLGE-LQSLSAT---LNLSYNHLSGK----IPKSLGNLPVTVSFDLR 247
DLS N +L S+ LNL N L G + +L + L
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 248 GNNL 251
+ +
Sbjct: 262 YDIV 265
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 30/152 (19%), Positives = 57/152 (37%), Gaps = 17/152 (11%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYY 472
+G+ G++++ L N VA++ E + E + + I + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+L+ D + +L + L + S T AK + +HE +
Sbjct: 76 QEGLHNVLVIDLLGP-SLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 533 VHGDIKPSNILLDNDFQP-----YISDFGLSR 559
V+ DIKP N L+ Y+ DFG+ +
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 28/150 (18%), Positives = 49/150 (32%), Gaps = 41/150 (27%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNP 568
+I + +GL YLH + + +H DIKP NILL + + ++ + +
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 569 SSSGGFMGGALPYMKPVQTEK---------------------------TNNYRAPEARVP 601
S+ A ++ K T YR+ E +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267
Query: 602 GNRPMQKW----DVYSFGVVLLELLTGKSP 627
+ D++S + EL TG
Sbjct: 268 -----SGYNTPADIWSTACMAFELATGDYL 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 32/150 (21%), Positives = 62/150 (41%), Gaps = 15/150 (10%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYY 472
+G G +Y + G VA++ E + +H + E + ++ I +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
D +++ + + +L + + + S T L +A + Y+H + F
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 533 VHGDIKPSNILL---DNDFQPYISDFGLSR 559
+H D+KP N L+ YI DFGL++
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 34/127 (26%), Positives = 44/127 (34%), Gaps = 24/127 (18%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILL-DNDFQPYISDFGLSRLINITGNNPSS 570
+ L YL + H D+KP NILL D F+ + +
Sbjct: 141 LYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 571 SGG-----FMGGA-------LPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVL 618
S G F G A + T YRAPE + D++SFG VL
Sbjct: 198 STGIKLIDF-GCATFKSDYHGSI---INTR---QYRAPEV-ILNLGWDVSSDMWSFGCVL 249
Query: 619 LELLTGK 625
EL TG
Sbjct: 250 AELYTGS 256
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 31/122 (25%), Positives = 43/122 (35%), Gaps = 20/122 (16%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP--- 568
+A L +LHE + H D+KP NIL N + + S N
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 569 ----SSSGGFMGGAL-PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT 623
S++ F V T +YR PE + Q DV+S G +L E
Sbjct: 184 ADFGSAT--FDHEHHTTI---VATR---HYRPPEV-ILELGWAQPCDVWSIGCILFEYYR 234
Query: 624 GK 625
G
Sbjct: 235 GF 236
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-07
Identities = 27/153 (17%), Positives = 56/153 (36%), Gaps = 19/153 (12%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYY 472
+G G + L VA++ E + R + E + ++ I ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 473 WAPDEKLLISDFISNG-NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
++ + + G +L + + S T L IA + Y+H +
Sbjct: 75 PCGKYNAMVLELL--GPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHS---KN 125
Query: 532 FVHGDIKPSNILLDNDFQP-----YISDFGLSR 559
++ D+KP N L+ +I DF L++
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 16/65 (24%), Positives = 32/65 (49%), Gaps = 5/65 (7%)
Query: 497 RNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL--DNDFQPYISD 554
+ P LS + L++A L +LHE ++VHG++ NI + ++ Q ++
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAG 204
Query: 555 FGLSR 559
+G +
Sbjct: 205 YGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 23/57 (40%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDFQPYISDFGLSR 559
ST L++ L Y+HE ++VHGDIK +N+LL N Q Y++D+GLS
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 33/244 (13%), Positives = 63/244 (25%), Gaps = 53/244 (21%)
Query: 415 LGKSGLGIVYKVVLGNG------IPVAVRRLGEGGEQRH-REFVTEVQ---------AIA 458
+G+ G V++ + + I + L G Q+ E + E+
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 459 KVKHPNIVKLRAYY--WAPDEKLLISDFI----SNGNLANALRGRNGQ------------ 500
+ + L + + LL+ + + G+ +
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 501 ------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554
+ S +T I LA +F H D+ N+LL +
Sbjct: 148 IDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHY 205
Query: 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY----RAPEARVPGNRPMQKWD 610
+ I S G + Y E G+ Q +D
Sbjct: 206 TLNGKSSTIP------SCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQ-FD 258
Query: 611 VYSF 614
+Y
Sbjct: 259 IYRL 262
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 117 TSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDLSNNSFSGSLPDGL-KNCKQLQRLILAR 174
+S + L N L SLP V + L +L L LS N SLPDG+ +L L L
Sbjct: 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHE 85
Query: 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP----NDLGELQSL 216
NK +P G++ +L L +L L N K +P + L LQ +
Sbjct: 86 NKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDL 148
L L +L+L N + SLPD +F+ T L ++L+ N L SLP V L +L+ L L
Sbjct: 50 KLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107
Query: 149 SNNSFSGSLPDG-LKNCKQLQRLILARN 175
N S+PDG LQ++ L N
Sbjct: 108 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 47/358 (13%), Positives = 102/358 (28%), Gaps = 99/358 (27%)
Query: 375 DSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGNGIPV 434
+V D S + T DE+ L + +V+ N P
Sbjct: 274 FKQVTD---FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN--PR 328
Query: 435 AVRRLGEGGEQRHREFVTEVQAIAKV---KHPNIVK----------LRAYYWAPDEKLLI 481
+ + E R+ + V K I++ R + ++L +
Sbjct: 329 RLSIIAE----SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----DRLSV 380
Query: 482 SDFISNGNLANALRGRNGQPSTSLS--WSTRLRIAKGTARGLAYLHECSPRKFVHGDIKP 539
F + ++ P+ LS W + + V+ K
Sbjct: 381 --FPPSAHI----------PTILLSLIWF--------------DVIKSDVMVVVNKLHKY 414
Query: 540 SNILLDNDFQPY-ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT--NNYRAP 596
S L++ + IS + + + N + ++ ++Y P
Sbjct: 415 S--LVEKQPKESTISIPSIYLELKVKLEN-----------EYAL-----HRSIVDHYNIP 456
Query: 597 EARVPGNRPMQKWDVYSF---GVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
+ + D Y + G L + + L D R++++ +
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFL-----DF-RFLEQKIRHD 510
Query: 654 ----NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707
N +++ LQ++ K I + DP+ + + + L +I
Sbjct: 511 STAWNASGSILN--TLQQLKFYKPYI---------CDNDPKYERLVNAILDFLPKIEE 557
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 23/57 (40%), Positives = 34/57 (59%), Gaps = 5/57 (8%)
Query: 505 LSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDFQPYISDFGLSR 559
S T L+++ L Y+HE ++VHGDIK SN+LL+ N Q Y+ D+GL+
Sbjct: 149 FSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 29/123 (23%), Positives = 48/123 (39%), Gaps = 22/123 (17%)
Query: 512 RIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP--- 568
++A + + +LH K H D+KP NIL + + R N
Sbjct: 122 KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 569 ----SSSGGFMGGALPYMKPVQTEKTNNYRAPEA--RVPGNRPMQKWDVYSFGVVLLELL 622
S++ + + V T +YRAPE + ++P DV+S G +L+E
Sbjct: 179 VDFGSAT--YDDEHHSTL--VSTR---HYRAPEVILALGWSQPC---DVWSIGCILIEYY 228
Query: 623 TGK 625
G
Sbjct: 229 LGF 231
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 12/116 (10%)
Query: 117 TSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNC-KQLQRLILARN 175
+ L N+L L L L L N SLP+G+ N L L L+ N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86
Query: 176 KFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN----DLGELQSLSATLNLSYNHL 227
+ +P G++ +L L +L L+ N + +P+ L +L+ L L N L
Sbjct: 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLK----DLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 33/88 (37%), Positives = 43/88 (48%), Gaps = 6/88 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSGSLPPSVCN-LPRLQNLDL 148
L L LNL N L SLP+ +F+ T L + L N L SLP V + L +L++L L
Sbjct: 74 KLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRL 131
Query: 149 SNNSFSGSLPDG-LKNCKQLQRLILARN 175
N S+PDG LQ + L N
Sbjct: 132 YQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 34/188 (18%), Positives = 59/188 (31%), Gaps = 37/188 (19%)
Query: 95 LRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-----NLPRLQN 145
L +NL + L +L + L N+L + + ++
Sbjct: 103 LDEVNLASCQLDPAGLRTLLPVF---LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITT 159
Query: 146 LDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSGQIPAGIW---PELEN---LVQL 195
L LSNN + + L +GL + L L G+ +L+ L +L
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG---DEGLELLAAQLDRNRQLQEL 216
Query: 196 DLSDNDFKGPIPNDLGEL----QSLSATLNLSYNHLS-------GKIPKSLGNLPVTVSF 244
+++ N L SL L+L +N LS + + V
Sbjct: 217 NVAYNGAGDTAALALARAAREHPSLE-LLHLYFNELSSEGRQVLRDLGGAAEGGARVVVS 275
Query: 245 DLRGNNLS 252
G +S
Sbjct: 276 LTEGTAVS 283
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 27/130 (20%), Positives = 44/130 (33%), Gaps = 22/130 (16%)
Query: 92 LIYLRRLNLHNNNL----FGSLPDQL-FNATSLHSIFLYGNNLSGS----LPPSVCNLPR 142
+ R+L L N+L L D L + + ++ L N L+ + L +
Sbjct: 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTS 184
Query: 143 LQNLDLSNNSFS----GSLPDGLKNCKQLQRLILARNKFSGQIPAGIW------PELENL 192
+ +L L + L L +QLQ L +A N E +L
Sbjct: 185 VTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG---DTAALALARAAREHPSL 241
Query: 193 VQLDLSDNDF 202
L L N+
Sbjct: 242 ELLHLYFNEL 251
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 9e-04
Identities = 41/192 (21%), Positives = 60/192 (31%), Gaps = 45/192 (23%)
Query: 94 YLRRLNLHNNNLFGSLPDQ--------LFNATSLHSIFLYGNNLSG----SLPPSVCNLP 141
LR+LNL + P + +L + L L +L P
Sbjct: 73 SLRQLNLAGVRM---TPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR-- 127
Query: 142 RLQNLDLSNNSFS----GSLPDGLK-NCKQLQRLILARNKFSGQIPAGIWPELE---NLV 193
+ L L NS L D L + Q+ L L+ N + A + L ++
Sbjct: 128 -ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVT 186
Query: 194 QLDLSDNDFKGPIPNDLGELQSLSA---------TLNLSYNHLSGKIPKSLGN-LPVTVS 243
L L D G L+ L+A LN++YN +L S
Sbjct: 187 HLSLLHTGLG-----DEG-LELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPS 240
Query: 244 F---DLRGNNLS 252
L N LS
Sbjct: 241 LELLHLYFNELS 252
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 1e-05
Identities = 24/230 (10%), Positives = 72/230 (31%), Gaps = 20/230 (8%)
Query: 11 LYFLHLCFALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPR 70
+ + + ++ W + D S I ++++
Sbjct: 112 ITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVL-DA 170
Query: 71 VVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNA--TSLHSIFLY--- 125
+ + + L+ L + + L S+ + + + +L + LY
Sbjct: 171 MPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGV 230
Query: 126 ----GNNLSGSLPP--SVCNLPRLQNLDLSNNSFSGSLPDGL---KNCKQLQRLILARNK 176
+ P S P L+ L + + + + QL+ + ++
Sbjct: 231 EDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290
Query: 177 FS---GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLS 223
+ ++ ++++L +++ N + +L +SL +++S
Sbjct: 291 LTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ--KSLPMKIDVS 338
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 15/150 (10%)
Query: 415 LGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYY 472
+G G +Y + VA++ E + +H + + E + ++ I +R +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
D +L+ D + +L + + + LS T L +A + ++H + F
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 533 VHGDIKPSNILL---DNDFQPYISDFGLSR 559
+H DIKP N L+ Q YI DFGL++
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 18/114 (15%)
Query: 446 RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSL 505
R E + +A VK I + D K ++ +I+ + +
Sbjct: 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIEDN-------- 433
Query: 506 SWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559
L IA + LH+ +H D+ SN + D D YI DFGL +
Sbjct: 434 -----LDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDKD--LYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.98 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.93 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.92 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.92 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.91 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.91 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.91 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.91 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.91 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.9 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.9 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.9 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.89 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.89 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.89 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.89 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.89 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.89 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.89 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.88 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.88 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.88 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.88 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.88 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.87 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.87 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.86 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.86 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.85 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.85 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.85 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.84 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.82 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.82 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.82 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.82 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.81 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.8 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.8 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.79 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.79 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.79 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.76 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.76 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.75 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.75 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.73 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.65 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.64 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.62 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.61 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.61 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.54 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.25 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.23 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.17 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.17 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.94 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.88 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.8 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.44 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.15 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.13 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.07 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.55 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.39 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.22 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.08 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.94 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.8 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.5 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.87 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.33 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=450.99 Aligned_cols=256 Identities=27% Similarity=0.425 Sum_probs=204.4
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 357999999999999864 47889999998877766789999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 486 SNGNLANALRGRNGQ----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
++|+|.++|+..... ....++|.++++|+.|||.||+|||+ ++||||||||+|||+++++.+||+||
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DF 202 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDF 202 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEccc
Confidence 999999999865421 12469999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+|+.......... .....||+.|||||++.. ..++.++|||||||++|||+| |+.||....
T Consensus 203 Gla~~~~~~~~~~~--------------~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~-- 265 (329)
T 4aoj_A 203 GMSRDIYSTDYYRV--------------GGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLS-- 265 (329)
T ss_dssp C------------------------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--
T ss_pred ccceeccCCCccee--------------cCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCC--
Confidence 99987653321111 123457999999999765 788999999999999999999 899996532
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..++...+....+...+ .....++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 266 ----~~~~~~~i~~g~~~~~p---------------~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 266 ----NTEAIDCITQGRELERP---------------RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ----HHHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHcCCCCCCc---------------ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 23444444443322211 122345789999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=448.77 Aligned_cols=256 Identities=27% Similarity=0.462 Sum_probs=209.0
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 347999999999999864 47889999998877666789999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 486 SNGNLANALRGRN--------GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 486 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
++|+|.++|+..+ +.....++|.++++|+.|||.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCccc
Confidence 9999999997643 2234579999999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTS 636 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~ 636 (707)
|+.......... .....||+.|||||++.. ..++.++|||||||++|||+| |+.||....
T Consensus 175 a~~~~~~~~~~~--------------~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---- 235 (299)
T 4asz_A 175 SRDVYSTDYYRV--------------GGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---- 235 (299)
T ss_dssp HHHHTGGGCEEE--------------TTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----
T ss_pred ceecCCCCceee--------------cCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----
Confidence 987653321110 022457999999999765 678999999999999999999 899997532
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..++...+........+ .....++.+|+.+||+.||++||||++|++.|+++.
T Consensus 236 --~~~~~~~i~~~~~~~~p---------------~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 236 --NNEVIECITQGRVLQRP---------------RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp --HHHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHHHHcCCCCCCC---------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 23444444443322211 122346789999999999999999999999999873
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=445.78 Aligned_cols=256 Identities=27% Similarity=0.357 Sum_probs=207.9
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 347999999999999863 568899999976533 3457899999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 005226 485 ISNGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~ 553 (707)
|++|+|.++|+..... ....++|.++++|+.|||+||+|||+ ++||||||||+|||+++++.+||+
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEEC
Confidence 9999999999764311 12469999999999999999999999 899999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 005226 554 DFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPT 632 (707)
Q Consensus 554 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~ 632 (707)
|||+|+.......... .....||+.|||||++.. ..++.++|||||||++|||+| |+.||....
T Consensus 188 DFGlar~~~~~~~~~~--------------~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 188 DLGLFREVYAADYYKL--------------LGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp CSCCBCGGGGGGCBCS--------------SSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred CcccceeccCCCceeE--------------ecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 9999987653322111 123457999999999765 678999999999999999999 899996532
Q ss_pred CCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..++...+........+ ......+.+|+.+||+.||++||||+||++.|+.+.
T Consensus 253 ------~~~~~~~i~~~~~~~~p---------------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 253 ------NQDVVEMIRNRQVLPCP---------------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ------HHHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ------HHHHHHHHHcCCCCCCc---------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 23455555443322211 123345789999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=437.59 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=198.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||+||+|++.+ .||||+++.. .....++|.+|++++++++|||||+++|+|. ++..++|||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCC
Confidence 4579999999999999754 5899998754 3344578999999999999999999999885 467899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++|+... ..++|.++++|+.|||.||+|||+ ++||||||||+|||+++++.+||+|||+|+..........
T Consensus 118 L~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~ 190 (307)
T 3omv_A 118 LYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190 (307)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence 999998653 359999999999999999999999 8999999999999999999999999999987643221111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|||||++.. ...++.++|||||||++|||+||+.||...... ..+...+.
T Consensus 191 --------------~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----~~~~~~~~ 251 (307)
T 3omv_A 191 --------------VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----DQIIFMVG 251 (307)
T ss_dssp -----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred --------------ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----HHHHHHHh
Confidence 123468999999998753 346899999999999999999999999753221 12222232
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........ ... .......+.+|+.+||+.||++||||+||++.|+.++
T Consensus 252 ~~~~~p~~-~~~----------~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 252 RGYASPDL-SKL----------YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp TTCCCCCS-TTS----------CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cCCCCCCc-ccc----------cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22221110 000 1123356789999999999999999999999998874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=427.28 Aligned_cols=269 Identities=21% Similarity=0.260 Sum_probs=196.5
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC----cceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD----EKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|++ +|+.||||+++...... ..+..|+..+.+++|||||+++|+|.+++ ..++|||||++|
T Consensus 9 ~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 4799999999999998 68899999997643322 23345666677899999999999998764 468999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS-----PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
+|.++|+.. .++|..+.+|+.|+|.||+|||+.+ .++||||||||+|||+|.++++||+|||+|+....
T Consensus 87 sL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999864 4899999999999999999999731 24899999999999999999999999999987654
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC--
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-----NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS-- 636 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~-- 636 (707)
...... .......||+.|||||++.+. ..++.++|||||||++|||+||++|+........
T Consensus 161 ~~~~~~------------~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 161 ATDTID------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp TTTEES------------CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCcee------------eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 322111 011235689999999997642 1357799999999999999999988754322110
Q ss_pred --c-cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 637 --I-EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 --~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. ......+.+........ .++.+.......+....+.+|+.+||+.||++||||+||++.|++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhcccccchHHHHHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0 00001111111111110 01111111112345567889999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=412.75 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=191.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----CCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA----PDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 485 (707)
..||+|+||+||+|... ++..||+|++... .....+.|.+|++++++++|||||+++++|.+ ++..|+|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 37999999999999964 6889999998654 33445789999999999999999999999865 24578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEcC-CCCeEEeccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLDN-DFQPYISDFGLSRLIN 562 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~ 562 (707)
++|+|.++++... .+++..+..|+.||+.||+|||+ ++ ||||||||+|||++. ++.+||+|||+|+...
T Consensus 112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999998643 69999999999999999999999 55 999999999999985 7999999999997533
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
... .....||+.|||||++. ..++.++|||||||++|||+||+.||..... ...+
T Consensus 184 ~~~------------------~~~~~GTp~YmAPE~~~--~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~ 238 (290)
T 3fpq_A 184 ASF------------------AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQI 238 (290)
T ss_dssp TTS------------------BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHH
T ss_pred CCc------------------cCCcccCccccCHHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHH
Confidence 110 02356899999999865 4589999999999999999999999964321 1222
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+....... .++ .....++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~i~~~~~~~-----~~~---------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 239 YRRVTSGVKPA-----SFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCCCG-----GGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHcCCCCC-----CCC---------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222221110 001 111235789999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=423.32 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=200.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||++|+|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 36999999999999975 78999999997655555577899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.........
T Consensus 160 ~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~--- 227 (346)
T 4fih_A 160 DIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--- 227 (346)
T ss_dssp HHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB---
T ss_pred HHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc---
Confidence 999753 49999999999999999999999 899999999999999999999999999998765322111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....||+.|||||++.. ..|+.++|||||||++|||++|++||.... .......+.....
T Consensus 228 -------------~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~ 287 (346)
T 4fih_A 228 -------------KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNLP 287 (346)
T ss_dssp -------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSSC
T ss_pred -------------cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC
Confidence 23468999999999764 678999999999999999999999996532 1223333322221
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .......++.+|+.+||..||++|||++|+++
T Consensus 288 ~~~~-------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRLK-------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCCS-------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC-------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 01122345789999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=429.43 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=204.9
Q ss_pred ccceecccCeeEEEEEEeCC------CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcC-CcceEE
Q 005226 411 SAYVLGKSGLGIVYKVVLGN------GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAP-DEKLLI 481 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~-~~~~lV 481 (707)
..+.||+|+||.||+|.+.. ++.||||+++... ....++|.+|+++|++++| ||||+++|+|.++ +..++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 35689999999999998532 3679999997653 3445789999999999965 9999999999765 567999
Q ss_pred EEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 482 SDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
||||++|+|.++|+.... .....++|..++.|+.|||+||+|||+ ++||||||||+|||+++++.+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~v 224 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV 224 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCE
Confidence 999999999999976432 113458999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+|+........ .......||+.|||||++.. ..++.++|||||||++|||+| |+.||.
T Consensus 225 Ki~DFGlar~~~~~~~~--------------~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 225 KICDFGLARDIYKDPDY--------------VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp EECCCGGGSCTTTCTTS--------------EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred EECcchhhhhcccCCCc--------------eeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999876432211 11123467999999999765 788999999999999999998 899997
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... ..+...+....+...+ .....++.+++.+||+.||++||||+||++.|+++
T Consensus 290 ~~~~~-----~~~~~~i~~g~~~~~p---------------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 290 GVKID-----EEFCRRLKEGTRMRAP---------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp TCCCS-----HHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCHH-----HHHHHHHHcCCCCCCC---------------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 54321 2334444443332221 11234577899999999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=420.60 Aligned_cols=250 Identities=21% Similarity=0.253 Sum_probs=197.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|+.. +|+.||||+++.... +.+|+.++++++|||||++++++.+++..|+|||||++|+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 347999999999999964 689999999975422 24699999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~~~ 569 (707)
.++|+..+ .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++ .+||+|||+|+..........
T Consensus 138 ~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 138 GQLIKQMG-----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99998653 59999999999999999999999 8999999999999999987 699999999987753321111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
. .......||+.|||||++.+ ..++.++|||||||++|||+||++||...... .+...+...
T Consensus 210 ~-----------~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~ 271 (336)
T 4g3f_A 210 L-----------LTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG------PLCLKIASE 271 (336)
T ss_dssp ---------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS------CCHHHHHHS
T ss_pred e-----------ecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHcC
Confidence 0 01123468999999999765 77899999999999999999999999764332 112222111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..++.+ ........+.+++.+||+.||++|||+.|+++.|...
T Consensus 272 ---~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 272 ---PPPIRE----------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ---CCGGGG----------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCchh----------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111000 0112234578999999999999999999999887653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=423.81 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=193.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|+.. +|+.||||++... .....+.|.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 47999999999999964 7899999998754 33445789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++|...+ ...+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 110 L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 181 (350)
T 4b9d_A 110 LFKRINAQK---GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-- 181 (350)
T ss_dssp HHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH--
T ss_pred HHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc--
Confidence 999997543 2357999999999999999999999 89999999999999999999999999999866422100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|||||++.+ ..++.++|||||||++|||+||+.||.... ...+...+...
T Consensus 182 --------------~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~ 240 (350)
T 4b9d_A 182 --------------ARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISG 240 (350)
T ss_dssp --------------HHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHT
T ss_pred --------------ccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcC
Confidence 023468999999999765 778999999999999999999999996532 12222222221
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... +.. .....++.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~--~~~-------------~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 SFP--PVS-------------LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCC--CCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC--CCC-------------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 100 112345789999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=423.55 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=200.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||++|+|.
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~ 236 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence 47999999999999964 78999999997665555577999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++.. .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+.......
T Consensus 237 ~~i~~~------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~--- 304 (423)
T 4fie_A 237 DIVTHT------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--- 304 (423)
T ss_dssp HHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB---
T ss_pred HHHhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc---
Confidence 999754 49999999999999999999999 899999999999999999999999999998765322111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....||+.|||||++.. ..|+.++|||||||++|||++|+.||.... .......+.....
T Consensus 305 -------------~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~ 364 (423)
T 4fie_A 305 -------------KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEP------PLKAMKMIRDNLP 364 (423)
T ss_dssp -------------CCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC
T ss_pred -------------cccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCC
Confidence 23568999999999765 778999999999999999999999996532 1223333322221
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .......++.+|+.+||..||++|||+.|+++
T Consensus 365 ~~~~-------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLK-------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCS-------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc-------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 00112345789999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=399.41 Aligned_cols=240 Identities=24% Similarity=0.339 Sum_probs=185.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|.. .+|+.||||++++.. ....+.+.+|++++++++|||||++++++.+++..|+||||+ +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 4799999999999996 478999999987542 223467999999999999999999999999999999999999 68
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 98 ~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~- 168 (275)
T 3hyh_A 98 ELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL- 168 (275)
T ss_dssp EHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCcc-
Confidence 9999997653 59999999999999999999999 89999999999999999999999999999865432111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.+...++.++||||+||++|||+||+.||.... ...+.+.+..
T Consensus 169 ----------------~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~ 226 (275)
T 3hyh_A 169 ----------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISN 226 (275)
T ss_dssp ----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH
T ss_pred ----------------CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc
Confidence 234689999999998764556789999999999999999999996421 1222222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ...+.+. ...++.+++.+|++.||++|||++|+++
T Consensus 227 ~---~~~~p~~-------------~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 G---VYTLPKF-------------LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp T---CCCCCTT-------------SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C---CCCCCCC-------------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 1111111 1235678999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=407.17 Aligned_cols=243 Identities=20% Similarity=0.285 Sum_probs=198.0
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+++..|+||||+++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 45899999999999996 478999999997542 23346789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++...+ .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+......
T Consensus 117 G~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 117 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999998653 59999999999999999999999 89999999999999999999999999999876532211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.. .....||+.|||||++.. ..++.++||||+||++|||+||+.||.... ...+...+.
T Consensus 189 ~~--------------~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~ 247 (311)
T 4aw0_A 189 AR--------------ANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKII 247 (311)
T ss_dssp CC--------------BCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH
T ss_pred cc--------------ccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHH
Confidence 10 123468999999999765 678999999999999999999999996532 122222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
.. ...+.+ ....++.+|+.+|++.||++|||++|+.
T Consensus 248 ~~---~~~~p~-------------~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 248 KL---EYDFPE-------------KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HT---CCCCCT-------------TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred cC---CCCCCc-------------ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 21 111111 1223567999999999999999999863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=401.38 Aligned_cols=237 Identities=25% Similarity=0.266 Sum_probs=185.2
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|+.. .++.||||+++... ......+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~ 108 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL 108 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence 348999999999999852 46789999987642 223356889999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++...+ .+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 109 ~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 109 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp TTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 9999999998653 69999999999999999999999 899999999999999999999999999998654322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....||+.|||||++.. ..++.++||||+||++|||+||+.||..... ..+...
T Consensus 181 ~~~----------------~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~ 237 (304)
T 3ubd_A 181 KKA----------------YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTM 237 (304)
T ss_dssp CCC----------------CSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred ccc----------------cccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHH
Confidence 111 23467999999999765 7789999999999999999999999975321 222222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
+.. ....+.+ ....++.+++.+||+.||++|||+
T Consensus 238 i~~---~~~~~p~-------------~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 238 ILK---AKLGMPQ-------------FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HHH---CCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred HHc---CCCCCCC-------------cCCHHHHHHHHHHcccCHHHCCCC
Confidence 222 1111111 122456799999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=393.71 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=182.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------------
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------------ 477 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------------ 477 (707)
.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+.
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 358999999999999964 78999999986543 3344779999999999999999999999876543
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
.|+||||+++|+|.+++..... ....++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCcc
Confidence 5899999999999999986542 2346788899999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
|+............ .............||+.|||||++.+ ..++.++|||||||++|||++ ||...
T Consensus 165 a~~~~~~~~~~~~~----~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~------ 230 (299)
T 4g31_A 165 VTAMDQDEEEQTVL----TPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ------ 230 (299)
T ss_dssp C------------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred ceecCCCccccccc----cccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc------
Confidence 98775433211110 00011112234568999999999765 778999999999999999996 76421
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+....+........ .+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~~~~~~~~~~------p~~~------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 --MERVRTLTDVRNLKF------PPLF------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --HHHHHHHHHHHTTCC------CHHH------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cHHHHHHHHHhcCCC------CCCC------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111111111111111 0111 122234568999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=393.61 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=194.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 483 (707)
+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++... +..|+|||
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 4899999999999996 479999999997543 33446788999999999999999999998643 56799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
||+ |+|.+++...+ .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+..
T Consensus 140 ~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 140 LME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 995 78999998653 69999999999999999999999 8999999999999999999999999999987643
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
....... ......||+.|+|||++.+...++.++||||+||++|||++|++||..... .+..
T Consensus 211 ~~~~~~~------------~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~------~~~l 272 (398)
T 4b99_A 211 SPAEHQY------------FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY------VHQL 272 (398)
T ss_dssp -----CC------------CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH------HHHH
T ss_pred Ccccccc------------ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH------HHHH
Confidence 2211110 113456899999999977656789999999999999999999999975322 1222
Q ss_pred HHHHhhccccCCCchhch--------HHHHhhh---------hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVD--------AMLLQEV---------HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d--------~~l~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+........ ..... ..+.... .......++.+|+.+||..||++|||++|+++
T Consensus 273 ~~I~~~~g~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPS--PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCC--GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCC--hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 22211111000 00000 0000000 00012346789999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=384.63 Aligned_cols=207 Identities=20% Similarity=0.278 Sum_probs=165.4
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||+||+|+.. .++.||||++..... ..++.+|+++|+++ +|||||++++++.++++.|+||||++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 348999999999999853 578899999866533 25678999999998 79999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccccC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITG 565 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~~~ 565 (707)
+|+|.+++. .+++.++..++.||+.||+|||+ ++||||||||+|||++.+ +.+||+|||+|+......
T Consensus 104 g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 104 HESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred cccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 999999994 38899999999999999999999 899999999999999877 799999999998654321
Q ss_pred CCCCCCC---------CCcCCCC---CCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 566 NNPSSSG---------GFMGGAL---PYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 566 ~~~~~~~---------~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
....... .....+. .........||+.|+|||++.+...++.++||||+||++|||+||+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1000000 0000000 0001123468999999999877667899999999999999999999999653
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=395.12 Aligned_cols=243 Identities=25% Similarity=0.283 Sum_probs=191.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHH---HHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREF---VTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.++||+|+||.||+|+.. +|+.||||++.+... .....+ ..++.+++.++|||||++++++.+++..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 468999999999999965 789999999865321 111223 3346677788999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
++||+|.++|...+ .+++..+..++.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+.....
T Consensus 274 ~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 274 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp CCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 99999999998653 69999999999999999999999 89999999999999999999999999999876422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.. ....||+.|||||++..+..++.++||||+||++|||++|++||...... +...+..
T Consensus 346 ~~------------------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~---~~~~i~~ 404 (689)
T 3v5w_A 346 KP------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDR 404 (689)
T ss_dssp CC------------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC---CHHHHHH
T ss_pred CC------------------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHH
Confidence 11 23468999999999876567899999999999999999999999753322 1111111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVS 699 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~ 699 (707)
.+ ......+. .....++.+|+.+|+..||.+|++ ++||.
T Consensus 405 ~i---~~~~~~~p-------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 405 MT---LTMAVELP-------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp HH---HHCCCCCC-------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred hh---cCCCCCCC-------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 11 11111111 112345689999999999999998 56664
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=370.94 Aligned_cols=270 Identities=35% Similarity=0.561 Sum_probs=218.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||||++........+.+.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 34799999999999998889999999988776666688999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... .....++|..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 124 ~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 196 (321)
T 2qkw_B 124 RHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH--- 196 (321)
T ss_dssp GGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC---
T ss_pred HHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc---
Confidence 9997653 223469999999999999999999999 899999999999999999999999999998654221110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
......||+.|+|||++.. ..++.++||||||+++|||+||+.||...... +......|......
T Consensus 197 -----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~ 261 (321)
T 2qkw_B 197 -----------LSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR---EMVNLAEWAVESHN 261 (321)
T ss_dssp -----------CBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS---SCCCHHHHTHHHHT
T ss_pred -----------cccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcH---HHHHHHHHhhhccc
Confidence 0123457899999998654 57889999999999999999999999865443 23344555443332
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... +...+++.+... ........+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 262 ~~~-~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 262 NGQ-LEQIVDPNLADK-IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TTC-CCSSSSSSCTTC-SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccc-HHHhcChhhccc-cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 221 234444333221 2355677899999999999999999999999999876
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=371.50 Aligned_cols=285 Identities=38% Similarity=0.600 Sum_probs=223.3
Q ss_pred ccchHHHHHhc-----cceecccCeeEEEEEEeCCCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEc
Q 005226 401 TFELDELLRAS-----AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWA 474 (707)
Q Consensus 401 ~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 474 (707)
.|.+.++.... .+.||+|+||.||+|...++..||||++..... .....|.+|++++++++||||+++++++.+
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 34444444433 358999999999999988899999999976532 223478999999999999999999999999
Q ss_pred CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 475 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
++..++||||+++|+|.++++.... ....++|..+..|+.|++.||+|||+.+..+|+||||||+||+++.++.+||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred CCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999987542 234699999999999999999999993223999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~ 634 (707)
||+++......... .....||+.|+|||++.. ..++.++||||||+++|||+||+.||......
T Consensus 178 fg~~~~~~~~~~~~---------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 178 FGLAKLMDYKDTHV---------------TTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp CSSCEECCSSSSCE---------------ECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred CccccccCcccccc---------------cccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 99998764322111 122347999999998654 56789999999999999999999999632111
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
. .......+|+........ ...+++..+.. .........+.+++.+||+.||.+|||+++|++.|+..
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 242 N-DDDVMLLDWVKGLLKEKK-LEALVDVDLQG-NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp T-TSCSBHHHHHTTTTSSCC-STTSSCTTCTT-SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred c-ccchhHHHHHHHHhhchh-hhhhcChhhcc-ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 1 123356677766555443 24555544432 23456678899999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.43 Aligned_cols=266 Identities=25% Similarity=0.406 Sum_probs=205.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||+||+|... ++..||+|++........+.|.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 358999999999999975 6899999998776666678899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...........
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 99998643 359999999999999999999999 89999999999999999999999999999876533221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.... ............||+.|+|||++.. ..++.++||||||+++|||++|..|+......................
T Consensus 168 ~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T 3s95_A 168 LRSL--KKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYC 244 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTC
T ss_pred cccc--cccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccC
Confidence 0000 0000000113468999999999765 778999999999999999999999986543321111111111111110
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.......+.+++.+||+.||++|||++++++.|+.++
T Consensus 245 -------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 245 -------------------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -------------------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122345788999999999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=394.29 Aligned_cols=246 Identities=24% Similarity=0.329 Sum_probs=200.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||+||+|... +|+.||+|++........+.+.+|+++|++++|||||++++++.+++..|+|||||++|+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 458999999999999964 7899999999876666667889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC--CCeEEecccccccccccCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND--FQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DfGla~~~~~~~~~~ 568 (707)
.++|.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+.....
T Consensus 242 ~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 242 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp HHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE--
T ss_pred HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc--
Confidence 99997543 359999999999999999999999 899999999999999854 8999999999987642211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ......+..
T Consensus 313 ---------------~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~ 370 (573)
T 3uto_A 313 ---------------VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKS 370 (573)
T ss_dssp ---------------EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHT
T ss_pred ---------------eeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHh
Confidence 123468999999999765 7789999999999999999999999975321 222222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ...+..- .......++.+|+.+||+.||++|||+.|+++
T Consensus 371 ~---~~~~~~~---------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 371 C---DWNMDDS---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp T---CCCCCSG---------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CCCCCcc---------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1110000 00112345679999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=368.90 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=205.5
Q ss_pred cceecccCeeEEEEEEe--------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVL--------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
.+.||+|+||.||+|.. .++..||||+++... ....+.+.+|+++++++ +||||++++++|..++..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 45899999999999985 245679999997653 34457899999999999 899999999999999999999
Q ss_pred EEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 482 SDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|||+++|+|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCE
Confidence 999999999999986531 123468999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+++.......... .....+|+.|+|||++.. ..++.++|||||||++|||+| |+.||.
T Consensus 243 kl~DFG~a~~~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~ 307 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKK--------------TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP 307 (370)
T ss_dssp EECCCSSCEETTCCCTTCT--------------TTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEccccCCcccCcccceec--------------ccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999986653221111 122345788999998765 678999999999999999999 999986
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
... ...+...+........+ ......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 308 ~~~------~~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 308 GIP------VEELFKLLKEGHRMDKP---------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp TCC------GGGHHHHHHTTCCCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC------HHHHHHHHhcCCCCCCC---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 532 22333333333222111 122345789999999999999999999999999863
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.65 Aligned_cols=264 Identities=26% Similarity=0.352 Sum_probs=201.2
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc----ceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE----KLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|... ++.||||++....... ..+.+|+.++++++||||+++++++..... .++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCchHH-HHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 348999999999999985 7899999997654333 556779999999999999999999987554 5999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC----------CceecCCCCCCeEEcCCCCeEEecccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR----------KFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
|+|.++++.. .++|..+..|+.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999764 48999999999999999999999 6 999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG----NRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~ 633 (707)
++.......... .....||+.|+|||++... ..++.++|||||||++|||+||+.||.....
T Consensus 178 a~~~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 178 ALKFEAGKSAGD--------------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp CEEECTTSCCCC--------------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred ccccccccCccc--------------cccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 987653322111 1234579999999987642 2445688999999999999999999976543
Q ss_pred CCCccc-------hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 634 STSIEV-------PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 634 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
...... .....+......... ...+. ..........++.+++.+||+.||++|||+++|++.|++|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKK--RPVLR----DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCC--CCCCC----GGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhcccC--CCCcc----ccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 211110 011111111111110 00001 11112344567899999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=353.67 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=204.3
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||+|++....... +++.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH-HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCH-HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 35899999999999999889999999998764443 67999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 163 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 163 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS---
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc---
Confidence 9997643 358999999999999999999999 899999999999999999999999999998654221111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||.+.. ..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 164 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~~~~~~~~~~ 224 (269)
T 4hcu_A 164 ------------STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF 224 (269)
T ss_dssp ------------TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC
T ss_pred ------------ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhcCc
Confidence 122345778999998654 678899999999999999999 999986432 123333333222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+ ......+.+++.+||+.||++||+++++++.|+++.
T Consensus 225 ~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 225 RLYKP---------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC---------------CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 11111 112345789999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=361.29 Aligned_cols=252 Identities=27% Similarity=0.485 Sum_probs=201.5
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... .+..||||+++.. .....+.|.+|++++++++||||+++++++.+++..++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 458999999999999974 3456999999765 33445789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++... ..+++..++.|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 134 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 134 NGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999997653 359999999999999999999999 8999999999999999999999999999987653321
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ......+|+.|+|||++.. ..++.++||||||+++|||++ |+.||.... ...+...
T Consensus 207 ~~~-------------~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~------~~~~~~~ 266 (325)
T 3kul_A 207 AAY-------------TTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMT------NRDVISS 266 (325)
T ss_dssp CCE-------------ECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHH
T ss_pred cee-------------eccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCC------HHHHHHH
Confidence 111 0012334778999998654 677899999999999999999 999986432 2233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........+ ......+.+++..||+.||++||++++|++.|+.+
T Consensus 267 ~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 267 VEEGYRLPAP---------------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp HHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3332221111 12234678999999999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=354.77 Aligned_cols=251 Identities=29% Similarity=0.425 Sum_probs=194.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||+||+|.. ++..||||++.... ....++|.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 45899999999999987 68889999987653 3345689999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|.+++..... ...+++..++.++.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 121 L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~- 194 (309)
T 3p86_A 121 LYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL- 194 (309)
T ss_dssp HHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc-
Confidence 9999986431 1248999999999999999999999 77 99999999999999999999999999975432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
......||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ......+.
T Consensus 195 ---------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~ 252 (309)
T 3p86_A 195 ---------------SSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVG 252 (309)
T ss_dssp ----------------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHH
T ss_pred ---------------ccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 1123457999999999765 6678999999999999999999999965321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
...... ... ......+.+++.+||+.||++|||++++++.|+.+
T Consensus 253 ~~~~~~-~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 253 FKCKRL-EIP-------------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp HSCCCC-CCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCC-CCC-------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111 001 11224578999999999999999999999999886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=367.38 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=193.1
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... ++..||||+++.. .....++|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 458999999999999864 5788999999765 33445789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++... ..+++.+++.|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999998653 358999999999999999999999 8999999999999999999999999999987653221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... .....++..|+|||++.. ..++.++||||||+++|||++ |+.||.... ...+.+.
T Consensus 203 ~~~~-------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------~~~~~~~ 262 (373)
T 2qol_A 203 AAYT-------------TRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMS------NQDVIKA 262 (373)
T ss_dssp ------------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------HHHHHHH
T ss_pred ccee-------------ccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 1110 011234678999998664 678899999999999999998 999986432 2233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........+ ......+.+++.+||+.||++||++.+|++.|+.+
T Consensus 263 i~~~~~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 263 VDEGYRLPPP---------------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHTTEECCCC---------------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 3332221111 12235678999999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=351.97 Aligned_cols=266 Identities=33% Similarity=0.527 Sum_probs=208.2
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|.. ++..||||++.... ....+.|.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 5799999999999987 68899999986532 233577999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++..... ...++|..+..|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 116 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 116 SLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp BHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred cHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 99999975431 2469999999999999999999999 899999999999999999999999999998654221110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......||+.|+|||.+. ..++.++||||||+++|||++|+.||....... .+..+...
T Consensus 191 --------------~~~~~~g~~~y~aPE~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~ 249 (307)
T 2nru_A 191 --------------MTSRIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-----LLLDIKEE 249 (307)
T ss_dssp --------------ECSSCCSCGGGCCHHHHT--TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS-----BTTHHHHH
T ss_pred --------------cccccCCCcCcCChHHhc--CCCCccchhHHHHHHHHHHHHCCCCcccCcchH-----HHHHHHHH
Confidence 012245799999999865 357899999999999999999999997643321 11122222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
.......+.+.+++.+. .........+.+++.+||+.||.+||++++|++.|+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11222222222322221 1234556778999999999999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=355.84 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=196.6
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 4799999999999997 58899999998654 33345678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--- 169 (328)
T 3fe3_A 101 VFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--- 169 (328)
T ss_dssp HHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---
Confidence 999997643 58999999999999999999999 8999999999999999999999999999976542211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++......+.++|||||||++|||++|+.||.... ...+.+.+...
T Consensus 170 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~ 229 (328)
T 3fe3_A 170 --------------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRG 229 (328)
T ss_dssp --------------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC
T ss_pred --------------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC
Confidence 1234579999999997764555689999999999999999999996532 11222222211
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... ......+.+++.+|+..||.+|||++|+++
T Consensus 230 ---~~~~p-------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 ---KYRIP-------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---CCCCC-------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---CCCCC-------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111 112245678999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=350.03 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=203.1
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||+|++....... +++.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH-HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcH-HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 34799999999999999888899999997654443 67899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~--- 161 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS--- 161 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE---
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc---
Confidence 9997643 258999999999999999999999 899999999999999999999999999998654321110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....+|+.|+|||.+.. ..++.++||||||+++|||+| |+.||..... ......+....
T Consensus 162 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~ 222 (268)
T 3sxs_A 162 ------------SVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQGH 222 (268)
T ss_dssp ------------CCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTTC
T ss_pred ------------ccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcCC
Confidence 012334778999998654 567899999999999999999 9999864321 12222222211
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
....+ ......+.+++.+||+.||++|||++++++.|+.+++
T Consensus 223 ~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 RLYRP---------------HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCC---------------TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCC---------------CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 11111 1112357899999999999999999999999999863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=370.69 Aligned_cols=252 Identities=27% Similarity=0.367 Sum_probs=202.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||+|... +++.||||+++... .....+|.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 458999999999999986 78999999987653 3334678999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 199 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 199 FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp HHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 999997543 258999999999999999999999 8999999999999999999999999999986432110000
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....++..|+|||.+.. ..++.++|||||||++|||+| |+.||.... .....+.+..
T Consensus 272 --------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~------~~~~~~~~~~ 330 (377)
T 3cbl_A 272 --------------GGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLS------NQQTREFVEK 330 (377)
T ss_dssp --------------SSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC------HHHHHHHHHT
T ss_pred --------------CCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc
Confidence 011234678999998654 567899999999999999999 999986432 2233333333
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..+...+ ......+.+++.+||+.||++|||+++|++.|++++
T Consensus 331 ~~~~~~~---------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 331 GGRLPCP---------------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC---------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2221111 112345789999999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=350.21 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=196.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++|+|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence 4799999999999995 578999999987655555577899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 106 ~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---- 172 (297)
T 3fxz_A 106 DVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---- 172 (297)
T ss_dssp HHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC----
T ss_pred HHHhhc------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc----
Confidence 999854 48999999999999999999999 89999999999999999999999999999865432211
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ............
T Consensus 173 ------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~ 233 (297)
T 3fxz_A 173 ------------RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT 233 (297)
T ss_dssp ------------BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS
T ss_pred ------------cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC
Confidence 123457999999999765 6789999999999999999999999964321 111111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~-------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQ-------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCS-------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCC-------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 01122345789999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.20 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHh--cCCCceeeeEEEEEcC----CcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK--VKHPNIVKLRAYYWAP----DEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~lV~e~~~ 486 (707)
+.||+|+||+||+|.. +++.||||++.... ...+.+|.+++.. ++||||+++++++... ...++||||++
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 4799999999999998 78899999986542 2556667777766 7999999999997653 34789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH--------ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
+|+|.++++.. .+++..+++|+.||+.||+||| + ++|+||||||+|||++.++.+||+|||++
T Consensus 90 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 90 MGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp TCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999643 5999999999999999999999 6 89999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC-----CCCchhhHHHHHHHHHHHHhC---------
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN-----RPMQKWDVYSFGVVLLELLTG--------- 624 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DV~S~Gv~l~elltg--------- 624 (707)
+........... ......||+.|+|||++.... .++.++|||||||++|||+||
T Consensus 161 ~~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~ 228 (301)
T 3q4u_A 161 VMHSQSTNQLDV------------GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228 (301)
T ss_dssp EEEETTTTEEEC------------CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred eecccccccccc------------cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence 866533221100 012346799999999976532 334799999999999999999
Q ss_pred -CCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 625 -KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 625 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
+.||........ ....+......... . .... ...........+.+++.+||+.||++|||+.+|++.|+
T Consensus 229 ~~~pf~~~~~~~~-~~~~~~~~~~~~~~-~---~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 229 YKPPFYDVVPNDP-SFEDMRKVVCVDQQ-R---PNIP-----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp CCCTTTTTSCSSC-CHHHHHHHHTTSCC-C---CCCC-----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccccCCCCc-chhhhhHHHhccCC-C---CCCC-----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 777765433211 11111111111100 0 0110 11112345677899999999999999999999999999
Q ss_pred hh
Q 005226 704 RI 705 (707)
Q Consensus 704 ~i 705 (707)
+|
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 86
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.82 Aligned_cols=244 Identities=22% Similarity=0.323 Sum_probs=198.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 50 ~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred cEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 347999999999999976 7999999999766555557899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 130 ~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--- 197 (321)
T 2c30_A 130 TDIVSQV------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--- 197 (321)
T ss_dssp HHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC---
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc---
Confidence 9999753 48999999999999999999999 89999999999999999999999999999865432111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++.. ..++.++||||||+++|||++|+.||.... .......+....
T Consensus 198 -------------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~ 257 (321)
T 2c30_A 198 -------------RKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQAMKRLRDSP 257 (321)
T ss_dssp -------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSS
T ss_pred -------------cccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCC
Confidence 023457999999999764 678899999999999999999999996432 112222222211
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... ........+.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 258 PPKLK-------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CCCCT-------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCcC-------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 00112345778999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=376.35 Aligned_cols=250 Identities=24% Similarity=0.465 Sum_probs=203.4
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||||+++..... .+.|.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCcc-HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 4589999999999999988899999999865433 478999999999999999999999986 66789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~--- 341 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA--- 341 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT---
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec---
Confidence 9998542 1258899999999999999999999 899999999999999999999999999998764221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||++.. ..++.++|||||||++|||+| |+.||.... .......+....
T Consensus 342 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~ 402 (454)
T 1qcf_A 342 ------------REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALERGY 402 (454)
T ss_dssp ------------TCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHHTC
T ss_pred ------------cCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC
Confidence 012234778999999754 678999999999999999999 999986432 223334443333
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+...+ ......+.+++.+||+.||++||||++|++.|+.+.
T Consensus 403 ~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 RMPRP---------------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCC---------------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 22211 122346789999999999999999999999999873
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.05 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=205.0
Q ss_pred cceecccCeeEEEEEEe--------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVL--------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 45899999999999985 234679999987653 34457899999999999 999999999999999999999
Q ss_pred EEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 482 SDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|||+++|+|.+++..... .....+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcE
Confidence 999999999999986542 112469999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+++.......... .....+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.
T Consensus 231 kL~DFG~a~~~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKK--------------TTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp EECSCSCCCCSSCCCTTCC--------------CTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEcccCccccccccccccc--------------ccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999986643221111 122345789999998764 778999999999999999999 999986
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ...+.+.+........+ .....++.+++.+||+.||++||++++|++.|+++
T Consensus 296 ~~~------~~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 350 (382)
T 3tt0_A 296 GVP------VEELFKLLKEGHRMDKP---------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350 (382)
T ss_dssp TCC------HHHHHHHHHTTCCCCCC---------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC------HHHHHHHHHcCCCCCCC---------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 432 22334444333222211 11234578999999999999999999999999887
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.82 Aligned_cols=261 Identities=24% Similarity=0.420 Sum_probs=198.5
Q ss_pred ceecccCeeEEEEEEe-----CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~ 485 (707)
+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++... ...++||||+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence 4799999999999984 36889999999877666668899999999999999999999999654 5589999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 96 PYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp TTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred CCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 9999999998653 258999999999999999999999 899999999999999999999999999998765322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ......++..|+|||.+.. ..++.++||||||+++|||+||..|+.... ......
T Consensus 169 ~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~-------~~~~~~ 227 (295)
T 3ugc_A 169 EFFK-------------VKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMRM 227 (295)
T ss_dssp --------------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHH-------HHHHHH
T ss_pred ceee-------------eccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCCh-------HHHHhh
Confidence 1111 0122345778999998664 678999999999999999999999986421 011111
Q ss_pred HHhhccccCCCchhchHHHHh----h---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQ----E---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~----~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
... .. ........+.. . .........+.+++.+||+.||++|||++++++.|+++.
T Consensus 228 ~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 228 IGN----DK-QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HCT----TC-CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcC----cc-ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000 00 00110000000 0 001223456889999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=378.50 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=204.8
Q ss_pred cceecccCeeEEEEEEeCC-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|.+.. +..||||+++..... .++|.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 4589999999999999764 789999999865443 47899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--- 374 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT--- 374 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE---
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCcee---
Confidence 99998643 2358999999999999999999999 89999999999999999999999999999876422110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
......++..|+|||++.. ..++.++|||||||++|||+| |+.||.... ...+.+.+...
T Consensus 375 ------------~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~ 435 (495)
T 1opk_A 375 ------------AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKD 435 (495)
T ss_dssp ------------CCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------GGGHHHHHHTT
T ss_pred ------------ecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcC
Confidence 1122334778999998654 668899999999999999999 999986532 22344444333
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+...+ ......+.+++.+||+.||++||||.+|++.|+.+
T Consensus 436 ~~~~~~---------------~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 436 YRMERP---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCC---------------CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 322211 12234578999999999999999999999999886
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=349.24 Aligned_cols=250 Identities=23% Similarity=0.389 Sum_probs=201.0
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||+||++...++..||+|++....... +++.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCH-HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH-HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 35899999999999999888899999998765443 67999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~--- 177 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--- 177 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS---
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccccc---
Confidence 9998632 359999999999999999999999 899999999999999999999999999998664321110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....+|+.|+|||.+.. ..++.++||||||+++|||+| |+.||.... .......+....
T Consensus 178 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~~ 238 (283)
T 3gen_A 178 ------------SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGL 238 (283)
T ss_dssp ------------TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTC
T ss_pred ------------ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHHHHHhccc
Confidence 012335778999998664 568899999999999999999 999986532 122333333222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+ ......+.+++.+||+.||++|||++++++.|+++.
T Consensus 239 ~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 239 RLYRP---------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCCC---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 21111 111245789999999999999999999999998863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=369.28 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=200.4
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-cceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD-EKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... +..||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 458999999999999984 7799999997654 3478999999999999999999999987765 68999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 343 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 343 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----
Confidence 99998653 2347999999999999999999999 899999999999999999999999999998543211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.. ..++.++|||||||++|||+| |+.||...... +....+...
T Consensus 344 --------------~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~ 402 (450)
T 1k9a_A 344 --------------DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKG 402 (450)
T ss_dssp -----------------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------THHHHHHTT
T ss_pred --------------cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC
Confidence 11234778999999765 678999999999999999999 99999754322 333334333
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.+...+ ......+.+++.+||+.||++|||+.++++.|+.|.
T Consensus 403 ~~~~~p---------------~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 403 YKMDAP---------------DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCC---------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 322211 122346789999999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.00 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=203.3
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|.+. ++..||||++... ......++.+|+.++++++||||+++++++...+..++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 347999999999999853 4678999999765 334456789999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEecccccc
Q 005226 485 ISNGNLANALRGRNG--QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~ 559 (707)
+++|+|.+++..... .....+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~ 232 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence 999999999976432 123469999999999999999999999 8999999999999999554 59999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
.......... .....+|+.|+|||++.. ..++.++|||||||++|||+| |+.||....
T Consensus 233 ~~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~------ 291 (367)
T 3l9p_A 233 DIYRAGYYRK--------------GGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------ 291 (367)
T ss_dssp HHHHHSSCTT--------------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cccccccccc--------------CCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 6643322111 123456889999998664 678999999999999999998 999986532
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
...+.+.+........+ ......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 292 ~~~~~~~i~~~~~~~~~---------------~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 292 NQEVLEFVTSGGRMDPP---------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCC---------------ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 22333333332221111 122345789999999999999999999999998763
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=354.03 Aligned_cols=250 Identities=25% Similarity=0.431 Sum_probs=194.3
Q ss_pred ceecccCeeEEEEEEeC-CCc----eEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGI----PVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||+||+|... ++. .||+|.+.... ....++|.+|+.++++++||||++++++|.++ ..++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 48999999999999954 443 36888886542 33457899999999999999999999999875 4789999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 100 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp TCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999998653 359999999999999999999999 8999999999999999999999999999987653322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....+|..|+|||++.. ..++.++|||||||++|||+| |+.||..... ..+...
T Consensus 173 ~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~ 231 (327)
T 3poz_A 173 EYH--------------AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSI 231 (327)
T ss_dssp ---------------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHH
T ss_pred ccc--------------ccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------HHHHHH
Confidence 111 022345789999999765 678999999999999999999 9999975322 233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........+ ......+.+++.+||+.||++||+++++++.|+.+.
T Consensus 232 ~~~~~~~~~~---------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 232 LEKGERLPQP---------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHTTCCCCCC---------------TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 3332221111 122345788999999999999999999999998763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.51 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=203.7
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||+|++....... +.+.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH-HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCH-HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 35799999999999999888999999998764443 67899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~--- 161 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS--- 161 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS---
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccccc---
Confidence 9998653 358999999999999999999999 899999999999999999999999999998654221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||++.. ..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 162 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~i~~~~ 222 (267)
T 3t9t_A 162 ------------STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF 222 (267)
T ss_dssp ------------TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC
T ss_pred ------------cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCC------HHHHHHHHhcCC
Confidence 012345778999998654 667899999999999999999 899986432 222333333322
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+ ......+.+++.+||+.||++||+++++++.|+++.
T Consensus 223 ~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 223 RLYKP---------------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC---------------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 21111 112245778999999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=355.11 Aligned_cols=256 Identities=28% Similarity=0.410 Sum_probs=203.4
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... ++..||||+++... ....+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 357999999999999974 35889999998653 33457899999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 485 ISNGNLANALRGRNGQ-------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
+++|+|.+++...... ....+++.+++.|+.||+.||+|||+ ++|+||||||+||+++
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~ 208 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG 208 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEC
Confidence 9999999999764311 11469999999999999999999999 8999999999999999
Q ss_pred CCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-C
Q 005226 546 NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-G 624 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g 624 (707)
.++.+||+|||+++.......... .....+|..|+|||++.. ..++.++||||||+++|||+| |
T Consensus 209 ~~~~~kl~Dfg~~~~~~~~~~~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 209 ENMVVKIADFGLSRNIYSADYYKA--------------DGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC------------------CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCeEEEeecCCCcccccCccccc--------------cCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999987643221110 122346889999998664 568899999999999999999 9
Q ss_pred CCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 625 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
+.||.... ...+...+........ .......+.+++.+||+.||++||++.+|++.|++
T Consensus 274 ~~p~~~~~------~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 274 LQPYYGMA------HEEVIYYVRDGNILAC---------------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp CCTTTTSC------HHHHHHHHHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcCCCCC------hHHHHHHHhCCCcCCC---------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 99986432 1223332222211110 01223457899999999999999999999999998
Q ss_pred hc
Q 005226 705 IG 706 (707)
Q Consensus 705 i~ 706 (707)
+.
T Consensus 333 ~~ 334 (343)
T 1luf_A 333 MC 334 (343)
T ss_dssp TT
T ss_pred HH
Confidence 74
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.32 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=201.5
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCc-ceEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDE-KLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~lV~ 482 (707)
.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 45899999999999973 356889999997653 33457799999999999 89999999999988655 89999
Q ss_pred EeecCCChHHHHhCCCCCC-------------------------------------------------------------
Q 005226 483 DFISNGNLANALRGRNGQP------------------------------------------------------------- 501 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------- 501 (707)
||+++|+|.++++......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998754210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCC
Q 005226 502 STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581 (707)
Q Consensus 502 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~ 581 (707)
...+++..++.|+.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-------------- 249 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-------------- 249 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC--------------
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc--------------
Confidence 1228999999999999999999999 89999999999999999999999999999865422211
Q ss_pred CCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhc
Q 005226 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMV 660 (707)
Q Consensus 582 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 660 (707)
.......||..|+|||++.. ..++.++||||||+++|||+| |+.||...... ..+...+........+
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----- 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTRMRAP----- 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----HHHHHHHHHTCCCCCC-----
T ss_pred hhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----HHHHHHHHcCCCCCCC-----
Confidence 01123456889999998664 678899999999999999999 99999654322 1222222222111111
Q ss_pred hHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 661 DAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 661 d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
......+.+++.+||+.||.+|||+++|++.|+++.
T Consensus 319 ----------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 319 ----------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp ----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 112245788999999999999999999999999863
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=370.92 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=198.2
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|.+.++..||||+++..... .++|.+|++++++++||||+++++++.+ +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 4589999999999999988888999999865433 3789999999999999999999999866 7789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~--- 337 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--- 337 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec---
Confidence 9997532 1258999999999999999999999 899999999999999999999999999998664221110
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||.+.. ..++.++|||||||++|||+| |+.||.... ..+....+....
T Consensus 338 ------------~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~~~ 398 (452)
T 1fmk_A 338 ------------RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGY 398 (452)
T ss_dssp -----------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTC
T ss_pred ------------ccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC
Confidence 122345788999998664 678999999999999999999 999986432 223333333332
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+...+ ......+.+++.+||+.||++|||+++|++.|+.+
T Consensus 399 ~~~~~---------------~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 399 RMPCP---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCC---------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22111 12234678999999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.55 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=189.8
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|.... +..||+|++.... ....+.|.+|+.++++++||||+++++++ .++..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCC
Confidence 4589999999999998642 4579999987643 33457899999999999999999999998 4567899999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 99 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999998643 358999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. .....+++.|+|||++.. ..++.++||||||+++|||++ |+.||..... .+....
T Consensus 172 ~~---------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~------~~~~~~ 229 (281)
T 1mp8_A 172 YK---------------ASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGR 229 (281)
T ss_dssp ----------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHH
T ss_pred cc---------------cccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCH------HHHHHH
Confidence 11 122345778999998654 678899999999999999997 9999875322 233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ . ......+.+++.+||+.||++||++.++++.|+++
T Consensus 230 i~~~~~~~~--~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 230 IENGERLPM--P-------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHTTCCCCC--C-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCC--C-------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 332211110 0 12234577999999999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=352.04 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=195.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 92 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence 47999999999999975 789999999865432 2336788999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 93 ~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 163 (323)
T 3tki_A 93 FDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL- 163 (323)
T ss_dssp GGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC-
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc-
Confidence 99997543 59999999999999999999999 8999999999999999999999999999986542221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++......+.++|||||||++|||++|+.||...... ......|.....
T Consensus 164 -------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~~~~~~~~ 226 (323)
T 3tki_A 164 -------------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKKT 226 (323)
T ss_dssp -------------BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT----SHHHHHHHTTCT
T ss_pred -------------cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHHhcccc
Confidence 023457999999999766445578999999999999999999999754332 122233322211
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... . .......+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~-~--------------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 YLN-P--------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TST-T--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCC-c--------------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 100 0 0122345678999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.20 Aligned_cols=255 Identities=29% Similarity=0.436 Sum_probs=203.9
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 45899999999999985 345889999997653 34457899999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 485 ISNGNLANALRGRNGQ-------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
+++|+|.+++...... ....+++..+++++.||+.||+|||+ ++|+||||||+||+++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVA 184 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEE
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEc
Confidence 9999999999865421 12348999999999999999999999 8999999999999999
Q ss_pred CCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-C
Q 005226 546 NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-G 624 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g 624 (707)
.++.+||+|||+++......... ......+++.|+|||.+.. ..++.++||||||+++|||+| |
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYV--------------KRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEE--------------CSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCEEEccccccccccccccce--------------eccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCC
Confidence 99999999999998664322111 1122345788999998654 667899999999999999999 9
Q ss_pred CCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 625 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
+.||..... ..+...+........+ ......+.+++.+||+.||++||++.++++.|++
T Consensus 250 ~~p~~~~~~------~~~~~~~~~~~~~~~~---------------~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 250 GNPYPGIPP------ERLFNLLKTGHRMERP---------------DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CCSSTTCCG------GGHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCH------HHHHHHhhcCCcCCCC---------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 999865332 2333333332211111 1223457899999999999999999999999998
Q ss_pred h
Q 005226 705 I 705 (707)
Q Consensus 705 i 705 (707)
+
T Consensus 309 ~ 309 (314)
T 2ivs_A 309 M 309 (314)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.64 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=196.1
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|...+++.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||++ |+|
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l 105 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDL 105 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEH
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCH
Confidence 37999999999999998899999999875432 234678899999999999999999999999999999999997 589
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 106 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-- 176 (311)
T 3niz_A 106 KKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-- 176 (311)
T ss_dssp HHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc--
Confidence 98887643 358999999999999999999999 899999999999999999999999999998664221111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....+|+.|+|||++.....++.++|||||||++|||++|+.||...... +....+....
T Consensus 177 --------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~ 236 (311)
T 3niz_A 177 --------------THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD------DQLPKIFSIL 236 (311)
T ss_dssp ---------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT------THHHHHHHHH
T ss_pred --------------cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHH
Confidence 22356899999999776567899999999999999999999999764432 1111121111
Q ss_pred cccCC--CchhchHHHHh------------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENP--LSDMVDAMLLQ------------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~--~~~~~d~~l~~------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+ .....+..... .........++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11100 00000000000 0000112346789999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=342.24 Aligned_cols=252 Identities=26% Similarity=0.361 Sum_probs=196.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||+|++... .....+.|.+|+.++++++||||+++++++.+++..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 47999999999999964 6889999988543 2334578999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 97 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 97 TLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 9999997643 58999999999999999999999 899999999999999999999999999998654321111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||.+.. ..++.++||||||+++|||+||+.||..... ......
T Consensus 169 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---------~~~~~~ 223 (294)
T 4eqm_A 169 ---------------TNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETA---------VSIAIK 223 (294)
T ss_dssp ---------------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---------HHHHHH
T ss_pred ---------------cCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHH
Confidence 123457999999998765 6778999999999999999999999965321 111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-ChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-RMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~v~~~L~~i 705 (707)
......+ .. ... ........+.+++.+|++.||++|| +++++.+.|+.+
T Consensus 224 ~~~~~~~--~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 224 HIQDSVP--NV-TTD-----VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHSSCCC--CH-HHH-----SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred HhhccCC--Cc-chh-----cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1111111 00 000 0112335678999999999999999 999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.81 Aligned_cols=256 Identities=26% Similarity=0.420 Sum_probs=203.6
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCch-hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGE-QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.||+|.. .++..||||++..... ...+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 45899999999999984 3578899999976533 3457899999999999 99999999999999999999999
Q ss_pred eecCCChHHHHhCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 484 FISNGNLANALRGRNGQ-------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|+++|+|.+++...... ....+++..+++++.||+.||+|||+ ++|+||||||+||+++.++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCE
Confidence 99999999999865421 12358999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+++......... ......+|..|+|||.+.. ..++.++||||||+++|||+| |+.||.
T Consensus 185 kl~Dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYV--------------VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp EECCCGGGSCTTSCTTSE--------------ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EEccccccccccccccce--------------eccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999998665322110 0122345788999998654 678899999999999999999 999986
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... ..+...+........+ ......+.+++.+||+.||.+||++.++++.|+++
T Consensus 250 ~~~~~-----~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 250 GMPVD-----SKFYKMIKEGFRMLSP---------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp TCCSS-----HHHHHHHHHTCCCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccch-----hHHHHHhccCCCCCCc---------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 54321 1222222222211110 12234578999999999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=346.19 Aligned_cols=241 Identities=25% Similarity=0.298 Sum_probs=194.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +|+.||+|++++.. ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 48999999999999975 68999999987542 233467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~- 161 (337)
T 1o6l_A 91 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 161 (337)
T ss_dssp BHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC-
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc-
Confidence 9999997543 58999999999999999999999 89999999999999999999999999999754321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+.+.+..
T Consensus 162 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~ 219 (337)
T 1o6l_A 162 ---------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILM 219 (337)
T ss_dssp ---------------BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH
T ss_pred ---------------ccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHc
Confidence 123467999999999765 678999999999999999999999996432 1122222111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
....+. ......+.+++.+||+.||++|| ++++|++
T Consensus 220 ---~~~~~p-------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 ---EEIRFP-------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---CCCCCC-------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCC-------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111 11234578999999999999999 8888864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=350.10 Aligned_cols=245 Identities=25% Similarity=0.297 Sum_probs=196.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchh------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +|..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 348999999999999975 6899999998754321 246789999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~ 560 (707)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.
T Consensus 97 ~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp CCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 99999999997543 69999999999999999999999 8999999999999998877 799999999987
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .
T Consensus 169 ~~~~~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~ 224 (361)
T 2yab_A 169 IEDGVEF-----------------KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK------Q 224 (361)
T ss_dssp CCTTCCC-----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------H
T ss_pred cCCCCcc-----------------ccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCH------H
Confidence 6532111 22457999999999664 6789999999999999999999999965321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+... ... ++... .......+.+++.+|+..||++|||+.|+++
T Consensus 225 ~~~~~i~~~---~~~----~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 225 ETLANITAV---SYD----FDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHHHHHTT---CCC----CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhc---CCC----CCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222222111 110 01111 0122345789999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=353.75 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=198.9
Q ss_pred ceecccCeeEEEEEEeCC------CceEEEEEcCCCchhh-----------HHHHHHHHHHHHhcCCCceeeeEEEEEcC
Q 005226 413 YVLGKSGLGIVYKVVLGN------GIPVAVRRLGEGGEQR-----------HREFVTEVQAIAKVKHPNIVKLRAYYWAP 475 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 475 (707)
+.||+|+||.||+|...+ ++.||||++....... ...+.+|+..++.++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 479999999999998754 4789999987653211 12344566677788899999999999775
Q ss_pred ----CcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc--CCCC
Q 005226 476 ----DEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDFQ 549 (707)
Q Consensus 476 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~--~~~~ 549 (707)
...++||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++ .++.
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTTC
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCCe
Confidence 3479999999 999999998643 359999999999999999999999 8999999999999999 8899
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
+||+|||+++.+.......... ........||+.|+|||++.. ..++.++|||||||++|||+||+.||.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYA---------ADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSS---------CCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEEECCcceecccCCcccccc---------cCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999998765433221110 001123458999999999765 668999999999999999999999997
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... .....+....+... +.+++++.+.. .....++.+++..||+.||++||++.+|++.|+++
T Consensus 263 ~~~~~-----~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 263 DNLKD-----PKYVRDSKIRYREN--IASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp GGTTC-----HHHHHHHHHHHHHC--HHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ccccC-----HHHHHHHHHHhhhh--HHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 53221 22333333222211 12333332211 12245688999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.35 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=189.9
Q ss_pred cceecccCeeEEEEEEeC--C--CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG--N--GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|... + +..||||.++.. .....++|.+|+.++++++||||++++++|.. ++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 348999999999999863 2 246899998764 33455789999999999999999999999865 45779999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999998643 358999999999999999999999 899999999999999999999999999998664322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... .......+|+.|+|||++.. ..++.++|||||||++|||+| |.+||...... +...
T Consensus 247 ~~~~------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~------~~~~ 307 (373)
T 3c1x_A 247 FDSV------------HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------DITV 307 (373)
T ss_dssp -----------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS------CHHH
T ss_pred cccc------------cccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH------HHHH
Confidence 1110 00122345788999998664 678899999999999999999 56676543221 2333
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+........+ ......+.+++.+||+.||++||+++++++.|+++
T Consensus 308 ~~~~~~~~~~p---------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 308 YLLQGRRLLQP---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp HHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCC---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33322211111 11234578999999999999999999999999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.98 Aligned_cols=255 Identities=29% Similarity=0.461 Sum_probs=201.9
Q ss_pred cceecccCeeEEEEEEeC--------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+++++++ +||||+++++++..++..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 458999999999999863 56789999997653 34457899999999999 999999999999999999999
Q ss_pred EEeecCCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 482 SDFISNGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|||+++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCE
Confidence 9999999999999865421 12358999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+++......... ......+++.|+|||++.. ..++.++||||||+++|||++ |+.||.
T Consensus 197 kL~Dfg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYK--------------KTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp EECCCTTCEECTTTSSEE--------------CCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred EEcccccccccccccccc--------------ccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 999999998664322110 0122345788999998654 567899999999999999999 999986
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ...+...+........+ ......+.+++.+||+.||.+||++.++++.|+++
T Consensus 262 ~~~------~~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 262 GIP------VEELFKLLKEGHRMDKP---------------ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp TCC------HHHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC------HHHHHHHHhcCCCCCCC---------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 432 22333333332211111 11234578899999999999999999999999887
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.79 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=202.4
Q ss_pred ccceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
..+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 345899999999999995 356789999987542 33447899999999999 9999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE
Q 005226 483 DFISNGNLANALRGRNGQ------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL 544 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll 544 (707)
||+++|+|.+++...... ....+++..++.++.||+.||+|||+ ++|+||||||+||++
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll 205 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 205 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEE
Confidence 999999999999865421 01348999999999999999999999 899999999999999
Q ss_pred cCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-
Q 005226 545 DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT- 623 (707)
Q Consensus 545 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt- 623 (707)
+.++.+||+|||+++......... ......+|+.|+|||.+.. ..++.++||||||+++|||+|
T Consensus 206 ~~~~~~kL~Dfg~~~~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 206 THGKVVKICDFGLARDIMSDSNYV--------------VRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSE--------------EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTT
T ss_pred cCCCcEEeCCCccCcccccCccce--------------eccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcC
Confidence 999999999999998665322110 1123446788999998654 678899999999999999998
Q ss_pred CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 624 GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 624 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
|+.||...... ..+...+........+ ......+.+++.+||+.||.+||++.++++.|+
T Consensus 271 g~~p~~~~~~~-----~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 271 GVNPYPGIPVD-----ANFYKLIQNGFKMDQP---------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp SCCSSTTCCCS-----HHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCcccCCcH-----HHHHHHHhcCCCCCCC---------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 99999754322 2233333332222111 112345788999999999999999999999998
Q ss_pred hhc
Q 005226 704 RIG 706 (707)
Q Consensus 704 ~i~ 706 (707)
.+.
T Consensus 331 ~~~ 333 (344)
T 1rjb_A 331 CQL 333 (344)
T ss_dssp HHC
T ss_pred HHH
Confidence 763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=343.60 Aligned_cols=249 Identities=27% Similarity=0.444 Sum_probs=192.1
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|.. .++.||||++.... ..+.|.+|++++++++||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEE-TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEE-CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 34899999999999998 47889999997543 3478999999999999999999999876 4589999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC-eEEecccccccccccCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ-PYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~-~kl~DfGla~~~~~~~~~~~~ 570 (707)
+++.... ....+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+++......
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 88 NVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 9998653 2235789999999999999999999965568999999999999998886 7999999997543211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....||..|+|||++.. ..++.++||||||+++|||+||+.||...... ............
T Consensus 161 --------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~~ 221 (307)
T 2eva_A 161 --------------TNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAVHNGT 221 (307)
T ss_dssp ------------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHHHTTC
T ss_pred --------------ccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHHhcCC
Confidence 12346899999999764 67899999999999999999999999753221 111111111111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.. ... ......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 222 ~~--~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 222 RP--PLI-------------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CC--CCB-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred CC--Ccc-------------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 11 000 112245778999999999999999999999998874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=348.88 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=189.2
Q ss_pred cceecccCeeEEEEEEeCCC----ceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcc------e
Q 005226 412 AYVLGKSGLGIVYKVVLGNG----IPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK------L 479 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~ 479 (707)
.+.||+|+||.||+|..... ..||||++... .....+.|.+|++++++++||||+++++++...+.. +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 34899999999999996533 27999998765 334457899999999999999999999999887665 9
Q ss_pred EEEEeecCCChHHHHhCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 480 LISDFISNGNLANALRGRNG-QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 480 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
+||||+++|+|.+++..... .....+++..+..|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeecccc
Confidence 99999999999999964321 122358999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSI 637 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~ 637 (707)
+.......... .....+++.|+|||.+.. ..++.++|||||||++|||++ |+.||.....
T Consensus 185 ~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---- 245 (323)
T 3qup_A 185 RKIYSGDYYRQ--------------GCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN---- 245 (323)
T ss_dssp ------------------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG----
T ss_pred ccccccccccc--------------cccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccCh----
Confidence 86643221111 122345778999998654 678899999999999999999 8999875322
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
......+........+ ......+.+++.+||+.||++|||+.++++.|+++
T Consensus 246 --~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 246 --AEIYNYLIGGNRLKQP---------------PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --GGHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCCCCC---------------CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2233322222111111 12234578999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=338.38 Aligned_cols=246 Identities=26% Similarity=0.450 Sum_probs=194.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchh-------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQ-------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|++++++++||||+++++++.+.. ++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence 4799999999999997 47899999998654321 1167899999999999999999999986544 799999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEcCCCC-----eEEecccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLDNDFQ-----PYISDFGL 557 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~~~~~-----~kl~DfGl 557 (707)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++. +||+|||+
T Consensus 103 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 103 VPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp CTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred cCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 99999999997643 369999999999999999999999 67 999999999999988776 99999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
++..... .....||+.|+|||++.. ...++.++||||||+++|||++|+.||......
T Consensus 176 ~~~~~~~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-- 234 (287)
T 4f0f_A 176 SQQSVHS-------------------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-- 234 (287)
T ss_dssp CBCCSSC-------------------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC--
T ss_pred ccccccc-------------------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc--
Confidence 8743311 123456899999998742 355688999999999999999999999754322
Q ss_pred ccchhHHHHHHh-hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 637 IEVPDLVRWVKK-GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 637 ~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.......... ...... .......+.+++.+||+.||++||+++++++.|+++
T Consensus 235 --~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 235 --KIKFINMIREEGLRPTI---------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --HHHHHHHHHHSCCCCCC---------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --HHHHHHHHhccCCCCCC---------------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111222111 111110 112234578999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=350.11 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=195.8
Q ss_pred ceecccCeeEEEEEEeC-CCce----EEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIP----VAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++.. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 47999999999999964 4444 7888775442 233356788999999999999999999885 567899999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 98 LGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp TCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999998653 358899999999999999999999 8999999999999999999999999999987653322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....++..|+|||++.. ..++.++||||||+++|||+| |+.||...... .+...
T Consensus 171 ~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~ 229 (325)
T 3kex_A 171 QLL--------------YSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------EVPDL 229 (325)
T ss_dssp CCC-------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------HHHHH
T ss_pred ccc--------------ccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------HHHHH
Confidence 111 023346789999999764 668899999999999999999 99999754322 33333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........+ ......+.+++.+||+.||++||+++++++.|+.+.
T Consensus 230 ~~~~~~~~~~---------------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 230 LEKGERLAQP---------------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHTTCBCCCC---------------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHcCCCCCCC---------------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3332221111 111234678999999999999999999999998864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=347.28 Aligned_cols=258 Identities=14% Similarity=0.153 Sum_probs=201.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++++ +||||+++++++..++..++||||+ +|+|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 4799999999999995 5789999999865432 24688999999999 9999999999999999999999999 9999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC-----eEEecccccccccccC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ-----PYISDFGLSRLINITG 565 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~~ 565 (707)
.+++.... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99998642 369999999999999999999999 89999999999999998887 9999999998765332
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... ..+.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.......
T Consensus 165 ~~~~---------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~---~~~~~~~~ 231 (330)
T 2izr_A 165 TKKH---------IPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD---TLKERYQK 231 (330)
T ss_dssp TCCB---------CCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS---SHHHHHHH
T ss_pred CCcc---------ccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccc---cHHHHHHH
Confidence 2111 11122244568999999999765 67899999999999999999999999765332 11111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....... + ...+ ..... ++.+++..||+.||.+||++.+|++.|+++
T Consensus 232 i~~~~~~~-~-----~~~~-----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 232 IGDTKRAT-P-----IEVL-----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHHHHHS-C-----HHHH-----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHhhhccC-C-----HHHH-----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 11110000 0 0000 01122 788999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=338.93 Aligned_cols=244 Identities=30% Similarity=0.417 Sum_probs=185.9
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch----hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE----QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|.. .+..||||++..... ...+.+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 13 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 4899999999999998 488899999875422 22467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC---ceecCCCCCCeEEcC--------CCCeEEecccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK---FVHGDIKPSNILLDN--------DFQPYISDFGL 557 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---iiHrDlk~~NIll~~--------~~~~kl~DfGl 557 (707)
+|.+++... .+++..+..++.|++.||+|||+ ++ |+||||||+||+++. ++.+||+|||+
T Consensus 92 ~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 92 PLNRVLSGK------RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred CHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999643 58999999999999999999999 66 999999999999986 67899999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
++....... ....||+.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~~~------------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---- 219 (271)
T 3dtc_A 163 AREWHRTTK------------------MSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---- 219 (271)
T ss_dssp -------------------------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----
T ss_pred ccccccccc------------------cCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 976542211 12346899999998654 6788999999999999999999999964321
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
............ .... .......+.+++.+||+.||++|||+.++++.|++|
T Consensus 220 --~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 --LAVAYGVAMNKL-ALPI-------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --HHHHHHHHTSCC-CCCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --HHHHHhhhcCCC-CCCC-------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111111111100 0000 012234578999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=375.68 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=198.7
Q ss_pred eecccCeeEEEEEEeC---CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG---NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|.+. ++..||||+++... ....++|.+|++++++++|||||+++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999863 56789999998653 3345789999999999999999999999976 56899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999997543 359999999999999999999999 8999999999999999999999999999987643221111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......+++.|+|||++.. ..++.++|||||||++|||+| |+.||..... .++...+..
T Consensus 495 -------------~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~~i~~ 554 (613)
T 2ozo_A 495 -------------ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQ 554 (613)
T ss_dssp --------------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HHHHHHHHT
T ss_pred -------------eccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHHc
Confidence 0112234688999999754 678999999999999999998 9999975332 234444444
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+...+ ......+.+++..||+.||++||++.+|++.|+.+
T Consensus 555 ~~~~~~p---------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 555 GKRMECP---------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp TCCCCCC---------------TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCC---------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3322211 12335678999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=340.87 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=199.9
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcc-eEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK-LLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV~e~~ 485 (707)
.+.||+|+||+||+|...+ +..||+|++..... ...+.|.+|++++++++||||+++++++.+.+.. ++|+||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4589999999999998532 33799999876533 4457899999999999999999999999877665 9999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
.+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999998643 358999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... .......++..|+|||.+.. ..++.++||||||+++|||++|+.|+.... +...+...
T Consensus 179 ~~~~------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~-----~~~~~~~~ 240 (298)
T 3pls_A 179 YYSV------------QQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHI-----DPFDLTHF 240 (298)
T ss_dssp GGCS------------CCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CGGGHHHH
T ss_pred cccc------------ccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccC-----CHHHHHHH
Confidence 1110 01123456889999999754 678899999999999999999766654322 22233343
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........+ ......+.+++.+||+.||.+|||++++++.|+++
T Consensus 241 ~~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 241 LAQGRRLPQP---------------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp HHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCCCCCC---------------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3333221111 11224578999999999999999999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=346.49 Aligned_cols=244 Identities=20% Similarity=0.272 Sum_probs=196.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|... ++..||+|.+..... ....+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 47999999999999965 688999999875543 3367889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC--CCCeEEecccccccccccCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN--DFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.......
T Consensus 90 ~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~--- 159 (321)
T 1tki_A 90 ERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159 (321)
T ss_dssp HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---
Confidence 9997543 358999999999999999999999 89999999999999987 78999999999987642211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 160 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~- 217 (321)
T 1tki_A 160 --------------FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMN- 217 (321)
T ss_dssp --------------EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-
T ss_pred --------------cccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHc-
Confidence 123457999999999764 5678999999999999999999999965321 122222211
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+ +... ......++.+++.+|+..||++|||+.|+++
T Consensus 218 --~~~~~----~~~~-----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 218 --AEYTF----DEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --TCCCC----CHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCCC----Chhh-----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 0000 0122356789999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=346.85 Aligned_cols=246 Identities=21% Similarity=0.325 Sum_probs=197.3
Q ss_pred cceecccCeeEEEEEEeCC-C-------ceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGN-G-------IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||+||+|.... + ..||+|++........+.|.+|++++++++||||+++++++..++..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 3479999999999998643 3 4699999977666666889999999999999999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC--------eEEecc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ--------PYISDF 555 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~Df 555 (707)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++. +||+||
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 999999999998653 248999999999999999999999 89999999999999998887 999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~ 635 (707)
|++...... ....++..|+|||++.....++.++||||||+++|||++|..|+.....
T Consensus 166 g~~~~~~~~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-- 223 (289)
T 4fvq_A 166 GISITVLPK--------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-- 223 (289)
T ss_dssp CSCTTTSCH--------------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred cccccccCc--------------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--
Confidence 998654311 2344688899999876546788999999999999999997655443211
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
............... ......+.+++.+||+.||++|||++++++.|+++-
T Consensus 224 ---~~~~~~~~~~~~~~~-----------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 224 ---SQRKLQFYEDRHQLP-----------------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ---HHHHHHHHHTTCCCC-----------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ---hHHHHHHhhccCCCC-----------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111111111111100 011234678999999999999999999999999873
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.46 Aligned_cols=245 Identities=20% Similarity=0.276 Sum_probs=189.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.++||+|+||.||+|+.. +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+++..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 348999999999999975 67889999987542 22235678899999887 89999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|..++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999998643 59999999999999999999999 8999999999999999999999999999975332111
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........... ...+++
T Consensus 209 ~----------------~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-~~~~~~ 270 (396)
T 4dc2_A 209 T----------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-NTEDYL 270 (396)
T ss_dssp C----------------BCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------CCHHHH
T ss_pred c----------------cccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-hhHHHH
Confidence 1 123467999999999765 6789999999999999999999999975432211000 001111
Q ss_pred Hhhc-cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 647 KKGF-EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 647 ~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
.... .....+ ......++.+++.+||+.||++||++
T Consensus 271 ~~~i~~~~~~~-------------p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 271 FQVILEKQIRI-------------PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHCCCCC-------------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHhccccCC-------------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111 111110 11123457899999999999999996
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.18 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=195.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchh------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +|..||+|.+...... ..+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 458999999999999975 6899999998654221 246789999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~ 560 (707)
+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.
T Consensus 96 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 96 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp CCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 99999999997543 59999999999999999999999 8999999999999999887 799999999987
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .
T Consensus 168 ~~~~~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~ 223 (326)
T 2y0a_A 168 IDFGNEF-----------------KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK------Q 223 (326)
T ss_dssp CCTTSCC-----------------CCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------H
T ss_pred CCCCCcc-----------------ccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------H
Confidence 6422111 22357999999998654 6788999999999999999999999964321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+... ... ..+.. .......+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~---~~~---~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 224 ETLANVSAV---NYE---FEDEY------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHHHHHT---CCC---CCHHH------HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhc---CCC---cCccc------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111 100 00110 0122345789999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.00 Aligned_cols=245 Identities=22% Similarity=0.298 Sum_probs=196.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 458999999999999965 6899999998654 2334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~ 565 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++......
T Consensus 114 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 114 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp BHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 9999997643 58999999999999999999999 899999999999999865 459999999998654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. ....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+...
T Consensus 186 ~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~------~~~~~~~ 241 (362)
T 2bdw_A 186 AW-----------------HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYAQ 241 (362)
T ss_dssp SC-----------------CCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred cc-----------------ccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHH
Confidence 11 22457999999999764 678999999999999999999999996432 1223332
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... + ........+.+++.+||+.||++||++.++++
T Consensus 242 i~~~~~~~~~------~------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 242 IKAGAYDYPS------P------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHTCCCCCT------T------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHhCCCCCCc------c------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2222111000 0 00112345789999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.39 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=200.0
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|...++..||||++...... .+.+.+|++++++++||||+++++++. ++..++||||+++|+|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc-HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 3489999999999999988889999998765433 378999999999999999999999986 55689999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 166 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--- 166 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC---
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc---
Confidence 9997532 1258999999999999999999999 899999999999999999999999999998765321111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||.+.. ..++.++||||||+++|||++ |+.||.... .......+....
T Consensus 167 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~ 227 (279)
T 1qpc_A 167 ------------REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGY 227 (279)
T ss_dssp ------------CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHTTC
T ss_pred ------------ccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccC------HHHHHHHHhccc
Confidence 012335778999998654 567899999999999999999 899986432 123333333222
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....+ ......+.+++.+|++.||++|||+.++++.|+++
T Consensus 228 ~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 RMVRP---------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCc---------------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11111 11234678999999999999999999999999886
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.51 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=203.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 358999999999999976 478899999976543 347899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 167 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--- 167 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE---
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCccc---
Confidence 99998643 2358999999999999999999999 89999999999999999999999999999865422110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
......+++.|+|||.+.. ..++.++||||||+++|||++ |+.||..... ....+.+...
T Consensus 168 ------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~~~~~~~~ 228 (288)
T 3kfa_A 168 ------------AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKD 228 (288)
T ss_dssp ------------EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHHHTT
T ss_pred ------------cccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcc
Confidence 1122345788999998654 678899999999999999999 9999865322 2333333332
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.....+ ......+.+++.+|++.||.+||++.++++.|+.+
T Consensus 229 ~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERP---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCC---------------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 222111 11234578999999999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=336.47 Aligned_cols=247 Identities=22% Similarity=0.314 Sum_probs=196.5
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|.. ++..||||++.... ....+.|.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 34899999999999998 48889999987653 34457899999999999999999999999887 678999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
|+|.+++.... ...+++..+..|+.||+.||+|||+ .+ |+||||||+||+++.++.++|+|||++.....
T Consensus 94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 99999998653 2358999999999999999999999 67 99999999999999999999999998654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN--RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
....||+.|+|||.+.... .++.++||||||+++|||++|+.||..... ....
T Consensus 166 -------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~ 220 (271)
T 3kmu_A 166 -------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIG 220 (271)
T ss_dssp -------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHH
T ss_pred -------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHH
Confidence 1234588999999876422 223489999999999999999999964321 1111
Q ss_pred HHH-HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 644 RWV-KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 644 ~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
... ........ . ......+.+++.+||+.||++|||++++++.|+++.+
T Consensus 221 ~~~~~~~~~~~~--~-------------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 221 MKVALEGLRPTI--P-------------PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHSCCCCCC--C-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHhcCCCCCC--C-------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 11111110 0 1123457899999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.38 Aligned_cols=259 Identities=15% Similarity=0.197 Sum_probs=202.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++..... ...+.+|+++++++ +|+|++++++++......++||||+ +|+|
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 4799999999999995 5789999999865432 25688899999999 8999999999999999999999999 9999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC-----eEEecccccccccccC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ-----PYISDFGLSRLINITG 565 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~DfGla~~~~~~~ 565 (707)
.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+||+++.++. +||+|||+++......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99998653 259999999999999999999999 89999999999999987776 9999999998765432
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ...+.......||+.|+|||++.. ..++.++||||||+++|||++|+.||....... .......
T Consensus 166 ~~~---------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~ 232 (298)
T 1csn_A 166 TKQ---------HIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYER 232 (298)
T ss_dssp TCC---------BCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHH
T ss_pred ccc---------cccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccc---cHHHHHH
Confidence 211 111122244568999999999665 678999999999999999999999997643321 1111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ .+. ........+.+++.+||+.||++||++++|++.|+++
T Consensus 233 ~~~~~~~~~------~~~-----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 233 IGEKKQSTP------LRE-----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHHHHHHSC------HHH-----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHhhccCcc------HHH-----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 111100000 000 0012345788999999999999999999999999886
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=341.45 Aligned_cols=268 Identities=21% Similarity=0.226 Sum_probs=202.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--cceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--EKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence 38999999999999975 58999999987643 233477889999999999999999999998765 668999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE----cCCCCeEEeccccccccccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL----DNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla~~~~~~ 564 (707)
+|.+++..... ...+++..++.|+.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 95 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 95 SLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp BHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 99999986532 2349999999999999999999999 899999999999999 78888999999999876532
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
... ....||..|+|||++.. +..++.++|||||||++|||+||+.||.......
T Consensus 170 ~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-- 230 (319)
T 4euu_A 170 EQF-----------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-- 230 (319)
T ss_dssp CCB-----------------CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--
T ss_pred Cce-----------------eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--
Confidence 211 12346899999998541 3678899999999999999999999997543221
Q ss_pred cchhHHHHHHhhccccCCCchhch---------HHH-HhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVD---------AML-LQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d---------~~l-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
........+......... ..+.+ ..+ ............+.+++.+||+.||++|||++|+++...+.
T Consensus 231 ~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 231 RNKEVMYKIITGKPSGAI-SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp GCHHHHHHHHHHCCTTCC-EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hhHHHHHHHhcCCCcccc-hhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111222212111110000 00000 000 00011244556788999999999999999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=339.03 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=190.0
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|...+ .||||+++... ....+.|.+|++++++++||||+++++++ ..+..++||||+++++|
T Consensus 30 ~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 489999999999998643 59999987543 34457899999999999999999999965 56678999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 107 ~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 177 (289)
T 3og7_A 107 YHHLHASE----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH-- 177 (289)
T ss_dssp HHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred HHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccc--
Confidence 99997543 359999999999999999999999 899999999999999999999999999997654221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......||+.|+|||.+. .+..++.++||||||+++|||++|+.||..... ...+.+.+..
T Consensus 178 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~ 240 (289)
T 3og7_A 178 ------------QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----RDQIIEMVGR 240 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----HHHHHHHHHH
T ss_pred ------------cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----HHHHHHHhcc
Confidence 012345799999999865 235678899999999999999999999965322 1222232222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....... ..+ .......+.+++.+||+.||++||++.++++.|+++.
T Consensus 241 ~~~~~~~-~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 241 GSLSPDL-SKV----------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp TSCCCCT-TSS----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cccCcch-hhc----------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 2111110 000 1122356789999999999999999999999999885
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.69 Aligned_cols=262 Identities=24% Similarity=0.295 Sum_probs=191.4
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc--CCCceeeeEEEEEcC----CcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV--KHPNIVKLRAYYWAP----DEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~~~lV~e~~ 485 (707)
.+.||+|+||.||+|... +..||||++..... ..+.+|.+++..+ +||||+++++++... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 458999999999999984 88999999864332 4455666666654 999999999999887 6789999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS-----PRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
++|+|.++++.. .+++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.+||+|||+++.
T Consensus 118 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 118 ENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 999999999754 4899999999999999999999820 12999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCc------hhhHHHHHHHHHHHHhC----------
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ------KWDVYSFGVVLLELLTG---------- 624 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~~DV~S~Gv~l~elltg---------- 624 (707)
......... ..+....||+.|+|||++.. ...+. ++|||||||++|||+||
T Consensus 192 ~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 192 FISDTNEVD------------IPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp CC---------------------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred ecccccccc------------CCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 653322111 11123467999999999765 33333 49999999999999999
Q ss_pred CCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 625 KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 625 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
+.||........ ........+.. ... ...+. ...........+.+++.+||+.||++|||+.+|++.|+.
T Consensus 259 ~~p~~~~~~~~~-~~~~~~~~~~~----~~~-~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 259 QLPYHDLVPSDP-SYEDMREIVCI----KKL-RPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCTTTTTSCSSC-CHHHHHHHHTT----SCC-CCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccHhhhcCCCC-chhhhHHHHhh----hcc-Ccccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 555543322110 11111111110 000 00011 111123456778999999999999999999999999998
Q ss_pred hc
Q 005226 705 IG 706 (707)
Q Consensus 705 i~ 706 (707)
+.
T Consensus 329 l~ 330 (337)
T 3mdy_A 329 MS 330 (337)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=338.63 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=200.6
Q ss_pred eecccCeeEEEEEEeC---CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG---NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||.||+|... ++..||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||+++|+
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 7999999999999853 67889999998753 34457899999999999999999999999 5567899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..........
T Consensus 96 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 96 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred HHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 999997543 358999999999999999999999 8999999999999999999999999999987643221110
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......+|+.|+|||++.. ..++.++||||||+++|||+| |+.||..... ..+...+..
T Consensus 169 -------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~i~~ 228 (287)
T 1u59_A 169 -------------ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQ 228 (287)
T ss_dssp -------------CCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHHHT
T ss_pred -------------ccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHhc
Confidence 1122345889999998654 567899999999999999999 9999965322 233333333
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
......+ ......+.+++.+||+.||++||++.++++.|+++
T Consensus 229 ~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 229 GKRMECP---------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TCCCCCC---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcCCCC---------------CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211111 12234678999999999999999999999999876
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=352.78 Aligned_cols=245 Identities=21% Similarity=0.274 Sum_probs=192.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
++||+|+||.||+|.. .+|..||+|+++.......+.|.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 4799999999999996 478999999998776666688999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE--cCCCCeEEecccccccccccCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL--DNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll--~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 9997542 358999999999999999999999 899999999999999 56789999999999876432211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 246 ---------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~- 302 (373)
T 2x4f_A 246 ---------------KVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILA- 302 (373)
T ss_dssp ---------------CCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-
T ss_pred ---------------ccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-
Confidence 12347999999998654 6788999999999999999999999965321 112111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.+. +. ........+.+++.+|++.||++||++.|+++
T Consensus 303 --~~~~~~---~~------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 303 --CRWDLE---DE------EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --TCCCSC---SG------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccCCCC---hh------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111100 00 00122356789999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.55 Aligned_cols=243 Identities=22% Similarity=0.319 Sum_probs=194.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||||+++|
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 48999999999999965 67889999986542 223467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 101 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~- 171 (384)
T 4fr4_A 101 DLRYHLQQNV-----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI- 171 (384)
T ss_dssp EHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB-
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce-
Confidence 9999998643 59999999999999999999999 89999999999999999999999999999865422111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....||+.|+|||++.. +..++.++|||||||++|||++|+.||...... ....+....
T Consensus 172 ----------------~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~ 232 (384)
T 4fr4_A 172 ----------------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---SSKEIVHTF 232 (384)
T ss_dssp ----------------CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---CHHHHHHHH
T ss_pred ----------------eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---cHHHHHHHH
Confidence 23457999999999764 345789999999999999999999999754332 111222222
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-hHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-MKNVS 699 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~v~ 699 (707)
.... ..+ .......+.+++.+||+.||.+||+ +++|.
T Consensus 233 ~~~~---~~~-------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 233 ETTV---VTY-------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHCC---CCC-------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred hhcc---cCC-------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 1111 110 0112345789999999999999998 66654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.40 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=195.4
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc-CCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA-PDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|...+ +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 3489999999999998642 2368999987643 3445789999999999999999999999754 45779999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..+..|+.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 9999999997643 358999999999999999999999 899999999999999999999999999998664322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK-SPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~-~P~~~~~~~~~~~~~~~~~ 644 (707)
.... .......+|+.|+|||.+.. ..++.++||||||+++|||++|. +||..... .+...
T Consensus 183 ~~~~------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------~~~~~ 243 (298)
T 3f66_A 183 YYSV------------HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITV 243 (298)
T ss_dssp GCBC-----------------CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT------TTHHH
T ss_pred hhcc------------ccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCH------HHHHH
Confidence 1110 01123456788999998654 67889999999999999999954 45543222 12233
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..........+ ......+.+++.+||+.||++||+++++++.|+++
T Consensus 244 ~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 244 YLLQGRRLLQP---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp HHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCCCCC---------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22222211111 11224578999999999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=339.46 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=194.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|...+++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||+++ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 47999999999999998899999999865432 2236788999999999999999999999999999999999975 99
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-- 157 (288)
T 1ob3_A 87 KKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-- 157 (288)
T ss_dssp HHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc--
Confidence 99998643 358999999999999999999999 899999999999999999999999999998654221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....+|+.|+|||++.....++.++|||||||++|||++|+.||..... .+....+....
T Consensus 158 --------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~ 217 (288)
T 1ob3_A 158 --------------THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRIL 217 (288)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHH
T ss_pred --------------ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHH
Confidence 2234689999999976656789999999999999999999999965321 11111111111
Q ss_pred cccCC--Cchh-----chHHHHh------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENP--LSDM-----VDAMLLQ------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~--~~~~-----~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... .... .++.+.. ..........+.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000 0000 0000000 0000122356789999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.31 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=201.8
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|.+.++..||||+++..... .++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 4589999999999999988888999999865433 3789999999999999999999999866 7789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
++++... ...+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--- 420 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--- 420 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT---
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec---
Confidence 9997532 1258999999999999999999999 899999999999999999999999999998654211000
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....++..|+|||++.. ..++.++|||||||++|||+| |+.||.... ..++.+.+....
T Consensus 421 ------------~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~------~~~~~~~i~~~~ 481 (535)
T 2h8h_A 421 ------------RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQVERGY 481 (535)
T ss_dssp ------------TCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC------HHHHHHHHHTTC
T ss_pred ------------ccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCC
Confidence 012234778999998664 678999999999999999999 899986432 223333333332
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+...+ ......+.+++.+||+.||++||++++|++.|+.+
T Consensus 482 ~~~~~---------------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 482 RMPCP---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCC---------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22111 12234578999999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=376.15 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=197.5
Q ss_pred ceecccCeeEEEEEEeC---CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|.+. .+..||||+++.... ...++|.+|++++++++|||||+++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 567899999976432 33578999999999999999999999996 4568899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 99999997543 58999999999999999999999 89999999999999999999999999999876533211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ......+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.... ...+...+
T Consensus 526 ~~-------------~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~------~~~~~~~i 585 (635)
T 4fl3_A 526 YK-------------AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAML 585 (635)
T ss_dssp ----------------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHH
T ss_pred cc-------------cccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH
Confidence 11 1122345788999999754 678999999999999999998 999996532 22333333
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
........+ .....++.+++..||+.||++||++.+|++.|+.+
T Consensus 586 ~~~~~~~~p---------------~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 586 EKGERMGCP---------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HTTCCCCCC---------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCC---------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 333222211 12235678999999999999999999999999876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.03 Aligned_cols=244 Identities=20% Similarity=0.276 Sum_probs=190.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 48999999999999975 68899999987542 23346788999999998 899999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 95 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 95 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 99999997543 58999999999999999999999 89999999999999999999999999999754322111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||........... .....+.
T Consensus 167 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~ 228 (345)
T 3a8x_A 167 ----------------TSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-NTEDYLF 228 (345)
T ss_dssp ----------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------CHHHHH
T ss_pred ----------------ccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-ccHHHHH
Confidence 123457999999999765 6789999999999999999999999975322111000 0011111
Q ss_pred hhc-cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 648 KGF-EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 648 ~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
... .....+ .......+.+++.+||+.||++||++
T Consensus 229 ~~i~~~~~~~-------------p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 229 QVILEKQIRI-------------PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHCCCCC-------------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHcCCCCC-------------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111 111000 11123457899999999999999996
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.17 Aligned_cols=246 Identities=22% Similarity=0.248 Sum_probs=195.1
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||+||+|.. .+|..+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 45899999999999986 478999999987543 334567899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc---CCCCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~ 565 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++......
T Consensus 96 ~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 96 ELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp BHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 9999998653 59999999999999999999999 8999999999999998 46789999999997654321
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ...+...
T Consensus 168 ~~~----------------~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~------~~~~~~~ 224 (444)
T 3soa_A 168 QAW----------------FGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDED------QHRLYQQ 224 (444)
T ss_dssp CBC----------------CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH
T ss_pred cee----------------ecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCcc------HHHHHHH
Confidence 110 22457999999999664 678999999999999999999999996432 1222222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... + ........+.+++.+|++.||++|||+.|+++
T Consensus 225 i~~~~~~~~~------~------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 225 IKAGAYDFPS------P------EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHTCCCCCT------T------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCc------c------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222111000 0 00112345789999999999999999999986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=347.17 Aligned_cols=240 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++||||+++++++.+++..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 4799999999999996 5789999999865321 12357889999999999999999999999999999999999 78
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 94 ~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~- 164 (336)
T 3h4j_B 94 ELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL- 164 (336)
T ss_dssp EHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT-
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccc-
Confidence 9999997543 59999999999999999999999 79999999999999999999999999999865432111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.+....++++|||||||++|||++|+.||........... +
T Consensus 165 ----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------i-- 220 (336)
T 3h4j_B 165 ----------------KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK------V-- 220 (336)
T ss_dssp ----------------CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC------C--
T ss_pred ----------------ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH------H--
Confidence 2235799999999977644447899999999999999999999975432211100 0
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ ......+.+++.+|++.||.+|||++|+++
T Consensus 221 -~~~~~~~p-------------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 -NSCVYVMP-------------DFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp -CSSCCCCC-------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred -HcCCCCCc-------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00000001 112245678999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.96 Aligned_cols=252 Identities=27% Similarity=0.495 Sum_probs=195.1
Q ss_pred cceecccCeeEEEEEEeCC-----CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGN-----GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||.||+|.... +..||||++.... ......|.+|++++++++||||+++++++...+..++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 3589999999999998642 3469999987653 334467999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999997643 358999999999999999999999 899999999999999999999999999998765322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ......+|..|+|||++.. ..++.++||||||+++|||++ |+.||.... ...+..
T Consensus 202 ~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~ 261 (333)
T 1mqb_A 202 EATY-------------TTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHEVMK 261 (333)
T ss_dssp ----------------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred cccc-------------ccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCC------HHHHHH
Confidence 1110 0012334778999998654 678899999999999999999 999986432 122333
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+........+ ......+.+++.+||+.||++||++.++++.|+++
T Consensus 262 ~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 262 AINDGFRLPTP---------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHHTTCCCCCC---------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHCCCcCCCc---------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33222111111 12234578999999999999999999999999876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=340.54 Aligned_cols=243 Identities=24% Similarity=0.306 Sum_probs=186.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--------------------------hhHHHHHHHHHHHHhcCCCce
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--------------------------QRHREFVTEVQAIAKVKHPNI 465 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~ni 465 (707)
+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 47999999999999964 688999999865421 113568899999999999999
Q ss_pred eeeEEEEEc--CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeE
Q 005226 466 VKLRAYYWA--PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNIL 543 (707)
Q Consensus 466 v~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIl 543 (707)
+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||+
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLL 169 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEE
Confidence 999999987 4578999999999999887543 259999999999999999999999 89999999999999
Q ss_pred EcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCC--CCchhhHHHHHHHHHHH
Q 005226 544 LDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNR--PMQKWDVYSFGVVLLEL 621 (707)
Q Consensus 544 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DV~S~Gv~l~el 621 (707)
++.++.+||+|||+++........ .....||+.|+|||.+..... ++.++|||||||++|||
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDAL----------------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCE----------------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred ECCCCCEEEecCCCcccccccccc----------------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999866432110 022357999999999765332 47889999999999999
Q ss_pred HhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 622 LTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 622 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
++|+.||.... ...+...+....... + . .......+.+++.+||+.||++||++.|+++
T Consensus 234 ~~g~~pf~~~~------~~~~~~~~~~~~~~~-~--~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 234 VFGQCPFMDER------IMCLHSKIKSQALEF-P--D-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHSSCSSCCSS------HHHHHHHHHHCCCCC-C--S-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHCCCCCCCcc------HHHHHHHHhcccCCC-C--C-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99999996421 112222221111000 0 0 0112345789999999999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.73 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=191.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------------
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------------ 477 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------------ 477 (707)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 347999999999999976 78999999987543 3345789999999999999999999999866542
Q ss_pred ---------------------------------------------ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHH
Q 005226 478 ---------------------------------------------KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512 (707)
Q Consensus 478 ---------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~ 512 (707)
.++||||+++|+|.+++..... ....++..++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHHH
Confidence 6899999999999999987542 34568888999
Q ss_pred HHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCcc
Q 005226 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592 (707)
Q Consensus 513 i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 592 (707)
++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++............ .....+.......||+.
T Consensus 169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~----~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL----TPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc----ccccccccccccCCCcC
Confidence 99999999999999 899999999999999999999999999998775432211100 00001112234568999
Q ss_pred ccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHH
Q 005226 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKK 672 (707)
Q Consensus 593 y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 672 (707)
|+|||++.. ..++.++|||||||++|||++|..|+.. ......... ....+ . ....
T Consensus 242 y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~~~---~~~~~------~------~~~~ 297 (332)
T 3qd2_B 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVR---NLKFP------L------LFTQ 297 (332)
T ss_dssp GSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHHHH---TTCCC------H------HHHH
T ss_pred ccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHHhh---ccCCC------c------cccc
Confidence 999999765 6789999999999999999998766421 111111111 11110 0 1122
Q ss_pred HHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 673 EVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 673 ~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+.+++.+||+.||++||+++|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3345688999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.95 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=196.1
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|...+ +..||+|.+... .....+.|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence 3489999999999998542 346999998765 33445789999999999999999999999764 56799999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 999999997543 358999999999999999999999 8999999999999999999999999999986643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. .....++..|+|||.+.. ..++.++||||||+++|||+| |+.||..... ......
T Consensus 169 ~~---------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~------~~~~~~ 226 (281)
T 3cc6_A 169 YK---------------ASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLEN------KDVIGV 226 (281)
T ss_dssp -------------------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG------GGHHHH
T ss_pred cc---------------cccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCCh------HHHHHH
Confidence 11 122345788999998654 678899999999999999998 9999964322 223333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+........ . ......+.+++.+||+.||++||++.++++.|+++
T Consensus 227 ~~~~~~~~~--~-------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 227 LEKGDRLPK--P-------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HHHTCCCCC--C-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCC--C-------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 322211111 1 11224578999999999999999999999999886
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.23 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=178.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|... +++.||||++... ....+.+|+.++++++ ||||+++++++.+++..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999975 6899999998653 2356788999999996 99999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... .+++..+..|+.||+.||+|||+ ++|+||||||+||+++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 94 FERIKKKK-----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp HHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 99998653 69999999999999999999999 8999999999999998765 8999999999865422111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .....+...
T Consensus 166 ~----------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~ 226 (325)
T 3kn6_A 166 L----------------KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT--CTSAVEIMK 226 (325)
T ss_dssp -----------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCCHHHHHH
T ss_pred c----------------cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccc--cccHHHHHH
Confidence 1 22356899999999764 6789999999999999999999999976433211 111111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ ..... ......++.+++.+|++.||++|||++++++
T Consensus 227 ~i~~~~~~---~~~~~------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 227 KIKKGDFS---FEGEA------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTTTCCC---CCSHH------HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHcCCCC---CCccc------ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111111 00000 1123456789999999999999999998863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.25 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=194.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 458999999999999864 68999999985421 113477899999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEeccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGLSRLIN 562 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~~~ 562 (707)
++|+|.+++.... .....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 109 ~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~ 184 (351)
T 3c0i_A 109 DGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184 (351)
T ss_dssp SSCBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECC
T ss_pred CCCCHHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEec
Confidence 9999998886432 112358999999999999999999999 89999999999999987654 9999999998765
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
...... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||... ...+
T Consensus 185 ~~~~~~----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~-------~~~~ 240 (351)
T 3c0i_A 185 ESGLVA----------------GGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT-------KERL 240 (351)
T ss_dssp TTSCBC----------------CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS-------HHHH
T ss_pred CCCeee----------------cCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc-------HHHH
Confidence 322110 23457999999999765 66789999999999999999999999642 1122
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+... ... .++.. .......+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~i~~~---~~~----~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 FEGIIKG---KYK----MNPRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHHHT---CCC----CCHHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHcC---CCC----CCccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2211111 100 00000 0112356789999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=344.82 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=201.8
Q ss_pred cceecccCeeEEEEEEeCC-C-----ceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGN-G-----IPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.||+|.... + ..||+|.+.... ....+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 4589999999999999642 2 479999987653 33457799999999999 89999999999999999999999
Q ss_pred eecCCChHHHHhCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 484 FISNGNLANALRGRNG---------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
|+++|+|.+++..... .....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECc
Confidence 9999999999975321 012358999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTT 633 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~ 633 (707)
||+++......... ......+|..|+|||.+.. ..++.++||||||+++|||+| |..||.....
T Consensus 208 fg~~~~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 208 FGLARDIMNDSNYI--------------VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp CGGGCCGGGCTTSE--------------ECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ccccccccccccee--------------ecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99998664322110 0122345788999998664 678899999999999999999 8999865332
Q ss_pred CCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. ..+...+........+ ......+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 273 ~-----~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 273 N-----SKFYKLVKDGYQMAQP---------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp S-----HHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred h-----HHHHHHHhcCCCCCCC---------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1 1222333322221111 112345788999999999999999999999998763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=349.58 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=186.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||++... +++.||||++....... +.+.+|+.++++++||||+++++++.+++..++||||+++|+|.
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHH
Confidence 47999999999999975 78999999997654333 67889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC--eEEecccccccccccCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ--PYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~~~~~~~~~~ 569 (707)
+++.... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++.......
T Consensus 105 ~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~--- 173 (361)
T 3uc3_A 105 ERICNAG-----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 173 (361)
T ss_dssp HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC---
Confidence 9997543 59999999999999999999999 89999999999999987765 99999999874332111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++......+.++|||||||++|||++|+.||....... .+.......
T Consensus 174 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~~~~~~ 234 (361)
T 3uc3_A 174 --------------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-----DYRKTIQRI 234 (361)
T ss_dssp ---------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-----CHHHHHHHH
T ss_pred --------------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-----HHHHHHHHH
Confidence 1234579999999997664444455999999999999999999997543321 122222221
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 235 LSVKYSIPD-----------DIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HTTCCCCCT-----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcCCCCCCC-----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 111111000 0012245679999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.23 Aligned_cols=259 Identities=20% Similarity=0.253 Sum_probs=193.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 47999999999999975 68899999986543 23347788999999999999999999999999999999999975 6
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+.+.+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 158 (292)
T 3o0g_A 87 LKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY- 158 (292)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC-
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc-
Confidence 666665432 359999999999999999999999 899999999999999999999999999998664221111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||+.|+|||++.....++.++|||||||++|||++|+.|+..... ..+....+...
T Consensus 159 ---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-----~~~~~~~i~~~ 218 (292)
T 3o0g_A 159 ---------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRL 218 (292)
T ss_dssp ---------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHH
T ss_pred ---------------cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-----HHHHHHHHHHH
Confidence 2345689999999977655689999999999999999999998653221 11222222221
Q ss_pred ccccCC--Cchhch-----------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP--LSDMVD-----------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~--~~~~~d-----------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ...+.+ ...............+.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111000 000000 000000000123356789999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=350.47 Aligned_cols=205 Identities=24% Similarity=0.304 Sum_probs=172.1
Q ss_pred ceeccc--CeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKS--GLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+| +||.||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 389999 99999999975 78999999987543 33456788999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 111 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 111 GSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp CBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred CCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 99999997653 2359999999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
... ....+....||..|+|||++... ..++.++|||||||++|||++|+.||....
T Consensus 185 ~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 241 (389)
T 3gni_B 185 QRV---------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 241 (389)
T ss_dssp CSC---------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred ccc---------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence 110 00112334678999999997653 568899999999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=341.55 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=196.5
Q ss_pred ceecccCeeEEEEEEe-----CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 484 (707)
+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 106 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence 4799999999999983 468999999987543 23447889999999999999999999999877 567899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 107 LPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp CTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 99999999996543 258999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......+|..|+|||.+.. ..++.++||||||+++|||+||+.|+.... .....
T Consensus 180 ~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~ 238 (302)
T 4e5w_A 180 KEYYT-------------VKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPM-------ALFLK 238 (302)
T ss_dssp CCEEE-------------CCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-------HHHHH
T ss_pred Cccee-------------ccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchh-------hHHhh
Confidence 21100 1123456888999998654 667889999999999999999999864310 00000
Q ss_pred HHHhhccccCCCchhchHHHHhh---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQE---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.. ...........+. ..+... .........+.+++.+||+.||.+|||++++++.|+++-
T Consensus 239 ~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 239 MI-GPTHGQMTVTRLV-NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HH-CSCCGGGHHHHHH-HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cc-CCcccccCHHHHH-HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 0000000000000 000000 001123356889999999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.76 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=196.0
Q ss_pred eecccCeeEEEEEEe---CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 414 VLGKSGLGIVYKVVL---GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.||+|+||+||+|.. .++..||||++.... ....+++.+|++++++++||||+++++++ ..+..++||||+++|
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 346889999987653 23357899999999999999999999999 567789999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 9999998643 58999999999999999999999 899999999999999999999999999998664322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ......++..|+|||.+.. ..++.++||||||+++|||+| |+.||.... ...+...+.
T Consensus 175 ~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~ 234 (291)
T 1xbb_A 175 K-------------AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAMLE 234 (291)
T ss_dssp E-------------C----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHH
T ss_pred c-------------ccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHH
Confidence 0 0122345788999998654 567889999999999999999 999986532 223333333
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....... .......+.+++.+||+.||++||++.+|++.|+++
T Consensus 235 ~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 235 KGERMGC---------------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp TTCCCCC---------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred cCCCCCC---------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2221111 012234578999999999999999999999999886
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.04 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEeC-CCce----EEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIP----VAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... ++.. |++|.+... .....+.+.+|+.++++++||||+++++++..+. .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence 48999999999999964 4444 577777544 3334578999999999999999999999998754 889999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..++.|+.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 100 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp SCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999998653 358999999999999999999999 8999999999999999999999999999987643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....+|..|+|||.+.. ..++.++|||||||++|||++ |+.||..... ..+...
T Consensus 173 ~~~--------------~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~ 231 (327)
T 3lzb_A 173 EYH--------------AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSI 231 (327)
T ss_dssp ---------------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHH
T ss_pred ccc--------------ccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHH
Confidence 111 112345778999998764 678899999999999999999 9999975322 233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+........+ ......+.+++.+||+.||++||++.++++.|+++.
T Consensus 232 ~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 232 LEKGERLPQP---------------PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHTTCCCCCC---------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3332211111 112345788999999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.21 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=193.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 48999999999999975 78999999987542 123467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 92 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~--- 160 (318)
T 1fot_A 92 ELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--- 160 (318)
T ss_dssp BHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB---
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCcc---
Confidence 9999998643 58999999999999999999999 899999999999999999999999999998654211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ......+..
T Consensus 161 ----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~ 217 (318)
T 1fot_A 161 ----------------YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILN 217 (318)
T ss_dssp ----------------CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH
T ss_pred ----------------ccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh
Confidence 12357999999999765 6788999999999999999999999964321 111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
....+.. ....++.+++.+|+..||++|| +++++++
T Consensus 218 ---~~~~~p~-------------~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 218 ---AELRFPP-------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CCCCCCT-------------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCCCCC-------------CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111111 1224577999999999999999 8888764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.09 Aligned_cols=239 Identities=23% Similarity=0.253 Sum_probs=187.9
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|... +++.||||++.... ......+..|+..+.++ +||||++++++|.+++..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 457999999999999976 78999999986542 23335566677777666 9999999999999999999999999 7
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ..++|..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 79999987653 359999999999999999999999 89999999999999999999999999998765432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++.+ .++.++|||||||++|||++|..|+... .....+.
T Consensus 214 -----------------~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~---------~~~~~~~ 265 (311)
T 3p1a_A 214 -----------------EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG---------EGWQQLR 265 (311)
T ss_dssp ------------------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH---------HHHHHHT
T ss_pred -----------------cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc---------cHHHHHh
Confidence 22347999999998653 6889999999999999999997765421 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. . ...+.+ .......+.+++.+||+.||++|||++++++
T Consensus 266 ~----~-----~~~~~~-----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 266 Q----G-----YLPPEF-----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp T----T-----CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred c----c-----CCCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1 0 011111 1123356889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.00 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=191.4
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc-----ceE
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE-----KLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~l 480 (707)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+. .++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 458999999999999853 3458999998754 33345779999999999999999999999987653 499
Q ss_pred EEEeecCCChHHHHhCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 481 ISDFISNGNLANALRGRNG-QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
||||+++|+|.+++..... .....+++..++.|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcce
Confidence 9999999999999954321 123469999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
......... ......+++.|+|||.+.. ..++.++||||||+++|||++ |+.||.....
T Consensus 196 ~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 255 (313)
T 3brb_A 196 KIYSGDYYR--------------QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN----- 255 (313)
T ss_dssp -----------------------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred ecccccccC--------------cccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----
Confidence 664322111 1123345788999999654 678899999999999999999 8888865322
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..+...+........+ ......+.+++.+||+.||.+||++.++++.|+++.
T Consensus 256 -~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 256 -HEMYDYLLHGHRLKQP---------------EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -GGHHHHHHTTCCCCCB---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCC---------------ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2333333322211111 122345789999999999999999999999998863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.53 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=197.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 347999999999999975 6889999998776555557889999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC--CCCeEEecccccccccccCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN--DFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~ 568 (707)
.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 136 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 136 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 99997543 358999999999999999999999 89999999999999974 47899999999987642211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .......+..
T Consensus 207 ---------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~i~~ 264 (387)
T 1kob_A 207 ---------------VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKR 264 (387)
T ss_dssp ---------------EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHH
T ss_pred ---------------eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCC------HHHHHHHHHh
Confidence 023457999999999765 678899999999999999999999996532 1122222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....... . .......++.+++.+||+.||++|||+.++++
T Consensus 265 ~~~~~~~--~----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 265 CDWEFDE--D----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCCCCCS--S----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCc--c----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 1110000 0 00112345789999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=346.71 Aligned_cols=236 Identities=22% Similarity=0.290 Sum_probs=188.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|+.. +++.||||+++... ......+.+|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 48999999999999965 68999999987542 23346688999999998 799999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 109 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 109 GDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 99999997643 59999999999999999999999 89999999999999999999999999999753321111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+.
T Consensus 181 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~ 237 (353)
T 3txo_A 181 ----------------TATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAIL 237 (353)
T ss_dssp ---------------------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred ----------------ccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHH
Confidence 123457999999998654 6678999999999999999999999965321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
. ....+. ......+.+++.+|++.||++||++
T Consensus 238 ~---~~~~~p-------------~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 238 N---DEVVYP-------------TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp H---CCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred c---CCCCCC-------------CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 1 111111 1122456789999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.36 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=197.7
Q ss_pred ceecccCeeEEEEEEeC-----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 484 (707)
+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++||||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence 47999999999998642 68899999998653 34457799999999999999999999999875 456899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 117 ~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 117 VPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred ccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 9999999999764 38999999999999999999999 89999999999999999999999999999876532
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... .......+|..|+|||++.. ..++.++||||||+++|||+||+.||..... ....
T Consensus 188 ~~~~-------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~-------~~~~ 246 (318)
T 3lxp_A 188 HEYY-------------RVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPT-------KFLE 246 (318)
T ss_dssp CSEE-------------EC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH-------HHHH
T ss_pred cccc-------------ccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccch-------hhhh
Confidence 2100 01123346888999998654 5678899999999999999999999864211 0000
Q ss_pred HHHhhccccCCCchhchHHHHh---hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQ---EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+.... ........ +...+.. ..........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 247 ~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 247 LIGIA-QGQMTVLR-LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHCSC-CHHHHHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccc-ccchhHHH-HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 00000 00000000 0000000 0001223356889999999999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.40 Aligned_cols=263 Identities=26% Similarity=0.383 Sum_probs=200.8
Q ss_pred cceecccCeeEEEEEEe-----CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|.+ .++..||||++........+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 34899999999999984 4688999999988766666789999999999999999999999874 4557899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999997643 258999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......+|..|+|||++.. ..++.++||||||+++|||++|+.||..... .
T Consensus 181 ~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----------~ 236 (327)
T 3lxl_A 181 KDYYV-------------VREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSA----------E 236 (327)
T ss_dssp CSEEE-------------CSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----------H
T ss_pred Cccce-------------eeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccc----------h
Confidence 21100 1123456888999998654 6678999999999999999999999864211 0
Q ss_pred HHHhhccc-cCCCchhchHHHHhh---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKGFEE-ENPLSDMVDAMLLQE---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~~~~-~~~~~~~~d~~l~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
........ .......+...+... .........+.+++.+||+.||++|||++++++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 301 (327)
T 3lxl_A 237 FLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301 (327)
T ss_dssp HHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred hhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00000000 000000000000000 01122345688999999999999999999999999886
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.34 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=198.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHh--cCCCceeeeEEEEEcCC----cceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAK--VKHPNIVKLRAYYWAPD----EKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e~~ 485 (707)
.+.||+|+||.||+|.. +++.||||++.... ...+.+|++++.. ++||||+++++++...+ ..++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 45899999999999998 68899999986532 3567889999887 79999999999998876 789999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH--------ECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
++|+|.+++... .+++..++.++.|++.||+||| + .+|+||||||+||+++.++.+||+|||+
T Consensus 123 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 123 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999754 4899999999999999999999 6 7999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCC-----CCchhhHHHHHHHHHHHHhC--------
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNR-----PMQKWDVYSFGVVLLELLTG-------- 624 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DV~S~Gv~l~elltg-------- 624 (707)
++.......... .......||+.|+|||++..... ++.++||||||+++|||+||
T Consensus 194 ~~~~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 194 AVRHDSATDTID------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp CEEEETTTTEEE------------ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred ceeccccccccc------------cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 987653221100 01123457999999999765322 23689999999999999999
Q ss_pred --CCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 625 --KSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 625 --~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
+.||....... .....+.......... .. +. ......+....+.+++.+||+.||++|||+++|++.|
T Consensus 262 ~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~-~~-~~----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 262 DYQLPYYDLVPSD----PSVEEMRKVVCEQKLR-PN-IP----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCCTTTTTSCSS----CCHHHHHHHHTTSCCC-CC-CC----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred ccccCccccCcCc----ccHHHHHHHHHHHHhC-CC-Cc----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67776543221 1112222211111100 00 01 0111234556789999999999999999999999999
Q ss_pred Hhhc
Q 005226 703 ERIG 706 (707)
Q Consensus 703 ~~i~ 706 (707)
+++.
T Consensus 332 ~~i~ 335 (342)
T 1b6c_B 332 SQLS 335 (342)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.39 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=190.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|... +++.||+|+++.... ...+.+.+|++++++++||||+++++++..++..++||||++ |+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L 89 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL 89 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence 37999999999999964 689999999865432 234678899999999999999999999999999999999998 699
Q ss_pred HHHHhCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 491 ANALRGRN-GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 491 ~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
.+++.... +.....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~- 165 (317)
T 2pmi_A 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF- 165 (317)
T ss_dssp HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC-
T ss_pred HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC-
Confidence 99986532 1223458999999999999999999999 899999999999999999999999999998764221111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||+.|+|||++.....++.++|||||||++|||++|+.||..... ......+...
T Consensus 166 ---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~ 224 (317)
T 2pmi_A 166 ---------------SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND------EEQLKLIFDI 224 (317)
T ss_dssp ---------------CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHH
T ss_pred ---------------CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHH
Confidence 2235689999999976656789999999999999999999999975321 1122222111
Q ss_pred ccccC-CC------------------chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEEN-PL------------------SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~-~~------------------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... .. ...+...+. ..........+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ-PHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG-GGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhc-ccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 11000 00 000011110 0001122356889999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=338.19 Aligned_cols=241 Identities=24% Similarity=0.283 Sum_probs=184.6
Q ss_pred ceecccCeeEEEEEEe----CCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 4899999999999997 478999999987652 22345678899999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 103 LSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred CCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 99999999997543 58999999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .....
T Consensus 175 ~~~~----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~ 231 (327)
T 3a62_A 175 GTVT----------------HTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTID 231 (327)
T ss_dssp --------------------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHH
T ss_pred Cccc----------------cccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence 1110 22357999999999765 6778999999999999999999999964321 12222
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.+... ...+. ......+.+++.+||+.||++|| ++.++++
T Consensus 232 ~i~~~---~~~~p-------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 232 KILKC---KLNLP-------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHT---CCCCC-------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHhC---CCCCC-------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 22111 11111 11224577999999999999999 6667654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=344.66 Aligned_cols=263 Identities=18% Similarity=0.239 Sum_probs=193.5
Q ss_pred ceecccCeeEEEEEEeC----CCceEEEEEcCCCchh-----------hHHHHHHHHHHHHhcCCCceeeeEEEEEc---
Q 005226 413 YVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGGEQ-----------RHREFVTEVQAIAKVKHPNIVKLRAYYWA--- 474 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~--- 474 (707)
+.||+|+||.||+|... ++..+|||+....... ....+.+|+..++.++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 48999999999999975 5788999998765321 11346788999999999999999999988
Q ss_pred -CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC--CeE
Q 005226 475 -PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF--QPY 551 (707)
Q Consensus 475 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~--~~k 551 (707)
....++||||+ +++|.+++.... .+++..++.|+.||+.||+|||+ .+|+||||||+||+++.++ .+|
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEE
T ss_pred CCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEE
Confidence 67789999999 999999998643 69999999999999999999999 8999999999999999887 999
Q ss_pred EecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 552 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
|+|||+++.+.......... ........||..|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQ---------ENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCC---------CCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred EEeCCCceecccccccccch---------hccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999998775432211100 001123467999999999665 67899999999999999999999999642
Q ss_pred CCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 632 TTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... .............. +...+............+.+++.+||+.||++||++++|++.|+.+
T Consensus 264 ~~~-----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 264 LKD-----PVAVQTAKTNLLDE------LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp TTC-----HHHHHHHHHHHHHT------TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred ccc-----cHHHHHHHHhhccc------ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 211 11111111111111 1111111000012345788999999999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=347.90 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=186.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc----CCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA----PDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~e~~~ 486 (707)
++||+|+||+||++... +++.||||++... ..+.+|++++.++ +||||+++++++.. .+..++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 47999999999999965 6889999998643 4567899987555 89999999999875 456799999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEecccccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINI 563 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~ 563 (707)
+|+|.+++.... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 999999998653 2369999999999999999999999 89999999999999998 78999999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||......... ....
T Consensus 217 ~~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~ 276 (400)
T 1nxk_A 217 HNSL-----------------TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMK 276 (400)
T ss_dssp ---------------------------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHH
T ss_pred CCcc-----------------ccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHH
Confidence 2110 23456999999999754 77899999999999999999999999764432111 1122
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+........ .+ .......++.+++.+||+.||++|||+.++++
T Consensus 277 ~~i~~~~~~~~------~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 277 TRIRMGQYEFP------NP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp HHHHHTCCCCC------TT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHcCcccCC------Cc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22221110000 00 00122345789999999999999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=341.91 Aligned_cols=239 Identities=19% Similarity=0.253 Sum_probs=194.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 348999999999999975 68999999986542 22346788999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-- 195 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc--
Confidence 99999998643 58999999999999999999999 899999999999999999999999999998654211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+.+.+.
T Consensus 196 -----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~ 251 (350)
T 1rdq_E 196 -----------------WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIV 251 (350)
T ss_dssp -----------------CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH
T ss_pred -----------------ccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHH
Confidence 23457999999999765 678899999999999999999999996432 112222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
.. ...+. ......+.+++.+||+.||++||+ +++|++
T Consensus 252 ~~---~~~~p-------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 252 SG---KVRFP-------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HC---CCCCC-------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cC---CCCCC-------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 11111 112345789999999999999998 777754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.55 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=200.9
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCC-cceEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPD-EKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 482 (707)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++++ +||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 45899999999999984 356889999997653 33456899999999999 7999999999998765 489999
Q ss_pred EeecCCChHHHHhCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 483 DFISNGNLANALRGRNGQP-----------STSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
||+++|+|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEE
Confidence 9999999999998754210 1238999999999999999999999 8999999999999999999999
Q ss_pred EecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 005226 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELS 630 (707)
Q Consensus 552 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~ 630 (707)
|+|||+++........ .......+|+.|+|||++.. ..++.++||||||+++|||+| |+.||..
T Consensus 189 l~Dfg~~~~~~~~~~~--------------~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 189 ICDFGLARDIYKDPDY--------------VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp ECCCGGGSCTTTCTTS--------------EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECCCccccccccCccc--------------eeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999865422110 01123456889999998654 678899999999999999998 9999865
Q ss_pred CCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... ..+...+........+ ......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 254 ~~~~-----~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKID-----EEFCRRLKEGTRMRAP---------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCS-----HHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh-----HHHHHHhccCccCCCC---------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3321 1222222222111110 11224578899999999999999999999999886
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.93 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=193.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... +++.||+|+++... ......+..|.+++.++ +||||+++++++.+.+..++||||+++
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 48999999999999975 68999999987542 22346678899999987 999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 103 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 103 GDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 99999997643 58999999999999999999999 89999999999999999999999999999754321111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+...+.
T Consensus 175 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~ 231 (345)
T 1xjd_A 175 ----------------TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD------EEELFHSIR 231 (345)
T ss_dssp ----------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH
T ss_pred ----------------ccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHH
Confidence 123457999999999765 678999999999999999999999996432 112222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH-HHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK-NVS 699 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~v~ 699 (707)
.. ...+.. .....+.+++.+|+..||++||++. +|.
T Consensus 232 ~~---~~~~p~-------------~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 MD---NPFYPR-------------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HC---CCCCCT-------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred hC---CCCCCc-------------ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11 111111 1224577999999999999999997 554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=344.22 Aligned_cols=241 Identities=23% Similarity=0.388 Sum_probs=191.9
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||+.
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~- 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence 34799999999999996 578999999986542 2334678999999999999999999999999999999999997
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 138 g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 138 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 68888886432 358999999999999999999999 89999999999999999999999999999765421
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
....||+.|+|||++. ....++.++|||||||++|||++|+.||..... ......
T Consensus 208 -----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~ 264 (348)
T 1u5q_A 208 -----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYH 264 (348)
T ss_dssp -----------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH
T ss_pred -----------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHH
Confidence 1234689999999864 246788999999999999999999999864321 111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+. ....+ ... .......+.+++.+||+.||++|||++++++
T Consensus 265 ~~---~~~~~--~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 265 IA---QNESP--ALQ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HH---HSCCC--CCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HH---hcCCC--CCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11 11111 000 0112245678999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=341.68 Aligned_cols=243 Identities=25% Similarity=0.330 Sum_probs=180.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|... +++.||||++.... ..+.+.+|++++++++||||+++++++.+++..++||||+++|+|.
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 47999999999999976 57889999987643 2366889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEecccccccccccCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++........
T Consensus 137 ~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 207 (349)
T 2w4o_A 137 DRIVEKG-----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM- 207 (349)
T ss_dssp HHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc-
Confidence 9997643 58999999999999999999999 89999999999999975 889999999999865422110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ......+..
T Consensus 208 ----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~ 265 (349)
T 2w4o_A 208 ----------------KTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILN 265 (349)
T ss_dssp ---------------------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHT
T ss_pred ----------------ccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHh
Confidence 22456999999999765 67899999999999999999999999643221 111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ... ...+ ........+.+++.+|++.||++|||+.++++
T Consensus 266 ~---~~~---~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 266 C---EYY---FISP------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp T---CCC---CCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C---CCc---cCCc------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 100 0000 00122346789999999999999999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.70 Aligned_cols=244 Identities=21% Similarity=0.270 Sum_probs=195.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 347999999999999975 5778999998776555567899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... .+++..+..|+.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++.........
T Consensus 94 ~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 94 FERVVHKR-----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp HHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 99997643 58999999999999999999999 899999999999999 78899999999999865422211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++.. .++.++||||||+++|||++|+.||..... ......+.
T Consensus 166 -----------------~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~ 220 (277)
T 3f3z_A 166 -----------------RTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIR 220 (277)
T ss_dssp -----------------CCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred -----------------hccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH
Confidence 22346899999998653 488999999999999999999999965321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ... ...... ......+.+++.+|++.||++||++.++++
T Consensus 221 ~~---~~~---~~~~~~------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 221 EG---TFT---FPEKDW------LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HC---CCC---CCHHHH------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hC---CCC---CCchhh------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 100 000000 112356789999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=348.22 Aligned_cols=246 Identities=16% Similarity=0.213 Sum_probs=193.1
Q ss_pred ceecccCeeEEEEEE------eCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC---CCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVV------LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK---HPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e 483 (707)
+.||+|+||+||+|. ..+++.||||+++.... .++.+|++++++++ |+||+++++++..++..++|||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 489999999999994 45789999999976543 56778888888886 9999999999999999999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-----------CCCeEE
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-----------DFQPYI 552 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-----------~~~~kl 552 (707)
|+++|+|.++++.........++|..++.|+.||+.||+|||+ .+||||||||+|||++. ++.+||
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl 224 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEEE
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEEE
Confidence 9999999999975332233469999999999999999999999 89999999999999998 899999
Q ss_pred ecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 553 SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 553 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
+|||+|+.+........ .....||..|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 225 ~DFG~a~~~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 225 IDLGQSIDMKLFPKGTI--------------FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp CCCTTCEEGGGSCTTEE--------------ECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred eeCchhhhhhccCCCce--------------eeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 99999976542211110 123457999999999765 668999999999999999999999985432
Q ss_pred CCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCC-CChHHHHHHHHhh
Q 005226 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR-PRMKNVSENLERI 705 (707)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~~v~~~L~~i 705 (707)
... ......+... .....+.+++..|++.+|.+| |+++++.+.|+++
T Consensus 290 ~~~--------------~~~~~~~~~~------------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 290 GGE--------------CKPEGLFRRL------------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp TTE--------------EEECSCCTTC------------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred CCc--------------eeechhcccc------------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 210 0000000000 112345678889999999988 6788888877764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=354.18 Aligned_cols=241 Identities=27% Similarity=0.362 Sum_probs=196.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 47999999999999975 789999999865422 23467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~- 172 (476)
T 2y94_A 102 ELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL- 172 (476)
T ss_dssp EHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB-
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccccc-
Confidence 9999997543 59999999999999999999999 89999999999999999999999999999876432111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++......+.++|||||||++|||++|+.||..... ..+...+..
T Consensus 173 ----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~ 230 (476)
T 2y94_A 173 ----------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICD 230 (476)
T ss_dssp ----------------CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHT
T ss_pred ----------------cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc
Confidence 2235799999999977644557899999999999999999999975321 222222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... .. .....+.+++.+||+.||++|||++++++
T Consensus 231 ~~~~~---p~-------------~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 231 GIFYT---PQ-------------YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TCCCC---CT-------------TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcCC---Cc-------------cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11110 11 11235678999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=331.27 Aligned_cols=241 Identities=22% Similarity=0.360 Sum_probs=190.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----CCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA----PDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 485 (707)
..||+|+||+||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 37999999999999864 6788999998654 33445789999999999999999999999875 34578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEc-CCCCeEEeccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLD-NDFQPYISDFGLSRLIN 562 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~ 562 (707)
++|+|.+++.... .+++..+..|+.||+.||+|||+ .+ |+||||||+||+++ .++.+||+|||++....
T Consensus 112 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred CCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999997643 58999999999999999999999 67 99999999999998 78999999999996543
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
... .....||+.|+|||++. ..++.++||||||+++|||++|+.||..... ....
T Consensus 184 ~~~------------------~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~ 238 (290)
T 1t4h_A 184 ASF------------------AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQI 238 (290)
T ss_dssp TTS------------------BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHH
T ss_pred ccc------------------cccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHH
Confidence 111 12345789999999865 4588999999999999999999999964321 1122
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+....... .. .......+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~-----~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 239 YRRVTSGVKPA-----SF---------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHTTTCCCG-----GG---------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhccCCcc-----cc---------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 22222111100 00 1111245789999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=340.68 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=201.0
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... ++..||||.+.... ......|.+|++++++++||||+++++++.+++..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 358999999999999864 36889999997653 33446799999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 485 ISNGNLANALRGRNG-----QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+++|+|.+++..... .....+++..+++++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCcccc
Confidence 999999999975320 112357999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~ 638 (707)
......... ......+|+.|+|||++.. ..++.++||||||+++|||+| |+.||....
T Consensus 187 ~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~------ 245 (322)
T 1p4o_A 187 DIYETDYYR--------------KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------ 245 (322)
T ss_dssp GGGGGGCEE--------------GGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------
T ss_pred ccccccccc--------------cccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCC------
Confidence 654322110 0122345788999998654 668899999999999999999 888886432
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.......+........ .......+.+++.+||+.||.+||++.++++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 246 NEQVLRFVMEGGLLDK---------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHHHHTTCCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHHHcCCcCCC---------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 1222222222111110 012234578999999999999999999999999876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=329.48 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=197.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++|+
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 347999999999999975 78999999986542 2344788999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...........
T Consensus 92 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999997542 58999999999999999999999 8999999999999999999999999999986542211000
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....|+..|+|||.+......+.++||||||+++|||++|+.||...... ...+..|....
T Consensus 164 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~ 225 (276)
T 2yex_A 164 --------------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKK 225 (276)
T ss_dssp --------------BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT----SHHHHHHHTTC
T ss_pred --------------ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH----HHHHHHhhhcc
Confidence 022456899999999766444578999999999999999999999764322 12222332211
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... . .......+.+++.+||+.||++|||+.++++
T Consensus 226 ~~~~-~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 TYLN-P--------------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTST-T--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccC-c--------------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1000 0 0112345678999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.91 Aligned_cols=262 Identities=24% Similarity=0.416 Sum_probs=200.1
Q ss_pred cceecccCeeEEEEEEe-----CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--cceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--EKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~ 484 (707)
.+.||+|+||.||++.. .+++.||||++........+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 34899999999999984 468899999998776666688999999999999999999999987654 67999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 126 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 126 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999998653 258999999999999999999999 89999999999999999999999999999876532
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......++..|+|||.+.. ..++.++||||||+++|||+||+.|+.... ..+.+
T Consensus 199 ~~~~~-------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~-------~~~~~ 257 (326)
T 2w1i_A 199 KEYYK-------------VKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPP-------AEFMR 257 (326)
T ss_dssp CSEEE-------------CSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-------HHHHH
T ss_pred ccccc-------------cccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-------HHHHH
Confidence 21100 0122345778999998654 567899999999999999999999875321 00111
Q ss_pred HHHhhccccCCCchhchHH----HHhh---hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 645 WVKKGFEEENPLSDMVDAM----LLQE---VHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~----l~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.. ..... .+..... +... ........++.+++.+||+.||++||++.+|++.|++++
T Consensus 258 ~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 258 MI----GNDKQ-GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HH----CTTCC-THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hh----ccccc-hhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 00000 0000000 0000 001123356889999999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=343.36 Aligned_cols=245 Identities=21% Similarity=0.286 Sum_probs=187.7
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCC--CceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKH--PNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++...++..||||++... .....+.+.+|++++++++| |||+++++++.+++..++||| +.+|
T Consensus 15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 93 (343)
T 3dbq_A 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 93 (343)
T ss_dssp EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCC
Confidence 489999999999999988999999998654 33345789999999999976 999999999999999999999 5688
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.........
T Consensus 94 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 94 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 9999998653 58999999999999999999999 8999999999999997 5789999999998664322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
......||+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 165 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---- 226 (343)
T 3dbq_A 165 --------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 226 (343)
T ss_dssp -------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred --------------cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----
Confidence 0123457999999998642 256789999999999999999999999643211
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+...+........ .. .....+.+++.+||+.||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~--~~-------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 227 ISKLHAIIDPNHEIEF--PD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHHCTTSCCCC--CC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhcCCcccCC--cc-------------cCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 1111111111111000 01 11235679999999999999999999975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.64 Aligned_cols=249 Identities=19% Similarity=0.208 Sum_probs=194.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.++||+|+||+||+|... +++.||+|++++... .....+.+|+.++..++||||++++++|.+++..++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 358999999999999976 578899999875321 2224588999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ..+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+........
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999998642 359999999999999999999999 89999999999999999999999999999765432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
. .....||+.|+|||++. ....++.++|||||||++|||++|+.||..... .+..
T Consensus 232 ~---------------~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~~ 290 (437)
T 4aw2_A 232 Q---------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETY 290 (437)
T ss_dssp E---------------CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHH
T ss_pred c---------------cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHHH
Confidence 1 12346799999999975 235688999999999999999999999975321 1222
Q ss_pred HHHHhhc-cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC--CCChHHHHH
Q 005226 644 RWVKKGF-EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV--RPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~v~~ 700 (707)
..+.... ....+ .. .......+.+++.+|+..+|++ ||+++|+++
T Consensus 291 ~~i~~~~~~~~~p--~~----------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 291 GKIMNHKERFQFP--TQ----------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHHTHHHHCCCC--SS----------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HhhhhccccccCC--cc----------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111100 00000 00 0112345678999999888888 999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.65 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=192.0
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-CcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-DEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||++.. +|..||||.++... ..+.|.+|++++++++||||+++++++.+. +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 34899999999999988 58899999997643 346789999999999999999999997655 478999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----- 171 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 171 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-----
Confidence 99997542 1238899999999999999999999 899999999999999999999999999987544211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||.+.. ..++.++||||||+++|||+| |+.||..... .+....+...
T Consensus 172 --------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~ 230 (278)
T 1byg_A 172 --------------DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEKG 230 (278)
T ss_dssp ------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGHHHHHTTT
T ss_pred --------------cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhcC
Confidence 12234788999998654 677899999999999999998 9999865321 2233333222
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
..... .......+.+++.+||+.||++||++.++++.|++++
T Consensus 231 ~~~~~---------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 231 YKMDA---------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCCC---------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCC---------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 11111 0122345789999999999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=347.51 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=188.6
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcC--CCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVK--HPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++||| +.+|
T Consensus 62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 489999999999999888999999998654 3344578999999999996 5999999999999999999999 5688
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.........
T Consensus 141 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 141 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 9999998653 58999999999999999999999 8999999999999995 5899999999998764321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
......||+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 212 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---- 273 (390)
T 2zmd_A 212 --------------VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 273 (390)
T ss_dssp ----------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----
T ss_pred --------------cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----
Confidence 0123457999999998643 136889999999999999999999999643211
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+...+....... +.. .....+.+++.+||+.||++||++.|+++
T Consensus 274 ~~~~~~~~~~~~~~~--~~~-------------~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 274 ISKLHAIIDPNHEIE--FPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHHHHCTTSCCC--CCC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCccccCC--CCc-------------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111111000 001 11245779999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.65 Aligned_cols=248 Identities=22% Similarity=0.299 Sum_probs=186.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcc----eEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK----LLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV~e~ 484 (707)
+.||+|+||.||+|.. .+++.||||++.... ......|.+|++++++++||||+++++++...... ++||||
T Consensus 18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~ 97 (311)
T 3ork_A 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97 (311)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence 4899999999999996 578999999987652 23346789999999999999999999999876554 999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.++++... .+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 98 VDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp CCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 99999999997543 58999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......||+.|+|||++.. ..++.++||||||+++|||+||+.||..... .+
T Consensus 170 ~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---------~~ 226 (311)
T 3ork_A 170 GNSVT-------------QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---------VS 226 (311)
T ss_dssp -------------------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---------HH
T ss_pred ccccc-------------cccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---------HH
Confidence 21111 1123457999999999765 6788999999999999999999999964321 11
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........... .+.. ........+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~-----~~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 227 VAYQHVREDPI-----PPSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HHHHHHHCCCC-----CHHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred HHHHHhcCCCC-----Cccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11111111110 0000 01123356789999999999999997666553
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.78 Aligned_cols=264 Identities=26% Similarity=0.338 Sum_probs=197.3
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----CCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA----PDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||++.. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (317)
T 2buj_A 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114 (317)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence 4899999999999996 5789999999876666666889999999999999999999999973 3467899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++..... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 115 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 115 GTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp CBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 999999975321 12469999999999999999999999 89999999999999999999999999998764321100
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN--RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ...........||+.|+|||++.... .++.++||||||+++|||++|+.||...... .......
T Consensus 191 ~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~ 259 (317)
T 2buj_A 191 SRQ-------ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK----GDSVALA 259 (317)
T ss_dssp HHH-------HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT----TSCHHHH
T ss_pred ccc-------cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc----cchhhHH
Confidence 000 00000001234688999999876422 3688999999999999999999998531110 0011111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........ ........+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 260 ~~~~~~~~---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 260 VQNQLSIP---------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHCC--CC---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred hhccCCCC---------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11111000 00122346789999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.06 Aligned_cols=256 Identities=21% Similarity=0.345 Sum_probs=191.7
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|.. .+|..||||++... .......+.+|++++++++||||+++++++..++..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 34799999999999996 47899999998753 234457789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .....+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 117 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 192 (310)
T 2wqm_A 117 GDLSRMIKHFK-KQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192 (310)
T ss_dssp CBHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred CCHHHHHHHhc-ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence 99999996421 112358999999999999999999999 89999999999999999999999999998765422111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ....|+..|+|||.+.. ..++.++||||||+++|||++|+.||..... ....+...+.
T Consensus 193 ~----------------~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~ 251 (310)
T 2wqm_A 193 A----------------HSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE 251 (310)
T ss_dssp ----------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHH
T ss_pred c----------------cccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhh
Confidence 0 12356889999998665 6788999999999999999999999864321 1112222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........ .......+.+++.+||+.||++||++.+|++.|++++
T Consensus 252 ~~~~~~~~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 252 QCDYPPLP--------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp TTCSCCCC--------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCCCCc--------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11110000 0112345789999999999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.08 Aligned_cols=259 Identities=17% Similarity=0.232 Sum_probs=198.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEE-EcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY-WAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++...... .++.+|++++++++|++++..+.++ ...+..++||||+ +|+|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence 4799999999999996 58899999998654332 4688999999999988877666666 5566779999999 9999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+||++ +.++.+||+|||+++........
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 99997543 259999999999999999999999 899999999999999 58899999999999876543221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ..++.......||..|+|||.+.. ..++.++|||||||++|||++|+.||......... .....+.
T Consensus 165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~ 231 (296)
T 3uzp_A 165 Q---------HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR---QKYERIS 231 (296)
T ss_dssp C---------BCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS---SHHHHHH
T ss_pred c---------ccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh---hhhhhhc
Confidence 1 111222345578999999999765 66899999999999999999999999764432111 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
...... + .+. ........+.+++.+||+.||++||++++|++.|+++
T Consensus 232 ~~~~~~-~-----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 232 EKKMST-P-----IEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHHS-C-----HHH-----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccccCC-c-----hHH-----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 100000 0 000 0012235688999999999999999999999999886
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.01 Aligned_cols=254 Identities=22% Similarity=0.321 Sum_probs=193.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 47999999999999975 589999998865532 234678899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 159 (311)
T 4agu_A 89 LHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY- 159 (311)
T ss_dssp HHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc-
Confidence 999987543 58999999999999999999999 899999999999999999999999999998765222111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||..|+|||++.....++.++||||||+++|||++|+.||...... +....+...
T Consensus 160 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~ 218 (311)
T 4agu_A 160 ---------------DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV------DQLYLIRKT 218 (311)
T ss_dssp ---------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHH
T ss_pred ---------------CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHH
Confidence 22356889999999766567899999999999999999999999653221 111111111
Q ss_pred ccccC----------------CC---chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEEN----------------PL---SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~----------------~~---~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... .. ........ ........+.+++.+||+.||++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL----KFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHH----HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccccccccCcCCCccccchhhh----hcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11000 00 00000000 00123355789999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.79 Aligned_cols=259 Identities=19% Similarity=0.255 Sum_probs=197.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEE-EcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY-WAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++...... ..+.+|++++++++|++++..++++ ..++..++||||+ +|+|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 4899999999999996 57899999986544322 4578899999999988877776666 5566779999999 9999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||+++........
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 99998543 259999999999999999999999 899999999999999 78899999999999876543221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ..++.......||+.|+|||.+.. ..++.++|||||||++|||++|+.||.......... .+.....
T Consensus 165 ~---------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~ 232 (296)
T 4hgt_A 165 Q---------HIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--KYERISE 232 (296)
T ss_dssp C---------BCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--HHHHHHH
T ss_pred c---------cCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh--hhhhhhc
Confidence 1 111223345678999999999765 678999999999999999999999997644331111 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... + . ..........+.+++.+||+.||++||++++|++.|+++
T Consensus 233 ~~~~~--~-----~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 233 KKMST--P-----I-----EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHHHS--C-----H-----HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccccc--h-----h-----hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 10000 0 0 000011235688999999999999999999999999886
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=351.21 Aligned_cols=246 Identities=20% Similarity=0.217 Sum_probs=193.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +++.||+|++++... .....+.+|+.+++.++||||+++++++.+++..|+||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 358999999999999975 688999999865321 2234588999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.++++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 224 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence 9999999754 48999999999999999999999 89999999999999999999999999999865432110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN---RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
. .....||+.|+|||++.... .++.++|||||||++|||++|+.||..... .....
T Consensus 225 ~---------------~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~ 283 (410)
T 3v8s_A 225 R---------------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYS 283 (410)
T ss_dssp E---------------CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHH
T ss_pred c---------------ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHH
Confidence 0 12346799999999976422 267899999999999999999999975321 12222
Q ss_pred HHHhhc-cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCC--CCChHHHHH
Q 005226 645 WVKKGF-EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEV--RPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~~v~~ 700 (707)
.+.... ....+ ........+.+++.+|+..+|.+ ||+++||++
T Consensus 284 ~i~~~~~~~~~p-------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 KIMNHKNSLTFP-------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHTHHHHCCCC-------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHhccccccCC-------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111110 00000 00112345789999999999988 999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.26 Aligned_cols=259 Identities=21% Similarity=0.263 Sum_probs=191.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
++||+|+||.||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++.+++..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 4799999999999995 47899999999766555557889999999995 899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+++........
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99997643 58999999999999999999999 89999999999999998776 999999999765422211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc-cc---
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI-EV--- 639 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~-~~--- 639 (707)
.... ........||+.|+|||++.. ...++.++|||||||++|||++|+.||......... ..
T Consensus 171 ~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 171 SPIS---------TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp --------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccc---------ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 1000 000123457999999998642 134678999999999999999999999765432100 00
Q ss_pred -----hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 640 -----PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 640 -----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.+.+.. .... ..+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~i~~---~~~~---~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 242 CPACQNMLFESIQE---GKYE---FPDKD------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CHHHHHHHHHHHHH---CCCC---CCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHHHHHHhc---cCcc---cCchh------cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 001111111 0000 00000 0112356789999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.14 Aligned_cols=245 Identities=24% Similarity=0.292 Sum_probs=196.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchh------hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ------RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +|..||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 458999999999999975 6899999998654221 246799999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~ 560 (707)
+++|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.
T Consensus 97 ~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 97 VSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp CCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999998643 58999999999999999999999 8999999999999999888 799999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .
T Consensus 169 ~~~~~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~ 224 (321)
T 2a2a_A 169 IEDGVEF-----------------KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK------Q 224 (321)
T ss_dssp CCTTCCC-----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------H
T ss_pred cCccccc-----------------cccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCH------H
Confidence 6532111 22346899999998654 6788999999999999999999999964321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+... ... .++... ......+.+++.+|++.||++|||+.++++
T Consensus 225 ~~~~~i~~~---~~~----~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 225 ETLANITSV---SYD----FDEEFF-----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHHTT---CCC----CCHHHH-----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhc---ccc----cChhhh-----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222211111 100 111110 112345789999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=341.47 Aligned_cols=191 Identities=26% Similarity=0.273 Sum_probs=165.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-----CCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-----HPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||+||+|.. .+++.||||++..... ..+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK-YTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCHH-HHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccchh-hhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 4799999999999997 4788999999975433 3367788999999996 999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC--------------------
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-------------------- 546 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-------------------- 546 (707)
+++|.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 999999998654 2358999999999999999999999 89999999999999975
Q ss_pred -----CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHH
Q 005226 547 -----DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621 (707)
Q Consensus 547 -----~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~el 621 (707)
++.+||+|||+|+...... ....||+.|+|||++.. ..++.++|||||||++|||
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~-------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYH-------------------GSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-------------------CSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHH
T ss_pred ccccCCCCEEEEeccCceecCCCC-------------------cCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHH
Confidence 7899999999997643211 12356899999999765 6789999999999999999
Q ss_pred HhCCCCCCCC
Q 005226 622 LTGKSPELSP 631 (707)
Q Consensus 622 ltg~~P~~~~ 631 (707)
++|+.||...
T Consensus 253 l~g~~pf~~~ 262 (360)
T 3llt_A 253 YTGSLLFRTH 262 (360)
T ss_dssp HHSSCSCCCS
T ss_pred HHCCCCCCCC
Confidence 9999999753
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=340.84 Aligned_cols=277 Identities=17% Similarity=0.227 Sum_probs=204.6
Q ss_pred CCcceEeecCCcccchHHHHHhccceecccCeeEEEEEEeCC---------CceEEEEEcCCCchhhHHHHHHHHHHHHh
Q 005226 389 GEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVLGN---------GIPVAVRRLGEGGEQRHREFVTEVQAIAK 459 (707)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 459 (707)
..+..+.-..+..|++.+ .||+|+||.||+|.... ++.||||.+... +.+.+|++++++
T Consensus 31 ~~g~~i~~~~~~~y~~~~-------~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~ 98 (352)
T 2jii_A 31 PTGTVLTDKSGRQWKLKS-------FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQR 98 (352)
T ss_dssp CTTCEEECTTSCEEEEEE-------EEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHH
T ss_pred CCCceeecccCCeEEEEE-------EecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHH
Confidence 344444333344555444 79999999999999763 789999998754 467899999999
Q ss_pred cCCCceee---------------eEEEEEc-CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 005226 460 VKHPNIVK---------------LRAYYWA-PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523 (707)
Q Consensus 460 l~H~niv~---------------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 523 (707)
++||||++ +++++.. ++..++||||+ +|+|.+++.... ...+++..++.|+.||+.||+|
T Consensus 99 l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHH
T ss_pred hcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHH
Confidence 99999988 6778876 67789999999 999999998642 2369999999999999999999
Q ss_pred HhhcCCCCceecCCCCCCeEEcCCC--CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC
Q 005226 524 LHECSPRKFVHGDIKPSNILLDNDF--QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP 601 (707)
Q Consensus 524 LH~~~~~~iiHrDlk~~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 601 (707)
||+ ++|+||||||+||+++.++ .+||+|||+++............. .......||+.|+|||++..
T Consensus 175 LH~---~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 175 LHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE---------GSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHH---TTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCT---------TSSCTTCSCTTTCCHHHHTT
T ss_pred HHh---CCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccc---------cccccccCCccccCHHHHcc
Confidence 999 8999999999999999998 899999999987654332211100 01123467999999998665
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHH
Q 005226 602 GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLA 681 (707)
Q Consensus 602 ~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~ 681 (707)
..++.++|||||||++|||++|+.||...... ...+........... ....+... ........+.+++
T Consensus 243 -~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~l~~li 310 (352)
T 2jii_A 243 -CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN----TEDIMKQKQKFVDKP---GPFVGPCG----HWIRPSETLQKYL 310 (352)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC----HHHHHHHHHHHHHSC---CCEECTTS----CEECCCHHHHHHH
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcccCCcC----HHHHHHHHHhccCCh---hhhhhhcc----ccCCCcHHHHHHH
Confidence 67899999999999999999999999754321 112222221111111 11111000 0001235678999
Q ss_pred HhccCCCCCCCCChHHHHHHHHhh
Q 005226 682 LACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 682 ~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.+||+.||++||++++|++.|+++
T Consensus 311 ~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 311 KVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhCChhhCCCHHHHHHHHHHH
Confidence 999999999999999999999886
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=333.26 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=190.5
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 348999999999999964 68899999987653 2345788999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~ 566 (707)
|.+++..... ....+++..+..|+.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++.......
T Consensus 107 L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 107 LLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp HHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred HHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence 9999964310 12359999999999999999999999 899999999999999 4567899999999976543211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. ....||+.|+|||++. ..++.++||||||+++|||++|+.||..... .......
T Consensus 183 ~-----------------~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~ 237 (285)
T 3is5_A 183 S-----------------TNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKA 237 (285)
T ss_dssp ---------------------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred C-----------------cCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhh
Confidence 1 2335689999999864 4678999999999999999999999965321 1222211
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~-------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 238 TYKEPNYAV-------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHCCCCCCC---------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccCCccccc-------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111110000 00112345678999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.51 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=197.6
Q ss_pred ceecccCeeEEEEEEe------CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVL------GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|.. .++..||||++... ......++.+|+.++++++||||+++++++...+..++||||+
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 4799999999999984 35678999999754 3344578999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEeccccccc
Q 005226 486 SNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRL 560 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~ 560 (707)
++|+|.+++...... ....+++..++.++.||+.||+|||+ .+|+||||||+||+++. +..+||+|||+++.
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 999999999865421 22458999999999999999999999 89999999999999984 45699999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccc
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEV 639 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~ 639 (707)
......... .....+++.|+|||.+.. ..++.++||||||+++|||+| |+.||.... .
T Consensus 193 ~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~ 251 (327)
T 2yfx_A 193 IYRASYYRK--------------GGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------N 251 (327)
T ss_dssp HHC--------------------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------H
T ss_pred ccccccccc--------------CCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------H
Confidence 543221110 123456889999998654 678899999999999999998 899986432 2
Q ss_pred hhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 640 PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 640 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....+++........+ ......+.+++.+||+.||.+||++.+|++.|+.+
T Consensus 252 ~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 252 QEVLEFVTSGGRMDPP---------------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCC---------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2333333332221111 11234578899999999999999999999999876
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.00 Aligned_cols=236 Identities=21% Similarity=0.275 Sum_probs=190.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
++||+|+||.||+|... +++.||+|+++... ......+.+|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 48999999999999976 57899999987542 22346788999999988 899999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 106 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 106 GDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 99999998643 59999999999999999999999 89999999999999999999999999999754321110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+.+.+.
T Consensus 178 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~ 234 (353)
T 2i0e_A 178 ----------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIM 234 (353)
T ss_dssp ----------------BCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH
T ss_pred ----------------cccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHH
Confidence 123457999999999765 678999999999999999999999996432 112222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
. ....+. .....++.+++.+|++.||++||++
T Consensus 235 ~---~~~~~p-------------~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 235 E---HNVAYP-------------KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp H---CCCCCC-------------TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred h---CCCCCC-------------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 111111 1123457899999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=340.07 Aligned_cols=252 Identities=28% Similarity=0.463 Sum_probs=196.1
Q ss_pred cceecccCeeEEEEEEeC-CCce--EEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIP--VAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|... ++.. +|+|.+... .....+.+.+|+++++++ +||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 348999999999999964 5554 589988754 233446789999999999 99999999999999999999999999
Q ss_pred CCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 487 NGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 487 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
+|+|.+++..... .....+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEccc
Confidence 9999999986530 122468999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~ 634 (707)
|+++....... .....++..|+|||++.. ..++.++||||||+++|||+| |+.||....
T Consensus 187 g~~~~~~~~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~-- 246 (327)
T 1fvr_A 187 GLSRGQEVYVK-----------------KTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-- 246 (327)
T ss_dssp TCEESSCEECC-----------------C----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred CcCcccccccc-----------------ccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCc--
Confidence 99874432111 122345788999998654 567899999999999999998 999996532
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
...+.+.+........+ ......+.+++.+||+.||.+||++.++++.|+++
T Consensus 247 ----~~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 247 ----CAELYEKLPQGYRLEKP---------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp ----HHHHHHHGGGTCCCCCC---------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHhhcCCCCCCC---------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12222222222111111 11234578999999999999999999999999876
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.18 Aligned_cols=210 Identities=22% Similarity=0.350 Sum_probs=157.6
Q ss_pred hHHHHHhccceecccCeeEEEEEEeC---CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcc
Q 005226 404 LDELLRASAYVLGKSGLGIVYKVVLG---NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEK 478 (707)
Q Consensus 404 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 478 (707)
+.+.....+++||+|+||+||+|... ++..||||++...... ..+.+|++++++++||||+++++++.. +...
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 33433334568999999999999965 5789999999765332 568899999999999999999999965 5678
Q ss_pred eEEEEeecCCChHHHHhCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE----cCCCCe
Q 005226 479 LLISDFISNGNLANALRGRN----GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL----DNDFQP 550 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll----~~~~~~ 550 (707)
++||||+. |+|.+++.... ......+++..+..|+.||+.||+|||+ .+|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 58888885321 1112359999999999999999999999 899999999999999 777899
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
||+|||+|+.......... ......||+.|+|||++.....++.++|||||||++|||++|+.||..
T Consensus 172 kl~Dfg~a~~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 238 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLA-------------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 238 (405)
T ss_dssp EECCTTCCC-----------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEEECCCceecCCCCcccc-------------cCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999987643211100 112346799999999977656689999999999999999999999976
Q ss_pred CC
Q 005226 631 PT 632 (707)
Q Consensus 631 ~~ 632 (707)
..
T Consensus 239 ~~ 240 (405)
T 3rgf_A 239 RQ 240 (405)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.17 Aligned_cols=239 Identities=25% Similarity=0.344 Sum_probs=191.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (279)
T 3fdn_A 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94 (279)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence 47999999999999865 577899999865421 22467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 95 ~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 164 (279)
T 3fdn_A 95 TVYRELQKLS-----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-- 164 (279)
T ss_dssp EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcccc--
Confidence 9999997643 58999999999999999999999 8999999999999999999999999999865432110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....|+..|+|||.+.. ..++.++||||||+++|||++|+.||..... ......+..
T Consensus 165 ----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~ 221 (279)
T 3fdn_A 165 ----------------TDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISR 221 (279)
T ss_dssp -------------------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH
T ss_pred ----------------cccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHHh
Confidence 22356899999998654 6778999999999999999999999964221 112211111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ...+.+ .....+.+++.+||+.||++||+++|+++
T Consensus 222 ~---~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 V---EFTFPD-------------FVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp T---CCCCCT-------------TSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C---CCCCCC-------------cCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 111111 12245678999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=341.06 Aligned_cols=256 Identities=21% Similarity=0.231 Sum_probs=192.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC-----chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-----GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 458999999999999964 6788999998643 2334578999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 005226 486 SNGNLANALRGRNGQ-----------------------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPR 530 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 530 (707)
++|+|.+++...... ....+++..+..|+.||+.||+|||+ .
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~ 187 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---Q 187 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---C
Confidence 999999999521100 01124677888999999999999999 8
Q ss_pred CceecCCCCCCeEEcCCC--CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCc
Q 005226 531 KFVHGDIKPSNILLDNDF--QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQ 607 (707)
Q Consensus 531 ~iiHrDlk~~NIll~~~~--~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 607 (707)
+|+||||||+||+++.++ .+||+|||+++.......... .......||+.|+|||++.. ...++.
T Consensus 188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY------------YGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------CCCGGGCCHHHHTCSSSCCCT
T ss_pred CccccCCChhhEEEecCCCceEEEeeccccccccccCcccc------------ccccccCCCccccCchhhccCCCCCCc
Confidence 999999999999998776 899999999987653221111 11133457999999998753 367789
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCC
Q 005226 608 KWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEA 687 (707)
Q Consensus 608 ~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~ 687 (707)
++||||||+++|||++|+.||..... .+....+.. ....+. .+ ........+.+++.+||+.
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~---~~~~~~---~~------~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLN---KKLCFE---NP------NYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH---CCCCTT---SG------GGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHh---cccccC---Cc------ccccCCHHHHHHHHHHcCC
Confidence 99999999999999999999964321 111111111 111000 00 0011234678999999999
Q ss_pred CCCCCCChHHHHH
Q 005226 688 DPEVRPRMKNVSE 700 (707)
Q Consensus 688 dP~~RPs~~~v~~ 700 (707)
||++||++.++++
T Consensus 318 ~p~~Rps~~~~l~ 330 (345)
T 3hko_A 318 NVDERFDAMRALQ 330 (345)
T ss_dssp CTTTSCCHHHHHH
T ss_pred ChhHCCCHHHHhc
Confidence 9999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.59 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=194.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++..++..++||||+++|+
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 47999999999999965 6889999998654 33345778899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEecccccccccccCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGLSRLINITGN 566 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~~~~~~~ 566 (707)
|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++........
T Consensus 92 l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 92 LFEDIVARE-----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999997643 58999999999999999999999 89999999999999987655 99999999976543221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. ....||+.|+|||++.. ..++.++||||||+++|||++|+.||.... .......+
T Consensus 164 ~-----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~~ 219 (284)
T 3kk8_A 164 W-----------------HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYAQI 219 (284)
T ss_dssp C-----------------CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHH
T ss_pred c-----------------cCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCc------hhHHHHHH
Confidence 1 12346899999999765 677899999999999999999999996432 11222222
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... + ........+.+++.+|++.||++|||+.|+++
T Consensus 220 ~~~~~~~~~------~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 220 KAGAYDYPS------P------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHTCCCCCT------T------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhccccCCc------h------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 221111000 0 00112345779999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=342.67 Aligned_cols=268 Identities=23% Similarity=0.326 Sum_probs=188.7
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHH--HHhcCCCceeeeEEEEEcC-----CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQA--IAKVKHPNIVKLRAYYWAP-----DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 485 (707)
+.||+|+||.||+|.. +++.||||++..... ..+..|.++ +..++||||+++++++... ...++||||+
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4799999999999987 788999999865432 344445444 4558999999999866431 2458999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC---------CceecCCCCCCeEEcCCCCeEEeccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR---------KFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
++|+|.+++.... .++..+.+|+.||+.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 95 PNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp TTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 9999999997653 6899999999999999999999 6 99999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG------NRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
+++.+.......... .........||+.|+|||++... ..++.++|||||||++|||++|+.||..
T Consensus 166 ~a~~~~~~~~~~~~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGE--------EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp TCEECSSSSCC-----------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred ceeecccccccCccc--------cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 998765332111000 00011234579999999986542 2445789999999999999999888755
Q ss_pred CCCCCCccchh--------HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 631 PTTSTSIEVPD--------LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 631 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
........... ..+........... ...+.... .........+.+++.+||+.||++|||++|+++.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-RPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhccccc-CCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 33221111000 00000000000000 00000000 01123445789999999999999999999999999
Q ss_pred Hhh
Q 005226 703 ERI 705 (707)
Q Consensus 703 ~~i 705 (707)
+++
T Consensus 314 ~~l 316 (336)
T 3g2f_A 314 AEL 316 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.84 Aligned_cols=250 Identities=21% Similarity=0.261 Sum_probs=191.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||++++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence 47999999999999965 788999999876532 23477899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 120 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 120 DLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 9999998643 58999999999999999999999 899999999999999999999999999987654321110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....|+..|+|||.+.. ..++.++||||||+++|||++|+.||.... ...+...+..
T Consensus 192 ---------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~ 249 (309)
T 2h34_A 192 ---------------LGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQ------LSVMGAHINQ 249 (309)
T ss_dssp --------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCH------HHHHHHHHHS
T ss_pred ---------------ccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCch------HHHHHHHhcc
Confidence 123356899999999765 677899999999999999999999996421 1111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-ChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-RMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~v~~~L~~i 705 (707)
.... ... ........+.+++.+||+.||++|| +++++++.|+++
T Consensus 250 ~~~~----~~~---------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 250 AIPR----PST---------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp CCCC----GGG---------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred CCCC----ccc---------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 1110 000 0112234578899999999999999 999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=348.08 Aligned_cols=268 Identities=21% Similarity=0.226 Sum_probs=201.6
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC--cceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--EKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g 94 (396)
T 4eut_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (396)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence 38999999999999975 58999999987643 233467889999999999999999999998765 669999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE----cCCCCeEEeccccccccccc
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL----DNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~DfGla~~~~~~ 564 (707)
+|.+++..... ...+++..++.|+.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||+++.....
T Consensus 95 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 95 SLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp EHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 99999986531 2349999999999999999999999 899999999999999 77888999999999876432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
... ....||..|+|||++.. ...++.++|||||||++|||++|+.||.......
T Consensus 170 ~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~-- 230 (396)
T 4eut_A 170 EQF-----------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR-- 230 (396)
T ss_dssp GGS-----------------SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--
T ss_pred Ccc-----------------ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--
Confidence 211 12346899999998542 1356789999999999999999999997543321
Q ss_pred cchhHHHHHHhhccccCCCchhch---------HHH-HhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVD---------AML-LQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d---------~~l-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
........+......... ..... ..+ ............+.+++.+||+.||++||++.++++.++++
T Consensus 231 ~~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 231 RNKEVMYKIITGKPSGAI-SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp TCHHHHHHHHHSCCTTCC-EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred chHHHHHHHhcCCCcccc-hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 111111111111110000 00000 000 00011245556788999999999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=332.47 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=194.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----------------
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA---------------- 474 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------------- 474 (707)
.+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 357999999999999975 78999999987543 456789999999999999999998864
Q ss_pred CCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEec
Q 005226 475 PDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISD 554 (707)
Q Consensus 475 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D 554 (707)
....++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECc
Confidence 344789999999999999997543 2368999999999999999999999 8999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 005226 555 FGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTS 634 (707)
Q Consensus 555 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~ 634 (707)
||+++........ ....|++.|+|||.+.. ..++.++||||||+++|||++|..|+..
T Consensus 166 fg~~~~~~~~~~~-----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~---- 223 (284)
T 2a19_B 166 FGLVTSLKNDGKR-----------------TRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE---- 223 (284)
T ss_dssp CTTCEESSCCSCC-----------------CCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH----
T ss_pred chhheeccccccc-----------------cccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh----
Confidence 9999876532211 22346899999998664 6778999999999999999999988631
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.......... .. +.+. ....+.+++.+||+.||++||++.++++.|+.++
T Consensus 224 ----~~~~~~~~~~---~~--~~~~-------------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 224 ----TSKFFTDLRD---GI--ISDI-------------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----HHHHHHHHHT---TC--CCTT-------------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----HHHHHHHhhc---cc--cccc-------------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1111111111 00 1111 1234678999999999999999999999998875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.98 Aligned_cols=237 Identities=20% Similarity=0.254 Sum_probs=193.0
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch--------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
.+.||+|+||.||+|.. .++..||||++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 35799999999999985 4789999999876431 12346788999999999999999999999999999999
Q ss_pred EeecCC-ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 483 DFISNG-NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 483 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
||+.+| +|.+++.... .+++..+..|+.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 109 e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp ECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999777 9999998653 59999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... ....||+.|+|||++......+.++|||||||++|||++|+.||......
T Consensus 181 ~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------- 236 (335)
T 3dls_A 181 ERGKLF-----------------YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------- 236 (335)
T ss_dssp CTTCCB-----------------CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------
T ss_pred CCCCce-----------------eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------
Confidence 432110 23457999999999776444588999999999999999999999642110
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
......... .....+.+++.+||+.||++|||+.++++.
T Consensus 237 --------~~~~~~~~~-------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 --------VEAAIHPPY-------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --------TTTCCCCSS-------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --------HhhccCCCc-------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 112357799999999999999999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=331.39 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=193.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||++... +|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 358999999999999975 7899999999866544446789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++......
T Consensus 94 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 94 FDRILERG-----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp HHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 99997543 58999999999999999999999 899999999999999 788999999999986533110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....|++.|+|||++.. ..++.++||||||+++|||++|+.||..... ..+.+.+.
T Consensus 164 ----------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~ 220 (304)
T 2jam_A 164 ----------------MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIK 220 (304)
T ss_dssp ----------------THHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH
T ss_pred ----------------cccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH
Confidence 123457999999999764 6788999999999999999999999965321 12222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....... .- ........+.+++.+|++.||++||++.++++
T Consensus 221 ~~~~~~~---~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 221 EGYYEFE---SP---------FWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HCCCCCC---TT---------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCCC---cc---------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111100 00 00122345789999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.66 Aligned_cols=209 Identities=26% Similarity=0.349 Sum_probs=158.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCC--cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPD--EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~e~~~ 486 (707)
+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++ ||||+++++++..++ ..|+||||++
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 4799999999999986 47899999998654 3344567889999999996 999999999998654 6799999997
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 -~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 95 -TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp -EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred -cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 6999999853 48999999999999999999999 8999999999999999999999999999987643211
Q ss_pred CCCCCCCCc-----CCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 567 NPSSSGGFM-----GGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 567 ~~~~~~~~~-----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
......... .............||+.|+|||++.....++.++|||||||++|||++|++||...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 100000000 00000001123468999999999776577899999999999999999999999753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=326.31 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=177.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (278)
T 3cok_A 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96 (278)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence 4799999999999996 5789999999865422 22367899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 97 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 97 EMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999998643 358999999999999999999999 899999999999999999999999999998654221110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ ...
T Consensus 170 ----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~~ 223 (278)
T 3cok_A 170 ----------------YTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---------LNK 223 (278)
T ss_dssp ---------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------
T ss_pred ----------------eeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---------HHH
Confidence 12356899999998664 6678999999999999999999999975432210 001
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... ......+.+++.+||+.||++||+++++++
T Consensus 224 ~~~~~~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 224 VVLADYEMP-------------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCSSCCCCC-------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhcccCCc-------------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 011110000 112245679999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.12 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=185.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--------hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--------EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 457999999999999864 67899999986532 112245889999999999999999999975 45579999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSR 559 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~ 559 (707)
||+++|+|.+++.... .+++..+..|+.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++
T Consensus 219 e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 219 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp ECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999997543 59999999999999999999999 899999999999999754 459999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
........ ....||+.|+|||++.. ...++.++|||||||++|||++|+.||......
T Consensus 291 ~~~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--- 350 (419)
T 3i6u_A 291 ILGETSLM-----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--- 350 (419)
T ss_dssp SCC----------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS---
T ss_pred ecCCCccc-----------------cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch---
Confidence 65422110 23457999999999753 356788999999999999999999999753322
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+.+.+...... ..... .......+.+++.+||+.||++||+++++++
T Consensus 351 --~~~~~~i~~~~~~------~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 351 --VSLKDQITSGKYN------FIPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --CCHHHHHHTTCCC------CCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHhcCCCC------CCchh------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1222222221110 00000 0122356789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=350.12 Aligned_cols=248 Identities=18% Similarity=0.203 Sum_probs=193.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.++||+|+||.||+++.. +|+.||+|++++.. ......+.+|.+++.+++||||+++++++.+.+..|+||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 358999999999999975 78999999987532 22335688999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++...+ ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++........
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999997542 258999999999999999999999 89999999999999999999999999999876432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
. .....||+.|+|||++.. ...++.++|||||||++|||++|+.||..... ..
T Consensus 219 ~---------------~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~ 277 (412)
T 2vd5_A 219 R---------------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AE 277 (412)
T ss_dssp E---------------CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HH
T ss_pred c---------------cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HH
Confidence 0 023467999999998752 35678999999999999999999999965321 11
Q ss_pred HHHHHHhhc-cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCC---CChHHHHH
Q 005226 642 LVRWVKKGF-EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR---PRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~-~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~~v~~ 700 (707)
....+.... ....+ . .......++.+++.+|+. +|++| |+++|+++
T Consensus 278 ~~~~i~~~~~~~~~p-------~-----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 278 TYGKIVHYKEHLSLP-------L-----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHHTHHHHCCCC----------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHHhcccCcCCC-------c-----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111111100 00000 0 001223567899999999 99998 58888864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.69 Aligned_cols=249 Identities=25% Similarity=0.302 Sum_probs=194.3
Q ss_pred cceecccCeeEEEEEEe----CCCceEEEEEcCCCc----hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGG----EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 34899999999999997 378999999987542 12335678899999999 6999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999997643 58999999999999999999999 899999999999999999999999999998654
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... .....||+.|+|||++..+ ..++.++|||||||++|||++|+.||....... .
T Consensus 211 ~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~ 270 (355)
T 1vzo_A 211 ADETER---------------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----S 270 (355)
T ss_dssp GGGGGG---------------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-----C
T ss_pred cCCCCc---------------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-----h
Confidence 221110 1234579999999997642 457889999999999999999999997543221 1
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSEN 701 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~~ 701 (707)
..............+. ......+.+++.+||+.||++|| +++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 271 QAEISRRILKSEPPYP-------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHHHHHHHHCCCCCC-------------TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHHHHHHHhccCCCCC-------------cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1111111111111111 11224567899999999999999 88888753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=339.27 Aligned_cols=258 Identities=20% Similarity=0.262 Sum_probs=191.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++..++..++||||++ |+|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 47999999999999975 7899999998754322 22355679999999999999999999999999999999997 599
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-- 157 (324)
T 3mtl_A 87 KQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-- 157 (324)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc--
Confidence 99997653 358999999999999999999999 899999999999999999999999999997554221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....||..|+|||++.....++.++|||||||++|||++|+.||..... .+....+....
T Consensus 158 --------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~ 217 (324)
T 3mtl_A 158 --------------DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV------EEQLHFIFRIL 217 (324)
T ss_dssp -------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHH
T ss_pred --------------ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHh
Confidence 2235689999999977656789999999999999999999999975321 12222222221
Q ss_pred cccC--CCchhchH-HHHhh-----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEEN--PLSDMVDA-MLLQE-----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~--~~~~~~d~-~l~~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ........ ..... .........+.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 1110 00111110 00000 000122356789999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.83 Aligned_cols=247 Identities=26% Similarity=0.291 Sum_probs=196.8
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.++||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 358999999999999975 78999999986542 22336688999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~- 341 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 341 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc-
Confidence 99999998653 2359999999999999999999999 8999999999999999999999999999987642211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ....+...+.
T Consensus 342 ----------------~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~ 402 (576)
T 2acx_A 342 ----------------IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVK 402 (576)
T ss_dssp ----------------EECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHH
T ss_pred ----------------ccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhh
Confidence 022467999999999765 678899999999999999999999997643321 1111222211
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.. ...+. ......+.+++.+|++.||.+|| +++||++
T Consensus 403 ~~---~~~~p-------------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 EV---PEEYS-------------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HC---CCCCC-------------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cc---cccCC-------------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11 10001 11234578999999999999999 6777764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.54 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|... +++.||+|++... ......++.+|+..+.++ +||||+++++++.+++..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 348999999999999975 7899999998754 233447788999999999 999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-------------------CC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-------------------DF 548 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-------------------~~ 548 (707)
|+|.+++..... ....+++..+..|+.||+.||+|||+ ++|+||||||+||+++. ..
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999975421 11358999999999999999999999 89999999999999984 44
Q ss_pred CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005226 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 549 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~ 628 (707)
.+||+|||.+...... ....||..|+|||++.....++.++||||||+++|||++|.+|+
T Consensus 172 ~~kl~Dfg~~~~~~~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSP--------------------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp CEEECCCTTCEETTCS--------------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEEEcccccccccCCc--------------------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 7999999998865421 12236899999999776556678999999999999999999876
Q ss_pred CCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 629 LSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... .....+........ . ......+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~---------~~~~~~~~~~~~~~--~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 232 RNG---------DQWHEIRQGRLPRI--P-------------QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp SSS---------HHHHHHHTTCCCCC--S-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cch---------hHHHHHHcCCCCCC--C-------------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 321 11111111111110 1 112245789999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.32 Aligned_cols=204 Identities=21% Similarity=0.293 Sum_probs=151.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e 483 (707)
.+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++|||||++++++... ...|+|||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e 137 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE 137 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence 348999999999999864 7899999998654 333457889999999999999999999999543 46799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +|+|.+++.... .+++..+..++.||+.||+|||+ .+||||||||+|||++.++.+||+|||+|+....
T Consensus 138 ~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 138 IA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred cc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 98 579999998643 59999999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCCCCCCCC----------CcCCCCC-CCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhC
Q 005226 564 TGNNPSSSGG----------FMGGALP-YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTG 624 (707)
Q Consensus 564 ~~~~~~~~~~----------~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg 624 (707)
.......... ....+.. ........||+.|+|||++..+..++.++|||||||++|||+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 3211110000 0000000 00112346799999999866667899999999999999999994
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.91 Aligned_cols=244 Identities=25% Similarity=0.295 Sum_probs=185.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHH-HHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQA-IAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|..+ ++.++||||+++++++.+.+..|+||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 348999999999999975 578899999876432 233556777777 567899999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 999999997643 58999999999999999999999 8999999999999999999999999999986432211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.... ...+.+.+
T Consensus 195 ~----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i 251 (373)
T 2r5t_A 195 T----------------TSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNI 251 (373)
T ss_dssp C----------------CCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHH
T ss_pred c----------------cccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHH
Confidence 1 123457999999999765 678999999999999999999999996432 11222211
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENL 702 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L 702 (707)
.. ....+. ......+.+++.+|++.||.+||++.+.++.+
T Consensus 252 ~~---~~~~~~-------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 252 LN---KPLQLK-------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp HH---SCCCCC-------------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred Hh---cccCCC-------------CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 11 111100 11224567899999999999999986544443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=346.86 Aligned_cols=253 Identities=22% Similarity=0.256 Sum_probs=186.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||+||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..|+|||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 47999999999999864 6899999999764 3334577889999999999999999999997654 4599999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++ +|.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 148 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 9975 57777753 38999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +..
T Consensus 217 ~~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~------~~~ 272 (464)
T 3ttj_A 217 SFMM-----------------TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQW 272 (464)
T ss_dssp CCCC---------------------CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred Cccc-----------------CCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 2110 23457999999999775 67899999999999999999999999753211 111
Q ss_pred HHHHhhc-------------------cccCCCchhchHHH-Hh------hhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 644 RWVKKGF-------------------EEENPLSDMVDAML-LQ------EVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 644 ~~~~~~~-------------------~~~~~~~~~~d~~l-~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
..+.... ..........-+.. .. .........++.+|+.+||..||++|||++|
T Consensus 273 ~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 352 (464)
T 3ttj_A 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352 (464)
T ss_dssp HHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 1111100 00000000000000 00 0001122467899999999999999999999
Q ss_pred HHH
Q 005226 698 VSE 700 (707)
Q Consensus 698 v~~ 700 (707)
+++
T Consensus 353 ~L~ 355 (464)
T 3ttj_A 353 ALQ 355 (464)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.31 Aligned_cols=251 Identities=22% Similarity=0.305 Sum_probs=186.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 4799999999999996 47899999998654 2334567899999999999999999999998763 4599999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 111 ~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 111 FM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 99 88999999753 48999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....+|+.|+|||++.....++.++||||+||++|||++|+.||..... .+..
T Consensus 181 ~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l 235 (367)
T 1cm8_A 181 EM-------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH------LDQL 235 (367)
T ss_dssp SC-------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred cc-------------------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence 11 1234689999999877656789999999999999999999999975321 1111
Q ss_pred HHHHhhccccCCCchhch--------HHHHhh---------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVD--------AMLLQE---------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d--------~~l~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+....... + .+... ..+... .........+.+++.+|+..||++|||++++++
T Consensus 236 ~~i~~~~g~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 236 KEIMKVTGTP-P-AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHCCC-C-HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCCC-C-HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1111111000 0 00000 000000 000112356789999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=326.65 Aligned_cols=241 Identities=21% Similarity=0.337 Sum_probs=194.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||++++
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 100 (294)
T 2rku_A 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 100 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCC
Confidence 48999999999999975 5788999988654 2334577899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 101 SLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 9999987543 58999999999999999999999 899999999999999999999999999998654222111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||..|+|||.+.. ..++.++||||||+++|||++|+.||..... .+....+.
T Consensus 173 ----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~- 228 (294)
T 2rku_A 173 ----------------KVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIK- 228 (294)
T ss_dssp ----------------CCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-
T ss_pred ----------------ccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-
Confidence 22456899999999654 6678999999999999999999999964321 11111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+.. .....+.+++.+||+.||++||+++++++
T Consensus 229 --~~~~~~~~-------------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 229 --KNEYSIPK-------------HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --TTCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --hccCCCcc-------------ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11111111 11235678999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.01 Aligned_cols=255 Identities=21% Similarity=0.327 Sum_probs=195.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 47999999999999975 6889999998765 334457899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
.+++.... .+++..+..++.+++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.......
T Consensus 119 ~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 187 (360)
T 3eqc_A 119 DQVLKKAG-----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 187 (360)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccc---
Confidence 99997643 58999999999999999999998 5 899999999999999999999999999976543211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||+.|+|||++.. ..++.++||||||+++|||++|+.||...... .+.......
T Consensus 188 ---------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~ 245 (360)
T 3eqc_A 188 ---------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK------ELELMFGCQ 245 (360)
T ss_dssp ------------------CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH------HHHHHHC--
T ss_pred ---------------cCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHhccc
Confidence 12346899999999765 67899999999999999999999999753211 100000000
Q ss_pred -------------------------ccccCCCchhchHHHHhhh---hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 -------------------------FEEENPLSDMVDAMLLQEV---HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 -------------------------~~~~~~~~~~~d~~l~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........+.++....... ........+.+++.+||+.||++|||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 246 VEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000111111111100 00112346889999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.25 Aligned_cols=262 Identities=21% Similarity=0.269 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--------CcceEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--------DEKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV 481 (707)
+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++... +..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 4799999999999997 5789999999865432 2235788999999999999999999999874 457899
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+++ +|.+.+.... ..+++..+..|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 999975 8888887543 359999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
......... ......||+.|+|||++.....++.++|||||||++|||+||+.||..... ..
T Consensus 175 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~ 236 (351)
T 3mi9_A 175 SLAKNSQPN------------RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------QH 236 (351)
T ss_dssp CCCSSSSCC------------CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HH
T ss_pred ccccccccc------------ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh------HH
Confidence 532211110 112345799999999877656789999999999999999999999975322 11
Q ss_pred HHHHHHhhccccCC--Cchhch--------------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENP--LSDMVD--------------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~--~~~~~d--------------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+........+ ....-+ ..+............+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 22222211111000 000000 000000000111345789999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.57 Aligned_cols=243 Identities=23% Similarity=0.283 Sum_probs=186.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +|..||||++... .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 458999999999999964 7899999998753 223346678899999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.||+.||+|||+. ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 233 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 305 (446)
T 4ejn_A 233 GELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305 (446)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcc
Confidence 99999997643 589999999999999999999963 58999999999999999999999999999754322111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+...+.
T Consensus 306 ----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~ 362 (446)
T 4ejn_A 306 ----------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELIL 362 (446)
T ss_dssp -----------------CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred ----------------cccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHH
Confidence 123457999999999755 6789999999999999999999999964321 12222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
. ....+. ......+.+++.+||+.||++|| +++|+++
T Consensus 363 ~---~~~~~p-------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 363 M---EEIRFP-------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp H---CCCCCC-------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred h---CCCCCC-------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1 111111 11224578999999999999999 9999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.27 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=190.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||++... +++.||||++..... .+.+|++++.++ +||||+++++++.+++..++||||+++|+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 358999999999999975 688999999876532 345688999888 89999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC----CCeEEecccccccccccC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND----FQPYISDFGLSRLINITG 565 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~~~~~~ 565 (707)
|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++.++ +.+||+|||+++......
T Consensus 103 L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 103 LLDKILRQK-----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp HHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 999998653 58999999999999999999999 899999999999998543 359999999998764322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ....+...
T Consensus 175 ~~~----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~ 234 (342)
T 2qr7_A 175 GLL----------------MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD---TPEEILAR 234 (342)
T ss_dssp CCB----------------CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS---CHHHHHHH
T ss_pred Cce----------------eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC---CHHHHHHH
Confidence 111 22356899999998654 45788999999999999999999999753221 12222222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....... .. .........+.+++.+|++.||++||++.++++
T Consensus 235 i~~~~~~~---~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 235 IGSGKFSL---SG---------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHCCCCC---CS---------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HccCCccc---Cc---------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22211100 00 000122345789999999999999999999875
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.65 Aligned_cols=250 Identities=18% Similarity=0.246 Sum_probs=191.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEc--CCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWA--PDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|.. .+++.||||+++... .+.+.+|++++++++ ||||+++++++.. ....++||||++++
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 4899999999999985 578999999987543 367889999999996 9999999999988 56679999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++........
T Consensus 119 ~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 9999985 38899999999999999999999 8999999999999999776 8999999999865432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH----
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV---- 643 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~---- 643 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||...... ...+.
T Consensus 188 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~----~~~l~~~~~ 246 (330)
T 3nsz_A 188 -----------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN----YDQLVRIAK 246 (330)
T ss_dssp -----------------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH----HHHHHHHHH
T ss_pred -----------------ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch----HHHHHHHHH
Confidence 22346889999999776577899999999999999999999999643221 11111
Q ss_pred --------HHHHhhccccCCCchhchHHHH-----------hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 --------RWVKKGFEEENPLSDMVDAMLL-----------QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 --------~~~~~~~~~~~~~~~~~d~~l~-----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+++....... ....+..+. ...........+.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIEL---DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHCHHHHHHHHHHTTCCC---CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hcCCchhhhHHHHhcccc---ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111100000 000000000 00001113467889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=325.81 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=193.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 358999999999999976 689999998865421 1247899999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~ 560 (707)
+++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++ .+||+|||+++.
T Consensus 90 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 90 VSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 99999999997543 58999999999999999999999 8999999999999998877 899999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....+++.|+|||++.. ..++.++||||||+++|||++|+.||..... .
T Consensus 162 ~~~~~~~-----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~ 217 (283)
T 3bhy_A 162 IEAGNEF-----------------KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETK------Q 217 (283)
T ss_dssp CC-------------------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------H
T ss_pred ccCCCcc-----------------cccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcch------H
Confidence 5432111 12346889999998654 6788999999999999999999999965321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+... ... .+... .......+.+++.+||+.||++||++.++++
T Consensus 218 ~~~~~~~~~---~~~----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 218 ETLTNISAV---NYD----FDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHHHHTT---CCC----CCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHhHhc---ccC----Ccchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 111111111 100 01111 0122346789999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.13 Aligned_cols=248 Identities=25% Similarity=0.329 Sum_probs=193.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+||+|+||.||+|.. .++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4899999999999996 468899999987765555578999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-CCCeEEecccccccccccCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
+++....+ ...+++..+..++.||+.||+|||+ .+|+||||||+||+++. ++.+||+|||+++........
T Consensus 108 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~--- 179 (295)
T 2clq_A 108 ALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--- 179 (295)
T ss_dssp HHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------
T ss_pred HHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc---
Confidence 99986532 2357899999999999999999999 89999999999999987 899999999999865422110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....|+..|+|||++..+ ..++.++||||||+++|||++|+.||...... ....+....
T Consensus 180 -------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~ 240 (295)
T 2clq_A 180 -------------TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGM 240 (295)
T ss_dssp --------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHH
T ss_pred -------------ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhcc
Confidence 0223568999999986542 23688999999999999999999998642211 111111111
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+. ......+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 241 FKVHPEIP-------------ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HCCCCCCC-------------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccc-------------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111101 112345778999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.17 Aligned_cols=241 Identities=26% Similarity=0.362 Sum_probs=188.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (276)
T 2h6d_A 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96 (276)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence 47999999999999975 78999999986542 123467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 97 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~- 167 (276)
T 2h6d_A 97 ELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL- 167 (276)
T ss_dssp BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred cHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCcce-
Confidence 9999997643 58999999999999999999999 89999999999999999999999999999765422110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....+++.|+|||.+......+.++||||||+++|||++|+.||.... ...+.+.+..
T Consensus 168 ----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~ 225 (276)
T 2h6d_A 168 ----------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKKIRG 225 (276)
T ss_dssp -------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH
T ss_pred ----------------ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhc
Confidence 123468899999997764445689999999999999999999986421 1122222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
... .+. ......+.+++.+|++.||++||++.++++
T Consensus 226 ~~~---~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 226 GVF---YIP-------------EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCC---CCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccc---cCc-------------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 001 111245678999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=334.51 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 48999999999999975 58999999886543 2334668899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 111 l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 181 (331)
T 4aaa_A 111 LDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY- 181 (331)
T ss_dssp HHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred HHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc-
Confidence 999877543 59999999999999999999999 899999999999999999999999999997654322111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||..|+|||++.....++.++|||||||++|||++|+.||...... ..+.......
T Consensus 182 ---------------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 241 (331)
T 4aaa_A 182 ---------------DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-----DQLYHIMMCL 241 (331)
T ss_dssp -----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred ---------------CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHh
Confidence 22346889999999776557899999999999999999999999653211 1111111100
Q ss_pred cc---------------ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FE---------------EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~---------------~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ....+....+..-. ..........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPL-ERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCChhhhhHhhhccccccccCccccccchh-hhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000000000 0000123466889999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.02 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=193.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 367999999999999965 68999999987643 23357889999999999 569999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEeccccccccccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINIT 564 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~~ 564 (707)
|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++.....
T Consensus 114 ~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 114 GEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99999996542 2469999999999999999999999 89999999999999998 789999999999876422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
... ....||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .....
T Consensus 188 ~~~-----------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~ 243 (327)
T 3lm5_A 188 CEL-----------------REIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYL 243 (327)
T ss_dssp -----------------------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred ccc-----------------ccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHH
Confidence 111 12356999999999764 6788999999999999999999999965321 11111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+....... + .. ........+.+++.+||+.||++|||++++++
T Consensus 244 ~i~~~~~~~-~-~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 244 NISQVNVDY-S-EE----------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHTCCCC-C-TT----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhccccc-C-ch----------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111111100 0 00 00122345779999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=333.35 Aligned_cols=241 Identities=21% Similarity=0.340 Sum_probs=194.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 126 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCC
Confidence 48999999999999975 5788999998654 2334577899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++.++..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 127 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 127 SLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 9999987543 58999999999999999999999 899999999999999999999999999998764222111
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||..|+|||++.. ..++.++||||||+++|||++|+.||..... ......+..
T Consensus 199 ----------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~ 255 (335)
T 2owb_A 199 ----------------KVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKK 255 (335)
T ss_dssp ----------------CCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH
T ss_pred ----------------cccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhc
Confidence 22456899999998664 6678999999999999999999999964221 111111111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+.. .....+.+++.+||+.||++||++.++++
T Consensus 256 ---~~~~~~~-------------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 256 ---NEYSIPK-------------HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---TCCCCCT-------------TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---CCCCCCc-------------cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111 11234678999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.06 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=187.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||++ |+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 118 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-ND 118 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CC
Confidence 48999999999999854 789999999975532 224567899999999999999999999999999999999997 59
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-----CCCCeEEeccccccccccc
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-----NDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-----~~~~~kl~DfGla~~~~~~ 564 (707)
|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 119 LKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp HHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 999998653 58999999999999999999999 8999999999999994 4556999999999876422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ....||..|+|||++.....++.++|||||||++|||++|+.||..... ...+..
T Consensus 191 ~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~ 249 (329)
T 3gbz_A 191 IRQF----------------THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-----IDQLFK 249 (329)
T ss_dssp -------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred cccc----------------CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH-----HHHHHH
Confidence 1111 2235689999999977656689999999999999999999999965321 111111
Q ss_pred HHHhhcccc-CC-------------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEE-NP-------------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~-~~-------------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....-... .. +.+.....+.. ........++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKR-VLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHH-HHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhh-hcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 111100000 00 00000000000 001112356789999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.58 Aligned_cols=242 Identities=22% Similarity=0.338 Sum_probs=195.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 107 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence 4799999999999986 468899999986543 33457899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 108 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--- 175 (303)
T 3a7i_A 108 LDLLEPG------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--- 175 (303)
T ss_dssp HHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC---
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc---
Confidence 9999743 58999999999999999999999 89999999999999999999999999999766432111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....|+..|+|||++.. ..++.++||||||+++|||++|+.||..... ......+....
T Consensus 176 -------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~ 235 (303)
T 3a7i_A 176 -------------RNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKNN 235 (303)
T ss_dssp -------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC
T ss_pred -------------cCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhcCC
Confidence 123356889999999765 6778999999999999999999999864321 12222222111
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~ 701 (707)
... +. ......+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~--~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPT--LE-------------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCC--CC-------------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCC--Cc-------------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110 00 1122457899999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.36 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=195.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--------hhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++...+..++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 368999999999999975 799999999865421 1135688999999999 899999999999999999999
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 179 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 99999999999997542 58999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
...... ....||+.|+|||++.. ...++.++|||||||++|||++|+.||....
T Consensus 251 ~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---- 309 (365)
T 2y7j_A 251 EPGEKL-----------------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---- 309 (365)
T ss_dssp CTTCCB-----------------CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred CCCccc-----------------ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----
Confidence 532111 22456999999998642 2457889999999999999999999996421
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+...... ...+.. ......+.+++.+|++.||++||++.++++
T Consensus 310 --~~~~~~~i~~~~~~------~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 310 --QILMLRMIMEGQYQ------FSSPEW------DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp --HHHHHHHHHHTCCC------CCHHHH------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HHHHHHHHHhCCCC------CCCccc------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11222222111100 000100 112345789999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=365.36 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=197.9
Q ss_pred hccceecccCeeEEEEEEeC----CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 410 ASAYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
...+.||+|+||.||+|... .+..||||++.... ....+.|.+|+.++++++||||+++++++. ++..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 34568999999999999864 24679999987643 334478999999999999999999999984 5678999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 472 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 472 CTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999998543 358999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 643 (707)
.... .....+|+.|+|||++.. ..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 545 ~~~~---------------~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~~~~~ 602 (656)
T 2j0j_A 545 TYYK---------------ASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVI 602 (656)
T ss_dssp ------------------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHH
T ss_pred ccee---------------ccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCC------HHHHH
Confidence 2111 122345788999998754 678899999999999999997 999986432 22333
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+........+ ......+.+++.+||+.||++||++.++++.|+++
T Consensus 603 ~~i~~~~~~~~~---------------~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 603 GRIENGERLPMP---------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCC---------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 333322211111 11234578999999999999999999999999886
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=349.34 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=194.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
++||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 47999999999999975 689999999865422 23467889999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 271 ~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~ 346 (543)
T 3c4z_A 271 DIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346 (543)
T ss_dssp BHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred CHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence 9999997643 123469999999999999999999999 899999999999999999999999999998764322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ....+...+.
T Consensus 347 ----------------~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~- 406 (543)
T 3c4z_A 347 ----------------KGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVL- 406 (543)
T ss_dssp ----------------CCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHH-
T ss_pred ----------------ccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHh-
Confidence 22357999999999765 678999999999999999999999997643221 1112222111
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
.....+. ......+.+++.+||+.||++||++
T Consensus 407 --~~~~~~p-------------~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 --EQAVTYP-------------DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --HCCCCCC-------------TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred --hcccCCC-------------cccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111111 1123456789999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=338.38 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=181.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEc--------CCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWA--------PDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--------~~~~~lV 481 (707)
.+.||+|+||.||+|... +++.||||++........+.+.+|+.+++++. ||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 448999999999999964 78999999987666666678999999999995 9999999999953 2346899
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
|||+. |+|.+++.... ....+++..++.|+.||+.||+|||+ .+ |+||||||+||+++.++.+||+|||+++
T Consensus 113 ~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 99995 79999986522 12359999999999999999999999 67 9999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
............. ............||+.|+|||++. .+..++.++||||||+++|||++|+.||......
T Consensus 187 ~~~~~~~~~~~~~----~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 187 TISHYPDYSWSAQ----RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp CCSSCC-----------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred eccccCccccccc----ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 7653322110000 000000112345799999999863 3467789999999999999999999999643221
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........... . ......+.+++.+||+.||++||++.++++.|+++.
T Consensus 260 ------~~~~~~~~~~~--~-------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 ------RIVNGKYSIPP--H-------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ------------CCCCT--T-------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HhhcCcccCCc--c-------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111000 0 011123678999999999999999999999998873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=335.71 Aligned_cols=258 Identities=23% Similarity=0.279 Sum_probs=192.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchh-----hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQ-----RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 95 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence 48999999999999975 6899999998754221 12468899999999999999999999999999999999997
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 96 ~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 96 T-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp E-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred C-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 5 8999997643 358889999999999999999999 8999999999999999999999999999986643221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ....||+.|+|||++.....++.++|||||||++|||++|.+||..... .+....+
T Consensus 168 ~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i 225 (346)
T 1ua2_A 168 AY----------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRI 225 (346)
T ss_dssp CC----------------CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred cC----------------CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence 11 2345689999999976656688999999999999999999999865321 1111111
Q ss_pred Hhhccc----cCC----CchhchHH----HHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEE----ENP----LSDMVDAM----LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~----~~~----~~~~~d~~----l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... .++ +.+.+... .............+.+++.+|++.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111100 000 00000000 0000000122356889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.76 Aligned_cols=257 Identities=22% Similarity=0.256 Sum_probs=190.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-----hhhHHHHHHHHHHHHhcC---CCceeeeEEEEEcCC-----cc
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-----EQRHREFVTEVQAIAKVK---HPNIVKLRAYYWAPD-----EK 478 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~-----~~ 478 (707)
+.||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++.... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 4799999999999995 578999999986332 111246677888877775 999999999998765 36
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccc
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla 558 (707)
++||||+. |+|.+++.... ...+++..+..|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 95 ~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred EEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 89999997 69999998654 2349999999999999999999999 89999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~~~-----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----- 224 (308)
T 3g33_A 168 RIYSYQMA-----------------LTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSE----- 224 (308)
T ss_dssp TTSTTCCC-----------------SGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----
T ss_pred cccCCCcc-----------------cCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence 76542111 133467999999999765 6689999999999999999999999965322
Q ss_pred chhHHHHHHhhccc----cCCCc-hhchHHHHh------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEE----ENPLS-DMVDAMLLQ------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~----~~~~~-~~~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+....+...... .++.. ...+..+.. .....+....+.+++.+|++.||++|||+.|+++
T Consensus 225 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 225 -ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp -HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1222222111110 00000 000000000 0000123356789999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=329.16 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=179.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch-h-hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE-Q-RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|.. .+++.||||++..... . ..+.+..+...++.++||||+++++++.+++..++||||++ |+
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence 4799999999999996 4789999999876522 2 22344455555788899999999999999999999999997 58
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
|.+++.... .....+++..+..|+.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++........
T Consensus 92 l~~~l~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 166 (290)
T 3fme_A 92 LDKFYKQVI-DKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK- 166 (290)
T ss_dssp HHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred hHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccccc-
Confidence 888875421 012369999999999999999999999 6 9999999999999999999999999999766432211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCC---CCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEAR---VPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
....||+.|+|||++ ..+..++.++||||||+++|||+||+.||..... ....+...
T Consensus 167 ----------------~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~ 226 (290)
T 3fme_A 167 ----------------DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----PFQQLKQV 226 (290)
T ss_dssp -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----HHHHHHHH
T ss_pred ----------------cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----hHHHHHHH
Confidence 123468899999986 2446788999999999999999999999964221 11112222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ + .......+.+++.+|++.||++|||+.++++
T Consensus 227 ~~~~~~~~-~--------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 VEEPSPQL-P--------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHSCCCCC-C--------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hccCCCCc-c--------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111110 0 0112345789999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=342.54 Aligned_cols=208 Identities=22% Similarity=0.307 Sum_probs=162.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 484 (707)
+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++... +..|+||||
T Consensus 32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 111 (432)
T 3n9x_A 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111 (432)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence 48999999999999964 6889999999764 233457889999999999999999999999776 567999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+. |+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 112 ~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 112 AD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred CC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 86 69999998643 59999999999999999999999 89999999999999999999999999999876533
Q ss_pred CCCCCCCCC---CcCC---CCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 565 GNNPSSSGG---FMGG---ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 565 ~~~~~~~~~---~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
......... ...+ ...........||+.|+|||++.....++.++|||||||++|||++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 211000000 0000 0000001345679999999986666789999999999999999998766554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.28 Aligned_cols=238 Identities=18% Similarity=0.199 Sum_probs=181.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC---chhhHHHHHHHH---HHHHhcCCCceeeeE-------EEEEcCCc-
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEV---QAIAKVKHPNIVKLR-------AYYWAPDE- 477 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~~~- 477 (707)
+.||+|+||+||+|.. .+|+.||||++... .....+.|.+|+ +++++++|||||+++ +++..++.
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 4899999999999995 57899999998743 334457899999 556666899999998 77665543
Q ss_pred ----------------ceEEEEeecCCChHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 005226 478 ----------------KLLISDFISNGNLANALRGRNGQ--PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKP 539 (707)
Q Consensus 478 ----------------~~lV~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 539 (707)
.++||||+ +|+|.+++...... ....++|..++.|+.||+.||+|||+ .+|+||||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp 234 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 234 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 78999999 68999999754211 11235578999999999999999999 8999999999
Q ss_pred CCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC----------CCCCchh
Q 005226 540 SNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG----------NRPMQKW 609 (707)
Q Consensus 540 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~ 609 (707)
+|||++.++.+||+|||+|+..... .....| +.|+|||++... ..++.++
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~~-------------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 294 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGAR-------------------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF 294 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTCE-------------------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred HHEEEcCCCCEEEEechhheecCCc-------------------ccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence 9999999999999999999853311 022345 889999997652 2688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCC
Q 005226 610 DVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADP 689 (707)
Q Consensus 610 DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP 689 (707)
|||||||++|||++|+.||.......... ++ .. . .......+.+++.+||+.||
T Consensus 295 DvwSlG~il~elltg~~Pf~~~~~~~~~~------~~---~~-~----------------~~~~~~~~~~li~~~L~~dp 348 (377)
T 3byv_A 295 DAWALGLVIYWIWCADLPITKDAALGGSE------WI---FR-S----------------CKNIPQPVRALLEGFLRYPK 348 (377)
T ss_dssp HHHHHHHHHHHHHHSSCCC------CCSG------GG---GS-S----------------CCCCCHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHHHCCCCCcccccccchh------hh---hh-h----------------ccCCCHHHHHHHHHHcCCCc
Confidence 99999999999999999996543221100 00 00 0 01112457889999999999
Q ss_pred CCCCChHHHHH
Q 005226 690 EVRPRMKNVSE 700 (707)
Q Consensus 690 ~~RPs~~~v~~ 700 (707)
++||++.++++
T Consensus 349 ~~Rpt~~e~l~ 359 (377)
T 3byv_A 349 EDRLLPLQAME 359 (377)
T ss_dssp GGCCCHHHHHT
T ss_pred hhCCCHHHHhh
Confidence 99999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=348.96 Aligned_cols=244 Identities=27% Similarity=0.361 Sum_probs=194.0
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||+||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 348999999999999975 78999999986432 223477899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc---CCCCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~ 565 (707)
+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++......
T Consensus 107 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 9999997543 58999999999999999999999 8999999999999995 45679999999998654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. ....||+.|+|||++.. .++.++||||+||++|||++|+.||..... ..+...
T Consensus 179 ~~-----------------~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~ 233 (486)
T 3mwu_A 179 KM-----------------KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKR 233 (486)
T ss_dssp --------------------CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cc-----------------CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 11 22357999999999753 588999999999999999999999965321 222222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... + ........+.+++.+||+.||++|||+.++++
T Consensus 234 i~~~~~~~~~------~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 234 VETGKYAFDL------P------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHHTCCCSCS------G------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCC------c------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 2221110000 0 01122345789999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=323.44 Aligned_cols=240 Identities=25% Similarity=0.327 Sum_probs=193.5
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 348999999999999975 67889999986542 12236789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 169 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR- 169 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB-
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccccc-
Confidence 99999997643 58999999999999999999999 8999999999999999999999999999865432110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....|+..|+|||++.. ..++.++||||||+++|||++|+.||..... ......+.
T Consensus 170 -----------------~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~ 225 (284)
T 2vgo_A 170 -----------------RTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIV 225 (284)
T ss_dssp -----------------CCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH
T ss_pred -----------------ccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHh
Confidence 22346899999999665 6778999999999999999999999964321 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+. ......+.+++.+|++.||.+||++.++++
T Consensus 226 ---~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 226 ---NVDLKFP-------------PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---TTCCCCC-------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccccCCC-------------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111111 112245679999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=330.43 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=194.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 487 (707)
+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 47999999999999975 7899999998754 23445779999999999999999999998854 4678999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK-----FVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
|+|.+++.... .....+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~ 167 (279)
T 2w5a_A 92 GDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 167 (279)
T ss_dssp EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred CCHHHHHHhhc-ccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeec
Confidence 99999997532 112358999999999999999999999 56 9999999999999999999999999997654
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
.... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.... ...+
T Consensus 168 ~~~~----------------~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~ 224 (279)
T 2w5a_A 168 HDTS----------------FAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKEL 224 (279)
T ss_dssp --CH----------------HHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHH
T ss_pred cccc----------------cccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHH
Confidence 2110 0012356889999998665 577899999999999999999999986532 1223
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
.+.+........+ ......+.+++.+||+.||++||++.+|++.+.
T Consensus 225 ~~~i~~~~~~~~~---------------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 225 AGKIREGKFRRIP---------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHTCCCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHhhcccccCC---------------cccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 3333222111100 112345789999999999999999999987653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=332.58 Aligned_cols=259 Identities=32% Similarity=0.571 Sum_probs=209.3
Q ss_pred cCCcccHHHHHHHHhcCcCCCCCCCCCCCCCCCCCce--eceeEeCCCCCCCCCcEEEEEcCCCCccc--cCCCCcCCCC
Q 005226 18 FALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCR--WSGISCMNITGFPDPRVVGVAISGKNVRG--YIPSELGSLI 93 (707)
Q Consensus 18 ~~~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~~C~--w~gv~c~~~~~~~~~~v~~L~L~~n~l~~--~~~~~l~~l~ 93 (707)
.|.++|..||++||+++. ||. .+++|+.+ .+||. |.||+|...+. ..+|+.|+|++|++.+ .+|..|.+++
T Consensus 2 ~c~~~~~~aL~~~k~~~~-~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~--~~~l~~L~L~~~~l~~~~~~~~~l~~l~ 76 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLG-NPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQ--TYRVNNLDLSGLNLPKPYPIPSSLANLP 76 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CCG-GGTTCCTT-SCTTTTCSTTEEECCSSS--CCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred CCCHHHHHHHHHHHHhcC-Ccc-cccCCCCC-CCCCcCCCcceEeCCCCC--CceEEEEECCCCCccCCcccChhHhCCC
Confidence 467889999999999996 665 78999864 36787 99999975331 2689999999999998 8899999999
Q ss_pred CCCEEEccc-CCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhh
Q 005226 94 YLRRLNLHN-NNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLIL 172 (707)
Q Consensus 94 ~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 172 (707)
+|++|+|++ |.+++.+|..|.++++|++|+|++|+|++.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|
T Consensus 77 ~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 156 (313)
T 1ogq_A 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEEC
Confidence 999999994 9999888988989999999999999888888888888888888888888888888888888888888888
Q ss_pred cCCcccccCCCcccccCC-CccEEeccCCCCCCCCCcc------------------------------------------
Q 005226 173 ARNKFSGQIPAGIWPELE-NLVQLDLSDNDFKGPIPND------------------------------------------ 209 (707)
Q Consensus 173 ~~N~l~~~lp~~~~~~l~-~L~~L~ls~N~l~~~~p~~------------------------------------------ 209 (707)
++|+|+|.+|..+ ..++ +|++|+|++|++++.+|..
T Consensus 157 ~~N~l~~~~p~~l-~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 157 DGNRISGAIPDSY-GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CSSCCEEECCGGG-GCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cCCcccCcCCHHH-hhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceee
Confidence 8888876666554 2343 5555555554444333222
Q ss_pred ----hhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCCCCCCCC
Q 005226 210 ----LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSC 284 (707)
Q Consensus 210 ----~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~~~~~~c 284 (707)
+..+++| ++|+|++|+|++.+|..+..+++|+.|++++|+++|.+|....+.++..+.+.+|+++||.|+. .|
T Consensus 236 ~~~~~~~l~~L-~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 236 DLGKVGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp BGGGCCCCTTC-CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ecCcccccCCC-CEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 3344566 6778888888888898999999999999999999999999888899999999999999998876 46
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=338.66 Aligned_cols=261 Identities=18% Similarity=0.212 Sum_probs=194.4
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC--------CCceeeeEEEEE----cCCcc
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK--------HPNIVKLRAYYW----APDEK 478 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~----~~~~~ 478 (707)
.+.||+|+||+||+|.. .+++.||||++..... ..+.+.+|++++++++ |+||+++++++. .....
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc-chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 34799999999999985 4688999999976533 3477899999999996 788999999997 45678
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCC---------
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDF--------- 548 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~--------- 548 (707)
++||||+ +|+|.+++.... ...+++..+..|+.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 9999999 667777775442 2359999999999999999999999 7 999999999999999775
Q ss_pred ----------------------------------------CeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccc
Q 005226 549 ----------------------------------------QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588 (707)
Q Consensus 549 ----------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (707)
.+||+|||+++...... ....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------------------~~~~ 254 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------------------TEDI 254 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------------------CSCC
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------------------ccCC
Confidence 79999999998654221 2235
Q ss_pred cCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccC--------------
Q 005226 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEEN-------------- 654 (707)
Q Consensus 589 gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 654 (707)
||..|+|||++.. ..++.++|||||||++|||+||+.||............+....+........
T Consensus 255 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 255 QTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp SCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 6999999999765 6688999999999999999999999976544321111111111111111000
Q ss_pred ----CC--------chhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 655 ----PL--------SDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 655 ----~~--------~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.. ....+...............+.+|+.+||+.||++|||++|+++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00 00000001111123455678899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.86 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=199.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .+++.||||++...... .++.+|+++++.++| +++..+..++...+..++||||+ +++|
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 4799999999999996 57899999987654332 457899999999976 56666667777788889999999 9999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++.... ..+++..++.|+.||+.||+|||+ ++||||||||+|||+ +.++.+||+|||+++........
T Consensus 90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 99998543 259999999999999999999999 899999999999999 68899999999999876543221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
. ...+.......||..|+|||++.. ..++.++|||||||++|||++|+.||....... .......+.
T Consensus 163 ~---------~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~ 229 (483)
T 3sv0_A 163 Q---------HIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKIS 229 (483)
T ss_dssp C---------BCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS---HHHHHHHHH
T ss_pred c---------ccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchh---HHHHHHHHh
Confidence 1 112223345678999999999765 678999999999999999999999997644321 111111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..... ..++. + ......++.+++..||+.||++||++.+|++.|+++
T Consensus 230 ~~~~~-----~~~~~-l-----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 230 EKKVA-----TSIEA-L-----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHHH-----SCHHH-H-----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred hcccc-----ccHHH-H-----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 10000 00000 0 012235788999999999999999999999999876
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=336.41 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=192.6
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||.||+|...+ .+|+|+++... ....+.|.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 3589999999999999754 58999987542 2233567889999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++ ++.+||+|||+++..........
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 999997643 358999999999999999999999 8999999999999998 67999999999876532211100
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
........|+..|+|||++.. ...++.++||||||+++|||++|+.||..... ..
T Consensus 188 -----------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~ 250 (319)
T 2y4i_B 188 -----------EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EA 250 (319)
T ss_dssp -----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HH
T ss_pred -----------ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HH
Confidence 001123457899999998653 24578899999999999999999999964321 12
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
....+......... . ......+.+++.+||+.||++||++.+++++|+++.
T Consensus 251 ~~~~~~~~~~~~~~-----~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 251 IIWQMGTGMKPNLS-----Q---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHHHHHTTCCCCCC-----C---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred HHHHhccCCCCCCC-----c---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22222222111100 0 011234679999999999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.92 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=194.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... ++..||||++.... ....+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 48999999999999964 78899999997543 33347789999999999999999999999765 3578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
. |+|.+++... .+++..+..|+.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 113 ~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 113 E-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp S-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred C-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 7 5999999754 49999999999999999999999 899999999999999999999999999998765332
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
..... .....||+.|+|||++..+..++.++|||||||++|||++|+.||...... +....
T Consensus 183 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~ 243 (364)
T 3qyz_A 183 DHTGF-------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNH 243 (364)
T ss_dssp CBCCT-------------TCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG------GHHHH
T ss_pred Ccccc-------------ccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH------HHHHH
Confidence 21110 123457999999998766566899999999999999999999999754321 22222
Q ss_pred HHhhccccCC--CchhchHHHHh---h----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENP--LSDMVDAMLLQ---E----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~--~~~~~d~~l~~---~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... .....+..... . .........+.+++.+|++.||++|||+.|+++
T Consensus 244 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2111111000 00000000000 0 000112356789999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.52 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=190.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 104 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence 47999999999999975 58899999987765555688999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++..........
T Consensus 105 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--- 174 (302)
T 2j7t_A 105 AIMLELD----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--- 174 (302)
T ss_dssp HHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred HHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc---
Confidence 9987532 358999999999999999999999 899999999999999999999999999986443211100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....|+..|+|||++. .+..++.++||||||+++|||++|+.||..... ........
T Consensus 175 -------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~ 235 (302)
T 2j7t_A 175 -------------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA 235 (302)
T ss_dssp -----------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH
T ss_pred -------------ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHh
Confidence 1234688999999863 346778999999999999999999999864321 11111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ...+ ... ........+.+++.+||+.||++|||+.++++
T Consensus 236 ~---~~~~--~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 236 K---SDPP--TLL--------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp H---SCCC--CCS--------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c---cCCc--ccC--------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 1110 000 01112345789999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=349.20 Aligned_cols=244 Identities=26% Similarity=0.340 Sum_probs=190.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 458999999999999975 78899999987543 223477899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~ 565 (707)
+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||+++......
T Consensus 122 ~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 122 ELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 9999987543 58999999999999999999999 899999999999999764 559999999998765321
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. ....||+.|+|||++. ..++.++||||+||++|||++|+.||..... ..+...
T Consensus 194 ~~-----------------~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~ 248 (494)
T 3lij_A 194 KM-----------------KERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRK 248 (494)
T ss_dssp CB-----------------CCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cc-----------------cccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 11 2245799999999864 4688999999999999999999999965321 222222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... + ........+.+++.+||+.||++|||+.++++
T Consensus 249 i~~~~~~~~~------~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 249 VEKGKYTFDS------P------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHTCCCCCS------G------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCCCCc------h------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 2221111000 0 00122345789999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.57 Aligned_cols=191 Identities=25% Similarity=0.313 Sum_probs=163.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhc------CCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKV------KHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||+||+|... +++.||||++..... ..+.+.+|+++++.+ +|+||+++++++...+..++||||+
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR-FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCccc-hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 48999999999999865 589999999976433 336778899998887 5679999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC--eEEecccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ--PYISDFGLSRLINI 563 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~~~~ 563 (707)
. |+|.+++.... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+|+....
T Consensus 182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 6 69999998654 2359999999999999999999999 79999999999999999987 99999999975432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
.. ....||+.|+|||++.. ..++.++|||||||++|||+||++||...
T Consensus 255 ~~-------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 255 RV-------------------YTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CC-------------------CSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc-------------------cccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 11 22356899999999765 67899999999999999999999999754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=350.62 Aligned_cols=244 Identities=28% Similarity=0.373 Sum_probs=196.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 458999999999999975 78999999986542 23457799999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE---cCCCCeEEeccccccccccc
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL---DNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~DfGla~~~~~~ 564 (707)
|+|.+++.... .+++..+..|+.||+.||+|||+ ++|+||||||+||++ +.++.+||+|||+++.....
T Consensus 111 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 111 GELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp CBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 99999998653 59999999999999999999999 899999999999999 56789999999999866422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.. .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ......
T Consensus 183 ~~-----------------~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~ 237 (484)
T 3nyv_A 183 KK-----------------MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN------EYDILK 237 (484)
T ss_dssp CS-----------------HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHH
T ss_pred cc-----------------cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCC------HHHHHH
Confidence 11 123457999999998653 68899999999999999999999997532 122333
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+......... + ........+.+++.+||+.||++|||+.++++
T Consensus 238 ~i~~~~~~~~~------~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 238 KVEKGKYTFEL------P------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHCCCCCCS------G------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCCCCCC------c------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 33222111000 0 01122345789999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=328.29 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=187.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--------------CCc
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--------------PDE 477 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------------~~~ 477 (707)
+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.. .+.
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 47999999999999976 589999999887666666889999999999999999999998843 356
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-CCCCeEEeccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFG 556 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfG 556 (707)
.++||||++ |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|||
T Consensus 97 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp EEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred eeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 789999997 6999999743 48999999999999999999999 8999999999999997 56799999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
+++.......... ......++..|+|||.+.....++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 230 (320)
T 2i6l_A 167 LARIMDPHYSHKG-------------HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--- 230 (320)
T ss_dssp TCBCC---------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred cccccCCCccccc-------------ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---
Confidence 9987642211110 012345688999999876656789999999999999999999999975321
Q ss_pred ccchhHHHHHHhhccccC---------CCchhchHHHHhhh-----hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEEN---------PLSDMVDAMLLQEV-----HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~---------~~~~~~d~~l~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+........ .....+........ .......++.+++.+|++.||++|||++++++
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 231 ---LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp ---HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111111111110000 00000000000000 00123456889999999999999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.68 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=188.5
Q ss_pred ceecccCeeEEEEEEeC--CC--ceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG--NG--IPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||+||+|.+. ++ ..||||+++.. .....+.+.+|++++++++||||+++++++..+. .++|+||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 47999999999999853 23 36899988754 2234578999999999999999999999997654 89999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 103 PLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp TTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred cCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 9999999997642 358999999999999999999999 899999999999999999999999999998764322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 644 (707)
... .......++..|+|||++.. ..++.++||||||+++|||++ |+.||.... ......
T Consensus 176 ~~~-------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~ 235 (291)
T 1u46_A 176 DHY-------------VMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILH 235 (291)
T ss_dssp CEE-------------EC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred cch-------------hhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCC------HHHHHH
Confidence 110 01123345778999998654 567889999999999999999 999986432 122222
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.+...... .+ ........+.+++.+||+.||++||++.++++.|+++.
T Consensus 236 ~~~~~~~~-~~-------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 236 KIDKEGER-LP-------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHTSCCC-CC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHccCCC-CC-------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 22211100 00 00122356789999999999999999999999998863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=328.93 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=189.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 482 (707)
.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++..++ .++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence 458999999999999965 678999999865421 12346889999999999999999999987654 89999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEecccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGLSR 559 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~ 559 (707)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||+++
T Consensus 94 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 94 ELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp ECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred ecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 9999999999997543 68999999999999999999999 89999999999999987654 9999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV--PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
....... .....||+.|+|||++. ....++.++|||||||++|||++|+.||......
T Consensus 166 ~~~~~~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 225 (322)
T 2ycf_A 166 ILGETSL-----------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--- 225 (322)
T ss_dssp ECCCCHH-----------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---
T ss_pred ecccccc-----------------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---
Confidence 6542100 02235789999999863 3467789999999999999999999999754322
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+...+...... .. +.. .......+.+++.+||+.||++||++.++++
T Consensus 226 --~~~~~~~~~~~~~------~~-~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 226 --VSLKDQITSGKYN------FI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --SCHHHHHHHTCCC------CC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHhCccc------cC-chh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1222222221110 00 000 0122356789999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=333.17 Aligned_cols=266 Identities=22% Similarity=0.264 Sum_probs=193.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 485 (707)
+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++..+ ...++||||+
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence 47999999999999975 68999999997543 33446788999999999999999999998764 5679999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
. |+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 97 Q-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp S-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred C-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 7 6999999753 48999999999999999999999 899999999999999999999999999998765332
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.......+ .........||+.|+|||++..+..++.++|||||||++|||++|+.||..... ......
T Consensus 167 ~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~ 234 (353)
T 2b9h_A 167 ADNSEPTG------QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY------RHQLLL 234 (353)
T ss_dssp -------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH
T ss_pred ccccCccc------cccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHH
Confidence 21110000 000012346799999999876557789999999999999999999999975321 111111
Q ss_pred HHhhcccc---CCCchhchHHHHhh-------------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEE---NPLSDMVDAMLLQE-------------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~---~~~~~~~d~~l~~~-------------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....... .............. ........++.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11111000 00000000000000 000123356789999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=333.59 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=178.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||.||+|.. .++..||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 100 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence 4899999999999985 478899999987543 23346788999999999999999999999999999999999999999
Q ss_pred HHHHhCC---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 491 ANALRGR---NGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+++... .......+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 9999641 11123458999999999999999999999 89999999999999999999999999999866432211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
... .......||+.|+|||++.....++.++||||||+++|||++|+.||...... .......
T Consensus 178 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~ 240 (303)
T 2vwi_A 178 TRN-----------KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTL 240 (303)
T ss_dssp ---------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHH
T ss_pred cch-----------hhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------hHHHHHh
Confidence 100 00123457899999998654346789999999999999999999999753221 1111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ ....+.. ........+.+++.+||+.||.+||++.++++
T Consensus 241 ~~~~~~~~-~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLE-TGVQDKE-----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTT-C-----C-----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccc-cccccch-----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11000000 0000000 00112346789999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=336.10 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=176.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 483 (707)
+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++... ...++|+|
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 4799999999999985 47899999999754 233457788999999999999999999999764 55799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 115 LM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred cc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 99 78999998752 59999999999999999999999 8999999999999999999999999999976432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....||..|+|||++.....++.++|||||||++|||++|+.||..... .+..
T Consensus 185 ~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~l 239 (367)
T 2fst_X 185 EM-------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQL 239 (367)
T ss_dssp -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHH
T ss_pred cC-------------------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence 10 2235689999999977656789999999999999999999999965321 1111
Q ss_pred HHHHhhccccCC--CchhchHHHH---hh----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENP--LSDMVDAMLL---QE----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~--~~~~~d~~l~---~~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+......... +..+...... .. .........+.+|+.+|+..||++|||+.++++
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 111111110000 0000000000 00 000112356789999999999999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.07 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=194.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---------hhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---------EQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 481 (707)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 47999999999999975 68999999986542 122467889999999995 99999999999999999999
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 103 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 103 FDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999997643 58999999999999999999999 89999999999999999999999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV-----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
...... ....++..|+|||++. ....++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---- 233 (298)
T 1phk_A 175 DPGEKL-----------------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---- 233 (298)
T ss_dssp CTTCCB-----------------CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred CCCccc-----------------ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc----
Confidence 422111 2234688999999864 23567899999999999999999999986422
Q ss_pred ccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......+........ .+ ........+.+++.+||+.||++||++.++++
T Consensus 234 --~~~~~~~~~~~~~~~~------~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 234 --QMLMLRMIMSGNYQFG------SP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHHHHHHHHHTCCCCC------TT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HHHHHHHHhcCCcccC------cc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1122222211111000 00 00122346789999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=334.92 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=186.7
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch-----------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC-----
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE-----------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD----- 476 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 476 (707)
+.||+|+||.||+|...+|..||||++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 48999999999999988899999999854321 12367899999999999999999999996533
Q ss_pred cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 477 EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
..++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEecC
Confidence 4689999997 69999988543 369999999999999999999999 899999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
+++........ ....+|+.|+|||++.....++.++|||||||++|||++|+.||......
T Consensus 180 ~~~~~~~~~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-- 240 (362)
T 3pg1_A 180 LAREDTADANK-----------------THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-- 240 (362)
T ss_dssp C--------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred ccccccccccc-----------------ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH--
Confidence 99754322111 22356889999998776567899999999999999999999999753211
Q ss_pred ccchhHHHHHHhhccccCCCchh---chHHHHh--------------hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 637 IEVPDLVRWVKKGFEEENPLSDM---VDAMLLQ--------------EVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~~~---~d~~l~~--------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
.....+......... .+. ....... ..........+.+++.+|++.||++|||+.+++
T Consensus 241 ----~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 241 ----NQLNKIVEVVGTPKI-EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp ----HHHHHHHHHHCCCCH-HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ----HHHHHHHHHcCCCCh-HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 111111111110000 000 0000000 000012235678999999999999999999998
Q ss_pred H
Q 005226 700 E 700 (707)
Q Consensus 700 ~ 700 (707)
+
T Consensus 316 ~ 316 (362)
T 3pg1_A 316 R 316 (362)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.54 Aligned_cols=253 Identities=20% Similarity=0.253 Sum_probs=184.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||.||+|... ++..||||++... .....+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 47999999999999864 6889999998754 2334567889999999999999999999997765 5699999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|++ |+|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 111 ~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 111 LMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 997 589998863 38999999999999999999999 8999999999999999999999999999976542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +..
T Consensus 180 ~~~-----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~ 235 (371)
T 2xrw_A 180 SFM-----------------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI------DQW 235 (371)
T ss_dssp ---------------------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred ccc-----------------cCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 211 022456899999999765 67889999999999999999999999753211 111
Q ss_pred HHHHhhcc-------------------ccCCCch-hchHHHHh------hhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 644 RWVKKGFE-------------------EENPLSD-MVDAMLLQ------EVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 644 ~~~~~~~~-------------------~~~~~~~-~~d~~l~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
..+..... ....+.. .++..+.. ..........+.+++.+|+..||++|||++|
T Consensus 236 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e 315 (371)
T 2xrw_A 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315 (371)
T ss_dssp HHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH
Confidence 11110000 0000000 00000000 0001223567899999999999999999999
Q ss_pred HHH
Q 005226 698 VSE 700 (707)
Q Consensus 698 v~~ 700 (707)
+++
T Consensus 316 ~l~ 318 (371)
T 2xrw_A 316 ALQ 318 (371)
T ss_dssp HHH
T ss_pred HhC
Confidence 986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=347.34 Aligned_cols=243 Identities=27% Similarity=0.334 Sum_probs=191.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-------------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcc
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-------------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK 478 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 478 (707)
+.||+|+||+||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 121 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 48999999999999975 678999999865421 2246789999999999999999999999999999
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC---CeEEecc
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF---QPYISDF 555 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~Df 555 (707)
++||||+++|+|.+++.... .+++..+..|+.||+.||+|||+ .+|+||||||+||+++.++ .+||+||
T Consensus 122 ~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999997643 59999999999999999999999 8999999999999998776 6999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~ 635 (707)
|+++........ ....||+.|+|||++. ..++.++||||+||++|+|++|+.||.....
T Consensus 194 g~a~~~~~~~~~-----------------~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-- 252 (504)
T 3q5i_A 194 GLSSFFSKDYKL-----------------RDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-- 252 (504)
T ss_dssp TTCEECCTTSCB-----------------CCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred CCCEEcCCCCcc-----------------ccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999866432111 2245799999999865 4688999999999999999999999975321
Q ss_pred CccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+...+... ... .+.. ........+.+++.+|++.||.+|||++|+++
T Consensus 253 ----~~~~~~i~~~---~~~----~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 ----QDIIKKVEKG---KYY----FDFN-----DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp ----HHHHHHHHHC---CCC----CCHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHHcC---CCC----CCcc-----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222222221 100 0000 00112356789999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=332.20 Aligned_cols=253 Identities=22% Similarity=0.257 Sum_probs=189.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcc------eEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEK------LLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~lV~ 482 (707)
.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.. ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 347999999999999864 68999999987642 33357889999999999999999999999887655 9999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+. |+|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 9997 689888843 38999999999999999999999 899999999999999999999999999997554
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
... ....||+.|+|||++.....++.++|||||||++|||++|+.||..... .+.
T Consensus 196 ~~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~ 250 (371)
T 4exu_A 196 AEM-------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQ 250 (371)
T ss_dssp -----------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHH
T ss_pred cCc-------------------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh------HHH
Confidence 211 1234688999999977657789999999999999999999999975321 111
Q ss_pred HHHHHhhccccCC-----Cc-hhchHHHHhh---------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENP-----LS-DMVDAMLLQE---------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~-----~~-~~~d~~l~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+......... +. .......... .........+.+++.+|++.||++|||++|+++
T Consensus 251 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 251 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1111111100000 00 0000000000 000112457889999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.07 Aligned_cols=243 Identities=22% Similarity=0.330 Sum_probs=190.0
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||.||+|... +|..||+|.+.... ....+.+|++++++++||||+++++++..++..++||||+++|+|.
T Consensus 35 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (314)
T 3com_A 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112 (314)
T ss_dssp EECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence 47999999999999975 58999999987543 2367899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 113 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~---- 181 (314)
T 3com_A 113 DIIRLRN----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK---- 181 (314)
T ss_dssp HHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC----
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc----
Confidence 9997432 358999999999999999999999 89999999999999999999999999999765422111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....|+..|+|||++.. ..++.++||||||+++|||++|+.||..... ............
T Consensus 182 ------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 242 (314)
T 3com_A 182 ------------RNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTNPP 242 (314)
T ss_dssp ------------BCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC
T ss_pred ------------cCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCC
Confidence 122356899999999765 5688999999999999999999999964321 111111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ........+.+++.+||+.||++||++.++++
T Consensus 243 ~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 PTFR-------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCS-------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccC-------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 00112345789999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.10 Aligned_cols=255 Identities=21% Similarity=0.289 Sum_probs=186.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC---------------
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD--------------- 476 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------------- 476 (707)
+.||+|+||+||+|.. .+|+.||||++..... ...+|++++++++||||+++++++...+
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 4899999999999986 5789999999865432 2347999999999999999999985432
Q ss_pred -----------------------cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 005226 477 -----------------------EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533 (707)
Q Consensus 477 -----------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii 533 (707)
..++||||++ |+|.+.+.... .....+++..+..++.||+.||+|||+ .+|+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~ 163 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI-RSGRSIPMNLISIYIYQLFRAVGFIHS---LGIC 163 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEE
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHH---CcCc
Confidence 3689999998 58887775321 012369999999999999999999999 8999
Q ss_pred ecCCCCCCeEEc-CCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHH
Q 005226 534 HGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVY 612 (707)
Q Consensus 534 HrDlk~~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~ 612 (707)
||||||+||+++ .++.+||+|||+|+........ ....+|+.|+|||++.+...++.++|||
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----------------VAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-----------------CCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-----------------cCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999999999998 6889999999999866432211 2234588999999877656689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccC--------------CCchhchHHHHhhhhhHHHHHHHH
Q 005226 613 SFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEEN--------------PLSDMVDAMLLQEVHAKKEVIAVF 678 (707)
Q Consensus 613 S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~~~l~ 678 (707)
|+||++|||++|+.||...... ..+.+.+.. ..... .+......... ..........+.
T Consensus 227 slG~il~ell~g~~pf~~~~~~-----~~~~~i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 299 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSI-----DQLVRIIQI-MGTPTKEQMIRMNPHYTEVRFPTLKAKDWR-KILPEGTPSLAI 299 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHH-HCCCCHHHHHHHCTTC--CCCCCCCCCCHH-HHSCTTCCHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHH-hCCCCHHHHHHhCcccccccCCccCcccHH-hhCCCCCCHHHH
Confidence 9999999999999999753211 111111111 10000 00000000000 001112335688
Q ss_pred HHHHhccCCCCCCCCChHHHHH
Q 005226 679 HLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 679 ~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+++.+||+.||++|||+.|+++
T Consensus 300 ~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 300 DLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhhCCCHHHHhc
Confidence 9999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=338.01 Aligned_cols=256 Identities=22% Similarity=0.303 Sum_probs=185.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------ceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------KLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e~~ 485 (707)
.++||+|+||+||+|...++..||+|++..... ...+|++++++++||||+++++++...+. .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 348999999999999987777799998765432 22469999999999999999999966543 67999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-CCCCeEEeccccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~~ 564 (707)
+++.+....+... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 8754433332111 12369999999999999999999999 8999999999999999 7899999999999876432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
... ....+|+.|+|||++.+...++.++|||||||++|||++|+.||...... ..+.+
T Consensus 196 ~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~l~~ 253 (394)
T 4e7w_A 196 EPN-----------------VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-----DQLVE 253 (394)
T ss_dssp CCC-----------------CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred CCC-----------------cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence 211 22346889999999776567899999999999999999999999753211 11111
Q ss_pred HHHhhccccC--------------CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEEN--------------PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.. ..... .+...-...+. .........++.+++.+||+.||++|||+.|+++
T Consensus 254 i~~~-~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 254 IIKV-LGTPSREQIKTMNPNYMEHKFPQIRPHPFS-KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHH-HCCCCHHHHHHHCGGGSSSCCCCCCCCCHH-HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHH-hCCCCHHHHHhhChhhhhhccccccCCcHH-HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111 00000 00000000000 0001113357889999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.67 Aligned_cols=257 Identities=26% Similarity=0.320 Sum_probs=186.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~ 484 (707)
.+.||+|+||.||+|... +|+.||||++.... +.+.+|++++++++|||||++++++...+ ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 348999999999999975 68999999986542 22347999999999999999999986432 25689999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINI 563 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~~~ 563 (707)
+++ +|.+.+.... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 135 ~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 135 VPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 975 6766664311 112369999999999999999999999 899999999999999965 5689999999987543
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.... ....||+.|+|||++.....++.++|||||||++|||++|+.||..... ...+.
T Consensus 210 ~~~~-----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~-----~~~l~ 267 (420)
T 1j1b_A 210 GEPN-----------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG-----VDQLV 267 (420)
T ss_dssp TCCC-----------------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred CCCc-----------------eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence 2211 1235689999999977656789999999999999999999999975321 11222
Q ss_pred HHHHhhccc--------cC-----CCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEE--------EN-----PLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~--------~~-----~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.+...-.. .. .+..+....+. .........++.+|+.+||+.||++||++.|+++
T Consensus 268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHH-HHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHH-HhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 222110000 00 00000000000 0001122356889999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=327.40 Aligned_cols=252 Identities=19% Similarity=0.278 Sum_probs=193.6
Q ss_pred ceecccCeeEEEEEEe--CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc------eeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL--GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN------IVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+++++.++|++ ++++++++...+..++||||
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 98 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR-YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL 98 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH-HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc-hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence 4799999999999986 3688999999976533 3477889999999997765 99999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC------------------
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN------------------ 546 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~------------------ 546 (707)
+ +++|.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.
T Consensus 99 ~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~ 171 (339)
T 1z57_A 99 L-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171 (339)
T ss_dssp C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred C-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence 9 899999998653 2358999999999999999999999 89999999999999987
Q ss_pred -CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC
Q 005226 547 -DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 547 -~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~ 625 (707)
++.+||+|||+++...... ....||+.|+|||++.. ..++.++|||||||++|||++|+
T Consensus 172 ~~~~~kl~Dfg~~~~~~~~~-------------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~ 231 (339)
T 1z57_A 172 INPDIKVVDFGSATYDDEHH-------------------STLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGF 231 (339)
T ss_dssp SCCCEEECCCSSCEETTSCC-------------------CSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCceEeeCcccccCcccc-------------------ccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCC
Confidence 6689999999997643211 22356899999999764 67899999999999999999999
Q ss_pred CCCCCCCCCCCccchhHHHHHHhhccccCCCchhch----------------------HHHH--------hhhhhHHHHH
Q 005226 626 SPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVD----------------------AMLL--------QEVHAKKEVI 675 (707)
Q Consensus 626 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----------------------~~l~--------~~~~~~~~~~ 675 (707)
.||...... +....+....... + ..+.. .... ..........
T Consensus 232 ~pf~~~~~~------~~~~~~~~~~~~~-p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 232 TVFPTHDSK------EHLAMMERILGPL-P-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp CSCCCSCHH------HHHHHHHHHHCSC-C-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred CCCCCCChH------HHHHHHHHHhCCC-C-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 999753221 1111111111100 0 00000 0000 0001123456
Q ss_pred HHHHHHHhccCCCCCCCCChHHHHH
Q 005226 676 AVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 676 ~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.+++.+||+.||++|||++|+++
T Consensus 304 ~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhCcCcccccCHHHHhc
Confidence 7899999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.67 Aligned_cols=249 Identities=14% Similarity=0.065 Sum_probs=174.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHHHHHHHHhc--CCCceeeeE-------EEEEcCC--
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVTEVQAIAKV--KHPNIVKLR-------AYYWAPD-- 476 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~~~~-- 476 (707)
.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.+++.+ +||||++++ +++..++
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 358999999999999965 789999999987542 3346677886555555 699988755 5554433
Q ss_pred ---------------cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCCceec
Q 005226 477 ---------------EKLLISDFISNGNLANALRGRNGQPSTSLSWSTR------LRIAKGTARGLAYLHECSPRKFVHG 535 (707)
Q Consensus 477 ---------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~iiHr 535 (707)
..++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+ ++|+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHr 218 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHG 218 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEET
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccC
Confidence 2699999998 89999998642 13455566 7888999999999999 899999
Q ss_pred CCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHH
Q 005226 536 DIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSF 614 (707)
Q Consensus 536 Dlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~ 614 (707)
||||+|||++.++.+||+|||+|+...... ....+|+.|+|||++... ..++.++|||||
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSl 279 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-------------------PASSVPVTYAPREFLNASTATFTHALNAWQL 279 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEE-------------------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHH
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCc-------------------cCccCCcCCcChhhccCCCCCcCccccHHHH
Confidence 999999999999999999999998654211 123457899999997531 467899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC
Q 005226 615 GVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR 694 (707)
Q Consensus 615 Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 694 (707)
||++|||+||+.||............. ........ .....+ ........+.+++.+||+.||++|||
T Consensus 280 G~il~elltg~~Pf~~~~~~~~~~~~~------~~~~~~~~-~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 280 GLSIYRVWCLFLPFGLVTPGIKGSWKR------PSLRVPGT-DSLAFG------SCTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp HHHHHHHHHSSCSTTBCCTTCTTCCCB------CCTTSCCC-CSCCCT------TSSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred HHHHHHHHhCCCCCCCcCcccccchhh------hhhhhccc-cccchh------hccCCCHHHHHHHHHHcCCChhhCCC
Confidence 999999999999997653321100000 00000000 000000 00122356789999999999999999
Q ss_pred hHHHHH
Q 005226 695 MKNVSE 700 (707)
Q Consensus 695 ~~~v~~ 700 (707)
+.++++
T Consensus 347 ~~e~l~ 352 (371)
T 3q60_A 347 PLEAME 352 (371)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.20 Aligned_cols=257 Identities=20% Similarity=0.289 Sum_probs=179.3
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc-------ceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE-------KLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------~~lV~e~ 484 (707)
+.||+|+||.||+|... ++..||||++....... ..+.+|++.++.++||||+++++++...+. .++||||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTTCC-CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 47999999999999974 68999999886543322 456788899999999999999999976443 6899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCceecCCCCCCeEEcC-CCCeEEecccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH--ECSPRKFVHGDIKPSNILLDN-DFQPYISDFGLSRLI 561 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~iiHrDlk~~NIll~~-~~~~kl~DfGla~~~ 561 (707)
+++ +|.+.+.... .....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 108 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 108 VPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp CSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred ccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 976 5555443211 11236899999999999999999999 7 89999999999999997 899999999999866
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... ....||+.|+|||++.....++.++|||||||++|||++|+.||..... ..
T Consensus 183 ~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~ 239 (360)
T 3e3p_A 183 SPSEPN-----------------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS------AG 239 (360)
T ss_dssp CTTSCC-----------------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HH
T ss_pred CCCCCc-----------------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh------HH
Confidence 532211 2234689999999976656689999999999999999999999975321 11
Q ss_pred HHHHHHhhccccCCCchhchHH----------------HHh--hhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAM----------------LLQ--EVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~----------------l~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+........ .+..... ... ..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 240 QLHEIVRVLGCPS--REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHHHHCCCC--HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCCC--HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111110000 0000000 000 0001113467889999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.81 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=187.2
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc------CCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA------PDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~e~ 484 (707)
+.||+|+||.||+|.. .+++.||||++...... ...+.+|+.+++++ +||||+++++++.. .+..++||||
T Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 4899999999999997 47899999998755433 37789999999999 89999999999987 4577999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999998643 2368999999999999999999999 89999999999999999999999999998765422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
... .....|+..|+|||++.. +..++.++||||||+++|||++|+.||..... .
T Consensus 183 ~~~----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~ 240 (326)
T 2x7f_A 183 VGR----------------RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------M 240 (326)
T ss_dssp ------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------H
T ss_pred ccc----------------cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------H
Confidence 110 122356899999998652 35678999999999999999999999864321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+...... ... .......+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~-----~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 RALFLIPRNPAP-----RLK---------SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHSCCC-----CCS---------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhcCccc-----cCC---------ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111000 000 0112245789999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=354.94 Aligned_cols=237 Identities=22% Similarity=0.278 Sum_probs=191.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.++||+|+||.||+|... +++.||||+++... ......+..|..++..+ +||+|+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 358999999999999965 67889999987532 22346788899999988 79999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++..+ .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999998643 59999999999999999999999 8999999999999999999999999999985432211
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..... ..+.+.+
T Consensus 498 ~----------------~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i 554 (674)
T 3pfq_A 498 T----------------TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSI 554 (674)
T ss_dssp C----------------BCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred c----------------cccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHH
Confidence 1 123467999999999765 6789999999999999999999999975321 1222222
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCCh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 695 (707)
. .....+. .....++.+|+.+||+.||++||++
T Consensus 555 ~---~~~~~~p-------------~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 555 M---EHNVAYP-------------KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp H---SSCCCCC-------------TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred H---hCCCCCC-------------ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1 1111111 1223457899999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.88 Aligned_cols=246 Identities=20% Similarity=0.280 Sum_probs=189.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc----hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG----EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~ 484 (707)
.+.||+|+||.||++... ++..||+|++.... ......+.+|++++++++||||+++++++.. .+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 348999999999999964 68899999987542 2234779999999999999999999999854 4578999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++| |.+++.... ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9876 777776543 2369999999999999999999999 89999999999999999999999999999865422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
..... .....|+..|+|||++... ..++.++||||||+++|||++|+.||.... .....
T Consensus 163 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~ 222 (305)
T 2wtk_C 163 AADDT--------------CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLF 222 (305)
T ss_dssp CSSCE--------------ECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHH
T ss_pred ccccc--------------cccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHH
Confidence 11100 0233578999999986542 234679999999999999999999996421 11222
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.+... ...+. ......+.+++.+||+.||++||+++++++
T Consensus 223 ~~i~~~---~~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 223 ENIGKG---SYAIP-------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHC---CCCCC-------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhcC---CCCCC-------------CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222111 11100 112345678999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=339.14 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=183.2
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+++..++||||+. |+|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4799999999987777789999999986532 25678899999987 89999999999999999999999995 6999
Q ss_pred HHHhCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-------------CCeEEeccc
Q 005226 492 NALRGRNGQPS--TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-------------FQPYISDFG 556 (707)
Q Consensus 492 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-------------~~~kl~DfG 556 (707)
+++........ ....+..++.|+.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 99986542111 112344567899999999999999 899999999999999754 489999999
Q ss_pred ccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC------CCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 557 LSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP------GNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 557 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
+++........... ......||+.|+|||++.. ...++.++|||||||++|||+| |+.||.
T Consensus 174 ~a~~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 174 LCKKLDSGQSSFRT------------NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp TCEECCC--------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred cceecCCCCcccee------------eecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 99876532211100 0123457999999998754 2568899999999999999999 999986
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .............. .... .......++.+++.+||+.||.+|||+.+|++
T Consensus 242 ~~~~-------~~~~i~~~~~~~~~-~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYS-------RESNIIRGIFSLDE-MKCL---------HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTT-------HHHHHHHTCCCCCC-CTTC---------CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cchh-------hHHHHhcCCCCccc-cccc---------ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 4321 11122222111111 0111 11234467889999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.94 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=187.1
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcC--CCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVK--HPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++||| +.+|
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 479999999999999888999999998654 3344578999999999996 5999999999999999999999 5688
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||++++ +.+||+|||+++.........
T Consensus 113 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 113 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 9999998643 58999999999999999999999 89999999999999965 899999999998664322110
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP----------GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
......|++.|+|||++.. ...++.++||||||+++|||++|+.||......
T Consensus 184 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 245 (313)
T 3cek_A 184 --------------VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---- 245 (313)
T ss_dssp --------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----
T ss_pred --------------cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----
Confidence 0123457999999998653 146788999999999999999999999643211
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+........... +.. .....+.+++.+||+.||++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~--~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 246 ISKLHAIIDPNHEIE--FPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHCTTSCCC--CCC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcccccC--Ccc-------------cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111111111000 001 11245788999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.08 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=190.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-----------CCceeeeEEEEEcCC----
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-----------HPNIVKLRAYYWAPD---- 476 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~~---- 476 (707)
+.||+|+||+||+|.. .+++.||||++..... ....+.+|++++++++ ||||+++++++...+
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EeeeecCCeEEEEEEecCCCcEEEEEEecCCcc-chhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 4799999999999996 5789999999976433 3367889999999886 899999999998654
Q ss_pred cceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEc------CCCC
Q 005226 477 EKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLD------NDFQ 549 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~------~~~~ 549 (707)
..++||||+ +++|.+++.... ...+++..+..|+.||+.||+|||+ + +|+||||||+|||++ ..+.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcce
Confidence 678999999 899999998643 2358999999999999999999999 7 999999999999994 4457
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
+||+|||+++...... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||.
T Consensus 177 ~kl~Dfg~a~~~~~~~-------------------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 177 IKIADLGNACWYDEHY-------------------TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp EEECCCTTCEETTBCC-------------------CSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred EEEcccccccccCCCC-------------------CCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9999999998664221 12346899999999765 668999999999999999999999997
Q ss_pred CCCCCCCccchhHHHHHHhhccccC------------------CCchh-------chHHHH-hhhhhHHHHHHHHHHHHh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEEN------------------PLSDM-------VDAMLL-QEVHAKKEVIAVFHLALA 683 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~-------~d~~l~-~~~~~~~~~~~l~~l~~~ 683 (707)
................+........ ....+ ....+. ...........+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 316 (373)
T 1q8y_A 237 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316 (373)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHH
Confidence 6443211111111111111111000 00000 000111 111224556788999999
Q ss_pred ccCCCCCCCCChHHHHH
Q 005226 684 CTEADPEVRPRMKNVSE 700 (707)
Q Consensus 684 Cl~~dP~~RPs~~~v~~ 700 (707)
||+.||++|||++|+++
T Consensus 317 ~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 317 MLQLDPRKRADAGGLVN 333 (373)
T ss_dssp GGCSSTTTCBCHHHHHT
T ss_pred HhccCccccCCHHHHhh
Confidence 99999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.88 Aligned_cols=193 Identities=25% Similarity=0.295 Sum_probs=162.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CC-----ceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HP-----NIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||+||+|... +++.||||+++.... ...++.+|+++++.++ |+ +|+++++++...+..++||||+
T Consensus 60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA-FLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSSHH-HHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH-HHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 48999999999999965 678999999975432 3467788999999884 55 4999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc--CCCCeEEecccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDFQPYISDFGLSRLINI 563 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~~ 563 (707)
+ |+|.+++.... ...+++..+..++.|++.||+|||+. ..+|+||||||+|||++ .++.+||+|||+++....
T Consensus 139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6 59999998653 23589999999999999999999942 16899999999999995 478899999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSP 631 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~ 631 (707)
.. ....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 214 ~~-------------------~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 214 RI-------------------YQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CC-------------------CSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc-------------------ccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 12356889999999765 67899999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=318.60 Aligned_cols=259 Identities=19% Similarity=0.313 Sum_probs=186.1
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-------------Cc
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-------------DE 477 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------------~~ 477 (707)
.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++++++||||+++++++.+. +.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 357999999999999964 78999999986533 3347889999999999999999999998653 45
Q ss_pred ceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccc
Q 005226 478 KLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGL 557 (707)
Q Consensus 478 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGl 557 (707)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 689999999999999998543 357889999999999999999999 8999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 005226 558 SRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637 (707)
Q Consensus 558 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~ 637 (707)
++.................+ .........|+..|+|||++.....++.++||||||+++|||++ ||... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~ 232 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPG--SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----M 232 (303)
T ss_dssp CSCTTC---------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----H
T ss_pred hhhcccccchhccccccccc--cccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----h
Confidence 98664321110000000000 00011234578999999997655578999999999999999998 54311 0
Q ss_pred cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.......+... ...+... ........+.+++.+||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ERVNILKKLRSV---SIEFPPD---------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHHHST---TCCCCTT---------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHHHhcccc---ccccCcc---------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111122222111 1000000 01122345789999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=316.56 Aligned_cols=244 Identities=27% Similarity=0.353 Sum_probs=193.4
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++|+||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 358999999999999975 78899999986542 234578899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC---CCeEEecccccccccccC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND---FQPYISDFGLSRLINITG 565 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~DfGla~~~~~~~ 565 (707)
+|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++.+ +.+||+|||+++......
T Consensus 107 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 107 ELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 9999987543 58999999999999999999999 899999999999999754 479999999998654221
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.. ....++..|+|||.+.. .++.++||||||+++|||++|+.||.... .......
T Consensus 179 ~~-----------------~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~ 233 (287)
T 2wei_A 179 KM-----------------KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKR 233 (287)
T ss_dssp SC-----------------SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH
T ss_pred cc-----------------ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHH
Confidence 10 12346889999998653 47899999999999999999999996532 1122222
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+......... . ........+.+++.+|++.||++|||+.++++
T Consensus 234 ~~~~~~~~~~-~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 VETGKYAFDL-P-----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHCCCCCCS-G-----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCCc-h-----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2221110000 0 00112345789999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=325.89 Aligned_cols=252 Identities=22% Similarity=0.265 Sum_probs=188.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc------ceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE------KLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e 483 (707)
+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+. .++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 47999999999999964 68999999987642 2334678999999999999999999999987754 499999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+. |+|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 110 ~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 110 FMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred ccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 997 688888752 38999999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....+|+.|+|||++.....++.++||||||+++|||++|+.||..... .+..
T Consensus 179 ~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~ 233 (353)
T 3coi_A 179 EM-------------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQL 233 (353)
T ss_dssp ------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH------HHHH
T ss_pred Cc-------------------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHH
Confidence 11 1234688999999877656788999999999999999999999975321 1111
Q ss_pred HHHHhhccccCC--CchhchHH---HHhh----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENP--LSDMVDAM---LLQE----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~--~~~~~d~~---l~~~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+......... ...+.+.. .... .........+.+++.+|++.||++|||++++++
T Consensus 234 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 234 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111100000 00000000 0000 000123456889999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.77 Aligned_cols=259 Identities=17% Similarity=0.190 Sum_probs=196.3
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhh-----------------HHHHHHHHHHHHhcCCCceeeeEEEEEcC
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQR-----------------HREFVTEVQAIAKVKHPNIVKLRAYYWAP 475 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 475 (707)
+.||+|+||.||+|.. ++..||||++....... .+.|.+|++++++++||||+++++++.+.
T Consensus 37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 4799999999999999 99999999986542211 17899999999999999999999999999
Q ss_pred CcceEEEEeecCCChHHH------HhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC
Q 005226 476 DEKLLISDFISNGNLANA------LRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ 549 (707)
Q Consensus 476 ~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~ 549 (707)
+..++||||+++|+|.++ +.... ...+++..+..++.||+.||+|||+. .+|+||||||+||+++.++.
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTTSC
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCCCc
Confidence 999999999999999999 54321 34699999999999999999999972 59999999999999999999
Q ss_pred eEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCc-hhhHHHHHHHHHHHHhCCCCC
Q 005226 550 PYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQ-KWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 550 ~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DV~S~Gv~l~elltg~~P~ 628 (707)
+||+|||+++...... .....|+..|+|||.+.....++. ++||||||+++|||++|+.||
T Consensus 191 ~kl~dfg~~~~~~~~~------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 191 VKLSDFGESEYMVDKK------------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp EEECCCTTCEECBTTE------------------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEEecccccccccccc------------------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999998654221 022356899999999776435555 999999999999999999999
Q ss_pred CCCCCCCCccchhHHHHHHhhccccCC-CchhchHHHH--hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 629 LSPTTSTSIEVPDLVRWVKKGFEEENP-LSDMVDAMLL--QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~l~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ..+...+......... ......+... ...........+.+++.+||+.||.+||++.++++
T Consensus 253 ~~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL-----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS-----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH-----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 754321 2333333222111000 0000000000 00000223356789999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=325.65 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=166.5
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHH-HHHhcCCCceeeeEEEEEc----CCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQ-AIAKVKHPNIVKLRAYYWA----PDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 485 (707)
.++||+|+||+||+|... +++.||||++.... ...+|+. .++.++||||+++++++.. +...++||||+
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 347999999999999976 68999999986542 2223333 3566799999999999976 34578999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEeccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLIN 562 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~ 562 (707)
++|+|.+++.... ...+++.++..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++...
T Consensus 109 ~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~ 182 (336)
T 3fhr_A 109 EGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182 (336)
T ss_dssp TTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-
T ss_pred CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceecc
Confidence 9999999998654 2369999999999999999999999 89999999999999976 4559999999997654
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhH
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~ 642 (707)
.... ....+|+.|+|||++.. ..++.++||||||+++|||++|+.||.......... ..
T Consensus 183 ~~~~------------------~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~ 241 (336)
T 3fhr_A 183 QNAL------------------QTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GM 241 (336)
T ss_dssp ----------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred cccc------------------ccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hH
Confidence 2111 22346899999999654 677889999999999999999999997543321000 00
Q ss_pred HHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...+... ... ... .........+.+++.+||+.||++|||++++++
T Consensus 242 ~~~~~~~---~~~---~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 242 KRRIRLG---QYG---FPN------PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ------------C---CCT------TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhcc---ccc---cCc------hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 000 000 000122346789999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=322.29 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=189.8
Q ss_pred ceecccCeeEEEEEEe--CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhc---CCCceeeeEEEEE-----cCCcceE
Q 005226 413 YVLGKSGLGIVYKVVL--GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKV---KHPNIVKLRAYYW-----APDEKLL 480 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~~~~~l 480 (707)
+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++. .....++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 4799999999999997 467899999886432 12224567888887776 8999999999997 4566799
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
||||+. |+|.+++.... ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 97 v~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 999997 69999998653 2358999999999999999999999 8999999999999999999999999999976
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
...... .....||..|+|||++.. ..++.++||||||+++|||++|+.||..... .
T Consensus 170 ~~~~~~-----------------~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~ 225 (326)
T 1blx_A 170 YSFQMA-----------------LTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------V 225 (326)
T ss_dssp CCGGGG-----------------GCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------H
T ss_pred ccCCCC-----------------ccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCH------H
Confidence 542211 122356889999999765 6688999999999999999999999975321 1
Q ss_pred hHHHHHHhhcc----ccCCCc-hhchHHHH------hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFE----EENPLS-DMVDAMLL------QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~----~~~~~~-~~~d~~l~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+..... ..++.. ......+. ...........+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12222211110 000000 00000000 00001122356789999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.26 Aligned_cols=252 Identities=22% Similarity=0.317 Sum_probs=173.5
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc-hhhHHHHHHHHH-HHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG-EQRHREFVTEVQ-AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... +|+.||||++.... .....++..|+. +++.++||||+++++++..++..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 347999999999999974 78999999987653 333456666776 67778999999999999999999999999975
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
+|.+++..........+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++........
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 182 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence 88888763111112468999999999999999999999 7 9999999999999999999999999999765422110
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCC---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV---PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
....||..|+|||++. .+..++.++||||||+++|||++|+.||...... .+
T Consensus 183 -----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~ 237 (327)
T 3aln_A 183 -----------------TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--------FD 237 (327)
T ss_dssp ----------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------
T ss_pred -----------------ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--------HH
Confidence 2235689999999973 3356789999999999999999999999653211 01
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..........+ .... .........+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~--~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 238 QLTQVVKGDPP--QLSN------SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCSCCC--CCCC------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHhcCCCC--CCCC------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111100 0000 000112346789999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.48 Aligned_cols=252 Identities=22% Similarity=0.293 Sum_probs=191.1
Q ss_pred ceecccCeeEEEEEEeC-CC-ceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc------eeeeEEEEEcCCcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG-NG-IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN------IVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~e~ 484 (707)
+.||+|+||+||+|... ++ ..||+|+++.... ..+.+.+|++++++++|++ ++.+++++...+..++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T 2eu9_A 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK-YREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL 103 (355)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred EEeeccCCeEEEEEEecCCCceEEEEEEEccccc-chhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence 47999999999999964 34 6899999976533 3467889999999998776 99999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE-------------------c
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL-------------------D 545 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll-------------------~ 545 (707)
+ +|+|.+++.... ...+++..+..|+.||+.||+|||+ ++|+||||||+|||+ +
T Consensus 104 ~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~ 176 (355)
T 2eu9_A 104 L-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176 (355)
T ss_dssp C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred c-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccccccc
Confidence 9 678888876543 2358999999999999999999999 899999999999999 6
Q ss_pred CCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC
Q 005226 546 NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~ 625 (707)
.++.+||+|||+++...... ....||+.|+|||++.. ..++.++|||||||++|||++|+
T Consensus 177 ~~~~~kl~Dfg~~~~~~~~~-------------------~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~ 236 (355)
T 2eu9_A 177 KNTSIRVADFGSATFDHEHH-------------------TTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGF 236 (355)
T ss_dssp SCCCEEECCCTTCEETTSCC-------------------CSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCcEEEeecCccccccccc-------------------cCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCC
Confidence 67899999999997643211 22356999999999765 67899999999999999999999
Q ss_pred CCCCCCCCCCCccchhHHHHHHhhccccCCCchh---------------------chHH-HHh--------hhhhHHHHH
Q 005226 626 SPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDM---------------------VDAM-LLQ--------EVHAKKEVI 675 (707)
Q Consensus 626 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~d~~-l~~--------~~~~~~~~~ 675 (707)
.||..... ......+....... + ..+ .+.. ... .........
T Consensus 237 ~pf~~~~~------~~~~~~~~~~~~~~-p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (355)
T 2eu9_A 237 TLFQTHEN------REHLVMMEKILGPI-P-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHV 308 (355)
T ss_dssp CSCCCSSH------HHHHHHHHHHHCCC-C-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred CCCCCCCH------HHHHHHHHHHcCCC-c-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHH
Confidence 99975322 11111111111100 0 000 0000 000 001122345
Q ss_pred HHHHHHHhccCCCCCCCCChHHHHH
Q 005226 676 AVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 676 ~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+.+++.+||+.||++|||+.|+++
T Consensus 309 ~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 309 QLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCcCHHHHhc
Confidence 7889999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.93 Aligned_cols=235 Identities=21% Similarity=0.300 Sum_probs=184.1
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch------hhHHHHHHHHHHHHhc----CCCceeeeEEEEEcCCcceE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE------QRHREFVTEVQAIAKV----KHPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~~~~~~~~~l 480 (707)
.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.++ +||||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 34899999999999986 4788999999976532 1224566799999999 89999999999999999999
Q ss_pred EEEe-ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-CCCCeEEeccccc
Q 005226 481 ISDF-ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLS 558 (707)
Q Consensus 481 V~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla 558 (707)
|+|| +++++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999 78999999998643 58999999999999999999999 7999999999999999 8899999999999
Q ss_pred ccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc
Q 005226 559 RLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE 638 (707)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~ 638 (707)
+....... ....|+..|+|||++......+.++||||||+++|||++|+.||...
T Consensus 188 ~~~~~~~~------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------- 242 (312)
T 2iwi_A 188 ALLHDEPY------------------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------- 242 (312)
T ss_dssp EECCSSCB------------------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-------
T ss_pred hhcccCcc------------------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-------
Confidence 87643211 22346889999998765444456999999999999999999998531
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. +.... ...+. ......+.+++.+||+.||++||++.++++
T Consensus 243 -~---~~~~~----~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 -Q---EILEA----ELHFP-------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -H---HHHHT----CCCCC-------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -H---HHhhh----ccCCc-------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11111 00000 112235678999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.00 Aligned_cols=234 Identities=22% Similarity=0.317 Sum_probs=188.6
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchh------hHHHHHHHHHHHHhcC--CCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQ------RHREFVTEVQAIAKVK--HPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e 483 (707)
+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.++++++ ||||+++++++..++..++|+|
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e 128 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence 4899999999999985 47899999998654221 2245778999999996 5999999999999999999999
Q ss_pred eecC-CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc-CCCCeEEecccccccc
Q 005226 484 FISN-GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLI 561 (707)
Q Consensus 484 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~DfGla~~~ 561 (707)
|+.+ ++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+||+++ +++.+||+|||+++..
T Consensus 129 ~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 129 RPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp CCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred cCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 9976 89999997643 58999999999999999999999 8999999999999999 7899999999999866
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
..... ....||+.|+|||++......+.++||||||+++|||++|+.||....
T Consensus 201 ~~~~~------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------- 253 (320)
T 3a99_A 201 KDTVY------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------- 253 (320)
T ss_dssp CSSCB------------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------
T ss_pred ccccc------------------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------
Confidence 42211 123468999999987654455789999999999999999999985310
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.... ...+. .....++.+++.+||+.||++||+++++++
T Consensus 254 --~~~~~----~~~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 --EIIRG----QVFFR-------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp --HHHHC----CCCCS-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --hhhcc----ccccc-------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 00001 111245679999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=330.03 Aligned_cols=245 Identities=23% Similarity=0.291 Sum_probs=180.3
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+.+..++||||+. |+|.
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 48999999997665566899999999865432 3356899999999 89999999999999999999999996 6999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-----CCCeEEecccccccccccCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-----DFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~~~ 566 (707)
+++..... .+.+..+..++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+|+.......
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 99986542 24445567899999999999999 89999999999999943 34688999999987653221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 643 (707)
... ......||+.|+|||++.. ...++.++|||||||++|||+| |+.||..... ...
T Consensus 179 ~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~ 238 (432)
T 3p23_A 179 SFS-------------RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQA 238 (432)
T ss_dssp --------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHH
T ss_pred cee-------------eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHH
Confidence 100 1123457999999999764 3566789999999999999999 8989853211 111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... .... ........+.+++.+||+.||++|||+.+|++
T Consensus 239 ~~~~~~~~~-----~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 239 NILLGACSL-----DCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHTTCCCC-----TTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhccCCc-----cccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111000 0000 01122345678999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.12 Aligned_cols=246 Identities=22% Similarity=0.270 Sum_probs=172.7
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
.+.||+|+||.||+|... +|+.||||++..... ...+.+..+..+++.++||||+++++++..++..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 457999999999999975 789999999876532 22234445555688889999999999999999999999999 55
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-CceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR-KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+..+..... ..+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++........
T Consensus 109 ~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 109 CAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 5555554322 358999999999999999999998 5 8999999999999999999999999998765422111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
....+++.|+|||++. ....++.++||||||+++|||++|+.||..... .....
T Consensus 182 -----------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~ 239 (318)
T 2dyl_A 182 -----------------DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVL 239 (318)
T ss_dssp ----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHH
T ss_pred -----------------cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHH
Confidence 2234689999999974 235678999999999999999999999964221 11111
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...........+ ........+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~-------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 240 TKVLQEEPPLLP-------------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHHSCCCCCC-------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhccCCCCCC-------------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111111100 00012245779999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=305.57 Aligned_cols=224 Identities=12% Similarity=0.129 Sum_probs=176.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +++.||||++.... ....+.|.+|+.++++++||||+++++++..++..|+||||++++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 37999999999999975 58999999997653 233478999999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++... ....++.+|+.|++.||+|||+ ++|+||||||+||+++.++.+||+++|
T Consensus 117 ~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 117 SLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred CHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------------
Confidence 999999532 3555788999999999999999 899999999999999999999998543
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
|++ .++.++|||||||++|||+||+.||............ ..
T Consensus 175 ------------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------~~ 216 (286)
T 3uqc_A 175 ------------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------ER 216 (286)
T ss_dssp ------------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------CB
T ss_pred ------------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------HH
Confidence 222 2478999999999999999999999865432111000 00
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.... ......- ........+.+++.+||+.||++| |+.++++.|+++.
T Consensus 217 ~~~~-----~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 217 DTAG-----QPIEPAD----IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CTTS-----CBCCHHH----HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred Hhcc-----CCCChhh----cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000 0000000 011223457899999999999999 9999999998864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=337.71 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=189.5
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc------CCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA------PDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV~e 483 (707)
.+.||+|+||.||+|.. .+|..||||++... .....+.|.+|++++++++||||+++++++.. ++..++|||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE 98 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence 34899999999999996 46899999998764 33445779999999999999999999999765 667799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC---eEEeccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ---PYISDFGLSRL 560 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~DfGla~~ 560 (707)
|+++|+|.+++..... ...+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 99 y~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 99 YCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred eCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 9999999999986542 2358899999999999999999999 89999999999999997765 99999999986
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....||..|+|||++.. ..++.++||||||+++|||++|+.||....
T Consensus 174 ~~~~~~~-----------------~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~-------- 227 (676)
T 3qa8_A 174 LDQGELC-----------------TEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNW-------- 227 (676)
T ss_dssp TTSCCCC-----------------CCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSC--------
T ss_pred ccccccc-----------------ccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCccc--------
Confidence 6432211 22356899999999764 778999999999999999999999996421
Q ss_pred hHHHHHHhhccccCC---Cchhch------HHHH-hhhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 641 DLVRWVKKGFEEENP---LSDMVD------AMLL-QEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~---~~~~~d------~~l~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
....|.......... ..+... ..+. ...........+.+++.+|+..||++|||+++
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 111111110000000 000000 0000 00011234567889999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=341.63 Aligned_cols=231 Identities=24% Similarity=0.331 Sum_probs=183.5
Q ss_pred ceecccCeeEEEEEEeC--CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc-----ceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVLG--NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE-----KLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV~e~ 484 (707)
+.||+|+||+||+|... +++.||||++.... ......|.+|++++++++||||+++++++...+. .|+||||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~ 165 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence 47999999999999975 68999999987543 3445678999999999999999999999988766 6999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++++|.+++.. .++|.+++.|+.||+.||+|||+ ++||||||||+|||++.+ .+||+|||+++.....
T Consensus 166 ~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 166 VGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp CCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred CCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 999999987753 48999999999999999999999 899999999999999986 8999999999865421
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
....||+.|+|||++.. .++.++|||||||++|||++|..||.......
T Consensus 235 --------------------~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------- 283 (681)
T 2pzi_A 235 --------------------GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVDG--------- 283 (681)
T ss_dssp --------------------SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECSS---------
T ss_pred --------------------CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCccccccc---------
Confidence 12346999999998654 34889999999999999999998876421110
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-hHHHHHHHHh
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-MKNVSENLER 704 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~~v~~~L~~ 704 (707)
.... .+ .......+.+++.+||+.||++||+ ++++...|..
T Consensus 284 -----~~~~-------~~-------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 284 -----LPED-------DP-------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----CCTT-------CH-------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----cccc-------cc-------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0000 00 0112245789999999999999995 5666666554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.87 Aligned_cols=224 Identities=21% Similarity=0.290 Sum_probs=173.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHH-HhcCCCceeeeEEEEEc----CCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAI-AKVKHPNIVKLRAYYWA----PDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~e~~~ 486 (707)
++||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 4799999999999996 47899999998653 4567899988 45599999999999977 567899999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEecccccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINI 563 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~ 563 (707)
+|+|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999998653 2369999999999999999999999 89999999999999998 7899999999886432
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
+..++.++|||||||++|||+||+.||...........
T Consensus 172 --------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---- 209 (299)
T 3m2w_A 172 --------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---- 209 (299)
T ss_dssp --------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----
T ss_pred --------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----
Confidence 13456899999999999999999999965432110000
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......... .....+. .......+.+++.+||+.||++|||+.|+++
T Consensus 210 --~~~~~~~~~--~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 --MKTRIRMGQ--YEFPNPE------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp --SCCSSCTTC--CSSCHHH------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHhhcc--ccCCchh------cccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000 0000000 0122356789999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.63 Aligned_cols=238 Identities=16% Similarity=0.105 Sum_probs=172.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCC-Ccee---------eeE---------
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKH-PNIV---------KLR--------- 469 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv---------~l~--------- 469 (707)
++||+|+||+||+|.. .+|+.||||++..... ...+.|.+|+.+++.++| +|.. ...
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 4899999999999995 4789999999874322 234789999999999977 3211 111
Q ss_pred ---EEEEc-----CCcceEEEEeecCCChHHHHhCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCC
Q 005226 470 ---AYYWA-----PDEKLLISDFISNGNLANALRGRN--GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKP 539 (707)
Q Consensus 470 ---~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~ 539 (707)
.++.. ....+++|+++ +|+|.+++.... ......+++..++.|+.||+.||+|||+ ++||||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp 239 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 239 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCccc
Confidence 11111 11335666654 789999984210 0112358899999999999999999999 8999999999
Q ss_pred CCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC---------CCCCCCchhh
Q 005226 540 SNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV---------PGNRPMQKWD 610 (707)
Q Consensus 540 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~D 610 (707)
+|||++.++.+||+|||+++...... ....| +.|+|||++. ....++.++|
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~~-------------------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D 299 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGASA-------------------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD 299 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEEE-------------------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred ceEEEecCCeEEEEeccceeecCCcc-------------------ccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence 99999999999999999988654321 22345 8899999872 3356788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCC
Q 005226 611 VYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPE 690 (707)
Q Consensus 611 V~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~ 690 (707)
||||||++|||+||+.||......... ...+... ......+.+++.+||+.||+
T Consensus 300 vwSlGvil~elltg~~Pf~~~~~~~~~---------~~~~~~~-----------------~~~~~~~~~li~~~l~~dP~ 353 (413)
T 3dzo_A 300 TWTLGLAIYWIWCADLPNTDDAALGGS---------EWIFRSC-----------------KNIPQPVRALLEGFLRYPKE 353 (413)
T ss_dssp HHHHHHHHHHHHHSSCCCCTTGGGSCS---------GGGGSSC-----------------CCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHCCCCCCCcchhhhH---------HHHHhhc-----------------ccCCHHHHHHHHHHccCChh
Confidence 999999999999999999753321100 0000000 01124578999999999999
Q ss_pred CCCChHHHHH
Q 005226 691 VRPRMKNVSE 700 (707)
Q Consensus 691 ~RPs~~~v~~ 700 (707)
+||++.++++
T Consensus 354 ~Rpt~~~~l~ 363 (413)
T 3dzo_A 354 DRLLPLQAME 363 (413)
T ss_dssp GSCCHHHHTT
T ss_pred hCcCHHHHHh
Confidence 9999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=305.00 Aligned_cols=237 Identities=16% Similarity=0.149 Sum_probs=176.5
Q ss_pred ccceecccCeeEEEEEEeCCCceEEEEEcCCCc--------hhhHHHHHHHHHHHHhcC---------CCceeeeEEEEE
Q 005226 411 SAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGG--------EQRHREFVTEVQAIAKVK---------HPNIVKLRAYYW 473 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~~~~~ 473 (707)
..+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++ |||||++.+.+.
T Consensus 24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 345899999999999998 78999999987542 223377899999999986 777777777643
Q ss_pred ------------------------------cCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 005226 474 ------------------------------APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523 (707)
Q Consensus 474 ------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 523 (707)
..+..++||||+++|++.+.+.. ..+++..+..|+.||+.||+|
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHHH
Confidence 26788999999999987777753 248999999999999999999
Q ss_pred Hh-hcCCCCceecCCCCCCeEEcCCC--------------------CeEEecccccccccccCCCCCCCCCCcCCCCCCC
Q 005226 524 LH-ECSPRKFVHGDIKPSNILLDNDF--------------------QPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582 (707)
Q Consensus 524 LH-~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~ 582 (707)
|| + .+|+||||||+|||++.++ .+||+|||+|+....
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------- 234 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------- 234 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------------
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------------
Confidence 99 8 7999999999999999887 899999999986642
Q ss_pred CccccccCccccCCCCCCCCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhch
Q 005226 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVV-LLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVD 661 (707)
Q Consensus 583 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~-l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 661 (707)
....||+.|+|||++.+ .. +.++||||++++ .+++++|..||.... ......+.+......... ..
T Consensus 235 --~~~~gt~~y~aPE~~~g-~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~----~~ 301 (336)
T 2vuw_A 235 --GIVVFCDVSMDEDLFTG-DG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQMTFKTK----CN 301 (336)
T ss_dssp --TEEECCCCTTCSGGGCC-CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHTCCCSSC----CC
T ss_pred --CcEEEeecccChhhhcC-CC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhhhccCcc----cc
Confidence 12357999999999764 33 889999998777 778888998873100 000011111111010000 00
Q ss_pred HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHH
Q 005226 662 AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVS 699 (707)
Q Consensus 662 ~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~ 699 (707)
. ........++.+|+.+||+.| |++|++
T Consensus 302 ~-----~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 302 T-----PAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp S-----HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred h-----hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 0 012344567899999999976 898887
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.98 E-value=7e-33 Score=292.25 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=224.5
Q ss_pred hcCCcccHHHHHHHHhcCcCCCCCCCCCCC---CCCCCCceeceeEeCCCC----CCCCCcEEEEEcCCCCccccCCCCc
Q 005226 17 CFALSPDGLTLLSLKSAIDQTDTSVFADWN---ENDPTPCRWSGISCMNIT----GFPDPRVVGVAISGKNVRGYIPSEL 89 (707)
Q Consensus 17 ~~~~~~d~~~l~~~k~~~~~~~~~~~~~W~---~~~~~~C~w~gv~c~~~~----~~~~~~v~~L~L~~n~l~~~~~~~l 89 (707)
+.+..+|..||++||..+..|+.+.+++|. ...+++|.|.|+.|...+ .....+|+.|+|++|+++ .+|..+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence 346788999999999999778888899995 445678999999995211 011268999999999999 778899
Q ss_pred CCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcc------
Q 005226 90 GSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKN------ 163 (707)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------ 163 (707)
+++++|++|+|++|.|+ .+|..+.++++|++|+|++|+|+ .+|..|.++++|+.|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 88999999999999999999999999998765
Q ss_pred ---cchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCC
Q 005226 164 ---CKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPV 240 (707)
Q Consensus 164 ---l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~ 240 (707)
+++|+.|+|++|+|+ .+|.. +..+++|++|+|++|+++ .+|..+..+++| ++|+|++|.+.+.+|..+..+++
T Consensus 179 ~~~l~~L~~L~L~~n~l~-~lp~~-l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L-~~L~Ls~n~~~~~~p~~~~~l~~ 254 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIR-SLPAS-IANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-EELDLRGCTALRNYPPIFGGRAP 254 (328)
T ss_dssp EEESTTCCEEEEEEECCC-CCCGG-GGGCTTCCEEEEESSCCC-CCCGGGGGCTTC-CEEECTTCTTCCBCCCCTTCCCC
T ss_pred hccCCCCCEEECcCCCcC-cchHh-hcCCCCCCEEEccCCCCC-cCchhhccCCCC-CEEECcCCcchhhhHHHhcCCCC
Confidence 999999999999999 99987 479999999999999999 477789999999 89999999999999999999999
Q ss_pred ccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccC
Q 005226 241 TVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCG 277 (707)
Q Consensus 241 L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~ 277 (707)
|+.|++++|++.+.+|. ...+.++..+.+.+|+.+..
T Consensus 255 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~ 292 (328)
T 4fcg_A 255 LKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292 (328)
T ss_dssp CCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred CCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence 99999999999999984 34566677788888776543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=317.43 Aligned_cols=242 Identities=28% Similarity=0.435 Sum_probs=200.4
Q ss_pred cCCcccHHHHHHHHhcCcCCCCCCCCCCCCCCCCCceeceeEeCCCCCCCCCcEEEEEcCCCCcccc---CC--------
Q 005226 18 FALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGY---IP-------- 86 (707)
Q Consensus 18 ~~~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~---~~-------- 86 (707)
++.++|+.||++||+++. ||. .+++|+.+ .+||+|.||+|+. ++|+.|+|+++++.|. +|
T Consensus 8 ~~~~~~~~all~~k~~~~-~~~-~l~~W~~~-~~~C~w~gv~C~~------~~v~~L~L~~~~l~g~~~~l~~~l~~L~~ 78 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLP-DKN-LLPDWSSN-KNPCTFDGVTCRD------DKVTSIDLSSKPLNVGFSAVSSSLLSLTG 78 (768)
T ss_dssp CCHHHHHHHHHHHHTTCS-CTT-SSTTCCTT-SCGGGSTTEEEET------TEEEEEECTTSCCCEEHHHHHHHTTTCTT
T ss_pred cCCHHHHHHHHHHHhhCC-Ccc-cccCCCCC-CCCcCCcceEECC------CcEEEEECCCCCcCCccCccChhHhccCc
Confidence 456789999999999998 777 99999854 4799999999982 7999999999999886 33
Q ss_pred ---------------CCcCCCCCCCEEEcccCCcCCCCCc--cccCCCCCceEEecCccCCCCCCccc-CCCCCccEEec
Q 005226 87 ---------------SELGSLIYLRRLNLHNNNLFGSLPD--QLFNATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDL 148 (707)
Q Consensus 87 ---------------~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L 148 (707)
..|+++++|++|+|++|.++|.+|. .+.++++|++|||++|.+++.+|..+ .++++|++|+|
T Consensus 79 L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L 158 (768)
T 3rgz_A 79 LESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158 (768)
T ss_dssp CCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEEC
T ss_pred ccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEEC
Confidence 5788888899999999988888888 88888999999999998888888766 78888888888
Q ss_pred cCCcccccCCCC---CcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccC
Q 005226 149 SNNSFSGSLPDG---LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYN 225 (707)
Q Consensus 149 s~N~l~~~~p~~---~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N 225 (707)
++|++++..|.. +.++++|++|+|++|++++.+|. ..+++|++|+|++|++++.+|. ++++++| ++|+|++|
T Consensus 159 s~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L-~~L~Ls~n 233 (768)
T 3rgz_A 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSAL-QHLDISGN 233 (768)
T ss_dssp CSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSC-CEEECCSS
T ss_pred CCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCC-CEEECcCC
Confidence 888888777766 77888888888888888765554 5778888888888888877776 8888888 78888888
Q ss_pred cCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 226 HLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
++++.+|..+..+++|+.|++++|++++.+|.. .+.++..+.+.+|..
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l 281 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKF 281 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEE
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCcc
Confidence 888888888888888888888888888877765 566677777766653
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=313.60 Aligned_cols=215 Identities=35% Similarity=0.621 Sum_probs=180.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++++.+|..|.++++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..++.+++|+.|+|
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 46777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred cCCcccccCCCCC-------------------------------------------------------------------
Q 005226 149 SNNSFSGSLPDGL------------------------------------------------------------------- 161 (707)
Q Consensus 149 s~N~l~~~~p~~~------------------------------------------------------------------- 161 (707)
++|+++|.+|..+
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 7777776666433
Q ss_pred ---cccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCC
Q 005226 162 ---KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL 238 (707)
Q Consensus 162 ---~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l 238 (707)
.++++|+.|+|++|+++|.+|..+ +.+++|+.|+|++|+|+|.+|..|+++++| +.|||++|+++|.+|..+..+
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l-~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L-~~LdLs~N~l~g~ip~~l~~l 703 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEI-GSMPYLFILNLGHNDISGSIPDEVGDLRGL-NILDLSSNKLDGRIPQAMSAL 703 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGG-GGCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEECCCGGGGGC
T ss_pred hhhhccccccEEECcCCcccccCCHHH-hccccCCEEeCcCCccCCCCChHHhCCCCC-CEEECCCCcccCcCChHHhCC
Confidence 334667788888888888888765 789999999999999999999999999999 899999999999999999999
Q ss_pred CCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCCCCCCCCCC
Q 005226 239 PVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSCKD 286 (707)
Q Consensus 239 ~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~~~~~~c~~ 286 (707)
+.|++|++++|+|+|.||+...+..+....|.|||.+||.|+. .|..
T Consensus 704 ~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~ 750 (768)
T 3rgz_A 704 TMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDP 750 (768)
T ss_dssp CCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCS
T ss_pred CCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCC
Confidence 9999999999999999999999999999999999999999887 8865
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=308.86 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=213.0
Q ss_pred cccHHHHHHHHhcCcCCCCCC-------CCCCCCCCCCCcee---ceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcC
Q 005226 21 SPDGLTLLSLKSAIDQTDTSV-------FADWNENDPTPCRW---SGISCMNITGFPDPRVVGVAISGKNVRGYIPSELG 90 (707)
Q Consensus 21 ~~d~~~l~~~k~~~~~~~~~~-------~~~W~~~~~~~C~w---~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~ 90 (707)
..|+.||.+|++++..+.+.. ..+|+.+ .++|.| .||+|+.. ++|+.|+|++|++.|.+|++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~-----~~V~~L~L~~~~l~g~lp~~l~ 102 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSN-----GRVTGLSLEGFGASGRVPDAIG 102 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTT-----CCEEEEECTTSCCEEEECGGGG
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCC-----CCEEEEEecCcccCCcCChHHh
Confidence 358999999999997555543 3489865 578999 99999752 6999999999999999999999
Q ss_pred CCCCCCEEEcccCC------------------------------------------------------------------
Q 005226 91 SLIYLRRLNLHNNN------------------------------------------------------------------ 104 (707)
Q Consensus 91 ~l~~L~~L~L~~N~------------------------------------------------------------------ 104 (707)
+|++|++|+|++|.
T Consensus 103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 99999999999984
Q ss_pred ------------cCCCCCccccCCCCCceEEecCccCCCC-----------------CCcccC--CCCCccEEeccCCcc
Q 005226 105 ------------LFGSLPDQLFNATSLHSIFLYGNNLSGS-----------------LPPSVC--NLPRLQNLDLSNNSF 153 (707)
Q Consensus 105 ------------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l 153 (707)
|++ +|..|.++++|++|+|++|+|++. +|..++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 445 788999999999999999999985 999999 999999999999999
Q ss_pred cccCCCCCcccchhhhhhhcCCc-ccc-cCCCcccccC------CCccEEeccCCCCCCCCCc--chhhhhccccEEEec
Q 005226 154 SGSLPDGLKNCKQLQRLILARNK-FSG-QIPAGIWPEL------ENLVQLDLSDNDFKGPIPN--DLGELQSLSATLNLS 223 (707)
Q Consensus 154 ~~~~p~~~~~l~~L~~L~l~~N~-l~~-~lp~~~~~~l------~~L~~L~ls~N~l~~~~p~--~~~~l~~L~~~L~l~ 223 (707)
.+.+|..|.++++|+.|+|++|+ ++| .+|..+ ..+ ++|++|+|++|+++ .+|. .++++++| +.|+|+
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~-~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L-~~L~L~ 338 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDW-QALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL-GMLECL 338 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHH-HHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC-CEEECC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHH-HhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC-CEEeCc
Confidence 99999999999999999999998 998 788876 344 99999999999999 8998 99999999 799999
Q ss_pred cCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCC-CCCcccCCCCc
Q 005226 224 YNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN-QGPTAFLSNPL 274 (707)
Q Consensus 224 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~-~~~~~~~~N~~ 274 (707)
+|+++|.+| .+..+++|+.|++++|+++..+.....+.+ +..+.+.+|..
T Consensus 339 ~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l 389 (636)
T 4eco_A 339 YNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389 (636)
T ss_dssp SCCCEEECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCC
T ss_pred CCcCccchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcC
Confidence 999999999 899999999999999999944444455666 77778877764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=311.26 Aligned_cols=238 Identities=23% Similarity=0.354 Sum_probs=208.4
Q ss_pred cccHHHHHHHHhcCcCCCCCCCCCCCCCC------CCCcee------------ceeEeCCCCCCCCCcEEEEEcCCCCcc
Q 005226 21 SPDGLTLLSLKSAIDQTDTSVFADWNEND------PTPCRW------------SGISCMNITGFPDPRVVGVAISGKNVR 82 (707)
Q Consensus 21 ~~d~~~l~~~k~~~~~~~~~~~~~W~~~~------~~~C~w------------~gv~c~~~~~~~~~~v~~L~L~~n~l~ 82 (707)
..|+.||++||+++. +| +|+.++ |++|.| .||+|+. ..+|+.|+|++|++.
T Consensus 268 ~~d~~ALl~~k~~l~-~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-----~~~V~~L~Ls~~~L~ 336 (876)
T 4ecn_A 268 IKDYKALKAIWEALD-GK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-----NGRVTGLSLAGFGAK 336 (876)
T ss_dssp HHHHHHHHHHHHHTT-GG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-----TSCEEEEECTTTCCE
T ss_pred hHHHHHHHHHHHHcC-CC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-----CCCEEEEECccCCCC
Confidence 469999999999996 44 787554 334999 9999986 279999999999999
Q ss_pred ccCCCCcCCCCCCCEEEc-ccCCcCCC-----------------------------------------------------
Q 005226 83 GYIPSELGSLIYLRRLNL-HNNNLFGS----------------------------------------------------- 108 (707)
Q Consensus 83 ~~~~~~l~~l~~L~~L~L-~~N~l~~~----------------------------------------------------- 108 (707)
|.+|+.|++|++|++|+| ++|.++|.
T Consensus 337 G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~ 416 (876)
T 4ecn_A 337 GRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416 (876)
T ss_dssp EEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCC
T ss_pred CcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccc
Confidence 999999999999999999 77765443
Q ss_pred -----------------------CCccccCCCCCceEEecCccCCC-----------------CCCcccC--CCCCccEE
Q 005226 109 -----------------------LPDQLFNATSLHSIFLYGNNLSG-----------------SLPPSVC--NLPRLQNL 146 (707)
Q Consensus 109 -----------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L 146 (707)
+|..|.++++|++|+|++|+|++ .+|+.++ ++++|+.|
T Consensus 417 i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred cccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 78889999999999999999997 3999988 99999999
Q ss_pred eccCCcccccCCCCCcccchhhhhhhcCCc-ccc-cCCCcc------cccCCCccEEeccCCCCCCCCCc--chhhhhcc
Q 005226 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNK-FSG-QIPAGI------WPELENLVQLDLSDNDFKGPIPN--DLGELQSL 216 (707)
Q Consensus 147 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~lp~~~------~~~l~~L~~L~ls~N~l~~~~p~--~~~~l~~L 216 (707)
+|++|++.+.+|..|.++++|+.|+|++|+ |+| .+|..+ +..+++|++|+|++|+|+ .+|. .|.++++|
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 999999999999999999999999999998 997 788754 234559999999999999 8998 99999999
Q ss_pred ccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC-CCCCCCC-CCCcccCCCCc
Q 005226 217 SATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP-QTGSFAN-QGPTAFLSNPL 274 (707)
Q Consensus 217 ~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p-~~~~~~~-~~~~~~~~N~~ 274 (707)
+.|+|++|+|+ .+| .+..+++|+.|++++|+++ .+| ....+.+ +..+.+.+|..
T Consensus 576 -~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L 631 (876)
T 4ecn_A 576 -GLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKL 631 (876)
T ss_dssp -CEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCC
T ss_pred -CEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCC
Confidence 79999999999 888 8999999999999999999 555 4555666 77788888764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=247.84 Aligned_cols=218 Identities=22% Similarity=0.277 Sum_probs=191.8
Q ss_pred CCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC
Q 005226 51 TPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS 130 (707)
Q Consensus 51 ~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 130 (707)
+.|.|.|+.|.-. ..++.+++++++++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+
T Consensus 3 ~~C~~~~~~C~c~-----~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 74 (270)
T 2o6q_A 3 ALCKKDGGVCSCN-----NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74 (270)
T ss_dssp CCBGGGTCSBEEE-----TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS
T ss_pred ccCCCCCCCCEeC-----CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC
Confidence 6899999998652 356789999999995 566554 68999999999999887789999999999999999999
Q ss_pred CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch
Q 005226 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210 (707)
Q Consensus 131 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 210 (707)
...+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+++ .++...|..+++|++|+|++|+|++..+..|
T Consensus 75 ~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 153 (270)
T 2o6q_A 75 TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153 (270)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHc
Confidence 666667899999999999999999777778899999999999999999 7888888999999999999999997766779
Q ss_pred hhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccCC
Q 005226 211 GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 211 ~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~~ 278 (707)
..+++| ++|+|++|++++..+..|..+++|+.|++++|++++.++. ...+.++..+.+.+||+-|.+
T Consensus 154 ~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 154 DKLTSL-KELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred cCCccc-ceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 999999 7999999999987777899999999999999999977664 345677888899999998874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=251.79 Aligned_cols=220 Identities=22% Similarity=0.238 Sum_probs=198.7
Q ss_pred eEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCcc-CCC
Q 005226 58 ISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN-LSG 131 (707)
Q Consensus 58 v~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~ 131 (707)
|.|.. .+...+++++.|+|++|++++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+ ++.
T Consensus 16 ~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~ 95 (285)
T 1ozn_A 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95 (285)
T ss_dssp EECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCC
T ss_pred EEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccc
Confidence 66753 233345789999999999999888999999999999999999998889999999999999999997 887
Q ss_pred CCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchh
Q 005226 132 SLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG 211 (707)
Q Consensus 132 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 211 (707)
..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++ .++...|..+++|++|+|++|+|++..+..|.
T Consensus 96 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 174 (285)
T 1ozn_A 96 VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (285)
T ss_dssp CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccCHHHhc
Confidence 77899999999999999999999888999999999999999999999 88888788999999999999999976667799
Q ss_pred hhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccCCC
Q 005226 212 ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 212 ~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~~~ 279 (707)
++++| +.|+|++|.+++..|..+..+++|+.|++++|++++.++. ...+.++..+.+.+|++.|.++
T Consensus 175 ~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 175 GLHSL-DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp TCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred Ccccc-CEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 99999 8999999999998899999999999999999999987654 4566778889999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-29 Score=286.30 Aligned_cols=185 Identities=15% Similarity=0.035 Sum_probs=129.5
Q ss_pred eecccCeeEEEEEE-eCCCceEEEEEcCCCc----------hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGG----------EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
..+.|++|.++.++ .-.|+.++||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666654 3358889999986531 12346799999999999 799999999999999999999
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||++||+|.++|...+ .++.. +|+.||+.||+|+|+ ++||||||||+|||++.++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 99999999999998654 45543 589999999999999 89999999999999999999999999999866
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P 627 (707)
...... .....||++|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus 390 ~~~~~~----------------~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCSW----------------PTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---CC----------------SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CCCCcc----------------ccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 432211 134568999999999753 466789999999998887665444
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=239.14 Aligned_cols=226 Identities=20% Similarity=0.210 Sum_probs=194.4
Q ss_pred CCceec--eeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEE
Q 005226 51 TPCRWS--GISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIF 123 (707)
Q Consensus 51 ~~C~w~--gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 123 (707)
|.|.+. .+.|.+ .|...+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 3 C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (276)
T 2z62_A 3 CVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82 (276)
T ss_dssp SEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred ceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEE
Confidence 334444 477864 3333446899999999999998888999999999999999999988888999999999999
Q ss_pred ecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccc-cCCCcccccCCCccEEeccCCCC
Q 005226 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG-QIPAGIWPELENLVQLDLSDNDF 202 (707)
Q Consensus 124 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~lp~~~~~~l~~L~~L~ls~N~l 202 (707)
|++|+|++..|..|.++++|++|++++|++++..+..+.++++|++|+|++|++++ .+|. .|..+++|++|+|++|+|
T Consensus 83 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~-~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 83 LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-YFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp CTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG-GGGGCTTCCEEECCSSCC
T ss_pred CCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCch-hhccCCCCCEEECCCCCC
Confidence 99999998888999999999999999999997777789999999999999999983 2455 458999999999999999
Q ss_pred CCCCCcchhhhhcccc----EEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccC
Q 005226 203 KGPIPNDLGELQSLSA----TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCG 277 (707)
Q Consensus 203 ~~~~p~~~~~l~~L~~----~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~ 277 (707)
++..+..+..++++ + .|++++|.+++..+..+ ...+|+.|++++|++++.++.. ..+.++..+.+.+||+-|.
T Consensus 162 ~~~~~~~~~~l~~L-~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 162 QSIYCTDLRVLHQM-PLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp CEECGGGGHHHHTC-TTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred CcCCHHHhhhhhhc-cccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 98888899998888 6 89999999996555555 4558999999999999877653 5577888899999999987
Q ss_pred CC
Q 005226 278 FP 279 (707)
Q Consensus 278 ~~ 279 (707)
++
T Consensus 240 c~ 241 (276)
T 2z62_A 240 CP 241 (276)
T ss_dssp TT
T ss_pred CC
Confidence 54
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=257.39 Aligned_cols=222 Identities=20% Similarity=0.209 Sum_probs=181.6
Q ss_pred eceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 55 WSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 55 w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
|..|.|.+ .|...+.+++.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788874 2333447899999999999999999999999999999999999988889999999999999999999
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcc-------------------------cchhhhhhhcCCcccccCCCc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKN-------------------------CKQLQRLILARNKFSGQIPAG 184 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------------------------l~~L~~L~l~~N~l~~~lp~~ 184 (707)
++..+..|..+++|++|+|++|+|+...+..|.+ +++|+.|+|++|+|+ .+|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 213 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN- 213 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCC-
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cccc-
Confidence 9777777999999999999999998655544444 455555555555555 4443
Q ss_pred ccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCC
Q 005226 185 IWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFAN 263 (707)
Q Consensus 185 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~ 263 (707)
+..+++|+.|+|++|+|++..|..|.++++| +.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. ..+.+
T Consensus 214 -~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 214 -LTPLVGLEELEMSGNHFPEIRPGSFHGLSSL-KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CTTCTTCCEEECTTSCCSEECGGGGTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -ccccccccEEECcCCcCcccCcccccCccCC-CEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 3466677777777888877778888899999 79999999999888889999999999999999999776643 44677
Q ss_pred CCCcccCCCCcccCCCC
Q 005226 264 QGPTAFLSNPLLCGFPL 280 (707)
Q Consensus 264 ~~~~~~~~N~~l~~~~~ 280 (707)
+..+.+.+||+-|.+.+
T Consensus 292 L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 292 LVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCEEECCSSCEECSTTT
T ss_pred CCEEEccCCCcCCCCCc
Confidence 88889999999998653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=256.63 Aligned_cols=222 Identities=20% Similarity=0.225 Sum_probs=177.5
Q ss_pred eceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 55 WSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 55 w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
|..|.|.+ .|...+..++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56789974 3444457899999999999999999999999999999999999988888999999999999999999
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccc-------------------------hhhhhhhcCCcccccCCCc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCK-------------------------QLQRLILARNKFSGQIPAG 184 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-------------------------~L~~L~l~~N~l~~~lp~~ 184 (707)
+...+..|..+++|+.|+|++|+|+...+..|.+++ +|+.|+|++|+|+ .+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN- 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-
Confidence 966667899999999999999988865554555444 4555555555555 4443
Q ss_pred ccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCC
Q 005226 185 IWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFAN 263 (707)
Q Consensus 185 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~ 263 (707)
+..+++|+.|+|++|+|++..|..|.++++| +.|+|++|+|++..|..|..+++|+.|+|++|+|++.++.. ..+.+
T Consensus 203 -~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 203 -LTPLIKLDELDLSGNHLSAIRPGSFQGLMHL-QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CTTCSSCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -cCCCcccCEEECCCCccCccChhhhccCccC-CEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 3456677777777777777777888888888 78888888888888888889999999999999999776643 44677
Q ss_pred CCCcccCCCCcccCCCC
Q 005226 264 QGPTAFLSNPLLCGFPL 280 (707)
Q Consensus 264 ~~~~~~~~N~~l~~~~~ 280 (707)
+..+.+.+||+.|.+.+
T Consensus 281 L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCEEECCSSCEECSSTT
T ss_pred CCEEEcCCCCccCCCCc
Confidence 88889999999998643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=245.89 Aligned_cols=227 Identities=20% Similarity=0.238 Sum_probs=142.5
Q ss_pred CCCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCC--CCcc----------
Q 005226 50 PTPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGS--LPDQ---------- 112 (707)
Q Consensus 50 ~~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~---------- 112 (707)
+|.|.|.+|.|.+ .|...+.+++.|+|++|+++...+..|.++++|++|+|++|+|+.. .|..
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 4679999999985 2223346899999999999976666689999999999999998732 2334
Q ss_pred -------------ccCCCCCceEEecCccCCCCCC-cccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCccc
Q 005226 113 -------------LFNATSLHSIFLYGNNLSGSLP-PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS 178 (707)
Q Consensus 113 -------------~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 178 (707)
+.++++|++|+|++|++++..+ ..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+++
T Consensus 84 ~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 163 (306)
T 2z66_A 84 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 163 (306)
T ss_dssp ECCSCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEG
T ss_pred ECCCCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccc
Confidence 4444555555555555553332 34555566666666666665555555666666666666666665
Q ss_pred ccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC
Q 005226 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258 (707)
Q Consensus 179 ~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 258 (707)
+.+....|..+++|++|+|++|+|++..|..+..+++| +.|+|++|++++..+..+..+++|+.|++++|++++.+|..
T Consensus 164 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (306)
T 2z66_A 164 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242 (306)
T ss_dssp GGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSS
T ss_pred cccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCC-CEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHH
Confidence 32222234566666666666666665556666666666 56666666666555555666666666666666666655532
Q ss_pred -CCC-CCCCCcccCCCCcccC
Q 005226 259 -GSF-ANQGPTAFLSNPLLCG 277 (707)
Q Consensus 259 -~~~-~~~~~~~~~~N~~l~~ 277 (707)
..+ .++..+.+.+|++-|.
T Consensus 243 ~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 243 LQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CCCCCTTCCEEECTTCCEECS
T ss_pred HHhhhccCCEEEccCCCeecc
Confidence 222 2455566666666554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=233.22 Aligned_cols=194 Identities=24% Similarity=0.288 Sum_probs=176.9
Q ss_pred CCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC
Q 005226 51 TPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS 130 (707)
Q Consensus 51 ~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 130 (707)
.||.|.|.+|.. ..+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+
T Consensus 3 ~Cp~~~gC~C~~-------~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~ 72 (251)
T 3m19_A 3 TCETVTGCTCNE-------GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ 72 (251)
T ss_dssp -CHHHHSSEEEG-------GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC
T ss_pred cCCCCCceEcCC-------CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC
Confidence 467999999963 4557999999999 4566665 68999999999999999999999999999999999999
Q ss_pred CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch
Q 005226 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210 (707)
Q Consensus 131 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 210 (707)
+..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|+|++..+..|
T Consensus 73 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 151 (251)
T 3m19_A 73 TLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAF 151 (251)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHc
Confidence 888888999999999999999999877888999999999999999999 8888888999999999999999997777789
Q ss_pred hhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 211 GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 211 ~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
.++++| +.|+|++|+|++..+..+..+++|+.|++++|++++...
T Consensus 152 ~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 152 DKLTNL-QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CcCcCC-CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 999999 899999999998888899999999999999999997744
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-25 Score=230.26 Aligned_cols=211 Identities=19% Similarity=0.261 Sum_probs=186.0
Q ss_pred CCCCCCCCCCc--eeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccC
Q 005226 43 ADWNENDPTPC--RWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFN 115 (707)
Q Consensus 43 ~~W~~~~~~~C--~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 115 (707)
-.|.... |.| .|..|.|.. .|...+..++.|+|++|++++..+..|.++++|++|+|++|+|+...+..|.+
T Consensus 5 C~~~~~~-C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~ 83 (270)
T 2o6q_A 5 CKKDGGV-CSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKE 83 (270)
T ss_dssp BGGGTCS-BEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSS
T ss_pred CCCCCCC-CEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcC
Confidence 3576432 345 467799974 33334468999999999999888889999999999999999999777777889
Q ss_pred CCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEE
Q 005226 116 ATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQL 195 (707)
Q Consensus 116 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L 195 (707)
+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|+ .+|...|..+++|+.|
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L 162 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCccccee
Confidence 999999999999999777778899999999999999999888888999999999999999999 8888888999999999
Q ss_pred eccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 196 ~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
+|++|+|++..+..|.++++| +.|+|++|+|++..+..+..+++|+.|++++|++....+
T Consensus 163 ~L~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 163 RLYNNQLKRVPEGAFDKLTEL-KTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp ECCSSCCSCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred EecCCcCcEeChhHhccCCCc-CEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 999999998777789999999 899999999998777789999999999999999986654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=250.26 Aligned_cols=226 Identities=22% Similarity=0.257 Sum_probs=174.2
Q ss_pred CCCceeceeEeC-------CCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceE
Q 005226 50 PTPCRWSGISCM-------NITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSI 122 (707)
Q Consensus 50 ~~~C~w~gv~c~-------~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 122 (707)
.++|.|.|+ |. ..|....++++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 367999987 54 2233334689999999999998878899999999999999999998888889999999999
Q ss_pred EecCccCCCCCCcccCCCCCccEEeccCCcccccCCC--CCcccchhhhhhhcCCc-ccccCCCcccccCCCccEEeccC
Q 005226 123 FLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPD--GLKNCKQLQRLILARNK-FSGQIPAGIWPELENLVQLDLSD 199 (707)
Q Consensus 123 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~-l~~~lp~~~~~~l~~L~~L~ls~ 199 (707)
+|++|+|++..+..|.++++|++|+|++|+++ .+|. .|.++++|++|++++|+ ++ .++...|..+++|++|++++
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEE
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCC
Confidence 99999999555555899999999999999999 4554 78899999999999985 55 67666677888888888888
Q ss_pred CCCCCCCCcchhhhhccc-----------------------cEEEeccCcCcCCC-------------------------
Q 005226 200 NDFKGPIPNDLGELQSLS-----------------------ATLNLSYNHLSGKI------------------------- 231 (707)
Q Consensus 200 N~l~~~~p~~~~~l~~L~-----------------------~~L~l~~N~l~~~~------------------------- 231 (707)
|++++..|..+.++++|. +.|++++|.+++..
T Consensus 184 n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~ 263 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263 (353)
T ss_dssp TTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH
T ss_pred CCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC
Confidence 888877777776655550 44555555555422
Q ss_pred ------CCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccCC
Q 005226 232 ------PKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 232 ------p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~~ 278 (707)
|..+..+++|+.|++++|+++..++.. ..+.++..+.+.+|++.|.+
T Consensus 264 ~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 264 ESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred cchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 223456778888888888888444432 45677777888888887764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=230.98 Aligned_cols=202 Identities=26% Similarity=0.251 Sum_probs=174.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++ ++.. ..+++|+.|+|
T Consensus 10 ~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEEC
T ss_pred CCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEEC
Confidence 478889999999984 565554 689999999999998888899999999999999999984 4433 78999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|+|+ .+|..+.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|++..+..|..+++| +.|+|++|+|+
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~ 161 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL-EKLSLANNNLT 161 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEECTTSCCS
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCC-CEEECCCCcCC
Confidence 999998 78888999999999999999999 8888888899999999999999997777778899999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~ 278 (707)
+..+..+..+++|+.|++++|+|+..++.......+..+.+.+||+.|.+
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 76666778899999999999999976665666667788888999998874
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=238.28 Aligned_cols=183 Identities=22% Similarity=0.285 Sum_probs=174.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCC---------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN--------- 139 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------- 139 (707)
.+++.|+|++|+++ .+|..++++++|++|+|++|+|+ .+|..+.++++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 58999999999999 88999999999999999999999 88999999999999999999999999998765
Q ss_pred CCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccE
Q 005226 140 LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSAT 219 (707)
Q Consensus 140 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~ 219 (707)
+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+++ .+|.. +..+++|++|+|++|++.+.+|..+.++++| ++
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~-l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L-~~ 257 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA-IHHLPKLEELDLRGCTALRNYPPIFGGRAPL-KR 257 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGG-GGGCTTCCEEECTTCTTCCBCCCCTTCCCCC-CE
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchh-hccCCCCCEEECcCCcchhhhHHHhcCCCCC-CE
Confidence 999999999999999 89999999999999999999999 68876 5799999999999999999999999999999 89
Q ss_pred EEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC
Q 005226 220 LNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257 (707)
Q Consensus 220 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 257 (707)
|+|++|.+.+.+|..+..+++|+.|++++|++.+.+|.
T Consensus 258 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~ 295 (328)
T 4fcg_A 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295 (328)
T ss_dssp EECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCG
T ss_pred EECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccH
Confidence 99999999999999999999999999999999999993
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.2e-25 Score=230.90 Aligned_cols=219 Identities=21% Similarity=0.272 Sum_probs=139.1
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEec
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLY 125 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 125 (707)
|.|.|+.+.|.+ .+...++.++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 558999999974 233334789999999999999888899999999999999999998889999999999999999
Q ss_pred CccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccc-cCCCcccccCC--------------
Q 005226 126 GNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG-QIPAGIWPELE-------------- 190 (707)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~lp~~~~~~l~-------------- 190 (707)
+|+|+ .+|..+. ++|+.|++++|++++..+..|.++++|+.|+|++|+++. .+....|..++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 99998 5665443 455555555555554444444444444444444444431 12222233444
Q ss_pred -------CccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCC
Q 005226 191 -------NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263 (707)
Q Consensus 191 -------~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~ 263 (707)
+|++|+|++|++++..|..|.++++| +.|+|++|++++..+..+..+++|+.|++++|+++..+.....+.+
T Consensus 186 l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~ 264 (330)
T 1xku_A 186 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNL-AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 264 (330)
T ss_dssp CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTC-CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSS
T ss_pred CCccccccCCEEECCCCcCCccCHHHhcCCCCC-CEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCC
Confidence 55555555555554445555555555 4555555555554444555555555555555555533222333344
Q ss_pred CCCcccCCCC
Q 005226 264 QGPTAFLSNP 273 (707)
Q Consensus 264 ~~~~~~~~N~ 273 (707)
+..+.+.+|+
T Consensus 265 L~~L~l~~N~ 274 (330)
T 1xku_A 265 IQVVYLHNNN 274 (330)
T ss_dssp CCEEECCSSC
T ss_pred cCEEECCCCc
Confidence 4444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-26 Score=234.59 Aligned_cols=186 Identities=23% Similarity=0.263 Sum_probs=174.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCC-cCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN-LFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
++++.|+|++|.+++..|..|..+++|++|+|++|. ++...|..|.++++|++|+|++|++++..|..|.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 689999999999999999999999999999999997 8877789999999999999999999988899999999999999
Q ss_pred ccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcC
Q 005226 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l 227 (707)
|++|++++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|++..|..|.++++| +.|+|++|++
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~l 213 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLYLFANNL 213 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCC
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCccc-ccCHHHhcCccccCEEECCCCcccccCHhHccCcccc-cEeeCCCCcC
Confidence 9999999777778999999999999999999 7888878899999999999999999889999999999 8999999999
Q ss_pred cCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 228 SGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 228 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
++..+..+..+++|+.|++++|++.+..+
T Consensus 214 ~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 214 SALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp SCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred CcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 98777789999999999999999987654
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=222.89 Aligned_cols=215 Identities=17% Similarity=0.236 Sum_probs=182.7
Q ss_pred CCcee-ce--eEeCCCCCC--CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCC-cCCCCCccccCCCCCceEEe
Q 005226 51 TPCRW-SG--ISCMNITGF--PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN-LFGSLPDQLFNATSLHSIFL 124 (707)
Q Consensus 51 ~~C~w-~g--v~c~~~~~~--~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 124 (707)
|.|.+ .+ |.|...+.. .+.+++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|
T Consensus 8 C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l 87 (239)
T 2xwt_C 8 CECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87 (239)
T ss_dssp CSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEE
T ss_pred CeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEEC
Confidence 55654 55 459652222 34689999999999999888899999999999999997 98777778999999999999
Q ss_pred cC-ccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhh---hhhhcCC-cccccCCCcccccCCCcc-EEecc
Q 005226 125 YG-NNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQ---RLILARN-KFSGQIPAGIWPELENLV-QLDLS 198 (707)
Q Consensus 125 ~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~lp~~~~~~l~~L~-~L~ls 198 (707)
++ |+|++..+..|.++++|+.|+|++|++++ +|. |.++++|+ .|++++| +++ .+|...|..+++|+ .|+|+
T Consensus 88 ~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~ 164 (239)
T 2xwt_C 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLY 164 (239)
T ss_dssp EEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECC
T ss_pred CCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcC
Confidence 99 99997777889999999999999999995 776 88888888 9999999 998 88888889999999 99999
Q ss_pred CCCCCCCCCcchhhhhccccEEEeccCc-CcCCCCCcCCCC-CCccEEEccCCcCcccCCCCCCCCCCCCcccCCC
Q 005226 199 DNDFKGPIPNDLGELQSLSATLNLSYNH-LSGKIPKSLGNL-PVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272 (707)
Q Consensus 199 ~N~l~~~~p~~~~~l~~L~~~L~l~~N~-l~~~~p~~~~~l-~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N 272 (707)
+|+|+ .+|......++| +.|+|++|+ +++..+..|..+ ++|+.|++++|++++.++ ..+.++..+.+.++
T Consensus 165 ~n~l~-~i~~~~~~~~~L-~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~--~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 165 NNGFT-SVQGYAFNGTKL-DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPS--KGLEHLKELIARNT 236 (239)
T ss_dssp SCCCC-EECTTTTTTCEE-EEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCC--TTCTTCSEEECTTC
T ss_pred CCCCc-ccCHhhcCCCCC-CEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCCh--hHhccCceeeccCc
Confidence 99999 566554444889 899999995 997777889999 999999999999996655 26667766665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-25 Score=242.00 Aligned_cols=162 Identities=21% Similarity=0.251 Sum_probs=140.6
Q ss_pred CCceece--eEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCC-CccccCCCCCceE
Q 005226 51 TPCRWSG--ISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSL-PDQLFNATSLHSI 122 (707)
Q Consensus 51 ~~C~w~g--v~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L 122 (707)
+.|.|.+ |.|.. .+. .+.+++.|+|++|++++..|..|.++++|++|+|++|.+.+.+ +..|.++++|++|
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~-l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L 84 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPE-LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIIL 84 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCC-CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEE
T ss_pred ceeEEEccccCcCCCCcccCCC-CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEE
Confidence 3466665 88874 233 3478999999999999999999999999999999999998655 5679999999999
Q ss_pred EecCccCCCCCCcccCCCCCccEEeccCCcccccCCCC--CcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCC
Q 005226 123 FLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDG--LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200 (707)
Q Consensus 123 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N 200 (707)
+|++|++++..|..|.++++|++|+|++|++++..|.. |.++++|++|+|++|++++..|...|..+++|++|+|++|
T Consensus 85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence 99999999888999999999999999999999755544 9999999999999999996667777889999999999999
Q ss_pred CCCCCCCcchhhh
Q 005226 201 DFKGPIPNDLGEL 213 (707)
Q Consensus 201 ~l~~~~p~~~~~l 213 (707)
++++..|..+..+
T Consensus 165 ~l~~~~~~~l~~l 177 (455)
T 3v47_A 165 KVKSICEEDLLNF 177 (455)
T ss_dssp CBSCCCTTTSGGG
T ss_pred cccccChhhhhcc
Confidence 9998888776654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=230.39 Aligned_cols=216 Identities=19% Similarity=0.237 Sum_probs=151.0
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEec
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLY 125 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 125 (707)
|.|.|..+.|.. .+....++++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 458999999974 233334689999999999999888999999999999999999998889999999999999999
Q ss_pred CccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccc------------------------cC
Q 005226 126 GNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG------------------------QI 181 (707)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~------------------------~l 181 (707)
+|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|++++|+++. .+
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI 187 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCcc
Confidence 99988 5555443 556666666666654444445555555555555555531 33
Q ss_pred CCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCC
Q 005226 182 PAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261 (707)
Q Consensus 182 p~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~ 261 (707)
|..++ ++|++|+|++|++++..|..+.++++| +.|+|++|++++..|..+..+++|+.|++++|+++..++....+
T Consensus 188 ~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l 263 (332)
T 2ft3_A 188 PKDLP---ETLNELHLDHNKIQAIELEDLLRYSKL-YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDL 263 (332)
T ss_dssp CSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTC-SCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGC
T ss_pred Ccccc---CCCCEEECCCCcCCccCHHHhcCCCCC-CEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcC
Confidence 33322 466666666666666666667777777 57777777777666666677777777777777776333333444
Q ss_pred CCCCCcccCCCC
Q 005226 262 ANQGPTAFLSNP 273 (707)
Q Consensus 262 ~~~~~~~~~~N~ 273 (707)
.++..+.+.+|+
T Consensus 264 ~~L~~L~l~~N~ 275 (332)
T 2ft3_A 264 KLLQVVYLHTNN 275 (332)
T ss_dssp TTCCEEECCSSC
T ss_pred ccCCEEECCCCC
Confidence 555556665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.4e-25 Score=241.01 Aligned_cols=126 Identities=25% Similarity=0.320 Sum_probs=90.0
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
++++..|..|.++++|+.|+|++|+++ .++...|..+++|++|+|++|+|++..|..|.++++| ++|+|++|++++..
T Consensus 286 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~ 363 (455)
T 3v47_A 286 KIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL-EVLDLSYNHIRALG 363 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC-CEEECCSSCCCEEC
T ss_pred cccccchhhcccCCCCCEEECCCCccc-ccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC-CEEECCCCcccccC
Confidence 333334555666677777777777777 4444445677788888888888877667777778888 68888888888777
Q ss_pred CCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccCCC
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~~~ 279 (707)
|..+..+++|+.|++++|++++.++.. ..+.++..+.+.+|++-|.+|
T Consensus 364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred hhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 778888888888888888888765543 456667777788888777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=234.66 Aligned_cols=200 Identities=25% Similarity=0.275 Sum_probs=144.0
Q ss_pred CcEEEEEcCCCCccccCCCCc--CCCCCCCEEEcccCCcCCCCCccccCC-----CCCceEEecCccCCCCCCcccCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSEL--GSLIYLRRLNLHNNNLFGSLPDQLFNA-----TSLHSIFLYGNNLSGSLPPSVCNLP 141 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~ 141 (707)
.+++.|+|++|++++.+|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|+.++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 467777888888877777765 7778888888888888766 7767666 7788888888888776667777888
Q ss_pred CccEEeccCCccccc--CCCCC--cccchhhhhhhcCCcccc--cCCCcccccCCCccEEeccCCCCCCCCC-cchhhhh
Q 005226 142 RLQNLDLSNNSFSGS--LPDGL--KNCKQLQRLILARNKFSG--QIPAGIWPELENLVQLDLSDNDFKGPIP-NDLGELQ 214 (707)
Q Consensus 142 ~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~--~lp~~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~ 214 (707)
+|+.|+|++|++.+. +|..+ .++++|++|+|++|+|++ .++..++..+++|++|+|++|+|++..| ..+..++
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 888888888877654 23333 677788888888887772 3344555667788888888888876664 4555667
Q ss_pred ccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 215 SLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 215 ~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+| ++|+|++|+|+ .+|..+. ++|+.|++++|+|++. |....+.++..+.+.+|++
T Consensus 254 ~L-~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l 308 (312)
T 1wwl_A 254 QL-NSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPF 308 (312)
T ss_dssp TC-CEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTT
T ss_pred CC-CEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCC
Confidence 77 67888888887 6777665 7788888888888766 5455666666677777653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-25 Score=249.94 Aligned_cols=190 Identities=18% Similarity=0.214 Sum_probs=143.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCch--------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.++||+|+||.||+|.. .+..+++|+...... ...+.|.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45899999999999955 567788887543211 113568999999999999999977777778888999999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+++|+|.+++.. +..|+.|++.||+|||+ ++|+||||||+|||++. .+||+|||+|+....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 9999999999974 45899999999999999 89999999999999999 999999999987653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC-CCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP-GNRPMQKWDVYSFGVVLLELLTGKSPEL 629 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DV~S~Gv~l~elltg~~P~~ 629 (707)
...... ..+.......||+.|+|||++.. ...|+..+|+|+..+-.++-+.++.+|.
T Consensus 482 ~~~~~~---------~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAV---------DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHH---------HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccc---------chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211000 00000123467999999998642 1345678899999999999998887763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.9e-25 Score=262.48 Aligned_cols=110 Identities=22% Similarity=0.221 Sum_probs=66.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|.+.+..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|
T Consensus 266 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 345 (844)
T 3j0a_A 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345 (844)
T ss_dssp SCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEEC
T ss_pred CCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEEC
Confidence 45666666666666666666666666666666666666555666666666666666666666555666666666666666
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCccc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFS 178 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 178 (707)
++|++++..+..|.++++|+.|+|++|.++
T Consensus 346 ~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 375 (844)
T 3j0a_A 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375 (844)
T ss_dssp CSCCCCCCCSSCSCSCCCCCEEEEETCCSC
T ss_pred CCCCCCccChhhhcCCCCCCEEECCCCCCC
Confidence 666665544555555555555555555544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=222.71 Aligned_cols=182 Identities=26% Similarity=0.237 Sum_probs=168.1
Q ss_pred CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEE
Q 005226 67 PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146 (707)
Q Consensus 67 ~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 146 (707)
.+.+++.|+|++|++++..+..|..+++|++|+|++|+|++..+ ...+++|++|+|++|+|+ .+|..+..+++|+.|
T Consensus 29 ~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 105 (290)
T 1p9a_G 29 LPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL 105 (290)
T ss_dssp CCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEE
T ss_pred CCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEE
Confidence 34789999999999999999999999999999999999995443 378999999999999999 889999999999999
Q ss_pred eccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCc
Q 005226 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNH 226 (707)
Q Consensus 147 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 226 (707)
+|++|+|++..|..|.++++|+.|+|++|+|+ .+|...|..+++|+.|+|++|+|++..+..|.++++| +.|+|++|+
T Consensus 106 ~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L-~~L~L~~N~ 183 (290)
T 1p9a_G 106 DVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL-DTLLLQENS 183 (290)
T ss_dssp ECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTC-CEEECCSSC
T ss_pred ECCCCcCcccCHHHHcCCCCCCEEECCCCCCC-ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCC-CEEECCCCc
Confidence 99999999777789999999999999999999 8899999999999999999999997666678899999 899999999
Q ss_pred CcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 227 LSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 227 l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
|+ .+|..+..+++|+.|++++|++...
T Consensus 184 l~-~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 184 LY-TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp CC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred CC-ccChhhcccccCCeEEeCCCCccCc
Confidence 99 7899999999999999999999753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=234.72 Aligned_cols=183 Identities=31% Similarity=0.464 Sum_probs=148.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCC-CccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLP-RLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ 147 (707)
.+++.|+|++|++++.+|..|.++++|++|+|++|+|++.+|..|.++++|++|+|++|+|++.+|..+..++ +|+.|+
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred CCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence 5788888888888888888888888888888888888888888888888888888888888878888888777 777777
Q ss_pred ccCCcccccCCCCCc-----------------------ccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCC
Q 005226 148 LSNNSFSGSLPDGLK-----------------------NCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~-----------------------~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~ 204 (707)
|++|++++.+|..+. ++++|+.|+|++|++++.+|. +..+++|++|+|++|+|++
T Consensus 181 L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK--VGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG--CCCCTTCCEEECCSSCCEE
T ss_pred CcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc--ccccCCCCEEECcCCcccC
Confidence 777777766555554 445555555555555543333 4577899999999999999
Q ss_pred CCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCc-CcccC
Q 005226 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN-LSGEI 255 (707)
Q Consensus 205 ~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~ 255 (707)
.+|..+..+++| +.|+|++|+|+|.+|.. ..+++|+.+++++|+ +.|.+
T Consensus 259 ~~p~~l~~l~~L-~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 259 TLPQGLTQLKFL-HSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCCGGGGGCTTC-CEEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred cCChHHhcCcCC-CEEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence 999999999999 89999999999999987 889999999999998 66643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=212.73 Aligned_cols=179 Identities=23% Similarity=0.283 Sum_probs=98.5
Q ss_pred CCCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 50 PTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 50 ~~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
.|.|+|.+|.|.... ++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 4 ~C~C~~~~v~c~~~~----------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (208)
T 2o6s_A 4 RCSCSGTTVECYSQG----------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL 64 (208)
T ss_dssp TCEEETTEEECCSSC----------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCEECCCEEEecCCC----------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCcc
Confidence 467899999997521 11 122222 23555555555555544444455555555555555555
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~ 209 (707)
++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|...|..+++|++|+|++|+|++..+..
T Consensus 65 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 143 (208)
T 2o6s_A 65 QSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGV 143 (208)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHH
Confidence 5444444555555555555555555444444555555555555555555 455554555566666666666665444444
Q ss_pred hhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 210 LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 210 ~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
+..+++| +.|+|++|.+.+ .+++|+.|+++.|+++|.+|
T Consensus 144 ~~~l~~L-~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip 182 (208)
T 2o6s_A 144 FDRLTSL-QYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVR 182 (208)
T ss_dssp TTTCTTC-CEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBB
T ss_pred hccCCCc-cEEEecCCCeec-------CCCCHHHHHHHHHhCCceee
Confidence 5555666 466666665543 33455566666666666655
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=238.25 Aligned_cols=217 Identities=17% Similarity=0.132 Sum_probs=190.6
Q ss_pred eceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 55 WSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 55 w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
|..|.|.. .|...+.+++.|+|++|+|++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 67899974 3334457899999999999999999999999999999999999998899999999999999999999
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~ 209 (707)
++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+++ .++...|..+++|+.|+|++|++++..+..
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCC-EECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccc-eeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 9666677899999999999999999999999999999999999999999 666666789999999999999999777778
Q ss_pred hhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCC
Q 005226 210 LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNP 273 (707)
Q Consensus 210 ~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~ 273 (707)
|.++++| +.|+|++|.+++..+..|..+++|+.|++++|++.+.+|.. ....++..+.+.+|.
T Consensus 172 l~~l~~L-~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 235 (477)
T 2id5_A 172 LSHLHGL-IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCN 235 (477)
T ss_dssp HTTCTTC-CEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSC
T ss_pred hcccCCC-cEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCc
Confidence 9999999 79999999999988889999999999999999887776642 222355556665553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=215.91 Aligned_cols=183 Identities=23% Similarity=0.290 Sum_probs=161.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|++++|.+... +.+..+++|++|+|++|.+++ + ..+.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 5788999999998853 458899999999999999986 3 47889999999999999999777778899999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|++..+..+.++++| +.|+|++|+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~ 194 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQL-KDLRLYQNQLK 194 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCS
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccC-CEEECCCCcCC
Confidence 999999777778899999999999999998 7887778889999999999999998777778899999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 257 (707)
+..|..+..+++|+.|++++|++.+..|.
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 88888889999999999999999887763
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=246.77 Aligned_cols=202 Identities=20% Similarity=0.214 Sum_probs=144.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|.|++..|..|+.+++|++|+|++|.|++..|..|.++++|++|+|++|.|++..+..|+++++|+.|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 35677777777777777777777888888888888877777777777888888888888877555555677788888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccC-------------------------------------CC
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPEL-------------------------------------EN 191 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l-------------------------------------~~ 191 (707)
++|.|++..|..|.++++|+.|+|++|+|+ .++...+..+ ++
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~ 233 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 233 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCS-BCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCC-CcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCC
Confidence 888887777777777888888888888777 3443222211 23
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS 271 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 271 (707)
|+.|+|++|.|++ +..+..+++| +.|+|++|.|++.+|..|..+++|+.|+|++|.+++.++....+.++..+.+.+
T Consensus 234 L~~L~L~~n~l~~--~~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~ 310 (597)
T 3oja_B 234 LTILKLQHNNLTD--TAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSH 310 (597)
T ss_dssp CCEEECCSSCCCC--CGGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCS
T ss_pred CCEEECCCCCCCC--ChhhccCCCC-CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCC
Confidence 4555555555553 3567777788 688888888887778888888888888888888887655555566777777777
Q ss_pred CCc
Q 005226 272 NPL 274 (707)
Q Consensus 272 N~~ 274 (707)
|+.
T Consensus 311 N~l 313 (597)
T 3oja_B 311 NHL 313 (597)
T ss_dssp SCC
T ss_pred CCC
Confidence 653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-24 Score=233.11 Aligned_cols=201 Identities=19% Similarity=0.208 Sum_probs=119.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 34556666666666555556666666666666666666555555666666666666666666333333466666666666
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccC-------------------------------------CC
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPEL-------------------------------------EN 191 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l-------------------------------------~~ 191 (707)
++|++++..|..|.++++|+.|+|++|+++ .++...+..+ ++
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 227 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 227 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCS-BCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSS
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCC-ccccccccccceeecccccccccCCCCcceEEECCCCeeeecccccccc
Confidence 666666555556666666666666666665 3332221111 13
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS 271 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 271 (707)
|+.|+|++|++++. ..+..+++| ++|+|++|.+++..|..+..+++|+.|++++|++++..+....+.++..+.+.+
T Consensus 228 L~~L~l~~n~l~~~--~~l~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~ 304 (390)
T 3o6n_A 228 LTILKLQHNNLTDT--AWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSH 304 (390)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTC-SEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCS
T ss_pred ccEEECCCCCCccc--HHHcCCCCc-cEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCC
Confidence 44444444444421 345666666 577777777776667777777777777777777776554444555666666666
Q ss_pred CC
Q 005226 272 NP 273 (707)
Q Consensus 272 N~ 273 (707)
|+
T Consensus 305 n~ 306 (390)
T 3o6n_A 305 NH 306 (390)
T ss_dssp SC
T ss_pred Cc
Confidence 54
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=248.83 Aligned_cols=210 Identities=18% Similarity=0.143 Sum_probs=188.5
Q ss_pred CcEEEEEcCCCCcccc--CCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC-cccCCCCCccE
Q 005226 69 PRVVGVAISGKNVRGY--IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP-PSVCNLPRLQN 145 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 145 (707)
++++.|+|++|.+++. +|..+..+++|++|+|++|.+++ +|..+.++++|++|+|++|++.+..| ..|..+++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 6788999999999877 48889999999999999999984 67889999999999999999998877 68999999999
Q ss_pred EeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccC
Q 005226 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYN 225 (707)
Q Consensus 146 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N 225 (707)
|++++|++++..|..+.++++|+.|+|++|++++.++...|..+++|++|+|++|++++..|..|.++++| ++|+|++|
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls~N 507 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL-QLLNMSHN 507 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECCSS
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccC-CEEECCCC
Confidence 99999999999999999999999999999999975444556899999999999999999999999999999 89999999
Q ss_pred cCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCC-CCCCcccCCCCcccCCCC
Q 005226 226 HLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFA-NQGPTAFLSNPLLCGFPL 280 (707)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~-~~~~~~~~~N~~l~~~~~ 280 (707)
++++.+|..+..+++|+.|++++|+|+..++....+. ++..+.+.+||+.|+++.
T Consensus 508 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp CCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred cCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 9999889999999999999999999996555444554 478889999999998754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=224.29 Aligned_cols=199 Identities=22% Similarity=0.263 Sum_probs=173.2
Q ss_pred cEEEEEcCCCCccccCCCCc--CCCCCCCEEEcccCCcCCCCC----ccccCCCCCceEEecCccCCCCCCcccCCCCCc
Q 005226 70 RVVGVAISGKNVRGYIPSEL--GSLIYLRRLNLHNNNLFGSLP----DQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 143 (707)
+++.|+|++|++.+..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|+|++..|..|..+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 59999999999999999998 999999999999999998666 455679999999999999998888999999999
Q ss_pred cEEeccCCccccc--C--CCCCcccchhhhhhhcCCcccccCCCc---ccccCCCccEEeccCCCCCCCCCcchhhh---
Q 005226 144 QNLDLSNNSFSGS--L--PDGLKNCKQLQRLILARNKFSGQIPAG---IWPELENLVQLDLSDNDFKGPIPNDLGEL--- 213 (707)
Q Consensus 144 ~~L~Ls~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~lp~~---~~~~l~~L~~L~ls~N~l~~~~p~~~~~l--- 213 (707)
++|+|++|++.+. + +..+.++++|++|+|++|+|+ .++.. ++..+++|++|+|++|+|++..|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 9999999998752 2 344578999999999999997 55543 56788999999999999998889888887
Q ss_pred hccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 214 QSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 214 ~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
++| ++|+|++|+|+ .+|..+. ++|+.|++++|+|++. |....+.++..+.+.+|++
T Consensus 251 ~~L-~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 251 SAL-NSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPF 306 (310)
T ss_dssp TTC-CCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTT
T ss_pred CcC-CEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCC
Confidence 688 79999999999 7888775 8999999999999974 3346778888899988875
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-23 Score=210.72 Aligned_cols=178 Identities=22% Similarity=0.263 Sum_probs=161.5
Q ss_pred CCc--eeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEE
Q 005226 51 TPC--RWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIF 123 (707)
Q Consensus 51 ~~C--~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 123 (707)
|.| .|..|.|.+ .+...+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+
T Consensus 10 C~C~~~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 89 (251)
T 3m19_A 10 CTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG 89 (251)
T ss_dssp SEEEGGGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred eEcCCCCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEE
Confidence 556 467788864 3333447899999999999999999999999999999999999998888999999999999
Q ss_pred ecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 124 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|+
T Consensus 90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 168 (251)
T 3m19_A 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ 168 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCS
T ss_pred CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC-ccCHHHcCcCcCCCEEECCCCcCC
Confidence 9999999888888999999999999999999777777899999999999999999 888887899999999999999999
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCC
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGK 230 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~ 230 (707)
+..+..|..+++| +.|+|++|.+++.
T Consensus 169 ~~~~~~~~~l~~L-~~L~l~~N~~~c~ 194 (251)
T 3m19_A 169 SVPHGAFDRLGKL-QTITLFGNQFDCS 194 (251)
T ss_dssp CCCTTTTTTCTTC-CEEECCSCCBCTT
T ss_pred ccCHHHHhCCCCC-CEEEeeCCceeCC
Confidence 8888899999999 7999999999854
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=239.93 Aligned_cols=179 Identities=23% Similarity=0.209 Sum_probs=155.8
Q ss_pred eceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 55 WSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 55 w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
+..|.|.+ .|...+.+++.|+|++|+|++..|..|+++++|++|+|++|+|++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 34578864 3444557899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~ 209 (707)
++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|+++ .++...+..+++|++|+|++|++++..|..
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 172 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCC-CCCCCTTCCCTTCCEEECCSSCCCEECHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCccc-ccCcccccCCcccCEEEcccCcccccChhh
Confidence 9888999999999999999999999777889999999999999999999 543222345999999999999999877888
Q ss_pred hhhhhcccc--EEEeccCcCcCCCCCcC
Q 005226 210 LGELQSLSA--TLNLSYNHLSGKIPKSL 235 (707)
Q Consensus 210 ~~~l~~L~~--~L~l~~N~l~~~~p~~~ 235 (707)
|..+++| + .|++++|.+++..|..+
T Consensus 173 ~~~l~~L-~~l~L~l~~n~l~~~~~~~~ 199 (606)
T 3t6q_A 173 MSSLQQA-TNLSLNLNGNDIAGIEPGAF 199 (606)
T ss_dssp HHTTTTC-CSEEEECTTCCCCEECTTTT
T ss_pred hhhhccc-ceeEEecCCCccCccChhHh
Confidence 8888888 6 68888888776666544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=244.20 Aligned_cols=219 Identities=19% Similarity=0.204 Sum_probs=187.4
Q ss_pred CceeceeEeCC-------CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEe
Q 005226 52 PCRWSGISCMN-------ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFL 124 (707)
Q Consensus 52 ~C~w~gv~c~~-------~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 124 (707)
.|.|.|+ |+. .|.....+++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5889888 752 23333468999999999999999999999999999999999999988899999999999999
Q ss_pred cCccCCCCCCcccCCCCCccEEeccCCcccc-cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 125 YGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG-SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 125 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
++|+|++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|++.+.+|...|..+++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998777789999999999999999996 367899999999999999999666898877899999999999999999
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcC-CCCCCccEEEccCCcCcccC----CCCCCCCCCCCcccCCCC
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSL-GNLPVTVSFDLRGNNLSGEI----PQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~~~~----p~~~~~~~~~~~~~~~N~ 273 (707)
+..|..+..+++| +.|++++|.+. .+|..+ ..+++|+.|++++|++++.. +......++..+.+.+|.
T Consensus 162 ~~~~~~l~~l~~L-~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 234 (549)
T 2z81_A 162 NYQSQSLKSIRDI-HHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234 (549)
T ss_dssp EECTTTTTTCSEE-EEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCE
T ss_pred ccChhhhhccccC-ceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccc
Confidence 9999999999999 79999999987 455443 56899999999999999842 222234455555555553
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-24 Score=236.78 Aligned_cols=209 Identities=21% Similarity=0.193 Sum_probs=166.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|.+.+..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 104 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence 57888888888888877888888888888888888888777777888888888888888887655556777777777777
Q ss_pred cCCcccccCCCCCcccch------------------------hhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCC
Q 005226 149 SNNSFSGSLPDGLKNCKQ------------------------LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~------------------------L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~ 204 (707)
++|.+++..+..|.++++ |+.|+|++|+|+ .+|...|..+++|+.|+|++|+|++
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~ 262 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCc
Confidence 777777665556665554 455555556666 6676667888999999999999998
Q ss_pred CCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccCCC
Q 005226 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 205 ~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~~~ 279 (707)
..+..|.++++| +.|+|++|++++..|..|..+++|+.|++++|+|++..+.. ..+.++..+.+.+||+.|.++
T Consensus 263 ~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 263 IEGSMLHELLRL-QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp ECTTSCTTCTTC-CEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred cChhhccccccC-CEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 777889999999 79999999999888999999999999999999999876642 455678888999999988754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=241.62 Aligned_cols=203 Identities=22% Similarity=0.156 Sum_probs=148.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCc-------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP------------- 135 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------------- 135 (707)
++++.|+|++|++++..|..|..+++|++|+|++|.|++..| |..+++|++|+|++|.|++..+.
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l 111 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence 478888888888888777788888888888888888876555 77788888777777777632211
Q ss_pred ---ccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhh
Q 005226 136 ---SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212 (707)
Q Consensus 136 ---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 212 (707)
....+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..++..+++|++|+|++|.|++. | .+..
T Consensus 112 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-~~~~ 189 (487)
T 3oja_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVV 189 (487)
T ss_dssp CCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCC
T ss_pred CCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-cccc
Confidence 0123567777888888887777777788888888888888887666666555778888888888888754 2 2334
Q ss_pred hhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccC
Q 005226 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCG 277 (707)
Q Consensus 213 l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~ 277 (707)
+++| +.|+|++|.|++ +|..+..+++|+.|++++|+|++.++....+.++..+.+.+|++.|+
T Consensus 190 l~~L-~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 190 FAKL-KTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTC-CEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCC-CEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 7777 688888888885 44447778888888888888887655555666777777788877765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=214.46 Aligned_cols=178 Identities=24% Similarity=0.264 Sum_probs=165.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++++. +.+..+++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 63 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 140 (272)
T 3rfs_A 63 PNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNL 140 (272)
T ss_dssp TTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence 6899999999999974 48999999999999999999888888999999999999999999888888999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|++..|..+..+++| +.|+|++|.+.
T Consensus 141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~~~ 218 (272)
T 3rfs_A 141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL-QYIWLHDNPWD 218 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC-CEEECCSSCBC
T ss_pred CCCccCccCHHHhccCccCCEEECCCCCcC-ccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCC-CEEEccCCCcc
Confidence 999999877788899999999999999999 7888888899999999999999998888889999999 79999999998
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQ 257 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 257 (707)
+ .+++|+.|++..|+++|.+|.
T Consensus 219 ~-------~~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 219 C-------TCPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp C-------CTTTTHHHHHHHHHTGGGBBC
T ss_pred c-------cCcHHHHHHHHHHhCCCcccC
Confidence 6 456789999999999999994
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=4.2e-24 Score=222.87 Aligned_cols=184 Identities=21% Similarity=0.250 Sum_probs=168.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC-ccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP-DQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
.+++.|+|++|.+.+ +|..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 678899999999885 56779999999999999999997655 6899999999999999999988999999999999999
Q ss_pred ccCCcccc-cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCc
Q 005226 148 LSNNSFSG-SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNH 226 (707)
Q Consensus 148 Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 226 (707)
|++|++++ .+|..+..+++|+.|+|++|+|+ .++...|..+++|++|+|++|+|++..+..+..+++| +.|+|++|+
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~ 234 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL-QVLDYSLNH 234 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTC-CEEECTTSC
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcC-CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccC-CEeECCCCC
Confidence 99999997 68999999999999999999999 5655566899999999999999998777789999999 899999999
Q ss_pred CcCCCCCcCCCCC-CccEEEccCCcCcccC
Q 005226 227 LSGKIPKSLGNLP-VTVSFDLRGNNLSGEI 255 (707)
Q Consensus 227 l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~ 255 (707)
+++..|..+..++ +|+.|++++|++++..
T Consensus 235 l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 235 IMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 9999999999995 9999999999999754
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=242.26 Aligned_cols=209 Identities=23% Similarity=0.215 Sum_probs=159.6
Q ss_pred CcEEEEEcCCCCccccC--CCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcc-cCCCCCccE
Q 005226 69 PRVVGVAISGKNVRGYI--PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPS-VCNLPRLQN 145 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~ 145 (707)
++++.|+|++|.+.+.. +..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|.. +..+++|+.
T Consensus 350 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 429 (606)
T 3t6q_A 350 ENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429 (606)
T ss_dssp TTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCE
T ss_pred CcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCE
Confidence 46777777777777665 666777777777777777777777777777778888888888777665544 777888888
Q ss_pred EeccCCcccccCCCCCcccchhhhhhhcCCccccc-CC-CcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEec
Q 005226 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQ-IP-AGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLS 223 (707)
Q Consensus 146 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-lp-~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~ 223 (707)
|+|++|.+++..|..+.++++|+.|+|++|++++. +| ...+..+++|++|+|++|++++..|..|.++++| ++|+|+
T Consensus 430 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~Ls 508 (606)
T 3t6q_A 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM-NHVDLS 508 (606)
T ss_dssp EECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECC
T ss_pred EECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCC-CEEECC
Confidence 88888888877777788888888888888888742 22 2446778888888888888887778888888888 788888
Q ss_pred cCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC-CCCCCCCCcccCCCCcccCCC
Q 005226 224 YNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT-GSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 224 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~~l~~~~ 279 (707)
+|++++..|..+..++.| .|++++|++++.+|.. ..+.++..+.+.+||+.|.++
T Consensus 509 ~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp SSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 888888888888888888 8888888888777642 345667788888898888643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=225.32 Aligned_cols=201 Identities=21% Similarity=0.200 Sum_probs=166.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++++..|..|+++++|++|+|++|+|+...+..|.++++|++|+|++|++++..|..|..+++|+.|+|
T Consensus 93 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 172 (390)
T 3o6n_A 93 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 172 (390)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEEC
T ss_pred CCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEEC
Confidence 68999999999999998999999999999999999999655555789999999999999999888888999999999999
Q ss_pred cCCcccccCCCCCccc-------------------------------------chhhhhhhcCCcccccCCCcccccCCC
Q 005226 149 SNNSFSGSLPDGLKNC-------------------------------------KQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l-------------------------------------~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
++|++++.....+.++ ++|+.|+|++|+++ .+ ..+..+++
T Consensus 173 ~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~-~~--~~l~~l~~ 249 (390)
T 3o6n_A 173 SSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLT-DT--AWLLNYPG 249 (390)
T ss_dssp CSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSSCCEEECCSSCCC-CC--GGGGGCTT
T ss_pred CCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccccccccEEECCCCCCc-cc--HHHcCCCC
Confidence 9999985432222222 24555566666665 23 23578899
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS 271 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 271 (707)
|++|+|++|.+++..|..|.++++| ++|+|++|++++ +|..+..+++|+.|++++|++++.++....+.++..+.+.+
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~ 327 (390)
T 3o6n_A 250 LVEVDLSYNELEKIMYHPFVKMQRL-ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDH 327 (390)
T ss_dssp CSEEECCSSCCCEEESGGGTTCSSC-CEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCS
T ss_pred ccEEECCCCcCCCcChhHccccccC-CEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCC
Confidence 9999999999998888999999999 799999999984 67777889999999999999987665555667777777777
Q ss_pred CCc
Q 005226 272 NPL 274 (707)
Q Consensus 272 N~~ 274 (707)
|+.
T Consensus 328 N~i 330 (390)
T 3o6n_A 328 NSI 330 (390)
T ss_dssp SCC
T ss_pred Ccc
Confidence 763
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=241.86 Aligned_cols=209 Identities=22% Similarity=0.219 Sum_probs=156.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC-ccccCCCCCceEEecCccCC-----------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP-DQLFNATSLHSIFLYGNNLS----------------- 130 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~----------------- 130 (707)
.+++.|+|++|++++..|..|..+++|+.|+|++|.+++.+| ..|.++++|++|+|++|++.
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 356667777777776666666667777777777776665444 45555666666666655543
Q ss_pred ---------CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCC--------CcccccCCCcc
Q 005226 131 ---------GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP--------AGIWPELENLV 193 (707)
Q Consensus 131 ---------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp--------~~~~~~l~~L~ 193 (707)
+.+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+++ .++ ...|..+++|+
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~~~~~~~~~l~~L~ 539 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLH 539 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCG-GGGSTTSTTSCCCTTTTCTTCC
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCcc-ccchhhccCCcchhhcCCCCCC
Confidence 356777788888888888888888776777888888888888888887 332 22367788889
Q ss_pred EEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCC--CCCCCCCcccCC
Q 005226 194 QLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTG--SFANQGPTAFLS 271 (707)
Q Consensus 194 ~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~--~~~~~~~~~~~~ 271 (707)
+|+|++|+|+...+..|.++++| +.|+|++|+|++..+..|..+++|+.|++++|+|++.+|... .+.++..+.+.+
T Consensus 540 ~L~L~~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~ 618 (680)
T 1ziw_A 540 ILNLESNGFDEIPVEVFKDLFEL-KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred EEECCCCCCCCCCHHHcccccCc-ceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence 99999999885444568889999 799999999997777778889999999999999998776422 466788889999
Q ss_pred CCcccCCC
Q 005226 272 NPLLCGFP 279 (707)
Q Consensus 272 N~~l~~~~ 279 (707)
||+.|+++
T Consensus 619 N~~~c~c~ 626 (680)
T 1ziw_A 619 NPFDCTCE 626 (680)
T ss_dssp CCCCBCCC
T ss_pred CCcccCCc
Confidence 99999865
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-23 Score=235.94 Aligned_cols=200 Identities=22% Similarity=0.246 Sum_probs=175.5
Q ss_pred CCceec----eeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCce
Q 005226 51 TPCRWS----GISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHS 121 (707)
Q Consensus 51 ~~C~w~----gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 121 (707)
+||.|. .|.|.+ .|...+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 556653 578864 34344578999999999999999999999999999999999999888999999999999
Q ss_pred EEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccc-cCCCcccccCCCccEEeccCC
Q 005226 122 IFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG-QIPAGIWPELENLVQLDLSDN 200 (707)
Q Consensus 122 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~lp~~~~~~l~~L~~L~ls~N 200 (707)
|+|++|+|++..|..|+++++|++|+|++|++++..|..|.++++|++|+|++|++++ .+|.. |..+++|++|+|++|
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY-FSNLTNLVHVDLSYN 163 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGG-GGTCTTCCEEECCSS
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHh-HhhcCCCCEEEccCC
Confidence 9999999998889999999999999999999997777899999999999999999984 46765 579999999999999
Q ss_pred CCCCCCCcchhhhhccc---cEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc
Q 005226 201 DFKGPIPNDLGELQSLS---ATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 201 ~l~~~~p~~~~~l~~L~---~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
++++..|..+..+++|. .+|++++|.+++..+..+.. .+|+.|++++|.++
T Consensus 164 ~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~-~~L~~L~L~~n~~~ 217 (606)
T 3vq2_A 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNS 217 (606)
T ss_dssp CCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCSC
T ss_pred cceecChhhhhhhhccccccceeeccCCCcceeCcccccC-ceeeeeeccCCccc
Confidence 99998888999988771 28999999999665555554 48999999999886
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.3e-23 Score=215.68 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=169.3
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++++..|..|.++++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 78 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l 154 (332)
T 2ft3_A 78 QHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEM 154 (332)
T ss_dssp TTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEEC
T ss_pred CCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEEC
Confidence 68999999999999998999999999999999999998 5666555 78899999999888666667888888888888
Q ss_pred cCCcccc--cCCCCCccc--------------------chhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCC
Q 005226 149 SNNSFSG--SLPDGLKNC--------------------KQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPI 206 (707)
Q Consensus 149 s~N~l~~--~~p~~~~~l--------------------~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~ 206 (707)
++|.++. ..|..+..+ ++|+.|+|++|+++ .++...|..+++|++|+|++|+|++..
T Consensus 155 ~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~-~~~~~~l~~l~~L~~L~L~~N~l~~~~ 233 (332)
T 2ft3_A 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIE 233 (332)
T ss_dssp CSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCC-CCCTTSSTTCTTCSCCBCCSSCCCCCC
T ss_pred CCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCC-ccCHHHhcCCCCCCEEECCCCcCCcCC
Confidence 8888852 455555443 57889999999999 666666789999999999999999888
Q ss_pred CcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCC-------CCCCCCcccCCCCccc
Q 005226 207 PNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGS-------FANQGPTAFLSNPLLC 276 (707)
Q Consensus 207 p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-------~~~~~~~~~~~N~~l~ 276 (707)
+..+..+++| ++|+|++|+|+ .+|..+..+++|+.|++++|++++..+.... ...+..+.+.+||+.+
T Consensus 234 ~~~~~~l~~L-~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 234 NGSLSFLPTL-RELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp TTGGGGCTTC-CEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred hhHhhCCCCC-CEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccc
Confidence 8899999999 89999999999 8999999999999999999999977653221 2345567788888654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=237.41 Aligned_cols=201 Identities=21% Similarity=0.199 Sum_probs=164.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|.|++..|..|..+++|+.|+|
T Consensus 99 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 178 (597)
T 3oja_B 99 HTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQL 178 (597)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEEC
Confidence 58999999999999999999999999999999999999766667899999999999999999888999999999999999
Q ss_pred cCCcccccCCCCCccc-------------------------------------chhhhhhhcCCcccccCCCcccccCCC
Q 005226 149 SNNSFSGSLPDGLKNC-------------------------------------KQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l-------------------------------------~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
++|.|++..+..+.++ ++|+.|+|++|++++ + ..+..+++
T Consensus 179 ~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~-~--~~l~~l~~ 255 (597)
T 3oja_B 179 SSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTD-T--AWLLNYPG 255 (597)
T ss_dssp TTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSCCCEEECCSSCCCC-C--GGGGGCTT
T ss_pred cCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCCCCEEECCCCCCCC-C--hhhccCCC
Confidence 9999986533322222 134555555555552 2 23578899
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS 271 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~ 271 (707)
|+.|+|++|.|++..|..|.++++| +.|+|++|.|++ +|..+..+++|+.|+|++|++++.++....+.++..+.+.+
T Consensus 256 L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~ 333 (597)
T 3oja_B 256 LVEVDLSYNELEKIMYHPFVKMQRL-ERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDH 333 (597)
T ss_dssp CSEEECCSSCCCEEESGGGTTCSSC-CEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCS
T ss_pred CCEEECCCCccCCCCHHHhcCccCC-CEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCC
Confidence 9999999999998888899999999 799999999985 67777888999999999999986555445566777777777
Q ss_pred CCc
Q 005226 272 NPL 274 (707)
Q Consensus 272 N~~ 274 (707)
|+.
T Consensus 334 N~l 336 (597)
T 3oja_B 334 NSI 336 (597)
T ss_dssp SCC
T ss_pred CCC
Confidence 753
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.9e-23 Score=213.16 Aligned_cols=187 Identities=22% Similarity=0.204 Sum_probs=167.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 68999999999999988889999999999999999999888899999999999999999999877778999999999999
Q ss_pred cCCccccc-CCCCCcccchhhhhhhcCCcccccCCCcccccCCCcc----EEeccCCCCCCCCCcchhhhhccccEEEec
Q 005226 149 SNNSFSGS-LPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLV----QLDLSDNDFKGPIPNDLGELQSLSATLNLS 223 (707)
Q Consensus 149 s~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~----~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~ 223 (707)
++|++++. +|..|.++++|+.|+|++|+|+ .++...|..+++|+ .|++++|++++..+..+. ..+| ++|+|+
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L-~~L~L~ 208 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRL-KELALD 208 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCC-EECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCE-EEEECC
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCC-cCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcc-cEEECC
Confidence 99999864 6999999999999999999999 66766667777777 899999999965554444 4578 899999
Q ss_pred cCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCC
Q 005226 224 YNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258 (707)
Q Consensus 224 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 258 (707)
+|+|++..+..+..+++|+.|++++|++++..|..
T Consensus 209 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 209 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp SSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred CCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 99999777777899999999999999999887644
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=234.92 Aligned_cols=162 Identities=22% Similarity=0.253 Sum_probs=144.0
Q ss_pred cCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccc--cCCCCCcccchhhhhhhcCCcccccCCCcccccCCC
Q 005226 114 FNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG--SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 114 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
..+++|++|+|++|++++.+|..+.++++|+.|+|++|++++ .+|..+.++++|+.|+|++|++++.+|...|..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 678999999999999999899999999999999999999996 335779999999999999999996699998899999
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFL 270 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~ 270 (707)
|++|+|++|+|++.+|..+. ++| +.|+|++|+|+ .+|..+..+++|+.|++++|+|++.++. ...+.++..+.+.
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L-~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKV-KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTC-SEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcC-CEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEec
Confidence 99999999999987777664 678 79999999999 7888888999999999999999965554 5667788889999
Q ss_pred CCCcccCCC
Q 005226 271 SNPLLCGFP 279 (707)
Q Consensus 271 ~N~~l~~~~ 279 (707)
+||+.|.++
T Consensus 506 ~N~~~c~c~ 514 (562)
T 3a79_B 506 DNPWDCTCP 514 (562)
T ss_dssp SCCBCCCHH
T ss_pred CCCcCCCcc
Confidence 999998754
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.2e-23 Score=236.82 Aligned_cols=186 Identities=21% Similarity=0.213 Sum_probs=156.4
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEec
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLY 125 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 125 (707)
|.|.++.|.|.. .|...+.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 456666788864 344445789999999999999888889999999999999999999999999999999999999
Q ss_pred CccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCC
Q 005226 126 GNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 126 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~ 205 (707)
+|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++ ++...+..+++|++|+|++|++++.
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSC-CCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccc-cCchhhcccccCCEEEccCCccccc
Confidence 999996555679999999999999999997777899999999999999999994 4555567899999999999999977
Q ss_pred CCcchh--hhhccccEEEeccCcCcCCCCCcCCCC
Q 005226 206 IPNDLG--ELQSLSATLNLSYNHLSGKIPKSLGNL 238 (707)
Q Consensus 206 ~p~~~~--~l~~L~~~L~l~~N~l~~~~p~~~~~l 238 (707)
.+..+. .+++| +.|++++|++++..|..+..+
T Consensus 161 ~~~~~~~~~~~~L-~~L~L~~n~l~~~~~~~~~~l 194 (680)
T 1ziw_A 161 KSEELDIFANSSL-KKLELSSNQIKEFSPGCFHAI 194 (680)
T ss_dssp CHHHHGGGTTCEE-SEEECTTCCCCCBCTTGGGGS
T ss_pred CHHHhhccccccc-cEEECCCCcccccChhhhhhh
Confidence 776654 34778 788888888887777665443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=212.60 Aligned_cols=202 Identities=23% Similarity=0.299 Sum_probs=152.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++++..|..|.++++|++|+|++|+|+ .+|..+. ++|++|+|++|++++..+..|.++++|+.|+|
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 152 (330)
T 1xku_A 76 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVEL 152 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEEC
Confidence 68999999999999888999999999999999999988 5555443 56666666666666554455555555555555
Q ss_pred cCCcccc--cCCCCCcccc---------------------hhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCC
Q 005226 149 SNNSFSG--SLPDGLKNCK---------------------QLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 149 s~N~l~~--~~p~~~~~l~---------------------~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~ 205 (707)
++|+++. ..+..+.+++ +|+.|+|++|+++ .++...|..+++|++|+|++|+|++.
T Consensus 153 ~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~ 231 (330)
T 1xku_A 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAV 231 (330)
T ss_dssp CSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCC-EECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCC-ccCHHHhcCCCCCCEEECCCCcCcee
Confidence 5555532 3444444444 5555555566665 34444567899999999999999988
Q ss_pred CCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCC-------CCCCCCCcccCCCCccc
Q 005226 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTG-------SFANQGPTAFLSNPLLC 276 (707)
Q Consensus 206 ~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-------~~~~~~~~~~~~N~~l~ 276 (707)
.+..+..+++| ++|+|++|+|+ .+|..+..+++|+.|++++|++++..+... ....+..+.+.+||..+
T Consensus 232 ~~~~~~~l~~L-~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 232 DNGSLANTPHL-RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CTTTGGGSTTC-CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ChhhccCCCCC-CEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence 88899999999 89999999999 899999999999999999999997765332 12345566777888654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-23 Score=221.17 Aligned_cols=199 Identities=22% Similarity=0.156 Sum_probs=137.4
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC-------------------
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS------------------- 130 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------- 130 (707)
+++.|+|++|++++..|..|..+++|++|+|++|+|++..+ +..+++|++|+|++|+|+
T Consensus 35 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~ 112 (317)
T 3o53_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (317)
T ss_dssp GCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCS
T ss_pred CCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccC
Confidence 55566666666655555555666666666666666554333 555555555555555554
Q ss_pred CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch
Q 005226 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210 (707)
Q Consensus 131 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 210 (707)
+..+ ..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+..++..+++|++|+|++|+|++. |. .
T Consensus 113 ~~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~ 187 (317)
T 3o53_A 113 RVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q 187 (317)
T ss_dssp EEEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred CcCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-c
Confidence 2222 23567888888888888777778888888888888888888544555555788888888888888744 32 3
Q ss_pred hhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccC
Q 005226 211 GELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCG 277 (707)
Q Consensus 211 ~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~ 277 (707)
..+++| ++|+|++|+|++ +|..+..+++|+.|++++|++++.++....+.++..+.+.+|++.|+
T Consensus 188 ~~l~~L-~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 188 VVFAKL-KTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CCCTTC-CEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cccccC-CEEECCCCcCCc-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccCc
Confidence 347788 788888888884 55558888888888888888886655555667777888888887765
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=232.59 Aligned_cols=216 Identities=22% Similarity=0.191 Sum_probs=171.2
Q ss_pred CCCCCCCCCCCCC---CCceec----eeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCc
Q 005226 38 DTSVFADWNENDP---TPCRWS----GISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNL 105 (707)
Q Consensus 38 ~~~~~~~W~~~~~---~~C~w~----gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 105 (707)
+...+++|+...| ++|.+. .|.|.. +|...+..++.|||++|+|+++.+..|.++++|++|+|++|+|
T Consensus 9 ~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i 88 (635)
T 4g8a_A 9 DDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 88 (635)
T ss_dssp ----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcC
Confidence 3445566664433 356543 477863 4545567899999999999999899999999999999999999
Q ss_pred CCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcc
Q 005226 106 FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI 185 (707)
Q Consensus 106 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~ 185 (707)
+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|+|++.-....
T Consensus 89 ~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~ 168 (635)
T 4g8a_A 89 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 168 (635)
T ss_dssp CEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGG
T ss_pred CCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchh
Confidence 98888899999999999999999997777889999999999999999997777789999999999999999984322345
Q ss_pred cccCCCccEEeccCCCCCCCCCcchhhhhcc---ccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 186 WPELENLVQLDLSDNDFKGPIPNDLGELQSL---SATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 186 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L---~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
+..+++|++|+|++|+|++..|..|..+.++ ...++++.|.++...+. ......+..+++.+|..+..
T Consensus 169 ~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~-~~~~~~~~~l~l~~n~~~~~ 239 (635)
T 4g8a_A 169 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLHKLTLRNNFDSLN 239 (635)
T ss_dssp GGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTT-TTTTCEEEEEEEESCCSSHH
T ss_pred hccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcc-cccchhhhhhhhhccccccc
Confidence 6789999999999999998888888887765 13689999999954444 44556778899999876643
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=5.2e-23 Score=231.11 Aligned_cols=162 Identities=20% Similarity=0.248 Sum_probs=143.3
Q ss_pred cCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccc--cCCCCCcccchhhhhhhcCCcccccCCCcccccCCC
Q 005226 114 FNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG--SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 114 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++ .+|..+.++++|+.|+|++|++++.+|...|..+++
T Consensus 321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~ 400 (520)
T 2z7x_B 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400 (520)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence 678899999999999998899999999999999999999996 566789999999999999999996699888889999
Q ss_pred ccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccC
Q 005226 192 LVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFL 270 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~ 270 (707)
|++|+|++|++++.+|..+. ++| +.|+|++|+|+ .+|..+..+++|+.|++++|+|+..++. ...+.++..+.+.
T Consensus 401 L~~L~Ls~N~l~~~~~~~l~--~~L-~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 476 (520)
T 2z7x_B 401 LLSLNMSSNILTDTIFRCLP--PRI-KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLH 476 (520)
T ss_dssp CCEEECCSSCCCGGGGGSCC--TTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEECcCCCCCcchhhhhc--ccC-CEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECc
Confidence 99999999999988777765 678 79999999999 7898888999999999999999965544 4567778889999
Q ss_pred CCCcccCCC
Q 005226 271 SNPLLCGFP 279 (707)
Q Consensus 271 ~N~~l~~~~ 279 (707)
+||+.|.++
T Consensus 477 ~N~~~c~c~ 485 (520)
T 2z7x_B 477 TNPWDCSCP 485 (520)
T ss_dssp SSCBCCCHH
T ss_pred CCCCcccCC
Confidence 999988754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-23 Score=219.40 Aligned_cols=178 Identities=25% Similarity=0.262 Sum_probs=157.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCC-----CCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCC--CCccc--CC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSL-----IYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGS--LPPSV--CN 139 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~ 139 (707)
++++.|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 6899999999999988 8888887 9999999999999998889999999999999999998865 34455 89
Q ss_pred CCCccEEeccCCcccc--cCC-CCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhcc
Q 005226 140 LPRLQNLDLSNNSFSG--SLP-DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSL 216 (707)
Q Consensus 140 l~~L~~L~Ls~N~l~~--~~p-~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 216 (707)
+++|++|+|++|+|++ .++ ..+.++++|+.|+|++|+|++.+|...+..+++|++|+|++|+|+ .+|..+. ++|
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L 276 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKL 276 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEE
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCc
Confidence 9999999999999983 222 344678999999999999997776666778999999999999999 7888877 788
Q ss_pred ccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 217 SATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 217 ~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
++|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 277 -~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 -SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp -EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred -eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 8999999999965 76 9999999999999999985
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-23 Score=242.90 Aligned_cols=198 Identities=23% Similarity=0.289 Sum_probs=176.9
Q ss_pred CcEEEEEcCCCCccc-----------------cCCCCcC--CCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCcc-
Q 005226 69 PRVVGVAISGKNVRG-----------------YIPSELG--SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN- 128 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~-----------------~~~~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~- 128 (707)
.+++.|+|++|++++ .+|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 689999999999999 4899988 99999999999999999999999999999999999998
Q ss_pred CCC-CCCcccCCCC-------CccEEeccCCcccccCCC--CCcccchhhhhhhcCCcccccCCCcccccCCCccEEecc
Q 005226 129 LSG-SLPPSVCNLP-------RLQNLDLSNNSFSGSLPD--GLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198 (707)
Q Consensus 129 l~~-~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls 198 (707)
|++ .+|..+++++ +|+.|+|++|+|+ .+|. .|.++++|+.|+|++|+|+ .|| .|..+++|+.|+|+
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp--~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE--AFGTNVKLTDLKLD 603 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC--CCCTTSEESEEECC
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch--hhcCCCcceEEECc
Confidence 998 7888666554 9999999999999 8999 9999999999999999999 999 56899999999999
Q ss_pred CCCCCCCCCcchhhhhc-cccEEEeccCcCcCCCCCcCCCCCC--ccEEEccCCcCcccCCCCC------CCCCCCCccc
Q 005226 199 DNDFKGPIPNDLGELQS-LSATLNLSYNHLSGKIPKSLGNLPV--TVSFDLRGNNLSGEIPQTG------SFANQGPTAF 269 (707)
Q Consensus 199 ~N~l~~~~p~~~~~l~~-L~~~L~l~~N~l~~~~p~~~~~l~~--L~~l~l~~N~l~~~~p~~~------~~~~~~~~~~ 269 (707)
+|+|+ .+|..+.++++ | +.|+|++|+|+ .+|..+..++. |+.|++++|++++.+|... ...++..+.+
T Consensus 604 ~N~l~-~lp~~l~~l~~~L-~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~L 680 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQV-EGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680 (876)
T ss_dssp SSCCS-CCCTTSCEECTTC-CEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEEC
T ss_pred CCccc-cchHHHhhccccC-CEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEc
Confidence 99999 89999999999 9 89999999999 89998888765 9999999999999887543 1224455555
Q ss_pred CCCC
Q 005226 270 LSNP 273 (707)
Q Consensus 270 ~~N~ 273 (707)
.+|.
T Consensus 681 s~N~ 684 (876)
T 4ecn_A 681 SYNE 684 (876)
T ss_dssp CSSC
T ss_pred cCCc
Confidence 5554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.7e-22 Score=229.27 Aligned_cols=199 Identities=20% Similarity=0.291 Sum_probs=114.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCC-CCEEEcccCCcCCCCCccccCCC--CCceEEecCccCCCCCCcccC-------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIY-LRRLNLHNNNLFGSLPDQLFNAT--SLHSIFLYGNNLSGSLPPSVC------- 138 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~~~~------- 138 (707)
.+++.|+|++|+++ .+|..+..+++ |++|+|++|+|+ .+|..+..++ +|++|+|++|++++.+|..|.
T Consensus 353 ~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~ 430 (636)
T 4eco_A 353 IKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430 (636)
T ss_dssp EEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCC
T ss_pred CCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccc
Confidence 35666666666666 55666666666 666666666666 5666555543 666666666666666666665
Q ss_pred CCCCccEEeccCCcccccCCCC-CcccchhhhhhhcCCcccccCCCcccccCC-------CccEEeccCCCCCCCCCcch
Q 005226 139 NLPRLQNLDLSNNSFSGSLPDG-LKNCKQLQRLILARNKFSGQIPAGIWPELE-------NLVQLDLSDNDFKGPIPNDL 210 (707)
Q Consensus 139 ~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~-------~L~~L~ls~N~l~~~~p~~~ 210 (707)
.+++|+.|+|++|+|+ .+|.. +..+++|+.|+|++|+|+ .+|...+..+. +|++|+|++|+|+ .+|..+
T Consensus 431 ~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 507 (636)
T 4eco_A 431 KGINVSSINLSNNQIS-KFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDF 507 (636)
T ss_dssp CCCCEEEEECCSSCCC-SCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGG
T ss_pred cCCCCCEEECcCCccC-cCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhh
Confidence 5556666666666666 34433 334566666666666665 55555544332 5566666666665 455555
Q ss_pred h--hhhccccEEEeccCcCcCCCCCcCCCCCCccEEEc------cCCcCcccCCC-CCCCCCCCCcccCCCCc
Q 005226 211 G--ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL------RGNNLSGEIPQ-TGSFANQGPTAFLSNPL 274 (707)
Q Consensus 211 ~--~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l------~~N~l~~~~p~-~~~~~~~~~~~~~~N~~ 274 (707)
. .+++| +.|+|++|+|++ +|..+..+++|+.|++ ++|++.+.+|. ...+.++..+.+.+|..
T Consensus 508 ~~~~l~~L-~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 578 (636)
T 4eco_A 508 RATTLPYL-VGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578 (636)
T ss_dssp STTTCTTC-CEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred hhccCCCc-CEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence 4 55555 456666666654 5555555566666655 34455555552 22334444455555543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-22 Score=211.96 Aligned_cols=221 Identities=20% Similarity=0.138 Sum_probs=180.9
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC-ccccCCCCCce-EE
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP-DQLFNATSLHS-IF 123 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~ 123 (707)
|-|+|..|.|++ +|...+.+++.|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|++ ++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 558899999974 333344689999999999998777889999999999999999977665 46789998775 67
Q ss_pred ecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcC-CcccccCCCcccccCC-CccEEeccCCC
Q 005226 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILAR-NKFSGQIPAGIWPELE-NLVQLDLSDND 201 (707)
Q Consensus 124 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~lp~~~~~~l~-~L~~L~ls~N~ 201 (707)
+++|+|+...|..|..+++|+.|++++|+|++..+..+....++..|++++ |++. .+|...|..+. .|+.|+|++|+
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhcccccc
Confidence 788999988889999999999999999999977777788888899999966 6777 88888777765 68999999999
Q ss_pred CCCCCCcchhhhhccccEEEecc-CcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCccc
Q 005226 202 FKGPIPNDLGELQSLSATLNLSY-NHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLC 276 (707)
Q Consensus 202 l~~~~p~~~~~l~~L~~~L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~ 276 (707)
|+ .+|.......+| ++|++++ |.++...++.|..+++|+.|++++|+|+..++ ..+.++..+...+++.+.
T Consensus 166 i~-~i~~~~f~~~~L-~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~--~~~~~L~~L~~l~~~~l~ 237 (350)
T 4ay9_X 166 IQ-EIHNSAFNGTQL-DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS--YGLENLKKLRARSTYNLK 237 (350)
T ss_dssp CC-EECTTSSTTEEE-EEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS--SSCTTCCEEECTTCTTCC
T ss_pred cc-CCChhhccccch-hHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh--hhhccchHhhhccCCCcC
Confidence 99 566665566788 6999975 67774444678999999999999999996655 456777777766665443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.6e-22 Score=236.10 Aligned_cols=190 Identities=21% Similarity=0.195 Sum_probs=174.5
Q ss_pred CCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCC-CccccCCCCCceEEecCccCCCCCCcccCCCCCccE
Q 005226 67 PDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSL-PDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145 (707)
Q Consensus 67 ~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 145 (707)
.+++++.|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..|+++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 4589999999999999999999999999999999999766665 888999999999999999999889999999999999
Q ss_pred EeccCCcccccCCCC--CcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhh--hccccEEE
Q 005226 146 LDLSNNSFSGSLPDG--LKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGEL--QSLSATLN 221 (707)
Q Consensus 146 L~Ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l--~~L~~~L~ 221 (707)
|+|++|.+++.+|.. |.++++|++|+|++|++++..+...|..+++|++|+|++|.+++..|..+..+ ++| +.|+
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L-~~L~ 180 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTL-SFFS 180 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSS-CCCE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCcc-ceEE
Confidence 999999999877765 99999999999999999965566678999999999999999999999999988 889 7999
Q ss_pred eccCcCcCCCCCcCCCCCC------ccEEEccCCcCcccCCC
Q 005226 222 LSYNHLSGKIPKSLGNLPV------TVSFDLRGNNLSGEIPQ 257 (707)
Q Consensus 222 l~~N~l~~~~p~~~~~l~~------L~~l~l~~N~l~~~~p~ 257 (707)
|++|.+++..|..+..+++ |+.|++++|.+++.+|.
T Consensus 181 L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~ 222 (844)
T 3j0a_A 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITG 222 (844)
T ss_dssp ECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTS
T ss_pred CCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHH
Confidence 9999999999988887776 99999999999887763
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=218.58 Aligned_cols=182 Identities=21% Similarity=0.237 Sum_probs=158.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCc-------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP------------- 135 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~------------- 135 (707)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+.
T Consensus 99 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 178 (452)
T 3zyi_A 99 HHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDL 178 (452)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeC
Confidence 6788999999999988888899999999999999999877777788888999999988888744332
Q ss_pred ------------ccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 136 ------------SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 136 ------------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
.|.++++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|+ .++...|..+++|+.|+|++|+|+
T Consensus 179 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~ 255 (452)
T 3zyi_A 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255 (452)
T ss_dssp CCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCS-EECGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCc-ccCcccccCccCCCEEEeCCCcCc
Confidence 35667778888888888874 44 5889999999999999999 666667789999999999999999
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
+..|..|.++++| +.|+|++|+|++..+..+..+++|+.|+|++|++...
T Consensus 256 ~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 256 LIERNAFDGLASL-VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp EECTTTTTTCTTC-CEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred eECHHHhcCCCCC-CEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 9889999999999 7999999999988888899999999999999998754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=226.55 Aligned_cols=199 Identities=25% Similarity=0.365 Sum_probs=163.8
Q ss_pred CCCCCCCCCCCCc-----eecee-EeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCcccc
Q 005226 41 VFADWNENDPTPC-----RWSGI-SCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF 114 (707)
Q Consensus 41 ~~~~W~~~~~~~C-----~w~gv-~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 114 (707)
.+.+|... ..+| .|.|+ .|.. .+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| .
T Consensus 32 ~l~~W~~~-~~~~~~~~~~~~~l~~C~~------~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~ 97 (571)
T 3cvr_A 32 AWDKWEKQ-ALPGENRNEAVSLLKECLI------NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---E 97 (571)
T ss_dssp HHHHHHTT-CCTTCCHHHHHHHHHHHHH------TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---C
T ss_pred HHHHHhcc-CCccccccchhhhcccccc------CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---c
Confidence 34567643 3567 79999 7865 589999999999997 677663 89999999999999 677 4
Q ss_pred CCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccE
Q 005226 115 NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194 (707)
Q Consensus 115 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~ 194 (707)
.+++|++|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|. .+++|++
T Consensus 98 ~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~ 164 (571)
T 3cvr_A 98 LPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLT-MLPE----LPTSLEV 164 (571)
T ss_dssp CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCE
T ss_pred ccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccC-cCCC----cCCCcCE
Confidence 57999999999999996 777 765 99999999999996 776 6899999999999999 5886 5789999
Q ss_pred EeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCc-------cEEEccCCcCcccCCCCCCCCCCCCc
Q 005226 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVT-------VSFDLRGNNLSGEIPQTGSFANQGPT 267 (707)
Q Consensus 195 L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L-------~~l~l~~N~l~~~~p~~~~~~~~~~~ 267 (707)
|+|++|+|++ +|. |. ++| +.|+|++|+|+ .+|. +.. +| +.|+|++|+|+..++....+.++..+
T Consensus 165 L~Ls~N~L~~-lp~-l~--~~L-~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L 235 (571)
T 3cvr_A 165 LSVRNNQLTF-LPE-LP--ESL-EALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTI 235 (571)
T ss_dssp EECCSSCCSC-CCC-CC--TTC-CEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEE
T ss_pred EECCCCCCCC-cch-hh--CCC-CEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEE
Confidence 9999999996 777 66 788 79999999999 7777 654 77 99999999999655445567777788
Q ss_pred ccCCCCcc
Q 005226 268 AFLSNPLL 275 (707)
Q Consensus 268 ~~~~N~~l 275 (707)
.+.+|+.-
T Consensus 236 ~L~~N~l~ 243 (571)
T 3cvr_A 236 ILEDNPLS 243 (571)
T ss_dssp ECCSSSCC
T ss_pred EeeCCcCC
Confidence 88888753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4e-22 Score=218.92 Aligned_cols=182 Identities=21% Similarity=0.243 Sum_probs=149.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC--------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP-------------- 134 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-------------- 134 (707)
.+++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+...+
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 567777788777777777777777777777777777776666667777777777777777663333
Q ss_pred -----------cccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 135 -----------PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 135 -----------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
..|.++++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|+ .++...|..+++|+.|+|++|+|+
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccC-ccChhhhccCccCCEEECCCCcee
Confidence 24666777788888888887 555 4788999999999999999 666667789999999999999999
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
+..+..|.++++| +.|+|++|+|++..+..+..+++|+.|+|++|++...
T Consensus 245 ~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 245 VIERNAFDNLQSL-VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp EECTTSSTTCTTC-CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred EEChhhhcCCCCC-CEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 9889999999999 8999999999988888899999999999999999753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.9e-22 Score=194.34 Aligned_cols=177 Identities=21% Similarity=0.240 Sum_probs=155.0
Q ss_pred ceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCC
Q 005226 53 CRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGS 132 (707)
Q Consensus 53 C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 132 (707)
|+..|++... .....+++.|+|++|++++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++.
T Consensus 14 c~~~~l~~~p--~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 91 (208)
T 2o6s_A 14 CYSQGRTSVP--TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91 (208)
T ss_dssp CCSSCCSSCC--SCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred ecCCCccCCC--CCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCcc
Confidence 6777765443 33346899999999999988888899999999999999999977777789999999999999999977
Q ss_pred CCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhh
Q 005226 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212 (707)
Q Consensus 133 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 212 (707)
.+..|..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|.+.+..
T Consensus 92 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~------ 164 (208)
T 2o6s_A 92 PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC------ 164 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCCT------
T ss_pred CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccCCCccEEEecCCCeecCC------
Confidence 7777899999999999999999777777999999999999999999 788888889999999999999988644
Q ss_pred hhccccEEEeccCcCcCCCCCcCCCCCC
Q 005226 213 LQSLSATLNLSYNHLSGKIPKSLGNLPV 240 (707)
Q Consensus 213 l~~L~~~L~l~~N~l~~~~p~~~~~l~~ 240 (707)
+.| +.|+++.|+++|.+|..++.++.
T Consensus 165 -~~l-~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 165 -PGI-RYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -TTT-HHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -CCH-HHHHHHHHhCCceeeccCccccC
Confidence 456 68899999999999998887654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=195.53 Aligned_cols=156 Identities=23% Similarity=0.321 Sum_probs=82.8
Q ss_pred CCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCC
Q 005226 51 TPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLS 130 (707)
Q Consensus 51 ~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 130 (707)
+.|+|++|.|... +++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 17 ~~Cs~~~v~c~~~----------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 77 (229)
T 3e6j_A 17 CSCSGTTVDCRSK----------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG 77 (229)
T ss_dssp CEEETTEEECTTS----------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CEEeCCEeEccCC----------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC
Confidence 6799999999752 121 2232222 45555555555555544555555555555555555554
Q ss_pred CCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch
Q 005226 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210 (707)
Q Consensus 131 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~ 210 (707)
...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+ ..+++|++|+|++|+|++..+..|
T Consensus 78 ~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~~~~~ 155 (229)
T 3e6j_A 78 ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSIPHGAF 155 (229)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCCCTTTT
T ss_pred CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCccCHHHH
Confidence 333344455555555555555555444444455555555555555555 555443 455555555555555554444445
Q ss_pred hhhhccccEEEeccCcCc
Q 005226 211 GELQSLSATLNLSYNHLS 228 (707)
Q Consensus 211 ~~l~~L~~~L~l~~N~l~ 228 (707)
..+++| +.|+|++|.+.
T Consensus 156 ~~l~~L-~~L~l~~N~~~ 172 (229)
T 3e6j_A 156 DRLSSL-THAYLFGNPWD 172 (229)
T ss_dssp TTCTTC-CEEECTTSCBC
T ss_pred hCCCCC-CEEEeeCCCcc
Confidence 555555 45555555555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.8e-23 Score=217.45 Aligned_cols=187 Identities=19% Similarity=0.223 Sum_probs=142.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC-cccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP-PSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 147 (707)
++++.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+ ..|..+++|+.|+
T Consensus 76 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~ 155 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEE
Confidence 678888888888888888888888888888888888886555558888888888888888884333 3677788888888
Q ss_pred ccCC-cccccCCCCCcccchhhhhhhcCCcccccCCCc-----------------------ccccCCCccEEeccCCCCC
Q 005226 148 LSNN-SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAG-----------------------IWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 148 Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~-----------------------~~~~l~~L~~L~ls~N~l~ 203 (707)
+++| .+.+..|..|.++++|+.|++++|++++..|.. .+..+++|+.|+|++|+++
T Consensus 156 l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~ 235 (353)
T 2z80_A 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLD 235 (353)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCT
T ss_pred CCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccc
Confidence 8877 466555667777777777777777776443432 2334567777777777777
Q ss_pred CC-------------------------------CCcchhhhhccccEEEeccCcCcCCCCCc-CCCCCCccEEEccCCcC
Q 005226 204 GP-------------------------------IPNDLGELQSLSATLNLSYNHLSGKIPKS-LGNLPVTVSFDLRGNNL 251 (707)
Q Consensus 204 ~~-------------------------------~p~~~~~l~~L~~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l 251 (707)
+. +|..+.++++| ++|+|++|+|+ .+|.. +..+++|+.|++++|++
T Consensus 236 ~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L-~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~ 313 (353)
T 2z80_A 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGL-LELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313 (353)
T ss_dssp TCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTC-CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCB
T ss_pred cccccccccccccchhhccccccccccCcchhhhHHHHhcccCC-CEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCc
Confidence 53 24456778899 79999999999 56665 58999999999999999
Q ss_pred cccCCC
Q 005226 252 SGEIPQ 257 (707)
Q Consensus 252 ~~~~p~ 257 (707)
++..|.
T Consensus 314 ~~~~~~ 319 (353)
T 2z80_A 314 DCSCPR 319 (353)
T ss_dssp CCCHHH
T ss_pred cCcCCC
Confidence 987763
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=221.90 Aligned_cols=143 Identities=21% Similarity=0.203 Sum_probs=123.1
Q ss_pred CCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCc
Q 005226 64 TGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143 (707)
Q Consensus 64 ~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 143 (707)
|...+++++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+ .+|.. .+++|
T Consensus 47 p~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L 123 (562)
T 3a79_B 47 PKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASL 123 (562)
T ss_dssp CTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTC
T ss_pred CCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccC
Confidence 3333478999999999999988899999999999999999999888999999999999999999999 77776 89999
Q ss_pred cEEeccCCcccc-cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCc--cEEeccCCCC--CCCCCcchhhh
Q 005226 144 QNLDLSNNSFSG-SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL--VQLDLSDNDF--KGPIPNDLGEL 213 (707)
Q Consensus 144 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L--~~L~ls~N~l--~~~~p~~~~~l 213 (707)
++|+|++|++++ .+|..|.++++|++|+|++|+|++ .. +..+++| ++|+|++|++ ++..|..+..+
T Consensus 124 ~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~-~~---~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l 194 (562)
T 3a79_B 124 RHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ-LD---LLPVAHLHLSCILLDLVSYHIKGGETESLQIP 194 (562)
T ss_dssp SEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT-TT---TGGGTTSCEEEEEEEESSCCCCSSSCCEEEEC
T ss_pred CEEECCCCCccccCchHhhcccCcccEEecCCCcccc-Cc---hhhhhhceeeEEEeecccccccccCccccccc
Confidence 999999999996 346899999999999999999983 22 3455666 9999999988 76766666553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=3.4e-22 Score=227.02 Aligned_cols=206 Identities=20% Similarity=0.249 Sum_probs=169.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCC--CccccCCCCCceEEecCccCCCCCCcccCCCCCccEE
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSL--PDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 146 (707)
++++.|++++|.+.+..+. ..+++|++|+|++|++++.. |..+.++++|++|+|++|++++ +|..+..+++|+.|
T Consensus 325 ~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L 401 (570)
T 2z63_A 325 KSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHL 401 (570)
T ss_dssp SSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCCEE
T ss_pred cccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCCEE
Confidence 4555666666665554443 67888999999999888554 6778889999999999999984 45558999999999
Q ss_pred eccCCcccccCC-CCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC-CCCCcchhhhhccccEEEecc
Q 005226 147 DLSNNSFSGSLP-DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK-GPIPNDLGELQSLSATLNLSY 224 (707)
Q Consensus 147 ~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~~L~l~~ 224 (707)
++++|.+.+..| ..+.++++|+.|+|++|++++.+ ...|..+++|++|+|++|+++ +.+|..+..+++| ++|+|++
T Consensus 402 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L-~~L~l~~ 479 (570)
T 2z63_A 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF-NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL-TFLDLSQ 479 (570)
T ss_dssp ECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECC-TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC-CEEECTT
T ss_pred EccCCccccccchhhhhcCCCCCEEeCcCCcccccc-hhhhhcCCcCcEEECcCCcCccccchhhhhcccCC-CEEECCC
Confidence 999999997766 57889999999999999998444 455688999999999999997 5788999999999 7999999
Q ss_pred CcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccCCC
Q 005226 225 NHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 225 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~~~ 279 (707)
|++++..|..+..+++|+.|++++|++++.+|. ...+.++..+.+.+|++.|.+|
T Consensus 480 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 480 CQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 999988899999999999999999999988775 3556778888899999888754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.5e-22 Score=201.99 Aligned_cols=129 Identities=19% Similarity=0.210 Sum_probs=106.8
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCch------------------hhHHHHHHHHHHHHhcCCCceeeeEEEEE
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE------------------QRHREFVTEVQAIAKVKHPNIVKLRAYYW 473 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 473 (707)
.+.||+|+||.||+|...+|+.||+|.++.... .....+.+|++++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 368999999999999997899999999864321 12456899999999999 4 56666443
Q ss_pred cCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEe
Q 005226 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYIS 553 (707)
Q Consensus 474 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~ 553 (707)
.+..++||||+++|+|.+ +.. .....++.||+.||+|||+ .+|+||||||+|||++ ++.+||+
T Consensus 172 -~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 -WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp -EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred -ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 366799999999999998 532 1234799999999999999 8999999999999999 9999999
Q ss_pred ccccccc
Q 005226 554 DFGLSRL 560 (707)
Q Consensus 554 DfGla~~ 560 (707)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999863
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=204.37 Aligned_cols=189 Identities=24% Similarity=0.355 Sum_probs=149.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|++++|++... | .+..+++|++|+|++|+|++..+ +.++++|++|+|++|+|++ +| .+..+++|+.|+|
T Consensus 41 ~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 4788888888888854 4 68888889999999998885444 8888889999999998884 33 6888888999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++ ++. +..+++|+.|+|++|+++ .++. +..+++|++|+|++|++++ ++. +..+++| +.|+|++|+++
T Consensus 115 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L-~~L~l~~n~l~ 186 (308)
T 1h6u_A 115 TSTQITD-VTP-LAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKL-TTLKADDNKIS 186 (308)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTC-CEEECCSSCCC
T ss_pred CCCCCCC-chh-hcCCCCCCEEECCCCccC-cCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCC-CEEECCCCccC
Confidence 9998885 443 888888999999999888 5555 5788889999999998885 443 8888888 78999999888
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+..+ +..+++|+.|++++|++++..| ...+.++..+.+.+|+.
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEE
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCee
Confidence 5444 7788889999999998887664 55666777777777764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=209.80 Aligned_cols=177 Identities=25% Similarity=0.243 Sum_probs=96.2
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcC-CCCCCCEEEcccCCcCCCCCccccCCCCCceEEe
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELG-SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFL 124 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 124 (707)
|.|.|..|.|.. .|...+..++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 346666666653 1222234455566666666655555555 5666666666666665555555556666666666
Q ss_pred cCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCccc---ccCCCccEEeccCCC
Q 005226 125 YGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIW---PELENLVQLDLSDND 201 (707)
Q Consensus 125 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~---~~l~~L~~L~ls~N~ 201 (707)
++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|..+| ..+++|+.|+|++|+
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~ 174 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK 174 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCC
Confidence 666665444445555666666666666665555555555666666666666665 5555554 345555555555555
Q ss_pred CCCCCCcchhhhhcc-ccEEEeccCcCc
Q 005226 202 FKGPIPNDLGELQSL-SATLNLSYNHLS 228 (707)
Q Consensus 202 l~~~~p~~~~~l~~L-~~~L~l~~N~l~ 228 (707)
|++..+..+..++.+ ++.|+|++|.+.
T Consensus 175 l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCccCHHHhhhccHhhcceEEecCCCcc
Confidence 554333444444432 134555555444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.1e-22 Score=221.38 Aligned_cols=138 Identities=21% Similarity=0.170 Sum_probs=121.2
Q ss_pred CCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 68 DPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 68 ~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
.++++.|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|||++|+|+ .+|.. .+++|++|+
T Consensus 20 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp CTTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred cccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 378999999999999888889999999999999999999888999999999999999999999 67776 899999999
Q ss_pred ccCCcccc-cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCc--cEEeccCCCC--CCCCCcchhh
Q 005226 148 LSNNSFSG-SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENL--VQLDLSDNDF--KGPIPNDLGE 212 (707)
Q Consensus 148 Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L--~~L~ls~N~l--~~~~p~~~~~ 212 (707)
|++|++++ .+|..|.++++|++|+|++|+|++ ..+..+++| +.|+|++|.+ .+..|..+..
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccch----hhccccccceeeEEEeecccccccccccccccc
Confidence 99999997 478999999999999999999984 235677788 9999999988 6666666655
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-21 Score=219.66 Aligned_cols=183 Identities=21% Similarity=0.217 Sum_probs=161.1
Q ss_pred CCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCc
Q 005226 64 TGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRL 143 (707)
Q Consensus 64 ~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 143 (707)
|...+.+++.|+|++|++++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|
T Consensus 23 p~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (570)
T 2z63_A 23 PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102 (570)
T ss_dssp CSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTC
T ss_pred CCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccc
Confidence 33345789999999999999999999999999999999999998888899999999999999999998888999999999
Q ss_pred cEEeccCCcccccCCCCCcccchhhhhhhcCCcccc-cCCCcccccCCCccEEeccCCCCCCCCCcchhhhhcc----cc
Q 005226 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG-QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSL----SA 218 (707)
Q Consensus 144 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L----~~ 218 (707)
++|+|++|++++..+..|.++++|++|+|++|++++ .+|.. |..+++|++|++++|++++..|..+..+++| .
T Consensus 103 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~- 180 (570)
T 2z63_A 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL- 180 (570)
T ss_dssp CEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCC-
T ss_pred ccccccccccccCCCccccccccccEEecCCCccceecChhh-hcccCCCCEEeCcCCccceecHHHccchhccchhhh-
Confidence 999999999996666689999999999999999984 36665 5799999999999999998888889998887 4
Q ss_pred EEEeccCcCcCCCCCcCCCCCCccEEEccCC
Q 005226 219 TLNLSYNHLSGKIPKSLGNLPVTVSFDLRGN 249 (707)
Q Consensus 219 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 249 (707)
.|++++|.+++..|..+..+ +|+.|++++|
T Consensus 181 ~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n 210 (570)
T 2z63_A 181 SLDLSLNPMNFIQPGAFKEI-RLHKLTLRNN 210 (570)
T ss_dssp EEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred hcccCCCCceecCHHHhccC-cceeEecccc
Confidence 79999999887777666554 6777777666
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=190.96 Aligned_cols=148 Identities=23% Similarity=0.277 Sum_probs=100.9
Q ss_pred CCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCccccc
Q 005226 77 SGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGS 156 (707)
Q Consensus 77 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 156 (707)
++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 19 ~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-- 93 (220)
T 2v9t_B 19 RGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-- 93 (220)
T ss_dssp TTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC--
T ss_pred CCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC--
Confidence 345555 3454443 56777777777776555556666666666666666666555666666666666666666555
Q ss_pred CCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCC
Q 005226 157 LPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLG 236 (707)
Q Consensus 157 ~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~ 236 (707)
.+|...|..+++|++|+|++|+|++..|..|.++++| +.|+|++|+|++..+..|.
T Consensus 94 -----------------------~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~ 149 (220)
T 2v9t_B 94 -----------------------ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNL-NLLSLYDNKLQTIAKGTFS 149 (220)
T ss_dssp -----------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTT
T ss_pred -----------------------ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCC-CEEECCCCcCCEECHHHHh
Confidence 5666666677777777777777777777777777777 6888888888876667777
Q ss_pred CCCCccEEEccCCcCcc
Q 005226 237 NLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 237 ~l~~L~~l~l~~N~l~~ 253 (707)
.+++|+.|++++|++..
T Consensus 150 ~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 150 PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp TCTTCCEEECCSSCEEC
T ss_pred CCCCCCEEEeCCCCcCC
Confidence 78888888888887764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.8e-21 Score=191.19 Aligned_cols=153 Identities=24% Similarity=0.356 Sum_probs=135.0
Q ss_pred CCCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEe
Q 005226 50 PTPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFL 124 (707)
Q Consensus 50 ~~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 124 (707)
.|.|.|..|.|.+ .|...+.+++.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 8 ~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 87 (220)
T 2v9t_B 8 ACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87 (220)
T ss_dssp TSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred CCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence 3668999999974 23333468999999999999998889999999999999999999988999999999999999
Q ss_pred cCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 125 YGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 125 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
++|+|+...+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .++...|..+++|+.|+|++|.+.
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC-EECHHHHhCCCCCCEEEeCCCCcC
Confidence 999999666667899999999999999999888888988999999999999988 777777778888888888888876
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.1e-22 Score=225.34 Aligned_cols=198 Identities=23% Similarity=0.294 Sum_probs=171.4
Q ss_pred CcEEEEEcCCCCccccCCCCc-CCCCCCCEEEcccCCcCCCCCc---cccCCCCCceEEecCccCCCCCC--cccCCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSEL-GSLIYLRRLNLHNNNLFGSLPD---QLFNATSLHSIFLYGNNLSGSLP--PSVCNLPR 142 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~ 142 (707)
++++.|+|++|.+. .+|..+ ..+++|++|+|++|++++.+|. .+..+++|++|+|++|+|++..+ ..+..+++
T Consensus 310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~ 388 (549)
T 2z81_A 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388 (549)
T ss_dssp TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence 57899999999987 566666 5799999999999999987643 47889999999999999995432 46899999
Q ss_pred ccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEe
Q 005226 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNL 222 (707)
Q Consensus 143 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l 222 (707)
|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|..++ ++|++|+|++|+|++.+ ..+++| ++|+|
T Consensus 389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~---~~L~~L~Ls~N~l~~~~----~~l~~L-~~L~L 458 (549)
T 2z81_A 389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP---QTLEVLDVSNNNLDSFS----LFLPRL-QELYI 458 (549)
T ss_dssp CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC---TTCSEEECCSSCCSCCC----CCCTTC-CEEEC
T ss_pred CCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhc---CCceEEECCCCChhhhc----ccCChh-cEEEC
Confidence 999999999999 78999999999999999999998 7887653 68999999999999643 467889 79999
Q ss_pred ccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccCCC
Q 005226 223 SYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 223 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~~~ 279 (707)
++|+|+ .+|. ...+++|+.|++++|++++.+|. ...+.++..+.+.+||+.|.+|
T Consensus 459 s~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 459 SRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 999999 6887 46799999999999999998885 4567788889999999988754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=194.43 Aligned_cols=174 Identities=16% Similarity=0.201 Sum_probs=157.1
Q ss_pred CcEEEEEcCCCC-ccccCCCCcCCCCCCCEEEccc-CCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCcc--
Q 005226 69 PRVVGVAISGKN-VRGYIPSELGSLIYLRRLNLHN-NNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ-- 144 (707)
Q Consensus 69 ~~v~~L~L~~n~-l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-- 144 (707)
++++.|+|++|+ ++++.+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|+|++ +|. |..+++|+
T Consensus 55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L 132 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF 132 (239)
T ss_dssp TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence 689999999997 9888888999999999999999 99998778899999999999999999995 776 88999998
Q ss_pred -EEeccCC-cccccCCCCCcccchhh-hhhhcCCcccccCCCcccccCCCccEEeccCCC-CCCCCCcchhhh-hccccE
Q 005226 145 -NLDLSNN-SFSGSLPDGLKNCKQLQ-RLILARNKFSGQIPAGIWPELENLVQLDLSDND-FKGPIPNDLGEL-QSLSAT 219 (707)
Q Consensus 145 -~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l-~~L~~~ 219 (707)
.|++++| ++++..+..|.++++|+ .|+|++|+++ .+|...|.. ++|+.|+|++|+ +++..+..|.++ ++| +.
T Consensus 133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L-~~ 209 (239)
T 2xwt_C 133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGP-SL 209 (239)
T ss_dssp EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCC-SE
T ss_pred cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCC-cE
Confidence 9999999 99977777899999999 9999999999 999988866 899999999995 997667889999 999 89
Q ss_pred EEeccCcCcCCCCCcCCCCCCccEEEccCCc
Q 005226 220 LNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250 (707)
Q Consensus 220 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 250 (707)
|++++|+|+ .+|.. .+++|+.|+++++.
T Consensus 210 L~l~~N~l~-~l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 210 LDVSQTSVT-ALPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp EECTTCCCC-CCCCT--TCTTCSEEECTTC-
T ss_pred EECCCCccc-cCChh--HhccCceeeccCcc
Confidence 999999999 45654 68899999998863
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=189.41 Aligned_cols=155 Identities=19% Similarity=0.223 Sum_probs=105.4
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC-ccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP-DQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.|++++|+++. +|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 34556666664 455443 345677777777775543 33556666666666666666555555666666666666655
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
+|+ .++...|..+++|++|+|++|+|++..|..|.++++| +.|+|++|+|++..
T Consensus 92 ~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 92 RLE-------------------------NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV-RLLSLYDNQITTVA 145 (220)
T ss_dssp CCC-------------------------CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTC-SEEECTTSCCCCBC
T ss_pred ccC-------------------------ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccC-CEEECCCCcCCEEC
Confidence 555 5555556677777788888888877777778888888 68888888888777
Q ss_pred CCcCCCCCCccEEEccCCcCcccCC
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
|..|..+++|+.|++++|++++..+
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSGG
T ss_pred HHHhcCCCCCCEEEecCcCCcCCCc
Confidence 8888888888888888888876543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-22 Score=232.57 Aligned_cols=219 Identities=19% Similarity=0.246 Sum_probs=123.1
Q ss_pred CcccHHHHHHHHhcCcCCCCCCCCCCCCCCCCCceeceeEeCCCC------------CCCCCcEEEEEcCCCCccc----
Q 005226 20 LSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPCRWSGISCMNIT------------GFPDPRVVGVAISGKNVRG---- 83 (707)
Q Consensus 20 ~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~~C~w~gv~c~~~~------------~~~~~~v~~L~L~~n~l~~---- 83 (707)
...+..+|+++..++..+.+..-..|......++.|.++.++... ......+..++|+.|.|.+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~ 209 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDI 209 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCcccc
Confidence 357889999999887545555556676554456789888776510 0011223334444444433
Q ss_pred -----cCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCC
Q 005226 84 -----YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLP 158 (707)
Q Consensus 84 -----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 158 (707)
..+..|..+++|+.|+|++|.|. .+|..++++++|++|+|++|+|+ .+|..|++|++|+.|+|++|+|+ .+|
T Consensus 210 ~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp 286 (727)
T 4b8c_D 210 ENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLP 286 (727)
T ss_dssp ------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCC
T ss_pred ccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccC
Confidence 23666777788888888888887 67777778888888888888888 77877888888888888888888 678
Q ss_pred CCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCC
Q 005226 159 DGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNL 238 (707)
Q Consensus 159 ~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l 238 (707)
..|.+|++|++|+|++|+|+ .||.. |..+++|++|+|++|+|++.+|..+..+......|+|++|.+++.+|..+
T Consensus 287 ~~~~~l~~L~~L~L~~N~l~-~lp~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l--- 361 (727)
T 4b8c_D 287 AELGSCFQLKYFYFFDNMVT-TLPWE-FGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER--- 361 (727)
T ss_dssp SSGGGGTTCSEEECCSSCCC-CCCSS-TTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred hhhcCCCCCCEEECCCCCCC-ccChh-hhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc---
Confidence 88888888888888888887 77776 57788888888888888877777776654332246788888887777654
Q ss_pred CCccEEEccCC
Q 005226 239 PVTVSFDLRGN 249 (707)
Q Consensus 239 ~~L~~l~l~~N 249 (707)
..|+++.|
T Consensus 362 ---~~l~l~~n 369 (727)
T 4b8c_D 362 ---RFIEINTD 369 (727)
T ss_dssp -----------
T ss_pred ---ceeEeecc
Confidence 34455555
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=5.3e-21 Score=199.44 Aligned_cols=171 Identities=22% Similarity=0.360 Sum_probs=152.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++.+..+ +..+++|++|+|++|+|++ ++ .+.++++|++|+|++|+|++ +|. +..+++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 689999999999997655 9999999999999999995 34 69999999999999999995 444 999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++..+ +.++++|+.|+|++|+++ .++. +..+++|+.|+|++|++++. +. +..+++| +.|+|++|+++
T Consensus 137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L-~~L~L~~N~l~ 208 (308)
T 1h6u_A 137 DLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTP--LANLSKLTTLKADDNKISDI-SP-LASLPNL-IEVHLKNNQIS 208 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC-GG-GGGCTTC-CEEECTTSCCC
T ss_pred CCCccCcCcc--ccCCCCccEEEccCCcCC-CChh--hcCCCCCCEEECCCCccCcC-hh-hcCCCCC-CEEEccCCccC
Confidence 9999995544 899999999999999999 6666 68999999999999999954 43 8999999 89999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEI 255 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~ 255 (707)
+..| +..+++|+.|++++|++++..
T Consensus 209 ~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 209 DVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp BCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred cccc--ccCCCCCCEEEccCCeeecCC
Confidence 6553 899999999999999998643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.8e-22 Score=222.52 Aligned_cols=180 Identities=24% Similarity=0.256 Sum_probs=146.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCc----------------cccCCCCCceEEecCccCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPD----------------QLFNATSLHSIFLYGNNLSGS 132 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~N~l~~~ 132 (707)
++++.|+|++|.+++..| |..+++|++|+|++|.|++..+. ....+++|+.|+|++|+|++.
T Consensus 58 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~ 135 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (487)
T ss_dssp TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence 456666676666666554 66666666666666655532110 112467899999999999988
Q ss_pred CCcccCCCCCccEEeccCCcccccCCCCCc-ccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchh
Q 005226 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLK-NCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG 211 (707)
Q Consensus 133 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 211 (707)
.|..|+.+++|+.|+|++|.|++..|..+. .+++|+.|+|++|+|+ .+|... .+++|++|+|++|.|++ +|..+.
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~-~~~~~~--~l~~L~~L~Ls~N~l~~-~~~~~~ 211 (487)
T 3oja_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLAF-MGPEFQ 211 (487)
T ss_dssp GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEECCC--CCTTCCEEECCSSCCCE-ECGGGG
T ss_pred CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc-cccccc--cCCCCCEEECCCCCCCC-CCHhHc
Confidence 899999999999999999999998898886 8999999999999999 555433 58999999999999996 555699
Q ss_pred hhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc-ccCC
Q 005226 212 ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS-GEIP 256 (707)
Q Consensus 212 ~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~p 256 (707)
.+++| +.|+|++|.|++ +|..+..+++|+.|++++|++. +.+|
T Consensus 212 ~l~~L-~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 212 SAAGV-TWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp GGTTC-SEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred CCCCc-cEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 99999 799999999995 8888999999999999999998 4444
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=186.77 Aligned_cols=156 Identities=21% Similarity=0.267 Sum_probs=142.4
Q ss_pred CCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcC
Q 005226 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILAR 174 (707)
Q Consensus 95 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (707)
.+.++.++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|+...+..|.++++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 357899999998 6776554 8999999999999998899999999999999999999866667789999999999999
Q ss_pred CcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 175 N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
|+|+ .+|...|..+++|++|+|++|+|+ .+|..+..+++| +.|+|++|+|++..+..+..+++|+.|++++|++.+.
T Consensus 98 N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL-THLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTC-SEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCC-CEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 9999 888888899999999999999999 789999999999 7999999999977778899999999999999999876
Q ss_pred CC
Q 005226 255 IP 256 (707)
Q Consensus 255 ~p 256 (707)
.+
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 54
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.1e-21 Score=187.47 Aligned_cols=156 Identities=20% Similarity=0.267 Sum_probs=132.9
Q ss_pred CCCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCC-CCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEE
Q 005226 50 PTPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIP-SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIF 123 (707)
Q Consensus 50 ~~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 123 (707)
.|.|.|..+.|++ .|...+..++.|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|.++++|++|+
T Consensus 8 ~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 3568999999974 233334578999999999998865 5589999999999999999988888999999999999
Q ss_pred ecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 124 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|+ .++...|..+++|+.|+|++|.+.
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCC-CBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCC-EECHHHhcCCCCCCEEEecCcCCc
Confidence 9999999888888999999999999999999888888888888888888888888 554455677888888888888887
Q ss_pred CCC
Q 005226 204 GPI 206 (707)
Q Consensus 204 ~~~ 206 (707)
...
T Consensus 167 c~c 169 (220)
T 2v70_A 167 CNC 169 (220)
T ss_dssp CSG
T ss_pred CCC
Confidence 543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=3.9e-21 Score=205.23 Aligned_cols=176 Identities=26% Similarity=0.281 Sum_probs=149.0
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCcccc-CCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.+++++++|+. +|..+. +.|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 68999999995 566554 4689999999999988888787 9999999999999999877888999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcch---hhhhccccEEEeccCcCc
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL---GELQSLSATLNLSYNHLS 228 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~~L~l~~N~l~ 228 (707)
+|++..+..|.++++|+.|+|++|+|+ .++...|..+++|+.|+|++|+|++..+..| ..+++| +.|+|++|+|+
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L-~~L~L~~N~l~ 176 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKL-MLLDLSSNKLK 176 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTC-CEEECCSSCCC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCccc-EECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcC-CEEECCCCCCC
Confidence 999777788999999999999999999 6766777899999999999999995443444 578889 79999999999
Q ss_pred CCCCCcCCCCCC--ccEEEccCCcCcc
Q 005226 229 GKIPKSLGNLPV--TVSFDLRGNNLSG 253 (707)
Q Consensus 229 ~~~p~~~~~l~~--L~~l~l~~N~l~~ 253 (707)
+..+..+..++. |+.|+|++|++..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 665567777776 4789999998874
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.7e-20 Score=193.86 Aligned_cols=170 Identities=28% Similarity=0.403 Sum_probs=148.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|++++|.+... +.+..+++|++|+|++|+|++..+ +.++++|++|+|++|+|++ +| .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 5789999999999866 358999999999999999996554 9999999999999999985 44 4999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++. ..+..+++|+.|+|++|+++ .+ ..+..+++|+.|+|++|+|++..| +..+++| +.|+|++|+|+
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~-~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L-~~L~L~~N~i~ 191 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKIT-DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL-QNLYLSKNHIS 191 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCC-CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTC-CEEECCSSCCC
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCC-cc--hhhccCCCCCEEEccCCccccchh--hcCCCcc-CEEECCCCcCC
Confidence 99999853 57889999999999999999 55 346899999999999999996544 9999999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCccc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
+ +| .+..+++|+.|++++|+++..
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccCC
Confidence 5 55 489999999999999999853
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.9e-21 Score=200.04 Aligned_cols=202 Identities=23% Similarity=0.219 Sum_probs=151.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC----------------ccccCCCCCceEEecCccCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP----------------DQLFNATSLHSIFLYGNNLSGS 132 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p----------------~~~~~l~~L~~L~L~~N~l~~~ 132 (707)
.+++.|+|++|.+++..+ +..+++|++|+|++|+|++..+ .....+++|++|+|++|+|++.
T Consensus 58 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~~ 135 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (317)
T ss_dssp TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCSG
T ss_pred CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCCc
Confidence 355666666666655443 5555556555555555543210 0112367899999999999988
Q ss_pred CCcccCCCCCccEEeccCCcccccCCCCCc-ccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchh
Q 005226 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLK-NCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLG 211 (707)
Q Consensus 133 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 211 (707)
.|..+..+++|+.|+|++|++++..|..+. .+++|+.|+|++|+|+ .+|... .+++|++|+|++|+|++ +|..+.
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~--~l~~L~~L~Ls~N~l~~-l~~~~~ 211 (317)
T 3o53_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV--VFAKLKTLDLSSNKLAF-MGPEFQ 211 (317)
T ss_dssp GGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEECCC--CCTTCCEEECCSSCCCE-ECGGGG
T ss_pred cchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccccc--ccccCCEEECCCCcCCc-chhhhc
Confidence 888999999999999999999987777774 7999999999999999 666544 58999999999999995 666799
Q ss_pred hhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc-ccCCCC-CCCCCCCCcccCCCCcccCC
Q 005226 212 ELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS-GEIPQT-GSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 212 ~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-~~~p~~-~~~~~~~~~~~~~N~~l~~~ 278 (707)
.+++| +.|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|.. ..+..+..+...+|+.+.+.
T Consensus 212 ~l~~L-~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~ 278 (317)
T 3o53_A 212 SAAGV-TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278 (317)
T ss_dssp GGTTC-SEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSS
T ss_pred ccCcc-cEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCC
Confidence 99999 79999999999 68999999999999999999999 544421 12223333444444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=5.8e-21 Score=199.48 Aligned_cols=202 Identities=18% Similarity=0.141 Sum_probs=164.5
Q ss_pred CcEEEEEcCCCCccccCC---CCcCCCCCCCEEEcccCCcCCCCCccc--cCCCCCceEEecCccCCCCCC----cccCC
Q 005226 69 PRVVGVAISGKNVRGYIP---SELGSLIYLRRLNLHNNNLFGSLPDQL--FNATSLHSIFLYGNNLSGSLP----PSVCN 139 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 139 (707)
.+++.|.+.++.+....- ..+..+++|++|+|++|.+++..|..+ .++++|++|+|++|++++..| ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 356778888877653211 112245679999999999999999998 899999999999999997666 44568
Q ss_pred CCCccEEeccCCcccccCCCCCcccchhhhhhhcCCccccc--CC-CcccccCCCccEEeccCCCCCCCCCc----chhh
Q 005226 140 LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQ--IP-AGIWPELENLVQLDLSDNDFKGPIPN----DLGE 212 (707)
Q Consensus 140 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--lp-~~~~~~l~~L~~L~ls~N~l~~~~p~----~~~~ 212 (707)
+++|++|+|++|++++..|..|.++++|++|+|++|++.+. ++ ...+..+++|++|+|++|+|+ .++. .+.+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 99999999999999988889999999999999999998742 33 333468999999999999997 4444 2577
Q ss_pred hhccccEEEeccCcCcCCCCCcCCCC---CCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 213 LQSLSATLNLSYNHLSGKIPKSLGNL---PVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 213 l~~L~~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+++| ++|+|++|+|++..|..+..+ ++|+.|++++|+|+ .+|... ..++..+.+.+|..
T Consensus 223 l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~-~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 223 GVQP-HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL-PAKLRVLDLSSNRL 284 (310)
T ss_dssp TCCC-SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC-CSCCSCEECCSCCC
T ss_pred CCCC-CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh-cCCCCEEECCCCcC
Confidence 8999 799999999998889888877 69999999999999 555432 36788888877753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-20 Score=199.36 Aligned_cols=192 Identities=20% Similarity=0.309 Sum_probs=93.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|+|++|++++ ++. +..+++|+.|++
T Consensus 132 ~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l 206 (347)
T 4fmz_A 132 TKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTA 206 (347)
T ss_dssp TTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeec
Confidence 456666666664443332 25666666666666666653322 5556666666666666552 222 444445555555
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCC--------------------cccccCCCccEEeccCCCCCCCCCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA--------------------GIWPELENLVQLDLSDNDFKGPIPN 208 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~--------------------~~~~~l~~L~~L~ls~N~l~~~~p~ 208 (707)
++|.+++..+ +..+++|+.|+|++|+++ .++. ..+..+++|++|++++|++++. .
T Consensus 207 ~~n~l~~~~~--~~~~~~L~~L~l~~n~l~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~ 281 (347)
T 4fmz_A 207 YVNQITDITP--VANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--S 281 (347)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCGGGTTCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--G
T ss_pred ccCCCCCCch--hhcCCcCCEEEccCCccC-CCcchhcCCCCCEEECCCCccCCChhHhcCCCcCEEEccCCccCCC--h
Confidence 5554443222 444444444444444444 3332 1134445555555555555432 2
Q ss_pred chhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCC
Q 005226 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272 (707)
Q Consensus 209 ~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N 272 (707)
.+..+++| +.|++++|++++..|..+..+++|+.|++++|++++.+| ...+.++..+.+.+|
T Consensus 282 ~~~~l~~L-~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 282 VLNNLSQL-NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQ 343 (347)
T ss_dssp GGGGCTTC-SEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC
T ss_pred hhcCCCCC-CEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhh
Confidence 34444555 455555555554444444555555555555555554443 333444444444444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=204.88 Aligned_cols=191 Identities=26% Similarity=0.307 Sum_probs=93.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC--------------------ccccCCCCCceEEecCcc
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP--------------------DQLFNATSLHSIFLYGNN 128 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~ 128 (707)
.+++.|+|++|.+.+. ..+..+++|++|+|++|.+++..| ..+..+++|++|+|++|+
T Consensus 177 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~ 254 (466)
T 1o6v_A 177 TTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 254 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred CCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccccccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCc
Confidence 3455555555555543 235555555555555555554333 234444444444444444
Q ss_pred CCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCc
Q 005226 129 LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208 (707)
Q Consensus 129 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~ 208 (707)
+++..| +..+++|+.|+|++|++++..+ +..+++|+.|+|++|+++ .++. +..+++|+.|+|++|++++..|
T Consensus 255 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~L~~n~l~~~~~- 326 (466)
T 1o6v_A 255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE-DISP--ISNLKNLTYLTLYFNNISDISP- 326 (466)
T ss_dssp CCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCS-CCGG--GGGCTTCSEEECCSSCCSCCGG-
T ss_pred cccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCccc-Cchh--hcCCCCCCEEECcCCcCCCchh-
Confidence 443222 4444555555555555543222 444555555555555554 2322 3445555555555555554333
Q ss_pred chhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 209 DLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 209 ~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+..+++| +.|++++|++++. ..+..+++|+.|++++|++++.+| ...+.++..+.+.+|++
T Consensus 327 -~~~l~~L-~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 327 -VSSLTKL-QRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAW 387 (466)
T ss_dssp -GGGCTTC-CEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEE
T ss_pred -hccCccC-CEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcc
Confidence 4455555 4555555555532 244555555555555555555544 34444444444444443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=2.7e-20 Score=213.87 Aligned_cols=209 Identities=21% Similarity=0.221 Sum_probs=173.1
Q ss_pred CcEEEEEcCCCCccc--cCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC-cccCCCCCccE
Q 005226 69 PRVVGVAISGKNVRG--YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP-PSVCNLPRLQN 145 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 145 (707)
++++.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|++....+ ..|..+++|+.
T Consensus 371 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~ 449 (635)
T 4g8a_A 371 PSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 449 (635)
T ss_dssp TTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE
T ss_pred cccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhcccccccccccccccccccc
Confidence 456666666666543 33445556666777777776666 345567788899999998887775554 46889999999
Q ss_pred EeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccC
Q 005226 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYN 225 (707)
Q Consensus 146 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N 225 (707)
+++++|.+.+..|..+..+++|+.|+|++|++.+.+++..|..+++|++|+|++|+|++..|..|.++++| ++|+|++|
T Consensus 450 l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L-~~L~Ls~N 528 (635)
T 4g8a_A 450 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNMSHN 528 (635)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC-CEEECTTS
T ss_pred ccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCC-CEEECCCC
Confidence 99999999999999999999999999999987656666677899999999999999999999999999999 89999999
Q ss_pred cCcCCCCCcCCCCCCccEEEccCCcCcccCCCCC-CC-CCCCCcccCCCCcccCCC
Q 005226 226 HLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTG-SF-ANQGPTAFLSNPLLCGFP 279 (707)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-~~-~~~~~~~~~~N~~l~~~~ 279 (707)
+|++..|..|..+++|+.|++++|+|++.+|... .+ .++..+.+.+|||.|.|.
T Consensus 529 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 529 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999889999999999999999999999988543 23 467788999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=196.54 Aligned_cols=181 Identities=20% Similarity=0.185 Sum_probs=103.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++++. | ++.+++|++|+|++|+|++. | +.++++|++|+|++|+|++ +| ++.+++|+.|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3555555555555543 2 55555555555555555543 2 5555555555555555553 23 555555555555
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|+|++ ++ +.++++|+.|++++|+..+.++ +..+++|++|++++|+|++ +| +..+++| +.|++++|+++
T Consensus 135 ~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L-~~L~l~~N~l~ 204 (457)
T 3bz5_A 135 ARNTLTE-ID--VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLL-NRLNCDTNNIT 204 (457)
T ss_dssp TTSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTC-CEEECCSSCCS
T ss_pred CCCccce-ec--cccCCcCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCC-CEEECcCCcCC
Confidence 5555554 22 5555556666666654433442 3456666666666666664 33 5666666 56666666666
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
+. .+..+++|+.|++++|++++ +| ...+.++..+.+.+|.
T Consensus 205 ~~---~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 205 KL---DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp CC---CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSC
T ss_pred ee---ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCc
Confidence 43 26666667777777777766 34 4455555555555553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.8e-19 Score=196.67 Aligned_cols=177 Identities=21% Similarity=0.178 Sum_probs=154.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|++++. + ++++++|++|+|++|+|++ +| +.++++|++|+|++|+|++. + ++.+++|+.|++
T Consensus 85 ~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l 155 (457)
T 3bz5_A 85 TNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDC 155 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEEC
Confidence 6899999999999986 3 9999999999999999997 44 89999999999999999964 3 889999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|+..+.+ .+..+++|+.|++++|+|+ .+| +..+++|+.|++++|+|++. .+..+++| +.|++++|+|+
T Consensus 156 ~~n~~~~~~--~~~~l~~L~~L~ls~n~l~-~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L-~~L~Ls~N~l~ 225 (457)
T 3bz5_A 156 HLNKKITKL--DVTPQTQLTTLDCSFNKIT-ELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQL-TFLDCSSNKLT 225 (457)
T ss_dssp TTCSCCCCC--CCTTCTTCCEEECCSSCCC-CCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTC-SEEECCSSCCS
T ss_pred CCCCccccc--ccccCCcCCEEECCCCccc-eec---cccCCCCCEEECcCCcCCee---ccccCCCC-CEEECcCCccc
Confidence 999766666 5889999999999999999 577 57899999999999999965 48899999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCccc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAF 269 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~ 269 (707)
+ +| +..+++|+.|++++|++++.++ ..+.++..+..
T Consensus 226 ~-ip--~~~l~~L~~L~l~~N~l~~~~~--~~l~~L~~L~l 261 (457)
T 3bz5_A 226 E-ID--VTPLTQLTYFDCSVNPLTELDV--STLSKLTTLHC 261 (457)
T ss_dssp C-CC--CTTCTTCSEEECCSSCCSCCCC--TTCTTCCEEEC
T ss_pred c-cC--ccccCCCCEEEeeCCcCCCcCH--HHCCCCCEEec
Confidence 7 67 8899999999999999998765 44555544433
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=203.05 Aligned_cols=163 Identities=26% Similarity=0.365 Sum_probs=142.4
Q ss_pred CCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 68 DPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 68 ~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
.++++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+
T Consensus 79 ~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 79 PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 368999999999999 566 568999999999999997 777 665 99999999999996 776 689999999
Q ss_pred ccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhcc------ccEEE
Q 005226 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSL------SATLN 221 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L------~~~L~ 221 (707)
|++|+|++ +|. .+++|+.|+|++|+|+ .+|. |. ++|+.|+|++|+|+ .+|. |.. +| ++.|+
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~-~lp~--l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~ 213 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLT-FLPE--LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFR 213 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC--CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEE
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCC-Ccch--hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEe
Confidence 99999995 776 6789999999999999 5988 44 99999999999999 6776 554 33 15999
Q ss_pred eccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 222 LSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 222 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
|++|+|+ .+|..+..+++|+.|+|++|+|++.+|
T Consensus 214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p 247 (571)
T 3cvr_A 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247 (571)
T ss_dssp CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHH
T ss_pred cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCH
Confidence 9999999 689988899999999999999999887
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=205.32 Aligned_cols=172 Identities=28% Similarity=0.399 Sum_probs=152.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|.|... + .|..|++|+.|+|++|+|++..| +..+++|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 43 ~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 5788999999999865 3 69999999999999999997655 9999999999999999994 44 7999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|+|++ + ..+..|++|+.|+|++|+|+ .+ ..+..+++|+.|+|++|+|++..| +..+++| +.|+|++|+|+
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~-~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L-~~L~Ls~N~i~ 188 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKIT-DI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKL-QNLYLSKNHIS 188 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCC-CC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTC-CEEECCSSCCC
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccC-Cc--hhhcccCCCCEEECcCCcCCCchh--hccCCCC-CEEECcCCCCC
Confidence 9999995 3 46999999999999999999 55 346899999999999999997666 9999999 79999999999
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
+ +| .+..+++|+.|+|++|++++.+.
T Consensus 189 ~-l~-~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 189 D-LR-ALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp B-CG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred C-Ch-HHccCCCCCEEEccCCcCcCCcc
Confidence 6 44 68999999999999999987543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=204.42 Aligned_cols=180 Identities=26% Similarity=0.305 Sum_probs=98.3
Q ss_pred CCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 68 DPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 68 ~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
+++++.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+
T Consensus 60 ~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~ 127 (622)
T 3g06_A 60 PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLW 127 (622)
T ss_dssp CTTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEE
T ss_pred CCCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEE
Confidence 3678888888888874 444 5677888888888877 3554 56677777777777763 333 233444444
Q ss_pred ccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcc--c--------------ccCCCccEEeccCCCCCCCCCcchh
Q 005226 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGI--W--------------PELENLVQLDLSDNDFKGPIPNDLG 211 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~--~--------------~~l~~L~~L~ls~N~l~~~~p~~~~ 211 (707)
|++|+|+ .+|.. +++|++|+|++|+|+ .+|... + ..+++|+.|+|++|+|++ +|..+.
T Consensus 128 L~~N~l~-~lp~~---l~~L~~L~Ls~N~l~-~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~ 201 (622)
T 3g06_A 128 IFGNQLT-SLPVL---PPGLQELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPS 201 (622)
T ss_dssp CCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCT
T ss_pred CCCCCCC-cCCCC---CCCCCEEECcCCcCC-CcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccc
Confidence 4444444 23322 133344444444433 222110 0 112445555555555542 222221
Q ss_pred h-----------------hhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 212 E-----------------LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 212 ~-----------------l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
+ +++| +.|+|++|+|++ +| ..+++|+.|++++|+|+. +|. .+.++..+.+.+|.
T Consensus 202 ~L~~L~L~~N~l~~l~~~~~~L-~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~--~~~~L~~L~Ls~N~ 272 (622)
T 3g06_A 202 ELYKLWAYNNRLTSLPALPSGL-KELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQ 272 (622)
T ss_dssp TCCEEECCSSCCSSCCCCCTTC-CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSC
T ss_pred hhhEEECcCCcccccCCCCCCC-CEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc--ccccCcEEeCCCCC
Confidence 1 1455 677777777774 55 345677777777777774 442 44556666666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=198.67 Aligned_cols=188 Identities=27% Similarity=0.362 Sum_probs=154.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+++ |++.+.. .+.++++|++|+|++|.+++. + .+.++++|++|+|++|++++..| ++.+++|+.|+|
T Consensus 156 ~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l 228 (466)
T 1o6v_A 156 TSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228 (466)
T ss_dssp TTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEEC
T ss_pred CcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-h-hhccCCCCCEEEecCCccccccc--ccccCCCCEEEC
Confidence 678899996 5666543 399999999999999999854 3 58999999999999999996655 778999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++ + ..+..+++|+.|++++|+++ .++. +..+++|+.|++++|++++..+ +..+++| +.|+|++|+++
T Consensus 229 ~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L-~~L~L~~n~l~ 300 (466)
T 1o6v_A 229 NGNQLKD-I-GTLASLTNLTDLDLANNQIS-NLAP--LSGLTKLTELKLGANQISNISP--LAGLTAL-TNLELNENQLE 300 (466)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTC-SEEECCSSCCS
T ss_pred CCCCccc-c-hhhhcCCCCCEEECCCCccc-cchh--hhcCCCCCEEECCCCccCcccc--ccCCCcc-CeEEcCCCccc
Confidence 9999985 3 46888999999999999998 4444 5788999999999999986443 8888888 79999999998
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+..| +..+++|+.|++++|++++..| ...+.++..+.+.+|+.
T Consensus 301 ~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l 343 (466)
T 1o6v_A 301 DISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKV 343 (466)
T ss_dssp CCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCC
T ss_pred Cchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCcc
Confidence 6554 7788999999999999988766 45667777777777753
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=184.89 Aligned_cols=169 Identities=25% Similarity=0.317 Sum_probs=146.8
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
+++.++|++|.+++.. .+..+++|++|+|++|+|+ .+| .+..+++|++|+|++|+|++. |. +..+++|+.|+|+
T Consensus 20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~ 93 (263)
T 1xeu_A 20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVN 93 (263)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECC
T ss_pred HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECC
Confidence 4667788999998664 6889999999999999998 456 789999999999999999954 44 9999999999999
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|++++ +|.... ++|+.|+|++|+|+ .++. +..+++|+.|+|++|+|++. + .+..+++| +.|+|++|+|++
T Consensus 94 ~N~l~~-l~~~~~--~~L~~L~L~~N~l~-~~~~--l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L-~~L~L~~N~i~~ 164 (263)
T 1xeu_A 94 RNRLKN-LNGIPS--ACLSRLFLDNNELR-DTDS--LIHLKNLEILSIRNNKLKSI-V-MLGFLSKL-EVLDLHGNEITN 164 (263)
T ss_dssp SSCCSC-CTTCCC--SSCCEEECCSSCCS-BSGG--GTTCTTCCEEECTTSCCCBC-G-GGGGCTTC-CEEECTTSCCCB
T ss_pred CCccCC-cCcccc--CcccEEEccCCccC-CChh--hcCcccccEEECCCCcCCCC-h-HHccCCCC-CEEECCCCcCcc
Confidence 999995 554333 99999999999999 5653 68999999999999999964 4 79999999 799999999996
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccC
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEI 255 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~ 255 (707)
. ..+..+++|+.|++++|++++.+
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred h--HHhccCCCCCEEeCCCCcccCCc
Confidence 5 77899999999999999998663
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=175.83 Aligned_cols=154 Identities=17% Similarity=0.232 Sum_probs=105.8
Q ss_pred CCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhh
Q 005226 90 GSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQR 169 (707)
Q Consensus 90 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 169 (707)
..+++|++|+|++|.|+ .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..+.++++|+.
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55667777777777777 455 5777777777777777665 2346677777777777777777666777777777777
Q ss_pred hhhcCCcccccCCCcccccCCCccEEeccCCC-CCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccC
Q 005226 170 LILARNKFSGQIPAGIWPELENLVQLDLSDND-FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248 (707)
Q Consensus 170 L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 248 (707)
|+|++|++++..|.. +..+++|++|+|++|+ ++ .+| .+..+++| +.|++++|++++ ++ .+..+++|+.|++++
T Consensus 117 L~Ls~n~i~~~~~~~-l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L-~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 117 LDISHSAHDDSILTK-INTLPKVNSIDLSYNGAIT-DIM-PLKTLPEL-KSLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp EECCSSBCBGGGHHH-HTTCSSCCEEECCSCTBCC-CCG-GGGGCSSC-CEEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred EEecCCccCcHhHHH-HhhCCCCCEEEccCCCCcc-ccH-hhcCCCCC-CEEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 777777777444433 4677777888888777 54 455 57777777 678888888774 44 677778888888888
Q ss_pred CcCcc
Q 005226 249 NNLSG 253 (707)
Q Consensus 249 N~l~~ 253 (707)
|++.+
T Consensus 191 N~i~~ 195 (197)
T 4ezg_A 191 QTIGG 195 (197)
T ss_dssp C----
T ss_pred cccCC
Confidence 87753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.5e-19 Score=187.42 Aligned_cols=189 Identities=23% Similarity=0.371 Sum_probs=131.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|++++..+ +..+++|++|+|++|.++. +| .+.++++|++|+|++|++++ +|. +..+++|+.|++
T Consensus 66 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l 139 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNL 139 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeEEEC
Confidence 578888888888876533 7788888888888888874 33 57788888888888888874 443 777788888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|.....+ ..+..+++|+.|++++|++. .++. +..+++|+.|++++|.+++ ++. +..+++| +.|++++|.++
T Consensus 140 ~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L-~~L~l~~n~l~ 212 (347)
T 4fmz_A 140 GANHNLSDL-SPLSNMTGLNYLTVTESKVK-DVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSL-HYFTAYVNQIT 212 (347)
T ss_dssp TTCTTCCCC-GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTC-CEEECCSSCCC
T ss_pred CCCCCcccc-cchhhCCCCcEEEecCCCcC-Cchh--hccCCCCCEEEccCCcccc-ccc-ccCCCcc-ceeecccCCCC
Confidence 887655333 34777777777777777777 4444 5677777777777777774 333 6677777 67777777777
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
+..+ +..+++|+.|++++|++++..+ ...+.++..+.+.+|.
T Consensus 213 ~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~ 254 (347)
T 4fmz_A 213 DITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQ 254 (347)
T ss_dssp CCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCc
Confidence 5443 6677777777777777775544 4455556666665553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=174.53 Aligned_cols=151 Identities=15% Similarity=0.237 Sum_probs=133.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|+++ .+| .+..+++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..|+.+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 57899999999999 445 7999999999999999876 3347999999999999999999888999999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCc-ccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcC
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNK-FSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l 227 (707)
++|++++..|..+.++++|+.|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++| +.|++++|+|
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~--~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L-~~L~l~~N~i 193 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM--PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKL-NQLYAFSQTI 193 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG--GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSC-CEEEECBC--
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH--hhcCCCCCCEEECCCCCCcC-hH-HhccCCCC-CEEEeeCccc
Confidence 9999998889999999999999999998 66 787 36899999999999999995 44 88999999 8999999998
Q ss_pred cC
Q 005226 228 SG 229 (707)
Q Consensus 228 ~~ 229 (707)
.+
T Consensus 194 ~~ 195 (197)
T 4ezg_A 194 GG 195 (197)
T ss_dssp --
T ss_pred CC
Confidence 74
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-19 Score=185.52 Aligned_cols=187 Identities=26% Similarity=0.318 Sum_probs=157.3
Q ss_pred EEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 72 VGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 72 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
..+.+..+.+.+.. .+..+++|+.|++++|.++.. + .+..+++|++|+|++|+|++..+ +..+++|+.|+|++|
T Consensus 27 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 34456666666543 356789999999999999854 4 48999999999999999995544 999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
++++ +| .+.++++|+.|+|++|+|+ .++ .+..+++|+.|+|++|+|++. ..+..+++| +.|+|++|+|++..
T Consensus 101 ~l~~-~~-~l~~l~~L~~L~L~~n~i~-~~~--~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L-~~L~L~~N~l~~~~ 172 (291)
T 1h6t_A 101 KVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN--GLVHLPQLESLYLGNNKITDI--TVLSRLTKL-DTLSLEDNQISDIV 172 (291)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCC-CCG--GGGGCTTCCEEECCSSCCCCC--GGGGGCTTC-SEEECCSSCCCCCG
T ss_pred cCCC-Ch-hhccCCCCCEEECCCCcCC-CCh--hhcCCCCCCEEEccCCcCCcc--hhhccCCCC-CEEEccCCccccch
Confidence 9985 44 4999999999999999999 564 357999999999999999964 689999999 89999999999765
Q ss_pred CCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcc
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLL 275 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l 275 (707)
| +..+++|+.|++++|++++. |....+.++..+.+.+|+..
T Consensus 173 ~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 173 P--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp G--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEE
T ss_pred h--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCccc
Confidence 5 89999999999999999964 55667777888888887643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.7e-19 Score=204.28 Aligned_cols=188 Identities=25% Similarity=0.324 Sum_probs=162.4
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
.+..+.|..+.+...++ +..|++|+.|+|++|.|.. +| .+..+++|+.|+|++|+|++..| +..+++|+.|+|+
T Consensus 22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 34556677777776644 6789999999999999984 45 59999999999999999996544 9999999999999
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
+|+|++ +| .+..+++|+.|+|++|+|+ .++. +..+++|+.|+|++|+|++. ..+..+++| +.|+|++|+|++
T Consensus 96 ~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~-~l~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L-~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 96 ENKIKD-LS-SLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITDI--TVLSRLTKL-DTLSLEDNQISD 167 (605)
T ss_dssp SSCCCC-CT-TSTTCTTCCEEECTTSCCC-CCGG--GGGCTTCSEEECCSSCCCCC--GGGGSCTTC-SEEECCSSCCCC
T ss_pred CCCCCC-Ch-hhccCCCCCEEEecCCCCC-CCcc--ccCCCccCEEECCCCccCCc--hhhcccCCC-CEEECcCCcCCC
Confidence 999984 44 7999999999999999999 5653 67999999999999999965 689999999 899999999998
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
..| +..+++|+.|+|++|+|++. |....+.++..+.+.+|+.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred chh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 777 99999999999999999975 6667778888888888864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.2e-19 Score=179.32 Aligned_cols=133 Identities=20% Similarity=0.224 Sum_probs=104.3
Q ss_pred cceecccCeeEEEEEEe-CCCce--EEEEEcCCCchh------------------------hHHHHHHHHHHHHhcCCCc
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIP--VAVRRLGEGGEQ------------------------RHREFVTEVQAIAKVKHPN 464 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n 464 (707)
...||+|+||.||+|.. .+|.. ||||+++..... ....+.+|++++.+++|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 45899999999999997 68888 999986543111 1136789999999998876
Q ss_pred e--eeeEEEEEcCCcceEEEEeecC-C----ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCceecC
Q 005226 465 I--VKLRAYYWAPDEKLLISDFISN-G----NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH-ECSPRKFVHGD 536 (707)
Q Consensus 465 i--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~iiHrD 536 (707)
+ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||+||| + .+|+|||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 4 344432 467999999943 4 67666532 224457789999999999999 8 7999999
Q ss_pred CCCCCeEEcCCCCeEEecccccccc
Q 005226 537 IKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 537 lk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=2.1e-19 Score=173.72 Aligned_cols=131 Identities=25% Similarity=0.315 Sum_probs=107.9
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCc-cccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPD-QLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.|++++|+++ .+|..+.. +|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 3455667775 56766644 899999999999977665 4889999999999999999888999999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p 207 (707)
+|++..|..|.++++|+.|+|++|+|++.+| ..|..+++|++|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMP-GSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECT-TSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cCCccCHHHhcCCCCCCEEECCCCcCCeeCH-HHhhcCCCCCEEEeCCCCccCcCc
Confidence 9998888888888899999999998885444 445788888888888888886544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-19 Score=197.36 Aligned_cols=183 Identities=20% Similarity=0.214 Sum_probs=108.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCC-------------ceEEecCccCCCCCCc
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSL-------------HSIFLYGNNLSGSLPP 135 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~~~~p~ 135 (707)
.+++.|++++|++ |.+|.++++|++|++|+|++|+++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5788899999998 7888889999999999999999988889888887764 888888888884 444
Q ss_pred ccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhc
Q 005226 136 SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQS 215 (707)
Q Consensus 136 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 215 (707)
. .++|+.|++++|++++ +|..+ ++|+.|++++|+++ .+|.. .++|++|++++|++++ +| .|+++++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred C---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 2 3678888888888875 66533 56777777777776 44431 1567777777777764 55 4666777
Q ss_pred cccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 216 LSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 216 L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
| ++|++++|++++ +|..+ .+|+.|++++|++++ +|....+.++..+.+.+|.
T Consensus 155 L-~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~~~~~l~~L~~L~l~~N~ 206 (454)
T 1jl5_A 155 L-KIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNS 206 (454)
T ss_dssp C-CEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSC
T ss_pred C-CEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-CccccCCCCCCEEECCCCc
Confidence 7 577777777764 55432 366667777777665 4455555555555555553
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-20 Score=197.28 Aligned_cols=201 Identities=19% Similarity=0.222 Sum_probs=150.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCC-CCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGS-LPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
.+++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+.++++|++|+|++|++++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5678888888888877555 56788888888888888765 777788888888888888888877788888888888888
Q ss_pred ccCC-ccccc-CCCCCcccchhhhhhhcCC-ccccc-CCCcccccCC-CccEEeccCC--CCC-CCCCcchhhhhccccE
Q 005226 148 LSNN-SFSGS-LPDGLKNCKQLQRLILARN-KFSGQ-IPAGIWPELE-NLVQLDLSDN--DFK-GPIPNDLGELQSLSAT 219 (707)
Q Consensus 148 Ls~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-lp~~~~~~l~-~L~~L~ls~N--~l~-~~~p~~~~~l~~L~~~ 219 (707)
|++| .+++. ++..+.++++|++|+|++| ++++. ++. .+..++ +|++|+|++| .++ +.+|..+.++++| +.
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~-~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L-~~ 226 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV-AVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL-VH 226 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH-HHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC-SE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH-HHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCC-CE
Confidence 8888 67652 6666788888888888888 88743 333 346788 8888888888 455 4566777888888 78
Q ss_pred EEeccCc-CcCCCCCcCCCCCCccEEEccCCc-Cccc-CCCCCCCCCCCCcccCCC
Q 005226 220 LNLSYNH-LSGKIPKSLGNLPVTVSFDLRGNN-LSGE-IPQTGSFANQGPTAFLSN 272 (707)
Q Consensus 220 L~l~~N~-l~~~~p~~~~~l~~L~~l~l~~N~-l~~~-~p~~~~~~~~~~~~~~~N 272 (707)
|++++|. +++..+..+..+++|+.|++++|. ++.. +.....+.++..+.+.+|
T Consensus 227 L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 8888888 776777788888888888888885 2211 111233455555666554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=162.83 Aligned_cols=138 Identities=23% Similarity=0.319 Sum_probs=113.0
Q ss_pred CCCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC
Q 005226 50 PTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 50 ~~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
.|.|+|.+|.|.. |+++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 4 ~C~C~~~~l~~~~----------------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 64 (177)
T 2o6r_A 4 RCSCSGTEIRCNS----------------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI 64 (177)
T ss_dssp TCEEETTEEECCS----------------SCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred CCEeCCCEEEecC----------------CCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcc
Confidence 4668899888864 3444 234333 36899999999999977777788999999999999999
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p 207 (707)
++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|.+.+..|
T Consensus 65 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 65 QSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred eEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9776777899999999999999999776777888899999999999998 7888888888999999999999886544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=9.5e-21 Score=204.28 Aligned_cols=204 Identities=18% Similarity=0.244 Sum_probs=141.5
Q ss_pred CcEEEEEcCCCCcccc----CCCCcCCCCCCCEEEcccC---CcCCCCCccc-------cCCCCCceEEecCccCCC---
Q 005226 69 PRVVGVAISGKNVRGY----IPSELGSLIYLRRLNLHNN---NLFGSLPDQL-------FNATSLHSIFLYGNNLSG--- 131 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~N~l~~--- 131 (707)
++++.|+|++|++.+. ++..|..+++|++|+|++| ++++.+|..+ .++++|++|+|++|+|++
T Consensus 32 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~ 111 (386)
T 2ca6_A 32 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 111 (386)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHH
Confidence 4678888888888775 3344677888888888885 4444555554 677888888888888886
Q ss_pred -CCCcccCCCCCccEEeccCCcccccCCCCC----ccc---------chhhhhhhcCCccc-ccCCC--cccccCCCccE
Q 005226 132 -SLPPSVCNLPRLQNLDLSNNSFSGSLPDGL----KNC---------KQLQRLILARNKFS-GQIPA--GIWPELENLVQ 194 (707)
Q Consensus 132 -~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l---------~~L~~L~l~~N~l~-~~lp~--~~~~~l~~L~~ 194 (707)
.+|..+..+++|+.|+|++|.|+...+..+ ..+ ++|++|+|++|+|+ +.+|. ..+..+++|++
T Consensus 112 ~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~ 191 (386)
T 2ca6_A 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 191 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred HHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCE
Confidence 367777788888888888888864433333 333 78888888888886 33442 23456778888
Q ss_pred EeccCCCCCC-----CCCcchhhhhccccEEEeccCcCc----CCCCCcCCCCCCccEEEccCCcCccc----CCCC---
Q 005226 195 LDLSDNDFKG-----PIPNDLGELQSLSATLNLSYNHLS----GKIPKSLGNLPVTVSFDLRGNNLSGE----IPQT--- 258 (707)
Q Consensus 195 L~ls~N~l~~-----~~p~~~~~l~~L~~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~----~p~~--- 258 (707)
|+|++|+|+. .+|..+..+++| +.|+|++|.|+ +.+|..+..+++|+.|+|++|++++. +|..
T Consensus 192 L~L~~n~l~~~g~~~l~~~~l~~~~~L-~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~ 270 (386)
T 2ca6_A 192 VKMVQNGIRPEGIEHLLLEGLAYCQEL-KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270 (386)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTC-CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHT
T ss_pred EECcCCCCCHhHHHHHHHHHhhcCCCc-cEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhh
Confidence 8888888762 234467777888 68888888885 56777777888888888888888764 2321
Q ss_pred CCCCCCCCcccCCCC
Q 005226 259 GSFANQGPTAFLSNP 273 (707)
Q Consensus 259 ~~~~~~~~~~~~~N~ 273 (707)
....++..+.+.+|.
T Consensus 271 ~~~~~L~~L~L~~n~ 285 (386)
T 2ca6_A 271 LENIGLQTLRLQYNE 285 (386)
T ss_dssp CSSCCCCEEECCSSC
T ss_pred ccCCCeEEEECcCCc
Confidence 224555666666654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1e-17 Score=183.97 Aligned_cols=178 Identities=26% Similarity=0.341 Sum_probs=121.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|.+++ +|.. +++|++|+|++|++++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 578888888888887 5543 3677788888887774 3321 1577888888888874 66 5777888888888
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++ +|..+ .+|++|++++|+++ .+|. +..+++|++|++++|++++ +|... ++| ++|++++|+++
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~-~l~~--~~~l~~L~~L~l~~N~l~~-l~~~~---~~L-~~L~l~~n~l~ 228 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELPE--LQNLPFLTAIYADNNSLKK-LPDLP---LSL-ESIVAGNNILE 228 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCS-SCCC--CTTCTTCCEEECCSSCCSS-CCCCC---TTC-CEEECCSSCCS
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCC-cCcc--ccCCCCCCEEECCCCcCCc-CCCCc---Ccc-cEEECcCCcCC
Confidence 8887774 55543 47777778888777 4663 5677777777777777774 44433 356 67777777777
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
.+|. +..+++|+.|++++|++++ +|. ...++..+.+.+|.
T Consensus 229 -~lp~-~~~l~~L~~L~l~~N~l~~-l~~--~~~~L~~L~l~~N~ 268 (454)
T 1jl5_A 229 -ELPE-LQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNY 268 (454)
T ss_dssp -SCCC-CTTCTTCCEEECCSSCCSS-CCS--CCTTCCEEECCSSC
T ss_pred -cccc-cCCCCCCCEEECCCCcCCc-ccc--cccccCEEECCCCc
Confidence 5663 7777777777777777775 332 23455555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=6.5e-19 Score=170.23 Aligned_cols=129 Identities=26% Similarity=0.415 Sum_probs=81.9
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCc-ccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPP-SVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILAR 174 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (707)
+.|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67888888886 56665543 777888888887755553 377777777777777777766666666666666666666
Q ss_pred CcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 175 N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
|+|+ .++...|..+++|++|+|++|+|++..|..|..+++| ++|+|++|.+++
T Consensus 88 N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~c 140 (192)
T 1w8a_A 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL-TSLNLASNPFNC 140 (192)
T ss_dssp CCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTC-CEEECTTCCBCC
T ss_pred CcCC-ccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCC-CEEEeCCCCccC
Confidence 6666 4444444555555555555555555555555555555 455555555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-21 Score=201.21 Aligned_cols=211 Identities=20% Similarity=0.237 Sum_probs=176.6
Q ss_pred CCceeceeEeCCCCCCCCCcEEEEEcCCCCccccCCCCcCCC--CCCCEEEcccCCcCCCCCccccCCCCCceEEecCcc
Q 005226 51 TPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSL--IYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN 128 (707)
Q Consensus 51 ~~C~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 128 (707)
.|.+|.++.|.. ..++.|++++|++. +..+..+ ++|+.|++++|.+++..+. +.++++|++|+|++|.
T Consensus 35 vc~~W~~~~~~~------~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~ 104 (336)
T 2ast_B 35 VCKRWYRLASDE------SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSV 104 (336)
T ss_dssp SCHHHHHHHTCS------TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCE
T ss_pred HHHHHHHHhcCc------hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCC
Confidence 345799998753 45889999999887 4567777 8999999999999977665 6789999999999999
Q ss_pred CCCC-CCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCC-ccccc-CCCcccccCCCccEEeccCC-CCCC
Q 005226 129 LSGS-LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN-KFSGQ-IPAGIWPELENLVQLDLSDN-DFKG 204 (707)
Q Consensus 129 l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-lp~~~~~~l~~L~~L~ls~N-~l~~ 204 (707)
+++. +|..+..+++|++|+|++|.+++..|..+.++++|++|+|++| .+++. ++ ..+..+++|++|+|++| .+++
T Consensus 105 l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~-~~~~~~~~L~~L~l~~~~~l~~ 183 (336)
T 2ast_B 105 IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ-TLLSSCSRLDELNLSWCFDFTE 183 (336)
T ss_dssp ECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH-HHHHHCTTCCEEECCCCTTCCH
T ss_pred cCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHH-HHHhcCCCCCEEcCCCCCCcCh
Confidence 9865 8888999999999999999999888999999999999999999 67743 44 34578999999999999 9986
Q ss_pred C-CCcchhhhh-ccccEEEeccC--cCc-CCCCCcCCCCCCccEEEccCCc-Cccc-CCCCCCCCCCCCcccCCCC
Q 005226 205 P-IPNDLGELQ-SLSATLNLSYN--HLS-GKIPKSLGNLPVTVSFDLRGNN-LSGE-IPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 205 ~-~p~~~~~l~-~L~~~L~l~~N--~l~-~~~p~~~~~l~~L~~l~l~~N~-l~~~-~p~~~~~~~~~~~~~~~N~ 273 (707)
. ++..+..++ +| ++|+|++| .++ +.+|..+..+++|+.|++++|. +++. ++....+.++..+.+.+|.
T Consensus 184 ~~~~~~~~~l~~~L-~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 184 KHVQVAVAHVSETI-TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp HHHHHHHHHSCTTC-CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred HHHHHHHHhcccCC-CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 4 677889999 99 89999999 555 4677788889999999999999 6654 3344556677777777775
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1e-20 Score=204.01 Aligned_cols=204 Identities=20% Similarity=0.216 Sum_probs=163.6
Q ss_pred CcEEEEEcCCC---CccccCCCCc-------CCCCCCCEEEcccCCcCC----CCCccccCCCCCceEEecCccCCCCCC
Q 005226 69 PRVVGVAISGK---NVRGYIPSEL-------GSLIYLRRLNLHNNNLFG----SLPDQLFNATSLHSIFLYGNNLSGSLP 134 (707)
Q Consensus 69 ~~v~~L~L~~n---~l~~~~~~~l-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p 134 (707)
++++.|+|++| ++.+.+|..+ ..+++|++|+|++|.|++ .+|..+.++++|++|+|++|.|+...+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 68999999996 5556666655 789999999999999997 478889999999999999999974444
Q ss_pred cccC----CC---------CCccEEeccCCccc-ccCC---CCCcccchhhhhhhcCCccccc----CCCcccccCCCcc
Q 005226 135 PSVC----NL---------PRLQNLDLSNNSFS-GSLP---DGLKNCKQLQRLILARNKFSGQ----IPAGIWPELENLV 193 (707)
Q Consensus 135 ~~~~----~l---------~~L~~L~Ls~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~ 193 (707)
..+. .+ ++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+|+.. +....+..+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 4333 34 89999999999997 4455 4677899999999999999721 2222357899999
Q ss_pred EEeccCCCCC----CCCCcchhhhhccccEEEeccCcCcCC----CCCcC--CCCCCccEEEccCCcCcc----cCCCC-
Q 005226 194 QLDLSDNDFK----GPIPNDLGELQSLSATLNLSYNHLSGK----IPKSL--GNLPVTVSFDLRGNNLSG----EIPQT- 258 (707)
Q Consensus 194 ~L~ls~N~l~----~~~p~~~~~l~~L~~~L~l~~N~l~~~----~p~~~--~~l~~L~~l~l~~N~l~~----~~p~~- 258 (707)
+|+|++|.|+ +.+|..+..+++| +.|+|++|.|++. +|..+ +.+++|+.|+|++|++++ .+|..
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~L-~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPNL-RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTC-CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCCc-CEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 9999999996 5788899999999 7999999999865 56666 448999999999999998 35532
Q ss_pred -CCCCCCCCcccCCCC
Q 005226 259 -GSFANQGPTAFLSNP 273 (707)
Q Consensus 259 -~~~~~~~~~~~~~N~ 273 (707)
..+.++..+.+.+|+
T Consensus 299 ~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 299 DEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHCTTCCEEECTTSB
T ss_pred HhcCCCceEEEccCCc
Confidence 224667777777765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.6e-21 Score=217.88 Aligned_cols=180 Identities=23% Similarity=0.278 Sum_probs=125.6
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCC-------------cCCCCCccccCCCCCceEE-ecCccCCCCCCc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN-------------LFGSLPDQLFNATSLHSIF-LYGNNLSGSLPP 135 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~p~ 135 (707)
+++.|+|++|+|+ .+|..+++|++|+.|++++|. +.+.+|..+.++++|+.|+ ++.|.+. .++.
T Consensus 350 ~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~ 427 (567)
T 1dce_A 350 QLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRS 427 (567)
T ss_dssp TSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHH
T ss_pred cceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhh
Confidence 4445666666665 446666666666666665553 3445555556666666665 4444322 1110
Q ss_pred ------ccCC--CCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC
Q 005226 136 ------SVCN--LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207 (707)
Q Consensus 136 ------~~~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p 207 (707)
.+.. ...|+.|+|++|+|++ +|. |.++++|+.|+|++|+|+ .+|..+ ..+++|+.|+|++|+|++ +|
T Consensus 428 l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~Ls~N~l~~-lp 502 (567)
T 1dce_A 428 KFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPAL-AALRCLEVLQASDNALEN-VD 502 (567)
T ss_dssp HHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGG-GGCTTCCEEECCSSCCCC-CG
T ss_pred hhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhh-hcCCCCCEEECCCCCCCC-Cc
Confidence 0000 1247788888888884 676 888888888888888888 888754 788888888888888885 66
Q ss_pred cchhhhhccccEEEeccCcCcCCC-CCcCCCCCCccEEEccCCcCcccCCCC
Q 005226 208 NDLGELQSLSATLNLSYNHLSGKI-PKSLGNLPVTVSFDLRGNNLSGEIPQT 258 (707)
Q Consensus 208 ~~~~~l~~L~~~L~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~p~~ 258 (707)
.++++++| +.|+|++|+|++.. |..+..+++|+.|+|++|+|++.+|..
T Consensus 503 -~l~~l~~L-~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 503 -GVANLPRL-QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp -GGTTCSSC-CEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred -ccCCCCCC-cEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 78888888 78888888888766 888888888888888888888877643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=161.51 Aligned_cols=126 Identities=28% Similarity=0.343 Sum_probs=104.6
Q ss_pred EEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcc
Q 005226 74 VAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153 (707)
Q Consensus 74 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 153 (707)
+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 455667777 4565543 58999999999998 7788899999999999999999988788899999999999999999
Q ss_pred cccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCC
Q 005226 154 SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 154 ~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~ 204 (707)
++..|..|.++++|+.|+|++|+|+ .+|...|..+++|+.|+|++|.+..
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeec
Confidence 9777778888888888888888888 7777777778888888888887763
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=189.73 Aligned_cols=183 Identities=26% Similarity=0.358 Sum_probs=118.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|.. +++|++|+|
T Consensus 81 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~L 148 (622)
T 3g06_A 81 PELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSV 148 (622)
T ss_dssp TTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEEC
T ss_pred CCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEEC
Confidence 678888888888885 444 66778888888888774 343 3455556666666555 24432 245555555
Q ss_pred cCCcccccCCCC---Cccc--------------chhhhhhhcCCcccccCCCcc----------------cccCCCccEE
Q 005226 149 SNNSFSGSLPDG---LKNC--------------KQLQRLILARNKFSGQIPAGI----------------WPELENLVQL 195 (707)
Q Consensus 149 s~N~l~~~~p~~---~~~l--------------~~L~~L~l~~N~l~~~lp~~~----------------~~~l~~L~~L 195 (707)
++|+|++ +|.. +..| ++|+.|+|++|+|+ .+|... ...+++|+.|
T Consensus 149 s~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~-~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L 226 (622)
T 3g06_A 149 SDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKEL 226 (622)
T ss_dssp CSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCSSCCCCCTTCCEE
T ss_pred cCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCC-CCCCccchhhEEECcCCcccccCCCCCCCCEE
Confidence 5555542 2222 2122 55566666666665 343211 0123778889
Q ss_pred eccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCc
Q 005226 196 DLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 196 ~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~ 274 (707)
+|++|+|++ +| ..+++| +.|+|++|+|+ .+|. .+++|+.|++++|+|+..++....+.++..+.+.+|++
T Consensus 227 ~Ls~N~L~~-lp---~~l~~L-~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l 296 (622)
T 3g06_A 227 IVSGNRLTS-LP---VLPSEL-KELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPL 296 (622)
T ss_dssp ECCSSCCSC-CC---CCCTTC-CEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCC
T ss_pred EccCCccCc-CC---CCCCcC-cEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCC
Confidence 999998885 66 345677 79999999999 5676 57889999999999994444445566777778888875
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2.6e-18 Score=162.16 Aligned_cols=132 Identities=23% Similarity=0.265 Sum_probs=81.0
Q ss_pred CcEEEEEcCCCCcc-ccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVR-GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
++++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 56666667777777777777777654 5566677777777777777655666666667777777
Q ss_pred ccCCcccccC-CCCCcccchhhhhhhcCCcccccCCC---cccccCCCccEEeccCCCCC
Q 005226 148 LSNNSFSGSL-PDGLKNCKQLQRLILARNKFSGQIPA---GIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 148 Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~lp~---~~~~~l~~L~~L~ls~N~l~ 203 (707)
|++|+|++.. +..+..+++|+.|+|++|+++ .+|. ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777666321 145555555555555555555 3443 33445555555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.8e-18 Score=178.81 Aligned_cols=196 Identities=20% Similarity=0.130 Sum_probs=159.0
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCC-cccCCCCCccE-EeccC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLP-PSVCNLPRLQN-LDLSN 150 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~Ls~ 150 (707)
.++.++++|+ .+|..+ .++|++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| ..|.++++|+. +++++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~ 89 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence 4788999999 557666 3689999999999996666789999999999999999976666 46889998775 67788
Q ss_pred CcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccC-CCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 151 NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD-NDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
|+|+...|..|.++++|++|++++|+|+ .+|...+....++..|++.+ |++....+..|..+...++.|+|++|+|+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~- 167 (350)
T 4ay9_X 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167 (350)
T ss_dssp TTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-
T ss_pred CcccccCchhhhhccccccccccccccc-cCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc-
Confidence 9999888899999999999999999999 78877777788899999966 67875556677777654379999999999
Q ss_pred CCCCcCCCCCCccEEEccCCcCcccCCC--CCCCCCCCCcccCCCC
Q 005226 230 KIPKSLGNLPVTVSFDLRGNNLSGEIPQ--TGSFANQGPTAFLSNP 273 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~~~~~~~~~~~~~~N~ 273 (707)
.+|.......+|+.|++++|+..+.+|. ...+.++..+.+.+|.
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~ 213 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 213 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSC
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCC
Confidence 5666666778999999986444445553 2456778888888875
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.8e-20 Score=195.73 Aligned_cols=203 Identities=22% Similarity=0.223 Sum_probs=144.8
Q ss_pred CcEEEEEcCCCCccccCC----CCcCCCC-CCCEEEcccCCcCCCCCccccCC-----CCCceEEecCccCCCCCCcccC
Q 005226 69 PRVVGVAISGKNVRGYIP----SELGSLI-YLRRLNLHNNNLFGSLPDQLFNA-----TSLHSIFLYGNNLSGSLPPSVC 138 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~ 138 (707)
.+++.|+|++|++++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 458889999998887766 6777888 89999999998887777777765 8899999999998866666443
Q ss_pred ----CC-CCccEEeccCCcccccCCCCCcc-----cchhhhhhhcCCcccccCCCcc---cccCC-CccEEeccCCCCCC
Q 005226 139 ----NL-PRLQNLDLSNNSFSGSLPDGLKN-----CKQLQRLILARNKFSGQIPAGI---WPELE-NLVQLDLSDNDFKG 204 (707)
Q Consensus 139 ----~l-~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~lp~~~---~~~l~-~L~~L~ls~N~l~~ 204 (707)
.+ ++|+.|+|++|+|++..+..+.. .++|++|+|++|+|++.-...+ +..++ +|++|+|++|+|++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 34 78999999999988655544433 2588889999998873222211 23444 88899999998887
Q ss_pred CCCcchhhh-----hccccEEEeccCcCcCC----CCCcCCC-CCCccEEEccCCcCcccCCC-----CCCCCCCCCccc
Q 005226 205 PIPNDLGEL-----QSLSATLNLSYNHLSGK----IPKSLGN-LPVTVSFDLRGNNLSGEIPQ-----TGSFANQGPTAF 269 (707)
Q Consensus 205 ~~p~~~~~l-----~~L~~~L~l~~N~l~~~----~p~~~~~-l~~L~~l~l~~N~l~~~~p~-----~~~~~~~~~~~~ 269 (707)
..+..+... ++| ++|+|++|.|+.. ++..+.. .++|+.|++++|++++..+. ...+.++..+.+
T Consensus 182 ~~~~~l~~~l~~~~~~L-~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L 260 (362)
T 3goz_A 182 KNCAELAKFLASIPASV-TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260 (362)
T ss_dssp SCHHHHHHHHHTSCTTC-CEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEE
T ss_pred hhHHHHHHHHHhCCCCC-CEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEe
Confidence 777666554 578 7899999988852 4445544 35888899999888764331 123344555555
Q ss_pred CCC
Q 005226 270 LSN 272 (707)
Q Consensus 270 ~~N 272 (707)
.+|
T Consensus 261 ~~n 263 (362)
T 3goz_A 261 DYD 263 (362)
T ss_dssp EHH
T ss_pred ccC
Confidence 554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-18 Score=161.00 Aligned_cols=133 Identities=24% Similarity=0.221 Sum_probs=81.9
Q ss_pred CCCCCEEEcccCCcC-CCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhh
Q 005226 92 LIYLRRLNLHNNNLF-GSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRL 170 (707)
Q Consensus 92 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 170 (707)
.++|++|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|+.|+|++|++++.+|..+.++++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 367788888888877 66777777777888888888877744 667777777777777777775555555555555555
Q ss_pred hhcCCcccccCCC-cccccCCCccEEeccCCCCCCCCC---cchhhhhccccEEEeccCcCc
Q 005226 171 ILARNKFSGQIPA-GIWPELENLVQLDLSDNDFKGPIP---NDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 171 ~l~~N~l~~~lp~-~~~~~l~~L~~L~ls~N~l~~~~p---~~~~~l~~L~~~L~l~~N~l~ 228 (707)
+|++|+|+ .+|. ..+..+++|++|+|++|++++..+ ..+..+++| +.|++++|.+.
T Consensus 101 ~Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L-~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLK-DISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQL-TYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCC-SSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSC-CEETTEETTSC
T ss_pred eccCCccC-cchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccC-cEecCCCCChh
Confidence 55555555 3332 233455555555555555553322 244444444 44555555444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-18 Score=177.49 Aligned_cols=170 Identities=22% Similarity=0.267 Sum_probs=146.7
Q ss_pred CCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhh
Q 005226 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRL 170 (707)
Q Consensus 91 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 170 (707)
.+.++..++|++|.+++. + .+..+++|++|+|++|+|+ .+| .+..+++|+.|+|++|+|++..| +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 566788899999999844 4 6889999999999999999 566 78999999999999999996544 9999999999
Q ss_pred hhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCc
Q 005226 171 ILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250 (707)
Q Consensus 171 ~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 250 (707)
+|++|+|+ .+|... . ++|++|+|++|+|++ ++ .+..+++| +.|+|++|+|++ +| .+..+++|+.|++++|+
T Consensus 91 ~L~~N~l~-~l~~~~--~-~~L~~L~L~~N~l~~-~~-~l~~l~~L-~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~ 161 (263)
T 1xeu_A 91 SVNRNRLK-NLNGIP--S-ACLSRLFLDNNELRD-TD-SLIHLKNL-EILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNE 161 (263)
T ss_dssp ECCSSCCS-CCTTCC--C-SSCCEEECCSSCCSB-SG-GGTTCTTC-CEEECTTSCCCB-CG-GGGGCTTCCEEECTTSC
T ss_pred ECCCCccC-CcCccc--c-CcccEEEccCCccCC-Ch-hhcCcccc-cEEECCCCcCCC-Ch-HHccCCCCCEEECCCCc
Confidence 99999999 677643 3 999999999999995 44 69999999 899999999996 45 68899999999999999
Q ss_pred CcccCCCCCCCCCCCCcccCCCCccc
Q 005226 251 LSGEIPQTGSFANQGPTAFLSNPLLC 276 (707)
Q Consensus 251 l~~~~p~~~~~~~~~~~~~~~N~~l~ 276 (707)
+++. +....+.++..+.+.+|+..+
T Consensus 162 i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 162 ITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred Ccch-HHhccCCCCCEEeCCCCcccC
Confidence 9987 666677778888888887544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-19 Score=192.89 Aligned_cols=199 Identities=22% Similarity=0.213 Sum_probs=157.1
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCC----ccccCCC-CCceEEecCccCCCCCCcccCCC-----CC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLP----DQLFNAT-SLHSIFLYGNNLSGSLPPSVCNL-----PR 142 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 142 (707)
.+.|++|+++|.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999888888889999999999997776 7788898 99999999999998878877775 99
Q ss_pred ccEEeccCCcccccCCCCCccc-----chhhhhhhcCCcccccCCCccc----cc-CCCccEEeccCCCCCCCCCcch--
Q 005226 143 LQNLDLSNNSFSGSLPDGLKNC-----KQLQRLILARNKFSGQIPAGIW----PE-LENLVQLDLSDNDFKGPIPNDL-- 210 (707)
Q Consensus 143 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~lp~~~~----~~-l~~L~~L~ls~N~l~~~~p~~~-- 210 (707)
|++|+|++|++++..+..+... ++|+.|+|++|+|+ ..+...+ .. .++|++|+|++|+|++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG-GSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC-cHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999997776655544 89999999999998 5554332 23 3699999999999996555444
Q ss_pred --hhhh-ccccEEEeccCcCcCCCCCcCC----CC-CCccEEEccCCcCccc----CCC-CCC-CCCCCCcccCCCC
Q 005226 211 --GELQ-SLSATLNLSYNHLSGKIPKSLG----NL-PVTVSFDLRGNNLSGE----IPQ-TGS-FANQGPTAFLSNP 273 (707)
Q Consensus 211 --~~l~-~L~~~L~l~~N~l~~~~p~~~~----~l-~~L~~l~l~~N~l~~~----~p~-~~~-~~~~~~~~~~~N~ 273 (707)
..++ +| ++|+|++|+|++..+..+. .+ ++|+.|+|++|.+++. ++. ... ..++..+.+.+|.
T Consensus 161 ~l~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 236 (362)
T 3goz_A 161 ILAAIPANV-NSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236 (362)
T ss_dssp HHHTSCTTC-CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSC
T ss_pred HHhcCCccc-cEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCC
Confidence 4444 78 8999999999977665443 44 6999999999999862 221 111 1356666666664
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-18 Score=201.19 Aligned_cols=175 Identities=22% Similarity=0.214 Sum_probs=125.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
..++.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|++|++|+.|+|
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 67999999999999 67888889999999999999999 89999999999999999999999 88999999999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccC---
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYN--- 225 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N--- 225 (707)
++|.|+ .+|..|.+|++|+.|+|++|+|+|.+|..+......+..|+|++|.+++.+|..+. .|++++|
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~-------~l~l~~n~~~ 372 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR-------FIEINTDGEP 372 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-------------------
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc-------eeEeeccccc
Confidence 999998 88999999999999999999999777765432212334589999999999997653 5566666
Q ss_pred -----cCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 226 -----HLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 226 -----~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
.|.+..+..+..+..+....+++|-+.+.
T Consensus 373 ~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~ 406 (727)
T 4b8c_D 373 QREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQH 406 (727)
T ss_dssp -----------------------------CCCGG
T ss_pred ccccCCccccccchhhcccccceeeeeccccccc
Confidence 44444455555666666677777766543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.6e-17 Score=157.24 Aligned_cols=128 Identities=25% Similarity=0.347 Sum_probs=79.9
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN 175 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 175 (707)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~-------------------- 68 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-------------------- 68 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCC--------------------
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCE--------------------
Confidence 46777777777 5555443 46667777777766 566666666666666666666664
Q ss_pred cccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 176 KFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 176 ~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
++...|..+++|++|+|++|+|++..|..|.++++| +.|+|++|+|++..+..|..+++|+.|++++|++.+
T Consensus 69 -----i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 69 -----LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSL-RLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp -----CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTC-CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred -----eCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCC-CEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 444444555555556666666655555556666666 566666666665444556667777777777776653
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.70 E-value=7.4e-18 Score=155.59 Aligned_cols=127 Identities=22% Similarity=0.230 Sum_probs=93.6
Q ss_pred CcEEEEEcCCCCcc-ccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVR-GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
++++.|++++|+++ +.+|..+..+++|++|+|++|.|++. ..+.++++|++|+|++|+|++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57888888888887 67777788888888888888888765 6677888888888888888866777777788888888
Q ss_pred ccCCccccc-CCCCCcccchhhhhhhcCCcccccCCC---cccccCCCccEEecc
Q 005226 148 LSNNSFSGS-LPDGLKNCKQLQRLILARNKFSGQIPA---GIWPELENLVQLDLS 198 (707)
Q Consensus 148 Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~lp~---~~~~~l~~L~~L~ls 198 (707)
|++|++++. .+..+.++++|+.|++++|+++ .+|. ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG-GSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc-chHHHHHHHHHHCCCcccccCC
Confidence 888888742 2366666677777777777766 4444 445566666666665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.9e-17 Score=153.31 Aligned_cols=132 Identities=23% Similarity=0.294 Sum_probs=80.3
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN 175 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 175 (707)
+.+++++|+++ .+|..+ .++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~--------------------- 65 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ--------------------- 65 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC---------------------
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce---------------------
Confidence 45666666655 334322 245555555555555444444455555555555555554
Q ss_pred cccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccC
Q 005226 176 KFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEI 255 (707)
Q Consensus 176 ~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 255 (707)
.+|...|..+++|++|+|++|+|++..+..+.++++| ++|+|++|+|++..+..+..+++|+.|++++|++++..
T Consensus 66 ----~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 66 ----SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQL-KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp ----CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred ----EeChhHccCCCccCEEECCCCCccccCHHHhhCCccc-CEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 4555555666667777777777765555556667777 67777777777555555677777788888888777665
Q ss_pred C
Q 005226 256 P 256 (707)
Q Consensus 256 p 256 (707)
|
T Consensus 141 ~ 141 (177)
T 2o6r_A 141 P 141 (177)
T ss_dssp H
T ss_pred c
Confidence 5
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-17 Score=152.96 Aligned_cols=127 Identities=24% Similarity=0.249 Sum_probs=71.3
Q ss_pred CCCCEEEcccCCcC-CCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhh
Q 005226 93 IYLRRLNLHNNNLF-GSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLI 171 (707)
Q Consensus 93 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 171 (707)
++|++|+|++|.++ +.+|..+..+++|++|+|++|+|++. ..+..+++|+.|+|++|++++.+|..+.+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-------- 86 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEK-------- 86 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHH--------
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhh--------
Confidence 55666666666666 56666666666666666666666643 55666666666666666666444444444
Q ss_pred hcCCcccccCCCcccccCCCccEEeccCCCCCCC-CCcchhhhhccccEEEeccCcCcCCCC---CcCCCCCCccEEEcc
Q 005226 172 LARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP-IPNDLGELQSLSATLNLSYNHLSGKIP---KSLGNLPVTVSFDLR 247 (707)
Q Consensus 172 l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~~L~l~~N~l~~~~p---~~~~~l~~L~~l~l~ 247 (707)
+++|++|++++|+|++. .+..+..+++| ++|++++|.+++..+ ..+..+++|+.|+++
T Consensus 87 -----------------l~~L~~L~ls~N~i~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 87 -----------------CPNLTHLNLSGNKIKDLSTIEPLKKLENL-KSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp -----------------CTTCCEEECTTSCCCSHHHHGGGGGCTTC-CEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred -----------------CCCCCEEECCCCcCCChHHHHHHhhCCCC-CEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 45555555555555431 22445555555 455555555553332 245555555555554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=4.1e-19 Score=199.96 Aligned_cols=177 Identities=20% Similarity=0.180 Sum_probs=149.4
Q ss_pred cCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCcc-------------CCCCCCcccCCCCCccEEe-ccCCccc
Q 005226 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN-------------LSGSLPPSVCNLPRLQNLD-LSNNSFS 154 (707)
Q Consensus 89 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~ 154 (707)
+..+++|+.|+|++|+|+ .+|.++.++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 345 ~~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp CSTTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 367899999999999998 889999999999999998886 6678888899999999999 6766544
Q ss_pred ccCCC------CCccc--chhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCc
Q 005226 155 GSLPD------GLKNC--KQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNH 226 (707)
Q Consensus 155 ~~~p~------~~~~l--~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 226 (707)
.++. .+..+ ..|+.|+|++|+|+ .+|. +..+++|+.|+|++|+|+ .+|..|+++++| +.|+|++|+
T Consensus 424 -~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~-~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L-~~L~Ls~N~ 497 (567)
T 1dce_A 424 -DLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCL-EVLQASDNA 497 (567)
T ss_dssp -HHHHHHHHHHHHHHHHHTTCSEEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTC-CEEECCSSC
T ss_pred -hhhhhhhhcccccccCccCceEEEecCCCCC-CCcC--ccccccCcEeecCccccc-ccchhhhcCCCC-CEEECCCCC
Confidence 1111 11111 25889999999999 6886 689999999999999999 889999999999 899999999
Q ss_pred CcCCCCCcCCCCCCccEEEccCCcCcccC-C-CCCCCCCCCCcccCCCCc
Q 005226 227 LSGKIPKSLGNLPVTVSFDLRGNNLSGEI-P-QTGSFANQGPTAFLSNPL 274 (707)
Q Consensus 227 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-p-~~~~~~~~~~~~~~~N~~ 274 (707)
|++ +| .++.+++|+.|+|++|+|++.+ | ....+.++..+.+.+|+.
T Consensus 498 l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 498 LEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp CCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 996 78 8999999999999999999985 4 455677788888888864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.64 E-value=9.2e-17 Score=152.75 Aligned_cols=132 Identities=21% Similarity=0.332 Sum_probs=78.3
Q ss_pred ccCCCCCceEEecCccCCCCCCcccCCC-CCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCC
Q 005226 113 LFNATSLHSIFLYGNNLSGSLPPSVCNL-PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN 191 (707)
Q Consensus 113 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~ 191 (707)
+.++.+|++|+|++|+|+ .+|. +..+ ++|+.|+|++|+|++. ..|.++++|+.|+|++|+|+ .+|..+|..+++
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~ 89 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPD 89 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTT
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCC
Confidence 334444445555555444 2332 2222 2555555555555532 34555555555555555555 556555666777
Q ss_pred ccEEeccCCCCCCCCCc--chhhhhccccEEEeccCcCcCCCCCc----CCCCCCccEEEccCCcCc
Q 005226 192 LVQLDLSDNDFKGPIPN--DLGELQSLSATLNLSYNHLSGKIPKS----LGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 192 L~~L~ls~N~l~~~~p~--~~~~l~~L~~~L~l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~ 252 (707)
|++|+|++|+|+ .+|. .+..+++| +.|++++|.++ .+|.. +..+++|+.||+++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L-~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSL-TYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTC-CEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCC-CEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 777777777775 4555 67777777 67777777777 45653 677777888887777765
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-16 Score=150.95 Aligned_cols=134 Identities=17% Similarity=0.159 Sum_probs=79.2
Q ss_pred CcCCCCCCCEEEcccCCcCCCCCccccCCC-CCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccch
Q 005226 88 ELGSLIYLRRLNLHNNNLFGSLPDQLFNAT-SLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQ 166 (707)
Q Consensus 88 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 166 (707)
.+.++++|++|+|++|+|+. +|. +..+. +|++|+|++|+|++. ..|..+++|+.|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 34455566666666666663 333 33333 666666666666643 45666666666666666666433333466666
Q ss_pred hhhhhhcCCcccccCCC-cccccCCCccEEeccCCCCCCCCCcc----hhhhhccccEEEeccCcCc
Q 005226 167 LQRLILARNKFSGQIPA-GIWPELENLVQLDLSDNDFKGPIPND----LGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 167 L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~~L~l~~N~l~ 228 (707)
|+.|+|++|+|+ .+|. ..+..+++|+.|+|++|.++ .+|.. +..+++| +.||+++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L-~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV-RVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC-SEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc-ceeCCCcCCHH
Confidence 666666666665 5554 23456666777777777766 44543 6666676 57777766654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.62 E-value=9.8e-19 Score=169.87 Aligned_cols=151 Identities=21% Similarity=0.254 Sum_probs=73.5
Q ss_pred CCCCEEEcccCCcCCCCCc------cccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccch
Q 005226 93 IYLRRLNLHNNNLFGSLPD------QLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQ 166 (707)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 166 (707)
..++.++|+.|.+++.+|. .+.++++|++|+|++|+|++ +| .+..+++|+.|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3344444444444444443 45555555555555555553 44 4555555555555555555 34444444455
Q ss_pred hhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC-cchhhhhccccEEEeccCcCcCCCCCc----------C
Q 005226 167 LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP-NDLGELQSLSATLNLSYNHLSGKIPKS----------L 235 (707)
Q Consensus 167 L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~~L~l~~N~l~~~~p~~----------~ 235 (707)
|+.|+|++|+|+ .+| .+..+++|++|+|++|+|++..+ ..+..+++| ++|++++|.+++.+|.. +
T Consensus 95 L~~L~L~~N~l~-~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 170 (198)
T 1ds9_A 95 LEELWISYNQIA-SLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL-EDLLLAGNPLYNDYKENNATSEYRIEVV 170 (198)
T ss_dssp CSEEEEEEEECC-CHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTC-SEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred CCEEECcCCcCC-cCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCC-CEEEecCCccccccccccchHHHHHHHH
Confidence 555555555554 333 13445555555555555552111 244555555 45555555555444432 4
Q ss_pred CCCCCccEEEccCCcCc
Q 005226 236 GNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 236 ~~l~~L~~l~l~~N~l~ 252 (707)
..+++|+.|| +|+++
T Consensus 171 ~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 171 KRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHCSSCSEEC--CGGGT
T ss_pred HhCCCcEEEC--CcccC
Confidence 4555555554 44443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-18 Score=190.11 Aligned_cols=205 Identities=19% Similarity=0.140 Sum_probs=145.1
Q ss_pred CcEEEEEcCCCCccccCCCCcC-----CCCCCCEEEcccCCcCCC----CCccccCCCCCceEEecCccCCCCC-----C
Q 005226 69 PRVVGVAISGKNVRGYIPSELG-----SLIYLRRLNLHNNNLFGS----LPDQLFNATSLHSIFLYGNNLSGSL-----P 134 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~-----p 134 (707)
++++.|+|++|.+....+..+. .+++|++|+|++|.+++. ++..+..+++|++|+|++|+++... +
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 5788999999988765444443 366899999999988864 5677778889999999999887432 2
Q ss_pred cccCCCCCccEEeccCCccccc----CCCCCcccchhhhhhhcCCcccccCC----CcccccCCCccEEeccCCCCCCC-
Q 005226 135 PSVCNLPRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSGQIP----AGIWPELENLVQLDLSDNDFKGP- 205 (707)
Q Consensus 135 ~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~lp----~~~~~~l~~L~~L~ls~N~l~~~- 205 (707)
..+..+++|+.|+|++|+++.. ++..+.++++|+.|+|++|++++..+ ..+....++|++|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 3334678899999999988854 56777778889999999988863222 12222336888888888888754
Q ss_pred ---CCcchhhhhccccEEEeccCcCcCCCCCcCCC-----CCCccEEEccCCcCcc----cCCC-CCCCCCCCCcccCCC
Q 005226 206 ---IPNDLGELQSLSATLNLSYNHLSGKIPKSLGN-----LPVTVSFDLRGNNLSG----EIPQ-TGSFANQGPTAFLSN 272 (707)
Q Consensus 206 ---~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~----~~p~-~~~~~~~~~~~~~~N 272 (707)
++..+..+++| ++|+|++|.+++..+..+.. .++|+.|++++|++++ .+|. .....++..+.+.+|
T Consensus 330 ~~~l~~~l~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N 408 (461)
T 1z7x_W 330 CSHFSSVLAQNRFL-LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408 (461)
T ss_dssp HHHHHHHHHHCSSC-CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSS
T ss_pred HHHHHHHHhhCCCc-cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCC
Confidence 45566677888 68888888887654444432 6688888888888875 4442 123456666777777
Q ss_pred Cc
Q 005226 273 PL 274 (707)
Q Consensus 273 ~~ 274 (707)
+.
T Consensus 409 ~i 410 (461)
T 1z7x_W 409 CL 410 (461)
T ss_dssp SC
T ss_pred CC
Confidence 53
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=160.37 Aligned_cols=135 Identities=11% Similarity=0.092 Sum_probs=97.9
Q ss_pred ccceecccCeeEEEEEEeCCCceEEEEEcCCCch--------------hhHH--------HHHHHHHHHHhcCCCceeee
Q 005226 411 SAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--------------QRHR--------EFVTEVQAIAKVKHPNIVKL 468 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~niv~l 468 (707)
....||+|+||.||+|...+|+.||||+++.... .... ...+|...|.++.+.++.-.
T Consensus 99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 3568999999999999999999999998653210 0001 12356777777755544222
Q ss_pred EEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC
Q 005226 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548 (707)
Q Consensus 469 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~ 548 (707)
.-+.. ...++||||+++++|.++... .....++.|++.+|.|||+ .+||||||||.|||+++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 11111 245899999999888665421 1235688999999999999 8999999999999998876
Q ss_pred ----------CeEEecccccccc
Q 005226 549 ----------QPYISDFGLSRLI 561 (707)
Q Consensus 549 ----------~~kl~DfGla~~~ 561 (707)
.+.|+||+.+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-18 Score=169.39 Aligned_cols=151 Identities=22% Similarity=0.275 Sum_probs=130.9
Q ss_pred CcEEEEEcCCCCccccCCC------CcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPS------ELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPR 142 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 142 (707)
.+++.++|+++.+.|.+|. .|..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4566777778888887776 89999999999999999996 67 8999999999999999999 78888888899
Q ss_pred ccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCC-cccccCCCccEEeccCCCCCCCCCcc----------hh
Q 005226 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA-GIWPELENLVQLDLSDNDFKGPIPND----------LG 211 (707)
Q Consensus 143 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~ls~N~l~~~~p~~----------~~ 211 (707)
|+.|+|++|++++ +| .+.++++|+.|+|++|+|+ .++. ..+..+++|++|++++|.+++.+|.. +.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC-chhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 9999999999995 55 6899999999999999998 5554 45678999999999999998766653 88
Q ss_pred hhhccccEEEeccCcCc
Q 005226 212 ELQSLSATLNLSYNHLS 228 (707)
Q Consensus 212 ~l~~L~~~L~l~~N~l~ 228 (707)
.+++| +.|| +|.++
T Consensus 172 ~l~~L-~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNL-KKLD--GMPVD 185 (198)
T ss_dssp HCSSC-SEEC--CGGGT
T ss_pred hCCCc-EEEC--CcccC
Confidence 89999 7776 77776
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-18 Score=188.62 Aligned_cols=203 Identities=15% Similarity=0.123 Sum_probs=159.2
Q ss_pred CcEEEEEcCCCCcccc----CCCCcCCCCCCCEEEcccCCcCCCCCcccc-----CCCCCceEEecCccCCCC----CCc
Q 005226 69 PRVVGVAISGKNVRGY----IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-----NATSLHSIFLYGNNLSGS----LPP 135 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~ 135 (707)
.+++.|+|++|++++. ++..+..+++|++|+|++|.++...+..+. .+++|++|+|++|+++.. ++.
T Consensus 142 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 221 (461)
T 1z7x_W 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCG 221 (461)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHH
T ss_pred CcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHH
Confidence 4799999999999974 366677889999999999998855444443 367999999999999964 577
Q ss_pred ccCCCCCccEEeccCCcccccC-----CCCCcccchhhhhhhcCCccccc----CCCcccccCCCccEEeccCCCCCCCC
Q 005226 136 SVCNLPRLQNLDLSNNSFSGSL-----PDGLKNCKQLQRLILARNKFSGQ----IPAGIWPELENLVQLDLSDNDFKGPI 206 (707)
Q Consensus 136 ~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~~L~ls~N~l~~~~ 206 (707)
.+..+++|+.|+|++|+++..- +..+..+++|+.|+|++|++++. ++.. +..+++|++|+|++|.+++..
T Consensus 222 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~~~~L~~L~Ls~n~i~~~~ 300 (461)
T 1z7x_W 222 IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV-LRAKESLKELSLAGNELGDEG 300 (461)
T ss_dssp HHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH-HHHCTTCCEEECTTCCCHHHH
T ss_pred HHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH-HhhCCCcceEECCCCCCchHH
Confidence 8888999999999999998542 23334689999999999999832 4544 467899999999999998665
Q ss_pred Ccchhhh-----hccccEEEeccCcCcCC----CCCcCCCCCCccEEEccCCcCcccCCCC------CCCCCCCCcccCC
Q 005226 207 PNDLGEL-----QSLSATLNLSYNHLSGK----IPKSLGNLPVTVSFDLRGNNLSGEIPQT------GSFANQGPTAFLS 271 (707)
Q Consensus 207 p~~~~~l-----~~L~~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~p~~------~~~~~~~~~~~~~ 271 (707)
+..+... ++| ++|+|++|.+++. ++..+..+++|+.|++++|++++..+.. ....++..+.+.+
T Consensus 301 ~~~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~ 379 (461)
T 1z7x_W 301 ARLLCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379 (461)
T ss_dssp HHHHHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred HHHHHHHhccCCccc-eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence 5556554 588 8999999999965 5667778899999999999998653311 0134666777777
Q ss_pred CC
Q 005226 272 NP 273 (707)
Q Consensus 272 N~ 273 (707)
|.
T Consensus 380 n~ 381 (461)
T 1z7x_W 380 CD 381 (461)
T ss_dssp SC
T ss_pred CC
Confidence 74
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.57 E-value=6.6e-15 Score=139.46 Aligned_cols=113 Identities=23% Similarity=0.330 Sum_probs=67.0
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCc
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNS 152 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 152 (707)
.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4666777765 4454443 566666666666665555566666666666666666664433444555555555555555
Q ss_pred ccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhh
Q 005226 153 FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQ 214 (707)
Q Consensus 153 l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 214 (707)
|+ .+|...|..+++|++|+|++|.+. -.+..+..+.
T Consensus 93 l~-------------------------~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~~~~l~ 128 (174)
T 2r9u_A 93 LK-------------------------SIPRGAFDNLKSLTHIYLYNNPWD-CECRDIMYLR 128 (174)
T ss_dssp CC-------------------------CCCTTTTTTCTTCSEEECCSSCBC-TTBGGGHHHH
T ss_pred cc-------------------------eeCHHHhccccCCCEEEeCCCCcc-cccccHHHHH
Confidence 55 555555567777777777777776 3444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=8e-15 Score=138.37 Aligned_cols=103 Identities=25% Similarity=0.338 Sum_probs=62.5
Q ss_pred EEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcc
Q 005226 74 VAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153 (707)
Q Consensus 74 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 153 (707)
|++++|+++. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|
T Consensus 14 l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 4455566663 454442 5666666666666665566666666666666666666644444555566666666665555
Q ss_pred cccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCC
Q 005226 154 SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 154 ~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~ 204 (707)
+ .+|...|..+++|++|+|++|.++.
T Consensus 91 ~-------------------------~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 91 K-------------------------SIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp C-------------------------CCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred C-------------------------EeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 5 4555555666777777777777763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=5.6e-15 Score=155.29 Aligned_cols=183 Identities=13% Similarity=0.082 Sum_probs=149.0
Q ss_pred CcEEEEEcCCCCcc--------------------ccCCCCcCC--------CCCCCEEEcccCCcCCCCCccccCCCCCc
Q 005226 69 PRVVGVAISGKNVR--------------------GYIPSELGS--------LIYLRRLNLHNNNLFGSLPDQLFNATSLH 120 (707)
Q Consensus 69 ~~v~~L~L~~n~l~--------------------~~~~~~l~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 120 (707)
++++.|||++|+|. .+.+..|.+ +++|+.|+|.+ +++.+-+..|.++++|+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~ 127 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK 127 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence 57889999999888 334556777 99999999999 88877778899999999
Q ss_pred eEEecCccCCCCCCcccCCCCCccEEeccCCcc----cccCCCCC-----------------------------------
Q 005226 121 SIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF----SGSLPDGL----------------------------------- 161 (707)
Q Consensus 121 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l----~~~~p~~~----------------------------------- 161 (707)
.|+|++|.+....+..|..+.++..+.++.+.. .......|
T Consensus 128 ~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l 207 (329)
T 3sb4_A 128 ICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFL 207 (329)
T ss_dssp EEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEE
T ss_pred eEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceE
Confidence 999999999877778888888888887766332 00000111
Q ss_pred ---------------cccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhcccc-EEEeccC
Q 005226 162 ---------------KNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSA-TLNLSYN 225 (707)
Q Consensus 162 ---------------~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~-~L~l~~N 225 (707)
..+++|+.|+|++|+++ .||...|.++.+|+.|+|.+| ++...+..|.++++| + .|++.+
T Consensus 208 ~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L-~~~l~l~~- 283 (329)
T 3sb4_A 208 TIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRL-AGTLELPA- 283 (329)
T ss_dssp EEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC-CEEEEECT-
T ss_pred EEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhc-cEEEEEcc-
Confidence 02789999999999999 999999999999999999998 886777889999999 8 999998
Q ss_pred cCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 226 HLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 226 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
.++..-+.+|.++++|+.+++++|+++...+
T Consensus 284 ~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~ 314 (329)
T 3sb4_A 284 SVTAIEFGAFMGCDNLRYVLATGDKITTLGD 314 (329)
T ss_dssp TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence 7876778999999999999999999986655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=1.3e-14 Score=136.86 Aligned_cols=104 Identities=30% Similarity=0.415 Sum_probs=56.2
Q ss_pred ceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccC
Q 005226 120 HSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199 (707)
Q Consensus 120 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~ 199 (707)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCC
Confidence 34455555554 3444332 45555555555555444444444444444444444444 55655566666666666666
Q ss_pred CCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 200 NDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 200 N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
|+|++..+..|.++++| +.|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L-~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSL-THIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTC-CEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCC-CEEEeCCCCCC
Confidence 66665444455555555 45555555555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=135.90 Aligned_cols=86 Identities=33% Similarity=0.453 Sum_probs=50.3
Q ss_pred CCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEE
Q 005226 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATL 220 (707)
Q Consensus 141 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L 220 (707)
++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+ .+|...|..+++|++|+|++|+|++..+..|..+++| +.|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L-~~L 110 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSL-THI 110 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-SEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCCCccceeCHHHhccccCC-CEE
Confidence 44444555555444443444444444444444444444 5666666677777777777777775444456666666 566
Q ss_pred EeccCcCc
Q 005226 221 NLSYNHLS 228 (707)
Q Consensus 221 ~l~~N~l~ 228 (707)
+|++|.+.
T Consensus 111 ~L~~N~~~ 118 (174)
T 2r9u_A 111 YLYNNPWD 118 (174)
T ss_dssp ECCSSCBC
T ss_pred EeCCCCcc
Confidence 66666666
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.46 E-value=7.5e-14 Score=146.68 Aligned_cols=200 Identities=14% Similarity=0.110 Sum_probs=145.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCC-CCCCCEEEcccCCcC--------------------CCCCccccC--------CCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGS-LIYLRRLNLHNNNLF--------------------GSLPDQLFN--------ATSL 119 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~-l~~L~~L~L~~N~l~--------------------~~~p~~~~~--------l~~L 119 (707)
.+++.|.++++ +...--..+.. +++|+.|||++|+|. .+.+..|.+ +++|
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L 103 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTL 103 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTC
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCC
Confidence 46778888764 21111112223 889999999999998 233456777 9999
Q ss_pred ceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCccc---ccCCCccc----------
Q 005226 120 HSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS---GQIPAGIW---------- 186 (707)
Q Consensus 120 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~lp~~~~---------- 186 (707)
+.|+|.+ +++.+-+.+|.++++|+.|+|++|.+....+..|.++.++..+.+..+... ..+....|
T Consensus 104 ~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i 182 (329)
T 3sb4_A 104 EKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTI 182 (329)
T ss_dssp CC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEE
T ss_pred cEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeE
Confidence 9999999 888677778999999999999999998777888999888887776663220 01111111
Q ss_pred ----------------------------------------ccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCc
Q 005226 187 ----------------------------------------PELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNH 226 (707)
Q Consensus 187 ----------------------------------------~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~ 226 (707)
..+++|+.|+|++|+++...+..|.++++| +.|+|.+|
T Consensus 183 ~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L-~~l~l~~n- 260 (329)
T 3sb4_A 183 QVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL-LKIKLPHN- 260 (329)
T ss_dssp EECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC-CEEECCTT-
T ss_pred EecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC-CEEECCcc-
Confidence 127899999999999997777789999999 89999998
Q ss_pred CcCCCCCcCCCCCCcc-EEEccCCcCcccCCCC-CCCCCCCCcccCCCC
Q 005226 227 LSGKIPKSLGNLPVTV-SFDLRGNNLSGEIPQT-GSFANQGPTAFLSNP 273 (707)
Q Consensus 227 l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~p~~-~~~~~~~~~~~~~N~ 273 (707)
++..-+.+|.++++|+ .+++.+ .++...+.. ....++..+.+.+|.
T Consensus 261 i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~ 308 (329)
T 3sb4_A 261 LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDK 308 (329)
T ss_dssp CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSC
T ss_pred cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCc
Confidence 8877788999999999 999998 676444421 122344445554443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.5e-13 Score=145.57 Aligned_cols=109 Identities=24% Similarity=0.270 Sum_probs=77.9
Q ss_pred CceeceeEeCCCCCCCCCcEEEEEcCCC-CccccCCCCcCCCCCCCEEEccc-CCcCCCCCccccCCCCCceEEecCccC
Q 005226 52 PCRWSGISCMNITGFPDPRVVGVAISGK-NVRGYIPSELGSLIYLRRLNLHN-NNLFGSLPDQLFNATSLHSIFLYGNNL 129 (707)
Q Consensus 52 ~C~w~gv~c~~~~~~~~~~v~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l 129 (707)
.|.|..|.|.+ + +|++ +|. |..+++|++|+|++ |+|++..+..|.+|++|++|+|++|+|
T Consensus 7 ~C~~~~v~~~~----------------~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 68 (347)
T 2ifg_A 7 PHGSSGLRCTR----------------DGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68 (347)
T ss_dssp CSSSSCEECCS----------------SCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCC
T ss_pred cccCCEEEcCC----------------CCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcc
Confidence 47777777743 3 5664 566 88888888888885 888877667777777777777777777
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCC
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~ 204 (707)
++..|..|.+|++|+.|+|++|+|+ .+|...|..++ |+.|+|++|.|..
T Consensus 69 ~~~~~~~~~~l~~L~~L~l~~N~l~-------------------------~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 69 RFVAPDAFHFTPRLSRLNLSFNALE-------------------------SLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CEECTTGGGSCSCCCEEECCSSCCS-------------------------CCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ceeCHHHhcCCcCCCEEeCCCCccc-------------------------eeCHHHcccCC-ceEEEeeCCCccC
Confidence 7777777777777777777777776 44444444444 7777777777763
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=2.3e-13 Score=144.06 Aligned_cols=103 Identities=20% Similarity=0.189 Sum_probs=68.0
Q ss_pred EEecCc-cCCCCCCcccCCCCCccEEeccC-CcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccC
Q 005226 122 IFLYGN-NLSGSLPPSVCNLPRLQNLDLSN-NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSD 199 (707)
Q Consensus 122 L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~ 199 (707)
+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|+ .+|...|..+++|+.|+|++
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc-eeCHHHhcCCcCCCEEeCCC
Confidence 344444 444 3444 55555555555553 5555444455555555555555555555 56666678999999999999
Q ss_pred CCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 200 NDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 200 N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
|+|++..+..|..++ | +.|+|++|.|..
T Consensus 90 N~l~~~~~~~~~~~~-L-~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-L-QELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCC-C-CEEECCSSCCCC
T ss_pred CccceeCHHHcccCC-c-eEEEeeCCCccC
Confidence 999976666666665 7 899999999983
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-15 Score=157.33 Aligned_cols=134 Identities=17% Similarity=0.144 Sum_probs=67.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCC-----CCCCCEEEcccCCcCCCCCccc-cCCCCCceEEecCccCCCCCCccc-----
Q 005226 69 PRVVGVAISGKNVRGYIPSELGS-----LIYLRRLNLHNNNLFGSLPDQL-FNATSLHSIFLYGNNLSGSLPPSV----- 137 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~----- 137 (707)
.+++.|+|++|.|+......|.. .++|++|+|++|.|+..-...+ ..+++|++|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 35667777777766533222222 2567777777776653222222 234566677777776653322222
Q ss_pred CCCCCccEEeccCCcccc----cCCCCCcccchhhhhhhcCCccccc----CCCcccccCCCccEEeccCCCCC
Q 005226 138 CNLPRLQNLDLSNNSFSG----SLPDGLKNCKQLQRLILARNKFSGQ----IPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 138 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|+|++. ++. .+...++|+.|+|++|.|+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~-~L~~~~~L~~L~Ls~N~i~ 224 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA-QLDRNRQLQELNVAYNGAG 224 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH-HGGGCSCCCEEECCSSCCC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH-HHhcCCCcCeEECCCCCCC
Confidence 234566666666666653 1223334455555555555555411 111 1233445555555555554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.25 E-value=2.3e-14 Score=152.81 Aligned_cols=161 Identities=21% Similarity=0.231 Sum_probs=119.6
Q ss_pred CCCCCEEEcccCCcCCCCCccccC-----CCCCceEEecCccCCCCCCccc-CCCCCccEEeccCCcccccCCCCC----
Q 005226 92 LIYLRRLNLHNNNLFGSLPDQLFN-----ATSLHSIFLYGNNLSGSLPPSV-CNLPRLQNLDLSNNSFSGSLPDGL---- 161 (707)
Q Consensus 92 l~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~---- 161 (707)
+++|+.|+|++|.|+......+.. .++|++|+|++|.|+......+ ..+++|+.|+|++|+|+..-...+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 467999999999998544444433 3799999999999974333333 346789999999999975433333
Q ss_pred -cccchhhhhhhcCCccccc----CCCcccccCCCccEEeccCCCCCCC----CCcchhhhhccccEEEeccCcCcCC--
Q 005226 162 -KNCKQLQRLILARNKFSGQ----IPAGIWPELENLVQLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSGK-- 230 (707)
Q Consensus 162 -~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~~-- 230 (707)
...++|+.|+|++|+|+.. ++.. +..+++|++|+|++|.|++. ++..+...++| ++|+|++|.|+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~-L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L-~~L~Ls~N~i~~~g~ 228 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLMEG-LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL-QELNVAYNGAGDTAA 228 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHHHH-HHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCC-CEEECCSSCCCHHHH
T ss_pred HhcCCccceeeCCCCCCChHHHHHHHHH-HhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCc-CeEECCCCCCCHHHH
Confidence 2457899999999999721 2222 25688999999999999743 24556677888 7999999999852
Q ss_pred --CCCcCCCCCCccEEEccCCcCccc
Q 005226 231 --IPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 231 --~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
++..+...++|+.|+|++|+|+..
T Consensus 229 ~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 229 LALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp HHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 344455678999999999999753
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.23 E-value=3.1e-11 Score=129.79 Aligned_cols=170 Identities=11% Similarity=0.101 Sum_probs=76.4
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
+++.+.|.++ ++.+-..+|.+. +|+.+.|.+ .++.+-+..|.++++|+.++|++|+++......|. ..+|+.+.|.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 3444444433 443434444442 355555543 34433444455555555555555555422222232 3445555544
Q ss_pred CCcccccCCCCCcccchhhhhhhcC---------------------CcccccCCCcccccCCCccEEeccCCCCC-----
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILAR---------------------NKFSGQIPAGIWPELENLVQLDLSDNDFK----- 203 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~---------------------N~l~~~lp~~~~~~l~~L~~L~ls~N~l~----- 203 (707)
+| ++..-..+|.++++|+.++|.. |.++ .|+...|..+++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L~~i~lp~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~ 289 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGITTVKLPNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEA 289 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCCSEEEEETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTC
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCCccCccccccccCCccEEEeCCCcc-EEChhHhhCCCCCCEEEeCCccccCCccc
Confidence 22 3333334444444444444443 3333 444444555555555555544443
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEcc
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 247 (707)
...+..|.++++| +.++|. |.++..-..+|.++++|+.+++.
T Consensus 290 ~I~~~aF~~c~~L-~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp 331 (401)
T 4fdw_A 290 MIHPYCLEGCPKL-ARFEIP-ESIRILGQGLLGGNRKVTQLTIP 331 (401)
T ss_dssp EECTTTTTTCTTC-CEECCC-TTCCEECTTTTTTCCSCCEEEEC
T ss_pred EECHHHhhCCccC-CeEEeC-CceEEEhhhhhcCCCCccEEEEC
Confidence 2233444555555 455554 22443334444555555555553
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=4.3e-11 Score=121.14 Aligned_cols=135 Identities=15% Similarity=0.088 Sum_probs=105.9
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
.++.|+++.||++... +..+++|+...........+.+|+++++.+ .|..+.++++++...+..++||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 4667778899999864 678999998653222235688999999999 46778899999998888999999999999987
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS-------------------------------------------- 528 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------------- 528 (707)
.+... .....++.+++++|..||+..
T Consensus 100 ~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 100 EYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred ccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 64211 123478889999999999821
Q ss_pred ------------CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 ------------PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ------------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876667899999764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.17 E-value=9.5e-11 Score=125.99 Aligned_cols=178 Identities=10% Similarity=0.140 Sum_probs=124.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.+.|.+ ++..+-+..|.++++|+.++|++|+++.+....|. ..+|+.+.|..| ++.+-..+|.++++|+.++|
T Consensus 157 ~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 157 STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 3566666664 55555566677777777777776666633232332 455555555432 44333344444444444444
Q ss_pred cC---------------------CcccccCCCCCcccchhhhhhhcCCccc----ccCCCcccccCCCccEEeccCCCCC
Q 005226 149 SN---------------------NSFSGSLPDGLKNCKQLQRLILARNKFS----GQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 149 s~---------------------N~l~~~~p~~~~~l~~L~~L~l~~N~l~----~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
.. |.++..-+..|.+|++|+.+++.+|.+. ..|+...|..+++|+.++|. |.++
T Consensus 234 ~~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~ 312 (401)
T 4fdw_A 234 PENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR 312 (401)
T ss_dssp CTTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC
T ss_pred CCCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE
Confidence 43 3455455678999999999999998874 24889999999999999999 5588
Q ss_pred CCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 204 GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 204 ~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
..-...|.++++| +.+.|.+| ++..-+.+|.++ +|+.+++++|.+..
T Consensus 313 ~I~~~aF~~c~~L-~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~ 359 (401)
T 4fdw_A 313 ILGQGLLGGNRKV-TQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ 359 (401)
T ss_dssp EECTTTTTTCCSC-CEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred EEhhhhhcCCCCc-cEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence 6777899999999 79999665 776778899999 99999999997764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.17 E-value=7.3e-13 Score=150.70 Aligned_cols=175 Identities=13% Similarity=0.004 Sum_probs=100.5
Q ss_pred CcEEEEEcCCCCcccc----CCCCcCCCCCCCEEEcccCCcCC----CCCccccCCCCCceEEecCccCCCCCCcccCCC
Q 005226 69 PRVVGVAISGKNVRGY----IPSELGSLIYLRRLNLHNNNLFG----SLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNL 140 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 140 (707)
++++.|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.++++|++|+|++|.+.+ +|..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhh
Confidence 5788899999987765 33345678888999999888873 334445678889999998888873 66677777
Q ss_pred CCccEEeccCCccc---ccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC-cchhhhhcc
Q 005226 141 PRLQNLDLSNNSFS---GSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP-NDLGELQSL 216 (707)
Q Consensus 141 ~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L 216 (707)
++|+.|+++++... +..+..+..+++|+.|+++++... .+|. ++..+++|++|+|++|.+++... ..+..+++|
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~-~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPI-LFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGG-GGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHH-HHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 77777777643322 122334455555555555554332 3333 23445555555555555443222 123445555
Q ss_pred ccEEEeccCcCcCCCCCcCCCCCCccEEEcc
Q 005226 217 SATLNLSYNHLSGKIPKSLGNLPVTVSFDLR 247 (707)
Q Consensus 217 ~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 247 (707)
+.|++++|...+.++..+..+++|+.|+++
T Consensus 321 -~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 321 -EVLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp -CEEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred -CEEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 455555222222222222344455555555
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.16 E-value=6e-13 Score=151.41 Aligned_cols=196 Identities=13% Similarity=0.063 Sum_probs=146.3
Q ss_pred cEEEEEcCCCC-ccc-cCCCCcCCCCCCCEEEcccCCcCCC----CCccccCCCCCceEEecCccCCC----CCCcccCC
Q 005226 70 RVVGVAISGKN-VRG-YIPSELGSLIYLRRLNLHNNNLFGS----LPDQLFNATSLHSIFLYGNNLSG----SLPPSVCN 139 (707)
Q Consensus 70 ~v~~L~L~~n~-l~~-~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~ 139 (707)
+++.|+|+++. ++. .++..+.++++|++|+|++|.+++. ++..+.++++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999987 221 1222334789999999999998866 44456678999999999999983 34455678
Q ss_pred CCCccEEeccCCcccccCCCCCcccchhhhhhhcCCccc---ccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhcc
Q 005226 140 LPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFS---GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSL 216 (707)
Q Consensus 140 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~---~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 216 (707)
+++|+.|+|++|.+.+ +|..+.++++|+.|+++++... +..+.. +..+++|+.|+++++... .+|..+..+++|
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~-l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L 295 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMN-LVFPRKLCRLGLSYMGPN-EMPILFPFAAQI 295 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSC-CCCCTTCCEEEETTCCTT-TGGGGGGGGGGC
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHH-hhccccccccCccccchh-HHHHHHhhcCCC
Confidence 9999999999999995 7788999999999999864332 122223 367889999999997554 788899999999
Q ss_pred ccEEEeccCcCcCCCC-CcCCCCCCccEEEccCCcCcc-cCCCC-CCCCCCCCcccC
Q 005226 217 SATLNLSYNHLSGKIP-KSLGNLPVTVSFDLRGNNLSG-EIPQT-GSFANQGPTAFL 270 (707)
Q Consensus 217 ~~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~-~~p~~-~~~~~~~~~~~~ 270 (707)
++|+|++|.+++... ..+..+++|+.|+++ |.+.. .++.. ..+.++..+.+.
T Consensus 296 -~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 296 -RKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp -CEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred -cEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEee
Confidence 899999999875443 346789999999999 54442 22211 123455555555
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=1e-10 Score=118.04 Aligned_cols=127 Identities=15% Similarity=0.102 Sum_probs=97.9
Q ss_pred ccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc--eeeeEEEEEcCCcceEEEEeecCCChHHHH
Q 005226 417 KSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN--IVKLRAYYWAPDEKLLISDFISNGNLANAL 494 (707)
Q Consensus 417 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l 494 (707)
.|..+.||++...+|..+++|..... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|. .
T Consensus 30 gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 30 GCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp TTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred CCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 45569999998877888999997654 2256788999999996544 556888888878889999999998884 2
Q ss_pred hCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------------
Q 005226 495 RGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS---------------------------------------------- 528 (707)
Q Consensus 495 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------------- 528 (707)
.. .+ ...++.++++.|..||+..
T Consensus 105 ~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 SH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred Cc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 11 11 2367788888888888742
Q ss_pred ---------CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 ---------PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ---------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+..++|+|++|.||+++++..++|+|||.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667899999865
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=5.3e-13 Score=151.87 Aligned_cols=201 Identities=14% Similarity=0.137 Sum_probs=137.1
Q ss_pred CcEEEEEcCCCCccccC-CCCcCCCCCCCEEEcccCCcCCC-CCccccCCCCCceEEecC---------ccCCCCCCccc
Q 005226 69 PRVVGVAISGKNVRGYI-PSELGSLIYLRRLNLHNNNLFGS-LPDQLFNATSLHSIFLYG---------NNLSGSLPPSV 137 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~---------N~l~~~~p~~~ 137 (707)
++++.|+|++|.+++.. +..+.++++|++|+|++| ++.. ++.....+++|++|+|++ |.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 57899999999877543 223568899999999988 4422 222233588899998843 45553322233
Q ss_pred C-CCCCccEEeccCCcccccCCCCCc-ccchhhhhhhc--C----CcccccCCCc-----ccccCCCccEEeccCCCCCC
Q 005226 138 C-NLPRLQNLDLSNNSFSGSLPDGLK-NCKQLQRLILA--R----NKFSGQIPAG-----IWPELENLVQLDLSDNDFKG 204 (707)
Q Consensus 138 ~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~--~----N~l~~~lp~~-----~~~~l~~L~~L~ls~N~l~~ 204 (707)
. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |+++ ..|.. ++..+++|+.|+|++ .+++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 3 478899999988988865555554 58899999998 4 5666 44321 246788999999977 6765
Q ss_pred CCCcchhh-hhccccEEEeccCcCcCCCCCcC-CCCCCccEEEccCCcCcccCCC--CCCCCCCCCcccCCCC
Q 005226 205 PIPNDLGE-LQSLSATLNLSYNHLSGKIPKSL-GNLPVTVSFDLRGNNLSGEIPQ--TGSFANQGPTAFLSNP 273 (707)
Q Consensus 205 ~~p~~~~~-l~~L~~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~~~~p~--~~~~~~~~~~~~~~N~ 273 (707)
..+..+.. +++| +.|+|++|.+++..+..+ ..+++|+.|++++|++++.... ...+.++..+.+.+|+
T Consensus 446 ~~~~~l~~~~~~L-~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 446 KVFEYIGTYAKKM-EMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHHHHHCTTC-CEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHHHHHHhchhc-cEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 55556665 7788 799999999876544444 5688999999999998653321 1234556666666554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.00 E-value=9.8e-13 Score=149.69 Aligned_cols=182 Identities=14% Similarity=0.146 Sum_probs=133.0
Q ss_pred CcEEEEEcCCCCcccc-CCCCcCCCCCCCEEEcc---------cCCcCCCCCcccc-CCCCCceEEecCccCCCCCCccc
Q 005226 69 PRVVGVAISGKNVRGY-IPSELGSLIYLRRLNLH---------NNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSV 137 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~ 137 (707)
++++.|+|++| +... ++.....+++|++|+|+ .|.+++.....+. ++++|++|+++.|++++..+..+
T Consensus 314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l 392 (594)
T 2p1m_B 314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI 392 (594)
T ss_dssp TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence 68999999988 4432 22223458999999994 3555533223333 48999999999999986666666
Q ss_pred C-CCCCccEEecc--C----Cccccc-----CCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCC
Q 005226 138 C-NLPRLQNLDLS--N----NSFSGS-----LPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 138 ~-~l~~L~~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~ 205 (707)
. .+++|+.|+|+ + |.++.. ++..+.++++|+.|+|++ .+++..+..+...+++|++|+|++|.+++.
T Consensus 393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 5 58999999999 4 566521 122266789999999977 666444444444489999999999999865
Q ss_pred CCcch-hhhhccccEEEeccCcCcCCCCC-cCCCCCCccEEEccCCcCcc
Q 005226 206 IPNDL-GELQSLSATLNLSYNHLSGKIPK-SLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 206 ~p~~~-~~l~~L~~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~ 253 (707)
.+..+ .++++| +.|+|++|.+++..+. .+..+++|+.|++++|+++.
T Consensus 472 ~~~~l~~~~~~L-~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 472 GMHHVLSGCDSL-RKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp HHHHHHHHCTTC-CEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred HHHHHHhcCCCc-CEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 55555 678999 8999999999754443 34558999999999999853
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.1e-09 Score=116.27 Aligned_cols=139 Identities=18% Similarity=0.200 Sum_probs=105.1
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcC--CCc-hhhHHHHHHHHHHHHhcC--CCceeeeEEEEEcC---CcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLG--EGG-EQRHREFVTEVQAIAKVK--HPNIVKLRAYYWAP---DEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~e~~ 485 (707)
.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.++ +..+.++++++.+. +..++||||+
T Consensus 45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 58889999999998755 577888775 332 122357888999999996 45678899888766 4579999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS------------------------------------- 528 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 528 (707)
+|..+.+.. ...++..++..++.++++.|..||+..
T Consensus 124 ~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 124 SGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred CCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 987774321 124778889999999999999999731
Q ss_pred ------------------CCCceecCCCCCCeEEcCCCC--eEEeccccccc
Q 005226 529 ------------------PRKFVHGDIKPSNILLDNDFQ--PYISDFGLSRL 560 (707)
Q Consensus 529 ------------------~~~iiHrDlk~~NIll~~~~~--~kl~DfGla~~ 560 (707)
+..++|+|+++.||+++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 69999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.94 E-value=7.9e-11 Score=124.38 Aligned_cols=180 Identities=17% Similarity=0.211 Sum_probs=119.1
Q ss_pred CcEEEEEcCCCCccc-c-------CCCCcCCCCCCCEEEcccCCcC---------CCCCccccCCCCCceEEecCcc-CC
Q 005226 69 PRVVGVAISGKNVRG-Y-------IPSELGSLIYLRRLNLHNNNLF---------GSLPDQLFNATSLHSIFLYGNN-LS 130 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~-~-------~~~~l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~-l~ 130 (707)
.+|+.|.+......| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|. +.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~ 186 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS 186 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce
Confidence 467788877665442 1 1334566788999988765432 1244455677899999998883 32
Q ss_pred CCCCcccCCCCCccEEeccCCcccccCCCCCc--ccchhhhhhhcC--Cccccc-----CCCccc-ccCCCccEEeccCC
Q 005226 131 GSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLK--NCKQLQRLILAR--NKFSGQ-----IPAGIW-PELENLVQLDLSDN 200 (707)
Q Consensus 131 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~-----lp~~~~-~~l~~L~~L~ls~N 200 (707)
++. +. +++|+.|+|..|.+.......+. .+++|+.|+|+. |...|. +...+. ..+++|++|+|++|
T Consensus 187 --l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~ 262 (362)
T 2ra8_A 187 --IGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262 (362)
T ss_dssp --CCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESC
T ss_pred --ecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCC
Confidence 333 43 78899999988887643333333 678888888853 222111 111111 24789999999999
Q ss_pred CCCCCCCcchh---hhhccccEEEeccCcCcCC----CCCcCCCCCCccEEEccCCcCcc
Q 005226 201 DFKGPIPNDLG---ELQSLSATLNLSYNHLSGK----IPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 201 ~l~~~~p~~~~---~l~~L~~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
.+.+..+..+. .+++| ++|+|+.|.|+.. ++..+..+++|+.|++++|.++.
T Consensus 263 ~i~~~~~~~la~a~~~~~L-~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 263 EEQNVVVEMFLESDILPQL-ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TTHHHHHHHHHHCSSGGGC-SEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCchHHHHHHHhCccCCCC-CEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 98754444444 37788 7999999998853 45555567899999999998874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.5e-12 Score=127.99 Aligned_cols=120 Identities=18% Similarity=0.141 Sum_probs=53.8
Q ss_pred CceeceeEeCCCCCCCCCcEEEEEcCC---CCccccC-CCCcCCCCCCCEEEcccCCcCCCCCc-cccCCCCCce--EEe
Q 005226 52 PCRWSGISCMNITGFPDPRVVGVAISG---KNVRGYI-PSELGSLIYLRRLNLHNNNLFGSLPD-QLFNATSLHS--IFL 124 (707)
Q Consensus 52 ~C~w~gv~c~~~~~~~~~~v~~L~L~~---n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~--L~L 124 (707)
.|.|.|+.|.... .+|..+...+ ..+.+.+ |+.+..++. .|...+|.-++.++- .|...+.|+. +++
T Consensus 77 l~~~~g~i~~~~~----~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l 150 (267)
T 3rw6_A 77 LKAVNYKILDREN----RRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDV 150 (267)
T ss_dssp HHHTTSSCBCTTS----CBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCC
T ss_pred HHhcCcEEECCCC----CEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccc
Confidence 5889999998522 3555444433 2222222 222222221 222333333322221 1344444544 555
Q ss_pred cCccCCCCCCc----ccCCCCCccEEeccCCcccc--cCCCCCcccchhhhhhhcCCccc
Q 005226 125 YGNNLSGSLPP----SVCNLPRLQNLDLSNNSFSG--SLPDGLKNCKQLQRLILARNKFS 178 (707)
Q Consensus 125 ~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~ 178 (707)
+.|+.. .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 151 ~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 151 VLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp CTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred cCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 656433 2221 12345666666666666664 22333444444444444444444
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=1.4e-09 Score=112.54 Aligned_cols=194 Identities=18% Similarity=0.149 Sum_probs=122.0
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCc--eeeeEEEEEcCC---cceEEEEeecC
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPN--IVKLRAYYWAPD---EKLLISDFISN 487 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lV~e~~~~ 487 (707)
.++.|....||+.. ..+++|..... .....+.+|+++++.+ .+.. +.+++......+ ..|+||+|++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 58899999999863 56888885432 2346788999999988 4433 344554443333 34899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS--------------------------------------- 528 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------------- 528 (707)
.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 888754331 3677788888999999999998621
Q ss_pred ----------------CCCceecCCCCCCeEEcC--CCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCcccccc-
Q 005226 529 ----------------PRKFVHGDIKPSNILLDN--DFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK- 589 (707)
Q Consensus 529 ----------------~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g- 589 (707)
+..++|+|++|.||++++ ...+.|+||+.+..-....+....... . ....+.....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~----~-~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED----D-EEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT----T-TSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh----c-cccCHHHHHHH
Confidence 135799999999999998 456899999988653211000000000 0 0000110000
Q ss_pred Cccc--cC-CCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005226 590 TNNY--RA-PEARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 590 t~~y--~a-PE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~ 628 (707)
-..| .. |+.. .......+.|+++.++|.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~---~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVL---EKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHH---HHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHH---HHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0112 12 2221 11122368999999999999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.80 E-value=2.4e-10 Score=120.74 Aligned_cols=176 Identities=18% Similarity=0.265 Sum_probs=119.0
Q ss_pred CcEEEEEcCCCCcc---------ccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccC-
Q 005226 69 PRVVGVAISGKNVR---------GYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC- 138 (707)
Q Consensus 69 ~~v~~L~L~~n~l~---------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 138 (707)
++++.|.|.++... +.++..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......++
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 57888888765431 123344577899999999988311 2333 3 389999999999988743333443
Q ss_pred -CCCCccEEeccC--Cccccc-----CCCCC--cccchhhhhhhcCCcccccCCCccc--ccCCCccEEeccCCCCCCC-
Q 005226 139 -NLPRLQNLDLSN--NSFSGS-----LPDGL--KNCKQLQRLILARNKFSGQIPAGIW--PELENLVQLDLSDNDFKGP- 205 (707)
Q Consensus 139 -~l~~L~~L~Ls~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~lp~~~~--~~l~~L~~L~ls~N~l~~~- 205 (707)
.+|+|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+.+..+..++ ..+++|++|+|+.|.|++.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 789999999863 322111 11122 3578999999999998744333332 2578999999999999863
Q ss_pred ---CCcchhhhhccccEEEeccCcCcCCCCCcCCC-CCCccEEEccCCc
Q 005226 206 ---IPNDLGELQSLSATLNLSYNHLSGKIPKSLGN-LPVTVSFDLRGNN 250 (707)
Q Consensus 206 ---~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~-l~~L~~l~l~~N~ 250 (707)
++..+.++++| +.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 296 ~~~L~~~L~~l~~L-~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 296 ARLLLDHVDKIKHL-KFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHTTHHHHTTC-SEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHhhcccCCcc-eEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 34455678999 79999999987433333322 2 3568888876
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.59 E-value=9.5e-10 Score=110.24 Aligned_cols=91 Identities=25% Similarity=0.241 Sum_probs=56.3
Q ss_pred cCCCCCCCE--EEcccCCcCCCCCc----cccCCCCCceEEecCccCCC--CCCcccCCCCCccEEeccCCcccccCCCC
Q 005226 89 LGSLIYLRR--LNLHNNNLFGSLPD----QLFNATSLHSIFLYGNNLSG--SLPPSVCNLPRLQNLDLSNNSFSGSLPDG 160 (707)
Q Consensus 89 l~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 160 (707)
|...+.|.. ++++.|+.. .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444444554 666777443 2222 22467888888888888886 4456677888888999998888853 22
Q ss_pred Ccccc--hhhhhhhcCCcccccCC
Q 005226 161 LKNCK--QLQRLILARNKFSGQIP 182 (707)
Q Consensus 161 ~~~l~--~L~~L~l~~N~l~~~lp 182 (707)
+..+. +|++|+|++|.+.+.+|
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhhcccCCcceEEccCCcCccccC
Confidence 33333 45555555555554444
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=1.9e-06 Score=88.94 Aligned_cols=134 Identities=19% Similarity=0.134 Sum_probs=95.2
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCC---ceeeeEEEEE-cCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHP---NIVKLRAYYW-APDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~e~~~~gs 489 (707)
.++.|....||+. +..+++|+-.. ......+.+|+++|+.+.+. .+.+.+.++. ..+..++||||++|.+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 5778888899988 56788888432 22346788999999999652 3566777774 4556789999999988
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS----------------------------------------- 528 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------- 528 (707)
+.+..-. .++..++..++.++++.|..||+..
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8764321 2445555666666666666666421
Q ss_pred ----------------CCCceecCCCCCCeEEcC---CCC-eEEeccccccc
Q 005226 529 ----------------PRKFVHGDIKPSNILLDN---DFQ-PYISDFGLSRL 560 (707)
Q Consensus 529 ----------------~~~iiHrDlk~~NIll~~---~~~-~kl~DfGla~~ 560 (707)
+..++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235699999999999987 455 48999997753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.40 E-value=9.2e-09 Score=97.96 Aligned_cols=94 Identities=20% Similarity=0.218 Sum_probs=52.8
Q ss_pred CCCCcCCCCCCCEEEcccC-CcCCC----CCccccCCCCCceEEecCccCCCC----CCcccCCCCCccEEeccCCcccc
Q 005226 85 IPSELGSLIYLRRLNLHNN-NLFGS----LPDQLFNATSLHSIFLYGNNLSGS----LPPSVCNLPRLQNLDLSNNSFSG 155 (707)
Q Consensus 85 ~~~~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~ 155 (707)
+...+...++|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3444566677777777777 66532 334455567777777777777621 23334445667777777777663
Q ss_pred c----CCCCCcccchhhhhhh--cCCccc
Q 005226 156 S----LPDGLKNCKQLQRLIL--ARNKFS 178 (707)
Q Consensus 156 ~----~p~~~~~l~~L~~L~l--~~N~l~ 178 (707)
. +...+...++|++|+| ++|.|.
T Consensus 108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 108 SGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2 2233333444444444 444443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=1.3e-06 Score=88.41 Aligned_cols=133 Identities=16% Similarity=0.182 Sum_probs=96.8
Q ss_pred ecccCee-EEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 415 LGKSGLG-IVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 415 lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+..|..| .||+.... ++..+++|+-... ...++.+|..+|+.+. +--+.++++++.+++..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 78988764 4567888875432 3356888999998883 334678899999999999999999998887
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS------------------------------------------- 528 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------------- 528 (707)
+...... .....++.+++..|..||+..
T Consensus 109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654321 223456667777777777521
Q ss_pred ------------CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 ------------PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ------------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+..++|+|+.+.||++++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137999999999999988777899999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.33 E-value=2.3e-08 Score=95.17 Aligned_cols=94 Identities=16% Similarity=0.190 Sum_probs=57.0
Q ss_pred CCccccCCCCCceEEecCc-cCCCC----CCcccCCCCCccEEeccCCccccc----CCCCCcccchhhhhhhcCCcccc
Q 005226 109 LPDQLFNATSLHSIFLYGN-NLSGS----LPPSVCNLPRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSG 179 (707)
Q Consensus 109 ~p~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 179 (707)
+...+...++|++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|+|..
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~ 107 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 107 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence 3445667889999999999 88732 344566778899999999988632 22233344556666666666652
Q ss_pred c----CCCcccccCCCccEEec--cCCCCC
Q 005226 180 Q----IPAGIWPELENLVQLDL--SDNDFK 203 (707)
Q Consensus 180 ~----lp~~~~~~l~~L~~L~l--s~N~l~ 203 (707)
. +... +...++|++|+| ++|.|.
T Consensus 108 ~g~~~l~~~-L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 108 SGILALVEA-LQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHHHG-GGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHH-HHhCCCceEEEecCCCCCCC
Confidence 1 1111 233445556666 555554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.3e-06 Score=90.36 Aligned_cols=78 Identities=6% Similarity=-0.050 Sum_probs=55.3
Q ss_pred ee-cccCeeEEEEEEeC-------CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcC-C--CceeeeEEEEEcC---C
Q 005226 414 VL-GKSGLGIVYKVVLG-------NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVK-H--PNIVKLRAYYWAP---D 476 (707)
Q Consensus 414 ~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~---~ 476 (707)
.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 56 78888999998764 26778888865432 111245788999998884 3 3567788887655 3
Q ss_pred cceEEEEeecCCChH
Q 005226 477 EKLLISDFISNGNLA 491 (707)
Q Consensus 477 ~~~lV~e~~~~gsL~ 491 (707)
..++||||++|..+.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 568999999886654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.15 E-value=5.6e-06 Score=88.67 Aligned_cols=153 Identities=14% Similarity=0.108 Sum_probs=105.5
Q ss_pred CCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccch
Q 005226 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQ 166 (707)
Q Consensus 87 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 166 (707)
......++|+.+.+..+ ++.+-...|.++.+|+.+.+..|... .....|..+..|+.+.+..+.+. ...|.++.+
T Consensus 224 ~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~ 298 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSS 298 (394)
T ss_dssp TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTT
T ss_pred hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccc
Confidence 33445567777777644 33344556777888888888777655 56667777778887777765432 346777778
Q ss_pred hhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEc
Q 005226 167 LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL 246 (707)
Q Consensus 167 L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 246 (707)
|+.+.+..+ ++ .|+...|.++.+|+.++|.++ ++..-..+|.++++| +.+.+..| ++..-..+|.++++|+.+++
T Consensus 299 L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L-~~i~lp~~-l~~I~~~aF~~C~~L~~i~l 373 (394)
T 4fs7_A 299 LTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSL-SNINFPLS-LRKIGANAFQGCINLKKVEL 373 (394)
T ss_dssp CCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTC-CEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred ccccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCC-CEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence 887777654 55 677777778888888888644 664556677788888 67887766 66455667788888888877
Q ss_pred cCC
Q 005226 247 RGN 249 (707)
Q Consensus 247 ~~N 249 (707)
..|
T Consensus 374 p~~ 376 (394)
T 4fs7_A 374 PKR 376 (394)
T ss_dssp EGG
T ss_pred CCC
Confidence 644
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.13 E-value=2.8e-06 Score=90.98 Aligned_cols=173 Identities=14% Similarity=0.118 Sum_probs=130.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccC-------------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNL------------------- 129 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l------------------- 129 (707)
.+++.+.|.++ +..+-...|.++++|+.+.+..| ++.+-...|.++..|+.+.+..+..
T Consensus 162 ~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~ 239 (394)
T 4fs7_A 162 ESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPD 239 (394)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECT
T ss_pred CCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceEEECC
Confidence 46888888755 44466778888999999988776 4445555666666666666554322
Q ss_pred --CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC
Q 005226 130 --SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP 207 (707)
Q Consensus 130 --~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p 207 (707)
+..-...|..+.+|+.+.+..|... .....|.++..|+.+.+..+. ++...|..+.+|+.+.+.+| ++....
T Consensus 240 ~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~~I~~ 313 (394)
T 4fs7_A 240 SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VKFIGE 313 (394)
T ss_dssp TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CCEECT
T ss_pred CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee----eccccccccccccccccccc-cceech
Confidence 1122346778899999999988765 667789999999988887654 56677889999999999766 665667
Q ss_pred cchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc
Q 005226 208 NDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 208 ~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
.+|.++++| +.++|.++ ++..-..+|.++.+|+.+++..| ++
T Consensus 314 ~aF~~c~~L-~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 314 EAFESCTSL-VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR 355 (394)
T ss_dssp TTTTTCTTC-CEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC
T ss_pred hhhcCCCCC-CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc
Confidence 789999999 79999755 77566789999999999999876 55
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.07 E-value=7.8e-06 Score=87.52 Aligned_cols=113 Identities=11% Similarity=0.263 Sum_probs=87.8
Q ss_pred CcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhh
Q 005226 134 PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGEL 213 (707)
Q Consensus 134 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 213 (707)
..+|.++.+|+.+.+.++..+ .-...|.++++|+.+.+. +.++ .|+...|.++.+|+.++|..| ++.....+|.++
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C 333 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGC 333 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTC
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCC
Confidence 345778888999988776554 556778888899988885 5566 788888888999999998765 665556788888
Q ss_pred hccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc
Q 005226 214 QSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 214 ~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
.+| +.+.|..+ ++..-..+|.++++|+.+++.+|...
T Consensus 334 ~~L-~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 334 EQL-ERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp TTC-CEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCC-CEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 888 78888654 66455678888999999998887654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.6e-05 Score=85.06 Aligned_cols=108 Identities=10% Similarity=0.243 Sum_probs=80.0
Q ss_pred CCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCC
Q 005226 158 PDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGN 237 (707)
Q Consensus 158 p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~ 237 (707)
..+|.++.+|+.+.+..+.. .|....|..+.+|+.+.+. +.++......|.++.+| +.+.|..| ++..-..+|.+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L-~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISL-KSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTC-CEEECCTT-CCEECTTTTTT
T ss_pred cceeeecccccEEecccccc--eecCcccccccccccccCC-CcccccCceeecCCCCc-CEEEeCCc-ccEehHhHhhC
Confidence 34678889999999976654 5888889999999999996 55665666789999999 79999865 66566788999
Q ss_pred CCCccEEEccCCcCcccCCCCCCC---CCCCCcccCCCC
Q 005226 238 LPVTVSFDLRGNNLSGEIPQTGSF---ANQGPTAFLSNP 273 (707)
Q Consensus 238 l~~L~~l~l~~N~l~~~~p~~~~~---~~~~~~~~~~N~ 273 (707)
+.+|+.+.+..+ ++ .|.. ..| .+|..+.+.+|.
T Consensus 333 C~~L~~i~ip~s-v~-~I~~-~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 333 CEQLERIAIPSS-VT-KIPE-SAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CTTCCEEEECTT-CC-BCCG-GGGTTCTTCCEEEESSCH
T ss_pred CCCCCEEEECcc-cC-EEhH-hHhhCCCCCCEEEECCce
Confidence 999999999755 44 2321 122 345555565553
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=2.9e-05 Score=81.09 Aligned_cols=141 Identities=18% Similarity=0.263 Sum_probs=80.2
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-----CCceeeeE-E--EEEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-----HPNIVKLR-A--YYWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lV~e~~ 485 (707)
.|+.|..+.||+....+|. +++|+.... . .++..|+.+++.+. .|.++... | +....+..++||+|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 4566778899999886654 888988752 1 23344555555542 34444310 0 122356678999999
Q ss_pred cCCChH--------------HHHhCCCC-C--C------CCCCCHHHHH-------------------------------
Q 005226 486 SNGNLA--------------NALRGRNG-Q--P------STSLSWSTRL------------------------------- 511 (707)
Q Consensus 486 ~~gsL~--------------~~l~~~~~-~--~------~~~l~~~~~~------------------------------- 511 (707)
+|.++. ..+|.... - + ...-.|....
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221110 0 0 0112343211
Q ss_pred HHHHHHHHHHHHHhh----------cCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 512 RIAKGTARGLAYLHE----------CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 512 ~i~~~ia~~L~yLH~----------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
.+...+..++++|+. ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123445667763 123689999999999999888899999999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.92 E-value=1.9e-05 Score=83.89 Aligned_cols=154 Identities=11% Similarity=0.100 Sum_probs=98.5
Q ss_pred cCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhh
Q 005226 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQ 168 (707)
Q Consensus 89 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 168 (707)
+.....+..+.+..+.-. .....+....+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.++.+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 344455555555443322 44555666777777777554 33244556677777777777655 4434456677777777
Q ss_pred hhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccC
Q 005226 169 RLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRG 248 (707)
Q Consensus 169 ~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 248 (707)
.+.+..+ ++ .++...|..+.+|+.+.+.+|.++..-...|.++.+| +.+.|..+ ++..-..+|.++.+|+.+.+..
T Consensus 267 ~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L-~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 267 TLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL-SSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC-CEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCC-CEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 7777543 55 6777777777778888777777775556677777777 67777644 5544456777777777776654
Q ss_pred C
Q 005226 249 N 249 (707)
Q Consensus 249 N 249 (707)
+
T Consensus 343 ~ 343 (379)
T 4h09_A 343 S 343 (379)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5e-05 Score=81.27 Aligned_cols=74 Identities=9% Similarity=0.117 Sum_probs=49.1
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-------hhHHHHHHHHHHHHhcCC--Cc-eeeeEEEEEcCCcceEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-------QRHREFVTEVQAIAKVKH--PN-IVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~lV 481 (707)
+.+|.|.++.||++... ++..++||....... .....+..|+++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 36899999999999754 467899997543211 122456789999988742 43 4455543 45567899
Q ss_pred EEeecCC
Q 005226 482 SDFISNG 488 (707)
Q Consensus 482 ~e~~~~g 488 (707)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.78 E-value=5e-05 Score=80.68 Aligned_cols=165 Identities=11% Similarity=0.039 Sum_probs=124.2
Q ss_pred ccccCCCCcCCCCCCCEEEcccCCcCC------------CCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 81 VRGYIPSELGSLIYLRRLNLHNNNLFG------------SLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 81 l~~~~~~~l~~l~~L~~L~L~~N~l~~------------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++.+-...|..+.+|+.+.+..+.... .....+.....+..+.+..+.-. .....+....+|+.+.+
T Consensus 146 v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~ 224 (379)
T 4h09_A 146 VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITI 224 (379)
T ss_dssp CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEEC
T ss_pred eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccceeee
Confidence 444556778899999998887665431 12234455666666666554433 55667788899999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
..+ +...-...|.++.+|+.+.+..+ ++ .|....|..+.+|+.+.+..+ ++......|.++++| +.+.+.+|.++
T Consensus 225 ~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L-~~i~l~~~~i~ 299 (379)
T 4h09_A 225 TSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL-TKVVMDNSAIE 299 (379)
T ss_dssp CTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC-CEEEECCTTCC
T ss_pred ccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceecccccccccccc-ccccccccccc
Confidence 766 44355678889999999999776 66 788888999999999999755 554556788999999 79999999898
Q ss_pred CCCCCcCCCCCCccEEEccCCcCc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
..-..+|.++.+|+.+.+..+ ++
T Consensus 300 ~I~~~aF~~c~~L~~i~lp~~-l~ 322 (379)
T 4h09_A 300 TLEPRVFMDCVKLSSVTLPTA-LK 322 (379)
T ss_dssp EECTTTTTTCTTCCEEECCTT-CC
T ss_pred eehhhhhcCCCCCCEEEcCcc-cc
Confidence 666788999999999999755 44
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00016 Score=74.32 Aligned_cols=138 Identities=14% Similarity=0.130 Sum_probs=92.1
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC---CCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK---HPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.|+.|.+..+|+... ++..+++|+.... ....|.+|++.|+.|. ...+.++++++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 578899999999986 4667888886542 2467889999998883 35688899888888889999999998764
Q ss_pred H-----------HHHhCCCCCCC-----------------CCCCHHHHH---HHHH----------------HHHH-HHH
Q 005226 491 A-----------NALRGRNGQPS-----------------TSLSWSTRL---RIAK----------------GTAR-GLA 522 (707)
Q Consensus 491 ~-----------~~l~~~~~~~~-----------------~~l~~~~~~---~i~~----------------~ia~-~L~ 522 (707)
. ..||.....+. ..-+|.... ++.. .+.. ...
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 2 13343321000 012565432 1111 1111 122
Q ss_pred HHhh-cCCCCceecCCCCCCeEEcCCCCeEEeccc
Q 005226 523 YLHE-CSPRKFVHGDIKPSNILLDNDFQPYISDFG 556 (707)
Q Consensus 523 yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~DfG 556 (707)
.|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 1236799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00035 Score=75.21 Aligned_cols=80 Identities=13% Similarity=0.112 Sum_probs=48.2
Q ss_pred CCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCc
Q 005226 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQ 607 (707)
Q Consensus 530 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 607 (707)
..++|+|+++.||+++.++ ++|+||+.+..-...-+... ....-...|.+|+.... +.....
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~---------------~l~~~~~~~~~~~~~~~~~~~~~~~ 295 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA---------------YLGNLILAFFAQDGHATQENDRKEY 295 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH---------------HHHHHHHHHHHGGGGCCSSCCSHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH---------------HHHHHHHHHHhcccccccccchHHH
Confidence 7899999999999998876 99999998764321100000 00000123555554321 011223
Q ss_pred hhhHHHHHHHHHHHHhCC
Q 005226 608 KWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 608 ~~DV~S~Gv~l~elltg~ 625 (707)
..++.+....+|+.++++
T Consensus 296 ~~~~~~~~~~~~~~y~~~ 313 (420)
T 2pyw_A 296 KQWILRTIEQTWNLFNKR 313 (420)
T ss_dssp HHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 456678888888888764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00045 Score=70.18 Aligned_cols=72 Identities=18% Similarity=0.322 Sum_probs=54.0
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-C--CceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-H--PNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+|.|..+.||+.++.+|+.|++|+-..........|.+|++.|+.|. . --+.+++++ +..++||||++++.
T Consensus 22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 589999999999999999999999876544333356889999999884 2 124455544 24589999988764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.39 E-value=2.8e-05 Score=72.20 Aligned_cols=84 Identities=12% Similarity=0.141 Sum_probs=56.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCC-cCCCCCccccCC----CCCceEEecCc-cCCCCCCcccCCCCC
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN-LFGSLPDQLFNA----TSLHSIFLYGN-NLSGSLPPSVCNLPR 142 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N-~l~~~~p~~~~~l~~ 142 (707)
-+++.|||+++.|+..--..+..+++|++|+|+++. |+..--..+..+ ++|++|+|+++ +|+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888776555567788888888888884 553222234443 36888888886 466332334566777
Q ss_pred ccEEeccCCc
Q 005226 143 LQNLDLSNNS 152 (707)
Q Consensus 143 L~~L~Ls~N~ 152 (707)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.28 E-value=2e-05 Score=73.21 Aligned_cols=35 Identities=9% Similarity=0.062 Sum_probs=20.1
Q ss_pred CCCCEEEcccCCcCCCCCccccCCCCCceEEecCc
Q 005226 93 IYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGN 127 (707)
Q Consensus 93 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 127 (707)
.+|+.|||+++.|+..--..+.++++|+.|+|+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 35677777776665332233455666666666665
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0017 Score=67.03 Aligned_cols=142 Identities=15% Similarity=0.096 Sum_probs=80.8
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCC--ceeeeEEE-----EEcCCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHP--NIVKLRAY-----YWAPDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lV~e~~~ 486 (707)
.++ |....||+....+|..+++|....... ....+..|..+++.+... .+.+++.. ....+..++||+|++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 777899998877787899999864321 224566788888877422 23444432 112345578999998
Q ss_pred CCChH-----H---------HHhCC----CCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHhhc--
Q 005226 487 NGNLA-----N---------ALRGR----NGQPSTSLSWSTR----LRI---------------AKGTARGLAYLHEC-- 527 (707)
Q Consensus 487 ~gsL~-----~---------~l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~-- 527 (707)
|..+. . .+|.. .......+++... ..+ ...+...++.+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75432 0 12211 0000112233221 001 11111223333221
Q ss_pred --CCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 528 --SPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 528 --~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
.+..++|+|+++.||+++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 235689999999999999 4 89999999765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0019 Score=66.55 Aligned_cols=143 Identities=10% Similarity=0.066 Sum_probs=80.0
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc--eeeeEEE------EEcCCcceEEEEee
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN--IVKLRAY------YWAPDEKLLISDFI 485 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~e~~ 485 (707)
.|+.|....+|+....+| .+++|...... ....+..|+.+++.+.... +.+++.. ....+..++|++|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788889999988666 67888876531 1134566788777763212 2333311 12235568999999
Q ss_pred cCCChHH--------------HHhCCC---CCCC-C---CCCHHHHHHH------------HHHHHHHHHHHhhc----C
Q 005226 486 SNGNLAN--------------ALRGRN---GQPS-T---SLSWSTRLRI------------AKGTARGLAYLHEC----S 528 (707)
Q Consensus 486 ~~gsL~~--------------~l~~~~---~~~~-~---~l~~~~~~~i------------~~~ia~~L~yLH~~----~ 528 (707)
+|..+.. .+|... ..+. . ...|.....- ...+...++++++. .
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8754321 122111 0000 0 0124331110 11244556666542 2
Q ss_pred CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999987666899999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0014 Score=69.16 Aligned_cols=142 Identities=20% Similarity=0.191 Sum_probs=84.2
Q ss_pred eecccCeeEEEEEEeCC--------CceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEe
Q 005226 414 VLGKSGLGIVYKVVLGN--------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+..|-...+|+....+ +..+++|+..... .....+.+|.++++.+. +.-..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 46667778899988752 4678999864322 22356678999998883 3334566666543 299999
Q ss_pred ecCCChHH-----------------HHhCCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHHh-
Q 005226 485 ISNGNLAN-----------------ALRGRNGQPSTSL--SWSTRLRIAKGTAR-------------------GLAYLH- 525 (707)
Q Consensus 485 ~~~gsL~~-----------------~l~~~~~~~~~~l--~~~~~~~i~~~ia~-------------------~L~yLH- 525 (707)
++|.+|.. -||.......... -|.+..++..++.. .+++|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755431 1232221111122 24555555544322 233332
Q ss_pred ---h-cCCCCceecCCCCCCeEEcCC----CCeEEeccccccc
Q 005226 526 ---E-CSPRKFVHGDIKPSNILLDND----FQPYISDFGLSRL 560 (707)
Q Consensus 526 ---~-~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~ 560 (707)
. ..+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123569999999999999877 7899999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0015 Score=66.83 Aligned_cols=138 Identities=17% Similarity=0.186 Sum_probs=74.8
Q ss_pred eecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCce-eeeEEEEEcCCcceEEEEee-cCCChH
Q 005226 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNI-VKLRAYYWAPDEKLLISDFI-SNGNLA 491 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~-~~gsL~ 491 (707)
.|+.|....+|+. ..+++|+........ ....+|+.+++.+....+ .+++++ ..+.-++|+||+ ++-++.
T Consensus 25 ~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 25 ERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred EcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 5788888999998 568888876532211 223568888877743233 455543 444568999999 554442
Q ss_pred H------------------HHhCCCCCCCCCCC-HHHHHHHHHH--------------HHHHH----HHHhh-cCCCCce
Q 005226 492 N------------------ALRGRNGQPSTSLS-WSTRLRIAKG--------------TARGL----AYLHE-CSPRKFV 533 (707)
Q Consensus 492 ~------------------~l~~~~~~~~~~l~-~~~~~~i~~~--------------ia~~L----~yLH~-~~~~~ii 533 (707)
. .+|..........+ +.....+... +...+ +.+.. ..+..++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 1 12222111011111 1111111110 11111 11111 1234689
Q ss_pred ecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 534 HGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 534 HrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
|+|+.+.||+ ..++.+.++||..+..
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ccCCCcCCEE-ECCCCEEEEecccccC
Confidence 9999999999 5667889999998753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0026 Score=65.89 Aligned_cols=142 Identities=14% Similarity=0.075 Sum_probs=73.5
Q ss_pred eecccCeeE-EEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-C-CceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGI-VYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-H-PNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.|+.|+... +|+....++..+++|....... ..+..|+.+++.+. + -.+.+++.+... .-++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcch
Confidence 354554443 6677664466777776544321 23445777777663 2 234566665332 23789999977666
Q ss_pred HHHHhCC---------------------CCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHh---h
Q 005226 491 ANALRGR---------------------NGQPSTSLSWSTRL-------R-------------IAKGTARGLAYLH---E 526 (707)
Q Consensus 491 ~~~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~~L~yLH---~ 526 (707)
.+++... .......++..... . ....+...++.+. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 5544321 10000112211100 0 0011122223331 1
Q ss_pred cCCCCceecCCCCCCeEEcCC----CCeEEeccccccc
Q 005226 527 CSPRKFVHGDIKPSNILLDND----FQPYISDFGLSRL 560 (707)
Q Consensus 527 ~~~~~iiHrDlk~~NIll~~~----~~~kl~DfGla~~ 560 (707)
..+..++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123689999999999999875 6799999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00043 Score=61.09 Aligned_cols=36 Identities=25% Similarity=0.504 Sum_probs=24.0
Q ss_pred hhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 167 LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 167 L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
|+.|+|++|+|+ .||.+.|..+++|+.|+|++|.+.
T Consensus 33 l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 444455555554 677777777777778888777764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0012 Score=58.27 Aligned_cols=36 Identities=31% Similarity=0.459 Sum_probs=18.2
Q ss_pred CceEEecCccCCCCCCcccCCCCCccEEeccCCccc
Q 005226 119 LHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 119 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 154 (707)
|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 444455555554333344455555555555555543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0054 Score=65.98 Aligned_cols=71 Identities=13% Similarity=0.101 Sum_probs=48.0
Q ss_pred eecccCeeEEEEEEeCC--------CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc-eeeeEEEEEcCCcceEEEEe
Q 005226 414 VLGKSGLGIVYKVVLGN--------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN-IVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~e~ 484 (707)
.|+.|....+|++...+ +..+++|+...... ...+.+|..+++.+...+ ..++++.+.+ .+|+||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 57778889999998753 46788998744211 145567999998884333 3567765532 389999
Q ss_pred ecCCCh
Q 005226 485 ISNGNL 490 (707)
Q Consensus 485 ~~~gsL 490 (707)
+++-+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0048 Score=66.82 Aligned_cols=72 Identities=17% Similarity=0.154 Sum_probs=46.3
Q ss_pred eecccCeeEEEEEEeCC-CceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCce-eeeEEEEEcCCcceEEEEeecCCCh
Q 005226 414 VLGKSGLGIVYKVVLGN-GIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNI-VKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.|+.|-...+|+....+ +..+++|+........ -+-.+|..+++.+...++ .++++.+. + .+|+||+++-+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 57778889999999865 4778888875432111 112578999998854444 56777662 2 369999987544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=6e-05 Score=71.27 Aligned_cols=112 Identities=17% Similarity=0.185 Sum_probs=50.8
Q ss_pred CCCCCCEEEcccC-CcCC----CCCccccCCCCCceEEecCccCCC----CCCcccCCCCCccEEeccCCccccc----C
Q 005226 91 SLIYLRRLNLHNN-NLFG----SLPDQLFNATSLHSIFLYGNNLSG----SLPPSVCNLPRLQNLDLSNNSFSGS----L 157 (707)
Q Consensus 91 ~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~ 157 (707)
+-+.|++|+|++| +|.. .+-..+..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|.|... +
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3445555555543 4431 122333444555555555555541 1122233334555555555555421 1
Q ss_pred CCCCcccchhhhhhhcCCcc---ccc----CCCcccccCCCccEEeccCCCCC
Q 005226 158 PDGLKNCKQLQRLILARNKF---SGQ----IPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 158 p~~~~~l~~L~~L~l~~N~l---~~~----lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
-..+..-+.|+.|+|++|.. ... |- ..+..-++|+.|+++.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia-~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM-MAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH-HHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHH-HHHHhCCCcCeEeccCCCcc
Confidence 12233334455556654322 110 11 12234467888888877653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0031 Score=66.45 Aligned_cols=72 Identities=13% Similarity=0.131 Sum_probs=43.7
Q ss_pred eecccCeeEEEEEEeCCC---------ceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCc-eeeeEEEEEcCCcceEEEE
Q 005226 414 VLGKSGLGIVYKVVLGNG---------IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN-IVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~---------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~e 483 (707)
.++.|....+|+....++ ..+++|+....... ......|.++++.+...+ +.++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 467777789999987542 67888887553221 122357888888884333 44666543 2478999
Q ss_pred eecCCCh
Q 005226 484 FISNGNL 490 (707)
Q Consensus 484 ~~~~gsL 490 (707)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00014 Score=68.75 Aligned_cols=65 Identities=22% Similarity=0.295 Sum_probs=32.3
Q ss_pred cCCCCCceEEecCc-cCCC----CCCcccCCCCCccEEeccCCcccccCCC----CCcccchhhhhhhcCCccc
Q 005226 114 FNATSLHSIFLYGN-NLSG----SLPPSVCNLPRLQNLDLSNNSFSGSLPD----GLKNCKQLQRLILARNKFS 178 (707)
Q Consensus 114 ~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~ 178 (707)
.+-+.|+.|+|++| +|.. .+-+.+..-+.|+.|+|++|+|...--. .+..-+.|+.|+|++|+|.
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 33455666666654 5541 1223344445566666666666522111 2223345666666666665
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0053 Score=63.81 Aligned_cols=31 Identities=32% Similarity=0.498 Sum_probs=27.8
Q ss_pred CCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 530 ~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.022 Score=54.07 Aligned_cols=104 Identities=14% Similarity=0.036 Sum_probs=68.8
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
-+|.++|...+ .++++++++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 48999998764 4799999999999999998776210 1111233456889999999988764 2111
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPE 628 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~ 628 (707)
.....+.|||... ...+.+.=|||+|+++|..+--..|-
T Consensus 98 --------------------~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 --------------------AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----------------------------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --------------------ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0022466888753 45578999999999999999866553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.019 Score=61.25 Aligned_cols=141 Identities=15% Similarity=0.143 Sum_probs=83.9
Q ss_pred eecccCeeEEEEEEeCC--------CceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEe
Q 005226 414 VLGKSGLGIVYKVVLGN--------GIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+..|-...+|+....+ +..+++|+........ -+-.+|.++++.+. +.-..++++.+ .-++|+||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 46667778999998753 5778888865432211 22357888888884 33344566533 23799999
Q ss_pred ecCCChHH-----------------HHhCCCC----C----CCCCCCHHHHHHHHHHH-------------------HHH
Q 005226 485 ISNGNLAN-----------------ALRGRNG----Q----PSTSLSWSTRLRIAKGT-------------------ARG 520 (707)
Q Consensus 485 ~~~gsL~~-----------------~l~~~~~----~----~~~~l~~~~~~~i~~~i-------------------a~~ 520 (707)
++|.+|.. .||.... - ...+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865421 1111100 0 11122355544444332 222
Q ss_pred HHHHhh---------------------cCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 521 LAYLHE---------------------CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 521 L~yLH~---------------------~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
+++|.+ ..+..++|+|+.+.||+ +.++.+.++||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11246899999999999 7888999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.50 E-value=0.75 Score=48.55 Aligned_cols=30 Identities=33% Similarity=0.497 Sum_probs=25.1
Q ss_pred CceecCCCCCCeEE------cCCCCeEEeccccccc
Q 005226 531 KFVHGDIKPSNILL------DNDFQPYISDFGLSRL 560 (707)
Q Consensus 531 ~iiHrDlk~~NIll------~~~~~~kl~DfGla~~ 560 (707)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.87 E-value=2.7 Score=39.87 Aligned_cols=83 Identities=18% Similarity=0.197 Sum_probs=61.7
Q ss_pred CCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCceecCCCC
Q 005226 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA-YLHECSPRKFVHGDIKP 539 (707)
Q Consensus 461 ~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~iiHrDlk~ 539 (707)
.||++ -..+-.+++...+.|+.-+++.=...++ .++...+++++..|+...+ +++. -+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 67888 3344466667667677654544444554 3788899999999888777 5654 47888999
Q ss_pred CCeEEcCCCCeEEeccccc
Q 005226 540 SNILLDNDFQPYISDFGLS 558 (707)
Q Consensus 540 ~NIll~~~~~~kl~DfGla 558 (707)
+|+++|.++.+++.-.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999988863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.33 E-value=2 Score=40.61 Aligned_cols=116 Identities=12% Similarity=0.083 Sum_probs=79.0
Q ss_pred CCCceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCC
Q 005226 461 KHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPS 540 (707)
Q Consensus 461 ~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~ 540 (707)
.||+.+.. .+-.+++...+.|+.-+.+-=...++ .++...+++++..|+...++++. -+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 68888876 45555665555555443222222233 37889999999999998876664 378899999
Q ss_pred CeEEcCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHH
Q 005226 541 NILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLE 620 (707)
Q Consensus 541 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~e 620 (707)
|+++|.++.+++.-.|+-..+ +|. ..++..=.-.+=+++..
T Consensus 109 NL~f~~~~~p~i~~RGik~~l---------------------------------~P~------~~~ee~fL~qyKAliia 149 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV---------------------------------DPL------PVSEAEFLTRYKALVIC 149 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB---------------------------------SCC------CCCHHHHHHHHHHHHHH
T ss_pred eEEEcCCCCEEEEEccCccCC---------------------------------CCC------CCCHHHHHHHHHHHHHH
Confidence 999999999999988863221 122 11233335567788888
Q ss_pred HHhCCCCCC
Q 005226 621 LLTGKSPEL 629 (707)
Q Consensus 621 lltg~~P~~ 629 (707)
+++++..|.
T Consensus 150 ll~~K~~Fe 158 (215)
T 4ann_A 150 AFNEKQSFD 158 (215)
T ss_dssp HHCTTCCHH
T ss_pred HHcCCCCHH
Confidence 999988874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 707 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-34 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-11 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-54
Identities = 65/294 (22%), Positives = 119/294 (40%), Gaps = 40/294 (13%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G G VYK + V + + Q+ + F EV + K +H NI+ Y
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
AP +++ + +L + L + + IA+ TA+G+ YLH + +
Sbjct: 75 APQ-LAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP--VQTEKTN 591
H D+K +NI L D I DFGL+ + + + + G++ +M P ++ + N
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ--LSGSILWMAPEVIRMQDKN 184
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651
Y + DVY+FG+VL EL+TG+ P + ++ V +G+
Sbjct: 185 PY------------SFQSDVYAFGIVLYELMTGQLPYSNIN-----NRDQIIFMVGRGYL 227
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P V + + + L C + + RP + ++E +
Sbjct: 228 S--PDLSKVRSNCPKAMK---------RLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 4e-51
Identities = 64/292 (21%), Positives = 120/292 (41%), Gaps = 44/292 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG G V+ VAV+ L + G F+ E + +++H +V+L A
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+ +I++++ NG+L + L+ +G L+ + L +A A G+A++ E R ++
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H D++ +NIL+ + I+DFGL+RLI + + P
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA---KFPIKWTAPEAIN----- 183
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
K DV+SFG++L E++T T+ P++++ +++G+
Sbjct: 184 --------YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGYRMV 230
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P + + + L C + PE RP + LE
Sbjct: 231 RP-DNCPEELY--------------QLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-50
Identities = 53/301 (17%), Positives = 104/301 (34%), Gaps = 24/301 (7%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+GK G V++ G VAV+ E+R E+ ++H NI+ A
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 474 APDEKL----LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE--- 526
+ L+SD+ +G+L + L +++ +++A TA GLA+LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 527 --CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H D+K NIL+ + I+D GL+ + + + G YM P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644
+ ++ D+Y+ G+V E+ S +
Sbjct: 182 -------EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704
+ + + + + + + + C A+ R + + L +
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
Query: 705 I 705
+
Sbjct: 295 L 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 9e-50
Identities = 67/324 (20%), Positives = 136/324 (41%), Gaps = 54/324 (16%)
Query: 392 ELVAIDKGFTFELD----ELLRASAYVLGKSGLGIVYKVVL----GNGIPVAVRRLGEG- 442
+ + F E+D ++ + V+G G V L I VA++ L G
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQ----VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 443 GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPS 502
E++ R+F++E + + HPN++ L ++I++F+ NG+L + LR +GQ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 503 TSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+ + +G A G+ YL +VH D+ NIL++++ +SDFGLSR +
Sbjct: 127 ----VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 563 ITGNNPSSSGGF-MGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLEL 621
++P+ + + + P + + DV+S+G+V+ E+
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQ-------------YRKFTSASDVWSYGIVMWEV 226
Query: 622 LTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLA 681
++ T+ D++ +++ + P+ A+ L
Sbjct: 227 MSYGERPYWDMTN-----QDVINAIEQDYRLPPPMD---------------CPSALHQLM 266
Query: 682 LACTEADPEVRPRMKNVSENLERI 705
L C + D RP+ + L+++
Sbjct: 267 LDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 68/310 (21%), Positives = 124/310 (40%), Gaps = 56/310 (18%)
Query: 399 GFTFELD--ELLRASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQA 456
G+ + +LL+ +GK G V G VAV+ + + + F+ E
Sbjct: 1 GWALNMKELKLLQ----TIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASV 53
Query: 457 IAKVKHPNIVKLRAYYWAPDEKL-LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAK 515
+ +++H N+V+L L +++++++ G+L + LR R L L+ +
Sbjct: 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSL 110
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFM 575
+ YL FVH D+ N+L+ D +SDFGL++ + T +
Sbjct: 111 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------- 158
Query: 576 GGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635
+ + APEA + + K DV+SFG++L E+ + P
Sbjct: 159 ----------TGKLPVKWTAPEA-LREKKFSTKSDVWSFGILLWEIYSFGRV---PYPRI 204
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695
++ D+V V+KG++ + P A+ + C D +RP
Sbjct: 205 PLK--DVVPRVEKGYKMDAP-DGCPPAVY--------------EVMKNCWHLDAAMRPSF 247
Query: 696 KNVSENLERI 705
+ E LE I
Sbjct: 248 LQLREQLEHI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 4e-48
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 44/292 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
+G G+V+ N VA++ + EG +F+ E + + K+ HP +V+L
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
L+ +F+ +G L++ LR + G + T L + G+AYL E +
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H D+ N L+ + +SDFG++R + ++ +S + +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWA----------- 169
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
+PE +R K DV+SFGV++ E+ + P + S ++V + GF
Sbjct: 170 -SPEV-FSFSRYSSKSDVWSFGVLMWEVFSEGKI---PYENRSNS--EVVEDISTGFRLY 222
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P + V+ + C + PE RP + L I
Sbjct: 223 KP---------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 5e-48
Identities = 63/295 (21%), Positives = 110/295 (37%), Gaps = 46/295 (15%)
Query: 415 LGKSGLGIVYKVVL---GNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKLRA 470
LG G V + V I VA++ L +G E+ E + E Q + ++ +P IV+L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
A +L+ + G L L G+ + + S + + G+ YL +
Sbjct: 77 VCQAE-ALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE---EK 128
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
FVH D+ N+LL N ISDFGLS+ + + ++ L + P
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK-WPLKWYAPECIN-- 185
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ + DV+S+GV + E L+ P P+++ ++++G
Sbjct: 186 -----------FRKFSSRSDVWSYGVTMWEALSYGQK---PYKKMKG--PEVMAFIEQGK 229
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
E P + + + L C E RP V + +
Sbjct: 230 RMECP-PECPPEL--------------YALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 67/298 (22%), Positives = 129/298 (43%), Gaps = 47/298 (15%)
Query: 414 VLGKSGLGIVYKVVLGNG-----IPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIVK 467
V+G G VYK +L +PVA++ L G ++ R +F+ E + + H NI++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L ++I++++ NG L LR ++G+ S + + +G A G+ YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN- 128
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+VH D+ NIL++++ +SDFGLSR++ ++ G
Sbjct: 129 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI----------- 175
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647
+ APEA + + DV+SFG+V+ E++T + ++++ +
Sbjct: 176 --PIRWTAPEA-ISYRKFTSASDVWSFGIVMWEVMTYGER-----PYWELSNHEVMKAIN 227
Query: 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
GF P A++ L + C + + RP+ ++ L+++
Sbjct: 228 DGFRLPTP---------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-47
Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 58/313 (18%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVK-HPNI 465
LG G V + + VAV+ L RE ++E++ ++ + H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS-------------LSWSTRLR 512
V L L+I+++ G+L N LR + S L L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
+ A+G+A+L + +H D+ NILL + I DFGL+R I ++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK--NDSNYVVK 204
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
G + +M + + DV+S+G+ L EL + S
Sbjct: 205 GNARLPVKWM-------------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692
S + +K+GF +P + ++ + C +ADP R
Sbjct: 252 PVDSK----FYKMIKEGFRMLSP---------------EHAPAEMYDIMKTCWDADPLKR 292
Query: 693 PRMKNVSENLERI 705
P K + + +E+
Sbjct: 293 PTFKQIVQLIEKQ 305
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 64/292 (21%), Positives = 120/292 (41%), Gaps = 44/292 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG+ G V+ VA++ L + G F+ E Q + K++H +V+L A
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+ ++++++S G+L + L+G G+ + +A A G+AY+ +V
Sbjct: 83 -EEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVE---RMNYV 135
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H D++ +NIL+ + ++DFGL+RLI +N ++ + + P
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEA------- 185
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEE 653
R K DV+SFG++L EL T + +++ V++G+
Sbjct: 186 ------ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVERGYRMP 234
Query: 654 NPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P + ++ L C +PE RP + + LE
Sbjct: 235 CP---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 2e-46
Identities = 73/318 (22%), Positives = 123/318 (38%), Gaps = 64/318 (20%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIV 466
+G+ G V++ VAV+ L E +F E +A+ +PNIV
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS-------------------LSW 507
KL L+ ++++ G+L LR + S LS
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
+ +L IA+ A G+AYL E KFVH D+ N L+ + I+DFGLSR I + +
Sbjct: 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY-SADY 195
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ G + PE + NR + DV+++GVVL E+ +
Sbjct: 196 YKADGNDAI-------------PIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEA 687
P + E +++ +V+ G P + + +++L C
Sbjct: 242 ---PYYGMAHE--EVIYYVRDGNILACP---------------ENCPLELYNLMRLCWSK 281
Query: 688 DPEVRPRMKNVSENLERI 705
P RP ++ L+R+
Sbjct: 282 LPADRPSFCSIHRILQRM 299
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-46
Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 46/293 (15%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYW 473
LG G+V VA++ + EG EF+ E + + + H +V+L
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 474 APDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFV 533
+I+++++NG L N LR + L + K + YL ++F+
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 534 HGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNY 593
H D+ N L+++ +SDFGLSR + + +SS G +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKF-------------PVRW 167
Query: 594 RAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGFEE 652
PE + ++ K D+++FGV++ E+ + GK P T S + + +G
Sbjct: 168 SPPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLRL 220
Query: 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
P V+ + +C + RP K + N+ +
Sbjct: 221 YRP---------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 1e-45
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 44/293 (15%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G VY+ V + VAV+ L E + EF+ E + ++KHPN+V+L
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+I++F++ GNL + LR N Q +S L +A + + YL + + F
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK---KNF 136
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+ N L+ + ++DFGLSRL+ + ++ + + P
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLA---- 189
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652
N+ K DV++FGV+L E+ T P + + ++K +
Sbjct: 190 ---------YNKFSIKSDVWAFGVLLWEIATYGMS---PYPGIDLS--QVYELLEKDYRM 235
Query: 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
E P + V+ L AC + +P RP + + E +
Sbjct: 236 ERP---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 46/298 (15%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRH-REFVTEVQAIAKVKHPNIVKL 468
V+G+ G VY L G I AV+ L + +F+TE + HPN++ L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 469 RAYYWAPDEK-LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
+ L++ ++ +G+L N +R P+ + A+G+
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT----VKDLIGFGLQVAKGM---KFL 146
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+ +KFVH D+ N +LD F ++DFGL+R + + + + +M
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----- 201
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647
A E+ + + K DV+SFGV+L EL+T +P P + D+ ++
Sbjct: 202 -------ALES-LQTQKFTTKSDVWSFGVLLWELMTRGAP---PYPDVNTF--DITVYLL 248
Query: 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
+G P D + + + L C E+RP + + I
Sbjct: 249 QGRRLLQP-EYCPDPL--------------YEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 2e-45
Identities = 62/282 (21%), Positives = 112/282 (39%), Gaps = 30/282 (10%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LG G+V+KV +G+ +A + + E + + E+Q + + P IV
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+++ E + + + G+L L+ + +++ +GL YL E K
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREK--HK 125
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KPSNIL+++ + + DFG+S + S + F+G T
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVG-------------TR 167
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651
+Y +PE R+ G + D++S G+ L+E+ G+ P P V+
Sbjct: 168 SYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELMFGCQVEGDAA 224
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
E P L + +A+F L P P
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 7e-45
Identities = 68/308 (22%), Positives = 119/308 (38%), Gaps = 57/308 (18%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKV-KHPNIVKL 468
V+G+ G V K + G + A++R+ + HR+F E++ + K+ HPNI+ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRN-----------GQPSTSLSWSTRLRIAKGT 517
L ++ +GNL + LR +++LS L A
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 518 ARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGG 577
ARG+ YL + ++F+H D+ NIL+ ++ I+DFGLSR +
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL----- 188
Query: 578 ALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSI 637
+ A E + + DV+S+GV+L E+++ P +
Sbjct: 189 ------------PVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGT---PYCGMTC 232
Query: 638 EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
+L + +G+ E P + D + L C P RP
Sbjct: 233 A--ELYEKLPQGYRLEKP-LNCDDEVY--------------DLMRQCWREKPYERPSFAQ 275
Query: 698 VSENLERI 705
+ +L R+
Sbjct: 276 ILVSLNRM 283
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-44
Identities = 67/316 (21%), Positives = 114/316 (36%), Gaps = 63/316 (19%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKV-KHPNI 465
VLG G V G I VAV+ L E + RE ++E++ + ++ H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 466 VKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTS------------------LSW 507
V L LI ++ G+L N LR + + S L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 508 STRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567
L A A+G+ +L + VH D+ N+L+ + I DFGL+R I + +N
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM-SDSN 219
Query: 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
G + APE + K DV+S+G++L E+ +
Sbjct: 220 YVVRGNARL-------------PVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 628 ELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEA 687
+ + ++ GF+ + P ++ + +C
Sbjct: 266 PYPGIP----VDANFYKLIQNGFKMDQP---------------FYATEEIYIIMQSCWAF 306
Query: 688 DPEVRPRMKNVSENLE 703
D RP N++ L
Sbjct: 307 DSRKRPSFPNLTSFLG 322
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 60/297 (20%), Positives = 95/297 (31%), Gaps = 48/297 (16%)
Query: 414 VLGKSGLGIVYKVVL---GNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKL 468
LG G V K VAV+ L E + E + ++ +P IV++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ +L+ + G L L+ + + + + G+ YL
Sbjct: 74 IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
FVH D+ N+LL ISDFGLS+ + N +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW------------ 172
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
+ APE + + K DV+SFGV++ E + P ++ ++K
Sbjct: 173 -PVKWYAPE-CINYYKFSSKSDVWSFGVLMWEAFSYGQK---PYRGMKGS--EVTAMLEK 225
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
G P + M L C D E RP V L
Sbjct: 226 GERMGCP-AGCPREMY--------------DLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 5e-44
Identities = 57/290 (19%), Positives = 99/290 (34%), Gaps = 47/290 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G VYK + A + + E+ +++ E+ +A HPNIVKL +
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ + ++ +F + G + + L+ S + K T L YLH+ K
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H D+K NIL D ++DFG+S T S G
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY---------------- 175
Query: 593 YRAPEARVPGNRPMQ----KWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
+ APE + + K DV+S G+ L+E+ + P + ++ + K
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAK 229
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+ C E + + R +
Sbjct: 230 SEPPTLAQPSRWSSNFK-------------DFLKKCLEKNVDARWTTSQL 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 58/292 (19%), Positives = 108/292 (36%), Gaps = 46/292 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G G K+ +G + + L G E + V+EV + ++KHPNIV+
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 471 YYWAPDEKLL--ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE-- 526
L + ++ G+LA+ + + + L LR+ L H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
+H D+KP+N+ LD + DFGL+R++N ++ S + F+
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---HDTSFAKAFV----------- 175
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
T Y +PE + +K D++S G +L EL P T+ +L +
Sbjct: 176 --GTPYYMSPEQ-MNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKELAGKI 226
Query: 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
++G + + L + + RP ++ +
Sbjct: 227 REG--KFRRIPYRYSDELNE-------------IITRMLNLKDYHRPSVEEI 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 3e-43
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 54/291 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+G G VY + N VA++++ G+ ++ ++ + EV+ + K++HPN ++ R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
Y L+ ++ + L + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+H D+K NILL + DFG + ++ + F+G
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-------PANSFVG------------- 173
Query: 590 TNNYRAPE--ARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647
T + APE + + K DV+S G+ +EL K P ++ + +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE 230
Query: 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+ S+ + C + P+ RP + +
Sbjct: 231 SPALQSGHWSEYFRNFVDS-----------------CLQKIPQDRPTSEVL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-42
Identities = 65/310 (20%), Positives = 119/310 (38%), Gaps = 53/310 (17%)
Query: 406 ELLRASAY----VLGKSGLGIVYKVVL-----GNGIPVAVRRLGEGG-EQRHREFVTEVQ 455
+L+ + + VLG G VYK + IPVA++ L E + ++E + E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 456 AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAK 515
+A V +P++ +L +L+ + G L + +R L
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG----SQYLLNWCV 118
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFM 575
A+G+ YL R+ VH D+ N+L+ I+DFGL++L+ + GG
Sbjct: 119 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG-- 173
Query: 576 GGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635
+ +M A E+ + + DV+S+GV + EL+T S P
Sbjct: 174 KVPIKWM------------ALES-ILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGI 217
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695
++ ++KG P I V+ + + C D + RP+
Sbjct: 218 PAS--EISSILEKGERLPQP---------------PICTIDVYMIMVKCWMIDADSRPKF 260
Query: 696 KNVSENLERI 705
+ + ++
Sbjct: 261 RELIIEFSKM 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-42
Identities = 61/287 (21%), Positives = 92/287 (32%), Gaps = 43/287 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
LG+ G V V VAV+ + + E+ + H N+VK +
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+ + L ++ S G L + + G + R G+ YLH
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
H DIKP N+LLD ISDFGL+ + N G T
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFR-YNNRERLLNKMCG-------------TL 169
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651
Y APE + DV+S G+VL +L G+ + K+
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQEYSDWKEKKT 224
Query: 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
NP + A L L +P R + ++
Sbjct: 225 YLNPWKKIDSAPL--------------ALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 5e-42
Identities = 55/293 (18%), Positives = 109/293 (37%), Gaps = 53/293 (18%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ VYK + + VA L + + + F E + + ++HPNIV+
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 471 YYWAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ + + +L+++ +++G L L+ + + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT 130
Query: 527 CSPRKFVHGDIKPSNILL-DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+P +H D+K NI + I D GL+ L S + +G
Sbjct: 131 RTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL-----KRASFAKAVIG--------- 175
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645
T + APE + + + DVY+FG+ +LE+ T + P S + R
Sbjct: 176 ----TPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRR 224
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
V G + + + + + C + + R +K++
Sbjct: 225 VTSGVKPASFDKVAIPEVK--------------EIIEGCIRQNKDERYSIKDL 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 70/313 (22%), Positives = 116/313 (37%), Gaps = 57/313 (18%)
Query: 402 FELD----ELLRASAYVLGKSGLGIVYKVVL----GNGIPVAVRRLGEGGEQRHRE-FVT 452
+E+ EL R +G+ G V++ + + VA++ RE F+
Sbjct: 2 YEIQRERIELGR----CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 57
Query: 453 EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLR 512
E + + HP+IVKL + +I + + G L + L+ R SL ++ +
Sbjct: 58 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY----SLDLASLIL 112
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
A + LAYL ++FVH DI N+L+ ++ + DFGLSR + + +S G
Sbjct: 113 YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
+ +M + R DV+ FGV + E+L P
Sbjct: 170 ---KLPIKWM-------------APESINFRRFTSASDVWMFGVCMWEILMHGVK---PF 210
Query: 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692
D++ ++ G E P+ L L C DP R
Sbjct: 211 QGVKNN--DVIGRIENG--ERLPMPPNCPPTLYS-------------LMTKCWAYDPSRR 253
Query: 693 PRMKNVSENLERI 705
PR + L I
Sbjct: 254 PRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 60/299 (20%), Positives = 101/299 (33%), Gaps = 48/299 (16%)
Query: 414 VLGKSGLGIVYKVVL----GNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIV 466
LG G+V + G + VAV+ L + +F+ EV A+ + H N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+L P K+ +++ G+L + LR G T R A A G+ YL
Sbjct: 75 RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLES 129
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
++F+H D+ N+LL I DFGL R + ++ + P
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP-QNDDHYVMQEHRKVPFAWCAPES 185
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
+ D + FGV L E+ T P + ++ +
Sbjct: 186 LK-------------TRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGS--QILHKI 227
Query: 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
K E D + ++ + C PE RP + + L
Sbjct: 228 DKEGERLPRPEDCPQDIY--------------NVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 9e-41
Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 46/286 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+G+ G VY + + G VA+R++ + + + E+ + + K+PNIV Y
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
DE ++ ++++ G+L + + + + + + L +LH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 533 VHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNN 592
+H DIK NILL D ++DFG I + S+ G T
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG----------------TPY 181
Query: 593 YRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652
+ APE V K D++S G++ +E++ G+ P L+ + L G E
Sbjct: 182 WMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PLRALYLIATNGTPE 235
Query: 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+ C + D E R K +
Sbjct: 236 LQNPEKLSAIFR--------------DFLNRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-40
Identities = 69/303 (22%), Positives = 110/303 (36%), Gaps = 59/303 (19%)
Query: 402 FELD--ELLRASAYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG---GEQRHREFVTEVQ 455
+ L+ E+ R LGK G VY + +A++ L + + EV+
Sbjct: 3 WALEDFEIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 58
Query: 456 AIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAK 515
+ ++HPNI++L Y+ LI ++ G + L+ +
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYIT 113
Query: 516 GTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFM 575
A L+Y H ++ +H DIKP N+LL + + I+DFG S PSS +
Sbjct: 114 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA------PSSRRTTL 164
Query: 576 GGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635
G L Y+ PE + G +K D++S GV+ E L GK P
Sbjct: 165 CGTLDYL------------PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP-------- 203
Query: 636 SIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRM 695
E K+ E D V L + +P RP +
Sbjct: 204 -FEANTYQETYKRISRVEFTFPDFVTEGAR-------------DLISRLLKHNPSQRPML 249
Query: 696 KNV 698
+ V
Sbjct: 250 REV 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-39
Identities = 71/313 (22%), Positives = 120/313 (38%), Gaps = 59/313 (18%)
Query: 414 VLGKSGLGIVYKVVL--------GNGIPVAVRRL-GEGGEQRHREFVTEVQAIAKV-KHP 463
LG+ G V VAV+ L + E+ + ++E++ + + KH
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNG-----------QPSTSLSWSTRLR 512
NI+ L +I ++ S GNL L+ R P LS +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 513 IAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572
A ARG+ YL +K +H D+ N+L+ D I+DFGL+R I+ ++
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632
+ +M + + DV+SFGV+L E+ T P
Sbjct: 197 --GRLPVKWM-------------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PY 238
Query: 633 TSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVR 692
+E +L + +K+G + P S+ + + + + C A P R
Sbjct: 239 PGVPVE--ELFKLLKEGHRMDKP-SNCTNEL--------------YMMMRDCWHAVPSQR 281
Query: 693 PRMKNVSENLERI 705
P K + E+L+RI
Sbjct: 282 PTFKQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 1e-38
Identities = 72/304 (23%), Positives = 121/304 (39%), Gaps = 50/304 (16%)
Query: 414 VLGKSGLGIVYKVVL------GNGIPVAVRRLGEGGEQRHR-EFVTEVQAIAKVKHPNIV 466
LG+ G+VY+ V VA++ + E R R EF+ E + + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGR-----NGQPSTSLSWSTRLRIAKGTARGL 521
+L L+I + ++ G+L + LR N S S +++A A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 522 AYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPY 581
AYL+ KFVH D+ N ++ DF I DFG++R I T G +
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL------ 197
Query: 582 MKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641
+ +PE+ + DV+SFGVVL E+ T P S E
Sbjct: 198 --------PVRWMSPES-LKDGVFTTYSDVWSFGVVLWEIATLAEQ---PYQGLSNE--Q 243
Query: 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSEN 701
++R+V +G + P +F L C + +P++RP + +
Sbjct: 244 VLRFVMEGGLLDKP---------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 702 LERI 705
++
Sbjct: 289 IKEE 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (358), Expect = 7e-38
Identities = 56/288 (19%), Positives = 101/288 (35%), Gaps = 46/288 (15%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG G+V++V G A + + E E+Q ++ ++HP +V L +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+E ++I +F+S G L + + + +S + + +GL ++HE +
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE---NNY 145
Query: 533 VHGDIKPSNILLDNDFQPYI--SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
VH D+KP NI+ + DFGL+ ++ P T T
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-----------------PKQSVKVTTGT 188
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ APE G D++S GV+ LL+G SP ++ +
Sbjct: 189 AEFAAPE-VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-----NVKSCDW 242
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
++ + ADP R +
Sbjct: 243 NMDDSAFSGISEDGK-------------DFIRKLLLADPNTRMTIHQA 277
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 6e-37
Identities = 65/312 (20%), Positives = 108/312 (34%), Gaps = 57/312 (18%)
Query: 414 VLGKSGLGIVYKVV------LGNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKH-PNI 465
LG+ G V + VAV+ L EG HR ++E++ + + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 466 VKLRAYYWAPDEKLLI-SDFISNGNLANALRGRNGQPSTS-----------LSWSTRLRI 513
V L P L++ +F GNL+ LR + + L+ +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 514 AKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGG 573
+ A+G+ +L RK +H D+ NILL I DFGL+R I +
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD- 195
Query: 574 FMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTT 633
L +M + + DV+SFGV+L E+ + +
Sbjct: 196 -ARLPLKWM-------------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 634 STSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
+ R +K+G P ++ L C +P RP
Sbjct: 242 ----IDEEFCRRLKEGTRMRAP---------------DYTTPEMYQTMLDCWHGEPSQRP 282
Query: 694 RMKNVSENLERI 705
+ E+L +
Sbjct: 283 TFSELVEHLGNL 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (350), Expect = 9e-37
Identities = 62/301 (20%), Positives = 114/301 (37%), Gaps = 45/301 (14%)
Query: 373 NEDSEVEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVV-LGNG 431
+ D ED K K + V + +G ++ ++L LG G+V++ V G
Sbjct: 3 DYDKFYEDIWK----KYVPQPVEVKQGSVYDYYDILE----ELGSGAFGVVHRCVEKATG 54
Query: 432 IPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491
+ + E+ + ++ HP ++ L + E +LI +F+S G L
Sbjct: 55 RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114
Query: 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551
+ + + + +S + + + GL ++HE VH DIKP NI+ +
Sbjct: 115 DRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASS 167
Query: 552 I--SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKW 609
+ DFGL+ +N ++ T + APE V
Sbjct: 168 VKIIDFGLATKLNPDEIVKVTTA-----------------TAEFAAPEI-VDREPVGFYT 209
Query: 610 DVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENP------LSDMVDAM 663
D+++ GV+ LL+G SP +E V+ F+E+ D + +
Sbjct: 210 DMWAIGVLGYVLLSGLSPF---AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266
Query: 664 L 664
L
Sbjct: 267 L 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 133 bits (336), Expect = 1e-35
Identities = 63/301 (20%), Positives = 116/301 (38%), Gaps = 49/301 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+LG G+ V+ L VAV+ L + F E Q A + HP IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 470 AYYWAPDEKL----LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
A ++ +++ L + + ++ + + + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFSH 128
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+ +H D+KP+NI++ + DFG++R I +GN+ + + +G
Sbjct: 129 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG--------- 176
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645
T Y +PE + G+ + DVYS G VL E+LTG+ P + V +
Sbjct: 177 ----TAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----PVSVAYQH 226
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-MKNVSENLER 704
V++ + + + A L V+ L +PE R + + +L R
Sbjct: 227 VREDPIPPSARHEGLSADL-------DAVV------LKALAKNPENRYQTAAEMRADLVR 273
Query: 705 I 705
+
Sbjct: 274 V 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 27/218 (12%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+LG+ V L A++ L E + E ++++ HP VKL
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ ++ + NG L +R S + L YLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG--- 126
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+ +H D+KP NILL+ D I+DFG +++++ ++ G Y+
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--FVGTAQYV------- 177
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+PE + + D+++ G ++ +L+ G P
Sbjct: 178 -----SPEL-LTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 8e-35
Identities = 50/303 (16%), Positives = 99/303 (32%), Gaps = 53/303 (17%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
LG+ GIV++ V + + + G + E+ + +H NI+ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
+ +E ++I +FIS ++ + + L+ + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 533 VHGDIKPSNILLDND--FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
H DI+P NI+ I +FG +R + N + A Y P +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-----LFTAPEYYAPEVHQ-- 176
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650
+ D++S G ++ LL+G +P L+ T IE + +
Sbjct: 177 -----------HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE-----NIMNAEY 220
Query: 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV------SENLER 704
+ + + + + R + +ER
Sbjct: 221 TFDEEAFKEISIEAMD-------------FVDRLLVKERKSRMTASEALQHPWLKQKIER 267
Query: 705 IGT 707
+ T
Sbjct: 268 VST 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (329), Expect = 1e-34
Identities = 62/296 (20%), Positives = 108/296 (36%), Gaps = 49/296 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---------GEGGEQRHREFVTEVQAIAKVK-H 462
+LG+ +V + + AV+ + E ++ + EV + KV H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 463 PNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLA 522
PNI++L+ Y L+ D + G L + L + LS +I + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVIC 124
Query: 523 YLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
LH+ VH D+KP NILLD+D ++DFG S + +P + G Y+
Sbjct: 125 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-----DPGEKLREVCGTPSYL 176
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
P E + N P ++ D++S GV++ LL G P ++ L
Sbjct: 177 APEIIECSMNDNHPGY-------GKEVDMWSTGVIMYTLLAGSPPFWHRK-----QMLML 224
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+ ++ +P D + L P+ R +
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVK-------------DLVSRFLVVQPQKRYTAEEA 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 50/238 (21%), Positives = 98/238 (41%), Gaps = 35/238 (14%)
Query: 399 GFTFELD---ELLRASAYVLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHRE-FVTE 453
G F++ L +G+ G+V N + VA++++ Q + + + E
Sbjct: 1 GQVFDVGPRYTNLS----YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE 56
Query: 454 VQAIAKVKHPNIVKLRAYYWAPD----EKLLISDFISNGNLANALRGRNGQPSTSLSWST 509
++ + + +H NI+ + AP + + + + +L L+ ++ LS
Sbjct: 57 IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDH 110
Query: 510 RLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569
RGL Y+H +H D+KPSN+LL+ I DFGL+R+ + ++
Sbjct: 111 ICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
++ YRAPE + + D++S G +L E+L+ +
Sbjct: 168 FLTEYVATR-------------WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 2e-34
Identities = 60/260 (23%), Positives = 96/260 (36%), Gaps = 35/260 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL------GEGGEQRHREFVTEVQAIAKVKHPNIV 466
++G+ G G VY G A++ L + GE + ++ P IV
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
+ + PD+ I D ++ G+L L + A GL ++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIILGLEHMHN 125
Query: 527 CSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
R V+ D+KP+NILLD ISD GL+ + KP
Sbjct: 126 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------------------KPHA 164
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
+ T+ Y APE G D +S G +L +LL G SP T E+ + +
Sbjct: 165 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
Query: 647 KKGFEEENP--LSDMVDAML 664
+ L +++ +L
Sbjct: 225 AVELPDSFSPELRSLLEGLL 244
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-33
Identities = 58/295 (19%), Positives = 101/295 (34%), Gaps = 33/295 (11%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ G+VYK G VA++ RL E + E+ + ++ HPNIVKL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
++ L+ +F+ T + +GLA+ H
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDA----SALTGIPLPLIKSYLFQLLQGLAFCHS---H 121
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+ +H D+KP N+L++ + ++DFGL+R + + +
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-------------- 167
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-------ELSPTTSTSIEVPDLV 643
YRAPE + D++S G + E++T ++ + ++ PD V
Sbjct: 168 --YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
W + S A L DP R K
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 126 bits (316), Expect = 8e-33
Identities = 60/294 (20%), Positives = 105/294 (35%), Gaps = 33/294 (11%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAY 471
+G+ G+VYK G A++ RL + E + E+ + ++KH NIVKL
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+L+ + + G L T G+AY H+ R+
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 532 FVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTN 591
+H D+KP N+L++ + + I+DFGL+R I + +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW--------------- 165
Query: 592 NYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE-------VPDLVR 644
YRAP+ + + D++S G + E++ G + + + P+
Sbjct: 166 -YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
W + + V L E K + L + DP R K
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (316), Expect = 1e-32
Identities = 43/296 (14%), Positives = 95/296 (32%), Gaps = 37/296 (12%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
+G G +Y + G VA++ + +H + E + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 473 WAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKF 532
A + ++ + +L + + + S T L +A + Y+H + F
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 533 VHGDIKPSNIL---LDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+H D+KP N L YI DFGL++ + +PY +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH---------QHIPYRENKNLTG 175
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649
T Y + + G ++ D+ S G VL+ G ++ +
Sbjct: 176 TARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGS-----LPWQGLKAATKRQKYERIS 229
Query: 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
++ + +++ E C + +P + + +
Sbjct: 230 EKKMSTPIEVLCKGYPSEFA---------TYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-32
Identities = 65/290 (22%), Positives = 102/290 (35%), Gaps = 49/290 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHRE-FVTEVQAIAKVKHPNIVKLRAY 471
VLG V VA++ + + + E+ + K+KHPNIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
Y + LI +S G L + + + + R+ + YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL---G 127
Query: 532 FVHGDIKPSNILL---DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
VH D+KP N+L D D + ISDFGLS++ + ++ G
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACG---------------- 171
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648
T Y APE + + D +S GV+ LL G P + E + +K
Sbjct: 172 -TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-----QILKA 224
Query: 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
+E ++P D + E DPE R +
Sbjct: 225 EYEFDSPYWDDISDSAKD-------------FIRHLMEKDPEKRFTCEQA 261
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 124 bits (312), Expect = 4e-32
Identities = 80/311 (25%), Positives = 121/311 (38%), Gaps = 54/311 (17%)
Query: 23 DGLTLLSLKSAIDQTDTSVFADWNEN-DPTPCRWSGISCMNITGFPDPRVVGVAISGKNV 81
D LL +K + + + + W D W G+ C T RV + +SG N+
Sbjct: 7 DKQALLQIKKDL--GNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTY--RVNNLDLSGLNL 62
Query: 82 RGY--IPSELGSLIYLRRLNLHNN-NLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC 138
IPS L +L YL L + NL G +P + T LH +++ N+SG++P +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 139 NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198
+ L LD S N+ SG+LP + + L + N+ SG IP + + +S
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 199 DNDFKGPIPND---------------------------------------------LGEL 213
N G IP L
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 214 QSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273
L+L N + G +P+ L L S ++ NNL GEIPQ G+ +A+ +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 274 LLCGFPLQKSC 284
LCG PL +C
Sbjct: 303 CLCGSPL-PAC 312
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 6e-32
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 30/219 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKV-KHPNIVKL 468
+LGK G V+ A++ L + + E + ++ +HP + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 469 RAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS 528
+ + + ++++ G+L ++ + S A GL +LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHS-- 121
Query: 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+ V+ D+K NILLD D I+DFG+ + + ++ G
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG--------------- 165
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
T +Y APE + G + D +SFGV+L E+L G+SP
Sbjct: 166 -TPDYIAPEI-LLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 1e-31
Identities = 63/295 (21%), Positives = 104/295 (35%), Gaps = 41/295 (13%)
Query: 414 VLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYY 472
V+G G+VY+ L +G VA++++ + ++RE +Q + K+ H NIV+LR ++
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFF 82
Query: 473 WAPDEK------LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
++ EK L+ D++ A + +L R LAY+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK--QTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 527 CSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
H DIKP N+LLD D + DFG ++ + + Y P
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-----VRGEPNVSYICSRYYRAPE 192
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP-------ELSPTTSTSIE 638
+Y DV+S G VL ELL G+ + +
Sbjct: 193 LIFGATDYT------------SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240
Query: 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP 693
P + + + A +V + L E P R
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (307), Expect = 1e-31
Identities = 44/299 (14%), Positives = 90/299 (30%), Gaps = 41/299 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAY 471
+G+ G++++ L N VA++ + E + + I + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK 531
+L+ D + G L G+ S T AK + +HE +
Sbjct: 70 GQEGLHNVLVIDLL--GPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 532 FVHGDIKPSNILLDNDFQP-----YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQ 586
V+ DIKP N L+ Y+ DFG+ + +PY +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY---------RDPVTKQHIPYREKKN 172
Query: 587 TEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646
T Y + G ++ D+ + G V + L G P +T+ + + +
Sbjct: 173 LSGTARYMSINT-HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231
Query: 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705
K+ + + + + P + ++
Sbjct: 232 KQSTPLRELCAGFPEEF--------------YKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-31
Identities = 57/295 (19%), Positives = 95/295 (32%), Gaps = 63/295 (21%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL------GEGGEQRHREFVTEVQAIAKVK--HPN 464
+LG G G VY + + + +PVA++ + G EV + KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 465 IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYL 524
+++L ++ PD +LI + G +L + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 525 HECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMK 583
H +H DIK NIL+D N + + DFG L+ T F G
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-----FDG------- 171
Query: 584 PVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643
T Y PE + V+S G++L +++ G P
Sbjct: 172 ------TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------- 209
Query: 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
FE + +++ + E HL C P RP + +
Sbjct: 210 ------FEHDE---EIIRGQVFFRQRVSSECQ---HLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 7e-31
Identities = 55/295 (18%), Positives = 99/295 (33%), Gaps = 54/295 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAY 471
VLG G V ++ A++ L Q + EV+ + + P+IV++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 472 YWAPDEK----LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
Y L++ + + G L + ++ R Q + I K + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHS- 129
Query: 528 SPRKFVHGDIKPSNILLDNDFQPY---ISDFGLSRLINITGNNPSSSGGFMGGALPYMKP 584
H D+KP N+L + ++DFG ++ +
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------SHNSL 170
Query: 585 VQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644
T Y APE + + + D++S GV++ LL G P + P +
Sbjct: 171 TTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIMYILLCGYPPF--YSNHGLAISPGMKT 227
Query: 645 WVKKG-FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
++ G +E NP V + L + +P R +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKM-------------LIRNLLKTEPTQRMTITEF 269
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 60/299 (20%), Positives = 104/299 (34%), Gaps = 40/299 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL-----GEGGEQRHREFVTEVQAIAKVKHPNIVK 467
LG+ VYK VA++++ E + +R + E++ + ++ HPNI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 468 LRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
L + L+ DF+ L+ S T +GL YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLHQH 119
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
+H D+KP+N+LLD + ++DFGL++ P
Sbjct: 120 WI---LHRDLKPNNLLLDENGVLKLADFGLAKSFGS----------------PNRAYTHQ 160
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647
T YRAPE D+++ G +L ELL P S ++ + +
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLG 218
Query: 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVF--------HLALACTEADPEVRPRMKNV 698
EE+ P + + + + +F L +P R
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-30
Identities = 59/301 (19%), Positives = 105/301 (34%), Gaps = 40/301 (13%)
Query: 414 VLGKSGLGIVYKV--VLGNGIPVAVRRL-----GEGGEQRHREFVTEVQAIAKVKHPNIV 466
+G+ G V+K + G VA++R+ EG V ++ + +HPN+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 467 KLRAYYWAPDEKLLISDFISNGNLAN-ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLH 525
+L + ++ + P + T + RGL +LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 526 ECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPV 585
+ VH D+KP NIL+ + Q ++DFGL+R+ + S
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV------------- 177
Query: 586 QTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645
T YRAPE + + D++S G + E+ K S+ ++ +
Sbjct: 178 ----TLWYRAPE-VLLQSSYATPVDLWSVGCIFAEMFRRKPL---FRGSSDVDQLGKILD 229
Query: 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVF--------HLALACTEADPEVRPRMKN 697
V EE+ D+ + + + L L C +P R +
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289
Query: 698 V 698
Sbjct: 290 A 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 2e-29
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 32/218 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LG G V+ + NG A++ L ++ E ++ V HP I+++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ + +I D+I G L + LR P A L YLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-----NPVAKFYAAEVCLALEYLHS--- 122
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
+ ++ D+KP NILLD + I+DFG ++ + + + G
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPD------------- 166
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y APE V + D +SFG+++ E+L G +P
Sbjct: 167 ---YIAPEV-VSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 3e-29
Identities = 51/301 (16%), Positives = 95/301 (31%), Gaps = 31/301 (10%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ G V+K G VA++++ E + E++ + +KH N+V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 471 YYWAPDEKLLISD---FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC 527
++ + L G + S R+ + GL Y+H
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN 136
Query: 528 SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQT 587
K +H D+K +N+L+ D ++DFGL+R ++ N+ + L Y P
Sbjct: 137 ---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 588 EKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEV-------- 639
+Y D++ G ++ E+ T T + +
Sbjct: 194 LGERDY------------GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 640 --PDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKN 697
E+ L + + A L DP R +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 698 V 698
Sbjct: 302 A 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 8e-29
Identities = 56/297 (18%), Positives = 103/297 (34%), Gaps = 37/297 (12%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVR--RLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G+ G V+K VA++ RL + E + E+ + ++KH NIV+L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ + L+ +F +GL + H R
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD-----PEIVKSFLFQLLKGLGFCH---SR 120
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+KP N+L++ + + +++FGL+R I S+ T
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEV----------------VT 164
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650
YR P+ D++S G + EL P L P ++ + R +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP-LFPGNDVDDQLKRIFRLLGTPT 223
Query: 651 EEENP-LSDMVDAMLLQEVHAKKEVIAVF--------HLALACTEADPEVRPRMKNV 698
EE+ P ++ + D A ++ V L + +P R +
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 9e-28
Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 26/217 (11%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G G V V G VA+++L E + E++ + ++H N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ + +DF G+ + L + +GL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA---A 140
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+KP N+ ++ D + I DFGL+R + + +
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRW-------------- 183
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
YRAPE + R Q D++S G ++ E++TGK+
Sbjct: 184 --YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 9e-28
Identities = 48/218 (22%), Positives = 79/218 (36%), Gaps = 29/218 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
+LGK G V V G A++ L + VTE + + +HP + L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ D + ++ + G L L + L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHS--- 123
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
R V+ DIK N++LD D I+DFGL + G + ++ G Y+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATMKTFCGTPEYL------- 172
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ N + D + GVV+ E++ G+ P
Sbjct: 173 ------APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 55/296 (18%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL------GEGGEQRHREFVTEVQAIAKVKHPNIV 466
LG +V K G+ A + + + EV + +++HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 467 KLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHE 526
L Y + +LI + ++ G L + L + L+ K G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLHS 131
Query: 527 CSPRKFVHGDIKPSNILLDNDFQP----YISDFGLSRLINITGNNPSSSGGFMGGALPYM 582
+ H D+KP NI+L + P I DFGL+ I + + G
Sbjct: 132 ---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI----DFGNEFKNIFG------ 178
Query: 583 KPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDL 642
T + APE V + D++S GV+ LL+G SP L T E
Sbjct: 179 -------TPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLAN 227
Query: 643 VRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNV 698
V V FE+E + A DP+ R +++
Sbjct: 228 VSAVNYEFEDEYFSNTSALAK---------------DFIRRLLVKDPKKRMTIQDS 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 2e-26
Identities = 39/218 (17%), Positives = 76/218 (34%), Gaps = 32/218 (14%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL---GEGGEQRHREFVTEVQAIAKVKHPNIVKLR 469
LG G V V +G A++ L ++ + E + + V P +VKL
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 470 AYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
+ ++ ++++ G + + LR S A YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHS--- 159
Query: 530 RKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEK 589
++ D+KP N+L+D ++DFG ++ + + G + P
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-------LCGTPEALAPEI--- 209
Query: 590 TNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ + D ++ GV++ E+ G P
Sbjct: 210 ----------ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 7e-26
Identities = 69/325 (21%), Positives = 112/325 (34%), Gaps = 59/325 (18%)
Query: 378 VEDQEKVESGKGEGELVAIDKGFTFELDELLRASAYVLGKSGLGIVYKVVL----GNGIP 433
V+ + + + G E V I+ FEL + VLG G V+ V G
Sbjct: 5 VKHELRTANLTGHAEKVGIEN---FELLK-------VLGTGAYGKVFLVRKISGHDTGKL 54
Query: 434 VAVRRL----GEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLISDFISNG 488
A++ L + TE Q + ++ P +V L + + LI D+I+ G
Sbjct: 55 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 114
Query: 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF 548
L L R + + L ++ DIK NILLD++
Sbjct: 115 ELFTHLSQRERFTEH--------EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166
Query: 549 QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQK 608
++DFGLS+ + + G + YM P ++
Sbjct: 167 HVVLTDFGLSKEFV---ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV---------- 213
Query: 609 WDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEV 668
D +S GV++ ELLTG SP E ++ + E P + A+
Sbjct: 214 -DWWSLGVLMYELLTGASPFTVDG-----EKNSQAEISRRILKSEPPYPQEMSALA---- 263
Query: 669 HAKKEVIAVFHLALACTEADPEVRP 693
K++I DP+ R
Sbjct: 264 ---KDLIQ------RLLMKDPKKRL 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 101 bits (253), Expect = 4e-24
Identities = 37/219 (16%), Positives = 81/219 (36%), Gaps = 36/219 (16%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAY 471
LG+ V++ + + N V V+ L + ++ E++ + ++ PNI+ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADI 98
Query: 472 YWAPDEKL--LISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSP 529
P + L+ + ++N + + +L+ + L Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS--- 147
Query: 530 RKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTE 588
+H D+KP N+++D++ + + D+GL+ + P + + P
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-----PGQEYNVRVASRYFKGPELLV 202
Query: 589 KTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
Y D++S G +L ++ K P
Sbjct: 203 DYQMY------------DYSLDMWSLGCMLASMIFRKEP 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 3e-23
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 26/217 (11%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G G V G+ VAV++L + E++ + +KH N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ +D +L A + L+ + RGL Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+KPSN+ ++ D + I DFGL+R + + T
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-------------------DEMTGYVAT 181
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
YRAPE + Q D++S G ++ ELLTG++
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.4 bits (236), Expect = 8e-22
Identities = 46/217 (21%), Positives = 76/217 (35%), Gaps = 26/217 (11%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRL--GEGGEQRHREFVTEVQAIAKVKHPNIVKLRA 470
+G GIV VA+++L + + E+ + V H NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 471 YYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPR 530
+ D L +A + Q + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQMLCGIKHLHSA--- 138
Query: 531 KFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKT 590
+H D+KPSNI++ +D I DFGL+R + T
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-----------------T 181
Query: 591 NNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
YRAPE + G + D++S G ++ E++ K
Sbjct: 182 RYYRAPE-VILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.1 bits (230), Expect = 6e-21
Identities = 47/186 (25%), Positives = 64/186 (34%), Gaps = 30/186 (16%)
Query: 90 GSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149
L L L NN + P + T+L + L GN L ++ +L L +LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIP-------------------AGIWPELE 190
NN S P L +L L L N+ S P L+
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 191 NLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN 250
NL L L N+ P + L L L + N +S SL NL N
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 251 LSGEIP 256
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.8 bits (185), Expect = 3e-15
Identities = 35/145 (24%), Positives = 49/145 (33%), Gaps = 29/145 (20%)
Query: 76 ISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATS----------------- 118
++ + P L L L L L N + P A +
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305
Query: 119 ---LHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN 175
L + LY NN+S P V +L +LQ L +NN S L N + L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 176 KFSGQIPAGIWPELENLVQLDLSDN 200
+ S P L + QL L+D
Sbjct: 362 QISDLTPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 11/69 (15%), Positives = 30/69 (43%), Gaps = 4/69 (5%)
Query: 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA 183
L N++ ++ + +L ++ L S+ DG++ L ++ + N+ + P
Sbjct: 29 LGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITPL 84
Query: 184 GIWPELENL 192
+L ++
Sbjct: 85 KNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 10/70 (14%), Positives = 21/70 (30%), Gaps = 5/70 (7%)
Query: 187 PELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL 246
L ++ L + + +L ++ TL + I + L +
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVT-TLQADRLGIK-SI-DGVEYLNNLTQINF 73
Query: 247 RGNNLSGEIP 256
N L+ P
Sbjct: 74 SNNQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 4e-04
Identities = 18/90 (20%), Positives = 35/90 (38%), Gaps = 11/90 (12%)
Query: 66 FPDP---RVVGVAISGKNVRGYIP-SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHS 121
F D + + NV + ++L + L + S+ D + +L
Sbjct: 16 FTDTALAEKMKTVLGKTNVTDTVSQTDLDQV---TTLQADRLGI-KSI-DGVEYLNNLTQ 70
Query: 122 IFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151
I N L+ P + NL +L ++ ++NN
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 7/78 (8%)
Query: 139 NLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLS 198
L L + + ++ + Q+ L R I G+ L NL Q++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVE-YLNNLTQINFS 74
Query: 199 DNDFKGPIPNDLGELQSL 216
+N P L L L
Sbjct: 75 NNQLTDITP--LKNLTKL 90
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.3 bits (220), Expect = 9e-20
Identities = 42/227 (18%), Positives = 78/227 (34%), Gaps = 31/227 (13%)
Query: 414 VLGKSGLGIVYKVV-LGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPN-------- 464
LG V+ + N VA++ + G + E++ + +V +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 465 ---IVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGL 521
I+KL ++ + + N L + +I+K GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 522 AYLHECSPRKFVHGDIKPSNILLD-NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALP 580
Y+H +H DIKP N+L++ D + ++ L N
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN--------------ACWY 182
Query: 581 YMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSP 627
+ +T YR+PE + G D++S ++ EL+TG
Sbjct: 183 DEHYTNSIQTREYRSPEVLL-GAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.7 bits (188), Expect = 9e-17
Identities = 20/159 (12%), Positives = 47/159 (29%), Gaps = 22/159 (13%)
Query: 414 VLGKSGLGIVYKVVLGNGIPVAV----------RRLGEGGEQRHREFVTEVQAIAKVKHP 463
++G+ V+ V +++ E + F A+ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 464 NIVKLRAYYWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAY 523
+ KL+ + + A + + + + + +A
Sbjct: 67 ALQKLQGLA--------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 524 LHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562
+ VHGD+ N+L+ + +I DF S +
Sbjct: 119 FYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 2e-15
Identities = 37/191 (19%), Positives = 59/191 (30%), Gaps = 28/191 (14%)
Query: 86 PSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQN 145
P+ L L L+L L P +L ++L N L + +L L +
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWP------------------ 187
L L N S + L RL+L +N+ + P
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217
Query: 188 -----ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTV 242
L L L L+DN + L + S + + +P+ L +
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK- 274
Query: 243 SFDLRGNNLSG 253
L N+L G
Sbjct: 275 --RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 5e-11
Identities = 44/223 (19%), Positives = 70/223 (31%), Gaps = 30/223 (13%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNN---------------- 128
+P + + +R+ LH N + +L ++L+ N
Sbjct: 26 VPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 129 ---------LSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG 179
L P + L RL L L P + LQ L L N
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 180 QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLP 239
+P + +L NL L L N L SL L N ++ P + +L
Sbjct: 144 -LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLG 201
Query: 240 VTVSFDLRGNNLSGEIPQTGSFANQGPTAFLS-NPLLCGFPLQ 281
++ L NNLS + + L+ NP +C +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 25/149 (16%), Positives = 44/149 (29%), Gaps = 29/149 (19%)
Query: 80 NVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCN 139
++ L L L LH N + SL + L+ N ++ P + +
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 140 LP------------------------RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN 175
L LQ L L++N + LQ+ + +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSS 258
Query: 176 KFSGQIPAGIWPELENLVQLDLSDNDFKG 204
+ +P L L+ ND +G
Sbjct: 259 EVPCSLP----QRLAGRDLKRLAANDLQG 283
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.9 bits (180), Expect = 7e-15
Identities = 35/176 (19%), Positives = 69/176 (39%), Gaps = 12/176 (6%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P +L L+L NN + N +LH++ L N +S P + L +L+
Sbjct: 25 VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK- 203
L LS N LP+ + Q L + N+ + + ++ L ++ ++L N K
Sbjct: 83 RLYLSKNQLK-ELPEKMPKTL--QELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKS 138
Query: 204 -GPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
G ++ LS ++ +++ +L L GN ++ +
Sbjct: 139 SGIENGAFQGMKKLSYI-RIADTNITTIPQGLPPSL---TELHLDGNKITKVDAAS 190
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 62.7 bits (151), Expect = 3e-11
Identities = 33/177 (18%), Positives = 58/177 (32%), Gaps = 12/177 (6%)
Query: 91 SLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSN 150
+ + + L + G L I + N++ ++P P L L L
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG--LPPSLTELHLDG 180
Query: 151 NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDL 210
N + LK L +L L+ N S G +L +L L++N +P L
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDN-GSLANTPHLRELHLNNNKLV-KVPGGL 238
Query: 211 GELQSLSATLNLSYNHLSG------KIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSF 261
+ + + + L N++S P L N + Q +F
Sbjct: 239 ADHKYIQ-VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTF 294
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 59.0 bits (142), Expect = 3e-11
Identities = 23/110 (20%), Positives = 37/110 (33%), Gaps = 8/110 (7%)
Query: 146 LDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205
L L++ + L+ + L L+ N+ P L L L++
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-----PPALAALRCLEVLQASDNAL 55
Query: 206 IPNDLGELQSLSATLNLSYNHL-SGKIPKSLGNLPVTVSFDLRGNNLSGE 254
D L L N L + L + P V +L+GN+L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 3e-09
Identities = 29/126 (23%), Positives = 50/126 (39%), Gaps = 6/126 (4%)
Query: 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG 155
R L+L + +L ++ L + + L N L PP++ L L+ L S+N+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALEN 57
Query: 156 SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQS 215
DG+ N +LQ L+L N+ LV L+L N L
Sbjct: 58 --VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 216 LSATLN 221
+ +++
Sbjct: 115 MLPSVS 120
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 4e-09
Identities = 23/108 (21%), Positives = 37/108 (34%), Gaps = 8/108 (7%)
Query: 124 LYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA 183
L +L+ + L + +LDLS+N P L+ L + + +
Sbjct: 5 LAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENV 58
Query: 184 GIWPELENLVQLDLSDNDFKG-PIPNDLGELQSLSATLNLSYNHLSGK 230
L L +L L +N + L L LNL N L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV-LLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 20/113 (17%), Positives = 36/113 (31%), Gaps = 27/113 (23%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLH----------------------SI 122
+ L L+ + L+L +N L P L L +
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 123 FLYGNNL-SGSLPPSVCNLPRLQNLDLSNNSFSG--SLPDGL-KNCKQLQRLI 171
L N L + + + PRL L+L NS + + L + + ++
Sbjct: 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 61.4 bits (147), Expect = 1e-10
Identities = 24/97 (24%), Positives = 39/97 (40%), Gaps = 10/97 (10%)
Query: 120 HSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSG 179
Y N S + P L+ L++SNN LP L+RLI + N +
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA- 317
Query: 180 QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSL 216
++P +NL QL + N + P+ ++ L
Sbjct: 318 EVP----ELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.7 bits (127), Expect = 3e-08
Identities = 23/125 (18%), Positives = 39/125 (31%), Gaps = 12/125 (9%)
Query: 44 DWNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNN 103
D E + + P + + N + SL LN+ NN
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL---EELNVSNN 294
Query: 104 NLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKN 163
L LP L + N+L+ +P L+ L + N PD ++
Sbjct: 295 KL-IELPALP---PRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIPES 345
Query: 164 CKQLQ 168
+ L+
Sbjct: 346 VEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 3e-07
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 10/83 (12%)
Query: 174 RNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPK 233
S + +L +L++S+N +P L+ L S+NHL+ ++P+
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE----RLIASFNHLA-EVPE 321
Query: 234 SLGNLPVTVSFDLRGNNLSGEIP 256
NL + N L E P
Sbjct: 322 LPQNL---KQLHVEYNPLR-EFP 340
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 2e-05
Identities = 14/66 (21%), Positives = 27/66 (40%), Gaps = 11/66 (16%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P+ L RL N+L +P+ N LH + N L P + ++
Sbjct: 299 LPALPPRL---ERLIASFNHL-AEVPELPQNLKQLH---VEYNPLR-EFPDIPES---VE 347
Query: 145 NLDLSN 150
+L +++
Sbjct: 348 DLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 2e-04
Identities = 15/59 (25%), Positives = 24/59 (40%), Gaps = 5/59 (8%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153
L L+N L SLP+ + SL N+L+ LP +L L + + +
Sbjct: 40 AHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 16/67 (23%), Positives = 32/67 (47%), Gaps = 9/67 (13%)
Query: 138 CNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197
C + L+L+N S SLP+ + L+ L+ + N + ++P ++L L +
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELP----ELPQSLKSLLV 85
Query: 198 SDNDFKG 204
+N+ K
Sbjct: 86 DNNNLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 18/54 (33%), Positives = 24/54 (44%), Gaps = 8/54 (14%)
Query: 115 NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQ 168
A L L LS SLP P L++L S NS + LP+ ++ K L
Sbjct: 39 QAHELE---LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLL 84
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 4e-10
Identities = 25/102 (24%), Positives = 46/102 (45%), Gaps = 4/102 (3%)
Query: 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG 155
+ L+L NL + +L + + + + + L + R+Q++DLSN+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 156 -SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+L L C +LQ L L + S I + + NLV+L+
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLA-KNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 1e-06
Identities = 17/97 (17%), Positives = 34/97 (35%), Gaps = 5/97 (5%)
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
Q LDL+ + + L + + + R+ + + +DLS++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF--SPFRVQHMDLSNSVIE 59
Query: 204 G-PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLP 239
+ L + L L+L LS I +L
Sbjct: 60 VSTLHGILSQCSKLQ-NLSLEGLRLSDPIVNTLAKNS 95
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 39/236 (16%), Positives = 77/236 (32%), Gaps = 37/236 (15%)
Query: 58 ISCMNITGFPDPRVVGVAIS----GKNVRGYIPSELGSLIYLRRLNLHNNNL-FGSLPDQ 112
++ N+ R++ + ++ +E S ++ ++L N+ + +L
Sbjct: 7 LTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGI 66
Query: 113 LFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS--NNSFSGSLPDGLKNCKQLQ-- 168
L + L ++ L G LS + ++ L L+LS + +L L +C +L
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 169 ---------------------------RLILARNKFSGQIPAGIWPELENLVQLDLSDND 201
L R + + NLV LDLSD+
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 202 FKGPIPNDLGELQSLSATLNLSY-NHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256
+ L+LS + + LG +P + + G G +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.003
Identities = 15/92 (16%), Positives = 28/92 (30%), Gaps = 6/92 (6%)
Query: 101 HNNNLFGSLPDQLFNATSLHSIFLYG-NNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPD 159
+ L + F L + L ++ + +P L+ L + G+L
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 160 GLKNCKQLQRLI-----LARNKFSGQIPAGIW 186
+ LQ +AR + IW
Sbjct: 244 LKEALPHLQINCSHFTTIARPTIGNKKNQEIW 275
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (140), Expect = 1e-09
Identities = 19/90 (21%), Positives = 31/90 (34%), Gaps = 8/90 (8%)
Query: 139 NLPRLQNLDLSNNSFSG----SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELEN--- 191
L+ L L++ S SL L L+ L L+ N + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 192 -LVQLDLSDNDFKGPIPNDLGELQSLSATL 220
L QL L D + + + L L+ +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 8/92 (8%)
Query: 143 LQNLDLSNNSFSGS-LPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE---NLVQLDLS 198
+Q+LD+ S + + L +Q Q + L + I L L +L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 199 DNDFKGPIPNDLGE-LQSLS---ATLNLSYNH 226
N+ + + + LQ+ S L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 2e-08
Identities = 18/96 (18%), Positives = 39/96 (40%), Gaps = 9/96 (9%)
Query: 110 PDQLFNATSLHSIFLYGNNLSG----SLPPSVCNLPRLQNLDLSNNSFSGS----LPDGL 161
+ L ++L ++S SL ++ L+ LDLSNN + L + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 162 K-NCKQLQRLILARNKFSGQIPAGIWPELENLVQLD 196
+ L++L+L +S ++ + ++ L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 15/88 (17%), Positives = 33/88 (37%), Gaps = 10/88 (11%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNA-TSLHSIFLYGNNLSG----SLPPSVCNLPRLQNLDLS 149
++ L++ L + +L + L L+ + ++ P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 150 NNSFSG----SLPDGLK-NCKQLQRLIL 172
+N + GL+ ++Q+L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 4e-08
Identities = 19/91 (20%), Positives = 32/91 (35%), Gaps = 5/91 (5%)
Query: 167 LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG----PIPNDLGELQSLSATLNL 222
+Q L + + S A + P L+ + L D I + L +L+ LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA-ELNL 62
Query: 223 SYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253
N L + T S ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 23/139 (16%), Positives = 40/139 (28%), Gaps = 13/139 (9%)
Query: 45 WNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN 104
C + ++ + VR LR L L + +
Sbjct: 321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 380
Query: 105 L----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-----NLPRLQNLDLSNNSFSG 155
+ SL L SL + L N L + + L+ L L + +S
Sbjct: 381 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440
Query: 156 SLPDGL----KNCKQLQRL 170
+ D L K+ L+ +
Sbjct: 441 EMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 5e-06
Identities = 14/72 (19%), Positives = 22/72 (30%), Gaps = 6/72 (8%)
Query: 191 NLVQLDLSDNDFK-GPIPNDLGELQSLSATLNLSYNHLSGK----IPKSLGNLPVTVSFD 245
++ LD+ + L LQ + L L+ I +L P +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQ-VVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 246 LRGNNLSGEIPQ 257
LR N L
Sbjct: 62 LRSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 18/83 (21%), Positives = 24/83 (28%), Gaps = 10/83 (12%)
Query: 184 GIWPELENLVQLDLSDNDFKG----PIPNDLGELQSLSATLNLSYNHLSGKIPKSLG--- 236
G+ L L L+D D + L SL L+LS N L L
Sbjct: 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR-ELDLSNNCLGDAGILQLVESV 421
Query: 237 --NLPVTVSFDLRGNNLSGEIPQ 257
+ L S E+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 14/76 (18%), Positives = 22/76 (28%), Gaps = 9/76 (11%)
Query: 85 IPSELGSLIYLRRLNLHNNNL----FGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-- 138
L L + + L + L + L +L + L N L V
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
Query: 139 ---NLPRLQNLDLSNN 151
++Q L L N
Sbjct: 79 LQTPSCKIQKLSLQNC 94
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 38/193 (19%), Positives = 62/193 (32%), Gaps = 9/193 (4%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQ 144
+P +L L+L N L+ L T L + NL + + L
Sbjct: 25 LPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQL-----NLDRAELTKLQVDGTLP 77
Query: 145 NLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKG 204
L + S + L +L + +Q +
Sbjct: 78 VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK 137
Query: 205 PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQ 264
+P L L+L+ N+L+ L L + L+ N+L IP+ ++
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 265 GPTAFLS-NPLLC 276
P AFL NP LC
Sbjct: 197 LPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 16/110 (14%), Positives = 32/110 (29%), Gaps = 2/110 (1%)
Query: 45 WNENDPTPCRWSGISCMNITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNN 104
++ ++ + + + N +P L + NN
Sbjct: 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158
Query: 105 LFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153
LP L +L ++ L N+L ++P L L N +
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 19/72 (26%), Positives = 27/72 (37%), Gaps = 4/72 (5%)
Query: 101 HNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDG 160
N S L N + L ++ N +S + +LP L + L NN S P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP-- 212
Query: 161 LKNCKQLQRLIL 172
L N L + L
Sbjct: 213 LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 16/66 (24%), Positives = 25/66 (37%), Gaps = 5/66 (7%)
Query: 134 PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLV 193
+ NL +L L +N S P L + L + L N+ S P NL
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA---NTSNLF 220
Query: 194 QLDLSD 199
+ L++
Sbjct: 221 IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 19/75 (25%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPN 208
S + S L N +L L NK S P L NL+++ L +N P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP- 212
Query: 209 DLGELQSLSATLNLS 223
L +L + L+
Sbjct: 213 -LANTSNLF-IVTLT 225
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (107), Expect = 4e-06
Identities = 24/123 (19%), Positives = 39/123 (31%), Gaps = 9/123 (7%)
Query: 141 PRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDN 200
Q LDL L L + + I + L+ L+LS+N
Sbjct: 22 GSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA--TLRIIEENIPELLSLNLSNN 75
Query: 201 DFKG--PIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQT 258
+ + + + +L LNLS N L + L GN+LS
Sbjct: 76 RLYRLDDMSSIVQKAPNLK-ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
Query: 259 GSF 261
++
Sbjct: 135 STY 137
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 1e-05
Identities = 28/131 (21%), Positives = 44/131 (33%), Gaps = 11/131 (8%)
Query: 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG--SLPPSVCNLP 141
+L + LN +++ +L N L S+ L N L + V P
Sbjct: 33 RSDPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91
Query: 142 RLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAG------IWPELENLVQL 195
L+ L+LS N +L+ L L N S I L++L
Sbjct: 92 NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRL 151
Query: 196 DLSDNDFKGPI 206
D ++ PI
Sbjct: 152 D--GHELPPPI 160
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 4e-06
Identities = 35/181 (19%), Positives = 68/181 (37%), Gaps = 12/181 (6%)
Query: 53 CRWSGISCMN--ITGFPD---PRVVGVAISGKNVRGYIPSEL-GSLIYLRRLNLHNNNLF 106
C + + C + P + ++ + L G L +L +L L N L
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 107 GSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQ 166
G P+ A+ + + L N + L +L+ L+L +N S +P ++
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 167 LQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNH 226
L L LA N F+ + E L + L+ + P+ + ++Q +L ++
Sbjct: 128 LTSLNLASNPFNCNCH--LAWFAEWLRKKSLNGGAARCGAPSKVRDVQ----IKDLPHSE 181
Query: 227 L 227
Sbjct: 182 F 182
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 6e-06
Identities = 27/150 (18%), Positives = 43/150 (28%), Gaps = 8/150 (5%)
Query: 95 LRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVC-NLPRLQNLDLSNNSF 153
L + L A +L +++ L L L+NL + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 154 SGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGEL 213
PD +L RL L+ N + +L +L LS N L L
Sbjct: 69 RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG--LSLQELVLSGNPLH--CSCALRWL 124
Query: 214 QSL--SATLNLSYNHLSGKIPKSLGNLPVT 241
Q + L L ++P
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 6e-05
Identities = 25/134 (18%), Positives = 41/134 (30%), Gaps = 2/134 (1%)
Query: 85 IPSELGSLIYLRRLNLHNNNLFGSLPDQLF-NATSLHSIFLYGNNLSGSLPPSVCNLPRL 143
L L L + N L + L ++ + + L P + PRL
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 144 QNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203
L+LS N+ SL LQ L+L+ N E + + +
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141
Query: 204 GPIPNDLGELQSLS 217
L + + S
Sbjct: 142 CHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 3e-04
Identities = 20/147 (13%), Positives = 34/147 (23%), Gaps = 26/147 (17%)
Query: 135 PSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQ 194
P C L + + L + L L + + + L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 195 LDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254
L + + + P+ P +L N L
Sbjct: 61 LTIVKSGLRFVAPDAFH-------------------------FTPRLSRLNLSFNALESL 95
Query: 255 IPQTGSFANQGPTAFLSNPLLCGFPLQ 281
+T + NPL C L+
Sbjct: 96 SWKTVQGLSLQELVLSGNPLHCSCALR 122
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (101), Expect = 1e-05
Identities = 14/75 (18%), Positives = 26/75 (34%), Gaps = 3/75 (4%)
Query: 112 QLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLI 171
Q NA + L G + + L + +D S+N DG ++L+ L+
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTLL 69
Query: 172 LARNKFSGQIPAGIW 186
+ N+
Sbjct: 70 VNNNRICRIGEGLDQ 84
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 5e-04
Identities = 20/116 (17%), Positives = 37/116 (31%), Gaps = 3/116 (2%)
Query: 87 SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNL 146
++ + + R L+L + + + +I N + L RL+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRK--LDGFPLLRRLKTL 68
Query: 147 DLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDF 202
++NN + L LIL N L++L L + N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 19/100 (19%), Positives = 30/100 (30%), Gaps = 20/100 (20%)
Query: 120 HSIFLYGNNLSGSLPPSV------CNLPRLQNLDLSNNSFSG----SLPDGLK-NCKQLQ 168
+ L LS +V LQ L L N +L + L
Sbjct: 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLL 305
Query: 169 RLILARNKFSGQIPAGIWPELENLVQL-------DLSDND 201
L L N+FS + + E+ + +L D +
Sbjct: 306 FLELNGNRFSEEDD--VVDEIREVFSTRGRGELDELDDME 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 9e-05
Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 15/89 (16%)
Query: 99 NLHNNNLFGSLPDQLFNA------TSLHSIFLYGNNLSGSLPPSVC-----NLPRLQNLD 147
L++ L + +A L ++ L N + ++ +P L L+
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 148 LSNNSFSGSLPDGLKNCKQLQRLILARNK 176
L+ N FS + +++ + R +
Sbjct: 309 LNGNRFS----EEDDVVDEIREVFSTRGR 333
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 12/75 (16%), Positives = 26/75 (34%), Gaps = 4/75 (5%)
Query: 97 RLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSG----SLPPSVCNLPRLQNLDLSNNS 152
+L+ S+ L S+ I L GN + L ++ + L+ + S+
Sbjct: 11 KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70
Query: 153 FSGSLPDGLKNCKQL 167
+ + + L
Sbjct: 71 TGRVKDEIPEALRLL 85
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 8/63 (12%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 143 LQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELE---NLVQLDLSD 199
L+ ++ S+ L ++ ++L+ N + + + +L + SD
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 200 NDF 202
Sbjct: 69 IFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 14/93 (15%), Positives = 30/93 (32%), Gaps = 6/93 (6%)
Query: 188 ELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGK----IPKSLGNLPVTVS 243
E ++L ++ D K + L E S+ + LS N + + + +++ +
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVK-EIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 244 FDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLC 276
+ + A L P L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (96), Expect = 1e-04
Identities = 15/79 (18%), Positives = 21/79 (26%)
Query: 98 LNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSL 157
L L+ N + NNL LD+S
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 158 PDGLKNCKQLQRLILARNK 176
GL+N K+L+ K
Sbjct: 218 SYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 13/54 (24%), Positives = 21/54 (38%), Gaps = 4/54 (7%)
Query: 179 GQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIP 232
++P ++ V LD+S L L+ L A S +L K+P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA---RSTYNLK-KLP 239
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 10/67 (14%), Positives = 22/67 (32%), Gaps = 5/67 (7%)
Query: 187 PELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDL 246
++ +L + + EL S+ + + + + + LP L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSID-QIIANNSDIKSVQG--IQYLPNVTKLFL 75
Query: 247 RGNNLSG 253
GN L+
Sbjct: 76 NGNKLTD 82
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 12/78 (15%), Positives = 27/78 (34%), Gaps = 3/78 (3%)
Query: 111 DQLFNATSL-HSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQR 169
Q+F+ + +I S + + L + + +N+ G++ + +
Sbjct: 15 KQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTK 72
Query: 170 LILARNKFSGQIPAGIWP 187
L L NK + P
Sbjct: 73 LFLNGNKLTDIKPLANLK 90
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 37/199 (18%), Positives = 62/199 (31%), Gaps = 49/199 (24%)
Query: 66 FPDP---RVVGVAISGKNVRGYIP-SELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHS 121
F D + + K+V + +EL S+ ++ +N+++ + ++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNSI---DQIIANNSDIKSVQG--IQYLPNVTK 72
Query: 122 IFLYGNNLSGSLPPSVCNLPRLQNLDL------------------SNNSFSGSLPDGLKN 163
+FL GN L+ P + LD S S +GL +
Sbjct: 73 LFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 164 CKQLQRLILARNKFSGQIPAGIWPE-------------------LENLVQLDLSDNDFKG 204
QL+ L L NK + + L L L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD 192
Query: 205 PIPNDLGELQSLSATLNLS 223
L L++L L L
Sbjct: 193 --LRALAGLKNLD-VLELF 208
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 11/37 (29%), Positives = 16/37 (43%), Gaps = 2/37 (5%)
Query: 134 PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRL 170
+ NL L+ LD+S+N S L L+ L
Sbjct: 165 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 12/80 (15%), Positives = 30/80 (37%), Gaps = 7/80 (8%)
Query: 111 DQLF---NATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQL 167
+Q+F L N++ ++ + +L ++ L S+ DG++ L
Sbjct: 9 NQIFTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNL 64
Query: 168 QRLILARNKFSGQIPAGIWP 187
++ + N+ + P
Sbjct: 65 TQINFSNNQLTDITPLKNLT 84
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 707 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.8 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.62 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.58 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.57 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.46 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.45 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.42 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.41 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.29 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.07 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.03 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.97 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.67 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.62 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.23 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.8 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.52 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.48 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.25 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.73 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=417.97 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=198.3
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChHH
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLAN 492 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 492 (707)
+.||+|+||+||+|.+.++..||||+++...... ++|.+|++++++++|||||+++|+|..++..++||||+++|+|.+
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH-HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH-HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 4799999999999999889999999998754443 789999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCCC
Q 005226 493 ALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSSG 572 (707)
Q Consensus 493 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 572 (707)
++.... ..++|..+++|+.|||.||+|||+ ++|+||||||+|||+|.++.+||+|||+|+.........
T Consensus 90 ~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~---- 158 (263)
T d1sm2a_ 90 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS---- 158 (263)
T ss_dssp HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred Hhhccc----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee----
Confidence 997653 368999999999999999999999 899999999999999999999999999998765332111
Q ss_pred CCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhccc
Q 005226 573 GFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFEE 652 (707)
Q Consensus 573 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+|++.|+.... ....+.+.+....+.
T Consensus 159 -----------~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~~~ 221 (263)
T d1sm2a_ 159 -----------STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGFRL 221 (263)
T ss_dssp -----------------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHHTCCC
T ss_pred -----------ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHhcCCC
Confidence 123457899999999765 678999999999999999999655543211 223344444443332
Q ss_pred cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 653 ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 653 ~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
..+ .....++.+++.+||+.||++||||++|++.|++|++
T Consensus 222 ~~p---------------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKP---------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCc---------------cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 221 1122457899999999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-51 Score=415.11 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=197.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|++++++++|||||+++|++. .+..++||||+++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 4589999999999998743 5999998754 3445678999999999999999999999875 456899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.++++..+ ..++|..+.+|+.|||+||+|||+ ++||||||||+|||++.++.+||+|||+|+..........
T Consensus 90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~ 162 (276)
T d1uwha_ 90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162 (276)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence 999998653 359999999999999999999999 8999999999999999999999999999987653221111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG--NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++... ..++.++|||||||++|||+||+.||...... ..+...+.
T Consensus 163 --------------~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----~~~~~~~~ 223 (276)
T d1uwha_ 163 --------------FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIFMVG 223 (276)
T ss_dssp -----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred --------------ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----HHHHHHHh
Confidence 1234679999999997542 45789999999999999999999999753321 12222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
........ .. ........+.+++.+||+.||++||||++|++.|+.++
T Consensus 224 ~~~~~p~~-~~----------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 224 RGYLSPDL-SK----------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HTSCCCCG-GG----------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCCCcc-hh----------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22211110 00 01122356789999999999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=417.63 Aligned_cols=254 Identities=27% Similarity=0.507 Sum_probs=195.4
Q ss_pred cceecccCeeEEEEEEeC-CC---ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NG---IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.++||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|||||+++|+|.+++..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 358999999999999974 22 36899998765 34455789999999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..++|.++++|+.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999998653 359999999999999999999999 8999999999999999999999999999987654322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
..... ......||+.|+|||++.. ..++.++|||||||++|||+| |+.||.... ..++...
T Consensus 184 ~~~~~-----------~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~------~~~~~~~ 245 (299)
T d1jpaa_ 184 DPTYT-----------SALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMT------NQDVINA 245 (299)
T ss_dssp -----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH
T ss_pred cceee-----------ecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 21111 0112346889999999665 678999999999999999998 899986532 2344444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....+...+ ......+.+++.+||+.||++||||+||++.|+++
T Consensus 246 i~~~~~~~~~---------------~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 246 IEQDYRLPPP---------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4443332211 12334578999999999999999999999999886
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=415.21 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=202.3
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||+||+|.+.++..||||+++..... .++|.+|++++++++|||||+++|++. ++..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC-HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC-HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 3479999999999999988899999999765443 378999999999999999999999875 46779999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...++|..+++|+.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+|+.........
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~--- 166 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--- 166 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC---
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc---
Confidence 9887543 2359999999999999999999999 899999999999999999999999999998765322111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.|+.... ....+...+....+
T Consensus 167 ------------~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~~~~ 228 (272)
T d1qpca_ 167 ------------REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERGYR 228 (272)
T ss_dssp ------------CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCC
T ss_pred ------------ccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCC
Confidence 123456889999999765 678999999999999999999766654321 22334444444332
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
...+ .....++.+++.+||+.||++||||++|++.|+.+
T Consensus 229 ~~~p---------------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 MVRP---------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc---------------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 2211 11224578999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=414.63 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=205.6
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||+||+|.+. +++.||||+++..... .++|.+|++++++++|||||+++|+|.+++..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 357999999999999975 5889999999765443 47899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... ...++|..++.|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~--- 171 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT--- 171 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE---
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce---
Confidence 99997643 2469999999999999999999999 89999999999999999999999999999876432111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
......|++.|+|||++.. ..++.++|||||||++|||++|+.|+.... +...+.+.+....
T Consensus 172 ------------~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~~~i~~~~ 233 (287)
T d1opja_ 172 ------------AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEKDY 233 (287)
T ss_dssp ------------EETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHTTC
T ss_pred ------------eeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHHHHHHHhcCC
Confidence 0122356889999998765 678999999999999999999887765322 2223334443333
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+...+ .....++.+|+.+||+.||++||||++|++.|+.+.
T Consensus 234 ~~~~~---------------~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERP---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCC---------------ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22211 112345789999999999999999999999998863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=402.56 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=206.8
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||+||+|+++++..||||+++...... ++|.+|+.++++++|||||+++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH-HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH-HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 35799999999999999888999999998765444 78999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++..+.+|+.|||+||+|||+ ++|+||||||+||+++.++.+||+|||+|+.........
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--- 157 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS--- 157 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC---
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee---
Confidence 9987653 358999999999999999999999 899999999999999999999999999998765332211
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+| |+.||.... ..++...+....
T Consensus 158 ------------~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~------~~~~~~~i~~~~ 218 (258)
T d1k2pa_ 158 ------------SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGL 218 (258)
T ss_dssp ------------CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHHHHTTC
T ss_pred ------------ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCC------HHHHHHHHHhCC
Confidence 123457899999999765 678999999999999999998 799986532 223444344333
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+...+ .....++.+++.+||+.||++||||++|++.|.+|
T Consensus 219 ~~~~p---------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 219 RLYRP---------------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCC---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCc---------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22221 11224678999999999999999999999999764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=407.06 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=201.8
Q ss_pred eecccCeeEEEEEEeC---CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 414 VLGKSGLGIVYKVVLG---NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|+++|++++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999863 45679999997653 3445789999999999999999999999865 56899999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|.+++...+ ..+++..+.+|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+........
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999987543 369999999999999999999999 8999999999999999999999999999987753322111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
......||+.|+|||++.. ..++.++|||||||++|||+| |+.||.... ..++...+..
T Consensus 168 -------------~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~------~~~~~~~i~~ 227 (285)
T d1u59a_ 168 -------------ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GPEVMAFIEQ 227 (285)
T ss_dssp -------------CCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------THHHHHHHHT
T ss_pred -------------cccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCC------HHHHHHHHHc
Confidence 1123456899999999765 678999999999999999998 899997532 2244444444
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
..+...+ .....++.+|+.+||+.||++||||.+|++.|+.+
T Consensus 228 ~~~~~~p---------------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 228 GKRMECP---------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TCCCCCC---------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCC---------------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 3332211 12234577999999999999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=407.16 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=198.0
Q ss_pred ceecccCeeEEEEEEeC---CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVLG---NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
+.||+|+||+||+|.+. .++.||||+++.. .....++|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 36999999999999864 3467999998654 23345789999999999999999999999864 567899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.++++... .++|..+++|+.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999998653 59999999999999999999999 89999999999999999999999999999876532211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ......||+.|+|||.+.. ..++.++|||||||++|||+| |+.||.... ...+...+
T Consensus 164 ~~-------------~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~~~~~i 223 (277)
T d1xbba_ 164 YK-------------AQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTAML 223 (277)
T ss_dssp EE-------------C----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHH
T ss_pred cc-------------cccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHHHHHHH
Confidence 11 1123457899999998765 678899999999999999998 899996532 22344444
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....+...+ .....++.+|+.+||+.||++||||++|+++|+.+
T Consensus 224 ~~~~~~~~p---------------~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EKGERMGCP---------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HTTCCCCCC---------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCC---------------cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 433222211 11234577999999999999999999999998764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=403.43 Aligned_cols=247 Identities=26% Similarity=0.308 Sum_probs=195.2
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 90 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence 48999999999999974 789999999865432 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+..........
T Consensus 91 ~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~- 161 (271)
T d1nvra_ 91 FDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL- 161 (271)
T ss_dssp GGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC-
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc-
Confidence 99997543 69999999999999999999999 8999999999999999999999999999987653221110
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
.....||+.|+|||++.....++.++|||||||++|||+||+.||...... ...+..+.....
T Consensus 162 -------------~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~~~~~~~~ 224 (271)
T d1nvra_ 162 -------------LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS----CQEYSDWKEKKT 224 (271)
T ss_dssp -------------BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT----SHHHHHHHTTCT
T ss_pred -------------ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCCC
Confidence 123568999999999776455578899999999999999999999754322 111111111100
Q ss_pred cccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ..+ ......++.+++.+||+.||++|||++|+++
T Consensus 225 ~-~~~--------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 Y-LNP--------------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp T-STT--------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-CCc--------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000 0112245678999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-49 Score=404.06 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=197.4
Q ss_pred cceecccCeeEEEEEEeCCC-----ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNG-----IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
.++||+|+||.||+|.+.+. ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 35899999999999986532 47999998765 3344567999999999999999999999999999999999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
.+|++.+++.... ..++|.++++|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999887553 369999999999999999999999 899999999999999999999999999998765332
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.|+.... ....+.+.
T Consensus 165 ~~~~~-------------~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~ 225 (283)
T d1mqba_ 165 EATYT-------------TSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKA 225 (283)
T ss_dssp ----------------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHH
T ss_pred ccceE-------------eccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHHH
Confidence 21110 122356899999998765 788999999999999999999777664322 22334444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....+...+ ......+.+|+.+||+.||++||||+||++.|+++
T Consensus 226 i~~~~~~~~~---------------~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 226 INDGFRLPTP---------------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHTTCCCCCC---------------TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HhccCCCCCc---------------hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 4443332221 12234578999999999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=396.83 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=197.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 458999999999999975 68899999986532 22346789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++.... .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 91 g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 91 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred CcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 99999998643 59999999999999999999999 899999999999999999999999999997654211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... ...+...+.
T Consensus 161 ----------------~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~ 217 (263)
T d2j4za1 161 ----------------RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRIS 217 (263)
T ss_dssp ----------------CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHH
T ss_pred ----------------ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCC------HHHHHHHHH
Confidence 123468999999999765 678999999999999999999999996432 112222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ....+.+. ...++.+++.+||+.||++|||++|+++
T Consensus 218 ~---~~~~~p~~-------------~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 R---VEFTFPDF-------------VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp T---TCCCCCTT-------------SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c---CCCCCCcc-------------CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 11111111 2245678999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=402.80 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=198.9
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
.+.||+|+||.||+|++.++..||||+++..... .+.|.+|+.++++++|||||+++|+|. ++..++||||+++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 4479999999999999988889999999765443 378999999999999999999999984 56789999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ...++|.++++|+.|||.||+|||+ ++|+||||||+|||+|.++++||+|||+|+.........
T Consensus 100 ~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~--- 170 (285)
T d1fmka3 100 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA--- 170 (285)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee---
Confidence 9997542 2359999999999999999999999 899999999999999999999999999998764322111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
.....||+.|+|||++.. ..++.++|||||||++|||+||+.|+.... ....+..++....+
T Consensus 171 ------------~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~~~ 232 (285)
T d1fmka3 171 ------------RQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERGYR 232 (285)
T ss_dssp -----------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTTCC
T ss_pred ------------eccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhcCC
Confidence 123457999999999765 678999999999999999999877765422 22344454444332
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
...+ .....++.+++.+||+.||++||+|++|+++|+++
T Consensus 233 ~~~~---------------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 233 MPCP---------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCC---------------cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 2211 12234578999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=397.85 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=197.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||+++|+|.
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 3799999999999995 478999999987655545578999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.........
T Consensus 106 ~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~--- 173 (293)
T d1yhwa1 106 DVVTET------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--- 173 (293)
T ss_dssp HHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB---
T ss_pred HHhhcc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc---
Confidence 998753 49999999999999999999999 899999999999999999999999999998765322111
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhcc
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGFE 651 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 651 (707)
....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ......+.....
T Consensus 174 -------------~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~ 233 (293)
T d1yhwa1 174 -------------STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT 233 (293)
T ss_dssp -------------CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS
T ss_pred -------------cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCC
Confidence 23457999999999765 6789999999999999999999999964321 111111111111
Q ss_pred ccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 652 EENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 652 ~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~-------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PELQ-------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCCS-------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 01112345789999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=408.65 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=200.7
Q ss_pred ccceecccCeeEEEEEEeCC------CceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEE
Q 005226 411 SAYVLGKSGLGIVYKVVLGN------GIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 411 ~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 482 (707)
..+.||+|+||+||+|+... ...||||++... .......|.+|+.++.++ +|||||++++++.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 35689999999999998642 236999998654 333446799999999998 8999999999999999999999
Q ss_pred EeecCCChHHHHhCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEE
Q 005226 483 DFISNGNLANALRGRNGQ------------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILL 544 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll 544 (707)
||+++|+|.++|+..... ....++|..++.|+.||+.||+|||+ ++||||||||+||++
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLV 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhcccc
Confidence 999999999999865421 12358999999999999999999999 899999999999999
Q ss_pred cCCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-
Q 005226 545 DNDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT- 623 (707)
Q Consensus 545 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt- 623 (707)
+.++.+||+|||+|+.......... .....||+.|+|||++.. ..++.++|||||||++|||+|
T Consensus 198 ~~~~~~Kl~DFGla~~~~~~~~~~~--------------~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 198 THGKVVKICDFGLARDIMSDSNYVV--------------RGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp ETTTEEEECCCGGGSCGGGCTTSEE--------------ETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTT
T ss_pred ccCCeEEEeeccccccccCCCceee--------------eccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhC
Confidence 9999999999999987653322110 123456899999998765 678999999999999999998
Q ss_pred CCCCCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHH
Q 005226 624 GKSPELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLE 703 (707)
Q Consensus 624 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~ 703 (707)
|+.||...... ..+.+.+....+...+ .....++.+|+.+||+.||++||||+||++.|.
T Consensus 263 g~~Pf~~~~~~-----~~~~~~~~~~~~~~~p---------------~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 263 GVNPYPGIPVD-----ANFYKLIQNGFKMDQP---------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SCCSSTTCCCS-----HHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCHH-----HHHHHHHhcCCCCCCC---------------CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 89998653322 2333444443332211 112345789999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=400.34 Aligned_cols=246 Identities=23% Similarity=0.310 Sum_probs=198.8
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|... ++..||||++........+.|.+|++++++++|||||++++++.+++..++||||+++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 47999999999999964 78999999998766666688999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSSS 571 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 571 (707)
+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.........
T Consensus 98 ~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~--- 167 (288)
T d2jfla1 98 AVMLELE----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--- 167 (288)
T ss_dssp HHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH---
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc---
Confidence 9986532 359999999999999999999999 899999999999999999999999999997654221100
Q ss_pred CCCcCCCCCCCCccccccCccccCCCCCC----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 572 GGFMGGALPYMKPVQTEKTNNYRAPEARV----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 572 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++. ....++.++|||||||++|||+||+.||...... +....+.
T Consensus 168 -------------~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~------~~~~~i~ 228 (288)
T d2jfla1 168 -------------DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM------RVLLKIA 228 (288)
T ss_dssp -------------TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHH
T ss_pred -------------cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH------HHHHHHH
Confidence 1245799999999864 2356789999999999999999999999754321 2222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ .......++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~-------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 KSEPPTLA-------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HSCCCCCS-------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCCCCCC-------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110000 01122346789999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=397.27 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=196.3
Q ss_pred cceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-CcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-DEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||.||+|.+ .|..||||+++... ..++|.+|++++++++|||||+++|+|.++ +..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 45799999999999998 57789999997643 336799999999999999999999999654 567999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.++|.... ...++|..+++|+.|||.||+|||+ ++|+||||||+||+++.++.+|++|||+++......
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----- 157 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 157 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----
Confidence 99997542 2258999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.. ..++.++|||||||++|||+| |++||... ...++..++...
T Consensus 158 --------------~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~------~~~~~~~~i~~~ 216 (262)
T d1byga_ 158 --------------DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEKG 216 (262)
T ss_dssp ------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS------CGGGHHHHHTTT
T ss_pred --------------ccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCC------CHHHHHHHHHcC
Confidence 12345889999999765 678999999999999999998 67777543 233556666554
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhcC
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIGT 707 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~~ 707 (707)
.+...+ .....++.+++.+||+.||.+||||++|+++|++|++
T Consensus 217 ~~~~~~---------------~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 YKMDAP---------------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC---------------ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 333221 1122456799999999999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=391.14 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=190.9
Q ss_pred eecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEc----CCcceEEEEeec
Q 005226 414 VLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWA----PDEKLLISDFIS 486 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~ 486 (707)
.||+|+||+||+|... +++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...++||||++
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 6999999999999965 6889999998654 33445789999999999999999999999865 345689999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceecCCCCCCeEEc-CCCCeEEecccccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRK--FVHGDIKPSNILLD-NDFQPYISDFGLSRLINI 563 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiHrDlk~~NIll~-~~~~~kl~DfGla~~~~~ 563 (707)
+|+|.+++.... .+++..+..++.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+....
T Consensus 96 ~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 96 SGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999997643 59999999999999999999999 56 99999999999996 578999999999975431
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. .....||+.|+|||++. ..++.++|||||||++|||++|+.||..... ...+.
T Consensus 168 ~~------------------~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~~~ 222 (270)
T d1t4ha_ 168 SF------------------AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIY 222 (270)
T ss_dssp TS------------------BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHH
T ss_pred Cc------------------cCCcccCccccCHHHhC--CCCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHHHH
Confidence 11 12346899999999875 3589999999999999999999999964321 12222
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.+....... .++ .....++.+++.+||+.||++|||++|+++
T Consensus 223 ~~i~~~~~~~-----~~~---------~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 223 RRVTSGVKPA-----SFD---------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHTTTCCCG-----GGG---------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHcCCCCc-----ccC---------ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2222211110 000 112235789999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=400.05 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=203.5
Q ss_pred cceecccCeeEEEEEEeCCC----ceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-CcceEEEEee
Q 005226 412 AYVLGKSGLGIVYKVVLGNG----IPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-DEKLLISDFI 485 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~ 485 (707)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++|||||+++|+|... +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 45899999999999997432 36899999754 445568899999999999999999999998764 5789999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|+|.++++... ..+++..+++++.|+|.||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999998653 357899999999999999999999 899999999999999999999999999998765433
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
..... ......||+.|+|||++.. ..++.++||||||+++|||+||+.||..... ..++..+
T Consensus 185 ~~~~~------------~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~~~~~ 246 (311)
T d1r0pa_ 185 FDSVH------------NKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVY 246 (311)
T ss_dssp CCCTT------------CTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHH
T ss_pred cccce------------ecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Confidence 22111 1123467999999998665 6789999999999999999998888764321 2234444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+....+...+ ......+.+++.+||+.||++||+|.||++.|+++.
T Consensus 247 i~~g~~~~~p---------------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 247 LLQGRRLLQP---------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp HHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCc---------------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4444332221 112245779999999999999999999999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=397.48 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=186.3
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEc--CCcceEEEEeecC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWA--PDEKLLISDFISN 487 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 487 (707)
+.||+|+||+||+|+. .+|+.||||.+.... ....+.|.+|++++++++|||||++++++.+ ++..|+||||+++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 4799999999999986 478999999987653 3345679999999999999999999999965 3557899999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECS--PRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
|+|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.++.+||+|||+|+......
T Consensus 90 g~L~~~i~~~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 168 (269)
T d2java1 90 GDLASVITKGT-KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168 (269)
T ss_dssp EEHHHHHHHHH-HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred CcHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence 99999996432 11236999999999999999999999832 1249999999999999999999999999998765322
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... ..++...
T Consensus 169 ~~~----------------~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~------~~~~~~~ 225 (269)
T d2java1 169 SFA----------------KAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGK 225 (269)
T ss_dssp -----------------------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHH
T ss_pred Ccc----------------ccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCC------HHHHHHH
Confidence 111 23457999999999765 678999999999999999999999996432 2233333
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+........+ .....++.+++.+||+.||++|||+.|+++
T Consensus 226 i~~~~~~~~~---------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 226 IREGKFRRIP---------------YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHTCCCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHcCCCCCCC---------------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 3222111110 112245789999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.9e-48 Score=398.82 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=205.2
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||+||+|+.. ++..||||+++.... ...++|.+|++++++++||||++++++|...+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 347999999999999863 457899999976533 3457899999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc
Q 005226 485 ISNGNLANALRGRNG-------------------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD 545 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~ 545 (707)
+++|+|.++++.... .....++|..++.|+.|+|.||+|||+ ++||||||||+|||+|
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld 174 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVG 174 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEEC
Confidence 999999999975431 112458999999999999999999999 8999999999999999
Q ss_pred CCCCeEEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC
Q 005226 546 NDFQPYISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK 625 (707)
Q Consensus 546 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~ 625 (707)
.++.+||+|||+|+.+........ .....|++.|+|||++.. ..++.++|||||||++|||++|.
T Consensus 175 ~~~~~Kl~DFGls~~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 175 ENMVVKIADFGLSRNIYSADYYKA--------------DGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp GGGCEEECCCSCHHHHTGGGCBC------------------CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCcEEEccchhheeccCCccccc--------------cCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccC
Confidence 999999999999987653322111 023456889999999765 77899999999999999999996
Q ss_pred C-CCCCCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHh
Q 005226 626 S-PELSPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLER 704 (707)
Q Consensus 626 ~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~ 704 (707)
. ||... ...++...+........+ .....++.+|+.+||+.||++||||.||+++|++
T Consensus 240 ~~p~~~~------~~~e~~~~v~~~~~~~~p---------------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~ 298 (301)
T d1lufa_ 240 LQPYYGM------AHEEVIYYVRDGNILACP---------------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298 (301)
T ss_dssp CCTTTTS------CHHHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCC------CHHHHHHHHHcCCCCCCC---------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 4 55432 223444444433322111 1223457899999999999999999999999999
Q ss_pred hcC
Q 005226 705 IGT 707 (707)
Q Consensus 705 i~~ 707 (707)
|.+
T Consensus 299 i~~ 301 (301)
T d1lufa_ 299 MCE 301 (301)
T ss_dssp TTC
T ss_pred hcC
Confidence 874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=392.11 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=192.4
Q ss_pred cceecccCeeEEEEEEeCC----CceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLGN----GIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||.||+|.+.. +..||||+++... ....+.|.+|++++++++|||||+++|++. ++..++||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 4589999999999998642 4578999987653 334578999999999999999999999985 567899999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..++.++.||+.||+|||+ ++||||||||+||+++.++.+||+|||+|+.......
T Consensus 91 ~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 91 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred CCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999987543 358999999999999999999999 8999999999999999999999999999987653222
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... ....||+.|+|||++.. ..++.++|||||||++|||+| |++||..... .++...
T Consensus 164 ~~~---------------~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~------~~~~~~ 221 (273)
T d1mp8a_ 164 YKA---------------SKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGR 221 (273)
T ss_dssp ----------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG------GGHHHH
T ss_pred eec---------------cceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCH------HHHHHH
Confidence 111 23456899999999764 678999999999999999998 8888865432 244444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
+....+...+ ......+.+|+.+||+.||++||||+||++.|++|.
T Consensus 222 i~~~~~~~~~---------------~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 222 IENGERLPMP---------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp HHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 4443222111 112345789999999999999999999999998873
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=400.78 Aligned_cols=194 Identities=24% Similarity=0.387 Sum_probs=169.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|.. .+|+.||+|+++.. .......+.+|+++|++++|||||+++++|.++++.++||||+++|+|
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L 91 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 4799999999999996 47899999998754 333447899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
.+++...+ .+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 ~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---- 160 (322)
T d1s9ja_ 92 DQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---- 160 (322)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC----
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc----
Confidence 99997643 599999999999999999999972 3899999999999999999999999999987653211
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 161 --------------~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 161 --------------NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -----------------CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred --------------ccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 23467999999999775 678999999999999999999999997643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=395.39 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=193.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch---hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|+. .+++.||||++..... ...+.|.+|++++++++|||||++++++.+++..++||||+++|
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 100 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence 4799999999999996 4789999999875432 33467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|..++.... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 101 ~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 101 ASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp HHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred chHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 9987776543 69999999999999999999999 89999999999999999999999999999865421
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVP--GNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
....||+.|+|||++.. ...++.++|||||||++|||++|+.||..... ......+
T Consensus 169 ----------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i 226 (309)
T d1u5ra_ 169 ----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHI 226 (309)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH
T ss_pred ----------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHH
Confidence 12357999999998753 34688999999999999999999999964321 1111111
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....+ ... .......+.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~--~~~---------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 ---AQNESP--ALQ---------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---HHSCCC--CCS---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---HhCCCC--CCC---------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 000 0112345789999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=400.19 Aligned_cols=267 Identities=22% Similarity=0.280 Sum_probs=196.1
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCchhhHHHHHH--HHHHHHhcCCCceeeeEEEEEcCC----cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVT--EVQAIAKVKHPNIVKLRAYYWAPD----EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~ 486 (707)
+.||+|+||.||+|++ +|+.||||+++.... +++.+ |+..+.+++|||||+++++|.+++ ..++|||||+
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 4799999999999997 688999999865432 33444 455556789999999999998754 4689999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC-----SPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
+|+|.++|+.. .++|..+++++.|+|.||+|||+. ..++||||||||+|||++.++.+||+|||+++..
T Consensus 85 ~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 85 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999999864 489999999999999999999973 1269999999999999999999999999999877
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGN-----RPMQKWDVYSFGVVLLELLTGKSPELSPTTSTS 636 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~ 636 (707)
........ .......||+.|+|||++.... .++.++|||||||++|||+||..|+........
T Consensus 159 ~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~ 226 (303)
T d1vjya_ 159 DSATDTID------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226 (303)
T ss_dssp ETTTTEEC------------C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred cCCCccee------------ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence 54332111 0113456899999999865421 256789999999999999999988754322110
Q ss_pred c-----cchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 637 I-----EVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 637 ~-----~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
. ......+.......... .++.+.......+....+.+++.+||+.||++||||.||++.|++|.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 227 PYYDLVPSDPSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSC-----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhcccccchHHHHHHHHhccc-----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 0 00011122222111111 01111111122345567889999999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=389.74 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=195.4
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||||+++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence 34899999999999997 478999999986532 23346789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++...+ .+++..+..++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+.+......
T Consensus 93 g~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 93 GELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999998654 69999999999999999999999 89999999999999999999999999999876532211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... ...+...+.
T Consensus 165 ~~--------------~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i~ 223 (288)
T d1uu3a_ 165 AR--------------ANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN------EYLIFQKII 223 (288)
T ss_dssp -------------------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHH
T ss_pred cc--------------cccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcC------HHHHHHHHH
Confidence 10 023457999999999765 678999999999999999999999997532 112222221
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ....+.+ ....++.+++.+||+.||++|||++|+++
T Consensus 224 ~---~~~~~p~-------------~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 224 K---LEYDFPE-------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp T---TCCCCCT-------------TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred c---CCCCCCc-------------cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1 1111111 12245679999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=394.32 Aligned_cols=249 Identities=25% Similarity=0.434 Sum_probs=196.0
Q ss_pred ceecccCeeEEEEEEeC-CCc----eEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVLG-NGI----PVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
++||+|+||+||+|.+. +|+ .||+|+++.. .....++|.+|++++++++|||||+++|+|.+ +..++++||+.
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~~ 93 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMP 93 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEecc
Confidence 48999999999999864 443 5899988654 33445789999999999999999999999976 46788999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++.... ..+++..+++|+.|||.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 94 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp TCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred CCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999987653 369999999999999999999999 8999999999999999999999999999987653322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 645 (707)
... .....||+.|+|||++.. ..++.++|||||||++|||+| |+.||..... ..+...
T Consensus 167 ~~~--------------~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------~~~~~~ 225 (317)
T d1xkka_ 167 EYH--------------AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISSI 225 (317)
T ss_dssp ----------------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------GGHHHH
T ss_pred ccc--------------ccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------HHHHHH
Confidence 111 122357999999998765 678999999999999999999 7888764322 233444
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....+...+ ......+.+++.+||+.||++||||+||++.|+.+
T Consensus 226 i~~~~~~~~p---------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 226 LEKGERLPQP---------------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHTCCCCCC---------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCC---------------cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 4433322211 12234578999999999999999999999998876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-47 Score=391.71 Aligned_cols=245 Identities=25% Similarity=0.286 Sum_probs=183.2
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch-hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE-QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~ 93 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 348999999999999975 689999999875532 233668899999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc---CCCCeEEecccccccccccCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~ 566 (707)
|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+||+++ +++.+||+|||+|+.......
T Consensus 94 L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 94 LFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp HHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred HHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999998643 69999999999999999999999 8999999999999995 578999999999986542221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. ....||+.|+|||++.. ..++.++|||||||++|||+||+.||.... ...+...+
T Consensus 166 ~-----------------~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~~~~~~~i 221 (307)
T d1a06a_ 166 L-----------------STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDEN------DAKLFEQI 221 (307)
T ss_dssp ------------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHH
T ss_pred e-----------------eeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence 1 23457999999999765 678999999999999999999999996432 12232322
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
........ .- .......++.+++.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~---~~---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 222 LKAEYEFD---SP---------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HTTCCCCC---TT---------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCCCCC---Cc---------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22111100 00 00122345789999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=388.15 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=200.8
Q ss_pred cceecccCeeEEEEEEeC--------CCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEE
Q 005226 412 AYVLGKSGLGIVYKVVLG--------NGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLI 481 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 481 (707)
.+.||+|+||.||+|+.. ++..||||+++... .....++.+|+..+.++ +|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 458999999999999852 23579999997654 34457899999999999 899999999999999999999
Q ss_pred EEeecCCChHHHHhCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 482 SDFISNGNLANALRGRNG-----------QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|||+++|+|.+++..... .....+++.++++++.|||.||+|||+ ++||||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCe
Confidence 999999999999976542 123569999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPEL 629 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~ 629 (707)
||+|||+++.......... .....+++.|+|||.+.. ..++.++|||||||++|||++ |++||.
T Consensus 175 kl~dfg~~~~~~~~~~~~~--------------~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKK--------------TTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp EECSTTCCCCGGGCCTTCC--------------CTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred Eeccchhhccccccccccc--------------cccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999987764332211 023456889999999765 688999999999999999998 677775
Q ss_pred CCCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 630 SPTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ...+.+.+....+...+ .....++.+|+.+||+.||++||||.||++.|++|
T Consensus 240 ~~~------~~~~~~~i~~~~~~~~p---------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 240 GVP------VEELFKLLKEGHRMDKP---------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp TCC------HHHHHHHHHTTCCCCCC---------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC------HHHHHHHHHcCCCCCCC---------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 322 22344444443332221 11224578999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=388.63 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=192.0
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCC-cceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPD-EKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 482 (707)
.+.||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++.++ +|+|||.+++++..++ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 458999999999999853 3468999999765 334457788999998888 7899999999987654 578999
Q ss_pred EeecCCChHHHHhCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 483 DFISNGNLANALRGRNGQ-----------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
||+++|+|.++++..... ....++|.+++.++.|||.||+|||+ ++||||||||+|||++.++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEE
Confidence 999999999999754321 12358999999999999999999999 8999999999999999999999
Q ss_pred EecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCC
Q 005226 552 ISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK-SPELS 630 (707)
Q Consensus 552 l~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~-~P~~~ 630 (707)
|+|||+|+.......... .....||+.|+|||++.. ..++.++|||||||++|||+||. +||..
T Consensus 175 l~DFGla~~~~~~~~~~~--------------~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVR--------------KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp ECC------CCSCTTSCC--------------TTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EccCcchhhccccccccc--------------cCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999986543322111 123467999999999765 77899999999999999999975 46643
Q ss_pred CCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ...+...+....+...+ .....++.+++.+||+.||++||||+||++.|++|
T Consensus 240 ~~~-----~~~~~~~~~~~~~~~~~---------------~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 240 VKI-----DEEFCRRLKEGTRMRAP---------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CCC-----SHHHHHHHHHTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCH-----HHHHHHHHhcCCCCCCC---------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 322 12233333333222111 11234578999999999999999999999999886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.6e-46 Score=393.80 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=199.5
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 34799999999999996 47899999999877666668899999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC--CCCeEEecccccccccccCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN--DFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~DfGla~~~~~~~~~~ 568 (707)
.+++.... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++. ++.+||+|||+|+.......
T Consensus 111 ~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 111 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp HHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence 99996543 359999999999999999999999 89999999999999964 57899999999987642211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
.....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... ..+....+..
T Consensus 182 ---------------~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~ 239 (350)
T d1koaa2 182 ---------------VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKS 239 (350)
T ss_dssp ---------------EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH
T ss_pred ---------------cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHh
Confidence 123567999999999765 678899999999999999999999996432 1122222221
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
. ....... .......++.+++.+||+.||++|||++|+++
T Consensus 240 ~---~~~~~~~---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 240 C---DWNMDDS---------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp T---CCCSCCG---------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred C---CCCCCcc---------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 1110000 00112345789999999999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=383.74 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=196.5
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch------hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE------QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||+||+|.. .+|+.||||+++.... ...+.|.+|+++|++++|||||++++++.+++..++||||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34899999999999997 4789999999864321 2247799999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC----CeEEeccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF----QPYISDFGLSRL 560 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~DfGla~~ 560 (707)
+++|+|.+++...+ .+++..+..++.||+.||+|||+ ++|+||||||+||+++.++ .+|++|||+|+.
T Consensus 95 ~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 95 VAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999997643 59999999999999999999999 8999999999999998776 499999999987
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
....... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... .
T Consensus 167 ~~~~~~~-----------------~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~ 222 (293)
T d1jksa_ 167 IDFGNEF-----------------KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTK------Q 222 (293)
T ss_dssp CTTSCBC-----------------SCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------H
T ss_pred cCCCccc-----------------cccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCH------H
Confidence 6532211 22456899999999765 6789999999999999999999999975321 1
Q ss_pred hHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+... ..... .+ . .......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~i~~~---~~~~~---~~-~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 223 ETLANVSAV---NYEFE---DE-Y-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHTT---CCCCC---HH-H-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhc---CCCCC---ch-h-----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222111 11100 00 0 0112345789999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=389.39 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=198.9
Q ss_pred cceecccCeeEEEEEEeC-CCc--eEEEEEcCCC-chhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGI--PVAVRRLGEG-GEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||+||+|.+. ++. .||||+++.. .....++|.+|+++|+++ +|||||+++|+|.+++..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 458999999999999975 333 5788887654 333456899999999999 79999999999999999999999999
Q ss_pred CCChHHHHhCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecc
Q 005226 487 NGNLANALRGRN-----------GQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDF 555 (707)
Q Consensus 487 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df 555 (707)
+|+|.++|+... ......++|..+.+++.|||.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEccc
Confidence 999999998652 1123569999999999999999999999 89999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCC
Q 005226 556 GLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKS-PELSPTTS 634 (707)
Q Consensus 556 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~-P~~~~~~~ 634 (707)
|+|+........ ....||..|+|||.+.. ..++.++|||||||++|||++|.. ||...
T Consensus 172 G~a~~~~~~~~~-----------------~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~--- 230 (309)
T d1fvra_ 172 GLSRGQEVYVKK-----------------TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--- 230 (309)
T ss_dssp TCEESSCEECCC---------------------CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTC---
T ss_pred cccccccccccc-----------------cceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCC---
Confidence 999865432211 22346889999999765 678999999999999999999765 55432
Q ss_pred CCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 635 TSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
....+.+.+....+...+ .....++.+|+.+||+.||++||||+||++.|+.+
T Consensus 231 ---~~~~~~~~i~~~~~~~~~---------------~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 231 ---TCAELYEKLPQGYRLEKP---------------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ---CHHHHHHHGGGTCCCCCC---------------TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHhcCCCCCC---------------ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 223444444433322211 11234678999999999999999999999999876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=386.43 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=203.8
Q ss_pred cceecccCeeEEEEEEe------CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEE
Q 005226 412 AYVLGKSGLGIVYKVVL------GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 483 (707)
.+.||+|+||.||+|++ .+++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+++..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 45899999999999985 356789999997653 34456899999999999 79999999999999999999999
Q ss_pred eecCCChHHHHhCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCe
Q 005226 484 FISNGNLANALRGRNGQ-------------PSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQP 550 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~ 550 (707)
|+++|+|.++++..... ....+++..+.+++.|||.||+|||+ ++||||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcc
Confidence 99999999999765321 22368999999999999999999999 899999999999999999999
Q ss_pred EEecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 005226 551 YISDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELS 630 (707)
Q Consensus 551 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~ 630 (707)
|++|||+++......... ......||+.|+|||++.. ..++.++|||||||++|||+|++.|+..
T Consensus 185 ki~DfG~~~~~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYV--------------VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp EECCCGGGSCTTSCTTSE--------------ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccchheeccCCCcce--------------EeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999998765322111 1123457899999999765 6789999999999999999995555432
Q ss_pred CCCCCCccchhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 631 PTTSTSIEVPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
... ....+.+.+....+...+ ......+.+|+.+||+.||++||||.+|+++|+++
T Consensus 250 ~~~----~~~~~~~~i~~~~~~~~~---------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 250 GMP----VDSKFYKMIKEGFRMLSP---------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp TCC----SSHHHHHHHHHTCCCCCC---------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC----HHHHHHHHHhcCCCCCCc---------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 211 112233444443332211 11234578999999999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=383.71 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=190.1
Q ss_pred ceecccCeeEEEEEEeC--C--CceEEEEEcCCC---chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG--N--GIPVAVRRLGEG---GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 485 (707)
+.||+|+||.||+|++. + ...||||+++.. .....++|.+|++++++++|||||+++|+|.+ +..++||||+
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~ 92 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELA 92 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeee
Confidence 37999999999999853 2 347899998754 22345789999999999999999999999965 5678999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccC
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITG 565 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~ 565 (707)
++|++.+++.... ..+++..+++++.|||.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 93 ~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 93 PLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp TTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred cCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999887543 359999999999999999999999 899999999999999999999999999999765332
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCCCccchhHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLT-GKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 644 (707)
.... ......|+..|+|||++.. ..++.++|||||||++|||+| |+.||... ...+...
T Consensus 166 ~~~~-------------~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~ 225 (273)
T d1u46a_ 166 DHYV-------------MQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILH 225 (273)
T ss_dssp CEEE-------------C-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHH
T ss_pred Ccce-------------ecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHH
Confidence 2111 1123456889999999765 678899999999999999998 89998643 2223444
Q ss_pred HHHhh-ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 645 WVKKG-FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 645 ~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
++... .+...+ ......+.+++.+||+.||++||||++|.+.|++.
T Consensus 226 ~i~~~~~~~~~~---------------~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 KIDKEGERLPRP---------------EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHTSCCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCCCc---------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 43322 111110 11224578999999999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.5e-46 Score=391.62 Aligned_cols=245 Identities=23% Similarity=0.289 Sum_probs=199.1
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|.. .+|+.||||+++.........+.+|++++++++|||||++++++.+++..|+||||+++|+|.
T Consensus 35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 114 (352)
T d1koba_ 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114 (352)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHH
Confidence 4899999999999996 479999999998766555678899999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc--CCCCeEEecccccccccccCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD--NDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+++.... ..+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.......
T Consensus 115 ~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--- 184 (352)
T d1koba_ 115 DRIAAED----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 184 (352)
T ss_dssp HHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc---
Confidence 9887543 359999999999999999999999 8999999999999998 678999999999987653211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....||+.|+|||++.. ..++.++||||+||++|||+||+.||.... .......+...
T Consensus 185 --------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~i~~~ 243 (352)
T d1koba_ 185 --------------VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGED------DLETLQNVKRC 243 (352)
T ss_dssp --------------EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHC
T ss_pred --------------eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhC
Confidence 123467999999999765 778999999999999999999999996432 12222222221
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..... ... ......++.+|+.+||+.||.+|||++|+++
T Consensus 244 ~~~~~--~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 DWEFD--EDA----------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCCC--SST----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCC--ccc----------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11100 000 0112345789999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=385.25 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=202.6
Q ss_pred cceecccCeeEEEEEEeC------CCceEEEEEcCCC-chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG------NGIPVAVRRLGEG-GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.+.||+|+||+||+|.+. ++..||||+++.. .......|.+|++++++++|||||+++|+|..++..++||||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 104 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence 457999999999999863 3578999999765 334456799999999999999999999999999999999999
Q ss_pred ecCCChHHHHhCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 485 ISNGNLANALRGRNG-----QPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+++|+|.+++..... .....++|..+.+|+.|+|+||.|||+ ++|+||||||+|||+|.++++||+|||+|+
T Consensus 105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccce
Confidence 999999999864321 122357999999999999999999999 899999999999999999999999999998
Q ss_pred cccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCCCcc
Q 005226 560 LINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGK-SPELSPTTSTSIE 638 (707)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~-~P~~~~~~~~~~~ 638 (707)
.......... .....||+.|+|||.+.. ..++.++||||||+++|||+||+ .||... .
T Consensus 182 ~~~~~~~~~~--------------~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~ 240 (308)
T d1p4oa_ 182 DIYETDYYRK--------------GGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGL------S 240 (308)
T ss_dssp GGGGGGCEEG--------------GGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------C
T ss_pred eccCCcceee--------------ccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCC------C
Confidence 7654322111 122356899999999665 67889999999999999999995 555432 1
Q ss_pred chhHHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhhc
Q 005226 639 VPDLVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERIG 706 (707)
Q Consensus 639 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i~ 706 (707)
.......+........+ ......+.+++.+||+.||++||||++|++.|++..
T Consensus 241 ~~~~~~~i~~~~~~~~p---------------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 241 NEQVLRFVMEGGLLDKP---------------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHHHHHHTTCCCCCC---------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHHHhCCCCCCc---------------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 22333333322211111 112246889999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=380.88 Aligned_cols=242 Identities=25% Similarity=0.292 Sum_probs=196.8
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||.||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++|||||++++++.+++..|+||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 35899999999999996 478999999987542 23347789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|.+++...+ .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+........
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence 99999998654 58999999999999999999999 89999999999999999999999999999865422211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.....||+.|+|||++.. ..++.++||||+||++|||++|++||..... ..+.+...
T Consensus 162 ----------------~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~ 218 (337)
T d1o6la_ 162 ----------------MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL 218 (337)
T ss_dssp ----------------BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH
T ss_pred ----------------cccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHh
Confidence 123568999999999765 6789999999999999999999999975321 22222222
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
.. ...+. .....++.+|+.+||+.||.+||+ ++|+++
T Consensus 219 ~~---~~~~p-------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 ME---EIRFP-------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HC---CCCCC-------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cC---CCCCC-------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 21 11111 112235678999999999999995 677764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-45 Score=379.34 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=195.6
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecC
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISN 487 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 487 (707)
.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||||+++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 35899999999999996 468999999986532 23347789999999999999999999999999999999999999
Q ss_pred CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCC
Q 005226 488 GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 488 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~ 567 (707)
|+|..++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred ccccccccccc-----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 99999998654 58899999999999999999999 899999999999999999999999999998764221
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
....||+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ..+...+.
T Consensus 159 -----------------~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~ 214 (316)
T d1fota_ 159 -----------------YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL 214 (316)
T ss_dssp -----------------CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH
T ss_pred -----------------ccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHH
Confidence 23457999999999764 6789999999999999999999999965321 12222111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
.....+.. ....++.+++.+|+..||.+|| |++++++
T Consensus 215 ---~~~~~~p~-------------~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 215 ---NAELRFPP-------------FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---HCCCCCCT-------------TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---cCCCCCCC-------------CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11111111 1224567899999999999996 8888865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3e-45 Score=374.88 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=194.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCc----ceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDE----KLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lV~e~ 484 (707)
+.||+|+||+||+|.. .+|+.||||+++... ......|.+|++++++++|||||++++++...+. .|+||||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence 4899999999999996 579999999997643 2334679999999999999999999999987543 6899999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++...+ .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.++++|||.++.....
T Consensus 93 ~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 93 VDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp CCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred CCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 99999999997653 59999999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
..... ......||+.|+|||++.. ..++.++|||||||++|||+||++||..... ...
T Consensus 165 ~~~~~-------------~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~-- 222 (277)
T d1o6ya_ 165 GNSVT-------------QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSV-- 222 (277)
T ss_dssp ---------------------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHH--
T ss_pred ccccc-------------ccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCH------HHH--
Confidence 22111 1134568999999999764 6789999999999999999999999964321 111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-ChHHHHHHHHhhc
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-RMKNVSENLERIG 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~~v~~~L~~i~ 706 (707)
.............. .......++.+++.+|++.||++|| |++++.+.|.++.
T Consensus 223 -~~~~~~~~~~~~~~---------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 223 -AYQHVREDPIPPSA---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -HHHHHHCCCCCGGG---------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -HHHHHhcCCCCCch---------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111111110000 0012235678999999999999999 8999999998874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.5e-45 Score=386.08 Aligned_cols=244 Identities=26% Similarity=0.285 Sum_probs=192.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCch---hhHHHHHH---HHHHHHhcCCCceeeeEEEEEcCCcceEEEEe
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGE---QRHREFVT---EVQAIAKVKHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.++||+|+||.||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+++..|+||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 348999999999999965 689999999864321 11233444 46677778899999999999999999999999
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+++|+|.+++.... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999997653 58999999999999999999999 89999999999999999999999999999866532
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
.. ....||+.|+|||++..+..++.++|||||||++|||+||+.||...... +...
T Consensus 161 ~~------------------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~ 216 (364)
T d1omwa3 161 KP------------------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------DKHE 216 (364)
T ss_dssp CC------------------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS------CHHH
T ss_pred cc------------------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 11 23457999999999876677899999999999999999999999764332 1111
Q ss_pred HHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 645 WVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
..+........+.+ ....++.+++.+||+.||++||| ++|+++
T Consensus 217 ~~~~~~~~~~~~~~-------------~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 217 IDRMTLTMAVELPD-------------SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHSSSCCCCCCS-------------SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHhcccCCCCCCC-------------CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 12222221111111 12235679999999999999999 577754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=380.09 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=192.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchh-----hHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQ-----RHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 4799999999999996 46899999998654322 12568899999999999999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
++++..+.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 88777666543 358889999999999999999999 8999999999999999999999999999986553221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.. ....||+.|+|||++..+..++.++|||||||++|||+||++||..... .+....+
T Consensus 156 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~------~~~l~~i 213 (299)
T d1ua2a_ 156 AY----------------THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRI 213 (299)
T ss_dssp CC----------------CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred cc----------------cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH------HHHHHHH
Confidence 11 2235699999999987667789999999999999999999999965321 1222222
Q ss_pred Hhhcccc----CC----------CchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEE----NP----------LSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~----~~----------~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....... ++ ........+.. .......++.+|+.+|++.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH--IFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH--HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHhcCCCChhhccchhccchhhhhccCCCCChHH--hcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 1111000 00 00000000000 00112356889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-44 Score=367.87 Aligned_cols=245 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred cceecccCeeEEEEEEe-CCCceEEEEEcCCCch---------hhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceE
Q 005226 412 AYVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE---------QRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLL 480 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 480 (707)
.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.++++++ |||||++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 34899999999999996 4789999999865421 12346889999999996 9999999999999999999
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
||||+++|+|.++++..+ .+++.++..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999997643 69999999999999999999999 8999999999999999999999999999987
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCC
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARV-----PGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTST 635 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~ 635 (707)
...... .....||..|+|||++. ....++.++||||+||++|||+||+.||.....
T Consensus 160 ~~~~~~-----------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-- 220 (277)
T d1phka_ 160 LDPGEK-----------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-- 220 (277)
T ss_dssp CCTTCC-----------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--
T ss_pred ccCCCc-----------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--
Confidence 653221 12345799999999864 234578899999999999999999999975321
Q ss_pred CccchhHHHHHHhh-ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 636 SIEVPDLVRWVKKG-FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 636 ~~~~~~~~~~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
......+... .....+ .......++.+++.+||+.||++|||+.||++
T Consensus 221 ----~~~~~~i~~~~~~~~~~-------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 221 ----MLMLRMIMSGNYQFGSP-------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ----HHHHHHHHHTCCCCCTT-------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHHHhCCCCCCCc-------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122211111 110000 00112346789999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=378.48 Aligned_cols=245 Identities=21% Similarity=0.282 Sum_probs=190.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEc----CCcceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWA----PDEKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~e~~~ 486 (707)
++||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++.+ +...|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 4799999999999996 57899999998653 5577899997766 89999999999865 356799999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC---CCCeEEecccccccccc
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN---DFQPYISDFGLSRLINI 563 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~DfGla~~~~~ 563 (707)
+|+|.+++...+ ...+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccC
Confidence 999999998653 2469999999999999999999999 89999999999999985 46799999999987653
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.... ....||+.|+|||++.. ..++.++|||||||++|||+||+.||....... ..
T Consensus 167 ~~~~-----------------~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~------~~ 222 (335)
T d2ozaa1 167 HNSL-----------------TTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------IS 222 (335)
T ss_dssp CCCC-----------------CCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------
T ss_pred CCcc-----------------ccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH------HH
Confidence 2211 23457999999999654 678999999999999999999999997543321 11
Q ss_pred HHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
..+........ .+...+. ......++.+|+.+|++.||++|||+.|+++
T Consensus 223 ~~~~~~i~~~~--~~~~~~~------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 223 PGMKTRIRMGQ--YEFPNPE------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----CCCSCS--SSCCTTH------HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCC--CCCCCcc------cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111110 0000110 1223456889999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-44 Score=378.37 Aligned_cols=238 Identities=19% Similarity=0.255 Sum_probs=195.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 488 (707)
+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||||+.+|
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g 126 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence 47999999999999964 79999999986532 233467899999999999999999999999999999999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNP 568 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~ 568 (707)
+|.+++...+ .+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 127 ~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~--- 195 (350)
T d1rdqe_ 127 EMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred chhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc---
Confidence 9999997653 59999999999999999999999 899999999999999999999999999998764211
Q ss_pred CCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHh
Q 005226 569 SSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKK 648 (707)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 648 (707)
....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... ...+...+..
T Consensus 196 ----------------~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~ 252 (350)
T d1rdqe_ 196 ----------------WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVS 252 (350)
T ss_dssp ----------------CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH
T ss_pred ----------------ccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhc
Confidence 23467999999999765 778999999999999999999999996432 1122222222
Q ss_pred hccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCC-----ChHHHHH
Q 005226 649 GFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRP-----RMKNVSE 700 (707)
Q Consensus 649 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~~v~~ 700 (707)
. ..... .....++.+++.+||..||.+|+ |++++++
T Consensus 253 ~---~~~~p-------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 G---KVRFP-------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C---CCCCC-------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C---CCCCC-------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1 11101 11224577999999999999994 8888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=375.68 Aligned_cols=244 Identities=20% Similarity=0.273 Sum_probs=195.7
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+.||+|+||+||+|... +++.||||.++...... ..+.+|+++|++++|||||++++++.+++..|+||||+++|+|.
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~-~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~ 89 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH-HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH-HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence 47999999999999975 68899999997764433 66889999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC--CCeEEecccccccccccCCCCC
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND--FQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~--~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+++...+ ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 90 ~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~--- 159 (321)
T d1tkia_ 90 ERINTSA----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--- 159 (321)
T ss_dssp HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc---
Confidence 9997653 258999999999999999999999 899999999999999854 5899999999986542211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
.....+|+.|+|||.... ..++.++||||+||++|||++|+.||..... .++...+..
T Consensus 160 --------------~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~- 217 (321)
T d1tkia_ 160 --------------FRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMN- 217 (321)
T ss_dssp --------------EEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-
T ss_pred --------------ccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-
Confidence 123456899999998654 6788999999999999999999999965321 122222211
Q ss_pred ccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+ +... ......++.+++.+|+..||.+|||+.|+++
T Consensus 218 --~~~~~----~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 218 --AEYTF----DEEA-----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --TCCCC----CHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCCC----Chhh-----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110 0000 0112345789999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=372.66 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=193.3
Q ss_pred cceecccCeeEEEEEEeC-CCceEEEEEcCCCc---hhhHHHHHHHHHHHH-hcCCCceeeeEEEEEcCCcceEEEEeec
Q 005226 412 AYVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGG---EQRHREFVTEVQAIA-KVKHPNIVKLRAYYWAPDEKLLISDFIS 486 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~e~~~ 486 (707)
.+.||+|+||+||+|... +++.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 358999999999999975 78999999997532 223456777888766 5799999999999999999999999999
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.++++... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999998654 58999999999999999999999 8999999999999999999999999999986542221
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ..+...+
T Consensus 159 ~----------------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i 215 (320)
T d1xjda_ 159 K----------------TNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSI 215 (320)
T ss_dssp C----------------BCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH
T ss_pred c----------------ccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHH
Confidence 1 123467999999999775 6789999999999999999999999975321 1222222
Q ss_pred HhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChH-HHH
Q 005226 647 KKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMK-NVS 699 (707)
Q Consensus 647 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-~v~ 699 (707)
... ...+.. ....++.+|+.+||..||.+||++. +++
T Consensus 216 ~~~---~~~~p~-------------~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 216 RMD---NPFYPR-------------WLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp HHC---CCCCCT-------------TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HcC---CCCCCc-------------cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 211 111111 1224578999999999999999996 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=366.70 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=192.4
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|.. .+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..|+||||+.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 4799999999999996 5789999999865432 2346889999999999999999999999999999999999975 4
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
+.+++.... ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.........
T Consensus 87 ~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~- 159 (298)
T d1gz8a_ 87 LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159 (298)
T ss_dssp HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT-
T ss_pred hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcccc-
Confidence 555554332 2369999999999999999999999 899999999999999999999999999998765322111
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....||+.|+|||.......++.++|||||||++|||++|+.||...... ..+..-....
T Consensus 160 ---------------~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-----~~~~~i~~~~ 219 (298)
T d1gz8a_ 160 ---------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-----DQLFRIFRTL 219 (298)
T ss_dssp ---------------TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHH
T ss_pred ---------------eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-----HHHHHHHHhc
Confidence 23457999999998776667789999999999999999999999753211 1111111100
Q ss_pred cccc-CCCch-------------hchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEE-NPLSD-------------MVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~-~~~~~-------------~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ..... ........ .......++.+++.+|+..||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSK--VVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHH--HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhhccccccccccccccccccccchhh--hccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 00000 00000000 00122356789999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-43 Score=364.54 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=194.5
Q ss_pred ceecccCeeEEEEEEeCCCceEEEEEcCCCch--hhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE--QRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|+..+|+.||||+++.... ...+.|.+|+.+|++++|||||++++++.+++..++++||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 47999999999999999999999999876532 2347899999999999999999999999999999999999988777
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPSS 570 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 570 (707)
..+.... ..+++..+..|+.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|..........
T Consensus 88 ~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 157 (286)
T d1ob3a_ 88 KLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-- 157 (286)
T ss_dssp HHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHhhc-----CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcccc--
Confidence 6666543 369999999999999999999999 899999999999999999999999999998765332111
Q ss_pred CCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhhc
Q 005226 571 SGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKGF 650 (707)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 650 (707)
....+++.|+|||.+.....++.++|||||||++|||++|+.||...... +....+....
T Consensus 158 --------------~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~------~~~~~i~~~~ 217 (286)
T d1ob3a_ 158 --------------THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA------DQLMRIFRIL 217 (286)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHH
T ss_pred --------------ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH------HHHHHHHHhh
Confidence 22346889999999877677899999999999999999999999753211 1111111110
Q ss_pred cccC--CCchhch-----HHHH------hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 651 EEEN--PLSDMVD-----AMLL------QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 651 ~~~~--~~~~~~d-----~~l~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... ...+... .... ...........+.+++.+|++.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0000000 0000 00001112346789999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=365.64 Aligned_cols=234 Identities=22% Similarity=0.313 Sum_probs=187.9
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCch------hhHHHHHHHHHHHHhcC--CCceeeeEEEEEcCCcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGE------QRHREFVTEVQAIAKVK--HPNIVKLRAYYWAPDEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e 483 (707)
+.||+|+||+||+|+. .+|+.||||++..... ....++.+|+.++++++ |||||++++++.+++..++|||
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 4899999999999996 4789999999864321 11244678999999996 8999999999999999999999
Q ss_pred eecC-CChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCC-CCeEEecccccccc
Q 005226 484 FISN-GNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDND-FQPYISDFGLSRLI 561 (707)
Q Consensus 484 ~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~DfGla~~~ 561 (707)
|+.+ +++.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 90 ~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 90 RPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp CCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceec
Confidence 9976 68888887543 59999999999999999999999 899999999999999854 79999999999865
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
..... ....||+.|+|||++.....++.++|||||||++|||+||+.||.... .
T Consensus 162 ~~~~~------------------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~ 215 (273)
T d1xwsa_ 162 KDTVY------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E 215 (273)
T ss_dssp CSSCB------------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H
T ss_pred ccccc------------------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------H
Confidence 42211 234579999999997664556788999999999999999999995310 1
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+.. ....+.. ....++.+++.+||+.||++|||++|+++
T Consensus 216 ----i~~---~~~~~~~-------------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 216 ----IIR---GQVFFRQ-------------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----HHH---CCCCCSS-------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----Hhh---cccCCCC-------------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111 1111111 11245788999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-42 Score=358.84 Aligned_cols=262 Identities=19% Similarity=0.225 Sum_probs=189.6
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC--------CcceEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP--------DEKLLI 481 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV 481 (707)
+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++... +..++|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 3799999999999996 57999999998654 223346789999999999999999999998653 457899
Q ss_pred EEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccc
Q 005226 482 SDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLI 561 (707)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~ 561 (707)
|||+.++.+....... ..++...+..|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 96 FDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 9999887766555433 368999999999999999999999 89999999999999999999999999999876
Q ss_pred cccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 562 NITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
......... ......||+.|+|||++.....++.++|||||||++|||++|+.||..... ..
T Consensus 168 ~~~~~~~~~------------~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~------~~ 229 (318)
T d3blha1 168 SLAKNSQPN------------RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE------QH 229 (318)
T ss_dssp CC-----CC------------CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HH
T ss_pred ccccccccc------------cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH------HH
Confidence 532211110 112346799999999987666789999999999999999999999965321 11
Q ss_pred HHHHHHhhccccC--CCchhchHH--------------HHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 642 LVRWVKKGFEEEN--PLSDMVDAM--------------LLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~--~~~~~~d~~--------------l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
....+........ ......... +............+.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1111111111000 000000000 0000001112345678999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=359.98 Aligned_cols=260 Identities=20% Similarity=0.291 Sum_probs=191.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc-hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC----cceEEEEeec
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG-EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD----EKLLISDFIS 486 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~ 486 (707)
+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++..+. ..+++++|+.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 4799999999999985 589999999997653 344578899999999999999999999997653 3466677788
Q ss_pred CCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCC
Q 005226 487 NGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGN 566 (707)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~ 566 (707)
+|+|.+++... .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.......
T Consensus 94 ~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 94 GADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred CCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 99999999754 49999999999999999999999 8999999999999999999999999999987653322
Q ss_pred CCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHH
Q 005226 567 NPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWV 646 (707)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~ 646 (707)
.... .....||+.|+|||++..+..++.++||||+||++|||++|+.||...... +.....
T Consensus 165 ~~~~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~------~~~~~~ 225 (345)
T d1pmea_ 165 HTGF-------------LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL------DQLNHI 225 (345)
T ss_dssp BCCT-------------TCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHH
T ss_pred ccee-------------eccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH------HHHHHH
Confidence 1111 123457999999999877677889999999999999999999999653221 111111
Q ss_pred HhhccccCCC--chhchHHHHhh---------h----hhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 647 KKGFEEENPL--SDMVDAMLLQE---------V----HAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 647 ~~~~~~~~~~--~~~~d~~l~~~---------~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......... ........... . .......++.+++.+|++.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000000 00000000000 0 00011235789999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=362.00 Aligned_cols=256 Identities=26% Similarity=0.299 Sum_probs=185.5
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEEee
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISDFI 485 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~~ 485 (707)
++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++|||||++++++.... +.++||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 47999999999999975 689999999876432 2347999999999999999999996532 358999999
Q ss_pred cCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEeccccccccccc
Q 005226 486 SNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINIT 564 (707)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~ 564 (707)
++|.+..+.+... ....+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 8764444332111 12469999999999999999999999 8999999999999999775 8999999999876432
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
... ....||..|+|||.+.....++.++||||+||++|||++|+.||...... ..+..
T Consensus 177 ~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-----~~l~~ 234 (350)
T d1q5ka_ 177 EPN-----------------VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-----DQLVE 234 (350)
T ss_dssp SCC-----------------CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-----HHHHH
T ss_pred ccc-----------------ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-----HHHHH
Confidence 211 22456899999998776678899999999999999999999999653211 11111
Q ss_pred HHHh-----------hccc--cCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKK-----------GFEE--ENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~-----------~~~~--~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.... .... ...+......... .........++.+|+.+|+..||++|||++|+++
T Consensus 235 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhCCChHHhhhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1110 0000 0000000000000 0001122345789999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=355.76 Aligned_cols=257 Identities=23% Similarity=0.260 Sum_probs=186.5
Q ss_pred ceecccCeeEEEEEEeC-C-CceEEEEEcCCCc--hhhHHHHHHHHHHHHhc---CCCceeeeEEEEEc-----CCcceE
Q 005226 413 YVLGKSGLGIVYKVVLG-N-GIPVAVRRLGEGG--EQRHREFVTEVQAIAKV---KHPNIVKLRAYYWA-----PDEKLL 480 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~~l 480 (707)
+.||+|+||+||+|... + ++.||||+++... ......+.+|+.+++.+ +||||++++++|.. ....++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 37999999999999963 4 5679999986432 22234567888887766 79999999999853 245789
Q ss_pred EEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccc
Q 005226 481 ISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRL 560 (707)
Q Consensus 481 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~ 560 (707)
+|||+.+|.+........ ..+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 999998887765555432 368999999999999999999999 8999999999999999999999999999876
Q ss_pred ccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccch
Q 005226 561 INITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVP 640 (707)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~ 640 (707)
...... .....||+.|+|||++.. ..++.++||||+||++|||+||++||......
T Consensus 166 ~~~~~~-----------------~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~------ 221 (305)
T d1blxa_ 166 YSFQMA-----------------LTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------ 221 (305)
T ss_dssp CCGGGG-----------------GCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------
T ss_pred hccccc-----------------CCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHH------
Confidence 542211 123467999999999765 77899999999999999999999999753221
Q ss_pred hHHHHHHhhcc----ccCCCchhc-hHHHH------hhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 641 DLVRWVKKGFE----EENPLSDMV-DAMLL------QEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 641 ~~~~~~~~~~~----~~~~~~~~~-d~~l~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
+....+..... ..++..... ..... ...........+.+|+.+|++.||++|||++|+++
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111111100 000000000 00000 00001112345778999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=359.37 Aligned_cols=254 Identities=22% Similarity=0.275 Sum_probs=185.8
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCC------cceEEEE
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPD------EKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 483 (707)
+.||+|+||+||+|.. .+|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ +.++|||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 3799999999999996 46999999999754 2334567899999999999999999999998765 4699999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+ +++|..+.+.. .+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+|++|||+|+....
T Consensus 104 ~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 104 FM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCC
Confidence 99 56888887643 49999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
.. ....||+.|+|||++.+...++.++||||+||++|||++|++||...... ..+.
T Consensus 174 ~~-------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-----~~~~ 229 (346)
T d1cm8a_ 174 EM-------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-----DQLK 229 (346)
T ss_dssp SC-------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred cc-------------------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-----HHHH
Confidence 21 23456899999999876667899999999999999999999999753211 1111
Q ss_pred HHHHhhcccc-----CCCchhchHHHHhh---------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 644 RWVKKGFEEE-----NPLSDMVDAMLLQE---------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 644 ~~~~~~~~~~-----~~~~~~~d~~l~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.......... .............. .........+.+|+.+|+..||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1111000000 00000000000000 000111245679999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.5e-41 Score=347.08 Aligned_cols=259 Identities=16% Similarity=0.216 Sum_probs=198.9
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|+.. +|+.||||++..... ...+.+|+++++.++| +|++.+++++..+...++||||+ +|+|
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 47999999999999964 789999998765432 2457889999999965 89999999999999999999998 7899
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcC-----CCCeEEecccccccccccC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDN-----DFQPYISDFGLSRLINITG 565 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~DfGla~~~~~~~ 565 (707)
.++++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+......
T Consensus 88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99997653 358999999999999999999999 89999999999999974 5789999999999875432
Q ss_pred CCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHH
Q 005226 566 NNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRW 645 (707)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 645 (707)
.... .+........||+.|+|||.+.. ..++.++|||||||++|||+||+.||....... .......
T Consensus 161 ~~~~---------~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~---~~~~~~~ 227 (293)
T d1csna_ 161 TKQH---------IPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYER 227 (293)
T ss_dssp TCCB---------CCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHH
T ss_pred cccc---------eeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchh---HHHHHHH
Confidence 2111 11112244578999999999765 778999999999999999999999997644331 1111111
Q ss_pred HHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 646 VKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
+....... + -+.+ ......++.+++..|++.+|++||+++.+.+.|+++
T Consensus 228 i~~~~~~~-~-----~~~l-----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 228 IGEKKQST-P-----LREL-----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHHHHS-C-----HHHH-----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HHhccCCC-C-----hHHh-----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11110000 0 0000 011235688999999999999999999998888765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-41 Score=349.58 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=190.7
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCceee-eEEEEEcCCcceEEEEeecCCCh
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNIVK-LRAYYWAPDEKLLISDFISNGNL 490 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~e~~~~gsL 490 (707)
+.||+|+||+||+|.. .+|+.||||++..... ..++.+|++++++++|+|++. +.++..+++..++||||+ +|+|
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l 89 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 89 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence 4799999999999996 4689999998765432 256789999999998776555 455556777888999998 5677
Q ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEc---CCCCeEEecccccccccccCCC
Q 005226 491 ANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLD---NDFQPYISDFGLSRLINITGNN 567 (707)
Q Consensus 491 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~DfGla~~~~~~~~~ 567 (707)
.+.+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+........
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 77765443 369999999999999999999999 8999999999999975 4567999999999987643322
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHH
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVK 647 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 647 (707)
.. ..+.......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||......... .....+..
T Consensus 163 ~~---------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~--~~~~~~~~ 230 (299)
T d1ckia_ 163 QH---------IPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR--QKYERISE 230 (299)
T ss_dssp CB---------CCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---------HHHHHH
T ss_pred cc---------eeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHH--HHHHHhhc
Confidence 11 11122244578999999999665 67899999999999999999999999764432110 01111111
Q ss_pred hhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHHHHHhh
Q 005226 648 KGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSENLERI 705 (707)
Q Consensus 648 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~~L~~i 705 (707)
.... .+ .+. .......++.+++..||+.||++||+++++.+.|+.+
T Consensus 231 ~~~~--~~-----~~~-----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 231 KKMS--TP-----IEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHH--SC-----HHH-----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred ccCC--CC-----hhH-----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0000 00 000 0112235688999999999999999999999888765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=348.17 Aligned_cols=259 Identities=20% Similarity=0.223 Sum_probs=197.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcCCcceEEEEeecCCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAPDEKLLISDFISNGN 489 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 489 (707)
+.||+|+||+||+|+. .+++.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++|+||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 4799999999999996 47889999998644 23345789999999999999999999999999999999999999999
Q ss_pred hHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccccCCCCC
Q 005226 490 LANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINITGNNPS 569 (707)
Q Consensus 490 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 569 (707)
|..++...+ .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+.........
T Consensus 88 l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~- 158 (292)
T d1unla_ 88 KKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY- 158 (292)
T ss_dssp HHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC-
T ss_pred ccccccccc-----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCccc-
Confidence 998887653 68999999999999999999999 899999999999999999999999999998765432211
Q ss_pred CCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHHHHHhh
Q 005226 570 SSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVRWVKKG 649 (707)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 649 (707)
....++..|+|||++.....++.++|||||||++|||++|+.||..... ..+....+...
T Consensus 159 ---------------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~ 218 (292)
T d1unla_ 159 ---------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRL 218 (292)
T ss_dssp ---------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-----HHHHHHHHHHH
T ss_pred ---------------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-----HHHHHHHHHhh
Confidence 1234577899999877666679999999999999999999999754221 11111111111
Q ss_pred ccccCC--Cch-----------hchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 650 FEEENP--LSD-----------MVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 650 ~~~~~~--~~~-----------~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
...... ... ..................+.+|+.+|++.||++|||++||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111000 000 000000000001122345788999999999999999999976
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-41 Score=351.53 Aligned_cols=248 Identities=25% Similarity=0.298 Sum_probs=192.7
Q ss_pred cceecccCeeEEEEEEeC----CCceEEEEEcCCCc----hhhHHHHHHHHHHHHhcCC-CceeeeEEEEEcCCcceEEE
Q 005226 412 AYVLGKSGLGIVYKVVLG----NGIPVAVRRLGEGG----EQRHREFVTEVQAIAKVKH-PNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 412 ~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 482 (707)
.+.||+|+||+||+|... +|+.||||.++... ....+.+.+|++++++++| |||+++++++.+.+..++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 348999999999999852 47899999986542 1234678899999999976 89999999999999999999
Q ss_pred EeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccc
Q 005226 483 DFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLIN 562 (707)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~ 562 (707)
||+.+|+|.+++.... .+.......++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+|+.+.
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999998654 47888999999999999999999 899999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchh
Q 005226 563 ITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPG-NRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPD 641 (707)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~ 641 (707)
...... .....|++.|+|||.+... ..++.++|||||||++|||+||+.||....... .
T Consensus 181 ~~~~~~---------------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-----~ 240 (322)
T d1vzoa_ 181 ADETER---------------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----S 240 (322)
T ss_dssp GGGGGG---------------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-----C
T ss_pred cccccc---------------ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----H
Confidence 322111 1234678999999987643 356889999999999999999999997654321 1
Q ss_pred HHHHHHhhccccCCCchhchHHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCC-----hHHHHH
Q 005226 642 LVRWVKKGFEEENPLSDMVDAMLLQEVHAKKEVIAVFHLALACTEADPEVRPR-----MKNVSE 700 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~~v~~ 700 (707)
...-.........++ ......++.+++.+||+.||++||| ++|+++
T Consensus 241 ~~~i~~~~~~~~~~~-------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 241 QAEISRRILKSEPPY-------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHHHCCCCC-------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHhcccCCCCC-------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111111111111110 1123456788999999999999995 778765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.4e-40 Score=345.08 Aligned_cols=257 Identities=18% Similarity=0.262 Sum_probs=189.5
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcC--CcceEEEEeecCC
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAP--DEKLLISDFISNG 488 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e~~~~g 488 (707)
+.||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||||+.+|
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 4799999999999996 578999999987643 367889999999995 99999999999754 4678999999999
Q ss_pred ChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCC-CeEEecccccccccccCCC
Q 005226 489 NLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDF-QPYISDFGLSRLINITGNN 567 (707)
Q Consensus 489 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~DfGla~~~~~~~~~ 567 (707)
+|..+.+ .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+........
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9977643 48999999999999999999999 8999999999999998665 6999999999876532211
Q ss_pred CCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCcc--------c
Q 005226 568 PSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIE--------V 639 (707)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~--------~ 639 (707)
....+|+.|+|||.+.....++.++||||+||++|||++|+.||.......... .
T Consensus 187 -----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 187 -----------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp -----------------CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred -----------------cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 233568999999998776678999999999999999999999997543210000 0
Q ss_pred hhHHHHHHhhccc-cCCCchhch-------HHHHhhhhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 640 PDLVRWVKKGFEE-ENPLSDMVD-------AMLLQEVHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 640 ~~~~~~~~~~~~~-~~~~~~~~d-------~~l~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.....|....-.. ...+.+... ..............++.+|+.+|+..||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111110000 000000000 000000011122346789999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=351.38 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=189.0
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCc--hhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC-----CcceEEEEe
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGG--EQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP-----DEKLLISDF 484 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 484 (707)
+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++... ...+++++|
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 3799999999999995 579999999997653 33446789999999999999999999998643 345788888
Q ss_pred ecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEeccccccccccc
Q 005226 485 ISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINIT 564 (707)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~~ 564 (707)
+.+|+|.++++.. .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++......
T Consensus 104 ~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 104 LMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCcc
Confidence 9999999999653 49999999999999999999999 89999999999999999999999999998754422
Q ss_pred CCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHHH
Q 005226 565 GNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLVR 644 (707)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~~ 644 (707)
. ....|++.|+|||.......++.++||||+||++|||++|+.||...... ....
T Consensus 175 ~-------------------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~------~~~~ 229 (348)
T d2gfsa1 175 M-------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI------DQLK 229 (348)
T ss_dssp G-------------------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHH
T ss_pred c-------------------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 1 23456899999998776667789999999999999999999999753211 1111
Q ss_pred HHHhhccccCC-----CchhchHHHHhh----------hhhHHHHHHHHHHHHhccCCCCCCCCChHHHHH
Q 005226 645 WVKKGFEEENP-----LSDMVDAMLLQE----------VHAKKEVIAVFHLALACTEADPEVRPRMKNVSE 700 (707)
Q Consensus 645 ~~~~~~~~~~~-----~~~~~d~~l~~~----------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~v~~ 700 (707)
.+......... ............ .........+.+|+.+|+..||++|||++|+++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11111100000 000000000000 000112345789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=343.64 Aligned_cols=253 Identities=22% Similarity=0.254 Sum_probs=181.4
Q ss_pred ceecccCeeEEEEEEeC-CCceEEEEEcCCC--chhhHHHHHHHHHHHHhcCCCceeeeEEEEEcC------CcceEEEE
Q 005226 413 YVLGKSGLGIVYKVVLG-NGIPVAVRRLGEG--GEQRHREFVTEVQAIAKVKHPNIVKLRAYYWAP------DEKLLISD 483 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 483 (707)
+.||+|+||+||+|... +|+.||||++... .......+.+|+.++++++|||||++++++... ...|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 37999999999999965 6999999998754 233446789999999999999999999999654 56799999
Q ss_pred eecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeEEecccccccccc
Q 005226 484 FISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPYISDFGLSRLINI 563 (707)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~DfGla~~~~~ 563 (707)
|+.+ ++.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++....
T Consensus 103 y~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 103 LMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcccc
Confidence 9965 55555542 48999999999999999999999 8999999999999999999999999999876543
Q ss_pred cCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCCCccchhHH
Q 005226 564 TGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPTTSTSIEVPDLV 643 (707)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~~~~~~~~~~~~ 643 (707)
... .....+|+.|+|||++.+ ..+++++||||+||+++||++|+.||...... ...
T Consensus 172 ~~~-----------------~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~------~~~ 227 (355)
T d2b1pa1 172 SFM-----------------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYI------DQW 227 (355)
T ss_dssp --------------------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred ccc-----------------cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHH------HHH
Confidence 221 123456899999999765 78899999999999999999999999653211 111
Q ss_pred HHHH-------------------hhccccCCCchhchHHHH-----h--hhhhHHHHHHHHHHHHhccCCCCCCCCChHH
Q 005226 644 RWVK-------------------KGFEEENPLSDMVDAMLL-----Q--EVHAKKEVIAVFHLALACTEADPEVRPRMKN 697 (707)
Q Consensus 644 ~~~~-------------------~~~~~~~~~~~~~d~~l~-----~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~~ 697 (707)
..+. ............-.+... . ..........+.+|+.+|+..||++|||++|
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 1000 000000000000000000 0 0011234567889999999999999999999
Q ss_pred HHH
Q 005226 698 VSE 700 (707)
Q Consensus 698 v~~ 700 (707)
+++
T Consensus 308 lL~ 310 (355)
T d2b1pa1 308 ALQ 310 (355)
T ss_dssp HHT
T ss_pred Hhc
Confidence 974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.4e-40 Score=341.26 Aligned_cols=259 Identities=31% Similarity=0.539 Sum_probs=222.2
Q ss_pred cCCcccHHHHHHHHhcCcCCCCCCCCCCCCCCCCCc--eeceeEeCCCCCCCCCcEEEEEcCCCCccc--cCCCCcCCCC
Q 005226 18 FALSPDGLTLLSLKSAIDQTDTSVFADWNENDPTPC--RWSGISCMNITGFPDPRVVGVAISGKNVRG--YIPSELGSLI 93 (707)
Q Consensus 18 ~~~~~d~~~l~~~k~~~~~~~~~~~~~W~~~~~~~C--~w~gv~c~~~~~~~~~~v~~L~L~~n~l~~--~~~~~l~~l~ 93 (707)
.|.++|++||++||+++. || ..+++|..++ ||| .|.||+|+.... ..||+.|+|++|++.| .+|+++++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~~-d~C~~~w~gv~C~~~~~--~~~v~~L~L~~~~l~g~~~lp~~l~~L~ 76 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPTT-DCCNRTWLGVLCDTDTQ--TYRVNNLDLSGLNLPKPYPIPSSLANLP 76 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCTTS-CTTTTCSTTEEECCSSS--CCCEEEEEEECCCCSSCEECCGGGGGCT
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCCCC-CCCCCcCCCeEEeCCCC--cEEEEEEECCCCCCCCCCCCChHHhcCc
Confidence 367899999999999997 44 4789998654 777 599999986432 2589999999999998 4799999999
Q ss_pred CCCEEEccc-CCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhh
Q 005226 94 YLRRLNLHN-NNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLIL 172 (707)
Q Consensus 94 ~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 172 (707)
+|++|+|++ |+++|.+|.+|.++++|++|+|++|+|.+..|..+..+++|+.|++++|++.+.+|..+.++++|+.+++
T Consensus 77 ~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l 156 (313)
T d1ogqa_ 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156 (313)
T ss_dssp TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEEC
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeec
Confidence 999999996 8999999999999999999999999999888888888899999999999988888888888888888888
Q ss_pred cCCcccccCCCccc-----------------------------------------------ccCCCccEEeccCCCCCCC
Q 005226 173 ARNKFSGQIPAGIW-----------------------------------------------PELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 173 ~~N~l~~~lp~~~~-----------------------------------------------~~l~~L~~L~ls~N~l~~~ 205 (707)
++|+++|.+|..+. ..+++|+.|++++|.+.+.
T Consensus 157 ~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~ 236 (313)
T d1ogqa_ 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236 (313)
T ss_dssp CSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888877775432 1234566666666666644
Q ss_pred CCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCCCCCCCC
Q 005226 206 IPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGFPLQKSC 284 (707)
Q Consensus 206 ~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~~~~~~c 284 (707)
+ ..+..++++ +.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|+...+.++..+.+.+|+.+||.|++ +|
T Consensus 237 ~-~~~~~~~~L-~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 237 L-GKVGLSKNL-NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp G-GGCCCCTTC-CEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred c-ccccccccc-ccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 3 356667888 7999999999999999999999999999999999999999888999999999999999999875 66
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2e-35 Score=314.10 Aligned_cols=263 Identities=19% Similarity=0.188 Sum_probs=182.3
Q ss_pred ceecccCeeEEEEEEe-CCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-----------CCceeeeEEEEEcC--Ccc
Q 005226 413 YVLGKSGLGIVYKVVL-GNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-----------HPNIVKLRAYYWAP--DEK 478 (707)
Q Consensus 413 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~--~~~ 478 (707)
+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++++++ |+||+++++++... ...
T Consensus 19 ~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~-~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH-HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc-hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 4899999999999996 57999999999865433 367788999988875 57899999988654 455
Q ss_pred eEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCC------eEE
Q 005226 479 LLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQ------PYI 552 (707)
Q Consensus 479 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~------~kl 552 (707)
+++++++..+.......... ....+++..+..++.||+.||+|||+. .+|+||||||+|||++.++. +|+
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccceeeE
Confidence 67777665544333322211 234689999999999999999999974 68999999999999987653 999
Q ss_pred ecccccccccccCCCCCCCCCCcCCCCCCCCccccccCccccCCCCCCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 005226 553 SDFGLSRLINITGNNPSSSGGFMGGALPYMKPVQTEKTNNYRAPEARVPGNRPMQKWDVYSFGVVLLELLTGKSPELSPT 632 (707)
Q Consensus 553 ~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DV~S~Gv~l~elltg~~P~~~~~ 632 (707)
+|||.|....... ....||+.|+|||++.. ..++.++||||+||+++||++|+.||....
T Consensus 174 ~dfg~s~~~~~~~-------------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 174 ADLGNACWYDEHY-------------------TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp CCCTTCEETTBCC-------------------CSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred eeccccccccccc-------------------ccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 9999987554211 23456999999998765 677899999999999999999999997543
Q ss_pred CCCCccch-hHHHHHHhhcc-----------------ccCC---Cch----hchHHH-HhhhhhHHHHHHHHHHHHhccC
Q 005226 633 TSTSIEVP-DLVRWVKKGFE-----------------EENP---LSD----MVDAML-LQEVHAKKEVIAVFHLALACTE 686 (707)
Q Consensus 633 ~~~~~~~~-~~~~~~~~~~~-----------------~~~~---~~~----~~d~~l-~~~~~~~~~~~~l~~l~~~Cl~ 686 (707)
........ .+...+...-. .... ... -..... ............+.+|+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 32111111 11111111000 0000 000 000000 1111234566788999999999
Q ss_pred CCCCCCCChHHHHH
Q 005226 687 ADPEVRPRMKNVSE 700 (707)
Q Consensus 687 ~dP~~RPs~~~v~~ 700 (707)
.||.+|||++|+++
T Consensus 314 ~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 314 LDPRKRADAGGLVN 327 (362)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999976
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=4.7e-25 Score=222.74 Aligned_cols=200 Identities=26% Similarity=0.251 Sum_probs=147.6
Q ss_pred EEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccC
Q 005226 71 VVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSN 150 (707)
Q Consensus 71 v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 150 (707)
...++.++++|+. +|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|+.|+|++
T Consensus 12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCS
T ss_pred CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccc
Confidence 3445667777774 565553 46788888888887666667778888888888888887 444 356778888888888
Q ss_pred CcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCC
Q 005226 151 NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGK 230 (707)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~ 230 (707)
|+++ ..+..+.++++|+.|++++|++. .++...+..+.+|++|++++|.++...+..+..++.+ +.|++++|+|++.
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l-~~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL-EKLSLANNNLTEL 163 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-CEEECTTSCCSCC
T ss_pred cccc-ccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccc-hhccccccccccc
Confidence 8887 45667777888888888888877 6777777778888888888888876666667777777 6888888888877
Q ss_pred CCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCCcccCC
Q 005226 231 IPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 231 ~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~~l~~~ 278 (707)
.+..|..+++|++|+|++|+|+..++....+..+..+.+.||||.|++
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 777777888888888888888744444555666777778888888864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=5.7e-25 Score=224.48 Aligned_cols=221 Identities=21% Similarity=0.231 Sum_probs=197.1
Q ss_pred ceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEec-CccC
Q 005226 56 SGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLY-GNNL 129 (707)
Q Consensus 56 ~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l 129 (707)
.-|.|++ .|...+..++.|+|++|+|+++.+..|.++++|++|++++|+|....+..+.++..++.|+.. .|.+
T Consensus 14 ~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 14 VTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp CEEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred eEEEcCCCCCCccCCCCCCCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 3477864 333345678999999999998888899999999999999999998888889999999999765 6778
Q ss_pred CCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcc
Q 005226 130 SGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPND 209 (707)
Q Consensus 130 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~ 209 (707)
+...|..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|+ .+|...|..+++|+.|+|++|+|++..+..
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~ 172 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERA 172 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhh
Confidence 8777889999999999999999999777888999999999999999999 899888999999999999999999888899
Q ss_pred hhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCC-CCCCCCCCCcccCCCCcccCC
Q 005226 210 LGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQ-TGSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 210 ~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~~l~~~ 278 (707)
|.++++| +.+++++|++++..|..|..+++|+.|++++|++++.+|. .....++..+.+.+||+-|.+
T Consensus 173 f~~l~~L-~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 173 FRGLHSL-DRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp TTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred hcccccc-chhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999 7999999999999999999999999999999999987763 235567888899999999864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.9e-24 Score=218.29 Aligned_cols=190 Identities=26% Similarity=0.259 Sum_probs=173.4
Q ss_pred eEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCC
Q 005226 58 ISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGS 132 (707)
Q Consensus 58 v~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 132 (707)
|.|.+ .|...+..++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+|+ .
T Consensus 15 v~C~~~~L~~iP~~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~ 91 (266)
T d1p9ag_ 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-S 91 (266)
T ss_dssp EECTTSCCSSCCSCCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-S
T ss_pred EEccCCCCCeeCcCcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-c
Confidence 77853 33334468999999999999888889999999999999999998 444 3678999999999999999 6
Q ss_pred CCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhh
Q 005226 133 LPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGE 212 (707)
Q Consensus 133 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 212 (707)
.+..+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|.++ .+|...+..+++|+.|++++|+|++..+..|..
T Consensus 92 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~ 170 (266)
T d1p9ag_ 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG 170 (266)
T ss_dssp CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTT
T ss_pred cccccccccccccccccccccceeeccccccccccccccccccccc-eeccccccccccchhcccccccccccCcccccc
Confidence 7888999999999999999999888889999999999999999999 899999999999999999999999888888999
Q ss_pred hhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcc
Q 005226 213 LQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 213 l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
+++| ++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 171 l~~L-~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 171 LENL-DTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTC-CEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred cccc-ceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 9999 79999999999 899999999999999999999875
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=9.3e-23 Score=210.09 Aligned_cols=218 Identities=23% Similarity=0.328 Sum_probs=153.0
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEec
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLY 125 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 125 (707)
|-|.|++|.|.+ .|...+..++.|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|+|+
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 458899999975 333334789999999999998777889999999999999999998889999999999999999
Q ss_pred CccCCCCCCcc------------------------------------------------cCCCCCccEEeccCCcccccC
Q 005226 126 GNNLSGSLPPS------------------------------------------------VCNLPRLQNLDLSNNSFSGSL 157 (707)
Q Consensus 126 ~N~l~~~~p~~------------------------------------------------~~~l~~L~~L~Ls~N~l~~~~ 157 (707)
+|+|+ .+|.. +..+++|+.+++++|.++ .+
T Consensus 88 ~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l 165 (305)
T d1xkua_ 88 KNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165 (305)
T ss_dssp SSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SC
T ss_pred CCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-cc
Confidence 99988 34332 223444445555555544 33
Q ss_pred CCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCC
Q 005226 158 PDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGN 237 (707)
Q Consensus 158 p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~ 237 (707)
|..+ +++|+.|++++|.+++. +...|..++.+++|++++|.+++..+..+.++++| ++|+|++|+|+ .+|..+..
T Consensus 166 ~~~~--~~~L~~L~l~~n~~~~~-~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L-~~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 166 PQGL--PPSLTELHLDGNKITKV-DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL-RELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp CSSC--CTTCSEEECTTSCCCEE-CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC-CEEECCSSCCS-SCCTTTTT
T ss_pred Cccc--CCccCEEECCCCcCCCC-ChhHhhccccccccccccccccccccccccccccc-eeeeccccccc-cccccccc
Confidence 3322 34555666666665532 33445667777777777777777667777777777 67888888777 56777777
Q ss_pred CCCccEEEccCCcCcccCCCC-------CCCCCCCCcccCCCCcc
Q 005226 238 LPVTVSFDLRGNNLSGEIPQT-------GSFANQGPTAFLSNPLL 275 (707)
Q Consensus 238 l~~L~~l~l~~N~l~~~~p~~-------~~~~~~~~~~~~~N~~l 275 (707)
+++|+.|+|++|+|+...... .....+..+.+.+||+-
T Consensus 241 l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 778888888888777432211 12233445566666653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.89 E-value=2.4e-24 Score=223.04 Aligned_cols=182 Identities=34% Similarity=0.522 Sum_probs=156.8
Q ss_pred CcEEEEEcCC-CCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISG-KNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
.+++.|+|++ |+++|.+|..|++|++|++|+|++|+|.+..+..+..+.+|+.|++++|++.+.+|..+.++++|+.++
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~ 155 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceee
Confidence 5899999997 899999999999999999999999999999998899999999999999999989999999999999999
Q ss_pred ccCCcccccCCCCCcccch------------------------------------------------hhhhhhcCCcccc
Q 005226 148 LSNNSFSGSLPDGLKNCKQ------------------------------------------------LQRLILARNKFSG 179 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~~l~~------------------------------------------------L~~L~l~~N~l~~ 179 (707)
+++|.+++.+|..+..+.+ |+.|++++|.+++
T Consensus 156 l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999988888876655544 3344444444443
Q ss_pred cCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCc-Cccc
Q 005226 180 QIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNN-LSGE 254 (707)
Q Consensus 180 ~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~ 254 (707)
.+| . +..+++|+.|+|++|+|+|.+|..|+++++| ++|+|++|+|+|.+|. ++++++|+.+++++|+ ++|.
T Consensus 236 ~~~-~-~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L-~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 236 DLG-K-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFL-HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp BGG-G-CCCCTTCCEEECCSSCCEECCCGGGGGCTTC-CEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred ccc-c-cccccccccccCccCeecccCChHHhCCCCC-CEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence 333 2 4678999999999999999999999999999 7999999999999995 6889999999999998 6665
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=5.2e-23 Score=196.56 Aligned_cols=133 Identities=19% Similarity=0.218 Sum_probs=105.3
Q ss_pred hccceecccCeeEEEEEEeCCCceEEEEEcCCCch------------------hhHHHHHHHHHHHHhcCCCceeeeEEE
Q 005226 410 ASAYVLGKSGLGIVYKVVLGNGIPVAVRRLGEGGE------------------QRHREFVTEVQAIAKVKHPNIVKLRAY 471 (707)
Q Consensus 410 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 471 (707)
+.++.||+|+||+||+|...+|+.||||+++.... .....+.+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34568999999999999998999999998653210 012345578899999999999998765
Q ss_pred EEcCCcceEEEEeecCCChHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCceecCCCCCCeEEcCCCCeE
Q 005226 472 YWAPDEKLLISDFISNGNLANALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHECSPRKFVHGDIKPSNILLDNDFQPY 551 (707)
Q Consensus 472 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiHrDlk~~NIll~~~~~~k 551 (707)
. ..++||||++++.+.+ +++....+++.|++.+|+|||+ .+|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 3 3489999998765432 3334456899999999999999 899999999999999965 589
Q ss_pred Eeccccccccc
Q 005226 552 ISDFGLSRLIN 562 (707)
Q Consensus 552 l~DfGla~~~~ 562 (707)
|+|||+|+...
T Consensus 143 liDFG~a~~~~ 153 (191)
T d1zara2 143 IIDFPQSVEVG 153 (191)
T ss_dssp ECCCTTCEETT
T ss_pred EEECCCcccCC
Confidence 99999987543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=3.4e-21 Score=196.12 Aligned_cols=186 Identities=23% Similarity=0.260 Sum_probs=173.2
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcc-cCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEe
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLH-NNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLD 147 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 147 (707)
..++.|++++|++.+..+..+..++.++.|+.. .|.++...|..|.++++|++|+|++|.+....+..+..+++|+.++
T Consensus 56 ~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~ 135 (284)
T d1ozna_ 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhh
Confidence 579999999999999999999999999999865 6778877788999999999999999999977788899999999999
Q ss_pred ccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcC
Q 005226 148 LSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHL 227 (707)
Q Consensus 148 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l 227 (707)
+++|+|++..+..|..+++|+.|+|++|+|+ .+|...|..+++|++|++++|++++..|..|.++++| ++|++++|.+
T Consensus 136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L-~~L~l~~N~i 213 (284)
T d1ozna_ 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL-MTLYLFANNL 213 (284)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEECCSSCC
T ss_pred hccccccccChhHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhc-cccccccccc
Confidence 9999999777788999999999999999999 8888899999999999999999999999999999999 7999999999
Q ss_pred cCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 228 SGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 228 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
++..|..|..+++|+.|++++|++.+.-+
T Consensus 214 ~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 214 SALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp SCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccCEEEecCCCCCCCcc
Confidence 99888999999999999999999997543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=5e-21 Score=182.78 Aligned_cols=169 Identities=21% Similarity=0.207 Sum_probs=134.6
Q ss_pred CCCCccccCCCCcCCCCCCCEEEcccCCcCCCC-CccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccc
Q 005226 77 SGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSL-PDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSG 155 (707)
Q Consensus 77 ~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 155 (707)
++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++....+..|..+++|++|+|++|+|+.
T Consensus 16 s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~ 92 (192)
T d1w8aa_ 16 TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE 92 (192)
T ss_dssp TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCE
T ss_pred eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccc
Confidence 445666 5566653 68999999999998644 5677889999999999999998889999999999999999999998
Q ss_pred cCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcC
Q 005226 156 SLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSL 235 (707)
Q Consensus 156 ~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~ 235 (707)
..|..|.++++|++|+|++|+|+ .||.+.|..+++|++|+|++|.+....+. ..-...+ +.+.+..|.++...|..+
T Consensus 93 l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l-~~~~l~~~~~~c~~p~~l 169 (192)
T d1w8aa_ 93 ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWL-RKKSLNGGAARCGAPSKV 169 (192)
T ss_dssp ECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHH-HHHCCSGGGCBBCSSTTT
T ss_pred cCHHHHhCCCcccccccCCcccc-ccCHHHhcCCcccccccccccccccccch-HHHhhhh-hhhcccCCCeEeCCChhh
Confidence 88888999999999999999999 89999999999999999999999854322 2212234 466777888876667544
Q ss_pred CCCCCccEEEccCCcCccc
Q 005226 236 GNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 236 ~~l~~L~~l~l~~N~l~~~ 254 (707)
..++.++|+.|.++..
T Consensus 170 ---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 170 ---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp ---TTSBGGGSCTTTCCCC
T ss_pred ---cCCEeeecCHhhCcCC
Confidence 4455667777777643
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.80 E-value=2.3e-20 Score=178.14 Aligned_cols=175 Identities=21% Similarity=0.301 Sum_probs=143.0
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCC-CcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSL-PPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILAR 174 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 174 (707)
++++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 47899999999 7787663 78999999999998644 56789999999999999999988899999999999999999
Q ss_pred CcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCccc
Q 005226 175 NKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGE 254 (707)
Q Consensus 175 N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 254 (707)
|+|+ .+|+..|.++++|++|+|++|+|++..|..|..+++| ++|+|++|.+....+. ..-...++.+.+..|.+++.
T Consensus 88 N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L-~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL-TSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTC-CEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBC
T ss_pred cccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCccc-ccccccccccccccch-HHHhhhhhhhcccCCCeEeC
Confidence 9999 8998899999999999999999998888889999999 7999999999843322 11123466677888888877
Q ss_pred CCCCCCCCCCCCcccCCCCcccCC
Q 005226 255 IPQTGSFANQGPTAFLSNPLLCGF 278 (707)
Q Consensus 255 ~p~~~~~~~~~~~~~~~N~~l~~~ 278 (707)
.| ..+.+..-..+..|.+-|..
T Consensus 165 ~p--~~l~~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 165 AP--SKVRDVQIKDLPHSEFKCSS 186 (192)
T ss_dssp SS--TTTTTSBGGGSCTTTCCCCC
T ss_pred CC--hhhcCCEeeecCHhhCcCCC
Confidence 77 44555555566667666653
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.78 E-value=7.8e-19 Score=180.33 Aligned_cols=193 Identities=26% Similarity=0.326 Sum_probs=156.2
Q ss_pred EEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 72 VGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 72 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
+.++=++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 45788899998 5577664 68999999999999766678999999999999999999888899999999999999999
Q ss_pred cccccCCCC------------------------------------------------CcccchhhhhhhcCCcccccCCC
Q 005226 152 SFSGSLPDG------------------------------------------------LKNCKQLQRLILARNKFSGQIPA 183 (707)
Q Consensus 152 ~l~~~~p~~------------------------------------------------~~~l~~L~~L~l~~N~l~~~lp~ 183 (707)
+|+ .+|.. +..+++|+.+++++|+++ .+|.
T Consensus 90 ~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~ 167 (305)
T d1xkua_ 90 QLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167 (305)
T ss_dssp CCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCS
T ss_pred ccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCc
Confidence 987 33332 223446667777777777 6666
Q ss_pred cccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCC
Q 005226 184 GIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263 (707)
Q Consensus 184 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~ 263 (707)
.. +++|+.|++++|.+++..+..|.+++.+ +.|++++|.+++..+..+..+++|++|+|++|+|+..++....+.+
T Consensus 168 ~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l-~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~ 243 (305)
T d1xkua_ 168 GL---PPSLTELHLDGNKITKVDAASLKGLNNL-AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243 (305)
T ss_dssp SC---CTTCSEEECTTSCCCEECTGGGTTCTTC-CEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSS
T ss_pred cc---CCccCEEECCCCcCCCCChhHhhccccc-cccccccccccccccccccccccceeeecccccccccccccccccC
Confidence 44 4678888888888888888888888888 6899999999888888888889999999999998865445556777
Q ss_pred CCCcccCCCC
Q 005226 264 QGPTAFLSNP 273 (707)
Q Consensus 264 ~~~~~~~~N~ 273 (707)
+..+.+.+|.
T Consensus 244 L~~L~Ls~N~ 253 (305)
T d1xkua_ 244 IQVVYLHNNN 253 (305)
T ss_dssp CCEEECCSSC
T ss_pred CCEEECCCCc
Confidence 7777777775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=3.5e-19 Score=176.39 Aligned_cols=218 Identities=18% Similarity=0.136 Sum_probs=170.3
Q ss_pred CCceeceeEeCC-----CCCCCCCcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCC-CccccCCCCCceEEe
Q 005226 51 TPCRWSGISCMN-----ITGFPDPRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSL-PDQLFNATSLHSIFL 124 (707)
Q Consensus 51 ~~C~w~gv~c~~-----~~~~~~~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L 124 (707)
|-|.+..|.|.. .|...+..++.|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++
T Consensus 6 C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 6 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 446677899974 23333468999999999999877778999999999999999998654 457889999999998
Q ss_pred cC-ccCCCCCCcccCCCCCccEEeccCCcccccCC-CCCcccchhhhhhhcCCcccccCCCcccccCC-CccEEeccCCC
Q 005226 125 YG-NNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLP-DGLKNCKQLQRLILARNKFSGQIPAGIWPELE-NLVQLDLSDND 201 (707)
Q Consensus 125 ~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~-~L~~L~ls~N~ 201 (707)
.. |++....+..|.++++|+.|++++|++....+ ..+..+..|..+..+++++. .++...|..++ .++.|++++|+
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeeccccc
Confidence 64 78887888889999999999999999984333 23456677777788888888 88877777765 78999999999
Q ss_pred CCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCC
Q 005226 202 FKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272 (707)
Q Consensus 202 l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N 272 (707)
++. ++....+..++.+.+++++|+|+...+..|.++++|+.|++++|+|+..++ ..+.++..+...++
T Consensus 165 l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~--~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 165 IQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS--YGLENLKKLRARST 232 (242)
T ss_dssp CCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS--SSCTTCCEEESSSE
T ss_pred ccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH--HHHcCCcccccCcC
Confidence 994 555555556663455678899996555678999999999999999995544 44566655554443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.8e-18 Score=167.20 Aligned_cols=164 Identities=29% Similarity=0.386 Sum_probs=133.8
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
..++.|++++|.++... .+..+++|++|+|++|+|++. + .+.++++|++|+|++|+|+ .+| .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCc-c-ccccCcccccccccccccc-ccc-ccccccccccccc
Confidence 36888999999988653 488899999999999999854 3 3688999999999999998 455 5888999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|.+. . ...+.++++|+.+++++|.++ .++. +..+++|+++++++|++++ ++ .+.++++| ++|+|++|+|+
T Consensus 120 ~~~~~~-~-~~~l~~l~~l~~l~~~~n~l~-~~~~--~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L-~~L~Ls~N~i~ 191 (210)
T d1h6ta2 120 EHNGIS-D-INGLVHLPQLESLYLGNNKIT-DITV--LSRLTKLDTLSLEDNQISD-IV-PLAGLTKL-QNLYLSKNHIS 191 (210)
T ss_dssp TTSCCC-C-CGGGGGCTTCCEEECCSSCCC-CCGG--GGGCTTCSEEECCSSCCCC-CG-GGTTCTTC-CEEECCSSCCC
T ss_pred cccccc-c-ccccccccccccccccccccc-cccc--ccccccccccccccccccc-cc-cccCCCCC-CEEECCCCCCC
Confidence 999886 3 346888899999999999987 4442 4678999999999999985 43 38888999 79999999998
Q ss_pred CCCCCcCCCCCCccEEEccC
Q 005226 229 GKIPKSLGNLPVTVSFDLRG 248 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~ 248 (707)
.+| .+..+++|+.|+|++
T Consensus 192 -~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 -DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -BCG-GGTTCTTCSEEEEEE
T ss_pred -CCh-hhcCCCCCCEEEccC
Confidence 455 588899999998864
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=4.4e-18 Score=163.02 Aligned_cols=145 Identities=32% Similarity=0.448 Sum_probs=64.2
Q ss_pred cEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEecc
Q 005226 70 RVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLS 149 (707)
Q Consensus 70 ~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 149 (707)
+++.|++++|+++.. +.+..+++|++|+|++|+|++..| +.++++|++|++++|.+. .++ .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 444555555554432 234445555555555555543221 445555555555555544 222 24445555555555
Q ss_pred CCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 150 NNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 150 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
+|.+... ..+..+++|+.|++++|++. .++. +..+++|+.|++++|++++ ++ .+.++++| ++|++++|+++
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~~--l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L-~~L~ls~N~i~ 185 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTIS-DISA--LSGLTSLQQLNFSSNQVTD-LK-PLANLTTL-ERLDISSNKVS 185 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCC-CG-GGTTCTTC-CEEECCSSCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhc-cccc--ccccccccccccccccccC-Cc-cccCCCCC-CEEECCCCCCC
Confidence 5544421 12344444444444444444 3321 2344444444444444442 11 24444444 34444444444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3.7e-18 Score=163.53 Aligned_cols=175 Identities=26% Similarity=0.351 Sum_probs=142.8
Q ss_pred EEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 72 VGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 72 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
..+.++.+++++.++ ...+.+|++|++++|.|+. ++ .+..+++|++|+|++|+|++. ++ ++++++|+.|++++|
T Consensus 21 i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n 94 (199)
T d2omxa2 21 MKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNN 94 (199)
T ss_dssp HHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSS
T ss_pred HHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCc-cc-ccCCccccccccccc
Confidence 344567777776543 3567899999999999984 43 588999999999999999954 43 999999999999999
Q ss_pred cccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCC
Q 005226 152 SFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKI 231 (707)
Q Consensus 152 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~ 231 (707)
.+. .++ .+.++++|+.|++++|.+. .++. +..+++|+.|++++|++. .++ .+..++++ ++|++++|++++.
T Consensus 95 ~~~-~~~-~l~~l~~L~~L~l~~~~~~-~~~~--~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L-~~L~l~~n~l~~l- 165 (199)
T d2omxa2 95 QIA-DIT-PLANLTNLTGLTLFNNQIT-DIDP--LKNLTNLNRLELSSNTIS-DIS-ALSGLTSL-QQLNFSSNQVTDL- 165 (199)
T ss_dssp CCC-CCG-GGTTCTTCSEEECCSSCCC-CCGG--GTTCTTCSEEECCSSCCC-CCG-GGTTCTTC-SEEECCSSCCCCC-
T ss_pred ccc-ccc-ccccccccccccccccccc-cccc--cchhhhhHHhhhhhhhhc-ccc-cccccccc-cccccccccccCC-
Confidence 998 444 4889999999999999998 5543 578999999999999998 344 68899999 7999999999954
Q ss_pred CCcCCCCCCccEEEccCCcCcccCCCCCCCCC
Q 005226 232 PKSLGNLPVTVSFDLRGNNLSGEIPQTGSFAN 263 (707)
Q Consensus 232 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~ 263 (707)
+ .+.++++|+.|++++|+++. ++....+.+
T Consensus 166 ~-~l~~l~~L~~L~ls~N~i~~-i~~l~~L~~ 195 (199)
T d2omxa2 166 K-PLANLTTLERLDISSNKVSD-ISVLAKLTN 195 (199)
T ss_dssp G-GGTTCTTCCEEECCSSCCCC-CGGGGGCTT
T ss_pred c-cccCCCCCCEEECCCCCCCC-CccccCCCC
Confidence 3 48899999999999999985 343333333
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=6.3e-18 Score=163.36 Aligned_cols=179 Identities=25% Similarity=0.321 Sum_probs=145.9
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCc
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNS 152 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 152 (707)
..++..+.+++.++. ..|.+|++|++++|.++.. + .+..+++|++|+|++|+|++ ++ .++.+++|+.|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccc
Confidence 345666777665543 3577899999999999854 3 38899999999999999995 44 47899999999999999
Q ss_pred ccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCC
Q 005226 153 FSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIP 232 (707)
Q Consensus 153 l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p 232 (707)
|+ .+| .+.++++|+.|++++|.+. .++. +..+++|+.+++++|.+++ +..+..+++| +.+++++|++++ ++
T Consensus 102 i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L-~~l~l~~n~l~~-i~ 172 (210)
T d1h6ta2 102 VK-DLS-SLKDLKKLKSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRLTKL-DTLSLEDNQISD-IV 172 (210)
T ss_dssp CC-CGG-GGTTCTTCCEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTC-SEEECCSSCCCC-CG
T ss_pred cc-ccc-ccccccccccccccccccc-cccc--ccccccccccccccccccc--cccccccccc-cccccccccccc-cc
Confidence 98 455 5899999999999999998 6653 5789999999999999984 4568889999 899999999995 44
Q ss_pred CcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcc
Q 005226 233 KSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTA 268 (707)
Q Consensus 233 ~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~ 268 (707)
.+..+++|+.|++++|+|+. +|....+.++..+.
T Consensus 173 -~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~ 206 (210)
T d1h6ta2 173 -PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLE 206 (210)
T ss_dssp -GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEE
T ss_pred -cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEE
Confidence 38899999999999999985 45445555555444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4.5e-17 Score=159.35 Aligned_cols=183 Identities=25% Similarity=0.345 Sum_probs=147.9
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|++.+|+|+.. +.+..+++|++|+|++|+|++..| +.++++|++|++++|.++ .++ .+..+++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 4789999999999965 459999999999999999986544 899999999999999998 444 5889999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|...+. ..+...+.++.+.++++.+. ..+. +..+++|+.|++++|.+++. ..+.++++| ++|+|++|+++
T Consensus 115 ~~~~~~~~--~~~~~~~~~~~l~~~~~~~~-~~~~--~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L-~~L~Ls~n~l~ 186 (227)
T d1h6ua2 115 TSTQITDV--TPLAGLSNLQVLYLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSDL--TPLANLSKL-TTLKADDNKIS 186 (227)
T ss_dssp TTSCCCCC--GGGTTCTTCCEEECCSSCCC-CCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTC-CEEECCSSCCC
T ss_pred cccccccc--chhccccchhhhhchhhhhc-hhhh--hccccccccccccccccccc--hhhcccccc-eecccCCCccC
Confidence 99998743 34667788899999999987 3332 46889999999999999843 348889999 79999999998
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcc
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTA 268 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~ 268 (707)
+ +|. +..+++|+.|++++|++++..| ...+.++..+.
T Consensus 187 ~-l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ 223 (227)
T d1h6ua2 187 D-ISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVT 223 (227)
T ss_dssp C-CGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEE
T ss_pred C-Chh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEE
Confidence 5 443 7889999999999999986543 44444444433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=4.8e-17 Score=172.06 Aligned_cols=187 Identities=25% Similarity=0.323 Sum_probs=151.1
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.++..|++++|.+++..| +...++|++|++++|+++. + ..+..+++|+.|++++|++++..+ +..+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeec
Confidence 567889999999987754 5677899999999999984 3 368889999999999999985433 788899999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++.. .+.+++.++.++++.|+++ .++. +..+++++.|++++|+|++. + .+..+++| ++|++++|+|+
T Consensus 271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~-~~~~--~~~~~~l~~L~ls~n~l~~l-~-~l~~l~~L-~~L~L~~n~l~ 342 (384)
T d2omza2 271 GANQISNIS--PLAGLTALTNLELNENQLE-DISP--ISNLKNLTYLTLYFNNISDI-S-PVSSLTKL-QRLFFANNKVS 342 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCS-CCGG--GGGCTTCSEEECCSSCCSCC-G-GGGGCTTC-CEEECCSSCCC
T ss_pred cCcccCCCC--ccccccccccccccccccc-cccc--cchhcccCeEECCCCCCCCC-c-ccccCCCC-CEEECCCCCCC
Confidence 999998543 3778888999999999998 4443 46889999999999999864 3 38888999 79999999998
Q ss_pred CCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSN 272 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N 272 (707)
+ +| .+..+++|+.|++++|+|++.+| ...+.++..+...+|
T Consensus 343 ~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 343 D-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp C-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred C-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 4 55 58889999999999999997665 555666666666655
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7.3e-17 Score=170.61 Aligned_cols=165 Identities=27% Similarity=0.374 Sum_probs=145.6
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|++++|.++.. +.+..+++|+.|++++|++++..+ +..+++|++|++++|++++.. .+..++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccc
Confidence 6899999999999864 478999999999999999996543 889999999999999999543 3788999999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
++|++++ ...+..+++|+.|++++|+|+ .++. +..+++|++|+|++|+|++ ++ .+.++++| ++|++++|+|+
T Consensus 293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~-~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L-~~L~l~~N~l~ 364 (384)
T d2omza2 293 NENQLED--ISPISNLKNLTYLTLYFNNIS-DISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNI-NWLSAGHNQIS 364 (384)
T ss_dssp CSSCCSC--CGGGGGCTTCSEEECCSSCCS-CCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTC-CEEECCSSCCC
T ss_pred ccccccc--ccccchhcccCeEECCCCCCC-CCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCC-CEEECCCCcCC
Confidence 9999985 345889999999999999999 5653 5789999999999999984 44 69999999 89999999999
Q ss_pred CCCCCcCCCCCCccEEEccCC
Q 005226 229 GKIPKSLGNLPVTVSFDLRGN 249 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~N 249 (707)
+..| +.++++|+.|++++|
T Consensus 365 ~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 365 DLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp BCGG--GTTCTTCSEEECCCE
T ss_pred CChh--hccCCCCCEeeCCCC
Confidence 7655 889999999999998
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.62 E-value=9.7e-16 Score=149.68 Aligned_cols=164 Identities=22% Similarity=0.346 Sum_probs=140.7
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|.+++..| +..+++|+.|++++|.++ .++ .+.++++|+.|++++|...+. ..+...+.++.+.+
T Consensus 63 ~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~ 136 (227)
T d1h6ua2 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYL 136 (227)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred CCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccccccccccc--chhccccchhhhhc
Confidence 689999999999997654 999999999999999998 444 588999999999999998843 34677899999999
Q ss_pred cCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCc
Q 005226 149 SNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLS 228 (707)
Q Consensus 149 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~ 228 (707)
+++.+... ..+.++++|+.|++++|+++ .++. +..+++|+.|+|++|++++ ++ .+.++++| ++|+|++|+|+
T Consensus 137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~-~~~~--l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L-~~L~Ls~N~lt 208 (227)
T d1h6ua2 137 DLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP--LANLSKLTTLKADDNKISD-IS-PLASLPNL-IEVHLKNNQIS 208 (227)
T ss_dssp CSSCCCCC--GGGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-CG-GGGGCTTC-CEEECTTSCCC
T ss_pred hhhhhchh--hhhccccccccccccccccc-cchh--hcccccceecccCCCccCC-Ch-hhcCCCCC-CEEECcCCcCC
Confidence 99998743 34788999999999999998 4443 5789999999999999985 44 48999999 89999999999
Q ss_pred CCCCCcCCCCCCccEEEccC
Q 005226 229 GKIPKSLGNLPVTVSFDLRG 248 (707)
Q Consensus 229 ~~~p~~~~~l~~L~~l~l~~ 248 (707)
+ +| .+.++++|+.|++++
T Consensus 209 ~-i~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 209 D-VS-PLANTSNLFIVTLTN 226 (227)
T ss_dssp B-CG-GGTTCTTCCEEEEEE
T ss_pred C-Cc-ccccCCCCCEEEeeC
Confidence 5 44 388999999999974
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.8e-16 Score=145.83 Aligned_cols=126 Identities=21% Similarity=0.275 Sum_probs=65.7
Q ss_pred cCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhh
Q 005226 89 LGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQ 168 (707)
Q Consensus 89 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 168 (707)
+.++.+|++|+|++|+|+ .++..+..+++|+.|||++|+|+ .++ .|..+++|++|+|++|+++
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-------------- 76 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-------------- 76 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC--------------
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc--------------
Confidence 444555555555555555 33444444555555555555555 222 3445555555555555554
Q ss_pred hhhhcCCcccccCCCcccccCCCccEEeccCCCCCCCCC--cchhhhhccccEEEeccCcCcCCCCC----cCCCCCCcc
Q 005226 169 RLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGPIP--NDLGELQSLSATLNLSYNHLSGKIPK----SLGNLPVTV 242 (707)
Q Consensus 169 ~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~~p--~~~~~l~~L~~~L~l~~N~l~~~~p~----~~~~l~~L~ 242 (707)
.+|..++..+++|+.|+|++|+|+. ++ ..+..+++| ++|++++|.++ ..|. .+..+++|+
T Consensus 77 -----------~l~~~~~~~l~~L~~L~L~~N~i~~-~~~l~~l~~l~~L-~~L~l~~N~i~-~~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 77 -----------RIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSL-TYLCILRNPVT-NKKHYRLYVIYKVPQVR 142 (162)
T ss_dssp -----------EECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTC-CEEECCSSGGG-GSTTHHHHHHHHCTTCS
T ss_pred -----------CCCccccccccccccceeccccccc-ccccccccccccc-chhhcCCCccc-cccchHHHHHHHCCCcC
Confidence 4555555555566666666666552 22 245555566 56666666665 3332 345566666
Q ss_pred EEE
Q 005226 243 SFD 245 (707)
Q Consensus 243 ~l~ 245 (707)
.||
T Consensus 143 ~LD 145 (162)
T d1a9na_ 143 VLD 145 (162)
T ss_dssp EET
T ss_pred eeC
Confidence 655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=5.4e-16 Score=135.65 Aligned_cols=76 Identities=32% Similarity=0.444 Sum_probs=37.6
Q ss_pred EEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcc
Q 005226 74 VAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSF 153 (707)
Q Consensus 74 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 153 (707)
|+|++|+|+.. + .+.++++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+ .+| .+..+++|+.|++++|+|
T Consensus 3 L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 45555555522 2 2455555555555555554 34444555555555555555555 222 244555555555555555
Q ss_pred c
Q 005226 154 S 154 (707)
Q Consensus 154 ~ 154 (707)
+
T Consensus 78 ~ 78 (124)
T d1dcea3 78 Q 78 (124)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=1.7e-16 Score=146.06 Aligned_cols=123 Identities=20% Similarity=0.194 Sum_probs=97.5
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
.+++.|+|++|+|+.+ +..+..+++|++|+|++|+|+. ++ .|..+++|++|+|++|+|+...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 5789999999999965 6667889999999999999994 44 5899999999999999999555555678999999999
Q ss_pred cCCcccccCC--CCCcccchhhhhhhcCCcccccCCC---cccccCCCccEEe
Q 005226 149 SNNSFSGSLP--DGLKNCKQLQRLILARNKFSGQIPA---GIWPELENLVQLD 196 (707)
Q Consensus 149 s~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~lp~---~~~~~l~~L~~L~ 196 (707)
++|+|+. ++ ..+..+++|++|++++|.++ .+|. .++..+++|++||
T Consensus 95 ~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 9999983 33 35666777777777777776 5553 2345566666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.58 E-value=9.9e-16 Score=133.95 Aligned_cols=118 Identities=28% Similarity=0.350 Sum_probs=99.1
Q ss_pred CEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCC
Q 005226 96 RRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARN 175 (707)
Q Consensus 96 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 175 (707)
++|+|++|+|+ .++ .+.++++|++|||++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 555 4899999999999999999 78889999999999999999999 455 5899999999999999
Q ss_pred cccccCCC-cccccCCCccEEeccCCCCCCC---CCcchhhhhccccEE
Q 005226 176 KFSGQIPA-GIWPELENLVQLDLSDNDFKGP---IPNDLGELQSLSATL 220 (707)
Q Consensus 176 ~l~~~lp~-~~~~~l~~L~~L~ls~N~l~~~---~p~~~~~l~~L~~~L 220 (707)
+|+ .+|. ..+..+++|++|++++|+++.. ...-+..++++ +.|
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L-~~L 122 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV-SSI 122 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC-SEE
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCc-ceE
Confidence 999 6664 5568999999999999999732 22234446666 444
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=5e-15 Score=145.97 Aligned_cols=196 Identities=17% Similarity=0.102 Sum_probs=153.6
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCC-CcccCCCCCccEEecc-C
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSL-PPSVCNLPRLQNLDLS-N 150 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls-~ 150 (707)
.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.++++++.|++. .
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 5778888988 6676653 58999999999999666678999999999999999998655 4568899999999986 4
Q ss_pred CcccccCCCCCcccchhhhhhhcCCcccccCCC-cccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcC
Q 005226 151 NSFSGSLPDGLKNCKQLQRLILARNKFSGQIPA-GIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSG 229 (707)
Q Consensus 151 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~ 229 (707)
|++....+..|.++++|+.|++++|++. .++. ..+..+..|..+..+++.+....+..|.+++...+.|++++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~ 167 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 167 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCC-SCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred ccccccccccccccccccccccchhhhc-ccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence 7888788889999999999999999998 4543 3445677888888899999866667777776333789999999995
Q ss_pred CCCCcCCCCCCccEE-EccCCcCcccCCC-CCCCCCCCCcccCCCC
Q 005226 230 KIPKSLGNLPVTVSF-DLRGNNLSGEIPQ-TGSFANQGPTAFLSNP 273 (707)
Q Consensus 230 ~~p~~~~~l~~L~~l-~l~~N~l~~~~p~-~~~~~~~~~~~~~~N~ 273 (707)
++.......++..+ ++++|+|+...+. ...+.++..+.+.+|.
T Consensus 168 -i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~ 212 (242)
T d1xwdc1 168 -IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 212 (242)
T ss_dssp -ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSC
T ss_pred -cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCc
Confidence 55555556665555 5788889855443 3456677778777775
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=6.7e-14 Score=127.47 Aligned_cols=93 Identities=24% Similarity=0.212 Sum_probs=54.2
Q ss_pred CCCCcCCCCCCCEEEcccC-CcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcc
Q 005226 85 IPSELGSLIYLRRLNLHNN-NLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKN 163 (707)
Q Consensus 85 ~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 163 (707)
.|..+..+++|++|+|++| .|+.+.+..|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|++|+|+
T Consensus 23 ~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~--------- 93 (156)
T d2ifga3 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE--------- 93 (156)
T ss_dssp TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS---------
T ss_pred CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc---------
Confidence 3555566666666666544 355444445555555555555555555444445555555555555555554
Q ss_pred cchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCC
Q 005226 164 CKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 164 l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~ 203 (707)
.+|.++|..+ +|+.|+|++|.+.
T Consensus 94 ----------------~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 ----------------SLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ----------------CCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ----------------ccChhhhccc-cccccccCCCccc
Confidence 6666666444 6888888888775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.46 E-value=2.9e-16 Score=149.58 Aligned_cols=41 Identities=22% Similarity=0.309 Sum_probs=16.6
Q ss_pred cccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCccc
Q 005226 112 QLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 112 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 154 (707)
.+..+++|++|+|++|+|+ .++ .|..+++|+.|+|++|+|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~ 83 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK 83 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC
T ss_pred HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc
Confidence 3444444444444444444 222 2334444444444444443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.45 E-value=8.9e-13 Score=136.65 Aligned_cols=185 Identities=26% Similarity=0.292 Sum_probs=113.4
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEec
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDL 148 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 148 (707)
++++.|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. + .+.|++|+|++|.|. .+|. ++.+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeecc
Confidence 57888888888888 45654 346777778877777 3332 1 135888888888887 5554 567888888888
Q ss_pred cCCcccccCC------------------CCCcccchhhhhhhcCCcccccCCCc------------------ccccCCCc
Q 005226 149 SNNSFSGSLP------------------DGLKNCKQLQRLILARNKFSGQIPAG------------------IWPELENL 192 (707)
Q Consensus 149 s~N~l~~~~p------------------~~~~~l~~L~~L~l~~N~l~~~lp~~------------------~~~~l~~L 192 (707)
++|.+....+ ..+..++.++.|++++|.+. .++.. .+..++.|
T Consensus 128 ~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L 206 (353)
T d1jl5a_ 128 DNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVAGNNILEELPELQNLPFL 206 (353)
T ss_dssp CSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCCCCTTCCEEECCSSCCSSCCCCTTCTTC
T ss_pred ccccccccccccccccchhhccccccccccccccccceeccccccccc-ccccccccccccccccccccccccccccccc
Confidence 8877662211 22344555666666666654 22210 12345566
Q ss_pred cEEeccCCCCCCCCCcch---------------------------------------------------------hhhhc
Q 005226 193 VQLDLSDNDFKGPIPNDL---------------------------------------------------------GELQS 215 (707)
Q Consensus 193 ~~L~ls~N~l~~~~p~~~---------------------------------------------------------~~l~~ 215 (707)
+.+++++|.... +|... ..+++
T Consensus 207 ~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
T d1jl5a_ 207 TTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 285 (353)
T ss_dssp CEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTT
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCC
Confidence 666666665432 11100 11245
Q ss_pred cccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCCCCCCCCCCCCcccCCCC
Q 005226 216 LSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIPQTGSFANQGPTAFLSNP 273 (707)
Q Consensus 216 L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~N~ 273 (707)
| ++|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|+ ...++..+.+.+|+
T Consensus 286 L-~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~--~~~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 286 L-EELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE--LPQNLKQLHVEYNP 335 (353)
T ss_dssp C-CEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC--CCTTCCEEECCSSC
T ss_pred C-CEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc--ccCCCCEEECcCCc
Confidence 6 68888888887 56653 567778888888887 4553 34566677777776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.42 E-value=3.7e-16 Score=148.88 Aligned_cols=114 Identities=22% Similarity=0.258 Sum_probs=90.3
Q ss_pred cCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcc
Q 005226 84 YIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKN 163 (707)
Q Consensus 84 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 163 (707)
.++..|..|++|++|+|++|+|+. ++ .+.++++|++|+|++|+|+ .+|..+..+++|+.|++++|+|+. + ..+.+
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 345678899999999999999994 55 5899999999999999998 677766667889999999999984 3 34677
Q ss_pred cchhhhhhhcCCcccccCCC-cccccCCCccEEeccCCCCC
Q 005226 164 CKQLQRLILARNKFSGQIPA-GIWPELENLVQLDLSDNDFK 203 (707)
Q Consensus 164 l~~L~~L~l~~N~l~~~lp~-~~~~~l~~L~~L~ls~N~l~ 203 (707)
+++|+.|+|++|+|+ .++. ..+..+++|+.|+|++|++.
T Consensus 114 l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 114 LVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred cccccccccccchhc-cccccccccCCCccceeecCCCccc
Confidence 788888888888887 5543 33566777777777777665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.41 E-value=1.5e-12 Score=134.82 Aligned_cols=171 Identities=26% Similarity=0.334 Sum_probs=118.0
Q ss_pred CcEEEEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCccCCCCC---------------
Q 005226 69 PRVVGVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGNNLSGSL--------------- 133 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--------------- 133 (707)
.+++.|++++|+++.. +. + .+.|++|+|++|.|+ .+|. +..+++|+.|++++|.+....
T Consensus 78 ~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~ 151 (353)
T d1jl5a_ 78 QSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151 (353)
T ss_dssp TTCCEEECCSSCCSCC-CS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred hhhhhhhhhhcccchh-hh-h--ccccccccccccccc-cccc-hhhhccceeeccccccccccccccccccchhhcccc
Confidence 6888999999888743 32 1 145888999998888 5564 677888888888888876322
Q ss_pred ---CcccCCCCCccEEeccCCcccccC------------------CCCCcccchhhhhhhcCCcccccCCC---------
Q 005226 134 ---PPSVCNLPRLQNLDLSNNSFSGSL------------------PDGLKNCKQLQRLILARNKFSGQIPA--------- 183 (707)
Q Consensus 134 ---p~~~~~l~~L~~L~Ls~N~l~~~~------------------p~~~~~l~~L~~L~l~~N~l~~~lp~--------- 183 (707)
+..+..++.++.|++++|.+.... ...+..++.|+.+++++|... .++.
T Consensus 152 ~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~-~~~~~~~~l~~~~ 230 (353)
T d1jl5a_ 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN 230 (353)
T ss_dssp CSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCSCCTTCCEEE
T ss_pred ccccccccccccceeccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccc
Confidence 123455667777777777655211 112344566666666666544 2221
Q ss_pred -----------------------------------------------cccccCCCccEEeccCCCCCCCCCcchhhhhcc
Q 005226 184 -----------------------------------------------GIWPELENLVQLDLSDNDFKGPIPNDLGELQSL 216 (707)
Q Consensus 184 -----------------------------------------------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 216 (707)
.++..+++|++|+|++|+|+ .+|.. +++|
T Consensus 231 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L 306 (353)
T d1jl5a_ 231 VRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRL 306 (353)
T ss_dssp CCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTC
T ss_pred cccccccccccccccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCC
Confidence 01122468999999999999 67765 4677
Q ss_pred ccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCcccCC
Q 005226 217 SATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLSGEIP 256 (707)
Q Consensus 217 ~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~p 256 (707)
+.|+|++|+|+ .+|.. +++|+.|++++|+|+ .+|
T Consensus 307 -~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp 340 (353)
T d1jl5a_ 307 -ERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFP 340 (353)
T ss_dssp -CEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCC
T ss_pred -CEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCC
Confidence 79999999999 67764 568999999999998 455
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.4e-12 Score=118.53 Aligned_cols=108 Identities=17% Similarity=0.143 Sum_probs=60.8
Q ss_pred CCceEEecCccCCCCCCcccCCCCCccEEeccCCcccccCCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEec
Q 005226 118 SLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNNSFSGSLPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDL 197 (707)
Q Consensus 118 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~l 197 (707)
..+.++.+++.+. ..|..+..+++|+.|+|++|+ .|+ .|+...|.++++|+.|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~-----------------------~l~-~i~~~~f~~l~~L~~L~L 63 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQ-----------------------HLQ-HLELRDLRGLGELRNLTI 63 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCS-----------------------SCC-EECGGGSCSCCCCSEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCc-----------------------ccc-ccCchhhccccccCccee
Confidence 3445555555555 445555555555555554332 233 555555556666666666
Q ss_pred cCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCCcCCCCCCccEEEccCCcCc
Q 005226 198 SDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPKSLGNLPVTVSFDLRGNNLS 252 (707)
Q Consensus 198 s~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~ 252 (707)
++|+|+...|..|..+++| ++|+|++|+|+ .+|.......+|+.|+|++|++.
T Consensus 64 s~N~l~~i~~~~f~~l~~L-~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 64 VKSGLRFVAPDAFHFTPRL-SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCCEECTTGGGSCSCC-CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccccCCcccccccccccc-cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 6666665555566666666 56666666666 33333333335677777777664
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.29 E-value=3.6e-14 Score=143.26 Aligned_cols=180 Identities=22% Similarity=0.255 Sum_probs=136.8
Q ss_pred CcEEEEEcCCCCcccc-CCCCcCCCCCCCEEEcccCCcCCCCCccccCCCCCceEEecCc-cCCCC-CCcccCCCCCccE
Q 005226 69 PRVVGVAISGKNVRGY-IPSELGSLIYLRRLNLHNNNLFGSLPDQLFNATSLHSIFLYGN-NLSGS-LPPSVCNLPRLQN 145 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 145 (707)
.+++.|||+++.+... +...+.++++|++|+|++|.++...+..+.++++|++|+|+++ .++.. +..-+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 5899999999988754 3455788999999999999998777888999999999999994 66521 2222456899999
Q ss_pred EeccCC-ccccc-CCCCCcc-cchhhhhhhcCC--cccccCCCcccccCCCccEEeccCC-CCCCCCCcchhhhhccccE
Q 005226 146 LDLSNN-SFSGS-LPDGLKN-CKQLQRLILARN--KFSGQIPAGIWPELENLVQLDLSDN-DFKGPIPNDLGELQSLSAT 219 (707)
Q Consensus 146 L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~lp~~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~~ 219 (707)
|+|+++ .++.. +...+.. .++|+.|++++. .++..--..++..+++|++|+|++| .+++.....+.++++| ++
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L-~~ 204 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL-QH 204 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC-CE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC-CE
Confidence 999985 44321 2222333 468999999875 3432212233467899999999986 5777778889999999 89
Q ss_pred EEecc-CcCcCCCCCcCCCCCCccEEEccCC
Q 005226 220 LNLSY-NHLSGKIPKSLGNLPVTVSFDLRGN 249 (707)
Q Consensus 220 L~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N 249 (707)
|+|++ +.++......++++++|+.|+++++
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 99999 4788777777889999999999887
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.07 E-value=2.5e-12 Score=129.48 Aligned_cols=197 Identities=20% Similarity=0.229 Sum_probs=136.0
Q ss_pred EEEcCCCCccccCCCCcCCCCCCCEEEcccCCcCCC-CCccccCCCCCceEEecCccCCCCCCcccCCCCCccEEeccCC
Q 005226 73 GVAISGKNVRGYIPSELGSLIYLRRLNLHNNNLFGS-LPDQLFNATSLHSIFLYGNNLSGSLPPSVCNLPRLQNLDLSNN 151 (707)
Q Consensus 73 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 151 (707)
.+.++...+.... .......+|++|||+++.++.. ++..+.++++|++|+|++|.++...+..+..+++|+.|+|+++
T Consensus 27 ~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 27 AFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp EEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred Eeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 4445544444332 2334566899999999998743 4455788999999999999998878888999999999999994
Q ss_pred -ccccc-CCCCCcccchhhhhhhcCC-ccccc-CCCcccccCCCccEEeccCC--CCCCC-CCcchhhhhccccEEEecc
Q 005226 152 -SFSGS-LPDGLKNCKQLQRLILARN-KFSGQ-IPAGIWPELENLVQLDLSDN--DFKGP-IPNDLGELQSLSATLNLSY 224 (707)
Q Consensus 152 -~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-lp~~~~~~l~~L~~L~ls~N--~l~~~-~p~~~~~l~~L~~~L~l~~ 224 (707)
.++.. +..-+.++++|++|+|+++ .++.. +...+....++|+.|+++++ .++.. +...+.++++| ++|++++
T Consensus 106 ~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L-~~L~L~~ 184 (284)
T d2astb2 106 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL-VHLDLSD 184 (284)
T ss_dssp BSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTC-SEEECTT
T ss_pred ccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccc-ccccccc
Confidence 56521 2223457899999999985 45421 22222233578999999975 34422 22334567899 8999998
Q ss_pred C-cCcCCCCCcCCCCCCccEEEccC-CcCcccCC-CCCCCCCCCCcccCC
Q 005226 225 N-HLSGKIPKSLGNLPVTVSFDLRG-NNLSGEIP-QTGSFANQGPTAFLS 271 (707)
Q Consensus 225 N-~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~p-~~~~~~~~~~~~~~~ 271 (707)
| .++...+..+..+++|++|++++ +.+++... ......++..+...|
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 6 58877888899999999999999 46764322 122333444444433
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.03 E-value=1.4e-12 Score=135.35 Aligned_cols=183 Identities=19% Similarity=0.172 Sum_probs=95.3
Q ss_pred CcEEEEEcCCCCcccc----------CCCCcCCCCCCCEEEcccCCcCCC----CCccccCCCCCceEEecCccCCCCCC
Q 005226 69 PRVVGVAISGKNVRGY----------IPSELGSLIYLRRLNLHNNNLFGS----LPDQLFNATSLHSIFLYGNNLSGSLP 134 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----------~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p 134 (707)
.+++.|+|+++.+... +...+...++|++|+|++|.++.. +...+...++|+.|+|++|.+...-.
T Consensus 59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~ 138 (344)
T d2ca6a1 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138 (344)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence 4666666666543321 122344566677777777766543 22333456667777777776541100
Q ss_pred c-------------ccCCCCCccEEeccCCccccc----CCCCCcccchhhhhhhcCCccccc----CCCcccccCCCcc
Q 005226 135 P-------------SVCNLPRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFSGQ----IPAGIWPELENLV 193 (707)
Q Consensus 135 ~-------------~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~ 193 (707)
. .....+.|+.|++++|+++.. +...+..+++|+.|+|++|+|+.. +-...+..+++|+
T Consensus 139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~ 218 (344)
T d2ca6a1 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 218 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence 0 012345666666666665421 222334455666666666666521 1112234566666
Q ss_pred EEeccCCCCCCC----CCcchhhhhccccEEEeccCcCcCCCCCcC----C--CCCCccEEEccCCcCc
Q 005226 194 QLDLSDNDFKGP----IPNDLGELQSLSATLNLSYNHLSGKIPKSL----G--NLPVTVSFDLRGNNLS 252 (707)
Q Consensus 194 ~L~ls~N~l~~~----~p~~~~~l~~L~~~L~l~~N~l~~~~p~~~----~--~l~~L~~l~l~~N~l~ 252 (707)
.|+|++|.|+.. +...+..+++| ++|+|++|.|++.-...+ . ..+.|+.|++++|+++
T Consensus 219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L-~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 219 VLDLQDNTFTHLGSSALAIALKSWPNL-RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTC-CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred ccccccccccccccccccccccccccc-hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 777776666422 22344555666 566777766653211111 1 2245666777776665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.97 E-value=8.8e-12 Score=129.14 Aligned_cols=184 Identities=20% Similarity=0.229 Sum_probs=127.9
Q ss_pred CcEEEEEcCCCCcccc----CCCCcCCCCCCCEEEcccCCcCCC----------CCccccCCCCCceEEecCccCCCC--
Q 005226 69 PRVVGVAISGKNVRGY----IPSELGSLIYLRRLNLHNNNLFGS----------LPDQLFNATSLHSIFLYGNNLSGS-- 132 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~~N~l~~~-- 132 (707)
..++.|+|++|.+... +...+...++|+.|+++++.+... +...+..+++|+.|+|++|.+...
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 5688999999987542 345677889999999998765422 122345678999999999998754
Q ss_pred --CCcccCCCCCccEEeccCCcccccCCCC-------------CcccchhhhhhhcCCcccccCC---CcccccCCCccE
Q 005226 133 --LPPSVCNLPRLQNLDLSNNSFSGSLPDG-------------LKNCKQLQRLILARNKFSGQIP---AGIWPELENLVQ 194 (707)
Q Consensus 133 --~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~l~~N~l~~~lp---~~~~~~l~~L~~ 194 (707)
+...+...++|+.|++++|.+...-... ....+.|+.|++++|+++..-- ...+...++|+.
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~ 190 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcc
Confidence 2334556789999999999875211111 1234567888888888762110 112345788999
Q ss_pred EeccCCCCCCC-----CCcchhhhhccccEEEeccCcCcCC----CCCcCCCCCCccEEEccCCcCcc
Q 005226 195 LDLSDNDFKGP-----IPNDLGELQSLSATLNLSYNHLSGK----IPKSLGNLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 195 L~ls~N~l~~~-----~p~~~~~l~~L~~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 253 (707)
|+|++|.|+.. +...+..+++| +.|+|++|.++.. +...+..+++|++|++++|+|++
T Consensus 191 L~L~~n~i~~~g~~~~l~~~l~~~~~L-~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 191 VKMVQNGIRPEGIEHLLLEGLAYCQEL-KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTC-CEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccccccccccccchhhhhcchhhh-cccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 99999988732 23346667788 7899999988632 34556778889999999998874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.67 E-value=4.7e-10 Score=102.20 Aligned_cols=82 Identities=27% Similarity=0.272 Sum_probs=37.3
Q ss_pred cccchhhhhhhcCCcccccCCC--cccccCCCccEEeccCCCCCCCCCcchhhhhccccEEEeccCcCcCCCCC------
Q 005226 162 KNCKQLQRLILARNKFSGQIPA--GIWPELENLVQLDLSDNDFKGPIPNDLGELQSLSATLNLSYNHLSGKIPK------ 233 (707)
Q Consensus 162 ~~l~~L~~L~l~~N~l~~~lp~--~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~~L~l~~N~l~~~~p~------ 233 (707)
..+++|++|+|++|+|+ .++. ..+..+++|+.|+|++|.|+..-+-.+.....| +.|++++|.++.....
T Consensus 62 ~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L-~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 62 ENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL-EELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCC-SSCCCTTSTTSSSSSSHHHHHH
T ss_pred HhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhcccc-ceeecCCCCcCcCcccchhHHH
Confidence 34444444444444444 3321 223445555555555555552222122223344 4555555555533322
Q ss_pred -cCCCCCCccEEE
Q 005226 234 -SLGNLPVTVSFD 245 (707)
Q Consensus 234 -~~~~l~~L~~l~ 245 (707)
.+..+|+|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 134566666664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=2.4e-10 Score=122.22 Aligned_cols=184 Identities=21% Similarity=0.149 Sum_probs=104.0
Q ss_pred CcEEEEEcCCCCccc-----cCCCCcCCCCCCCEEEcccCCcCCC----CCccccCCCCCceEEecCccCCCCCCcc---
Q 005226 69 PRVVGVAISGKNVRG-----YIPSELGSLIYLRRLNLHNNNLFGS----LPDQLFNATSLHSIFLYGNNLSGSLPPS--- 136 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~-----~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~--- 136 (707)
..++.+++.+|.+.. ..+........|+.|++++|.+... ....+...+.++.+++++|.++......
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 345667777766532 2233344566777777777776532 2223445677777777777775221111
Q ss_pred --cCCCCCccEEeccCCcccccCCCC----CcccchhhhhhhcCCccccc----CCCcccccCCCccEEeccCCCCCCC-
Q 005226 137 --VCNLPRLQNLDLSNNSFSGSLPDG----LKNCKQLQRLILARNKFSGQ----IPAGIWPELENLVQLDLSDNDFKGP- 205 (707)
Q Consensus 137 --~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~~----lp~~~~~~l~~L~~L~ls~N~l~~~- 205 (707)
......|+.+++++|.++..-... +...++|++|+|++|+|++. ++..+....+.|++|+|++|+|+..
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 123356777777777776432222 23344677777777777521 2222323455677777777777632
Q ss_pred ---CCcchhhhhccccEEEeccCcCcCCCCC----cCC-CCCCccEEEccCCcCcc
Q 005226 206 ---IPNDLGELQSLSATLNLSYNHLSGKIPK----SLG-NLPVTVSFDLRGNNLSG 253 (707)
Q Consensus 206 ---~p~~~~~l~~L~~~L~l~~N~l~~~~p~----~~~-~l~~L~~l~l~~N~l~~ 253 (707)
++..+..+++| ++|+|++|+|+..... .+. ....|+.|++.+|.+..
T Consensus 386 ~~~l~~~l~~~~~L-~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 386 CSSLAATLLANHSL-RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHCCCC-CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHHHhcCCCC-CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 33445556777 6777777777632211 121 23357777777777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=4.7e-10 Score=102.19 Aligned_cols=66 Identities=24% Similarity=0.229 Sum_probs=30.9
Q ss_pred CCCCccEEeccCCccccc--CCCCCcccchhhhhhhcCCcccccCCCcccccCCCccEEeccCCCCCCC
Q 005226 139 NLPRLQNLDLSNNSFSGS--LPDGLKNCKQLQRLILARNKFSGQIPAGIWPELENLVQLDLSDNDFKGP 205 (707)
Q Consensus 139 ~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~lp~~~~~~l~~L~~L~ls~N~l~~~ 205 (707)
.+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+ .+++-.+-...+|+.|+|++|.+...
T Consensus 63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcC
Confidence 344444444444444421 1222344455555555555554 44432223344566666666666543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=1.4e-06 Score=85.16 Aligned_cols=129 Identities=16% Similarity=0.116 Sum_probs=92.2
Q ss_pred eeEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcC-CCceeeeEEEEEcCCcceEEEEeecCCChHHHHhCCC
Q 005226 420 LGIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVK-HPNIVKLRAYYWAPDEKLLISDFISNGNLANALRGRN 498 (707)
Q Consensus 420 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~ 498 (707)
.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++.+...++..++||+++++.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 368999875 55567788876554433456788998888773 434677888888888899999999998887654321
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------------------
Q 005226 499 GQPSTSLSWSTRLRIAKGTARGLAYLHECS-------------------------------------------------- 528 (707)
Q Consensus 499 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------------------- 528 (707)
. ....++.++++.++.||+..
T Consensus 105 ------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 105 ------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp ------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred ------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 12345666677777777532
Q ss_pred ------CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 ------PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ------~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+..++|+|+.|.||+++++..+-|.||+.+.
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0137899999999999987767899999765
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.23 E-value=1.9e-08 Score=107.05 Aligned_cols=110 Identities=20% Similarity=0.229 Sum_probs=73.8
Q ss_pred CcEEEEEcCCCCccccC-CCCcCCCCCCCEEEcccCCcCC----CCCccccCCCCCceEEecCccCCCC----CCcccC-
Q 005226 69 PRVVGVAISGKNVRGYI-PSELGSLIYLRRLNLHNNNLFG----SLPDQLFNATSLHSIFLYGNNLSGS----LPPSVC- 138 (707)
Q Consensus 69 ~~v~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~- 138 (707)
.+|+.||+++|++++.. ..-+..+++|++|+|++|.|+. .++..+..+++|++|||++|+|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 46889999999987642 3335667888899999998872 2345567788888888888887521 222232
Q ss_pred CCCCccEEeccCCccccc----CCCCCcccchhhhhhhcCCccc
Q 005226 139 NLPRLQNLDLSNNSFSGS----LPDGLKNCKQLQRLILARNKFS 178 (707)
Q Consensus 139 ~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 178 (707)
...+|+.|+|++|+++.. ++..+..+++|++|+|++|+|+
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 234688888888887632 3344555666666666666654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=4.4e-06 Score=81.06 Aligned_cols=129 Identities=15% Similarity=0.088 Sum_probs=85.7
Q ss_pred ecccCe-eEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCC--CceeeeEEEEEcCCcceEEEEeecCCChH
Q 005226 415 LGKSGL-GIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKH--PNIVKLRAYYWAPDEKLLISDFISNGNLA 491 (707)
Q Consensus 415 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 491 (707)
+..|.. +.||+....++..+++|....... ..+..|+..++.+.. -.+.+++++..+++..++||+|+++-++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 689999988888889998655432 346778888887743 33567788888888889999999876553
Q ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 005226 492 NALRGRNGQPSTSLSWSTRLRIAKGTARGLAYLHEC-------------------------------------------- 527 (707)
Q Consensus 492 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------------- 527 (707)
+.- .. ...++.++++.|.-||+.
T Consensus 95 ~~~----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 95 SSH----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TSC----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccc----------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 210 11 011222333333333321
Q ss_pred -------C----CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 528 -------S----PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 528 -------~----~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
. +..++|+|+.|.||+++++..+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 1237999999999999987777899999764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.55 E-value=4.4e-06 Score=75.49 Aligned_cols=42 Identities=19% Similarity=0.270 Sum_probs=18.5
Q ss_pred ccCCCCCceEEecCccCCC----CCCcccCCCCCccEEeccCCccc
Q 005226 113 LFNATSLHSIFLYGNNLSG----SLPPSVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 113 ~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 154 (707)
+...++|++|+|++|.|.. .+...+...+.|+.|+|++|.|+
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3344445555555555441 11122233344555555555544
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.45 E-value=3.5e-06 Score=76.16 Aligned_cols=86 Identities=16% Similarity=0.128 Sum_probs=65.1
Q ss_pred CcEEEEEcCCC-Ccccc----CCCCcCCCCCCCEEEcccCCcCC----CCCccccCCCCCceEEecCccCCCC----CCc
Q 005226 69 PRVVGVAISGK-NVRGY----IPSELGSLIYLRRLNLHNNNLFG----SLPDQLFNATSLHSIFLYGNNLSGS----LPP 135 (707)
Q Consensus 69 ~~v~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 135 (707)
++++.|+|+++ .+... +-..+...++|++|+|++|.|.. .+...+...+.|++|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 68999999975 46542 34457788899999999999973 2334556678999999999999832 223
Q ss_pred ccCCCCCccEEeccCCccc
Q 005226 136 SVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 136 ~~~~l~~L~~L~Ls~N~l~ 154 (707)
.+..-+.|++|+|++|++.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 4667788999999988765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00036 Score=71.72 Aligned_cols=74 Identities=11% Similarity=0.125 Sum_probs=47.3
Q ss_pred eecccCeeEEEEEEeCC-CceEEEEEcCCC----c---hhhHHHHHHHHHHHHhc-CC--CceeeeEEEEEcCCcceEEE
Q 005226 414 VLGKSGLGIVYKVVLGN-GIPVAVRRLGEG----G---EQRHREFVTEVQAIAKV-KH--PNIVKLRAYYWAPDEKLLIS 482 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l-~H--~niv~l~~~~~~~~~~~lV~ 482 (707)
.||.|....||++...+ +..++||.-... . .....+...|.+.|+.+ .+ ..+.+++.+ +++..++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEE
Confidence 58999999999998654 577888864321 1 11123455688888776 33 345556544 556778999
Q ss_pred EeecCCC
Q 005226 483 DFISNGN 489 (707)
Q Consensus 483 e~~~~gs 489 (707)
||+++..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.80 E-value=0.0015 Score=65.18 Aligned_cols=136 Identities=13% Similarity=0.085 Sum_probs=76.7
Q ss_pred eEEEEEEeCCCceEEEEEcCCCchhhHHHHHHHHHHHHhcCCCce--eeeE-----EEEEcCCcceEEEEeecCCChH--
Q 005226 421 GIVYKVVLGNGIPVAVRRLGEGGEQRHREFVTEVQAIAKVKHPNI--VKLR-----AYYWAPDEKLLISDFISNGNLA-- 491 (707)
Q Consensus 421 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL~-- 491 (707)
-.||++..++|..+++|..+..... .+++..|.+.+..|....+ +..+ ......+..+.|+++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s-~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT-ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC-HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC-HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999997654322 3667788888887742222 1111 1123345568899998763321
Q ss_pred ---H-------------HHhCCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHhh----cCCCCc
Q 005226 492 ---N-------------ALRGRNGQPSTSLSWST-------------------RLRIAKGTARGLAYLHE----CSPRKF 532 (707)
Q Consensus 492 ---~-------------~l~~~~~~~~~~l~~~~-------------------~~~i~~~ia~~L~yLH~----~~~~~i 532 (707)
. ............+++.. +..+...+...++.+.. ..+.++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 11111111111122211 11122222333333322 234679
Q ss_pred eecCCCCCCeEEcCCCCeEEecccccc
Q 005226 533 VHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 533 iHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
||+|+.+.|||++++ ..+.||+-+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ecCCCCcccEEEeCC--ceEEechhcc
Confidence 999999999999754 4689999765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.52 E-value=6.3e-05 Score=67.45 Aligned_cols=64 Identities=20% Similarity=0.186 Sum_probs=30.4
Q ss_pred CCCCCCEEEccc-CCcCCC----CCccccCCCCCceEEecCccCCCC----CCcccCCCCCccEEeccCCccc
Q 005226 91 SLIYLRRLNLHN-NNLFGS----LPDQLFNATSLHSIFLYGNNLSGS----LPPSVCNLPRLQNLDLSNNSFS 154 (707)
Q Consensus 91 ~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 154 (707)
+.+.|++|+|++ |.|+.. +-..+...++|++|+|++|.|+.. +-..+...+.|+.|++++|.+.
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 445556666654 334311 222233455566666666655421 1122334455666666665554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.48 E-value=3.5e-05 Score=69.20 Aligned_cols=86 Identities=19% Similarity=0.265 Sum_probs=61.8
Q ss_pred CcEEEEEcCC-CCcccc----CCCCcCCCCCCCEEEcccCCcCCC----CCccccCCCCCceEEecCccCCCC----CCc
Q 005226 69 PRVVGVAISG-KNVRGY----IPSELGSLIYLRRLNLHNNNLFGS----LPDQLFNATSLHSIFLYGNNLSGS----LPP 135 (707)
Q Consensus 69 ~~v~~L~L~~-n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 135 (707)
+.++.|+|++ +.++.. +...+...++|++|+|++|.++.. +-..+...++|+.|++++|.+... +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 6899999998 456432 345566889999999999998743 333456689999999999999732 234
Q ss_pred ccCCCCCccEEec--cCCccc
Q 005226 136 SVCNLPRLQNLDL--SNNSFS 154 (707)
Q Consensus 136 ~~~~l~~L~~L~L--s~N~l~ 154 (707)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5667788887555 455554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.25 E-value=0.0052 Score=62.77 Aligned_cols=71 Identities=14% Similarity=0.092 Sum_probs=46.8
Q ss_pred eecccCeeEEEEEEeCCC--------ceEEEEEcCCCchhhHHHHHHHHHHHHhc-CCCceeeeEEEEEcCCcceEEEEe
Q 005226 414 VLGKSGLGIVYKVVLGNG--------IPVAVRRLGEGGEQRHREFVTEVQAIAKV-KHPNIVKLRAYYWAPDEKLLISDF 484 (707)
Q Consensus 414 ~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~ 484 (707)
.|+.|-.=.+|++...++ ..|.+++.... ... ....+|..+++.+ .+.-..++++++. -.+|+||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETE-SHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCH-HHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chh-hHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 467777789999987543 44666665532 222 3446789998888 4443457777764 2689999
Q ss_pred ecCCCh
Q 005226 485 ISNGNL 490 (707)
Q Consensus 485 ~~~gsL 490 (707)
+++-++
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.73 E-value=0.029 Score=54.91 Aligned_cols=31 Identities=23% Similarity=0.352 Sum_probs=27.7
Q ss_pred CCCceecCCCCCCeEEcCCCCeEEecccccc
Q 005226 529 PRKFVHGDIKPSNILLDNDFQPYISDFGLSR 559 (707)
Q Consensus 529 ~~~iiHrDlk~~NIll~~~~~~kl~DfGla~ 559 (707)
+.++||+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999998777999999874
|